PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bosak, A; Ramic, A; Smidlehner, T; Hrenar, T; Primozic, I; Kovarik, Z				Bosak, Anita; Ramic, Alma; Smidlehner, Tamara; Hrenar, Tomica; Primozic, Ines; Kovarik, Zrinka			Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE INHIBITORS; HUMAN CHOLINESTERASES; ENANTIOMERS; RESOLUTION; BINDING; POTENT; ETHOPROPAZINE; DERIVATIVES; BAMBUTEROL	This paper describes the synthesis and anticholinesterase potency of Cinchona-based alkaloids; ten quaternary derivatives of cinchonines and their corresponding pseudo-enantiomeric cinchonidines. The quaternization of quinuclidine moiety of each compound was carried out with groups diverse in their size: methyl, benzyl and differently meta-and para-substituted benzyl groups. All of the prepared compounds reversibly inhibited human butyrylcholinesterase and acetylcholinesterase with K-i constants within nanomolar to micromolar range. Five cinchonidine derivatives displayed 95-510 times higher inhibition selectivity to butyrylcholinesterase over acetylcholinesterase and four were potent butyrylcholinesterase inhibitors with K-i constants up to 100 nM, of which N-para-bromobenzyl cinchonidinium bromide can be considered a lead for further modifications and optimizations for possible use in the treatment of neurodegenerative diseases.	[Bosak, Anita; Kovarik, Zrinka] Inst Med Res & Occupat Hlth, Ksaverska Cesta 2, Zagreb, Croatia; [Ramic, Alma; Smidlehner, Tamara; Hrenar, Tomica; Primozic, Ines] Univ Zagreb, Fac Sci, Horvatovac 102A, Zagreb, Croatia	Institute for Medical Research & Occupational Health (IMROH); University of Zagreb	Bosak, A (corresponding author), Inst Med Res & Occupat Hlth, Ksaverska Cesta 2, Zagreb, Croatia.; Primozic, I (corresponding author), Univ Zagreb, Fac Sci, Horvatovac 102A, Zagreb, Croatia.	abosak@imi.hr; ines.primozic@chem.pmf.hr	Smidlehner, Tamara/AAA-9006-2021	Smidlehner, Tamara/0000-0001-5097-9606; Hrenar, Tomica/0000-0002-4570-0524; Primozic, Ines/0000-0003-1154-4735	Croatian Science Foundation [IP-2016-06-3775 ADESIRE, IP-2013-11-4307 CHOLINESTERASE]	Croatian Science Foundation	This work was supported by the Croatian Science Foundation, Projects No: IP-2016-06-3775 ADESIRE (TH) and IP-2013-11-4307 CHOLINESTERASE (ZK), URL: https://www.hrzz.hr/	BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bosak A, 2005, CROAT CHEM ACTA, V78, P121; Bosak A, 2013, ARCH BIOCHEM BIOPHYS, V529, P140, DOI 10.1016/j.abb.2012.11.012; Bosak A, 2012, J MED CHEM, V55, P6716, DOI 10.1021/jm300289k; Eagleson M, 1994, CONCISE ENCY CHEM; Edwards A, 2014, TETRAHEDRON-ASYMMETR, V25, P1537, DOI 10.1016/j.tetasy.2014.10.017; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Frisch M.J, 2016, GAUSSIAN16 REVISON A; Galdeano C, 2018, MOLECULES, V23, DOI 10.3390/molecules23030634; Gazic I, 2006, ANAL BIOANAL CHEM, V385, P1513, DOI 10.1007/s00216-006-0566-3; Giacobini E., 2003, BUTYRYLCHOLINESTERAS, V1st; Giacobini E., 2006, BRAIN CHOLINERGIC SY, P235, DOI [10.1201/b14486-19, DOI 10.1201/B14486-19]; Greig NH, 2001, CURR MED RES OPIN, V17, P159; Gurung P., 2017, J PHARMACOGN PHOTOCH, V6, P162, DOI 10.22271/phyto; Hrenar T., 2017, QUANTUM CHEM CODE, P682; Hrenar T., 2017, PROGRAM MANIPULATION; Kamal MA, 2008, J NEURAL TRANSM, V115, P889, DOI 10.1007/s00702-008-0022-y; Karlsson D, 2014, NAT PROD COMMUN, V9, P455; Karlsson D, 2012, EUR J PHARM SCI, V47, P190, DOI 10.1016/j.ejps.2012.05.014; Katalinic M, 2017, MOLECULES, V22, DOI 10.3390/molecules22071234; Kosak U, 2016, SCI REP-UK, V6, DOI 10.1038/srep39495; Kovarik Z, 2003, BIOCHEM J, V373, P33, DOI 10.1042/BJ20021862; Kovarik Z, 2003, CROAT CHEM ACTA, V76, P63; Lan JS, 2017, EUR J MED CHEM, V133, P184, DOI 10.1016/j.ejmech.2017.02.045; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li Q, 2017, EUR J MED CHEM, V132, P294, DOI 10.1016/j.ejmech.2017.03.062; Lian MM, 2010, EUR J ORG CHEM, V2010, P6525, DOI 10.1002/ejoc.201001175; Lockridge O, 2016, CHEM RES TOXICOL, V29, P1381, DOI 10.1021/acs.chemrestox.6b00228; Marakovic N, 2016, CHEM-BIOL INTERACT, V259, P122, DOI 10.1016/j.cbi.2016.05.035; Mohammad D, 2017, EXPERT OPIN DRUG SAF, V16, P1009, DOI 10.1080/14740338.2017.1351540; Musilek K, 2011, EUR J MED CHEM, V46, P811, DOI 10.1016/j.ejmech.2010.12.011; Nawaz SA, 2011, BIOCHEM BIOPH RES CO, V404, P935, DOI 10.1016/j.bbrc.2010.12.084; Ng YP, 2015, NEUROCHEM INT, V89, P260, DOI 10.1016/j.neuint.2015.07.018; Ngamelue MN, 2007, ACTA CRYSTALLOGR F, V63, P723, DOI 10.1107/S1744309107037335; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Palm K, 1999, J PHARMACOL EXP THER, V291, P435; Primozic I, 2012, MOLECULES, V17, P786, DOI 10.3390/molecules17010786; Reiner E., 2000, CHOLINESTERASES CHOL, V3rd, P103; Savini L, 2001, BIOORG MED CHEM LETT, V11, P1779, DOI 10.1016/S0960-894X(01)00294-3; Saxena A, 2003, EUR J BIOCHEM, V270, P4447, DOI 10.1046/j.1432-1033.2003.03837.x; Simeon-Rudolf V, 2001, CROAT CHEM ACTA, V74, P173; Sinko G, 2011, BIOCHIMIE, V93, P1797, DOI 10.1016/j.biochi.2011.06.023; Song C. E., 2009, CINCHONA ALKALOIDS S, DOI DOI 10.1002/9783527628179; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tasker Andrea, 2005, Expert Rev Neurother, V5, P101, DOI 10.1586/14737175.5.1.101	46	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205193	10.1371/journal.pone.0205193	http://dx.doi.org/10.1371/journal.pone.0205193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289893	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500056
J	Fang, Y; Xu, PR; Yang, JL; Qin, YF				Fang, Yun; Xu, Peirong; Yang, Jialiang; Qin, Yufang			A quantile regression forest based method to predict drug response and assess prediction reliability	PLOS ONE			English	Article							CANCER; SENSITIVITY	Drug response prediction is a critical step for personalized treatment of cancer patients and ultimately leads to precision medicine. A lot of machine-learning based methods have been proposed to predict drug response from different types of genomic data. However, currently available methods could only give a "point" prediction of drug response value but fail to provide the reliability and distribution of the prediction, which are of equal interest in clinical practice. In this paper, we proposed a method based on quantile regression forest and applied it to the CCLE dataset. Through the out-of-bag validation, our method achieved much higher prediction accuracy of drug response than other available tools. The assessment of prediction reliability by prediction intervals and its significance in personalized medicine were illustrated by several examples. Functional analysis of selected drug response associated genes showed that the proposed method achieves more biologically plausible results.	[Fang, Yun; Xu, Peirong] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Yang, Jialiang] Hainan Normal Univ, Sch Math & Stat, Haikou, Hainan, Peoples R China; [Yang, Jialiang] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Qin, Yufang] Shanghai Ocean Univ, Coll Informat Technol, Shanghai, Peoples R China	Shanghai Normal University; Hainan Normal University; Icahn School of Medicine at Mount Sinai; Shanghai Ocean University	Yang, JL (corresponding author), Hainan Normal Univ, Sch Math & Stat, Haikou, Hainan, Peoples R China.; Yang, JL (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Qin, YF (corresponding author), Shanghai Ocean Univ, Coll Informat Technol, Shanghai, Peoples R China.	jialiang.yang@mssm.edu; yfqin@shou.edu.cn			National Natural Science Foundation of China [11201306, 61572327, 61702325, 11501099]; Innovation Program of Shanghai Municipal Education Commission [13YZ065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the National Natural Science Foundation of China (11201306 (YF), 61572327(XZ), 61702325(YQ) and 11501099 (PX)), the Innovation Program of Shanghai Municipal Education Commission (13YZ065(YF)).	Barnes ML, 2002, SSRN ELECT J; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120408; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geeleher P, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r47; Gobel G, 1900, CANCER GENOM PROTEOM, V10, P81; Gong ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110674; Hadley KE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-334; Hall P, 2009, J COMPUT GRAPH STAT, V18, P533, DOI 10.1198/jcgs.2009.08041; Hastie T., 2016, ELEMENTS STAT LEARNI; Haura EB, 2011, WIPO Patent Application, Patent No. [WO/2011/034919, 2011034919]; Hyvonen N., COMPUTATIONAL METHOD; James G., 2017, INTRO STAT LEARNING; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Levene H., 1960, CONTRIBUTIONS PROBAB, P279; Li GR, 2012, ANN STAT, V40, P1846, DOI 10.1214/12-AOS1024; Li RZ, 2012, J AM STAT ASSOC, V107, P1129, DOI 10.1080/01621459.2012.695654; Lipsitz SR, 1997, J R STAT SOC C-APPL, V46, P463, DOI 10.1111/1467-9876.00084; Liu JY, 2015, SCI CHINA MATH, V58, P2033, DOI 10.1007/s11425-015-5062-9; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Montenegro C, 2016, ESTUD ECONOMIA, V25, P71; Morlacchi P, 2014, FUTURE MED CHEM, V6, P1909, DOI 10.4155/fmc.14.120; Nowotarski J, 2015, COMPUTATION STAT, V30, P791, DOI 10.1007/s00180-014-0523-0; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Roth JV, 2009, J CLIN MONIT COMPUT, V23, P181, DOI 10.1007/s10877-009-9165-0; Sen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048770; Sharma PS, 2009, CURR PHARM DESIGN, V15, P758, DOI 10.2174/138161209787582219; Tsai IC, 2012, J INT FINANC MARK I, V22, P609, DOI 10.1016/j.intfin.2012.04.005; Wan Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101183; Wang L, 2012, J AM STAT ASSOC, V107, P518, DOI 10.1080/01621459.2012.665198; Wei W, 2013, J CLIN INVEST, V123, P4435, DOI 10.1172/JCI70625; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343	37	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205155	10.1371/journal.pone.0205155	http://dx.doi.org/10.1371/journal.pone.0205155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289891	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500052
J	Fruci, M; Poole, K				Fruci, Michael; Poole, Keith			Aminoglycoside-inducible expression of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: Involvement of the envelope stress-responsive AmgRS two-component system	PLOS ONE			English	Article							OXIDATION-SENSING MECHANISM; CYSTIC-FIBROSIS PATIENTS; MEXCD-OPRJ; ANTIBIOTIC-RESISTANCE; PROTEIN AGGREGATION; BIOFILM TOLERANCE; ESCHERICHIA-COLI; CROSS-RESISTANCE; PUMP EXPRESSION; REGULATOR MEXR	Exposure of P. aeruginosa to the aminoglycoside (AG) paromomycin (PAR) induced expression of the PA3720-armR locus and the mexAB-oprM multidrug efflux operon that AmgR controls, although PAR induction of mexAB-oprM was independent of armR. Multiple AGs promoted mexAB-oprM expression and this was lost in the absence of the amgRS locus encoding an aminoglycoside-activated envelope stress-responsive 2-component system (TCS). Purified AmgR bound to the mexAB-oprM promoter region consistent with this response regulator directly regulating expression of the efflux operon. The thiol-active reagent, diamide, which, like AGs, promotes protein aggregation and cytoplasmic membrane damage also promoted AmgRS-dependent mexAB-oprM expression, a clear indication that the MexAB-OprM efflux system is recruited in response to membrane perturbation and/or circumstances that lead to this. Despite the AG and diamide induction of mexAB-oprM, however, MexAB-OprM does not appear to contribute to resistance to these agents.	[Fruci, Michael; Poole, Keith] Queens Univ, Dept Biomed & Mol Sci, Botterell Hall, Kingston, ON, Canada	Queens University - Canada	Poole, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall, Kingston, ON, Canada.	poolek@queensu.ca			Canadian Institutes of Health Research [MOP - 102740]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research to KP (MOP - 102740; http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2013, J ANTIMICROB CHEMOTH, V68, pi31, DOI 10.1093/jac/dkt024; Adewoye L, 2002, J BACTERIOL, V184, P4308, DOI 10.1128/JB.184.15.4308-4312.2002; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Bordes P, 2011, J BACTERIOL, V193, P246, DOI 10.1128/JB.00884-10; Braz VS, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw166; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cao L, 2004, MOL MICROBIOL, V53, P1423, DOI 10.1111/j.1365-2958.2004.04210.x; Caughlan RE, 2012, ANTIMICROB AGENTS CH, V56, P17, DOI 10.1128/AAC.05417-11; Chalhoub H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40208; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen H, 2010, EMBO REP, V11, P685, DOI 10.1038/embor.2010.96; Chen WZ, 2016, MOL MICROBIOL, V100, P749, DOI 10.1111/mmi.13346; Choudhury D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149156; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Daigle DM, 2007, J BACTERIOL, V189, P5441, DOI 10.1128/JB.00543-07; Engman J, 2015, MOL MICROBIOL, V95, P51, DOI 10.1111/mmi.12842; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Evans K, 1998, J BACTERIOL, V180, P5443, DOI 10.1128/JB.180.20.5443-5447.1998; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; Ghosh S, 2011, MOL MICROBIOL, V79, P1547, DOI 10.1111/j.1365-2958.2011.07544.x; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Jalal S, 2000, ANTIMICROB AGENTS CH, V44, P710, DOI 10.1128/AAC.44.3.710-712.2000; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Jo JTH, 2003, ANTIMICROB AGENTS CH, V47, P1101, DOI 10.1128/AAC.47.3.1101-1111.2003; Jorth P, 2017, MBIO, V8, DOI 10.1128/mBio.00517-17; Ketelboeter LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178084; Khanam S, 2017, CELL CALCIUM, V61, P32, DOI 10.1016/j.ceca.2016.11.004; Krahn T, 2012, ANTIMICROB AGENTS CH, V56, P5591, DOI 10.1128/AAC.01446-12; Lamour V, 2002, J BIOL CHEM, V277, P18947, DOI 10.1074/jbc.M111740200; Lau CHF, 2015, MICROBIOLOGYOPEN, V4, P121, DOI 10.1002/mbo3.226; Lau CHF, 2013, ANTIMICROB AGENTS CH, V57, P2243, DOI 10.1128/AAC.00170-13; Lau CHF, 2012, ANTIMICROB AGENTS CH, V56, P5171, DOI 10.1128/AAC.00846-12; Lee S, 2009, P NATL ACAD SCI USA, V106, P14570, DOI 10.1073/pnas.0903619106; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; Li XZ, 2000, J ANTIMICROB CHEMOTH, V46, P885, DOI 10.1093/jac/46.6.885; Liao J, 2013, J BACTERIOL, V195, P3352, DOI 10.1128/JB.00318-13; Liao JL, 2012, J BACTERIOL, V194, P4823, DOI 10.1128/JB.00765-12; Ling JQ, 2012, MOL CELL, V48, P713, DOI 10.1016/j.molcel.2012.10.001; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Lopez-Causape C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00685; Maseda H, 2004, ANTIMICROB AGENTS CH, V48, P1320, DOI 10.1128/AAC.48.4.1320-1328.2004; MASUDA N, 1992, ANTIMICROB AGENTS CH, V36, P1847, DOI 10.1128/AAC.36.9.1847; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Morita Y, 2006, J BACTERIOL, V188, P1847, DOI 10.1128/JB.188.5.1847-1855.2006; Morita Y, 2006, J BACTERIOL, V188, P8649, DOI 10.1128/JB.01342-06; Muller A, 2013, J BACTERIOL, V195, P2807, DOI 10.1128/JB.00127-13; Nehme D, 2004, J BACTERIOL, V186, P2973, DOI 10.1128/JB.186.10.2973-2983.2004; Olivares J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00103; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Poole K, 2013, MICROBIAL EFFLUX PUMPS: CURRENT RESEARCH, P175; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Purssell A, 2013, MICROBIOL-SGM, V159, P2058, DOI 10.1099/mic.0.069286-0; Runde S, 2014, MOL MICROBIOL, V91, P1036, DOI 10.1111/mmi.12521; Saito K, 1999, FEMS MICROBIOL LETT, V179, P67, DOI 10.1016/S0378-1097(99)00394-8; Sambrook J., 2001, MOL CLONING LAB MANU; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sobel ML, 2005, ANTIMICROB AGENTS CH, V49, P1782, DOI 10.1128/AAC.49.5.1782-1786.2005; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Srikumar R, 1998, ANTIMICROB AGENTS CH, V42, P65, DOI 10.1128/AAC.42.1.65; Srikumar R, 2000, J BACTERIOL, V182, P1410, DOI 10.1128/JB.182.5.1410-1414.2000; Srikumar R., 1999, CLIN MICROBIOL INFEC, V5; Starr LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032684; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sugimura M, 2008, ANTIMICROB AGENTS CH, V52, P4141, DOI 10.1128/AAC.00511-08; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; Tian ZX, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005932; Vestergaard M, 2016, INT J ANTIMICROB AG, V47, P48, DOI 10.1016/j.ijantimicag.2015.09.014; WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0; Wieland K, 2018, AM J INFECT CONTROL, V46, P643, DOI 10.1016/j.ajic.2017.12.014; Wilson DN, 2011, ANN NY ACAD SCI, V1241, P1, DOI 10.1111/j.1749-6632.2011.06192.x; Zhao QX, 1998, ANTIMICROB AGENTS CH, V42, P1682, DOI 10.1128/AAC.42.7.1682; Ziha-Zarifi I, 1999, ANTIMICROB AGENTS CH, V43, P287, DOI 10.1128/AAC.43.2.287	74	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205036	10.1371/journal.pone.0205036	http://dx.doi.org/10.1371/journal.pone.0205036			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289929	gold, Green Submitted, Green Published			2022-12-27	WOS:000446545500040
J	Klimek, P; Jimenez, R; Hidalgo, M; Hinteregger, A; Thurner, S				Klimek, Peter; Jimenez, Raul; Hidalgo, Manuel; Hinteregger, Abraham; Thurner, Stefan			Forensic analysis of Turkish elections in 2017-2018	PLOS ONE			English	Article							FRAUD	With a majority of 'Yes' votes in the Constitutional Referendum of 2017, Turkey continued its drift towards an autocracy. By the will of the Turkish people, this referendum transferred practically all executive power to president Erdogan. However, the referendum was confronted with a substantial number of allegations of electoral misconducts and irregularities, ranging from state coercion of 'No' supporters to the controversial validity of unstamped ballots. Here we report the results of an election forensic analysis of recent Turkish elections to clarify to what extent it is plausible that these voting irregularities were present and able to influence the outcome of the referendum. We apply statistical forensics tests to identify the specific nature of the alleged electoral malpractices. In particular, we test whether the data contains fingerprints for ballot stuffing (submission of multiple ballots per person during the vote) and voter rigging (coercion and intimidation of voters). Additionally, we perform tests to identify numerical anomalies in the election results. For the 2017 Constitutional Referendum we find systematic and highly significant statistical support for the presence of both ballot stuffing and voter rigging. In 11% of stations we find signs for ballot stuffing with a standard deviation (uncertainty of ballot stuffing probability) of 2.7% (4 sigma event). Removing such ballot-stuffing-characteristic anomalies from the data would tip the overall balance from 'No' to a majority of 'Yes' votes. The 2017 election was followed by early elections in 2018 to directly vote for a new president who would now be head of state and government. We find statistical irregularities in the 2018 presidential and parliamentary elections similar in size and direction to those in 2017. These findings validate that our results unveil systematic and potentially even fraudulent biases that require further attention in order to combat electoral malpractices.	[Klimek, Peter; Hinteregger, Abraham; Thurner, Stefan] Med Univ Vienna, CeMSIIS, Sect Sci Complex Syst, Vienna, Austria; [Klimek, Peter; Thurner, Stefan] Complex Sci Hub Vienna, Vienna, Austria; [Jimenez, Raul] Univ Carlos III Madrid, Dept Stat, Madrid, Spain; [Hidalgo, Manuel] Univ Carlos III Madrid, Dept Social Sci, Madrid, Spain; [Thurner, Stefan] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA; [Thurner, Stefan] IIASA, Laxenburg, Austria	Medical University of Vienna; Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Klimek, P (corresponding author), Med Univ Vienna, CeMSIIS, Sect Sci Complex Syst, Vienna, Austria.; Klimek, P (corresponding author), Complex Sci Hub Vienna, Vienna, Austria.	Peter.Klimek@meduniwien.ac.at	Klimek, Peter/AAC-2723-2019; Jimenez, Raul/K-6438-2014	Klimek, Peter/0000-0003-1187-6713; Jimenez, Raul/0000-0002-8125-1586; HIDALGO, MANUEL/0000-0001-6352-2576	H2020 European Research Council [700621]	H2020 European Research Council	This work was supported by H2020 European Research Council (grant 700621 to Dr. Peter Klimek).	[Anonymous], 1996, MILLIYET; [Anonymous], 2017, THE OBSERVERS   0418; [Anonymous], 2018, STATEMENT PRELIMINAR; [Anonymous], 2018, THE GUARDIAN; [Anonymous], 2017, WALL STREET J; [Anonymous], 2014, IS SOMETHING ROTTEN; [Anonymous], 2018, HURRIYET DAILY NEWS; [Anonymous], 2018, AL JAZEERA; [Anonymous], 2017, NY TIMES; Beber B, 2012, POLIT ANAL, V20, P211, DOI 10.1093/pan/mps003; Cantu F, 2011, POLIT ANAL, V19, P409, DOI 10.1093/pan/mpr033; Cavus G, 2018, ELECTIONS2018 USER R; CRESSIE N, 1984, J ROY STAT SOC B MET, V46, P440; Deckert J, 2010, 9 CALTECH MIT VOT TE; Editorial Board, 2018, WASHINGTON POST; Esen B, 2016, THIRD WORLD Q, V37, P1581, DOI 10.1080/01436597.2015.1135732; Ferrari D, 2018, 2018 ANN M MODW POL; Hausmann R, 2011, STAT SCI, V26, P543, DOI 10.1214/11-STS373; International Referendum Observation Mission, 2017, REPUBLIC TURKEY CONS; Jimenez R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602363; Jimenez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100884; Jimenez R, 2011, STAT SCI, V26, P564, DOI 10.1214/11-STS375; Kemahlioglu O, 2015, S EUR SOC POLIT, V20, P445, DOI 10.1080/13608746.2015.1115581; Kirisci K, 2018, NATL INTEREST; Klimek P, 2012, P NATL ACAD SCI USA, V109, P16469, DOI 10.1073/pnas.1210722109; KONDA, 2017, ANAL APRIL 16 REFERE; Levin I, 2009, EVT WOTE 09 P 2009 C; Mebane W, 2016, 2016 ANN M MODW POL; Mebane Walter., 2008, ELECTION FRAUD DETEC, P162; Montgomery JM, 2015, POLIT ANAL, V23, P488, DOI 10.1093/pan/mpv023; Myakgov M, 2009, FORENSICS ELECTION F; Pericchi L, 2011, STAT SCI, V26, P502, DOI 10.1214/09-STS296; Prado R, 2011, STAT SCI, V26, P517, DOI 10.1214/09-STS295; Rozenas A, 2017, POLIT ANAL, V25, P41, DOI 10.1017/pan.2016.9	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204975	10.1371/journal.pone.0204975	http://dx.doi.org/10.1371/journal.pone.0204975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289899	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000446545500034
J	Choi, CH; Park, SY; Park, JM; Wu, HG; Kim, JH; Kim, JI				Choi, Chang Heon; Park, So-Yeon; Park, Jong Min; Wu, Hong-Gyun; Kim, Jin-Ho; Kim, Jung-in			Comparison of the IPSA and HIPO algorithms for interstitial tongue high-dose-rate brachytherapy	PLOS ONE			English	Article							RATE PROSTATE BRACHYTHERAPY; OPTIMIZATION ALGORITHMS; AMERICAN BRACHYTHERAPY; HDR BRACHYTHERAPY; CANCER; RADIOTHERAPY; PERFORMANCE	Purpose This study aimed to compare the inverse planning simulated annealing (IPSA) stochastic algorithm with the hybrid inverse planning and optimization (HIPO) algorithm for interstitial tongue high-dose-rate (HDR) brachytherapy. Methods Twenty patients who received radiotherapy for tongue cancer using interstitial HDR brachy-therapy were retrospectively selected for this study. Oncentra Brachy v. 4.3 was used for IPSA and HIPO planning. Four to eight fixed catheter configurations were determined according to the target shape. During the optimization process, predetermined constrain values were used for each IPSA and HIPO plan. The dosimetric parameters and dwell time were analyzed to evaluate the performances of the plans. Results The total dwell time using IPSA was 4 seconds longer than that of HIPO. The number of active positions per catheter for the IPSA plans were approximately 2.5 fewer than those of the HIPO plans. The dose-volumetric parameters related to the clinical target volume with IPSA were lower than those with HIPO. In terms of the dose-volumetric parameters related to normal tissue, HIPO tended to associate with slightly higher values than IPSA, without statistical significance. After GrO, the target coverages were satisfied to clinical goal for all patients. The total dwell times was approximately increased by 10%. Conclusions The IPSA and HIPO dose optimization algorithms generate similar dosimetric results. In terms of the dwell time, HIPO appears to be more beneficial.	[Choi, Chang Heon; Park, So-Yeon; Park, Jong Min; Wu, Hong-Gyun; Kim, Jin-Ho; Kim, Jung-in] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Choi, Chang Heon; Park, So-Yeon; Park, Jong Min; Wu, Hong-Gyun; Kim, Jin-Ho; Kim, Jung-in] Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea; [Choi, Chang Heon; Park, So-Yeon; Park, Jong Min; Wu, Hong-Gyun; Kim, Jin-Ho; Kim, Jung-in] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Ctr Convergence Res Robot, Suwon, South Korea; [Wu, Hong-Gyun] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JH; Kim, JI (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Kim, JH; Kim, JI (corresponding author), Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea.; Kim, JH; Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	jinho.kim.md@gmail.com; madangin@gmail.com		Kim, Jung-in/0000-0002-0305-5969	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1631200]; National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2017R1C1B1006636]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (No. 1631200) to JK and by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2017R1C1B1006636) to CHC.	Balvert M, 2015, PHYS MED BIOL, V60, P537, DOI 10.1088/0031-9155/60/2/537; Bansal A, 2016, J CONTEMP BRACHYTHER, V8, P56, DOI 10.5114/jcb.2016.58082; Choi Chang Heon, 2017, [PROGRESS in MEDICAL PHYSICS, 의학물리], V28, P39, DOI 10.14316/pmp.2017.28.2.39; Choi CH, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160652; Dinkla AM, 2015, BRACHYTHERAPY, V14, P279, DOI 10.1016/j.brachy.2014.09.006; Erickson BA, 2017, BRACHYTHERAPY, V16, P75, DOI 10.1016/j.brachy.2016.05.006; Farrus B, 1996, RADIOTHER ONCOL, V38, P145, DOI 10.1016/0167-8140(95)01685-6; FRIEDRICH RE, 1995, J CRANIO MAXILL SURG, V23, P238, DOI 10.1016/S1010-5182(05)80214-8; Hsu I-Chow J, 2004, Brachytherapy, V3, P147, DOI 10.1016/j.brachy.2004.05.007; Inoue T, 2001, INT J RADIAT ONCOL, V51, P171, DOI 10.1016/S0360-3016(01)01561-9; Jacob D, 2008, INT J RADIAT ONCOL, V72, P820, DOI 10.1016/j.ijrobp.2008.02.009; Jamema SV, 2011, BRACHYTHERAPY, V10, P306, DOI 10.1016/j.brachy.2010.08.011; Katimoto N, 2003, RADIOTHER ONCOL, V68, P123, DOI 10.1016/S0167-8140(03)00055-0; Leung TW, 2002, HEAD NECK-J SCI SPEC, V24, P274, DOI 10.1002/hed.10021; Mavroidis Panayiotis, 2010, J Contemp Brachytherapy, V2, P117; Morton GC, 2008, BRACHYTHERAPY, V7, P12, DOI 10.1016/j.brachy.2007.10.001; Panettieri V, 2014, J APPL CLIN MED PHYS, V15, P256, DOI 10.1120/jacmp.v15i6.5055; Peppa V, 2017, PHYS MED; Poder J, 2016, J CONTEMP BRACHYTHER, V8, P203, DOI 10.5114/jcb.2016.60499; Pokharel S, 2013, J APPL CLIN MED PHYS, V14, P96, DOI 10.1120/jacmp.v14i4.4198; Poulin E, 2016, BRACHYTHERAPY, V15, P102, DOI 10.1016/j.brachy.2015.09.010; Pouliot J, 2004, INT J RADIAT ONCOL, V59, P1196, DOI 10.1016/j.ijrobp.2004.02.055; Takacsi-Nagy Z, 2017, BRACHYTHERAPY, V16, P44, DOI 10.1016/j.brachy.2016.07.005; Trnkova Petra, 2010, J Contemp Brachytherapy, V2, P163; Trnkova P, 2009, RADIOTHER ONCOL, V93, P331, DOI 10.1016/j.radonc.2009.10.004; Umeda M, 2000, ORAL SURG ORAL MED O, V90, P667, DOI 10.1067/moe.2000.110087; Vargo JA, 2014, WORLD J CLIN ONCOL, V5, P921, DOI 10.5306/wjco.v5.i5.921; Yamazaki H, 2004, INT J RADIAT ONCOL, V58, P139, DOI 10.1016/S0360-3016(03)01459-7; Yamazaki H, 2013, J RADIAT RES, V54, P1, DOI 10.1093/jrr/rrs103; Yoshida K, 2017, J CONTEMP BRACHYTHER, V9, P66, DOI 10.5114/jcb.2017.65163	30	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205229	10.1371/journal.pone.0205229	http://dx.doi.org/10.1371/journal.pone.0205229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286187	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500100
J	Diem, AK; Carare, RO; Weller, RO; Bressloff, NW				Diem, Alexandra K.; Carare, Roxana O.; Weller, Roy O.; Bressloff, Neil W.			A control mechanism for intra-mural peri-arterial drainage via astrocytes: How neuronal activity could improve waste clearance from the brain	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; ALZHEIMERS-DISEASE; PERIVASCULAR DRAINAGE; LIFE-STYLE; DEMENTIA; MODEL; DYSFUNCTION; EXERCISE; SOLUTES; FLUID	The mechanisms behind the clearance of soluble waste from deep within the parenchyma of the brain remain unclear. Experimental evidence reveals that one pathway for clearance of waste, termed intra-mural peri-arterial drainage (IPAD), is the rapid drainage of interstitial fluid along basement membranes (BM) of the smooth muscle cells of cerebral arteries; failure of IPAD is closely associated with the pathology of Alzheimer's disease (AD), but its driving mechanism remains unclear. We have previously shown that arterial pulsations generated by the heart beat are not strong enough to drive IPAD. Here we present computational evidence for a mechanism for clearance of waste from the brain that is driven by functional hyperaemia, that is, the dilatation of cerebral arterioles as a consequence of increased nutrient demand from neurons. This mechanism is based on our model for the flow of fluid through the vascular BM. It accounts for clearance rates observed in mouse experiments, and aligns with pathological observations and recommendations to lower the individual risk of AD, such as mental and physical activity. Thus, our neurovascular hypothesis should act as the new working hypothesis for the driving force behind IPAD.	[Diem, Alexandra K.] Simula Res Lab, Dept Computat Physiol, N-1364 Fornebu, Norway; [Diem, Alexandra K.; Bressloff, Neil W.] Univ Southampton, Fac Engn & Environm, Computat Engn & Design, Southampton Boldrewood Innovat Campus, Southampton SO16 7QF, Hants, England; [Carare, Roxana O.] Univ Southampton, Southampton Gen Hosp, Fac Med, Clin Neurosci, Southampton SO16 6YD, Hants, England; [Weller, Roy O.] Southampton Gen Hosp, Neuropathol, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton	Diem, AK (corresponding author), Simula Res Lab, Dept Computat Physiol, N-1364 Fornebu, Norway.; Diem, AK (corresponding author), Univ Southampton, Fac Engn & Environm, Computat Engn & Design, Southampton Boldrewood Innovat Campus, Southampton SO16 7QF, Hants, England.	alexandra@simula.no		Diem, Alexandra K./0000-0003-1719-1942	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/N509747/1]	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by the UK Engineering and Physical Sciences Research Council (EPSRC) grant number EP/N509747/1 (AKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Albargothy NJ, 2018, ACTA NEUROPATHOL, V136, P139, DOI 10.1007/s00401-018-1862-7; Alnaes MS, 2015, ARCH NUMBERICAL SOFT, V3; Alzheimer's Society, 2016, FACTSH RISK FACT DEM; Arbel-Ornath M, 2013, ACTA NEUROPATHOL, V126, P353, DOI 10.1007/s00401-013-1145-2; Asgari M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15024; BLACK JA, 1985, NEUROSCI LETT, V55, P371, DOI 10.1016/0304-3940(85)90464-1; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Diem AK, 2017, RESCIENCE, V3, P11; Diem AK, 2016, THESIS; Diem AK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00475; Farr H, 2011, J THEOR BIOL, V286, P13, DOI 10.1016/j.jtbi.2011.07.006; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Haglund MM, 2014, J NEUROSURG, V4, P654; Hannocks MJ, 2018, J CEREBR BLOOD F MET, V38, P669, DOI 10.1177/0271678X17749689; Hawkes CA, 2014, BRAIN PATHOL, V24, P396, DOI 10.1111/bpa.12159; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heppell C, 2015, B MATH BIOL, V77, P1101, DOI 10.1007/s11538-015-0078-4; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Horsburgh K, 2018, CLIN SCI, V132, P851, DOI 10.1042/CS20171620; Kotliar K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13349-5; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Morris AWJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00251; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Ostergaard L, 2013, NEUROBIOL AGING, V34, P1018, DOI 10.1016/j.neurobiolaging.2012.09.011; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schley D, 2006, J THEOR BIOL, V238, P962, DOI 10.1016/j.jtbi.2005.07.005; Sharp MK, 2016, ANN BIOMED ENG, V44, P1553, DOI 10.1007/s10439-015-1457-6; Smith JC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00061; Weller RO, 2018, ACTA NEUROPATHOL, V135, P363, DOI 10.1007/s00401-018-1809-z; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Witthoft A, 2012, J THEOR BIOL, V311, P80, DOI 10.1016/j.jtbi.2012.07.014; Woodard JL, 2012, CURR ALZHEIMER RES, V9, P436, DOI 10.2174/156720512800492477; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205276	10.1371/journal.pone.0205276	http://dx.doi.org/10.1371/journal.pone.0205276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286191	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000446383500104
J	Mahrholz, G; Belin, P; McAleer, P				Mahrholz, Gaby; Belin, Pascal; McAleer, Phil			Judgements of a speaker's personality are correlated across differing content and stimulus type	PLOS ONE			English	Article							PREDICTS INDIVIDUAL-DIFFERENCES; 1ST IMPRESSIONS; VOICE PITCH; VOCAL ATTRACTIVENESS; JUDGING PERSONALITY; WOMENS PREFERENCES; PHYSICAL STRENGTH; ZERO ACQUAINTANCE; SOCIAL JUDGMENTS; TRAIT INFERENCES	It has previously been shown that first impressions of a speaker's personality, whether accurate or not, can be judged from short utterances of vowels and greetings, as well as from prolonged sentences and readings of complex paragraphs. From these studies, it is established that listeners' judgements are highly consistent with one another, suggesting that different people judge personality traits in a similar fashion, with three key personality traits being related to measures of valence (associated with trustworthiness), dominance, and attractiveness. Yet, particularly in voice perception, limited research has established the reliability of such personality judgements across stimulus types of varying lengths. Here we investigate whether first impressions of trustworthiness, dominance, and attractiveness of novel speakers are related when a judgement is made on hearing both one word and one sentence from the same speaker. Secondly, we test whether what is said, thus adjusting content, influences the stability of personality ratings. 60 Scottish voices (30 females) were recorded reading two texts: one of ambiguous content and one with socially-relevant content. One word (similar to 500 ms) and one sentence (similar to 3000 ms) were extracted from each recording for each speaker. 181 participants (138 females) rated either male or female voices across both content conditions (ambiguous, socially-relevant) and both stimulus types (word, sentence) for one of the three personality traits (trustworthiness, dominance, attractiveness). Pearson correlations showed personality ratings between words and sentences were strongly correlated, with no significant influence of content. In short, when establishing an impression of a novel speaker, judgments of three key personality traits are highly related whether you hear one word or one sentence, irrespective of what they are saying. This finding is consistent with initial personality judgments serving as elucidators of approach or avoidance behaviour, without modulation by time or content. All data and sounds are available on OSF (osf.io/s3cxy).	[Mahrholz, Gaby; McAleer, Phil] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland; [Belin, Pascal] CNRS, UMR 7289, Inst Neurosci Timone, Marseille, France; [Belin, Pascal] Univ Aix Marseille, Marseille, France	University of Glasgow; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Mahrholz, G; McAleer, P (corresponding author), Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland.	g.mahrholz.1@research.gla.ac.uk; philip.mcaleer@glasgow.ac.uk	; McAleer, Phil/A-8178-2011	Mahrholz, Gaby/0000-0002-2135-6888; McAleer, Phil/0000-0002-4523-2097	1+3 Economic and Social Research Council (ESRC) award from the Scottish Graduate School of Social Science (SGSSS)	1+3 Economic and Social Research Council (ESRC) award from the Scottish Graduate School of Social Science (SGSSS)	Gaby Mahrholz is a recipient of a 1+3 Economic and Social Research Council (ESRC) award from the Scottish Graduate School of Social Science (SGSSS).	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; ALBRIGHT L, 1988, J PERS SOC PSYCHOL, V55, P387, DOI 10.1037/0022-3514.55.3.387; Allport GW, 1934, J SOC PSYCHOL, V5, P37, DOI 10.1080/00224545.1934.9921582; Ames DR, 2010, PERS SOC PSYCHOL B, V36, P264, DOI 10.1177/0146167209354519; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; ARONOVITCH CD, 1976, J SOC PSYCHOL, V99, P207, DOI 10.1080/00224545.1976.9924774; Bar M, 2006, EMOTION, V6, P269, DOI 10.1037/1528-3542.6.2.269; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; BERRY DS, 1990, J NONVERBAL BEHAV, V14, P141, DOI 10.1007/BF00996223; Biesanz JC, 2011, SOC PSYCHOL PERS SCI, V2, P452, DOI 10.1177/1948550610397211; BORKENAU P, 1993, J PERS, V61, P477, DOI 10.1111/j.1467-6494.1993.tb00779.x; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Carney DR, 2007, J RES PERS, V41, P1054, DOI 10.1016/j.jrp.2007.01.004; Cowan ML, 2016, EVOL HUM BEHAV, V37, P97, DOI 10.1016/j.evolhumbehav.2015.09.002; Dickinson ER, 2012, ARCH SEX BEHAV, V41, P325, DOI 10.1007/s10508-011-9887-1; Dunbar NE, 2005, J SOC PERS RELAT, V22, P207, DOI 10.1177/0265407505050944; Ekstrom C., 2020, PWR BASIC FUNCTIONS; Fairbanks G., 1960, VOICE ARTICULATION D, V2; Ferdenzi C, 2013, BEHAV RES METHODS, V45, P405, DOI 10.3758/s13428-012-0275-0; Fischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024490; Funder DC, 2012, CURR DIR PSYCHOL SCI, V21, P177, DOI 10.1177/0963721412445309; Gorn GJ, 2008, J CONSUM RES, V35, P36, DOI 10.1086/529533; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Herzog H, 1933, Z PSYCHOL PHYSIOL SI, V130, P300; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hughes SM, 2010, J SOC EVOL CULT PSYC, V4, P290, DOI DOI 10.1037/H0099282; Hughes SM, 2008, J NONVERBAL BEHAV, V32, P93, DOI 10.1007/s10919-007-0042-6; Hughes SM, 2013, PERCEPTION, V42, P941, DOI 10.1068/p7526; Imhof M., 2010, INT J LISTENING, V24, P19, DOI [10.1080/10904010903466295, DOI 10.1080/10904010903466295]; Jack RE, 2018, TRENDS COGN SCI, V22, P1, DOI 10.1016/j.tics.2017.10.002; Jiang XM, 2015, CORTEX, V66, P9, DOI 10.1016/j.cortex.2015.02.002; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kahneman D., 2011, THINKING FAST SLOW; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; KENNY DA, 1992, J PERS SOC PSYCHOL, V62, P88, DOI 10.1037/0022-3514.62.1.88; Klofstad CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133779; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Knight S, 2018, P NATL ACAD SCI USA, V115, pE6103, DOI 10.1073/pnas.1806345115; KRAMER E, 1970, J PERS ASSESS, V34, P426, DOI 10.1080/0091651X.1970.10380278; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Krauss RM, 2002, J EXP SOC PSYCHOL, V38, P618, DOI 10.1016/S0022-1031(02)00510-3; Lander K, 2008, ANIM BEHAV, V75, P817, DOI 10.1016/j.anbehav.2007.07.001; Latinus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041384; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Lavan N, 2018, BREAKING VOICE IDENT; Lavan N, 2019, PSYCHON B REV, V26, P90, DOI 10.3758/s13423-018-1497-7; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; McAleer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090779; Mehl MR, 2006, J PERS SOC PSYCHOL, V90, P862, DOI 10.1037/0022-3514.90.5.862; Mileva M, 2017, J EXPT PSYCHOL HUMAN; MONTEPARE JM, 1987, J EXP SOC PSYCHOL, V23, P331, DOI 10.1016/0022-1031(87)90045-X; Moyse E, 2014, EUR J AGEING, V11, P241, DOI 10.1007/s10433-014-0305-0; Nesse RM, 2005, EVOL HUM BEHAV, V26, P88, DOI 10.1016/j.evolhumbehav.2004.08.002; O'Connor JJM, 2017, EVOL HUM BEHAV, V38, P506, DOI 10.1016/j.evolhumbehav.2017.03.001; O'Connor JJM, 2014, EVOL HUM BEHAV, V35, P368, DOI 10.1016/j.evolhumbehav.2014.05.001; O'Connor JJM, 2018, BRIT J PSYCHOL; Olivola CY, 2010, J NONVERBAL BEHAV, V34, P83, DOI 10.1007/s10919-009-0082-1; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; PASSINI FT, 1966, J PERS SOC PSYCHOL, V4, P44, DOI 10.1037/h0023519; Pear T. H., 1931, VOICE PERSONALITY; Pisanski K, 2016, ANIM BEHAV, V112, P13, DOI 10.1016/j.anbehav.2015.11.008; Pisanski K, 2014, ANIM BEHAV, V95, P89, DOI 10.1016/j.anbehav.2014.06.011; Ponsot E, 2018, P NATL ACAD SCI USA, V115, pE6104, DOI 10.1073/pnas.1806857115; Ponsot E, 2018, P NATL ACAD SCI USA, V115, P3972, DOI 10.1073/pnas.1716090115; Puts DA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2830; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Rendall D, 2007, J EXP PSYCHOL HUMAN, V33, P1208, DOI 10.1037/0096-1523.33.5.1208; Rezlescu C, 2015, J NONVERBAL BEHAV, V39, P355, DOI 10.1007/s10919-015-0214-8; Rule NO, 2011, PERS SOC PSYCHOL B, V37, P1499, DOI 10.1177/0146167211415630; Satchell L., 2018, PHOTOGRAPH FACE TO F; SCHERER KR, 1972, J PERS, V40, P191, DOI 10.1111/j.1467-6494.1972.tb00998.x; Schroeder J, 2015, PSYCHOL SCI, V26, P877, DOI 10.1177/0956797615572906; Scott SK, 2014, TRENDS COGN SCI, V18, P618, DOI 10.1016/j.tics.2014.09.002; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Simons DJ, 2017, PERSPECT PSYCHOL SCI, V12, P1123, DOI 10.1177/1745691617708630; STARKWEATHER JA, 1956, J ABNORM SOC PSYCH, V52, P394, DOI 10.1037/h0041133; Sutherland CAM, 2017, BRIT J PSYCHOL, V108, P397, DOI 10.1111/bjop.12206; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Tomlinson JM, 2011, COGNITION, V119, P58, DOI 10.1016/j.cognition.2010.12.005; Toscano H, 2016, PERS SOC PSYCHOL B, V42, P1603, DOI 10.1177/0146167216666266; Toscano H, 2014, EVOL PSYCHOL-US, V12, P1; Tsantani MS, 2016, PERCEPTION, V45, P946, DOI 10.1177/0301006616643675; Tyler JC, 2015, J ENGL LINGUIST, V43, P284, DOI 10.1177/0075424215607061; Vernon RJW, 2014, P NATL ACAD SCI USA, V111, pE3353, DOI 10.1073/pnas.1409860111; Vukovic J, 2008, PERS INDIV DIFFER, V45, P451, DOI 10.1016/j.paid.2008.05.013; Vukovic J, 2011, BRIT J PSYCHOL, V102, P37, DOI 10.1348/000712610X498750; Wang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161114; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Willis ML, 2011, SOC COGNITION, V29, P415, DOI 10.1521/soco.2011.29.4.415; Wood TJ, 2014, ADV HEALTH SCI EDUC, V19, P409, DOI 10.1007/s10459-013-9453-9; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004; Zacks JM, 2007, CURR DIR PSYCHOL SCI, V16, P80, DOI 10.1111/j.1467-8721.2007.00480.x; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x; Zebrowitz LA, 2014, EXP AGING RES, V40, P375, DOI 10.1080/0361073X.2014.897151; Zebrowitz LA, 2013, PSYCHOL AGING, V28, P202, DOI 10.1037/a0030927; ZUCKERMAN M, 1989, J NONVERBAL BEHAV, V13, P67	109	16	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204991	10.1371/journal.pone.0204991	http://dx.doi.org/10.1371/journal.pone.0204991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286148	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000446383500071
J	Nagamani, S; Muthusamy, K				Nagamani, Selvaraman; Muthusamy, Karthikeyan			A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis	PLOS ONE			English	Article							GROWTH-FACTOR 23; D-RECEPTOR ACTIVATION; HOMOLOGY MODEL; A-RING; VITAMIN; ANALOGS; DOCKING; BINDING; CYP24A1; CYTOCHROME-P450	The level of the vitamin D in the bloodstream is regulated by cytochrome P450 enzyme 24-hydroxylase A1 (CYP24A1). Over expression of CYP24A1 enzyme is correlated with vitamin D deficiency and resistance to vitamin D therapy. Chronic kidney disease (CKD) patients are commonly reported with the above said expression variations. This deregulation could be solved by ligands that act as a vitamin D receptor (VDR) agonists and CYP24A1 antagonists. Posner et al., (2010) first time reported two new vitamin D analogues namely CTA-091 and CTA-018 to inhibit CYP24A1. The CTA-018 inhibited CYP24A1 with an IC50 27 +/- 6 nM (10 times more potent than the ketoconazole (253 +/- 20 nM)). CTA-018 induced VDR expression (15-fold lower than 1 alpha,25(OH)(2)D-3) and is under phase II clinical trial, whereas CTA-091 was not able to efficiently induce the VDR expression (>2000 nM). To explore the molecular mechanism, binding specificity of these two vitamin D analogues along with native ligand was extensively studied through in silico approaches. Through molecular dynamics simulations studies, we shown that the sulfonic group (0 = S = 0) in the side chain of CTA-018 plays an important role in the regulation of VDR agonistic activity. The electron lone pairs of the sulfonic group that interacted with His393 lead to be a factor for agonistic mechanism of VDR activity. Compared to azol-based compounds, CTA-018 binds the different sites in the CYP24A1 binding cavity and thus it could be a potent antagonistic for CYP24A1enzyme.	[Nagamani, Selvaraman; Muthusamy, Karthikeyan] Alagappa Univ, Dept Bioinformat, Karaikkudi, Tamil Nadu, India	Alagappa University	Muthusamy, K (corresponding author), Alagappa Univ, Dept Bioinformat, Karaikkudi, Tamil Nadu, India.	mkbioinformatics@gmail.com		Muthusamy, Karthikeyan/0000-0001-7755-3381	Indian Council of Medical Research (ICMR), Govt. of. India Senior Research Fellowship [BIC/11(09)/14]	Indian Council of Medical Research (ICMR), Govt. of. India Senior Research Fellowship	Authors gratefully acknowledge financial support provided by Indian Council of Medical Research (ICMR), Govt. of. India Senior Research Fellowship to S. Nagamani (F. No.: BIC/11(09)/14).	Alam A, 2009, J COMPUT AID MOL DES, V23, P209, DOI 10.1007/s10822-008-9252-1; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1996, J BIOMOL STRUCT DYN, V13, P615, DOI 10.1080/07391102.1996.10508874; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; [Anonymous], 2015, PRIM VERS 3 9; [Anonymous], 2015, LIGPREP VERS 2 8; [Anonymous], 2013, JAG VERS 8 2; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; Belorusova AY, 2014, J MED CHEM, V57, P4710, DOI 10.1021/jm5002524; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; BOUILLON R, 1993, J BONE MINER RES, V8, P1009; Cozzolino M, 2010, HIPPOKRATIA, V14, P7; Damasiewicz MJ, 2011, NEPHROLOGY, V16, P261, DOI 10.1111/j.1440-1797.2011.01443.x; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Das D, 2009, J CHEM INF MODEL, V49, P2851, DOI 10.1021/ci900320p; Gomaa MS, 2007, J STEROID BIOCHEM, V104, P53, DOI 10.1016/j.jsbmb.2006.09.041; Goodman WG, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1002; Jones G, 2013, ANNU REV NUTR, V33, P23, DOI 10.1146/annurev-nutr-071812-161203; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kakuda S, 2010, ACTA CRYSTALLOGR D, V66, P918, DOI 10.1107/S0907444910020810; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Loh ZY, 2012, CLIN KIDNEY J, V5, P303, DOI 10.1093/ckj/sfs074; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Masuda S, 2007, ARCH BIOCHEM BIOPHYS, V460, P177, DOI 10.1016/j.abb.2006.11.030; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; OKAMURA WH, 1989, J ORG CHEM, V54, P4072, DOI 10.1021/jo00278a018; OSTREM VK, 1987, J BIOL CHEM, V262, P14164; Perlstein J., 2001, INT UNION CRYSTALLOG, V123, P191, DOI [DOI 10.1021/JA0047368, 10.1021/ja0047368]; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Petkovich M, 2011, CURR OPIN NEPHROL HY, V20, P337, DOI 10.1097/MNH.0b013e3283477a7b; Posner GH, 2010, J STEROID BIOCHEM, V121, P13, DOI 10.1016/j.jsbmb.2010.03.065; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shen XL, 2012, J MOL MODEL, V18, P203, DOI 10.1007/s00894-011-1066-8; Sicinski RR, 2007, J MED CHEM, V50, P6154, DOI 10.1021/jm070635+; Singh KD, 2011, J MOL GRAPH MODEL, V30, P186, DOI 10.1016/j.jmgm.2011.07.004; Singh KD, 2013, ACTA PHARMACOL SIN, V34, P1592, DOI 10.1038/aps.2013.129; TEETER MM, 1990, J PHYS CHEM-US, V94, P8091, DOI 10.1021/j100384a021; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wan M, 2013, NEPHROL DIAL TRANSPL, V28, P153, DOI 10.1093/ndt/gfs411; Yamamoto K, 2000, P NATL ACAD SCI USA, V97, P1467, DOI 10.1073/pnas.020522697	42	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203194	10.1371/journal.pone.0203194	http://dx.doi.org/10.1371/journal.pone.0203194			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286109	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500006
J	Oliveira, KM; Binda, NS; Lavor, MSL; Silva, CMO; Rosado, IR; Gabellini, ELA; Da Silva, JF; Oliveira, CM; Melo, MM; Gomez, MV; Melo, EG				Oliveira, Karen M.; Binda, Nancy S.; Lavor, Mario Sergio L.; Silva, Carla M. O.; Rosado, Isabel R.; Gabellini, Endrigo L. A.; Da Silva, Juliana F.; Oliveira, Camila M.; Melo, Marilia M.; Gomez, Marcus Vinicius; Melo, Eliane G.			Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats	PLOS ONE			English	Article							CALCIUM-CHANNEL ANTAGONIST; TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; N-TYPE; OXIDATIVE STRESS; NITRIC-OXIDE; MITOCHONDRIAL DYSFUNCTION; OMEGA-CONOTOXIN; INTRATHECAL ZICONOTIDE; BLOCKER ZICONOTIDE	This study evaluates whether intrathecal MVIIA injection after spinal cord injury (SCI) elicits neuroprotective effects. The test rats were randomly distributed into six groups- sham, placebo, MVIIA 2.5 mu M, MVIIA 5 mu M, MVIIA 10 mu M, and MVIIA 20 mu M-and were administered the treatment four hours after SCI. After the optimal MVIIA dose (MVIIA 10 mu M) was defined, the best time for application, one or four hours, was analyzed. Locomotor hind limb function and side effects were assessed. Forty-eight hours after the injury and immediately after euthanasia, spinal cord segments were removed from the test rats. Cell viability, reactive oxygen species, lipid peroxidation, and glutamate release were investigated. To examine the MVIIA mechanism of action, the gene expressions of pro-apoptotic (Bax, nNOS, and caspase-3, -8, -9, -12) and anti-apoptotic (Bcl-xl) factors in the spinal cord tissue samples were determined by real-time PCR, and the activities of antioxidant enzymes were also investigated. Application of intrathecal MVIIA 10 mu M four hours after SCI prompted a neuroprotective effect: neuronal death decreased (22.46%), oxidative stress diminished, pro-apoptotic factors (Bax, nNOS, and caspase-3, -8) were expressed to a lesser extent, and mitochondrial viability as well as anti-apoptotic factor (Bcl-xl) expression increased. These results suggested that MVIIA provided neuroprotection through antioxidant effects. Indeed, superoxide dismutase (188.41%), and glutathione peroxidase (199.96%), reductase (193.86%), and transferase (175.93%) expressions increased. Therefore, intrathecal MVIIA (MVIIA 10 mu M, 4 h) application has neuroprotective potential, and the possible mechanisms are related to antioxidant agent modulation and to intrinsic and extrinsic apoptotic pathways.	[Oliveira, Karen M.; Silva, Carla M. O.; Melo, Marilia M.; Melo, Eliane G.] Minas Gerais Fed Univ, Clin & Surg Dept, Sch Vet, Campus Pampulha, Belo Horizonte, MG, Brazil; [Binda, Nancy S.; Da Silva, Juliana F.; Gomez, Marcus Vinicius] Inst Educ & Res, Lab Toxins, Belo Horizonte, MG, Brazil; [Lavor, Mario Sergio L.] Univ Estadual Santa Cruz, Dept Agr & Environm Sci, Ilheus, BA, Brazil; [Rosado, Isabel R.; Gabellini, Endrigo L. A.] Univ Uberaba, Dept Vet Med, Uberaba, MG, Brazil; [Oliveira, Camila M.] Univ Fed Parana, Sch Med, Curitiba, Parana, Brazil	Insper; Universidade Estadual de Santa Cruz; Universidade de Uberaba (Uniube); Universidade Federal do Parana	Oliveira, KM (corresponding author), Minas Gerais Fed Univ, Clin & Surg Dept, Sch Vet, Campus Pampulha, Belo Horizonte, MG, Brazil.	kamoliveira@yahoo.com.br	DE LAVOR, MARIO SERGIO LIMA/Y-4138-2019; da Silva, Juliana/AAN-4275-2021	DE LAVOR, MARIO SERGIO LIMA/0000-0003-0795-5320; da Silva, Juliana/0000-0002-2906-517X; Binda, Nancy/0000-0003-0603-0342	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [140633/2012-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): http://cnpq.br/ grant number: 140633/2012-0 (KMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bingham JP, 2010, CHEM-BIOL INTERACT, V183, P1, DOI 10.1016/j.cbi.2009.09.021; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOWERSOX SS, 1995, J PHARMACOL EXP THER, V273, P248; Bowersox SS, 1998, TOXICON, V36, P1651, DOI 10.1016/S0041-0101(98)00158-5; Bowersox SS, 1997, BRAIN RES, V747, P343; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHAN AM, 1994, J CEREBR BLOOD F MET, V14, P903, DOI 10.1038/jcbfm.1994.121; Burns LH, 1999, J VASC SURG, V30, P334, DOI 10.1016/S0741-5214(99)70145-X; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Dasuri K, 2013, FREE RADICAL BIO MED, V62, P170, DOI 10.1016/j.freeradbiomed.2012.09.016; Oliveira KM, 2016, CIENC RURAL, V46, P150, DOI 10.1590/0103-8478cr20141203; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Eckert MJ, 2017, SURG CLIN N AM, V97, P1031, DOI 10.1016/j.suc.2017.06.008; Fang MR, 2011, TOXICOL LETT, V206, P325, DOI 10.1016/j.toxlet.2011.07.022; Galang N, 2000, TOXICOLOGY, V148, P111, DOI 10.1016/S0300-483X(00)00201-8; GAUR S, 1994, NEUROPHARMACOLOGY, V33, P1211, DOI 10.1016/S0028-3908(05)80012-7; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GOHIL K, 1994, BRAIN RES, V653, P258, DOI 10.1016/0006-8993(94)90398-0; Goncaves JM, 2011, CELL MOL NEUROBIOL, V31, P277, DOI 10.1007/s10571-010-9618-5; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Greenberg DA, 1997, ANN NEUROL, V42, P275, DOI 10.1002/ana.410420302; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; Hama A, 2009, NEUROPHARMACOLOGY, V56, P556, DOI 10.1016/j.neuropharm.2008.10.008; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Horvath G, 2002, N-S ARCH PHARMACOL, V366, P270, DOI 10.1007/s00210-002-0591-5; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Igelmund P, 1996, EXP BRAIN RES, V109, P22; ISAAC L, 1995, SURG NEUROL, V43, P484, DOI 10.1016/0090-3019(95)80094-W; Ishikawa T, 1996, No To Shinkei, V48, P259; Jia XF, 2013, J INTENSIVE CARE MED, V28, P12, DOI 10.1177/0885066611403270; Johnson Simon, 2012, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0939s61; Torres BBJ, 2010, INT J EXP PATHOL, V91, P530, DOI 10.1111/j.1365-2613.2010.00738.x; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lanz O, 2000, VET MED-US, V95, P851; Lee S, 2010, MOL PAIN, V6, P1, DOI [10.1186/1744-8069-6-1, DOI 10.1186/1744-8069-6-1]; Leo M, 2017, EXP NEUROL, V288, P62, DOI 10.1016/j.expneurol.2016.11.003; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU DX, 1993, BRAIN RES, V609, P293, DOI 10.1016/0006-8993(93)90885-Q; Liu WM, 2011, J NEUROSCI RES, V89, P791, DOI 10.1002/jnr.22602; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Luo HX, 2014, BIOMED REP, V2, P207, DOI 10.3892/br.2013.212; MALMBERG AB, 1994, J NEUROSCI, V14, P4882; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Martins BD, 2018, SPINE J, V18, P532, DOI 10.1016/j.spinee.2017.10.067; Maulik N, 1998, FREE RADICAL BIO MED, V24, P869, DOI 10.1016/S0891-5849(97)00388-2; McDowell GC, 2016, NEUROMODULATION, V19, P522, DOI 10.1111/ner.12392; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Minami K, 2001, FEBS LETT, V491, P127, DOI 10.1016/S0014-5793(01)02183-4; Montazeri F, 2013, J SPINAL CORD MED, V36, P231, DOI 10.1179/2045772312Y.0000000077; NADASDI L, 1995, BIOCHEMISTRY-US, V34, P8076, DOI 10.1021/bi00025a013; Naderi A, 2014, METAB BRAIN DIS, V29, P763, DOI 10.1007/s11011-014-9570-z; Nagai T, 2001, FOOD CHEM, V75, P237, DOI 10.1016/S0308-8146(01)00193-5; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NEWCOMB R, 1994, BRAIN RES, V638, P95, DOI 10.1016/0006-8993(94)90637-8; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira KM, 2014, INT J CLIN EXP PATHO, V7, P3524; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Perez-Pinzon MA, 1997, J NEUROL SCI, V153, P25, DOI 10.1016/S0022-510X(97)00196-2; Pitkanen A., 2005, DRUG DISCOV TODAY DI, V2, P409, DOI DOI 10.1016/J.DDMEC.2005.11.011; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Priestley John V, 2012, Handb Clin Neurol, V109, P463, DOI 10.1016/B978-0-444-52137-8.00029-2; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P3365, DOI 10.1016/j.biortech.2007.08.018; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rosado IR, 2014, INT J CLIN EXP PATHO, V7, P4617; Samraj AK, 2007, MOL BIOL CELL, V18, P84, DOI 10.1091/mbc.E06-04-0263; Sanford M, 2013, CNS DRUGS, V27, P989, DOI 10.1007/s40263-013-0107-5; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; SELIGMAN ML, 1977, LIPIDS, V12, P945, DOI 10.1007/BF02533316; Siniscalco D, 2007, PHARMACOL RES, V55, P158, DOI 10.1016/j.phrs.2006.11.009; Siqueira IR, 2004, BRAIN RES, V1025, P226, DOI 10.1016/j.brainres.2004.08.005; Skov MJ, 2007, INT J TOXICOL, V26, P411, DOI 10.1080/10915810701582970; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Song YX, 2013, LIFE SCI, V92, P1215, DOI 10.1016/j.lfs.2013.05.007; SOUZA A. H., 2011, TOXICON, V58, P626, DOI [10.1016/j.toxicon.2011.09.008, DOI 10.1016/J.TOXICON.2011.09.008]; Souza AH, 2013, CELL MOL NEUROBIOL, V33, P59, DOI [10.1007/s10571-012-9871-x, DOI 10.1007/S10571-012-9871-X]; Souza AH, 2008, PAIN, V140, P115, DOI 10.1016/j.pain.2008.07.014; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; TAKIZAWA S, 1995, J CEREBR BLOOD F MET, V15, P611, DOI 10.1038/jcbfm.1995.75; Twede VD, 2009, IDRUGS, V12, P231; Uchitel OD, 1997, TOXICON, V35, P1161, DOI 10.1016/S0041-0101(96)00210-3; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wang F, 2016, NEUROPHARMACOLOGY, V101, P137, DOI 10.1016/j.neuropharm.2015.08.047; Wang LY, 2008, J IMMUNOL, V180, P3072, DOI 10.4049/jimmunol.180.5.3072; Wermeling D, 2003, J CLIN PHARMACOL, V43, P624, DOI 10.1177/0091270003253349; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wu KLH, 2009, J NEUROTRAUM, V26, P965, DOI 10.1089/neu.2008.0692; Xia YZ, 2017, EXP THER MED, V14, P1589, DOI 10.3892/etm.2017.4674; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xu GY, 2004, EXP NEUROL, V187, P329, DOI 10.1016/j.expneurol.2004.01.029; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yamamoto T, 1998, BRAIN RES, V794, P329, DOI 10.1016/S0006-8993(98)00306-0; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhang H, 2014, J TRANSL MED, V12, P1, DOI [10.1186/1479-5876-12-1, DOI 10.1186/1479-5876-12-1]	121	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204948	10.1371/journal.pone.0204948	http://dx.doi.org/10.1371/journal.pone.0204948			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286181	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500066
J	Playe, B; Azencott, CA; Stoven, V				Playe, Benoit; Azencott, Chloe-Agathe; Stoven, Veronique			Efficient multi-task chemogenomics for drug specificity prediction	PLOS ONE			English	Article							TARGET INTERACTION PREDICTION; HOSPITALIZED-PATIENTS; HOMOLOGY DETECTION; CHEMICAL GENOMICS; CROSS-VALIDATION; KERNELS; SUPPORT; INFORMATION; DISCOVERY	Adverse drug reactions, also called side effects, range from mild to fatal clinical events and significantly affect the quality of care. Among other causes, side effects occur when drugs bind to proteins other than their intended target. As experimentally testing drug specificity against the entire proteome is out of reach, we investigate the application of chemogenomics approaches. We formulate the study of drug specificity as a problem of predicting interactions between drugs and proteins at the proteome scale. We build several benchmark datasets, and propose NN-MT, a multi-task Support Vector Machine (SVM) algorithm that is trained on a limited number of data points, in order to solve the computational issues or proteome-wide SVM for chemogenomics. We compare NN-MTto different state-of-the-art methods, and show that its prediction performances are similar or better, at an efficient calculation cost. Compared to its competitors, the proposed method is particularly efficient to predict (protein, ligand) interactions in the difficult double-orphan case, i.e. when no interactions are previously known for the protein nor for the ligand. The NN-MTalgorithm appears to be a good default method providing state-of-the-art or better performances, in a wide range of prediction scenario that are considered in the present study: proteome-wide prediction, protein family prediction, test (protein, ligand) pairs dissimilar to pairs in the train set, and orphan cases.	[Playe, Benoit; Azencott, Chloe-Agathe; Stoven, Veronique] PSL Res Univ, Mines ParisTech, Ctr Computat Biol, Paris, France; [Playe, Benoit; Azencott, Chloe-Agathe; Stoven, Veronique] Inst Curie, F-75248 Paris, France; [Playe, Benoit; Azencott, Chloe-Agathe; Stoven, Veronique] INSERM, U900, F-75248 Paris, France	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Playe, B (corresponding author), PSL Res Univ, Mines ParisTech, Ctr Computat Biol, Paris, France.; Playe, B (corresponding author), Inst Curie, F-75248 Paris, France.; Playe, B (corresponding author), INSERM, U900, F-75248 Paris, France.	benoit.playe@mines-paristech.fr		Playe, Benoit/0000-0003-3836-2683; Azencott, Chloe-Agathe/0000-0003-1003-301X				Allenby GM, 1999, J ECONOMETRICS, V89, P57; Arora N, 1998, MARKET SCI, V17, P29, DOI 10.1287/mksc.17.1.29; Azencott CA, 2007, J CHEM INF MODEL, V47, P965, DOI 10.1021/ci600397p; Bakker B, 2003, J MACHINE LEARNING R, V4, P83; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Caruana R, 1998, LEARNING TO LEARN, P95, DOI 10.1007/978-1-4615-5529-2_5; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Erhan D, 2006, J CHEM INF MODEL, V46, P626, DOI 10.1021/ci050367t; Eskin E, 2002, NIPS, P1417; Faulon JL, 2008, BIOINFORMATICS, V24, P225, DOI 10.1093/bioinformatics/btm580; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gonen M, 2012, BIOINFORMATICS, V28, P2304, DOI 10.1093/bioinformatics/bts360; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Hizukuri Y, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0158-1; Hue M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-144; Jaakkola T, 2000, J COMPUT BIOL, V7, P95, DOI 10.1089/10665270050081405; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Jacob L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-363; Johnson C. C., 2014, P ADV NEUR INF PROC, V27, P1; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kashima H., 2003, P 20 INT C MACHINE L, P321; Kellenberger E, 2008, J CHEM INF MODEL, V48, P1014, DOI 10.1021/ci800023x; Kramer C, 2010, J CHEM INF MODEL, V50, P1961, DOI 10.1021/ci100264e; Kuang Rui, 2005, Journal of Bioinformatics and Computational Biology, V3, P527, DOI 10.1142/S021972000500120X; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LESLIE C, 2002, P PSB, V7, P566; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu Y, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004760; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinez-Lopez Y, 2017, CURR TOP MED CHEM, V17, P2957, DOI 10.2174/1568026617666170821123856; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Miguel A, 2012, PHARMACOEPIDEM DR S, V21, P1139, DOI 10.1002/pds.3309; Napolitano F, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-30; Nascimento AC RB, 2016, BMC BIOINFORMATICS, V17, P1, DOI [10.1186/s12859-016-0890-3, DOI 10.1186/S12859-016-0890-3]; Okuno Y, 2008, NUCLEIC ACIDS RES, V36, pD907, DOI 10.1093/nar/gkm948; Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0553-2; Pahikkala T, 2015, BRIEF BIOINFORM, V16, P325, DOI 10.1093/bib/bbu010; Paul N, 2004, PROTEINS, V54, P671, DOI 10.1002/prot.10625; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Swamidass SJ, 2005, BIOINFORMATICS, V21, pI359, DOI 10.1093/bioinformatics/bti1055; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; van Laarhoven T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066952; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Vert JP, 2008, COMB CHEM HIGH T SCR, V11, P677, DOI 10.2174/138620708785739899; Warmuth MK, 2003, J CHEM INF COMP SCI, V43, P667, DOI 10.1021/ci025620t; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Xu Xianjin, 2018, Biophys Rep, V4, P1, DOI 10.1007/s41048-017-0045-8; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2013, MOL INFORM, V32, P991, DOI 10.1002/minf.201300079; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yuan QJ, 2016, BIOINFORMATICS, V32, P18, DOI 10.1093/bioinformatics/btw244; Zheng XD, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1025	67	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204999	10.1371/journal.pone.0204999	http://dx.doi.org/10.1371/journal.pone.0204999			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286165	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500072
J	Rahm, J; Johansson, M				Rahm, Johan; Johansson, Maria			Assessing the pedestrian response to urban outdoor lighting: A full-scale laboratory study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OBSTACLE DETECTION; PERCEPTION; RECOGNITION; WALKING; EXPERIENCES; SIMULATION; LUMINANCE; DESIGN; IMPACT	This study identifies and applies methods for evaluating the human response to pedestrian lighting applications intended for future use by the municipality of Malmo, Sweden. The methods employed provide a supplementary perspective to that given by the photometric properties of the lighting applications. The study involved 89 participants from two age groups (Young: N: 43, 19-31 yrs.; Elderly: N: 46, 62-77 yrs.). Data were collected in a full-scale laboratory using a mock-up pedestrian pathway. Three lighting applications (one ceramic metal halide and two LED) were presented and the participants' behavior (walking speed), perception (ability to perform visual tasks-recognize facial expressions, detect obstacles, read street signpost), affective response, and evaluation of the lighting quality were assessed. The three lighting applications significantly differed with regard to the human response. The facial expression recognition distance, sign reading distance and the obstacle detection task, along with the evaluation of lighting quality and level of arousal, distinguished one of the LEDs (Correlated Color Temperature: 3810, Color Rendering Index: 75, Scotopic/Photopic ratio: 1.48) from the other two lighting applications-the participants performed better on the visual tasks, and the lighting was perceived as brighter, more arousing and less pleasant. Methods to capture human perception, evaluation and behavior in relation to outdoor lighting, provide a valuable perspective that should be systematically applied when municipalities consider different pedestrian lighting applications.	[Rahm, Johan; Johansson, Maria] Lund Univ, Dept Architecture & Built Environm, Environm Psychol, Lund, Sweden	Lund University	Rahm, J (corresponding author), Lund Univ, Dept Architecture & Built Environm, Environm Psychol, Lund, Sweden.	johan.rahm@arkitektur.lth.se		Rahm, Johan/0000-0002-7331-1286	Swedish energy agency [2012-00-3180]; INTERREG-project Lighting Metropolis - European Regional Development Fund [NYPS 20200430]	Swedish energy agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); INTERREG-project Lighting Metropolis - European Regional Development Fund	This research was funded by the Swedish energy agency, dnr: 2012-00-3180 (www.energimyndigheten.se), and by the INTERREG-project Lighting Metropolis, funded by the European Regional Development Fund, NYPS 20200430 (www.lightingmetropolis.com).	Addy CL, 2004, AM J PUBLIC HEALTH, V94, P440, DOI 10.2105/AJPH.94.3.440; Boyce P. R., 2000, International Journal of Lighting Research and Technology, V32, P79, DOI 10.1177/096032710003200205; Boyce PR, 2009, LIGHTING RES TECHNOL, V41, P245, DOI 10.1177/1477153509338887; British Standards Institution (BSI), 2013, 548912013 BSI; Caminada J. F., 1980, INT LIGHTING REV, V3, P69; Choi JS, 2014, ACTA BIOENG BIOMECH, V16, P3, DOI 10.5277/abb140101; Corseuil MW, 2011, PREV MED, V53, P289, DOI 10.1016/j.ypmed.2011.07.016; Corseuil MW, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/641010; Davoudian N, 2012, LIGHTING RES TECHNOL, V44, P438, DOI 10.1177/1477153512437157; de lEclairage C.I., 2010, 1152010 CIE; Dong M, 2015, LIGHTING RES TECHNOL, V47, P693, DOI 10.1177/1477153514539781; Ekman P., 2007, EMOTIONS REVEALED RE; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Eyler AA, 2002, WOMEN HEALTH, V36, P1, DOI 10.1300/J013v36n02_01; Fotios S, 2017, LIGHTING RES TECHNOL, V49, P243, DOI 10.1177/1477153515616166; Fotios S, 2020, LIGHTING RES TECHNOL, V52, P607, DOI 10.1177/1477153519876972; Fotios S, 2018, LIGHTING RES TECHNOL, V50, P390, DOI 10.1177/1477153516659783; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P548, DOI 10.1177/1477153514529299; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P301, DOI 10.1177/1477153513510311; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P149, DOI 10.1177/1477153514522473; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P133, DOI 10.1177/1477153514522472; Fotios S, 2013, LIGHTING RES TECHNOL, V45, P362, DOI 10.1177/1477153512444112; Fotios S, 2009, LIGHTING RES TECHNOL, V41, P321, DOI 10.1177/1477153509102343; Fotios S, 2017, LIGHTING RES TECHNOL; Gustafsson B, 2011, 32011 SWED RES COUNC; Hanyu K, 1997, J ENVIRON PSYCHOL, V17, P301, DOI 10.1006/jevp.1997.0067; International Energy Agency, 2006, LIGHTS LAB LOST POL; Itoh N, 2006, GERONTECHNOLOGY, V5, P246, DOI DOI 10.4017/GT.2006.05.04.010.00; Iwata M., 2011, J LIGHT VISUAL ENV, V35, P42; IZARD CE, 1993, J PERS SOC PSYCHOL, V64, P847, DOI 10.1037/0022-3514.64.5.847; Jackson GR, 1999, VISION RES, V39, P3975, DOI 10.1016/S0042-6989(99)00092-9; Jagerbrand A, 2013, 786 VTI SWED NAT ROA; Jago R, 2005, AM J PREV MED, V29, P98, DOI 10.1016/j.amepre.2005.04.002; Johansson M, 2014, J ENVIRON PSYCHOL, V39, P14, DOI 10.1016/j.jenvp.2013.12.002; Johansson M, 2011, LIGHTING RES TECHNOL, V43, P31, DOI 10.1177/1477153510370757; Johansson M, 2016, J URBAN DES, V21, P256, DOI 10.1080/13574809.2015.1133225; Kim S, 2014, TRANSPORT RES D-TR E, V30, P10, DOI 10.1016/j.trd.2014.05.005; Knight C, 2010, LIGHTING RES TECHNOL, V42, P313, DOI 10.1177/1477153510376794; Kohko S, 2008, J LIGHT VISUAL ENV, V32, P315; Kuhn L, 2013, LIGHTING RES TECHNOL, V45, P568, DOI 10.1177/1477153512464968; Kuller R, 1996, ENVIRON INT, V22, P33, DOI 10.1016/0160-4120(95)00101-8; Kuller R., 1993, Lighting Research and Technology, V25, P71; Lee C, 2008, BUILD RES INF, V36, P395, DOI 10.1080/09613210802045547; Lin Y, 2015, LIGHTING RES TECHNOL, V47, P221, DOI 10.1177/1477153513505306; Lin YD, 2015, INVEST OPHTH VIS SCI, V56, P1649, DOI 10.1167/iovs.14-15963; Park N. K., 2007, J INT DESIGN, V33, P17, DOI DOI 10.1111/j.1939-1668.2007.tb00419.x; Park S, 2014, TRANSPORT RES REC, P126, DOI 10.3141/2464-16; Park S, 2015, INT J SUSTAIN TRANSP, V9, P529, DOI 10.1080/15568318.2013.825036; Pedersen E, 2018, LIGHTING RES TECHNOL, V50, P522, DOI 10.1177/1477153516684544; Quartier K, 2014, J ENVIRON PSYCHOL, V39, P32, DOI 10.1016/j.jenvp.2014.04.005; Rahm J, 2016, 26 DEP ARCH BUILT EN; Raynham P, 2011, LIGHTING RES TECHNOL, V43, P129; Rea MS, 2009, LIGHTING RES TECHNOL, V41, P297, DOI 10.1177/1477153509102342; Rosenberg DE, 2013, GERONTOLOGIST, V53, P268, DOI 10.1093/geront/gns119; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Shikakura T., 1992, J ILLUM ENG I JPN, V74, P648, DOI [10.2150/jieij1980.74.10_648, DOI 10.2150/JIEIJ1980.74.10_648]; Swedish Transport Administration, 2015, 2015086 SWED TRANSP; Uttley J, 2017, LIGHTING RES TECHNOL, V49, P211, DOI 10.1177/1477153515602954; van den Berg T.J.T.P., 2009, J OPTOM, V2, P112, DOI 10.3921/joptom.2009.112; Viliunas V, 2014, LIGHTING RES TECHNOL, V46, P421, DOI 10.1177/1477153513491760; Yang B, 2015, LIGHTING RES TECHNOL, V47, P964, DOI 10.1177/1477153514547753; Yang Chunyu, 2013, ING ILLUM, VV15, P19; Yao Q, 2009, LEUKOS, V6, P169, DOI 10.1582/LEUKOS.2009.06.02006; Zeng WL, 2017, TRANSPORT RES C-EMER, V80, P37, DOI 10.1016/j.trc.2017.04.009; Zeng WL, 2014, PROCD SOC BEHV, V138, P521, DOI 10.1016/j.sbspro.2014.07.233	65	13	13	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204638	10.1371/journal.pone.0204638	http://dx.doi.org/10.1371/journal.pone.0204638			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286094	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500029
J	Hauer, R; Tessitore, A; Binder, N; Tschan, H				Hauer, Richard; Tessitore, Antonio; Binder, Nicole; Tschan, Harald			Physiological, perceptual, and technical responses to continuous and intermittent small-sided games in lacrosse players	PLOS ONE			English	Article							YOUTH SOCCER PLAYERS; HEART-RATE RESPONSES; VIDEO INCIDENT ANALYSIS; RECOVERY TEST; PHYSICAL PERFORMANCE; EXERCISE INTENSITY; BASKETBALL PLAYERS; WOMENS LACROSSE; RELIABILITY; VALIDITY	Purpose The present study was designed to investigate the influence of two distinct small-sided game (SSG) regimes on physiological, perceptual, and technical parameters in male elite lacrosse players. Method Data were collected in twelve elite male Austrian lacrosse players (25.8 +/- 5.5 years; 80.1 +/- 7.7 kg; 178.5 +/- 6.2 cm). Players' were assigned to an intermittent (SSG-I) or a continuous (SSG-C) SSG regime, respectively. Regimes were equated for total practice time, but not active playing time. SSG data from eight sessions of 3 vs. 3 self-regulated match-play were collected along a 4-week pre-season period. Players' YoYo-Level 1 (YYL1) performance before and after the training intervention was recorded. Further, heart-rate (HR), rating of perceived exertion (RPE), physical activity enjoyment scale (PACES), and technical actions during and after SSG sessions were analyzed. Results Both SSG regimes showed improvement with medium to very large effect sizes (ES) in YYL1 total distance covered pre- to post-intervention (SSG-C mean-difference +/- SD: 840 +/- 299 m; p = 0.003; d = 1.08; CI = 0.60 to 1.56 and SSG-I: 607 +/- 274 m; p = 0.003; d = 1.25; CI = 0.66 to 1.85 respectively). Higher %HRmax values with very large ES (92 +/- 0.6%; p = 0.002; d = 5.33; CI = 2.78 to 7.88) and time spent in HR zone 4 (1248.0 +/- 122.7 s; p = 0.000; d = 3.43; CI = 2.31 to 4.55) were observed for SSG-C. No differences between regimes were found for any of the assessed technical actions, global RPE, and PACES scores. Conclusions Both SSG regimes investigated in this study were effective in improving YYL1 performance. Further, findings indicate that the regime does not influence players' subjective feelings and technical actions in SSG play. However, SSG-I in lacrosse specific training could have additional benefits such as lower signs of fatigue. Further, breaks can be used to give technical and tactical inputs by coaches.	[Hauer, Richard; Binder, Nicole; Tschan, Harald] Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria; [Tessitore, Antonio] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy	University of Vienna; Foro Italico University of Rome	Hauer, R (corresponding author), Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria.	richard.hauer@univie.ac.at	Tessitore, Antonio/H-9922-2014	Tessitore, Antonio/0000-0002-3542-0991; Hauer, Richard/0000-0001-6835-4030	University of Vienna	University of Vienna	Open access funding was provided by University of Vienna. The authors received no other specific funding for this work.	Atl H, 2013, J STRENGTH COND RES, V27, P352, DOI 10.1519/JSC.0b013e3182542674; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Borg G., 1998, BORGS PERCEIVED EXER, V8; Brandes M, 2012, J STRENGTH COND RES, V26, P1353, DOI 10.1519/JSC.0b013e318231ab99; Carter EA, 2010, INT J INJ CONTROL SA, V17, P111, DOI 10.1080/17457300903524888; Castagna C, 2008, J SCI MED SPORT, V11, P202, DOI 10.1016/j.jsams.2007.02.013; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Chamari K, 2005, BRIT J SPORT MED, V39, P24, DOI 10.1136/bjsm.2003.009985; Christopher J, 2016, HUM MOVEMENT SCI, V48, P1, DOI 10.1016/j.humov.2016.03.013; Clemente FM, 2017, J HUM KINET, V58, P141, DOI 10.1515/hukin-2017-0080; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins SM, 2014, J STRENGTH COND RES, V28, P2673, DOI 10.1519/JSC.0000000000000454; Delextrat A, 2018, J STRENGTH COND RES, V32, P1882, DOI 10.1519/JSC.0000000000002570; Dellal A, 2011, INT J SPORT PHYSIOL, V6, P322, DOI 10.1123/ijspp.6.3.322; Dellal A, 2008, J STRENGTH COND RES, V22, P1449, DOI 10.1519/JSC.0b013e31817398c6; Deprez D, 2014, J SPORT SCI, V32, P903, DOI 10.1080/02640414.2013.876088; Dolan P, 2017, J STRENGTH COND RES, V31, P2473, DOI 10.1519/JSC.0000000000001819; Enemark-Miller EA, 2009, J STRENGTH COND RES, V23, P39, DOI 10.1519/JSC.0b013e318185f07c; Fanchini M, 2011, J STRENGTH COND RES, V25, P453, DOI 10.1519/JSC.0b013e3181c1f8a2; Federation-of-International-Lacrosse, 2013, 2013 WOM LACR WORLD; Federation-of-International-Lacrosse, 2017, FIL MEMB MEMB TYP; Federation-of-International-Lacrosse, 2014 WORLD CHAMP 201; Fleay B, 2018, J STRENGTH COND RES, V32, P2039, DOI 10.1519/JSC.0000000000002423; Foster CD, 2010, J STRENGTH COND RES, V24, P906, DOI 10.1519/JSC.0b013e3181aeb11a; Gaudino P, 2014, HUM MOVEMENT SCI, V36, P123, DOI 10.1016/j.humov.2014.05.006; Gutowski AE, 2011, STRENGTH COND, V33, P7; Halouani J, 2014, J STRENGTH COND RES, V28, P3594, DOI 10.1519/JSC.0000000000000564; Hauer R, 2017, KINESIOLOGIA SLOVENI, V23, P14; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hill-Haas SV, 2009, J STRENGTH COND RES, V23, P111, DOI 10.1519/JSC.0b013e31818efc1a; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hoff J, 2002, BRIT J SPORT MED, V36, P218, DOI 10.1136/bjsm.36.3.218; Hoffman JR, 2009, J STRENGTH COND RES, V23, P1524, DOI 10.1519/JSC.0b013e3181b3391d; Hughes M., 2004, NOTATIONAL ANAL SPOR; Impellizzeri FM, 2006, INT J SPORTS MED, V27, P483, DOI 10.1055/s-2005-865839; Kelly DA, 2009, J SCI MED SPORT, V12, P475, DOI 10.1016/j.jsams.2008.01.010; Kennett DC, 2012, J STRENGTH COND RES, V26, P2037, DOI 10.1519/JSC.0b013e31823a3b26; Koklu Y, 2017, INT J SPORT PHYSIOL, V12, P1370, DOI 10.1123/ijspp.2016-0584; Koklu Y, 2012, J HUM KINET, V31, P89, DOI 10.2478/v10078-012-0009-5; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Roman PAL, 2014, J ASTHMA, V51, P633, DOI 10.3109/02770903.2014.898773; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Los Arcos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137224; Los Arcos A, 2014, J STRENGTH COND RES, V28, P752, DOI 10.1519/JSC.0b013e3182a47f0b; Macaulay CAJ, 2017, J SPORT SCI, V35, P2350, DOI 10.1080/02640414.2016.1267385; Mara JK, 2016, INT J SPORT PHYSIOL, V11, P953, DOI 10.1123/IJSPP.2015-0087; Martone D, 2017, J STRENGTH COND RES, V31, P1486, DOI 10.1519/JSC.0000000000001615; Mullen SP, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-103; O'donoghue P., 2009, RES METHODS SPORTS P; Plisk S. S, 1994, J STRENGTH COND RES, V8, P28; Polley CS, 2015, J STRENGTH COND RES, V29, P126, DOI 10.1519/JSC.0000000000000599; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tessitore A, 2006, J SPORT MED PHYS FIT, V46, P36; Vennum Thomas, 1994, AM INDIAN LACROSSE L; Vescovi JD, 2007, J SCI MED SPORT, V10, P334, DOI 10.1016/j.jsams.2006.07.010	58	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203832	10.1371/journal.pone.0203832	http://dx.doi.org/10.1371/journal.pone.0203832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281632	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400031
J	Mirzadeh, A; Yoosefy, A; Kazemirad, E; Barati, Z; Golkar, M; Babaie, J; Jafarihaghighi, F; Valadkhani, Z				Mirzadeh, Abolfazl; Yoosefy, Asiyeh; Kazemirad, Elham; Barati, Zahra; Golkar, Majid; Babaie, Jalal; Jafarihaghighi, Farid; Valadkhani, Zarrintaj			Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; BOLIVIAN ALTIPLANO; LEUCINE AMINOPEPTIDASE; SECRETORY PRODUCTS; ESCHERICHIA-COLI; HEPATICA; DIAGNOSIS; PROTEIN; ELISA; EXPRESSION	Diagnosis of fascioliasis with high sensitivity and specificity antigens play a vital role in the management of the disease. Majority of commercial serological tests use F. hepatica native antigens and indicate wide diversities in test accuracy. Nowadays, recombinant antigens have been introduced as diagnostic reagents offer better test standardization. A combination of highly pure recombinant antigens associated with correct folding will leads to improve specificity and sensitivity of ELISA for diagnosis of Fascioliasis. In this article, Fasciola hepatica saposin-like protein 2 (SAP-2), ferritin protein (Ftn-1) and leucine aminopeptidase (LAP) recombinant antigens were considered as tools for the detection of F. hepatica immunoglobulin G antibodies in persons with chronic human fasciolasis. The recombinant antigens were obtained as fusion proteins, expressed in Escherichia coli and purified by immobilized metal affinity chromatography (IMAC). The refolding processes of denatured recombinant proteins were performed using dialysis method in the presence of chemical additives, and reduced/oxidized glutathione (in vitro). The immunoreactivity of the recombinant antigens was assessed individually and in a combination compared with excretory/secretory antigen (E/S) in an enzyme-linked immunosorbent assay (ELISA) test. The experiments were optimized using 213 serum samples from humans, including patients with chronic fascioliasis, patients with other parasitic diseases, and healthy subjects. The results indicated 95% sensitivity and 98% specificity for rtFhSAP-2, 96% sensitivity and 91% specificity for E/S, 80% and 83.3% for rtFhFtn-1, 84% and 88% for FhLAP, and also, 96% and 95% for combination of recombinant antigens, respectively. In conclusion, the results of this investigation showed that rtFhSAP-2 with the highest specificity and acceptable sensitivity has a considerable superiority compared to mentioned antigens and even in combination with these antigens in serodiagnosis of human fascioliasis.	[Mirzadeh, Abolfazl; Yoosefy, Asiyeh; Barati, Zahra; Golkar, Majid; Babaie, Jalal; Jafarihaghighi, Farid; Valadkhani, Zarrintaj] Pasteur Inst Iran, Dept Med Parasitol, Tehran, Iran; [Kazemirad, Elham] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences	Valadkhani, Z (corresponding author), Pasteur Inst Iran, Dept Med Parasitol, Tehran, Iran.	z_valadkhani@pasteur.ac.ir	Kazemirad, Elham/ABA-8391-2020; jafarihaghighi, farid/AAV-4144-2020; Babaie, Jalal/B-2938-2018	Kazemirad, Elham/0000-0001-8634-5584; Babaie, Jalal/0000-0002-4989-5998; Mirzadeh, Abolfazl/0000-0002-0336-3486	Pasteur Institute of Iran, Tehran [836]	Pasteur Institute of Iran, Tehran	Zarrintaj Valadkhani is the project designer no. 836, that granted by Pasteur Institute of Iran, Tehran. http://www.pasteur.ac.ir. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbaset AE, 2017, EXP PARASITOL, V172, P1, DOI 10.1016/j.exppara.2016.11.003; Acosta D, 2008, MOL BIOCHEM PARASIT, V158, P52, DOI 10.1016/j.molbiopara.2007.11.011; Valero MA, 2012, TROP MED INT HEALTH, V17, P630, DOI 10.1111/j.1365-3156.2012.02964.x; Attallah AM, 2013, CLIN VACCINE IMMUNOL; Caban-Hernandez K, 2012, MOL BIOCHEM PARASIT, V182, P54, DOI 10.1016/j.molbiopara.2011.12.005; Cordova M, 1997, AM J TROP MED HYG, V57, P660, DOI 10.4269/ajtmh.1997.57.660; Espino AM, 2004, J PARASITOL, V90, P876, DOI 10.1645/GE-215R; Espino AM, 2003, J PARASITOL, V89, P545, DOI 10.1645/GE-3113; Espino Ana M, 2010, Ethn Dis, V20, pS1; Figueroa-Santiago O, 2011, DIAGN MICR INFEC DIS, V70, P355, DOI 10.1016/j.diagmicrobio.2011.03.016; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Gottstein B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002860; HILLYER GV, 1992, AM J TROP MED HYG, V46, P603, DOI 10.4269/ajtmh.1992.46.603; Jayaraj R, 2011, DIAGN MICR INFEC DIS, V71, P403, DOI 10.1016/j.diagmicrobio.2011.09.007; Kuerpick B, 2013, VET PARASITOL, V193, P206, DOI 10.1016/j.vetpar.2012.11.021; Marcilla A, 2008, CLIN VACCINE IMMUNOL, V15, P95, DOI 10.1128/CVI.00338-07; Mas-Coma S, 2005, J HELMINTHOL, V79, P207, DOI 10.1079/JOH2005296; Mas-Coma S, 1999, TROP MED INT HEALTH, V4, P454, DOI 10.1046/j.1365-3156.1999.00418.x; Mas-Coma S, 1999, B WORLD HEALTH ORGAN, V77, P340; Mas-Coma S, 1999, FASCIOLOSIS, V411, P434; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Middelberg APJ, 2002, TRENDS BIOTECHNOL, V20, P437, DOI 10.1016/S0167-7799(02)02047-4; Mirzadeh A, 2017, ACTA TROP, V171, P163, DOI 10.1016/j.actatropica.2017.03.002; Mirzadeh A, 2017, PROTEIN EXPRES PURIF, V133, P66, DOI 10.1016/j.pep.2017.03.001; O'Neill SM, 1998, AM J TROP MED HYG, V58, P417, DOI 10.4269/ajtmh.1998.58.417; Okumura M, 2011, FEBS J, V278, P1137, DOI 10.1111/j.1742-4658.2011.08039.x; Organization WH, 2007, WHO INF M US TRICL F, V92; Patil NA, 2015, INT J MOL SCI, V16, P1791, DOI 10.3390/ijms16011791; Perez-Sanchez R, 2006, PROTEOMICS, V6, pS226, DOI 10.1002/pmic.200500420; Ramon A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00056; Rokni MB, 2008, ANN TROP MED PARASIT, V102, P283, DOI 10.1179/136485908X300805; Rokni MB, 2002, DIAGN MICR INFEC DIS, V44, P175, DOI 10.1016/S0732-8893(02)00431-5; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Santana BG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002414; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Valero MA, 2009, ACTA TROP, V111, P150, DOI 10.1016/j.actatropica.2009.04.005	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203490	10.1371/journal.pone.0203490	http://dx.doi.org/10.1371/journal.pone.0203490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281608	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400023
J	Badovinac, S; Martin, J; Guerin-Marione, C; O'Neill, M; Riddell, RP; Bureau, JF; Spiegel, R				Badovinac, Shaylea; Martin, Jodi; Guerin-Marione, Camille; O'Neill, Monica; Riddell, Rebecca Pillai; Bureau, Jean-Francois; Spiegel, Rebecca			Associations between mother-preschooler attachment and maternal depression symptoms: A systematic review and meta-analysis	PLOS ONE			English	Review							DISORGANIZED ATTACHMENT; SCHOOL-AGE; EARLY-CHILDHOOD; BIRTH-WEIGHT; BEHAVIOR; SENSITIVITY; SECURITY; CHILDREN; QUALITY; ANXIETY	The current study aimed to systematically review and meta-analyze concurrent and longitudinal associations between maternal depression symptoms and mother-child attachment during the preschool period (aged 2 to 7 years) as assessed using the coding systems by Cassidy and Marvin (1992) and Main and Cassidy (1988). The review was pre-registered with PROSPERO (International Prospective Register of Systematic Reviews; Registration number CRD42017073417) and was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A total of 7,969 records were screened and 18 articles were deemed as eligible for inclusion in the review. Studies were reviewed using qualitative synthesis techniques and, where appropriate, meta-analysis. Qualitative synthesis indicated that mothers of disorganized/controlling children most consistently reported the highest levels of depressive symptoms, both concurrently and longitudinally. The association between disorganized/controlling child attachment and concurrent maternal depressive symptoms was significant (n = 1,787; g = 0.27, 95% CI [0.13,0.40]), and was not moderated by sample type, child gender, or risk of bias. Findings of a relationship between child attachment insecurity and maternal depressive symptoms must be qualified due to significant within-study heterogeneity and publication bias. Results suggest that maternal depressive symptoms may confer risk for disorganized/controlling attachment during the preschool period.	[Badovinac, Shaylea; Martin, Jodi; O'Neill, Monica; Riddell, Rebecca Pillai; Spiegel, Rebecca] York Univ, Dept Psychol, Toronto, ON, Canada; [Guerin-Marione, Camille; Bureau, Jean-Francois] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Riddell, Rebecca Pillai] Hosp Sick Children, Dept Psychiat Res, Toronto, ON, Canada; [Riddell, Rebecca Pillai] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	York University - Canada; University of Ottawa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Riddell, RP (corresponding author), York Univ, Dept Psychol, Toronto, ON, Canada.; Riddell, RP (corresponding author), Hosp Sick Children, Dept Psychiat Res, Toronto, ON, Canada.; Riddell, RP (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.	rpr@yorku.ca		Pillai Riddell, Rebecca/0000-0003-3990-3680	Social Sciences and Humanities Research Council through Joseph-Armand Bombardier Canada Graduate Scholarships [767-2017-1883]; Social Sciences and Humanities Research Council [435-2013-0203]; Louise and Alan Edwards Postdoctoral Fellowship in Pediatric Pain; Canadian Institutes of Health Research through a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award [GSD 134896]; York Research Chair in Pain and Mental Health; Lillian Meighen Wright Foundation; Pain in Child Health, a strategic training initiative of the Canadian Institutes of Health Research; Ontario Graduate Scholarship program	Social Sciences and Humanities Research Council through Joseph-Armand Bombardier Canada Graduate Scholarships; Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Louise and Alan Edwards Postdoctoral Fellowship in Pediatric Pain; Canadian Institutes of Health Research through a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR)); York Research Chair in Pain and Mental Health; Lillian Meighen Wright Foundation; Pain in Child Health, a strategic training initiative of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship program(Ontario Graduate Scholarship)	This research was supported by the Social Sciences and Humanities Research Council (www.sshrc-crsh.gc.ca) through Joseph-Armand Bombardier Canada Graduate Scholarships awarded to SB (Master's) and CGM (Doctoral; #767-2017-1883), as well as through operating funds awarded to JFB (#435-2013-0203). JM was supported by a Louise and Alan Edwards Postdoctoral Fellowship in Pediatric Pain (www.painresearchcenter.mcgill.ca), MO was supported by the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) through a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award (GSD 134896), and RPR was supported by a York Research Chair in Pain and Mental Health. SB and MO also received funds from the Lillian Meighen Wright Foundation (meighenwrightfoundation.com) and Pain in Child Health, a strategic training initiative of the Canadian Institutes of Health Research (www.sickkids.ca/PICH/index.html), and SB was supported by the Ontario Graduate Scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RR., 1995, PSYCHOL ASSESSMENT R; Ainsworth M., 1978, PATTERNS ATTACHMENT; [Anonymous], 1992, ATTACHMENT ORG PRESC; [Anonymous], [No title captured]; Atkinson L, 2000, CLIN PSYCHOL REV, V20, P1019, DOI 10.1016/S0272-7358(99)00023-9; Bowlby, 1982, ATTACHMENT LOSS, VI, DOI DOI 10.1177/000306518403200125; Bretherton I., 1990, ASSESSING INTERNAL W, P308; Campbell SB, 2004, DEV PSYCHOPATHOL, V16, P231, DOI 10.1017/S0954579404044499; Cicchetti D., 1990, ATTACHMENT PRESCHOOL, P3; Cohen J, 1988, STAT POWER ANAL FRO; Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Cooper H. M., 2009, HDB RES SYNTHESIS ME; COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29; CRITTENDEN PM, 1992, DEV PSYCHOPATHOL, V4, P209, DOI 10.1017/S0954579400000110; Crombie I.K., 2007, POCKET GUIDE CRITICA; Cyr C, 2001, CAN J BEHAV SCI, V33, P77, DOI 10.1037/h0087130; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dubois-Comtois K, 2004, CAN J BEHAV SCI, V36, P267, DOI 10.1037/h0087236; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fearon RP, 2010, CHILD DEV, V81, P435, DOI 10.1111/j.1467-8624.2009.01405.x; Graffi J, 2018, INFANT BEHAV DEV, V50, P64, DOI 10.1016/j.infbeh.2017.11.004; Greenberg M.T., 1992, DEV PSYCHOPATHOL, V3, P413, DOI DOI 10.1017/S0954579400007604; Groh AM, 2014, ATTACH HUM DEV, V16, P103, DOI 10.1080/14616734.2014.883636; Groh AM, 2012, CHILD DEV, V83, P591, DOI 10.1111/j.1467-8624.2011.01711.x; Hedges L.V., 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Lipsey M. W., 2001, PRACTICAL METAANALYS, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Madigan S, 2006, ATTACH HUM DEV, V8, P89, DOI 10.1080/14616730600774458; Madigan S, 2013, DEV PSYCHOL, V49, P672, DOI 10.1037/a0028793; MAIN M, 1988, DEV PSYCHOL, V24, P415, DOI 10.1037/0012-1649.24.3.415; Main M., 1990, ATTACHMENT PRESCHOOL, P161, DOI DOI 10.1016/J.NCL.2015.11.007; Main M, 1990, ATTACHMENT PRESCHOOL, P121; MANASSIS K, 1994, J AM ACAD CHILD PSY, V33, P1106, DOI 10.1097/00004583-199410000-00006; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Milan S, 2009, DEV PSYCHOL, V45, P1019, DOI 10.1037/a0016164; Mills-Koonce WR, 2008, ATTACH HUM DEV, V10, P299, DOI 10.1080/14616730802113612; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moss E, 2004, DEV PSYCHOL, V40, P519, DOI 10.1037/0012-1649.40.4.519; Moss E, 2004, DEV PSYCHOL, V40, P323, DOI 10.1037/0012-1649.40.3.323; Moss E, 1998, CHILD DEV, V69, P1390, DOI 10.2307/1132273; National Heart Lungs and Blood Institute, 2017, QUAL ASS TOOL OBS CO; O'Connor E, 2011, INFANT MENT HEALTH J, V32, P450, DOI 10.1002/imhj.20305; O'Neill M, 2017, PROSPERO INT PROSPEC; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; R Development Core Team, 2009, R LANG ENV STAT COMP; Rahman A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001442; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Seifer R, 2004, CHILD DEV, V75, P850, DOI 10.1111/j.1467-8624.2004.00710.x; Solomon J, 2016, HANDBOOK OF ATTACHMENT, 3 EDITION, P366; Spieker Susan, 2010, Clin Child Psychol Psychiatry, V15, P97, DOI 10.1177/1359104509345878; Stevenson-Hinde J, 2013, ATTACH HUM DEV, V15, P618, DOI 10.1080/14616734.2013.830387; Stevenson-Hinde J, 2011, ATTACH HUM DEV, V13, P199, DOI 10.1080/14616734.2011.562409; STEVENSONHINDE J, 1995, CHILD DEV, V66, P583, DOI 10.1111/j.1467-8624.1995.tb00891.x; Thompson RA, 1991, EDUC PSYCHOL REV, V3, P269, DOI 10.1007/BF01319934; Toth SL, 2006, J CONSULT CLIN PSYCH, V74, P1006, DOI 10.1037/0022-006X.74.6.1006; Toth SL, 2009, CHILD DEV, V80, P192, DOI 10.1111/j.1467-8624.2008.01254.x; van Ijzendoorn MH, 1999, DEV PSYCHOPATHOL, V11, P225, DOI 10.1017/S0954579499002035; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wazana A, 2015, DEV PSYCHOPATHOL, V27, P1145, DOI 10.1017/S0954579415000735; Werner K., 2009, EMOTION REGULATION P; World Health Organization, 2017, DEP COMM MENT DIS GL	65	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204374	10.1371/journal.pone.0204374	http://dx.doi.org/10.1371/journal.pone.0204374			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278066	Green Submitted, gold, Green Published			2022-12-27	WOS:000446010200012
J	Pel, J; Choi, WWY; Leung, A; Shibahara, G; Gelinas, L; Despotovic, M; Ung, WL; Marziali, A				Pel, Joel; Choi, Wendy W. Y.; Leung, Amy; Shibahara, Gosuke; Gelinas, Laura; Despotovic, Milenko; Ung, W. Lloyd; Marziali, Andre			Duplex Proximity Sequencing (Pro-Seq): A method to improve DNA sequencing accuracy without the cost of molecular barcoding redundancy	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; CELL-FREE DNA; LUNG-CANCER PATIENTS; RARE MUTATIONS; QUANTIFICATION; AMPLIFICATION; MECHANISMS; MULTIPLEX; TISSUES; ERRORS	A challenge in the clinical adoption of cell-free DNA (cfDNA) liquid biopsies for cancer care is their high cost compared to potential reimbursement. The most common approach used in liquid biopsies to achieve high specificity detection of circulating tumor DNA (ctDNA) among a large background of normal cfDNA is to attach molecular barcodes to each DNA template, amplify it, and then sequence it many times to reach a low-error consensus. In applications where the highest possible specificity is required, error rate can be lowered further by independently detecting the sequences of both strands of the starting cfDNA. While effective in error reduction, the additional sequencing redundancy required by such barcoding methods can increase the cost of sequencing up to 100-fold over standard next-generation sequencing (NGS) of equivalent depth. We present a novel library construction and analysis method for NGS that achieves comparable performance to the best barcoding methods, but without the increase in sequencing and subsequent sequencing cost. Named Proximity-Sequencing (Pro-Seq), the method merges multiple copies of each template into a single sequencing read by physically linking the molecular copies so they seed a single sequencing cluster. Since multiple DNA copies of the same template are compared for consensus within the same cluster, sequencing accuracy is improved without the use of redundant reads. Additionally, it is possible to represent both senses of the starting duplex in a single cluster. The resulting workflow is simple, and can be completed by a single technician in a work day with minimal hands on time. Using both cfDNA and cell line DNA, we report the average per-mutation detection threshold and per-base analytical specificity to be 0.003% and >99.9997% respectively, demonstrating that Pro-Seq is among the highest performing liquid biopsy technologies in terms of both sensitivity and specificity, but with greatly reduced sequencing costs compared to existing methods of comparable accuracy.	[Pel, Joel; Choi, Wendy W. Y.; Leung, Amy; Shibahara, Gosuke; Gelinas, Laura; Despotovic, Milenko; Ung, W. Lloyd; Marziali, Andre] Boreal Genom Inc, Vancouver, BC, Canada; [Marziali, Andre] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada	University of British Columbia	Marziali, A (corresponding author), Boreal Genom Inc, Vancouver, BC, Canada.; Marziali, A (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada.	andre@phas.ubc.ca		Shibahara, Gosuke/0000-0001-8871-0952	Boreal Genomics, Inc.	Boreal Genomics, Inc.	This work was funded by Boreal Genomics, Inc., however, no authors received specific funding for this work. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbosh C., 2017, NATURE; [Anonymous], 2014, NEXT GENER SEQ APPL, DOI DOI 10.4172/JNGSA.100010625699289; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Chan KCA, 2016, P NATL ACAD SCI USA, V113, pE8159, DOI 10.1073/pnas.1615800113; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Gregory MT, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv915; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hoang ML, 2016, P NATL ACAD SCI USA, V113, P9846, DOI 10.1073/pnas.1607794113; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jee J, 2016, NATURE, V534, P693, DOI 10.1038/nature18313; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kirkizlar E, 2015, TRANSL ONCOL, V8, P407, DOI 10.1016/j.tranon.2015.08.004; Krimmel JD, 2016, P NATL ACAD SCI USA, V113, P6005, DOI 10.1073/pnas.1601311113; Kukita Y, 2015, DNA RES, V22, P269, DOI 10.1093/dnares/dsv010; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Lv WG, 2015, CLIN CHEM, V61, P172, DOI 10.1373/clinchem.2014.229328; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Paweletz CP, 2016, CLIN CANCER RES, V22, P915, DOI 10.1158/1078-0432.CCR-15-1627-T; Peng Q, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1806-8; Potapov V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169774; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Stahlberg A, 2017, NAT PROTOC, V12, P664, DOI 10.1038/nprot.2017.006; Stahlberg A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw224; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729	33	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204265	10.1371/journal.pone.0204265	http://dx.doi.org/10.1371/journal.pone.0204265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278055	gold, Green Published, Green Submitted			2022-12-27	WOS:000446010200010
J	Rogers-Carter, MM; Djerdjaj, A; Culp, AR; Elbaz, JA; Christianson, JP				Rogers-Carter, Morgan M.; Djerdjaj, Anthony; Culp, Amelia R.; Elbaz, Joshua A.; Christianson, John P.			Familiarity modulates social approach toward stressed conspecifics in female rats	PLOS ONE			English	Article							CONDITIONED FEAR RESPONSES; MEDIAL PREFRONTAL CORTEX; DECISION-MAKING; AUTISM SPECTRUM; BEHAVIOR; PAIN; EMPATHY; OXYTOCIN; AMYGDALA; BRAIN	Familiarity between conspecifics may influence how social affective cues shape social behaviors. In a social affective preference test, experimental rats, when given the choice to explore an unfamiliar stressed or a naive adult, will avoid interaction with a stressed conspecific. To determine if familiarity would influence social interactions with stressed conspecifics, male and female test rats underwent 2 social affective preference tests in isosexual triads where an experimental rat was presented with a naive and a stressed target conspecific who were either familiar (cagemate) or unfamiliar. Male and female experimental rats avoided stressed unfamiliar conspecifics. However, experimental female rats demonstrated a preference to interact with their stressed, familiar cagemates. Male and female rats exhibited more self-grooming and immobility behavior in the presence of stressed conspecifics, which may indicate emotion contagion. These findings suggest a sex-specific role of familiarity in social approach and avoidance, and warrant further mechanistic exploration.	[Rogers-Carter, Morgan M.; Djerdjaj, Anthony; Culp, Amelia R.; Elbaz, Joshua A.; Christianson, John P.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	Boston College	Rogers-Carter, MM (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	rogersop@bc.edu		Rogers-Carter, Morgan/0000-0001-9632-8796; Djerdjaj, Anthony/0000-0002-0168-0832	National Science Foundation Graduate Research Fellowship Program; Boston College Undergraduate Research Fellowships; Gianinno Family; National Institute of Mental Health [MH109545]; NSF Graduate Research Fellowship Program; NIH [MH109545]; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH109545] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Boston College Undergraduate Research Fellowships; Gianinno Family; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding in support of this research was provided by the National Science Foundation Graduate Research Fellowship Program to M.M.R.-C. (https://www.nsf.gov/); the Boston College Undergraduate Research Fellowships (A.C. & J. A. E.); the Gianinno Family (J.P.C) and National Institute of Mental Health Grant MH109545 to J.P.C. (https://www.nimh.nih.gov/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have no competing financial or commercial interests to declare. Funding in support of this research was provided by the NSF Graduate Research Fellowship Program (M.M.R-C.); the Boston College Undergraduate Research Fellowships (A.C. & J.A.E.); the Gianinno Family (J.P.C) and NIH Grant MH109545 (J.P.C.). We would like to thank Nancy McGilloway and the Boston College Animal Care Facility Staff for the husbandry of research animals involved in this study.	Arakawa H, 2010, NEUROSCIENCE, V171, P1141, DOI 10.1016/j.neuroscience.2010.10.013; Arakawa H, 2011, PSYCHONEUROENDOCRINO, V36, P557, DOI 10.1016/j.psyneuen.2010.09.001; Argue KJ, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0034-x; Baas D, 2008, PSYCHOL MED, V38, P747, DOI 10.1017/S0033291707001729; Bartal IB, 2014, ELIFE, V3, DOI 10.7554/eLife.01385; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; BOUTON ME, 1979, J EXP PSYCHOL ANIM B, V5, P368, DOI 10.1037/0097-7403.5.4.368; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Burkett JP, 2016, SCIENCE, V351, P375, DOI 10.1126/science.aac4785; Chen J, 2018, NEUROSCI BULL, V34, P216, DOI 10.1007/s12264-017-0135-0; Delmonte S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00430; Gonzalez-Liencres C, 2014, BEHAV BRAIN RES, V263, P16, DOI 10.1016/j.bbr.2014.01.020; Harnasato EK, 2017, PHYSIOL BEHAV, V182, P128, DOI 10.1016/j.physbeh.2017.10.011; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hinterbuchinger B, 2018, COGN NEUROPSYCHIATRY, V23, P117, DOI 10.1080/13546805.2018.1453791; Humphreys KL, 2016, J ABNORM CHILD PSYCH, V44, P1023, DOI 10.1007/s10802-015-0095-7; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Ishii A, 2016, HORM BEHAV, V81, P53, DOI 10.1016/j.yhbeh.2016.03.003; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kavaliers M, 2004, HORM BEHAV, V46, P272, DOI 10.1016/j.yhbeh.2004.03.005; Kavaliers M, 2012, PHYSIOL BEHAV, V107, P751, DOI 10.1016/j.physbeh.2012.03.017; Kiyokawa Y, 2005, BRAIN RES, V1043, P145, DOI 10.1016/j.brainres.2005.02.061; Kiyokawa Y, 2007, EUR J NEUROSCI, V26, P3606, DOI 10.1111/j.1460-9568.2007.05969.x; Kiyokawa Y, 2018, PHYSIOL BEHAV, V194, P177, DOI 10.1016/j.physbeh.2018.05.027; Kiyokawa Y, 2017, CURR TOP BEHAV NEURO, V30, P47, DOI 10.1007/7854_2015_406; Kiyokawa Y, 2014, BEHAV BRAIN RES, V267, P189, DOI 10.1016/j.bbr.2014.03.043; Knapska E, 2006, P NATL ACAD SCI USA, V103, P3858, DOI 10.1073/pnas.0511302103; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Levin IP, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00539; Li Z, 2014, PAIN, V155, P1253, DOI 10.1016/j.pain.2014.03.019; Lu YF, 2018, NEUROSCI LETT, V662, P385, DOI 10.1016/j.neulet.2017.10.063; Lungwitz EA, 2014, NEUROPSYCHOPHARMACOL, V39, P1009, DOI 10.1038/npp.2013.302; Meyza KZ, 2017, NEUROSCI BIOBEHAV R, V76, P216, DOI 10.1016/j.neubiorev.2016.10.028; Mikosz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18114; Nakamura K, 2016, HORM BEHAV, V82, P72, DOI 10.1016/j.yhbeh.2016.05.003; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; Rogers-Carter MM, 2018, NAT NEUROSCI, V21, P404, DOI 10.1038/s41593-018-0071-y; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; Silberberg A, 2014, ANIM COGN, V17, P609, DOI [10.1007/s10071-013-0623-1, 10.1007/s10071-013-0692-1]; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith CJW, 2017, HORM BEHAV, V93, P94, DOI 10.1016/j.yhbeh.2017.05.005; Staub E, J PERSONALITY SOCIAL, V30, P279; Sterley TL, 2018, NAT NEUROSCI, V21, P393, DOI 10.1038/s41593-017-0044-6; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Yang LQ, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1313-3; ZALAQUETT C, 1991, PHYSIOL BEHAV, V50, P221, DOI 10.1016/0031-9384(91)90524-R	48	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0200971	10.1371/journal.pone.0200971	http://dx.doi.org/10.1371/journal.pone.0200971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278039	gold, Green Submitted, Green Published			2022-12-27	WOS:000446010200001
J	Sitthiyotha, T; Pichyangkura, R; Chunsrivirot, S				Sitthiyotha, Thassanai; Pichyangkura, Rath; Chunsrivirot, Surasak			Molecular dynamics provides insight into how N251A and N251Y mutations in the active site of Bacillus licheniformis RN-01 levansucrase disrupt production of long-chain levan	PLOS ONE			English	Article							SWISS-MODEL; FREE-ENERGY; CRYSTAL-STRUCTURE; MM-PBSA; SIMULATIONS; BINDING; PERFORMANCE; MM/PBSA; GENE; MM/GBSA	Produced by levansucrase, levan and levan oligosaccharides (GF(n)) have potential applications in food and pharmaceutical industries such as prebiotics, anti-tumor and anti-inflammatory agents. Previous study reported that Bacillus licheniformis RN-01 levansucrase could produce levan oligosaccharides and long-chain levan. However, its N251A and N251Y mutants could effectively produce short-chain oligosaccharides upto GF(3), but they could not produce long-chain levan. We hypothesized that these mutations probably reduced GF(3) binding affinity in levansucrase active site that contains fructosyl-Asp93 intermediate and caused GF(3) to be in an unfavorable orientation for transfructosylation; therefore, levansucrase could not effectively extend GF(3) by one fructosyl residue to produce GF(4) and subsequently long-chain levan. However, these mutations probably did not significantly reduce binding affinity or drastically change orientation of GF(2); therefore, levansucrase could still extend GF(2) to produce GF(3). Using this hypothesis, we employed molecular dynamics to investigate effects of these mutations on GF(2)/GF(3) binding in levansucrase active site. Our results reasonably support this hypothesis as N251A and N251Y mutations did not significantly reduce GF(2) binding affinity, as calculated by MM-GBSA technique and hydrogen bond occupations, or drastically change orientation of GF(2) in levansucrase active site, as measured by distance between atoms necessary for transfructosylation. However, these mutations drastically decreased GF(3) binding affinity and caused GF(3) to be in an unfavorable orientation for transfructosylation. Furthermore, the free energy decomposition and hydrogen bond occupation results suggest the importance of Arg255 in GF(2)/GF(3) binding in levansucrase active site. This study provides important and novel insight into the effects of N251A and N251Y mutations on GF(2)/GF(3) binding in levansucrase active site and how they may disrupt production of long-chain levan. This knowledge could be beneficial in designing levansucrase to efficiently produce levan oligosaccharides with desired length.	[Sitthiyotha, Thassanai; Pichyangkura, Rath; Chunsrivirot, Surasak] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Sitthiyotha, Thassanai; Chunsrivirot, Surasak] Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok, Thailand.	surasak.ch@chula.ac.th		Pichyangkura, Rath/0000-0003-2451-5941	Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement [07/2557]; Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University; Graduate School, Chulalongkorn University; Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project"; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University [RGN_2558_002_01_23]; Thailand Research Fund [TRG5880222, IRG 5780008]	Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement; Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University; Graduate School, Chulalongkorn University(Chulalongkorn University); Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project"; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University; Thailand Research Fund(Thailand Research Fund (TRF))	This research is supported by the Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement [Grant no. 07/2557 to SC] and Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University. TS was partially supported by the Scholarship from Graduate School, Chulalongkorn University to commemorate The Celebrations on the Auspicious Occasion of Her Royal Highness Princess Maha Chakri Sirindhorn's 5th Cycle (60th) Birthday. RP was partially supported by Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project." SC was also partially supported by the Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University [Grant no. RGN_2558_002_01_23] and the Thailand Research Fund [Grant no. TRG5880222 and IRG 5780008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arvidson SA, 2006, CARBOHYD POLYM, V65, P144, DOI 10.1016/j.carbpol.2005.12.039; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bryce RA, 2001, BIOPHYS J, V81, P1373, DOI 10.1016/S0006-3495(01)75793-1; Cao RY, 2012, J PHYS CHEM B, V116, P6087, DOI 10.1021/jp3010647; Case D.A., 2022, AMBER; Dal Bello F, 2001, SYST APPL MICROBIOL, V24, P232, DOI 10.1078/0723-2020-00033; Dennington R., 2009, GAUSSVIEW VERSION 5; Fadda E, 2010, DRUG DISCOV TODAY, V15, P596, DOI 10.1016/j.drudis.2010.06.001; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; GEIER G, 1993, PHYSIOL MOL PLANT P, V42, P387, DOI 10.1006/pmpp.1993.1029; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Goldman D, 2008, J BIOL CHEM, V283, P32209, DOI 10.1074/jbc.M805985200; Gonzalez-Garcinuno A, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0703-z; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Han J, 2016, APPL ENVIRON MICROB, V82, P1383, DOI 10.1128/AEM.02944-15; Han Y W, 1990, Adv Appl Microbiol, V35, P171, DOI 10.1016/S0065-2164(08)70244-2; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Kang FK, 2005, BBA-GENE STRUCT EXPR, V1727, P5, DOI 10.1016/j.bbaexp.2004.10.012; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim KH, 2005, J COSMET SCI, V56, P395; Kim MG, 1998, BIOTECHNOL LETT, V20, P333, DOI 10.1023/A:1005310926399; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Li Y, 1997, BBA-GENE STRUCT EXPR, V1353, P203, DOI 10.1016/S0167-4781(97)00103-6; Liu JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12359; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Mena-Ulecia K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142774; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Nakapong S., 2011, THESIS; Niu YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145219; Olarte-Avellaneda S, 2016, INTERDISCIP SCI, P1; Rairakhwada D, 2007, FISH SHELLFISH IMMUN, V22, P477, DOI 10.1016/j.fsi.2006.06.005; Rairakhwada D, 2010, J IND MICROBIOL BIOT, V37, P195, DOI 10.1007/s10295-009-0664-2; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Seibel J, 2006, CARBOHYD RES, V341, P2335, DOI 10.1016/j.carres.2006.07.001; Singh PK, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-2935-y; Song KB, 1998, ANN NY ACAD SCI, V864, P506, DOI 10.1111/j.1749-6632.1998.tb10369.x; Srikanth R, 2015, CARBOHYD POLYM, V120, P102, DOI 10.1016/j.carbpol.2014.12.003; STEINMETZ M, 1985, MOL GEN GENET, V200, P220, DOI 10.1007/BF00425427; Strube CP, 2011, J BIOL CHEM; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P22035, DOI 10.1039/c4cp03179b; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Virtanen SI, 2015, J MOL GRAPH MODEL, V62, P303, DOI 10.1016/j.jmgm.2015.10.012; Visnapuu T, 2011, J BIOTECHNOL, V155, P338, DOI 10.1016/j.jbiotec.2011.07.026; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Wuerges J, 2015, J STRUCT BIOL, V191, P290, DOI 10.1016/j.jsb.2015.07.010; Xu L, 2013, J PHYS CHEM B, V117, P8408, DOI 10.1021/jp404160y; Ylilauri M, 2013, J CHEM INF MODEL, V53, P2626, DOI 10.1021/ci4002475; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608; Zuo ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37584	65	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204915	10.1371/journal.pone.0204915	http://dx.doi.org/10.1371/journal.pone.0204915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278092	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200027
J	Stewart, D; Thomas, B; MacLure, K; Wilbur, K; Wilby, K; Pallivalapila, A; Dijkstra, A; Ryan, C; El Kassem, W; Awaisu, A; McLay, JS; Singh, R; Al Hail, M				Stewart, Derek; Thomas, Binny; MacLure, Katie; Wilbur, Kerry; Wilby, Kyle; Pallivalapila, Abdulrouf; Dijkstra, Andrea; Ryan, Cristin; El Kassem, Wessam; Awaisu, Ahmed; McLay, James S.; Singh, Rajvir; Al Hail, Moza			Exploring facilitators and barriers to medication error reporting among healthcare professionals in Qatar using the theoretical domains framework: A mixed-methods approach	PLOS ONE			English	Article							ATTITUDES; HOSPITALS; NURSES	Background There is a need for theory informed interventions to optimise medication reporting. This study aimed to quantify and explain behavioural determinants relating to error reporting of healthcare professionals in Qatar as a basis of developing interventions to optimise the effectiveness and efficiency of error reporting. Methods A sequential explanatory mixed methods design comprising a cross-sectional survey followed by focus groups in Hamad Medical Corporation, Qatar. All doctors, nurses and pharmacists were invited to complete a questionnaire that included items of behavioural determinants derived from the Theoretical Domains Framework (TDF), an integrative framework of 33 theories of behaviour change. Principal component analysis (PCA) was used to identify components, with total component scores computed. Differences in total scores among demographic groupings were tested using Mann-Whitney U test (2 groups) or Kruskal-Wallis (>2 groups). Respondents expressing interest in focus group participation were sampled purposively, and discussions based on survey findings using the TDF to provide further insight to survey findings. Ethical approval was received from Hamad Medical Corporation, Robert Gordon University, and Qatar University. Results One thousand, six hundred and four questionnaires were received (67.9% nurses, 13.3% doctors, 12.9% pharmacists). Questionnaire items clustered into six components of: knowledge and skills related to error reporting; feedback and support; action and impact; motivation; effort; and emotions. There were statistically significant higher scores in relation to age (older more positive, p<0.001), experience as a healthcare professional (more experienced most positive apart from those with the highest level of experience, p<0.001), and profession (pharmacists most positive, p<0.05). Fifty-four healthcare professionals from different disciplines participated in the focus groups. Themes mapped to nine of fourteen TDF domains. In terms of emotions, the themes that emerged as barriers to error reporting were: fear and worry on submitting a report; that submitting was likely to lead to further investigation that could impact performance evaluation and career progression; concerns over the impact on working relationships; and the potential lack of confidentiality. Conclusions This study has quantified and explained key facilitators and barriers of medication error reporting. Barriers appeared to be largely centred on issues relating to emotions and related beliefs of consequences. Quantitative results demonstrated that while these were issues for all healthcare professionals, those younger and less experienced were most concerned. Qualitative findings highlighted particular concerns relating to these emotional aspects. These results can be used to develop theoretically informed interventions with the aims of improving the effectiveness and efficiency of the medication reporting systems impacting patient safety.	[Stewart, Derek; Thomas, Binny; MacLure, Katie] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland; [Thomas, Binny; Pallivalapila, Abdulrouf; El Kassem, Wessam; Al Hail, Moza] Hamad Med Corp, Womens Hosp, Doha, Qatar; [Wilbur, Kerry; Wilby, Kyle; Awaisu, Ahmed] Qatar Univ, Coll Pharm, Doha, Qatar; [Dijkstra, Andrea; Singh, Rajvir] Hamad Med Corp, Doha, Qatar; [Ryan, Cristin] Royal Coll Surgeons Ireland, Sch Pharm, Dublin, Ireland; [McLay, James S.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	Robert Gordon University; Hamad Medical Corporation; Qatar University; Hamad Medical Corporation; Royal College of Surgeons - Ireland; University of Aberdeen	Stewart, D (corresponding author), Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland.	d.stewart@rgu.ac.uk	MacLure, Katie/GRJ-8912-2022; Thomas, Binny/AFT-6887-2022; Awaisu, Ahmed/AAU-3959-2020; Elkassem, Wessam/H-9989-2019; Thomas, Binny/H-6129-2017; Wilby, Kyle/R-3018-2018	Awaisu, Ahmed/0000-0002-9029-8925; Elkassem, Wessam/0000-0003-2145-7555; Alhail, Moza/0000-0002-7442-3773; Ryan, Cristin/0000-0002-6037-4413; Stewart, Derek/0000-0001-7360-8592; Wilbur, Kerry/0000-0002-5936-4429; Thomas, Binny/0000-0003-1065-8343; MacLure, Katie/0000-0003-0686-948X; Wilby, Kyle/0000-0002-1670-2512	Qatar National Research Fund [NPRP-7-388-3-095]	Qatar National Research Fund(Qatar National Research Fund (QNRF))	This work was supported by the Qatar National Research Fund, NPRP-7-388-3-095.	Alqubaisi M, 2016, EUR J CLIN PHARMACOL, V72, P1401, DOI 10.1007/s00228-016-2124-z; Alqubaisi M, 2016, EUR J CLIN PHARMACOL, V72, P887, DOI 10.1007/s00228-016-2054-9; Bahadori Mohammadkarim, 2013, ISRN Nurs, V2013, P876563, DOI 10.1155/2013/876563; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Chiang HY, 2010, NURS OUTLOOK, V58, P17, DOI 10.1016/j.outlook.2009.06.001; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Costello A.B., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Craig P, 2008, BMJ-BRIT MED J, V337, pa1665; Creswell J, 2006, CHOOSING MIXED METHO; Donaldson LJ, 2017, LANCET, V389, P1680, DOI 10.1016/S0140-6736(17)31047-4; Evans SM, 2006, QUAL SAF HEALTH CARE, V15, P39, DOI 10.1136/qshc.2004.012559; Evans SM, 2007, QUAL SAF HEALTH CARE, V16, P169, DOI 10.1136/qshc.2006.019349; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Fusch PI, 2015, QUAL REP, V20, P1408; Halligan M, 2011, BMJ QUAL SAF, V20, P338, DOI 10.1136/bmjqs.2010.040964; Hamad Medical Corporation, 2011, MAN REP MED ERR NEAR; Hartnell N, 2012, BMJ QUAL SAF, V21, P361, DOI 10.1136/bmjqs-2011-000299; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Huijg JM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-33; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Kingston MJ, 2004, MED J AUSTRALIA, V181, P36, DOI 10.5694/j.1326-5377.2004.tb06158.x; Kohn, 2000, ERR IS HUMAN BUILDIN; KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308; Michie S, 2015, HEALTH TECHNOL ASSES, P19; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Nunnally K, 2010, PSYCHOMETRIC THEORY, V3rd; Patrician PA, 2009, J NURS CARE QUAL, V24, P277, DOI 10.1097/NCQ.0b013e3181afa4cb; Pluye P, 2014, ANNU REV PUBL HEALTH, V35, P29, DOI 10.1146/annurev-publhealth-032013-182440; Ritchie J, 2002, QUALITATIVE RES COMP, P305, DOI DOI 10.4135/9781412986274; Sarvadikar A, 2010, EUR J CLIN PHARMACOL, V66, P843, DOI 10.1007/s00228-010-0838-x; Shenton A. K., 2004, ED INFORM, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Stratton Karen M, 2004, J Pediatr Nurs, V19, P385; Wakefield DS, 1999, AM J MED QUAL, V14, P81, DOI 10.1177/106286069901400203; Williams SD, 2013, RES SOC ADMIN PHARM, V9, P80, DOI 10.1016/j.sapharm.2012.02.002; World Health Organization, 2017, MED HARM WHO GLOB PA	35	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204987	10.1371/journal.pone.0204987	http://dx.doi.org/10.1371/journal.pone.0204987			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278077	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200030
J	Donohue, JM; Guclu, H; Gellad, WF; Chang, CCH; Huskamp, HA; Choudhry, NK; Zhang, RX; Lo-Ciganic, WH; Junker, SP; Anderson, T; Richards-Shubik, S				Donohue, Julie M.; Guclu, Hasan; Gellad, Walid F.; Chang, Chung-Chou H.; Huskamp, Haiden A.; Choudhry, Niteesh K.; Zhang, Ruoxin; Lo-Ciganic, Wei-Hsuan; Junker, Stefanie P.; Anderson, Timothy; Richards-Shubik, Seth			Influence of peer networks on physician adoption of new drugs	PLOS ONE			English	Article							PATIENT-SHARING NETWORKS; PRIMARY-CARE; SOCIAL NETWORKS; DIFFUSION; BEHAVIOR; CENTRALITY; INNOVATION; CONTAGION; MEDICARE; DECISION	Although physicians learn about new medical technologies from their peers, the magnitude and source of peer influence is unknown. We estimate the effect of peer adoption of three first-in-class medications (dabigatran, sitigliptin, and aliskiren) on physicians' own adoption of those medications. We included 11,958 physicians in Pennsylvania prescribing anticoagulant, antidiabetic, and antihypertensive medications. We constructed 4 types of peer networks based on shared Medicare and Medicaid patients, medical group affiliation, hospital affiliation, and medical school/residency training. Instrumental variables analysis was used to estimate the causal effect of peer adoption (fraction of peers in each network adopting the new drug) on physician adoption (prescribing at least the median number prescriptions within 15 months of the new drug's introduction). We illustrate how physician network position can inform targeting of interventions to physicians by computing a social multiplier. Dabigatran was adopted by 25.2%, sitagliptin by 24.5% and aliskiren by 8.3% of physicians. A 10-percentage point increase in peer adoption in the patient-sharing network led to a 5.90% (SE = 1.50%, p<0.001) increase in physician adoption of dabigatran, 8.32% (SE = 1.51%, p<0.001) increase in sitagliptin, and 7.84% increase in aliskiren adoption (SE = 2.93%, p<0.001). Peer effects through shared hospital affiliation were positive but not significant, and medical group and training network effects were not reliably estimated. Physicians in the top decile of patient-sharing network peers were estimated to have nearly 2-fold stronger influence on their peers' adoption compared to physicians in the top decile of prescribing volume. Limitations include lack of detailed clinical information and pharmaceutical promotion, variables which may influence physician adoption but which are unlikely to bias our peer effect estimates. Peer adoption, especially by those with whom physicians share patients, strongly influenced physician adoption of new drugs. Our study shows the potential for using information on physician peer networks to improve technology diffusion.	[Donohue, Julie M.; Junker, Stefanie P.] Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Guclu, Hasan] Istanbul Medeniyet Univ, Sch Engn & Nat Sci, Dept Stat, Istanbul, Turkey; [Guclu, Hasan] Istanbul Medeniyet Univ, Sch Med, Dept Biostat & Med Informat, Istanbul, Turkey; [Gellad, Walid F.] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Hlth Policy Inst, Pittsburgh, PA USA; [Gellad, Walid F.; Chang, Chung-Chou H.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Gellad, Walid F.] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA USA; [Huskamp, Haiden A.] Harvard Univ, Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Choudhry, Niteesh K.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Choudhry, Niteesh K.] Harvard Med Sch, Boston, MA USA; [Zhang, Ruoxin] Permanente Med Grp Inc, Qual & Operat Support, Oakland, CA USA; [Lo-Ciganic, Wei-Hsuan] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA; [Anderson, Timothy] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Richards-Shubik, Seth] Lehigh Univ, Coll Business & Econ, Dept Econ, Bethlehem, PA 18015 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Istanbul Medeniyet University; Istanbul Medeniyet University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Permanente Medical Groups; University of Arizona; University of California System; University of California San Francisco; Lehigh University	Donohue, JM (corresponding author), Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA.	jdonohue@pitt.edu	Guclu, Hasan/B-7080-2008	Guclu, Hasan/0000-0003-3582-9460; Donohue, Julie/0000-0003-2418-6017	National Heart, Lung, and Blood Institute [R01HL119246]; Permanente Medical Group, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119246] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Permanente Medical Group, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Heart, Lung, and Blood Institute (R01HL119246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of our authors (RZ) is now employed by The Permanente Medical Group, Inc. She was employed solely by the University of Pittsburgh when the analyses for this manuscript were conducted. The Permanente Medical Group, Inc. provided support in the form of salary for author RZ when this work was submitted to PLOS ONE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Altalib HH, 2017, EPILEPSY BEHAV, V73, P31, DOI 10.1016/j.yebeh.2017.05.026; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Barnett ML, 2012, MED CARE, V50, P152, DOI 10.1097/MLR.0b013e31822dcef7; Barnett ML, 2011, HEALTH SERV RES, V46, P1592, DOI 10.1111/j.1475-6773.2011.01262.x; Becker G., 2000, SOCIAL ECONOMICS; Bhatia T, 2011, INT J RES MARK, V28, P51, DOI 10.1016/j.ijresmar.2010.10.002; Blume L.E., 2011, HDB SOCIAL EC, V1B; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Casalino LP, 2015, MED CARE, V53, P534, DOI 10.1097/MLR.0000000000000365; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Chambers D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041911; Christakis NA, 2010, CONTAGION PRESCRIBIN; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Fattore G, 2009, HEALTH POLICY, V92, P141, DOI 10.1016/j.healthpol.2009.03.005; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Flodgren G, 2011, COCHRANE DATABASE SY, V8; Gaviria A, 2001, REV ECON STAT, V83, P257, DOI 10.1162/00346530151143798; Grimshaw JM, 2001, MED CARE, V39, pII2; Institute of Medicine, 2013, VARIATION HLTH CARE, DOI [10.17226/18393, DOI 10.17226/18393]; Iyengar R, 2011, MARKET SCI, V30, P195, DOI 10.1287/mksc.1100.0566; Kaiser Family Foundation, HLTH INS COV TOT POP; Kang CH, 2016, ARTIF INTELL, V239, P70, DOI 10.1016/j.artint.2016.06.008; Keating NL, 2007, J GEN INTERN MED, V22, P794, DOI 10.1007/s11606-007-0190-8; Keating NL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx009; Landon BE, 2012, JAMA-J AM MED ASSOC, V308, P265, DOI 10.1001/jama.2012.7615; Lewis JM, 2008, SOC SCI MED, V67, P280, DOI 10.1016/j.socscimed.2008.03.046; Liu QH, 2018, CHAOS INTERDISCIPLIN, V28; LOMAS J, 1991, JAMA-J AM MED ASSOC, V265, P2202, DOI 10.1001/jama.265.17.2202; Manchanda P, 2008, MARKET SCI, V27, P961, DOI 10.1287/mksc.1070.0354; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Mascia D, 2011, SOC SCI MED, V72, P798, DOI 10.1016/j.socscimed.2010.12.011; McGettigan P, 2001, BRIT J CLIN PHARMACO, V51, P184; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meltzer D, 2010, SOC SCI MED, V71, P1119, DOI 10.1016/j.socscimed.2010.05.012; Menchik DA, 2010, J HEALTH SOC BEHAV, V51, P137, DOI 10.1177/0022146510372231; Moen EL, 2016, HEALTH SERV OUTCOME, V16, P132, DOI 10.1007/s10742-016-0152-x; Moffitt R.A., 2001, SOCIAL DYNAMICS, P45; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Nair HS, 2010, J MARKETING RES, V47, P883, DOI 10.1509/jmkr.47.5.883; Neumann PJ, 2005, NEW ENGL J MED, V353, P1516, DOI 10.1056/NEJMsb050564; Norris S., 2010, DRUG CLASS REV DIREC; Pollack CE, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw330; Pollack CE, 2012, HEALTH SERV RES, V47, P380, DOI 10.1111/j.1475-6773.2011.01331.x; Prosser H, 2006, SOC SCI MED, V62, P1565, DOI 10.1016/j.socscimed.2005.08.035; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61; Scott J, 2005, ANN FAM MED, V3, P443, DOI 10.1370/afm.344; Smith M., 2013, BUSINESS MODELS RESP; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Stock J., 2005, NBER TECHNICAL WORKI, P80; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valente TW, 1999, ANN AM ACAD POLIT SS, V566, P55, DOI 10.1177/0002716299566001005; Van den Bulte C, 2001, AM J SOCIOL, V106, P1409, DOI 10.1086/320819; Van Hoof TJ, 2015, AM HEALTH DRUG BENEF, V8, P414; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yeh JS, 2016, AM HEALTH DRUG BENEF, V9, P42; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zheng K, 2010, J AM MED INFORM ASSN, V17, P328, DOI 10.1136/jamia.2009.000877	63	25	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204826	10.1371/journal.pone.0204826	http://dx.doi.org/10.1371/journal.pone.0204826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273368	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700037
J	Mezghani, N; Mechmeche, I; Mitiche, A; Ouakrim, Y; de Guise, JA				Mezghani, Neila; Mechmeche, Imene; Mitiche, Amar; Ouakrim, Youssef; de Guise, Jacques A.			An analysis of 3D knee kinematic data complexity in knee osteoarthritis and asymptomatic controls	PLOS ONE			English	Article							CLASSIFIER DOMAINS; COMPETENCE; SYSTEM	Three-dimensional (3D) knee kinematic data, measuring flexion/extension, abduction/ adduction, and internal/external rotation angle variations during locomotion, provide essential information to diagnose, classify, and treat musculoskeletal knee pathologies. However, and so across genders, the curse of dimensionality, intra-class high variability, and interclass proximity make this data usually difficult to interpret, particularly in tasks such as knee pathology classification. The purpose of this study is to use data complexity analysis to get some insight into this difficulty. Using 3D knee kinematic measurements recorded from osteoarthritis and asymptomatic subjects, we evaluated both single feature complexity, where each feature is taken individually, and global feature complexity, where features are considered simultaneously. These evaluations afford a characterization of data complexity independent of the used classifier and, therefore, provide information as to the level of classification performance one can expect. Comparative results, using reference databases, reveal that knee kinematic data are highly complex, and thus foretell the difficulty of knee pathology classification.	[Mezghani, Neila; Ouakrim, Youssef] TELUQ Univ, LICEF Res Ctr, 5800 Rue St Denis, Montreal, PQ H2S 3L4, Canada; [Mechmeche, Imene; Mitiche, Amar] INRS Ctr Energie Mat & Telecommun, 800 Rue Gauchetiere West, Montreal, PQ H5A 1E4, Canada; [Mezghani, Neila; Ouakrim, Youssef; de Guise, Jacques A.] Ecole Technol Super, Ctr Rech CHUM, Lab Rech Imagerie & Orthopedie, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada	University of Quebec; Universite TELUQ; University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; University of Quebec; Ecole de Technologie Superieure - Canada	Mezghani, N (corresponding author), TELUQ Univ, LICEF Res Ctr, 5800 Rue St Denis, Montreal, PQ H2S 3L4, Canada.; Mezghani, N (corresponding author), Ecole Technol Super, Ctr Rech CHUM, Lab Rech Imagerie & Orthopedie, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada.	neila.mezghani@teluq.ca			Natural Sciences and Engineering Research Council Grant [RGPIN-2015-03853]; Canada Research Chair on Biomedical Data Mining [950-231214]	Natural Sciences and Engineering Research Council Grant; Canada Research Chair on Biomedical Data Mining	This research was supported in part by the Natural Sciences and Engineering Research Council Grant (RGPIN-2015-03853) (http://www.nserc-crsng.gc.ca/professors-professeurs/rpp-pp/crd-rdc_eng.asp) and the Canada Research Chair on Biomedical Data Mining (950-231214) (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) (NM).	Altman R, 2006, ARTHRITIS RHEUM, V29, P2512; Bensalma F, 2018, 20 BIENN M CAN SOC B; Bernado-Mansilla E, 2005, IEEE T EVOLUT COMPUT, V9, P82, DOI 10.1109/TEVC.2004.840153; Beynon MJ, 2006, IEEE T SYST MAN CY A, V36, P173, DOI 10.1109/TSMCA.2006.859098; Boivin K, 2006, GAIT POSTURE, V24, pS164, DOI [10.1016/j.gaitpost.2006.11.114, DOI 10.1016/J.GAITPOST.2006.11.114]; Bytyqi D, 2014, INT ORTHOP, V38, P1191, DOI 10.1007/s00264-014-2312-3; Chen J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10376-0; Clement J, 2018, GAIT POSTURE, V64, P198, DOI 10.1016/j.gaitpost.2018.06.024; Duda R. O., 2001, PATTERN CLASSIFICATI; FRIEDMAN JH, 1979, ANN STAT, V7, P697, DOI 10.1214/aos/1176344722; Fuentes A, 2011, ORTHOPAEDIC P, V93, P278; Gaudreault N, 2011, CLIN BIOMECH, V26, P284, DOI 10.1016/j.clinbiomech.2010.10.004; Hagemeister N, 2005, J BIOMECH, V38, P1926, DOI 10.1016/j.jbiomech.2005.05.013; Ho TK, 2006, ADV INFO KNOW PROC, P135; Ho TK, 2002, PATTERN ANAL APPL, V5, P102, DOI 10.1007/s100440200009; Ho TK, 1997, IEEE T PATTERN ANAL, V19, P1067, DOI 10.1109/34.625107; Hunter DJ, 2013, OSTEOARTHR CARTILAGE, V21, pS253, DOI 10.1016/j.joca.2013.02.524; Hunter DJ, 2009, THER ADV MUSCULOSKEL, V1, P35, DOI 10.1177/1759720X09342132; KADABA MP, 1989, J ORTHOPAED RES, V7, P849, DOI 10.1002/jor.1100070611; KOLMOGOROV AN, 1968, INT J COMPUT MATH, V2, P157, DOI 10.1080/00207166808803030; Lebourgeois F., 1996, Proceedings of the 13th International Conference on Pattern Recognition, P256, DOI 10.1109/ICPR.1996.547426; Li M., 2009, INTRO KOLMOGOROV COM; Lorena AC, 2015, LECT NOTES COMPUT SC, V9489, P158, DOI 10.1007/978-3-319-26532-2_18; Lustig S, 2012, KNEE SURG SPORT TR A, V20, P633, DOI 10.1007/s00167-011-1867-4; MACIEJOWSKI JM, 1979, AUTOMATICA, V15, P579, DOI 10.1016/0005-1098(79)90006-2; Mansilla EB, 2004, INT C PATT RECOG, P136, DOI 10.1109/ICPR.2004.1334026; Mechmeche I, 2016, IEEE ENG MED BIO, P884, DOI 10.1109/EMBC.2016.7590842; Medved V., 2000, MEASUREMENT HUMAN LO; Mezghani N, 2012, OSTEOARTHR CARTILAGE, V20, pS97, DOI 10.1016/j.joca.2012.02.102; Mezghani N, 2008, J MECH MED BIOL, V8, P45, DOI 10.1142/S0219519408002474; Mezghani N, 2008, IEEE T BIO-MED ENG, V55, P1230, DOI 10.1109/TBME.2007.905388; Mezghani N, 2017, J BIOMECH, V52, P106, DOI 10.1016/j.jbiomech.2016.12.022; Ouakrim Y, 2018, 20 BIENN M CAN SOC B; Sati M, 1997, Comput Aided Surg, V2, P108, DOI 10.1002/(SICI)1097-0150(1997)2:2<108::AID-IGS4>3.0.CO;2-3; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; SMITH SP, 1988, IEEE T PATTERN ANAL, V10, P757, DOI 10.1109/34.6789; Thorp LE, 2006, ARTHRITIS RHEUM, V54, P3842, DOI 10.1002/art.22247; Turcot K, 2008, ARCH PHYS MED REHAB, V89, P732, DOI 10.1016/j.apmr.2007.09.033; Wilson JLA, 2011, OSTEOARTHR CARTILAGE, V19, P186, DOI 10.1016/j.joca.2010.10.020	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0202348	10.1371/journal.pone.0202348	http://dx.doi.org/10.1371/journal.pone.0202348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273346	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000446124700003
J	Garcia, LG; Pierce, GJ; Autret, E; Torres-Palenzuela, JM				Gonzalez Garcia, Laura; Pierce, Graham J.; Autret, Emmanuelle; Torres-Palenzuela, Jesus M.			Multi-scale habitat preference analyses for Azorean blue whales	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BALAENOPTERA-MUSCULUS; MESOSCALE VARIABILITY; MARINE ANIMALS; NORTH-ATLANTIC; FIN WHALES; SEA; CETACEANS; WATERS; OCEAN	Blue whales are sighted every year around the Azores islands, which apparently provide an important seasonal foraging area. In this paper we aim to characterize habitat preferences and analyze the temporal distribution of blue whales around Sao Miguel Island. To do so, we applied Generalized Additive Models to an opportunistic cetacean occurrence dataset and remotely sensed environmental data on bathymetry, sea surface temperature, chlorophyll concentration and altimetry. We provide a brief description of the oceanography of the area, emphasizing its high spatio-temporal variability. In order to capture this dynamism, we used environmental data with two different spatial resolutions (low and high) and three different temporal resolutions (daily, weekly and monthly), thus accounting for both long-term oceanographic events such as the spring bloom, and shorter-term features such as eddies or fronts. Our results show that blue whales have a well-defined ecological niche around the Azores. They usually cross the archipelago from March to June and habitat suitability is highest in dynamic areas (with high Eddy Kinetic Energy) characterized by convergence or aggregation zones where productivity is enhanced. Multi-scale studies are useful to understand the ecological niche and habitat requirements of highly mobile species that can easily react to short-term changes in the environment.	[Gonzalez Garcia, Laura; Torres-Palenzuela, Jesus M.] Univ Vigo, Appl Phys Dept, Vigo, Spain; [Pierce, Graham J.] CSIC, Inst Invest Marinas, Vigo, Spain; [Pierce, Graham J.] Univ Aveiro, CESAM, Aveiro, Portugal; [Pierce, Graham J.] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Autret, Emmanuelle] IFREMER, Lab Oceanog Phys & Spatiale, Brest, France	Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Universidade de Aveiro; Universidade de Aveiro; Ifremer	Garcia, LG; Torres-Palenzuela, JM (corresponding author), Univ Vigo, Appl Phys Dept, Vigo, Spain.	lauragonzalez@uvigo.es; jesu@uvigo.es	Palenzuela, Jesus M Torres/AAB-1994-2019; Pierce, Graham/A-5404-2018	Palenzuela, Jesus M Torres/0000-0002-0629-0710; Pierce, Graham/0000-0002-4744-4501; AUTRET, Emmanuelle/0000-0002-0979-9192; Gonzalez Garcia, Laura/0000-0001-7353-0983	Applied Physics Department of the Universidad de Vigo (Spain); Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [Modalidade B] [PRE/2013/409]; LabexMER	Applied Physics Department of the Universidad de Vigo (Spain); Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [Modalidade B]; LabexMER	This work was supported by the Applied Physics Department of the Universidad de Vigo (Spain); a predoctoral grant from Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [Modalidade B] (PRE/2013/409) for the Marine Science, Technology and Management (DOMAR) PhD Program (www.edu.xunta.gal/); and a grant from LabexMER action for young researchers in 2016 (https://www.labexmer.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bashmachnikov Igor, 2004, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, P19; Becker E. A., 2012, Endangered Species Research, V16, P97, DOI 10.3354/esr00390; Becker EA, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020149; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Caldeira RMA, 2002, REMOTE SENS ENVIRON, V80, P336, DOI 10.1016/S0034-4257(01)00316-9; Caldeira RMA, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00037; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Canny J., 1987, READINGS COMPUTER VI, P184; Clarke R., 1981, International Whaling Commission Report of the Commission, V31, P607; Correia AM, 2015, J MARINE SYST, V143, P73, DOI 10.1016/j.jmarsys.2014.10.016; Cotte C, 2011, LIMNOL OCEANOGR, V56, P219, DOI 10.4319/lo.2011.56.1.0219; Dave AC, 2015, J GEOPHYS RES-OCEANS, V120, P3958, DOI 10.1002/2015JC010787; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Doniol-Valcroze Thomas, 2012, Endangered Species Research, V17, P255, DOI 10.3354/esr00427; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Esteban R, 2014, J MAR BIOL ASSOC UK, V94, P1317, DOI 10.1017/S002531541300091X; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Fernandez M, 2017, J BIOGEOGR, V44, P2816, DOI 10.1111/jbi.13080; Forney KA, 2015, ENDANGER SPECIES RES, V27, P1, DOI 10.3354/esr00632; Friedlaender AS, 2015, MAR MAMMAL SCI, V31, P345, DOI 10.1111/mms.12134; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Goncalves Joao M., 1996, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V14A, P57; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hasegawa D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039743; Hastie T., 2009, UNSUPERVISED LEARNIN; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hauser Donna D. W., 2006, Journal of Cetacean Research and Management, V8, P273; Hoyt E., 2005, DOLPHINS PORPOISES W; Hoyt E, MARINE MAMMAL PROTEC; Hupman K, 2015, NEW ZEAL J MAR FRESH, V49, P132, DOI 10.1080/00288330.2014.980278; Ingram SN, 2007, J MAR BIOL ASSOC UK, V87, P149, DOI 10.1017/S0025315407054884; Irvine LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102959; Lambert C, 2017, DEEP-SEA RES PT II, V141, P133, DOI 10.1016/j.dsr2.2016.06.011; Levy M, 2008, LECT NOTES PHYS, V744, P219, DOI 10.1007/978-3-540-75215-8_9; MacLeod CD, 2008, HYDROBIOLOGIA, V612, P21, DOI 10.1007/s10750-008-9491-0; Mannocci L, 2017, DIVERS DISTRIB, V23, P1098, DOI 10.1111/ddi.12609; Martinez A., 2017, FARO DE VIGO    1010; Marubini F, 2009, MAR ECOL PROG SER, V381, P297, DOI 10.3354/meps07893; Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014; Miller BS, 2015, ENDANGER SPECIES RES, V26, P257, DOI 10.3354/esr00642; Olsen Erik, 2009, Aquatic Mammals, V35, P313, DOI 10.1578/AM.35.3.2009.313; OLSON DB, 1985, J MAR RES, V43, P113, DOI 10.1357/002224085788437325; Olson PA, 2012, SC64SH8; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; Panigada Simone, 2005, Journal of Cetacean Research and Management, V7, P137; Pascual A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024633; Pebesma E.J., 2005, R NEWS, V5, P9; Perez FF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000360; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pike Daniel G., 2009, NAMMCO Scientific Publications, V7, P19; Prieto R, 2017, DEEP-SEA RES PT II, V141, P155, DOI 10.1016/j.dsr2.2016.07.015; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Ramp C, 2006, MAR ECOL PROG SER, V319, P287, DOI 10.3354/meps319287; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Redfern JV, 2017, DIVERS DISTRIB, V23, P394, DOI 10.1111/ddi.12537; Reilly S. B., 2008, IUCN RED LIST THREAT, DOI [10. 2305/iucn. uk. 2008. rlts. t2477a9447146. en, DOI 10.2305/IUCN.UK.2008.RLTS.T2477A9447146.EN]; Reynolds RW, 2013, J CLIMATE, V26, P2514, DOI 10.1175/JCLI-D-12-00787.1; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rogerson P.A., 2001, STAT METHODS GEOGRAP; Sala I, 2016, J MARINE SYST, V154, P146, DOI 10.1016/j.jmarsys.2015.10.001; Santos MB, 2015, HYDROBIOLOGIA, V750, P13, DOI 10.1007/s10750-014-2164-2; Scales KL, 2017, ECOGRAPHY, V40, P210, DOI 10.1111/ecog.02272; Sears R, 2002, COSEWIC ASSESSMENT U; Sears R, 2005, 16 BIENN C BIOL MAR; Sigurjonsson J., 1990, REPORT INT WHALING C REPORT INT WHALING C, V40, P537; Sigurjonsson Johann, 1997, Journal of Northwest Atlantic Fishery Science, V22, P271; Silva Monica A., 2003, Aquatic Mammals, V29, P77, DOI 10.1578/016754203101024095; Silva MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076507; Silva MA, 2014, MAR BIOL RES, V10, P123, DOI 10.1080/17451000.2013.793814; Spyrakos E, 2011, HYDROBIOLOGIA, V670, P87, DOI 10.1007/s10750-011-0722-4; Tarling GA, 2003, LIMNOL OCEANOGR, V48, P2020, DOI 10.4319/lo.2003.48.5.2020; Tepsich P, 2014, MAR ECOL PROG SER, V508, P247, DOI 10.3354/meps10851; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Visser F, 2011, MAR ECOL PROG SER, V440, P267, DOI 10.3354/meps09349; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	84	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0201786	10.1371/journal.pone.0201786	http://dx.doi.org/10.1371/journal.pone.0201786			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265673	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500005
J	Hiraide, T; Sawano, M; Shiraishi, Y; Ueda, I; Numasawa, Y; Noma, S; Negishi, K; Ohki, T; Yuasa, S; Hayashida, K; Miyata, H; Fukuda, K; Kohsaka, S				Hiraide, Takahiro; Sawano, Mitsuaki; Shiraishi, Yasuyuki; Ueda, Ikuko; Numasawa, Yohei; Noma, Shigetaka; Negishi, Kouji; Ohki, Takahiro; Yuasa, Shinsuke; Hayashida, Kentaro; Miyata, Hiroaki; Fukuda, Keiichi; Kohsaka, Shun			Impact of catheter-induced iatrogenic coronary artery dissection with or without postprocedural flow impairment: A report from a Japanese multicenter percutaneous coronary intervention registry	PLOS ONE			English	Article							CLINICAL-OUTCOMES; NATIONAL-HEART; COMPLICATIONS; MORTALITY; EVOLUTION; WOMEN; RISK; REVASCULARIZATION; ANGIOPLASTY; PREDICTORS	Despite the ever-increasing complexity of percutaneous coronary intervention (PCI), the incidence, predictors, and in-hospital outcomes of catheter-induced coronary artery dissection (CICAD) is not well defined. In addition, there are little data on whether persistent coronary flow impairment after CICAD will affect clinical outcomes. We evaluated 17,225 patients from 15 participating hospitals within the Japanese PCI registry from January 2008 to March 2016. Associations between CICAD and in-hospital adverse cardiovascular events were evaluated using multivariate logistic regression. Outcomes of patients with CICAD with or without postprocedural flow impairment (TIMI flow <= 2 or 3, respectively) were analyzed. The population was predominantly male (79.4%; mean age, 68.2 +/- 11.0 years); 35.6% underwent PCI for complex lesions (eg. chronic total occlusion or a bifurcation lesion.). CICAD occurred in 185 (1.1%), and its incidence gradually decreased (p < 0.001 for trend); postprocedural flow impairment was observed in 43 (23.2%). Female sex, complex PCI, and target lesion in proximal vessel were independent predictors (odds ratio [OR], 2.18; 95% confidence interval [CI], 1.53-3.10; OR, 2.19; 95% CI, 1.58-3.04; and OR, 1.55; 95% CI, 1.06-2.28, respectively). CICAD was associated with an increased risk of in-hospital adverse events (composite of new-onset cardiogenic shock and new-onset heart failure) regardless of postprocedural flow impairment (OR, 10.9; 95% CI, 5.30-22.6 and OR, 2.27; 95% CI, 1.20-4.27, respectively for flow-impaired and flow-recovered CICAD). In conclusion, CICAD occurred in roughly 1% of PCI cases; female sex, complex PCI, and proximal lesion were its independent risk factors. CICAD was associated with adverse in-hospital cardiovascular events regardless of final flow status. Our data implied that the appropriate selection of PCI was necessary for women with complex lesions.	[Hiraide, Takahiro; Sawano, Mitsuaki; Shiraishi, Yasuyuki; Ueda, Ikuko; Yuasa, Shinsuke; Hayashida, Kentaro; Fukuda, Keiichi; Kohsaka, Shun] Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Numasawa, Yohei] Japanese Red Cross Ashikaga Hosp, Dept Cardiol, Ashikaga, Tochigi, Japan; [Noma, Shigetaka] Saiseikai Utsunomiya Hosp, Dept Cardiol, Utsunomiya, Tochigi, Japan; [Negishi, Kouji] Yokohama Municipal Citizens Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Ohki, Takahiro] Tokyo Dent Coll Ichikawa Gen Hosp, Dept Cardiol, Chiba, Japan; [Miyata, Hiroaki] Univ Tokyo, Dept Healthcare Qual Assessment, Grad Sch Med, Tokyo, Japan	Keio University; Tokyo Dental College; University of Tokyo	Kohsaka, S (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan.	sk@keio.jp	Numasawa, Yohei/AAC-9604-2020; Hayashida, Kentaro/M-4967-2019	Numasawa, Yohei/0000-0002-1739-2800; Hayashida, Kentaro/0000-0002-1750-1982; Yuasa, Shinsuke/0000-0001-5593-7552	Japan Society for the Promotion of Science (JSPS) KAKENHI [16KK0186, 16H05215, 25460630, 25460777]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 16KK0186, 16H05215, 25460630, and 25460777).	Abazid RM, 2017, J SAUDI HEART ASSOC, V29, P15, DOI 10.1016/j.jsha.2016.05.002; BEACH ML, 1989, CONTROL CLIN TRIALS, V10, pS161; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P540, DOI 10.1093/eurheartj/ehi618; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Cappelletti A, 1999, J AM COLL CARDIOL, V34, P1484, DOI 10.1016/S0735-1097(99)00395-2; Dash Debabrata, 2016, Indian Heart J, V68, P737, DOI 10.1016/j.ihj.2016.03.009; Dash D, 2013, HEART ASIA, V5, P61, DOI 10.1136/heartasia-2013-010304; DORROS G, 1983, CIRCULATION, V67, P723, DOI 10.1161/01.CIR.67.4.723; Eeckhout E, 2007, HEART, V93, P632, DOI 10.1136/hrt.2005.074849; Endo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127217; Falk Jeremy A, 2008, Proc Am Thorac Soc, V5, P543, DOI 10.1513/pats.200708-142ET; Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, 1994, LANCET, V343, P311; Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125; Giustino G, 2016, JACC-CARDIOVASC INTE, V9, P674, DOI 10.1016/j.jcin.2015.12.013; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; HERMANS WRM, 1992, J AM COLL CARDIOL, V20, P767, DOI 10.1016/0735-1097(92)90171-I; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; HUBER MS, 1991, AM J CARDIOL, V68, P467, DOI 10.1016/0002-9149(91)90780-O; Kardys I, 2007, AM J EPIDEMIOL, V166, P403, DOI 10.1093/aje/kwm115; Kirtane AJ, 2016, CIRCULATION, V134, P422, DOI 10.1161/CIRCULATIONAHA.116.022061; Lansky AJ, 2005, CIRCULATION, V111, P940, DOI 10.1161/01.CIR.0000155337.50423.C9; Lichtman JH, 2014, AM HEART J, V167, P376, DOI 10.1016/j.ahj.2013.11.001; Numasawa Y, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0116496; Numasawa Y, 2017, J CARDIOL, V69, P272, DOI 10.1016/j.jjcc.2016.05.003; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Prasad A, 2005, HEART, V91, P1530, DOI 10.1136/hrt.2005.064485; Rogers Jason H, 2004, J Invasive Cardiol, V16, P493; Rogowski S, 2017, CATHETER CARDIO INTE, V89, P59, DOI 10.1002/ccd.26383; Sand NPR, 2018, JACC CARDIOVASC IMAG; Sangiorgi G, 2013, J VASC SURG, V57, P338, DOI 10.1016/j.jvs.2012.07.052; SHARMA SK, 1993, AM HEART J, V126, P39, DOI 10.1016/S0002-8703(07)80008-1; Sharma V, 2017, AM J CARDIOL, V119, P535, DOI 10.1016/j.amjcard.2016.11.004; Smith Jr SC, 2006, J AM COLL CARDIOL, V47, P1; Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327; Venkitachalam L, 2009, CIRC-CARDIOVASC INTE, V2, P6, DOI 10.1161/CIRCINTERVENTIONS.108.825323; Wilensky RL, 2002, AM J CARDIOL, V90, P216, DOI 10.1016/S0002-9149(02)02457-8	37	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204333	10.1371/journal.pone.0204333	http://dx.doi.org/10.1371/journal.pone.0204333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265698	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500030
J	Teixeira, DL; Larrain, R; Hotzel, MJ				Lemos Teixeira, Dayane; Larrain, Rafael; Hotzel, Maria Jose			Are views towards egg farming associated with Brazilian and Chilean egg consumers' purchasing habits?	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ANIMAL-WELFARE; FOOD-ANIMALS; ATTITUDES; CITIZENS; MEAT; METAANALYSIS; INFORMATION; PERCEPTIONS; ORIGIN	In many industrialised countries, public rejection of intensive animal production systems has led to the development of legislation and industry actions that have resulted in significant changes in animal care at the farm level. However, little is known about the views of citizens from emerging countries regarding animal production. The aims of this study were to explore the views of Brazilian and Chilean consumers towards egg farming, and to investigate if these views are associated with participants' eggs purchasing habits and reported willingness to pay (WTP) more for eggs produced in the conditions they perceive as important. In an open question, participants (n = 716) were asked to describe an ideal egg production farm and explain their reasons. This was followed by closed questions asking egg purchasing habits, willingness to pay for eggs produced in the conditions they perceive as important and demographic information. Participants main concerns were with animal welfare, naturalness, hygiene, production, and ethical aspects, which many associated with improved health, sensory, and nutritional quality of the eggs. The views of participants towards an ideal egg production farm were associated, to some extent, with type of egg purchasing habits and WTP a premium for organic or free-range eggs. Our results suggest a demand for more natural, animal friendly egg production systems; furthermore, they indicate a disconnect between lay citizens' expectations and industry practices, given that intensive confined systems typically fail to supply many of the expected characteristics.	[Lemos Teixeira, Dayane; Larrain, Rafael] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Ciencias Anim, Santiago, Chile; [Lemos Teixeira, Dayane; Hotzel, Maria Jose] Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada, Florianopolis, SC, Brazil	Pontificia Universidad Catolica de Chile; Universidade Federal de Santa Catarina (UFSC)	Hotzel, MJ (corresponding author), Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada, Florianopolis, SC, Brazil.	maria.j.hotzel@ufsc.br	Hötzel, Maria José/H-6975-2014; Teixeira, Dayane/AAA-6807-2020; Teixeira, Dayane L/H-8640-2018	Hötzel, Maria José/0000-0003-1034-3202; Teixeira, Dayane/0000-0001-5063-7972; 	CNPq (National Council for Scientific and Technological Development, Brazil) [300131/2015-1]; Facultad de Agronomia e Ingenieria Forestal of the Pontificia Universidad Catolica de Chile; CNPq	CNPq (National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Facultad de Agronomia e Ingenieria Forestal of the Pontificia Universidad Catolica de Chile; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DLT was awarded a Young Talent Fellowship (grant number 300131/2015-1) from CNPq (National Council for Scientific and Technological Development, Brazil) and a Postdoctoral Fellowship in Sustainable Agriculture from Facultad de Agronomia e Ingenieria Forestal of the Pontificia Universidad Catolica de Chile. MJH received support fromCNPq.	ABPA, 2016, PROD OV BRAS CREASC; Aerts S., 2013, ETHICS CONSUMPTION C, P172; Anderson EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160424; [Anonymous], 2005, SPECIAL EUROBAROMETE; Appleby M. C., 2003, STATE ANIM, V2003, P159; Avicultura, 2016, CONS HUEV CHIL SUP 2; Avicultura Insdustrial, 2016, OP REST MCDONALD AM; Behrens JH, 2010, FOOD CONTROL, V21, P963, DOI 10.1016/j.foodcont.2009.07.018; Bejaei M, 2011, POULTRY SCI, V90, P1088, DOI 10.3382/ps.2010-01129; Benard M, 2013, J AGR ENVIRON ETHIC, V26, P1015, DOI 10.1007/s10806-013-9438-y; Bennett R, 1996, J AGR ECON, V47, P224, DOI 10.1111/j.1477-9552.1996.tb00686.x; Bokma-Bakker M.H., 2014, 714 LIV RES LEL, P1; Breidert C., 2006, INNOV MARK, V2, P8; Cardoso CS, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7120089; Cardoso CS, 2016, J DAIRY SCI, V99, P1663, DOI 10.3168/jds.2015-9925; Centner TJ, 2010, J AGR ENVIRON ETHIC, V23, P469, DOI 10.1007/s10806-009-9225-y; Clark B, 2017, FOOD POLICY, V68, P112, DOI 10.1016/j.foodpol.2017.01.006; Clark B, 2016, J AGR ENVIRON ETHIC, V29, P455, DOI 10.1007/s10806-016-9615-x; Clarke N, 2017, VET REC, V180, DOI 10.1136/vr.104165; de Barcellos MD, 2011, INT J CONSUM STUD, V35, P391, DOI 10.1111/j.1470-6431.2010.00978.x; Duffy B, 2005, INT J MARKET RES, V47, P615, DOI 10.1177/147078530504700602; Elkhoraibi C, 2014, POULTRY SCI, V93, P2920, DOI 10.3382/ps.2014-04154; EMOL, 2016, HUEV GALL LIBR VAL P; Farnsworth V, 2016, BRIT J EDUC STUD, V64, P139, DOI 10.1080/00071005.2015.1133799; Fearne A., 1996, British Food Journal, V98, P7, DOI 10.1108/00070709610111269; Fraser D, 2006, ANIM WELFARE, V15, P93; Fraser D, 1997, ANIM WELFARE, V6, P187; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Gaymard S, 2015, SOC INDIC RES, V120, P801, DOI 10.1007/s11205-014-0610-1; Goddard E., 2007, CONSUMER ATTITUDES W, P92; Grunert KG, 2018, MEAT SCI, V137, P123, DOI 10.1016/j.meatsci.2017.11.022; Guivant JS, 2015, PATHWAY SUSTAIN, P74; Harper G. C., 2002, British Food Journal, V104, P287, DOI 10.1108/00070700210425723; Heng Y, 2013, J AGR RESOUR ECON, V38, P418; Hotzel MJ, 2017, J DAIRY SCI, V100, P4150, DOI 10.3168/jds.2016-11933; Hotzel MJ, 2014, DILEMMAS IN ANIMAL WELFARE, P67, DOI 10.1079/9781780642161.0067; HSI, 2015, FAC SUA PART DIG NAO; Huberman AM, 1994, HDB QUALITATIVE RES, P643; Lagerkvist CJ, 2011, EUR REV AGRIC ECON, V38, P55, DOI 10.1093/erae/jbq043; Lassen J, 2006, LIVEST SCI, V103, P221, DOI 10.1016/j.livsci.2006.05.008; Lemos Teixeira Dayane, 2018, PLoS One, V13, pe0190671, DOI 10.1371/journal.pone.0190671; Lusk JL, 2010, SOC INDIC RES, V96, P551, DOI 10.1007/s11205-009-9492-z; Maria GA, 2006, LIVEST SCI, V103, P250, DOI 10.1016/j.livsci.2006.05.011; Miranda-de la Lama GC, 2017, MEAT SCI, V125, P106, DOI 10.1016/j.meatsci.2016.12.001; ODEPA, 2016, HUEV OF EST POL AGR; Pettersson IC, 2016, BRIT FOOD J, V118, P1979, DOI 10.1108/BFJ-02-2016-0065; Rollin Bernard E, 1995, FARM ANIMAL WELFARE; Sato P, 2017, ANIMALS, V7, DOI 10.3390/ani7080064; Savory CJ, 2004, ANIM WELFARE, V13, pS153; Schnettler B, 2009, FOOD QUAL PREFER, V20, P156, DOI 10.1016/j.foodqual.2008.07.006; Schnettler B, 2015, FOOD SCI TECH-BRAZIL, V35, P570, DOI 10.1590/1678-457X.6699; Steinfeld H, 2010, P NATL ACAD SCI USA, V107, P18237, DOI 10.1073/pnas.1012541107; Thorslund CAH, 2016, LIVEST SCI, V193, P58, DOI 10.1016/j.livsci.2016.09.007; Van Boeckel TP, 2017, SCIENCE, V357, P1350, DOI 10.1126/science.aao1495; von Keyserlingk MAG, 2013, J DAIRY SCI, V96, P5405, DOI 10.3168/jds.2012-6354; von Keyserlingk MAG, 2015, J AGR ENVIRON ETHIC, V28, P179, DOI 10.1007/s10806-014-9518-7; WATT Global Media, 2015, GLOB EGG CONS RIS WO; Yunes MC, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7100075; Yunes MC, ANIMAL WELFARE	59	12	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203867	10.1371/journal.pone.0203867	http://dx.doi.org/10.1371/journal.pone.0203867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265672	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500012
J	Reverdy, A; Chen, Y; Hunter, E; Gozzi, K; Chai, YR				Reverdy, Alicyn; Chen, Yun; Hunter, Evan; Gozzi, Kevin; Chai, Yunrong			Protein lysine acetylation plays a regulatory role in Bacillus subtilis multicellularity	PLOS ONE			English	Article							A SYNTHETASE ACSA; BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; HISTIDINE KINASE; SPORE FORMATION; COMPLEX; COENZYME; DEGU; INVOLVEMENT	Protein lysine acetylation is a post-translational modification that alters the charge, conformation, and stability of proteins. A number of genome-wide characterizations of lysine-acetylated proteins, or acetylomes, in bacteria have demonstrated that lysine acetylation occurs on proteins with a wide diversity of functions, including central metabolism, transcription, chemotaxis, and cell size regulation. Bacillus subtilis is a model organism for studies of sporulation, motility, cell signaling, and multicellular development (or biofilm formation). In this work, we investigated the role of global protein lysine acetylation in multicellular development in B. subtilis. We analyzed the B. subtilis acetylome under biofilm-inducing conditions and identified acetylated proteins involved in multicellularity, specifically, swarming and biofilm formation. We constructed various single and double mutants of genes known to encode enzymes involved in global protein lysine acetylation in B. subtilis. Some of those mutants showed a defect in swarming motility while others demonstrated altered biofilm phenotypes. Lastly, we picked two acetylated proteins known to be important for biofilm formation, YmcA (also known as RicA), a regulatory protein critical for biofilm induction, and GtaB, an UTP-glucose-1-phosphate uridylyltransferase that synthesizes a nucleotide sugar precursor for biosynthesis of exopolysaccharide, a key biofilm matrix component. We performed site-directed mutagenesis on the acetylated lysine codons in ymcA and gtaB, respectively, and assayed cells bearing those point mutants for biofilm formation. The mutant alleles of ymcA(K64R), gtaB(K89R), and gtaB(K191R) all demonstrated a severe biofilm defect. These results indicate the importance of acetylated lysine residues in both YmcA and GtaB. In summary, we propose that protein lysine acetylation plays a global regulatory role in B. subtilis multicellularity.	[Reverdy, Alicyn; Hunter, Evan; Gozzi, Kevin; Chai, Yunrong] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Chen, Yun] Zhejiang Univ, Inst Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Gozzi, Kevin] MIT, Dept Microbiol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Northeastern University; Zhejiang University; Massachusetts Institute of Technology (MIT)	Chai, YR (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	y.chai@northeastern.edu	Chen, Yun/J-6959-2014	Chen, Yun/0000-0002-5663-2352; Gozzi, Kevin/0000-0002-1168-1425	National Science Foundation [MCB1651732]; National Natural Science Foundation of China [31301707]; Northeastern University	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northeastern University	This work was supported in part by a grant from National Science Foundation (MCB1651732, https://www.nsf.gov) to Y. Chai. Y. Chen was supported by a grant from the National Natural Science Foundation of China (31301707, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yiyang Yu (Northeastern University) for construction of some of the strains used in this study. We also thank members of the Chai laboratory, especially Jennifer Greenwich, for helpful suggestions during the preparation of the manuscript. This work was supported in part by a grant from National Science Foundation (MCB1651732) to Y. Chai. Y. Chen was supported by a grant from the National Natural Science Foundation of China (31301707). KG was supported by a Provost Research Fund from Northeastern University.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Bernal V, 2014, NEW BIOTECHNOL, V31, P586, DOI 10.1016/j.nbt.2014.03.002; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Cairns LS, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0410-z; Carabetta VJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00107-17; Carabetta VJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00005-16; Chai YR, 2012, MBIO, V3, DOI 10.1128/mBio.00184-12; Chan JM, 2014, J BACTERIOL, V196, P740, DOI 10.1128/JB.01217-13; Chen Y, 2015, MICROB CELL, V2, P406, DOI 10.15698/mic2015.10.233; Chen Y, 2015, MBIO, V6, DOI 10.1128/mBio.00392-15; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DAHL MK, 1992, J BIOL CHEM, V267, P14509; DeLoughery A, 2016, MOL MICROBIOL, V99, P425, DOI 10.1111/mmi.13240; Diehl A, 2018, P NATL ACAD SCI USA, V115, P3237, DOI 10.1073/pnas.1718102115; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dubnau EJ, 2016, MOL MICROBIOL, V101, P606, DOI 10.1111/mmi.13411; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Erskine E, 2017, BIORXIV, DOI [10.1101/188995, DOI 10.1101/188995]; Gardner JG, 2008, J BACTERIOL, V190, P5132, DOI 10.1128/JB.00340-08; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Gardner JG, 2009, J BACTERIOL, V191, P1749, DOI 10.1128/JB.01674-08; Gozzi K, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0016-3; GRUNDY FJ, 1993, J BACTERIOL, V175, P7348, DOI 10.1128/JB.175.22.7348-7355.1993; GRYCZAN TJ, 1978, J BACTERIOL, V134, P318, DOI 10.1128/JB.134.1.318-329.1978; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Harshey RM, 2015, J MOL BIOL, V427, P3683, DOI 10.1016/j.jmb.2015.07.025; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kochanowski K, 2015, CURR OPIN MICROBIOL, V27, P10, DOI 10.1016/j.mib.2015.05.007; Kolodkin-Gal I, 2013, GENE DEV, V27, P887, DOI 10.1101/gad.215244.113; Kosono S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131169; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20108; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Mordini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085065; Mukherjee S, 2014, ANNU REV GENET, V48, P319, DOI 10.1146/annurev-genet-120213-092406; Ouidir T, 2015, PROTEOMICS, V15, P2152, DOI 10.1002/pmic.201500056; Post DMB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179621; Rajkovic A, 2016, J BIOL CHEM, V291, P10976, DOI 10.1074/jbc.M115.712091; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rybtke M, 2015, J MOL BIOL, V427, P3628, DOI 10.1016/j.jmb.2015.08.016; Schroeder JW, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01085-13; Shemesh M, 2013, J BACTERIOL, V195, P2747, DOI 10.1128/JB.00028-13; Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tan IS, 2014, ENV MICROBIOL REP, V6, P212, DOI 10.1111/1758-2229.12130; Tanner AW, 2017, MOL MICROBIOL, V104, P837, DOI 10.1111/mmi.13667; Thoden JB, 2007, PROTEIN SCI, V16, P432, DOI 10.1110/ps.062626007; Tortosa P, 2000, MOL MICROBIOL, V35, P1110, DOI 10.1046/j.1365-2958.2000.01779.x; VARON D, 1993, J BACTERIOL, V175, P3964; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; YASBIN RE, 1974, J VIROL, V14, P1343, DOI 10.1128/JVI.14.6.1343-1348.1974; Zhang Y, 2014, SCI CHINA CHEM, V57, P732, DOI 10.1007/s11426-014-5100-4	64	21	22	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204687	10.1371/journal.pone.0204687	http://dx.doi.org/10.1371/journal.pone.0204687			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265683	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500044
J	Aristidou, C; Theodosiou, A; Bak, M; Mehrjouy, MM; Constantinou, E; Alexandrou, A; Papaevripidou, I; Christophidou-Anastasiadou, V; Skordis, N; Kitsiou-Tzeli, S; Tommerup, N; Sismani, C				Aristidou, Constantia; Theodosiou, Athina; Bak, Mads; Mehrjouy, Mana M.; Constantinou, Efthymia; Alexandrou, Angelos; Papaevripidou, Ioannis; Christophidou-Anastasiadou, Violetta; Skordis, Nicos; Kitsiou-Tzeli, Sophia; Tommerup, Niels; Sismani, Carolina			Position effect, cryptic complexity, and direct gene disruption as disease mechanisms in de novo apparently balanced translocation cases	PLOS ONE			English	Article							CHROMOSOMAL REARRANGEMENTS; INTELLECTUAL DISABILITY; PRENATAL-DIAGNOSIS; INNER-EAR; POU3F4; DEAFNESS; EXPRESSION; UPSTREAM; INACTIVATION; GENERATION	The majority of apparently balanced translocation (ABT) carriers are phenotypically normal. However, several mechanisms were proposed to underlie phenotypes in affected ABT cases. In the current study, whole-genome mate-pair sequencing (WG-MPS) followed by Sanger sequencing was applied to further characterize de novo ABTs in three affected individuals. WG-MPS precisely mapped all ABT breakpoints and revealed three possible underlying molecular mechanisms. Firstly, in a t(X;1) carrier with hearing loss, a highly skewed X-inactivation pattern was observed and the der(X) breakpoint mapped similar to 87kb upstream an X-linked deafness gene namely POU3F4, thus suggesting an underlying long-range position effect mechanism. Secondly, cryptic complexity and a chromothripsis rearrangement was identified in a t(6;7;8;12) carrier with intellectual disability. Two translocations and a heterozygous deletion disrupted SOX5; a dominant nervous system development gene previously reported in similar patients. Finally, a direct gene disruption mechanism was proposed in a t (4;9) carrier with dysmorphic facial features and speech delay. In this case, the der(9) breakpoint directly disrupted NFIB, a gene involved in lung maturation and development of the pons with important functions in main speech processes. To conclude, in contrast to familial ABT cases with identical rearrangements and discordant phenotypes, where translocations are considered coincidental, translocations seem to be associated with phenotype presentation in affected de novo ABT cases. In addition, this study highlights the importance of investigating both coding and non-coding regions to decipher the underlying pathogenic mechanisms in these patients, and supports the potential introduction of low coverage WG-MPS in the clinical investigation of de novo ABTs.	[Aristidou, Constantia; Theodosiou, Athina; Constantinou, Efthymia; Alexandrou, Angelos; Papaevripidou, Ioannis; Sismani, Carolina] Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus; [Aristidou, Constantia; Sismani, Carolina] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus; [Bak, Mads; Mehrjouy, Mana M.; Tommerup, Niels] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, Copenhagen N, Denmark; [Christophidou-Anastasiadou, Violetta] Cyprus Inst Neurol & Genet, Dept Clin Genet, Nicosia, Cyprus; [Christophidou-Anastasiadou, Violetta] Archbishop Makarios III Med Ctr, Nicosia, Cyprus; [Skordis, Nicos] Paedi Ctr Specialized Pediat, Div Pediat Endocrinol, Nicosia, Cyprus; [Skordis, Nicos] Univ Nicosia, St Georges Univ, London Med Sch, Nicosia, Cyprus; [Kitsiou-Tzeli, Sophia] Univ Athens, Med Sch, Dept Med Genet, Athens, Greece	University of Copenhagen; University of Nicosia; National & Kapodistrian University of Athens	Sismani, C (corresponding author), Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus.; Sismani, C (corresponding author), Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus.	csismani@cing.ac.cy	Constantinou, Efthymia/AAG-3527-2021	Theodosiou, Athina/0000-0003-4363-8162; Bak, Mads/0000-0003-2762-1002	Lundbeck Foundation [2013-14290]; University of Copenhagen's Programme for Interdisciplinary Research (Global Genes, Local Concerns); The Danish Council for Independent Research-Medical Sciences [4183-00482B]; Norway Grants through the Directorate General for European Programmes, Coordination and Development of the Republic of Cyprus; Telethon Cyprus through the Cyprus School of Molecular Medicine	Lundbeck Foundation(Lundbeckfonden); University of Copenhagen's Programme for Interdisciplinary Research (Global Genes, Local Concerns); The Danish Council for Independent Research-Medical Sciences; Norway Grants through the Directorate General for European Programmes, Coordination and Development of the Republic of Cyprus; Telethon Cyprus through the Cyprus School of Molecular Medicine	This work was supported by The Lundbeck Foundation [2013-14290] (NT); the University of Copenhagen's Programme for Interdisciplinary Research (Global Genes, Local Concerns) (NT); The Danish Council for Independent Research-Medical Sciences [4183-00482B] (NT); and Norway Grants through the Directorate General for European Programmes, Coordination and Development of the Republic of Cyprus (CS). C.A. was funded by a research grant scholarship from Telethon Cyprus provided through the Cyprus School of Molecular Medicine (CS, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Anger GJ, 2014, AM J AUDIOL, V23, P1, DOI 10.1044/1059-0889(2013/13-0018); Aristidou C, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0619935, DOI 10.1371/JOURNAL.PONE.0619935]; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; BUHLER EM, 1983, ANN GENET-PARIS, V26, P133; Calounova G, 2006, NEUROENDOCRINOL LETT, V27, P579; Cordova-Fletes C, 2015, NEUROGENETICS, V16, P287, DOI 10.1007/s10048-015-0452-2; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, HUM MOL GENET, V4, P2145; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Du W, 2017, CHINESE MED J-PEKING, V130, P88, DOI 10.4103/0366-6999.196565; Halgren C, 2018, AM J HUM GENET, V102, P1090, DOI 10.1016/j.ajhg.2018.04.005; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumbasar A, 2009, J COMP NEUROL, V513, P98, DOI 10.1002/cne.21943; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lamb AN, 2012, HUM MUTAT, V33, P728, DOI 10.1002/humu.22037; LEINER HC, 1989, BEHAV NEUROSCI, V103, P998, DOI 10.1037/0735-7044.103.5.998; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lorda-Sanchez I J, 2000, Ophthalmic Genet, V21, P185, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT185; Marlin S, 2009, CLIN GENET, V76, P558, DOI 10.1111/j.1399-0004.2009.01215.x; Naranjo S, 2010, HUM GENET, V128, P411, DOI 10.1007/s00439-010-0864-x; Nazaryan-Petersen L., 2016, CHROMOTHRIPSIS HUMAN, P1, DOI [10.1002/9780470015902.a0024627, DOI 10.1002/9780470015902.A0024627]; Nishitani N, 2005, PHYSIOLOGY, V20, P60, DOI 10.1152/physiol.00043.2004; Patsalis PC, 2004, EUR J HUM GENET, V12, P647, DOI 10.1038/sj.ejhg.5201211; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rozen S, 2000, Methods Mol Biol, V132, P365; Schluth-Bolard C, 2009, EUR J MED GENET, V52, P291, DOI 10.1016/j.ejmg.2009.05.011; Sismani C, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-15; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; TOMMERUP N, 1993, J MED GENET, V30, P713, DOI 10.1136/jmg.30.9.713; Van den Veyver IB, 2001, SEMIN REPROD MED, V19, P183, DOI 10.1055/s-2001-15398; Vore AP, 2005, ARCH OTOLARYNGOL, V131, P1057, DOI 10.1001/archotol.131.12.1057; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	40	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205298	10.1371/journal.pone.0205298	http://dx.doi.org/10.1371/journal.pone.0205298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289920	Green Published, gold			2022-12-27	WOS:000446545500063
J	de Figueiredo, MN; Krippeit, L; Ihorst, G; Sattel, H; Bylund, CL; Joos, A; Bengel, J; Lahmann, C; Fritzsche, K; Wuensch, A				de Figueiredo, Marcelo Niglio; Krippeit, Lorena; Ihorst, Gabriele; Sattel, Heribert; Bylund, Carma L.; Joos, Andreas; Bengel, Juergen; Lahmann, Claas; Fritzsche, Kurt; Wuensch, Alexander			ComOn-Coaching: The effect of a varied number of coaching sessions on transfer into clinical practice following communication skills training in oncology: Results of a randomized controlled trial	PLOS ONE			English	Article							PATIENT COMMUNICATION; CANCER CARE; PHYSICIANS; PROGRAM; EDUCATION; EFFICACY; BAD; PARADIGM; VALIDITY; NURSES	Objective To investigate the effect of the number of coaching sessions after communication skills training on the medical communicative performance of oncologists in clinical practice. Methods/Design The training, consisting of a workshop and one (control group) vs. four (intervention group) sessions of individual coaching, was evaluated in a randomized controlled trial. Eligible participants included physicians working in any setting where patients with oncological diseases were treated. Real medical consultations were video recorded at three time points: before the workshop (t0), after the workshop (t1) and after completion of coaching (t2). The 1.5-day workshop was based on role-playing in small groups; in the coaching sessions, the videos recorded at t1 were analyzed in detail by both the trainer and the physician. The coaching sessions were manualized and based on the physician's learning goals. The primary hypothesis was that the intervention group would improve to a higher extent than the control group, as assessed by external raters using rating scales specially developed for this project. Physicians were stratified for sex and setting and randomized by an independent statistician. The group assignment was revealed for physicians and trainers at the end of the workshop, while the raters were blinded to group assignments and assessment points. Results A total of 72 physicians participated in one of 8 workshops and could be allocated to either the control or intervention group. The intervention group showed a statistically significant improvement (ES d = 0.41, p<.01) in the All items domain of the rating scales between t1 and t2 and showed a significant advantage compared with the CG (ES = .41, p = .04). The impact on diverse specified skills was heterogeneous; a larger sample is necessary for more detailed analysis. Conclusions The training achieved some observable and significant changes in the communicative behavior of oncologists in clinical practice. The four coaching sessions showed some significant advantages compared to the single coaching session. Considerable effort is necessary to achieve sustained changes in communication in clinical every-day practice. Thus, our coaching concept is a promising method for this purpose.	[de Figueiredo, Marcelo Niglio; Krippeit, Lorena; Joos, Andreas; Lahmann, Claas; Fritzsche, Kurt; Wuensch, Alexander] Univ Freiburg, Fac Med, Med Ctr, Dept Psychosomat Med & Psychotherapy, Freiburg, Germany; [de Figueiredo, Marcelo Niglio] Univ Freiburg, Fac Med, Med Ctr, Clin Dermatol & Venereol, Freiburg, Germany; [Ihorst, Gabriele] Univ Freiburg, Fac Med, Med Ctr, Clin Trials Unit, Freiburg, Germany; [Sattel, Heribert; Wuensch, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Psychosomat Med & Psychotherapy, Munich, Germany; [Bylund, Carma L.] Univ Florida, Coll Med, Coll Journalism & Commun, Gainesville, FL USA; [Bengel, Juergen] Univ Freiburg, Inst Psychol Rehabil Psychol & Psychotherapy, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Technical University of Munich; State University System of Florida; University of Florida; University of Freiburg	de Figueiredo, MN (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Psychosomat Med & Psychotherapy, Freiburg, Germany.; de Figueiredo, MN (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Clin Dermatol & Venereol, Freiburg, Germany.	marcelo.de.figueiredo@uniklinik-freiburg.de	Ihorst, Gabriele/AAA-7445-2021	Lahmann, Claas/0000-0003-0947-116X	German Cancer Aid (Deutsche Krebshilfe) [109980]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	This Study was funded by German Cancer Aid (Deutsche Krebshilfe, https://www.krebshilfe.de), Funding Number 109980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; Baile WF, 1999, ONCOLOGY-NY, V13, P1021; Barth J, 2011, ANN ONCOL, V22, P1030, DOI 10.1093/annonc/mdq441; Berkhof M, 2011, PATIENT EDUC COUNS, V84, P152, DOI 10.1016/j.pec.2010.06.010; Boissy A, 2016, J GEN INTERN MED, V31, P755, DOI 10.1007/s11606-016-3597-2; Boon H, 1998, PATIENT EDUC COUNS, V35, P161, DOI 10.1016/S0738-3991(98)00063-9; Brown H, 2015, APPL MIXED MODELS ME; Brown RF, 2008, ACAD MED, V83, P37, DOI 10.1097/ACM.0b013e31815c631e; Brunett PH, 2001, ACAD MED, V76, P390, DOI 10.1097/00001888-200104000-00021; Butow P, 2008, PSYCHO-ONCOLOGY, V17, P209, DOI 10.1002/pon.1217; Butow PN, 2010, HDB COMMUNICATION ON, P707; Bylund CL, 2018, PATIENT EDUC COUNS, V101, P1924, DOI 10.1016/j.pec.2018.05.026; Bylund CL, 2017, PATIENT EDUC COUNS, V100, P1408, DOI 10.1016/j.pec.2017.02.006; Cegala DJ, 2002, MED EDUC, V36, P1004, DOI 10.1046/j.1365-2923.2002.01331.x; Comert M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152717; Curtis JR, 2001, J GEN INTERN MED, V16, P41; de Figueiredo MN, 2019, J CANCER EDUC, V34, P73, DOI 10.1007/s13187-017-1269-5; de Figueiredo MN, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1454-z; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; Frankel R M, 2001, J Med Pract Manage, V16, P184; Fujimori M, 2014, PALLIAT SUPPORT CARE, V12, P379, DOI 10.1017/S147895151300031X; Gillis AE, 2015, POSTGRAD MED J, V91, P13, DOI 10.1136/postgradmedj-2014-132772; Giroldi E, 2016, FAM PRACT, V33, P100, DOI 10.1093/fampra/cmv094; Goelz T, 2011, J CLIN ONCOL, V29, P3402, DOI 10.1200/JCO.2010.31.6372; Goelz T, 2010, ONKOLOGIE, V33, P65, DOI 10.1159/000264626; Grossman R, 2011, INT J TRAIN DEV, V15, P103, DOI 10.1111/j.1468-2419.2011.00373.x; Gysels M, 2005, SUPPORT CARE CANCER, V13, P356, DOI 10.1007/s00520-004-0732-0; Haidet P, 2016, MED EDUC, V50, P1208, DOI 10.1111/medu.13083; Heaven C, 2006, PATIENT EDUC COUNS, V60, P313, DOI 10.1016/j.pec.2005.08.008; Kanfer F., 2012, SELBSTMANAGEMENT THE, V5; Kissane DW, 2012, J CLIN ONCOL, V30, P1242, DOI 10.1200/JCO.2011.39.6184; Kurtz SM, 1996, MED EDUC, V30, P83, DOI 10.1111/j.1365-2923.1996.tb00724.x; Langewitz W, 2012, BUNDESGESUNDHEITSBLA, V55, P1176, DOI 10.1007/s00103-012-1533-0; Langewitz W, 2010, J ADV NURS, V66, P2266, DOI 10.1111/j.1365-2648.2010.05386.x; Lienard A, 2010, BRIT J CANCER, V103, P171, DOI 10.1038/sj.bjc.6605749; Lipkin M, 2010, HDB COMMUNICATION ON, P3; Lundeby T, 2015, PATIENT EDUC COUNS, V98, P598, DOI 10.1016/j.pec.2015.01.015; Lutz G, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0823-x; Makoul G, 2001, PATIENT EDUC COUNS, V45, P1, DOI 10.1016/S0738-3991(01)00145-8; Moore P, 2009, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD003751.pub3, DOI 10.1002/14651858.CD003751.PUB2]; Moore PM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003751.pub3; O'Callaghan A, 2016, THESIS; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Ramani S, 2008, MED TEACH, V30, P347, DOI 10.1080/01421590802061613; Razavi D, 2003, J CLIN ONCOL, V21, P3141, DOI 10.1200/JCO.2003.08.031; Razavi D, 2002, BRIT J CANCER, V87, P1, DOI 10.1038/sj.bjc.6600412; Rider E. A., 2010, PRACTICAL GUIDE TEAC, V2nd, P1; Rosenbaum ME, 2017, PATIENT EDUC COUNS, V100, P2054, DOI 10.1016/j.pec.2017.05.035; Salmon P, 2005, PATIENT EDUC COUNS, V58, P225, DOI 10.1016/j.pec.2005.05.018; Salmon P, 2017, MED EDUC, V51, P258, DOI 10.1111/medu.13204; Salmon P, 2013, PATIENT EDUC COUNS, V90, P193, DOI 10.1016/j.pec.2012.04.010; Salmon P, 2011, MED EDUC, V45, P217, DOI 10.1111/j.1365-2923.2010.03801.x; Schirmer JM, 2005, FAM MED, V37, P184; Setyonugroho W, 2015, PATIENT EDUC COUNS, V98, P1482, DOI 10.1016/j.pec.2015.06.004; Stiefel F, 2010, ANN ONCOL, V21, P204, DOI 10.1093/annonc/mdp564; Stiefel F, 2010, HDB COMMUNICATION ON, P641; Stiefel F, 2006, COMMUNICATION CANC C; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Tulsky JA, 2011, ANN INTERN MED, V155, P593, DOI 10.7326/0003-4819-155-9-201111010-00007; van den Eertwegh V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125958; Wuensch A, 2011, EUR J CANCER CARE, V20, P570, DOI 10.1111/j.1365-2354.2010.01233.x; Wuensch A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3238-0; Zill JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112637	65	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205315	10.1371/journal.pone.0205315	http://dx.doi.org/10.1371/journal.pone.0205315			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289905	gold, Green Published, Green Submitted			2022-12-27	WOS:000446545500066
J	Crosetto, P; Mantovani, M				Crosetto, Paolo; Mantovani, Marco			Representation effects in the centipede game	PLOS ONE			English	Article							FORM	We explore the effects on strategic behavior of alternative representations of a centipede game that differ in terms of complexity. In a laboratory experiment, we manipulate the way in which payoffs are presented to subjects in two different ways. In both cases, information is made less accessible relative to the standard representation of the game. Results show that these manipulations shift the distribution of take nodes further away from the equilibrium prediction. The evidence is consistent with the view that failures of game-form recognition and the resulting limits to strategic reasoning are crucial for explaining non-equilibrium behavior in the centipede game.	[Crosetto, Paolo] Univ Grenoble Alpes, CNRS, INRA, Grenoble INP,GAEL, F-38000 Grenoble, France; [Mantovani, Marco] Univ Milano Bicocca, DEMS, Pza Ateneo Nuovo 1, I-20126 Milan, Italy	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; University of Milano-Bicocca	Mantovani, M (corresponding author), Univ Milano Bicocca, DEMS, Pza Ateneo Nuovo 1, I-20126 Milan, Italy.	marco.mantovani@unimib.it	Crosetto, Paolo/M-1304-2019		Max Planck Insitute fur Okonomik in Jena, Germany-ESI, Strategic INteraction Group	Max Planck Insitute fur Okonomik in Jena, Germany-ESI, Strategic INteraction Group	The study was funded by internal funds of (now closed) Max Planck Insitute fur Okonomik in Jena, Germany-ESI, Strategic INteraction Group: http://www.econ.mpg.de/english/.	Bartling B, 2015, Q J ECON, V130, P219, DOI 10.1093/qje/qju031; Cason TN, 2014, J POLIT ECON, V122, P1235, DOI 10.1086/677254; Cox JC, 2012, ECONOMETRICA, V80, P883, DOI 10.3982/ECTA9589; Devetag G, 2003, J ECON PSYCHOL, V24, P189, DOI 10.1016/S0167-4870(02)00202-7; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Dufwenberg M, 2004, GAME ECON BEHAV, V47, P268, DOI 10.1016/j.geb.2003.06.003; Eichberger J, 2017, AMBIGUITY CENTIPEDE; EVANS GW, 1966, J PERS SOC PSYCHOL, V3, P486, DOI 10.1037/h0023035; Falk A, 2013, SCIENCE, V340, P707, DOI 10.1126/science.1231566; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frechette GR, 2012, EXP ECON, V15, P485, DOI 10.1007/s10683-011-9309-1; Gamba A, 2015, PREFERENCES DEPENDEN; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Kawagoe T, 2012, J ECON BEHAV ORGAN, V82, P548, DOI 10.1016/j.jebo.2012.03.010; Kreps D.M, 1990, GAME THEORY EC MODEL; Levitt SD, 2011, AM ECON REV, V101, P975, DOI 10.1257/aer.101.2.975; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1023/A:1009905800005; MCKELVEY RD, 1992, ECONOMETRICA, V60, P803, DOI 10.2307/2951567; Nagel R, 1998, J MATH PSYCHOL, V42, P356, DOI 10.1006/jmps.1998.1225; Palacios-Huerta I, 2009, AM ECON REV, V99, P1619, DOI 10.1257/aer.99.4.1619; Ponti G, 2000, GAME ECON BEHAV, V30, P115, DOI 10.1006/game.1998.0707; PRUITT DG, 1967, J PERS SOC PSYCHOL, V7, P21, DOI 10.1037/h0024914; Rapoport A, 2003, GAME ECON BEHAV, V43, P239, DOI 10.1016/S0899-8256(03)00009-5; ROSENTHAL RW, 1981, J ECON THEORY, V25, P92, DOI 10.1016/0022-0531(81)90018-1; Spiliopoulos L, 2018, J EXPT PSYCHOL LEARN; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Zauner KG, 1999, GAME ECON BEHAV, V26, P157, DOI 10.1006/game.1998.0649	27	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204422	10.1371/journal.pone.0204422	http://dx.doi.org/10.1371/journal.pone.0204422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286092	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500019
J	Willingham-Lane, JM; Coulson, GB; Hondalus, MK				Willingham-Lane, Jennifer M.; Coulson, Garry B.; Hondalus, Mary K.			Identification of a VapA virulence factor functional homolog in Rhodococcus equi isolates housing the pVAPB plasmid	PLOS ONE			English	Article							17-KILODALTON ANTIGENS; INTRACELLULAR SURVIVAL; PATHOGENICITY ISLAND; CORYNEBACTERIUM-EQUI; LYMPH-NODES; PROTEIN-A; MACROPHAGES; INFECTION; PIGS; 15-KILODALTON	Rhodococcus equi is a facultative intracellular bacterium of macrophages and is an important pathogen of animals and immunocompromised people wherein disease results in abcessation of the lungs and other sites. Prior work has shown that the presence of the major virulence determinant, VapA, encoded on the pVAPA-type plasmid, disrupts normal phagosome development and is essential for bacterial replication within macrophages. pVAPA- type plasmids are typical of R. equi strains derived from foals while strains from pigs carry plasmids of the pVAPB-type, lacking vapA, and those from humans harbor various types of plasmids including pVAPA and pVAPB. Through the creation and analysis of a series of gene deletion mutants, we found that vapK1 or vapK2 is required for optimal intracellular replication of an R. equi isolate carrying a pVAPB plasmid type. Complementation analysis of a Delta vapA R. equi strain with vapK1 or vapK2 showed the VapK proteins of the pVAPB-type plasmid could restore replication capacity to the macrophage growth-attenuated Delta vapA strain. Additionally, in contrast to the intracellular growth capabilities displayed by an equine R. equi transconjugent strain carrying a pVAPB-type plasmid, a transconjugant strain carrying a pVAPB-type plasmid deleted of vapK1 and vapK2 proved incapable of replication in equine macrophages. Cumulatively, these data indicate that VapK1 and K2 are functionally equivalent to VapA.	[Willingham-Lane, Jennifer M.; Coulson, Garry B.; Hondalus, Mary K.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hondalus, MK (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	hondalus@uga.edu						Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; BARTON MD, 1984, VET MICROBIOL, V9, P65, DOI 10.1016/0378-1135(84)90079-8; Coulson GB, 2015, INFECT IMMUN, V83, P3137, DOI 10.1128/IAI.00230-15; Coulson GB, 2010, INFECT IMMUN, V78, P3323, DOI 10.1128/IAI.00081-10; Fernandez-Mora E, 2005, TRAFFIC, V6, P635, DOI 10.1111/j.1600-0854.2005.00304.x; Flynn O, 2001, VET MICROBIOL, V78, P221, DOI 10.1016/S0378-1135(00)00297-2; Geerds C, 2014, ACTA CRYSTALLOGR F, V70, P866, DOI 10.1107/S2053230X14009911; Giguere S, 1999, INFECT IMMUN, V67, P3548; GOLUB B, 1967, ANN INTERN MED, V66, P1174, DOI 10.7326/0003-4819-66-6-1174; HONDALUS MK, 1994, INFECT IMMUN, V62, P4167, DOI 10.1128/IAI.62.10.4167-4175.1994; Jain S, 2003, MOL MICROBIOL, V50, P115, DOI 10.1046/j.1365-2958.2003.03689.x; JOHNSON JA, 1983, VET PATHOL, V20, P440, DOI 10.1177/030098588302000407; Letek M, 2008, J BACTERIOL, V190, P5797, DOI 10.1128/JB.00468-08; Luhrmann A, 2004, INFECT IMMUN, V72, P853, DOI 10.1128/IAI.72.2.853-862.2004; Madarame H, 1998, FEMS IMMUNOL MED MIC, V22, P329, DOI 10.1111/j.1574-695X.1998.tb01222.x; Okoko T, 2015, VET MICROBIOL, V179, P42, DOI 10.1016/j.vetmic.2015.01.027; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; TAKAI S, 1992, INFECT IMMUN, V60, P2995, DOI 10.1128/IAI.60.7.2995-2997.1992; Takai S, 1996, J CLIN MICROBIOL, V34, P1034, DOI 10.1128/JCM.34.4.1034-1037.1996; TAKAI S, 1991, J CLIN MICROBIOL, V29, P439, DOI 10.1128/JCM.29.3.439-443.1991; TAKAI S, 1993, J CLIN MICROBIOL, V31, P1726, DOI 10.1128/JCM.31.7.1726-1729.1993; TAKAI S, 1986, JPN J VET SCI, V48, P445; Takai S, 2000, INFECT IMMUN, V68, P6840, DOI 10.1128/IAI.68.12.6840-6847.2000; TAKAI S, 1995, FEMS IMMUNOL MED MIC, V11, P181, DOI 10.1111/j.1574-695X.1995.tb00115.x; TKACHUKSAAD O, 1991, J CLIN MICROBIOL, V29, P2696, DOI 10.1128/JCM.29.12.2696-2700.1991; Toyooka K, 2005, J MED MICROBIOL, V54, P1007, DOI 10.1099/jmm.0.46086-0; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Tripathi VN, 2012, J BACTERIOL, V194, P6790, DOI 10.1128/JB.01210-12; Valero-Rello A, 2015, INFECT IMMUN, V83, P2725, DOI 10.1128/IAI.00376-15; van der Geize R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn811; von Bargen K, 2009, INFECT IMMUN, V77, P5676, DOI 10.1128/IAI.00856-09; Whittingham JL, 2014, ACTA CRYSTALLOGR D, V70, P2139, DOI 10.1107/S1399004714012632; Willingham-Lane JM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00186-16; Wright LM, 2018, MOL MICROBIOL, V107, P428, DOI 10.1111/mmi.13892; YAGER JA, 1987, VET MICROBIOL, V14, P225, DOI 10.1016/0378-1135(87)90109-X	36	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204475	10.1371/journal.pone.0204475	http://dx.doi.org/10.1371/journal.pone.0204475			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286098	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500022
J	Herz, K; Dietz, S; Gorzolka, K; Haider, S; Jandt, U; Scheel, D; Bruelheide, H				Herz, Katharina; Dietz, Sophie; Gorzolka, Karin; Haider, Sylvia; Jandt, Ute; Scheel, Dierk; Bruelheide, Helge			Linking root exudates to functional plant traits	PLOS ONE			English	Article							LEAF-AREA; RHIZOSPHERE; COMMUNICATION; METABOLOMICS; ARABIDOPSIS; DIVERSITY; GRASS	Primary and secondary metabolites exuded by plant roots have mainly been studied under laboratory conditions, while knowledge of root exudate patterns of plants growing in natural communities is very limited. Focusing on ten common European grassland plant species, we asked to which degree exuded metabolite compositions are specific to species or growth forms (forbs and grasses), depend on environments and local neighbourhoods, and reflect traditional plant functional traits. Root exudates were collected under field conditions and analysed using a non-targeted gas chromatography coupled mass spectrometry (GC-MS) approach. In total, we annotated 153 compounds of which 36 were identified by structure and name as metabolites mainly derived from the primary metabolism. Here we show by using variance partitioning, that the composition of exuded polar metabolites was mostly explained by plot identity, followed by plant species identity while plant species composition of the local neighbourhood played no role. Total and root dry biomass explained the largest proportion of variance in exudate composition, with additional variance explained by traditional plant traits. Although the exudate composition was quite similar between the two growth forms, we found some metabolites that occurred only in one of the two growth forms. Our study demonstrated the feasibility of measuring polar exudates under non-sterile field conditions by mass spectrometry, which opens new avenues of research for functional plant ecology.	[Herz, Katharina; Haider, Sylvia; Jandt, Ute; Bruelheide, Helge] Martin Luther Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany; [Herz, Katharina; Haider, Sylvia; Jandt, Ute; Bruelheide, Helge] Martin Luther Univ Halle Wittenberg, Bot Garden, Halle, Germany; [Dietz, Sophie; Gorzolka, Karin; Scheel, Dierk] Leibniz Inst Plant Biochem, Halle, Germany; [Haider, Sylvia; Jandt, Ute; Scheel, Dierk; Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzenbiochemie	Herz, K (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany.; Herz, K (corresponding author), Martin Luther Univ Halle Wittenberg, Bot Garden, Halle, Germany.	katharina.herz@gmx.net	Haider, Sylvia/M-2990-2014; Bruelheide, Helge/G-3907-2013; Jandt, Ute/S-7886-2016	Haider, Sylvia/0000-0002-2966-0534; Bruelheide, Helge/0000-0003-3135-0356; Jandt, Ute/0000-0002-3177-3669; Scheel, Dierk/0000-0002-2105-6711	DFG Priority Program 1374	DFG Priority Program 1374	The work has been funded by the DFG Priority Program 1374 (http://gepris.dfg.de/gepris/projekt/60761519) "Infrastructure-BiodiversityExploratories" (Project BE LOW, BR 1698/11-3 by HB and SCHE 235/16-3 by DS; http://gepris.dfg.de/gepris/projekt/61580740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger B, 2012, MOL PLANT MICROBE IN, V25, P993, DOI 10.1094/MPMI-01-12-0006-R; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Badri DV, 2013, J BIOL CHEM, V288, P4502, DOI 10.1074/jbc.M112.433300; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; De-la-Pena C, 2010, J BIOL CHEM, V285, P30654, DOI 10.1074/jbc.M110.119040; Eisenhauer N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44641; Faure D, 2009, PLANT SOIL, V321, P279, DOI 10.1007/s11104-008-9839-2; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Freschet GT, 2015, NEW PHYTOL, V206, P1247, DOI 10.1111/nph.13352; Gorzolka K, 2012, J BIOTECHNOL, V159, P177, DOI 10.1016/j.jbiotec.2012.03.012; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; Herz K, 2017, J VEG SCI, V28, P705, DOI 10.1111/jvs.12534; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Kuijken RCP, 2015, J EXP BOT, V66, P5389, DOI 10.1093/jxb/erv239; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Mir-Marques A, 2016, FOOD CHEM, V196, P1023, DOI 10.1016/j.foodchem.2015.10.048; Moles AT, 2014, J VEG SCI, V25, P1167, DOI 10.1111/jvs.12190; Neuweger H, 2008, BIOINFORMATICS, V24, P2726, DOI 10.1093/bioinformatics/btn452; Oburger E, 2018, RHIZOSPHERE-NETH, V6, P116, DOI 10.1016/j.rhisph.2018.06.004; Oksanen J., 2022, R PACKAGE VERSION; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; R Development Core Team, 2009, R LANG ENV STAT COMP; Ravenek JM, 2014, OIKOS, V123, P1528, DOI 10.1111/oik.01502; Siebenkas A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv029; Strehmel N, 2014, PHYTOCHEMISTRY, V108, P35, DOI 10.1016/j.phytochem.2014.10.003; Valentinuzzi F, 2015, BIOL FERT SOILS, V51, P757, DOI 10.1007/s00374-015-1015-2; van Dam NM, 2016, TRENDS PLANT SCI, V21, P256, DOI 10.1016/j.tplants.2016.01.008; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x	37	42	43	17	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204128	10.1371/journal.pone.0204128	http://dx.doi.org/10.1371/journal.pone.0204128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281675	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400041
J	Hiller, M; Falzarano, MS; Garcia-Jimenez, I; Sardone, V; Verheul, RC; Popplewell, L; Anthony, K; Ruiz-Del-Yerro, E; Osman, H; Goeman, JJ; Mamchaoui, K; Dickson, G; Ferlini, A; Muntoni, F; Aartsma-Rus, A; Arechavala-Gomeza, V; Datson, NA; Spitali, P				Hiller, Monika; Falzarano, Maria Sofia; Garcia-Jimenez, Iker; Sardone, Valentina; Verheul, Ruurd C.; Popplewell, Linda; Anthony, Karen; Ruiz-Del-Yerro, Estibaliz; Osman, Hana; Goeman, Jelle J.; Mamchaoui, Kamel; Dickson, George; Ferlini, Alessandra; Muntoni, Francesco; Aartsma-Rus, Annemieke; Arechavala-Gomeza, Virginia; Datson, Nicole A.; Spitali, Pietro			A multicenter comparison of quantification methods for antisense oligonucleotide- induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures	PLOS ONE			English	Article							ETEPLIRSEN; MUTATIONS; PHASE-2; MUSCLE	Background Duchenne muscular dystrophy is a lethal disease caused by lack of dystrophin. Skipping of exons adjacent to out-of-frame deletions has proven to restore dystrophin expression in Duchenne patients. Exon 51 has been the most studied target in both preclinical and clinical settings and the availability of standardized procedures to quantify exon skipping would be advantageous for the evaluation of preclinical and clinical data. Objective To compare methods currently used to quantify antisense oligonucleotide-induced exon 51 skipping in the DMD transcript and to provide guidance about the method to use. Methods Six laboratories shared blinded RNA samples from Duchenne patient-derived muscle cells treated with different amounts of exon 51 targeting antisense oligonucleotide. Exon 51 skipping levels were quantified using five different techniques: digital droplet PCR, single PCR assessed with Agilent bioanalyzer, nested PCR with agarose gel image analysis by either ImageJ or GeneTools software and quantitative real-time PCR. Results Differences in mean exon skipping levels and dispersion around the mean were observed across the different techniques. Results obtained by digital droplet PCR were reproducible and showed the smallest dispersion. Exon skipping quantification with the other methods showed overestimation of exon skipping or high data variation. Conclusions Our results suggest that digital droplet PCR was the most precise and quantitative method. The quantification of exon 51 skipping by Agilent bioanalyzer after a single round of PCR was the second-best choice with a 2.3-fold overestimation of exon 51 skipping levels compared to digital droplet PCR.	[Hiller, Monika; Aartsma-Rus, Annemieke; Spitali, Pietro] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Falzarano, Maria Sofia; Osman, Hana; Ferlini, Alessandra] Univ Ferrara, UOL Med Genet, Ferrara, Italy; [Garcia-Jimenez, Iker; Ruiz-Del-Yerro, Estibaliz; Arechavala-Gomeza, Virginia] Biocruces Bizkaia Hlth Res Inst, Neuromuscular Disorders Grp, Baracaldo, Spain; [Sardone, Valentina; Anthony, Karen; Muntoni, Francesco] UCL, Dubowitz Neuromuscular Ctr, Great Ormond St Inst Child Hlth, London, England; [Verheul, Ruurd C.; Datson, Nicole A.] BioMarin Nederland BV, Leiden, Netherlands; [Popplewell, Linda; Dickson, George] Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, London, England; [Anthony, Karen] Univ Northampton, Fac Hlth & Soc, Northampton, England; [Goeman, Jelle J.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Mamchaoui, Kamel] UPMC Univ Paris 6, Sorbonne Univ, Ctr Res Myol, INSERM,Inst Myol, Paris, France; [Muntoni, Francesco] UCL, MRC Ctr Neuromuscular Dis, Great Ormond St Inst Child Hlth, London, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Ferrara; University of London; University College London; University of London; Royal Holloway University London; University of Northampton; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London	Spitali, P (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands.	p.spitali@lumc.nl	Anthony, Karen/H-6027-2019; Arechavala-Gomeza, Virginia/C-1546-2008; Datson, Nicole A./O-8797-2014; Goeman, Jelle/AAT-1300-2020; Spitali, Pietro/Y-2948-2018	Anthony, Karen/0000-0002-3638-2405; Arechavala-Gomeza, Virginia/0000-0001-7703-3255; Goeman, Jelle/0000-0003-4283-0259; Spitali, Pietro/0000-0003-2783-688X; Datson, Nicole/0000-0003-2887-0238; Aartsma-Rus, Annemieke/0000-0003-1565-654X; RUIZ DEL YERRO, ESTIBALIZ/0000-0003-1193-7280; FERLINI, ALESSANDRA/0000-0001-8385-9870; Mamchaoui, kamel/0000-0002-0323-9290; Garcia Jimenez, Iker/0000-0003-1844-5705	COST (Cooperation of Science and Technology) Action [BM1207]; COST action [BM1207]; Prinses Beatrix Spierfonds [W.OR14-13]; Institute of Health Carlos III (ISCIII) [CP12/03057, PI15/00333]; ASEM (Spanish Federation of Neuromuscular Disorders); FEDER (Spanish Federation of rare diseases); Isabel Gemio's Foundation [P36]; ISCIII [CP12/03057]; European Regional Development Fund; Marie Skoodowska-Curie Career Integration Grant from the EU, FP7-PEOPLE- 2013-CIG [618003]; EU grant SKIP-NMD [HEALTH-F4-2012-30537]; Sarepta Therapeutics; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; regional grant on rare diseases (RARER); Duchenne Parent Project Italy; Muscular Dystrophy UK [RA5/3068, 16GRO-PG36-0083] Funding Source: researchfish	COST (Cooperation of Science and Technology) Action; COST action(European Cooperation in Science and Technology (COST)); Prinses Beatrix Spierfonds; Institute of Health Carlos III (ISCIII); ASEM (Spanish Federation of Neuromuscular Disorders); FEDER (Spanish Federation of rare diseases); Isabel Gemio's Foundation; ISCIII(Instituto de Salud Carlos III); European Regional Development Fund(European Commission); Marie Skoodowska-Curie Career Integration Grant from the EU, FP7-PEOPLE- 2013-CIG; EU grant SKIP-NMD; Sarepta Therapeutics; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; regional grant on rare diseases (RARER); Duchenne Parent Project Italy; Muscular Dystrophy UK	This project was supported by COST (Cooperation of Science and Technology) Action BM1207. COST is a European framework to support the cooperation in science and technology among researchers across Europe. COST action BM1207 (www.exonskipping.eu) coordinated by Prof. Aartsma-Rus aims to standardize techniques to quantify exon skipping and dystrophin levels. MH and PS acknowledge the Prinses Beatrix Spierfonds (grant W.OR14-13) for supporting this work. ERdY was funded by project grants CP12/03057 and PI15/00333 from the Institute of Health Carlos III (ISCIII). IGJ was funded by ASEM (Spanish Federation of Neuromuscular Disorders), FEDER (Spanish Federation of rare diseases) and Isabel Gemio's Foundation by means of the "Todos Somos Raros" telemarathon (P36). VAG holds a Miguel Servet Fellowship from the ISCIII (CP12/03057) that is part-funded by the European Regional Development Fund and a Marie Skoodowska-Curie Career Integration Grant (618003) from the EU, FP7-PEOPLE- 2013-CIG. VS is supported by the EU grant SKIP-NMD (No. HEALTH-F4-2012-30537) and by Sarepta Therapeutics. FM is supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. The support of MDUK, of the MRC Neuromuscular Centre support to the Dubowitz Neuromuscular Centre Biobank, and of the EU grant SKIP-NMD (No. HEALTH-F4-2012-30537) is also gratefully acknowledged. AF is supported by a regional grant on rare diseases (RARER) and by funding of the Duchenne Parent Project Italy. RCV and NAD are employees of BioMarin Nederland BV. BioMarin did not contribute to the funding of this study, other than the salaries and lab consumables for the work performed by RCV and NAD.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-rus A, 2007, ANTISENSE MEDIATED E, P1609, DOI [10.1261/rna.653607.RNA, DOI 10.1261/RNA.653607.RNA]; Aartsma-Rus A, 2017, NUCLEIC ACID THER, V27, P1, DOI 10.1089/nat.2016.0657; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Anthony K, 2014, NEUROLOGY, V83, P2062, DOI 10.1212/WNL.0000000000001025; Anthony K, 2012, HUM GENE THER METHOD, V23, P336, DOI 10.1089/hgtb.2012.117; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Arechavala-Gomeza V, 2010, NEUROPATH APPL NEURO, V36, P265, DOI 10.1111/j.1365-2990.2009.01056.x; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Brown K, 2013, J INTERV STATEBUILD, V7, P492, DOI 10.1080/17502977.2012.727539; BUSHBY KMD, 1993, J NEUROL, V240, P98, DOI 10.1007/BF00858725; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P618, DOI 10.1016/j.nmd.2013.05.006; Goemans NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161955; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hulsker Margriet, 2016, J Neuromuscul Dis, V3, P77; Machado Darlene L, 2012, BMC Res Notes, V5, P435, DOI 10.1186/1756-0500-5-435; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Niks E.H., 2016, EXPERT OPIN BIOL TH, P1, DOI [DOI 10.1080/14712598.2017, 10.1080/14712598.2017]; Pramono ZAD, 2012, HUM GENE THER, V23, P781, DOI 10.1089/hum.2011.205; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Spurney CF, 2011, MUSCLE NERVE, V44, P8, DOI 10.1002/mus.22097; Syed YY, 2016, DRUGS, V76, P1699, DOI 10.1007/s40265-016-0657-1; Thorley M, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0115-5; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Verheul RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162467; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4	33	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204485	10.1371/journal.pone.0204485	http://dx.doi.org/10.1371/journal.pone.0204485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278058	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000446010200013
J	Genkin, M; Wang, C; Berry, G; Brashears, ME				Genkin, Michael; Wang, Cheng; Berry, George; Brashears, Matthew E.			Blaunet: An R-based graphical user interface package to analyze Blau space	PLOS ONE			English	Article							SOCIAL SELECTION; NETWORKS; ECOLOGY; ORGANIZATIONS; MEMBERSHIP; LANDSCAPE; DIVERSITY; CONFLICT; PATTERNS; BEHAVIOR	McPherson's Blau space and affiliation ecology model is a powerful tool for analyzing the ecological competition among social entities, such as organizations, along a combination of sociodemographic characteristics of their members. In this paper we introduce the R-based Graphical User Interface (GUI) package Blaunet, an integrated set of tools to calculate, visualize, and analyze the statuses of individuals and social entities in Blau space, parameterized by multiple sociodemographic traits as dimensions. The package is able to calculate the Blau statuses at the nodal, dyadic, and meso levels based on three types of information: sociodemographic characteristics, group affiliations (e.g., membership in groups/organizations), and network ties. To facilitate this, Blaunet has the following five main capabilities, it can: 1) identify a list of possible salient dimensions; 2) calculate, plot, and analyze niches for social entities by measuring the social distance along the salient dimensions between individuals affiliated with them; 3) generate Blau bubbles for individuals, thereby allowing the study of interpersonal influence of similar others even with limited or no network information; 4) capture niche dynamics cross-sectionally by calculating the intensity of exploitation from the carrying capacity and the membership rate; and 5) analyze the niche movement longitudinally by estimating the predicted niche movement equations. We illustrate these capabilities of Blaunet with example datasets.	[Genkin, Michael] Singapore Management Univ, Sch Social Sci, Singapore, Singapore; [Wang, Cheng] Univ Notre Dame, Dept Sociol, Notre Dame, IN 46556 USA; [Berry, George] Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA; [Brashears, Matthew E.] Univ South Carolina, Dept Sociol, Columbia, SC USA	Singapore Management University; University of Notre Dame; Cornell University; University of South Carolina System; University of South Carolina Columbia	Wang, C (corresponding author), Univ Notre Dame, Dept Sociol, Notre Dame, IN 46556 USA.	cwang3@nd.edu	Wang, Cheng/E-5189-2015	Wang, Cheng/0000-0002-4693-6424	Defense Threat Reduction Agency grant [HDTRA1-10-1-0043]	Defense Threat Reduction Agency grant(United States Department of DefenseDefense Threat Reduction Agency)	This study was funded by Defense Threat Reduction Agency grant (HDTRA1-10-1-0043): "Uncovering and Penetrating CBRN Networks: A General Methodology for Mapping Covert Networks" (http://www.dtra.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral S, 2008, PNAS US, V106, P21544; Behler R, NETW SCI; Blau P.M., 1977, INEQUALITY HETEROGEN; BLAU PM, 1974, AM SOCIOL REV, V39, P615, DOI 10.2307/2094309; BLAU PM, 1977, AM J SOCIOL, V83, P26, DOI 10.1086/226505; Bonato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106052; Bonikowski B, 2005, DANCING DARWINS BEAT; Brandes U, 2016, METHODOLOGICAL INNOV, V9, P1, DOI DOI 10.1177/2059799116630650; Brashears ME, 2017, AM J SOCIOL, V123, P787, DOI 10.1086/693703; Centola D, 2015, AM J SOCIOL, V120, P1295, DOI 10.1086/681275; Corbetta R, 2015, CONFLICT MANAG PEACE, V32, P3, DOI 10.1177/0738894214544879; Crosnoe R, 2008, SOC FORCES, V86, P1189; Crossley N, 2015, CULT SOCIOL-LONDON, V9, P3, DOI 10.1177/1749975514546236; Davis AP, 2017, SOC SCI RES, V67, P115, DOI 10.1016/j.ssresearch.2017.06.002; FELD SL, 1981, AM J SOCIOL, V86, P1015, DOI 10.1086/227352; Frank KA, 2010, AM J SOCIOL, V113, P1, DOI DOI 10.1086/587153; Garcia-Diaz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144574; Geard N, 2010, ADV COMPLEX SYST, V13, P501, DOI 10.1142/S0219525910002712; Godart FC, 2015, REG STUD, V49, P973, DOI 10.1080/00343404.2012.732693; Goodreau Steven M, 2008, J Stat Softw, V24, P1; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Hannan M.T., 2007, LOGICS ORG THEORY AU; Hannan MT, 2005, J ECON PERSPECT, V19, P51, DOI 10.1257/0895330053147985; Hipp JR, 2009, CRIMINOLOGY, V47, P521, DOI 10.1111/j.1745-9125.2009.00150.x; Hipp JR, 2017, CHALLENGING CRIMINOL; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Joseph K, 2014, ACM T INTEL SYST TEC, V5, DOI 10.1145/2566617; Kim PH, 2014, J BUS VENTURING, V29, P785, DOI 10.1016/j.jbusvent.2013.10.002; Kitts JA, 1999, SOCIOL INQ, V69, P551, DOI 10.1111/j.1475-682X.1999.tb00886.x; Lazarsfeld P. F., 1954, FREEDOM CONTROL MOD, V18, P18, DOI DOI 10.1111/J.1467-8705.2012.02056_3.X; Leuthold H, 2007, ENVIRON PLANN B, V34, P785, DOI 10.1068/b3304t; Lewis K, 2012, P NATL ACAD SCI USA, V109, P68, DOI 10.1073/pnas.1109739109; Mark N, 1998, SOC FORCES, V77, P453, DOI 10.2307/3005535; MCADAM D, 1993, AM J SOCIOL, V99, P640, DOI 10.1086/230319; MCPHERSON JM, 1992, AM SOCIOL REV, V57, P153, DOI 10.2307/2096202; McPherson JM, 1996, AM SOCIOL REV, V61, P179, DOI 10.2307/2096330; MCPHERSON JM, 1991, SOC FORCES, V70, P19, DOI 10.2307/2580060; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; McPherson M, 2004, IND CORP CHANGE, V13, P263, DOI 10.1093/icc/13.1.263; MCPHERSON M, 1983, AM SOCIOL REV, V48, P519, DOI 10.2307/2117719; Mercken L, 2007, ADDICTION, V102, P1483, DOI 10.1111/j.1360-0443.2007.01905.x; Mohr JW, 2010, RES SOCIOL ORGAN-RES, V31, P321, DOI 10.1108/S0733-558X(2010)0000031013; Neal ZP, 2006, BUILDING BLAUURBAN S; Peli G, 2006, SOC NETWORKS, V28, P449, DOI 10.1016/j.socnet.2005.11.002; POPIELARZ PA, 1995, AM J SOCIOL, V101, P698, DOI 10.1086/230757; Popielarz PA, 2007, ANNU REV SOCIOL, V33, P65, DOI 10.1146/annurev.soc.32.061604.123118; Rapp I, 2015, COMP POPUL STUD, V40, P229, DOI 10.12765/CPoS-2015-08en; Rawlings CM, 2004, POETICS, V32, P411, DOI 10.1016/S0304-422X(04)00057-9; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Robins Garry, 2013, EXPONENTIAL RANDOM G, P91; Schroder T, 2017, J ENVIRON PSYCHOL, V52, P136, DOI 10.1016/j.jenvp.2016.03.007; Shi YR, 2017, AM SOCIOL REV, V82, P407, DOI 10.1177/0003122417693616; Steglich C, 2010, SOCIOL METHODOL, V40, P329, DOI 10.1111/j.1467-9531.2010.01225.x; Suh CS, 2017, SOC FORCES, V96, P423, DOI 10.1093/sf/sox046; Suh CS, 2016, SOC SCI RES, V58, P279, DOI 10.1016/j.ssresearch.2015.12.004; Sun LJ, 2013, P NATL ACAD SCI USA, V110, P13774, DOI 10.1073/pnas.1306440110; Wolf I, 2015, TECHNOL FORECAST SOC, V94, P269, DOI 10.1016/j.techfore.2014.10.010	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204990	10.1371/journal.pone.0204990	http://dx.doi.org/10.1371/journal.pone.0204990			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273404	gold, Green Published			2022-12-27	WOS:000446124700057
J	Gilberti, M; Baruffini, E; Donnini, C; Dallabona, C				Gilberti, Micol; Baruffini, Enrico; Donnini, Claudia; Dallabona, Cristina			Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DEPLETION; HUMAN-DISEASE; PROTEIN; DEFECTS; ENCODES; REPLICATION; MUTATIONS; CHANNEL	Mitochondrial DNA depletion syndromes (MDDS) are a genetically and clinically heterogeneous group of human diseases caused by mutations in nuclear genes and characterized by a severe reduction in mitochondrial DNA (mtDNA) copy number leading to impaired energy production in affected tissues and organs. Mutations in the MPV17 gene, whose role is still elusive, were described as cause of the hepatocerebral form of MDDS and Navajo neuro-hepathopathy. The high degree of conservation observed between MPV17 and its yeast homolog SYM1 made the latter a good model for the study of the pathology. Here, we used Saccharomyces cerevisiae to elucidate the molecular consequences of seven MPV17 missense mutations identified in patients and localized in different protein domains. The phenotypic analysis of the appropriate sym1 mutant strains created demonstrated deleterious effect for all mutations regarding OXPHOS metabolism and mtDNA stability. We deepened the pathogenic effect of the mutations by investigating whether they prevented the correct protein localization into the mitochondria or affected the stability of the proteins. All the Sym1 mutant proteins correctly localized into the mitochondria and only one mutation predominantly affects protein stability. All the other mutations compromised the formation of the high molecular weight complex of unknown composition, previously identified both in yeast, cell cultures and mouse tissues, as demonstrated by the consistent fraction of the Sym1 mutant proteins found free or in not fully assembled complex, strengthening its role as protein forming part of a high molecular weight complex.	[Gilberti, Micol; Baruffini, Enrico; Donnini, Claudia; Dallabona, Cristina] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy	University of Parma	Donnini, C (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy.	claudia.donnini@unipr.it	Baruffini, Enrico/AAL-2608-2020; Baruffini, Enrico/C-1057-2015; Donnini, Claudia/B-5548-2015	Baruffini, Enrico/0000-0002-8280-7849; Baruffini, Enrico/0000-0002-8280-7849; Donnini, Claudia/0000-0002-4901-2358; DALLABONA, Cristina/0000-0003-4397-9143	Telethon Foundation [GGP15041]	Telethon Foundation(Fondazione Telethon)	This work was supported by Telethon Foundation GGP15041 (www.telethon.it).	Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083; Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581; El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017; El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913; KARASAWA M, 1993, HUM MOL GENET, V2, P1829, DOI 10.1093/hmg/2.11.1829; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Lodi T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00106; Lollgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Reinhold R, 2012, MOL CELL BIOL, V32, P5009, DOI 10.1128/MCB.00843-12; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004; Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205014	10.1371/journal.pone.0205014	http://dx.doi.org/10.1371/journal.pone.0205014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273399	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700058
J	Ma, MH; Liang, SD				Ma, Minghui; Liang, Shidong			An optimization approach for freeway network coordinated traffic control and route guidance	PLOS ONE			English	Article							VARIABLE-SPEED LIMITS; PREDICTIVE CONTROL; MOTORWAY NETWORKS; CONTROL SCHEME; CONGESTION; EMISSIONS; WAVES	Traffic congestion in freeway network is a prevalent transportation problem and leads to a strong degradation of freeway network facilities. This paper proposes a new coordinated optimization approach for freeway network, aiming to relieve the traffic congestion in freeway network equipped with the coordinated traffic controllers. The challenge is how to solve the problem between the traffic control goals of each path and those of the network. In this paper, the bi-level programming theory is used to address this problem. More exactly, in the path level, the optimal control model is designed to relieve congestion in each path of the test network. Furthermore, in the network level, the optimal model considers the traffic equilibrium and cost optimization. The efficiency of the proposed approach is tested on a well-known traffic network calibrated by the field test data of freeway network. The results show that the proposed approach has positive effects in balancing traffic load and improving the service level of freeway networks.	[Ma, Minghui] Shanghai Univ Engn Sci, Automobile Engn Coll, Shanghai, Peoples R China; [Liang, Shidong] Univ Shanghai Sci & Technol, Business Sch, Shanghai, Peoples R China	Shanghai University of Engineering Science; University of Shanghai for Science & Technology	Liang, SD (corresponding author), Univ Shanghai Sci & Technol, Business Sch, Shanghai, Peoples R China.	sdliang@hotmail.com		Liang, Shidong/0000-0002-2191-6187	Shanghai Youth Teacher Training Assistance Scheme [ZZGCD16025, ZZslg18013]; National Natural Science Foundation of China [71801153, 71801149]	Shanghai Youth Teacher Training Assistance Scheme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Research was supported by Shanghai Youth Teacher Training Assistance Scheme (ZZGCD16025, ZZslg18013), National Natural Science Foundation of China (Grant NO. 71801153), and National Natural Science Foundation of China (Grant NO. 71801149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty M, 2017, TRANSP RES PROC, V27, P577, DOI 10.1016/j.trpro.2017.12.061; Carlson RC, 2014, TRANSPORT RES C-EMER, V46, P209, DOI 10.1016/j.trc.2014.05.017; Habtemichael FG, 2013, TRANSPORT RES REC, P7, DOI 10.3141/2386-02; Hadiuzzaman M, 2013, CAN J CIVIL ENG, V40, P46, DOI 10.1139/cjce-2012-0101; Han Y, 2017, TRANSPORT RES C-EMER, V77, P405, DOI 10.1016/j.trc.2017.02.009; Hasanpour MZ, 2017, ENG TECHNOL APPL SCI, V7, P1535; Hegyi A, 2003, TRANSPORT RES REC, P167, DOI 10.3141/1852-21; Hellinga B, 2011, J TRANSP ENG, V137, P260, DOI 10.1061/(ASCE)TE.1943-5436.0000214; Heydecker BG, 2011, TRANSPORT RES C-EMER, V19, P206, DOI 10.1016/j.trc.2010.05.008; Jamshidnejad A., 2017, IEEE T CONTR SYST T, VPP, P1; Karimi A, 2004, P AMER CONTR CONF, P5533; Kotsialos A, 2002, IEEE T INTELL TRANSP, V3, P282, DOI 10.1109/TITS.2002.806804; Kotsialos A, 2001, TRANSPORT RES REC, P55; Kotsialos A, 2002, TRANSPORT RES C-EMER, V10, P65, DOI 10.1016/S0968-090X(01)00005-5; Li ZB, 2014, ACCIDENT ANAL PREV, V72, P134, DOI 10.1016/j.aap.2014.06.018; Liu M, 2016, INT J MODERN PHYS C, V27; Ma M, 2016, T I MEASUREMENT CONT; Ma M, 2015, MATH PROBL ENG, V2015, P1; Messmer A., 1990, TRAF C ENG CONTROL, V31, P466, DOI DOI 10.1007/978-1-4419-6142-611; Pasquale C, 2017, TRANSPORT RES C-EMER, V80, P384, DOI 10.1016/j.trc.2017.04.007; Pasquale C, 2016, IFAC PAPERSONLINE, V49, P329, DOI 10.1016/j.ifacol.2016.07.055; Stackelberg H.Von., 1952, THEORY MARKET EC; Wang YB, 2000, TRAFFIC AND TRANSPORTATION STUDIES, P642; Yang XF, 2013, PROCD SOC BEHV, V96, P2362, DOI 10.1016/j.sbspro.2013.08.265	24	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204255	10.1371/journal.pone.0204255	http://dx.doi.org/10.1371/journal.pone.0204255			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265696	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500022
J	Mendez-Lara, KA; Santos, D; Farre, N; Ruiz-Nogales, S; Leanez, S; Sanchez-Quesada, JL; Zapico, E; Lerma, E; Escola-Gil, JC; Blanco-Vaca, F; Martin-Campos, JM; Julve, J; Pol, O				Alejandra Mendez-Lara, Karen; Santos, David; Farre, Nuria; Ruiz-Nogales, Sheila; Leanez, Sergi; Luis Sanchez-Quesada, Jose; Zapico, Edgar; Lerma, Enrique; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep; Pol, Olga			Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; MONOXIDE-RELEASING MOLECULE; CARBON-MONOXIDE; INSULIN-RESISTANCE; OXIDATIVE STRESS; NADPH OXIDASE; MOUSE MODELS; PAIN; EXPRESSION	antinociceptive effects of the carbon monoxide-releasing molecule tricarbonyldichloror-uthenium (II) dimer (CORM-2) during chronic pain are well documented, but most of its possible side-effects remain poorly understood. In this work, we examine the impact of CORM- 2 treatment on the lipoprotein profile and two main atheroprotective functions attributed to high-density lipoprotein (HDL) in a mouse model of type 1 diabetes while analyzing the effect of this drug on diabetic neuropathy. Streptozotocin (Stz)-induced diabetic mice treated with CORM-2 (Stz-CORM-2) or vehicle (Stz-vehicle) were used to evaluate the effect of this drug on the modulation of painful diabetic neuropathy using nociceptive behavioral tests. Plasma and tissue samples were used for chemical and functional analyses, as appropriate. Two main antiatherogenic properties of HDL, i.e., the ability of HDL to protect low-density lipoprotein (LDL) from oxidation and to promote reverse cholesterol transport from macrophages to the liver and feces in vivo (m-RCT), were also assessed. Stz-induced diabetic mice displayed hyperglycemia, dyslipidemia and pain hypersensitivity. The administration of 10 mg/kg CORM-2 during five consecutive days inhibited allodynia and hyperalgesia and significantly ameliorated spinal cord markers (Cybb and Bdkrb /expression) of neuropathic pain in Stz mice, but it did not reduce the combined dyslipidemia shown in Stz-treated mice. Its administration to Stz-treated mice led to a significant increase in the plasma levels of cholesterol (similar to 1.4-fold vs. Ctrl,similar to 1.3- fold vs. Stz-vehicle; p < 0.05) and was attributed to significant elevations in both non-HDL (similar to 1.8-fold vs. Ctrl;similar to 1.6-fold vs. Stz-vehicle; p < 0.05) and HDL cholesterol (similar to 1.3-fold vs. Ctrl, similar to 1.2-fold vs. Stz-vehicle; p <0.05). The increased HDL in plasma was not accompanied by a commensurate elevation in m-RCT in Stz-CORM-2 compared to Stz-vehicle mice; instead, it was worsened as revealed by decreased [H-3]-tracer trafficking into the feces in vivo. Furthermore, the HDL-mediated protection against LDL oxidation ex vivo shown by the HDL isolated from Stz-CORM-2 mice did not differ from that obtained in Stz-vehicle mice. In conclusion, the antinociceptive effects produced by a high dose of CORM-2 were accompanied by antioxidative effects but were without favorable effects on the dyslipidemia manifested in diabetic mice.	[Alejandra Mendez-Lara, Karen; Farre, Nuria; Ruiz-Nogales, Sheila; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep] Hosp Santa Creu & Sant Pau, Inst Recerca, Grp Bases Metab Risc Cardiovasc, Barcelona, Spain; [Alejandra Mendez-Lara, Karen; Farre, Nuria; Ruiz-Nogales, Sheila; Leanez, Sergi; Luis Sanchez-Quesada, Jose; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep; Pol, Olga] IIB St Pau, Barcelona, Spain; [Alejandra Mendez-Lara, Karen; Luis Sanchez-Quesada, Jose; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Santos, David; Luis Sanchez-Quesada, Jose; Carles Escola-Gil, Joan; Blanco-Vaca, Francisco; Maria Martin-Campos, Jesus; Julve, Josep] CIBERDEM, CIBER Diabet & Enfermedades Metab Asociades, Inst Recerca, Barcelona, Spain; [Leanez, Sergi; Pol, Olga] Hosp Santa Creu & Sant Pau, Grp Neurofarmacol Mol, Barcelona, Spain; [Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, Grp Neurofarmacol Mol, Barcelona, Spain; [Luis Sanchez-Quesada, Jose] Hosp Santa Creu & Sant Pau, Inst Recerca, Grp Bioquim Cardiovasc, Barcelona, Spain; [Zapico, Edgar] Hosp Santa Creu & Sant Pau, Dept Bioquim, Barcelona, Spain; [Lerma, Enrique] Hosp Santa Creu & Sant Pau, Dept Patol, Barcelona, Spain; [Lerma, Enrique] Univ Autonoma Barcelona, Dept Ciencies Morfol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Julve, J (corresponding author), Hosp Santa Creu & Sant Pau, Inst Recerca, Grp Bases Metab Risc Cardiovasc, Barcelona, Spain.; Julve, J; Pol, O (corresponding author), IIB St Pau, Barcelona, Spain.; Julve, J (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.; Julve, J (corresponding author), CIBERDEM, CIBER Diabet & Enfermedades Metab Asociades, Inst Recerca, Barcelona, Spain.; Pol, O (corresponding author), Hosp Santa Creu & Sant Pau, Grp Neurofarmacol Mol, Barcelona, Spain.; Pol, O (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Grp Neurofarmacol Mol, Barcelona, Spain.	jjulve@santpau.cat; opol@santpau.es	Martín-Campos, Jesús M./AAQ-5478-2021; Escolà, Joan Carles/U-1521-2019; Mendez Lara, Karen/GZH-2511-2022; Julve, Josep/I-1003-2017; Blanco-Vaca, Francisco/AAC-2600-2022; Pol, Olga/O-2146-2019; Escolà-Gil, Joan Carles/H-9522-2014; Mendez Lara, Karen Alejandra/Q-1750-2017	Escolà, Joan Carles/0000-0001-9021-2485; Julve, Josep/0000-0002-6531-2246; Pol, Olga/0000-0002-4621-8457; Santos, David/0000-0003-1157-4969; Blanco-Vaca, Francisco/0000-0001-7380-5385; Mendez Lara, Karen Alejandra/0000-0002-8372-2310	Ministerio de Economia y Competitividad; Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER), Union Europea [PI17/00232, PI16/00139, PI16/00471, PI0900968, PI1400927]; FEDER "Una manera de hacer Europa"; Fundacio La Marato de TV3 [201602-31]; Miguel Servet Type 1 contract ISCIII [CP13/00070]; AGAUR [FI-DGR2014]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER), Union Europea; FEDER "Una manera de hacer Europa"; Fundacio La Marato de TV3; Miguel Servet Type 1 contract ISCIII; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was partly supported by the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER), Union Europea grants PI17/00232 (to JJ), PI16/00139 (to JCE-G), PI16/00471 (to JLS-Q), PI0900968 and PI1400927 (to OP), and FEDER "Una manera de hacer Europa"; and Fundacio La Marato de TV3 (grant number 201602-31 to JJ). JJ is recipient of a Miguel Servet Type 1 contract ISCIII (CP13/00070). KAM-L is recipient of an AGAUR grant FI-DGR2014 (Generalitat de Catalunya). CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) is a project of the Instituto de Salud Carlos III. Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA).	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bierhaus A, 2012, EXP CLIN ENDOCR DIAB, V120, P188, DOI 10.1055/s-0032-1304567; Bijjem KRV, 2013, N-S ARCH PHARMACOL, V386, P79, DOI 10.1007/s00210-012-0816-1; Bloks VW, 2004, DIABETOLOGIA, V47, P104, DOI 10.1007/s00125-003-1261-y; Boemi M, 2001, ATHEROSCLEROSIS, V155, P229, DOI 10.1016/S0021-9150(00)00556-6; Boulton AJM, 2013, DIABETES-METAB RES, V29, P327, DOI 10.1002/dmrr.2397; Castany S, 2016, NEUROSCI LETT, V614, P49, DOI 10.1016/j.neulet.2015.12.059; Catanzaro O, 2013, PEPTIDES, V44, P100, DOI 10.1016/j.peptides.2013.01.019; Cedo L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189834; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chi PL, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/279171; Connelly PW, 2004, J LIPID RES, V45, P561, DOI 10.1194/jlr.M300464-JLR200; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; de Boer JF, 2012, J LIPID RES, V53, P348, DOI 10.1194/jlr.M018671; Errico TL, 2017, TRANSL RES, V186, P19, DOI 10.1016/j.trsl.2017.05.004; Escola-Gil JC, 2015, METHODS MOL BIOL, V1339, P211, DOI 10.1007/978-1-4939-2929-0_15; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Farbstein D, 2012, EXPERT REV CARDIOVAS, V10, P353, DOI [10.1586/erc.11.182, 10.1586/ERC.11.182]; Gabra BH, 2005, REGUL PEPTIDES, V127, P245, DOI 10.1016/j.regpep.2004.12.003; Guilford BL, 2011, EXP DIABETES RES, DOI 10.1155/2011/848307; Gylling H, 2004, DIABETES, V53, P2217, DOI 10.2337/diabetes.53.9.2217; Haemmerle G, 2003, CURR OPIN LIPIDOL, V14, P289, DOI 10.1097/00041433-200306000-00009; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hervera A, 2013, PSYCHOPHARMACOLOGY, V228, P463, DOI 10.1007/s00213-013-3053-5; Hervera A, 2013, ANESTHESIOLOGY, V118, P1180, DOI 10.1097/ALN.0b013e318286d085; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Jarvisalo M, 2006, DIABETES CARE, V29, P2300, DOI 10.2337/dc05-2235; Julve J, 2013, MOL NUTR FOOD RES, V57, P1814, DOI 10.1002/mnfr.201300133; Julve J, 2010, ARTERIOSCL THROM VAS, V30, P232, DOI 10.1161/ATVBAHA.109.198226; Kalogerakis G, 2005, CLIN SCI, V108, P497, DOI 10.1042/CS20040312; Karlsson H, 2015, HDB EXPT PHARM, V224, P207, DOI DOI 10.1007/978-3-319-09665-0_5; Kennedy JM, 2005, DIABETES, V54, P830, DOI 10.2337/diabetes.54.3.830; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Kontush A, 2008, CURR DIABETES REP, V8, P51, DOI 10.1007/s11892-008-0010-5; Lee-Rueckert M, 2016, BBA-MOL CELL BIOL L, V1861, P566, DOI 10.1016/j.bbalip.2016.03.004; Liu XM, 2016, PAIN MED, V17, P220, DOI 10.1111/pme.12906; Low H, 2012, DIABETOLOGIA, V55, P2513, DOI 10.1007/s00125-012-2570-9; Motterlini R, 2017, AM J PHYSIOL-CELL PH, V312, pC302, DOI 10.1152/ajpcell.00360.2016; Navab M, 2000, J LIPID RES, V41, P1481; Negrete R, 2014, PSYCHOPHARMACOLOGY, V231, P853, DOI 10.1007/s00213-013-3302-7; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Ory DS, 2010, DIABETES, V59, P2358, DOI 10.2337/db10-1040; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Rochette L, 2013, PHARMACOL THERAPEUT, V137, P133, DOI 10.1016/j.pharmthera.2012.09.007; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; SAID G, 1983, BRAIN, V106, P791, DOI 10.1093/brain/106.4.791; Sampaio E, 2013, DIABETES RES CLIN PR, V99, P321, DOI 10.1016/j.diabres.2012.12.012; Sinnreich M, 2005, NEUROLOGIST, V11, P63, DOI 10.1097/01.nrl.0000156314.24508.ed; Stadler K, 2013, ADV EXP MED BIOL, V771, P272; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Tahrani AA, 2010, EXPERT OPIN EMERG DR, V15, P661, DOI 10.1517/14728214.2010.512610; Takada J, 2007, METABOLISM, V56, P977, DOI 10.1016/j.metabol.2006.05.021; Talbot S, 2012, EXP NEUROL, V234, P373, DOI 10.1016/j.expneurol.2011.11.032; Talbot S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-36; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785	60	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204841	10.1371/journal.pone.0204841	http://dx.doi.org/10.1371/journal.pone.0204841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286142	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500048
J	Stiles, NRB; Li, M; Levitan, CA; Kamitani, Y; Shimojo, S				Stiles, Noelle R. B.; Li, Monica; Levitan, Carmel A.; Kamitani, Yukiyasu; Shimojo, Shinsuke			What you saw is what you will hear: Two new illusions with audiovisual postdictive effects	PLOS ONE			English	Article							PERCEPTION; SOUND; CONVERGENCE; UNCERTAINTY; MOVEMENT; AUDITION; OBJECTS; HUMANS; MOTION; COLOR	Neuroscience investigations are most often focused on the prediction of future perception or decisions based on prior brain states or stimulus presentations. However, the brain can also process information retroactively, such that later stimuli impact conscious percepts of the stimuli that have already occurred (called "postdiction"). Postdictive effects have thus far been mostly unimodal (such as apparent motion), and the models for postdiction have accordingly been limited to early sensory regions of one modality. We have discovered two related multimodal illusions in which audition instigates postdictive changes in visual perception. In the first illusion (called the "Illusory Audiovisual Rabbit"), the location of an illusory flash is influenced by an auditory beep-flash pair that follows the perceived illusory flash. In the second illusion (called the "Invisible Audiovisual Rabbit"), a beep-flash pair following a real flash suppresses the perception of the earlier flash. Thus, we showed experimentally that these two effects are influenced significantly by postdiction. The audiovisual rabbit illusions indicate that postdiction can bridge the senses, uncovering a relatively-neglected yet critical type of neural processing underlying perceptual awareness. Furthermore, these two new illusions broaden the Double Flash Illusion, in which a single real flash is doubled by two sounds. Whereas the double flash indicated that audition can create an illusory flash, these rabbit illusions expand audition's influence on vision to the suppression of a real flash and the relocation of an illusory flash. These new additions to auditory-visual interactions indicate a spatio-temporally fine-tuned coupling of the senses to generate perception.	[Stiles, Noelle R. B.; Li, Monica; Shimojo, Shinsuke] CALTECH, Biol & Biol Engn, Pasadena, CA 91125 USA; [Levitan, Carmel A.] Occident Coll, Cognit Sci, Los Angeles, CA USA; [Kamitani, Yukiyasu] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Kamitani, Yukiyasu] ATR Computat Neurosci Labs, Kyoto, Japan	California Institute of Technology; Kyoto University	Stiles, NRB (corresponding author), CALTECH, Biol & Biol Engn, Pasadena, CA 91125 USA.	nstiles@caltech.edu			National Institutes of Health; Philanthropic Educational Organization Scholar Award Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philanthropic Educational Organization Scholar Award Program	We are grateful for research grants from the National Institutes of Health, the Philanthropic Educational Organization Scholar Award Program, from the Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), and from JSPS KAKENHI Grant number JP15H05710. ATR Computational Neuroscience Laboratories did not provided support in the form of salaries and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2003, CURR BIOL, V13, P59, DOI 10.1016/S0960-9822(02)01402-1; Bachmann T, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00593; BECK J, 1977, PERCEPT PSYCHOPHYS, V21, P33, DOI 10.3758/BF03199464; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GELDARD FA, 1972, SCIENCE, V178, P178, DOI 10.1126/science.178.4057.178; Goldreich D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00221; Heron J, 2004, VISION RES, V44, P2875, DOI 10.1016/j.visres.2004.07.001; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Kamitani Y, 1999, NAT NEUROSCI, V2, P767, DOI 10.1038/11245; KOLERS PA, 1976, VISION RES, V16, P329, DOI 10.1016/0042-6989(76)90192-9; KOLERS PA, 1975, SCIENCE, V187, P757, DOI 10.1126/science.1114322; MACDONALD J, 1978, PERCEPT PSYCHOPHYS, V24, P253, DOI 10.3758/BF03206096; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sergent C, 2013, CURR BIOL, V23, P150, DOI 10.1016/j.cub.2012.11.047; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Shams L., 2000, NATURE; Sheth BR, 2000, NAT NEUROSCI, V3, P489, DOI 10.1038/74865; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Shimojo S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00196; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Spence C., 2012, NEURAL BASEMULTISE, DOI DOI 10.1201/B11092; Vidal M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172028; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Wu CT, 2009, CURR BIOL, V19, P2003, DOI 10.1016/j.cub.2009.10.017; Yamada Y, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00166	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204217	10.1371/journal.pone.0204217	http://dx.doi.org/10.1371/journal.pone.0204217			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281629	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000446342400044
J	La Rosa, JV; Ryan, P; Alvaro-Meca, A; Troya, J; Cuevas, G; Gutierrez, J; Moreno, S				Valencia La Rosa, Jorge; Ryan, Pablo; Alvaro-Meca, Alejandro; Troya, Jesus; Cuevas, Guillermo; Gutierrez, Jorge; Moreno, Santiago			HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INJECT DRUGS; RISK-FACTORS; INFECTION; HIV; PREVALENCE; INTERVENTIONS; TRANSMISSION; PREVENT; MODELS	Background and aims Harm reduction strategies have been shown to decrease the incidence of human immunodeficiency virus (HIV) infection in people who inject drugs (PWID), but the results have been inconsistent when it comes to prevention of hepatitis C virus (HCV) infection. We aimed to examine the rate of HCV seroconversion among people who use drugs (PWUD) followed at a mobile harm reduction unit (MHRU) to evaluate if a low-threshold methadone substitution program (LTMSP) is associated with a low HCV seroconversion rate and subsequently identify barriers for elimination. Materials and methods A cohort of PWUD have been followed at a MRHU in Madrid between 2013 and 2016. Individuals who were negative for HCV antibodies at baseline and who had at least one retest for HCV antibodies were eligible. Kaplan-Meier methods were employed to estimate the global incidence density. Results During the study period, 946 PWUD were screened for HCV at least once. At baseline 127 PWUD were negative for HCV antibodies and had at least one follow-up HCV antibodies test. The baseline HCV prevalence was 33%. After a median 0.89 (IQR 0.3-1.5) years of follow-up and 135 person-years of risk for HCV infection, 28 subjects seroconverted. The incidence density for HCV seroconversion for this sample was 20.7 cases (95% CI: 14.3-29.7) per 100 person-years. Injecting drugs in the last year was strongly associated to HCV seroconversion (AHR 15.5, 95%CI 4.3-55.8, p < 0.001). Methadone status was not associated to HCV seroconversion. Conclusions A high incidence of HCV infection was found among PWUD at a MHRU in Madrid. In this setting opiate substitutive treatment (OST) as a LTMSP does not appear to protect against HCV seroconversion.	[Valencia La Rosa, Jorge] Subdirecc Gen Asistencia Adicc, Unidad Movil Reducc Dano, Madrid, Spain; [Ryan, Pablo; Troya, Jesus; Cuevas, Guillermo] Hosp Univ Infanta Leonor, Med Interna, Madrid, Spain; [Alvaro-Meca, Alejandro] Univ Rey Juan Carlos, Dept Bioestadist, Madrid, Spain; [Gutierrez, Jorge] Org Gubernamental Madrid Posit, Madrid, Spain; [Moreno, Santiago] Univ Alcala, IRYCIS, Hosp Univ Ramon y Cajal, Serv Enfermedades Infecciosas, Madrid, Spain	Hospital Universitario Infanta Leonor; Universidad Rey Juan Carlos; Hospital Universitario Ramon y Cajal; Universidad de Alcala	La Rosa, JV (corresponding author), Subdirecc Gen Asistencia Adicc, Unidad Movil Reducc Dano, Madrid, Spain.	jorge_vlr@yahoo.es	RYAN, PABLO/GRF-3462-2022; Ryan, Pablo/AAM-1924-2021; Troya-García, Jesus/Y-9721-2019	RYAN, PABLO/0000-0002-4212-7419; Ryan, Pablo/0000-0002-4212-7419; Troya-García, Jesus/0000-0001-7323-114X; Alvaro-Meca, Alejandro/0000-0003-1315-4386; valencia, jorge/0000-0002-0148-2422	Fundacion para la InvestigacionBiomedica de Atencion Primaria (FIBAP) of the Community of MadridGrants for Translation/Publications 2017	Fundacion para la InvestigacionBiomedica de Atencion Primaria (FIBAP) of the Community of MadridGrants for Translation/Publications 2017	The work has been partially funded by the "Fundacion para la InvestigacionBiomedica de Atencion Primaria (FIBAP) of the Community of MadridGrants for Translation/Publications 2017". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu D, 2015, INDIAN J MED RES, V142, P311, DOI 10.4103/0971-5916.166596; Bruggmann P, 2013, CLIN INFECT DIS, V57, pS56, DOI 10.1093/cid/cit271; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Dore GJ, 2016, ANN INTERN MED, V165, P625, DOI 10.7326/M16-0816; Fernandes RM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4210-2; Folch C, 2016, SUBST USE MISUSE, V51, P250, DOI 10.3109/10826084.2015.1092991; Grassi A, 2017, WORLD J GASTROENTERO, V23, P3569, DOI 10.3748/wjg.v23.i20.3569; Grebely J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097726; Gyarmathy VA, 2009, EUR ADDICT RES, V15, P163, DOI 10.1159/000220344; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Hellard M, 2014, HEPATOLOGY, V60, P1861, DOI 10.1002/hep.27403; Hernandez-Aguado I, 2001, EUR J EPIDEMIOL, V17, P539, DOI 10.1023/A:1014560431726; Kim C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-270; Larney S, 2017, LANCET GLOB HEALTH, V5, pE1208, DOI [10.1016/S2214-109X(17)30373-X, 10.1016/s2214-109x(17)30373-x]; Lima VD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143836; Litwin AH, 2017, J HEPATOL, V66, pS72, DOI 10.1016/S0168-8278(17)30406-3; Maher L, 2006, ADDICTION, V101, P1499, DOI 10.1111/j.1360-0443.2006.01543.x; Martinello M, 2017, CURR HIV-AIDS REP, V14, P110, DOI 10.1007/s11904-017-0358-8; Metzig C, IMPACT HEPATITIS C T; Munoz F, 2015, AIDS BEHAV, V19, P199, DOI 10.1007/s10461-014-0815-y; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Organization WH.,, 2017, GLOB HEP REP 2017; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Platt L, 2009, EUR J PUBLIC HEALTH, V19, P428, DOI 10.1093/eurpub/ckp041; Reyes-Uruena J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2442-6; Roy E, 2007, INT J STD AIDS, V18, P23, DOI 10.1258/095646207779949880; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Silva MJ, 2017, EUR J GASTROEN HEPAT, V29, P657, DOI 10.1097/MEG.0000000000000843; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Thompson VV, 2005, AIDS, V19, pS208, DOI 10.1097/01.aids.0000192091.38883.f9; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Thorpe LE, 2000, J INFECT DIS, V182, P1588, DOI 10.1086/317607; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416; Vallejo F, 2015, J EPIDEMIOL COMMUNIT; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	36	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204795	10.1371/journal.pone.0204795	http://dx.doi.org/10.1371/journal.pone.0204795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281616	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400058
J	Wang, VG; Kim, H; Chuang, JH				Wang, Victor G.; Kim, Hyunsoo; Chuang, Jeffrey H.			Whole-exome sequencing capture kit biases yield false negative mutation calls in TCGA cohorts	PLOS ONE			English	Article							NONCODING RNA MALAT1; CELL LUNG-CANCER; METASTASIS; ONCOGENE	The Cancer Genome Atlas (TCGA) provides a genetic characterization of more than ten thousand tumors, enabling the discovery of novel driver mutations, molecular subtypes, and enticing drug targets across many histologies. Here we investigated why some mutations are common in particular cancer types but absent in others. As an example, we observed that the gene CCDC168 has no mutations in the stomach adenocarcinoma (STAD) cohort despite its common presence in other tumor types. Surprisingly, we found that the lack of called mutations was due to a systematic insufficiency in the number of sequencing reads in the STAD and other cohorts, as opposed to differential driver biology. Using strict filtering criteria, we found similar behavior in four other genes across TCGA cohorts, with each gene exhibiting systematic sequencing depth issues affecting the ability to call mutations. We identified the culprit as the choice of exome capture kit, as kit choice was highly associated with the set of genes that have insufficient reads to call a mutation. Overall, we found that thousands of samples across all cohorts are subject to some capture kit problems. For example, for the 6353 samples using the Broad Institute's Custom capture kit there are undercalling biases for at least 4833 genes. False negative mutation calls at these genes may obscure biological similarities between tumor types and other important cancer driver effects in TCGA datasets.	[Wang, Victor G.; Kim, Hyunsoo; Chuang, Jeffrey H.] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Wang, Victor G.; Chuang, Jeffrey H.] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA	Jackson Laboratory; University of Connecticut	Chuang, JH (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.; Chuang, JH (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT 06030 USA.	jeff.chuang@jax.org		Chuang, Jeffrey/0000-0002-3298-2358	National Cancer Institute [P30CA034196, R21CA191848, U24CA224067, R01CA230031]; NATIONAL CANCER INSTITUTE [U24CA224067, P30CA034196, R21CA191848, R01CA230031] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors VW, HK, and JC are supported by the National Cancer Institute grants P30CA034196, R21CA191848, U24CA224067, and R01CA230031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Buckley AR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3770-y; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Choi YJ, 2014, HUM PATHOL, V45, P1674, DOI 10.1016/j.humpath.2014.04.013; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cortes-Ciriano I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15180; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fang J, 2016, BIOCHEM BIOPH RES CO, V478, P811, DOI 10.1016/j.bbrc.2016.08.030; Gustavsson E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-187; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Huang YS, 2016, ONCOTARGET, V7, P43256, DOI 10.18632/oncotarget.9673; Integrated DNA Technologies, XGEN EX RES PAN; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McNeil C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv193; Noorbakhsh J, 2017, NAT GENET, V49, P1288, DOI 10.1038/ng.3876; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Ren SC, 2013, J UROLOGY, V190, P2278, DOI 10.1016/j.juro.2013.07.001; Roche, SEQCAP EZ HGSC VCROM; Sernbo S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-405; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; SureSelect Yi Y., LEADER TARGET ENRICH; The Cancer Genome Atlas, TCGA TISS SAMPL REQ; Wang QY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01005-x; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034	33	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204912	10.1371/journal.pone.0204912	http://dx.doi.org/10.1371/journal.pone.0204912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281678	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400067
J	Zheng, GQ; Yu, HY; Kanerva, A; Forsti, A; Sundquist, K; Hemminki, K				Zheng, Guoqiao; Yu, Hongyao; Kanerva, Anna; Forsti, Asta; Sundquist, Kristina; Hemminki, Kari			Familial risks of ovarian cancer by age at diagnosis, proband type and histology	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MUTATIONS; MORTALITY; CARCINOMA; SUBTYPE; HISTORY; BRCA1; WOMEN; CARRIERS; SWEDEN	Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age at diagnosis and histology are limited. Such data can assist genetic counseling and help elucidate etiologic differences among various histologic types of ovarian malignancies. By using the Swedish Family-Cancer Database, we calculated relative risks (RRs) for detailed family histories using a two-way comparison, which implied e.g. estimation of RRs for overall ovarian cancer when family history was histology-specific ovarian cancer, and conversely, RRs for histology-specific ovarian cancer when family history was overall ovarian cancer. In families of only mother, only sisters or both mother and sisters diagnosed with ovarian cancer, cancer risks for ovary were 2.40, 2.59 and 10.40, respectively; and were higher for cases diagnosed before the age of 50 years. All histological types showed a familial risk in two-way analyses, except mucinous and sex cord-stromal tumors. RRs for concordant histology were found for serous (2.47), endometrioid (3.59) and mucinous ovarian cancers (6.91). Concordant familial risks were highest for mucinous cancer; for others, some discordant associations, such as endometrioid-undifferentiated (9.27) and serous-undifferentiated (4.80), showed the highest RRs. Familial risks are high for early-onset patients and for those with multiple affected relatives. Sharing of different histological types of ovarian cancer is likely an indication of the complexity of the underlying mechanisms.	[Zheng, Guoqiao; Yu, Hongyao; Forsti, Asta; Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Kanerva, Anna] Univ Helsinki, Fac Med, Canc Gene Therapy Grp, Helsinki, Finland; [Kanerva, Anna] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Forsti, Asta; Sundquist, Kristina; Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Lund University	Zheng, GQ (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	g.zheng@dkfz.de			German Cancer Aid; Swedish Research Council for Health, Working Life and Welfare (in Swedish: FORTE) [2013-1836]; FORTE [2014-0804]; Swedish Research Council [2012-2378, 2014-10134]; Region Skane; China Scholarship Council [201606100057]	German Cancer Aid(Deutsche Krebshilfe); Swedish Research Council for Health, Working Life and Welfare (in Swedish: FORTE); FORTE; Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane; China Scholarship Council(China Scholarship Council)	This work was supported by the German Cancer Aid; and the Swedish Research Council for Health, Working Life and Welfare (in Swedish: FORTE; Reg. no. 2013-1836), and FORTE (Reg. no. 2014-0804) and the Swedish Research Council (2012-2378 and 2014-10134); and ALF funding from Region Skane. This research was also supported by the China Scholarship Council (201606100057 to GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Beral V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001200; Centre for Epidemiology, 2013, CANC INC SWED 2012; Chui MH, 2013, ADV ANAT PATHOL, V20, P378, DOI 10.1097/PAP.0b013e3182a92cf8; Conklin CM, 2013, EXPERT REV OBSTET GY, V8, P67, DOI [10.1586/eog.12.72, DOI 10.1586/EOG.12.72]; Frank C, 2017, INT J CANCER, V140, P1510, DOI 10.1002/ijc.30583; Gates MA, 2010, AM J EPIDEMIOL, V171, P45, DOI 10.1093/aje/kwp314; Geary J, 2008, FAM CANCER, V7, P163, DOI 10.1007/s10689-007-9164-6; Hemminki K, 2004, INT J CANCER, V110, P291, DOI 10.1002/ijc.20107; Hemminki K, 2003, INT J CANCER, V105, P692, DOI 10.1002/ijc.11150; Hemminki K, 2011, CANCER-AM CANCER SOC, V117, P3972, DOI 10.1002/cncr.26016; Hemminki K, 2010, INT J CANCER, V126, P2259, DOI 10.1002/ijc.24795; Jervis S, 2013, J MED GENETICS; Ji JG, 2008, ACTA ONCOL, V47, P1133, DOI 10.1080/02841860701784544; Kari H, 2003, INT J CANCER, V105, P701, DOI 10.1002/ijc.11151; Kim SI, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e5; Kjaerbye-Thygesen A, 2005, ACTA OBSTET GYN SCAN, V84, P1006, DOI 10.1111/j.0001-6349.2005.00878.x; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Pal T, 2012, BRIT J CANCER, V107, P1783, DOI 10.1038/bjc.2012.452; Riman T, 2002, AM J EPIDEMIOL, V156, P363, DOI 10.1093/aje/kwf048; Roett MA, 2009, AM FAM PHYSICIAN, V80, P609; Skirnisdottir I, 2008, INT J CANCER, V123, P1897, DOI 10.1002/ijc.23724; Soegaard M, 2007, CANCER EPIDEM BIOMAR, V16, P1160, DOI 10.1158/1055-9965.EPI-07-0089; Sopik V, 2015, GYNECOL ONCOL, V138, P741, DOI 10.1016/j.ygyno.2015.06.017; Teerlink CC, 2012, GENET MED, V14, P107, DOI 10.1038/gim.2011.2; Torre L.A., 2017, GLOBAL CANC WOMEN BU; Watson P, 2001, GYNECOL ONCOL, V82, P223, DOI 10.1006/gyno.2001.6279; Wentzensen N, 2016, J CLIN ONCOL, V34, P2888, DOI 10.1200/JCO.2016.66.8178	34	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205000	10.1371/journal.pone.0205000	http://dx.doi.org/10.1371/journal.pone.0205000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281663	gold, Green Submitted, Green Published			2022-12-27	WOS:000446342400074
J	Lee, SM; Ha, DH; Han, SH				Lee, Sang Min; Ha, Doo Hoe; Han, Soo Hong			Differential sonographic features of the extensor pollicis longus tendon rupture and other finger tendons rupture in the setting of hand and wrist trauma	PLOS ONE			English	Article							MUSCULOSKELETAL ULTRASONOGRAPHY; ULTRASOUND EVALUATION; DISTAL RADIUS; ANATOMY; DIAGNOSIS; INJURY; TEARS; CT	Purpose To investigate the difference between sonographic findings in extensor pollicis longus tendons rupture and other finger tendons rupture in patients sustaining hand and wrist trauma. Methods Twenty-four patients who presented with signs and symptoms clinically suspicious for tendon injury and surgically confirmed tendon rupture were included in this study. We analyzed 6 sonographic features: discontinuity of the tendon, pseudomass formation, decreased echogenicity of the tendon, retraction of the ruptured tendon, fluid collection within the tendon sheath, and the motion of the tendon. We compared the sonographic features of ruptured extensor pollicis longus tendons with the other ruptured finger tendons. Results Discontinuity of the tendon was the most common sonographic findings and retraction of the ruptured tendon was the second most common findings. Fourteen of 16 cases with a dynamic study on sonography showed loss of normal motion of the tendon. Pseudomass formation was the second most common feature in ruptured extensor pollicis longus tendons, in contrast to the other ruptured finger tendons (p < 0.05). Conclusion Using ultrasonography, detection of discontinuity of the tendon, retraction of the ruptured tendon, and limitation of tendon motion could be very helpful for diagnosing a tendon rupture in hand and wrist trauma. Pseudomass formation could be more specific for diagnosing extensor pollicis longus tendon ruptures compared with other finger tendons.	[Lee, Sang Min; Ha, Doo Hoe] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Seongnam, South Korea; [Han, Soo Hong] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Orthoped, Seongnam, South Korea	Pochon Cha University; Pochon Cha University	Lee, SM (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Seongnam, South Korea.	smlee@cha.ac.kr		Lee, Sang Min/0000-0002-1331-0214				Bianchi S, 2005, SKELETAL RADIOL, V34, P500, DOI 10.1007/s00256-005-0956-1; Bjorkman A, 2004, SCAND J PLAST RECONS, V38, P32, DOI 10.1080/02844310310013046; CHHEM RK, 1994, RADIOL CLIN N AM, V32, P275; Cvitanic OA, 2007, AM J ROENTGENOL, V189, P1190, DOI 10.2214/AJR.07.2281; De Maeseneer M, 2005, AM J ROENTGENOL, V184, P175, DOI 10.2214/ajr.184.1.01840175; Dezfuli B, 2016, ANN PLAS SURG, V76, P187, DOI 10.1097/SAP.0000000000000524; Fessell DP, 1998, RADIOGRAPHICS, V18, P325, DOI 10.1148/radiographics.18.2.9536481; FORNAGE BD, 1988, RADIOL CLIN N AM, V26, P87; Gitto S, 2018, J ULTRAS MED, V37, P51, DOI 10.1002/jum.14313; HOVE LM, 1994, ACTA ORTHOP SCAND, V65, P199, DOI 10.3109/17453679408995434; Jacobson JA, 1998, ORTHOP CLIN N AM, V29, P135, DOI 10.1016/S0030-5898(05)70010-9; Klauser A, 1999, AM J SPORT MED, V27, P733, DOI 10.1177/03635465990270060801; Lee DH, 2000, J HAND SURG-AM, V25A, P236, DOI 10.1053/jhsu.2000.jhsu25a0236; Mattox R, 2017, J ULTRASOUND, V20, P237, DOI 10.1007/s40477-016-0223-4; Nanno M, 2015, J NIPPON MED SCH, V82, P220, DOI 10.1272/jnms.82.220; Owers KL, 2007, J HAND SURG-BRIT EUR, V32E, P467, DOI 10.1016/j.jhsb.2006.11.021; Parellada AJ, 2007, SKELETAL RADIOL, V36, P203, DOI 10.1007/s00256-006-0238-6; Rockwell WB, 2000, PLAST RECONSTR SURG, V106, P1592, DOI 10.1097/00006534-200012000-00024; Santiago FR, 2008, EUR J RADIOL, V66, P112, DOI 10.1016/j.ejrad.2007.05.007; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Soni P, 2009, PLAST RECONSTR SURG, V123, pE52, DOI [10.1097/PRS.0b013e318197b692, 10.1097/01.prs.0000345599.95343.2a]; Sunagawa T, 2003, J COMPUT ASSIST TOMO, V27, P169, DOI 10.1097/00004728-200303000-00012; VANHOLSBEECK M, 1992, RADIOL CLIN N AM, V30, P907; VONSCHROEDER HP, 1995, J HAND SURG-AM, V20A, P27, DOI 10.1016/S0363-5023(05)80053-X	24	1	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205111	10.1371/journal.pone.0205111	http://dx.doi.org/10.1371/journal.pone.0205111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278069	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200039
J	Medeiros, FS; Martins, AES; Gomes, RG; de Oliveira, SAV; Welkovic, S; Maruza, M; Menezes, MLB; Ximenes, RAD; Diniz, GTN; Donadi, EA; Lucena-Silva, N				Medeiros, Fernanda Silva; Silva Martins, Albert Eduardo; Gomes, Renan Garcia; Vieira de Oliveira, Savio Augusto; Welkovic, Stefan; Maruza, Magda; Bezerra Menezes, Maria Luiza; de Alencar Ximenes, Ricardo Arraes; Nunes Diniz, George Tadeu; Donadi, Eduardo Antonio; Lucena-Silva, Norma			Variation sites at the HLA-G 3 ' untranslated region confer differential susceptibility to HIV/HPV co-infection and aneuploidy in cervical cell	PLOS ONE			English	Article							LEUKOCYTE ANTIGEN-G; TO-CHILD TRANSMISSION; HUMAN-PAPILLOMAVIRUS; G POLYMORPHISMS; HPV INFECTION; G EXPRESSION; G GENE; CANCER; RISK; ASSOCIATION	Post-transcriptional regulatory elements associated with transcript degradation or transcript instability have been described at the 3' untranslated region (3'UTR) of the HLA-G gene. Considering that HPV infection and aneuploidy, which causes gene instability, are associated with cervical cell malignancy, as well as the fact that HIV infection and HLA-G may modulate the immune response, the present study aimed to compare the frequencies of HLA-G 3'UTR polymorphic sites (14-base pair insertion/deletion, +3142C/G, and +3187A/G) between 226 HIV+ women co-infected (n = 82) or not with HPV (n = 144) and 138 healthy women. We also evaluated the relationship between those HLA-G 3'UTR variants and aneuploidy in cervical cells. HPV types and HLA-G polymorphisms were determined by PCR and sequencing of cervical samples DNA. Aneuploidy in cervical cell was measured by flow cytometry. The HLA-G 3'UTR 14-bp ins/del was not associated with either HIV nor HIV/ HPV co-infection. The +3142G allele (p= 0.049) and +3142GG genotype (p = 0.047) were overrepresented in all HIV-infected women. On the other hand, the +3187G allele (p = 0.028) and the +3187GG genotype (p = 0.026) predominated among healthy women. The +3142G (p = 0.023) and +3187A (p = 0.003) alleles were associated with predisposition to HIV infection, irrespective of the presence or not of HIV/HPV co-infection. The diplotype formed by the combination of the +3142CX (CC or CG) and +3187AA genotype conferred the highest risk for aneuploidy in cervical cell induced by HPV. The HLA-G 3'UTR +3142 and +3187variants conferred distinct susceptibility to HIV infection and aneuploidy.	[Medeiros, Fernanda Silva; Silva Martins, Albert Eduardo; Gomes, Renan Garcia; Vieira de Oliveira, Savio Augusto; Lucena-Silva, Norma] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Dept Immunol, Lab Immunogenet, Recife, PE, Brazil; [Welkovic, Stefan] Univ Pernambuco, Integrated Hlth Ctr Amaury de Medeiros CISAM, Recife, PE, Brazil; [Maruza, Magda] Hlth Secretariat Pernambuco, Hosp Correia Picanco, Recife, PE, Brazil; [Bezerra Menezes, Maria Luiza] Univ Pernambuco UPE, Fac Med Sci, Maternal & Child Dept, Recife, PE, Brazil; [de Alencar Ximenes, Ricardo Arraes] Fed Univ Pernambuco UFPE, Dept Trop Med, Recife, PE, Brazil; [Nunes Diniz, George Tadeu] Aggeu Magalhaes Inst, Dept Publ Hlth, Lab Computat Methods, Recife, PE, Brazil; [Donadi, Eduardo Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Ribeirao Preto, Brazil; [Lucena-Silva, Norma] IMIP Hosp, Pediat Oncol Serv, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco; Universidade de Sao Paulo	Lucena-Silva, N (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Dept Immunol, Lab Immunogenet, Recife, PE, Brazil.; Lucena-Silva, N (corresponding author), IMIP Hosp, Pediat Oncol Serv, Recife, PE, Brazil.	norma.lucena@hotmail.com	Lucena-Silva, Norma/AAH-9437-2019; donadi, eduardo/H-7080-2013	Garcia Gomes, Renan/0000-0003-4950-7614; donadi, eduardo/0000-0002-9457-9601	Brazilian Health Ministry Project DECIT-FINEP [1299-13;401700/2015-1]; CAPES Project PROCAD [88881-068436/2014-09]; Foundation for Science and Technology of the State of Pernambuco (FACEPE) [PROEP-APQ16804.01/15, IBPG-0849-4.01/16]; Brazilian National Council for Scientific and Technological Development (CNPq) [310364/2015-9, 304931/2014.1]	Brazilian Health Ministry Project DECIT-FINEP; CAPES Project PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Science and Technology of the State of Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from: (1) Brazilian Health Ministry Project DECIT-FINEP #1299-13;401700/2015-1; (2) CAPES Project PROCAD #88881-068436/2014-09; (3) Foundation for Science and Technology of the State of Pernambuco (FACEPE), grant PROEP-APQ16804.01/15 and award #IBPG-0849-4.01/16 to F.S.M.; (4) Brazilian National Council for Scientific and Technological Development (CNPq), Award #310364/2015-9 to N.L.-S. and #304931/2014.1 to E.A.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AG, 2013, JAIDS-J ACQ IMM DEF, V62, P405, DOI 10.1097/QAI.0b013e31828177d7; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Ananworanich J, 2015, J VIRUS ERAD, V1, P30; Rodriguez JA, 2012, PATHOBIOLOGY, V79, P72, DOI 10.1159/000334089; Baricordi Olavio R., 2008, Inflammation & Allergy Drug Targets, V7, P67, DOI 10.2174/187152808785107615; Bortolotti D, 2014, TISSUE ANTIGENS, V83, P113, DOI 10.1111/tan.12281; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Carosella ED, 2011, IMMUNOL LETT, V138, P22, DOI 10.1016/j.imlet.2011.02.011; Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; da Silva GK, 2014, INFECT GENET EVOL, V21, P418, DOI 10.1016/j.meegid.2013.12.013; de Albuquerque RS, 2016, HUM IMMUNOL, V77, P358, DOI 10.1016/j.humimm.2016.02.001; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; Dong DD, 2010, REPROD SCI, V17, P718, DOI 10.1177/1933719110369183; Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356; Ferguson R, 2011, HUM IMMUNOL, V72, P337, DOI 10.1016/j.humimm.2011.01.010; Garbuglia AR, 2012, J CLIN VIROL, V54, P141, DOI 10.1016/j.jcv.2012.02.013; Gimenes F, 2014, BBA-REV CANCER, V1846, P576, DOI 10.1016/j.bbcan.2014.10.004; Hong HA, 2015, INFECT GENET EVOL, V30, P147, DOI 10.1016/j.meegid.2014.12.021; Huang JH, 2010, J VIROL, V84, P10784, DOI 10.1128/JVI.01292-10; Hviid TVF, 2004, IMMUNOGENETICS, V56, P135, DOI 10.1007/s00251-004-0673-2; Lajoie J, 2010, HUM IMMUNOL, V71, P182, DOI 10.1016/j.humimm.2009.11.007; Larsen MH, 2013, J INFECT DIS, V207, P903, DOI 10.1093/infdis/jis924; Li T, 2015, MOL GENET GENOMICS, V290, P1235, DOI 10.1007/s00438-014-0985-3; Lucena-Silva N, 2013, MOL GENET GENOM MED, V1, P123, DOI 10.1002/mgg3.14; Lucena-Silva N, 2012, TISSUE ANTIGENS, V79, P272, DOI 10.1111/j.1399-0039.2012.01842.x; Lucena-Silva N, 2013, J RHEUMATOL, V40, P1104, DOI 10.3899/jrheum.120814; MANOS MM, 1989, CANCER CEL, V7, P209; Lozano JM, 2009, VIRAL IMMUNOL, V22, P463, DOI 10.1089/vim.2009.0041; Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742; Melsheimer P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565; Metcalfe S, 2013, HUM IMMUNOL, V74, P1610, DOI 10.1016/j.humimm.2013.08.279; Murdaca G, 2009, CLIN IMMUNOL, V133, P238, DOI 10.1016/j.clim.2009.08.002; Naucler P, 2011, J GEN VIROL, V92, P2784, DOI 10.1099/vir.0.034298-0; Porto IOP, 2015, MOL IMMUNOL, V65, P230, DOI 10.1016/j.molimm.2015.01.030; Rocha-Brischiliari SC, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-6; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schneider ML, 1998, ATLAS DIAGNOSTICO DI, P165; Segat L, 2014, TISSUE ANTIGENS, V83, P161, DOI 10.1111/tan.12296; Silva ID, 2013, HUM IMMUNOL, V74, P452, DOI 10.1016/j.humimm.2012.11.025; Martins AES, 2014, MEM I OSWALDO CRUZ, V109, P738, DOI 10.1590/0074-0276140070; Martins AES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104801; Simoes RT, 2009, MODERN PATHOL, V22, P1075, DOI 10.1038/modpathol.2009.67; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Xu HH, 2014, TISSUE ANTIGENS, V84, P216, DOI 10.1111/tan.12359; Yang YC, 2014, EUR J CANCER, V50, P469, DOI 10.1016/j.ejca.2013.10.018; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059; Yoon BS, 2007, INT J GYNECOL OBSTET, V98, P48, DOI 10.1016/j.ijgo.2007.03.041	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204679	10.1371/journal.pone.0204679	http://dx.doi.org/10.1371/journal.pone.0204679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278059	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200020
J	Almeer, RS; El-Khadragy, MF; Abdelhabib, S; Moneim, AEA				Almeer, Rafa S.; El-Khadragy, Manal F.; Abdelhabib, Semlali; Moneim, Ahmed E. Abdel			Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; MATRIX METALLOPROTEINASES; MANSONI INFECTION; GROWTH-FACTOR; L. WILLD; PROTECTS; EXPRESSION; APOPTOSIS; INJURY; TISSUE	Schistosomiasis is a widespread parasitic infection that affects humans, as well as wild and domestic animals. It ranks second after malaria, with a significant health and socio-economic impact in the developing countries. The objective of this study was to assess the anti-schistosomal impact of Ziziphus spina-christi leaf extract (ZLE) on Schistosoma mansoni-induced liver fibrosis in CD-1 Swiss male albino mice. S. mansoni infection was achieved by dipping of mouse tails in schistosomal cercariae. ZLE treatment was initiated at 46 days post-infection by administering a dose of the extract on a daily basis for 10 consecutive days. S. mansoni infection resulted in liver granuloma and fibrosis, with a drastic elevation in liver function factors, nitric oxide, and lipid peroxidation, which were associated with a reduction in glutathione content and substantial inhibition of antioxidant enzyme activities compared to those of the control. Induction of hepatic granuloma, oxidative stress, and fibrosis in the liver was controlled by ZLE administration, which also produced inhibition of matrix metalloproteinase-9, alpha-smooth muscle actin, transforming growth factor-beta, and tissue inhibitors of metalloproteinases expressions. In addition, the S. mansoni-infected group exhibited an increase in Box and caspase-3 levels and a decrease in Bcl-2 level. However, treatment with ZLE mainly mitigated apoptosis in the liver. Thus, the findings of this study revealed that Ziziphus spina-christi had anti-apoptotic, anti-fibrotic, antioxidant, and protective effects on S. mansoni-induced liver wounds. The benefits of Ziziphus spina-christi extract on S. mansoni were partly partially mediated by enhancing anti-fibrinogenic and nuclear factor erythroid 2-related factor 2 (Nrf2) pathways.	[Almeer, Rafa S.; El-Khadragy, Manal F.] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia; [El-Khadragy, Manal F.; Moneim, Ahmed E. Abdel] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt; [Abdelhabib, Semlali] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh, Saudi Arabia	King Saud University; Egyptian Knowledge Bank (EKB); Helwan University; King Saud University	Almeer, RS (corresponding author), King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia.; Moneim, AEA (corresponding author), Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt.	ralmeer@ksu.edu.sa; aest1977@hotmail.com	Semlali, Abdelhabib/AAP-7043-2020; Moneim, Ahmed E. Abdel/C-7461-2012	Semlali, Abdelhabib/0000-0002-1643-0377; Moneim, Ahmed E. Abdel/0000-0002-2654-2591	Deanship of Scientific Research at King Saud University [R6-17-03-55]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this work through the Research Project No. R6-17-03-55.	Abdel Moneim AE, 2013, CNS NEUROL DISORD DR; Adenowo AF, 2015, BRAZ J INFECT DIS, V19, P196, DOI 10.1016/j.bjid.2014.11.004; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aguiar DD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167135; Al-Olayan EM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1389-1; Al-Olayan E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/381413; Almeer RS, 2018, FOOD CHEM TOXICOL, V115, P49, DOI 10.1016/j.fct.2018.03.002; Aly HF, 2013, PARASITOL INT, V62, P380, DOI 10.1016/j.parint.2013.04.002; Amin A, 2009, FOOD CHEM TOXICOL, V47, P2111, DOI 10.1016/j.fct.2009.05.038; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Benammar C, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-54; de Oliveira RB, 2013, INT J PARASITOL, V43, P371, DOI 10.1016/j.ijpara.2012.12.006; Dkhil MA, 2018, INFLAMMOPHARMACOLOGY, V26, P779, DOI 10.1007/s10787-017-0439-8; Dkhil MA, 2018, BIOMED PHARMACOTHER, V102, P64, DOI 10.1016/j.biopha.2018.03.032; Dkhil MA, 2014, PAK J ZOOL, V46, P763; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Du WD, 1999, WORLD J GASTROENTERO, V5, P397; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; El-Lakkany NM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-9; Elaloui M, 2017, NAT PROD RES, V31, P1209, DOI 10.1080/14786419.2016.1226830; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fabre V, 2011, J INFECT DIS, V203, P707, DOI 10.1093/infdis/jiq099; Factor VM, 1998, J BIOL CHEM, V273, P15846, DOI 10.1074/jbc.273.25.15846; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Han HX, 2013, PARASITOL INT, V62, P100, DOI 10.1016/j.parint.2012.09.008; Kadioglu O, 2016, PHYTOMEDICINE, V23, P293, DOI 10.1016/j.phymed.2016.01.004; Khandoga A, 2006, J LEUKOCYTE BIOL, V79, P1295, DOI 10.1189/jlb.0805468; Lee EF, 2014, TRENDS PARASITOL, V30, P75, DOI 10.1016/j.pt.2013.12.005; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; Li L, 2015, PARASITOLOGY, V142, P341, DOI 10.1017/S0031182014001115; Liang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023908; Liu Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00116; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundy SK, 2001, INFECT IMMUN, V69, P271, DOI 10.1128/IAI.69.1.271-280.2001; Michel CG, 2011, J ETHNOPHARMACOL, V133, P53, DOI 10.1016/j.jep.2010.09.001; Moneim AEA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158965; Nabavi SF, 2016, CRIT REV CL LAB SCI, V53, P293, DOI 10.3109/10408363.2015.1129530; Naik SR, 2007, LIVER INT, V27, P393, DOI 10.1111/j.1478-3231.2007.01463.x; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Shaker Y, 2014, J CLIN TRANSL HEPATO, V2, P212, DOI 10.14218/JCTH.2014.00018; de Almeida LMS, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/9521349; Singh KP, 2004, IMMUNOLOGY, V111, P343, DOI 10.1111/j.0019-2805.2004.01817.x; Sobhy MMK, 2018, EXP PARASITOL, V185, P115, DOI 10.1016/j.exppara.2018.01.013; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Wang M, 2014, FREE RADICAL BIO MED, V71, P109, DOI 10.1016/j.freeradbiomed.2014.03.015; Wang Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00377-4; WHO, 2014, WHO TECH REP SER; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Zhu DD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0640-9	57	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204923	10.1371/journal.pone.0204923	http://dx.doi.org/10.1371/journal.pone.0204923			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273397	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700048
J	Januszek, R; Dziewierz, A; Siudak, Z; Rakowski, T; Dudek, D; Bartus, S				Januszek, Rafal; Dziewierz, Artur; Siudak, Zbigniew; Rakowski, Tomasz; Dudek, Dariusz; Bartus, Stanislaw			Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions	PLOS ONE			English	Article							VASCULAR COMPLICATIONS; MORTALITY; ARTERY; COPD	Background The relationship between chronic obstructive pulmonary disease (COPD) and periprocedural complications of percutaneous coronary interventions (PCIs) is influenced by several factors. We aimed to investigate the association between COPD, its complication type and rate in patients undergoing PCI. Methods Data were prospectively collected using the Polish Cardiovascular Intervention Society national registry (ORPKI) on all PCIs performed in Poland between January 2015 and December 2016. COPD was present in 5,594 of the 221,187 patients undergoing PCI. We assessed the frequency and predictors of periprocedural complications in PCI. Results Patients with COPD were elder individuals (70.3 +/- 9.9 vs. 67 +/- 10.8 years; p < 0.05). We noted 145 (2.6%) periprocedural complications in the COPD group and 4,121 (1.9%) in the non-COPD group (p < 0.001). The higher incidence of periprocedural complications in the COPD patients was mainly attributed to cardiac arrest (p = 0.001), myocardial infarctions (p = 0.002) and no-reflows (p < 0.001). COPD was not an independent predictor of all periprocedural complications. On the other hand, COPD was found to be an independent predictor of increased no-reflow risk (odds ratio [OR] 1.447, 95% CI 1.085-1.929; p = 0.01), and at the same time, of decreased risk of periprocedural allergic reactions (OR 0.117, 95% CI 0.016-0.837; p = 0.03). Conclusions In conclusion, periprocedural complications of PCIs are more frequent in patients with COPD. COPD is an independent positive predictor of no-reflow and a negative predictor of periprocedural allergic reactions.	[Januszek, Rafal; Dziewierz, Artur; Rakowski, Tomasz; Dudek, Dariusz; Bartus, Stanislaw] Univ Hosp, Dept Cardiol & Cardiovasc Intervent 2, Krakow, Poland; [Dziewierz, Artur; Rakowski, Tomasz; Dudek, Dariusz; Bartus, Stanislaw] Jagiellonian Univ, Dept Cardiol 2, Med Coll, Krakow, Poland; [Siudak, Zbigniew] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Kielce, Poland; [Dudek, Dariusz] Jagiellonian Univ, Dept Intervent Cardiol, Med Coll, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jan Kochanowski University; Jagiellonian University; Collegium Medicum Jagiellonian University	Bartus, S (corresponding author), Univ Hosp, Dept Cardiol & Cardiovasc Intervent 2, Krakow, Poland.; Bartus, S (corresponding author), Jagiellonian Univ, Dept Cardiol 2, Med Coll, Krakow, Poland.	stanislaw.bartus@uj.edu.pl	Rakowski, Tomasz/AFV-5238-2022; Januszek, Rafał/AFK-5634-2022	Rakowski, Tomasz/0000-0001-6478-6186; Siudak, Zbigniew/0000-0002-8033-3977; Januszek, Rafal/0000-0002-6591-1919; Bartus, Stanislaw/0000-0003-4508-3551				Ahmed B, 2009, CIRC-CARDIOVASC INTE, V2, P423, DOI 10.1161/CIRCINTERVENTIONS.109.860494; ALESSANDRI C, 1994, THROMB HAEMOSTASIS, V72, P343; Applegate RJ, 2008, JACC-CARDIOVASC INTE, V1, P317, DOI 10.1016/j.jcin.2008.03.013; de Miguel-Diez J, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S92614; Dziewierz A, 2009, KARDIOL POL, V67, P115; Enriquez JR, 2011, CHEST, V140, P604, DOI 10.1378/chest.10-2644; Gayed M, 2017, INT HEART J, V58, P180, DOI 10.1536/ihj.16-083; Hadi HAR, 2010, CLIN CARDIOL, V33, P228, DOI 10.1002/clc.20751; Januszek R, 2018, CATHETER CARDIO INTE, V92, pE278, DOI 10.1002/ccd.27372; Januszek R, 2018, POL ARCH INTERN MED, V128, P195, DOI 10.20452/pamw.4237; Januszek R, 2018, POL ARCH INTERN MED, V128, P24, DOI 10.20452/pamw.4145; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Montalescot G, 2011, INT J CARDIOL, V150, P79, DOI 10.1016/j.ijcard.2010.02.077; Mukherjee B, 2017, J CLIN DIAGN RES, V11, pBC19, DOI 10.7860/JCDR/2017/25933.10667; Nishiyama K, 2010, INT J CARDIOL, V143, P178, DOI 10.1016/j.ijcard.2009.02.010; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Siudak Z, 2017, EUROINTERVENTION, V13, P843, DOI 10.4244/EIJ-D-17-00078; Sung Pei-Hsun, 2013, Biomed J, V36, P274, DOI 10.4103/2319-4170.113373; Zhang M, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/1395701	20	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204257	10.1371/journal.pone.0204257	http://dx.doi.org/10.1371/journal.pone.0204257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273363	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700017
J	Robles-Bykbaev, Y; Tarrio-Saavedra, J; Quintana-Pita, S; Diaz-Prado, S; Saban, FJG; Naya, S				Robles-Bykbaev, Yaroslava; Tarrio-Saavedra, Javier; Quintana-Pita, Sara; Diaz-Prado, Silvia; Garcia Saban, Francisco Javier; Naya, Salvador			Statistical degradation modelling of Poly(D,L-lactide-co-glycolide) copolymers for bioscaffold applications	PLOS ONE			English	Article							GENERALIZED LOGISTIC FUNCTION; BIODEGRADABLE POLYMERS; PLGA MICROSPHERES; IN-VITRO; SCAFFOLDS; KINETICS; FABRICATION; DELIVERY; PLA; RELEASE	This methodology permits to simulate the performance of different Poly(D,L-lactide-co-glycolide) copolymer formulations (PDLGA) in the human body, to identify the more influencing variables on hydrolytic degradation and, thus, to estimate biopolymer degradation level. The PDLGA characteristic degradation trends, caused by hydrolysis processes, have been studied to define their future biomedical applications as dental scaffolds. For this purpose, the mass loss, pH, glass transition temperature (T-g) and absorbed water mass of the different biopolymers have been obtained from samples into a phosphate-buffered saline solution (PBS) with initial pH of 7.4, at 37 degrees C (human body conditions). The mass loss has been defined as the variable that characterize the biopolymer degradation level. Its dependence relationship with respect to time, pH and biopolymer formulation has been modelled using statistical learning tools. Namely, generalized additive models (GAM) and nonlinear mixed effects regression with logistic and asymptotic functions have been applied. GAM model provides information about the relevant variables and the parametric functions that relate mass loss, pH and time. Mixed effects are introduced to model and estimate the degradation properties, and to compare the PDLGA biopolymer populations. The degradation path for each polymer formulation has been estimated and compared with respect to the others for helping to use the proper polymer for each specific medical application, performing selection criteria. It was found that the mass loss differences in PDLGA copolymers are strongly related with the way the pH decay versus time, due to carboxylic acid groups formation. This may occur in those environments in which the degradation products remain relatively confined with the non degraded mass. This is the case emulated with the present experimental procedure. The results show that PDLGA polymers degradation degree, in terms of half life and degradation rate, is increasing when acid termination is included, when DL-lactide molar ratio is reduced, decreasing the midpoint viscosity, or when glycolide is not included.	[Robles-Bykbaev, Yaroslava; Diaz-Prado, Silvia] Univ A Coruna, Dept Med, SERGAS, Inst Invest Biomed A Coruna INIBIC,CHUAC, La Coruna, Spain; [Robles-Bykbaev, Yaroslava] Univ Politecn Salesiana, GIIATa, Cuenca, Ecuador; [Tarrio-Saavedra, Javier; Naya, Salvador] Univ A Coruna, Escola Politecn Super, Dept Matemat, Grp MODES, Ferrol, Spain; [Tarrio-Saavedra, Javier; Naya, Salvador] Univ A Coruna, CITIC, La Coruna, Spain; [Quintana-Pita, Sara; Garcia Saban, Francisco Javier] DevelopBiosystem SL, Cedeira, Spain; [Naya, Salvador] ITMATI, Santiago De Compostela, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Universidad Politecnica Salesiana; Universidade da Coruna; Universidade da Coruna	Tarrio-Saavedra, J (corresponding author), Univ A Coruna, Escola Politecn Super, Dept Matemat, Grp MODES, Ferrol, Spain.; Tarrio-Saavedra, J (corresponding author), Univ A Coruna, CITIC, La Coruna, Spain.	jtarrio@udc.es	DÍAZ-PRADO, SILVIA MARIA/ABH-6665-2020; Naya, Salvador/F-7405-2014; Robles-Bykbaev, Yaroslava/Y-6019-2019; Tarrío-Saavedra, Javier/K-9077-2017	DÍAZ-PRADO, SILVIA MARIA/0000-0001-9776-2180; Naya, Salvador/0000-0003-4931-9859; Robles-Bykbaev, Yaroslava/0000-0003-3177-8344; Tarrío-Saavedra, Javier/0000-0002-9584-127X	Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation) [ED431G/01 2016-2019]; Xunta de Galicia (Grupos de Referencia Competitiva) [ED431C2016-015]; MINECO [MTM2014-52876-R]; European Union (European Regional Development Fund - ERDF); Ecuador's Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT); Inditex-UDC International Doctoral School Grant; DevelopBiosystem SL	Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation); Xunta de Galicia (Grupos de Referencia Competitiva)(Xunta de Galicia); MINECO(Spanish Government); European Union (European Regional Development Fund - ERDF); Ecuador's Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT); Inditex-UDC International Doctoral School Grant; DevelopBiosystem SL	The research of Salvador Naya and Javier Tarrio-Saavedra has been partially supported by the Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation [ED431G/01 2016-2019] and Grupos de Referencia Competitiva [ED431C2016-015]) and by the MINECO [Grant MTM2014-52876-R]. These grants are cofunded by the European Union (European Regional Development Fund - ERDF). The research of Yaroslava Robles has been supported by the Ecuador's Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT) and Inditex-UDC International Doctoral School Grant for pre-doctoral students. Francisco Javier Garcia Saban and Sara Quintana-Pita are employed by DevelopBiosystem SL. DevelopBiosystem SL provided support in the form of salaries for J.G.S and S.Q.P. authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author	Akl MA, 2016, J DRUG DELIV SCI TEC, V32, P10, DOI 10.1016/j.jddst.2016.01.007; Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; Ballester JJ, 2011, BIOMATERIALES SUSTIT; Breche Q, 2016, POLYM DEGRAD STABIL, V131, P145, DOI 10.1016/j.polymdegradstab.2016.07.014; Carral-Couce L, 2017, P I MECH ENG M-J ENG, V231, P600, DOI 10.1177/1475090216677130; Carreno JM, 2016, VACCINE, V34, P4263, DOI 10.1016/j.vaccine.2016.05.036; Chen YH, 2011, ACTA BIOMATER, V7, P1140, DOI 10.1016/j.actbio.2010.09.038; Chew SA, 2016, J BIOMED MATER RES A, V104, P1202, DOI 10.1002/jbm.a.35657; Cristallini C, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7176154; Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032; Escobar, 1998, STAT METHODS RELIABI; Francisco-Fernandez M, 2017, J THERM ANAL CALORIM, V127, P499, DOI 10.1007/s10973-016-5917-5; Francisco-Fernandez M, 2015, J THERM ANAL CALORIM, V120, P541, DOI 10.1007/s10973-014-4260-y; Ghorbani F, 2016, MAT SCI ENG C-MATER, V69, P208, DOI 10.1016/j.msec.2016.06.079; Han X, 2017, WOODH PUBL SER BIOM, V117, P427, DOI 10.1016/B978-0-08-100372-5.00015-5; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hoque M. E., 2012, REGENERATIVE RES, V1, P58; Idaszek J, 2016, POLYM DEGRAD STABIL, V124, P119, DOI 10.1016/j.polymdegradstab.2015.12.020; Janeiro-Arocas J, 2016, J MECH BEHAV BIOMED, V63, P456, DOI 10.1016/j.jmbbm.2016.07.014; Ji YH, 2017, J BIOMED MATER RES A, V105, P1593, DOI 10.1002/jbm.a.35962; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kaur MAS, 2008, POLY DL LACTIDE CO G; Lazzari S, 2014, POLYM DEGRAD STABIL, V110, P80, DOI 10.1016/j.polymdegradstab.2014.08.012; Li H., 2016, ABU DHABI INT PET EX, P1, DOI [10.2118/183215-MS, DOI 10.2118/183215-MS]; Meneses A, 2016, SPRINGER P MATH STAT, V175, P211, DOI 10.1007/978-3-319-41582-6_15; Nikkola L, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0145-1; Parisi O.I., 2015, ADV POLYM MED, P1; Pinheiro J., 2018, NLME LINEAR NONLINEA; Pinheiro J.C., 2000, STAT COMPUTING; PITT C G, 1987, Journal of Controlled Release, V4, P283, DOI 10.1016/0168-3659(87)90020-4; Rios-Fachal M, 2014, J THERM ANAL CALORIM, V116, P1141, DOI 10.1007/s10973-013-3623-0; Ronkko S, 2011, OPHTHALMIC RES, V46, P55, DOI 10.1159/000322996; Samami H., 2016, WOODHEAD PUBLISHING, P45; Sandino C, 2008, J BIOMECH, V41, P1005, DOI 10.1016/j.jbiomech.2007.12.011; Schliecker G, 2003, BIOMATERIALS, V24, P3835, DOI 10.1016/S0142-9612(03)00243-6; Tarrio-Saaavedra J, 2008, POLYM DEGRAD STABIL, V93, P2133, DOI 10.1016/j.polymdegradstab.2008.08.006; Tarrio-Saavedra J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169866; Tarrio-Saavedra J, 2015, J THERM ANAL CALORIM, V122, P1203, DOI 10.1007/s10973-015-5083-1; Tarrio-Saavedra J, 2014, J THERM ANAL CALORIM, V118, P1253, DOI 10.1007/s10973-014-3887-z; Thavornyutikarn B, 2014, PROG BIOMATER, V3, P61, DOI 10.1007/s40204-014-0026-7; Tyler B, 2016, ADV DRUG DELIVER REV, V107, P163, DOI 10.1016/j.addr.2016.06.018; Tzeng SY, 2016, J CONTROL RELEASE, V233, P101, DOI 10.1016/j.jconrel.2016.05.012; Upson SJ, 2016, MAT SCI ENG C-MATER, V69, P470, DOI 10.1016/j.msec.2016.06.012; Valenzuela LM, 2016, INT J BIOMATER, V2016, DOI 10.1155/2016/6273414; Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034; Wang LM, 2016, APPL NANOBIOMATER, V4, P241, DOI 10.1016/B978-0-323-42862-0.00008-0; Wood S.N., 2017, GEN ADDITIVE MODELS; Zeng L, 2016, IIE TRANS, V48, P16, DOI 10.1080/0740817X.2015.1019164; Zhao W, 2016, MAT SCI ENG C-MATER, V59, P1181, DOI 10.1016/j.msec.2015.11.026	50	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204004	10.1371/journal.pone.0204004	http://dx.doi.org/10.1371/journal.pone.0204004			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273349	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700012
J	Roloff, K; Stepanyan, G; Valenzuela, G				Roloff, Kristina; Stepanyan, Gohar; Valenzuela, Guillermo			Prevalence of oropharyngeal group B Streptococcus colonization in mothers, family, and health care providers	PLOS ONE			English	Article							BREAST-MILK TRANSMISSION; NOSOCOMIAL TRANSMISSION; ONSET DISEASE; SEPSIS; THROAT; YOUNG	Objective To determine the prevalence and serotype of oropharyngeal Group B Streptococcal (GBS) colonization of mothers, their family & friends, and health care providers of recently delivered patients as a potential reservoir of neonatal exposure to GBS. Methods This is a prospective, single-center observational study of: (1) patients, (2) their family and friends, and (3) health care providers all of whom may come in close contact with neonates. Oropharyngeal GBS colonization and serotype was determined. Results Three hundred and seventy three samples were collected. The prevalence of oropharyngeal GBS colonization among all study participants was 23.1% (N = 86). The most commonly found serotypes were 1b (12.8%, N = 11), III (27.9%, N = 24), and V (17.4%, N = 15). The prevalence of oropharyngeal GBS colonization among mothers was 26% (N = 31/121), 22% (N = 39/178) in family and friends, and 21.6% (N = 16/74) in health care providers. Conclusion Group B Streptococcus colonizes the oropharynx in 1 in 5 mothers, family and friends, and health care providers who come in direct contact with neonates. Further research is needed to determine if this potential reservoir for neonatal exposure could lead to early or late onset neonatal GBS colonization or infection.	[Roloff, Kristina; Valenzuela, Guillermo] Arrowhead Reg Med Ctr, Dept Womens Hlth, Colton, CA 92324 USA; [Stepanyan, Gohar] Southern Calif Permanente Med Grp, Fontana, CA USA	Permanente Medical Groups	Roloff, K (corresponding author), Arrowhead Reg Med Ctr, Dept Womens Hlth, Colton, CA 92324 USA.	kristyroloff@gmail.com	Roloff, Kristina/P-9258-2019	Roloff, Kristina/0000-0002-9316-747X	Department of Women's Health, Arrowhead Regional Medical Center	Department of Women's Health, Arrowhead Regional Medical Center	Laboratory analysis of Group B Streptococcal cultures and serotyping was paid for by the Department of Women's Health, Arrowhead Regional Medical Center. No other sources of funding were received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG committee opinion, 1996, INT J GYNECOL OBSTET, V54, P197, DOI DOI 10.1016/S0020-7292(96)90083-1; Berardi A, 2013, PEDIATRICS, V131, pE361, DOI 10.1542/peds.2012-1231; BOYER KM, 1983, J INFECT DIS, V148, P802, DOI 10.1093/infdis/148.5.802; Brandolini M, 2014, EARLY HUM DEV, V90, pS84, DOI 10.1016/S0378-3782(14)70025-8; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P473; Chrenien JH, 1979, J CLIN MICROBIOL, P163; CHRISTENSEN KK, 1978, SCAND J INFECT DIS, V10, P209, DOI 10.3109/inf.1978.10.issue-3.09; DENTON M, 1993, J HOSP INFECT, V23, P271, DOI 10.1016/0195-6701(93)90144-O; EASMON CSF, 1981, BRIT MED J, V283, P459, DOI 10.1136/bmj.283.6289.459; Foxman B, 2007, ANN EPIDEMIOL, V17, P854, DOI 10.1016/j.annepidem.2007.05.014; Foxman B, 2006, AM J EPIDEMIOL, V163, P544, DOI 10.1093/aje/kwj075; HAMMERSCHLAG MR, 1977, PEDIATRICS, V60, P473; HOFFMANN S, 1985, ACTA PATH MICRO IM B, V93, P347; JAFARI HS, 1995, PEDIATR INFECT DIS J, V14, P662, DOI 10.1097/00006454-199508000-00003; Jawa G, 2013, BREASTFEED MED, V8, P134, DOI 10.1089/bfm.2012.0016; Koenig JM, 2009, PEDIATR CLIN N AM, V56, P689, DOI 10.1016/j.pcl.2009.04.003; Lanari M, 2007, NEW MICROBIOL, V30, P253; Lin FYC, 1998, J INFECT DIS, V177, P790, DOI 10.1086/517810; Lukacs, 2012, J PEDIATR-US, V161, P573; Manning SD, 2004, CLIN INFECT DIS, V39, P380, DOI 10.1086/422321; Manning SD, 2008, CLIN INFECT DIS, V47, P388, DOI 10.1086/589864; Morinis J, 2011, PAED CHILD HEALT-CAN, V16, pE48, DOI 10.1093/pch/16.6.e48; Nowakowska Maria, 2004, Polish Journal of Microbiology, V53, P17; Olver WJ, 2000, ARCH DIS CHILD-FETAL, V83, pF48, DOI 10.1136/fn.83.1.F48; PAREDES A, 1977, PEDIATRICS, V59, P679; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Rivera L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0460-2; Schrag S, 2000, REV GUIDELINES CDC M, V51, P1; Silbert S, 2016, J CLIN MICROBIOL, V54, P1660, DOI 10.1128/JCM.00445-16; Zaleznik DF, 2000, CLIN INFECT DIS, V30, P276, DOI 10.1086/313665; Zangwill Kenneth M., 1992, Morbidity and Mortality Weekly Report, V41, P25	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204617	10.1371/journal.pone.0204617	http://dx.doi.org/10.1371/journal.pone.0204617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265687	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500040
J	Leslie, HH; Zhou, X; Spiegelman, D; Kruk, ME				Leslie, Hannah H.; Zhou, Xin; Spiegelman, Donna; Kruk, Margaret E.			Health system measurement: Harnessing machine learning to advance global health	PLOS ONE			English	Article							EFFECTIVE COVERAGE; QUALITY; CARE; PREDICTION; READINESS; COUNTRIES; MORTALITY; SERVICES	Background Further improvements in population health in low- and middle-income countries demand high-quality care to address an increasingly complex burden of disease. Health facility surveys provide an important but costly source of information on readiness to provide care. To improve the efficiency of health system measurement, we applied unsupervised machine learning methods to assess the performance of the service readiness index (SRI) defined by the World Health Organization and compared it to empirically derived indices. Methods We drew data from nationally representative Service Provision Assessment surveys conducted in 10 countries between 2007 and 2015. We extracted 649 items in domains such as infrastructure, medication, and management to calculate an index using all available information and classified facilities into quintiles. We compared three approaches against the full item set: the SRI, a new index based on sequential backward selection, and an enriched SRI that added empirically selected items to the SRI. We evaluated index performance with a cross-validated kappa statistic comparing classification using the candidate index against the 649-item index. Results 9238 facilities were assessed. The 49-item SRI performed poorly against the index using all 649 items, with a kappa value of 0.35. New empirically derived indices with 50 and 100 items captured much more information, with cross-validated kappa statistics of 0.71 and 0.80, respectively. Items varied across the indices and in sensitivity analyses. A 100-item enriched SRI reliably captured the information from the full index: 83% of the facilities were classified into correct quintiles of service readiness based on the full index. Conclusion A facility readiness measure developed by global health experts performed poorly in capturing the totality of readiness information collected during facility surveys. Using a machine learning approach with sequential selection and cross-validation to identify the most informative items dramatically improved performance. Such approaches can make assessment of health facility readiness more efficient. Further improvements in measurement will require identification of external criteria-such as patient outcomes-to guide and validate measure development.	[Leslie, Hannah H.; Spiegelman, Donna; Kruk, Margaret E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Zhou, Xin; Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Zhou, Xin; Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Spiegelman, Donna] Yale Sch Publ Hlth, Ctr Methods Implementat & Prevent Sci, New Haven, CT USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Yale University	Leslie, HH (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	hleslie@hsph.harvard.edu		Leslie, Hannah Hogan/0000-0002-7464-3645	Bill and Melinda Gates Foundation [OPP1161450]; National Institutes of Health [DP1ES025459]; McLennan Family Fund (MEK); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES025459] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McLennan Family Fund (MEK); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/, OPP1161450, MEK), the National Institutes of Health (https://www.niehs.nih.gov/index.cfm, DP1ES025459, DS), and the McLennan Family Fund (MEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akachi Y, 2017, B WORLD HEALTH ORGAN, V95, P465, DOI 10.2471/BLT.16.180190; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Das J, 2014, ANNU REV ECON, V6, P525, DOI 10.1146/annurev-economics-080213-041350; Demographic and Health Surveys Program, 2017, DHS PROGR SERV PROV; Do M, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020501; Gage AJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1097-3; Hastie T., 2009, UNSUPERVISED LEARNIN; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hubbard A, 2013, J TRAUMA ACUTE CARE, V75, pS53, DOI 10.1097/TA.0b013e3182914553; Kanyangarara M, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.021101; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kruk M, 2018, LANCET GLOBAL HLTH; Leslie HH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002464; Leslie HH, 2017, BMJ GLOBAL HLTH, V2; Leslie HH, 2017, B WHO, V95; Liu H, 1998, FEATURE EXTRACTION C, DOI 10. 1007/978-1-4615-5725-8; Mbondji PE, 2014, J ROY SOC MED, V107, P34, DOI 10.1177/0141076814531750; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Nguhiu PK, 2017, TROP MED INT HEALTH, V22, P442, DOI 10.1111/tmi.12841; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Rose S, 2016, HLTH SERVICES RES, V51; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; Sobel HL, 2016, HEALTH POLICY PLANN, V31, P547, DOI 10.1093/heapol/czv095; The World Health Organization, 2013, SERV AV READ ASS SAR; UN, 2015, SUSTAINABLE DEV GOAL	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204958	10.1371/journal.pone.0204958	http://dx.doi.org/10.1371/journal.pone.0204958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289935	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500032
J	Fahmy, AM; Khabir, M; Blanchet, M; Labonte, P				Fahmy, Ahmed M.; Khabir, Marwa; Blanchet, Matthieu; Labonte, Patrick			LC3B is not recruited along with the autophagy elongation complex (ATG5-12/16L1) at HCV replication site and is dispensable for viral replication	PLOS ONE			English	Article							HEPATITIS-C VIRUS; UNFOLDED PROTEIN RESPONSE; ATG12-ATG5 CONJUGATE; MEMBRANE; INFECTION; CELLS; RNA; LIPIDATION; INDUCTION; MACHINERY	Hepatitis C virus (HCV) infection is known to induce autophagosome accumulation as observed by the typical punctate cytoplasmic distribution of LC3B-II in infected cells. Previously, we showed that viral RNA-dependent RNA polymerase (NS5B) interacts with ATG5, a major component of the autophagy elongation complex that is involved in the formation of double-membrane vesicles (DMV), and demonstrated that the autophagy elongation complex (ATG5-12/16L1) but not LC3B is required for proper membranous web formation. In this study, the colocalization and in situ interaction of all HCV replicase components with the constituent of the autophagy elongation complex and LC3B were analyzed. The results clearly show the recruitment of the elongation complex to the site of viral replication. Using in situ proximity ligation assay, we show that ATG5, but not ATG16L1, interacts with several HCV replicase components suggesting that the recruitment is directed via the ATG5-12 conjugate. Interestingly, no E3-like conjugation activity of ATG5-12/16L1 can be detected at the at HCV replication site since LC3B-II is not found along with the elongation complex at the site of viral replication. In agreement with this result, no sign of in situ interaction of LC3B with the replicase components is observed. Finally, using dominant negative forms of ATG proteins, we demonstrate that ATG5-12 conjugate, but not LC3-II formation, is critical for viral replication. Altogether, these findings suggest that although HCV needs the elongation complex for its replication, it has developed a mechanism to avoid canonical LC3-II accumulation at viral replication site.	[Fahmy, Ahmed M.; Khabir, Marwa; Blanchet, Matthieu; Labonte, Patrick] Inst Natl Rech Sci, INRS Inst Armand Frappier, Laval, PQ, Canada; [Fahmy, Ahmed M.] NRC, Div Med Res, Dept Reprod Med, Mol Med Res Grp, Dokki, Egypt	University of Quebec; Institut national de la recherche scientifique (INRS); Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Labonte, P (corresponding author), Inst Natl Rech Sci, INRS Inst Armand Frappier, Laval, PQ, Canada.	patrick.labonte@iaf.inrs.ca	Fahmy, Ahmed/U-4709-2019	Fahmy, Ahmed/0000-0003-0444-383X	NCRTP-HepC; Natural Science and Engineering Research Council of Canada	NCRTP-HepC; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by AMF was supported by a fellowship from NCRTP-HepC. PL was funded by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Biering SB, 2017, AUTOPHAGY, V13, P2010, DOI 10.1080/15548627.2017.1371396; Biering SB, 2017, CELL HOST MICROBE, V22, P74, DOI 10.1016/j.chom.2017.06.005; Blanchet M, 2012, ANTIVIR RES, V95, P159, DOI 10.1016/j.antiviral.2012.05.006; Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323; Combs C, 1997, GASTROENTEROLOGY, V112, P1372, DOI 10.1016/S0016-5085(97)70152-5; Doring T, 2018, J VIROL, V92, DOI 10.1128/JVI.01513-17; Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Eyre NS, 2014, J VIROL, V88, P3636, DOI 10.1128/JVI.02490-13; Fahmy AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40351; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Granato M, 2014, J VIROL, V88, P12715, DOI 10.1128/JVI.02199-14; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Guevin C, 2009, ANTIVIR RES, V84, P14, DOI 10.1016/j.antiviral.2009.07.009; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Huang H, 2013, AUTOPHAGY, V9, P175, DOI 10.4161/auto.22791; Into T, 2012, CELL SIGNAL, V24, P1150, DOI 10.1016/j.cellsig.2012.01.020; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kim JH, 2017, J VIROL, V91, DOI 10.1128/JVI.01206-16; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Le QT, 2015, J BIOL CHEM, V290, P23385, DOI 10.1074/jbc.M115.642991; Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001; Liu QH, 2012, VIROLOGY, V429, P136, DOI 10.1016/j.virol.2012.03.022; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mohl BP, 2016, J GEN VIROL, V97, P680, DOI 10.1099/jgv.0.000387; Mohl BP, 2012, J VIROL, V86, P10724, DOI 10.1128/JVI.01667-12; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Oh JE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00044; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Santana S, 2012, J ALZHEIMERS DIS, V30, P815, DOI 10.3233/JAD-2012-112000; Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Tian L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0271-0; Wang LY, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006609; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Webster DP, 2009, LANCET INFECT DIS, V9, P108, DOI 10.1016/S1473-3099(09)70020-9; Zhao Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11105-3	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205189	10.1371/journal.pone.0205189	http://dx.doi.org/10.1371/journal.pone.0205189			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286180	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500096
J	Matsuoka, K; Hamada, S; Shimizu, M; Nanki, K; Mizuno, S; Kiyohara, H; Arai, M; Sugimoto, S; Iwao, Y; Ogata, H; Hisamatsu, T; Naganuma, M; Kanai, T; Mochizuki, M; Hashiguchi, M				Matsuoka, Katsuyoshi; Hamada, Shunsuke; Shimizu, Mikiko; Nanki, Kosaku; Mizuno, Shinta; Kiyohara, Hiroki; Arai, Mari; Sugimoto, Shinya; Iwao, Yasushi; Ogata, Haruhiko; Hisamatsu, Tadakazu; Naganuma, Makoto; Kanai, Takanori; Mochizuki, Mayumi; Hashiguchi, Masayuki			Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; ANTI-TNF; GENETIC POLYMORPHISMS; FACTOR-ALPHA; BIOLOGICAL RESPONSE; ASSOCIATION; EFFICACY; METAANALYSIS; INDUCTION	Since anti-tumor necrosis factor (TNF)-alpha agents (TNF-alpha inhibitors) induce both clinical response and remission in patients with moderate to severe inflammatory bowel disease (IBD), the use of anti-TNF therapies has fundamentally changed the approach to treatment for patients with IBD. Infliximab (IFX) is a TNF-alpha inhibitor approved for the induction and remission of Crohn's disease (CD). However, even among patients who initially demonstrate a clinical response to IFX therapy, secondary loss of response occurs, although the reason remains unknown. We therefore investigated predictive factors associated with the response to IFX in long-term maintenance treatment in Japanese CD patients. Eight types of single-nucleotide polymorphisms (SNPs) were investigated using the real-time PCR method, and patient characteristics were collected from the electronic medical records. The Crohn's Disease Activity Index criteria were used as the response to IFX therapy. The observation period was 1 year after IFX had been administered for more than 1 year. Associations between the IFX response and patient characteristics were evaluated using the multivariate logistic regression model. We studied 121 unrelated adult Japanese with CD treated for more than 1 year with IFX as outpatients at Keio University Hospital from November 1, 2014 to November 30, 2015. Among them, 71 were classified as in remisson. In multivariate analysis, patients with the TNF-alpha 857C>T C/C genotype, shorter disease duration, without double dosing, and combination treatment with an immunomodulator had higher remisson rates than those with the C/T or T/T genotype, longer disease duration, with double dosing, and no combination treatment with an immunomodulator. The response to IFX in Japanese CD patients may therefore be predicted by these 4 characteristics in actual clinical practice.	[Matsuoka, Katsuyoshi; Nanki, Kosaku; Mizuno, Shinta; Kiyohara, Hiroki; Arai, Mari; Sugimoto, Shinya; Hisamatsu, Tadakazu; Naganuma, Makoto; Kanai, Takanori] Keio Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Shinjuku Ku, Shinanomachi, Tokyo, Japan; [Hamada, Shunsuke; Mochizuki, Mayumi; Hashiguchi, Masayuki] Keio Univ, Div Evaluat & Anal Drug Informat, Fac Pharm, Minato Ku, Tokyo, Japan; [Shimizu, Mikiko] Keio Univ, Dept Hyg Chem, Fac Pharm, Minato Ku, Tokyo, Japan; [Iwao, Yasushi] Keio Univ, Ctr Prevent Med, Sch Med, Shinjuku Ku, Shinanomachi, Tokyo, Japan; [Ogata, Haruhiko] Keio Univ, Ctr Diagnost & Therapeut Endoscopy, Sch Med, Shinjuku Ku, Shinanomachi, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; Keio University	Hashiguchi, M (corresponding author), Keio Univ, Div Evaluat & Anal Drug Informat, Fac Pharm, Minato Ku, Tokyo, Japan.	hashiguchi-ms@pha.keio.ac.jp	Matsuoka, Katsuyoshi/AAB-1580-2022; Sugimoto, Shinya/X-6548-2018	Matsuoka, Katsuyoshi/0000-0002-2950-7660; Sugimoto, Shinya/0000-0002-1560-1605; Kanai, Takanori/0000-0002-1466-4532; Nanki, Kosaku/0000-0003-4232-0523				Allez M, 2010, J CROHNS COLITIS, V4, P355, DOI 10.1016/j.crohns.2010.04.004; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Ben-Horin S, 2011, ALIMENT PHARM THER, V33, P987, DOI 10.1111/j.1365-2036.2011.04612.x; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Cholapranee A, 2017, ALIMENT PHARM THER, V45, P1291, DOI 10.1111/apt.14030; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; Hibi T, 2006, J GASTROENTEROL, V41, P10, DOI 10.1007/s00535-005-1744-3; Kimura K, 2016, APMIS, V124, P669, DOI 10.1111/apm.12559; Lopez-Hernandez R, 2014, INT J IMMUNOGENET, V41, P63, DOI 10.1111/iji.12059; Louis E, 2004, ALIMENT PHARM THER, V19, P511, DOI 10.1111/j.1365-2036.2004.01871.x; Matsukura H, 2008, ALIMENT PHARM THERAP, V27, P765, DOI 10.1111/j.1365-2036.2008.03630.x; Medrano LM, 2014, HUM IMMUNOL, V75, P71, DOI 10.1016/j.humimm.2013.09.017; Miligkos M, 2016, CLIN THER, V38, P1342, DOI 10.1016/j.clinthera.2016.03.018; Montes A, 2014, PHARMACOGENET GENOM, V24, P238, DOI 10.1097/FPC.0000000000000042; Moroi R, 2013, IMMUNOGENETICS, V65, P265, DOI 10.1007/s00251-013-0679-8; Papamichael K, 2011, ANN GASTROENTEROL, V24, P35; Papamichael K, 2015, INFLAMM BOWEL DIS, V21, P182, DOI 10.1097/MIB.0000000000000202; Pierik M, 2004, ALIMENT PHARM THER, V20, P303, DOI 10.1111/j.1365-2036.2004.01946.x; Romero-Cara P, 2018, INT J MED SCI, V15, P10, DOI 10.7150/ijms.22812; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Steenholdt C, 2012, ALIMENT PHARM THER, V36, P650, DOI 10.1111/apt.12010; Urabe S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/416838; Vermeire S, 2000, GASTROENTEROLOGY, V118, pA654, DOI 10.1016/S0016-5085(00)84757-5	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204632	10.1371/journal.pone.0204632	http://dx.doi.org/10.1371/journal.pone.0204632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286108	Green Submitted, gold, Green Published			2022-12-27	WOS:000446383500028
J	Qin, SL; Clausen, E; Nouraie, SM; Kingsley, L; McMahon, D; Kleerup, E; Huang, L; Ghedin, E; Greenblatt, RM; Morris, A				Qin, Shulin; Clausen, Emily; Nouraie, Seyed Mehdi; Kingsley, Lawrence; McMahon, Deborah; Kleerup, Eric; Huang, Laurence; Ghedin, Elodie; Greenblatt, Ruth M.; Morris, Alison			Tropheryma whipplei colonization in HIV-infected individuals is not associated with lung function or inflammation	PLOS ONE			English	Article							DIFFUSING-CAPACITY; PULMONARY-FUNCTION; STANDARDIZATION; IMPAIRMENT; ACTIVATION; INSIGHTS; DISEASE; SAMPLE	Studies demonstrate that Tropheryma whipplei (T. whipplei) is present in the lungs of healthy individuals without acute respiratory symptoms or acute respiratory infection and is more common in the lungs of HIV-infected individuals and in smokers. The impact of T. whipplei colonization in the lung on local inflammation and pulmonary dysfunction in HIV-infected individuals is currently unknown. In this study, we performed specific polymerase chain reaction (PCR) and sequencing for T. whipplei in bronchoalveolar lavage (BAL) and induced sputum (IS) samples in 76 HIV-infected participants from three clinical sites. Pulmonary function and proinflammatory cytokine and chemokine levels in BAL were measured. Frequency of T. whipplei in either BAL or IS was 43.4%. The sensitivity and specificity of IS compared to BAL for detection of T. whipplei was 92.3% and 84.2%, respectively, and isolates of T. whipplei in the BAL and IS in the same subject shared genetic identity. Pulmonary function measures were not associated with T. whipplei colonization, and proinflammatory cytokine and chemokine levels in BAL and plasma as well as percentages of inflammatory cells in BAL and IS were not higher in colonized individuals. Overall, these results indicate that T. whipplei colonization in the lung is common, but may not be associated with decreased pulmonary function or inflammation in HIV-infected individuals.	[Qin, Shulin; Clausen, Emily; Nouraie, Seyed Mehdi; McMahon, Deborah; Morris, Alison] Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA; [Kingsley, Lawrence] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Kleerup, Eric] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Huang, Laurence] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ghedin, Elodie] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Ghedin, Elodie] NYU, Global Inst Publ Hlth, New York, NY USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Morris, Alison] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; New York University; New York University; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Morris, A (corresponding author), Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA.; Morris, A (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	morrisa@upmc.edu	Nouraie, Seyed Mehdi/O-4071-2018; Huang, Laurence/AAZ-7120-2021; Ghedin, Elodie/Y-5654-2019; Qin, Shulin/ABA-3986-2020; Huang, Laurence/AAE-1590-2019	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Huang, Laurence/0000-0003-3888-2195; Ghedin, Elodie/0000-0002-1515-725X; Qin, Shulin/0000-0003-2496-3007; 	NIH [U01 HL098962, R01 HL120398, R01 HL125049, K24 HL023342, K24 HL087713]; University of Pittsburgh CTRC [UL1 TR001857]; MACS [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041]; WIHS [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; National Cancer Institute [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041]; National Institute of Allergy and Infectious Diseases [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131];  [U01-AI-103390]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001857] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, R01HL125049, K24HL123342, R01HL120398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh CTRC(University of Pittsburgh); MACS; WIHS; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from NIH U01 HL098962, R01 HL120398, R01 HL125049, K24 HL023342 and University of Pittsburgh CTRC UL1 TR001857 (AM). Dr. Huang was partially supported by NIH K24 HL087713 (LH). San Francisco WIHS data used for this study were supported by U01-AI-103390 (RG). MACS (UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041); WIHS (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A subset of subjects in this cohort was recruited from sites of the Multicenter AIDS Cohort Study (MACS) with centers University of California, Los Angeles (Roger Detels) and University of Pittsburgh (Charles R. Rinaldo, Lawrence Kingsley). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute. UO1-AI-35042, UL1-RR025005 (GCRC), UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041. Website located at http://www.statepi.jhsph.edu/macs/macs.html. A subset of subjects in this cohort was recruited from the Connie Wofsy Study Consortium of Northern California Ruth Greenblatt, Phyllis Tien and Bradley Aouizerat) of the Women's Interagency HIV Study (WIHS) Collaborative Study Group. The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The WIHS is cofunded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131).	Beck JM, 2015, AM J RESP CRIT CARE, V192, P1335, DOI 10.1164/rccm.201501-0128OC; Crothers K, 2013, JAIDS-J ACQ IMM DEF, V64, P271, DOI 10.1097/QAI.0b013e3182a9215a; Cui LJ, 2015, AM J RESP CRIT CARE, V191, P932, DOI 10.1164/rccm.201409-1583OC; Desnues B, 2010, MICROBES INFECT, V12, P1102, DOI 10.1016/j.micinf.2010.08.001; Drummond MB, 2014, LANCET RESP MED, V2, P583, DOI 10.1016/S2213-2600(14)70017-7; Durand DV, 1997, MEDICINE, V76, P170, DOI 10.1097/00005792-199705000-00003; Fitzpatrick ME, 2016, AIDS, V30, P1327, DOI 10.1097/QAD.0000000000001092; Fitzpatrick ME, 2014, AIDS, V28, P2505, DOI 10.1097/QAD.0000000000000471; Fitzpatrick ME, 2013, JAIDS-J ACQ IMM DEF, V64, P284, DOI 10.1097/QAI.0b013e3182a9213a; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gershman NH, 1996, EUR RESPIR J, V9, P2448, DOI 10.1183/09031936.96.09122448; Gingo MR, 2014, EUR RESPIR J, V43, P195, DOI 10.1183/09031936.00157712; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Iwai S, 2012, J CLIN MICROBIOL, V50, P2995, DOI 10.1128/JCM.00278-12; Lozupone C, 2013, AM J RESP CRIT CARE, V187, P1110, DOI 10.1164/rccm.201211-2145OC; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgenegg S, 2000, J CLIN MICROBIOL, V38, P2248; Morris A, 2008, J INFECT DIS, V197, P10, DOI 10.1086/523814; Morris A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0183-0; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Neas LM, 1996, AM J RESP CRIT CARE, V153, P656, DOI 10.1164/ajrccm.153.2.8564114; Qin SL, 2016, AM J RESP CRIT CARE, V194, P243, DOI 10.1164/rccm.201601-0162LE; Simpson JL, 2016, EUR RESPIR J, V47, P792, DOI 10.1183/13993003.00405-2015; Sze MA, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0303-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205065	10.1371/journal.pone.0205065	http://dx.doi.org/10.1371/journal.pone.0205065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286195	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500081
J	Ryde, GC; Booth, JN; Brooks, NE; Chesham, RA; Moran, CN; Gorely, T				Ryde, Gemma C.; Booth, Josephine N.; Brooks, Naomi E.; Chesham, Ross A.; Moran, Colin N.; Gorely, Trish			The Daily Mile: What factors are associated with its implementation success?	PLOS ONE			English	Article							PROMOTE PHYSICAL-ACTIVITY; INTERVENTIONS; ADOLESCENTS; CHILDREN	Background Despite the known benefits of a physically active lifestyle, there are few examples of interventions that have been successfully implemented at a population level over a long period of time. One such example is The Daily Mile, a school based physical activity initiative, where a teacher takes their class out daily during class time for a short bout of ambulatory activity. At one school, this activity appears has been sustained over a long period (6 years), has the whole school participating and is now incorporated into its daily routine. The aim of this paper was to understand how The Daily Mile was implemented in primary schools and to assess factors associated with its successful implementation. Methods Semi-structured interviews with school staff who had a significant role in implementing The Daily Mile were conducted at four primary schools in central Scotland. Interviews were digitally recorded and transcribed verbatim. Data were analysed using thematic analysis and descriptive analysis and interpretation of data undertaken. Details regarding the school grounds and facilities were also noted during the interviews. Results Having simple core intervention components, flexible delivery that supports teacher autonomy and being adaptable to suit the specific primary school context appear to be key aspects of The Daily Mile that are related to its implementation success. Other factors relating to how The Daily Mile was developed, trialled and rolled out might also have contributed towards its successful implementation. Conclusion The Daily Mile appears to have several factors which may relate to its implementation success. These are important considerations for others looking to implement The Daily Mile effectively in their primary school or in other contexts.	[Ryde, Gemma C.; Brooks, Naomi E.; Chesham, Ross A.; Moran, Colin N.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Booth, Josephine N.] Univ Edinburgh, Inst Educ Community & Soc, Edinburgh, Midlothian, Scotland; [Gorely, Trish] Univ Highlands & Isl, Dept Nursing, Inverness, Scotland	University of Stirling; University of Edinburgh; UHI Millennium Institute	Ryde, GC (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland.	gemma.ryde@stir.ac.uk	Moran, Colin Neil/F-5416-2011	Moran, Colin Neil/0000-0001-6226-8131; Booth, Josephine/0000-0002-2867-9719; Chesham, Ross/0000-0002-2411-4147	University of Stirling; University of Edinburgh; Stirling Council	University of Stirling; University of Edinburgh; Stirling Council	This research project was partially funded from internal sources at the University of Stirling and the University of Edinburgh. Neither of the funders had involvement in the data analysis, data interpretation, data collection, or writing of the paper. The views expressed in this publication are those of the authors and not necessarily of the funding bodies listed here.; We extend sincere thanks to all the teachers who took part in the present study. We would also like to thank Stirling Council for their ongoing support of this research. Additional thanks goes to our colleague Dr Amy Nimegeer from the University of Glasgow, Institute of Health and Wellbeing for her assistance with data analysis and interpretation.	[Anonymous], 2017, THE DAILY MILE; Chalkley AE, 2016, 6 INT SOC PHYS ACT H; Chesham RA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1049-z; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Dudley D, 2011, EUR PHYS EDUC REV, V17, P353, DOI 10.1177/1356336X11416734; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Erwin HE, 2011, J SCHOOL HEALTH, V81, P455, DOI 10.1111/j.1746-1561.2011.00614.x; Fullan M., 2007, NEW MEANING ED CHANG; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hewitt-Taylor J, 2001, Nurs Stand, V15, P39; Holt E, 2013, J PHYS ACT HEALTH, V10, P480, DOI 10.1123/jpah.10.4.480; Jamshed Shazia, 2014, J Basic Clin Pharm, V5, P87, DOI 10.4103/0976-0105.141942; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Naylor PJ, 2006, J SCI MED SPORT, V9, P413, DOI 10.1016/j.jsams.2006.06.013; Naylor PJ, 2015, PREV MED, V72, P95, DOI 10.1016/j.ypmed.2014.12.034; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Phillippi J, 2018, QUAL HEALTH RES, V28, P381, DOI 10.1177/1049732317697102; Rogers RH, 2018, QUAL REP, V23, P889; Scottish National Party, 2016, IS SNP ENC PEOPL BE; The Scottish Government, 2018, SCOTT GOV URB RUR CL; The Scottish Government, 2016, SCOTT IND MULT DEPR; van Sluijs EMF, 2008, BRIT J SPORT MED, V42, P653, DOI 10.1136/bmj.39320.843947.BE; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024	25	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204988	10.1371/journal.pone.0204988	http://dx.doi.org/10.1371/journal.pone.0204988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286175	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500070
J	Hojreh, A; Homolka, P; Gamper, J; Unterhumer, S; Kienzl-Palma, D; Balassy, C; Wrba, T; Prosch, H				Hojreh, Azadeh; Homolka, Peter; Gamper, Jutta; Unterhumer, Sylvia; Kienzl-Palma, Daniela; Balassy, Csilla; Wrba, Thomas; Prosch, Helmut			Automated tube voltage selection in pediatric non-contrast chest CT	PLOS ONE			English	Article							EUROPEAN CYSTIC-FIBROSIS; COMPUTED-TOMOGRAPHY; KILOVOLTAGE SELECTION; SOCIETY STANDARDS; IMAGE QUALITY; POTENTIAL SELECTION; CURRENT MODULATION; ANGIOGRAPHY; SCANS; RISK	Background Modern CT scanners provide automatic dose adjustment systems, which are promising options for reducing radiation dose in pediatric CT scans. Their impact on patient dose, however, has not been investigated sufficiently thus far. Objective To evaluate automated tube voltage selection (ATVS) in combination with automated tube current modulation (ATCM) in non-contrast pediatric chest CT, with regard to the diagnostic image quality. Materials and methods There were 160 non-contrast pediatric chest CT scans (8.7 +/- 5.4 years) analyzed retrospectively without and with ATVS. Correlations of volume CT Dose Index (CTDIvol) and effective diameter, with and without ATVS, were compared using Fisher's z-transformation. Image quality was assessed by mean signal-difference-to-noise ratios (SDNR) in the aorta and in the left main bronchus using the independent samples t-test. Two pediatric radiologists and a general radiologist rated overall subjective Image quality. Readers' agreement was assessed using weighted kappa coefficients. A p value <0.05 was considered significant. Results CTDIvol correlation with the effective diameter was r = 0.62 without and r = 0.80 with ATVS (CI: -0.04 to -0.60; p = 0.025). Mean SDNR was 10.88 without and 10.03 with ATVS (p = 0.0089). Readers' agreement improved with ATVS (weighted kappa between pediatric radiologists from 0.1 (0.03-0.16) to 0.27 (0.09-0.45) with ATVS; between general and each pediatric radiologist from 0.1 (0.06-0.14) to 0.12 (0.05-0.20), and from 0.22 (0.11-0.34) to 0.36 (0.24-0.49)). Conclusion ATVS, combined with ATCM, results in a radiation dose reduction for pediatric non-contrast chest CT without a loss of diagnostic image quality and prevents errors in manual tube voltage setting, and thus protecting larger children against an unnecessarily high radiation exposure.	[Hojreh, Azadeh; Unterhumer, Sylvia; Kienzl-Palma, Daniela; Balassy, Csilla; Prosch, Helmut] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Homolka, Peter] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Gamper, Jutta] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Wrba, Thomas] Med Univ Vienna, IT Syst & Commun, IT4Sci, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Hojreh, A (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	azadeh.hojreh@meduniwien.ac.at	Hojreh, Azadeh/X-8161-2019; Homolka, Peter/I-2168-2012; Prosch, Helmut/A-7619-2008	Homolka, Peter/0000-0002-2300-3015; Prosch, Helmut/0000-0002-6119-6364; Wrba, Thomas/0000-0002-4915-4620; Hojreh, Azadeh/0000-0002-4556-1931				AAPM, 2011, 204 AAPM, P204; Austrian Standards Institute, 2010, DIAGN REF LEV XRAY D; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Conway S, 2014, J CYST FIBROS, V13, pS3, DOI 10.1016/j.jcf.2014.03.009; Frellesen C, 2014, EUR RADIOL, V24, P1725, DOI 10.1007/s00330-014-3197-7; Granata C, 2013, EUR J RADIOL, V82, P1098, DOI 10.1016/j.ejrad.2011.12.008; Hojreh A, 2015, EUR J RADIOL, V84, P1574, DOI 10.1016/j.ejrad.2015.04.027; Hough DM, 2012, AM J ROENTGENOL, V199, P1070, DOI 10.2214/AJR.12.8637; Huda W, 2000, RADIOLOGY, V217, P430, DOI 10.1148/radiology.217.2.r00nv35430; International Atomic Ernergy Agency, 2013, IAEA HUM HLTH SER, V24; Krazinski AW, 2014, EUR RADIOL, V24, P2677, DOI 10.1007/s00330-014-3312-9; Kuo WY, 2014, AM J RESP CRIT CARE, V189, P1328, DOI 10.1164/rccm.201311-2099CI; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee CH, 2008, RADIOGRAPHICS, V28, P1451, DOI 10.1148/rg.285075075; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; National Research Council, 2006, HLTH RISKS EXP LOW L, P141; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peng Y, 2009, ACTA RADIOL, V50, P1175, DOI 10.3109/02841850903241914; Siegel MJ, 2013, RADIOLOGY, V268, P538, DOI 10.1148/radiol.13122438; Siegel MJ, 2013, INVEST RADIOL, V48, P584, DOI 10.1097/RLI.0b013e318289f918; Siemens Healthcare website. Grant K, CARE KV AUTOMATED DO; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Sorantin E, 2013, EUR J RADIOL, V82, P1043, DOI 10.1016/j.ejrad.2011.11.041; Spearman JV, 2016, RADIOLOGY, V279, P167, DOI 10.1148/radiol.2015141507; Stern M, 2014, J CYST FIBROS, V13, pS43, DOI 10.1016/j.jcf.2014.03.011; Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091; Suh YJ, 2013, RADIOLOGY, V269, P722, DOI 10.1148/radiol.13130408; Winklehner A, 2015, EUR RADIOL, V25, P2346, DOI 10.1007/s00330-015-3632-4; Winklehner A, 2011, INVEST RADIOL, V46, P767, DOI 10.1097/RLI.0b013e3182266448; Yu LF, 2011, RADIOGRAPHICS, V31, P835, DOI 10.1148/rg.313105079	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204794	10.1371/journal.pone.0204794	http://dx.doi.org/10.1371/journal.pone.0204794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281614	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400057
J	Yamada, M; Minoura, K; Mizoguchi, T; Nakamatsu, K; Taguchi, T; Kameda, T; Sekiguchi, M; Suzutani, T; Konno, S				Yamada, Miho; Minoura, Kiyoshi; Mizoguchi, Takashi; Nakamatsu, Kenichiro; Taguchi, Tokio; Kameda, Takuya; Sekiguchi, Miho; Suzutani, Tatsuo; Konno, Shinichi			Antibacterial effects of nano-imprinted moth-eye film in practical settings	PLOS ONE			English	Article							BACTERICIDAL SURFACES; STAPHYLOCOCCUS-AUREUS; NANOPARTICLES; CONTAMINATION	Background Recent studies report that surfaces displaying micrometer- or nanometer-sized undulating structures exhibit antibacterial effects. In previous work, we described the use of an advanced nanofabrication technique to generate an artificial biomimetic Moth-eye film by coating a polyethylene terephthalate (PET) film with nanoscale moth-eye protrusions made from a hydrophilic resin. This moth-eye film exhibited enhanced antibacterial effects in in vitro experiments. The aim of the present study was to verify the antibacterial efficacy of the Moth-eye film in practical environments. Materials and methods The antibacterial effects of three types of film (Moth-eye film, Flat film, and PET film) were compared. Sample films were pasted onto hand washing basins at the testing locations. After several hours, bacteria were collected from the surface of the sample films with one of three kinds of culture media stamper (to permit identification of bacterial species). The stampers were incubated for 48 hours at 35 degrees C, and the numbers of colonies were counted. Results and discussion The number of common bacteria including E. coli and S. aureus obtained from the Moth-eye film was significantly lower than those from the PET film (p<0.05) and Flat film at 1 hour (p<0.05). This study found that the Moth-eye film showed a long-term (6h) antibacterial effect and the Moth-eye structure (PET coated with nanoscale cone-shaped pillars) demonstrated a physical antibacterial effect from earlier time points. Therefore, the Moth-eye film appears to have potential general-purpose applications in practical environments.	[Yamada, Miho; Minoura, Kiyoshi] Sharp Co Ltd, Display Technol Dev Ctr, Dev Grp, Display Device Co, Tenri, Nara, Japan; [Mizoguchi, Takashi; Nakamatsu, Kenichiro; Taguchi, Tokio] Sharp Co Ltd, New Business Promot Ctr, Dev Grp, Display Device Co, Tenri, Nara, Japan; [Kameda, Takuya; Sekiguchi, Miho; Konno, Shinichi] Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima, Japan; [Suzutani, Tatsuo] Fukushima Med Univ, Sch Med, Dept Microbiol, Fukushima, Japan	Hisense; Sharp Corporation; Hisense; Sharp Corporation; Fukushima Medical University; Fukushima Medical University	Yamada, M (corresponding author), Sharp Co Ltd, Display Technol Dev Ctr, Dev Grp, Display Device Co, Tenri, Nara, Japan.	yamada.miho@sharp.co.jp		Minoura, Kiyoshi/0000-0002-5236-3087; Kameda, Takuya/0000-0001-8770-4884	Sharp Corporation	Sharp Corporation	The authors received no specific funding for this work. Sharp Corporation provided support in the form of salaries for authors [MY, KM, TM, KN and TT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; Dickson MN, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4922157; Egusa M, 2015, INT J MOL SCI, V16, P26202, DOI 10.3390/ijms161125947; Gunawan C, 2013, SMALL, V9, P3554, DOI 10.1002/smll.201300761; Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5; Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017; Hoshino Y, 2009, SMALL, V5, P1562, DOI 10.1002/smll.200900186; Ivanova EP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3838; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; Kimura S, 2009, JPN J ENV INFECT, V24, P21; Kitada M, 2015, FUJI FILM TECHNICAL, V60, P6; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; Minoura K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185366; Muller MP, 2016, J HOSP INFECT, V92, P7, DOI 10.1016/j.jhin.2015.09.008; Ono H, 1998, BIOSCI BIOTECH BIOCH, V62, P363, DOI 10.1271/bbb.62.363; Roe D, 2008, J ANTIMICROB CHEMOTH, V61, P869, DOI 10.1093/jac/dkn034; Tarana Sarwat, 2015, International Journal of Current Microbiology and Applied Sciences, V4, P286; Teramoto T, 2003, JPN J FOOD MICROBIAL, V20, P217; Tokoro M, 1987, J JPN ASS INFECT DIS, V61, P1376; Tripathy A, 2017, ADV COLLOID INTERFAC, V248, P85, DOI 10.1016/j.cis.2017.07.030; Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P7769, DOI 10.1128/AEM.02144-12; Vitiello G, 2018, CURR TOP MED CHEM, V18, P22, DOI 10.2174/1568026618666180206101129; Vitiello G, 2017, MAT SCI ENG C-MATER, V75, P454, DOI 10.1016/j.msec.2016.12.135; Vitiello G, 2015, J MATER CHEM B, V3, P2808, DOI 10.1039/c5tb00039d; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015	26	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0198300	10.1371/journal.pone.0198300	http://dx.doi.org/10.1371/journal.pone.0198300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281619	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400002
J	Choi, Y; Yang, HJ				Choi, Youngchol; Yang, Hyun Jong			On-demand route discovery in a unicast manner	PLOS ONE			English	Article							WIRELESS AD-HOC; RANDOM FORWARDING GERAF; SENSOR NETWORKS; OVERHEAD	While having high bandwidth-efficiency, the ad-hoc on-demand distance vector (AODV) routing protocol suffers from high signaling overhead due to route request (RREQ) messages flooding, especially when the node density and the number of connections are increased. In order to resolve this broadcast storm problem of the AODV in a high node density mobile ad-hoc network, we propose a geographical on-demand route discovery scheme. Assuming a known location of the destination, the RREQ of the proposed routing protocol is propagated in a unicast manner by employing a novel parsing mechanism for possible duplicate RREQs. The routing overhead of the proposed routing protocol is greatly robust to the node density change. We derive the node density required for the proposed routing protocol to keep the same connectivity as the AODV under the circumstance where the nodes are uniformly distributed. In addition, we present an imaginary destination consideration method to incorporate the uncertainty of the destination's location due to mobility. Computer simulations show that the proposed scheme enables the RREQ propagation to cover 95% of the one-hop communication area centered at the originally known location of the destination without sacrificing the unicast feature.	[Choi, Youngchol] Korea Res Inst Ships & Ocean Engn, Marine ICT Res Div, Daejeon 34103, South Korea; [Yang, Hyun Jong] UNIST, Sch Elect & Comp Engn, Ulsan 44919, South Korea	Korea Research Institute of Ships & Ocean Engineering; Ulsan National Institute of Science & Technology (UNIST)	Yang, HJ (corresponding author), UNIST, Sch Elect & Comp Engn, Ulsan 44919, South Korea.	hjyang@unist.ac.kr	Yang, Hyun Jong/A-4696-2019	Yang, Hyun Jong/0000-0002-0717-3794	National R&D Project "Development of marine RF based ad-hoc network for ship"; National R&D Project "Development of wide-area underwater mobile communication systems" - Ministry of Oceans and Fisheries, Korea [PMS3792, PMS3930]; MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) [IITP-2018-2017-0-01635]; IITP grant - Korea government (MSIT) [2018-0-00958]	National R&D Project "Development of marine RF based ad-hoc network for ship"; National R&D Project "Development of wide-area underwater mobile communication systems" - Ministry of Oceans and Fisheries, Korea; MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center); IITP grant - Korea government (MSIT)	This work was supported by grants from National R&D Projects "Development of marine RF based ad-hoc network for ship" and "Development of wide-area underwater mobile communication systems" funded by Ministry of Oceans and Fisheries, Korea (PMS3792, PMS3930), by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2018-2017-0-01635) supervised by the IITP (Institute for Information & communications Technology Promotion), and by the IITP grant funded by the Korea government (MSIT) (No. 2018-0-00958, Development of joint Electrical/Mechanical Drone Beamforming based on Target Detection and Precise Attitude Control). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National R&DProjects "Development of marine RF based ad-hoc network for ship" and "Development of wide-area underwater mobile communication systems" funded by Ministry of Oceans and Fisheries, Korea(PMS3792, PMS3930), by the MSIT(Ministry of Science and ICT), Korea, under the ITRC(Information Technology Research Center) support program(IITP-2018-2017-0-01635) supervised by the IITP(Institute for Information & communications Technology Promotion), and by the IITP grant funded by the Korea government(MSIT) (No. 2018-0-00958, Development of joint Electrical/Mechanical Drone Beamforming based on Target Detection and Precise Attitude Control).	Akyildiz I. F., 2005, Ad Hoc Networks, V3, P257, DOI 10.1016/j.adhoc.2005.01.004; Alotaibi E, 2012, COMPUT NETW, V56, P940, DOI 10.1016/j.comnet.2011.10.011; An K, 2016, INT J E-NAVIG MARIT, V4, P13, DOI 10.1016/j.enavi.2016.06.002; [Anonymous], M18421 ITUR; [Anonymous], M13715 ITUR; [Anonymous], 2013, PTC13INFO16 CPG; Belding-Royer E., 2003, RFC3561 AD HOC ON DE; Beraldi R., 2006, Ad Hoc Networks, V4, P547, DOI 10.1016/j.adhoc.2005.06.004; Beraldi R, 2008, AD HOC NETW, V6, P79, DOI 10.1016/j.adhoc.2006.08.002; Boukerche A, 2011, COMPUT NETW, V55, P3032, DOI 10.1016/j.comnet.2011.05.010; Breton D, 2016, INT J E-NAVIG MARIT, V4, P23, DOI 10.1016/j.enavi.2016.06.003; Campolo C, 2015, VEH COMMUN, V2, P158, DOI 10.1016/j.vehcom.2015.06.002; Colagrosso M, 2004, ICWN'04 & PCC'04, VOLS, 1 AND 2, PROCEEDINGS, P924; Cui JH, 2006, IEEE NETWORK, V20, P12; Dubois-Ferriere H., 2003, P 4 ACM INT S MOBILE, P257, DOI DOI 10.1145/778415.778446; Gao W, 2015, IEEE T MOBILE COMPUT, V14, P714, DOI 10.1109/TMC.2014.2333756; Giust F, 2015, IEEE COMMUN MAG, V53, P142, DOI 10.1109/MCOM.2015.7010527; Gorrieri A, 2016, IEEE T MOBILE COMPUT, V15, P2706, DOI 10.1109/TMC.2015.2508804; Haas ZJ, 2006, IEEE ACM T NETWORK, V14, P479, DOI 10.1109/TNET.2006.876186; Hartenstein H, 2008, IEEE COMMUN MAG, V46, P164, DOI 10.1109/MCOM.2008.4539481; Johnson D. B., 1996, DYNAMIC SOURCE ROUTI; Kang C. G., 2006, P IEEE INT S WIR PER; Ko YB, 2000, WIREL NETW, V6, P307, DOI 10.1023/A:1019106118419; Kwon TJ, 2003, P IEEE, V91, P1210, DOI 10.1109/JPROC.2003.814920; Li F, 2007, IEEE VEH TECHNOL MAG, V2, P12, DOI 10.1109/MVT.2007.912927; Li XY, 2005, MOBILE NETW APPL, V10, P61, DOI 10.1023/B:MONE.0000048546.90440.0d; Nikolov M, 2015, IEEE T MOBILE COMPUT, V14, P1530, DOI 10.1109/TMC.2014.2356466; Partan J., 2006, P 1 ACM INT WORKSH U, P11; Perkins C. E., 1994, Computer Communication Review, V24, P234, DOI 10.1145/190809.190336; Perkins CE, 1999, WMCSA '99, SECOND IEEE WORKSHOP ON MOBILE COMPUTING SYSTEMS AND APPLICATIONS, PROCEEDINGS, P90, DOI 10.1109/MCSA.1999.749281; Qayyum A, 2000, MULTIPOINT RELAYING; Reina DG, 2015, AD HOC NETW, V25, P263, DOI 10.1016/j.adhoc.2014.10.001; Shin K, 2015, IEEE COMMUN MAG, V53, P118, DOI 10.1109/MCOM.2015.7010524; Sozer EM, 2000, IEEE J OCEANIC ENG, V25, P72, DOI 10.1109/48.820738; Sze-Yao Ni, 1999, MobiCom'99. Proceedings of Fifth Annual ACM/IEEE International Conference on Mobile Computing and Networking, P151; Wang Y., 2015, P INT C COMP NETW CO; Williams B., 2002, MOBIHOC 2002. Proceedings of the Third ACM International Symposium on Mobile Ad Hoc Networking and Computing, P194, DOI 10.1145/513800.513825; Yoo H, 2015, IEEE T MOBILE COMPUT, V14, P1490, DOI 10.1109/TMC.2014.2359664; Zhang XM, 2013, IEEE T MOBILE COMPUT, V12, P424, DOI 10.1109/TMC.2011.277; Zhang XM, 2011, IEEE T VEH TECHNOL, V60, P3473, DOI 10.1109/TVT.2011.2158865; Zhang X, 2014, 2014 AUSTRALASIAN TELECOMMUNICATION NETWORKS AND APPLICATIONS CONFERENCE (ATNAC), P23, DOI 10.1109/ATNAC.2014.7020868; Zhu C., 2004, P IEEE CONS COMM NET; Zorzi M, 2003, IEEE T MOBILE COMPUT, V2, P337, DOI 10.1109/TMC.2003.1255648; Zorzi M, 2003, IEEE T MOBILE COMPUT, V2, P349, DOI 10.1109/TMC.2003.1255650	44	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204555	10.1371/journal.pone.0204555	http://dx.doi.org/10.1371/journal.pone.0204555			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273378	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700025
J	Moketla, MB; Wadley, AL; Kamerman, P; Rosa, DD				Moketla, Marvin Blessings; Wadley, Antonia L.; Kamerman, Peter; Rosa, Debra de Assis			Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; RIBONUCLEOTIDE REDUCTASE; GENETIC-VARIANTS; RISK-FACTORS; HIV PATIENTS; POPULATION; POLYMORPHISMS; MUTATIONS; TRANSPORT; TOXICITY	Background The use of the HIV antiretroviral drug stavudine (d4T), a thymidine analogue, is associated with the development of mitochondrial toxicities such as sensory neuropathy (SN). Genetic variation in genes relating to d4T transport and metabolism, as well as genetic variation in the thymidine synthesis pathway, could influence occurrence of d4T-related toxicity. Methods We examined this hypothesis in a cohort of HIV-positive South African adults exposed to d4T, including 143 cases with SN and 120 controls without SN. Ten SNPs in four genes associated with stavudine transport, and 16 SNPs in seven genes of the thymidine synthesis / phosphorylation pathway were genotyped using Agena mass spectrometry methods. Associations between sensory neuropathy and genetic variants were evaluated using PLINK by univariate and multivariable analyses. Result Age and height were significantly associated with SN occurrence. Using logistic regression with age and height as covariates, and uncorrected empirical p-values, genetic variation in SLC28A1, SAMHD1, MTHFR and RRM2B was associated with SN in South Africans using d4T. Conclusion Variation in genes relating to d4T transport and metabolism, as well as genetic variation in the thymidine synthesis pathway may influence occurrence of d4T-related SN. These data PLOS contribute to the characterisation of African pharmacogenetic variation and its role in adverse response to antiretroviral therapy.	[Moketla, Marvin Blessings; Rosa, Debra de Assis] Univ Witwatersrand, Fac Sci, Sch Mol & Cell Biol, Johannesburg, South Africa; [Wadley, Antonia L.; Kamerman, Peter] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa; [Kamerman, Peter] Curtin Univ, Fac Hlth Sci, Sch Pharm & Biomed Sci, Perth, WA, Australia	University of Witwatersrand; University of Witwatersrand; Curtin University	Rosa, DD (corresponding author), Univ Witwatersrand, Fac Sci, Sch Mol & Cell Biol, Johannesburg, South Africa.	Debbie.deassisrosa@wits.ac.za	Wadley, Antonia/CAJ-1596-2022	Kamerman, Peter/0000-0002-3103-5295; de Assis Rosa, Debra/0000-0002-9342-2661	National Research Foundation of South Africa [91513]	National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was funded by the National Research Foundation of South Africa (unrated researchers programme), grant no 91513 to DdAR, www.nrf.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amie SM, 2013, J BIOL CHEM, V288, P20683, DOI 10.1074/jbc.M113.472159; Andrade CH, 2011, BRAZ J PHARM SCI, V47, P209, DOI 10.1590/S1984-82502011000200003; [Anonymous], 2010, NAT ANT TREATM GUID; [Anonymous], 2004, NAT ANT TREATM GUID; Ballana E, 2014, ANTIMICROB AGENTS CH, V58, P4804, DOI 10.1128/AAC.03145-14; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boulle A, 2007, ANTIVIR THER, V12, P753; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cano-Soldado P, 2012, MED RES REV, V32, P428, DOI 10.1002/med.20221; Chan LMS, 2004, EUR J PHARM SCI, V21, P25, DOI 10.1016/j.ejps.2003.07.003; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; Coon S, 2012, AIDS RES HUM RETROV, V28, P1565, DOI [10.1089/AID.2012.0039, 10.1089/aid.2012.0039]; Dandara C, 2011, PHARMACOGENOMICS, V12, P1663, DOI [10.2217/PGS.11.106, 10.2217/pgs.11.106]; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; Domingo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067035; Domingo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057347; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Errasti-Murugarren E, 2010, PHARMACOGENOMICS, V11, P809, DOI [10.2217/pgs.10.70, 10.2217/PGS.10.70]; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Goullee H, 2016, J NEUROVIROL, V22, P508, DOI 10.1007/s13365-015-0421-4; Johnson JA, 2003, TRENDS GENET, V19, P660, DOI 10.1016/j.tig.2003.09.008; Kamerman PR, 2012, CURR PAIN HEADACHE R, V16, P226, DOI 10.1007/s11916-012-0257-z; Kampira E, 2013, JAIDS-J ACQ IMM DEF, V63, P647, DOI 10.1097/QAI.0b013e3182968ea5; Kerb R, 2009, LANCET INFECT DIS, V9, P760, DOI 10.1016/S1473-3099(09)70320-2; Kis O, 2010, TRENDS PHARMACOL SCI, V31, P22, DOI 10.1016/j.tips.2009.10.001; Kroetz DL, 2010, CLIN PHARMACOL THER, V87, P109, DOI 10.1038/clpt.2009.226; Maritz J, 2010, MUSCLE NERVE, V41, P599, DOI 10.1002/mus.21535; Menezes CN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-244; Michaud V, 2012, PHARMACOL REV, V64, P803, DOI 10.1124/pr.111.005553; Miller S. A., 1998, NUCLEIC ACIDS RES, V16, P215, DOI DOI 10.1093/NAR/16.3.1215; Minuesa G, 2011, PHARMACOL THERAPEUT, V132, P268, DOI 10.1016/j.pharmthera.2011.06.007; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Njuguna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063596; Pastor-Anglada M, 2005, VIRUS RES, V107, P151, DOI 10.1016/j.virusres.2004.11.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Scholtz CL, 2002, SAMJ S AFR MED J, V92, P464; Selvaraj S, 2014, CLIN PHARMACOL THER, V96, P110, DOI 10.1038/clpt.2014.64; Sinxadi PZ, 2013, AIDS RES HUM RETROV, V29, P1031, DOI [10.1089/aid.2012.0373, 10.1089/AID.2012.0373]; Tekola-Ayele F, 2015, PHARMACOGENOMICS J, V15, P101, DOI 10.1038/tpj.2014.39; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Wadley AL, 2013, MOL IMMUNOL, V55, P197, DOI 10.1016/j.molimm.2013.02.002; Wadley AL, 2015, EUR J HUM GENET, V23, P363, DOI 10.1038/ejhg.2014.104; Wadley AL, 2011, J PAIN SYMPTOM MANAG, V41, P700, DOI 10.1016/j.jpainsymman.2010.07.006; Warnich Louise, 2011, Current Pharmacogenomics & Personalized Medicine, V9, P191	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204111	10.1371/journal.pone.0204111	http://dx.doi.org/10.1371/journal.pone.0204111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273369	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700015
J	Patterson, JA; Nippita, T; Randall, DA; Irving, DO; Ford, JB				Patterson, Jillian A.; Nippita, Tanya; Randall, Deborah A.; Irving, David O.; Ford, Jane B.		Obstet Transfusion Steering Grp	Outcomes of subsequent pregnancy following obstetric transfusion in a first birth	PLOS ONE			English	Article							SEVERE POSTPARTUM HEMORRHAGE; BLOOD-TRANSFUSION; RISK-FACTORS; RECURRENCE; ALLOIMMUNIZATION; VALIDATION; ANTIBODIES; PLACENTA; COHORT; CELL	Background Increasing rates of postpartum haemorrhage and obstetric transfusion mean that more women are entering subsequent pregnancies with a history of blood transfusion. This study investigates subsequent pregnancy outcomes of women with a prior obstetric red cell transfusion, compared to women without a transfusion. Methods All women with a first pregnancy resulting in a liveborn singleton infant of at least 20 weeks gestation delivering in hospitals in New South Wales, Australia, between 2003 and 2012 were included in the study, with followup for second births until June 2015. Linked hospital and births data were used to identify women with a transfusion and/or postpartum haemorrhage in their first birth, time to second pregnancy and adverse birth outcomes (including transfusion, postpartum haemorrhage and severe morbidity) in their subsequent birth. Results There were 358,384 singleton births to primiparous women, with 1.4% receiving an obstetric blood transfusion. Sixty-three percent of women had at least one subsequent birth. The relative risk (RR) of requiring a transfusion in a second birth was 4.9 (95% CI 4.1,6.1) for women with a previous transfusion compared with women without. The risk (RR) of severe morbidity in a second birth was 4.1 times higher (95% CI 2.2,7.4) for those receiving a transfusion without haemorrhage in their first birth compared with women with neither haemorrhage nor transfusion. Conclusion It is important to consider a woman's history of transfusion and/or haemorrhage as part of her obstetric history to ensure management in a manner that minimises risk in subsequent pregnancies.	[Patterson, Jillian A.; Nippita, Tanya; Randall, Deborah A.; Ford, Jane B.] Kolling Inst, Northern Sydney Local Hlth Dist, Clin & Populat Perinatal Hlth Res, St Leonards, NSW, Australia; [Patterson, Jillian A.; Nippita, Tanya; Randall, Deborah A.; Ford, Jane B.] Univ Sydney, Northern Clin Sch, St Leonards, NSW, Australia; [Nippita, Tanya] Royal North Shore Hosp, Dept Obstet & Gynaecol, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia; [Irving, David O.] Australian Red Cross Blood Serv, Res & Dev, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; University of Sydney; Royal North Shore Hospital; Australian Red Cross Blood Service	Patterson, JA (corresponding author), Kolling Inst, Northern Sydney Local Hlth Dist, Clin & Populat Perinatal Hlth Res, St Leonards, NSW, Australia.; Patterson, JA (corresponding author), Univ Sydney, Northern Clin Sch, St Leonards, NSW, Australia.	jillian.patterson@sydney.edu.au	Patterson, Jillian/A-7384-2015; Irving, David/AAS-9892-2021; Peek, Michael/D-5991-2016	Peek, Michael/0000-0001-6055-5129; Patterson, Jillian/0000-0002-9888-9818; Randall, Deborah/0000-0002-5075-0227	Australian National Health and Medical Research Centre (NHMRC) [1094822]; Australian Research Council Future Fellowship [120100069]	Australian National Health and Medical Research Centre (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by an Australian National Health and Medical Research Centre (NHMRC) Partnership grant (#1094822; https://www.nhmrc.gov.au/). JF is supported by an Australian Research Council Future Fellowship (#120100069; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ananth CV, 2017, AM J OBSTET GYNECOL, V217, P167, DOI 10.1016/j.ajog.2017.04.016; Baldwin HJ, 2017, ACTA OBSTET GYN SCAN, V96, P1373, DOI 10.1111/aogs.13201; Chen JS, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-68; Copen C.E., 2015, NATL VITAL STAT REPO, V64, P1; Dajak S, 2013, BLOOD TRANSFUS-ITALY, V11, P528, DOI 10.2450/2013.0193-12; Egbor M, 2012, BEST PRACT RES CL OB, V26, P119, DOI 10.1016/j.bpobgyn.2011.10.004; Ford JB, 2007, MED J AUSTRALIA, V187, P391, DOI 10.5694/j.1326-5377.2007.tb01308.x; Ford JB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0788-5; Ford JB, 2013, AUST HEALTH REV, V37, P495, DOI 10.1071/AH12017; Ford JB, 2012, MATERN CHILD HLTH J, V16, P1542, DOI 10.1007/s10995-011-0919-1; Fullerton G, 2013, BJOG-INT J OBSTET GY, V120, P621, DOI 10.1111/1471-0528.12120; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Gottvall K, 2002, BJOG-INT J OBSTET GY, V109, P254, DOI 10.1111/j.1471-0528.2002.01200.x; Holm C, 2012, BJOG-INT J OBSTET GY, V119, P596, DOI 10.1111/j.1471-0528.2011.03267.x; James AH, 2008, J WOMENS HEALTH, V17, P1279, DOI 10.1089/jwh.2007.0605; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Koelewijn JM, 2009, BJOG-INT J OBSTET GY, V116, P655, DOI 10.1111/j.1471-0528.2008.01984.x; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Lain SJ, 2008, AUST NZ J OBSTET GYN, V48, P481, DOI 10.1111/j.1479-828X.2008.00910.x; Liumbruno GM, 2010, BLOOD TRANSFUS-ITALY, V8, P8, DOI 10.2450/2009.0108-09; Mehrabadi A, 2014, J OBSTET GYNAECOL CA, V36, P21, DOI 10.1016/S1701-2163(15)30680-0; National Blood Authority, 2015, PAT BLOOD MAN GUID M; Oberg AS, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.872; Pal M, 2015, PATHOLOGY, V47, P151, DOI 10.1097/PAT.0000000000000225; Patterson JA, 2015, VOX SANG, V108, P37, DOI 10.1111/vox.12186; Patterson JA, 2014, OBSTET GYNECOL, V123, P126, DOI 10.1097/AOG.0000000000000054; Prick BW, 2014, BJOG-INT J OBSTET GY, V121, P1005, DOI 10.1111/1471-0528.12531; Rn L, 2013, ACTA OBSTET GYN SCAN, V92, P210, DOI [10.1111/aogs.12034, DOI 10.1111/AOGS.12034]; Roberts CL, 2008, MED CARE, V46, P786, DOI 10.1097/MLR.0b013e318178eae4; Roberts CL, 2012, AUST NZ J OBSTET GYN, V52, P483, DOI 10.1111/j.1479-828X.2012.01470.x; Roberts CL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-7; Seeho SK, AM J OBSTET GYNECOLO; Smith Heather M, 2013, Immunohematology, V29, P127; The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016, MAN POSTP HAEM PPH; Thompson JF, 2011, AUST NZ J OBSTET GYN, V51, P365, DOI 10.1111/j.1479-828X.2011.01317.x; Wikkelso AJ, 2014, J MATERN-FETAL NEO M, V27, P1661, DOI 10.3109/14767058.2013.872095	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203195	10.1371/journal.pone.0203195	http://dx.doi.org/10.1371/journal.pone.0203195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265674	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500006
J	Cheruiyot, A; Li, S; Nickless, A; Roth, R; Fitzpatrick, JAJ; You, ZS				Cheruiyot, Abigael; Li, Shan; Nickless, Andrew; Roth, Robyn; Fitzpatrick, James A. J.; You, Zhongsheng			Compound C inhibits nonsense-mediated RNA decay independently of AMPK	PLOS ONE			English	Article							CANCER-CELL-PROLIFERATION; MESSENGER-RNA; MAMMALIAN-CELLS; PROTEIN-KINASE; MONITORING AUTOPHAGY; GENE-EXPRESSION; STRESS-RESPONSE; NMD; PATHWAY; MUTATIONS	The nonsense mediated RNA decay (NMD) pathway safeguards the integrity of the transcriptome by targeting mRNAs with premature translation termination codons (PTCs) for degradation. It also regulates gene expression by degrading a large number of non-mutant RNAs (including mRNAs and noncoding RNAs) that bear NMD-inducing features. Consequently, NMD has been shown to influence development, cellular response to stress, and clinical outcome of many genetic diseases. Small molecules that can modulate NMD activity provide critical tools for understanding the mechanism and physiological functions of NMD, and they also offer potential means for treating certain genetic diseases and cancer. Therefore, there is an intense interest in identifying small-molecule NMD inhibitors or enhancers. It was previously reported that both inhibition of NMD and treatment with the AMPK-selective inhibitor Compound C (CC) induce autophagy in human cells, raising the possibility that CC may be capable of inhibiting NMD. Here we show that CC indeed has a NMD-inhibitory activity. Inhibition of NMD by CC is, however, independent of AMPK activity. As a competitive ATP analog, CC does not affect the kinase activity of SMG1, an essential NMD factor and the only known kinase in the NMD pathway. However, CC treatment down-regulates the protein levels of several NMD factors. The induction of autophagy by CC treatment is independent of ATF4, a NMD target that has been shown to promote autophagy in response to NMD inhibition. Our results reveal a new activity of CC as a NMD inhibitor, which has implications for its use in basic research and drug development.	[Cheruiyot, Abigael; Li, Shan; Nickless, Andrew; Roth, Robyn; Fitzpatrick, James A. J.; You, Zhongsheng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Roth, Robyn; Fitzpatrick, James A. J.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO USA; [Fitzpatrick, James A. J.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Fitzpatrick, James A. J.] Washington Univ, Sch Med, Ctr Cellular Imaging, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	You, ZS (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	zyou@wustl.edu		Cheruiyot, Abigael/0000-0003-0612-6280; You, Zhongsheng/0000-0002-9719-8791	NIH [R01GM098535]; American Cancer Society Research Scholar Grant [RSG-13-212-01-DMC]; Siteman Investment Program grant from the Siteman Cancer Center of Washington University [4036]; Howard Hughes Medical Institute International Student Research fellow; Washington University Center for Cellular Imaging (WUCCI) by Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505]; Foundation for Barnes-Jewish Hospital [3770]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098535] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); Siteman Investment Program grant from the Siteman Cancer Center of Washington University; Howard Hughes Medical Institute International Student Research fellow; Washington University Center for Cellular Imaging (WUCCI) by Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Foundation for Barnes-Jewish Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.C., S.L., A.N. and Z.Y. were supported by a NIH grant (R01GM098535), an American Cancer Society Research Scholar Grant (RSG-13-212-01-DMC), and a Siteman Investment Program grant (4036) from the Siteman Cancer Center of Washington University to Z.Y. A.C. was also supported by a Howard Hughes Medical Institute International Student Research fellow. R.R. and J.A.J.F. were supported by the Washington University Center for Cellular Imaging (WUCCI) which was in turn supported by Washington University School of Medicine, The Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CDI-CORE-2015-505) and the Foundation for Barnes-Jewish Hospital (3770).	Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhuvanagiri M, 2014, EMBO MOL MED, V6, P1593, DOI 10.15252/emmm.201404461; Bordeira-Carrico R, 2012, TRENDS MOL MED, V18, P667, DOI 10.1016/j.molmed.2012.09.004; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Chen XQ, 2013, NUCLEIC ACIDS RES, V41, P9325, DOI 10.1093/nar/gkt672; Dai RY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.419; Dang YJ, 2009, J BIOL CHEM, V284, P23613, DOI 10.1074/jbc.M109.009985; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Garulli C, 2014, CELL SIGNAL, V26, P352, DOI 10.1016/j.cellsig.2013.11.022; Gollavilli PN, 2015, FEBS J, V282, P3971, DOI 10.1111/febs.13391; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; HA J, 1994, J BIOL CHEM, V269, P22162; HAO JJ, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.0002904; Hauer C, 2016, CELL REP, V16, P1588, DOI 10.1016/j.celrep.2016.06.096; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hu JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068291; Hu ZY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15943; Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031; Huang SW, 2013, TOXICOL APPL PHARM, V267, P113, DOI 10.1016/j.taap.2012.12.016; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; Jin Y, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0070-z; Karam R, 2015, EMBO REP, V16, P599, DOI 10.15252/embr.201439696; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim N, 2016, J ENDOCRINOL, V228, P105, DOI 10.1530/JOE-15-0302; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li TL, 2015, EMBO J, V34, P1630, DOI 10.15252/embj.201489947; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Longman D, 2013, NUCLEIC ACIDS RES, V41, P8319, DOI 10.1093/nar/gkt585; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Lou CH, 2016, STEM CELL REP, V6, P844, DOI 10.1016/j.stemcr.2016.05.008; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Madhu V, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1035374; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nickless A, 2018, METHODS MOL BIOL, V1720, P213, DOI 10.1007/978-1-4939-7540-2_16; Nickless A, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0153-7; Nickless A, 2014, NAT MED, V20, P961, DOI 10.1038/nm.3620; Nomakuchi TT, 2016, NAT BIOTECHNOL, V34, P164, DOI 10.1038/nbt.3427; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Rios M, 2013, CANCER RES, V73, P2628, DOI 10.1158/0008-5472.CAN-12-0861; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Sanduja S, 2016, ONCOGENE, V35, P5295, DOI 10.1038/onc.2016.70; Tani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055684; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Vucicevic L, 2011, AUTOPHAGY, V7, P40, DOI 10.4161/auto.7.1.13883; Wang G, 2013, BIOCHEM BIOPH RES CO, V435, P16, DOI 10.1016/j.bbrc.2013.03.129; Wengrod J, 2013, MOL CELL BIOL, V33, P2128, DOI 10.1128/MCB.00174-13; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yang WL, 2012, J SURG ONCOL, V106, P680, DOI 10.1002/jso.23184; Yepiskoposyan H, 2011, RNA, V17, P2108, DOI 10.1261/rna.030247.111; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	64	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204978	10.1371/journal.pone.0204978	http://dx.doi.org/10.1371/journal.pone.0204978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289931	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500035
J	Katz, S; Backeris, P; Merck, C; Suprun, M; D'Souza, S; Bishop, DF; Desnick, RJ; Moore, K; Ubarretxena-Belandia, I; Lemischka, IR				Katz, Suzanna; Backeris, Peter; Merck, Christopher; Suprun, Maria; D'Souza, Sunita; Bishop, David F.; Desnick, Robert J.; Moore, Kateri; Ubarretxena-Belandia, Iban; Lemischka, Ihor R.			Design and validation of an open-source modular Microplate Photoirradiation System for high-throughput photobiology experiments	PLOS ONE			English	Article							INDUCED PROTOPORPHYRIN IX; PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; METHYL AMINOLEVULINATE; ACTINIC KERATOSES; LIGHT; PORPHYRINS; SKIN; INACTIVATION; EXPRESSION	Research in photobiology is currently limited by a lack of devices capable of delivering precise and tunable irradiation to cells in a high-throughput format. This limits researchers to using expensive commercially available or custom-built light sources which make it difficult to replicate, standardize, optimize, and scale experiments. Here we present an open-source Microplate Photoirradiation System (MPS) developed to enable high-throughput light experiments in standard 96 and 24-well microplates for a variety of applications in photobiology research. This open-source system features 96 independently controlled LEDs (4 LEDs per well in 24-well), Wi-Fi connected control and programmable graphical user interface (GUI) for control and programming, automated calibration GUI, and modular control and LED boards for maximum flexibility. A web-based GUI generates light program files containing irradiation parameters for groups of LEDs. These parameters are then uploaded wirelessly, stored and used on the MPS to run photoirradiation experiments inside any incubator. A rapid and semi-quantitative porphyrin metabolism assay was also developed to validate the system in wild-type fibroblasts. Protoporphyrin IX (PpIX) fluorescence accumulation was induced by incubation with 5-aminolevulinic acid (ALA), a photosensitization method leveraged clinically to destroy malignant cell types in a process termed photodynamic therapy (PDT), and cells were irradiated with 405nm light with varying irradiance, duration and pulsation parameters. Immediately after light treatment with the MPS, subsequent photobleaching was measured in live, adherent cells in both 96-well and a 24-well microplates using a microplate reader. Results demonstrate the utility and reliability of the Microplate Photoirradiation System to irradiate cells with precise irradiance and timing parameters in order to measure PpIx photobleaching kinetics in live adherent cells and perform comparable experiments with both 24 and 96 well microplate formats. The high-throughput capability of the MPS enabled measurement of enough irradiance conditions in a single microplate to fit PpIX fluorescence to a bioexponential decay model of photobleaching, as well as reveal a dependency of photobleaching on duty-cycle-but not frequency-in a pulsed irradiance regimen.	[Katz, Suzanna; D'Souza, Sunita; Moore, Kateri; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA; [Backeris, Peter] Icahn Sch Med Mt Sinai, Dept Neurosurg, Sinai Biodesign, New York, NY 10029 USA; [Merck, Christopher] Merck Engn LLC, Hamburg, NJ 07495 USA; [Suprun, Maria] Icahn Sch Med Mt Sinai, Dept Pediat Allergy & Immunol, New York, NY 10029 USA; [Bishop, David F.; Desnick, Robert J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ubarretxena-Belandia, Iban; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Ubarretxena-Belandia, Iban] Univ Basque Country, UPV EHU, CSIC, Biofisika Inst, Leioa, Spain	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Backeris, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosurg, Sinai Biodesign, New York, NY 10029 USA.	peter.backeris@mssm.edu	Bishop, David F./X-4102-2019; Ubarretxena-Belandia, Iban/AAA-8939-2019; Suprun, Maria/ABE-8323-2020; Suprun, Maria/AAE-5507-2022	Suprun, Maria/0000-0001-9161-4021; Bishop, David/0000-0003-1958-8601	Graduate School of Biological Sciences; Black Family Stem Cell Institute at Icahn School of Medicine	Graduate School of Biological Sciences; Black Family Stem Cell Institute at Icahn School of Medicine	We thank the Graduate School of Biological Sciences and the Black Family Stem Cell Institute at Icahn School of Medicine for providing financial support for the project. Chris Merck is affiliated with his own LLC (Merck Engineering LLC). Merck Engineering LLC did not contribute funding to the development of the MPS or its biological validation and has no pecuniary interest in this study. Chris Merck worked as a volunteer collaborator not representing any company or institution. Merck Engineering LLC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Akilov O.E., 2006, MED LASER APPL, V21, P251, DOI [DOI 10.1016/J.MLA.2006.07.002, 10.1016/j.mla.2006.07.002]; Alexiades-Armenakas Macrene, 2006, J Drugs Dermatol, V5, P45; Issa MCA, 2010, DERMATOL SURG, V36, P39, DOI 10.1111/j.1524-4725.2009.01385.x; Bagdonas S, 2000, PHOTOCHEM PHOTOBIOL, V72, P186, DOI 10.1562/0031-8655(2000)072<0186:POAAIP>2.0.CO;2; Boere IA, 2003, PHOTOCHEM PHOTOBIOL, V78, P271, DOI 10.1562/0031-8655(2003)078<0271:MISDAP>2.0.CO;2; Chen DX, 2012, ADV DIFFER EQU-NY, P1, DOI 10.1186/1687-1847-2012-33; Clements IP, 2016, PROC SPIE, V9690, DOI 10.1117/12.2213708; Curnow A, 2000, J PHOTOCH PHOTOBIO B, V58, P149, DOI 10.1016/S1011-1344(00)00120-2; Dragieva G, 2004, BRIT J DERMATOL, V151, P196, DOI 10.1111/j.1365-2133.2004.06054.x; GEBRIL M, 1990, NEPHRON, V55, P159, DOI 10.1159/000185945; Georgakoudi I, 1997, PHOTOCHEM PHOTOBIOL, V65, P135, DOI 10.1111/j.1751-1097.1997.tb01889.x; Georgakoudi I, 1998, PHOTOCHEM PHOTOBIOL, V67, P612, DOI 10.1111/j.1751-1097.1998.tb09463.x; Gerhardt KP, 2016, SCI REP-UK, V6, DOI 10.1038/srep35363; GUTNIAK O, 1966, ANAL BIOCHEM, V16, P20, DOI 10.1016/0003-2697(66)90076-5; Hadis MA, 2017, J BIOPHOTONICS, V10, P1514, DOI 10.1002/jbio.201600273; Haj-Hosseini N, 2009, PROC SPIE, V7161, DOI 10.1117/12.808156; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hannanta-anan P, 2016, CELL SYST, V2, P283, DOI 10.1016/j.cels.2016.03.010; Quintanar LFH, 2016, PHOTOMED LASER SURG, V34, P108, DOI 10.1089/pho.2015.4030; Hodgkinson N, 2017, CERVICAL CANC CELLS; Issa M, 2010, ANAIS BRASILEIROS DE; Issa MCA, 2009, BRIT J DERMATOL, V161, P647, DOI 10.1111/j.1365-2133.2009.09326.x; Jori G, 2004, PHOTOCH PHOTOBIO SCI, V3, P403, DOI 10.1039/b311904c; Kaestner L, 2004, PHOTOCH PHOTOBIO SCI, V3, P981, DOI 10.1039/b403127j; Karrer S, 2000, TOPICAL PHOTODYNAMIC; Kasermann F, 1997, ANTIVIR RES, V34, P65, DOI 10.1016/S0166-3542(96)01207-7; Katsambas A, 2008, DERMATOL THER, V21, P86, DOI 10.1111/j.1529-8019.2008.00175.x; Krishnamohan M, 2006, ENVIRON TOXICOL, V1, P192; Martinelli ALC, 1999, J CLIN GASTROENTEROL, V29, P327, DOI 10.1097/00004836-199912000-00006; Meier Daniela, 2014, J Vis Exp, DOI 10.3791/51213; Moan J, 1997, INT J CANCER, V70, P90, DOI 10.1002/(SICI)1097-0215(19970106)70:1<90::AID-IJC14>3.0.CO;2-H; Muller P J, 1996, J Clin Laser Med Surg, V14, P263; Nakai Y, 2015, PHOTODIAGN PHOTODYN, V12, P282, DOI 10.1016/j.pdpdt.2014.12.010; Niu TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138754; Oleinick N.L., 2011, BASIC PHOTOSENSITIZA; Orenstein A, 1997, FEMS IMMUNOL MED MIC, V19, P307, DOI 10.1016/S0928-8244(97)00097-7; Piacquadio DJ, 2004, ARCH DERMATOL, V140, P41, DOI 10.1001/archderm.140.1.41; Pieslinger A., 2006, MED LASER APPL, V21, P277; Pogue BW, 2008, PROTOPORPHYRIN 9 FLU, V13, DOI [10.1117/1.2937, 10.1117/1.2937476, DOI 10.1117/1.2937476]; Pollock B, 2004, BRIT J DERMATOL, V151, P616, DOI 10.1111/j.1365-2133.2004.06110.x; Reis SA, 2016, NAT CHEM BIOL, V12, P317, DOI [10.1038/NCHEMBIO.2042, 10.1038/nchembio.2042]; Rick K, 1997, J PHOTOCH PHOTOBIO B, V40, P313, DOI 10.1016/S1011-1344(97)00076-6; RIMINGTON C, 1960, BIOCHEM J, V75, P620, DOI 10.1042/bj0750620; Robinson DJ, 1999, PHOTOCHEM PHOTOBIOL, V69, P61, DOI 10.1111/j.1751-1097.1999.tb05307.x; Robinson DJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P140, DOI 10.1562/0031-8655(1998)067<0140:FPOAIP>2.3.CO;2; Roeder B, 1990, LASERS MED SCI; Stringer MR, 2006, PHOTODIAGN PHOTODYN, V3, P19, DOI 10.1016/S1572-1000(05)00155-9; Sudworth CD, 2003, APPL SPECTROSC, V57, P682, DOI 10.1366/000370203322005382; Szeimies RM, 2007, DERMATOL CLIN, V25, P89, DOI 10.1016/j.det.2006.09.008; Wainwright M, 2000, INT J ANTIMICROB AG, V16, P381, DOI 10.1016/S0924-8579(00)00207-7; Wainwright M, 2002, CHEM SOC REV, V31, P128, DOI 10.1039/b101905h; Wainwright M, 2002, CURR MED CHEM, V9, P127, DOI 10.2174/0929867023371355; White B, 2016, 5 AMINOLEVULINIC ACI, DOI DOI 10.1089/PH0.2016.4091; Wilson BC, 1997, LASERS MED SCI; Yin L, 2013, CONTROLLING DELICATE; Yin L, 2013, CONTROLLING THE DELI; Zhang SJ, 2004, PHOTOCHEM PHOTOBIOL, V79, P545, DOI 10.1562/MU-03-32.1; Zhao JZ, 2013, CHEM SOC REV, V42, P5323, DOI 10.1039/c3cs35531d; Zhu TC, 2005, MED PHYS	60	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203597	10.1371/journal.pone.0203597	http://dx.doi.org/10.1371/journal.pone.0203597			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289930	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500005
J	Ameh, CA; White, S; Dickinson, F; Mdegela, M; Madaj, B; van den Broek, N				Ameh, Charles A.; White, Sarah; Dickinson, Fiona; Mdegela, Mselenge; Madaj, Barbara; van den Broek, Nynke			Retention of knowledge and skills after Emergency Obstetric Care training: A multi-country longitudinal study	PLOS ONE			English	Article							PEDIATRIC RESIDENTS; NEWBORN CARE; PROVIDERS; PROGRAM; COURSES	Objective To determine retention of knowledge and skills after standardised "skills and drills" training in Emergency Obstetric Care. Design Longitudinal cohort study. Setting Ghana, Malawi, Nigeria, Kenya, Tanzania and Sierra Leone. Population 609 maternity care providers, of whom 455 were nurse/midwives (NMWs) Methods Knowledge and skills assessed before and after training, and, at 3, 6, 9 and 12 months. Analysis of variance to explore differences in scores by country and level of healthcare facility for each cadre. Mixed effects regression analysis to account for potential explanatory factors including; facility type, years of experience providing maternity care, months since training and number of repeat assessments. Main outcome measures Change in knowledge and skills. Results Before training the overall mean (SD) score for skills was 48.8% (11.6%) and 65.6% (10.7%). for knowledge. After training the mean (95% CI) relative improvement in knowledge was 30.8% (29.1% - 32.6%) and 59.8% (58.6%- 60.9%) for skills. Mean scores for knowledge and skills at each subsequent assessment remained between those immediately post-training and those at 3 months. NMWs who attended all four assessments demonstrated statistically better retention of skills (14.9%, 95% CI 7.8%, 22.0% p<0.001) but not knowledge (8.6%, 95% CI -0.3%, 17.4%. p = 0.06) compared to those who attended one or two assessments only. Health care facility level or experience were not determinants of retention. Conclusions After training, healthcare providers retain knowledge and skills for up to 12 months. This effect can likely be enhanced by short repeat skills-training sessions, or, 'fire drills'.	[Ameh, Charles A.; White, Sarah; Dickinson, Fiona; Mdegela, Mselenge; Madaj, Barbara; van den Broek, Nynke] Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine	Ameh, CA (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England.	Charles.Ameh@lstmed.ac.uk	Ameh, Charles Anawo/I-9872-2019	Ameh, Charles Anawo/0000-0002-2341-7605; White, Sarah/0000-0001-5535-8075; Dickinson, Fiona/0000-0002-5298-9127	Support Department for International Development United Kingdom; UNICEF Sierra Leone who funded the 'Making it Happen' programme [202945-101]	Support Department for International Development United Kingdom; UNICEF Sierra Leone who funded the 'Making it Happen' programme	This study was supported by the Support Department for International Development United Kingdom and UNICEF Sierra Leone who funded the 'Making it Happen' programme (contract 202945-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040220; Allott HA, 2017, GLOB HEALTH-SCI PRAC, V5, P175, DOI 10.9745/GHSP-D-17-00055; Ameh CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167270; Childhealth Advocacy International (CAI), 2010, EV ESS SURG SKILLS E; Crofts JF, 2013, INT J GYNECOL OBSTET, V123, P81, DOI 10.1016/j.ijgo.2013.04.015; Grady K, 2011, J OBSTET GYNAECOL, V31, P18, DOI 10.3109/01443615.2010.533218; Homaifar N, 2013, INT J GYNECOL OBSTET, V120, P195, DOI 10.1016/j.ijgo.2012.07.031; Mazza A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186731; Monod C, 2014, ARCH GYNECOL OBSTET, V289, P733, DOI 10.1007/s00404-013-3111-6; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-94; RCOG, 2007, LIF SAV SKILLS MAN E, V2nd; Sutton RM, 2011, PEDIATRICS, V128, pE145, DOI 10.1542/peds.2010-2105; Tang JH, 2016, INT J GYNECOL OBSTET, V132, P240, DOI 10.1016/j.ijgo.2015.06.062; Trevisanuto D, 2005, PEDIATR ANESTH, V15, P944, DOI 10.1111/j.1460-9592.2005.01589.x; Trevisanuto D, 2007, PEDIATR ANESTH, V17, P28, DOI 10.1111/j.1460-9592.2006.02001.x; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 2007, MAK PREGN SAF CRIT R; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Yang CW, 2012, RESUSCITATION, V83, P1055, DOI 10.1016/j.resuscitation.2012.02.027	19	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203606	10.1371/journal.pone.0203606	http://dx.doi.org/10.1371/journal.pone.0203606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286129	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000446383500009
J	Burrola-Mendez, Y; Toro-Hernandez, ML; Goldberg, M; Pearlman, J				Burrola-Mendez, Yohali; Toro-Hernandez, Maria Luisa; Goldberg, Mary; Pearlman, Jon			Implementation of the hybrid course on basic wheelchair service provision for Colombian wheelchair service providers	PLOS ONE			English	Article							ASSISTIVE TECHNOLOGY; EDUCATION; REHABILITATION; CHALLENGES; COUNTRIES	Introduction People with mobility impairments often rely on wheelchairs as their primary means of mobility. Untrained wheelchair service providers may provide inappropriate wheelchairs and services which result in negative consequences in wheelchair users' health, quality of life, safety, and social participation. This study aimed to evaluate the influence of the Spanish Hybrid Course on Basic Wheelchair Service Provision, a training based on the World Health Organization's Wheelchair Service Training Program-Basic Level, to increase knowledge in basic level wheelchair service provision among a group of wheelchair service providers from Colombia. In addition, we developed a satisfaction survey which participants completed after the training to understand levels of satisfaction with the training intervention. Methods A quasi-experimental study was conducted to evaluate changes in basic level wheelchair knowledge using the Wheelchair Service Provision-Basic Test. Paired sample t tests were used to assess pre-and post-training changes in basic level wheelchair knowledge. The Hybrid Satisfaction Survey was developed in collaboration with a multidisciplinary, international stakeholders' group. The survey's construct of interest was level of satisfaction determined by interaction, instructor, instruction methodology, content, and technology, using a five-point Likert scale (0 = strongly disagree to 4 = strongly agree). The survey was completed anonymously after the training intervention and analyzed using frequencies and percentages. Results Fifteen wheelchair service providers in Colombia completed the Spanish Hybrid Course. Mean post-scores were significantly higher (Mean (M) = 56.13, Standard Deviation (SD) = 7.8), than pre-assessment scores (M = 50.07, SD = 8.38, t(14) = 4.923, p = <0.0001). Participants who completed the surveys (N = 15) reported that the Spanish Hybrid Course was well received, with 98.66% of responses distributed in favorable levels (>3). Conclusions The Spanish Hybrid Course proved to be effective in increasing basic level wheelchair knowledge with a high satisfaction level among participants. Further testing is needed to evaluate the effectiveness of this course across different individuals and countries as a potential tool to build professional capacity in basic level wheelchair provision.	[Burrola-Mendez, Yohali; Goldberg, Mary; Pearlman, Jon] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA 15260 USA; [Burrola-Mendez, Yohali; Goldberg, Mary; Pearlman, Jon] Univ Pittsburgh, ISWP, Pittsburgh, PA 15260 USA; [Burrola-Mendez, Yohali] Consejo Nacl Ciencia & Technol, Mexico City, DF, Mexico; [Toro-Hernandez, Maria Luisa] Univ CES, Sch Phys Therapy, Medellin, Colombia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goldberg, M (corresponding author), Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA 15260 USA.; Goldberg, M (corresponding author), Univ Pittsburgh, ISWP, Pittsburgh, PA 15260 USA.	mgoldberg@pitt.edu		Pearlman, Jon/0000-0003-0830-9136; Burrola-Mendez, Yohali/0000-0001-9357-7543	University of Pittsburgh through Advancing Partners & Communities (APC) [APC-GM-0068]; U.S. Agency for International Development [AID-OAA-A-12-00047]; Consejo Nacional de Ciencia y Tecnologia Mexico (CONACYT) Graduate Student Fellowship	University of Pittsburgh through Advancing Partners & Communities (APC); U.S. Agency for International Development(United States Agency for International Development (USAID)); Consejo Nacional de Ciencia y Tecnologia Mexico (CONACYT) Graduate Student Fellowship	This study was produced by ISWP in collaboration with the University of Pittsburgh, subaward number APC-GM-0068, through Advancing Partners & Communities (APC), a cooperative agreement funded by the U.S. Agency for International Development under Agreement No. AID-OAA-A-12-00047, beginning October 1, 2012. This study is based upon work supported by Consejo Nacional de Ciencia y Tecnologia Mexico (CONACYT) Graduate Student Fellowship. The contents of this publication do not necessarily reflect the view of CONACYT.	Abou Naaj M, 2012, J INF TECHNOL EDUC-R, V11, P185; Al AlHassan S., 2017, ENGLISH LANGUAGE TEA, V10, P190, DOI DOI 10.5539/ELT.V10N6P190; [Anonymous], 2015, WHEELCH SERV TRAIN P; [Anonymous], 2022, WHEELCHAIR SKILLS PR; [Anonymous], 2018, WHEELCHAIR SERVICE T; [Anonymous], 2008, GUIDELINES PROVISION; [Anonymous], 2016, AC FIN TERM CONFL CO; [Anonymous], 2015, PROTOCOLO ADM PRESCR; [Anonymous], 4 S LAT POS SENT MOV; Banks LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189996; Borg J, 2009, LANCET, V374, P1863, DOI 10.1016/S0140-6736(09)61872-9; Bowen SJ, 2013, ARCH PHYS MED REHAB, V94, pS3, DOI 10.1016/j.apmr.2012.04.037; Buamah Christine., 2018, THESIS FORDHAM LAW S; Burrola-Mendez Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199251; Camargo DA, 2011, PROCESO ACTUALIZACIO; Camden C, 2015, DISABIL REHABIL, V37, P1390, DOI 10.3109/09638288.2014.963705; Carver J, 2016, DISABIL REHABIL-ASSI, V11, P468, DOI 10.3109/17483107.2015.1027295; Economic Commission for Latin America and the Caribbean (ELAC), 2012, SOC PAN LAT AM; Etchart Linda., 2018, CHEVRON ECUADOR EXTR; Fullerton JT, 2013, MIDWIFERY, V29, P1129, DOI 10.1016/j.midw.2013.07.006; Fung KH, 2017, AFR J DISABIL, V6, DOI 10.4102/ajod.v6i0.340; Gartz R, 2017, DISABIL REHABIL-ASSI, V12, P333, DOI 10.3109/17483107.2016.1166527; Goudreau Johanne, 2009, Int J Nurs Educ Scholarsh, V6, pArticle15, DOI 10.2202/1548-923X.1685; Grupo de Gestion en Discapacidad Oficina de Promocion Social, 2014, LIN NAC REH BAS COM; Hinchcliff R, 2014, INT J QUAL HEALTH C, V26, P124, DOI 10.1093/intqhc/mzu009; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; International Association for Humanitarian Policy and Conflict Research, EMP PERS DIS PEAC BU; International Classification of Functioning DaH, 2017, ICF WORKSH 2017; Jaeger RG, 1998, HERPETOLOGICA, V54, pS64; Khan F, 2018, J REHABIL MED, V50, P358, DOI 10.2340/16501977-2207; Khan F, 2017, J REHABIL MED, V49, P10, DOI 10.2340/16501977-2149; Khan F, 2015, J REHABIL MED, V47, P688, DOI 10.2340/16501977-1995; Luft J., 1955, P W TRAIN LAB GROUP; Mahler Cornelia, 2014, GMS Z Med Ausbild, V31, pDoc40, DOI 10.3205/zma000932; McSweeney E, 2019, DISABIL REHABIL-ASSI, V14, P33, DOI 10.1080/17483107.2017.1392621; Moore CG, 2011, CTS-CLIN TRANSL SCI, V4, P332, DOI 10.1111/j.1752-8062.2011.00347.x; Munera S, 2017, AFR J DISABIL, V6, DOI 10.4102/ajod.v6i0.360; Nemoto T, 2014, JALT2013; O'Brien L, 2015, J CONTIN EDUC HEALTH, V35, P46, DOI 10.1002/chp.21262; O'Sullivan C, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00107; Organizacion Mundial de la Salud, 2014, PAQ CAP SERV SILL RU; Pascal MR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00143; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rincon AR, 2007, LINEAMIENTOS OTORGAM, P107; Roach V, 2006, SATISFACTION ONLINE, V5; Schiappa V, 2018, 34 INT SEAT S VANC B; Sheldon S., 2007, PROSTHET ORTHOT INT, V31, P217; Simons Gary F., 2018, ETHNOLOGUE LANGUAGES, V21st; Stang-Alva MF, 2011, PERSONAS CON DISCAPA; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; Sullivan Gail M, 2011, J Grad Med Educ, V3, P119, DOI 10.4300/JGME-D-11-00075.1; Tait AR, 2015, PEDIATR ANESTH, V25, P656, DOI 10.1111/pan.12680; Taylor DCM, 2013, MED TEACH, V35, pE1561, DOI 10.3109/0142159X.2013.828153; Toro ML, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1268-y; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; Visagie S, 2013, AFR J DISABIL, V2, DOI 10.4102/ajod.v2i1.63; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Bank, 2018, DIS INCL 2018; World Bank, 2018, WORLD BANK COUNTR LE; World Bank, 2016, WORLD DEV IND POP 20; World Economic Forum, 2018, THES AR WORLDS MOST; World Health Organization, 2015, WHO GLOB DIS ACT PLA; World Health Organization, 2018, WHEELCH SERV TRAIN T; World Health Organization, 2015, WORLD MAL REP 2015 K, px; World Health Organization (WHO) & USAID, 2013, WHEELCH SERV TRAIN P; Worldometers, COUNTR LAT AM CAR WO; Worldometers, 2018, LAT AM CAR POP 2018; Yarber L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1224-2	68	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204769	10.1371/journal.pone.0204769	http://dx.doi.org/10.1371/journal.pone.0204769			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286127	Green Submitted, gold, Green Published			2022-12-27	WOS:000446383500039
J	Machado, MC; da Costa-Neto, JM; Portela, RD; D'Assis, MJMH; Martins, OA; Barrouin-Melo, SM; Borges, NF; Silva, FL; Estrela-Lima, A				Machado, Marilia Carneiro; da Costa-Neto, Joao Moreira; Portela, Ricardo Dias; Melhor Heine D'Assis, Mario Jorge; Martins-Filho, Olindo Assis; Barrouin-Melo, Stella Maria; Borges, Natalie Ferreira; Silva, Fabiana Lessa; Estrela-Lima, Alessandra			The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma	PLOS ONE			English	Article							LOW-DOSE NALTREXONE; REGULATORY T-CELL; CANCER; RECEPTORS; PAIN	The objective of this study was to evaluate the effect of low-dose naltrexone (LDN) as a carboplatin chemotherapy-associated drug in female dogs with mammary carcinoma in benign mixed tumors (MC-BMT) after mastectomy and to assess its association with quality of life and survival rates. Sixty female dogs were included in this study, all of which had histopathological diagnosis of MC-BMT and were divided into three groups: G1 (control), consisting of animals submitted only to mastectomy with or without regional metastasis; G2, composed of treated animals that did not present with metastasis; and G3, treated dogs that presented with metastasis. G2 and G3 were also subdivided according to the treatment administered: chemotherapy alone (MC-BMT(-) C/MC-BMT(+) C) or LDN and chemotherapy (MC-BMT(-) C+LDN/MC-BMT(+) C+LDN). All animals were subjected to clinical evaluation, mastectomy, peripheral blood lymphocyte immunophenotyping, beta-endorphin and met-enkephalin quantification, and evaluation of survival rates and quality of life scores. The results showed higher serum concentrations of beta-endorphin and met-enkephalin, fewer chemotherapy-related side effects, and better quality of life and survival rates in the LDN-treated groups than in LDN-untreated groups (P<0.05). Evaluation of clinical and pathological parameters indicated a significant association between the use of LDN and both prolonged survival and enhanced quality of life. These results indicate that LDN is a viable chemotherapy-associated treatment in female dogs with MC-BMT, maintaining their quality of life and prolonging survival rates.	[Machado, Marilia Carneiro; da Costa-Neto, Joao Moreira; Melhor Heine D'Assis, Mario Jorge; Barrouin-Melo, Stella Maria; Estrela-Lima, Alessandra] Univ Fed Bahia, Dept Anat, Pathol Clin, Salvador, BA, Brazil; [Machado, Marilia Carneiro; da Costa-Neto, Joao Moreira; Melhor Heine D'Assis, Mario Jorge; Barrouin-Melo, Stella Maria; Estrela-Lima, Alessandra] Univ Fed Bahia, Dept Anat, Vet Clin, Salvador, BA, Brazil; [Portela, Ricardo Dias] Univ Fed Bahia, Inst Hlth Sci, Lab Immunol & Mol Biol, Salvador, BA, Brazil; [Martins-Filho, Olindo Assis] Fundacao Oswaldo Cruz, Res Ctr Rene Rachou, Lab Diagnost & Monitoring Biomarkers, Belo Horizonte, MG, Brazil; [Borges, Natalie Ferreira] Fed Univ Reconcavo da Bahia, Ctr Agr Environm & Biol Sci, Cruz Das Almas, BA, Brazil; [Silva, Fabiana Lessa] Estadual Univ Santa Cruz, Dept Agr & Environm Sci, Ilheus, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Fundacao Oswaldo Cruz	Estrela-Lima, A (corresponding author), Univ Fed Bahia, Dept Anat, Pathol Clin, Salvador, BA, Brazil.; Estrela-Lima, A (corresponding author), Univ Fed Bahia, Dept Anat, Vet Clin, Salvador, BA, Brazil.	alestrela@gmail.com	Estrela-Lima, Alessandra/AAL-2745-2021; Martins-Filho, Olindo Assis/ABE-6278-2021; Barrouin-Melo, Stella Maria/B-5152-2013; Silva, Fabiana/GWU-9143-2022; Portela, RW/H-5638-2013; Portela, Ricardo/W-1794-2019	Estrela-Lima, Alessandra/0000-0002-9879-7999; Martins-Filho, Olindo Assis/0000-0002-5494-4889; Barrouin-Melo, Stella Maria/0000-0003-3501-7366; Portela, RW/0000-0001-9095-776X; Portela, Ricardo/0000-0001-9095-776X; Carneiro de Araujo Machado, Marilia/0000-0002-6867-4576	Foundation for Research Support of Bahia State (FAPESB) [3538/2013]	Foundation for Research Support of Bahia State (FAPESB)	This work was supported by the Foundation for Research Support of Bahia State (FAPESB - grant 3538/2013). The authors are profoundly grateful to the Program of Postgraduate Studies in Tropical Animal Science (PPgCAT). Marilia Carneiro Machado is a Master fellow from the Coordination on Higher Education Personnel Improvement (CAPES). Alessandra Estrela-Lima and Olindo Assis Martins-Filho are research fellows from National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, VET COMP ONCOL, V14, P417, DOI 10.1111/vco.283; Araujo MSS, 2008, VACCINE, V26, P2211, DOI 10.1016/j.vaccine.2008.02.044; Berkson BM, 2006, INTEGR CANCER THER, V5, P83, DOI 10.1177/1534735405285901; Bidlack JM, 2000, CLIN DIAGN LAB IMMUN, V7, P719, DOI 10.1128/CDLI.7.5.719-723.2000; Brown N, 2009, MED HYPOTHESES, V72, P333, DOI 10.1016/j.mehy.2008.06.048; Cassali G. D., 2014, Brazilian Journal of Veterinary Pathology, V7, P38; Cassali Geovanni Dantas, 2013, BMC Proc, V7 Suppl 2, pK6, DOI 10.1186/1753-6561-7-S2-K6; Coles EH, 1986, VET CLIN PATHOL, P516; Damasceno KA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-195; Donahue RN, 2011, EXP BIOL MED, V236, P883, DOI 10.1258/ebm.2011.011096; Estrela-Lima A, 2012, BREAST CANCER RES TR, V131, P751, DOI 10.1007/s10549-011-1452-z; Estrela-Lima A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-256; Ferreira E, 2003, ARQ BRAS MED VET ZOO, V55, P105, DOI 10.1590/S0102-09352003000100017; HAZUM E, 1979, SCIENCE, V205, P1033, DOI 10.1126/science.224457; Lana SE, 2013, WITHROW MACEWENS SMA, P619; Lavalle GE, 2012, IN VIVO, V26, P375; Lee MW, 2009, EXPERT OPIN PHARMACO, V10, P1841, DOI 10.1517/14656560903048959; Metze D, 1999, J AM ACAD DERMATOL, V41, P533, DOI 10.1016/S0190-9622(99)80048-6; Misdorp W., 2002, Tumors in domestic animals, P575, DOI 10.1002/9780470376928.ch12; Moretti P, 2017, VET COMP ONCOL, V15, P215, DOI 10.1111/vco.12156; Oun R, 2018, DALTON T, V47, P6645, DOI 10.1039/c8dt00838h; Owen L. N., 1980, TNM classification of tumours in domestic animals.; Philibert JC, 2003, J VET INTERN MED, V17, P102, DOI 10.1111/j.1939-1676.2003.tb01330.x; Salas Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127381; Shafiee R, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-79; Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x; Sontas BH, 2012, REPROD DOMEST ANIM, V47, P125, DOI 10.1111/j.1439-0531.2011.01810.x; Sorenmo K, 2003, VET CLIN N AM-SMALL, V33, P573, DOI 10.1016/S0195-5616(03)00020-2; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Yazbek KVB, 2005, JAVMA-J AM VET MED A, V226, P1354, DOI 10.2460/javma.2005.226.1354; Yoo KY, 2001, CANCER LETT, V167, P57, DOI 10.1016/S0304-3835(01)00463-3; Zagon IS, 2005, NEUROPEPTIDES, V39, P495, DOI 10.1016/j.npep.2005.07.001	33	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204830	10.1371/journal.pone.0204830	http://dx.doi.org/10.1371/journal.pone.0204830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286124	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500047
J	Reid, LEM; Pretsch, U; Jones, MC; Lone, NI; Weir, CJ; Morrison, Z				Reid, Lindsay E. M.; Pretsch, Ursula; Jones, Michael C.; Lone, Nazir, I; Weir, Christopher J.; Morrison, Zoe			The acute medical unit model: A characterisation based upon the National Health Service in Scotland	PLOS ONE			English	Article							ADMISSIONS; TIME	Background Acute medical units (AMUs) receive the majority of acute medical patients presenting to hospital as an emergency in the United Kingdom (UK) and in other international settings. They have emerged as a result of local service innovation in the context of a limited evidence base. As such, the AMU model is not well characterised in terms of its boundaries, patient populations and components of care. This makes service optimisation and development through strategic resource planning, quality improvement and research challenging. Aim This study aims to evaluate a national set of AMUs with the intent of characterising the AMU model. Methods Twenty-nine AMUs in Scotland were identified. Data were collected by semi-structured interviews with multidisciplinary healthcare professionals working in each AMU. A draft report was produced for each unit and verified by a unit representative. The unit reports were then analysed to develop a conceptual framework of key components of AMUs and a service definition of the boundaries of acute medical care. Results Acute medical care in Scotland can be described as being delivered in "acute medical services" rather than geographically distinct AMUs. Twelve key components of AMU care were identified: care areas, functions, populations, patient flow, support services, communication, nurse care, allied healthcare professional care, non-consultant medical care, consultant care, patient assessment and specialty care. Discussion This empirically derived characterisation of the AMU model is likely to be of utility to practitioners, managers, policy makers and researchers: it is relevant on an operational level, will aid quality improvement and is a foundation to needed further research into how best to deliver care in AMUs. This is important given the central role AMUs play in the journey of the majority of patients presenting to hospital acutely in Scotland, the UK and internationally.	[Reid, Lindsay E. M.] Ko Awatea Hlth Syst Innovat & Improvement, Dev & Delivery Dept, Auckland, New Zealand; [Reid, Lindsay E. M.; Pretsch, Ursula; Jones, Michael C.] Royal Coll Phys Edinburgh, Qual Res & Stand, Edinburgh, Midlothian, Scotland; [Reid, Lindsay E. M.; Lone, Nazir, I; Weir, Christopher J.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Weir, Christopher J.] Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Weir, Christopher J.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Morrison, Zoe] Univ Aberdeen, Business Sch, Aberdeen, Scotland	University of Edinburgh; University of Edinburgh; University of Aberdeen	Reid, LEM (corresponding author), Ko Awatea Hlth Syst Innovat & Improvement, Dev & Delivery Dept, Auckland, New Zealand.; Reid, LEM (corresponding author), Royal Coll Phys Edinburgh, Qual Res & Stand, Edinburgh, Midlothian, Scotland.; Reid, LEM (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.	Lindsay.Reid@nhs.net		Weir, Christopher/0000-0002-6494-4903; Lone, Nazir I/0000-0003-2707-2779	Scottish Government; Royal College of Physicians of Edinburgh; NHS Lothian via the Edinburgh Clinical Trials Unit	Scottish Government; Royal College of Physicians of Edinburgh; NHS Lothian via the Edinburgh Clinical Trials Unit	This work was funded by the Scottish Government and The Royal College of Physicians of Edinburgh (MCJ). The Royal College of Physicians of Edinburgh had regular input into the study design, collection, analysis, decision to publish and preparation of the manuscript. The Scottish Government had input into the study design and data collection. CJW was supported in this work by NHS Lothian via the Edinburgh Clinical Trials Unit.	Acute Medicine Task Force, 2007, AC MED CAR RIGHT PER; Beckett DJ, 2009, EMERG MED J, V26, P878, DOI 10.1136/emj.2008.059295; Diepeveen BA, 2009, THESIS; Dowdle JR, 2004, EMERG MED J, V21, P652, DOI 10.1136/emj.2003.012211; Ilyas M, 2010, CLIN MED, V10, P304, DOI 10.7861/clinmedicine.10-3-304; Jayawarna C, 2010, J ROY COLL PHYS EDIN, V40, P201, DOI 10.4997/JRCPE.2010.303; Lewis, 2006, QUALITATIVE RES PRAC; Liamputtong P., 2019, QUALITATIVE RES METH, P9; McNeill GBS, 2011, INTERN MED J, V41, P19, DOI 10.1111/j.1445-5994.2010.02359.x; McNeill GBS, 2009, CLIN MED, V9, P214, DOI 10.7861/clinmedicine.9-3-214; Medical Research Council, 1998, MRC GUID GOOD CLIN P; Providence C, 2012, INTERN MED J, V42, P51, DOI 10.1111/j.1445-5994.2010.02331.x; Realdi G, 2011, INTERN EMERG MED, V6, P85, DOI 10.1007/s11739-011-0681-9; Reid LEM, 2018, QJM-INT J MED, V111, P515, DOI 10.1093/qjmed/hcx161; Reid LEM, 2015, ACUTE MED, V14, P61; Reid LEM, 2016, INT J QUAL HEALTH C, V28, P433, DOI 10.1093/intqhc/mzw056; Vork JC, 2011, DAN MED BULL, V58; Ward D, 2009, CLIN MED, V9, P553, DOI 10.7861/clinmedicine.9-6-553; Watts M, 2011, Ir Med J, V104, P47; West Midlands Urgent Care Pathway Group, 2012, QUAL STAND AC MED UN	20	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204010	10.1371/journal.pone.0204010	http://dx.doi.org/10.1371/journal.pone.0204010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281643	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400037
J	Dhall, S; Sathyamoorthy, M; Kuang, JQ; Hoffman, T; Moorman, M; Lerch, A; Jacob, V; Sinclair, SM; Danilkovitch, A				Dhall, Sandeep; Sathyamoorthy, Malathi; Kuang, Jin-Qiang; Hoffman, Tyler; Moorman, Matthew; Lerch, Anne; Jacob, Vimal; Sinclair, Steven Michael; Danilkovitch, Alla			Properties of viable lyopreserved amnion are equivalent to viable cryopreserved amnion with the convenience of ambient storage	PLOS ONE			English	Article							MEMBRANE TRANSPLANTATION; PLACENTAL MEMBRANE; SOLUBLE FACTORS; CELLS; LYOPHILIZATION; PRESERVATION; PLATELETS; QUALITY	Human amniotic membrane (AM) has a long history of clinical use for wound treatment. AM serves as a wound protective barrier maintaining proper moisture. AM is anti-inflammatory, anti-microbial and antifibrotic, and supports angiogenesis, granulation tissue formation and wound re-epithelialization. These properties of AM are attributed to its native extracellular matrix, growth factors, and endogenous cells including mesenchymal stem cells. Advances in tissue preservation have helped to overcome the short shelf life of fresh AM and led to the development of AM products for clinical use. Viable cryopreserved amnion (VCAM), which retains all native components of fresh AM, has shown positive outcomes in clinical trials for wound management. However, cryopreservation requires ultra-low temperature storage and shipment that limits widespread use of VCAM. We have developed a lyopreservation technique to allow for ambient storage of living tissues. Here, we compared the structural, molecular, and functional properties of a viable lyopreserved human amniotic membrane (VLAM) with properties of VCAM using in vitro and in vivo wound models. We found that the structure, growth factors, and cell viability of VLAM is similar to that of VCAM and fresh AM. Both, VCAM and VLAM inhibited TNF-alpha secretion and upregulated VEGF expression in vitro under conditions designed to mimic inflammation and hypoxia in a wound microenvironment, and resulted in wound closure in a diabetic mouse chronic wound model. Taken together, these data demonstrate that VLAM structural and functional properties are equivalent to VCAM but without the constraints of ultra-low temperature storage.	[Dhall, Sandeep; Sathyamoorthy, Malathi; Kuang, Jin-Qiang; Hoffman, Tyler; Moorman, Matthew; Lerch, Anne; Jacob, Vimal; Sinclair, Steven Michael; Danilkovitch, Alla] Osiris Therapeut Inc, Columbia, MD 21046 USA	Osiris Therapeutics	Dhall, S (corresponding author), Osiris Therapeut Inc, Columbia, MD 21046 USA.	sdhall@osiris.com		moorman, matthew/0000-0001-8236-9546	Osiris Therapeutics Inc.	Osiris Therapeutics Inc.	All authors are full time paid employees of Osiris Therapeutics Inc.	Allen CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078441; Bissoyi A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3604203; Boothby TC, 2017, MOL CELL, V65, P975, DOI 10.1016/j.molcel.2017.02.018; Breitkreutz D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/179784; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; BURGOS H, 1983, EUR J CLIN INVEST, V13, P289, DOI 10.1111/j.1365-2362.1983.tb00103.x; Capriotti Kara, 2012, J Clin Aesthet Dermatol, V5, P24; Casillo A, 2017, CARBOHYD POLYM, V156, P364, DOI 10.1016/j.carbpol.2016.09.037; Castellanos G, 2017, PLACENTA, V59, P146, DOI 10.1016/j.placenta.2017.04.005; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Damsteegt EL, 2016, ANAL BIOCHEM, V511, P92, DOI 10.1016/j.ab.2016.08.005; de L Janz F, 2012, J BIOMED BIOTECHNOL, V2012, P1, DOI [10.1155/2012/649353, DOI 10.1155/2012/649353]; Dehghani Mehdi, 2017, Bull Emerg Trauma, V5, P249, DOI 10.18869/acadpub.beat.5.4.452.; Dhall S, 2018, WOUND REPAIR REGEN, V26, pA1, DOI [10.1111/wrr.12622, DOI 10.1111/WRR.12622]; Dhall S, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/562625; Duan-Arnold Y, 2015, ADV WOUND CARE, V4, P523, DOI 10.1089/wound.2015.0636; Duan-Arnold Y, 2015, ADV WOUND CARE, V4, P513, DOI 10.1089/wound.2015.0638; Duan-Arnold Y, 2015, ADV WOUND CARE, V4, P329, DOI 10.1089/wound.2015.0637; Dwarshuis NJ, 2017, ADV DRUG DELIVER REV, V114, P222, DOI 10.1016/j.addr.2017.06.005; ElHeneidy H, 2016, INT J WOMENS HEALTH, V8, P225, DOI 10.2147/IJWH.S96636; Elliott GD, 2017, CRYOBIOLOGY, V76, P74, DOI 10.1016/j.cryobiol.2017.04.004; Eskandarlou M, 2016, WORLD J PLAST SURG, V5, P39; Fairbairn NG, 2014, J PLAST RECONSTR AES, V67, P662, DOI 10.1016/j.bjps.2014.01.031; Frykberg RG, 2017, INT WOUND J, V14, P569, DOI 10.1111/iwj.12649; Gibbons GW, 2015, ADV WOUND CARE, V4, P534, DOI 10.1089/wound.2015.0647; Gupta RJ, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001638; Hara M, 2017, J PLANT PHYSIOL, V210, P18, DOI 10.1016/j.jplph.2016.12.003; HAYNES WC, 1955, APPL MICROBIOL, V3, P361, DOI 10.1128/AEM.3.6.361-368.1955; Jirsova K, 2017, CELL TISSUE BANK, V18, P193, DOI 10.1007/s10561-017-9618-5; Johnson A, 2017, ANN PLAS SURG, V79, P203, DOI 10.1097/SAP.0000000000001101; Johnson Eric L, 2016, J Am Coll Clin Wound Spec, V8, P31, DOI 10.1016/j.jccw.2017.09.001; Johnson EL, 2017, WOUND REPAIR REGEN, V25, P145, DOI 10.1111/wrr.12503; Kanias T, 2006, MAMMALIAN CELL DESIC, P4, DOI [10.1089/cpt.2006.9996, DOI 10.1089/CPT.2006.9996]; Kanias T, 2010, FEBS J, V277, P343, DOI 10.1111/j.1742-4658.2009.07472.x; Kitala D, 2017, STEM CELLS DEV, V26, P694, DOI 10.1089/scd.2016.0198; Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012; Kubo M, 2015, IMMUNOGENICITY HUMAN, p1539 ; Lavery LA, 2014, INT WOUND J, V11, P554, DOI 10.1111/iwj.12329; Loi P, 2008, REPROD DOMEST ANIM, V43, P417, DOI 10.1111/j.1439-0531.2008.01193.x; Mao Y, 2018, J FUNCT BIOMATER, V9, DOI 10.3390/jfb9010003; Mao Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13310-6; Nakamura T, 2008, BIOMATERIALS, V29, P3729, DOI 10.1016/j.biomaterials.2008.05.023; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Nishishita T, 2004, BIOCHEM BIOPH RES CO, V325, P24, DOI 10.1016/j.bbrc.2004.10.003; Perepelkin NMJ, 2016, CELL TISSUE BANK, V17, P39, DOI 10.1007/s10561-015-9530-9; Polo L, 2017, J APPL MICROBIOL, V122, P1603, DOI 10.1111/jam.13465; Rama Paolo, 2001, Cell and Tissue Banking, V2, P155, DOI 10.1023/A:1020158206073; Ramuta TZ, 2018, CELL TRANSPLANT, V27, P77, DOI 10.1177/0963689717725528; Raspovic KM, 2018, WOUND REPAIR REGEN, V26, P213, DOI 10.1111/wrr.12635; READ MS, 1995, P NATL ACAD SCI USA, V92, P397, DOI 10.1073/pnas.92.2.397; Rebecchi L, 2007, ISJ-INVERT SURVIV J, V4, P65; Regulski M, 2013, OSTOMY WOUND MANAG, V59, P38; Sant'Anna LB, 2016, CELL TRANSPLANT, V25, P2245, DOI 10.3727/096368916X692645; Shimmura S, 2001, CORNEA, V20, P408, DOI 10.1097/00003226-200105000-00015; Silini A, 2013, CURR STEM CELL RES T, V8, P6, DOI 10.2174/1574888X11308010003; Singh A, 2017, J BASIC MICROB, V57, P770, DOI 10.1002/jobm.201700182; Stern M, 1913, J AMER MED ASSOC, V60, P973, DOI 10.1001/jama.1913.04340130021008; Sun M, 2016, MAT SCI ENG C-MATER, V60, P60, DOI 10.1016/j.msec.2015.10.057; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Witherel CE, 2017, CELL MOL BIOENG, V10, P451, DOI 10.1007/s12195-017-0494-7; Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306; Yuan ZQ, 2016, CYTOTHERAPY, V18, P860, DOI 10.1016/j.jcyt.2016.04.005; Zare-Bidaki Majid, 2017, J Reprod Infertil, V18, P218; Zhang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06542-z; Zhang SZ, 2010, J ZHEJIANG UNIV-SC B, V11, P889, DOI 10.1631/jzus.B1000184; Zheng YJ, 2017, BIOMATERIALS, V113, P56, DOI 10.1016/j.biomaterials.2016.10.031	68	21	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204060	10.1371/journal.pone.0204060	http://dx.doi.org/10.1371/journal.pone.0204060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278042	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200009
J	Hoover, KC				Hoover, Kara C.			Intragenus (Homo) variation in a chemokine receptor gene (CCR5)	PLOS ONE			English	Article							WEST-NILE-VIRUS; GENOME SEQUENCE; INFECTIOUS-DISEASE; HIV-1 INFECTION; FUSION COFACTOR; CLIMATE-CHANGE; EVOLUTION; NEANDERTHAL; RESISTANCE; ORIGIN	Humans have a comparatively higher rate of more polymorphisms in regulatory regions of the primate CCR5 gene, an immune system gene with both general and specific functions. This has been interpreted as allowing flexibility and diversity of gene expression in response to varying disease loads. A broad expression repertoire is useful to humans-the only globally distributed primate-due to our unique adaptive pattern that increased pathogen exposure and disease loads (e.g., sedentism, subsistence practices). The main objective of the study was to determine if the previously observed human pattern of increased variation extended to other members of our genus, Homo. The data for this study are mined from the published genomes of extinct hominins (four Neandertals and two Denisovans), an ancient human (Ust'-Ishim), and modern humans (1000 Genomes). An average of 15 polymorphisms per individual were found in human populations (with a total of 262 polymorphisms). There were 94 polymorphisms identified across extinct Homo (an average of 13 per individual) with 41 previously observed in modern humans and 53 novel polymorphisms (32 in Denisova and 21 in Neandertal). Neither the frequency nor distribution of polymorphisms across gene regions exhibit significant differences within the genus Homo. Thus, humans are not unique with regards to the increased frequency of regulatory polymorphisms and the evolution of variation patterns across CCR5 gene appears to have originated within the genus. A broader evolutionary perspective on regulatory flexibility may be that it provided an advantage during the transition to confrontational foraging (and later hunting) that altered human-environment interaction as well as during migration to Eurasia and encounters with novel pathogens.	[Hoover, Kara C.] Univ Alaska Fairbanks, Dept Anthropol, Fairbanks, AK 99775 USA; [Hoover, Kara C.] Univ Alaska Fairbanks, Biochem & Mol Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Hoover, KC (corresponding author), Univ Alaska Fairbanks, Dept Anthropol, Fairbanks, AK 99775 USA.; Hoover, KC (corresponding author), Univ Alaska Fairbanks, Biochem & Mol Biol, Fairbanks, AK 99775 USA.	kchoover@alaska.edu		Hoover, Kara C./0000-0001-6394-930X				Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Abrantes J, 2011, CONSERV GENET, V12, P325, DOI 10.1007/s10592-009-9990-1; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alkhatib G, 1997, NATURE, V388, P238, DOI 10.1038/40789; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angelici, 2016, PROBLEMATIC WILDLIFE, P507, DOI [10.1007/978-3-319-22246-2_24, DOI 10.1007/978-3-319-22246-2_24]; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Berens AJ, 2017, HUM BIOL OCEANIA, V89; Brantingham PJ, 1998, J ANTHROPOL ARCHAEOL, V17, P327, DOI 10.1006/jaar.1998.0326; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brinkworth JF, 2017, HUM BIOL, V89, P47, DOI 10.13110/humanbiology.89.1.03; Carmo CR, 2006, IMMUNOGENETICS, V58, P494, DOI 10.1007/s00251-006-0095-4; Carrington M, 1997, AM J HUM GENET, V61, P1261, DOI 10.1086/301645; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Chen MF, 2017, P NATL ACAD SCI USA, V114, P8089, DOI 10.1073/pnas.1620664114; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; de Heinzelin J, 1999, SCIENCE, V284, P625; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Diamond MS, 2006, TRENDS MICROBIOL, V14, P287, DOI 10.1016/j.tim.2006.05.004; Dominguez-Rodrigo M, 2003, EVOL ANTHROPOL, V12, P275, DOI 10.1002/evan.10119; Dominguez-Rodrigo M, 2002, J WORLD PREHIST, V16, P1, DOI 10.1023/A:1014507129795; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dudley JP, 2015, ECOHEALTH, V12, P713, DOI 10.1007/s10393-015-1036-1; Essig A, 2014, J BIOL CHEM, V289, P34953, DOI 10.1074/jbc.M114.599878; Esteves PJ, 2007, INT J IMMUNOGENET, V34, P321, DOI 10.1111/j.1744-313X.2007.00716.x; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2016, ANTIQUITY, V90, P1373, DOI 10.15184/aqy.2016.134; Hardy K, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-016-1420-x; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Holmes EC, 2001, BIOL REV, V76, P239, DOI 10.1017/S1464793101005668; Hoover KC, 2016, WIRES CLIM CHANGE, V7, P283, DOI 10.1002/wcc.382; Hu Y, 2015, BIORXIV; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Hummel S, 2005, GENES IMMUN, V6, P371, DOI 10.1038/sj.gene.6364172; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691; Limborska SA, 2002, HUM HERED, V53, P49, DOI 10.1159/000048605; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; Marciniak S, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.65; Mecsas J, 2004, NATURE, V427, P606, DOI 10.1038/427606a; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moleon M, 2014, BIOSCIENCE, V64, P394, DOI 10.1093/biosci/biu034; Mossoun A, 2017, J VIROL, V91, DOI [10.1128/JVI.02479-16, 10.1128/jvi.02479-16]; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mummidi S, 1997, J BIOL CHEM, V272, P30662, DOI 10.1074/jbc.272.49.30662; Niemitz C, 2010, NATURWISSENSCHAFTEN, V97, P241, DOI 10.1007/s00114-009-0637-3; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Perelygin AA, 2008, J HERED, V99, P500, DOI 10.1093/jhered/esn029; Pimenoff VN, 2017, MOL BIOL EVOL, V34, P4, DOI 10.1093/molbev/msw214; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quintana-Murci L, 2016, CR BIOL, V339, P278, DOI 10.1016/j.crvi.2016.04.005; Racimo F, 2017, MOL BIOL EVOL, V34, P296, DOI 10.1093/molbev/msw216; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Ribeiro Ieda P., 2005, Infection Genetics and Evolution, V5, P271, DOI 10.1016/j.meegid.2004.07.009; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; SHIPMAN P, 1981, CURR ANTHROPOL, V22, P257, DOI 10.1086/202663; Slon V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700186; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Steve AM, 2017, ECOHEALTH, V14, P100, DOI 10.1007/s10393-016-1202-0; Temme S, 2014, J BIOL CHEM, V289, P639, DOI 10.1074/jbc.M113.515767; Van Vliet N, 2017, ETHNOBIOL CONSERV, V6, DOI 10.15451/ec2017-04-6.3-1-45; Vazquez-Salat N, 2007, GENOMICS, V90, P213, DOI 10.1016/j.ygeno.2007.04.009; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Winder IC, 2015, J HUM EVOL, V87, P48, DOI 10.1016/j.jhevol.2015.07.002; Zhang YW, 1999, MOL BIOL EVOL, V16, P1145, DOI 10.1093/oxfordjournals.molbev.a026205; Zhang YW, 2003, MOL BIOL EVOL, V20, P1722, DOI 10.1093/molbev/msg198; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	93	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204989	10.1371/journal.pone.0204989	http://dx.doi.org/10.1371/journal.pone.0204989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278065	Green Submitted, Green Published, gold			2022-12-27	WOS:000446010200031
J	Ansaripour, A; Zendehdel, K; Tadayon, N; Sadeghi, F; Uyl-de Groot, CA; Redekop, WK				Ansaripour, Amir; Zendehdel, Kazem; Tadayon, Niki; Sadeghi, Fatemeh; Uyl-de Groot, Carin A.; Redekop, W. Ken			Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; TRASTUZUMAB; TRIAL	Introduction Patient registries play an important role in obtaining real-world evidence of the cost-effectiveness of treatments. However, their implementation is costly and sometimes infeasible in many middle-income countries (MICs). We explored the combination of data-mining and a large claims database to estimate the direct healthcare costs of HER2-positive breast cancer (BC) treatment in Iran and the fraction of total costs from trastuzumab use. Method We performed a retrospective analysis of claims data from the Iran Social Security Organization, a health insurer which covers approximately 50%(-40 million) of the Iranian population, in the period of 21/03/2011-20/03/2014. A data-mining algorithm using R software and validated using patient dossiers in the Cancer Research Center identified 1295 patients and divided them into the three main HER2-positive breast cancer stages (early, loco-regional and advanced). A payer perspective was used to calculate the absolute and relative direct costs of healthcare services associated with the treatment of HER2-positive breast cancer in the public and private healthcare systems. Results The number of women totaled 802 (early), 125 (loco-regional) and 218 (advanced). The mean age[SD] was 45[10], 46[10] and 48[10] years, respectively, while mean follow-up in all stages was approximately one year. Average costs of direct healthcare care in early, loco-regional and advanced stages were (sic)11,796 (95%CI: (sic)9,356-(sic)12,498), (sic)8,253 (95% CI: (sic)6,843-(sic)10,002), and (sic)17,742 (95%CI: (sic)15,720-(sic)19,505), respectively. Trastuzumab accounted for the largest share of total costs in all three stages (range: 53-76%). Conclusion Wherever comprehensive patient registries are infeasible or costly, real-world costs can be estimated through claims databases and data-mining strategies. Using this method, real-world costs have been estimated in Iran. The stage-specific cost estimates derived from this study can be used to perform real-world cost-effectiveness analyses of therapies for HER2-positive BC and support healthcare financing decisions.	[Ansaripour, Amir; Uyl-de Groot, Carin A.; Redekop, W. Ken] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Zendehdel, Kazem; Sadeghi, Fatemeh] Univ Tehran Med Sci, Canc Res Ctr, Canc Inst Iran, Tehran, Iran; [Tadayon, Niki] Shahid Beheshti Univ Med Sci, Shohadaye Tajrish Med Ctr, Dept Gen & Vasc Surg, Tehran, Iran	Erasmus University Rotterdam; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Ansaripour, A (corresponding author), Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands.	ansaripour@eshpm.eur.nl	Ansaripour, Amir/AAI-5719-2021; tadayon, niki/AAZ-3631-2020; Redekop, Ken/AAA-2423-2020	Ansaripour, Amir/0000-0002-9298-6393; tadayon, niki/0000-0001-9431-4411; Zendehdel, Kazem/0000-0002-0269-4945; Redekop, Ken/0000-0001-9538-4083				[Anonymous], 2016, NEWS REPORT PHYS PRI; [Anonymous], 2016, GLOBOCAN 2012; Ansaripour A, 2016, J Cancer Policy, V9, P8, DOI 10.1016/j.jcpo.2016.05.005; Ansaripour Amir, 2014, Value Health Reg Issues, V3, P174, DOI 10.1016/j.vhri.2014.04.010; CRNN, 2012, GUID PRESCR TRAST PR; Daroudi R, 2015, IRAN J PUBLIC HEALTH, V44, P1225; Davari M, 2013, INT J PREVENTIVE MED, V4, P748; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Freitas AA., 2013, DISCOVERY DATA MININ; Gradishar Wj, 2014, NCCN CLIN PRACTICE G; Iran Social Security Organization, 1392 IR SOC SEC ORG; Iranian Government, 2013, DET DIAGN THER SERV; Jazayeri SB, 2015, CANCER EPIDEMIOL, V39, P519, DOI 10.1016/j.canep.2015.04.016; Larose DT., 2004, ANONYMOUS DISCOVERIN, P180; Larose DT., 2004, DISCOVERING KNOWLEDG, P147; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mousavi SM, 2007, BREAST J, V13, P383, DOI 10.1111/j.1524-4741.2007.00446.x; Paik S, 2000, J NATL CANCER I, V92, P1991, DOI 10.1093/jnci/92.24.1991; Parsa M, 2015, IRAN J PUBLIC HEALTH, V44, P79; Pivot X, 2013, LANCET ONCOL, V14, P741, DOI 10.1016/S1470-2045(13)70225-0; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; SSO, GEN STAT REP SOC SEC; Team RC., 2013, R LANG ENV STAT COMP; Vera-Llonch M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-250; Vostakolaei FA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/517976; World Health Organization, 2016, BREAST CANC PREV CON; World Health Organization, 2006, GUID MAN BREAST CANC	27	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205079	10.1371/journal.pone.0205079	http://dx.doi.org/10.1371/journal.pone.0205079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273393	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700063
J	Loiselle, AR; de Kleine, E; van Dijk, P; Jansonius, NM				Loiselle, Allison R.; de Kleine, Emile; van Dijk, Pim; Jansonius, Nomdo M.			Noninvasive intracranial pressure assessment using otoacoustic emissions: An application in glaucoma	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPEN-ANGLE GLAUCOMA; MENIERES-DISEASE; HYPERTENSION; POSTURE	The theory that glaucoma patients have a lower intracranial pressure (ICP) than healthy subjects is a controversial one. The aim of this study was to assess ICP noninvasively by determining the relationship between distortion product otoacoustic emission (DPOAE) phase and body position and to compare this relationship between patients with primary open angle glaucoma (POAG), patients with normal tension glaucoma (NTG), and controls. The relationship was also calibrated using published data regarding invasive measurements of ICP versus body position. DPOAEs were measured in 30 controls and 32 glaucoma patients (17 POAG, 15 NTG) at the following body positions (assuming 90 degrees as upright): 45, 30, 20, 10, 0 (supine), -10, and -20 degrees. DPOAE phase had a clear, nonlinear relationship with body position. The mean DPOAE phase shifts between the two most extreme body positions (45 to -20 degrees) were 73.6, 80.7, and 66.3 degrees for healthy, POAG, and NTG, respectively (P = 0.73), and the groups showed the same, nonlinear behaviour. This indicates that there is no evidence that glaucoma patients have a reduced ICP. When calibrated with invasive data, ICP and DPOAE phase were linearly related over an ICP of 3 mmHg. This suggests that, more broadly, DPOAEs could be used in the future to monitor changes in ICP in a clinical setting and to measure dynamic changes in ICP such as diurnal fluctuations or changes induced by certain medications.	[Loiselle, Allison R.; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Loiselle, Allison R.; de Kleine, Emile; van Dijk, Pim; Jansonius, Nomdo M.] Univ Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands; [de Kleine, Emile; van Dijk, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.; Jansonius, NM (corresponding author), Univ Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands.	n.m.jansonius@umcg.nl	Van Dijk, Pim/E-8019-2010; de Kleine, Emile/P-2350-2014	Van Dijk, Pim/0000-0002-8023-7571; Loiselle, Allison/0000-0003-2686-0634; de Kleine, Emile/0000-0001-9525-3032; Jansonius, Nomdo/0000-0002-6495-6568	European Union (EU) Horizon 2020 [661883]; Uitzicht [2015-11]	European Union (EU) Horizon 2020; Uitzicht	This study was funded by the European Union (EU) Horizon 2020 grant No 661883 European Glaucoma Research Training Program (EGRET) and by Uitzicht grant No 2015-11 (ANVVB, Glaucoomfonds, LSBS, Novartisfonds, Oogfonds, Stichting Blinden-Penning). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Avan P, 2011, HEARING RES, V277, P88, DOI 10.1016/j.heares.2011.03.006; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bershad EM, 2014, NEUROSURGERY, V75, P445, DOI 10.1227/NEU.0000000000000449; Buki B, 2000, HEARING RES, V140, P202, DOI 10.1016/S0378-5955(99)00202-6; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Chaaban MR, 2013, INT FORUM ALLERGY RH, V3, P718, DOI 10.1002/alr.21188; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; de Kleine E, 2000, J ACOUST SOC AM, V107, P3308, DOI 10.1121/1.429403; Flammer J, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-14; Gallina P, 2018, J NEUROSURG, V129, P1078, DOI 10.3171/2017.5.JNS163062; Gerenton G, 2015, HEARING RES, V327, P199, DOI 10.1016/j.heares.2015.07.016; GUCER G, 1978, J NEUROSURG, V49, P256, DOI 10.3171/jns.1978.49.2.0256; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Jonas JB, 2015, PROG BRAIN RES, V221, P33, DOI 10.1016/bs.pbr.2015.06.002; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; Linden C, 2018, OPHTHALMOLOGY, V125, P361, DOI 10.1016/j.ophtha.2017.09.022; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Pircher A, 2017, ACTA OPHTHALMOL, V95, pE524, DOI 10.1111/aos.13302; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Smith SV, 2017, HEADACHE, V57, P1303, DOI 10.1111/head.13144; Voss SE, 2010, HEARING RES, V263, P43, DOI 10.1016/j.heares.2010.03.003; Williams MA, 2016, AEROSP MED HUM PERF, V87, P844, DOI 10.3357/AMHP.4572.2016	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204939	10.1371/journal.pone.0204939	http://dx.doi.org/10.1371/journal.pone.0204939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273407	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700052
J	Tam, J; Hoffmann, T; Fischer, S; Bornstein, S; Grassler, J; Noack, B				Tam, Jonathan; Hoffmann, Thomas; Fischer, Sabine; Bornstein, Stefan; Graessler, Juergen; Noack, Barbara			Obesity alters composition and diversity of the oral microbiota in patients with type 2 diabetes mellitus independently of glycemic control	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; PERIODONTAL-DISEASE; INFLAMMATION; DEFINITIONS; ASSOCIATION; SENSITIVITY; GENETICS; DATABASE; HEALTH; WOMEN	Background and objective The involvement of the oral microbiota as a possible link between periodontitis, type 2 diabetes mellitus and obesity is still not well understood. The objective of the study was to investigate if glycemic control and obesity play a role in modulating the composition and diversity of the oral microbial ecology. Material and methods A cohort of patients with type 2 diabetes mellitus (n = 18) was recruited. Participants demonstrating improved glycemic control after 3 months (n = 6) were included in a second examination. A full mouth examination was performed to estimate periodontitis severity followed by sample collection (subgingival plaque and saliva). Generation of large sequence libraries was performed using the high-throughput Illumina MiSeq sequencing platform. Results The majority of participants (94.4%, n = 17) presented with moderate or severe forms of periodontitis. Differences in microbial composition and diversity between obese (BMI >= 30 kg/m(2)) and non-obese (BMI < 30 kg/m(2)) groups were statistically significant. Cross-sectional and longitudinal approaches failed to reveal statistically significant associations between HbA(1c) level and species composition or diversity. Conclusions Obesity was significantly associated with the oral microbial composition. The impact of glycemic control on oral microbiota, however, could not be assured statistically.	[Tam, Jonathan; Hoffmann, Thomas; Noack, Barbara] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Periodontol, Dresden, Germany; [Fischer, Sabine; Bornstein, Stefan; Graessler, Juergen] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept & Outpatient Dept Med 3, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Noack, B (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Periodontol, Dresden, Germany.	barbara.noack@uniklinikum-dresden.de		Graessler, Juergen/0000-0003-3619-8517	Open Access Publication Funds of the SLUB/TU Dresden	Open Access Publication Funds of the SLUB/TU Dresden	The authors acknowledge support by the Open Access Publication Funds of the SLUB/TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chapple ILC, 2013, J CLIN PERIODONTOL, V40, pS106, DOI [10.1902/jop.2013.1340011, 10.1111/jcpe.12077]; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Crommen S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010010; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ganesan SM, 2017, ISME J, V11, P2075, DOI 10.1038/ismej.2017.73; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hall MW, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-016-0011-0; Hinkle D. E., 2003, APPL STAT BEHAV SCI, P109; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kodukula K, 2017, BIORESEARCH OPEN ACC, V6, P123, DOI 10.1089/biores.2017.0020; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lin SW, 2015, OBESITY, V23, P862, DOI 10.1002/oby.21020; Maciel SS, 2016, J CLIN PERIODONTOL, V43, P1003, DOI 10.1111/jcpe.12634; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Nakajima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134234; Noack B, 2013, J PERIODONTOL, V84, P614, DOI 10.1902/jop.2012.120062; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Polak D, 2018, J CLIN PERIODONTOL, V45, P150, DOI 10.1111/jcpe.12803; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shungin D, 2015, INT J EPIDEMIOL, V44, P638, DOI 10.1093/ije/dyv075; Silva-Boghossian CM, 2018, J PERIODONTOL, V89, P186, DOI 10.1002/JPER.17-0236; Talbott K, 1976, J PREV DENT, V4, P28; Taylor John J, 2013, J Periodontol, V84, pS113, DOI [10.1111/jcpe.12059, 10.1902/jop.2013.134005]; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Tsuda A, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.20; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang BH, 2017, ENGINEERING, V3, P71, DOI 10.1016/J.ENG.2017.01.008; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	51	40	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204724	10.1371/journal.pone.0204724	http://dx.doi.org/10.1371/journal.pone.0204724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273364	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700033
J	Annerer-Walcher, S; Korner, C; Benedek, M				Annerer-Walcher, Sonja; Koerner, Christof; Benedek, Mathias			Eye behavior does not adapt to expected visual distraction during internally directed cognition	PLOS ONE			English	Article							WORKING-MEMORY; PREFRONTAL CORTEX; MIND; PUPILLOMETRY; PERFORMANCE; DIFFICULTY; ATTENTION; DOPAMINE; THOUGHT; TASKS	When focused on a specific internal task like calculating a multiplication in mind we are able to ignore sensory distraction. This may be achieved by effective perceptual decoupling during internally directed cognition. The present study investigated whether decoupling from external events during internally directed cognition represents an active shielding mechanism that adapts to expected external distraction or a passive/automatic shielding mechanism that is independent of external distraction. Participants performed multiplications in mind (e.g. 26 x 7), a task that required to turn attention inward as soon as the problem was encoded. At the beginning of a block of trials, participants were informed whether or not distractors could appear during the calculation period, thereby potentially allowing them to prepare for the distractors. We tracked their eye behavior as markers of perceptual decoupling and workload. Turning attention inward to calculate the multiplication elicited evidence of perceptual decoupling for five of six eye parameters: blink rate, saccade and microsaccade rate increased, gaze was less constricted to the center, and pupils dilated. Although participants perceived blocks with distractors as more challenging, performance and eye behavior markers of both perceptual decoupling and workload were unaffected. This result supports the notion of perceptual decoupling as an automatic mechanism: focusing inward induces desensitization to external events independent of external distraction.	[Annerer-Walcher, Sonja; Koerner, Christof; Benedek, Mathias] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria	University of Graz	Annerer-Walcher, S (corresponding author), Karl Franzens Univ Graz, Inst Psychol, Graz, Austria.	sonja.walcher@uni-graz.at	Benedek, Mathias/B-6110-2012	Benedek, Mathias/0000-0001-6258-4476; Korner, Christof/0000-0002-3846-2337; Annerer-Walcher, Sonja/0000-0002-1174-1475	Austrian Science Fund (FWF) [P29801-B27]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported bythe Austrian Science Fund (FWF): P29801-B27 (https://fwf.ac.at/en/) to SAW and MB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198242; Abeles D, 2017, COGNITION, V168, P99, DOI 10.1016/j.cognition.2017.06.021; [Anonymous], 2021, LANG ENV STAT COMP; Barron E, 2011, PSYCHOL SCI, V22, P596, DOI 10.1177/0956797611404083; Benedek M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01092; Benedek M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22959; Benedek M, 2011, NEUROPSYCHOLOGIA, V49, P3505, DOI 10.1016/j.neuropsychologia.2011.09.004; Bone M., 2018, CEREB CORTEX, V2018, P1, DOI [10.1093/cercor/bhy014, DOI 10.1093/CERCOR/BHW342, 10.1093/cercor/bhw342]; Broadway JM, 2018, COGN AFFECT BEHAV NE, V18, P509, DOI 10.3758/s13415-018-0584-6; Buetti S, 2016, J EXP PSYCHOL GEN, V145, P1382, DOI 10.1037/xge0000213; Chatham CH, 2015, CURR OPIN BEHAV SCI, V1, P23, DOI 10.1016/j.cobeha.2014.08.001; Choi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189667; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; Dixon ML, 2014, NEUROPSYCHOLOGIA, V62, P321, DOI 10.1016/j.neuropsychologia.2014.05.024; Doherty-Sneddon G, 2005, MEM COGNITION, V33, P727, DOI 10.3758/BF03195338; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fink A, 2014, NEUROSCI BIOBEHAV R, V44, P111, DOI 10.1016/j.neubiorev.2012.12.002; Gao X, 2015, J VISION, V15, DOI 10.1167/15.3.3; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Guilford J. P., 1967, NATURE HUMAN INTELLI; Hu NT, 2012, CONSCIOUS COGN, V21, P139, DOI 10.1016/j.concog.2011.12.007; Huestegge L, 2018, ACTA PSYCHOL, V188, P139, DOI 10.1016/j.actpsy.2018.06.004; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; Johansson R, 2012, J EXP PSYCHOL HUMAN, V38, P1289, DOI 10.1037/a0026585; Kajimura S, 2016, COGNITION, V157, P352, DOI 10.1016/j.cognition.2016.10.002; Kim H, 2018, BRAIN RES, V1683, P55, DOI 10.1016/j.brainres.2018.01.022; Konishi M, 2017, COGNITION, V168, P16, DOI 10.1016/j.cognition.2017.06.006; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Michael A, 2016, R PACKAGE VERSION 4; Miller J, 2014, ATTEN PERCEPT PSYCHO, V76, P2560, DOI 10.3758/s13414-014-0730-3; Morey R. D., 2018, R package version 0.9.12-4.2.; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Salvi C, 2015, PSYCHON B REV, V22, P1814, DOI 10.3758/s13423-015-0845-0; Simmons JP, 2012, DIALOGUE OFFICIAL NE, DOI [10.2139/ssrn.2160588, DOI 10.2139/SSRN.2160588]; Slagter HA, 2012, J COGNITIVE NEUROSCI, V24, P1932, DOI 10.1162/jocn_a_00255; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Steinborn MB, 2017, PSYCHOL RES-PSYCH FO, V81, P1135, DOI 10.1007/s00426-016-0810-1; Steinborn MB, 2011, ACTA PSYCHOL, V136, P405, DOI 10.1016/j.actpsy.2011.01.008; Tops M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00429; Trukenbrod H, 2015, MICROSACCADE TOOLBOX; Unsworth N, 2018, COGN AFFECT BEHAV NE, V14, P1, DOI [DOI 10.3758/S13415-017-0546-4, 10.3758/s13415-017-0546-4]; Unsworth N, 2017, J EXP PSYCHOL LEARN, V43, P1962, DOI 10.1037/xlm0000421; Walcher S, 2017, CONSCIOUS COGN, V53, P165, DOI 10.1016/j.concog.2017.06.009	48	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204963	10.1371/journal.pone.0204963	http://dx.doi.org/10.1371/journal.pone.0204963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265715	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500059
J	Cao, M; Breidt, FJ; Solomon, JN; Conteh, A; Gavin, MC				Cao, Meng; Breidt, F. Jay; Solomon, Jennifer N.; Conteh, Abu; Gavin, Michael C.			Understanding the drivers of sensitive behavior using Poisson regression from quantitative randomized response technique data	PLOS ONE			English	Article							ECOLOGICAL KNOWLEDGE; FOREST PRODUCTS; CENTRAL-AFRICA; SOCIAL NORMS; CONSERVATION; MODEL; METAANALYSIS; VALIDATION; VARIABLES; IMPACTS	Understanding sensitive behaviors-those that are socially unacceptable or non-compliant with rules or regulations-is essential for creating effective interventions. Sensitive behaviors are challenging to study, because participants are unlikely to disclose sensitive behaviors for fear of retribution or due to social undesirability. Methods for studying sensitive behavior include randomized response techniques, which provide anonymity to interviewees who answer sensitive questions. A variation on this approach, the quantitative randomized response technique (QRRT), allows researchers to estimate the frequency or quantity of sensitive behaviors. However, to date no studies have used QRRT to identify potential drivers of non-compliant behavior because regression methodology has not been developed for the nonnegative count data produced by QRRT. We develop a Poisson regression methodology for QRRT data, based on maximum likelihood estimation computed via the expectation-maximization (EM) algorithm. The methodology can be implemented with relatively minor modification of existing software for generalized linear models. We derive the Fisher information matrix in this setting and use it to obtain the asymptotic variance-covariance matrix of the regression parameter estimates. Simulation results demonstrate the quality of the asymptotic approximations. The method is illustrated with a case study examining potential drivers of non-compliance with hunting regulations in Sierra Leone. The new methodology allows assessment of the importance of potential drivers of different quantities of non-compliant behavior, using a likelihood-based, information-theoretic approach. Free, open-source software is provided to support QRRT regression.	[Cao, Meng; Breidt, F. Jay] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Solomon, Jennifer N.; Gavin, Michael C.] Colorado State Univ, Dept Human Dimens Nat Resources, Ft Collins, CO 80523 USA; [Conteh, Abu] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand	Colorado State University; Colorado State University; Victoria University Wellington	Cao, M (corresponding author), Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA.	meng.cao@colostate.edu		Gavin, Michael/0000-0002-2169-4668; Cao, Meng/0000-0002-3338-304X	Colorado State University Libraries Open Access Research and Scholarship Fund	Colorado State University Libraries Open Access Research and Scholarship Fund	We acknowledge support from the Colorado State University Libraries Open Access Research and Scholarship Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABULELA ALA, 1967, J AM STAT ASSOC, V62, P900; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002; Becker G.S., 1968, EC DIMENSIONS CRIME, P13; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Chang C.H., 2017, ZAPSTRR ZOOLOGICAL P; Chaudhuri A., 1988, RANDOMIZED RESPONSE; Cialdini RB, 2007, PSYCHOMETRIKA, V72, P263, DOI 10.1007/s11336-006-1560-6; Conteh A., 2010, THESIS; Conteh A, 2017, ENVIRON CONSERV, V44, P131, DOI [10.1017/S0376892916000321, 10.1]; Conteh A, 2017, BIODIVERS CONSERV, V26, P983, DOI 10.1007/s10531-016-1283-7; Conteh A, 2015, BIOL CONSERV, V189, P16, DOI 10.1016/j.biocon.2015.02.002; Cruyff MJLF, 2008, ANN APPL STAT, V2, P316, DOI 10.1214/07-AOAS135; Cruyff MJLF, 2008, J R STAT SOC B, V70, P21; Damania R, 2005, P ROY SOC B-BIOL SCI, V272, P259, DOI 10.1098/rspb.2004.2945; de Merode E, 2007, BIOL LETTERS, V3, P299, DOI 10.1098/rsbl.2007.0010; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fahrmeir L, 2013, MULTIVARIATE STAT MO; Fernandez-Gimenez ME, 2000, ECOL APPL, V10, P1318, DOI 10.1890/1051-0761(2000)010[1318:TROMNP]2.0.CO;2; Foerster S, 2012, CONSERV BIOL, V26, P335, DOI 10.1111/j.1523-1739.2011.01802.x; Fox J.A., 1986, RANDOMIZED RESPONSE; Gavin MC, 2007, ECOL ECON, V60, P752, DOI 10.1016/j.ecolecon.2006.01.010; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; GREENBERG BG, 1971, J AM STAT ASSOC, V66, P243, DOI 10.2307/2283916; Heck DW, 2017, RRREG CORRELATION RE; Hegde R, 2000, ENVIRON CONSERV, V27, P250, DOI 10.1017/S037689290000028X; Jones JPG, 2008, CONSERV BIOL, V22, P976, DOI 10.1111/j.1523-1739.2008.00970.x; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; King DM, 2010, MAR POLICY, V34, P7, DOI 10.1016/j.marpol.2009.04.023; L'Roe J, 2014, ECOL ECON, V97, P1, DOI 10.1016/j.ecolecon.2013.10.017; Lacuna-Richman C, 2002, ENVIRON CONSERV, V29, P253, DOI 10.1017/S0376892902000152; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; LIU PT, 1976, J AM STAT ASSOC, V71, P72, DOI 10.2307/2285733; McCarter J, 2014, AMBIO, V43, P288, DOI 10.1007/s13280-013-0431-5; McKenzie-Mohr D., 2011, FOSTERING SUSTAINABL, Vthird; Nelder J. A., 1972, GEN LINEAR MODELS; Nielsen JR, 2003, MAR POLICY, V27, P409, DOI 10.1016/S0308-597X(03)00024-1; Nuno A, 2013, CONSERV BIOL, V27, P1355, DOI 10.1111/cobi.12124; Quinlan MB, 2007, MED ANTHROPOL Q, V21, P169, DOI [10.1525/maq.2007.21.2.169, 10.1525/MAQ.2007.21.2.169]; Rimal RN, 2005, J HEALTH COMMUN, V10, P433, DOI 10.1080/10810730591009880; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Solomon J., 2007, HUM DIMENS WILDL, V12, P75, DOI [10.1080/10871200701195365, DOI 10.1080/10871200701195365]; Solomon JN, 2015, DETECTING UNDERSTAND; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; St John FAV, 2010, WILDLIFE RES, V37, P658, DOI 10.1071/WR10032; Thomas AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163868; Thomas AS, 2015, BIOL CONSERV, V189, P24, DOI 10.1016/j.biocon.2014.09.048; TRACY PE, 1981, AM SOCIOL REV, V46, P187, DOI 10.2307/2094978; TYLER TOM R., 2006, CONTEMP SOCIOL, DOI [DOI 10.2307/2076193, 10.1515/9781400828609]; UMESH UN, 1991, SOCIOL METHOD RES, V20, P104, DOI 10.1177/0049124191020001004; van den Hout A, 2007, COMPUT STAT DATA AN, V51, P6060, DOI 10.1016/j.csda.2006.12.002; Viteri C, 2007, OCEAN COAST MANAGE, V50, P253, DOI 10.1016/j.ocecoaman.2006.05.002; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Whytock RC, 2018, BIOL CONSERV, V218, P18, DOI 10.1016/j.biocon.2017.11.034; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871	57	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204433	10.1371/journal.pone.0204433	http://dx.doi.org/10.1371/journal.pone.0204433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265700	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500032
J	Menendez-Ortiz, A; Feregrino-Uribe, C; Garcia-Hernandez, JJ				Menendez-Ortiz, Alejandra; Feregrino-Uribe, Claudia; Juan Garcia-Hernandez, Jose			Self-recovery scheme for audio restoration using auditory masking	PLOS ONE			English	Article							FRAGILE WATERMARKING; DIGITAL AUDIO; AUTHENTICATION; TRANSFORM	Self-recovery schemes identify and restore tampering, using as a reference a compressed representation of a signal embedded into itself. In addition, audio self-recovery must comply with a transparency threshold, adequate for applications such as on-line music distribution or speech transmission. In this manuscript, an audio self-recovery scheme is proposed. Auditory masking properties of the signals are used to determine the frequencies that better mask the embedding distortion. Frequencies in the Fourier domain are mapped to the intDCT domain for embedding and extraction of reference bits for signal restoration. The contribution of this work is the use of auditory masking properties for the frequency selection and the mapping to the intDCT domain. Experimental results demonstrate that the proposed scheme satisfies a threshold of -2 ODG, suitable for audio applications. The efficacy of the scheme, in terms of its restoration capabilities, is also shown.	[Menendez-Ortiz, Alejandra; Feregrino-Uribe, Claudia] INAOE, Comp Sci Dept, Luis Enrique Erro 1, Puebla 72840, Mexico; [Juan Garcia-Hernandez, Jose] IPN, Ctr Invest & Estudios Avanzados, Unidad Tamaulipas, Km 5-5 Carr Cd Victoria Solo La Marina, Cd Victoria 87130, Tamps, Mexico; [Menendez-Ortiz, Alejandra] Ctr Invest Matemat AC, Guanajuato, Mexico	Instituto Nacional de Astrofisica, Optica y Electronica	Garcia-Hernandez, JJ (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Unidad Tamaulipas, Km 5-5 Carr Cd Victoria Solo La Marina, Cd Victoria 87130, Tamps, Mexico.	jjuan@tamps.cinvestav.mx	Garcia-Hernandez, Jose Juan/E-8633-2010; Feregrino, Claudia/AAW-2607-2021	Garcia-Hernandez, Jose Juan/0000-0002-1249-5413; 	PRODEP-SEP; CONACY [PDCPN2013- 01-216689, PDCPN2017-01-5814, 351601]	PRODEP-SEP; CONACY	This work was supported by PRODEP-SEP and CONACY under grants PDCPN2013- 01-216689, PDCPN2017-01-5814, and Ph.D. scholarship No. 351601. There was no additional external funding received for this study.	Bartolini F, 2001, P IEEE, V89, P1403, DOI 10.1109/5.959338; Bravo-Solorio S, 2012, IEEE IMAGE PROC, P2197, DOI 10.1109/ICIP.2012.6467330; Bravo-Solorio S, 2012, IEEE INT WORKS INFOR, P217, DOI 10.1109/WIFS.2012.6412652; Celik MU, 2002, PROC SPIE, V4675, P531, DOI 10.1117/12.465311; Chen Q, 2013, LECT NOTES COMPUTER, V7809, P395, DOI [10.1007/978-3-642-40099-5_33, DOI 10.1007/978-3-642-40099-533]; Cvejic N., 2008, DIGITAL AUDIO WATERM; Dortmund University, 2005, MUS AUD BENCHM DAT S; Fan MQ, 2013, INT J COMPUT MATH, V90, P2588, DOI 10.1080/00207160.2013.805752; Fridrich J, 2002, PROC SPIE, V4675, P691, DOI 10.1117/12.465330; FRIDRICH J, 1999, S CONT SEC DAT HID D, P1; Gomez E, 2002, INT TEL S D ITS2002, P1; Gouyon F., 2006, BALLROOM DATASET; Hassan A.M., 2009, WORLD ACAD SCI ENG T, V2009, P69; He HJ, 2012, IEEE T INF FOREN SEC, V7, P185, DOI 10.1109/TIFS.2011.2162950; Huang HB, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL IV, PROCEEDINGS, P177; Hung KL, 2007, LECT NOTES COMPUT SC, V4610, P333; Garcia-Hernandez JJ, 2013, MIDWEST SYMP CIRCUIT, P1375, DOI 10.1109/MWSCAS.2013.6674912; Lin Y., 2015, AUDIO WATERMARK COMP; Liu ZH, 2017, MULTIMED TOOLS APPL, V76, P12481, DOI 10.1007/s11042-016-3664-z; Lu C., 2004, MULTIMEDIA SECURITY, DOI [10.5860/choice.42-2260, DOI 10.5860/CHOICE.42-2260]; Luo X, 2014, WUHAN UNIV J NAT SCI, V19, P497, DOI [DOI 10.1007/s11859-014-1044-y, 10.1007/s11859-014-1044-y]; Menendez-Ortiz A, 2017, INVENTORS ASSIGNEE S; Menendez-Ortiz A, 2018, AUDIO DATABASE SELF, V1, DOI [10.7910/DVN/ZXW0NP, DOI 10.7910/DVN/ZXW0NP]; Menendez-Ortiz A, 2017, MULTIMED TOOLS APPL, V76, P14197, DOI 10.1007/s11042-016-3783-6; Mobasseri B. G., 2000, Proceedings International Conference on Information Technology: Coding and Computing (Cat. No.PR00540), P68, DOI 10.1109/ITCC.2000.844185; Newton H., 2011, POINTS VIEW MUSIC CE, V1, P1; NFSTC, 2010, SIMPL GUID FOR AUD V; Owen M., 2007, PRACTICAL SIGNAL PRO; Sarreshtedari S, 2015, IEEE-ACM T AUDIO SPE, V23, P1917, DOI 10.1109/TASLP.2015.2456431; Shi YJ, 2013, OPTIK, V124, P3827, DOI 10.1016/j.ijleo.2012.11.078; Steinebach M, 2003, EURASIP J APPL SIG P, V2003, P1001, DOI 10.1155/S1110865703304081; Thiede T, 2000, J AUDIO ENG SOC, V48, P3; Wang HX, 2010, SCI CHINA INFORM SCI, V53, P619, DOI 10.1007/s11432-010-0058-0; Wang S. M., 2007, SE CULTURE, V5, P12, DOI DOI 10.1016/j.engappai.2007.05.012; Xu TT, 2009, LECT NOTES COMPUT SC, V5879, P1281; Zhang XP, 2011, IEEE T IMAGE PROCESS, V20, P485, DOI 10.1109/TIP.2010.2066981; Zhang XP, 2008, IEEE T MULTIMEDIA, V10, P1490, DOI 10.1109/TMM.2008.2007334; Zhu X, 2007, SIGNAL PROCESS-IMAGE, V22, P515, DOI 10.1016/j.image.2007.03.004	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204442	10.1371/journal.pone.0204442	http://dx.doi.org/10.1371/journal.pone.0204442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265725	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500033
J	Subedi, D; Vijay, AK; Kohli, GS; Rice, SA; Willcox, M				Subedi, Dinesh; Vijay, Ajay Kumar; Kohli, Gurjeet Singh; Rice, Scott A.; Willcox, Mark			Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa	PLOS ONE			English	Article							III SECRETION SYSTEM; REAL-TIME-PCR; FLUOROQUINOLONE RESISTANCE; MEXAB-OPRM; ANTIMICROBIAL RESISTANCE; MICROBIAL KERATITIS; TOPOISOMERASE-IV; CYSTIC-FIBROSIS; EFFLUX PUMPS; RISK-FACTORS	Virulent strains of Pseudomonas aeruginosa are often associated with an acquired cytotoxic protein, exoenzyme U (ExoU) that rapidly destroys the cell membranes of host cells by its phospholipase activity. Strains possessing the exoU gene are predominant in eye infections and are more resistant to antibiotics. Thus, it is essential to understand treatment options for these strains. Here, we have investigated the resistance profiles and genes associated with resistance for fluoroquinolone and beta-lactams. A total of 22 strains of P. aeruginosa from anterior eye infections, microbial keratitis (MK), and the lungs of cystic fibrosis (CF) patients were used. Based on whole genome sequencing, the prevalence of the exoU gene was 61.5% in MK isolates whereas none of the CF isolates possessed this gene. Overall, higher antibiotic resistance was observed in the isolates possessing exoU. Of the exoUstrains, all except one were resistant to fluoroquinolones, 100% were resistant to beta-lactams. 75% had mutations in quinolone resistance determining regions (T81I gyrA and/or S87L parC) which correlated with fluoroquinolone resistance. In addition, exoUstrains had mutations at K76Q, A110T, and V126E in ampC, Q155I and V356I in ampR and E114A, G283E, and M288R in mexR genes that are associated with higher beta-lactamase and efflux pump activities. In contrast, such mutations were not observed in the strains lacking exoU. The expression of the ampC gene increased by up to nine-fold in all eight exoUstrains and the ampR was upregulated in seven exoUstrains compared to PAO1. The expression of mexR gene was 1.4 to 3.6 fold lower in 75% of exoUstrains. This study highlights the association between virulence traits and antibiotic resistance in pathogenic P. aeruginosa.	[Subedi, Dinesh; Vijay, Ajay Kumar; Willcox, Mark] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Kohli, Gurjeet Singh; Rice, Scott A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Rice, Scott A.] Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Technology Sydney	Subedi, D (corresponding author), Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	d.subedi@unsw.edu.au	Vijay, Ajay Kumar/AAF-7460-2020; Subedi, Dinesh/R-1686-2017; Rice, Scott/A-6084-2019; Vijay, Ajay Kumar/M-2194-2017	Vijay, Ajay Kumar/0000-0002-8248-6379; Subedi, Dinesh/0000-0002-1357-9520; Rice, Scott/0000-0002-9486-2343; Vijay, Ajay Kumar/0000-0002-8248-6379; willcox, mark/0000-0003-3842-7563	National Research Foundation Singapore; Ministry of Education; Nanyang Technological University; National University of Singapore	National Research Foundation Singapore(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University(Nanyang Technological University); National University of Singapore(National University of Singapore)	The authors would like to acknowledge the Singapore Centre for Environmental Life Sciences Engineering (SCELSE), whose research is supported by the National Research Foundation Singapore, Ministry of Education, Nanyang Technological University and National University of Singapore, under its Research Centre of Excellence Programme. Sequencing of DNA was carried out with the help of Daniela Moses and Stephan Schuster using the sequencing facilities at SCELSE. We are also thankful to UNSW high performance computing facility KATANA for providing us cluster for data analysis.	Adewoye L, 2002, J BACTERIOL, V184, P4308, DOI 10.1128/JB.184.15.4308-4312.2002; Agnello M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01591; Agnello M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042973; Akasaka T, 2001, ANTIMICROB AGENTS CH, V45, P2263, DOI 10.1128/AAC.45.8.2263-2268.2001; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berrazeg M, 2015, ANTIMICROB AGENTS CH, V59, P6248, DOI 10.1128/AAC.00825-15; Berthelot P, 2003, J INFECT DIS, V188, P512, DOI 10.1086/377000; Borkar DS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-54; Bradbury RS, 2010, J MED MICROBIOL, V59, P881, DOI 10.1099/jmm.0.018283-0; Bruchmann S, 2013, ANTIMICROB AGENTS CH, V57, P1361, DOI 10.1128/AAC.01581-12; Cho HH, 2014, ANN LAB MED, V34, P286, DOI 10.3343/alm.2014.34.4.286; Choudhury D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149156; Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clinical and Laboratory Standard Institute (CLSI), 2012, METH DIL ANT SUSC TE, V32; CLSI, 2012, M100S22 CLSI, V32; Ding CY, 2016, INT J INFECT DIS, V49, P119, DOI 10.1016/j.ijid.2016.06.014; Dumas JL, 2006, FEMS MICROBIOL LETT, V254, P217, DOI 10.1111/j.1574-6968.2005.00008.x; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Silva KDFD, 2017, BURNS, V43, P137, DOI 10.1016/j.burns.2016.07.002; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Fleiszig Suzanne M. J., 1998, CLAO Journal, V24, P41; Garey KW, 2008, J CHEMOTHERAPY, V20, P714, DOI 10.1179/joc.2008.20.6.714; Georgescu M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1396-3; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Heidary Zohreh, 2016, Acta Med Iran, V54, P201; Hirose K, 2002, ANTIMICROB AGENTS CH, V46, P3249, DOI 10.1128/AAC.46.10.3249-3252.2002; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1887, DOI 10.1128/AAC.47.6.1887-1894.2003; Hsu DI, 2005, J ANTIMICROB CHEMOTH, V55, P535, DOI 10.1093/jac/dki026; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Keay L, 2008, CLIN EXP OPHTHALMOL, V36, P209, DOI 10.1111/j.1442-9071.2008.01722.x; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Lee JK, 2005, INT J ANTIMICROB AG, V25, P290, DOI 10.1016/j.ijantimicag.2004.11.012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ling JM, 2003, ANTIMICROB AGENTS CH, V47, P3567, DOI 10.1128/AAC.47.11.3567-3573.2003; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Mitov I, 2010, BRAZ J MICROBIOL, V41, P588, DOI 10.1590/S1517-83822010000300008; Park MH, 2017, AURIS NASUS LARYNX, V44, P258, DOI 10.1016/j.anl.2016.07.005; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Saito K, 1999, FEMS MICROBIOL LETT, V179, P67, DOI 10.1016/S0378-1097(99)00394-8; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sawa T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0668-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stewart RMK, 2011, J CLIN MICROBIOL, V49, P993, DOI 10.1128/JCM.02036-10; Tam VH, 2007, CLIN MICROBIOL INFEC, V13, P413, DOI 10.1111/j.1469-0691.2006.01674.x; Tingpej P, 2007, J CLIN MICROBIOL, V45, P1697, DOI 10.1128/JCM.02364-06; Tran QT, 2011, FOODBORNE PATHOG DIS, V8, P451, DOI 10.1089/fpd.2010.0687; Vaez Hamid, 2014, Adv Biomed Res, V3, P117, DOI 10.4103/2277-9175.133183; Walker SE, 2013, METHOD ENZYMOL, V530, P337, DOI 10.1016/B978-0-12-420037-1.00019-1; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wong-Beringer A, 2008, CLIN MICROBIOL INFEC, V14, P330, DOI 10.1111/j.1469-0691.2007.01939.x; Yahr TL, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P704, DOI 10.1007/0-387-30746-x_22; Yamaguchi S, 2014, J INFECT CHEMOTHER, V20, P407, DOI 10.1016/j.jiac.2014.02.007	63	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204936	10.1371/journal.pone.0204936	http://dx.doi.org/10.1371/journal.pone.0204936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265709	Green Published, gold			2022-12-27	WOS:000446005500057
J	Teter, J; Yeh, S; Khanna, M; Berndes, G				Teter, Jacob; Yeh, Sonia; Khanna, Madhu; Berndes, Goren			Water impacts of US biofuels: Insights from an assessment combining economic and biophysical models	PLOS ONE			English	Article							BIOENERGY CROPS; BIOMASS PRODUCTION; USE EFFICIENCY; CLIMATE-CHANGE; FOOTPRINT; QUALITY; SWITCHGRASS; MISCANTHUS; LCA; CONSUMPTION	Biofuels policies induce land use changes (LUC), including cropland expansion and crop switching, and this in turn alters water and soil management practices. Policies differ in the extent and type of land use changes they induce and therefore in their impact on water resources. We quantify and compare the spatially varying water impacts of biofuel crops stemming from LUC induced by two different biofuels policies by coupling a biophysical model with an economic model to simulate the economically viable mix of crops, land uses, and crop management choices under alternative policy scenarios. We assess the outputs of an economic model with a high-resolution crop-water model for major agricultural crops and potential cellulosic feedstocks in the US to analyze the impacts of three alternative policy scenarios on water balances: a counterfactual 'no-biofuels policy' (BAU) scenario, a volumetric mandate (Mandate) scenario, and a clean fuel-intensity standard (CFS) scenario incentivizing fuels based on their carbon intensities. While both biofuel policies incentivize more biofuels than in the counterfactual, they differ in the mix of corn ethanol and advanced biofuels from miscanthus and switchgrass (more corn ethanol in Mandate and more cellulosic biofuels in CFS). The two policies differ in their impact on irrigated acreage, irrigation demand, groundwater use and runoff. Net irrigation requirements increase 0.7% in Mandate and decrease 3.8% in CFS, but in both scenarios increases are concentrated in regions of Kansas and Nebraska that rely upon the Ogallala aquifer for irrigation water. Our study illustrates the importance of accounting for the overall LUC and shifts in agricultural production and management practices in response to policies when assessing the water impacts of biofuels.	[Teter, Jacob] Int Energy Agcy, Sustainable Technol Outlooks, Paris, France; [Yeh, Sonia; Berndes, Goren] Chalmers Univ Technol, Dept Space Earth & Environm, Gothenburg, Sweden; [Khanna, Madhu] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL USA; [Khanna, Madhu] Univ Illinois, DOE Ctr Adv Bioenergy & Bioprod Innovat, Urbana, IL USA	Chalmers University of Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Teter, J (corresponding author), Int Energy Agcy, Sustainable Technol Outlooks, Paris, France.	jacob.TETER@iea.org	Yeh, Sonia/Q-3632-2017	Yeh, Sonia/0000-0002-4852-1177	California Energy Commission; Sustainable Transportation Energy Pathways (STEPS) program at the Institute of Transportation Studies, UC Davis; National Center for Sustainable Transportation; DOE Center for Advanced Bioenergy and Bioproducts Innovation (U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research) [DE-SC0018420]	California Energy Commission; Sustainable Transportation Energy Pathways (STEPS) program at the Institute of Transportation Studies, UC Davis; National Center for Sustainable Transportation; DOE Center for Advanced Bioenergy and Bioproducts Innovation (U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research)(United States Department of Energy (DOE))	The authors were funded by the California Energy Commission and the Sustainable Transportation Energy Pathways (STEPS) program at the Institute of Transportation Studies, UC Davis, as well as a dissertation grant from the National Center for Sustainable Transportation, for funding the research (JT, SY). Madhu Khanna is grateful for funding provided by the DOE Center for Advanced Bioenergy and Bioproducts Innovation (U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research under Award Number DE-SC0018420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RG, 2005, J IRRIG DRAIN ENG, V131, P2, DOI 10.1061/(ASCE)0733-9437(2005)131:1(2); [Anonymous], 2010, EN INF ADM; Argonne National Laboratory, 2015, WAT AN TOOL EN RES V; Arnold J, 1994, SWAT SOIL WATER ASSE; Barton B, 2014, WATER CLIMATE RISKS; Boulay A-M, 2017, INT J LIFE CYCLE ASS; Boulay AM, 2015, INT J LIFE CYCLE ASS, V20, P577, DOI 10.1007/s11367-015-0869-8; Cai H, 2013, APPL ENERG, V111, P644, DOI 10.1016/j.apenergy.2013.05.023; Casler MD, 2012, SWITCHGRASS GREEN EN; Chen XG, 2014, J ENVIRON ECON MANAG, V67, P241, DOI 10.1016/j.jeem.2013.09.006; Chiu YW, 2012, ENVIRON SCI TECHNOL, V46, P9155, DOI 10.1021/es3002162; Chiu YW, 2009, ENVIRON SCI TECHNOL, V43, P2688, DOI 10.1021/es8031067; Christopher KW, 2017, ENVIRON RES LETT, V12; Cibin R, 2016, GCB BIOENERGY; Cibin R, 2016, GCB BIOENERGY, V8, P837, DOI 10.1111/gcbb.12307; Deb D, 2015, WATER-SUI, V7, P3283, DOI 10.3390/w7073283; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Dominguez-Faus R, 2013, ENVIRON SCI TECHNOL, V47, P6030, DOI 10.1021/es400435n; Economic NRCCo Production EIoIB, 2011, REN ELOLB REN FUEL S; EIA, 2009, MONTHL BIOD PROD REP; Emmenegger MF, 2011, INT J LIFE CYCLE ASS, V16, P869, DOI 10.1007/s11367-011-0327-1; Engel B, 2010, BIOFUELS-UK, V1, P463, DOI 10.4155/BFS.10.17; Environment and Climate Change Canada, 2017, CLEAN FUEL STAND DIS; Feng KS, 2011, ECON SYST RES, V23, P371, DOI 10.1080/09535314.2011.638276; Fingerman KR, 2011, BIOFUEL BIOPROD BIOR, V5, P375, DOI 10.1002/bbb.294; Fingerman KR, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014020; Gerbens-Leenes PW, 2012, GLOBAL ENVIRON CHANG, V22, P764, DOI 10.1016/j.gloenvcha.2012.04.001; Gerbens-Leenes PW, 2009, ECOL ECON, V68, P1052, DOI 10.1016/j.ecolecon.2008.07.013; Gerbens-Leenes W, 2011, ENERG ENVIRON SCI, V4, P2658, DOI 10.1039/c1ee01187a; Hamilton SK, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/6/064015; Han WG, 2012, COMPUT ELECTRON AGR, V84, P111, DOI 10.1016/j.compag.2012.03.005; Hertel T, 2013, AGR ECON-BLACKWELL, V44, P129, DOI 10.1111/agec.12057; Holgate TC, 2016, INT ENERGY CONVERS; Hoogeveen J, 2009, IRRIG DRAIN, V58, pS148, DOI 10.1002/ird.479; Housh M, 2015, ENVIRON SCI TECHNOL, V49, P11932, DOI 10.1021/acs.est.5b02712; Huang H, ECONOMETRIC ANAL US; Huang HX, 2013, ENERG POLICY, V56, P5, DOI 10.1016/j.enpol.2012.06.002; Hudiburg TW, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.5; Johnson R, 2008 FARM BILL MAJOR; Khanna M, 2012, CLIMATE CHANGE EC, V3; Khanna M, 2012, ANNU REV RESOUR ECON, V4, P160, DOI 10.1146/annurev-resource-110811-114523; Khanna M, 2011, AM J AGR ECON, V93, P473, DOI 10.1093/ajae/aaq119; King CW, 2008, ENVIRON SCI TECHNOL, V42, P7866, DOI 10.1021/es800367m; Kiniry J.R., 2008, NEW RES BIOFUELS, P1; Lark TJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044003; Le PVV, 2011, P NATL ACAD SCI USA, V108, P15085, DOI 10.1073/pnas.1107177108; Lee J, 2012, GCB BIOENERGY, V4, P521, DOI 10.1111/j.1757-1707.2011.01140.x; Lienden vA, 2010, BIOFUEL SCENARIOS WA; Love BJ, 2011, BIOMASS BIOENERG, V35, P2200, DOI 10.1016/j.biombioe.2011.02.041; McIsaac GF, 2010, J ENVIRON QUAL, V39, P1790, DOI 10.2134/jeq2009.0497; Mishra GS, 2011, ENVIRON SCI TECHNOL, V45, P4563, DOI 10.1021/es104145m; Mu Q., 2013, ALGORITHM THEORETICA; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Mueller H, 2015, REMOTE SENS ENVIRON, V156, P490, DOI 10.1016/j.rse.2014.10.014; NASS, 2010, NASS AGR HDB NUMB, V628; NASS U, 2008, FARM RANCH IRR SURV; Ng TL, 2010, ENVIRON SCI TECHNOL, V44, P7138, DOI 10.1021/es9039677; Parajuli P. B., 2013, J SUSTAINABLE BIOENE, V3, P202, DOI [10.4236/jsbs.2013.33028, DOI 10.4236/JSBS.2013.33028]; Parish ES, 2012, BIOFUEL BIOPROD BIOR, V6, P58, DOI 10.1002/bbb.342; Pfister S, 2017, ECOL INDIC, V72, P352, DOI 10.1016/j.ecolind.2016.07.051; Reitsma KD, 2016, AGRON J, V108, P266, DOI 10.2134/agronj2015.0288; RFA, 2017, IND STAT; Schaible G., 2012, USDA ERS EC INFORM B, V99; Scherer L, 2015, ENVIRON SCI TECHNOL, V49, P4971, DOI 10.1021/acs.est.5b00429; Scown CD, 2011, ENVIRON SCI TECHNOL, V45, P2541, DOI 10.1021/es102633h; Smith CM, 2013, J ENVIRON QUAL, V42, P219, DOI 10.2134/jeq2012.0210; Sophocleous M, 2010, HYDROGEOL J, V18, P559, DOI 10.1007/s10040-009-0540-1; Ssegane H, 2015, BIOMASS BIOENERG, V80, P179, DOI 10.1016/j.biombioe.2015.04.012; Team RC., 2013, R LANG ENV STAT COMP; Teter J., 2015, AGR WATER USE IMPACT; VanLoocke A, 2016, GCB BIOENERGY; VanLoocke A, 2012, AGR FOREST METEOROL, V164, P82, DOI 10.1016/j.agrformet.2012.05.016; Wagner KL, 2017, J CONTEMP WAT RES ED, V162, P1, DOI 10.1111/j.1936-704X.2017.03255.x; Wallander S, 2011, USDA ERS EC INFORM B; Wang WW, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/114019; WatkinsJr DW, 2015, ENVIRON MANAGE, P1; Williams J. R., 1995, Computer models of watershed hydrology., P909; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Wu M, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011809; Wu M, 2009, ENVIRON MANAGE, V44, P981, DOI 10.1007/s00267-009-9370-0; Wu YP, 2012, BIOMASS BIOENERG, V36, P182, DOI 10.1016/j.biombioe.2011.10.030; Yeh S, 2012, UCDITSRR1210; Yeh S, 2012, UCDITSRR1211; Yeh S, 2016, ENERG POLICY, V97, P220, DOI 10.1016/j.enpol.2016.07.029; Yeh S, 2013, ENERG POLICY, V56, P1, DOI 10.1016/j.enpol.2013.01.008; Yeh S, 2011, BIOFUEL BIOPROD BIOR, V5, P361, DOI 10.1002/bbb.308; Yi FJ, 2014, GCB BIOENERGY, V6, P672, DOI 10.1111/gcbb.12075; Zeri M, 2013, J GEOPHYS RES-BIOGEO, V118, P581, DOI 10.1002/jgrg.20052; Zhuang QL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015020; Zilberman D, 2013, AM J AGR ECON, V95, P1332, DOI 10.1093/ajae/aat038	90	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204298	10.1371/journal.pone.0204298	http://dx.doi.org/10.1371/journal.pone.0204298			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265704	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500027
J	Deng, JM; Zhang, W; Qin, BQ; Zhang, YL; Paerl, HW; Salmaso, N				Deng, Jianming; Zhang, Wei; Qin, Boqiang; Zhang, Yunlin; Paerl, Hans W.; Salmaso, Nico			Effects of climatically-modulated changes in solar radiation and wind speed on spring phytoplankton community dynamics in Lake Taihu, China	PLOS ONE			English	Article							LARGE SHALLOW LAKE; HARMFUL CYANOBACTERIAL BLOOMS; MICROCYSTIS SPP. BLOOMS; FRESH-WATER ECOSYSTEMS; CLIMATE-CHANGE; GLOBAL EXPANSION; NUTRIENT RELEASE; LIGHT CLIMATE; SEDIMENT; SURFACE	Many studies have focused on the interactive effects of temperature increases due to global warming and nutrient enrichment on phytoplankton communities. Recently, non-temperature effects of climate change (e.g., decreases in wind speed and increases in solar radiation) on large lakes have received increasing attention. To evaluate the relative contributions of both temperature and non-temperature effects on phytoplankton communities in a large eutrophic subtropical shallow lake, we analyzed long-term monitoring data from Lake Taihu, China from 1997 to 2016. Results showed that Lake Taihu's spring phytoplankton biovolume and composition changed dramatically over this time frame, with a change in dominant species. Stepwise multiple linear regression models indicated that spring phytoplankton biovolume was strongly influenced by total phosphorus (TP), light condition, wind speed and total nitrogen (TN) (r(adj)(2) = 0.8, p < 0.01). Partial redundancy analysis (pRDA) showed that light condition accounted for the greatest variation of phytoplankton community composition, followed by TP and wind speed, as well as the interactions between TP and wind speed. Our study points to the additional importance of non-temperature effects of climate change on phytoplankton community dynamics in Lake Taihu.	[Deng, Jianming; Qin, Boqiang; Zhang, Yunlin] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Taihu Lake Lab Ecosyst Res Stn, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Zhang, Wei] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Minist Educ,Ctr Res Environm Ecol & Fish Nutr, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Paerl, Hans W.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA; [Paerl, Hans W.] Hohai Univ, Coll Environm, Nanjing, Jiangsu, Peoples R China; [Salmaso, Nico] FEM, Res & Innovat Ctr, San Michele All Adige, Italy	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Shanghai Ocean University; University of North Carolina; University of North Carolina Chapel Hill; Hohai University; Fondazione Edmund Mach	Qin, BQ (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, Taihu Lake Lab Ecosyst Res Stn, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	qinbq@niglas.ac.cn	Deng, Jianming/F-3822-2011; Deng, Jianming/AAN-2998-2020; Zhang, Yunlin/N-5464-2014	Deng, Jianming/0000-0003-2432-6307; Deng, Jianming/0000-0003-2432-6307; Zhang, Yunlin/0000-0002-3382-4570	Natural Science Foundation of China [41501215, 41621002, 41661134036]; Key Research Program of Frontier Sciences, CAS [QYZDB-SSW-DQC016]; Natural Science Foundation of Jiangsu Province, China [BK20171517]; US National Science Foundation Dimensions of Biodiversity [1240851, 1831096]; CBET Programs [1230543]; China Scholarship Council	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences, CAS; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); US National Science Foundation Dimensions of Biodiversity(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); CBET Programs; China Scholarship Council(China Scholarship Council)	The study was jointly supported by the Natural Science Foundation of China (Grant No.: 41501215, 41621002 and 41661134036), the Key Research Program of Frontier Sciences, CAS (Grant No: QYZDB-SSW-DQC016) and the Natural Science Foundation of Jiangsu Province, China (Grant No.: BK20171517). H.W. Paerl was supported by the US National Science Foundation Dimensions of Biodiversity (1240851, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503446), (1831096) and CBET (1230543) Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was jointly supported by the Natural Science Foundation of China (Grant No.: 41501215, 41621002 and 41661134036), the Key Research Program of Frontier Sciences, CAS (Grant No: QYZDB-SSW-DQC016) and the Natural Science Foundation of Jiangsu Province, China (Grant No.: BK20171517). H.W. Paerl was supported by the US National Science Foundation Dimensions of Biodiversity (1240851, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503446), (1831096) and CBET (1230543) Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank the Taihu Laboratory for Lake Ecosystem Research (TLLER) for providing long-term monitoring data for Lake Taihu, and Zijuan Chen for helping us drawing Fig 1. The authors also would also like to thank the two anonymous reviewers and editor for their useful comments and constructive suggestions for manuscript. The work was finished while J.M. visited Aarhus University (Silkeborg, Denmark) as a visiting postdoctoral researcher, sponsored by the China Scholarship Council.	[Anonymous], R LANG ENV STAT COMP; [Anonymous], 1980, FRESHWATER ALGAE CHI; Barton A. D., 2014, LIMNOL OCEANOGR FLUI, V4, P34, DOI [10.1215/21573689-2651533, DOI 10.1215/21573689-2651533]; Barton AD, 2016, P NATL ACAD SCI USA, V113, P2964, DOI 10.1073/pnas.1519080113; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bleiker W, 1997, AQUAT SCI, V59, P135, DOI 10.1007/s000270050081; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; CARPENTER SR, 1992, ANNU REV ECOL SYST, V23, P119, DOI 10.1146/annurev.es.23.110192.001003; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Deng JM, 2018, SCI TOTAL ENVIRON, V645, P1361, DOI 10.1016/j.scitotenv.2018.07.208; Deng JM, 2015, INT J CLIMATOL, V35, P3385, DOI 10.1002/joc.4212; Deng JM, 2014, FRESHWATER BIOL, V59, P1076, DOI 10.1111/fwb.12330; Diamond SL, 2013, ECOL MODEL, V264, P98, DOI 10.1016/j.ecolmodel.2013.05.001; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Elliott JA, 2010, GLOBAL CHANGE BIOL, V16, P864, DOI 10.1111/j.1365-2486.2009.01998.x; Guo WJ, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6318-3; Hamilton DP, 2016, AQUAT ECOL, V50, P351, DOI 10.1007/s10452-016-9594-z; Izaguirre I, 2012, HYDROBIOLOGIA, V698, P203, DOI 10.1007/s10750-012-1069-1; Jeppesen E, 2011, HYDROBIOLOGIA, V663, P1, DOI 10.1007/s10750-010-0547-6; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Jiang L, 2017, ECOL MODEL, V363, P68, DOI 10.1016/j.ecolmodel.2017.08.026; Jiang X, 2008, WATER RES, V42, P2251, DOI 10.1016/j.watres.2007.12.003; Jin X., 1990, STANDARD METHODS OBS; Korsak MN, 2009, MOSCOW U BIOL SCI B, V64, P37, DOI DOI 10.3103/S0096392509010088; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; Legendre L., 1998, NUMERICAL ECOLOGY DE; Lepparanta M, 2010, HYDROL RES, V41, P50, DOI 10.2166/nh.2010.122; Li XY, 2014, MAR POLLUT BULL, V81, P210, DOI 10.1016/j.marpolbul.2013.08.006; [刘霞 Liu Xia], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P821; Liu Xia, 2012, Hupo Kexue, V24, P142; Lurling M, 2013, FRESHWATER BIOL, V58, P552, DOI 10.1111/j.1365-2427.2012.02866.x; Mooij WM, 2005, AQUAT ECOL, V39, P381, DOI 10.1007/s10452-005-9008-0; Myhre G., 2013, CONTRIBUTION WORKING; Nathans L.L., 2012, PRACTICAL ASSESSMENT, V17; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Ozkundakci D, 2016, GLOBAL CHANGE BIOL, V22, P284, DOI 10.1111/gcb.13085; Oksanen J, 2017, COMMUNITY ECOLOGY PA, V2; Pacheco J, 2010, HYDROBIOLOGIA, V646, P187, DOI 10.1007/s10750-010-0180-4; Paerl H. W., 2014, J FRESHWATER ECOL, P1; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2017, MICROB BIOTECHNOL, V10, P1106, DOI 10.1111/1751-7915.12725; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Qin B., 2008, LAKE TAIHU CHINA DYN; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Reichwaldt ES, 2012, WATER RES, V46, P1372, DOI 10.1016/j.watres.2011.11.052; Salmaso N, 2007, HYDROBIOLOGIA, V578, P97, DOI 10.1007/s10750-006-0437-0; Salmaso N, 2015, FRESHWATER BIOL, V60, P603, DOI 10.1111/fwb.12520; Shatwell T, 2012, LIMNOL OCEANOGR, V57, P541, DOI 10.4319/lo.2012.57.2.0541; Shi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40326; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Sommer U, 2011, GLOBAL CHANGE BIOL, V17, P154, DOI 10.1111/j.1365-2486.2010.02182.x; Torremorell A, 2009, FRESHWATER BIOL, V54, P437, DOI 10.1111/j.1365-2427.2008.02119.x; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Van Duin EHS, 2001, HYDROBIOLOGIA, V444, P25, DOI 10.1023/A:1017512614680; Vautard R, 2010, NAT GEOSCI, V3, P756, DOI [10.1038/ngeo979, 10.1038/NGEO979]; Wang H, 2016, WATER RES, V98, P280, DOI 10.1016/j.watres.2016.04.037; Wang JJ, 2015, ENVIRON SCI POLLUT R, V22, P10471, DOI 10.1007/s11356-015-4247-7; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Winder M, 2012, MAR BIOL, V159, P2491, DOI 10.1007/s00227-012-1964-z; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Woolway RI, 2017, CLIMATIC CHANGE, V141, P759, DOI 10.1007/s10584-017-1909-0; Wu TF, 2015, SCI TOTAL ENVIRON, V518, P24, DOI 10.1016/j.scitotenv.2015.02.090; Xiong Wen, 2012, Hupo Kexue, V24, P698; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yang JR, 2017, WATER RES, V120, P52, DOI 10.1016/j.watres.2017.04.062; You QL, 2010, THEOR APPL CLIMATOL, V101, P445, DOI 10.1007/s00704-009-0231-9; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219; Zhang M, 2012, WATER RES, V46, P442, DOI 10.1016/j.watres.2011.11.013; Zhang YL, 2004, THEOR APPL CLIMATOL, V78, P217, DOI 10.1007/s00704-003-0030-7; Zhang YL, 2016, ENVIRON SCI POLLUT R, V23, P12811, DOI 10.1007/s11356-016-6856-1; Zhu GW, 2005, CHINESE SCI BULL, V50, P577, DOI 10.1360/04wd0083; Zhu MY, 2014, HARMFUL ALGAE, V39, P310, DOI 10.1016/j.hal.2014.09.003	78	12	13	7	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205260	10.1371/journal.pone.0205260	http://dx.doi.org/10.1371/journal.pone.0205260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289946	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500061
J	Dyer, J; Tamburini, D; O'Connell, ER; Harrison, A				Dyer, Joanne; Tamburini, Diego; O'Connell, Elisabeth R.; Harrison, Anna			A multispectral imaging approach integrated into the study of Late Antique textiles from Egypt	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; IDENTIFICATION; DYES; ANTHRAQUINONES; FLUORESCENCE; COMPONENTS; DYESTUFFS; LAC; MS	This work explores the use of multispectral imaging (MSI) techniques applied to the investigation of Late Antique (c. 250-800 AD) textiles found in Egypt. Although the use of these techniques is well-established in the study of polychrome surfaces, they have only been sparingly and often unsystematically applied to the investigation of textiles. The aim of this work is therefore to bridge this gap by showing how this non-invasive, relatively inexpensive and portable methodology can be used to map the photoluminescence and reflective characteristics of textiles under different wavelengths of light, and to provide qualitative and holistic insights into the chemical nature of the materials that compose them. Standardised acquisition and post-processing methods were applied to produce visible-reflected (VIS), ultraviolet-induced visible luminescence (UVL), infrared-reflected (IRR), infrared-reflected false colour (IRRFC), ultraviolet-reflected (UVR) and ultraviolet-reflected false colour (UVRFC) images that provided preliminary indications of the colourants used and their spatial distribution. This proved to be an important aid in planning more targeted and effective sampling strategies and facilitated comparisons between objects. Visible-induced visible luminescence (VIVL) and multiband-reflected (MBR) imaging were also explored for the first time with application to textiles, demonstrating their potential in mapping red and blue colourants respectively. The physical properties observed from all of these images were then related to the more detailed information provided by complementary non-invasive techniques, such as fibre optic reflectance spectroscopy (FORS), and micro-invasive approaches, such as high-performance liquid chromatography mass spectrometry (HPLC-MS). Guidelines towards the interpretation of complex MSI images and a discussion of the potential and limitations of relating multispectral data to chemical properties are presented. An important result of this work is the delineation of a protocol, which combines optical microscopy (OM), MSI, FORS and HPLC-MS and shows a high degree of potential, not only for the investigation of Late Antique textiles but for textiles in museum and historic collections generally.	[Dyer, Joanne; Tamburini, Diego] British Museum, Dept Sci Res, London, England; [O'Connell, Elisabeth R.] British Museum, Dept Ancient Egypt & Sudan, London, England; [Harrison, Anna] British Museum, Dept Conservat, London, England	Natural History Museum London; Natural History Museum London; Natural History Museum London	Dyer, J (corresponding author), British Museum, Dept Sci Res, London, England.	jdyer@britishmuseum.org	Tamburini, Diego/AAF-7377-2020; Dyer, Joanne/H-9762-2016	Tamburini, Diego/0000-0002-4107-0430; Dyer, Joanne/0000-0002-3275-8612				Aceto M, 2014, ANAL METHODS-UK, V6, P1488, DOI 10.1039/c3ay41904e; ALDROVANDI A., 2005, 8 INT C NOND INV AN; [Anonymous], 2004, COLOURFUL ORIGINS CH; Baldia CM, 2007, J ARCHAEOL SCI, V34, P519, DOI 10.1016/j.jas.2006.06.010; Borrego P, 2015, GREEK ROMAN TEXTILES, P374; Boudin M, 2017, RADIOCARBON DATING R; Cartwright CR, 2016, 201634 DEP SCI RES A; Clementi C, 2007, ANAL CHIM ACTA, V596, P46, DOI 10.1016/j.aca.2007.05.036; COLLINS S, 1994, DYES PIGMENTS, V24, P151, DOI 10.1016/0143-7208(94)80007-3; Coremans P., 1938, B MUSEES ROYAUX DART, V10, P87; Daniels V., 2014, BRIT MUSEUM TECHNICA, P13; De Moor A, 2015, TEXTILES TOOLS TECHN, P131; Degano I, 2009, APPL SPECTROSC REV, V44, P363, DOI 10.1080/05704920902937876; Derksen GCH, 2004, PHYTOCHEM ANALYSIS, V15, P397, DOI 10.1002/pca.800; Dyer J., 2014, BRIT MUSEUM TECHNICA, V8, P93; DYER J., 2013, MULTISPECTRAL IMAGIN; Dyer J, 2018, DYES PIGMENTS, V149, P122, DOI 10.1016/j.dyepig.2017.09.062; Dyer J, 2017, HERIT SCI, V5, DOI 10.1186/s40494-017-0137-2; Gal L, 2013, ANAL BIOANAL CHEM, V405, P9085, DOI 10.1007/s00216-013-7333-z; Gulmini M, 2013, DYES PIGMENTS, V98, P136, DOI 10.1016/j.dyepig.2013.02.010; Gulmini M, 2017, ARCHAEOL ANTHROP SCI, V9, P1; Haldane E. A., 2010, TEXTILE CONSERVATION, P237; Han J, 2017, J CHROMATOGR A, V1479, P87, DOI 10.1016/j.chroma.2016.11.044; Higgitt C., 2005, NATL GALLERY TECH B, V26, P71, DOI DOI 10.1002/C01.5080050319; Jancovicova V, 2007, CHEM PAP, V61, P391, DOI 10.2478/s11696-007-0053-0; Kirby J., 2017, DIVERSITY DYES HIST, P148; Martinez K, 2005, IEEE IMAGE PROC, P2485; Nakamura R, 2009, ANAL CHEM, V81, P5691, DOI 10.1021/ac900428a; O'Connell ER, 2014, BRIT MUSEUM STUDIES, V21, P121; O'Connell ER, 2014, ANTINOUPOLIS 2 SCAVI, P467; Otowska O., 2018, MOLECULES, V23, P339; Petroviciu I, 2010, MICROCHEM J, V95, P247, DOI 10.1016/j.microc.2009.12.009; Pritchard F, 2018, EXCAVATING ANAL RECO, P60; Romano C, 2014, DYES HIST ARCH 33 AN; Rosenberg E, 2008, ANAL BIOANAL CHEM, V391, P33, DOI 10.1007/s00216-008-1977-0; Santos R, 2015, DYES PIGMENTS, V118, P129, DOI 10.1016/j.dyepig.2015.02.024; Sanyova J, 2006, J CULT HERIT, V7, P229, DOI 10.1016/j.culher.2006.06.003; Sanyova J, 2000, ART CHIMIE, P14; Scott RA, 2005, TEXTILES PROTECTION, P365; Surowiec I, 2007, J SEP SCI, V30, P2070, DOI 10.1002/jssc.200700041; Tamburini D, 2018, ARCHAEOL ANTHROP SCI, V10, P1; Tamburini D, 2018, MICROCHEM J, V137, P238, DOI 10.1016/j.microc.2017.10.022; Verri G, 2009, PROC SPIE, V7391, DOI 10.1117/12.827331; Verri G., 2010, BRIT MUSEUM TECHNICA, V4, P39; Webb EK., 2014, TEXTILE GROUP POSTPR, V24, P23; Wouters J., 2008, DYES HIST ARCHAEOLOG, V21, P1	46	16	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204699	10.1371/journal.pone.0204699	http://dx.doi.org/10.1371/journal.pone.0204699			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286139	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500036
J	Akpan, GE; Adepoju, KA; Oladosu, OR; Adelabu, SA				Akpan, Godwin E.; Adepoju, Kayode A.; Oladosu, Olakunle R.; Adelabu, Samuel A.			Dominant malaria vector species in Nigeria: Modelling potential distribution of Anopheles gambiae sensu lato and its siblings with MaxEnt	PLOS ONE			English	Article							ECOLOGICAL ZONES; CLIMATE-CHANGE; TRANSMISSION; ARABIENSIS; MOSQUITOS	Malaria is a major infectious disease that still affects nearly half of the world's population. Information on spatial distribution of malaria vector species is needed to improve malaria control efforts. In this study we used Maximum Entropy Model (MaxEnt) to estimate the potential distribution of Anopheles gambiae sensu lato and its siblings: Anopheles gambiae sensu stricto, and Anopheles arabiensis in Nigeria. Species occurrence data collected during the period 1900-2010 was used together with 19 bioclimatic, landuse and terrain variables. Results show that these species are currently widespread across all ecological zones. Temperature fluctuation from mean diurnal temperature range, extreme temperature and precipitation conditions, high humidity in dry season from precipitation during warm months, and land use and land cover dynamics have the greatest influence on the current seasonal distribution of the Anopheles species. MaxEnt performed statistically significantly better than random with AUC approximately 0.7 for estimation of the Anopheles species environmental suitability, distribution and variable importance. This model result can contribute to surveillance efforts and control strategies for malaria eradication.	[Akpan, Godwin E.; Oladosu, Olakunle R.] Obafemi Awolowo Univ, ARCSSTEE, Ife, Osun State, Nigeria; [Adepoju, Kayode A.; Adelabu, Samuel A.] Univ Free State, Dept Geog, Qwaqwa Campus, Qwagwa, Phuthaditjhaba, South Africa	Obafemi Awolowo University; University of the Free State	Akpan, GE (corresponding author), Obafemi Awolowo Univ, ARCSSTEE, Ife, Osun State, Nigeria.	profjedidiah@yahoo.com	Adepoju, Kayode/E-2976-2015; Adelabu, Samuel Adewale SA/M-4938-2015; Akpan, Godwin/AAY-2541-2021; Taylan Ozkan, Aysegul/B-9721-2016	Adepoju, Kayode/0000-0001-7906-3415; Adelabu, Samuel Adewale SA/0000-0001-9362-9948; Akpan, Godwin/0000-0001-8204-9219; Taylan Ozkan, Aysegul/0000-0001-8421-3625				Altamiranda-Saavedra M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179093; Amajoh CN, 1997, REV MALARIA VECTOR B; [Anonymous], 2017, BRIEF TUTORIAL MAXEN; [Anonymous], 1998, REGIONAL IMPACTS CLI; [Anonymous], 2017, MAL LAG STAT REC 1 2; [Anonymous], 1996, FAO SOILS B, V73; Autino B, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.060; Awolola TS, 2005, T ROY SOC TROP MED H, V99, P525, DOI 10.1016/j.trstmh.2004.12.003; Briga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16600; Bruce-Chwatt L. J., 1951, Bulletin of the World Health Organization, V4, P301; CDC, 2015, AN MOSQ; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Consultative Group on International Agricultural Research Consortium for Spatial Information (CGIAR-CSI), 2017, SRTM 90M DIG EL DAT; Dalitz MK, 2005, THESIS; Dimitrov NB, 2009, OPER RES COMPUT SCI, P167, DOI 10.1007/978-0-387-88843-9_9; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Evangelista P., 2011, MAXENT MODEL V3 3 3E; Ewona, 2014, INT J PURE APPL PHYS, V2, P1; Foley DH, 2009, J MED ENTOMOL, V46, P680, DOI 10.1603/033.046.0336; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gilles MT, 1987, ANOPHELINAE AFRICA S, P55; Gillies M.T., 1968, PUBL S AFRICAN I MED, V54, P3; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; IPCC, 1995, CLIMATE CHANGE 1995; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Metz, 1991, NIGERIA COUNTRY STUD; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; NMEP, 2014, DESCR EP MAL GUID PL; Okorie Patricia N., 2014, Journal of Entomology and Zoology Studies, V2, P164; Okorie PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028347; Okwa OO, 2009, ANN AFR MED, V8, P1, DOI 10.4103/1596-3519.55756; Olayemi IK, 2014, APP SCI REPORT, V5, P110, DOI [10.15192/PSCP.ASR.2014.1.3.110117, DOI 10.15192/PSCP.ASR.2014.1.3.110117]; Onyabe DY, 2003, T ROY SOC TROP MED H, V97, P605, DOI 10.1016/S0035-9203(03)80045-7; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Ostfeld RS, 2009, ECOLOGY, V90, P903, DOI 10.1890/08-0659.1; Owoseye A., 2017, PREMIUM TIMES; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Siettos CI, 2013, VIRULENCE, V4, P295, DOI 10.4161/viru.24041; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Siteti MC., 2016, CHRISMED J HEALTH RE, V3, P45; Sunday O, 2006, AEJSR, P31; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Takken W, 2003, WAG UR FRON, V2, P75; Tappan GG, 2016, W AFRICA LAND USE LA, DOI [10.5066/F73N21JF, DOI 10.5066/F73N21JF]; Umar A., 2015, Advanced Studies in Biology, V7, P323; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 UNDESA; USAID, 2002, LAG100990001300 USAI; WHO, 2016, WORLD MAL REP 2016; WHO, 2015, WORLD MAL REP 2015; World Guides, 2016, NIG WEATH GO CLIM IN; World Health Organization, 2017, DEPRESSION; WorldClim D, GLOB CLIM DAT FREE C	66	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204233	10.1371/journal.pone.0204233	http://dx.doi.org/10.1371/journal.pone.0204233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281634	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400045
J	Jembere, GB; Cho, Y; Jung, M				Jembere, Gizachew Balew; Cho, Youngtae; Jung, Myunggu			Decomposition of Ethiopian life expectancy by age and cause of mortality; 1990-2015	PLOS ONE			English	Article							UPDATED SYSTEMATIC ANALYSIS; ARMED CONFLICT; CHILD-MORTALITY; ADULT MORTALITY; GLOBAL BURDEN; DISEASE; COUNTRIES; HEALTH; LOST	Ethiopia's average life expectancy has improved by more than 18 years from 1990 to 2015. This initiated interest to study the gain in life expectancy with respect to age structure and cause of death. Applying a life expectancy decomposition technique on secondary data obtained from the Institute of Health Metrics and Evaluation, the study found that the burden of disease in Ethiopia has declined from 626.18 in 1990 to 225.69 in 2015 per 1000 population measured in age-standardized rate of life years lost. The major causes of burden in 1990; namely lower respiratory tract infections, neonatal disorders, diarrheal diseases and neglected tropical diseases at rates of 89.2, 63.2, 61.2, and 42.2 age-standardized years of life lost per 1000 population respectively; have shown a fast decline in 2015. Deaths from neglected tropical disease showed 94.95% reduction, contributing to 5.71(27.30%) years gain in life expectancy followed by lower respiratory tract infection and diarrheal disease contributing about 4.65 years (22.23%) and 1.48 years (7.10%) respectively. On the other hand, about 3.3 (15.73%) years and 6.4 (30.71%) years of increase in life expectancy are achieved through improved longevity in infants and children aged 1-4 years respectively. In conclusion, the study found that reductions in under-five child mortality and decline in burden of major communicable diseases could explain the major gain in life expectancy. However, findings also revealed that the prevalence of non-communicable diseases and injuries are on the rise calling for the need to be addressed by the public health system.	[Jembere, Gizachew Balew; Cho, Youngtae] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Jung, Myunggu] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	Seoul National University (SNU); University of London; London School of Hygiene & Tropical Medicine	Cho, Y (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.	youngtae@snu.ac.kr		Jembere, Gizachew Balew/0000-0003-2607-0333; Jung, Myunggu/0000-0003-3713-4558				Abdulahi H, 2001, ETHIOPIAN MED J, V39, P271; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], UNDP HUM DEV REP; [Anonymous], 2014, UN MILL DEV GOALS RE, P26; Bhutta ZA, 2012, LANCET, V379, P2126, DOI 10.1016/S0140-6736(12)60686-2; Castro MC, 2001, MATH POPUL STUD, V9, P181; Central Statistical Agency (CSA) [Ethiopia] ICF, 2016, ETHIOPIA DEMOGRAPHIC; Chapman G, 2006, TROP MED INT HEALTH, V11, P660, DOI 10.1111/j.1365-3156.2006.01601.x; CSA [Ethiopia] and ICF, 2012, 2011 ETH DEM HLTH SU; Fantahun M, 2004, ETHIOPIAN MED J, V42, P165; Federal Ministry of Health Ethiopia (FMoH), 2015, HLTH SECT TRANSF PLA; FMOH Ethiopia, 2010, NAT EXP PROGR IMM CO; Gates S, 2012, WORLD DEV, V40, P1713, DOI 10.1016/j.worlddev.2012.04.031; GBD, 2016, GLOB BURD DIS STUD 2; GBD, 2015, GLOB BURD DIS GBD 20; IHME, 2013, GLOB HLTH DAT EXCH; Li Q, 2005, J PEACE RES, V42, P471, DOI 10.1177/0022343305054092; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Measure Evaluation, 2015, M E LEARN CTR LESS 5; Ministry of Health FDRoE, 2011, HLTH HLTH REL IND; Ministry of Health FDRoE, 2012, MIN HLTH FACTSH; MINTZ A, 1995, J CONFLICT RESOLUT, V39, P283, DOI 10.1177/0022002795039002004; Misganaw A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-130; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ngoc NTN, 2006, B WORLD HEALTH ORGAN, V84, P699, DOI 10.2471/BLT.05.027300; Norman L, 1996, 1577 WORLD BANK SOC; Plumper T, 2006, INT ORGAN, V60, P723, DOI 10.1017/S0020818306060231; Ponnapalli KM, 2005, DEMOGR RES, V12, P141; Reza HA, 2011, B WORLD HEALTH ORGAN, P2; ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143; Smith D, 1998, USERS GUIDE PROGRAMM; Timaeus IM, 2004, DEMOGRAPHY, V41, P757, DOI 10.1353/dem.2004.0037; United Nations, 2014, LIF EXP RIS; United Nations Department of Economic and Social Affairs (UN DESA), 2012, WORLD POP PROSP 2012; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WHO, 2014, WHO TECHN REP SER, P59; WHO regional office for Africa, 2016, ETH IMM; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2018, WHO METH DAT SOURC C; World Health Organization, 2017, WHO METH DAT SOURC G; World Health Organization (WHO), 2014, WHOHISHSIGHE20147; World Life Expectancy, 2014, WORLD LIF EXP LIV LO	46	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204395	10.1371/journal.pone.0204395	http://dx.doi.org/10.1371/journal.pone.0204395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281624	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000446342400047
J	Zhang, ZG; Wu, L; Wang, JL; Li, G; Feng, DY; Zhang, B; Li, LH; Yang, JD; Ma, LT; Qin, HZ				Zhang, Zhiguo; Wu, Lin; Wang, Julei; Li, Gang; Feng, Dayun; Zhang, Bin; Li, Lihong; Yang, Jiandong; Ma, Lianting; Qin, Huaizhou			Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell Apoptosis (vol 9, e96283, 2014)	PLOS ONE			English	Correction																		Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Zhang ZG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096283	2	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205391	10.1371/journal.pone.0205391	http://dx.doi.org/10.1371/journal.pone.0205391			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281640	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400090
J	den Drijver, E; Verweij, JJ; Verhulst, C; Oome, S; Soer, J; Willemsen, I; Schrauwen, EJA; Kluytmans-van den Bergh, MFQ; Kluytmans, JAJW				den Drijver, Evert; Verweij, Jaco J.; Verhulst, Carlo; Oome, Stijn; Soer, Joke; Willemsen, Ina; Schrauwen, Eefje J. A.; Kluytmans-van den Bergh, Marjolein F. Q.; Kluytmans, Jan A. J. W.			Decline in AmpC beta-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016)	PLOS ONE			English	Article							EXTENDED-SPECTRUM; MOLECULAR CHARACTERIZATION; RISK-FACTORS; CTX-M; PREVALENCE; ENTEROBACTERIACEAE; COLONIZATION; EPIDEMIOLOGY; INFECTIONS; MICROARRAY	Objective The objective of this study is to determine the prevalence of rectal carriage of plasmid- and chromosome-encoded AmpC beta-lactamase-producing Escherichia coli and Klebsiella spp. in patients in a Dutch teaching hospital between 2013 and 2016. Methods Between 2013 and 2016, hospital-wide yearly prevalence surveys were performed to determine the prevalence of AmpC beta-lactamase-producing E. coli and Klebsiella spp. rectal carriage. Rectal swabs were taken and cultured using an enrichment broth and selective agar plates. All E. coli and Klebsiella spp. isolates were screened for production of AmpC beta-lactamase using phenotypic confirmation tests and for the presence of plasmid-encoded AmpC (pAmpC) genes. E. coli isolates were screened for chromosome-encoded AmpC (cAmpC) promoter/attenuator alterations. Results Fifty (2.4%) of 2,126 evaluable patients were identified as rectal carrier of AmpC beta-lactamase-producing E. coll. No carriage of AmpC beta-lactamase producing Klebsiella spp. was found. Nineteen (0.9%) patients harboured isolates with pAmpC genes and 30 (1,4%) patients harboured isolates with cAmpC promoter/attenuator alterations associated with AmpC beta-lactamase overproduction. For one isolate, no pAmpC genes or cAmpC promotor/attenuator alterations could be identified. During the study period, a statistically significant decline in the prevalence of rectal carriage with E. coil with cAmpC promotor/attenuator alterations was found (p = 0.012). The prevalence of pAmpC remained stable over the years. Conclusions The prevalence of rectal carriage of AmpC-producing E. coli and Klebsiella spp. in patients in Dutch hospitals is low and a declining trend was observed for E. coli with cAmpC promotor/attenuator alterations.	[den Drijver, Evert; Verhulst, Carlo; Oome, Stijn; Soer, Joke; Willemsen, Ina; Schrauwen, Eefje J. A.; Kluytmans-van den Bergh, Marjolein F. Q.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [den Drijver, Evert; Verweij, Jaco J.; Kluytmans, Jan A. J. W.] Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Oome, Stijn; Soer, Joke; Schrauwen, Eefje J. A.] AVANS Univ Appl Sci, Avans Acad Technol Hlth & Environm, Breda, Netherlands; [Kluytmans-van den Bergh, Marjolein F. Q.] Amphia Hosp, Amphia Acad Infect Dis Fdn, Breda, Netherlands; [Kluytmans-van den Bergh, Marjolein F. Q.; Kluytmans, Jan A. J. W.] Univ Utrecht, Julius Ctr Hlth Sci & Primary Care, UMC Utrecht, Utrecht, Netherlands	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Amphia Hospital; Utrecht University	den Drijver, E (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.; den Drijver, E (corresponding author), Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.	e.dendrijver@etz.nl	van den Bergh, Marjolein Kluytmans -/A-7267-2016	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408; Verweij, Jaco J./0000-0001-8553-931X				Alonso N, 2016, INT J ANTIMICROB AG, V47, P62, DOI 10.1016/j.ijantimicag.2015.10.007; Bogaerts P, 2016, INT J ANTIMICROB AG, V48, P189, DOI 10.1016/j.ijantimicag.2016.05.006; Corvec S, 2002, ANTIMICROB AGENTS CH, V46, P3265, DOI 10.1128/AAC.46.10.3265-3267.2002; Cunningham SA, 2016, J CLIN MICROBIOL, V54, P1368, DOI 10.1128/JCM.03302-15; Cuzon G, 2012, J ANTIMICROB CHEMOTH, V67, P1865, DOI 10.1093/jac/dks156; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Garrido A, 2014, MICROB DRUG RESIST, V20, P301, DOI 10.1089/mdr.2013.0109; Hordijk J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00242; Hordijk J, 2013, J ANTIMICROB CHEMOTH, V68, P1970, DOI 10.1093/jac/dkt132; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Husickova V, 2012, BIOMED PAP, V156, P348, DOI 10.5507/bp.2012.039; Ingram PR, 2011, J MED MICROBIOL, V60, P715, DOI 10.1099/jmm.0.029140-0; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jorgensen RL, 2010, J ANTIMICROB CHEMOTH, V65, P460, DOI 10.1093/jac/dkp484; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kluytmans-van den Bergh MFQ, 2015, J CLIN MICROBIOL, V53, P2709, DOI 10.1128/JCM.01251-15; Koningstein M, 2015, J PEDIAT INF DIS SOC, V4, pE93, DOI 10.1093/jpids/piv042; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Nourrisson C, 2015, EUR J CLIN MICROBIOL, V34, P975, DOI 10.1007/s10096-014-2305-6; Park MJ, 2013, ANN LAB MED, V33, P353, DOI 10.3343/alm.2013.33.5.353; Pascual V, 2016, EUR J CLIN MICROBIOL, V35, P1997, DOI 10.1007/s10096-016-2752-3; Pascual V, 2015, J ANTIMICROB CHEMOTH, V70, P899, DOI 10.1093/jac/dku468; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Reuland EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113033; Rodriguez-Bano J, 2012, J INFECTION, V64, P176, DOI 10.1016/j.jinf.2011.11.016; Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999; Tracz DM, 2007, FEMS MICROBIOL LETT, V270, P265, DOI 10.1111/j.1574-6968.2007.00672.x; Ulstad CR, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0156-x; van Hoek AHAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129085; Veldman K. T, 2016, MARAN 2016 MONITORIN; Willemsen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141765	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204864	10.1371/journal.pone.0204864	http://dx.doi.org/10.1371/journal.pone.0204864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273375	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700044
J	Esculier, JF; Krowchuk, NM; Li, LC; Taunton, JE; Hunt, MA				Esculier, Jean-Francois; Krowchuk, Natasha M.; Li, Linda C.; Taunton, Jack E.; Hunt, Michael A.			What are the perceptions about running and knee joint health among the public and healthcare practitioners in Canada?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY GUIDELINES; OLDER-ADULTS; OSTEOARTHRITIS; HIP; EXERCISE; PEOPLE; ASSOCIATION; COMMUNITY; PAIN	Objectives To evaluate the perceptions of the general public and healthcare practitioners (HCP) in Canada about the relationship between running and knee joint health, and to explore HCP's usual recommendations to runners with knee osteoarthritis (KOA). Methods Non-runners and runners (with and without KOA) and HCP completed an online survey regarding the safety of running for knee joint health. HCP also provided information related to usual clinical recommendations. Proportions of agreement were compared between non-runners and runners. Results A total of 114 non-runners, 388 runners and 329 HCP completed the survey. Overall, running was perceived as detrimental for the knee joint by 13.1% of the general public, while 25.9% were uncertain. More uncertainty was reported regarding frequent (33.9%) and long-distance (43.6%) running. Statistical analyses revealed greater proportions of non-runners perceiving running negatively compared with runners. Overall, 48.4% believed that running in the presence of KOA would lead to disease progression, while 53.1% believed running would lead to premature arthroplasty. In HCP, 8.2%, 9.1% and 22.2% perceived that running in general, running frequently, or running long-distances are risk factors for KOA, respectively. 37.1% and 2.7% of HCP typically recommended patients with KOA to modify their running training or to quit running, respectively. Conclusion High rates of uncertainty among the general public and HCP in Canada outline the need for further studies about running and knee joint health. Filling knowledge gaps will help inform knowledge translation strategies to better orientate the general public and HCP about the safety of running for knee joint health.	[Esculier, Jean-Francois; Krowchuk, Natasha M.; Li, Linda C.; Hunt, Michael A.] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada; [Li, Linda C.] Arthrit Res Canada, Richmond, BC, Canada; [Taunton, Jack E.] Univ British Columbia, Fac Med, Dept Family Med, Vancouver, BC, Canada	University of British Columbia; Arthritis Research Canada; University of British Columbia	Hunt, MA (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada.	michael.hunt@ubc.ca	Li, Linda C./P-8485-2015	Li, Linda C./0000-0001-6280-0511; Hunt, Michael/0000-0002-8648-1591	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Any funding secured is limited to scholarship or salary support from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research. The funders had no role in any aspect of the study	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; Alentorn-Geli E, 2017, J ORTHOP SPORT PHYS, V47, P373, DOI 10.2519/jospt.2017.7137; Bombardier C., 2011, IMPACT ARTHRITIS CAN; Bricca A, 2018, BR J SPORTS MED; Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3; Gay C, 2017, JOINT BONE SPINE; Hansen P, 2012, PM&R, V4, pS117, DOI 10.1016/j.pmrj.2012.02.011; Hespanhol LC, 2015, SPORTS MED, V45, P1455, DOI 10.1007/s40279-015-0359-y; Holden MA, 2012, ARTHRIT CARE RES, V64, P1554, DOI 10.1002/acr.21700; Jinks C, 2016, OSTEOARTHR CARTILAGE, V24, pS186, DOI 10.1016/j.joca.2016.01.365; Li LC, 2011, J RHEUMATOL, V38, P2230, DOI 10.3899/jrheum.110264; Lo GH, 2018, CLIN RHEUMATOL; Lo GH, 2017, ARTHRIT CARE RES, V69, P183, DOI 10.1002/acr.22939; Macintyre JG, 1991, CLIN J SPORT MED, V1, P81, DOI DOI 10.1097/00042752-199104000-00002; Miller RH, 2017, EXERC SPORT SCI REV, V45, P87, DOI 10.1249/JES.0000000000000105; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Nicolson PJA, 2018, ARTHRIT CARE RES, V70, P388, DOI 10.1002/acr.23297; Ponzio DY, 2018, J BONE JOINT SURG AM, V100, P131, DOI 10.2106/JBJS.16.01071; Semanik PA, 2012, PM&R, V4, pS37, DOI 10.1016/j.pmrj.2012.02.015; Stubbs B, 2015, CLIN REHABIL, V29, P80, DOI 10.1177/0269215514538069; Szabo A, 2013, PSYCHOL HEALTH MED, V18, P251, DOI 10.1080/13548506.2012.701755; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Timmins KA, 2017, AM J SPORT MED, V45, P1447, DOI 10.1177/0363546516657531; Wallis JA, 2013, OSTEOARTHR CARTILAGE, V21, P1648, DOI 10.1016/j.joca.2013.08.003; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Williams PT, 2013, MED SCI SPORT EXER, V45, P1292, DOI 10.1249/MSS.0b013e3182885f26	26	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204872	10.1371/journal.pone.0204872	http://dx.doi.org/10.1371/journal.pone.0204872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273410	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700045
J	Li, YX; Huang, JB; Yan, Y; Liang, JJ; Liang, QK; Lu, YY; Zhao, L; Li, HF				Li, Yunxia; Huang, Jinbing; Yan, Yuan; Liang, Jingjing; Liang, Qiankun; Lu, Yanyu; Zhao, Li; Li, Hongfang			Preventative effects of resveratrol and estradiol on streptozotocin-induced diabetes in ovariectomized mice and the related mechanisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; VASCULAR RESPONSIVENESS; HOMA-IR; GLUCOSE; MUSCLE; HYPERGLYCEMIA; PROTECTION; SECRETION	Resveratrol, a non-flavonoid polyphenolic compound, is structurally and functionally similar to estrogen and has drawn great attention for its potentially beneficial effects on diabetes. However, it is not known whether it shares the same protective effect against diabetes as estrogen and the underlying mechanisms. The aim of the present study was to investigate the protective effects of phytoestrogen resveratrol and exogenous 17 beta-estradiol against streptozotocin (STZ)-induced type 1 diabetes. Female mice were ovariectomized (OVX) and chronically injected with different concentrations of resveratrol (0.1, 1 or 10 mg/kg) and 17 beta-estradiol (0.01, 0.1 or 1 mg/kg) subcutaneously for 4 weeks, and the levels of blood glucose, plasma insulin, plasma antioxidant capacity, the changes of pancreatic islet cells and the expressions of glucose transporter 4 (GLUT4), insulin receptor substrate 1 (IRS-1) and phosphorylation of extracellular signal-regulated kinase (p-ERK) were detected. Resveratrol and 17 beta-estradiol significantly inhibited the increase of the blood glucose level and the rise of plasma malondialdehyde in STZ-induced diabetic mice, improved the levels of plasma antioxidant capacity and plasma insulin, protected the pancreatic islet cells, and increased the expressions of GLUT4 and IRS-1, but decreased p-ERK expression in skeletal muscle and myocardial tissue. The results suggest that resveratrol or 17 beta-estradiol shows obvious protection against STZ-induced diabetes in OVX mice, the mechanisms probably involve their ameliorating antioxidant activities and islet function, promoting muscle glucose uptake and inhibiting the expression of p-ERK.	[Li, Yunxia; Huang, Jinbing; Yan, Yuan; Liang, Jingjing; Liang, Qiankun; Zhao, Li; Li, Hongfang] Lanzhou Univ, Coll Basic Med, Dept Physiol, Lanzhou, Gansu, Peoples R China; [Lu, Yanyu] Lanzhou Univ, Funct Lab Coll Basic Med, Lanzhou, Gansu, Peoples R China; [Li, Hongfang] Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Li, HF (corresponding author), Lanzhou Univ, Coll Basic Med, Dept Physiol, Lanzhou, Gansu, Peoples R China.; Li, HF (corresponding author), Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou, Gansu, Peoples R China.	lihf@lzu.edu.cn			Administration of Traditional Chinese Medicine of Gansu Province [GZK-2015-238]	Administration of Traditional Chinese Medicine of Gansu Province	Funding was provided by the Administration of Traditional Chinese Medicine of Gansu Province (grant # GZK-2015-238) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Acconcia F, 2017, MOL CELL ENDOCRINOL, V457, P3, DOI 10.1016/j.mce.2016.10.033; Alvim RO, 2015, AN ACAD BRAS CIENC, V87, P351, DOI 10.1590/0001-3765201520140225; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Arrick DM, 2011, AM J PHYSIOL-HEART C, V301, pH696, DOI 10.1152/ajpheart.00312.2011; Ates O, 2007, J CLIN NEUROSCI, V14, P256, DOI 10.1016/j.jocn.2005.12.010; Borissova AM, 2002, GYNECOL ENDOCRINOL, V16, P67, DOI 10.1080/713602987; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Brussaard HE, 1997, ARTERIOSCL THROM VAS, V17, P324, DOI 10.1161/01.ATV.17.2.324; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Catanuto P, 2009, 17 BETA ESTRADIOL TA, V75, P1194, DOI [10.1038/ki.2009.69, DOI 10.1038/KI.2009.69]; Catanuto Paola, 2017, Curr Trends Endocinol, V9, P19; Cetkovic-Cvrlje M, 2017, J IMMUNOTOXICOL, V14, P160, DOI 10.1080/1547691X.2017.1334722; Chang CC, 2012, CHINESE J PHYSIOL, V55, P192, DOI [10.4077/CJP.2011.BAA012, 10.4077/CJP.2012.BAA012]; Chen KH, 2011, AM J PHYSIOL-ENDOC M, V301, pE853, DOI 10.1152/ajpendo.00048.2011; Chi TC, 2007, LIFE SCI, V80, P1713, DOI 10.1016/j.lfs.2007.02.002; Choi J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010051; Barros RPD, 2008, MOL CELL ENDOCRINOL, V295, P24, DOI 10.1016/j.mce.2008.07.008; Deng JY, 2008, DIABETES, V57, P1814, DOI 10.2337/db07-1750; Do GM, 2012, MOL NUTR FOOD RES, V56, P1282, DOI 10.1002/mnfr.201200067; Ekladous D, 2008, CLIN EXP PHARMACOL P, V35, P971, DOI 10.1111/j.1440-1681.2008.04944.x; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gencoglu H, 2015, INT J FOOD SCI NUTR, V66, P314, DOI 10.3109/09637486.2014.1003534; Kara A, 2014, GYNECOL ENDOCRINOL, V30, P226, DOI 10.3109/09513590.2013.864270; Li HF, 2006, PHYSIOL RES, V55, P365, DOI 10.33549/physiolres.930826; Mossmann M, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0085-5; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Nakhjavani M, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0102-5; Negi G, 2011, J PINEAL RES, V50, P124, DOI 10.1111/j.1600-079X.2010.00821.x; Opara EC, 2002, J R SOC PROMO HEALTH, V122, P28, DOI 10.1177/146642400212200112; Ordonez P, 2008, J STEROID BIOCHEM, V111, P287, DOI 10.1016/j.jsbmb.2008.07.001; Palsamy P, 2008, BIOMED PHARMACOTHER, V62, P598, DOI 10.1016/j.biopha.2008.06.037; Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008; Prasannarong M, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-28; Rahavi H, 2017, J IMMUNOTOXICOL, V14, P160; Roghani M, 2010, PHYTOTHER RES, V24, pS148, DOI 10.1002/ptr.3032; Santos RS, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0151-9; Schindler CE, 2014, AM J PHYSIOL-REG I, V307, pR434, DOI 10.1152/ajpregu.00123.2014; Shen KP, 2018, KAOHSIUNG J MED SCI, V34, P142, DOI 10.1016/j.kjms.2017.11.003; Silan C, 2008, BIOL PHARM BULL, V31, P897, DOI 10.1248/bpb.31.897; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Szkudelski T, 2015, BBA-MOL BASIS DIS, V1852, P1145, DOI 10.1016/j.bbadis.2014.10.013; Tang Q, 2015, DRUG DISCOV THER, V9, P380, DOI 10.5582/ddt.2015.01207; Vogel H, 2013, HORM METAB RES, V45, P430, DOI 10.1055/s-0032-1331700; Wang M, 2018, J DIABETES INVEST, V9, P762, DOI 10.1111/jdi.12775; Wang Q, 2008, DIABETOLOGIA, V51, P1202, DOI 10.1007/s00125-008-1026-8; Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983; Whitcroft Sovra, 2011, Menopause Int, V17, P24, DOI 10.1258/mi.2011.011003; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yan CF, 2016, MOL ENDOCRINOL, V30, P600, DOI 10.1210/me.2015-1277; Yoh K, 2008, GENES CELLS, V13, P1159, DOI 10.1111/j.1365-2443.2008.01234.x; Yoshihara E, 2016, CELL METAB, V23, P622, DOI 10.1016/j.cmet.2016.03.005; Zhang JY, 2012, DIABETES RES CLIN PR, V97, P474, DOI 10.1016/j.diabres.2012.02.029; Zhou YQ, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/506390	57	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204499	10.1371/journal.pone.0204499	http://dx.doi.org/10.1371/journal.pone.0204499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273360	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700024
J	Pollini, S; Di Pilato, V; Landini, G; Di Maggio, T; Cannatelli, A; Sottotetti, S; Cariani, L; Aliberti, S; Blasi, F; Sergio, F; Rossolini, GM; Pallecchi, L				Pollini, Simona; Di Pilato, Vincenzo; Landini, Giulia; Di Maggio, Tiziana; Cannatelli, Antonio; Sottotetti, Samantha; Cariani, Lisa; Aliberti, Stefano; Blasi, Francesco; Sergio, Francesco; Rossolini, Gian Maria; Pallecchi, Lucia			In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm	PLOS ONE			English	Article							LUNG TRANSPLANTATION; CYSTIC-FIBROSIS; RESISTANCE; INFECTION; PATHOGENS; MODEL	Stenotrophomonas maltophilia and Burkholderia cepacia complex (Bcc) have been increasingly recognized as relevant pathogens in hospitalized, immunocompromised and cystic fibrosis (CF) patients. As a result of complex mechanisms, including biofilm formation and multidrug resistance phenotype, S. maltophilia and Bcc respiratory infections are often refractory to therapy, and have been associated with a worse outcome in CF patients. Here we demonstrate for the first time that N-acetylcysteine (NAC), a mucolytic agent with antioxidant and anti-inflammatory properties, may exhibit antimicrobial and antibiofilm activity against these pathogens. The antimicrobial and antibiofilm activity of high NAC concentrations, potentially achievable by topical administration, was tested against a collection of S. maltophilia (n = 19) and Bcc (n = 19) strains, including strains from CF patients with acquired resistance traits. Minimum Inhibitory Concentrations (MICs) and Minimum Bactericidal Concentrations (MBCs) ranged from 16 to 32 mg/ml and from 32 to >32 mg/ml, respectively. Sub-MIC concentrations (i.e., 0.25 x MIC) slowed down the growth kinetics of most strains. In time-kill assays, 2-day-old biofilms were more affected than planktonic cultures, suggesting a specific antibiofilm activity of NAC against these pathogens. Indeed, a dose- and time-dependent antibiofilm activity of NAC against most of the S. maltophilia and Bcc strains tested was observed, with a sizable antibiofilm activity observed also at 0.5 and 1 x MIC NAC concentrations. Furthermore, at those concentrations, NAC was also shown to significantly inhibit biofilm formation with the great majority of tested strains.	[Pollini, Simona; Di Pilato, Vincenzo; Rossolini, Gian Maria] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Landini, Giulia; Di Maggio, Tiziana; Cannatelli, Antonio; Pallecchi, Lucia] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Sottotetti, Samantha; Cariani, Lisa] Osped Maggiore Policlin, Cyst Fibrosis Microbiol Lab, IRCCS Fdn Ca Granda, Milan, Italy; [Aliberti, Stefano; Blasi, Francesco] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Aliberti, Stefano; Blasi, Francesco] Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Internal Med Dept, Resp Unit, Milan, Italy; [Aliberti, Stefano; Blasi, Francesco] Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Reg Adult Cyst Fibrosis Ctr, Milan, Italy; [Sergio, Francesco] Zambon SpA, Global Resp Med Affairs, Bresso, Italy; [Rossolini, Gian Maria] Florence Careggi Univ Hosp, Clin Microbiol & Virol Unit, Florence, Italy	University of Florence; University of Siena; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; Zambon; University of Florence; Azienda Ospedaliero Universitaria Careggi	Pallecchi, L (corresponding author), Univ Siena, Dept Med Biotechnol, Siena, Italy.	lucia.pallecchi@unisi.it	Aliberti, Stefano/K-9115-2016; Pollini, Simona/D-1709-2017; Aliberti, Stefano/AAL-8032-2021; Pallecchi, Lucia/S-7193-2018; Di Pilato, Vincenzo/K-1182-2018; Blasi, Francesco/O-5885-2017	Aliberti, Stefano/0000-0002-0090-4531; Aliberti, Stefano/0000-0002-0090-4531; Pallecchi, Lucia/0000-0001-7999-5140; Di Pilato, Vincenzo/0000-0002-5863-5805; Blasi, Francesco/0000-0002-2285-9970	Zambon S.p.A.	Zambon S.p.A.	This work was funded by a research grant from Zambon S.p.A. FS is employed at Corporate Respiratory Medical Affairs, Zambon S.p.A. Zambon S.p.A. provided support in the form of salary for author FS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Abbott IJ, 2015, SEMIN RESP CRIT CARE, V36, P99, DOI 10.1055/s-0034-1396929; Amaral EP, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0872-7; Bach E, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx076; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barsky EE, 2017, PEDIATR PULM, V52, P1276, DOI 10.1002/ppul.23781; Blasi F, 2016, RESP MED, V117, P190, DOI 10.1016/j.rmed.2016.06.015; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Chiew AL, 2016, BRIT J CLIN PHARMACO, V81, P471, DOI 10.1111/bcp.12789; CLSI, 1999, M26A CLIN LAB STAND; Domenech M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01992-16; Eroshenko D, 2017, MICROB PATHOGENESIS, V105, P145, DOI 10.1016/j.micpath.2017.02.030; Esposito A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01590; Ferris RA, 2016, J CLIN MICROBIOL, V54, P631, DOI 10.1128/JCM.02861-15; Gautam V, 2015, EXPERT REV ANTI-INFE, V13, P629, DOI 10.1586/14787210.2015.1025056; Goswami M, 2010, ANTIMICROB AGENTS CH, V54, P3529, DOI 10.1128/AAC.00710-10; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Landini G, 2016, ANTIMICROB AGENTS CH, V60, P7513, DOI 10.1128/AAC.01334-16; Lewis ERG, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw070; Mata AF, 2013, PEDIATRICS, V132, pE1418, DOI 10.1542/peds.2013-0912; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Rodriguez-Beltran J, 2015, ANTIMICROB AGENTS CH, V59, P3246, DOI 10.1128/AAC.00017-15; SAMBROOK J, 2000, MOL CLONING LAB MANU; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Scoffone VC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01592; Snell G, 2017, J CYST FIBROS, V16, P553, DOI 10.1016/j.jcf.2017.06.008; Volgers C, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx087; Wang RB, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13236; Waters V, 2013, J CYST FIBROS, V12, P482, DOI 10.1016/j.jcf.2012.12.006; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140	31	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203941	10.1371/journal.pone.0203941	http://dx.doi.org/10.1371/journal.pone.0203941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273348	Green Published, gold			2022-12-27	WOS:000446124700009
J	Corbin, V; Frange, P; Veber, F; Blanche, S; Runel-Belliard, C; Lalande, M; Gandemer, V; Moukagni-Pelzer, M; Dollfus, C; Coban, D; Prouteau, J; Jacomet, C; Lesens, O				Corbin, Violaine; Frange, Pierre; Veber, Florence; Blanche, Stephane; Runel-Belliard, Camille; Lalande, Muriel; Gandemer, Virginie; Moukagni-Pelzer, Marie; Dollfus, Catherine; Coban, Dilek; Prouteau, Justine; Jacomet, Christine; Lesens, Olivier		HIV Adopted Children Study Grp	Clinical, virological and immunological features of HIV-positive children internationally adopted in France from 2005-2015	PLOS ONE			English	Article							INFECTIOUS-DISEASES; MUTATIONS; FAILURE	Objective(s) To describe the clinical, virological and immune characteristics of internationally adopted children on arrival in France and after 6-months follow-up. Design Multicenter retrospective study. Methods 30 centers from 24 cities were asked to include, after informed consent, HIV+ children living in France and internationally adopted between 1st Jan 2005 and 1st Jan 2015. Sociodemographic, medical and biological variables collected during the first medical evaluation in France and 6 months later were analyzed. Results 41 HIV+ adoptees were included (female: 56%; median age: 3.91 years) in 14 centers. Adoptees tend to represent an increasing part of newly diagnosed HIV positive children over the years. The majority came from East-Asia. At arrival, one child was diagnosed with lymphobronchial tuberculosis and three with latent chronic hepatitis B, cleared HBV infection and chronic active hepatitis C, respectively. The mean CD4%. was 32.8 +/- 9% (range: 13-49%). The 34 children (83%) have been initiated on treatment from their countries of origin. Of these, 25 (74%) had an undetectable viral load (VL) on arrival. Resistance to ART was detected in five. At 6 months, 36 adoptees received ART, and the VL was undetectable in 29 children (71%), with one acquired resistance to NRTI & NNRTI. Conclusions An increasing number of HIV-infected children have been internationally adopted in France since 2005. Most of the children have been initiated on treatment from their countries of origin, had good immunity, with few opportunistic infections, and infrequently detectable VL. Low level of mutation conferring resistance was detected.	[Corbin, Violaine; Coban, Dilek; Prouteau, Justine; Jacomet, Christine; Lesens, Olivier] CHU Clermont Ferrand, Serv Malad Infect & Trop, Clermont Ferrand, France; [Frange, Pierre; Veber, Florence; Blanche, Stephane] Hop Univ Necker Enfants Malades, AP HP, Unite Immunol Hematol & Rhumatol Pediatr, Paris, France; [Frange, Pierre] Hop Univ Necker Enfants Malades, AP HP, Lab Microbiol Clin, Paris, France; [Frange, Pierre] Univ Paris 05, Sorbonne Paris Cite, EA7327, Paris, France; [Runel-Belliard, Camille] CHU Bordeaux, Hop Pellegrin, Serv Urgences Pediatr, Ctr Competence Drepanocytose, Bordeaux, France; [Lalande, Muriel] CHRU Montpellier, Hop Arnaud Villeneuve, Pole Femme Mere Enfant, Serv Pediat Gen Infectiol & Immunol Clin, Montpellier, France; [Gandemer, Virginie] CHU Hop Sud, Serv Hematooncol Pediat, Pole Femme Enfant, Rennes, France; [Moukagni-Pelzer, Marie] GH ICL, Hop St Vincent de Paul, Clin Pediat St Antoine, Lille, France; [Dollfus, Catherine] Hop Enfants Armand Trousseau, AP HP, Serv Hematol & Oncol Pediat, Paris, France; [Lesens, Olivier] Univ Auvergne, LMGE, UMR 6023, Clermont Ferrand, France	CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Universite de Montpellier; CHU de Montpellier; CHU Rennes; UNICANCER; Institut de cancerologie de Lorraine (ICL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Lesens, O (corresponding author), CHU Clermont Ferrand, Serv Malad Infect & Trop, Clermont Ferrand, France.; Lesens, O (corresponding author), Univ Auvergne, LMGE, UMR 6023, Clermont Ferrand, France.	olesens@chu-clermontferrand.fr	Frange, Pierre/O-6311-2017	Jeziorski, Eric/0000-0003-0318-3044				Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Ampofo K, 2013, CURR OPIN PEDIATR, V25, P78, DOI 10.1097/MOP.0b013e32835c1357; Boerma RS, 2016, CLININFECT DIS, DOI [10.1145/2901790.2901866, DOI 10.1145/2901790.2901866]; Caldwell MB, 1994, MMWR-MORBID MORTAL W, V43, P5; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Centers for Disease Control and Prevention, PERC DAT FIL LMS VAL; Dartiguenave C, 2012, Bull Soc Pathol Exot, V105, P109, DOI 10.1007/s13149-012-0215-3; Gallien S, 2015, J ANTIMICROB CHEMOTH, V70, P562, DOI 10.1093/jac/dku395; Henaff F, 2015, J TRAVEL MED, V22, P179, DOI 10.1111/jtm.12196; HOSTETTER MK, 1991, NEW ENGL J MED, V325, P479, DOI 10.1056/NEJM199108153250706; Luzuriaga K, 2016, NEW ENGL J MED, V374, P761, DOI 10.1056/NEJMra1505256; Morlat P, 2013, RECOMMANDATIONS GROU; Sciauvaud J, 2014, CLIN MICROBIOL INFEC, V20, P746, DOI 10.1111/1469-0691.12454; Sigaloff KCE, 2011, LANCET INFECT DIS, V11, P769, DOI 10.1016/S1473-3099(11)70141-4; UNICEF, 2016, ANN REP 2015; Wolf ER, 2016, PEDIATR INFECT DIS J, V35, P422, DOI 10.1097/INF.0000000000001020	16	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203438	10.1371/journal.pone.0203438	http://dx.doi.org/10.1371/journal.pone.0203438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265670	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500008
J	Doyle, AM; Floyd, S; Baisley, K; Orindi, B; Kwaro, D; Mthiyane, TN; Muuo, S; Shahmanesh, M; Ziraba, A; Birdthistle, I				Doyle, Aoife M.; Floyd, Sian; Baisley, Kathy; Orindi, Benedict; Kwaro, Daniel; Mthiyane, Thandiwe N.; Muuo, Sheru; Shahmanesh, Maryam; Ziraba, Abdhalah; Birdthistle, Isolde			Who are the male sexual partners of adolescent girls and young women? Comparative analysis of population data in three settings prior to DREAMS roll-out	PLOS ONE			English	Article							AGE-DISPARATE RELATIONSHIPS; HIV-INFECTION; SOUTH-AFRICA; LIKOMA ISLAND; RISK; PREVALENCE; PROFILE; ACQUISITION; EPIDEMICS; BEHAVIOR	Background The DREAMS (Determined Resilient Empowered AIDS-free, Mentored and Safe) Partnership aims to reduce HIV incidence among adolescent girls and young women (AGYW,15-24y) with a core package of evidence-based interventions. Some interventions, including voluntary HIV counselling and testing and circumcision, will be targeted at the male sexual partners of AGYW. A priority of DREAMS is to characterise the male partners for effective targeting. Methods Using population-based data (2010-2015) in three DREAMS impact evaluation settings in Kenya and South Africa, we describe the demographic characteristics and sexual behaviour of male partners reported by AGYW, and the characteristics of males who report sexual activity with AGYW. Results In all settings, over 90% of recent male partners reported by AGYW were aged <35 years. Median ages of spousal and non-spousal partners were 29 and 23 years respectively in uMkhanyakude (rural South Africa) and 21 and 20 years respectively in Nairobi (urban Kenya). Most males reporting an AGYW partner had never been married (89%) and many were in school (39%). Most male partners reported only 1 AGYW partner in the past year; in Gem (rural Kenya) and Nairobi 25%-29% reported 2+(AGYW or older female) partners. Concurrent partners were reported by 16% of male partners in Gem and 3-4% in uMkhanyakude. Two thirds of male partners in Gem reported testing for HIV in the past 6 months and under half in uMkhanyakude reported testing for HIV in the past year. Almost all (96%) partners in Nairobi were circumcised, compared to 45% in Gem and 43% in uMkhanyakude. Conclusions With almost all AGYW's sexual partners aged 15-34 years, this is an appropriate target group for DREAMS interventions. Encouraging young men to reduce their number of partners and concurrency, and uptake prevention and treatment services such as HIV testing, circumcision and ART is crucial in the effort to reduce HIV among both AGYW and young men.	[Doyle, Aoife M.; Floyd, Sian; Baisley, Kathy] London Sch Hyg & Trop Med, Dept Infect Dis, MRC Trop Epidemiol Grp, London, England; [Baisley, Kathy; Mthiyane, Thandiwe N.; Shahmanesh, Maryam] African Hlth Res Inst, Kwa Zulu, South Africa; [Orindi, Benedict; Muuo, Sheru; Ziraba, Abdhalah] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Orindi, Benedict] Katholieke Univ Leuven, Leuven, Belgium; [Kwaro, Daniel] Kenya Govt Med Res Ctr, Gem, Siaya County, Kenya; [Shahmanesh, Maryam] UCL, London, England; [Birdthistle, Isolde] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; African Population & Health Research Centre; KU Leuven; Kenya Medical Research Institute; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Doyle, AM (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis, MRC Trop Epidemiol Grp, London, England.	aoife.doyle@lshtm.ac.uk	Ziraba, Abdhalah/T-3707-2019; Doyle, Aoife/AAX-3525-2020	Doyle, Aoife/0000-0002-3305-7738; Kwaro, Daniel/0000-0002-0929-8072; Orindi, Benedict/0000-0002-4601-7890; Ziraba, Abdhalah/0000-0002-3417-6536; Shahmanesh, Maryam/0000-0001-7129-8535	Wellcome Trust [082384/Z/07/Z, GR 07830 M]; Bill and Melinda Gates Foundation [OPP1136774]	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Africa Health Research Institute is supported by a grant from the Wellcome Trust (082384/Z/07/Z). The Transitions-To-Adulthood study was part of a larger project on Urbanization, Poverty and Health Dynamics, that was funded by the Wellcome Trust (Grant Number GR 07830 M). The impact evaluation of DREAMS, including these analyses for baseline data, is funded by the Bill and Melinda Gates Foundation (OPP1136774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akullian A, 2017, AIDS, V31, P1755, DOI [10.1097/QAD.0000000000001553, 10.1097/qad.0000000000001553]; Balkus JE, 2015, JAIDS-J ACQ IMM DEF, V70, P212, DOI 10.1097/QAI.0000000000000715; Beauclair R, 2016, SCI REP-UK, V6, DOI 10.1038/srep36121; Beguy D, 2015, INT J EPIDEMIOL, V44, P462, DOI 10.1093/ije/dyu251; Beguy D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101034; Biraro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055060; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Doyle AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182567; Evans M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21310; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Hallman Kelly P S, 2016, ASERT METHOD REVEALS; Harling G, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0403-8; Harling G, 2014, JAIDS-J ACQ IMM DEF, V66, P443, DOI 10.1097/QAI.0000000000000198; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; Hosegood V, 2009, DEMOGR RES, V20, P279, DOI 10.4054/DemRes.2009.20.13; Iwuji CC, 2018, LANCET HIV, V5, pE116, DOI 10.1016/S2352-3018(17)30205-9; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156776; Larmarange J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123345; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Mah TL, 2010, AIDS BEHAV, V14, P11, DOI 10.1007/s10461-008-9433-x; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mathur S, 2015, JAIDS-J ACQ IMM DEF, V69, P75, DOI 10.1097/QAI.0000000000000539; Maughan-Brown B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159162; Mavedzenge SN, 2011, J ADOLESCENT HEALTH, V49, P559, DOI 10.1016/j.jadohealth.2011.02.012; McGrath N, 2015, LANCET HIV, V2, pE252, DOI 10.1016/S2352-3018(15)00045-4; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; PEPFAR, 2015, PREV HIV AD GIRLS YO; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Plummer ML, 2011, LEXINGTON BOOKS, V2011; Program TD, 2015, DHS MOD QUEST PHAS 7; Reniers G, 2016, INT J EPIDEMIOL, V45, P83, DOI 10.1093/ije/dyv343; Rositch AF, 2012, INT J STD AIDS, V23, P468, DOI 10.1258/ijsa.2012.011361; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Statistics KNBo, 2009, POP HOUS CHAR KENYA; Swartzendruber A, 2013, SEX TRANSM DIS, V40, P372, DOI 10.1097/OLQ.0b013e318283d2c9; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; UNAIDS, 2016, GET FAST TRACK LIFE; WHO, 2017, GLOB ACC ACT HLTH AD	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0198783	10.1371/journal.pone.0198783	http://dx.doi.org/10.1371/journal.pone.0198783			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265667	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000446005500001
J	Middendorf, M; Wieseke, N				Middendorf, Martin; Wieseke, Nicolas			A strict upper bound for the partition distance and the cluster distance of phylogenetic trees for each fixed pair of topological trees	PLOS ONE			English	Article								For each given pair of (rooted or unrooted) topological trees with the same number of leaves a strict upper bound is shown for the tree partition distance (also called symmetric difference metric and Robinson-Foulds distance)-in case of unrooted trees-and for the cluster distance (also called Robinson-Foulds distance)-in case of rooted trees-of corresponding phylogenetic trees. In particular, it is shown that there exist assignments of labels (e.g., species) to the leaves of both topological tree where each label is assigned to exactly one leaf in each tree such that: i) in the unrooted case, the tree partition distance between the corresponding phylogenetic trees equals the number of internal edges in both trees minus the number of nodes with degree 2 in both trees, ii) in the rooted case, the cluster distance between any two corresponding phylogenetic trees equals the number of internal edges in both trees minus the number of nodes with degree 2 in both trees, and iii) the values in (i) and (ii) are also the maximum values with respect to all possible assignments. The shown strict worst case bounds are needed as normalization factor to compute a normalized version of the respective tree partition metrics.	[Middendorf, Martin; Wieseke, Nicolas] Univ Leipzig, Fac Math & Comp Sci, Swarm Intelligence & Complex Syst Grp, Leipzig, Germany	Leipzig University	Middendorf, M (corresponding author), Univ Leipzig, Fac Math & Comp Sci, Swarm Intelligence & Complex Syst Grp, Leipzig, Germany.	middendorf@informatik.uni-leipzig.de	Middendorf, Martin/AAF-6805-2019	Middendorf, Martin/0000-0002-5426-1092				Bogdanowicz D, 2012, EVOL BIOINFORM, V8, P475, DOI 10.4137/EBO.S9657; Bourque M., 1978, THESIS; Bryant D, 2009, IEEE ACM T COMPUT BI, V6, P420, DOI 10.1109/TCBB.2009.32; Geoghegan JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006215; Gorecki P., 2012, LECT NOTES COMPUTER, V7292, P115; Guillerme T, 2016, MOL PHYLOGENET EVOL, V94, P146, DOI 10.1016/j.ympev.2015.08.023; HENDY MD, 1984, SIAM J APPL MATH, V44, P1054, DOI 10.1137/0144075; Ho SYW, 2015, MOL ECOL RESOUR, V15, P688, DOI 10.1111/1755-0998.12320; Kupczok A, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-37; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Robinson DF, 1979, LECT NOTES MATH, V748, P119, DOI DOI 10.1007/BFB0102678; Steel M. A., 1988, SIAM J DISCRETE MATH, V1, P541, DOI DOI 10.1137/0401050; STEEL MA, 1993, SYST BIOL, V42, P126, DOI 10.2307/2992536; Weyenberg G, 2016, ENCY EVOLUTIONARY BI, V3, P285	15	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204907	10.1371/journal.pone.0204907	http://dx.doi.org/10.1371/journal.pone.0204907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265723	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500054
J	Moreira, PS; Santos, N; Castanho, T; Amorim, L; Portugal-Nunes, C; Sousa, N; Costa, P				Moreira, Pedro Silva; Santos, Nadine; Castanho, Teresa; Amorim, Liliana; Portugal-Nunes, Carlos; Sousa, Nuno; Costa, Patricio			Longitudinal measurement invariance of memory performance and executive functioning in healthy aging	PLOS ONE			English	Article							COVARIANCE	In this work, we examined the longitudinal measurement invariance of a battery composed of distinct cognitive parameters. A sample of 86 individuals (53.5% females; mean age = 65.73), representative of the Portuguese older population, with respect to sex, age and level of education was assessed twice over an average of two years. By means of a confirmatory factor analysis approach, we tested whether a two-factor solution [corresponding to measures of memory performance (MEM) and executive functioning (EXEC)] was reliable over time. Nested models of longitudinal invariance demonstrated the existence of partial strong invariance over time. In other words, this indicates that there is an equivalence of the factorial structure and factor loadings for all items; this was also observed for the item intercepts for all the items, except for one of the items from the EXEC dimension. Stability coefficients revealed high associations between the dimensions over time and that, whereas there was a significant decline of the MEM across time, this was not observed for the EXEC dimension. These findings reveal that changes in MEM and EXEC scores can be attributed to true changes on these constructs, enabling the use of this battery as a reliable method to study cognitive aging.	[Moreira, Pedro Silva; Santos, Nadine; Castanho, Teresa; Amorim, Liliana; Portugal-Nunes, Carlos; Sousa, Nuno; Costa, Patricio] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Moreira, Pedro Silva; Santos, Nadine; Castanho, Teresa; Amorim, Liliana; Portugal-Nunes, Carlos; Sousa, Nuno; Costa, Patricio] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Moreira, Pedro Silva; Santos, Nadine; Castanho, Teresa; Amorim, Liliana; Portugal-Nunes, Carlos; Sousa, Nuno; Costa, Patricio] Clin Acad Ctr Braga, Braga, Portugal	Universidade do Minho	Costa, P (corresponding author), Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.; Costa, P (corresponding author), PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.; Costa, P (corresponding author), Clin Acad Ctr Braga, Braga, Portugal.	pcosta@med.uminho.pt	Amorim, Liliana/Q-7807-2019; Santos, Nadine/K-7431-2015; Costa, Patrício/A-3072-2013; Santos, Nadine Correia/AAC-2873-2019; Sousa, Nuno JC/N-9137-2017; Portugal-Nunes, Carlos/AGW-4051-2022; Castanho, Teresa/L-7238-2019; Moreira, Pedro Silva/E-4471-2018	Amorim, Liliana/0000-0002-5105-7045; Santos, Nadine/0000-0001-8110-7173; Costa, Patrício/0000-0002-1201-9177; Sousa, Nuno JC/0000-0002-8755-5126; Portugal-Nunes, Carlos/0000-0001-8398-1366; Castanho, Teresa/0000-0002-4162-0359; Moreira, Pedro Silva/0000-0002-2800-3903	FCT [PDE/BDE/113601/2015, SFRH/BD/90078/2012, SFRH/BD/101398/2014, PD/BD/106050/2015]; Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 (P2020) Partnership Agreement, through the European Regional Development Fund (FEDER) [NORTE-01-0145-FEDER-000013]; Operational Programme Competitiveness and Internationalization (COMPETE 2020) [POCI-01-0145-FEDER-016428]; Regional Operational Program of Lisbon; National Funding through Portuguese Foundation for Science and Technology (FCT, Portugal); Portuguese North Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (QREN), through FEDER, the Fundacao Calouste Gulbenkian (Portugal) [139977]; SwitchBox-FP7-HEALTH-2010-grant [259772-2]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 (P2020) Partnership Agreement, through the European Regional Development Fund (FEDER); Operational Programme Competitiveness and Internationalization (COMPETE 2020); Regional Operational Program of Lisbon; National Funding through Portuguese Foundation for Science and Technology (FCT, Portugal); Portuguese North Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (QREN), through FEDER, the Fundacao Calouste Gulbenkian (Portugal); SwitchBox-FP7-HEALTH-2010-grant	The authors have no conflict of interest to disclose. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The paper has not been published previously, or is under consideration for publication elsewhere, in English or in any other language. PSM (ref: PDE/BDE/113601/2015 - PhD-iHES program), TCC (ref: SFRH/BD/90078/2012), LA (SFRH/BD/101398/2014) and CPN (ref: PD/BD/106050/2015 - PhDOC program) were supported by FCT fellowship grants. The work has been developed under the scope of the projects NORTE-01-0145-FEDER-000013 supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 (P2020) Partnership Agreement, through the European Regional Development Fund (FEDER) and POCI-01-0145-FEDER-016428 supported by the Operational Programme Competitiveness and Internationalization (COMPETE 2020) and the Regional Operational Program of Lisbon and National Funding through Portuguese Foundation for Science and Technology (FCT, Portugal); and, by the Portuguese North Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (QREN), through FEDER, the Fundacao Calouste Gulbenkian (Portugal) (contract grant number: P-139977; project "TEMPO - Better mental health during ageing based on temporal prediction of individual brain ageing trajectories") and SwitchBox-FP7-HEALTH-2010-grant 259772-2.	BRANNICK MT, 1995, J ORGAN BEHAV, V16, P201, DOI 10.1002/job.4030160303; Buschke H, 1995, J Int Neuropsychol Soc, V1, P483; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Ferrer E, 2005, PSYCHOL AGING, V20, P412, DOI 10.1037/0882-7974.20.3.412; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glisky Elizabeth L., 2007, P3; Lee KL, 2016, ADV HEALTH SCI EDUC, V21, P401, DOI 10.1007/s10459-015-9638-5; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Little T.D., 2013, LONGITUDINAL STRUCTU; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Maydeu-Olivares A, 2017, STRUCT EQU MODELING, V24, P383, DOI 10.1080/10705511.2016.1269606; Milfont TL, 2010, INT J PSYCHOL RES, V3; Millsap R. E., 2011, STAT APPROACHES MEAS, V1st, DOI 10.4324/9780203821961; Moeller J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01389; Muthen B, 2012, PSYCHOL METHODS, V17, P313, DOI 10.1037/a0026802; Muthen LK, 2007, STAT ANAL LATENT VAR, V3; Oort FJ, 2005, QUAL LIFE RES, V14, P599, DOI 10.1007/s11136-004-0831-x; Pornprasertmanit S., 2013, SIMSEM SIMULATED STR; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Santos NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124229; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Wu CH, 2009, PERS INDIV DIFFER, V46, P396, DOI 10.1016/j.paid.2008.11.002	30	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204012	10.1371/journal.pone.0204012	http://dx.doi.org/10.1371/journal.pone.0204012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265688	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500015
J	Ahs, JW; Dhejne, C; Magnusson, C; Dal, H; Lundin, A; Arver, S; Dalman, C; Kosidou, K				Ahs, Jill W.; Dhejne, Cecilia; Magnusson, Cecilia; Dal, Henrik; Lundin, Andreas; Arver, Stefan; Dalman, Christina; Kosidou, Kyriaki			Proportion of adults in the general population of Stockholm County who want gender-affirming medical treatment	PLOS ONE			English	Article							IDENTITY/GENDER DYSPHORIA QUESTIONNAIRE; HEALTH; ADOLESCENTS; PREVALENCE; CARE	The number of patients presenting for care at gender clinics is increasing, yet the proportion of adults in the general population who want gender-affirming medical treatment remains essentially unknown. We measured the wish for cross-sex hormones or gender-affirming surgery, as well as other aspects of gender incongruence, among the general adult population of Stockholm County, Sweden. A population-representative sample of 50,157 Stockholm County residents ages 22 and older comprise the Stockholm Public Health Cohort. They were enrolled in 2002, 2006, and 2010 and followed-up in roughly 4-year intervals, with questions on health, lifestyle and social characteristics. In 2014, participants received the item "I would like hormones or surgery to be more like someone of a different sex." Two additional items concerned other aspects of gender incongruence: "I feel like someone of a different sex, and I would like to live as or be treated as someone of a different sex." Each item had four answer options ("Not at all correct," "Somewhat or occasionally correct," "Quite correct," and "Absolutely correct"). For each item, any of the three affirmative answer choices were considered as some level of agreement. Calibration weights were used to estimate population-representative rates with 95% confidence intervals. The desire for cross-sex hormones or surgery was reported by 0.5% (95% CI, 0.4%-0.7%) of participants. Feeling like someone of a different sex was reported by 2.3% (95% CI, 2.1%-2.6%). Wanting to live as or be treated as a person of another sex was reported by 2.8% (95% CI, 2.4%-3.1%). These findings greatly exceed estimates of the number of patients receiving gender-affirming medical care. Clinicians must be prepared to recognize and care for patients experiencing discomfort due to gender incongruence and those who would like gender-affirming medical treatment.	[Ahs, Jill W.; Magnusson, Cecilia; Dal, Henrik; Lundin, Andreas; Dalman, Christina; Kosidou, Kyriaki] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Dhejne, Cecilia; Arver, Stefan] Karolinska Univ Hosp, ANOVA, Ctr Expertise Androl Sexual Med &Transgender Med, Stockholm, Sweden; [Dhejne, Cecilia; Arver, Stefan] Karolinska Inst, Dept Med, Stockholm, Sweden; [Dhejne, Cecilia; Arver, Stefan] Karolinska Univ Hosp, Stockholm, Sweden; [Magnusson, Cecilia; Dal, Henrik; Dalman, Christina; Kosidou, Kyriaki] Stockholm Cty Council, Ctr Epidemiol & Community Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stockholm County Council	Ahs, JW (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	jill.w.ahs@gmail.com	Dhejne, Cecilia/AAH-5737-2019	Kosidou, Kyriaki/0000-0002-1165-9455; Dalman, Christina/0000-0002-3579-2357; Magnusson, Cecilia/0000-0002-8567-6725; Dhejne, Cecilia/0000-0003-1743-9012	Stockholm County Council; Swedish Research Council [2012-2264, 523-2010-1052]; Stockholm County Council [2007008]; Swedish Council for Working Life and Social Research [2007-2064]; Swedish Regional agreement on medical training and clinical research	Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Regional agreement on medical training and clinical research	This work was supported by the Stockholm County Council and the Swedish Research Council (Grant # 2012-2264). The data linkages and staff costs have also been supported by grants from the Stockholm County Council (Grant # 2007008), Swedish Council for Working Life and Social Research (Grant # 2007-2064), Swedish Research Council (Grant # 523-2010-1052), and Swedish Regional agreement on medical training and clinical research. The study sponsors had no role in the design and conduct of the study; the analysis or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Aitken M, 2015, J SEX MED, V12, P756, DOI 10.1111/jsm.12817; Algars M, 2010, SEX ROLES, V63, P118, DOI 10.1007/s11199-010-9758-6; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; [Anonymous], 2016, STAT YB STOCKHOLM 20; Arcelus J, 2015, EUR PSYCHIAT, V30, P807, DOI 10.1016/j.eurpsy.2015.04.005; Atkinson SR, 2015, AUST FAM PHYSICIAN, V44, P792, DOI 10.1016/jc.2009-0345; Bockting WO, 2008, SEXOLOGIES, V17, P211, DOI 10.1016/j.sexol.2008.08.001; Byne W, 2012, ARCH SEX BEHAV, V41, P759, DOI 10.1007/s10508-012-9975-x; Collin L, 2016, J SEX MED, V13, P613, DOI 10.1016/j.jsxm.2016.02.001; Commission of the European Communities European Commission. Eurobarometer, 2012, 393 COMM EUR COMM, pv; de Vries A. L. C., 2015, TRANSGENDER HEALTHCA, P10; Deogracias JJ, 2007, J SEX RES, V44, P370, DOI 10.1080/00224490701586730; Socias ME, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0081-7; Flores AR, 2016, RACE ETHNICITY ADULT; Gooren LJ, 2014, CURR OPIN ENDOCRINOL, V21, P233, DOI 10.1097/MED.0000000000000064; Hannan P, 2014, J GEN INTERN MED, V29, pS506; Kuyper L, 2014, ARCH SEX BEHAV, V43, P377, DOI 10.1007/s10508-013-0140-y; Lai MC, 2010, ARCH SEX BEHAV, V39, P1415, DOI 10.1007/s10508-009-9570-y; Laitila T, 2012, RES DEV METHODOLOGY; Lundstrom Sixten., 1999, J OFF STAT, V15, P305, DOI DOI 10.1002/SIM.1903.; Pfaefflin F, 2003, 18 BIENN S HBIGDA GH; Raffoul M, 2016, J AM BOARD FAM MED, V29, P496, DOI 10.3122/jabfm.2016.04.150317; Satistics Sweden (SCB), 2014, LONG INT DAT HLTH IN; Schneider C, 2016, ARCH SEX BEHAV, V45, P551, DOI 10.1007/s10508-016-0702-x; Statistics Sweden (SCB), 2014, TEKN RAPPT HALS STOC; Svensson AC, 2013, INT J EPIDEMIOL, V42, P1263, DOI 10.1093/ije/dys126; Unger CA, 2015, J WOMENS HEALTH, V24, P114, DOI 10.1089/jwh.2014.4918; Van Caenegem E, 2015, ARCH SEX BEHAV, V44, P1281, DOI 10.1007/s10508-014-0452-6; Vance SR, 2015, J ADOLESCENT HEALTH, V56, P251, DOI 10.1016/j.jadohealth.2014.11.002; Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8; World Health Organization, 1992, INT CLASS DIS ICD 10	31	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204606	10.1371/journal.pone.0204606	http://dx.doi.org/10.1371/journal.pone.0204606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289896	Green Submitted, Green Published, gold			2022-12-27	WOS:000446545500021
J	Sun, YQ; Zhong, S; Yu, JQ; Zhu, JX; Ji, DF; Hu, GY; Wu, CM; Li, YG				Sun, Yuqing; Zhong, Shi; Yu, Jiaqi; Zhu, Jianxun; Ji, Dongfeng; Hu, Guiyan; Wu, Chongming; Li, Yougui			The aqueous extract of Phellinus igniarius (SH) ameliorates dextran sodium sulfate-induced colitis in C57BL/6 mice	PLOS ONE			English	Article							MEDICINAL MUSHROOM; LINTEUS; CELLS; POLYSACCHARIDES; COMPLEX; CANCER	Phellinus igniarius, which is called Sanghuang in Chinese, is a fungal herb widely used in Traditional Chinese Medicine to treat stomachache, inflammation and tumors. Recent studies have demonstrated the antitumor, anti-diabetic, anti-inflammatory and immunity-modulating activities of P. igniarius. In the present study, we investigated that ameliorating effect of the aqueous extract of P. igniarius fruiting body (SH) on dextran sodium sulfate (DSS)-induced colitis in C57BL/6 mice. Treatment with SH (250 and 400 mg/kg) for 8 weeks effectively alleviated the pathological indicators of colitis such as bodyweight reduction, disease activity index score, shortening of colon length and abnormal colon histology. The plasma levels of lipopolysaccharide (LPS) and inflammatory factors such as interleukin-6 (IL-6), IL-1 beta and tumor necrosis factor (TNF)-alpha were all significantly reduced. Supplementation of SH (10 mg/L) also inhibited LPS-elicited IL-1 beta production by RAW264.7 macrophages. Real-time PCR and western blot showed that treatment with SH significantly inhibited the phosphorylation of nuclear factor kappa B inhibitor alpha (I kappa B alpha) and decreased the expression of IL-6/IL-1 beta-maturation genes such as apoptosis-associated speck-like protein (ASC3) and caspase-1 in the colon of DSS-induced colitis mice. These results suggest that SH is adequate for the treatment of colitis. Inhibiting the expression and release of inflammatory factors may participate in the colitis-ameliorating effect of SH.	[Sun, Yuqing; Zhong, Shi; Zhu, Jianxun; Ji, Dongfeng; Hu, Guiyan; Li, Yougui] Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China; [Yu, Jiaqi; Wu, Chongming] Chinese Acad Med Sci, Pharmacol & Toxicol Res Ctr, Inst Med Plant Dev, Beijing, Peoples R China; [Yu, Jiaqi; Wu, Chongming] Peking Union Med Coll, Beijing, Peoples R China	Zhejiang Academy of Agricultural Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, YG (corresponding author), Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China.; Wu, CM (corresponding author), Chinese Acad Med Sci, Pharmacol & Toxicol Res Ctr, Inst Med Plant Dev, Beijing, Peoples R China.; Wu, CM (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	cmwu@implad.ac.cn; liyougui3@126.com	Wu, Chongming/GOJ-9081-2022; Yu, Jiaqi/AAZ-7577-2020; Wu, Chongming/AAQ-9085-2021	Wu, Chongming/0000-0003-2898-370X	Science and Technology Department of Zhejiang Province [2018C02003, LGN18C170005]; National Natural Science Foundation of China [81673663]; Modern Agro-industry Technology Research System of China [CARS-22-ZJ0105]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-3-015]; Key Laboratory of Creative Agriculture(pilot run), Ministry of Agriculture, P.R. China	Science and Technology Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System of China; CAMS Innovation Fund for Medical Sciences (CIFMS); Key Laboratory of Creative Agriculture(pilot run), Ministry of Agriculture, P.R. China	This work was supported financially by Foundation from Science and Technology Department of Zhejiang Province (2018C02003, LGN18C170005), National Natural Science Foundation of China (81673663), Modern Agro-industry Technology Research System of China (CARS-22-ZJ0105), CAMS Innovation Fund for Medical Sciences (CIFMS) 2016-I2M-3-015 and Key Laboratory of Creative Agriculture(pilot run), Ministry of Agriculture, P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma YT, 2010, INT IMMUNOPHARMACOL, V10, P1261, DOI 10.1016/j.intimp.2010.07.007; Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368; Cheng P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00547; Dey G, 2017, CELL SIGNAL, V35, P24, DOI 10.1016/j.cellsig.2017.03.017; Dionne S, 1997, DIGEST DIS SCI, V42, P1557, DOI 10.1023/A:1018895500721; Gao WW, 2017, EXP THER MED, V14, P4627, DOI 10.3892/etm.2017.5191; He AQ, 2016, INFLAMMATION, V39, P172, DOI 10.1007/s10753-015-0236-8; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Im KH, 2016, INT J MED MUSHROOMS, V18, P1011, DOI 10.1615/IntJMedMushrooms.v18.i11.60; Jang BS, 2004, BIOTECHNOL LETT, V26, P31, DOI 10.1023/B:BILE.0000009456.63616.32; Lee S, 2017, MOLECULES, V22, DOI 10.3390/molecules22101583; Li L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/218274; Lin CJ, 2014, J BIOSCI BIOENG, V118, P88, DOI 10.1016/j.jbiosc.2014.01.001; Song MJ, 2014, J ETHNOPHARMACOL, V154, P311, DOI 10.1016/j.jep.2013.12.059; Song TY, 2008, J ETHNOPHARMACOL, V115, P50, DOI 10.1016/j.jep.2007.09.001; Stewart DC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200377; Suabjakyong P, 2015, FOOD FUNCT, V6, P2834, DOI [10.1039/C5FO00491H, 10.1039/c5fo00491h]; Suabjakyong P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122733; Sun ZM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186592; Vyleta ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036044; Wang FF, 2017, INT J MED MUSHROOMS, V19, P561, DOI 10.1615/IntJMedMushrooms.v19.i6.70; Wu CM, 2014, J CELL MOL MED, V18, P293, DOI 10.1111/jcmm.12187; Wu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035764; Yan Guang Hai, 2014, Immune Netw, V14, P107, DOI 10.4110/in.2014.14.2.107; Zheng SJ, 2018, FOOD FUNCT, V9, P614, DOI [10.1039/c7fo01460k, 10.1039/C7FO01460K]; Zhou C, 2014, ASIAN PAC J CANCER P, V15, P3659, DOI 10.7314/APJCP.2014.15.8.3659	26	13	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205007	10.1371/journal.pone.0205007	http://dx.doi.org/10.1371/journal.pone.0205007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289941	Green Submitted, gold, Green Published			2022-12-27	WOS:000446545500037
J	Yao, F; Zhang, ED; Gao, ZL; Ji, HP; Marmouri, M; Xia, XB				Yao, Fei; Zhang, Endong; Gao, Zhaolin; Ji, Hongpei; Marmouri, Mahmoud; Xia, Xiaobo			Did you choose appropriate tracer for retrograde tracing of retinal ganglion cells? The differences between cholera toxin subunit B and Fluorogold	PLOS ONE			English	Article							OPTIC-NERVE CRUSH; INTRAOCULAR-PRESSURE ELEVATION; AXONAL-TRANSPORT; RAT MODEL; MITOCHONDRIAL DYSFUNCTION; EXPERIMENTAL GLAUCOMA; SUPERIOR COLLICULUS; DEGENERATION CAUSES; NUCLEUS RECEIVES; VISUAL-SYSTEM	Cholera toxin subunit B (CTB) and Fluorogold(FG) are two widely utilized retrograde tracers to assess the number and function of retinal ganglion cells (RGCs). However, the relative advantages and disadvantages of these tracers remain unclear, which may lead to their inappropriate application. In this study, we compared these tracers by separately injecting the tracer into the superior Colliculi (SC) in rats, one or 2 weeks later, the rats were sacrificed, and their retinas, brains, and optic nerves were collected. From the first to second week, FG displayed a greater number of labeled RGCs and a larger diffusion area in the SC than CTB; The number of CTB labeled RGCs and the diffusion area of CTB in the SC increased significantly, but there was no distinction between FG; Furthermore, CTB exhibited more labeled RGC neurites and longer neurites than FG, but no difference was evident between the same trace; The optic nerves labeled using CTB were much clearer than those labeled using FG. In conclusion, both CTB and FG can be used for the retrograde labeling of RGCs in rats at 1 or 2 weeks. FG achieves retrograde labeling of a greater number of RGCs than CTB, whereas CTB better delineates the morphology of RGCs. Furthermore, CTB seems more suitable for retrograde labeling of some small, non-image forming nuclei in the brain to which certain RGC subtypes project their axons.	[Yao, Fei; Zhang, Endong; Gao, Zhaolin; Marmouri, Mahmoud; Xia, Xiaobo] Cent S Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Ji, Hongpei] Peoples Hosp Guizhou Prov, Dept Ophthalmol, Guiyang, Guizhou, Peoples R China	Central South University	Xia, XB (corresponding author), Cent S Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China.	xbxia21@163.com		Xia, Xiaobo/0000-0002-2785-3391	National Natural Science Foundation of China [81670858, 81500721]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant numbers 81670858 to Xiaobo Xia, 81500721 to Endong Zhang], http://www.nsfc.gov.cn/.	Abbott CJ, 2014, INVEST OPHTH VIS SCI, V55, P674, DOI 10.1167/iovs.13-12811; Abbott CJ, 2013, BIOMED OPT EXPRESS, V4, P364, DOI 10.1364/BOE.4.000364; Abdel-Majid RM, 2005, BRAIN RES, V1063, P114, DOI 10.1016/j.brainres.2005.09.046; Aksar AT, 2015, INT J OPHTHALMOL-CHI, V8, P239, DOI 10.3980/j.issn.2222-3959.2015.02.05; Al-Zubidi N, 2014, J NEURO-OPHTHALMOL, V34, P95, DOI 10.1097/WNO.0000000000000069; Chang CH, 2014, EXP EYE RES, V118, P109, DOI 10.1016/j.exer.2013.11.012; Chien JY, 2016, EXP EYE RES, V143, P148, DOI 10.1016/j.exer.2015.10.004; Choe TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113011; Conte WL, 2009, NAT PROTOC, V4, P1157, DOI 10.1038/nprot.2009.93; Dang YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01815-z; de Sousa TB, 2013, ANN ANAT, V195, P32, DOI 10.1016/j.aanat.2012.04.005; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Garcia-Ayuso D, 2017, EXP EYE RES, V161, P10, DOI 10.1016/j.exer.2017.05.010; Garcia-Ayuso D, 2015, INVEST OPHTH VIS SCI, V56, P4592, DOI 10.1167/iovs.15-16808; Gomez-Ramirez AM, 1999, INVEST OPHTH VIS SCI, V40, P414; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hayreh SS, 2009, PROG RETIN EYE RES, V28, P34, DOI 10.1016/j.preteyeres.2008.11.002; Hu W, 2013, NEURAL REGEN RES, V8, P1253, DOI 10.3969/j.issn.1673-5374.2013.14.001; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Jeffries AM, 2014, J PHYSIOL-PARIS, V108, P3, DOI 10.1016/j.jphysparis.2013.10.001; Jehle T, 2008, GRAEF ARCH CLIN EXP, V246, P1255, DOI 10.1007/s00417-007-0746-7; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069938; Jiang WM, 2016, AM J TRANSL RES, V8, P799; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Krabichler Q, 2017, J COMP NEUROL, V525, P2514, DOI 10.1002/cne.24195; Lanciego JL, 2011, J CHEM NEUROANAT, V42, P157, DOI 10.1016/j.jchemneu.2011.07.001; Levkovitch-Verbin H, 2015, PROG BRAIN RES, V220, P37, DOI 10.1016/bs.pbr.2015.05.005; Li HB, 2017, CELL PHYSIOL BIOCHEM, V43, P2117, DOI 10.1159/000484231; Li XT, 2015, INVEST OPHTH VIS SCI, V56, P8373, DOI 10.1167/iovs.15-16614; Lindqvist N, 2004, EXP NEUROL, V187, P487, DOI 10.1016/j.expneurol.2004.02.002; Marangoz D, 2018, INT OPHTHALMOL, V38, P2553, DOI 10.1007/s10792-017-0768-z; Mead B, 2016, EXP EYE RES, V151, P96, DOI 10.1016/j.exer.2016.08.006; Nadal-Nicolas FM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0982-7; Nadal-Nicolas FM, 2015, EXP EYE RES, V131, P12, DOI 10.1016/j.exer.2014.12.005; Pereira LS, 2018, J NEURO-OPHTHALMOL, V38, P561, DOI 10.1097/WNO.0000000000000639; PERRY VH, 1984, NEUROSCIENCE, V12, P1125, DOI 10.1016/0306-4522(84)90007-1; Ramsey DJ, 2013, SEMIN OPHTHALMOL, V28, P406, DOI 10.3109/08820538.2013.825294; Ren CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103306; Reynolds AJ, 2000, BRAIN RES REV, V33, P169, DOI 10.1016/S0165-0173(00)00028-X; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Scalia F, 2015, J COMP NEUROL, V523, P1756, DOI 10.1002/cne.23723; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; SCHMUED LC, 1986, BRAIN RES, V377, P147, DOI 10.1016/0006-8993(86)91199-6; Shao XL, 2012, TRANSPLANTATION, V94, pE58, DOI 10.1097/TP.0b013e31826dde21; Song WT, 2015, EXP BIOL MED, V240, P682, DOI 10.1177/1535370214560965; Vidal-Sanz M, 2015, PROG BRAIN RES, V220, P1, DOI 10.1016/bs.pbr.2015.04.008; Wang LP, 2010, J NEUROSCI, V30, P16573, DOI 10.1523/JNEUROSCI.3305-10.2010; Wang RB, 2017, EXP EYE RES, V159, P49, DOI 10.1016/j.exer.2017.03.008; Wang RB, 2016, BRAIN RES, V1632, P82, DOI 10.1016/j.brainres.2015.12.015; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; WESSENDORF MW, 1991, BRAIN RES, V553, P135, DOI 10.1016/0006-8993(91)90241-M; Wilhelm H, 2009, LARYNGO RHINO OTOL, V88, P194, DOI 10.1055/s-0029-1192010; Wostyn P, 2017, CLIN EXP OPHTHALMOL, V45, P539, DOI 10.1111/ceo.12915; Zhao TT, 2011, GRAEF ARCH CLIN EXP, V249, P1021, DOI 10.1007/s00417-011-1635-7	55	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205133	10.1371/journal.pone.0205133	http://dx.doi.org/10.1371/journal.pone.0205133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289890	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500051
J	Bogovic, P; Lusa, L; Stupica, D; Rojko, T; Korva, M; Avsic-Zupanc, T; Strle, K; Wormser, GP; Strle, F				Bogovic, Petra; Lusa, Lara; Stupica, Dasa; Rojko, Tereza; Korva, Misa; Avsic-Zupanc, Tatjana; Strle, Klemen; Wormser, Gary P.; Strle, Franc			Impact of pre-existing treatment with statins on the course and outcome of tick-borne encephalitis	PLOS ONE			English	Article							CENTRAL-EUROPE; SEPSIS; METAANALYSIS; INFECTION; MORTALITY; THERAPY; VIRUS	Objectives Although statins have anti-inflammatory and potentially also antimicrobial (including antiviral) activity, their therapeutic impact on infectious diseases is controversial. In this study, we evaluated whether pre-existing statin use influenced the course and outcome of tick-borne encephalitis. Methods To assess the influence of statin usage on the severity of acute illness and the outcome of tick-borne encephalitis, univariate and multivariable analyses were performed for 700 adult patients with tick-borne encephalitis of whom 77 (11%) were being treated with statins, and for 410 patients of whom 53 (13%) were receiving statins, respectively. Results Multivariable analyses found no statistically significant association between statin usage and having a milder acute illness. There was also no statistically significant benefit with respect to a favorable outcome defined by the absence of post-encephalitic syndrome (ORs for a favorable outcome at 6 months was 0.96, 95% CI: 0.46-2.04, P= 0.926; at 12 months 0.29, 95% CI: 0.06-1.33, P= 0.111; at 2-7 years after acute illness 0.44, 95% CI: 0.092.22, P= 0.321), by a reduction in the frequency of six nonspecific symptoms (fatigue, myalgia/arthralgia memory disturbances, headache, concentration disturbances, irritability) occurring during the 4 week period before the last examination, or by higher SF-36 scores in any of the eight separate domains of health as well as in the physical and mental global overall component. Furthermore, there were no significant differences between patients receiving statins and those who were not in the cerebrospinal fluid or serum levels for any the 24 tokines/chemokines measured. Conclusions In this observational study, we could not prove that pre existing use of statins affected either the severity of the acute illness or the long term outcome of tick borne encephalitis.	[Bogovic, Petra; Stupica, Dasa; Rojko, Tereza; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Bogovic, Petra; Stupica, Dasa; Strle, Franc] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Lusa, Lara] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia; [Lusa, Lara] Univ Primorska, Fac Math Nat Sci & Informat Technol, Dept Math, Koper, Slovenia; [Korva, Misa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Strle, Klemen] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA USA; [Wormser, Gary P.] New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA	University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana; University of Primorska; University of Ljubljana; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York Medical College	Bogovic, P (corresponding author), Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia.; Bogovic, P (corresponding author), Univ Ljubljana, Fac Med, Ljubljana, Slovenia.	petra.bogovic@kclj.si	Lusa, Lara/C-6692-2015	Lusa, Lara/0000-0002-8981-2421; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688; Strle, Franc/0000-0003-4163-0503; Korva, Misa/0000-0003-1501-1004	Slovenian Research Agency (Javna agencija za raziskovalno dejavnost Republike Slovenije; ARRS);  [P3-0296]	Slovenian Research Agency (Javna agencija za raziskovalno dejavnost Republike Slovenije; ARRS); 	This work was supported by Grant number: P3-0296, Funder: Slovenian Research Agency (Javna agencija za raziskovalno dejavnost Republike Slovenije; ARRS); www.arrs.si. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, R LANG ENV STAT COMP; Bader T, 2008, AM J GASTROENTEROL, V103, P1383, DOI 10.1111/j.1572-0241.2008.01876.x; Bogovic P, 2018, TICKS TICK-BORNE DIS, V9, P369, DOI 10.1016/j.ttbdis.2017.12.001; Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430; Bogovic P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/841027; Butt AA, 2015, HEPATOLOGY, V62, P365, DOI 10.1002/hep.27835; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Deshpande A, 2015, AM J MED, V128, P410, DOI 10.1016/j.amjmed.2014.10.057; Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458; Hennessy E, 2016, ANTIMICROB AGENTS CH, V60, P5111, DOI 10.1128/AAC.00192-16; Hui DSC, 2013, INFLUENZA OTHER RESP, V7, P52, DOI 10.1111/irv.12171; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Ma BX, 2015, J INT MED RES, V43, P610, DOI 10.1177/0300060515583708; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Potena L, 2004, CIRCULATION, V109, P532, DOI 10.1161/01.CIR.0000109485.79183.81; Quinn M, 2016, INDIAN J CRIT CARE M, V20, P534, DOI 10.4103/0972-5229.190366; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reis PA, 2017, BRAIN BEHAV IMMUN, V60, P293, DOI 10.1016/j.bbi.2016.11.006; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Tralhao AFR, 2014, POSTGRAD MED, V126, DOI 10.3810/pgm.2014.11.2832; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; Ware JE, 1993, SF36 HLTH SURVEY MAN; Welch ML, 2013, MED MYCOL, V51, P219, DOI 10.3109/13693786.2012.692490	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204773	10.1371/journal.pone.0204773	http://dx.doi.org/10.1371/journal.pone.0204773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286159	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500041
J	Djuric, O; Markovic-Denic, L; Jovanovic, B; Bumbasirevic, V				Djuric, Olivera; Markovic-Denic, Ljiljana; Jovanovic, Bojan; Bumbasirevic, Vesna			Agreement between CDC/NHSN surveillance definitions and ECDC criteria in diagnosis of healthcare-associated infections in Serbian trauma patients	PLOS ONE			English	Article							CDC DEFINITIONS; PRIORITIES	After three national point prevalence studies (PPS) of healthcare associated infections (HAI) conducted in Serbian acute care hospitals using US (CDC/NHSN) surveillance definitions, Serbia is about to switch to European (ECDC) criteria for the purpose of the fourth HAI PPS. The aim of this study was to compare the US and the European HAI definitions in Serbian trauma intensive care unit (ICU). Prospective surveillance was performed at two surgical-trauma ICUs of the Emergency department of Clinical Center of Serbia. HAIs were prospectively diagnosed by experienced clinician and epidemiologists using both types of HAI definitions simultaneously. The level of agreement between two case definitions was assessed by Cohen's kappa statistic (k). Of 406 patients, 107 (26.3%) acquired at least one HAI (total of 107 according to US definitions and 141 according to European criteria). For microbiologically confirmed pneumonia agreement was k = 0.99 (95% CI, 0.96-1.00) and for clinically defined k = 0.86 (95% CI, 0.58-1.00). Agreement for bloodstream infections (BSI) was 0.79 (CI 95%, 0.70-0.89). When secondary BSI was excluded from the European classification, (30.9% of all BSI), concordance was k = 1.00 and when microbiologically confirmed catheter related BSI were reported separately as recommended by latest ECDC protocol update, (20.0% of all BSI), concordance was 0.60 (CI 95%, 0.41-0.80). No agreement was found between CLABSI and CRI while slight agreement was found when compared CLABSI and CR13 (k = 0.11; 95%CI, 0.0-0.22). Agreement for overall UTI was moderate (k = 0.66; 95%CI, 0.53-0.79) while for microbiologically-confirmed symptomatic UTI was perfect (k = 1.00). For CAUTI good agreement was observed (k = 0.77; 95%CI, 0.34-1.0). Microbiological confirmation of PN and UTI should be stimulated and comparison of BSI should be done with emphasis on whether secondary BSI is included.	[Djuric, Olivera; Markovic-Denic, Ljiljana; Jovanovic, Bojan; Bumbasirevic, Vesna] Univ Belgrade, Fac Med, Belgrade, Serbia; [Djuric, Olivera; Markovic-Denic, Ljiljana] Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia; [Jovanovic, Bojan; Bumbasirevic, Vesna] Clin Ctr Serbia, Ctr Anaesthesiol, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Djuric, O (corresponding author), Univ Belgrade, Fac Med, Belgrade, Serbia.; Djuric, O (corresponding author), Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia.	oliveradjuric87@gmail.com	Djuric, Olivera/H-8580-2019	Djuric, Olivera/0000-0002-8574-5938	Ministry of Education, Science and technological development of Serbia [175046]	Ministry of Education, Science and technological development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and technological development of Serbia, contract No. 175046, 2011-2018.	Centers for Disease Control and Prevention/National Healthcare Safety Network, 2014, DEV ASS MOD; Centers for Disease Control and Prevention/National Healthcare Safety Network, 2014, NAT HEALTHC SAF NETW; Centers for Disease Control and Prevention/ National Healthcare Safety Network, 2017, CDC NHSN SURV DEF SP; Centers for Disease Control and Prevention/National Healthcare Safety Network, 2017, ID HEALTHC ASS INF H; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Drndarevic D, 2008, DEFINITIONS HOSP INF; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P349, DOI 10.1016/j.ajic.2011.04.011; ECDC, 2008, ANN EP REP COMM DIS; European Centre for Disease Prevention and Control, 2012, POINT PREV SURV HLTH; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; European Centre for Disease Prevention and Control, 2016, POINT PREV SURV HEAL; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Garner JS, 1970, P INT C NOSOCOMIAL I, P171; Gould C, 2009, CLIN INFECT DIS, V49, P1288, DOI 10.1086/605692; Hansen S, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-28; Hebden JN, 2012, AM J INFECT CONTROL, V40, pS29, DOI 10.1016/j.ajic.2012.03.009; HELICS-ICU working group, 2004, SURV NOS INF INT CAR; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Horan TC., 2004, HOSP EPIDEMIOL INFEC, P1659; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Krinsley JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11185; Licker M, 2017, J HOSP INFECT, V96, P85, DOI 10.1016/j.jhin.2016.12.024; Markovic-Denic L, 2017, HLTH CARE ASS INFECT; Mertens R, 1996, Euro Surveill, V1, P28; Mitchell Brett G, 2015, Nurs Stand, V29, P52, DOI 10.7748/ns.29.23.52.e9609; Press MJ, 2013, INFECT CONT HOSP EP, V34, P313, DOI 10.1086/669525; Safdar N, 2014, INFECT CONT HOSP EP, V35, P480, DOI 10.1086/675821; The Joint Commission, 2012, PREV CENTR LIN ASS B; Wilson APR, 2012, J ANTIMICROB CHEMOTH, V67, pI23, DOI 10.1093/jac/dks198	29	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204893	10.1371/journal.pone.0204893	http://dx.doi.org/10.1371/journal.pone.0204893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286119	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500059
J	Dubinski, D; Won, SY; Behmanesh, B; Brawanski, N; Geisen, C; Seifert, V; Senft, C; Konczalla, J				Dubinski, Daniel; Won, Sae-Yeon; Behmanesh, Bedjan; Brawanski, Nina; Geisen, Christof; Seifert, Volker; Senft, Christian; Konczalla, Juergen			The clinical relevance of ABO blood type in 100 patients with acute subdural hematoma	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; PROGNOSTIC-FACTORS; VASCULAR-DISEASE; MIDLINE SHIFT; RISK-FACTOR; FACTOR-VIII; METAANALYSIS	Objective The correlation of depleted blood through midline shift in acute subdural hematoma remains the most reliable clinical predictor to date. On the other hand, patient's ABO blood type has a profound impact on coagulation and hemostasis. We conducted this study to evaluate the role of patient's blood type in terms of incidence, clinical course and outcome after acute subdural hematoma bleeding. Methods 100 patients with acute subdural hematoma treated between 2010 and 2015 at the author's institution were included. Baseline characteristics and clinical findings including Glasgow coma scale, Glasgow outcome scale, hematoma volume, rebleeding, midline shift, postoperative seizures and the presence of anticoagulation were analyzed for their association with ABO blood type. Results Patient's with blood type O were found to have a lower midline shift (p<0.01) and significantly less seizures (OR: 0.43; p<0.05) compared to non-O patients. Furthermore, patients with blood type A had the a significantly higher midline shift (p<0.05) and a significantly increased risk for postoperative seizures (OR: 4.01; p<0.001). There was no difference in ABO blood type distribution between acute subdural hematoma patients and the average population. Conclusion The ABO blood type has significant influence on acute subdural hematoma sequelae. Patient's with blood type O benefit in their clinical course after acute subdural hematoma whereas blood type A patients are at highest risk for increased midline shift and postoperative seizures. Further studies elucidating the biological mechanisms of blood type depended hemostaseology and its role in acute subdural hematoma are required for the development of an appropriate intervention.	[Dubinski, Daniel; Won, Sae-Yeon; Behmanesh, Bedjan; Brawanski, Nina; Seifert, Volker; Senft, Christian; Konczalla, Juergen] Goethe Univ, Univ Hosp, Dept Neurosurg, Frankfurt, Germany; [Geisen, Christof] Goethe Univ, Inst Transfus Med & Immunohematol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Dubinski, D (corresponding author), Goethe Univ, Univ Hosp, Dept Neurosurg, Frankfurt, Germany.	daniel.dubinski@kgu.de	Konczalla, Juergen/AAJ-8528-2021; Dubinski, Daniel/AAH-2910-2021; Won, Sae-Yeon/AFQ-0295-2022; Senft, Christian/F-4252-2010; Won, Sae-Yeon/AAK-3408-2020; Brawanski, Nina/AAL-7455-2020	Dubinski, Daniel/0000-0001-5568-8429; Senft, Christian/0000-0003-1288-6913; Brawanski, Nina/0000-0003-1502-4980; Konczalla, Juergen/0000-0001-9771-7806	Else KronerFresenius-Foundation	Else KronerFresenius-Foundation	Dr. Daniel Dubinski is a Else KronerFresenius-Foundation scholar.	Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Dentali F, 2014, SEMIN THROMB HEMOST, V40, P49, DOI 10.1055/s-0033-1363460; Dentali F, 2013, SEMIN THROMB HEMOST, V39, P72, DOI 10.1055/s-0032-1329550; Dentali F, 2012, SEMIN THROMB HEMOST, V38, P535, DOI 10.1055/s-0032-1315758; He MA, 2012, ARTERIOSCL THROM VAS, V32, P2314, DOI 10.1161/ATVBAHA.112.248757; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Kahr MK, 2018, HAEMOPHILIA, V24, pE207, DOI 10.1111/hae.13537; KLUN B, 1984, ACTA NEUROCHIR, V71, P171, DOI 10.1007/BF01401312; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; LAU CS, 1991, BRIT J RHEUMATOL, V30, P433; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Streiff MB, 2004, CANCER-AM CANCER SOC, V100, P1717, DOI 10.1002/cncr.20150; Streiff MB, 2015, J NEURO-ONCOL, V124, P299, DOI 10.1007/s11060-015-1840-z; Terraube V, 2010, HAEMOPHILIA, V16, P3, DOI 10.1111/j.1365-2516.2009.02005.x; Won SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199809; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17421; Wu O, 2008, J THROMB HAEMOST, V6, P62; Zabaneh D, 2011, ANN HUM GENET, V75, P456, DOI 10.1111/j.1469-1809.2011.00654.x; Zhang HR, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/641917	24	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204331	10.1371/journal.pone.0204331	http://dx.doi.org/10.1371/journal.pone.0204331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286106	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500017
J	Lee, CW; Schoenherr, C; Battmer, K; Ganser, A; Hilfiker-Kleiner, D; David, S; Eder, M; Scherr, M				Lee, Chun-Wei; Schoenherr, Caroline; Battmer, Karin; Ganser, Arnold; Hilfiker-Kleiner, Denise; David, Sascha; Eder, Matthias; Scherr, Michaela			miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; MICRORNA-125B; EXPRESSION; INFLAMMATION; APOPTOSIS; MIGRATION; MIR-17-92; ALPHA; DEATH	The evolutionary conserved miR-125b is highly expressed in hematopoietic stem cells (HSC) enhancing self-renewal and survival. Accordingly, over-expression of miR-125b in HSC may induce myeloproliferative neoplasms and leukemia with long latency. During hematopoietic cell maturation miR-125b expression decreases, and the function of miR125b in mature granulocytes is not yet known. We here use transplantation of miR-125b over-expressing HSC into syngeneic hosts to generate and analyse miR-125b overexpressing granulocytes. Under steady state conditions, miR-125b over-expression inhibits granulocytic chemotaxis and LPS- but not PMA- and TNF alpha- induced cell death. Inflammatory signals modulate the effects of miR-125b over-expression as demonstrated in a sterile peritonitis and a polymicrobial sepsis model. In particular, survival of mice with miR-125b over-expressing granulocytes is significantly reduced as compared to controls in the polymicrobial sepsis model. These data demonstrate inflammation dependent effects of miR-125b in granulocytes and may point to therapeutic intervention strategies in the future.	[Lee, Chun-Wei; Schoenherr, Caroline; Battmer, Karin; Ganser, Arnold; Eder, Matthias; Scherr, Michaela] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [David, Sascha] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Eder, M; Scherr, M (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	Eder.Matthias@mh-hannover.de; Scherr.Michaela@mh-hannover.de	David, Sascha/AAL-6909-2021		Deutsche Jose Carreras Leukaemie Stiftung [R14/21]; Deutsche Forschungsgemeinschaft [SCHE 550/6-1, ED34/4-1]; DFG-REBIRTH [SFB738/3 TP A08]	Deutsche Jose Carreras Leukaemie Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-REBIRTH(German Research Foundation (DFG))	This work was supported by Deutsche Jose Carreras Leukaemie Stiftung R14/21 to MS and ME, www.carreras-stiftung.de; Deutsche Forschungsgemeinschaft SCHE 550/6-1 to MS, ED34/4-1 to ME, and DFG-REBIRTH to ME, SFB738/3 TP A08 to ME, www.dfg.de.	Ajuebor MN, 1999, J IMMUNOL, V162, P1685; Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bousquet M, 2012, HAEMATOL-HEMATOL J, V97, P1713, DOI 10.3324/haematol.2011.061515; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Duroux-Richard I, 2016, BLOOD, V128, P3125, DOI [10.1182/blood-201602-697003, 10.1182/blood-2016-02-697003]; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Gong J, 2013, ONCOGENE, V32, P3071, DOI 10.1038/onc.2012.318; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Huang YF, 2016, EUR REV MED PHARMACO, V20, P4055; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Klusmann JH, 2010, GENE DEV, V24, P478, DOI 10.1101/gad.1856210; Liu J, 2017, BLOOD, V129, P1491, DOI 10.1182/blood-2016-06-721027; Matsukawa T, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4164; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Romero PV, 2015, LEUKEMIA, V29, P2442, DOI 10.1038/leu.2015.117; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; Surdziel E, 2011, BLOOD, V117, P4338, DOI 10.1182/blood-2010-06-289058; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Willimott S, 2012, LEUKEMIA, V26, P1113, DOI 10.1038/leu.2011.299; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yoon Hyonok, 2011, Environ Health Toxicol, V26, pe2011017, DOI 10.5620/eht.2011.26.e2011017; Yu XZ, 2015, CANCER GENET-NY, V208, P76, DOI 10.1016/j.cancergen.2015.01.006; Zhang H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-108; Zhang XH, 2017, ONCOTARGET, V8, P50642, DOI 10.18632/oncotarget.16892	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204942	10.1371/journal.pone.0204942	http://dx.doi.org/10.1371/journal.pone.0204942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286140	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500065
J	Gomez, JD; Vital, CE; Oliveira, MGA; Ramos, HJO				Gomez, Jenny D.; Vital, Camilo E.; Oliveira, Maria G. A.; Ramos, Humberto J. O.			Broad range flavonoid profiling by LC/MS of soybean genotypes contrasting for resistance to Anticarsia gemmatalis (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; CHEMICAL-COMPOUNDS; RUTIN; BIOLOGY; ACCUMULATION; ISOFLAVONES; MODULATION; GLYCOSIDES; GROUNDNUT	Attack by herbivores is a major biotic stress limiting the soybean crop production. Plant defenses against caterpillars include the production of secondary metabolites such as flavonoids, which constitute a diverse group of plant secondary metabolites. Thus, a more discriminate metabolic profiling between genotypes are important for a more comprehensive and reliable characterization of soybean resistance. Therefore, in this study a non-targeted LC/MS-based for analysis of flavonoid profiles of soybean genotypes contrasting to the resistance to A. gemmatalis was applied. Clustering analysis revealed profiles highly distinct between the susceptible UFV 105 AP and the resistant IAC 17 genotypes. This comparative approach enables to identify directly from leaf extract some new compounds related to resistance, some of which were present in higher abundance specifically in the IAC 17 genotype: four Quercetin conjugates, Rutin (Quercetin 3-O-Rutinoside), Quercetin-3,7-O- di-glucoside, Quercetin-3-O-rhamnosylglycoside-7-O-glucoside and Quercetin-3-O-rhamnopyranosyl-glucopyranoside-rhamnopyranoside; two Genistein conjugates, Genistein-7-O-diglucosidedimalonylated and Genistein-7-O-6-O-malonylglucoside; and one Daidzein conjugate, Daidzein-7-O-Glucoside-malonate. The most abundant flavonoid glycoconjugates in soybean leaves belongs to Quercetin and Kaempferol classes. However, only one from the identified compounds was classified as a Kaempferol. The Kaempferol-3-O-L-rhamnopyranosyl-glucopyranoside showed high abundance in the resistant genotype IAC 17. The metabolic profiles generated by LC/MS allowed the reconstruction of the flavonoid biosynthetic pathways, which revealed a constitutive character for herbivory resistance in the resistant genotype IAC-17 and a metabolic regulation for the rechanneling of Quercetin, Kaempferol and Genistein conjugates in soybean. Highest relative abundances were detected for glyconjugates, such as Rutin, Quercetin 3-O-rhamnosylglycoside-7-O-glucoside and Quercitin-3-O-rhamnopyranosyl-glucopyranoside-rhamnopyranoside in the leaves of the resistant genotype.	[Gomez, Jenny D.; Oliveira, Maria G. A.; Ramos, Humberto J. O.] Univ Fed Vicosa, Lab Enzymol Biochem Prot & Peptides, Dept Biochem & Mol Biol, BIOAGRO INCT IPP, Vicosa, MG, Brazil; [Vital, Camilo E.; Ramos, Humberto J. O.] Univ Fed Vicosa, Ctr Anal Biomol, NuBioMol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Ramos, HJO (corresponding author), Univ Fed Vicosa, Lab Enzymol Biochem Prot & Peptides, Dept Biochem & Mol Biol, BIOAGRO INCT IPP, Vicosa, MG, Brazil.; Ramos, HJO (corresponding author), Univ Fed Vicosa, Ctr Anal Biomol, NuBioMol, Vicosa, MG, Brazil.	humramos.ufv.br@gmail.com	OLIVEIRA, Maria Goreti A./AGP-5215-2022	Gomez Arrieta, Jenny Dimelza/0000-0001-9994-3030; Vital, Camilo/0000-0002-2567-9780	NuBioMol (Center of Analyses of Biomolecules-UFV, Brazil); National Institute of Science and Technology in Plant-Pest Interaction (INCT-IPP); Brazilian Soybean Genome Consortium (GENOSOJA); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	NuBioMol (Center of Analyses of Biomolecules-UFV, Brazil); National Institute of Science and Technology in Plant-Pest Interaction (INCT-IPP); Brazilian Soybean Genome Consortium (GENOSOJA); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by NuBioMol (Center of Analyses of Biomolecules-UFV, Brazil), the National Institute of Science and Technology in Plant-Pest Interaction (INCT-IPP), The Brazilian Soybean Genome Consortium (GENOSOJA), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Abranko L, 2015, J MASS SPECTROM, V50, P71, DOI 10.1002/jms.3474; Bentivenha JPF, 2018, ARTHROPOD-PLANT INTE, V12, P311, DOI 10.1007/s11829-017-9578-5; Bortolotto O.C., 2015, AGRON SCI BIOTECHNOL, V1, P25, DOI DOI 10.33158/ASB.2015V1I1P25; Boue SM, 2003, J CHROMATOGR A, V991, P61, DOI 10.1016/S0021-9673(03)00209-7; CABALLERO P, 1986, J NAT PROD, V49, P1126, DOI 10.1021/np50048a030; Farag MA, 2008, PLANT PHYSIOL, V146, P387, DOI 10.1104/pp.107.108431; Silva TRFB, 2016, ACTA SCI-AGRON, V38, P165, DOI 10.4025/actasciagron.v38i2.27956; Ferreira C. C. A., 2005, Bioscience Journal, V21, P49; Fugi CCQ, 2005, SCI AGR, V62, P31, DOI 10.1590/S0103-90162005000100006; Ganie, 2017, CHEM SCI REV LETT, V6, P1941; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Ho HM, 2002, BIOMED PHARMACOTHER, V56, P289, DOI 10.1016/S0753-3322(02)00191-9; Hoffmann-Campo C, 1995, THESIS; Hoffmann-Campo CB, 2001, ENTOMOL EXP APPL, V98, P181, DOI 10.1023/A:1018728515734; Hoffmann-Campo CB, 2006, PESQUI AGROPECU BRAS, V41, P1453, DOI 10.1590/S0100-204X2006001000001; Lourencao AL, 1989, WORLD SOYB RES C 4, V4, P1578; Lourencao AL, 2010, NEOTROP ENTOMOL, V39, P275, DOI 10.1590/S1519-566X2010000200020; Mallikarjuna N, 2004, J APPL ENTOMOL, V128, P321, DOI 10.1111/j.1439-0418.2004.00834.x; Matos Neto Fausto da Costa, 2002, Rev. Bras. entomol., V46, P237, DOI 10.1590/S0085-56262002000300002; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Mithofer A, 2017, TOXINOLOGY, P3, DOI 10.1007/978-94-007-6464-4_21; Murakami S, 2014, METABOLITES, V4, P532, DOI 10.3390/metabo4030532; O'Neill BF, 2010, J CHEM ECOL, V36, P35, DOI 10.1007/s10886-009-9727-0; Onkokesung N, 2014, J EXP BOT, V65, P2203, DOI 10.1093/jxb/eru096; Paixão Gilson Petrônio, 2016, Idesia, V34, P69; Pandey P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00537; Juhasz ACP, 2017, SOYBEAN BREEDING, P375, DOI 10.1007/978-3-319-57433-2_20; Piubelli GC, 2005, J CHEM ECOL, V31, P1509, DOI 10.1007/S10886-005-5794-z; ROSE RL, 1988, J ECON ENTOMOL, V81, P1288, DOI 10.1093/jee/81.5.1288; Salvador MC, 2010, NEOTROP ENTOMOL, V39, P774, DOI 10.1590/S1519-566X2010000500017; Song HH, 2014, METABOLOMICS, V10, P833, DOI 10.1007/s11306-014-0640-3; Souza ED, 2013, CHIL J AGR RES, V73, P351, DOI 10.4067/S0718-58392013000400004; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Stracke R, 2010, NEW PHYTOL, V188, P985, DOI 10.1111/j.1469-8137.2010.03421.x; Valle GE, 2002, NEOTROP ENTOMOL, V31, P285; War AR, 2015, PEST MANAG SCI, V71, P72, DOI 10.1002/ps.3764; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Wu QL, 2004, J AGR FOOD CHEM, V52, P2763, DOI 10.1021/jf035053p	38	36	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205010	10.1371/journal.pone.0205010	http://dx.doi.org/10.1371/journal.pone.0205010			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281662	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400075
J	Ilievski, V; Zuchowska, PK; Green, SJ; Toth, PT; Ragozzino, ME; Le, K; Aljewari, HW; O'Brien-Simpson, NM; Reynolds, EC; Watanabe, K				Ilievski, Vladimir; Zuchowska, Paulina K.; Green, Stefan J.; Toth, Peter T.; Ragozzino, Michael E.; Le, Khuong; Aljewari, Haider W.; O'Brien-Simpson, Neil M.; Reynolds, Eric C.; Watanabe, Keiko			Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice	PLOS ONE			English	Article							SPORADIC ALZHEIMERS-DISEASE; PORPHYROMONAS-GINGIVALIS; MATRIX METALLOPROTEINASES; CHLAMYDIA-PNEUMONIAE; VIRULENCE FACTORS; EPITHELIAL-CELLS; TRANSGENIC MICE; SEX-DIFFERENCES; MOUSE MODEL; TOOTH LOSS	Background The results from cross sectional and longitudinal studies show that periodontitis is closely associated with cognitive impairment (CI) and Alzhemer's Disease (AD). Further, studies using animal model of periodontitis and human post-mortem brain tissues from subjects with AD strongly suggest that a gram-negative periodontal pathogen, Porphyromonas gingivalis (Pg) and/or its product gingipain is/are translocated to the brain. However, neuropathology resulting from Pg oral application is not known. In this work, we tested the hypothesis that repeated exposure of wild type C57BU6 mice to orally administered Pg results in neuroinflammation, neurodegeneration, microgliosis, astrogliosis and formation of intra- and extracellular amyloid plaque and neurofibrillary tangles (NFTs) which are pathognomonic signs of AD. Methods Experimental chronic periodontitis was induced in ten wild type 8-week old C57BL/6 WT mice by repeated oral application (MWF/week) of Pg/gingipain for 22 weeks (experimental group). Another 10 wild type 8-week old C57BL/6 mice received vehicle alone (control group) MWF per week for 22 weeks. Brain tissues were collected and the presence of Pg/gingipain was determined by immunofluorescence (IF) microscopy, confocal microscopy, and quantitative PCR (qPCR). The hippocampi were examined for the signs of neuropathology related to AD: TNF alpha, IL1 beta, and IL6 expression (neuroinflammation), NeuN and Fluoro Jade C staining (neurodegeneration) and amyloid beta(1-42) (A beta(42)) production and phosphorylation of tau protein at Ser396 were assessed by IF and confocal microscopy. Further, gene expression of amyloid precursor protein (APP), beta-site APP cleaving enzyme 1 (BACE1), a disintegrin and metalloproteinase domain-containing protein10 (ADAM10) for alpha-secretase and presenilinl (PSEN1) for gamma-secretase, and NeuN (rbFox3) were determined by RT-qPCR. Microgliosis and astrogliosis were also determined by IF microscopy. Results Pg/gingipain was detected in the hippocampi of mice in the experimental group by immunohistochemistry, confocal microscopy, and qPCR confirming the translocation of orally applied Pg to the brain. Pg/gingipain was localized intra-nuclearly and peri-nuclearly in microglia (Iba1+), astrocytes (GFAP+), neurons (NeuN+) and was evident extracellularly. Significantly greater levels of expression of IL6, TNF alpha and IL1 beta were evident in experimental as compared to control group (p<0.01, p<0.00001, p<0.00001 respectively). In addition, microgliosis and astrogliosis were evident in the experimental but not in control group (p <0.01, p<0.0001 respectively). Neurodegeneration was evident in the experimental group based on a fewer number of intact neuronal cells assessed by NeuN positivity and rbFOX3 gene expression, and there was a greater number of degenerating neurons in the hippocampi of experimental mice assessed by Fluoro Jade C positivity. APP and BACE1 gene expression were increased in experimental group compared with control group (p<0.05, p<0.001 respectively). PSEN1 gene expression was higher in experimental than control group but the difference was not statistically significant (p = 0.07). ADAM10 gene expression was significantly decreased in experimental group compared with control group (p<0.01). Extracellular A beta(42) was detected in the parenchyma in the experimental but not in the control group (p<0.00001). Finally, phospho-Tau (Ser396) protein was detected and NFTs were evident in experimental but not in the control group (p<0.00001). Conclusions This study is the first to show neurodegeneration and the formation of extracellular A beta(42) in young adult WT mice after repeated oral application of Pg. The neuropathological features observed in this study strongly suggest that low grade chronic periodontal pathogen infection can result in the development of neuropathology that is consistent with that of AD.	[Ilievski, Vladimir; Aljewari, Haider W.; Watanabe, Keiko] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60607 USA; [Zuchowska, Paulina K.; Le, Khuong] Univ Illinois, Undergrad Program, Chicago, IL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Toth, Peter T.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Ragozzino, Michael E.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [O'Brien-Simpson, Neil M.; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic, Australia; [Green, Stefan J.] Univ Illinois, DNA Core Facil, Chicago, IL USA; [Toth, Peter T.] Univ Illinois, Fluorescence Imaging Core Facil, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Melbourne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Watanabe, K (corresponding author), Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60607 USA.	keiko@uic.edu	O'Brien-Simpson, Neil/B-2901-2009	O'Brien-Simpson, Neil/0000-0001-8462-5603; Aljewari, Haider/0000-0002-1509-3612; Toth, Peter/0000-0003-2168-0124	National Institute of Health [R01DE021405]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by R01DE021405, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud Orwa, 2014, J Neurol Disord, V2; Aguilera G, 2018, ANTIOXID REDOX SIGN, V28, P1626, DOI 10.1089/ars.2017.7099; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; BAKER PJ, 1994, ARCH ORAL BIOL, V39, P1035, DOI 10.1016/0003-9969(94)90055-8; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Boutaga K, 2003, J CLIN MICROBIOL, V41, P4950, DOI 10.1128/JCM.41.11.4950-4954.2003; Chakrabarti S, 2015, AGING DIS, V6, P282, DOI 10.14336/AD.2014.002; Chu J, 2015, BIOL PSYCHIAT, V77, P720, DOI 10.1016/j.biopsych.2014.06.003; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Djordjevic J, 2017, NEUROSCIENCE, V361, P81, DOI 10.1016/j.neuroscience.2017.08.006; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Eke PI, 2016, PERIODONTOL 2000, V72, P76, DOI 10.1111/prd.12145; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Emery DC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00195; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Guo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080706; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Herbst-Robinson KJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18286; Hujoel PP, 2001, J PERIODONTAL RES, V36, P48, DOI 10.1034/j.1600-0765.2001.00011.x; Ide M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151081; Ilievski V, 2017, J PERIODONTAL RES, V52, P1032, DOI 10.1111/jre.12474; Ilievski V, 2016, J ORAL BIOL, V3; Ilievski V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136502; Ishida N, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0015-x; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Iwai T, 2009, J PERIODONTAL RES, V44, P689, DOI 10.1111/j.1600-0765.2008.01165.x; Kinane JA, 2012, CELL MICROBIOL, V14, P1085, DOI 10.1111/j.1462-5822.2012.01780.x; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Li N, 2011, EUR J MICROBIOL IMMU, V1, P41, DOI 10.1556/EuJMI.1.2011.1.7; Little CS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00304; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07465-5; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Martande SS, 2014, AM J ALZHEIMERS DIS, V29, P498, DOI 10.1177/1533317514549650; Matyi J, 2017, J GERONTOL A-BIOL, V72, P1607, DOI 10.1093/gerona/glx092; MIKLOSSY J, 1993, NEUROREPORT, V4, P841, DOI 10.1097/00001756-199307000-00002; Miklossy J, 2004, J ALZHEIMERS DIS, V6, P639; Miklossy J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-90; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Moodley KK, 2014, FRONT NEUROL NEUROSC, V34, P95, DOI 10.1159/000356430; Mosconi L, 2017, NEUROLOGY, V89, P1382, DOI 10.1212/WNL.0000000000004425; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Noble JM, 2009, J NEUROL NEUROSUR PS, V80, P1206, DOI 10.1136/jnnp.2009.174029; O'Brien-Simpson NM, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.22; Okamoto M, 2005, BIOCHEM BIOPH RES CO, V336, P1214, DOI 10.1016/j.bbrc.2005.08.251; Polak D, 2009, J CLIN PERIODONTOL, V36, P406, DOI 10.1111/j.1600-051X.2009.01393.x; Poole S, 2015, J ALZHEIMERS DIS, V43, P67, DOI 10.3233/JAD-140315; Poole S, 2013, J ALZHEIMERS DIS, V36, P665, DOI 10.3233/JAD-121918; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Renvert S, 2013, J PERIODONTOL, V84, P1134, DOI 10.1902/jop.2012.120378; Riviere GR, 2002, ORAL MICROBIOL IMMUN, V17, P113, DOI 10.1046/j.0902-0055.2001.00100.x; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; Scragg MA, 2002, INFECT IMMUN, V70, P5740, DOI 10.1128/IAI.70.10.5740-5750.2002; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Singhrao SK, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2016.1270602; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wu Z, 2017, BRAIN BEHAV IMMUN, V65, P350, DOI 10.1016/j.bbi.2017.06.002; Xu GL, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0252-9; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yu YH, 2008, J AM GERIATR SOC, V56, P1693, DOI 10.1111/j.1532-5415.2008.01847.x; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zelkha SA, 2010, PERIODONTOL 2000, V54, P207, DOI 10.1111/j.1600-0757.2010.00358.x	73	141	144	7	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204941	10.1371/journal.pone.0204941	http://dx.doi.org/10.1371/journal.pone.0204941			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281647	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400070
J	Foris, B; Zebunke, M; Langbein, J; Melzer, N				Foris, Borbala; Zebunke, Manuela; Langbein, Jan; Melzer, Nina			Evaluating the temporal and situational consistency of personality traits in adult dairy cattle	PLOS ONE			English	Article							OPEN-FIELD TEST; INDIVIDUAL-DIFFERENCES; BEHAVIORAL VARIATION; ANIMAL PERSONALITY; TEMPERAMENT; STRESS; CALVES; RESPONSES; WELFARE; PIGS	Recent research suggests that personality, defined as consistent individual behavioral variation, in farm animals could be an important factor when considering their health, welfare, and productivity. However, behavioral tests are often performed individually and they might not reflect the behavioral differences manifested in every-day social environments. Furthermore, the contextual and longer-term temporal stability of personality traits have rarely been investigated in adult dairy cattle. In this study, we tested three groups of lactating Holstein cows (40 cows) using an individual arena test and a novel object test in groups to measure the contextual stability of behavior. Among the recorded individual test parameters, we used seven in the final analysis, which were determined by a systematic parameter reduction procedure. We found positive correlations between novel object contact duration in the group test and individual test parameters object contact duration (R-s = 0.361, P = 0.026) and movement duration (R-s = 0.336, P = 0.039). Both tests were repeated 6 months later to investigate their temporal stability whereby four individual test parameters were repeatable. There was no consistency in the group test results for 25 cows tested twice, possibly due to group composition changes. Furthermore, based on the seven individual test parameters, two personality traits (activity/exploration and boldness) were identified by principal component analysis. We found a positive association between the first and second tests for activity/exploration (R-s = 0.334, P = 0.058) and for boldness (R-s = 0.491, P = 0.004). Our results support the multidimensional nature of personality in adult dairy cattle and they indicate a link between behavior in individual and within-group situations. The lack of stability according to the group test results implies that group companions might have a stronger influence on individual behavior than expected. We suggest repeating the within-group behavioral measurements to study the relationship between the social environment and the manifestation of personality traits in every-day situations.	[Foris, Borbala; Zebunke, Manuela; Melzer, Nina] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dummerstorf, Mecklenburg Wes, Germany; [Langbein, Jan] Leibniz Inst Farm Anim Biol, Inst Behav Physiol, Dummerstorf, Mecklenburg Wes, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Melzer, N (corresponding author), Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dummerstorf, Mecklenburg Wes, Germany.	melzer@fbn-dummerstorf.de	Langbein, Jan/AFO-8965-2022; Foris, Borbala/AAR-2661-2020	Foris, Borbala/0000-0002-0901-3057; Langbein, Jan/0000-0002-1170-5431	German Federal Ministry of Education and Research (BMBF) [0315536G]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was part of the joint project "PHAENOMICS" with financial support of the German Federal Ministry of Education and Research (BMBF; Grant No. 0315536G).	[Anonymous], 2001, ANIM BEHAV, V61, P271, DOI [10.1006/anbe.2000.1652, 10.1016/S0003-3472(15)00461-3]; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Brand B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125044; Budaev S., 2011, FISH COGNITION BEHAV, P135, DOI DOI 10.1002/9781444342536.CH7; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Canario L, 2013, ANIMAL, V7, P357, DOI 10.1017/S1751731112001978; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Costa JHC, 2015, J DAIRY SCI, V98, P6381, DOI 10.3168/jds.2015-9395; DEPASSILLE AM, 1995, APPL ANIM BEHAV SCI, V45, P201, DOI 10.1016/0168-1591(95)00622-Y; Finkemeier MA, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00131; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Friedrich J, 2015, ARCH TIERZUCHT, V58, P13, DOI 10.5194/aab-58-13-2015; Friedrich J, 2016, ANIM GENET, V47, P12, DOI 10.1111/age.12371; Galef B. G., 1988, SOCIAL LEARNING PSYC, P119; Gibbons JM, 2011, APPL ANIM BEHAV SCI, V131, P15, DOI 10.1016/j.applanim.2011.01.009; Gibbons JM, 2010, APPL ANIM BEHAV SCI, V122, P84, DOI 10.1016/j.applanim.2009.11.011; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Graunke KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074579; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Haskell MJ, 2012, ANIM WELFARE, V21, P319, DOI 10.7120/09627286.21.3.319; Hedlund L, 2015, J DAIRY SCI, V98, P5819, DOI 10.3168/jds.2014-8667; KILGOUR R, 1975, ANIM BEHAV, V23, P615, DOI 10.1016/0003-3472(75)90139-6; Koene Paul, 2014, Animals, V4, P93, DOI 10.3390/ani4010093; Koolhaas JM, 2016, J ANIM SCI, V94, P2284, DOI 10.2527/jas.2015-0125; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Koski SE, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00070; Kovacs L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136294; Krause A, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00103; Krause J, 2010, PHILOS T R SOC B, V365, P4099, DOI 10.1098/rstb.2010.0216; Lecorps B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17214-3; LENEINDRE P, 1989, APPL ANIM BEHAV SCI, V23, P129, DOI 10.1016/0168-1591(89)90013-0; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; MacKay JRD, 2015, ANIMALS, V5, P455, DOI 10.3390/ani5030366; MacKay JRD, 2014, APPL ANIM BEHAV SCI, V152, P7, DOI 10.1016/j.applanim.2013.12.008; Marino L., 2017, ANIM BEHAV COGN, V4, P474, DOI [10.26451/abc.04.04.06.2017, DOI 10.26451/ABC.04.04.06.2017]; Meagher RK, 2017, APPL ANIM BEHAV SCI, V195, P8, DOI 10.1016/j.applanim.2017.06.006; Meagher RK, 2016, APPL ANIM BEHAV SCI, V185, P15, DOI 10.1016/j.applanim.2016.10.007; Muller R, 2005, BEHAVIOUR, V142, P1289, DOI 10.1163/156853905774539346; Muller R, 2006, APPL ANIM BEHAV SCI, V99, P193, DOI 10.1016/j.applanim.2005.05.012; Neave HW, 2018, J DAIRY SCI, V101, P7437, DOI 10.3168/jds.2017-14248; Neja W, 2015, ARCH TIERZUCHT, V58, P193, DOI 10.5194/aab-58-193-2015; Niemela PT, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00049; Ohl F, 2014, ACTA BIOTHEOR, V62, P35, DOI 10.1007/s10441-013-9205-5; Phillips CJC, 2001, J DAIRY SCI, V84, P807, DOI 10.3168/jds.S0022-0302(01)74537-7; R Core Team, 2020, R LANG ENV STAT COMP; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Revelle W., 2014, PSYCH PROCEDURES PER; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Schrader L, 2002, APPL ANIM BEHAV SCI, V77, P255, DOI 10.1016/S0168-1591(02)00075-8; Shi R, 2009, ANN ALLERG ASTHMA IM, V103, pS34; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2016, CURR OPIN BEHAV SCI, V12, P18, DOI 10.1016/j.cobeha.2016.08.008; van Erp-van der Kooij E, 2000, APPL ANIM BEHAV SCI, V66, P171, DOI 10.1016/S0168-1591(99)00094-5; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; Van Reenen CG, 2004, APPL ANIM BEHAV SCI, V85, P11, DOI 10.1016/j.applanim.2003.09.007; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Zebunke M, 2017, APPL ANIM BEHAV SCI, V194, P7, DOI 10.1016/j.applanim.2017.05.011; Zuckerman M., 1991, PSYCHOBIOLOGY PERSON	62	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204619	10.1371/journal.pone.0204619	http://dx.doi.org/10.1371/journal.pone.0204619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273367	Green Published, gold			2022-12-27	WOS:000446124700027
J	Choi, J; Kim, JW; Jeon, TJ; Lee, IJ				Choi, Jinhyun; Kim, Jun Won; Jeon, Tae Joo; Lee, Ik Jae			The F-18-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes	PLOS ONE			English	Article							CORD COMPRESSION; BONE METASTASES; EMISSION-TOMOGRAPHY; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; SURVIVAL; CANCER; THERAPY; PREDICTION; RECIST	Purpose To evaluate the potential role of F-18-fluorodeoxyglucose-positron emission tomography/computerized tomography (FDG-PET/CT) for predicting treatment response after radiotherapy (RT) in patients with spinal metastases. Materials and methods A retrospective analysis was performed of 42 patients with spinal metastases who received RT from January 2010 to December 2014. All patients underwent FDG-PET/CT before and after treatment. Changes in metabolic responses, expressed as the maximum, mean, peak standardized uptake values (SUVmax, SUVmean, SUVpeak), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were analyzed to determine their association with clinical outcomes. Results The median age at the time of spinal metastasis diagnosis was 58 years. Median progression-free survival (PFS) and overall survival after RT were 15 months and 22.4 months, respectively. RT produced a significant decrease in SUVmean (2.27 to 1.41), SUVmax (6.87 to 2.99), SUVpeak (5.75 to 2.33) and TLG (52.84 to 24.17) when compared with the baseline values (p<0.001). The mean pain score decreased from 3.86 before RT to 0.79 after RT (p<0.001). There were significant linear relationships between maximum SUV and pain scores at baseline (r = 0.321, p = 0.038) and after treatment (r = 0.369, p = 0.016) as well as TLG at baseline (r = 0.428, p = 0.005) and after treatment (r = 0.403, p = 0.009). Local progression after treatment was identified in 12 patients (28.6%). Univariate analyses showed that >70% reduction in maximum SUV after treatment was independently associated with good PFS (p = 0.036). Conclusions RT is an effective treatment for patients with spinal metastases, and there were significant changes in PET parameters compared with baseline. The metabolic response measured by SUV and TLG changes in FDG-PET/CT correlated with the clinical outcomes, especially with shorter PFS in patients who had higher residual maximum SUV after treatment.	[Choi, Jinhyun; Kim, Jun Won; Lee, Ik Jae] Yonsei Univ, Gangnam Severance Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Choi, Jinhyun] Jeju Natl Univ, Jeju Natl Univ Hosp, Dept Radiat Oncol, Sch Med, Jeju, South Korea; [Jeon, Tae Joo] Yonsei Univ, Gangnam Severance Hosp, Dept Nucl Med, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Jeju National University; Yonsei University; Yonsei University Health System	Lee, IJ (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea.; Jeon, TJ (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Nucl Med, Coll Med, Seoul, South Korea.	tjeonnm@yuhs.ac; ikjae412@yuhs.ac		Jeon, Tae Joo/0000-0002-7574-6734; Lee, Ik Jae/0000-0001-7165-3373; Kim, Jun Won/0000-0003-1358-364X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1D1A1B03930229]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1D1A1B03930229 to IJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ND, 2018, WORLD NEUROSURG, V115, pE67, DOI 10.1016/j.wneu.2018.03.171; Bartels RHMA, 2008, CA-CANCER J CLIN, V58, P245, DOI 10.3322/CA.2007.0016; Berriolo-Riedinger A, 2006, EUR J NUCL MED MOL I, V33, pS167; Blakaj DM, 2015, WORLD NEUROSURG, V84, P6, DOI 10.1016/j.wneu.2015.02.014; Chang JS, 2014, INT J RADIAT ONCOL, V90, P126, DOI 10.1016/j.ijrobp.2014.05.030; Choi C, 2015, GUT LIVER, V9, P94, DOI 10.5009/gnl14009; Chow E, 2012, CLIN ONCOL-UK, V24, P112, DOI 10.1016/j.clon.2011.11.004; Hicks RJ, 2009, J NUCL MED, V50, p31S, DOI 10.2967/jnumed.108.057216; Janjan N, 2009, J PALLIAT MED, V12, P417, DOI 10.1089/jpm.2009.9633; Kalff V, 2006, J NUCL MED, V47, P14; Lee E, 2015, RADIAT ONCOL J, V33, P217, DOI 10.3857/roj.2015.33.3.217; Michaelis LC, 2006, NAT REV CANCER, V6, P409, DOI 10.1038/nrc1883; Mizumoto M, 2008, CANCER-AM CANCER SOC, V113, P2816, DOI 10.1002/cncr.23888; Park S, 2016, RADIAT ONCOL J, V34, P128, DOI 10.3857/roj.2016.01718; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Prior JO, 2009, J CLIN ONCOL, V27, P439, DOI 10.1200/JCO.2008.17.2742; Rades D, 2006, J CLIN ONCOL, V24, P3388, DOI 10.1200/JCO.2005.05.0542; Rades D, 2013, CANCER-AM CANCER SOC, V119, P897, DOI 10.1002/cncr.27849; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Sheikhbahaei S, 2016, NUCL MED COMMUN, V37, P231, DOI 10.1097/MNM.0000000000000436; Tahara T, 2016, INT J RADIAT ONCOL, V94, P322, DOI 10.1016/j.ijrobp.2015.10.036; Tateishi U, 2008, RADIOLOGY, V247, P189, DOI 10.1148/radiol.2471070567; Thibault I, 2015, LANCET ONCOL, V16, pE595, DOI 10.1016/S1470-2045(15)00166-7; Topkan E, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-123; Tralins KS, 2002, J NUCL MED, V43, P1667; van der Linden YM, 2005, CANCER-AM CANCER SOC, V103, P320, DOI 10.1002/cncr.20756; van der Linden YM, 2006, RADIOTHER ONCOL, V78, P245, DOI 10.1016/j.radonc.2006.02.007; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Weber WA, 2009, J NUCL MED, V50, p1S, DOI 10.2967/jnumed.108.057174; Wu JSY, 2006, CLIN ONCOL-UK, V18, P539, DOI 10.1016/j.clon.2006.05.003	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204918	10.1371/journal.pone.0204918	http://dx.doi.org/10.1371/journal.pone.0204918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265736	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500055
J	Clifton-Brown, JC; Senior, H; Purdy, SJ; Horsnell, R; Lankamp, B; Muennekhoff, AK; Virk, D; Guillemois, E; Chetty, V; Cookson, A; Girdwood, S; Clifton-Brown, G; Tan, MLMC; Awty-Carroll, D; Bentley, AR				Clifton-Brown, John C.; Senior, Hannah; Purdy, Sarah J.; Horsnell, Richard; Lankamp, Bernd; Mueennekhoff, Ann-Katrin; Virk, Daljit; Guillemois, Estelle; Chetty, Vera; Cookson, Alan; Girdwood, Sarah; Clifton-Brown, Gabi; Tan, Mei Lie M. C.; Awty-Carroll, Danny; Bentley, Alison R.			Investigating the potential of novel non-woven fabrics for efficient pollination control in plant breeding	PLOS ONE			English	Article							SEED YIELD; ARABIDOPSIS-THALIANA; HIGH-TEMPERATURE; POLLEN DEVELOPMENT; HARVEST INDEX; WHEAT; SIZE; BAGS; HYBRIDIZATION; SWITCHGRASS	Plant breeding is achieved through the controlled self- or cross-pollination of individuals and typically involves isolation of floral parts from selected parental plants. Paper, cellulose or synthetic materials are used to avoid self pollination or cross contamination. Low seed set limits the rate of breeding progress and increases costs. We hypothesized that a novel 'non-woven' fabric optimal for both pollination and seed set in multiple plant species could be developed. After determining the baseline pollen characteristics and usage requirements we established iterative three phase development and biological testing. This determined (1) that white fabric gave superior seed return and informed the (2) development of three non-woven materials using different fibre and layering techniques. We tested their performance in selfing and hybridisation experiments recording differences in performance by material type within species. Finally we (3) developed further advanced fabrics with increased air permeability and tested biological performance. An interaction between material type and species was observed and environmental decoupling investigated, showing that the non-woven fabrics had superior water vapour transmission and temperature regulation compared to controls. Overall, non-woven fabrics outperformed existing materials for both pollination and seed set and we found that different materials can optimize species-specific, rather than species-generic performance.	[Clifton-Brown, John C.; Purdy, Sarah J.; Cookson, Alan; Girdwood, Sarah; Clifton-Brown, Gabi; Awty-Carroll, Danny] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Senior, Hannah; Virk, Daljit] PBS Int, Scarborough, England; [Horsnell, Richard; Bentley, Alison R.] NIAB, John Bingham Lab, Cambridge, England; [Lankamp, Bernd; Mueennekhoff, Ann-Katrin] KWS SAAT SE, Einbeck, Germany; [Guillemois, Estelle; Chetty, Vera] Nonwovens Innovat & Res Inst Ltd, Leeds, W Yorkshire, England; [Tan, Mei Lie M. C.] CreaNova Consultancy, Munden, Germany	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Bentley, AR (corresponding author), NIAB, John Bingham Lab, Cambridge, England.	alison.bentley@niab.com	Clifton-Brown, John/AAE-8154-2022; Awty-Carroll, Danny/AAR-4866-2020	Clifton-Brown, John/0000-0001-6477-5452; Awty-Carroll, Danny/0000-0001-5855-0775	InnovateUK (via Agri-Tech Early-Stage Feasibility Project) [131893]; UK Biotechnology and Biological Sciences Research Council [BBSRC: IBERS BB/N0071X/1, NIAB BB/N004752/1]; InnovateUK; BBSRC; Biotechnology and Biological Sciences Research Council [BB/N00471X/1] Funding Source: researchfish; BBSRC [BBS/E/C/000I0280, BB/N00471X/1, BB/N004752/1] Funding Source: UKRI	InnovateUK (via Agri-Tech Early-Stage Feasibility Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); InnovateUK(UK Research & Innovation (UKRI)Innovate UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by InnovateUK (via Agri-Tech Early-Stage Feasibility Project 131893) with the academic partners receiving funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC: IBERS BB/N0071X/1; NIAB BB/N004752/1). The funders (InnovateUK and BBSRC) did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial participants (PBS International, KWS SAAT SE, Nonwovens Innovation & Research Institute Ltd & CreaNova Consultancy) primarily contributed staff time as a matched contribution to InnovateUK funding. The objective of InnovateUK Agri-Tech funding is to catalyse public-private partnerships including commercially relevant R&D as described in this paper.	Adhikari L, 2015, BIOENERG RES, V8, P380, DOI 10.1007/s12155-014-9528-3; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; BALL ST, 1992, CROP SCI, V32, P1155, DOI 10.2135/cropsci1992.0011183X003200050019x; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; Brewbaker HE, 1934, J AGRIC RES, V48, P0323; Bridgwater FE, 1998, FOREST CHRON, V74, P185, DOI 10.5558/tfc74185-2; CHHABRA N, 1978, ANN BOT-LONDON, V42, P1109, DOI 10.1093/oxfordjournals.aob.a085551; CHOWDHURY SI, 1978, AUST J AGR RES, V29, P205, DOI 10.1071/AR9780205; Clifton-Brown J, 2017, GCB BIOENERGY, V9, P6, DOI 10.1111/gcbb.12357; Demirel N, 2006, CROP PROT, V25, P1062, DOI 10.1016/j.cropro.2006.01.009; Du Pont, 1986, TYV HOUS MAT SPEC IN; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Elwell AL, 2011, PLANT CELL ENVIRON, V34, P291, DOI 10.1111/j.1365-3040.2010.02243.x; FOSTER CA, 1970, EUPHYTICA, V19, P61, DOI 10.1007/BF01904667; FOSTER CA, 1968, EUPHYTICA, V17, P102; Gitz D. C., 2015, American Journal of Plant Sciences, V6, P265, DOI 10.4236/ajps.2015.62030; Gitz D.C., 2013, AM J PLANT SCI, V4, P571, DOI [10.4236/ajps.2013.43074, DOI 10.4236/AJPS.2013.43074]; Goins GD, 1997, J EXP BOT, V48, P1407, DOI 10.1093/jxb/48.7.1407; Harsant J, 2013, J EXP BOT, V64, P2971, DOI 10.1093/jxb/ert142; Jensen E, 2011, GCB BIOENERGY, V3, P387, DOI 10.1111/j.1757-1707.2011.01097.x; JURADO E, 1992, J ECOL, V80, P407, DOI 10.2307/2260686; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KNIGHT R, 1966, EUPHYTICA, V15, P374, DOI 10.1007/BF00022182; Kumar RR, 2014, J PLANT BIOCHEM BIOT, V23, P293, DOI 10.1007/s13562-013-0214-x; LEISHMAN MR, 1994, J ECOL, V82, P249, DOI 10.2307/2261293; MCADAM NJ, 1987, PLANT BREEDING, V98, P178, DOI 10.1111/j.1439-0523.1987.tb01113.x; Muller F, 2016, PLANT REPROD, V29, P107, DOI 10.1007/s00497-016-0282-x; PICKERING RA, 1982, EUPHYTICA, V31, P439, DOI 10.1007/BF00021661; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; Simmonds J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0191-9; Team RC., 2013, R LANG ENV STAT COMP; Van Daele I, 2012, PLANT BIOTECHNOL J, V10, P488, DOI 10.1111/j.1467-7652.2012.00687.x; Vogel KP, 2014, CROP SCI, V54, P1621, DOI 10.2135/cropsci2013.09.0647; Windham GL, 2007, PHYTOPARASITICA, V35, P277, DOI 10.1007/BF02981161; Yun HG, 2017, MYCOBIOLOGY, V45, P192, DOI [10.5941/MYCO.2017.45.3.192, 10.5941/myco.2017.45.3.192]	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204728	10.1371/journal.pone.0204728	http://dx.doi.org/10.1371/journal.pone.0204728			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265713	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500047
J	Faber, H; van Soest, AJ; Kistemaker, DA				Faber, Herre; van Soest, Arthur J.; Kistemaker, Dinant A.			Inverse dynamics of mechanical multibody systems: An improved algorithm that ensures consistency between kinematics and external forces	PLOS ONE			English	Article							OPTIMIZATION; SIMULATIONS; MOMENTS; WALKING; GAIT; LEG	Inverse dynamics is a technique in which measured kinematics and, possibly, external forces are used to calculate net joint torques in a rigid body linked segment model. However, kinematics and forces are usually not consistent due to incorrect modelling assumptions and measurement errors. This is commonly resolved by introducing 'residual forces and torques' which compensate for this problem, but do not exist in reality. In this study a constrained optimization algorithm is proposed that finds the kinematics that are mechanically consistent with measured external forces and mimic the measured kinematics as closely as possible. The algorithm was tested on datasets containing planar kinematics and ground reaction forces obtained during human walking at three velocities (0.8 m/s, 1.25 and 1.8 m/s). Before optimization, the residual force and torque were calculated for a typical example. Both showed substantial values, indicating the necessity of developing a mechanically consistent algorithm. The proposed optimization algorithm converged to a solution in which the residual forces and torques were zero, without changing the ground reaction forces and with only minor changes to the measured kinematics. When using a rigid body approach, our algorithm ensures a consistent description of forces and kinematics, thereby improving the validity of calculated net joint torque and power values.	[Faber, Herre; van Soest, Arthur J.; Kistemaker, Dinant A.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands; [Faber, Herre] Hague Univ Appl Sci, Fac Hlth Nutr & Sports, The Hague, Netherlands	Vrije Universiteit Amsterdam	Faber, H (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands.; Faber, H (corresponding author), Hague Univ Appl Sci, Fac Hlth Nutr & Sports, The Hague, Netherlands.	h.faber@hhs.nl			Nederlandse Organisatie voor Wetenschappelijk Onderzoek [023.006.090]; HORIZON 2020, The EU Framework Programme for Research and Innovation [H2020-MSCA-IF-665457]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); HORIZON 2020, The EU Framework Programme for Research and Innovation	Funded by Nederlandse Organisatie voor Wetenschappelijk Onderzoek. Url: https://www.nwo.nl/. Grant number: 023.006.090. HORIZON 2020, The EU Framework Programme for Research and Innovation. Url: https://ec.europa.eu/programmes/horizon2020/en. Grant number: H2020-MSCA-IF-665457.	Cahouet V, 2002, J BIOMECH, V35, P1507, DOI 10.1016/S0021-9290(02)00176-8; CHAO EY, 1973, J BIOMECH, V6, P497, DOI 10.1016/0021-9290(73)90008-0; De Groote F, 2008, J BIOMECH, V41, P3390, DOI 10.1016/j.jbiomech.2008.09.035; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Elftman H, 1939, AM J PHYSIOL, V125, P339, DOI 10.1152/ajplegacy.1939.125.2.339; Fluit R, 2014, J BIOMECH, V47, P2321, DOI 10.1016/j.jbiomech.2014.04.030; Hatze H, 2002, J BIOMECH, V35, P109, DOI 10.1016/S0021-9290(01)00158-0; Kingma I, 1996, HUM MOVEMENT SCI, V15, P833, DOI 10.1016/S0167-9457(96)00034-6; Kuo AD, 1998, J BIOMECH ENG-T ASME, V120, P148, DOI 10.1115/1.2834295; Mazza C, 2004, ANN BIOMED ENG, V32, P764, DOI 10.1023/B:ABME.0000030241.26857.75; Remy CD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005148; Riemer R, 2008, J BIOMECH, V41, P1503, DOI 10.1016/j.jbiomech.2008.02.011; Riemer R, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005155; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; van den Bogert AJ, 2008, COMPUT METHOD BIOMEC, V11, P3, DOI 10.1080/10255840701550865; van Soest AJ, P 15 C ISB JYV; VAUGHAN CL, 1982, J BIOMECH ENG-T ASME, V104, P38, DOI 10.1115/1.3138301; Winter DA, 1990, BIOMECHANICS MOTOR C	18	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204575	10.1371/journal.pone.0204575	http://dx.doi.org/10.1371/journal.pone.0204575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265727	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500038
J	Marencakova, J; Maly, T; Sugimoto, D; Gryc, T; Zahalka, F				Marencakova, Jitka; Maly, Tomas; Sugimoto, Dai; Gryc, Tomas; Zahalka, Frantisek			Foot typology, body weight distribution, and postural stability of adolescent elite soccer players: A 3-year longitudinal study	PLOS ONE			English	Article							UNIPEDAL STANCE; INJURIES; STRENGTH; PERFORMANCE; AGE; ASYMMETRIES; BREAK; ANKLE; ARCH	Objective The unique foot morphology and distinctive functions facilitate complex tasks and strategies such as standing, walking, and running. In those weight-bearing activities, postural stability (PS) plays an important role. Correlations among foot type, PS, and other musculoskeletal problems that increase sport injury risk are known. However, long-term associations among the foot type, the PS, and body weight (BW) distribution are lacking. Thus, the purpose of this study was to longitudinally identify changes in foot morphology, PS, and symmetry in BW distribution during adolescence among elite male soccer players. Methods Thirty-five Czech elite male soccer players (age, 15.49 +/- 0.61 years; BW, 64.11 +/- 6.16 kg; body height, 174.62 +/- 5.71 cm) underwent foot type, PS, and BW distribution measurements during 3 consecutive years (T1, T2, T3). The Chippaux-Smirak index (CSI), BW distribution, and centre of pressure (COP) displacement (total traveled way [TTW]) of each player for the preferred (PL) and non-preferred leg (NL) were acquired. Repeated-measures analysis of variance (RM ANOVA), Bonferroni's post hoc tests, and partial eta-squared (eta(2)(p)) coefficient were used for investigating the effect of time on selected variables and effect size evaluation. Results Statistically significant effect of time on CSI values (PL: F-2,F-68 = 5.08, p < 0.01, eta(2)(p) = 0.13 and NL: F-2,F-68 = 10.87, p < 0.01, eta(2)(p) = 0.24) and COP displacement values (PL: F-2,F-68 = 5.07, p < 0.01, eta(2)(p) = 0.13; NL: F-2,F-68 = 3.53, p <0.05, eta(2)(p) = 0.09) for both legs over 3-years period was identified. Furthermore, the Bonferroni's post hoc analysis revealed a significant improvement of PS values in the PL (TTWT1 = 1617.11 +/- 520.22 mm vs. TTWT2 = 1405.29 +/- 462.76, p < 0.05; and between TTWT1 = 1617.11 +/- 520.22 mm vs. TTWT3 = 1370.46 +/- 373.94, p < 0.05). Only BW distribution parameter showed no significant differences, although that slightly improved over time. Conclusions We observed changes in foot typology, PS, and BW distribution in young elite male soccer players during 3 consecutive years. Results demonstrated that changes in PS and body weight distribution under the high-load sport conditions during adolescence may improve with aging, except for foot morphology. Therefore, foot morphology should be carefully monitored to minimize sport injury risk in professional young soccer players during adolescence. Further research is necessary to determine more clear associations between these parameters, soccer-related injuries, and sport performances.	[Marencakova, Jitka; Maly, Tomas; Gryc, Tomas; Zahalka, Frantisek] Charles Univ Prague, Fac Phys Educ & Sport, Sport Res Ctr, Prague, Czech Republic; [Sugimoto, Dai] Childrens Hosp Boston, Orthoped Ctr, Boston, MA USA; [Sugimoto, Dai] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Sugimoto, Dai] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA	Charles University Prague; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Maly, T (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Sport Res Ctr, Prague, Czech Republic.	maly@ftvs.cuni.cz	Maly, Tomas/AAK-2224-2021; Marenčáková, Jitka/D-9406-2017; Maly, Tomas/R-1147-2017; Gryc, Tomáš/E-3827-2017	Maly, Tomas/0000-0001-5439-6766; Marenčáková, Jitka/0000-0003-1981-818X; Maly, Tomas/0000-0001-5439-6766; Gryc, Tomáš/0000-0002-6793-6490	GACR [16-21791 S]; Czech Science Foundation [GACR 16-21791 S]; Charles University, Prague, Czech Republic [UNCE/HUM/032]	GACR(Grant Agency of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Charles University, Prague, Czech Republic(Czech Republic Government)	This study was supported by GACR 16-21791 S and UNCE/HUM/032: 1) GACR 16-21791 S was supported by Czech Science Foundation (Applicant Tomas Maly, Ph.D.); 2) UNCE/HUM/032 was supported by Charles University, Prague, Czech Republic (Applicant Prof. Frantisek Zahalka, Ph.D.).	Beynnon BD, 2002, J ATHL TRAINING, V37, P376; Billis E, 2007, FOOT, V17, P65, DOI DOI 10.1016/J.FOOT.2006.09.005; Cheng PT, 2001, ARCH PHYS MED REHAB, V82, P1650, DOI 10.1053/apmr.2001.26256; DeSilva JM, 2015, AM J PHYS ANTHROPOL, V156, P543, DOI 10.1002/ajpa.22699; DeSilva JM, 2013, AM J PHYS ANTHROPOL, V151, P495, DOI 10.1002/ajpa.22287; Dvorak J, 2008, F MARC MANUAL FOTBAL; Dvorak R, 2000, REHAB FYZ LEK, V3, P102; Earls J., 2014, BORN WALK MYOFASCIAL; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; EKSTRAND J, 1983, MED SCI SPORT EXER, V15, P267, DOI 10.1249/00005768-198315030-00014; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Gill SV, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0554-5; Gill SV, 2014, BIOMED RES INT, V2014, P1; Haendlmayer KT., 2009, ORTHOPAEDICS TRAUMA, V23, P395; Harrison P.L., 2010, INDIAN J PHYSIOTHER, V4, P21; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Inklaar H, 1996, INT J SPORTS MED, V17, P229, DOI 10.1055/s-2007-972837; Junge Astrid, 2004, Sports Med, V34, P929, DOI 10.2165/00007256-200434130-00004; Kapteyn T S, 1983, Agressologie, V24, P321; Kaufman KR, 1999, AM J SPORT MED, V27, P585, DOI 10.1177/03635465990270050701; Klementa J., 1987, SOMATOMETRIE NOHY; KNAPIK JJ, 1991, AM J SPORT MED, V19, P76, DOI 10.1177/036354659101900113; Le Gall F, 2006, AM J SPORT MED, V34, P928, DOI 10.1177/0363546505283271; Lin YC, 2010, J SPORT REHABIL, V19, P21, DOI 10.1123/jsr.19.1.21; Mala L, 2017, ACTA KINESIOL, V11, P101; Maly T, 2018, INT J SPORTS MED, V39, P297, DOI 10.1055/s-0043-123648; Maly T, 2016, INT J MORPHOL, V34, P1339, DOI 10.4067/S0717-95022016000400027; Maly T, 2015, OPEN MED-WARSAW, V10, P224, DOI 10.1515/med-2015-0034; Marencakova J, 2016, ACTA GYMNICA, V46, P74, DOI 10.5507/ag.2016.004; Onodera Andrea Naomi, 2008, Foot (Edinb), V18, P142, DOI 10.1016/j.foot.2008.03.003; Paillard T, 2006, J ATHL TRAINING, V41, P172; Philippaerts RM, 2006, J SPORT SCI, V24, P221, DOI 10.1080/02640410500189371; Queen RM, 2007, FOOT ANKLE INT, V28, P456, DOI 10.3113/FAI.2007.0456; Queen RM, 2009, GAIT POSTURE, V29, P582, DOI 10.1016/j.gaitpost.2008.12.010; Scott G, 2007, GAIT POSTURE, V26, P68, DOI 10.1016/j.gaitpost.2006.07.009; Smith EP, 2018, J CLIN SPORT PSYCHOL, P1; TIBERIO D, 1988, PHYS THER, V68, P1840, DOI 10.1093/ptj/68.12.1840; TROPP H, 1984, MED SCI SPORT EXER, V16, P64; Villarroya MA, 2009, EUR J PEDIATR, V168, P559, DOI 10.1007/s00431-008-0789-8; Wong P, 2005, BRIT J SPORT MED, V39, P473, DOI 10.1136/bjsm.2004.015511; Wright WG, 2012, J NEUROPHYSIOL, V107, P1513, DOI 10.1152/jn.00256.2011	41	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204578	10.1371/journal.pone.0204578	http://dx.doi.org/10.1371/journal.pone.0204578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265689	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500039
J	Miyazaki, M; Nakashima, A; Nakamura, Y; Sakamoto, Y; Matsuo, K; Goto, M; Uchiyama, M; Okamura, K; Mitsutake, R; Urata, H; Kamimura, H; Imakyure, O				Miyazaki, Motoyasu; Nakashima, Akio; Nakamura, Yoshihiko; Sakamoto, Yuya; Matsuo, Koichi; Goto, Miwa; Uchiyama, Masanobu; Okamura, Keisuke; Mitsutake, Ryoko; Urata, Hidenori; Kamimura, Hidetoshi; Imakyure, Osamu			Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study	PLOS ONE			English	Article							DABIGATRAN; NONADHERENCE; PERSISTENCE; WARFARIN; THERAPY; QUESTIONNAIRE; DETERMINANTS; OUTCOMES; DISEASE; CANCER	Objective The aim of this study was to examine the association between medication adherence and illness perceptions, and to explore the factors associated with poor medication adherence in atrial fibrillation (AF) patients receiving direct oral anticoagulants (DOACs) in a real-world clinical setting. Methods An observational cross-sectional pilot study was conducted at a single Japanese university hospital. One hundred and twenty-nine patients who were diagnosed with AF and who were taking DOACs were recruited from outpatients between January 4th and April 25th , 2017. We evaluated medication adherence to DOACs using the Morisky Medication Adherence Scale-8 (MMAS-8) and illness perceptions using the Brief Illness Perception Questionnaire (BIPQ). The patients' characteristics and clinical data were collected from electronic medical records. Results Ninety-nine (76.7%) patients (male, n = 74; mean age, 71.4 +/- 9.8 years) participated in this study. According to the MMAS-8, 21 (21.2%) of the patients were classified into the poor adherence group (MMAS-8 score of <6), and 78 (78.8%) were classified into the good adherence group (MMAS-8 score of 6-8). A multivariate logistic regression analysis revealed that age (per year, odds ratio [OR] 0.912, 95% confidence interval [CI] 0.853-0.965, p = 0.001), a history of warfarin use (OR 0.181, 95% CI 0.033-0.764, p = 0.019), duration of DOAC exposure (per 100 days, OR 1.245, 95% CI 1.084-1.460, p = 0.001), and the BIPQ emotional response score (per 1 point, OR 1.235, 95% CI 1.015-1.527, p = 0.035) were significantly associated with poor medication adherence in AF patients receiving DOACs. Conclusion Poor medication adherence to DOACs was strongly associated with a stronger emotional response (i.e. stronger feelings of anger, anxiety, and depression), as well as younger age, the absence of a history of warfarin treatment, and longer DOAC exposure. Further evaluation of the factors associated with medication adherence in AF patients and the development and execution of strategies for improving poor adherence are warranted in the real-world clinical setting.	[Miyazaki, Motoyasu; Nakashima, Akio; Sakamoto, Yuya; Matsuo, Koichi; Goto, Miwa; Uchiyama, Masanobu; Imakyure, Osamu] Fukuoka Univ, Chikushi Hosp, Dept Pharm, Fukuoka, Fukuoka, Japan; [Nakamura, Yoshihiko] Fukuoka Univ, Fac Med, Dept Emergency & Crit Care Med, Fukuoka, Fukuoka, Japan; [Okamura, Keisuke; Mitsutake, Ryoko; Urata, Hidenori] Fukuoka Univ, Chikushi Hosp, Dept Cardiovasc Dis, Fukuoka, Fukuoka, Japan; [Kamimura, Hidetoshi] Fukuoka Univ Hosp, Dept Pharm, Fukuoka, Fukuoka, Japan	Fukuoka University; Fukuoka University; Fukuoka University; Fukuoka University	Miyazaki, M (corresponding author), Fukuoka Univ, Chikushi Hosp, Dept Pharm, Fukuoka, Fukuoka, Japan.	motayasu@fukuoka-u.ac.jp		Miyazaki, Motoyasu/0000-0002-4526-3045	 [16H00555]		This study is supported by Grant-in-Aid for Encouragement of Scientists (16H00555).	Arnsten JH, 1997, AM J MED, V103, P11, DOI 10.1016/S0002-9343(97)90048-6; Avgil-Tsadok M, 2016, THROMB HAEMOSTASIS, V115, P152, DOI 10.1160/TH15-03-0247; Balfour L, 2006, AIDS CARE, V18, P830, DOI 10.1080/09540120500466820; Baroletti S, 2010, CIRCULATION, V121, P1455, DOI 10.1161/CIRCULATIONAHA.109.904003; Beyer-Westendorf J, 2016, EUROPACE, V18, P1150, DOI 10.1093/europace/euv421; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Butler JA, 2004, NEPHROL DIAL TRANSPL, V19, P3144, DOI 10.1093/ndt/gfh505; Castellucci LA, 2015, THROMB RES, V136, P727, DOI 10.1016/j.thromres.2015.07.007; Clarkesmith DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074037; Coleman CI, 2016, INT J CARDIOL, V212, P171, DOI 10.1016/j.ijcard.2016.03.051; Gallagher AM, 2008, J THROMB HAEMOST, V6, P1500, DOI 10.1111/j.1538-7836.2008.03059.x; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Iskandarsyah A, 2014, PSYCHO-ONCOLOGY, V23, P1118, DOI 10.1002/pon.3534; Karatas T, 2017, ASIA-PAC J ONCOL NUR, V4, P77, DOI 10.4103/2347-5625.199080; Kugbey Nuworza, 2017, BMC Res Notes, V10, P381, DOI 10.1186/s13104-017-2707-5; Lee GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062775; Manzoor BS, 2017, PHARMACOTHERAPY, V37, P1221, DOI 10.1002/phar.1989; Mekaj YH, 2015, THER CLIN RISK MANAG, V11, DOI [10.2147/TCRM.S92222, 10.2147/TCRM.S84210]; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Olszanecka-Glinianowicz M, 2014, POSTEP DERM ALERGOL, V31, P235, DOI 10.5114/pdia.2014.45070; Raparelli V, 2017, THROMB HAEMOSTASIS, V117, P209, DOI 10.1160/TH16-10-0757; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Saarti S, 2016, J HUM HYPERTENS, V30, P341, DOI 10.1038/jhh.2015.86; Schulman S, 2013, J THROMB HAEMOST, V11, P1295, DOI 10.1111/jth.12241; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Steffel J, 2018, EUROPACE, V20, P1231, DOI 10.1093/europace/euy054; van der Have M, 2016, J CROHNS COLITIS, V10, P549, DOI 10.1093/ecco-jcc/jjw002; Villines TC, 2015, THROMB HAEMOSTASIS, V114, P1290, DOI 10.1160/TH15-06-0453	28	23	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204814	10.1371/journal.pone.0204814	http://dx.doi.org/10.1371/journal.pone.0204814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265710	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500051
J	Moravcova, S; Pacesova, D; Melkes, B; Kyclerova, H; Spisska, V; Novotny, J; Bendova, Z				Moravcova, Simona; Pacesova, Dominika; Melkes, Barbora; Kyclerova, Hana; Spisska, Veronika; Novotny, Jiri; Bendova, Zdenka			The day/night difference in the circadian clock's response to acute lipopolysaccharide and the rhythmic Stat3 expression in the rat suprachiasmatic nucleus	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA LEVELS; REV-ERB-ALPHA; TNF-ALPHA; GENE-EXPRESSION; PARAVENTRICULAR NUCLEUS; BIOLOGICAL CLOCK; PHASE-SHIFTS; MOUSE; RECEPTOR	The circadian clock in the suprachiasmatic nucleus (SCN) regulates daily rhythms in physiology and behaviour and is an important part of the mammalian homeostatic system. Previously, we have shown that systemic inflammatory stimulation with lipopolysaccharide (LPS) induced the daytime-dependent phosphorylation of STAT3 in the SCN. Here, we demonstrate the LPS-induced Stat3 mRNA expression in the SCN and show also the circadian rhythm in Stat3 expression in the SCN, with high levels during the day. Moreover, we examined the effects of LPS (1mg/kg), applied either during the day or the night, on the rhythm in locomotor activity of male Wistar rats. We observed that recovery of normal locomotor activity patterns took longer when the animals were injected during the night. The clock genes Pert, Per2and Nr1d1, and phosphorylation of kinases ERK1/2 and GSK3 beta are sensitive to external cues and function as the molecular entry for external signals into the circadian clockwork. We also studied the immediate changes in these clock genes expressions and the phosphorylation of ERK1/2 and GSK3 beta in the suprachiasmatic nucleus in response to daytime or night-time inflammatory stimulation. We revealed mild and transient changes with respect to the controls. Our data stress the role of STAT3 in the circadian clock response to the LPS and provide further evidence of the interaction between the circadian clock and immune system.	[Moravcova, Simona; Pacesova, Dominika; Melkes, Barbora; Kyclerova, Hana; Spisska, Veronika; Novotny, Jiri; Bendova, Zdenka] Charles Univ Prague, Fac Sci, Dept Physiol, Prague, Czech Republic; [Moravcova, Simona; Pacesova, Dominika; Bendova, Zdenka] Natl Inst Mental Hlth, Dept Sleep Med & Chronobiol, Klecany, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic	Bendova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Physiol, Prague, Czech Republic.; Bendova, Z (corresponding author), Natl Inst Mental Hlth, Dept Sleep Med & Chronobiol, Klecany, Czech Republic.	zdenka.bendova@natur.cuni.cz	Novotny, Jiri/B-2163-2012; Bendová, Zdeňka/GSE-1065-2022; Melkes, Barbora/AAL-5349-2020; Pačesová, Dominika/N-3885-2017; Bendová, Zdenka/T-7733-2019; Míková, Hana/AAB-8201-2020; Bendová, Zdeňka/J-5045-2014; Benediktova, Simona/N-3888-2017	Novotny, Jiri/0000-0002-6372-0131; Bendová, Zdeňka/0000-0002-2693-2143; Pačesová, Dominika/0000-0002-7359-5135; Bendová, Zdenka/0000-0002-2693-2143; Míková, Hana/0000-0003-0151-9042; Bendová, Zdeňka/0000-0002-2693-2143; Benediktova, Simona/0000-0002-0959-8673	Charles University Grant Agency [361115]; Czech Science Foundation [18-08423S]; MEYS under the NPU I programme [LO1611]	Charles University Grant Agency; Czech Science Foundation(Grant Agency of the Czech Republic); MEYS under the NPU I programme	This work was supported by Charles University Grant Agency no. 361115 (SM); by the Czech Science Foundation, contract grant number 18-08423S (ZB), and by institutional project no. LO1611 with financial support from the MEYS under the NPU I programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Bendova Z, 2012, NEUROCHEM INT, V61, P43, DOI 10.1016/j.neuint.2012.04.016; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Beynon AL, 2010, CHRONOBIOL INT, V27, P1546, DOI 10.3109/07420528.2010.501927; Bhattacharya A, 2013, J NEUROSCI, V33, P8035, DOI 10.1523/JNEUROSCI.4682-12.2013; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Cervena K, 2015, J MOL NEUROSCI, V56, P371, DOI 10.1007/s12031-015-0563-0; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Chen CC, 1999, MOL PHARMACOL, V55, P481; Damm J, 2013, NEUROPHARMACOLOGY, V71, P98, DOI 10.1016/j.neuropharm.2013.03.014; Duhart JM, 2016, NEUROPHARMACOLOGY, V108, P373, DOI 10.1016/j.neuropharm.2016.05.005; Duhart JM, 2013, J IMMUNOL, V191, P4656, DOI 10.4049/jimmunol.1300450; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Fukuhara C, 2001, NEUROSCI LETT, V314, P119, DOI 10.1016/S0304-3940(01)02304-7; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Guerrero-Vargas NN, 2014, J NEUROIMMUNOL, V273, P22, DOI 10.1016/j.jneuroim.2014.05.012; Hahnova K, 2016, CHRONOBIOL INT, V33, P141, DOI 10.3109/07420528.2015.1120741; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Leone MJ, 2012, CHRONOBIOL INT, V29, P715, DOI 10.3109/07420528.2012.682681; Kalsbeek A, 2012, CHRONOBIOL INT, V29, P835, DOI 10.3109/07420528.2012.699123; Kiessling S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11297-8; Kurabayashi N, 2006, CHRONOBIOL INT, V23, P129, DOI 10.1080/07420520500464478; Leone MJ, 2006, J NEUROSCI RES, V84, P1521, DOI 10.1002/jnr.21042; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DG, 2016, EXP CELL RES, V341, P54, DOI 10.1016/j.yexcr.2016.01.009; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Mateju K, 2009, EUR J NEUROSCI, V29, P490, DOI 10.1111/j.1460-9568.2009.06609.x; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Moravcova S, 2016, J NEUROSCI RES, V94, P99, DOI 10.1002/jnr.23673; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Osland TM, 2011, J PSYCHOPHARMACOL, V25, P924, DOI 10.1177/0269881110379508; Pacesova D, 2015, BRIT J PHARMACOL, V172, P3638, DOI 10.1111/bph.13152; Paladino N, 2014, CHRONOBIOL INT, V31, P668, DOI 10.3109/07420528.2014.886588; Paladino N, 2010, J NEUROIMMUNOL, V225, P62, DOI 10.1016/j.jneuroim.2010.04.015; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Rawadi G, 1998, J IMMUNOL, V160, P1330; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Rummel C, 2016, BRAIN BEHAV IMMUN, V54, P1, DOI 10.1016/j.bbi.2015.09.003; Sadki A, 2007, NEUROBIOL AGING, V28, P296, DOI 10.1016/j.neurobiolaging.2005.12.007; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Sato S, 2014, SCI WORLD J, DOI 10.1155/2014/685854; Sato S, 2014, J IMMUNOL, V192, P407, DOI 10.4049/jimmunol.1301982; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Singru PS, 2008, ENDOCRINOLOGY, V149, P2283, DOI 10.1210/en.2007-1478; Sotak M, 2011, AM J PHYSIOL-GASTR L, V301, pG1066, DOI 10.1152/ajpgi.00256.2011; Svobodova I, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00192; Takahashi S, 2001, ENDOCRINOLOGY, V142, P4910, DOI 10.1210/en.142.11.4910; Wachulec M, 1997, J BIOL RHYTHM, V12, P226, DOI 10.1177/074873049701200304; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	60	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0199405	10.1371/journal.pone.0199405	http://dx.doi.org/10.1371/journal.pone.0199405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265676	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500002
J	Batailler, C; Fary, C; Servien, E; Lustig, S				Batailler, Cecile; Fary, Camdon; Servien, Elvire; Lustig, Sebastien			Influence of femoral broach shape on stem alignment using anterior approach for total hip arthroplasty: A radiologic comparative study of 3 different stems	PLOS ONE			English	Article							20-YEAR FOLLOW-UP; CEMENTLESS; VARUS; COMPONENTS; 10-YEAR; CAVITY	Background Malalignment of the femoral stem in total hip arthroplasty (THA) can detrimentally affect outcome. Poor preparation of the femur intraoperatively is an important cause of stem malalignment. Purposes The objective was to compare coronal alignment of three different stems using three different broaches. Methods Retrospective study of three groups of 60 patients following primary THA via direct anterior approach, by the same surgeon, between January 2015 and January 2016. Each group had a similar designed stem (Corail Depuy, Targos Lepine or Meije Tornier). Groups were matched for age, body mass index, gender, side, neck shaft angle and indications. The significant difference between groups was the broach shape. Broaches for the Corail and Meije stems had a prominent shoulder laterally, while the broach of the Targos stem had a rounded less prominent shape laterally. Coronal alignment was determined radiologically at 2 months. Results The mean varus was significantly lower for the Targos stems (1.1 degrees +/-0.8) compared to the Corail (2.3 degrees +/-1.5) and Meije stems (1.9 degrees +/-1.2) (p<0.0001). There were significantly less Targos stems with varus greater than 3 degrees (1.7%, n = 1) compared to the Corail (40%, n = 24) and Meije stems (20%, n = 12) (p<0.001). Conclusion A femoral broach with a prominent lateral shoulder when performing a THA via direct anterior approach will increase the risk of varus femoral stem alignment compared to a less laterally prominent broach.	[Batailler, Cecile; Servien, Elvire; Lustig, Sebastien] Lyon North Univ Hosp, Dept Orthopaed Surg, Lyon, France; [Fary, Camdon] Western Hlth, Dept Orthopaed Surg, Melbourne, Vic, Australia; [Fary, Camdon] Univ Melbourne, St Albans, Vic, Australia; [Fary, Camdon] Western Hlth, St Albans, Vic, Australia	CHU Lyon; University of Melbourne	Batailler, C (corresponding author), Lyon North Univ Hosp, Dept Orthopaed Surg, Lyon, France.	cecile-batailler@hotmail.fr	Lustig, Sébastien/E-3375-2013; Batailler, Cécile/AAE-4327-2020	Batailler, Cécile/0000-0003-3990-0906; Fary, Camdon/0000-0002-9586-6602				Batailler C, 2017, INT ORTHOP, V41, P499, DOI 10.1007/s00264-016-3333-x; D'Angelo F, 2010, HIP INT, V20, P81, DOI 10.1177/112070001002000112; Devitt A, 1997, J ARTHROPLASTY, V12, P479, DOI 10.1016/S0883-5403(97)90169-8; Eingartner C, 2006, HIP INT, V16, P23, DOI 10.5301/HIP.2008.5638; Evola FR, 2014, BONE JOINT J, V96B, P455, DOI 10.1302/0301-620X.96B4.32607; Gill TJ, 1999, J ARTHROPLASTY, V14, P982, DOI 10.1016/S0883-5403(99)90014-1; Hjorth MH, 2017, J ARTHROPLASTY, V32, P1894, DOI 10.1016/j.arth.2016.12.029; Jaffe WL, 1999, J ARTHROPLASTY, V14, P708, DOI 10.1016/S0883-5403(99)90226-7; Kandel L, 2006, HIP INT, V16, P210, DOI 10.5301/HIP.2008.2615; Khalily C, 2002, J ARTHROPLASTY, V17, P463, DOI 10.1054/arth.2002.32171; KOBAYASHI S, 1994, CLIN ORTHOP RELAT R, P73; Mallory TH, 1996, J ARTHROPLASTY, V11, P653, DOI 10.1016/S0883-5403(96)80002-7; Min BW, 2008, J ARTHROPLASTY, V23, P418, DOI 10.1016/j.arth.2007.04.002; Murphy CG, 2016, HIP INT, V26, P554, DOI 10.5301/hipint.5000412; Nogler M, 2006, J ARTHROPLASTY, V21, P1206, DOI 10.1016/j.arth.2006.08.003; Selmi TAS, 2006, REV CHIR ORTHOP, V92, P752, DOI 10.1016/S0035-1040(06)75943-8; Soyer J, 1997, REV CHIR ORTHOP, V83, P416; Pertegas MV, 2010, HIP INT, V20, pS79, DOI 10.5301/HIP.2010.644; Vresilovic E J, 1994, J Arthroplasty, V9, P137, DOI 10.1016/0883-5403(94)90062-0; WIRTA J, 1993, ACTA ORTHOP SCAND, V64, P263, DOI 10.3109/17453679308993621; Woolson ST, 2009, J ARTHROPLASTY, V24, P999, DOI 10.1016/j.arth.2009.04.001	21	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204591	10.1371/journal.pone.0204591	http://dx.doi.org/10.1371/journal.pone.0204591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289882	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500019
J	Pantoja, PD; Carvalho, AR; Ribas, LR; Peyre-Tartaruga, LA				Pantoja, Patricia Dias; Carvalho, Alberito Rodrigo; Ribas, Leonardo Rossato; Peyre-Tartaruga, Leonardo Alexandre			Effect of weighted sled towing on sprinting effectiveness, power and force-velocity relationship	PLOS ONE			English	Article							ACCELERATION PHASE; PERFORMANCE; KINEMATICS; MECHANICS	This study aimed to compare the components of force-velocity (F-V) and power-velocity (P-V) profiles and the mechanical effectiveness of force application (or force ratio-RF) among various sled-towing loads during the entire acceleration phase of a weighted sled sprint. Eighteen sprinters performed four 50-m sprints in various conditions: unloaded; with a load corresponding to 20% of the athlete's body mass (BM); with a load of 30% BM; and with a load of 40% BM. Data were collected with five video cameras, and the images were digitised to obtain velocity from the derivation of the centre-of-mass position. F-V and P-V components and RF were estimated from sprinting velocity-time data for each load using a validated method that is based on an inverse dynamic approach applied to the sprinter's centreof-mass (it models the horizontal antero-posterior and vertical ground reaction force components) and requires only measurement of anthropometric and spatiotemporal variables (body mass, stature and instantaneous position or velocity during the acceleration phase). The theoretical maximal velocity decreased with load compared with the unloaded condition (for 20% BM: -6%, effect size (ES) = 0,38; for 30% BM: -15%, ES = 1.02; for 40% BM: -18%, ES = 1.10). The theoretical maximal horizontal force (FO) and maximal power were not different among conditions. However, power at the end of the acceleration phase increased with load (40% BM vs 0%: 72%; ES = 2.73) as well as the maximal mechanical effectiveness (12%; ES = 0.85). The linear decrease in RF was different between 30 or 40% BM and the unloaded condition (-23%; ES = 0.74 and 0.66). Better effectiveness may be developed with 40% BM load at the beginning of the acceleration and with the various load-induced changes in the components of the F-V and P-V relationships, allowing a more accurate determination of optimal loading conditions for maximizing power.	[Pantoja, Patricia Dias; Carvalho, Alberito Rodrigo; Peyre-Tartaruga, Leonardo Alexandre] Univ Fed Rio Grande do Sul, Sch Phys Educ Phys Therapy & Dance, Exercise Res Lab, Porto Alegre, RS, Brazil; [Carvalho, Alberito Rodrigo] State Univ Western Parana, Cascavel, Parana, Brazil; [Ribas, Leonardo Rossato] Gymnast Soc Porto Alegre SOGIPA, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Peyre-Tartaruga, LA (corresponding author), Univ Fed Rio Grande do Sul, Sch Phys Educ Phys Therapy & Dance, Exercise Res Lab, Porto Alegre, RS, Brazil.	leonardo.tartaruga@ufrgs.br	de Carvalho, Alberito Rodrigo/AAN-5373-2021; Peyré-Tartaruga, Leonardo Alexandre/C-7103-2013	de Carvalho, Alberito Rodrigo/0000-0002-5520-441X; Peyré-Tartaruga, Leonardo Alexandre/0000-0003-1742-5016	CAPES/Brazil; CNPq-Brazil [483510/2013, 203182/2014-6]; Lapex/Ufrgs [028/2015]	CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Lapex/Ufrgs	This study was supported by CAPES/Brazil, CNPq-Brazil (483510/2013 and 203182/2014-6), and Lapex/Ufrgs (028/2015).	Alcaraz PE, 2008, J STRENGTH COND RES, V22, P890, DOI 10.1519/JSC.0b013e31816611ea; Arsac LM, 2002, J APPL PHYSIOL, V92, P1781, DOI 10.1152/japplphysiol.00754.2001; CAVAGNA GA, 1971, J PHYSIOL-LONDON, V217, P709, DOI 10.1113/jphysiol.1971.sp009595; Corn RJ, 2003, J STRENGTH COND RES, V17, P72; Cottle CA, 2014, J STRENGTH COND RES, V28, P1241, DOI 10.1519/JSC.0000000000000396; Cross MR, 2017, INT J SPORT PHYSIOL, V12, P1069, DOI 10.1123/ijspp.2016-0362; Cross MR, 2017, J SPORT SCI, V35, P2198, DOI 10.1080/02640414.2016.1261178; di Prampero PE, 2005, J EXP BIOL, V208, P2809, DOI 10.1242/jeb.01700; Drinkwater EJ, 2007, J SPORT SCI, V25, P869, DOI 10.1080/02640410600907870; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jaric S, 2015, INT J SPORTS MED, V36, P699, DOI 10.1055/s-0035-1547283; Kawamori N, 2014, J STRENGTH COND RES, V28, P2738, DOI 10.1519/JSC.0b013e3182915ed4; Kawamori N, 2014, J SPORT SCI, V32, P1139, DOI 10.1080/02640414.2014.886129; Linthorne NP, 2013, SPORTS ENG, V16, P61, DOI 10.1007/s12283-013-0114-2; Lockie RG, 2003, J STRENGTH COND RES, V17, P760; Martinez-Valencia MA., 2013, SCI SPORT, V28, pe175, DOI 10.1016/j.scispo.2013.02.004; Maulder PS, 2008, J STRENGTH COND RES, V22, P1992, DOI 10.1519/JSC.0b013e31818746fe; Morin JB, 2010, J BIOMECH, V43, P1970, DOI 10.1016/j.jbiomech.2010.03.012; Morin JB, 2006, INT J SPORTS MED, V27, P158, DOI 10.1055/s-2005-837569; Morin JB, 2016, INT J SPORT PHYSIOL, V11, P267, DOI 10.1123/ijspp.2015-0638; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P3921, DOI 10.1007/s00421-012-2379-8; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; Murray A, 2005, J SPORT SCI, V23, P927, DOI 10.1080/02640410400023332; Nagahara R, 2018, J SPORT SCI, V36, P1392, DOI 10.1080/02640414.2017.1389101; Palmieri J., 1993, STRENGTH COND J, V15, P12; Petrakos G, 2016, SPORTS MED, V46, P381, DOI 10.1007/s40279-015-0422-8; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; Samozino P, 2016, SCAND J MED SCI SPOR, V26, P648, DOI 10.1111/sms.12490; Samozino P, 2012, MED SCI SPORT EXER, V44, P313, DOI 10.1249/MSS.0b013e31822d757a; Smirniotou A, 2011, J BIOL EXER, V7, P7, DOI DOI 10.4127/JBE.2011.0040; Spiriev B, 2014, IAAF SCORING TABLES; Winter DA, 1990, BIOMECHANICS MOTOR C; Young W, 2001, STRENGTH COND J, V23, P7, DOI 10.1519/1533-4295(2001)023<0007:RTFSSA>2.0.CO;2; Young WB, 2006, INT J SPORT PHYSIOL, V1, P74, DOI 10.1123/ijspp.1.2.74	34	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204473	10.1371/journal.pone.0204473	http://dx.doi.org/10.1371/journal.pone.0204473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289907	gold, Green Published, Green Submitted			2022-12-27	WOS:000446545500016
J	Xie, Q; Lu, YR; Tan, X; Tang, ZX; Hu, B				Xie, Qi; Lu, Yanrong; Tan, Xiao; Tang, Zhixiong; Hu, Bin			Security and efficiency enhancement of an anonymous three-party password- authenticated key agreement using extended chaotic maps	PLOS ONE			English	Article							EXCHANGE PROTOCOL; CRYPTANALYSIS	Recently, Lu et al. claimed that Xie et al.'s three-party password-authenticated key agreement protocol (3PAKA) using chaotic maps has three security vulnerabilities; in particular, it cannot resist offline password guessing attack, Bergamo et al.'s attack and impersonation attack, and then they proposed an improved protocol. However, we demonstrate that Lu et al.'s attacks on Xie et al.'s scheme are unworkable, and their improved protocol is insecure against stolen-verifier attack and off-line password guessing attack. Furthermore, we propose a novel scheme with enhanced security and efficiency. We use formal verification tool ProVerif, which is based on pi calculus, to prove security and authentication of our scheme. The efficiency of the proposed scheme is higher than other related schemes.	[Xie, Qi; Tan, Xiao; Tang, Zhixiong; Hu, Bin] Hangzhou Normal Univ, Key Lab Cryptog & Network Secur, Hangzhou, Zhejiang, Peoples R China; [Lu, Yanrong] Tianjin Univ, Sch Comp Sci & Technol, Tianjin Key Lab Adv Networking, Tianjin, Peoples R China	Hangzhou Normal University; Tianjin University	Xie, Q (corresponding author), Hangzhou Normal Univ, Key Lab Cryptog & Network Secur, Hangzhou, Zhejiang, Peoples R China.	qixie68@126.com	XIE, Qi/AAO-2190-2020		National Natural Science Foundation of China [61702152, 61802276]; National Key R&D Program of China [2017YFB0802000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	This research was supported by the National Natural Science Foundation of China (Grant Nos. 61702152 and 61802276, URL http://www.nsfc.gov.cn/), and the National Key R&D Program of China (Grant No.2017YFB0802000, URL http://www.most.gov.cn/).	Abadi M, 2001, ACM SIGPLAN NOTICES, V36, P104, DOI 10.1145/373243.360213; Abadi M, 2009, LECT NOTES COMPUT SC, V5643, P35, DOI 10.1007/978-3-642-02658-4_5; Amin R, 2016, COMPUT NETW, V101, P42, DOI 10.1016/j.comnet.2016.01.006; Bergamo P, 2005, IEEE T CIRCUITS-I, V52, P1382, DOI 10.1109/TCSI.2005.851701; Chang CC, 2004, COMPUT STAND INTER, V26, P471, DOI 10.1016/j.csi.2003.12.001; Chun-Li Lin, 2000, Operating Systems Review, V34, P12, DOI 10.1145/506106.506108; Ding Y., 1995, Operating Systems Review, V29, P77, DOI 10.1145/219282.219298; Farash MS, 2017, INT J COMMUN SYST, V30, DOI 10.1002/dac.3019; Farash MS, 2014, NONLINEAR DYNAM, V77, P399, DOI 10.1007/s11071-014-1304-6; Guo H, 2008, COMPUT SECUR, V27, P16, DOI 10.1016/j.cose.2008.03.001; Hu XX, 2014, NONLINEAR DYNAM, V78, P1293, DOI 10.1007/s11071-014-1515-x; Jiang Q, 2018, J AMB INTEL HUM COMP, V9, P1061, DOI 10.1007/s12652-017-0516-2; Jiang Q, 2017, COMPUT ELECTR ENG, V63, P182, DOI 10.1016/j.compeleceng.2017.03.016; Jiang Q, 2017, IEEE ACCESS, V5, P3376, DOI 10.1109/ACCESS.2017.2673239; Kim TH, 2012, J SYST SOFTWARE, V85, P2899, DOI 10.1016/j.jss.2012.06.063; Kumari S, 2017, PEER PEER NETW APPL, V10, P92, DOI 10.1007/s12083-015-0409-0; Lee CC, 2015, NONLINEAR DYNAM, V79, P2485, DOI 10.1007/s11071-014-1827-x; Lee CC, 2013, NONLINEAR DYNAM, V73, P125, DOI 10.1007/s11071-013-0772-4; Lee TF, 2004, COMPUT SECUR, V23, P571, DOI 10.1016/j.cose.2004.06.007; Lin CL, 2001, IEEE COMMUN LETT, V5, P497, DOI 10.1109/4234.974498; Lo NW, 2009, COMPUT STAND INTER, V31, P1167, DOI 10.1016/j.csi.2009.03.002; Lu RX, 2007, COMPUT SECUR, V26, P94, DOI 10.1016/j.cose.2006.08.005; Lu YR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153870; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; Nohl K., 2008, P 17 C USENIX SEC S, P185, DOI DOI 10.1109/54.785838; Phan RCW, 2008, INFORM SCIENCES, V178, P2849, DOI 10.1016/j.ins.2008.02.008; Siddiqui Z, 2014, J MED SYST, V38, DOI 10.1007/s10916-013-9997-5; Steiner M., 1995, Operating Systems Review, V29, P22, DOI 10.1145/206826.206834; Wang XY, 2010, COMMUN NONLINEAR SCI, V15, P4052, DOI 10.1016/j.cnsns.2010.02.014; Xie Q, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/11/110505; Xie Q, 2015, NONLINEAR DYNAM, V79, P2345, DOI 10.1007/s11071-014-1816-0; Xie Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102747; Xie Q, 2013, NONLINEAR DYNAM, V74, P1021, DOI 10.1007/s11071-013-1020-7; Xue KP, 2012, COMMUN NONLINEAR SCI, V17, P2969, DOI 10.1016/j.cnsns.2011.11.025; Yoon EJ, 2008, COMPUT STAND INTER, V30, P309, DOI 10.1016/j.csi.2007.08.018; Yoon EJ, 2011, COMMUN NONLINEAR SCI, V16, P2383, DOI 10.1016/j.cnsns.2010.09.021; Zhang LH, 2008, CHAOS SOLITON FRACT, V37, P669, DOI 10.1016/j.chaos.2006.09.047	37	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203984	10.1371/journal.pone.0203984	http://dx.doi.org/10.1371/journal.pone.0203984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289897	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500010
J	Arganaraz, JP; Landi, MA; Scavuzzo, CM; Bellis, LM				Arganaraz, Juan P.; Landi, Marcos A.; Marcelo Scavuzzo, Carlos; Bellis, Laura M.			Determining fuel moisture thresholds to assess wildfire hazard: A contribution to an operational early warning system	PLOS ONE			English	Article							FIRE DANGER ASSESSMENT; MODIS IMAGES; VEGETATION; FOREST; CORDOBA; SPREAD; MOUNTAINS; IGNITION; MANAGEMENT; SHRUBLAND	Fuel moisture content (FMC) is an important fuel property for assessing wildfire hazard, since it influences fuel flammability and fire behavior. The relationship between FMC and fire activity differs among land covers and seems to be a property of each ecosystem. Our objectives were to analyze pre-fire FMC among different land covers and to propose a wildfire hazard classification for the Sierras Chicas in the Chaco Serrano subregion (Argentina), by analyzing pre-fire FMC distributions observed for grasslands, shrublands and forests and using percentiles to establish thresholds. For this purpose, we used a fire database derived from Landsat imagery (30 m) and derived FMC maps every 8 days from 2002 to 2016 using MODIS reflectance products and empirical equations of FMC. Our results indicated that higher FMC constrains the extent of wildfires, whereas at lower FMC there are other factors affecting their size. Extreme and high fire hazard thresholds for grasslands were established at FMC of 55% and 67% respectively, at 72% and 105% for forests and at 106% and 121% for shrublands. Our FMC thresholds were sensitive to detect extreme fire hazard conditions during years with high fire activity in comparison to average conditions. The differences in the distributions of pre-fire FMC among land covers and between ecosystems highlighted the need to locally determine land cover-specific FMC thresholds to assess wildfire hazard. Our wildfire hazard classification applied to FMC maps in an operational framework will contribute to improving early warning systems in the Sierras Chicas. However, moisture alone is not sufficient to represent true fire hazard in Chaco forests and the combination with other variables would provide better hazard assessments. These operational wildfire hazard maps will help to better allocation of fire protective resources to minimize negative impact on people, property and ecosystems. To the best of our knowledge, this is the first study analyzing pre-fire FMC over several fire seasons in a non-Mediterranean ecosystem, aiming at assessing wildfire hazard.	[Arganaraz, Juan P.; Landi, Marcos A.; Bellis, Laura M.] Univ Nacl Cordoba, IDEA, CONICET, Cordoba, Argentina; [Arganaraz, Juan P.; Landi, Marcos A.; Bellis, Laura M.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina; [Arganaraz, Juan P.; Marcelo Scavuzzo, Carlos; Bellis, Laura M.] Univ Nacl Cordoba, Inst Altos Estudios Espaciales Mario Gulich, Comis Nacl Actividades Espaciales, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; National University of Cordoba	Arganaraz, JP (corresponding author), Univ Nacl Cordoba, IDEA, CONICET, Cordoba, Argentina.; Arganaraz, JP (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina.; Arganaraz, JP (corresponding author), Univ Nacl Cordoba, Inst Altos Estudios Espaciales Mario Gulich, Comis Nacl Actividades Espaciales, Cordoba, Argentina.	argajuan@gmail.com	scavuzzo, carlos marcelo/M-9829-2015; Argañaraz, Juan/W-8022-2019; Landi, Marcos Alejandro/ADZ-2022-2022	/0000-0003-1388-9219; carlos marcelo, scavuzzo/0000-0003-0905-6361	Secretaria de Ciencia y Tecnica (SECyT) - Universidad Nacional de Cordoba; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) (PICT) [1147-2012]; CONICET	Secretaria de Ciencia y Tecnica (SECyT) - Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) (PICT)(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by grants to L.M. B. from Secretaria de Ciencia y Tecnica (SECyT) - Universidad Nacional de Cordoba and Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) (PICT No 1147-2012). J.P.A. and M.A.L. have Postdoctoral fellowships from CONICET and L.M.B. is a researcher at CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi S, 2014, J FOREST RES-JPN, V19, P105, DOI 10.1007/s10310-012-0388-4; Andrews PL, 2003, INT J WILDLAND FIRE, V12, P213, DOI 10.1071/WF02059; [Anonymous], R LANG ENV STAT COMP; Arganaraz JP, 2017, J ENVIRON MANAGE, V196, P499, DOI 10.1016/j.jenvman.2017.03.058; Arganaraz JP, 2016, DINAMICA ESPACIAL FU; Arganaraz JP, 2018, IEEE LAT AM T, V16, P977; Arganaraz JP, 2015, SCI TOTAL ENVIRON, V520, P1, DOI 10.1016/j.scitotenv.2015.02.081; Arganaraz JP, 2015, FIRE ECOL, V11, P55, DOI 10.4996/fireecology.1101055; Barraza V, 2014, IEEE J-STARS, V7, P421, DOI 10.1109/JSTARS.2013.2268011; Bellis LM, 2015, IGARSS 2015; Bianchi LO, 2015, INT J WILDLAND FIRE, V24, P340, DOI 10.1071/WF13099; Bonansea M, 2013, WATER SCI TECHNOL, V67, P217, DOI 10.2166/wst.2012.560; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bucher E.H., 2004, ACAD NACL CIENCIAS C, V101, P1; Cabido M, 2018, APPL VEG SCI, V21, P298, DOI 10.1111/avsc.12369; Caccamo G, 2012, INT J WILDLAND FIRE, V21, P257, DOI 10.1071/WF11024; Calkin D.E., 2013, RMRSGTR315 USDA FOR; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; CHLADIL MA, 1995, INT J WILDLAND FIRE, V5, P165, DOI 10.1071/WF9950165; Chowdhury EH, 2015, ISPRS J PHOTOGRAMM, V104, P224, DOI 10.1016/j.isprsjprs.2014.03.011; Chuvieco E, 2014, INT J WILDLAND FIRE, V23, P606, DOI 10.1071/WF12052; Chuvieco E, 2002, INT J REMOTE SENS, V23, P2145, DOI 10.1080/01431160110069818; Chuvieco E, 2009, INT J WILDLAND FIRE, V18, P430, DOI 10.1071/WF08020; Cingolani AM, 2013, RANGELAND J, V35, P285, DOI 10.1071/RJ12095; Cruz MG, 2015, INT J WILDLAND FIRE, V24, P838, DOI 10.1071/WF14146; Davidson A, 2006, INT J APPL EARTH OBS, V8, P225, DOI 10.1016/j.jag.2005.10.002; Davies GM, 2011, FIRE TECHNOL, V47, P421, DOI 10.1007/s10694-010-0162-0; Davies GM, 2009, J APPL ECOL, V46, P1054, DOI 10.1111/j.1365-2664.2009.01681.x; de Jong MC, 2016, NAT HAZARD EARTH SYS, V16, P1217, DOI 10.5194/nhess-16-1217-2016; de Torres Curth Monica I., 2008, Ecologia Austral, V18, P153; Dennison PE, 2008, INT J WILDLAND FIRE, V17, P18, DOI 10.1071/WF07017; Dennison PE, 2009, INT J WILDLAND FIRE, V18, P1021, DOI 10.1071/WF08055; Dentoni MC, 2001, METEOROL APPL, V8, P361, DOI 10.1017/S1350482701003127; Dibble AC, 2007, INT J WILDLAND FIRE, V16, P426, DOI 10.1071/WF05103; Gander W, 1993, SOLVING PROBLEMS SCI, P121, DOI DOI 10.1007/978-3-642-975333-2_9; Gavier-Pizarro GI, 2012, REMOTE SENS ENVIRON, V122, P134, DOI 10.1016/j.rse.2011.09.023; Giorgis MA, 2013, B SOC ARGENT BOT, V48, P493; Giorgis Melisa A, 2011, Kurtziana, V36, P9; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Hantson S, 2015, GLOBAL ECOL BIOGEOGR, V24, P77, DOI 10.1111/geb.12246; Hawbaker TJ, 2013, ECOL APPL, V23, P565, DOI 10.1890/12-1816.1; Heinsch FA, 2009, P 8 S FIR FOR MET; Hsu C. W., 2010, TECHNICAL REPORT; Hurtado Hernandez A., 2018, PHYTOMA ESPANA, V301, P50; Jaureguiberry P, 2011, AUSTRAL ECOL, V36, P821, DOI 10.1111/j.1442-9993.2010.02222.x; Jolly WM, 2012, FOREST ECOL MANAG, V269, P52, DOI 10.1016/j.foreco.2011.12.022; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Jurdao S, 2013, REMOTE SENS ENVIRON, V132, P59, DOI 10.1016/j.rse.2013.01.004; Jurdao S, 2012, FIRE ECOL, V8, P77, DOI 10.4996/fireecology.0801077; KOENKER R., 2013, QUANTREG QUANTILE RE; Kunst C, 2015, RIA. Rev. investig. agropecu., V41, P83; Kunst C, 2014, RIA. Rev. investig. agropecu., V40, P165; McAllister S, 2017, COMBUST SCI TECHNOL, V189, P231, DOI 10.1080/00102202.2016.1206086; McKenzie D, 2011, ECOL STUD-ANAL SYNTH, V213, P1, DOI 10.1007/978-94-007-0301-8; Melnik O.M., 2016, THESIS U ALBERTA EDM, DOI [10.7939/R3862BH01, DOI 10.7939/R3862BH01]; Meyer D, 2015, MISC FUNCTIONS DEP S; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Arganaraz JP, 2016, IEEE J-STARS, V9, P5339, DOI 10.1109/JSTARS.2016.2575366; Pellizzaro G, 2007, INT J WILDLAND FIRE, V16, P232, DOI 10.1071/WF06081; Peterson SH, 2008, REMOTE SENS ENVIRON, V112, P4272, DOI 10.1016/j.rse.2008.07.012; Qi Y, 2012, FIRE ECOL, V8, P71, DOI 10.4996/fireecology.0803071; Renison D, 2002, REV CHIL HIST NAT, V75, P719; Rossa CG, 2017, FOREST SYST, V26, DOI 10.5424/fs/2017263-12019; Rossa CG, 2017, INT J WILDLAND FIRE, V26, P24, DOI 10.1071/WF16049; Schoenberg FP, 2003, INT J WILDLAND FIRE, V12, P1, DOI 10.1071/WF02053; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; Talamo A, 2003, FOREST ECOL MANAG, V184, P79, DOI 10.1016/S0378-1127(03)00150-6; Tiribelli F, 2018, J VEG SCI, V29, P147, DOI 10.1111/jvs.12620; TURNER MG, 1994, J VEG SCI, V5, P731, DOI 10.2307/3235886; Van Wagner C.E., 1987, DEV STRUCTURE CANADI; Viegas DX, 2001, INT J WILDLAND FIRE, V10, P223, DOI 10.1071/WF01022; Weise DR, 2016, INT J WILDLAND FIRE, V25, P980, DOI 10.1071/WF15177; Weise DR, 2005, INT J WILDLAND FIRE, V14, P99, DOI 10.1071/WF04049; Weise DR, 1998, FIR EC MAN SHIFT PAR; Yebra M, 2008, AGR FOREST METEOROL, V148, P523, DOI 10.1016/j.agrformet.2007.12.005; Yebra M, 2013, REMOTE SENS ENVIRON, V136, P455, DOI 10.1016/j.rse.2013.05.029; Zak M., 2008, PATRONES ESPACIALES; Zak MR, 2008, ENVIRON MANAGE, V42, P181, DOI 10.1007/s00267-008-9101-y; Zylstra PJ, 2018, AUSTRAL ECOL, V43, P578, DOI 10.1111/aec.12594	79	18	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204889	10.1371/journal.pone.0204889	http://dx.doi.org/10.1371/journal.pone.0204889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286128	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500057
J	Lin, WR; Ling, ZJ; Liu, SQ; Lee, JTB; Lim, M; Goh, A; Lim, S; Manning, PG; Feng, ML; Loh, TP				Lin, Wenrong; Ling, Zheng Jye; Liu, Siqi; Lee, Joel Tye Beng; Lim, Marcus; Goh, Aloysius; Lim, Sean; Manning, Peter George; Feng, Mengling; Loh, Tze Ping			A knowledge, attitude, and practice survey on mediation among clinicians in a tertiary-care hospital in Singapore (vol 13, e0199885, 2018)	PLOS ONE			English	Correction									[Lin, Wenrong] Natl Univ Singapore Hosp, Legal Off, Singapore, Singapore; [Ling, Zheng Jye] Natl Univ Singapore Hosp, Acad Informat Off, Singapore, Singapore; [Liu, Siqi; Feng, Mengling] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Lee, Joel Tye Beng; Lim, Marcus] Singapore Int Mediat Inst, Singapore, Singapore; [Goh, Aloysius] Singapore Int Mediat Ctr, Singapore, Singapore; [Lim, Sean] Peacemakers Consulting Serv Pte Ltd, Singapore, Singapore; [Manning, Peter George; Loh, Tze Ping] Natl Univ Singapore Hosp, Clin Risk Management, Singapore, Singapore; [Loh, Tze Ping] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Loh, Tze Ping] Natl Univ Singapore, Biomed Inst Global Hlth Res & Technol, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lin, WR (corresponding author), Natl Univ Singapore Hosp, Legal Off, Singapore, Singapore.			Loh, Tze Ping/0000-0002-4272-0001				Lin WR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199885	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205451	10.1371/journal.pone.0205451	http://dx.doi.org/10.1371/journal.pone.0205451			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286194	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500107
J	Massoud, D; Lao-Perez, M; Hurtado, A; Abdo, W; Palomino-Morales, R; Carmona, FD; Burgos, M; Jimenez, R; Barrionuevo, FJ				Massoud, Diaa; Lao-Perez, Miguel; Hurtado, Alicia; Abdo, Walied; Palomino-Morales, Rogelio; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.			Germ cell desquamation-based testis regression in a seasonal breeder, the Egyptian long-eared hedgehog, Hemiechinus auritus	PLOS ONE			English	Article							HAMSTERS MESOCRICETUS-AURATUS; PERITUBULAR MYOID CELLS; LARGE HAIRY ARMADILLO; MINK MUSTELA-VISION; SEMINIFEROUS EPITHELIUM; CHAETOPHRACTUS-VILLOSUS; TESTICULAR REGRESSION; IBERIAN MOLE; APOPTOSIS; PROLIFERATION	Testes of seasonally breeding species experience a severe functional regression before the non-breeding period, which implies a substantial mass reduction due to massive germ-cell depletion. Two alternative mechanisms of seasonal germ-cell depletion have been described in mammals, apoptosis and desquamation (sloughing), but their prevalence has not been determined yet due to reduced number of species studied. We performed a morphological, hormonal, and molecular study of the mechanism of seasonal testicular regression in males of the Egyptian long eared-hedgehog (Hemiechinus auritus). Our results show that live, non-apoptotic, germ cells are massively depleted by desquamation during the testis regression process. This is concomitant with both decreased levels of serum testosterone and irregular distribution of the cell-adhesion molecules in the seminiferous epithelium. The inactive testes maintain some meiotic activity as meiosis onset is not halted and spermatocytes die by apoptosis at the pachytene stage. Our data support the notion that apoptosis is not the major testis regression effector in mammals. Instead, desquamation appears to be a common mechanism in this class.	[Massoud, Diaa] Fayoum Univ, Fac Sci, Dept Zool, Al Fayyum, Egypt; [Lao-Perez, Miguel; Hurtado, Alicia; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.] Univ Granada, Dept Genet, Granada, Spain; [Lao-Perez, Miguel; Hurtado, Alicia; David Carmona, Francisco; Burgos, Miguel; Jimenez, Rafael; Barrionuevo, Francisco J.] Univ Granada, Inst Biotecnol, Granada, Spain; [Abdo, Walied] Kafr El Sheikh Univ, Fac Vet Med, Dept Pathol, Kafr Al Sheikh, Egypt; [Palomino-Morales, Rogelio] Univ Granada, Dept Bioquim & Biol Mol 1, Granada, Spain	Egyptian Knowledge Bank (EKB); Fayoum University; University of Granada; University of Granada; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; University of Granada	Jimenez, R (corresponding author), Univ Granada, Dept Genet, Granada, Spain.; Jimenez, R (corresponding author), Univ Granada, Inst Biotecnol, Granada, Spain.	rjimenez@ugr.es	Abdo, Walied/AAF-2032-2019; Carmona, F. David/F-9953-2016; Jiménez, Rafael/AAQ-3775-2021; Palomino-Morales, Rogelio J/L-5720-2014; Jiménez, Rafael/J-4103-2012; Barrionuevo, Francisco/AAA-7639-2019; Massoud, Diaa/A-6492-2018; Burgos, Miguel/L-3709-2014	Carmona, F. David/0000-0002-1427-7639; Jiménez, Rafael/0000-0003-4103-8219; Palomino-Morales, Rogelio J/0000-0003-3507-343X; Jiménez, Rafael/0000-0003-4103-8219; Barrionuevo, Francisco/0000-0003-2651-1530; , Walied/0000-0003-4635-8342; Massoud, Diaa/0000-0001-8646-9253; Burgos, Miguel/0000-0003-4446-9313	Agencia de Innovacion y Desarrollo de la "Junta de Andalucia" through Group PAI [BIO-109]; Spanish "Secretaria de Estado de Investigacion, Desarrollo e Innovacion" [CGL-2015-67108-P]; FEDER	Agencia de Innovacion y Desarrollo de la "Junta de Andalucia" through Group PAI; Spanish "Secretaria de Estado de Investigacion, Desarrollo e Innovacion"; FEDER(European Commission)	This study has been supported by the Agencia de Innovacion y Desarrollo de la "Junta de Andalucia" through Group PAI BIO-109 and the Spanish "Secretaria de Estado de Investigacion, Desarrollo e Innovacion" through the grant CGL-2015-67108-P, which includes FEDER funds.	ASAWA SC, 1981, ACTA ANAT, V111, P259; Barrionuevo FJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15635; Batias C, 1999, CELL TISSUE RES, V298, P113, DOI 10.1007/s004419900076; Berg KA, 2001, INT J ANDROL, V24, P284, DOI 10.1046/j.1365-2605.2001.00300.x; BLOTTNER S, 1995, THERIOGENOLOGY, V44, P321, DOI 10.1016/0093-691X(95)00187-D; Blottner S, 2007, CELL TISSUE RES, V327, P615, DOI 10.1007/s00441-006-0328-8; CHAPMAN DL, 1994, INT J DEV BIOL, V38, P491; Dadhich RK, 2011, SEX DEV, V5, P77, DOI 10.1159/000323805; Dadhich RK, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106708; Dadhich RK, 2010, BIOL REPROD, V83, P83, DOI 10.1095/biolreprod.109.080135; Flower MSS., 1932, P ZOOL SOC LOND, V102, P369, DOI [10.1111/j.1096-3642.1932.tb01081.x, DOI 10.1111/J.1096-3642.1932.TB01081.X]; FURUTA I, 1994, BIOL REPROD, V51, P1315, DOI 10.1095/biolreprod51.6.1315; Gonzalez CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191126; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; GOYAL RP, 1974, ACTA ANAT, V90, P462; Hamer G, 2008, THERIOGENOLOGY, V69, P333, DOI 10.1016/j.theriogenology.2007.09.029; Islam MN, 2012, THERIOGENOLOGY, V77, P1854, DOI 10.1016/j.theriogenology.2012.01.002; Jimenez R, 2015, SEX DEV, V9, P205, DOI 10.1159/000439039; Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011; Kingdon J, 2013, MAMMALS AFRICA BLOOM; KIRKPATRICK CM, 1955, AM J ANAT, V97, P229, DOI 10.1002/aja.1000970203; Luaces JP, 2013, REPROD FERT DEVELOP, V25, P547, DOI 10.1071/RD12127; Luaces JP, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113118; Massoud D, 2014, J EXP ZOOL PART B, V322, P304, DOI 10.1002/jez.b.22582; McClusky LM, 2012, CELL TISSUE RES, V349, P703, DOI 10.1007/s00441-011-1288-1; Morales E, 2002, INT J ANDROL, V25, P281, DOI 10.1046/j.1365-2605.2002.00363.x; Morales E, 2007, J ANDROL, V28, P123, DOI 10.2164/jandrol.106.000778; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Neill JD, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1; PALOMBI F, 1992, ANAT REC, V233, P32, DOI 10.1002/ar.1092330106; Pastor LM, 2011, REPROD DOMEST ANIM, V46, P155, DOI 10.1111/j.1439-0531.2009.01573.x; PELLETIER RM, 1988, AM J ANAT, V183, P68, DOI 10.1002/aja.1001830105; PELLETIER RM, 1986, AM J ANAT, V175, P91, DOI 10.1002/aja.1001750109; Prakash I., 1960, INDIA J MAMMAL, V41, P386, DOI DOI 10.2307/1377497; RICHARDSON LL, 1995, BIOL REPROD, V52, P320, DOI 10.1095/biolreprod52.2.320; SCHOENFELD M, 1985, MAMMALIA, V49, P339, DOI 10.1515/mamm.1985.49.3.339; Seco-Rovira V, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112649; Shukla Kamla Kant, 2012, Front Biosci (Elite Ed), V4, P746; Stanton PG, 2016, SEMIN CELL DEV BIOL, V59, P166, DOI 10.1016/j.semcdb.2016.06.018; Strbenc M, 2003, ANAT HISTOL EMBRYOL, V32, P48, DOI 10.1046/j.1439-0264.2003.00437.x; Tarulli GA, 2008, REPRODUCTION, V135, P867, DOI 10.1530/REP-07-0572; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; Wright S, 1932, P 6 INT C GEN ITH NE; Yazawa T, 2000, ENDOCRINOLOGY, V141, P2027, DOI 10.1210/en.141.6.2027; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Young KA, 2001, REPRODUCTION, V122, P677, DOI 10.1530/rep.0.1220677; Young KA, 2001, BIOL REPROD, V64, P706, DOI 10.1095/biolreprod64.2.706; Young KA, 1999, ENDOCRINOLOGY, V140, P3133, DOI 10.1210/en.140.7.3133; Zhang L, 2008, THERIOGENOLOGY, V69, P1148, DOI 10.1016/j.theriogenology.2008.01.028	49	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204851	10.1371/journal.pone.0204851	http://dx.doi.org/10.1371/journal.pone.0204851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286149	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500050
J	Van Treuren, T; Vishwanatha, JK				Van Treuren, Timothy; Vishwanatha, Jamboor K.			CRISPR deletion of MIEN1 in breast cancer cells	PLOS ONE			English	Article							METASTASIS; C17ORF37; GENE; MIGRATION; NUCLEASES; AMPLICON; C35	Migration and Invasion Enhancer (MIEN1) is an oncogene which is involved in facilitating motility of cancer cells through actin dynamics and gene expression. Increased MIEN1 expression in many types of tumors leads to disease progression and metastatic propensity. It is unclear precisely how MIEN1 is involved in this process and more studies are required to tease out the mechanisms. Here we show that Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) genome editing effectively produced specific genomic deletions in the MIEN1 gene which led to the abrogation of its expression in breast cancer cells. The single guide RNAs (sgRNAs) mediated targeting of MIEN1 was specific and none of the clones screened for off-target cleavage revealed any insertions or deletions (indels). Additionally, disruption of the MIEN1 gene did not alter the cell morphology, growth, proliferation or survival. Knocking out MIEN1 in these breast cancer cells will allow future studies to determine the exact role MIEN1 plays in breast tumor metastasis, which might lead to production of novel therapeutics to treat this and other cancers.	[Van Treuren, Timothy; Vishwanatha, Jamboor K.] Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Inst Canc Res, Ft Worth, TX 76107 USA; [Vishwanatha, Jamboor K.] Univ North Texas, Hlth Sci Ctr, Texas Ctr Hlth Dispar, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Van Treuren, T (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Inst Canc Res, Ft Worth, TX 76107 USA.	tim.vantreuren@gmail.com		Vishwanatha, Jamboor/0000-0002-0266-6020	National Institute on Minority Health and Health Disparities [1P20 MD006882]	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institute on Minority Health and Health Disparities Grant 1P20 MD006882 to JKV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer DE, 2015, JOVE-J VIS EXP, DOI 10.3791/52118; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cho S. W., 2013, GENOME RES; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Dasgupta S, 2011, J BIOL CHEM, V286, P25935, DOI 10.1074/jbc.M111.254599; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kpetemey M, 2016, ONCOTARGET; Kpetemey M, 2016, ONCOTARGET, V7, P54913, DOI 10.18632/oncotarget.10798; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Rajendiran S, 2015, CANCER BIOL THER, V16, P876, DOI 10.1080/15384047.2015.1040962; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Smith I, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003213; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Zhao H, 2017, GENETICS MOL RES GMR, V16; Zheng QP, 2014, BIOTECHNIQUES, V57, P115, DOI 10.2144/000114196	22	19	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204976	10.1371/journal.pone.0204976	http://dx.doi.org/10.1371/journal.pone.0204976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286132	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500069
J	Wada, H; Shimizu, A; Osada, T; Tanaka, Y; Fukaya, S; Sasaki, E				Wada, Hiroshi; Shimizu, Atsushi; Osada, Toshihiro; Tanaka, Yuki; Fukaya, Satoshi; Sasaki, Eiji			Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design (vol 13, e0199249, 2018)	PLOS ONE			English	Correction														Osada, Toshihiro/0000-0001-8331-9655				Wada H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199249	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205567	10.1371/journal.pone.0205567	http://dx.doi.org/10.1371/journal.pone.0205567			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286206	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500113
J	Shang, C; Yadav, A; Stoklosa, M; Kontsevaya, A; Lewis, FB; Pana, A; Reyes, I				Shang, Ce; Yadav, Amit; Stoklosa, Michel; Kontsevaya, Anna; Lewis, Fabian B.; Pana, Adrian; Reyes, Irene			Country-specific costs of implementing the WHO FCTC tobacco control policies and potential financing sources	PLOS ONE			English	Article							SMOKING PREVALENCE; CIGARETTE PRICES; EXPOSURE; MPOWER; IMPACT	Background One of the major obstacles to the full implementation of the World Health Organization (WHO) Framework Convention of Tobacco Control (FCTC) tobacco control measures is the lack of sustainable financing resources. Goal To update and simulate country-specific indicators that are highly relevant to the costs and financial resources of the treaty policy implementation. We also developed an Excel tool for simulation and assessed the aggregated-level indicators by the 2016 World Bank income groups. Approaches Using mostly 2016 data or 2014-15 data if 2016 one are not available, we updated five indicators relevant to the treaty implementation, which are the gap between current and desirable policy implementation, cigarette affordability, the costs of implementing best- buy tobacco control policies, the number of smoking-attributable deaths, and the simulated tax revenue resulting from a $1 tax increase. We also aggregated indicators and simulation results by the World Bank income groups, encompassing the five indicators and the reduction in smoking and in attributable deaths due to a hypothetical 11$ tax increase. Finally, the policy implementation cost was compared with tax revenue and revenue increases. Findings As of 2016, smoking remains one of the leading causes of premature deaths worldwide while the implementation of best-buy tobacco control policies was below the recommended levels. Meanwhile, there was room to further increase cigarette taxes and prices, as cigarettes remained affordable in many countries. The total costs of implementing best-buy policies in the next 15 years merely account for 8.3% of the 2016 excise tax revenue, indicating that a small proportion of annual tax revenue could fund the implementation of tobacco control policies recommended by the WHO FCTC. Conclusions Increasing taxes could have a multiplier impact on curbing tobacco use through aiding the implementation of the WHO FCTC.	[Shang, Ce] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Tobacco Res Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73107 USA; [Shang, Ce] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73107 USA; [Yadav, Amit] HRIDAY, Publ Hlth Law & Advocacy, New Delhi, India; [Stoklosa, Michel] Amer Canc Soc, Atlanta, GA 30329 USA; [Kontsevaya, Anna] Natl Res Ctr Prevent Med, Moscow, Russia; [Lewis, Fabian B.] Minist Finance & Publ Serv, Kingston, Jamaica; [Pana, Adrian] Ctr Hlth Outcomes & Evaluat, Sectorul, Romania; [Reyes, Irene] Hlth Justice, Quezon City, Philippines	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; American Cancer Society; National Medical Research Center for Therapy & Preventive Medicine	Shang, C (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Tobacco Res Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73107 USA.; Shang, C (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73107 USA.	ce-shang@ouhsc.edu	Yadav, Amit/AAJ-7796-2020	Yadav, Amit/0000-0002-0638-2105	World Heart Federation (WHF)	World Heart Federation (WHF)	This research project is funded by the World Heart Federation (WHF).	Ali N, 2016, SCI TOTAL ENVIRON, V573, P1607, DOI 10.1016/j.scitotenv.2016.09.134; [Anonymous], 2015, **NON-TRADITIONAL**; Blecher EH, 2004, TOB CONTROL, V13, P339, DOI 10.1136/tc.2003.006726; Blecher E, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2012-050575; Chaloupka FJ, 2014, NICOTINE TOB RES, V16, pS3, DOI 10.1093/ntr/ntt121; Drope J., 2018, TOBACCO ATLAS; Drope J, 2016, J HLTH INEQUALITIES, V2, P128, DOI [10.5114/jhi.2016.65348, DOI 10.5114/JHI.2016.65348]; Dubray J, 2015, TOB CONTROL, V24, P540, DOI 10.1136/tobaccocontrol-2014-051834; Goodchild M, 2016, B WORLD HEALTH ORGAN, V94, P250, DOI 10.2471/BLT.15.164707; Gravely S, 2017, LANCET PUBLIC HEALTH, V2, pE166, DOI 10.1016/S2468-2667(17)30045-2; Miller LS, 2010, TOB CONTROL, V19, pI68, DOI 10.1136/tc.2008.029421; Ngo A, 2017, PREV MED, V105, pS10, DOI 10.1016/j.ypmed.2017.05.006; Organization WH, 2012, SCAL ACT NONC DIS MU; Gomes JFP, 2012, INHAL TOXICOL, V24, P425, DOI 10.3109/08958378.2012.684077; Shang C, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-050966; Stoklosa M, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2013-051467; WHO, 2016, EARM TOB TAX LESS LE; WHO, 2011, SCAL ACT NONC DIS MU	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204903	10.1371/journal.pone.0204903	http://dx.doi.org/10.1371/journal.pone.0204903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281668	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400066
J	Jakel, F; Worm, O; Lange, S; Mertelsmann, R				Jaekel, Frank; Worm, Oliver; Lange, Sascha; Mertelsmann, Roland			A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; CANCER; CLASSIFICATION; DISEASE	A model for hematopoiesis is presented that explicitly includes the erythrocyte, granulocyte, and thrombocyte lineages and their common precursors. A small number of stem cells proliferate and differentiate through different compartments to produce the vast number of blood cells needed every day. Growth factors regulate the proliferation of cells dependent on the current demand. We provide a steady state analysis of the model and rough parameter estimates. Furthermore, we extend the model to include mutations that alter the replicative capacity of cells and introduce differentiation blocks. With these mutations the model develops signs of acute myeloid leukemia.	[Jaekel, Frank; Worm, Oliver; Lange, Sascha] Psiori GmbH, Freiburg, Germany; [Mertelsmann, Roland] Univ Klinikum Freiburg, Innere Med 1, Freiburg, Germany	University of Freiburg	Jakel, F (corresponding author), Psiori GmbH, Freiburg, Germany.	frank@psiori.com			Addison Fischer Institute for Research and Ethical Use of Artificial Intelligence	Addison Fischer Institute for Research and Ethical Use of Artificial Intelligence	Funding was partly provided by the private Addison Fischer Institute for Research and Ethical Use of Artificial Intelligence through a grant to PSIORI GmbH, Freiburg. FJ and OW were employees of PSIORI at the time the research was conducted. SL is the CEO of PSIORI. There was no additional external funding received for this study. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; This research was partly funded by the Addison Fischer Institute for Research and Ethical Use of Artificial Intelligence. The authors would like to thank Theresa Go E bel for combing through clinical records.	Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Dingli D, 2009, CELL PROLIFERAT, V42, P330, DOI 10.1111/j.1365-2184.2009.00598.x; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Dingli D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000345; Dingli D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000002; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Foley C, 2009, J MATH BIOL, V58, P285, DOI 10.1007/s00285-008-0165-3; Garcia HG, 2007, 1 EXPOSURE STAT MECH; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Groten J, 2016, JOSHA, V3, P1; Hamey FK, 2017, NAT CELL BIOL, V19, P261, DOI 10.1038/ncb3494; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARKER LA, 1969, J CLIN INVEST, V48, P963, DOI 10.1172/JCI106077; HJORT NL, 1990, ANN STAT, V18, P1259, DOI 10.1214/aos/1176347749; Krinner A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-117; Luzzatto L, 2015, NEW ENGL J MED, V373, P84, DOI 10.1056/NEJMsb1502456; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Peixoto D, 2011, MATH COMPUT MODEL, V53, P1546, DOI 10.1016/j.mcm.2010.04.013; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pujo-Menjouet L, 2015, MATH MODEL NAT PHENO, V10, P182; Rapin N, 2014, BLOOD, V123, P894, DOI 10.1182/blood-2013-02-485771; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sidorov I, 2009, EXP HEMATOL, V37, P514, DOI 10.1016/j.exphem.2008.11.009; Stiehl T, 2012, MATH MODEL NAT PHENO, V7, P166, DOI 10.1051/mmnp/20127199; Stiehl T, 2015, CELL DIVISION PATTER; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Traulsen A, 2010, CANCER LETT, V294, P43, DOI 10.1016/j.canlet.2010.01.020; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Werner B, 2015, ELIFE, V4, DOI 10.7554/eLife.08687; Werner B, 2014, CANCER RES, V74, P5386, DOI 10.1158/0008-5472.CAN-14-1210; Werner B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002290	34	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204393	10.1371/journal.pone.0204393	http://dx.doi.org/10.1371/journal.pone.0204393			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273383	gold, Green Submitted, Green Published			2022-12-27	WOS:000446124700020
J	Stolarczyk, RE; Schmidt, P				Stolarczyk, Regine E.; Schmidt, Patrick			Is early silcrete heat treatment a new behavioural proxy in the Middle Stone Age?	PLOS ONE			English	Article							DIEPKLOOF ROCK SHELTER; SOUTH-AFRICA; HOWIESONS-POORT; WESTERN CAPE; BLOMBOS CAVE; SIBUDU CAVE; COMPLEX COGNITION; HOMO-SAPIENS; TOOLS; OCHRE	The South African Middle Stone Age (MSA) has in recent years become increasingly important for our understanding of the emergence of 'modern human behaviours'. Several key innovations appeared in this context for the first time, significantly pre-dating their re-invention in the European Upper Palaeolithic. One of these innovations was heat treatment of stone to improve its quality for the production of stone tools. Heat treatment may even be the oldest well-documented technique used to intentionally alter the properties of materials in general. It is commonly thought of as requiring the skilled use of fire, a high degree of planning depth and complex cognitive abilities. However, to work on these fundamental concepts we need to analyse the techniques and procedures used to heat-treat and we need to understand what they imply. In this paper, we present a direct and expedient comparison between the technical complexities of four alternative heat treatment procedures by coding the behaviours required for their set-up in so-called cognigrams, a relatively new method for understanding complexity based on the problem-solution distance. Our results show that although the techniques significantly differ in complexity, the techniques used in the MSA fall within the range of complexities known from other MSA techniques. Heat treatment in above-ground fires, as it was practised during this period in South Africa, was even one of the most complex techniques at the time of its invention. Early heat treatment can therefore be considered an important behavioural proxy that may shed light on the behaviour and socioeconomic structure of past groups. The implications of this are highlighted by the ongoing debate about 'modernity', 'behavioural flexibility' and 'complex cognition' of early anatomically modern humans in Africa.	[Stolarczyk, Regine E.; Schmidt, Patrick] Eberhard Karls Univ Tubingen, Dept Prehist & Quaternary Ecol, Tubingen, Baden Wurttembe, Germany; [Stolarczyk, Regine E.] Univ Tubingen, Res Ctr Role Culture Early Expans Humans, Heidelberg Acad Sci & Humanities, Baden Wurttemberg, Germany; [Schmidt, Patrick] Eberhard Karls Univ Tubingen, Dept Geosci Appl Mineral, Tubingen, Baden Wurttembe, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Schmidt, P (corresponding author), Eberhard Karls Univ Tubingen, Dept Prehist & Quaternary Ecol, Tubingen, Baden Wurttembe, Germany.; Schmidt, P (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci Appl Mineral, Tubingen, Baden Wurttembe, Germany.	patrick.schmidt@uni-tuebingen.de	Schmidt, Patrick/D-3925-2016	Schmidt, Patrick/0000-0002-8727-6127	Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of University of Tubingen; DFG [SCHM 3275/2-1, HA 2744/9-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; DFG(German Research Foundation (DFG))	We acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of University of Tubingen. We also thank the DFG for funding the research of PS (Grant Nr: SCHM 3275/2-1) and the research of RS (Grant Nr: HA 2744/9-2).	[Anonymous], 1985, ARCHAEOL OCEAN, DOI DOI 10.1002/j.1834-4453.1985.tb00116.x; [Anonymous], 1974, PLAINS ANTHROPOL; Arthur KW, 2010, AM ANTHROPOL, V112, P228, DOI 10.1111/j.1548-1433.2010.01222.x; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Bentsen SE, 2014, J ARCHAEOL RES, V22, P141, DOI 10.1007/s10814-013-9069-x; Bettinger RL., 1997, ARCHEOLOGICAL PAPERS, V7, P177; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Bordes F, 1969, B SOC PREHISTORIQUE, V66, P197, DOI DOI 10.3406/BSPF.1969.10404; Brown K, 2010, PALEOANTHROPOLOGY, V2010; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; Clark JD, 1989, OLD PROBLEMS NEW PER, P29; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2008, J ARCHAEOL SCI, V35, P2675, DOI 10.1016/j.jas.2008.04.023; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; Delagnes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163874; Domanski M, 2009, J ARCHAEOL SCI, V36, P1400, DOI 10.1016/j.jas.2009.02.002; Dusseldorp G., 2013, S AFR J SCI, V109, P1, DOI DOI 10.1590/sajs.2013/20120042; FLENNIKEN JJ, 1987, ARCTIC ANTHROPOL, V24, P117; Griffiths DR, 1987, HUMAN USES FLINT CHE, P43; Grinnell GB, 1895, STORY INDIAN; Grunberg JM, 2002, ANTIQUITY, V76, P15, DOI 10.1017/S0003598X00089638; Haidle MN, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01472; Haidle MN, 2012, THINK TOOLS COMP COG; Hart JP, 2002, DARWIN ARCHAEOLOGY H; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Hodgskiss T, 2014, CAMB ARCHAEOL J, V24, P405, DOI 10.1017/S0959774314000663; HORGAN J, 1995, SCI AM, V272, P104, DOI 10.1038/scientificamerican0695-104; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Kohler W, 1963, INTELLIGENZPRUFUNGEN; Koller J., 2001, EUR J ARCHAEOL, V4, P385, DOI DOI 10.3346/jkms.2014.29.12.1597; Lea V, 2012, REV RUBRICATUM, P119; Leroi-Gourhan A., 1965, GESTE PAROLE; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P57; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Lombard M, 2012, CAMB ARCHAEOL J, V22, P237, DOI 10.1017/S095977431200025X; Lombard M, 2011, J ARCHAEOL SCI, V38, P1918, DOI 10.1016/j.jas.2011.04.001; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McDonald J., 1994, AUST ARCHAEOL, V38, P46; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Pawlik A., 2011, QUATERNARY SCI J, V60, P66, DOI [10.3285/eg.60.1.04, DOI 10.3285/EG.60.1.04]; Pawlik AF, 2011, J ARCHAEOL SCI, V38, P1699, DOI 10.1016/j.jas.2011.03.001; Porraz G, 2016, SOUTH AFR HUMANIT, V29, P203; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Powell JW., 1874, REPORT EXPLORATIONS; Rifkin RF, 2012, J ANTHROPOL ARCHAEOL, V31, P174, DOI 10.1016/j.jaa.2011.11.004; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Santaniello F, 2016, QUATERN INT, V402, P80, DOI 10.1016/j.quaint.2015.08.006; Schild R, 1997, MAN FLINT, P325; Schlanger N, 1996, CAMB ARCHAEOL J, V6, P231, DOI DOI 10.1017/S0959774300001724; Schmidt P, 2019, ARCHAEOL ANTHROP SCI, V11, P713, DOI 10.1007/s12520-017-0566-6; Schmidt P, 2017, PHYS CHEM MINER, V44, P21, DOI 10.1007/s00269-016-0833-6; Schmidt P, 2016, ARCHAEOL ANTHROP SCI, V8, P839, DOI 10.1007/s12520-015-0259-y; Schmidt P, 2016, AFR ARCHAEOL REV, V33, P99, DOI 10.1007/s10437-016-9217-z; Schmidt P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149243; Schmidt P, 2015, J HUM EVOL, V85, P22, DOI 10.1016/j.jhevol.2015.05.001; Schmidt P, 2014, ARCHAEOL ANTHROP SCI, V6, P107, DOI 10.1007/s12520-013-0162-3; Schmidt P, 2013, J ARCHAEOL SCI, V40, P3519, DOI 10.1016/j.jas.2012.10.016; Schmidt P, 2012, J ARCHAEOL SCI, V39, P135, DOI 10.1016/j.jas.2011.09.012; Schmidt P, 2011, SPECTROCHIM ACTA A, V81, P552, DOI 10.1016/j.saa.2011.06.050; Shea J.J., 2010, PALAEOANTHROPOLOGY, V2010, P100; Shea JJ, 2011, CURR ANTHROPOL, V52, P1, DOI 10.1086/658067; Shea JJ, 2009, VERTEBR PALEOBIOL PA, P189, DOI 10.1007/978-1-4020-9699-0_14; Shippee JM., 1963, PLAINS ANTHROPOL, V8, P271; Sorensen A, 2014, J ARCHAEOL SCI, V42, P476, DOI 10.1016/j.jas.2013.11.032; Speth J.D., 2015, PALEOANTHROPOLOGY, V2015, P54, DOI [DOI 10.4207/PA.2015.ART96, 10.4207/PA.2015.ART96]; Sykes RMW, 2015, SETTLEMENT, SOCIETY AND COGNITION IN HUMAN EVOLUTION: LANDSCAPES IN MIND, P117; Texier PJ, 2013, J ARCHAEOL SCI, V40, P3412, DOI 10.1016/j.jas.2013.02.021; Tiffagom M., 1998, PALEO, V10, P147, DOI DOI 10.3406/PAL.1998.1134; Tixier J., 2001, PALEORIENT, V26, P23; Torchy L, AMONT VERS AVAL FONC; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2014, J HUM EVOL, V70, P49, DOI 10.1016/j.jhevol.2013.11.003; Wadley L, 2013, CAMB ARCHAEOL J, V23, P163, DOI 10.1017/S0959774313000309; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Weiner S, 2015, J ARCHAEOL SCI, V54, P45, DOI 10.1016/j.jas.2014.11.023; Wilke P. J., 1991, J CALIFORNIA GREAT B, V13, P242; Wobber V, 2008, J HUM EVOL, V55, P340, DOI 10.1016/j.jhevol.2008.03.003; Wrangham RW, 2009, CATCHING FIRE COOKIN; Wurz S, 2007, SOUTH AFR HUMANIT, V19, P1	89	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204705	10.1371/journal.pone.0204705	http://dx.doi.org/10.1371/journal.pone.0204705			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273411	gold, Green Published			2022-12-27	WOS:000446124700032
J	Osei, M; Ansah, F; Matrevi, SA; Asante, KP; Awandare, GA; Quashie, NB; Duah, NO				Osei, Musah; Ansah, Felix; Matrevi, Sena A.; Asante, Kwaku P.; Awandare, Gordon A.; Quashie, Neils B.; Duah, Nancy O.			Amplification of GTP-cyclohydrolase 1 gene in Plasmodium falciparum isolates with the quadruple mutant of dihydrofolate reductase and dihydropteroate synthase genes in Ghana	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; SULFADOXINE-PYRIMETHAMINE; ANTIFOLATE RESISTANCE; STEPWISE ACQUISITION; MOLECULAR MARKERS; MUTATIONS; SURVEILLANCE; SYNTHETASE; SUSCEPTIBILITY; CYCLOGUANIL	Sulfadoxine-pyrimethamine (SP) is used as malaria chemoprophylaxis for pregnant women and children in Ghana. Plasmodium falciparum resistance to SP is linked to mutations in the dihydropteroate synthase gene (pfdhps), dihydrofolate reductase gene (pfdhfr) and amplification of GTP cyclohydrolase 1 (pfgch1) gene. The pfgch1 duplication is associated with pfdhfr L164, a crucial mutant for high level pyrimethamine resistance which is rare in Ghana. The presence of amplified pfgch1 in Ghanaian isolates could be an indicator of the evolution of the L164 mutant. This study therefore determined the pfgch1 copy number variations and SP resistance mutations in clinical isolates from Ghana. One hundred and ninety-two (192) blood samples collected from children aged <= 14 years with uncomplicated malaria in 2013-14 and 2015-16 were used. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the pfgch1 copy number and nested PCR-Sanger sequencing used to detect mutations in pfdhps and pfdhfr genes. Twelve parasites (6.3%) harbored double copies of the pfgch1 gene out of the 192 samples. Of the 12, 75% had the pfdhfr I51-R59-N108, 92% had the pfdhps G437 mutant, 8% had the pfdhps E540 and 67% had the SP resistance haplotype IRNG. No L164 was detected in samples with amplified pfgch1. The rare T108 mutant associated with cycloguanil resistance showed predominance (60%) over N108 in the 2015-16 isolates. The observation of parasites with increased copy number of pfgch1 gene is indicative of the future evolution of the rare quadruple pfdhfr mutant, I51-R59-N108-L164, in Ghanaian parasites. Mutant pfdhps isolates also had increased gch1 copy number suggestive that it may also facilitate sulphadoxine resistance. The selection of parasites with pfgch1 gene amplification will enhance the sustenance and persistence of parasites with SP resistance in the country. Policy makers need to begin the search for a replacement chemoprophylaxis drug for malaria vulnerable groups in Ghana.	[Osei, Musah; Ansah, Felix; Matrevi, Sena A.; Awandare, Gordon A.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens WACCB, Dept Biochem Cell & Mol Biol, Sch Biol Sci,Coll Basic & Appl Sci, Legon, Accra, Ghana; [Osei, Musah; Asante, Kwaku P.] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Matrevi, Sena A.; Quashie, Neils B.; Duah, Nancy O.] Univ Ghana, Dept Epidemiol, Noguchi Mem Inst Med Res, Coll Hlth Sci, Legon, Accra, Ghana; [Quashie, Neils B.] Univ Ghana, Ctr Trop Clin Pharmacol & Therapeut, Sch Med & Dent, Coll Hlth Sci, Legon, Accra, Ghana	University of Ghana; Kintampo Health Research Centre; University of Ghana; University of Ghana	Duah, NO (corresponding author), Univ Ghana, Dept Epidemiol, Noguchi Mem Inst Med Res, Coll Hlth Sci, Legon, Accra, Ghana.	nduah@noguchi.ug.edu.gh		Ansah, Felix/0000-0002-6928-2363; Awandare, Gordon/0000-0002-8793-3641; Duah-Quashie, Nancy/0000-0001-8819-1793; QUASHIE, NEILS/0000-0002-2538-0324	World Bank African Centres of Excellence [ACE02-WACCBIP]; Global Fund for Tuberculosis, AIDS and Malaria/National Malaria Control Programme, Ghana	World Bank African Centres of Excellence; Global Fund for Tuberculosis, AIDS and Malaria/National Malaria Control Programme, Ghana	This work was supported by funds from Musah Osei Master's fellowship from a World Bank African Centres of Excellence Grant (ACE02-WACCBIP: Awandare). Field work for 2015-6 samples was supported by the Global Fund for Tuberculosis, AIDS and Malaria/National Malaria Control Programme, Ghana. The views expressed in this publication are those of the author(s) and not necessarily those of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugri J, 2018, AAS OPEN RES, V1, P1, DOI DOI 10.12688/aasopenres.12825.1; Alam MT, 2011, J INFECT DIS, V203, P220, DOI 10.1093/infdis/jiq038; Andriantsoanirina V, 2010, ANTIMICROB AGENTS CH, V54, P2323, DOI 10.1128/AAC.01511-09; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; Brown KM, 2010, MOL BIOL EVOL, V27, P2682, DOI 10.1093/molbev/msq160; Chookajorn T, 2011, VIRULENCE, V2, P244, DOI 10.4161/viru.2.3.16194; Cisse M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1695-1; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Duah NO, 2012, AM J TROP MED HYG, V87, P996, DOI 10.4269/ajtmh.2012.12-0202; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; Freeman Alexander, 2017, J Pharm Policy Pract, V10, P15, DOI 10.1186/s40545-017-0103-0; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Hamour S, 2005, T ROY SOC TROP MED H, V99, P548, DOI 10.1016/j.trstmh.2004.10.003; Heinberg A, 2015, ANN NY ACAD SCI, V1342, P10, DOI 10.1111/nyas.12662; Heinberg A, 2013, MOL MICROBIOL, V88, P702, DOI 10.1111/mmi.12162; Hossain T, 2004, P NATL ACAD SCI USA, V101, P5158, DOI 10.1073/pnas.0401342101; Kateera F, 2016, ACTA TROP, V164, P329, DOI 10.1016/j.actatropica.2016.09.008; Kiara SM, 2009, ANTIMICROB AGENTS CH, V53, P3793, DOI 10.1128/AAC.00308-09; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kumpornsin K, 2014, MOL BIOL EVOL, V31, P1649, DOI 10.1093/molbev/msu140; Kumpornsin K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-150; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Mbogo GW, 2014, AM J TROP MED HYG, V91, P54, DOI 10.4269/ajtmh.13-0647; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P901, DOI 10.1111/j.1365-3156.2005.01471.x; Muller IB, 2010, FUTURE MICROBIOL, V5, P1857, DOI 10.2217/FMB.10.136; Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Ravenhall M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1634-6; Tahita MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137440; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204871	10.1371/journal.pone.0204871	http://dx.doi.org/10.1371/journal.pone.0204871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265714	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500052
J	Giordani, C; Rivera-Gutierrez, H; Zhe, S; Micheletto, R				Giordani, Cristiano; Rivera-Gutierrez, Hector; Zhe, Sun; Micheletto, Ruggero			Simulation of the song motor pathway in birds: A single neuron initiates a chain of events that produces birdsong with realistic spectra properties	PLOS ONE			English	Article							MODEL; NUCLEUS	Birdsong is a complex learned behavior regulated by Neuromuscular coordination of different muscle sets necessary for producing relevant sounds. We developed a heterogeneous and stochastically connected neural network representing the pathway from the high vocal center (HVC) to the robust nucleus of the arcopallium (RA) neurons that drive the muscles to generate sounds. We show that a single active neuron is sufficient to initiate a chain of spiking events that results to excite the entire network system. The network could synthesize realistic bird sounds spectra, with spontaneous generation of intermittent sound bursts typical of birdsong (song syllables). This study confirms experiments on animals and on humans, where results have shown that single neurons are responsible for the activation of complex behavior or are associated with high-level perception events.	[Giordani, Cristiano] Univ Antioquia, Inst Fis, Calle 70 52-21, Medellin, Colombia; [Rivera-Gutierrez, Hector] Univ Antioquia, Inst Biol, Calle 70 52-21, Medellin, Colombia; [Zhe, Sun] RIKEN, Head Off Informat Syst & Cybersecur, Computat Engn Applicat Unit, 2-1 Hirosawa, Wako, Saitama, Japan; [Zhe, Sun] Riken, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama, Japan; [Zhe, Sun; Micheletto, Ruggero] Yokohama City Univ, 22-2 Seto, Yokohama, Kanagawa, Japan	Universidad de Antioquia; Universidad de Antioquia; RIKEN; RIKEN; Yokohama City University	Micheletto, R (corresponding author), Yokohama City Univ, 22-2 Seto, Yokohama, Kanagawa, Japan.	ruggero@yokohama-cu.ac.jp	; Rivera-Gutierrez, Hector Fabio/C-8587-2011	zhe, sun/0000-0002-6531-0769; Micheletto, Ruggero/0000-0003-1707-6493; Rivera-Gutierrez, Hector Fabio/0000-0001-6025-3470; Giordani, Cristiano/0000-0001-5432-8085	Sabbatical research fund of Yokohama City University; University of Antioquia (CODI, UdeA, Medellin, Colombia) [IN641CE, Act 8700-3278]	Sabbatical research fund of Yokohama City University; University of Antioquia (CODI, UdeA, Medellin, Colombia)	This work has been partially funded by the Sabbatical research fund of Yokohama City University, 2015-2016 and by Committee for Research Development from University of Antioquia (CODI, UdeA, Medellin, Colombia) through grant n. IN641CE (Act 8700-3278, May 28, 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2004, J NEUROPHYSIOL, V92, P96, DOI 10.1152/jn.01146.2003; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Catchpole CK, 2000, ADV STUD BEHAV, V29, P45, DOI 10.1016/S0065-3454(08)60103-5; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gardner T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208101; Gaunt AS, 1988, SOUND PRODUCTION BIR; Hahnloser RHR, 2003, NATURE, V421, P294, DOI 10.1038/nature01221; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2010, PHILOS T R SOC A, V368, P5061, DOI 10.1098/rsta.2010.0130; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jin DZ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051902; Laje R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051921; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOWICKI S, 1988, MUSIC PERCEPT, V5, P391; Nowicki S, 1997, ENCY ACOUSTICS, P1813; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Podos J, 2009, ADV STUDY BEHAV, V40; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sugase-Miyamoto Y, 2014, J NEUROSCI, V34, P12457, DOI 10.1523/JNEUROSCI.0485-14.2014; Voigt BC, 2008, J NEUROSCI, V28, P12362, DOI 10.1523/JNEUROSCI.3046-08.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0200998	10.1371/journal.pone.0200998	http://dx.doi.org/10.1371/journal.pone.0200998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289918	gold, Green Published, Green Submitted			2022-12-27	WOS:000446545500003
J	Leijten, P; Gardner, F; Melendez-Torres, GJ; Knerr, W; Overbeek, G				Leijten, Patty; Gardner, Frances; Melendez-Torres, G. J.; Knerr, Wendy; Overbeek, Geertjan			Parenting behaviors that shape child compliance: A multilevel meta-analysis	PLOS ONE			English	Article							EXTERNALIZING BEHAVIOR; INTRINSIC MOTIVATION; CORPORAL PUNISHMENT; EFFORTFUL CONTROL; TODDLERS; OUTCOMES; PRAISE; RISK; INTERVENTIONS; FAMILIES	Background What are the parenting behaviors that shape child compliance? Most research on parentchild interactions relies on correlational research or evaluations of "package deal" interventions that manipulate many aspects of parenting at the same time. Neither approach allows for identifying the specific parenting behaviors that shape child compliance. To overcome this, we systematically reviewed and meta-analyzed available evidence on the effects of experimentally manipulated, discrete parenting behaviors-a niche in parent-child interaction research that contributes unique information on the specific parenting behaviors that shape child behavior. Methods We identified studies by systematically searching databases and through contacting experts. Nineteen studies (75 effect sizes) on four discrete parenting behaviors were included: praise, verbal reprimands, time-out, and ignore. In multilevel models, we tested for each parenting behavior whether it increased child compliance, including both observed and parent-reported measures of child compliance. Results Providing "time-out" for noncompliance robustly increased both observed and parentreported child compliance (ds = 0.84-1.72; 95% CI 0.30 to 2.54). The same holds for briefly ignoring the child after non-compliance (ds = 0.36-1.77; 95% CI 0.04 to 2.90). When observed and parent-reported outcomes were combined, but not when they were examined separately, verbal reprimands also increased child compliance (d = 0.72; 95% CI 0.26 to 1.19). Praise did not increase child compliance (ds = -0.27-1.19; 95% CI-2.04 to 1.59). Conclusion Our findings suggest that of the discrete parenting behaviors that are experimentally studied in multiple trials, especially time-out and ignore, and to some extent verbal reprimands, shape child compliance.	[Leijten, Patty; Gardner, Frances; Knerr, Wendy] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England; [Leijten, Patty; Overbeek, Geertjan] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands; [Leijten, Patty; Overbeek, Geertjan] Univ Amsterdam, Res Prior Area YIELD, Amsterdam, Netherlands; [Melendez-Torres, G. J.] Warwick Med Sch, Div Hlth Sci, Gibbet Hill Campus, Coventry, W Midlands, England; [Melendez-Torres, G. J.] Cardiff Univ, DECIPHer, Sch Social Sci, Cardiff, S Glam, Wales; [Knerr, Wendy] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	University of Oxford; University of Amsterdam; University of Amsterdam; University of Warwick; Cardiff University; University of Glasgow	Leijten, P (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, England.; Leijten, P (corresponding author), Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands.; Leijten, P (corresponding author), Univ Amsterdam, Res Prior Area YIELD, Amsterdam, Netherlands.	p.leijten@uva.nl		Leijten, Patty/0000-0002-8828-4049; Melendez-Torres, G.J./0000-0002-9823-4790	UBS Optimus Foundation (CH); National Institute for Health Research (UK); MRC [MC_UU_12017/14] Funding Source: UKRI	UBS Optimus Foundation (CH); National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by UBS Optimus Foundation (CH); National Institute for Health Research (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BERNHARDT AJ, 1975, J EXP CHILD PSYCHOL, V19, P536, DOI 10.1016/0022-0965(75)90082-X; Campbell SB, 2000, DEV PSYCHOPATHOL, V12, P467, DOI 10.1017/S0954579400003114; CATALDO MF, 1986, ANAL INTERVEN DEVEL, V6, P265, DOI 10.1016/S0270-4684(86)80009-X; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Cheung MWL, 2014, PSYCHOL METHODS, V19, P211, DOI 10.1037/a0032968; Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dishion TJ, 2008, CHILD DEV, V79, P1395, DOI 10.1111/j.1467-8624.2008.01195.x; Dix T, 2007, CHILD DEV, V78, P1204, DOI 10.1111/j.1467-8624.2007.01061.x; Eisenberg N, 2005, CHILD DEV, V76, P1055, DOI 10.1111/j.1467-8624.2005.00897.x; EISENSTADT TH, 1993, J CLIN CHILD PSYCHOL, V22, P42, DOI 10.1207/s15374424jccp2201_4; Everett G.E., 2005, EDUC TREAT CHILD, V28 (1), P48, DOI DOI 10.1016/S0005-7894(78)80009-4; Ferguson CJ, 2013, CLIN PSYCHOL REV, V33, P196, DOI 10.1016/j.cpr.2012.11.002; Forgatch M.S., 2010, EVIDENCE BASED PSYCH, V2nd ed., P159; Gardner F, 2000, Clin Child Fam Psychol Rev, V3, P185, DOI 10.1023/A:1009503409699; GARDNER HL, 1976, J ABNORM CHILD PSYCH, V4, P277, DOI 10.1007/BF00917764; Gershoff ET, 2002, PSYCHOL BULL, V128, P539, DOI 10.1037//0033-2909.128.4.539; HALL RV, 1972, J APPL BEHAV ANAL, V5, P53, DOI 10.1901/jaba.1972.5-53; Hanf C., 1969, M W PSYCH ASS VANC C; Henderlong J, 2002, PSYCHOL BULL, V128, P774, DOI 10.1037//0033-2909.128.5.774; HERBERT EW, 1973, J APPL BEHAV ANAL, V6, P15, DOI 10.1901/jaba.1973.6-15; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Kochanska G, 2008, J CHILD PSYCHOL PSYC, V49, P1220, DOI 10.1111/j.1469-7610.2008.01932.x; Kochanska G, 2013, J CLIN CHILD ADOLESC, V42, P700, DOI 10.1080/15374416.2013.782815; KUCZYNSKI L, 1990, DEV PSYCHOL, V26, P398, DOI 10.1037/0012-1649.26.3.398; Leijten P, 2018, CHILD DEV, V89, P1970, DOI 10.1111/cdev.13051; Leijten P, 2015, CLIN PSYCHOL-SCI PR, V22, P47, DOI 10.1111/cpsp.12087; Maccoby E., 1983, HDB CHILD PSYCHOL SO, V4, P1; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mengersen K, 2015, ESSENTIAL GUIDE N OF, P211; Owen DJ, 2012, CLIN CHILD FAM PSYCH, V15, P364, DOI 10.1007/s10567-012-0120-0; PFIFFNER LJ, 1989, J ABNORM CHILD PSYCH, V17, P527, DOI 10.1007/BF00916511; Posthumus JA, 2012, J ABNORM CHILD PSYCH, V40, P487, DOI 10.1007/s10802-011-9580-9; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; SAMEROFF A, 1975, HUM DEV, V18, P65, DOI 10.1159/000271476; Sanders M R, 1999, Clin Child Fam Psychol Rev, V2, P71, DOI 10.1023/A:1021843613840; Serbin LA, 2015, DEV PSYCHOPATHOL, V27, P969, DOI 10.1017/S0954579415000632; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Spinrad TL, 2012, DEV PSYCHOL, V48, P552, DOI 10.1037/a0025898; Stormshak EA, 2000, J CLIN CHILD PSYCHOL, V29, P17, DOI 10.1207/S15374424jccp2901_3; Van den Noortgate W, 2015, BEHAV RES METHODS, V47, P1274, DOI 10.3758/s13428-014-0527-2; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Waller R, 2014, J ABNORM CHILD PSYCH, V42, P1275, DOI 10.1007/s10802-014-9871-z; Warneken F, 2014, MOTIVATION SCI, V1, P43, DOI DOI 10.1037/2333-8113.1.S.43; Webster-Stratton C, 2010, EVIDENCE BASED PSYCH, P194; Zisser A, 2010, EVIDENCE BASED PSYCH, P194; Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020	52	11	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204929	10.1371/journal.pone.0204929	http://dx.doi.org/10.1371/journal.pone.0204929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289928	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000446545500028
J	Meier, A; Tunger, D				Meier, Andreas; Tunger, Dirk			Survey on opinions and usage patterns for the ResearchGate platform	PLOS ONE			English	Article								Based on a survey, the following study investigates opinions and also usage patterns relating to the ResearchGate social networking site for scientists and researchers. The survey consisted of 19 questions and was conducted online with 695 scientists from the disciplines of physics, biology, medicine, and neuroscience. Amongst other issues, the research questions concerned how much time and effort the interviewees expended on ResearchGate, what added value they perceived in using the site, the extent to which social aspects influence use, how participants planned to use the platform in future, and what role Research-Gate's own metric, the RG score, played for the scientists. In addition, we discuss which of the factors of age, sex, origin, and scientific discipline have a decisive influence on the responses of the interviewees and which are of no statistical significance The results clearly show that the origin of the participants is frequently decisive, but that the remaining factors also have a considerable influence on the responses for more than 25% of the questions.	[Meier, Andreas; Tunger, Dirk] Forschungszentrum Julich, Cent Lib, Julich, Germany	Helmholtz Association; Research Center Julich	Meier, A (corresponding author), Forschungszentrum Julich, Cent Lib, Julich, Germany.	a.meier@fz-juelich.de		Tunger, Dirk/0000-0001-6383-9194				Bender R, 2007, DTSCH MED WOCHENSCHR; Haustein S, 2016, BIT ONLINE, V19, P110; Haustein S, 2014, BEYOND BIBLIOMETRICS: HARNESSING MULTIDIMENSIONAL INDICATORS OF SCHOLARLY IMPACT, P327; Hicks Diana, 2015, Nature, V520, P429, DOI 10.1038/520429a; Jordan K, 2015, QUANT ASCW 15 OXF; Kraker P, 2015, QUANTIFYING ANAL SCH; Likert R.A., 1932, ARCH PSYCHOL, V22, P5, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Ortega JL, 2015, J INFORMETR, V9, P39, DOI 10.1016/j.joi.2014.11.004; Mahrt M, 2013, TWITTER SCHOLARLY CO; Meier A, 2018, INFORM SERVICES USE; Mushtaq Q., 2007, NOT AM MATH SOC, V54, P821; Priem J, ALTMETRICS MANIFESTO; Thelwall M, 2014, J ASSOC INF SCI TECH, V65, P721, DOI 10.1002/asi.23038; Tunger D., 2017, ALTMETRICS FEASIBILI; Van Noorden R, 2014, NATURE, V512, P126, DOI 10.1038/512126a; Venkatesh V, 2003, MIS Q SOC INFORM MAN	16	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204945	10.1371/journal.pone.0204945	http://dx.doi.org/10.1371/journal.pone.0204945			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289904	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500030
J	Otsuka, K; Takehara, A; Chiba, N; Matsui, Y				Otsuka, Kei; Takehara, Asuka; Chiba, Natsuko; Matsui, Yasuhisa			Identification of KLF9 and BCL3 as transcription factors that enhance reprogramming of primordial germ cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; IN-VITRO; CYCLIN D1; DERIVATION; CULTURE; MICE; PROLIFERATION; INDUCTION; GROWTH; P52	Primordial germ cells (PGCs) are precursors of eggs and sperm. Although PGCs are unipotent cells in vivo, they are reprogrammed into pluripotent stem cells (PSCs), also known as embryonic germ cells (EGCs), in the presence of leukemia inhibitory factor and basic fibro-blast growth factor (bFGF) in vitro. However, the molecular mechanisms responsible for their reprogramming are not fully understood. Here we show identification of transcription factors that mediate PGC reprogramming. We selected genes encoding transcription factors or epigenetic regulatory factors whose expression was significantly different between PGCs and PSCs with in silico analysis and RT-qPCR. Among the candidate genes, over-expression (OE) of Bcl3 or Klf9 significantly enhanced PGC reprogramming. Notably, EGC formation was stimulated by Klf9-OE even without bFGF. G-protein-coupled receptor signaling-related pathways, which are involved in PGC reprogramming, were enriched among genes down-regulated by Klf9-OE, and forskolin which activate adenylate cyclase, rescued repressed EGC formation by knock-down of Klf9, suggesting a molecular linkage between KLF9 and such signaling.	[Otsuka, Kei; Takehara, Asuka; Matsui, Yasuhisa] Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan; [Otsuka, Kei; Chiba, Natsuko] Tohoku Univ, Dept Canc Biol, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Takehara, Asuka; Matsui, Yasuhisa] Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chuo Ku, Tokyo, Japan; [Chiba, Natsuko; Matsui, Yasuhisa] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Matsui, Yasuhisa] Tohoku Univ, Ctr Regulatory Epigenome & Dis, Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Matsui, Y (corresponding author), Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chuo Ku, Tokyo, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Ctr Regulatory Epigenome & Dis, Sch Med, Sendai, Miyagi, Japan.	yasuhisa.matsui.d3@tohoku.ac.jp		Matsui, Yasuhisa/0000-0001-7026-6355	Ministry of Education, Culture, Sports, Science and Technology of Japan [25114003]; AMED-CREST from the Japan Agency for Medical Research and Development [JP17gm0510017h]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was funded by a Grant-in-Aid for Scientific Research (KAKENHI) in the Innovative Areas, "Mechanisms regulating gamete formation in animals" (grant #25114003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, http://www.jsps.go.jp/english/index.html, and AMED-CREST (grant #JP17gm0510017h) from the Japan Agency for Medical Research and Development, https://www.amed.go.jp/en/index.html.	Chen CY, 2015, STEM CELLS, V33, P3468, DOI 10.1002/stem.2201; Cook MS, 2011, DEVELOPMENT, V138, P23, DOI 10.1242/dev.057000; DEFELICI M, 1993, DEV BIOL, V157, P277, DOI 10.1006/dbio.1993.1132; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Gu W, 2018, BIOL OPEN, V7, DOI 10.1242/bio.032318; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Koshimizu U, 1996, DEVELOPMENT, V122, P1235; Leitch HG, 2013, STEM CELL REP, V1, P66, DOI 10.1016/j.stemcr.2013.03.004; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Maeda I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2780; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Matsui Y, 2014, DEVELOPMENT, V141, P4457, DOI 10.1242/dev.113779; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagamatsu G, 2015, STEM CELL REP, V5, P111, DOI 10.1016/j.stemcr.2015.05.007; Nagamatsu G, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096792; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Ohta H, 2017, EMBO J, V36, P1888, DOI 10.15252/embj.201695862; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka T, 2015, J REPROD DEVELOP, V61, P473, DOI 10.1262/jrd.2015-059; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Yoshimizu T, 1991, DEV GROWTH DIFFER, V4, P675; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	36	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205004	10.1371/journal.pone.0205004	http://dx.doi.org/10.1371/journal.pone.0205004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286177	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500074
J	Parker, J; Fowler, N; Walmsley, ML; Schmidt, T; Scharrer, J; Kowaleski, J; Grimes, T; Hoyos, S; Chen, J				Parker, Jayme; Fowler, Nisha; Walmsley, Mary Louise; Schmidt, Terri; Scharrer, Jason; Kowaleski, James; Grimes, Teresa; Hoyos, Shanann; Chen, Jack			Analytical Sensitivity Comparison between Singleplex Real- Time PCR and a Multiplex PCR Platform for Detecting Respiratory Viruses (vol 10, e0143164, 2015)	PLOS ONE			English	Correction																		Parker J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143164	1	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205483	10.1371/journal.pone.0205483	http://dx.doi.org/10.1371/journal.pone.0205483			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286169	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500108
J	Peng, YF				Peng, YuFeng			B cell responses to apoptotic cells in MFG-E8-/- mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; OXIDATION-SPECIFIC EPITOPES; MARGINAL ZONE; OXIDIZED LDL; MFG-E8-DEFICIENT MICE; GERMINAL-CENTERS; IMPAIRED UPTAKE; RECEPTOR; MACROPHAGES; TOLERANCE	Defective clearance of apoptotic cells in MFG-E8 deficient mice results in lupus-like disease in the mixed B6x129, but not pure B6 background. The lack of overt autoimmunity in MFGE8-/- B6 mice suggests that accumulation of apoptotic cells is not sufficient to break central tolerance. However, the delayed clearance of apoptotic cells in the follicles of MFG-E8-/- B6 mice provides an excellent opportunity to investigate how B cells respond to excessive apoptotic cells in the periphery under relatively non-inflammatory conditions. In MFG-E8-/- B6 mice, we found increased IgG2c production against apoptotic cells and oxidized LDL. Apoptotic cell induced antibody responses depended on MyD88 signal and T cell help. In addition, MFG-E8-/- B6 mice had enlarged MZ B cell compartments as well as an enhanced antibody response to NP-Ficoll. Moreover, a significant percentage of MZ B cells in aged MFG-E8-/- B6 mice migrated into follicles. Injecting apoptotic cells or oxidized LDL into wild type mice as well as physiological accumulation of LDL in ApoE-/- mice recapitulated the translocation of MZ B cells. To determine how MFG-E8 deficiency affects the functions of autoreactive B cells specific for nucleic acids in the periphery under non-inflammatory conditions, we utilized BCR transgenic mice to bypass central selection and compared the differentiation of TLR9 dependent anti-dsDNA 56R B cells and TLR7 dependent anti-ssRNA H564 B cells in MFG-E8-/- mice. In MFG-E8-/- 56R mice, anti-dsDNA specific 56RNK38c B cells differentiated into MZ B cells but not AFCs. On the contrary, in MFG-E8-/-H564 mice, anti-ssRNA specific H564 B cells further differentiated into GC B cells and AFCs. Adoptive transfer of activated autoreactive B cells confirmed that H564 B cells were more sensitive to apoptotic cell antigens than 56R B cells. Our observations provide new insights about the MZ B cell translocation in lupus patients as well as the dichotomy of TLR9 and TLR7 signals in the pathogenesis of lupus.	[Peng, YuFeng] Univ Washington, Dept Med, Div Rheumatol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Peng, YF (corresponding author), Univ Washington, Dept Med, Div Rheumatol, Seattle, WA 98195 USA.	yfpeng2014@gmail.com	peng, yu/GXW-2071-2022		Lupus Research Institute	Lupus Research Institute	This work was funded by the Lupus Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Biggiogera M, 1998, J HISTOCHEM CYTOCHEM, V46, P999, DOI 10.1177/002215549804600903; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chikazawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068468; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Dammers PM, 2000, J IMMUNOL, V165, P6156, DOI 10.4049/jimmunol.165.11.6156; Dammers PM, 2005, EUR J IMMUNOL, V35, P2089, DOI 10.1002/eji.200526118; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Gatto D, 2004, J IMMUNOL, V173, P4308, DOI 10.4049/jimmunol.173.7.4308; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Grasset EK, 2015, P NATL ACAD SCI USA, V112, pE2030, DOI 10.1073/pnas.1421227112; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Kishi Y, 2012, P NATL ACAD SCI USA, V109, P7811, DOI 10.1073/pnas.1204509109; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Li H, 2015, J CLIN INVEST, V125, P2877, DOI 10.1172/JCI81059; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Miyanishi M, 2012, INT IMMUNOL, V24, P551, DOI 10.1093/intimm/dxs064; Nundel K, 2015, J IMMUNOL, V194, P2504, DOI 10.4049/jimmunol.1402425; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Pewzner-Jung Y, 1998, J IMMUNOL, V161, P4634; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Qian Y, 2004, J IMMUNOL, V172, P625, DOI 10.4049/jimmunol.172.1.625; Richardson C, 2013, J IMMUNOL, V191, P4926, DOI 10.4049/jimmunol.1202263; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; Sekiguchi DR, 2006, J IMMUNOL, V176, P6879, DOI 10.4049/jimmunol.176.11.6879; Shao WH, 2010, J AUTOIMMUN, V35, P368, DOI 10.1016/j.jaut.2010.08.001; Soni C, 2014, J IMMUNOL, V193, P4400, DOI 10.4049/jimmunol.1401720; Stoehr AD, 2011, J IMMUNOL, V187, P2953, DOI 10.4049/jimmunol.1003340; Tsao PY, 2008, J IMMUNOL, V181, P7770, DOI 10.4049/jimmunol.181.11.7770; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Wermeling F, 2010, J EXP MED, V207, P943, DOI 10.1084/jem.20091314; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205172	10.1371/journal.pone.0205172	http://dx.doi.org/10.1371/journal.pone.0205172			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286201	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500094
J	Reneaux, M; Gupta, R; Karmeshu				Reneaux, Melissa; Gupta, Rahul; Karmeshu			Stochastic Mesocortical Dynamics and Robustness of Working Memory during Delay-Period (vol 10, e0144378, 2015)	PLOS ONE			English	Correction															Department of Science and Technology, India, under the DST PURSE-II grant	Department of Science and Technology, India, under the DST PURSE-II grant	The following information is missing from the Funding section: The authors received funding from the Department of Science and Technology, India, under the DST PURSE-II grant towards publication charges.	Reneaux M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144378	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205615	10.1371/journal.pone.0205615	http://dx.doi.org/10.1371/journal.pone.0205615			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286193	gold, Green Published			2022-12-27	WOS:000446383500114
J	Talavera-Velasco, B; Luceno-Moreno, L; Garcia, JM; Vazquez-Estevez, D				Talavera-Velasco, Beatriz; Luceno-Moreno, Lourdes; Martin Garcia, Jesus; Vazquez-Estevez, Daniel			DECORE-21: Assessment of occupational stress in police. Confirmatory factor analysis of the original model	PLOS ONE			English	Article							OFFICERS; BURNOUT	There is scarce research on stress in Spanish police officers and on the use of instruments to assess this construct in this professional group. In Spain, the DECORE questionnaire has been one of the most used. Nevertheless, it had not been previously applied to police officers. The aim of this study was to analyze both the construct validity and the reliability of the original model of 44 items. A cross-sectional design and a non-probabilistic quota sampling were used. A total of 223 Spanish police officers participated. 202 police personnel were men (90.6%) and 21 were women (9.4%). The average age was 41 years old (SD = 7.52). These police officers answered the DECORE questionnaire. Confirmatory Factor Analysis was carried out. The results showed an unsatisfactory adjustment using the original model of 44 items. A final solution of 21 items and four factors was formulated with both suitable validity and reliability indexes. In this model, 23 items that did not weigh highly in any of the four factors were removed. The DECORE-21 questionnaire is recommended to assess work-related stress in police officers.	[Talavera-Velasco, Beatriz; Luceno-Moreno, Lourdes; Martin Garcia, Jesus; Vazquez-Estevez, Daniel] Univ Complutense Madrid, Fac Psychol, Dept Social Org & Differential Psychol, Madrid, Spain	Complutense University of Madrid	Talavera-Velasco, B (corresponding author), Univ Complutense Madrid, Fac Psychol, Dept Social Org & Differential Psychol, Madrid, Spain.	beatriztalavera@ucm.es		Talavera Velasco, Beatriz/0000-0003-4662-1999; Vazquez, Daniel/0000-0003-0178-9114				AERA, 2014, STAND ED PSYCH TEST; Alvarez CJ, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.58; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Chalmers RP, 2012, J STAT SOFTW, V48, P1; de la Fuente EI, 2013, INT J CLIN HLTH PSYC, V13, P216, DOI 10.1016/S1697-2600(13)70026-7; Duxbury L, 2015, CRIM JUSTICE BEHAV, V42, P361, DOI 10.1177/0093854814551017; European Commission, 2010, WORK REL STRESS GUID; Fernandez CJ, 2014, STRATEGIC MANAGEMENT; Garbarino S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002791; Garcia-Albuerne Y, 2015, ANXIETY STRESS, V21, P57; Gerber M, 2013, J OCCUP HEALTH, V55, P376, DOI 10.1539/joh.13-0030-OA; Gu Guizhen, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P924; Houdmont J., 2010, CONT OCCUPATIONAL HL; IBM Corp, 2021, IBM SPSS STAT WIND V; Karasek R., 1985, JOB CONTENT QUESTION; Kivimaki M, 2013, CAN MED ASSOC J, V185, P763, DOI 10.1503/cmaj.121735; Korre M, 2014, POLIC-J POLICY PRACT, V8, P109, DOI 10.1093/police/pau001; Lang J, 2012, SOC SCI MED, V75, P1163, DOI 10.1016/j.socscimed.2012.04.015; Lloret-Segura S, 2014, AN PSICOL-SPAIN, V30, P1151, DOI 10.6018/analesps.30.3.199361; Luceno-Moreno L, 2008, DECORE QUESTIONNAIRE; Luceuo L., 2010, ANSIEDAD ESTRES, V16, P237; Maran DA, 2015, OCCUP MED-OXFORD, V65, P466, DOI 10.1093/occmed/kqv060; McCreary D.R., 2006, INT J STRESS MANAGE, V13, P494, DOI [10.1037/1072-5245.13.4.494, DOI 10.1037/1072-5245.13.4.494]; McDonald RP, 1999, TEST THEORY UNIFIED; Moreno-Jimenez B, 2010, PSYCHOSOCIAL RISK FA; National Institute of Health and Safety NIHS, 1997, 2 NAT SURV WORK COND; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Page KS, 2011, PSYCHOL SERV, V8, P12, DOI 10.1037/a0021796; Park HI, 2014, APPL PSYCHOL-INT REV, V63, P607, DOI 10.1111/apps.12008; Patil RR, 2014, INT J OCCUP MED ENV, V27, P523, DOI 10.2478/s13382-014-0285-5; R Development Core Team, 2011, R FDN STAT COMP; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Sanchez-Teruel D, 2014, J WORK ORGAN PSYCHOL, V30, P75, DOI [10.1016/j.rpto.2014.06.003, DOI 10.1016/J.RPTO.2014.06.003]; Siegrist J, 1998, THEORIES OF ORGANIZATIONAL STRESS, P190; Taris TW, 2010, J OCCUP ORGAN PSYCH, V83, P455, DOI 10.1348/096317909X424583; Vagg P R, 1999, J Occup Health Psychol, V4, P288, DOI 10.1037/1076-8998.4.3.288; van der Velden PG, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001720; Vilardell Molas Jordi, 2014, Med Clin (Barc), V142 Suppl 2, P30, DOI 10.1016/S0025-7753(14)70069-7; Violanti John M, 2011, Int J Emerg Ment Health, V13, P209	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205028	10.1371/journal.pone.0205028	http://dx.doi.org/10.1371/journal.pone.0205028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286155	Green Submitted, gold, Green Published			2022-12-27	WOS:000446383500079
J	Weiberg, D; Basic, M; Smoczek, M; Bode, U; Bornemann, M; Buettner, M				Weiberg, Desiree; Basic, Marijana; Smoczek, Margarethe; Bode, Ulrike; Bornemann, Melanie; Buettner, Manuela			Participation of the spleen in the IgA immune response in the gut	PLOS ONE			English	Article							INTESTINAL DENDRITIC CELLS; SPLENIC MARGINAL ZONE; T-CELLS; LYMPH-NODE; B-CELLS; B1B CELLS; RAT; HYPOSPLENISM; MEMORY; BLOOD	The role of the spleen in the induction of an immune response to orally administered antigens is still under discussion. Although it is well known that after oral antigen administration specific germinal centres are not only formed in the Peyers patches (PP) and the mesenteric lymph nodes (mLN) but also in the spleen, there is still a lack of functional data showing a direct involvement of splenic B cells in an IgA immune response in the gut. In addition, after removal of mLN a high level of IgA+ B cells was observed in the gut. Therefore, in this study we analysed the role of the spleen in the induction of IgA+ B cells in the gut after mice were orally challenged with antigens. Here we have shown that antigen specific splenic IgM+ B cells after in vitro antigen stimulation as well as oral immunisation of donor mice were able to migrate into the gut of recipient mice, where they predominantly switch to IgA+ plasma cells. Furthermore, stimulation of recipient mice by orally administered antigens enhanced the migration of the splenic B cells into the gut as well as their switch to IgA+ plasma cells. Removal of the mLN led to a higher activation level of the splenic B cells. Altogether, our results imply that splenic IgM+ B cells migrate in the intestinal lamina propria, where they differentiate into IgA+ plasma cells and subsequently proliferate. In conclusion, we demonstrated that the spleen plays a major role in the gut immune response serving as a reservoir of immune cells that migrate to the site of antigen entrance.	[Weiberg, Desiree; Bode, Ulrike; Bornemann, Melanie; Buettner, Manuela] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Weiberg, Desiree] Hannover Med Sch, Dept Nucl Med, Hannover, Germany; [Basic, Marijana; Smoczek, Margarethe; Buettner, Manuela] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Buettner, M (corresponding author), Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany.; Buettner, M (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany.	Buettner.Manuela@MH-Hannover.de			German Research Foundation [SFB621/A10]	German Research Foundation(German Research Foundation (DFG))	The work was supported by German Research Foundation SFB621/A10; http://www.dfg.de/en/; UB recieved the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt M, 2008, J IMMUNOL, V181, P1898, DOI 10.4049/jimmunol.181.3.1898; Altamura M, 2001, IMMUNOPHARM IMMUNOT, V23, P153, DOI 10.1081/IPH-100103856; Awaad A, 2016, ACTA HISTOCHEM, V118, P596, DOI 10.1016/j.acthis.2016.06.005; Bode U, 1999, EUR J IMMUNOL, V29, P1487, DOI 10.1002/(SICI)1521-4141(199905)29:05<1487::AID-IMMU1487>3.0.CO;2-1; Bode U, 2001, EUR J IMMUNOL, V31, P2116, DOI 10.1002/1521-4141(200107)31:7<2116::AID-IMMU2116>3.0.CO;2-Q; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Buettner M, 2013, SCAND J IMMUNOL, V77, P238, DOI 10.1111/sji.12034; Crivellato E, 2004, TRENDS IMMUNOL, V25, P210, DOI 10.1016/j.it.2004.02.008; Di Sabatino A, 2007, J ALLERGY CLIN IMMUN, V120, P1461, DOI 10.1016/j.jaci.2007.07.054; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Hahn A, 2010, IMMUNOLOGY, V129, P427, DOI 10.1111/j.1365-2567.2009.03197.x; Howe SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086656; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jiang JQ, 2008, J VIROL, V82, P6812, DOI 10.1128/JVI.00450-08; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Lee DJ, 2013, J IMMUNOL, V191, P4103, DOI 10.4049/jimmunol.1300182; Liu LM, 1998, J IMMUNOL, V161, P1146; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mebius RE, 2004, CRIT REV IMMUNOL, V24, P449, DOI 10.1615/CritRevImmunol.v24.i6.40; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; MULLER AF, 1995, GUT, V36, P165, DOI 10.1136/gut.36.2.165; Munyaka P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109272; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Pabst R, 1999, CLIN EXP IMMUNOL, V117, P423; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Pritchett-Corning KR, 2014, J AM ASSOC LAB ANIM, V53, P633; Quesenberry PJ, 1999, ANN NY ACAD SCI, V872, P40, DOI 10.1111/j.1749-6632.1999.tb08451.x; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; ROTHKOTTER HJ, 1993, CLIN EXP IMMUNOL, V92, P317; Sallusto F, 2004, CURR OPIN IMMUNOL, V16, P724, DOI 10.1016/j.coi.2004.09.012; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; Spencer J, 2009, MUCOSAL IMMUNOL, V2, P380, DOI 10.1038/mi.2009.91; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Svensson Marcus, 2006, Expert Rev Clin Immunol, V2, P759, DOI 10.1586/1744666X.2.5.759; Veninga H, 2015, EUR J IMMUNOL, V45, P747, DOI 10.1002/eji.201444983; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Wade WF, 2014, PATHOG DIS, V70, P153, DOI 10.1111/2049-632X.12085; Westermann J, 1996, EUR J IMMUNOL, V26, P1866, DOI 10.1002/eji.1830260830; William BM, 2007, HEMATOLOGY, V12, P89, DOI 10.1080/10245330600938463; William BM, 2007, HEMATOLOGY, V12, P1, DOI 10.1080/10245330600938422; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yang LL, 2011, BLOOD, V118, P3039, DOI 10.1182/blood-2011-04-349746; Yang ZT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145807; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x	53	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205247	10.1371/journal.pone.0205247	http://dx.doi.org/10.1371/journal.pone.0205247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286198	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500102
J	AlMahmoud, T; Hashim, MJ; Almahmoud, R; Branicki, F; Elzubeir, M				AlMahmoud, Tahra; Hashim, M. Jawad; Almahmoud, Rabah; Branicki, Frank; Elzubeir, Margaret			Informed consent learning: Needs and preferences in medical clerkship environments	PLOS ONE			English	Article							ETHICS; PROFESSIONALISM; STUDENTS; CURRICULUM; KNOWLEDGE; ATTITUDES; EDUCATION; DOCTOR; LIFE; END	Purpose Limited information exists regarding students' routine educational needs in support of ethics and professionalism practices faced in real clinical practice. As such the authors aimed to explore medical students learning needs and preferences for informed consent and relevant ethical issues in the clerkship environments. Materials and methods A cross-sectional study using a self-administered, printed survey distributed to final year clinical clerks. Results 84% completed the survey. Students indicated the need for more attention to all topics related to informed consent (mean = 7.1 on a scale of 0 to 9; +/- 1.2). Most additional instructional attention was requested for topics raised in discussions with patients concerning the risks, benefits and alternatives to recommended treatments (7.3 +/- 1.4). The cohort expressed the need for education in the care of vulnerable patients (7.2 +/- 1.2) with a maximum score for the care of abused children. Women perceived greater need for education concerning informed consent than male respondents (p>0.05). There were significant differences between students who scored high or low on the item "being treated in professional manner" and "endorsement of educational needs for care of adolescents" (p = 0.05). Conclusion There was heightened perception among final year medical students of the need for greater attention to be paid to informed consent education.	[AlMahmoud, Tahra; Branicki, Frank] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Surg, Al Ain, U Arab Emirates; [Hashim, M. Jawad] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Family Med, Al Ain, U Arab Emirates; [Almahmoud, Rabah] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates; [Elzubeir, Margaret] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Med Educ, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; University of Sharjah; United Arab Emirates University	AlMahmoud, T (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Surg, Al Ain, U Arab Emirates.	uaeye27@hotmail.com	Branicki, Frank J/A-3365-2013					Al-Eraky MM, 2014, MED TEACH, V36, pS8, DOI 10.3109/0142159X.2014.886013; Al-Eraky MM, 2012, MED TEACH, V34, pS90, DOI 10.3109/0142159X.2012.656754; Al-Jundi SHS, 2010, J DENT EDUC, V74, P1159; AlMahmoud T, 2017, MED EDUC ONLINE, V22, DOI 10.1080/10872981.2017.1328257; Ben Yehuda Y, 2010, ISR MED ASSOC J, V12, P598; BICKEL J, 1995, ACAD MED, V70, P552, DOI 10.1097/00001888-199506000-00021; Bourdieu P., 1977, OUTLINE THEORY OFPRA; Brown S., 2010, LIKERT SCALE EXAMPLE; Calkins E V, 1992, J Am Med Womens Assoc (1972), V47, P58; CHRISTAKIS DA, 1993, ACAD MED, V68, P249, DOI 10.1097/00001888-199304000-00003; D'Antonio I J, 1993, Matern Child Nurs J, V21, P39; DAUBMAN KA, 1992, SEX ROLES, V27, P187, DOI 10.1007/BF00290017; DeCosta A, 2004, J MED ETHICS, V30, P318, DOI 10.1136/jme.2002.001065; Del Pozo PR, 2008, CAMB Q HEALTHC ETHIC, V17, P273, DOI 10.1017/S096318010808033X; Doukas DJ, 2013, ACAD MED, V88, P1624, DOI 10.1097/ACM.0b013e3182a7f8e3; Emmerich N, 2013, SOCIOL PERSPECT, P21; Goldie J, 2007, MED EDUC, V41, P610, DOI 10.1111/j.1365-2923.2007.02772.x; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Hafferty FW, 1998, ACAD MED, V73, P403, DOI 10.1097/00001888-199804000-00013; Haidet P, 2002, MED EDUC, V36, P568, DOI 10.1046/j.1365-2923.2002.01233.x; Hall DE, 2012, CAN MED ASSOC J, V184, P533, DOI 10.1503/cmaj.112120; Hammami MM, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-3; Kharawala Saifuddin, 2011, Perspect Clin Res, V2, P8, DOI 10.4103/2229-3485.76284; Knowles M.S., 1973, ADULT LEARNER NEGLEC; Kolb D, 1984, EXPERIENTIAL LEANING; KOPELMAN L, 1983, JAMA-J AM MED ASSOC, V250, P2006, DOI 10.1001/jama.250.15.2006; Lapid M, 2009, ACAD PSYCHIATR, V33, P461, DOI 10.1176/appi.ap.33.6.461; Lehrmann JA, 2009, ACAD PSYCHIATR, V33, P470, DOI 10.1176/appi.ap.33.6.470; Mattick K, 2006, MED EDUC, V40, P329, DOI 10.1111/j.1365-2929.2006.02407.x; Meisel A, 1996, ARCH INTERN MED, V156, P2521, DOI 10.1001/archinte.156.22.2521; Moehring B, 2011, J PALLIAT MED, V14, P1206, DOI 10.1089/jpm.2011.0184; Nijhawan LP, 2013, J ADV PHARM TECHNOL, V4, P134, DOI 10.4103/2231-4040.116779; Palincsar AS, 1998, ANNU REV PSYCHOL, V49, P345, DOI 10.1146/annurev.psych.49.1.345; Roberts LW, 2005, ACAD PSYCHIATR, V29, P301, DOI 10.1176/appi.ap.29.3.301; Roberts LW, 2004, ACAD PSYCHIATR, V28, P170, DOI 10.1176/appi.ap.28.3.170; Roberts LW, 2005, PSYCHOSOMATICS, V46, P440; Sahin F, 2009, TURKISH J PEDIATR, V51, P336; Schildmann J, 2005, MED TEACH, V27, P649, DOI 10.1080/01421590500138747; Schon D.A, 2017, REFLECTIVE PRACTITIO; Searight HR, 2005, AM FAM PHYSICIAN, V71, P515; SHELP EE, 1981, J MED ETHICS, V7, P70, DOI 10.1136/jme.7.2.70; Vagias W.M., 2006, LIKERT TYPE SCALE RE	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202466	10.1371/journal.pone.0202466	http://dx.doi.org/10.1371/journal.pone.0202466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281603	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400013
J	Jones, KA; Luo, Y; Dukes-Rimsky, L; Srivastava, DP; Koul-Tewari, R; Russell, TA; Shapiro, LP; Srivastava, AK; Penzes, P				Jones, Kelly A.; Luo, Yue; Dukes-Rimsky, Lynn; Srivastava, Deepak P.; Koul-Tewari, Richa; Russell, Theron A.; Shapiro, Lauren P.; Srivastava, Anand K.; Penzes, Peter			Neurodevelopmental disorder-associated ZBTB20 gene variants affect dendritic and synaptic structure	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; INTELLECTUAL DISABILITY; MENTAL-RETARDATION; NEURON DEVELOPMENT; PRIMROSE SYNDROME; MUTATIONS; PLASTICITY; HIPPOCAMPUS; MECHANISMS; ISOFORMS	Dendritic spine morphology and dendritic arborization are key determinants of neuronal connectivity and play critical roles in learning, memory and behavior function. Recently, defects of ZBTB20, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and autism. Here we show distinct effects of expression of two major isoforms, long and short, of ZBTB20, and its neurodevelopmental disorder-linked variants, on dendritic architecture of cultured rat cortical pyramidal neurons. The N-terminal of ZBTB20 showed a role in regulating dendritic spine morphology. Two ZBTB20 single nucleotide variants, located at the N-terminal and central regions of the protein and potentially conferring autism risk, altered dendritic spine morphology. In contrast, a single nucleotide variant identified in patients with intellectual disability and located at the C-terminus of ZBTB20 affected dendritic arborization and dendritic length but had no effect on dendritic spine morphology. Furthermore, truncation of the extreme C-terminus of ZBTB20 caused spine and dendritic morphological changes that were similar but distinct from those caused by the C-terminal variant. Taken together, our study suggests ZBTB20's role in dendritic and synaptic structure and provide possible mechanisms of its effect in neurodevelopmental disorders.	[Jones, Kelly A.; Srivastava, Deepak P.; Russell, Theron A.; Shapiro, Lauren P.; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Luo, Yue; Dukes-Rimsky, Lynn; Koul-Tewari, Richa; Srivastava, Anand K.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Koul-Tewari, Richa; Srivastava, Anand K.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA; [Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Greenwood Genetic Center; Clemson University; Northwestern University; Feinberg School of Medicine	Penzes, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.; Srivastava, AK (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA.; Srivastava, AK (corresponding author), Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA.; Penzes, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.	anand@ggc.org; p-penzes@northwestern.edu			National Institute of Child Health and Human Development [R01-HD039331]; Brain & Behavior Research Foundation; National Institute of Mental Health [R01MH107182-04]; National Institutes of Health [1F31MH085362]; MRC [MR/L021064/1, MR/N026063/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097216] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Brain & Behavior Research Foundation(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by grants from the National Institute of Child Health and Human Development (https://www.nichd.nih.gov/) (R01-HD039331) to A.K.S., the Brain & Behavior Research Foundation (formerly the National Alliance for Research on Schizophrenia and Depression; https://www.bbrfoundation.org/) and the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml) (R01MH107182-04) to P.P., and the National Institutes of Health (https://www.nih.gov/) (1F31MH085362) to K.A.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Casertano A, 2017, AM J MED GENET A; Chen JL, 2010, CURR OPIN NEUROBIOL, V20, P557, DOI 10.1016/j.conb.2010.06.002; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Dukes-Rimsky L, 2018, EUR J HUM GENET; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim TA, 2005, J CELL SCI, V118, P5537, DOI 10.1242/jcs.02643; Koul R, 2013, AM SOC HUM GEN ANN M; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Mattioli F, 2016, AM J MED GENET A, V170, P1626, DOI 10.1002/ajmg.a.37645; Mitchelmore C, 2002, J BIOL CHEM, V277, P7598, DOI 10.1074/jbc.M110023200; Nielsen JV, 2007, DEVELOPMENT, V134, P1133, DOI 10.1242/dev.000265; Nielsen JV, 2014, CEREB CORTEX, V24, P1216, DOI 10.1093/cercor/bhs400; Nielsen JV, 2010, CEREB CORTEX, V20, P1904, DOI 10.1093/cercor/bhp261; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Rasmussen MB, 2014, J MED GENET, V51, P605, DOI 10.1136/jmedgenet-2014-102535; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Vaillend C, 2008, BEHAV BRAIN RES, V192, P88, DOI 10.1016/j.bbr.2008.01.009; Valnegri P, 2012, ADV EXP MED BIOL, V970, P433, DOI 10.1007/978-3-7091-0932-8_19; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; West AE, 2011, COLD SPRING HARB PER, V3; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zhang WP, 2001, BIOCHEM BIOPH RES CO, V282, P1067, DOI 10.1006/bbrc.2001.4689; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203760	10.1371/journal.pone.0203760	http://dx.doi.org/10.1371/journal.pone.0203760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281617	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400028
J	Zhou, KD; Wang, HY; Wang, Y; Liu, ZH; He, C; Feng, JM				Zhou, Kai-di; Wang, Hong-yi; Wang, Yi; Liu, Zhi-hong; He, Chuan; Feng, Jian-min			Is topical or intravenous tranexamic acid preferred in total hip arthroplasty? A randomized, controlled, noninferiority clinical trial	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; REDUCES BLOOD-LOSS; TRANSFUSION RATES; ORTHOPEDIC-SURGERY; DOUBLE-BLIND; METAANALYSIS; REPLACEMENT; FIBRINOLYSIS; MANAGEMENT	Purpose The present study aimed to confirm the efficacy and safety of topical and intravenous tranexamic acid (TXA) compared with that of topical placebo and to assess the noninferiority between the two application methods of TXA in patients undergoing unilateral primary total hip arthroplasty. Methods Our randomized controlled trial investigated 170 patients with 1:1:1 allocation to two doses of 10-mg/kg intravenous TXA, 3-g topical TXA, and topical placebo of 60-ml physiological saline groups. The primary outcome, total blood loss, was calculated with Nadler and Gross formula. The secondary outcomes included allogeneic blood transfusion requirement, drain blood loss, decreased hemoglobin level. Noninferiority would be established when the upper limit 95% CI is lower than 250 ml of the noninferiority margin for the mean difference of total blood loss between topical and intravenous TXA. Thromboembolic complication incidence was considered as a safety outcome. Results The total blood loss of patients administered intravenous (mean +/- standard deviation, 1125 +/- 514 ml) and topical TXA (1211 +/- 425 ml) was significantly reduced compared with that of those administered topical placebo (1464 +/- 556 ml) (p = 0.0012). Drain blood loss and hemoglobin level reduction in patients administered with TXA were also significantly lower than those in patients administered topical placebo. The mean difference of total blood loss between topical and intravenous TXA is 86 ml (95% CI, -88 to 260 ml). The complications were comparable between patients managed with TXA and patients with topical placebo. Conclusion The noninferiority of topical TXA to intravenous TXA can not be concluded. Considering no significant difference was found in all efficacy outcomes between the two administration methods. Any of the two TXA administration methods can be adopted for blood loss prevention in total hip arthroplasty.	[Zhou, Kai-di; Wang, Hong-yi; Wang, Yi; Liu, Zhi-hong; He, Chuan; Feng, Jian-min] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Orthoped, Shanghai, Peoples R China; [Wang, Hong-yi; Wang, Yi; Liu, Zhi-hong; He, Chuan; Feng, Jian-min] Shanghai Inst Traumatol & Orthoped, Shanghai, Peoples R China; [Zhou, Kai-di] Wuxi Xinrui Hosp, Ruijin Hosp, Wuxi Branch, Dept Orthoped, Wuxi, Jiangsu, Peoples R China	Shanghai Jiao Tong University	Feng, JM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Orthoped, Shanghai, Peoples R China.; Feng, JM (corresponding author), Shanghai Inst Traumatol & Orthoped, Shanghai, Peoples R China.	fengjm@96590.net						Alshryda S, 2014, BONE JOINT J, V96B, P1005, DOI 10.1302/0301-620X.96B8.33745; Alshryda S, 2013, J BONE JOINT SURG AM, V95A, P1969, DOI 10.2106/JBJS.L.00908; Benoni G, 1997, THROMB RES, V85, P195, DOI 10.1016/S0049-3848(97)00004-2; Benoni G, 2000, ACTA ORTHOP SCAND, V71, P250, DOI 10.1080/000164700317411834; Bierbaum BE, 1999, J BONE JOINT SURG AM, V81A, P2, DOI 10.2106/00004623-199901000-00002; Dunn CJ, 1999, DRUGS, V57, P1005, DOI 10.2165/00003495-199957060-00017; Erstad BL, 2001, ANN PHARMACOTHER, V35, P925, DOI 10.1345/aph.10337; Gill JB, 2006, J ARTHROPLASTY, V21, P869, DOI 10.1016/j.arth.2005.09.009; Gomez-Barrena E, 2014, J BONE JOINT SURG AM, V96A, P1937, DOI 10.2106/JBJS.N.00060; GROSS JB, 1983, ANESTHESIOLOGY, V58, P277, DOI 10.1097/00000542-198303000-00016; Ho KM, 2003, ANAESTH INTENS CARE, V31, P529, DOI 10.1177/0310057X0303100507; Jansen AJ, 1999, BRIT J ANAESTH, V83, P596, DOI 10.1093/bja/83.4.596; Kagoma YK, 2009, THROMB RES, V123, P687, DOI 10.1016/j.thromres.2008.09.015; Konig G, 2013, J ARTHROPLASTY, V28, P1473, DOI 10.1016/j.arth.2013.06.011; Lopez-Balderas N, 2015, J INFECT DEV COUNTR, V9, P274, DOI 10.3855/jidc.4812; Martin JG, 2014, J ARTHROPLASTY, V29, P889, DOI 10.1016/j.arth.2013.10.005; NADLER SB, 1962, SURGERY, V51, P224; Nilsson I M, 1980, J Clin Pathol Suppl (R Coll Pathol), V14, P41; North WT, 2016, J ARTHROPLASTY, V31, P1022, DOI 10.1016/j.arth.2015.11.003; Oremus K, 2014, TRANSFUSION, V54, P31, DOI 10.1111/trf.12224; Patel JN, 2014, J ARTHROPLASTY, V29, P1528, DOI 10.1016/j.arth.2014.03.011; RISBERG B, 1985, ACTA CHIR SCAND, P245; Saleh A, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.00825; Sarzaeem MM, 2014, J ARTHROPLASTY, V29, P1521, DOI 10.1016/j.arth.2014.02.031; Sehat KR, 2000, KNEE, V7, P151, DOI 10.1016/S0968-0160(00)00047-8; Soni A, 2014, J ARTHROPLASTY, V29, P1525, DOI 10.1016/j.arth.2014.03.039; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; Sun YB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186174; Tuttle JR, 2014, J ARTHROPLASTY, V29, P1512, DOI 10.1016/j.arth.2014.01.031; Wei W, 2014, J ARTHROPLASTY, V29, P2113, DOI 10.1016/j.arth.2014.07.019; Wei Z, 2015, TRANSFUSION MED, V25, P151, DOI 10.1111/tme.12212; Wind TC, 2014, J ARTHROPLASTY, V29, P387, DOI 10.1016/j.arth.2013.05.026; Wong J, 2010, J BONE JOINT SURG AM, V92A, P2503, DOI 10.2106/JBJS.I.01518; Yamasaki S, 2004, INT ORTHOP, V28, P69, DOI 10.1007/s00264-003-0511-4; Zeng Y, 2016, J BONE JOINT SURG AM, V98, P983, DOI 10.2106/JBJS.15.00638; Zhou KD, 2016, CLIN TRIALS ORTHOP D, V1, P1; Zufferey P, 2006, ANESTHESIOLOGY, V105, P1034, DOI 10.1097/00000542-200611000-00026	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204551	10.1371/journal.pone.0204551	http://dx.doi.org/10.1371/journal.pone.0204551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278067	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200016
J	Ehler, E; Sterling, D; Dusenbery, K; Lawrence, J				Ehler, Eric; Sterling, David; Dusenbery, Kathryn; Lawrence, Jessica			Workload implications for clinic workflow with implementation of three-dimensional printed customized bolus for radiation therapy: A pilot study	PLOS ONE			English	Article							PHOTON-BEAM RADIOTHERAPY; PATIENT-SPECIFIC BOLUS; MEGAVOLTAGE PHOTON; ELECTRON-BEAMS; WET GAUZE; AIR-GAP; PERTURBATION	Bolus is commonly used in radiation therapy to improve radiation dose distribution to the target volume, but commercially available products do not always conform well to the patient surface. Tumor control may be compromised, particularly for superficial tumors, if bolus does not conform well and air gaps exist between the patient surface and the bolus. Three-dimensional (3D) printing technology allows the creation of highly detailed, variable shaped objects, making it an attractive and affordable option for customized, patient-specific bolus creation. The use of 3D printing in the clinical setting remains limited. Therefore, the objective of this study was to assess the implications on time and clinical fit using a workflow for 3D printing of customized bolus in companion animals with spontaneous tumors treated with radiation therapy. The primary aim of this study was to evaluate the time required to create a clinical 3D printed bolus. The secondary aims were to evaluate the clinical fit of the bolus and to verify the skin surface dose. Time to segmentation and 3D printing were documented, while the clinical fit of the bolus was assessed in comparison to the bolus created in the treatment planner. The mean and median time from segmentation to generation of 3D printed boluses was 6.15 h and 5.25 h, respectively. The 3D printed bolus was significantly less deviated from the planned bolus compared to the conventional bolus (p = 0.0078) with measured dose under the bolus within 5% agreement of expected dose in 88% of the measurements. Clinically acceptable 3D printed customized bolus was successfully created for treatment within one working day. The most significant impact on time is the 3D printing itself, which therefore has minimal implications on personnel and staffing. Quality assurance steps are recommended when implementing a 3D printing workflow to the radiotherapy clinic.	[Ehler, Eric; Sterling, David; Dusenbery, Kathryn] Univ Minnesota, Med Sch, Dept Radiat Oncol, Minneapolis, MN 55455 USA; [Lawrence, Jessica] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lawrence, J (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55455 USA.	jlawrenc@umn.edu	Lawrence, Jessica/AAD-8460-2019	Lawrence, Jessica/0000-0002-8315-1909; Ehler, Eric/0000-0003-1151-8481	Department of Radiation Oncology at the University of Minnesota	Department of Radiation Oncology at the University of Minnesota	This work was supported by internal funds awarded to EE from the Department of Radiation Oncology at the University of Minnesota. The Department (funder) did not have direct role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Behrens CF, 2006, PHYS MED BIOL, V51, P5937, DOI 10.1088/0031-9155/51/22/015; Benoit J, 2009, VET RADIOL ULTRASOUN, V50, P555, DOI 10.1111/j.1740-8261.2009.01573.x; Butson MJ, 2000, RADIAT MEAS, V32, P201, DOI 10.1016/S1350-4487(99)00276-0; Canters RA, 2016, RADIOTHER ONCOL, V121, P148, DOI 10.1016/j.radonc.2016.07.011; Chiu T, 2018, PRACT RADIAT ONCOL, V8, pE167, DOI 10.1016/j.prro.2017.11.001; Craft DF, 2018, MED PHYS, V45, P1614, DOI 10.1002/mp.12839; Dancewicz OL, 2017, PHYS MEDICA, V38, P111, DOI 10.1016/j.ejmp.2017.05.051; Fujimoto K, 2017, PHYS MEDICA, V38, P1, DOI 10.1016/j.ejmp.2017.04.023; Giannopoulos AA, 2016, J THORAC IMAG, V31, P253, DOI 10.1097/RTI.0000000000000217; Kim SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110746; Kong M, 2007, AUSTRALAS PHYS ENG S, V30, P111, DOI 10.1007/BF03178415; Lewis D, 2012, MED PHYS, V39, P3741, DOI 10.1118/1.4735223; Lukowiak M, 2017, J APPL CLIN MED PHYS, V18, P76, DOI 10.1002/acm2.12013; Madamesila J, 2016, PHYS MEDICA, V32, P242, DOI 10.1016/j.ejmp.2015.09.013; Matsumoto JS, 2015, RADIOGRAPHICS, V35, P1990, DOI 10.1148/rg.2015140260; Mitsouras D, 2015, RADIOGRAPHICS, V35, P1966, DOI 10.1148/rg.2015140320; Morrison RJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010825; Nagata K, 2012, VET RADIOL ULTRASOUN, V53, P96, DOI 10.1111/j.1740-8261.2011.01866.x; Park JW, 2016, CANCER RADIOTHER, V20, P205, DOI 10.1016/j.canrad.2015.11.003; Park JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177562; Ricotti R, 2017, PHYS MEDICA, V39, P25, DOI 10.1016/j.ejmp.2017.06.004; Rustgi A K, 1997, Med Dosim, V22, P95, DOI 10.1016/S0958-3947(97)00001-0; SHARMA SC, 1993, MED PHYS, V20, P377, DOI 10.1118/1.597079; Su S., 2014, J APPL CLIN MED PHYS, V15, P4831, DOI [DOI 10.1120/JACMP.V15I4.4831, 10.1120/jacmp.v15i4.4831]; Vyas V, 2013, MED DOSIM, V38, P268, DOI 10.1016/j.meddos.2013.02.007; Yoon J, 2018, J APPL CLIN MED PHYS, V19, P137, DOI 10.1002/acm2.12269; Zhao YZ, 2017, MED DOSIM, V42, P150, DOI 10.1016/j.meddos.2017.03.001	27	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204944	10.1371/journal.pone.0204944	http://dx.doi.org/10.1371/journal.pone.0204944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273403	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700053
J	Korenblum, D				Korenblum, Daniel			Laplacian mixture modeling for network analysis and unsupervised learning on graphs	PLOS ONE			English	Article								Laplacian mixture models identify overlapping regions of influence in unlabeled graph and network data in a scalable and computationally efficient way, yielding useful low-dimensional representations. By combining Laplacian eigenspace and finite mixture modeling methods, they provide probabilistic or fuzzy dimensionality reductions or domain decompositions for a variety of input data types, including mixture distributions, feature vectors, and graphs or networks. Provable optimal recovery using the algorithm is analytically shown for a nontrivial class of cluster graphs. Heuristic approximations for scalable high-performance implementations are described and empirically tested. Connections to PageRank and community detection in network analysis demonstrate the wide applicability of this approach. The origins of fuzzy spectral methods, beginning with generalized heat or diffusion equations in physics, are reviewed and summarized. Comparisons to other dimensionality reduction and clustering methods for challenging unsupervised machine learning problems are also discussed.	[Korenblum, Daniel] Nanobio Md, Res Div, San Francisco, CA 10001 USA		Korenblum, D (corresponding author), Nanobio Md, Res Div, San Francisco, CA 10001 USA.	d@nanobio.md		Korenblum, Daniel/0000-0002-8539-4445				Azran A., 2006, IEEE COMPUTER VISION, V1, P190, DOI DOI 10.1109/CVPR.2006.289; Banushkina P, 2005, LECT NOTES COMPUT SC, V3695, P208; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bett DK, 2015, IEEE INT C BIOINFORM, P1614, DOI 10.1109/BIBM.2015.7359917; Bishop Christopher M., 2006, PATTERN RECOGNITION; Chung F., 1998, J COMB, V6, P163; Chung F.R.K., 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Dmitriev N., 1945, C R DOKL ACAD SCI UR, V49, P159; Everitt B S, 1996, Stat Methods Med Res, V5, P107, DOI 10.1177/096228029600500202; Fasshauer G.E., 2007, MESHFREE APPROXIMATI, V6; FIEDLER M, 1973, CZECH MATH J, V23, P298; Gleich DF, 2015, SIAM REV, V57, P321, DOI 10.1137/140976649; Gould S, 2014, LECT NOTES COMPUT SC, V8689, P632, DOI 10.1007/978-3-319-10590-1_41; Guo JM, 2007, COMPUT MATH APPL, V54, P709, DOI 10.1016/j.camwa.2007.02.009; Heath JR, 2015, P NATL ACAD SCI USA, V112, P14436, DOI 10.1073/pnas.1515202112; Kondor R.I., 2002, P 19 INT C MACHINE L, P315; Korenblum D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056704; KRAMER HP, 1959, ANN MATH STAT, V30, P149, DOI 10.1214/aoms/1177706367; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; MAAS C, 1987, Z ANGEW MATH MECH, V67, pT428; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McAuliffe JD, 2006, STAT COMPUT, V16, P5, DOI 10.1007/s11222-006-5196-2; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nie F., 2010, ADV NEURAL INFORM PR, V23, DOI DOI 10.1007/978-3-319-10690-8_12; Nie FP, 2010, IEEE T IMAGE PROCESS, V19, P1921, DOI 10.1109/TIP.2010.2044958; Pardalos P. M., 1993, Annals of Operations Research, V43, P87, DOI 10.1007/BF02024487; PARDALOS PM, 1994, J GLOBAL OPTIM, V4, P117, DOI 10.1007/BF01096719; Parter SV., 1962, J MATH ANAL APPL, V4, P102, DOI [10.1016/0022-247X(62)90032-X, DOI 10.1016/0022-247X(62)90032-X]; Patil A, 2011, NUCLEIC ACIDS RES, V39, pD744, DOI 10.1093/nar/gkq897; Risken H., 1989, FOKKER PLANCK EQUATI, DOI [10.1007/978-3-642-61544-3, DOI 10.1007/978-3-642-61544-3, 10.1007/978-3-642-61544-3_4]; Ronan T, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1932; ROWLINSON P, 1990, B LOND MATH SOC, V22, P209, DOI 10.1112/blms/22.3.209; Schiebinger G, 2015, ANN STAT, V43, P819, DOI 10.1214/14-AOS1283; Shalloway D, 1996, J CHEM PHYS, V105, P9986, DOI 10.1063/1.472830; Shamir R, 2004, DISCRETE APPL MATH, V144, P173, DOI 10.1016/j.dam.2004.01.007; Shi T, 2009, ANN STAT, V37, P3960, DOI 10.1214/09-AOS700; Smola AJ, 2003, LECT NOTES ARTIF INT, V2777, P144, DOI 10.1007/978-3-540-45167-9_12; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang R, 2017, IEEE T IMAGE PROCESS, V26, P5019, DOI 10.1109/TIP.2017.2726188; White BS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056705; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204096	10.1371/journal.pone.0204096	http://dx.doi.org/10.1371/journal.pone.0204096			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273384	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700014
J	Sagadevan, S; Chowdhury, ZZ; Bin Johan, MR; Khan, AA; Aziz, FA; Rafique, RF; Hoque, ME				Sagadevan, Suresh; Chowdhury, Zaira Zaman; Bin Johan, Mohd Rafie; Khan, Ali A.; Aziz, Fauziah Abdul; Rafique, Rahman F.; Hoque, Md Enamul			A facile hydrothermal approach for catalytic and optical behavior of tin oxide- graphene (SnO2/G) nanocomposite	PLOS ONE			English	Article							POLLUTANT SOOT; NANOPARTICLES; GRAPHITE; DEGRADATION; NANOSHEETS; PERFORMANCE; COMPOSITE; GROWTH; FILMS; TIO2	A cost-effective, facile hydrothermal approach was made for the synthesis of SnO2/graphene (Gr) nano-composites. XRD diffraction spectra clearly confirmed the presence of tetragonal crystal system of SnO2 which was maintaining its structure in both pure and composite materials' matrix. The stretching and bending vibrations of the functional groups were analyzed using FTIR analysis. FESEM images illustrated the surface morphology and the texture of the synthesized sample. HRTEM images confirmed the deposition of SnO2 nanoparticles over the surface of graphene nano-sheets. Raman Spectroscopic analysis was carried out to confirm the in-plane blending of SnO2 and graphene inside the composite matrix. The photocatalytic performance of the synthesized sample under UV irradiation using methylene blue dye was observed. Incorporation of grapheme into the SnO2 sample had increased the photocatalytic activity compared with the pure SnO2 sample. The electrochemical property of the synthesized sample was evaluated.	[Sagadevan, Suresh] AMET Univ, Ctr Nanotechnol, Madras, Tamil Nadu, India; [Sagadevan, Suresh; Aziz, Fauziah Abdul] Natl Def Univ Malaysia, Ctr Def Fdn Studies, Dept Phys, Kuala Lumpur, Malaysia; [Chowdhury, Zaira Zaman; Bin Johan, Mohd Rafie; Khan, Ali A.] Univ Malaya, Nanotechnol & Catalysis Res Ctr, Kuala Lumpur, Malaysia; [Rafique, Rahman F.] Rutgers State Univ, Rutgers Cooperat Extens Water Resources Program, New Brunswick, NJ USA; [Hoque, Md Enamul] Mil Inst Sci & Technol MIST Mirpur Cantonment, Dept Biomed Engn, Dhaka, Bangladesh	Universiti Pertahanan Nasional Malaysia; Universiti Malaya; Rutgers State University New Brunswick	Sagadevan, S (corresponding author), AMET Univ, Ctr Nanotechnol, Madras, Tamil Nadu, India.; Sagadevan, S (corresponding author), Natl Def Univ Malaysia, Ctr Def Fdn Studies, Dept Phys, Kuala Lumpur, Malaysia.; Chowdhury, ZZ (corresponding author), Univ Malaya, Nanotechnol & Catalysis Res Ctr, Kuala Lumpur, Malaysia.	drsureshnano@gmail.com; zaira.chowdhury76@gmail.com	JOHAN, MOHD RAFIE/B-9106-2010; Rafique, Rahman Faizur/AAE-5229-2020; chowdhury, zaira zaman/B-3016-2017; Chowdhury, Zaira Zaman/R-7276-2016; Sagadevan, Suresh/ABF-3381-2021; Hoque, Enamul/L-9825-2017; Abdul Aziz, Fauziah/C-3374-2011	JOHAN, MOHD RAFIE/0000-0003-1133-9977; Rafique, Rahman Faizur/0000-0002-1186-4061; chowdhury, zaira zaman/0000-0001-7788-8747; Chowdhury, Zaira Zaman/0000-0001-7788-8747; Hoque, Enamul/0000-0003-0393-6771; Abdul Aziz, Fauziah/0000-0003-0773-4990; Sagadevan, Suresh/0000-0003-0393-7344; Sagadevan, Suresh/0000-0003-2779-6339	University Malaya, Malaysia [RP044C-17AET, RP044D-17AET]; Ministry of Higher Education under the Niche Research Grant Scheme (NRGS) [NRGS/2013/UPNM/PK/P1]	University Malaya, Malaysia; Ministry of Higher Education under the Niche Research Grant Scheme (NRGS)	This work has been conducted under the grants RP044C-17AET and RP044D-17AET of University Malaya, Malaysia to Z.C. The authors F.A and S.S would like to acknowledge the financial support provided by The Ministry of Higher Education under the Niche Research Grant Scheme (NRGS) NRGS/2013/UPNM/PK/P1.	Abergel DSL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768625; Baek S, 2011, RSC ADV, V1, P1687, DOI 10.1039/c1ra00797a; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cozzoli PD, 2004, J AM CHEM SOC, V126, P3868, DOI 10.1021/ja0395846; Dresselhaus MS, 2002, ADV PHYS, V51, P1, DOI [10.1080/00018730110113644, 10.1080/00018738100101367]; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hirata M, 2004, CARBON, V42, P2929, DOI 10.1016/j.carbon.2004.07.003; Hou CY, 2011, CARBON, V49, P47, DOI 10.1016/j.carbon.2010.08.040; Khare P, 2018, ACS SUSTAIN CHEM ENG, V6, P579, DOI 10.1021/acssuschemeng.7b02929; Kim H, 2010, NANO RES, V3, P813, DOI 10.1007/s12274-010-0050-4; Kumar M, 2017, VACUUM, V146, P517, DOI 10.1016/j.vacuum.2017.03.002; Kumar M, 2016, PLASMONICS, V11, P261, DOI 10.1007/s11468-015-0044-x; Kumar M, 2015, SCRIPTA MATER, V105, P46, DOI 10.1016/j.scriptamat.2015.04.030; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Kumar M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3555593; Kumar M, 2009, PHYS STATUS SOLIDI B, V246, P2232, DOI 10.1002/pssb.200844464; Li FH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455602; Li J, 2012, MATER LETT, V78, P106, DOI 10.1016/j.matlet.2012.03.013; Li ZS, 2013, ENERG ENVIRON SCI, V6, P347, DOI 10.1039/c2ee22618a; Meng XB, 2011, J MATER CHEM, V21, P12321, DOI 10.1039/c1jm11511a; Mishra YK, 2018, MATER TODAY, V21, P631, DOI 10.1016/j.mattod.2017.11.003; Muhulet A, 2018, MATER TODAY ENERGY, V9, P154, DOI 10.1016/j.mtener.2018.05.002; Naebe M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04375; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Paek SM, 2009, NANO LETT, V9, P72, DOI 10.1021/nl802484w; Pan XY, 2013, J PHYS CHEM C, V117, P17996, DOI 10.1021/jp4064802; Park SK, 2012, J MATER CHEM, V22, P2520, DOI 10.1039/c1jm14199f; Ramachandran R, 2014, RSC ADV, V4, P21151, DOI 10.1039/c4ra01515k; Sagadevan S, 2018, J MATER SCI-MATER EL, V29, P9099, DOI 10.1007/s10854-018-8937-z; Sagadevan S, 2018, MATER RES EXPRESS, V5, DOI 10.1088/2053-1591/aab173; Sagadevan S, 2017, MATER RES EXPRESS, V4, DOI 10.1088/2053-1591/aa9a8c; Sagadevan S, 2017, J MATER SCI-MATER EL, V28, P17193, DOI 10.1007/s10854-017-7648-1; Sagadevan S, 2017, J ALLOY COMPD, V728, P645, DOI 10.1016/j.jallcom.2017.09.061; Sagadevan S, 2017, J MATER SCI-MATER EL, V28, P7892, DOI 10.1007/s10854-017-6488-3; Seema H, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/35/355705; Singh A, 2017, ACS SUSTAIN CHEM ENG, V5, P8860, DOI 10.1021/acssuschemeng.7b01645; Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003; Smazna D., NANOSCALE, V10, P1, DOI [10.1039/x0xx00000x, DOI 10.1039/X0XX00000X]; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Talebian N, 2010, THIN SOLID FILMS, V518, P2210, DOI 10.1016/j.tsf.2009.07.135; Tripathi KM, 2018, SUSTAIN MATER TECHNO, V16, P1, DOI 10.1016/j.susmat.2018.01.001; Tripathi KM, 2017, ACS SUSTAIN CHEM ENG, V5, P2906, DOI 10.1021/acssuschemeng.6b01937; Tripathi KM, 2016, ACS SUSTAIN CHEM ENG, V4, P6399, DOI 10.1021/acssuschemeng.6b01045; Tran TS, 2017, MATER RES BULL, V96, P395, DOI 10.1016/j.materresbull.2017.04.012; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Wang W, 2018, RSC ADV, V8, P2410, DOI 10.1039/c7ra12455d; Xiong ZG, 2010, CHEM COMMUN, V46, P6099, DOI 10.1039/c0cc01259a; Xu MW, 2007, J SOLID STATE ELECTR, V11, P1101, DOI 10.1007/s10008-006-0246-4; Xu M, 2007, J PHYS CHEM C, V111, P19141, DOI 10.1021/jp076730b; Zhang JT, 2011, J MATER CHEM, V21, P3634, DOI 10.1039/c0jm03827j; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhou XZ, 2009, J PHYS CHEM C, V113, P10842, DOI 10.1021/jp903821n; Zhu YQ, 2013, RSC ADV, V3, P11860, DOI 10.1039/c3ra41863d	56	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0202694	10.1371/journal.pone.0202694	http://dx.doi.org/10.1371/journal.pone.0202694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273344	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700005
J	Sobhkhez, M; Krasnov, A; Robertsen, B				Sobhkhez, Mehrdad; Krasnov, Aleksei; Robertsen, Borre			Transcriptome analyses of Atlantic salmon muscle genes induced by a DNA vaccine against salmonid alphavirus, the causative agent of salmon pancreas disease (PD)	PLOS ONE			English	Article							HEMATOPOIETIC NECROSIS VIRUS; ALDRICH-SYNDROME PROTEIN; AFFINITY IGG RECEPTOR; CLASS-II GENES; INTERFERON-GAMMA; INFLAMMATORY DISEASE; RAINBOW-TROUT; EXPRESSION; INDUCTION; CHEMOKINES	Salmonid alphavirus (SAV) is the causative agent of pancreas disease (PD) in farmed Atlantic salmon. A previous study showed that vaccination of pre-smolt salmon with a plasmid encoding the structural polypeptide of SAV gave protection against infection and development of PD accompanied by production of antibodies against the virus. In the present work we analyzed transcript responses in the muscle to vaccination with this plasmid (here named pSAV). The purpose was to shed light on how pSAV might initiate adaptive immune responses in the fish. The work was based on microarray and reverse transcription quantitative PCR analyses of muscle at the injection site 7 days after vaccination. The results showed that pSAV and pcDNA3.3 had similar abilities to up-regulate type I IFN stimulated genes. In contrast, pSAV caused higher up-regulation of IFN gamma and several IFN gamma inducible genes. Compared to pcDNA3.3, pSAV also gave larger increase in transcripts of marker genes for B-cells, T-cells and antigen presenting cells (APCs), which suggest attraction and role of these cells in the adaptive immune responses elicited by pSAV. Moreover, pSAV caused a stronger up-regulation of the chemokine CXCL10 and the proinflammatory cytokines IL-1 beta and TNF alpha, which may explain attraction of lymphocytes and APCs. The present work shows that the expression profile of genes resulting from vaccination with pSAV is different from the expression profiles obtained previously by vaccination of salmonids with DNA vaccines against infectious salmon anemia virus and infectious hematopoietic necrosis virus.	[Sobhkhez, Mehrdad; Robertsen, Borre] UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway; [Krasnov, Aleksei] Nofima As, Norwegian Inst Food Fisheries & Aquaculture Res, AS, Norway	UiT The Arctic University of Tromso; Nofima	Robertsen, B (corresponding author), UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway.	borre.robertsen@uit.no			Aquaculture programme of the Research Council of Norway [254907/E40]; NOFIMA AS; Research Council of Norway; Ministry of Trade, Industry and Fisheries; Norwegian Seafood Research Fund (FHF)	Aquaculture programme of the Research Council of Norway; NOFIMA AS(Nofima); Research Council of Norway(Research Council of Norway); Ministry of Trade, Industry and Fisheries; Norwegian Seafood Research Fund (FHF)	Borre Robertsen received funding from the Aquaculture programme of the Research Council of Norway (https://www.forskningsradet.no/en/Home_page/1177315753906), grant no. 254907/E40. NOFIMA AS (https://nofima.no/en/research/) provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. NOFIMA AS is a non-profit research institution supported by grants from the following sources: The Research Council of Norway; The Ministry of Trade, Industry and Fisheries; The Norwegian Seafood Research Fund (FHF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Heidemann K, 2002, IMMUNOL LETT, V83, P197, DOI 10.1016/S0165-2478(02)00104-9; Ai KT, 2018, FISH SHELLFISH IMMUN, V72, P31, DOI 10.1016/j.fsi.2017.10.042; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Anderson ED, 1996, MOL MAR BIOL BIOTECH, V5, P114; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Bergan V, 2010, MOL IMMUNOL, V47, P2005, DOI 10.1016/j.molimm.2010.04.015; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chang CJ, 2017, J FISH DIS, V40, P1775, DOI 10.1111/jfd.12644; Chang CJ, 2015, VACCINE, V33, P2442, DOI 10.1016/j.vaccine.2015.03.093; Chang CJ, 2014, VACCINE, V32, P4695, DOI 10.1016/j.vaccine.2014.05.059; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; Hallen LC, 2007, J INTERF CYTOK RES, V27, P675, DOI 10.1089/jir.2007.0021; Hultqvist M, 2005, CELL IMMUNOL, V233, P97, DOI 10.1016/j.cellimm.2005.04.008; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Krasnov A, 2011, COMP BIOCHEM PHYS D, V6, P31, DOI 10.1016/j.cbd.2010.04.006; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Ma WL, 1997, J BIOL CHEM, V272, P16585, DOI 10.1074/jbc.272.26.16585; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; Morley Sharon Celeste, 2012, Int J Cell Biol, V2012, P935173, DOI 10.1155/2012/935173; Orange JS, 2002, P NATL ACAD SCI USA, V99, P11351, DOI 10.1073/pnas.162376099; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Salonius K, 2007, CURR OPIN INVEST DR, V8, P635; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; Sobhkhez M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188456; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Sun BJ, 2011, J VIROL, V85, P9188, DOI 10.1128/JVI.00319-11; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Traxler GS, 1999, DIS AQUAT ORGAN, V38, P183, DOI 10.3354/dao038183; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tsuboi S, 2006, J IMMUNOL, V176, P6576, DOI 10.4049/jimmunol.176.11.6576; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; van den Elsen PJ, 1998, IMMUNOL TODAY, V19, P308, DOI 10.1016/S0167-5699(98)01287-0; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102	41	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204924	10.1371/journal.pone.0204924	http://dx.doi.org/10.1371/journal.pone.0204924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273392	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700049
J	Fan, HC; Chen, CY; Hsu, YC; Chou, RH; Teng, CLJ; Chiu, CH; Hsu, CY; Muo, CH; Chang, MY; Chang, KH				Fan, Hueng-Chuen; Chen, Chiu-Ying; Hsu, Yi-Chao; Chou, Ruey-Hwang; Teng, Chieh-Lin Jerry; Chiu, Chun-Hsiang; Hsu, Chung Y.; Muo, Chih-Hsin; Chang, Mei-Yin; Chang, Kuang-Hsi			Increased risk of incident nasopharyngeal carcinoma with exposure to air pollution	PLOS ONE			English	Article							BREAST-CANCER; EPIDEMIOLOGY; NITROSAMINES; CONSUMPTION; SHANGHAI; WORKERS	Background Nasopharyngeal carcinoma (NPC) is a race-specific malignancy. The nasal cavity is the main entry point for air pollutants or poisonous gases into the human body. However, the risk of NPC in populations exposed to air pollution remains unknown. Methods We combined data from the Taiwan Air Quality Monitoring Database (TAQMD) and the Longitudinal Health Insurance Database (LHID) to assess the risk of NPC in a population exposed to air pollution. Results Multivariate analysis revealed positive trends for the association between the risk of NPC and exposure to air pollution. After adjusting for potential covariates, the risk of developing NPC increased with the increase in nitrogen dioxide (NO2) and fine particulate matter (PM2.5) exposure concentrations from 1.39 to 2.28 and 2.01 to 1.97, respectively, compared to the risks at the lowest concentration levels. Conclusions We identified a significant risk of NPC in a population exposed to air pollution. However, this study had several limitations. Moreover, additional experimental and clinical studies on the associations between environmental factors and NPC risk are warranted.	[Fan, Hueng-Chuen; Chang, Kuang-Hsi] Tungs Taichung Metroharbor Hosp, Dept Med Res, Taichung, Taiwan; [Fan, Hueng-Chuen] Tungs Taichung Metroharbor Hosp, Dept Med Res, Dept Pediat, Taichung, Taiwan; [Fan, Hueng-Chuen; Chang, Kuang-Hsi] Jen Teh Jr Coll Med Nursing & Management, Dept Rehabil, Miaoli, Taiwan; [Chen, Chiu-Ying] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Hsu, Yi-Chao] Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan; [Chou, Ruey-Hwang; Hsu, Chung Y.; Chang, Kuang-Hsi] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Taichung Vet Gen Hosp, Dept Med, Div Hematol Med Oncol, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Chiu, Chun-Hsiang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chiu, Chun-Hsiang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chang, Mei-Yin] Fooyin Univ, Sch Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	Tungs' Taichung MetroHarbor Hospital; Tungs' Taichung MetroHarbor Hospital; China Medical University Taiwan; Mackay Medical College; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Taichung Veterans General Hospital; Tunghai University; Chung Shan Medical University; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Fooyin University	Chang, KH (corresponding author), Tungs Taichung Metroharbor Hosp, Dept Med Res, Taichung, Taiwan.; Chang, KH (corresponding author), Jen Teh Jr Coll Med Nursing & Management, Dept Rehabil, Miaoli, Taiwan.; Chang, KH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	kuanghsichang@gmail.com	Teng, Chieh-Lin Jerry/AAC-7441-2020; Chou, Ruey-Hwang/K-8541-2013; Hsu, Yi-Chao/AAK-7478-2021	Teng, Chieh-Lin Jerry/0000-0001-9744-0368; Chou, Ruey-Hwang/0000-0002-2297-2180; Chang, Kuang Hsi/0000-0002-4453-0068	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325B-039 -006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan from the Ministry of Education of Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan from the Ministry of Education of Taiwan	This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); the NRPB Stroke Clinical Trial Consortium (MOST 103-2325B-039 -006); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; the Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and the CMU under the Aim for Top University Plan from the Ministry of Education of Taiwan. (CMU is China Medical University; NRPB is National Research Program for Biopharmaceuticals.)	Bourouba M, 2015, CYTOKINE, V74, P157, DOI 10.1016/j.cyto.2015.04.003; Bradshaw PT, 2016, EPIDEMIOLOGY, V27, P6, DOI 10.1097/EDE.0000000000000394; Busson P, 2004, TRENDS MICROBIOL, V12, P356, DOI 10.1016/j.tim.2004.06.005; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000733; Chang KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001485; Chang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103078; Chang KH, 2014, AGE, V36, P967, DOI 10.1007/s11357-013-9608-x; Chen RW, 2015, ONCOTARGETS THER, V8, P2835, DOI 10.2147/OTT.S90430; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Database NHIR, 2015, TAIWAN; Enoch MA, 2002, AM FAM PHYSICIAN, V65, P441; Fashi M, 2015, IRAN J CANCER PREV, V8, DOI 10.17795/ijcp2333; Feng BJ, 2009, BRIT J CANCER, V101, P1207, DOI 10.1038/sj.bjc.6605281; Hamra GB, 2015, ENVIRON HEALTH PERSP, V123, P1107, DOI 10.1289/ehp.1408882; Ho CK, 1999, OCCUP ENVIRON MED, V56, P426, DOI 10.1136/oem.56.6.426; Huang WY, 2015, CLIN OTOLARYNGOL, V40, P327, DOI 10.1111/coa.12371; Li PY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1895-4; Li W, 2006, OCCUP ENVIRON MED, V63, P39, DOI 10.1136/oem.2005.021709; Lin JH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1902-9; Lourembam Deepak Singh, 2015, Asian Pac J Cancer Prev, V16, P4927; Miller BA, 2002, AM J EPIDEMIOL, V155, P534, DOI 10.1093/aje/155.6.534; Murphy BA, 2015, J CLIN ONCOL, V33, P3314, DOI 10.1200/JCO.2015.61.3836; Ni L, 2015, FRONT PHYSIOL, V6, DOI [10.3339/fphys.2015.00294, 10.3389/fphys.2015.00294]; Panasevich S, 2009, OCCUP ENVIRON MED, V66, P747, DOI 10.1136/oem.2008.043471; Parkin WSL, 1997, IARC PUBL, Vi-xxxiv, P1; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Polesel J, 2013, CANCER CAUSE CONTROL, V24, P1157, DOI 10.1007/s10552-013-0195-z; Shen ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121420; Song HN, 2016, CANCER RES TREAT, V48, P789, DOI 10.4143/crt.2015.062; Tseng CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131911; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; Xie SH, 2014, ENVIRON MOL MUTAGEN, V55, P751, DOI 10.1002/em.21894; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1990, INT J CANCER, V45, P1033, DOI 10.1002/ijc.2910450609; Yuan JM, 2000, INT J CANCER, V85, P364, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;364::AID-IJC12&gt;3.0.CO;2-C; Zhang Y, 2015, ENVIRON TOXICOL; ZHENG YM, 1994, BRIT J CANCER, V69, P508, DOI 10.1038/bjc.1994.92; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202	39	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204568	10.1371/journal.pone.0204568	http://dx.doi.org/10.1371/journal.pone.0204568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265690	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500037
J	Voolstra, O; Strauch, L; Mayer, M; Huber, A				Voolstra, Olaf; Strauch, Lisa; Mayer, Matthias; Huber, Armin			Functional characterization of the three Drosophila retinal degeneration C (RDGC) protein phosphatase isoforms	PLOS ONE			English	Article							IN-VIVO; RHODOPSIN; APOPTOSIS; PHOSPHORYLATION; PHOTORECEPTORS; ENCODES; CHANNEL; OPSIN; STATE; GENE	Drosophila retinal degeneration C (RDGC) is the founding member of the PPEF family of protein phosphatases. RDGC mediates dephosphorylation of the visual pigment rhodopsin and the TRP ion channel. From the rdgC locus, three protein isoforms, termed RDGC-S, -M, and -L, with different N-termini are generated. Due to fatty acylation, RDGC-M and -L are attached to the plasma membrane while RDGC-S is soluble. To assign physiological roles to these RDGC isoforms, we constructed flies that express various combinations of RDGC protein isoforms. Expression of the RDGC-L isoform alone did not fully prevent rhodopsin hyperphosphorylation and resulted in impaired photoreceptor physiology and in decelerated TRP dephosphorylation at Ser936. However, expression of RDGC-L alone as well as RDGC-S/M was sufficient to prevent degeneration of photoreceptor cells which is a hallmark of the rdgC null mutant. Membrane-attached RDGC-M displayed higher activity of TRP dephosphorylation than the soluble isoform RDGC-S. Taken together, in vivo activities of RDGC splice variants are controlled by their N-termini.	[Voolstra, Olaf; Strauch, Lisa; Mayer, Matthias; Huber, Armin] Univ Hohenheim, Inst Physiol, Dept Biochem, Stuttgart, Germany	University Hohenheim	Voolstra, O (corresponding author), Univ Hohenheim, Inst Physiol, Dept Biochem, Stuttgart, Germany.	olaf.voolstra@uni-hohenheim.de	Huber, Armin/GYU-6322-2022					ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Bentrop J, 1997, EMBO J, V16, P1600, DOI 10.1093/emboj/16.7.1600; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Lee SJ, 2001, NEURON, V32, P1097, DOI 10.1016/S0896-6273(01)00538-4; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Sherman PM, 1997, P NATL ACAD SCI USA, V94, P11639, DOI 10.1073/pnas.94.21.11639; Shieh BH, 2014, J BIOL CHEM, V289, P18526, DOI 10.1074/jbc.M114.571224; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Strauch L, 2018, FEBS LETT, V592, P2403, DOI 10.1002/1873-3468.13163; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Voolstra O, 2017, J NEUROSCI, V37, P4213, DOI 10.1523/JNEUROSCI.3670-16.2017; Voolstra O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073787; Voolstra O, 2010, J BIOL CHEM, V285, P14275, DOI 10.1074/jbc.M110.102053	24	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204933	10.1371/journal.pone.0204933	http://dx.doi.org/10.1371/journal.pone.0204933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265717	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500056
J	Azizova, TV; Bannikova, MV; Grigoryeva, ES; Rybkina, VL				Azizova, Tamara, V; Bannikova, Maria, V; Grigoryeva, Evgeniya S.; Rybkina, Valentina L.			Risk of malignant skin neoplasms in a cohort of workers occupationally exposed to ionizing radiation at low dose rates	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; CUTANEOUS MELANOMA; CANCER-MORTALITY; LUNG-CANCER; MAYAK; BONE; METAANALYSIS; DAMAGE; LIVER	Recently an increasing trend in skin cancer rates has been observed in various populations including those exposed to different radiation types. Risk and dose-response following prolonged radiation exposure remain unclear. The present study was aimed to assess skin melanoma (SM) and non-melanoma skin cancer (NMSC) incidence risks in a cohort of workers occupationally exposed to ionizing radiation at low dose rates over prolonged periods. The study cohort included workers of a Russian nuclear production facility, Mayak Production Association (PA), who were first employed in 1948 +/- 1982 and followed up till the end of 2013 (the total of 22,377 individuals with 25% of females). Using AMFIT module of EPICURE software, relative risk and excess relative risk per unit dose (RR and ERR/Sv) were calculated. 60 SM and 294 NMSC cases were registered in members of the study cohort. SM and NMSC incidence was dependent on sex, attained age, age at first employment at the enterprise, type of facility, education level and was not dependent on calendar period of first employment, calendar period of diagnosis, duration of employment, smoking and alcohol consumption statuses. The risk of NMSC incidence was found to be significantly increased in workers occupationally exposed to ionizing radiation at cumulative doses above 2.0 Sv (RR = 2.52; 95% CI: 1.60, 3.97) compared to a reference dose category (0-0.05 Sv). NMSC incidence was found to be significantly associated with cumulative external gamma-dose with ERR/Sv of 0.49 (95% CI: 0.22, 0.90) without an adjustment for neutron dose and 0.51 (95% CI: 0.22, 0.93) while adjusted for neutron dose. Results of the analysis did not reveal a significant association of SM incidence with cumulative dose from external gamma-rays with ERR/Sv of 0.22 (95% CI: -0.29, 1.46) not including a neutron dose adjustment and of 0.15 (95% CI: -0.41, 1.31) while adjusted for dose from neutron exposure.	[Azizova, Tamara, V; Bannikova, Maria, V; Grigoryeva, Evgeniya S.; Rybkina, Valentina L.] SUBI, Clin Dept, Ozyorsk, Chelyabinsk Reg, Russia	Southern Urals Biophysics Institute	Azizova, TV (corresponding author), SUBI, Clin Dept, Ozyorsk, Chelyabinsk Reg, Russia.	clinic@subi.su	Bannikova, Maria V./Z-1343-2019; Grigoryeva, Evgeniya S./B-9142-2016; Azizova, Tamara V./R-5295-2019; Rybkina, Valentina L./AAA-7420-2019	Bannikova, Maria V./0000-0002-2755-6282; Grigoryeva, Evgeniya S./0000-0003-1806-9922; Azizova, Tamara V./0000-0001-6954-2674; Rybkina, Valentina L./0000-0001-5096-9774				[Anonymous], 2011, RCE19 AGIR HPA, P1; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; Ferlay JSH, 2008, IARC CANCERBASE; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Gilbert ES, 2004, RADIAT RES, V162, P505, DOI 10.1667/RR3259; Hunter N, 2013, BRIT J CANCER, V109, P1989, DOI 10.1038/bjc.2013.543; Karagas MR, 1996, J NATL CANCER I, V88, P1848, DOI 10.1093/jnci/88.24.1848; Karpin AD, 2016, MORBIDITY MORTALITY; Khalesi M, 2013, CANCER EPIDEM BIOMAR, V22, P1483, DOI 10.1158/1055-9965.EPI-13-0424; Koshurnikova NA, 2000, RADIAT RES, V154, P237, DOI 10.1667/0033-7587(2000)154[0237:BCIMW]2.0.CO;2; Kungurova NV, 2016, DERMATOONCOLOGIYA MA; Kuznetsova IS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162710; Lee T, 2015, OCCUP ENVIRON MED, V72, P862, DOI 10.1136/oemed-2015-102880; Ouyang Yun-Hsuan, 2010, Semin Plast Surg, V24, P117, DOI 10.1055/s-0030-1255329; Petrova GV, 2015, MALIGNANT NEOPLASMS, P250; PRESTON D. L., 1993, EPICURE USERS GUIDE; Rajaraman P, 2016, AJR, V206, P1, DOI [10.2214/AJR.15.15725, DOI 10.2214/AJR.15.15725]; Rastrelli M, 2014, IN VIVO, V28, P1005; Rota M, 2014, BRIT J DERMATOL, V170, P1021, DOI 10.1111/bjd.12856; Sanlorenzo M, 2015, JAMA DERMATOL, V151, P51, DOI 10.1001/jamadermatol.2014.1077; Shilnikova NS, 2003, RADIAT RES, V159, P787, DOI 10.1667/0033-7587(2003)159[0787:CMRAWA]2.0.CO;2; Shore RE, 2001, MED PEDIATR ONCOL, V36, P549, DOI 10.1002/mpo.1128; Sokolnikov ME, 2008, INT J CANCER, V123, P905, DOI 10.1002/ijc.23581; Song FJ, 2012, INT J EPIDEMIOL, V41, P1694, DOI 10.1093/ije/dys146; Sugiyama H, 2014, RADIAT RES, V181, P531, DOI 10.1667/RR13494.1; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Vasilenko EK, 2010, AAHP SPEC SESS HLTH; World Health Organization, 1980, ICD 9 GUID COD DIS T, P752; Yen H, 2017, BRIT J DERMATOL, V177, P696, DOI 10.1111/bjd.15647; Yoshinaga S, 2005, INT J CANCER, V115, P828, DOI 10.1002/ijc.20939	33	14	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205060	10.1371/journal.pone.0205060	http://dx.doi.org/10.1371/journal.pone.0205060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289933	gold, Green Submitted, Green Published			2022-12-27	WOS:000446545500043
J	Nasir, SA; Ramli, R; Abd Jabar, N				Nasir, Suraya Ahmad; Ramli, Roszalina; Abd Jabar, Nazimi			Predictors of enophthalmos among adult patients with pure orbital blowout fractures	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; FLOOR FRACTURES; RETROSPECTIVE ANALYSIS; WALL FRACTURE; REPAIR; RECONSTRUCTION; CLASSIFICATION; SURGERY; SIZE	The aim of this study was to determine the predictors of post-traumatic enophthalmos (PE) in relation to the internal orbital changes following pure orbital blowout fractures. The design was a 10-year retrospective cross-sectional study analysing 629 medical records and computed tomography (CT) data of patients with orbital fractures from January 2008 to January 2017. Demographic, etiology, co-morbidity and clinical characteristics were obtained from the medical records. Assessment of the PE, fracture site and size, intraorbital structures and muscle change were performed using the Digital Imaging and Communications in Medicine (DICOM) viewer software, OsiriX v5.8.2. Of the 629 patients with orbital fractures, 87 were pure orbital blowout fractures. Demographic pattern showed that males outnumbered females in the series, with male: female ratio of 5.7:1. The mean age was 37.2 +/- 14.7 and the main etiology was motor vehicle accident. Orbital floor fracture was the most common fracture location (67.8%). The involvement of the posterior ledge and inferior orbital fissure showed statistical significant difference with PE (Fisher's exact test, p = 0.03). Binary logistic regression showed that after controlling for age, patients with fracture size of more than 150 mm 2 had three times the odds of sustaining a PE, (adjusted odds ratio (AOR) = 3.01 (95% CI 1.17-7.92). Fracture size larger than 150 mm(2) was a radiological predictor of PE. Additional research investigating further on the role of concurrent fracture of the posterior ledge and inferior orbital fissure is advocated.	[Nasir, Suraya Ahmad; Ramli, Roszalina; Abd Jabar, Nazimi] Univ Kebangsaan Malaysia, Fac Dent, Ctr Oral & Maxillofacial Surg, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia	Ramli, R (corresponding author), Univ Kebangsaan Malaysia, Fac Dent, Ctr Oral & Maxillofacial Surg, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia.	roszalina@ppukm.ukm.edu.my	nasir, suraya ahmad/AAM-8194-2021; Jabar, Nazimi Abdul/M-6175-2014	Jabar, Nazimi Abdul/0000-0003-3761-1342				Allen RC, 2006, ESSENT OPHTHALMOL, P237; Ang CH, 2015, CRANIOMAX TRAUM REC, V8, P289, DOI 10.1055/s-0034-1399800; Ben Simon GJ, 2009, OPHTHAL SURG LAS IM, V40, P141, DOI 10.3928/15428877-20090301-05; Burm JS, 1999, PLAST RECONSTR SURG, V104, P1350, DOI 10.1097/00006534-199910000-00017; Burnstine MA, 2002, OPHTHALMOLOGY, V109, P1207, DOI 10.1016/S0161-6420(02)01057-6; Burnstine Michael A, 2003, Curr Opin Ophthalmol, V14, P236, DOI 10.1097/00055735-200310000-00002; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chang AA, 1995, AUST NZ J OPHTHALMOL, V23, P315, DOI 10.1111/j.1442-9071.1995.tb00182.x; Chen Chien-Tzung, 2006, Chang Gung Med J, V29, P251; Chen HH, 2016, FORMOS J SURG, V49, P1, DOI 10.1016/j.fjs.2015.06.002; Chiasson G, 2010, CRANIOMAX TRAUM REC, V3, P125, DOI 10.1055/s-0030-1262954; Choi Woong Kyu, 2016, Arch Craniofac Surg, V17, P128, DOI 10.7181/acfs.2016.17.3.128; Clauser L, 2008, J CRANIOFAC SURG, V19, P351, DOI 10.1097/SCS.0b013e3180534361; de Silva DJ, 2011, OPHTHALMOLOGY, V118, P1677, DOI 10.1016/j.ophtha.2011.05.001; Ellis E, 2003, J ORAL MAXIL SURG, V61, P442, DOI 10.1053/joms.2003.50085; Escaravage GK, 2013, OPHTHAL PLAST RECONS, V29, P150, DOI 10.1097/IOP.0b013e3182859716; Eski M, 2006, J CRANIOFAC SURG, V17, P1059, DOI 10.1097/01.scs.0000235111.92988.b2; Essig H, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-18; Furuta M, 2001, JPN J OPHTHALMOL, V45, P600, DOI 10.1016/S0021-5155(01)00419-1; Garcia BG, 2016, REV ESP CIR ORAL MAX, V38, P42, DOI [10.1016/j.maxilo.2014.03.011, DOI 10.1016/J.MAXILO.2014.03.011]; Gart MS, 2014, PLAST RECONSTR SURG, V134, P1345, DOI 10.1097/PRS.0000000000000719; Hammond D, 2013, J SURG CASE REP, DOI 10.1093/jscr/rjt054; HAWES MJ, 1983, OPHTHALMOLOGY, V90, P1066; Hazani R, 2012, ARCH PLAST SURG-APS, V39, P11, DOI 10.5999/aps.2012.39.1.11; He Y, 2012, J CRANIOFAC SURG, V23, P1050, DOI 10.1097/SCS.0b013e3182564ef3; Higashino T, 2011, J CRANIOFAC SURG, V22, P1210, DOI 10.1097/SCS.0b013e31821c0d13; Hosal Banu M, 2002, Orbit, V21, P27; Kim G, 2012, J DIGIT IMAGING, V25, P486, DOI 10.1007/s10278-012-9458-6; Kim YK, 2009, J PLAST RECONSTR AES, V62, P1379, DOI 10.1016/j.bjps.2008.06.042; Koo L, 2006, OPHTHAL PLAST RECONS, V22, P274, DOI 10.1097/01.iop.0000226865.22184.6a; Kunz C, 2014, CRANIOMAX TRAUM REC, V7, pS92, DOI 10.1055/s-0034-1389562; Lang W., 1889, T OPHTHAL SOC UK, V9, P41; Layton CJ, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/412397; Lee HB, 2016, J ORAL MAXIL SURG, V74, P2457, DOI 10.1016/j.joms.2016.07.013; Lee WT, 2009, J CRANIOFAC SURG, V20, P75, DOI 10.1097/SCS.0b013e318190df0d; Lima LB, 2015, REV PORT ESTOMATOL M, V56, P122, DOI 10.1016/j.rpemd.2015.04.010; Lin KY, 2012, SAUDI J OPHTHALMOL, V26, P427, DOI 10.1016/j.sjopt.2012.08.002; Matic DB, 2007, J CRANIOFAC SURG, V18, P127, DOI 10.1097/SCS.0b013e31802ccdc8; NOLASCO FP, 1995, OTOLARYNG HEAD NECK, V112, P549, DOI 10.1016/S0194-5998(95)70210-5; Nordin R, 2015, J ORAL MAX SURG MED, V27, P166, DOI 10.1016/j.ajoms.2014.01.001; Novelli G, 2014, J CRANIO MAXILL SURG, V42, P2025, DOI 10.1016/j.jcms.2014.09.009; Raskin EM, 1998, OPHTHALMIC PLAST REC, V14, P19, DOI 10.1097/00002341-199801000-00006; Shah HA, 2013, AM J OTOLARYNG, V34, P695, DOI 10.1016/j.amjoto.2013.02.006; Shin JW, 2013, J CRANIOFAC SURG, V24, P703, DOI 10.1097/SCS.0b013e31829026ca; SMITH B, 1957, AM J OPHTHALMOL, V44, P734; Sung YS, 2013, ARCH PLAST SURG-APS, V40, P335, DOI 10.5999/aps.2013.40.4.335; Tong L, 2001, PLAST RECONSTR SURG, V108, P612, DOI 10.1097/00006534-200109010-00003; WHITEHOUSE RW, 1994, BRIT J OPHTHALMOL, V78, P618, DOI 10.1136/bjo.78.8.618	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204946	10.1371/journal.pone.0204946	http://dx.doi.org/10.1371/journal.pone.0204946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289909	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500031
J	Foister, S; Doeschl-Wilson, A; Roehe, R; Arnott, G; Boyle, L; Turner, S				Foister, Simone; Doeschl-Wilson, Andrea; Roehe, Rainer; Arnott, Gareth; Boyle, Laura; Turner, Simon			Social network properties predict chronic aggression in commercial pig systems	PLOS ONE			English	Article							BEHAVIOR; CONNECTIONS; FITNESS; STRESS; GROWTH	Post-mixing aggression in pigs is a harmful and costly behaviour which negatively impacts both animal welfare and farm efficiency. There is vast unexplained variation in the amount of acute and chronic aggression that dyadic behaviours do not fully explain. This study hypothesised that certain pen-level network properties may improve prediction of lesion outcomes due to the incorporation of indirect social interactions that are not captured by dyadic traits. Utilising current SNA theory, we investigate whether pen-level network properties affect the number of aggression-related injuries at 24 hours and 3 weeks post-mixing (24hr-PM and 3wk-PM). Furthermore we compare the predictive value of network properties to conventional dyadic traits. A total of 78 pens were video recorded for 24hr post-mixing. Each aggressive interaction that occurred during this time period was used to construct the pen-level networks. The relationships between network properties at 24hr and the pen level injuries at 24hr-PM and 3wk-PM were analysed using mixed models and verified using permutation tests. The results revealed that network properties at 24hr could predict long term aggression (3wk-PM) better than dyadic traits. Specifically, large clique formation in the first 24hr-PM predicted fewer injuries at 3wk-PM and high betweenness centralisation at 24hr-PM predicted increased rates of injury at 3wk-PM. This study demonstrates that network properties present during the first 24hr-PM have predictive value for chronic aggression, and have potential to allow identification and intervention for at risk groups.	[Foister, Simone; Roehe, Rainer; Turner, Simon] SRUC, Roslin Inst Bldg, Anim & Vet Sci, Easter Bush, Midlothian, Scotland; [Doeschl-Wilson, Andrea] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Doeschl-Wilson, Andrea] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Arnott, Gareth] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Boyle, Laura] TEAGASC, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Queens University Belfast; Teagasc	Foister, S (corresponding author), SRUC, Roslin Inst Bldg, Anim & Vet Sci, Easter Bush, Midlothian, Scotland.	simone.foister@sruc.ac.uk		Roehe, Rainer/0000-0002-4880-3756; Turner, Simon/0000-0001-9198-9448; Boyle, Laura/0000-0001-7080-1776; Wilson, Andrea/0000-0002-2658-6973	Teagasc Walsh Fellowship Scheme (2015) [REF 2015004]; Scottish Government; BBSRC [BBS/E/D/30002276] Funding Source: UKRI	Teagasc Walsh Fellowship Scheme (2015); Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded through the Teagasc Walsh Fellowship Scheme (2015, REF 2015004). SRUC receives financial support from the Scottish Government.	[Anonymous], 2011, SAS 9 3 MACR LANG RE; Bhadra A, 2009, ECOL COMPLEX, V6, P48, DOI 10.1016/j.ecocom.2008.10.004; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Borgatti S., 2013, ANAL SOCIAL NETWORKS; Boyland NK, 2016, APPL ANIM BEHAV SCI, V174, P1, DOI 10.1016/j.applanim.2015.11.016; Brent LJN, 2015, ANIM BEHAV, V103, P211, DOI 10.1016/j.anbehav.2015.01.020; Buttner K, 2015, APPL ANIM BEHAV SCI, V168, P24, DOI 10.1016/j.applanim.2015.04.017; Camerlink I, 2013, APPL ANIM BEHAV SCI, V145, P84, DOI 10.1016/j.applanim.2013.02.008; Canario L, 2012, J ANIM SCI, V90, P4706, DOI 10.2527/jas.2012-5392; Cheney DL, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160255; Coutellier L, 2007, APPL ANIM BEHAV SCI, V105, P102, DOI 10.1016/j.applanim.2006.05.007; Croft DP, 2016, CURR OPIN BEHAV SCI, V12, P52, DOI 10.1016/j.cobeha.2016.09.001; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Csardi G, 2006, INTERJOURNAL; D'Eath RB, 2010, ANIMAL, V4, P604, DOI 10.1017/S1751731109991406; Desire S, 2015, APPL ANIM BEHAV SCI, V166, P52, DOI 10.1016/j.applanim.2015.02.015; Farine DR, 2017, METHODS ECOL EVOL, V8, P1309, DOI 10.1111/2041-210X.12772; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Faucitano L, 2001, CAN J ANIM SCI, V81, P39, DOI 10.4141/A00-031; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gilby IC, 2013, BEHAV ECOL SOCIOBIOL, V67, P373, DOI 10.1007/s00265-012-1457-6; Griffin RH, 2012, EVOL ECOL, V26, P779, DOI 10.1007/s10682-011-9526-2; Lehmann J, 2016, BEHAV ECOL, V27, P20, DOI 10.1093/beheco/arv169; Li YZ, 2018, ANIMALS, V8, DOI 10.3390/ani8010013; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; Makagon MM, 2012, APPL ANIM BEHAV SCI, V138, P152, DOI 10.1016/j.applanim.2012.02.003; Marchant JN, 1995, APPL ANIM BEHAV SCI, V46, P49, DOI 10.1016/0168-1591(95)00636-2; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; McCowan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022350; MEESE GB, 1973, ANIM BEHAV, V21, P326, DOI 10.1016/S0003-3472(73)80074-0; MENDL M, 1992, ANIM BEHAV, V44, P1107, DOI 10.1016/S0003-3472(05)80323-9; MORROWTESCH JL, 1994, J ANIM SCI, V72, P2599, DOI 10.2527/1994.72102599x; Olesen LS, 1996, APPL ANIM BEHAV SCI, V46, P167, DOI 10.1016/0168-1591(95)00650-8; Pitts AD, 2000, APPL ANIM BEHAV SCI, V68, P191, DOI 10.1016/S0168-1591(00)00104-0; Stanton MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047508; STOOKEY JM, 1994, J ANIM SCI, V72, P2804, DOI 10.2527/1994.72112804x; TAN SSL, 1991, ANIM PROD, V52, P201, DOI 10.1017/S0003356100005845; Turner SP, 2009, J ANIM SCI, V87, P3076, DOI 10.2527/jas.2008-1558; Turner SP, 2017, APPL ANIM BEHAV SCI, V191, P98, DOI 10.1016/j.applanim.2017.02.002; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Wilson ADM, 2014, BEHAV ECOL SOCIOBIOL, V68, P915, DOI 10.1007/s00265-014-1704-0	45	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205122	10.1371/journal.pone.0205122	http://dx.doi.org/10.1371/journal.pone.0205122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286157	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500089
J	Stewart, C; Subbarayan, S; Paton, P; Gemmell, E; Abraha, I; Myint, PK; O'Mahony, D; Cruz-Jentoft, AJ; Cherubini, A; Soiza, RL				Stewart, Carrie; Subbarayan, Selvarani; Paton, Pamela; Gemmell, Elliot; Abraha, Iosief; Myint, Phyo Kyaw; O'Mahony, Denis; Cruz-Jentoft, Alfonso J.; Cherubini, Antonio; Soiza, Roy L.			Non-pharmacological interventions for the improvement of post-stroke activities of daily living and disability amongst older stroke survivors: A systematic review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; OCCUPATIONAL-THERAPY INTERVENTION; MOTOR RELEARNING PROGRAM; INDUCED MOVEMENT THERAPY; SELF-CARE INTERVENTION; QUALITY-OF-LIFE; SUBACUTE STROKE; ISCHEMIC-STROKE; ACUPUNCTURE TREATMENT; UNILATERAL NEGLECT	Globally, stroke remains a leading cause of death and disability, with older adults disproportionately affected. Numerous non-pharmacological stroke rehabilitation approaches are in use to address impairments, but their efficacy in older persons is largely unknown. This systematic review examined the evidence for such interventions as part of the Optimal Evidence- Based Non-Drug Therapies in Older Persons (ONTOP) project conducted under an European Union funded project called the Software Engine for the Assessment and Optimisation of Drug and Non-Drug Therapies in Older Persons (SENATOR) [http://www. senatorproject. eu]. A Delphi panel of European geriatric experts agreed activities of daily living and disability to be of critical importance as stroke rehabilitation outcomes. A comprehensive search strategy was developed and five databases (Pubmed, CINAHL, Embase, PsycInfo and Cochrane Database of Systematic Reviews) searched for eligible systematic reviews. Primary studies meeting our criteria (non-pharmacologic interventions, involving stroke survivors aged >= 65 years, assessing activities of daily living and/or disability as outcome) were then identified from these reviews. Eligible papers were double reviewed, and due to heterogeneity, narrative analysis performed. Cochrane risk of bias and GRADE assessment tools were used to assess bias and quality of evidence, allowing us to make recommendations regarding specific non-pharmacologic rehabilitation in older stroke survivors. In total, 72 primary articles were reviewed spanning 14 types of non-pharmacological intervention. Non-pharmacological interventions based on physiotherapy and occupational therapy techniques improved activities of daily living amongst older stroke survivors. However, no evidence was found to support use of any non-pharmacological approach to benefit older stroke survivors' disability. Evidence was limited by poor study quality and the small number of studies targeting older stroke survivors. We recommend future studies explore such interventions exclusively in older adult populations and improve methodological and outcome reporting.	[Stewart, Carrie; Subbarayan, Selvarani; Paton, Pamela; Gemmell, Elliot; Myint, Phyo Kyaw; Soiza, Roy L.] Aberdeen Royal Infirm, Dept Old Age Med, Aberdeen, Scotland; [Subbarayan, Selvarani; Myint, Phyo Kyaw; Soiza, Roy L.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Abraha, Iosief; Cherubini, Antonio] IRCCS INRCA, Geriatria, Accettaz Geriatr, Ancona, Italy; [Abraha, Iosief; Cherubini, Antonio] IRCCS INRCA, Ctr Ric Invecchiamento, Ancona, Italy; [O'Mahony, Denis] Univ Coll Cork, Dept Geriatr Med, Cork, Ireland; [Cruz-Jentoft, Alfonso J.] Hosp Univ Ramon y Cajal, Fdn Invest Biomed, Madrid, Spain	University of Aberdeen; University of Aberdeen; IRCCS INRCA; IRCCS INRCA; University College Cork; Hospital Universitario Ramon y Cajal	Stewart, C (corresponding author), Aberdeen Royal Infirm, Dept Old Age Med, Aberdeen, Scotland.	carrie.stewart.06@aberdeen.ac.uk	Cherubini, Antonio/AAL-4632-2020; , roysoiza/Q-3525-2019; Cruz-Jentoft, Alfonso J/G-2675-2015; myint, phyo/G-5730-2013; Abraha, Iosief/K-4327-2018	, roysoiza/0000-0002-1397-4272; Cruz-Jentoft, Alfonso J/0000-0001-7628-4861; stewart, carrie/0000-0002-2325-3380; myint, phyo/0000-0003-3852-6158; Abraha, Iosief/0000-0002-5440-775X; O'Mahony, Denis/0000-0003-2236-5222	European Union [305930]	European Union(European Commission)	This work was supported by the European Union Seventh Framework program (FP7/2007-2013) under grant agreement no. 305930 (www.senator-project.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha I, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007488; Askim T, 2010, STROKE, V41, P1697, DOI 10.1161/STROKEAHA.110.584284; Bagley P, 2005, CLIN REHABIL, V19, P354, DOI 10.1191/0269215505cr874oa; Barrett JA, 2001, CLIN REHABIL, V15, P32, DOI 10.1191/026921501672264719; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Bowen A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub2; Bradley L, 1998, CLIN REHABIL, V12, P11, DOI 10.1191/026921598677671932; Bradt J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub2; Braun SM, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2010.07.009; Chiu CWY, 2004, OTJR-OCCUP PART HEAL, V24, P113, DOI 10.1177/153944920402400305; Clark MS, 2003, CLIN REHABIL, V17, P703, DOI 10.1191/0269215503cr681oa; Corr S, 1995, CLIN REHABIL, V9, P291; de Seze M, 2001, ARCH PHYS MED REHAB, V82, P793, DOI 10.1053/apmr.2001.0820793; DICKSTEIN R, 1986, PHYS THER, V66, P1233, DOI 10.1093/ptj/66.8.1233; Donkervoort M, 2001, NEUROPSYCHOL REHABIL, V11, P549, DOI 10.1080/09602010143000093; Duncan P, 1998, STROKE, V29, P2055, DOI 10.1161/01.STR.29.10.2055; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Ertel KA, 2007, CLIN REHABIL, V21, P511, DOI 10.1177/0269215507078312; Forster A, 1996, BRIT MED J, V312, P1642, DOI 10.1136/bmj.312.7047.1642; Franceschini M, 2009, STROKE, V40, P3079, DOI 10.1161/STROKEAHA.109.555540; Galvin R, 2011, STROKE, V42, P681, DOI 10.1161/STROKEAHA.110.594689; Gelber DA, 1995, J NEUROL REHABIL, V9, P191; Gilbertson L, 2000, BRIT MED J, V320, P603, DOI 10.1136/bmj.320.7235.603; Glass TA, 2004, PSYCHOSOM MED, V66, P889, DOI 10.1097/01.psy.0000146326.01642.ca; Gosman-Hedstrom G, 1998, STROKE, V29, P2100, DOI 10.1161/01.STR.29.10.2100; Green J, 2002, LANCET, V359, P199, DOI 10.1016/S0140-6736(02)07443-3; Guidetti S, 2011, DISABIL REHABIL, V33, P494, DOI 10.3109/09638288.2010.498553; Guidetti S, 2010, SCAND J OCCUP THER, V17, P276, DOI 10.3109/11038120903281169; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hopwood V, 2008, J NEUROL, V255, P858, DOI 10.1007/s00415-008-0790-1; Hsieh RL, 2007, J REHABIL MED, V39, P205, DOI 10.2340/16501977-0032; Johansson BB, 2001, STROKE, V32, P707, DOI 10.1161/01.STR.32.3.707; JOHANSSON K, 1993, NEUROLOGY, V43, P2189, DOI 10.1212/WNL.43.11.2189; Johnston M, 2007, DISABIL REHABIL, V29, P1117, DOI 10.1080/03323310600950411; JONGBLOED L, 1989, AM J OCCUP THER, V43, P391, DOI 10.5014/ajot.43.6.391; Kalra L, 2004, BMJ-BRIT MED J, V328, P1099, DOI 10.1136/bmj.328.7448.1099; Kalra L, 1997, STROKE, V28, P1386, DOI 10.1161/01.STR.28.7.1386; Keeney S, 2001, INT J NURS STUD, V38, P195, DOI 10.1016/S0020-7489(00)00044-4; Kim SM, 2016, J PHYS THER SCI, V28, P169, DOI 10.1589/jpts.28.1669; Kwakkel G, 2002, J NEUROL NEUROSUR PS, V72, P473; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Landi F, 2006, GERONTOLOGY, V52, P85, DOI 10.1159/000090953; Langhammer B, 2003, CLIN REHABIL, V17, P731, DOI 10.1191/0269215503cr670oa; Langhammer B, 2000, CLIN REHABIL, V14, P361, DOI 10.1191/0269215500cr338oa; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Lee G, 2013, J PHYS THER SCI, V25, P595, DOI 10.1589/jpts.25.595; Lieberman D, 2005, J REHABIL RES DEV, V42, P47, DOI 10.1682/JRRD.2004.01.0001; Lincoln NB, 1999, STROKE, V30, P573, DOI 10.1161/01.STR.30.3.573; Lincoln NB, 2003, STROKE, V34, P111, DOI 10.1161/01.STR.0000044167.44670.55; Liu CH, 2016, ACUPUNCT MED, V34, P349, DOI 10.1136/acupmed-2015-010825; Liu KPY, 2016, EUR J NEUROL, V23, P1351, DOI 10.1111/ene.13037; Logan PA, 2004, BMJ-BRIT MED J, V329, P1372, DOI 10.1136/bmj.38264.679560.8F; Logan PA, 1997, CLIN REHABIL, V11, P107, DOI 10.1177/026921559701100203; Lozano-Montoya I, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.12.091; Macdonell R A, 1994, J Stroke Cerebrovasc Dis, V4, P155, DOI 10.1016/S1052-3057(10)80178-8; Mao Min, 2008, J Tradit Chin Med, V28, P90; Masiero S, 2007, ARCH PHYS MED REHAB, V88, P142, DOI 10.1016/j.apmr.2006.10.032; Mizuno K, 2011, NEUROREHAB NEURAL RE, V25, P711, DOI 10.1177/1545968311407516; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Morris JH, 2008, ARCH PHYS MED REHAB, V89, P1237, DOI 10.1016/j.apmr.2007.11.039; National Institute for Health and Care Excellence (NICE), 2013, STROK STROKE REHABIL; Ng MFW, 2008, STROKE, V39, P154, DOI 10.1161/STROKEAHA.107.495705; Nir Z, 2004, AM J PHYS MED REHAB, V83, P522, DOI 10.1097/01.PHM.0000130026.12790.20; Owolabi MO, 2015, CARDIOVASC J AFR, V26, pS27, DOI 10.5830/CVJA-2015-038; Park J, 2005, ARCH INTERN MED, V165, P2026, DOI 10.1001/archinte.165.17.2026; Parker CJ, 2001, CLIN REHABIL, V15, P42, DOI 10.1191/026921501666968247; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Pei J, 2001, J Tradit Chin Med, V21, P270; Pohjasvaara T, 1997, STROKE, V28, P729, DOI 10.1161/01.STR.28.4.729; Rabadi MH, 2008, CLIN REHABIL, V22, P1071, DOI 10.1177/0269215508095358; Raglio A, 2017, NEUROL SCI, V38, P893, DOI 10.1007/s10072-017-2827-7; Rimland JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161579; Rodgers H, 1999, STROKE, V30, P2585, DOI 10.1161/01.STR.30.12.2585; Rodgers M., 2006, GUIDANCE CONDUCT NAR, DOI DOI 10.13140/2.1.1018.4643; Royal College of Physicians Intercollegiate Stroke Working Party (RCP), 2016, NATIONAL CLINICAL GU; Rydwik E, 2006, CLIN REHABIL, V20, P645, DOI 10.1191/0269215506cre986oa; Sackley C, 2006, STROKE, V37, P2336, DOI 10.1161/01.STR.0000237124.20596.92; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Schuler MS, 2005, J AM GERIATR SOC, V53, P549, DOI 10.1111/j.1532-5415.2005.53178_6.x; Scottish Intercollegiate Guidelines Network (SIGN), 2010, GUIDELINE NUMBER 118; SIVENIUS J, 1985, STROKE, V16, P928, DOI 10.1161/01.STR.16.6.928; Smith J, 2004, CLIN REHABIL, V18, P726, DOI 10.1191/0269215504cr790oa; Soiza RL, 2017, THER ADV DRUG SAF, V8, P81, DOI 10.1177/2042098616675851; Sonde L, 1998, SCAND J REHABIL MED, V30, P95; Sonde L, 2000, CLIN REHABIL, V14, P14, DOI 10.1191/026921500673534278; Stroke Association, 2017, STATE OF THE NATION; Studenski S, 2005, STROKE, V36, P1764, DOI 10.1161/01.STR.0000174192.87887.70; SUNDERLAND A, 1992, J NEUROL NEUROSUR PS, V55, P530, DOI 10.1136/jnnp.55.7.530; Sze FKH, 2002, STROKE, V33, P186, DOI 10.1161/hs0102.101815; Tangiisuran B., 2009, ADVERSE DRUG REACTIO; Teasell Robert W, 2003, Top Stroke Rehabil, V10, P29; Tsang MHM, 2009, DISABIL REHABIL, V31, P630, DOI 10.1080/09638280802240621; Vafadar AK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/729768; van Vliet PM, 2005, J NEUROL NEUROSUR PS, V76, P503, DOI 10.1136/jnnp.2004.040436; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5; WALKER MF, 1996, CLIN REHABIL, V10, P23, DOI DOI 10.1177/026921559601000105; Watkins CL, 2007, STROKE, V38, P1004, DOI 10.1161/01.STR.0000258114.28006.d7; Watts G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3445; Wellwood I, 2004, CLIN REHABIL, V18, P529, DOI 10.1191/0269215504cr768oa; Wiart L, 1997, ARCH PHYS MED REHAB, V78, P424, DOI 10.1016/S0003-9993(97)90236-7; Wu CY, 2007, ARCH PHYS MED REHAB, V88, P273, DOI 10.1016/j.apmr.2006.11.021; Zhu Y, 2013, PHYS THER, V93, P1447, DOI 10.2522/ptj.20110138	107	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204774	10.1371/journal.pone.0204774	http://dx.doi.org/10.1371/journal.pone.0204774			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286144	gold, Green Submitted, Green Published			2022-12-27	WOS:000446383500042
J	Gao, J; Tomonaga, M				Gao, Jie; Tomonaga, Masaki			The body inversion effect in chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							FACE PERCEPTION; OBJECTS; EXPERTISE; NEURONS; MONKEY	Bodies are important social cues for animals. Body recognition in humans is deteriorated by inversion. This inversion effect suggests the configural processing of bodies, which is different from the processing used for other objects. However, it is not known if this type of body processing exists in non-human primates. We tested seven chimpanzees using upright and inverted chimpanzee body stimuli and other stimuli in matching-to-sample tasks to examine the body inversion effect and the body parts that invoke it. Our results reflected the body inversion effect for intact chimpanzee bodies, bodies with complete body contours, and bodies with clear faces but not for the objects and other conditions that did not present complete body contours and clear faces. The results show that chimpanzees share configural body processing with humans and that bodies are special to them compared with other objects. The results also revealed the functions of faces and body contours in configural processing by chimpanzees.	[Gao, Jie; Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan; [Gao, Jie] Japan Soc Promot Sci, Tokyo, Japan	Kyoto University; Japan Society for the Promotion of Science	Gao, J (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan.; Gao, J (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	gao.jie.87c@kyoto-u.jp	Gao, Jie/Q-8597-2019	Gao, Jie/0000-0002-1463-8481	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); KAKENHI [23220006, 24000001, 15H05709, 16H06283, 18J21474]; JSPS Core-to-Core CCSN; National Bio Resource Project-Great Ape Information Network (NBRP-GAIN) [152121];  [JSPS-LGP-U04]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core CCSN; National Bio Resource Project-Great Ape Information Network (NBRP-GAIN); 	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; URL: http://www.mext.go.jp/en/)/Japan Society for the Promotion of Science (JSPS; URL: http://www.jsps.go.jp/english/) KAKENHI (23220006, 24000001, 15H05709, 16H06283, and 18J21474), JSPS-LGP-U04, JSPS Core-to-Core CCSN, National Bio Resource Project-Great Ape Information Network (NBRP-GAIN; URL: http://www.nbrp.jp/), and MEXT Scholarship (#152121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1999, NEUROREPORT, V10, P189, DOI 10.1097/00001756-199901180-00036; Barraclough NE, 2006, PROG BRAIN RES, V154, P135, DOI 10.1016/S00079-6123(06)54007-5; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; CAREY S, 1992, PHILOS T ROY SOC B, V335, P95, DOI 10.1098/rstb.1992.0012; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Dahl CD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02504; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Hobaiter C, 2014, CURR BIOL, V24, P1596, DOI 10.1016/j.cub.2014.05.066; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Jellema T, 2003, NEUROPSYCHOLOGIA, V41, P1728, DOI 10.1016/S0028-3932(03)00175-1; Jones Clyde, 1996, Mammalian Species, V529, P1; Kaneko T, 2011, P ROY SOC B-BIOL SCI, V278, P3694, DOI 10.1098/rspb.2011.0611; Martinez L, 2009, ANIM COGN, V12, pS71, DOI 10.1007/s10071-009-0269-1; Matsuno T, 2008, PERCEPTION, V37, P162; Matsuzawa T, 2003, ANIM COGN, V6, P199, DOI 10.1007/s10071-003-0199-2; Matsuzawa T, 2011, THE CHIMPANZEES OF B; Matsuzawa T, 2011, PRIMATE ORIGINS HUMA; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; R Development Core Team, 2009, R LANG ENV STAT COMP; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TOMONAGA M, 1993, FOLIA PRIMATOL, V61, P110, DOI 10.1159/000156737; Tomonaga M, 1999, PRIMATES, V40, P417, DOI 10.1007/BF02557579; Tomonaga M, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P55; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2010, J EXP PSYCHOL HUMAN, V36, P759, DOI 10.1037/a0017451	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204131	10.1371/journal.pone.0204131	http://dx.doi.org/10.1371/journal.pone.0204131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281635	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400042
J	Ha, HJ; Park, HH				Ha, Hyun Ji; Park, Hyun Ho			RAIDD mutations underlie the pathogenesis of thin lissencephaly (TLIS)	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CASPASE-2 ACTIVATION; PIDDOSOME; APOPTOSIS; COMPLEX; PIDD; SUPERFAMILY; PEPTIDES; STRESS; CARD	Abnormal regulation of caspase-2-mediated neuronal cell death causes neurodegenerative diseases and defective brain development. PIDDosome is caspase-2 activating complex composed of PIDD, RAIDD, and caspase-2. Recent whole-exome sequencing study showed that the RAIDD mutations in the death domain (DD), including G128R, F164C, R170C, and R170H mutations, cause thin lissencephaly (TLIS) by reducing caspase-2-mediated neuronal apoptosis. Given that the molecular structure of the RAIDD DD:PIDD DD complex is available, in this study, we analyzed the molecular mechanisms underlying TLIS caused by the RAIDD TLIS variants by performing mutagenesis and biochemical assays.	[Ha, Hyun Ji; Park, Hyun Ho] Chung Ang Univ, Coll Pharm, Seoul, South Korea	Chung Ang University	Park, HH (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.	xrayleox@cau.ac.kr		park, hyun ho/0000-0001-9928-0847	Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology [NRF-2017M3A9D8062960, NRF-2018R1A2B2003635]; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI17C0155]	Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (NRF-2017M3A9D8062960 and NRF-2018R1A2B2003635) and a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI17C0155).	Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Choi JY, 2017, P NATL ACAD SCI USA, V114, P7361, DOI 10.1073/pnas.1705949114; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; Di Donato N, 2016, AM J HUM GENET, V99, P1117, DOI 10.1016/j.ajhg.2016.09.010; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Fisher DE, 2001, HEMATOL ONCOL CLIN N, V15, P931, DOI 10.1016/S0889-8588(05)70258-6; Ha HJ, 2017, FEBS LETT, V591, P2919, DOI 10.1002/1873-3468.12783; Harvey N L, 1998, Adv Biochem Eng Biotechnol, V62, P107; Heger K, 2018, NATURE, V559, P120, DOI 10.1038/s41586-018-0256-2; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jang TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31198; Jang TH, 2012, BIOCHEM PHARMACOL, V83, P218, DOI 10.1016/j.bcp.2011.10.013; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Manzl C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.470; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Navratil J S, 2001, Curr Rheumatol Rep, V3, P191, DOI 10.1007/s11926-001-0018-1; Nematollahi LA, 2015, J MOL BIOL, V427, P737, DOI 10.1016/j.jmb.2014.11.021; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Niizuma K, 2008, P NATL ACAD SCI USA, V105, P16368, DOI 10.1073/pnas.0806222105; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2007, ACTA CRYSTALLOGR F, V63, P229, DOI 10.1107/S1744309107007889; Peltzer N, 2018, NATURE, V557, P112, DOI 10.1038/s41586-018-0064-8; RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Salvesen GS, 2002, ESSAYS BIOCHEM, V38, P9, DOI 10.1042/bse0380009; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	44	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205042	10.1371/journal.pone.0205042	http://dx.doi.org/10.1371/journal.pone.0205042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281648	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400079
J	Toldra, A; Andree, KB; Bertomeu, E; Roque, A; Carrasco, N; Gairin, I; Furones, MD; Campas, M				Toldra, Anna; Andree, Karl B.; Bertomeu, Edgar; Roque, Ana; Carrasco, Noelia; Gairin, Ignasi; Furones, M. Dolores; Campas, Monica			Rapid capture and detection of ostreid herpesvirus-1 from Pacific oyster Crassostrea gigas and seawater using magnetic beads	PLOS ONE			English	Article							MALEIC ANHYDRIDE)-COATED BEADS; OSHV-1 MU-VAR; ANIONIC POLYMER; VIRUS; MORTALITY; TRANSMISSION; PCR; INFECTIONS; HEMOCYTES; GENES	Ostreid herpesvirus-1 (OsHV-1) has been involved in mass mortality episodes of Pacific oysters Crassostrea gigas throughout the world, causing important economic losses to the aquaculture industry. In the present study, magnetic beads (MBs) coated with an anionic polymer were used to capture viable OsHV-1 from two types of naturally infected matrix: oyster homogenate and seawater. Adsorption of the virus on the MBs and characterisation of the MB-virus conjugates was demonstrated by real-time quantitative PCR (qPCR). To study the infective capacity of the captured virus, MB-virus conjugates were injected in the adductor muscle of naive spat oysters, using oyster homogenate and seawater without MBs as positive controls, and bare MBs and sterile water as negative controls. Mortalities were induced after injection with MB-virus conjugates and in positive controls, whereas no mortalities were recorded in negative controls. Subsequent OsHV-1 DNA and RNA analysis of the oysters by qPCR and reverse transcription qPCR (RT-qPCR), respectively, confirmed that the virus was the responsible for the mortality event and the ability of the MBs to capture viable viral particles. The capture of viable OsHV-1 using MBs is a rapid and easy isolation method and a promising tool, combined with qPCR, to be applied to OsHV-1 detection in aquaculture facilities.	[Toldra, Anna; Andree, Karl B.; Bertomeu, Edgar; Roque, Ana; Carrasco, Noelia; Gairin, Ignasi; Furones, M. Dolores; Campas, Monica] IRTA, Tarragona, Spain	IRTA	Campas, M (corresponding author), IRTA, Tarragona, Spain.	monica.campas@irta.cat	Gairin, Isasi/AAB-6540-2019; Toldrà, Anna/AAE-8360-2019; Roque, Ana/ABE-4787-2021; Querol, Noèlia Carrasco/AAF-6702-2019; Campàs, Mònica/J-9900-2013	Gairin, Isasi/0000-0003-2438-999X; Toldrà, Anna/0000-0001-6371-6055; Roque, Ana/0000-0001-8717-9186; Querol, Noèlia Carrasco/0000-0002-5876-7082; Campàs, Mònica/0000-0002-1220-7100	European Commission Horizon 2020 (H2020) Framework Programme [678589]; CERCA Programme/Generalitat de Catalunya; IRTA-Universitat Rovira i Virgili-Banco Santander [2015PMF-PIPF-67]	European Commission Horizon 2020 (H2020) Framework Programme; CERCA Programme/Generalitat de Catalunya; IRTA-Universitat Rovira i Virgili-Banco Santander	This research has received funding from the European Commission Horizon 2020 (H2020) Framework Programme through grant agreement no 678589 (VIVALDI project). The authors also acknowledge support from CERCA Programme/Generalitat de Catalunya. Anna Toldra acknowledges IRTA-Universitat Rovira i Virgili-Banco Santander for her PhD grant (2015PMF-PIPF-67).	Araya MT, 2008, J INVERTEBR PATHOL, V99, P326, DOI 10.1016/j.jip.2008.08.002; Arzul I, 2001, J GEN VIROL, V82, P865, DOI 10.1099/0022-1317-82-4-865; Burge CA, 2006, DIS AQUAT ORGAN, V72, P31, DOI 10.3354/dao072031; Burge CA, 2012, MICROB ECOL, V63, P596, DOI 10.1007/s00248-011-9937-1; Carrasco N, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00125; Davison AJ, 2005, J GEN VIROL, V86, P41, DOI 10.1099/vir.0.80382-0; Degremont L, 2013, AQUACULTURE, V416, P129, DOI 10.1016/j.aquaculture.2013.09.011; Degremont L, 2013, AQUACULTURE, V408, P51, DOI 10.1016/j.aquaculture.2013.05.025; EFSA, 2015, EFSA J, V13, P4122; FAO, CULT AQ SPEC INF PRO; Jenkins C, 2013, DIS AQUAT ORGAN, V105, P109, DOI 10.3354/dao02623; Keeling SE, 2014, DIS AQUAT ORGAN, V109, P231, DOI 10.3354/dao02735; Lipart C, 2002, J VIROL METHODS, V101, P1, DOI 10.1016/S0166-0934(01)00413-X; Martenot C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177448; Martenot C, 2016, J INVERTEBR PATHOL, V136, P124, DOI 10.1016/j.jip.2016.04.002; Morga B, 2017, J INVERTEBR PATHOL, V150, P45, DOI 10.1016/j.jip.2017.09.007; Morga B, 2010, FISH SHELLFISH IMMUN, V29, P937, DOI 10.1016/j.fsi.2010.07.028; Patramool S, 2013, J VIROL METHODS, V193, P55, DOI 10.1016/j.jviromet.2013.04.016; Paul-Pont I, 2015, DIS AQUAT ORGAN, V113, P137, DOI 10.3354/dao02826; Pepin JF, 2008, J VIROL METHODS, V149, P269, DOI 10.1016/j.jviromet.2008.01.022; Pernet F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088469; Petton B, 2013, AQUACULT ENV INTERAC, V3, P257, DOI 10.3354/aei00070; Renault T., 1994, Bulletin of the European Association of Fish Pathologists, V14, P64; Rodriguez RA, 2009, APPL ENVIRON MICROB, V75, P297, DOI 10.1128/AEM.01150-08; Roque A, 2012, AQUACULTURE, V324, P303, DOI 10.1016/j.aquaculture.2011.10.018; Sakudo A, 2016, INT J NANOMED, V11, P1847, DOI 10.2147/IJN.S104926; Sakudo A, 2012, INT J MOL MED, V30, P437, DOI 10.3892/ijmm.2012.1009; Sakudo A, 2012, INT J MOL MED, V30, P3, DOI 10.3892/ijmm.2012.962; Sakudo A, 2011, INT J MOL MED, V28, P625, DOI 10.3892/ijmm.2011.733; Sakudo A, 2009, BIOORG MED CHEM LETT, V19, P4488, DOI 10.1016/j.bmcl.2009.05.127; Sakudo A, 2009, BIOORGAN MED CHEM, V17, P752, DOI 10.1016/j.bmc.2008.11.046; Sauvage C, 2009, VIRUS RES, V142, P181, DOI 10.1016/j.virusres.2009.02.013; Schikorski D, 2011, VIRUS RES, V155, P28, DOI 10.1016/j.virusres.2010.07.031; Schikorski D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-27; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Segarra A, 2014, J INVERTEBR PATHOL, V119, P5, DOI 10.1016/j.jip.2014.03.002; Webb SC, 2007, AQUACULTURE, V272, P126, DOI 10.1016/j.aquaculture.2007.07.224; Yonchevai K, 2008, J MICROENCAPSUL, V25, P82, DOI [10.1080/02652040701776083, 10.1080/02652040701776083 ]	38	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205207	10.1371/journal.pone.0205207	http://dx.doi.org/10.1371/journal.pone.0205207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281676	Green Submitted, gold, Green Published			2022-12-27	WOS:000446342400087
J	Wang, SH; Chien, WC; Chung, CH; Wang, YC; Lin, LC; Pan, RY				Wang, Sheng-Hao; Chien, Wu-Chien; Chung, Chi-Hsiang; Wang, Yung-Chih; Lin, Leou-Chyr; Pan, Ru-Yu			Long-term results of posterior cruciate ligament tear with or without reconstruction: A nationwide, population-based cohort study	PLOS ONE			English	Article							10-YEAR FOLLOW-UP; ARTHROSCOPIC EVALUATION; NONOPERATIVE TREATMENT; ISCHEMIC-STROKE; DEFICIENT KNEE; INJURIES; ASSOCIATION; OUTCOMES; TAIWAN; OSTEOARTHRITIS	Background There is increasing interest in the long-term outcomes of patients with posterior cruciate ligament (PCL) tears following conservative treatment or reconstruction. However, limited information is available regarding these results because of the relative rarity of cases and lack of long-term follow-up. Purpose The goals of this study are to (1) compare the occurrence of secondary meniscal tears, osteoarthritis (OA) or subsequent total knee replacement (TKR) in patients with or without PCL injury, and (2) evaluate the potential protective effect of PCL reconstruction against longterm sequela in patients with PCL deficiency. Study design Cohort study; Level of evidence, 3 Methods This retrospective cohort study evaluated the long-term results of PCL deficiency with or without reconstruction in Taiwan based on data from the National Health Insurance Research Database (NHIRD) from 2000 to 2015. The cumulative incidence rates of meniscus tear, OA and TKR were analyzed using the Kaplan-Meier estimator. Cox proportional hazards models were applied to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results A total of 4,169 patients diagnosed with PCL tear from 2000 to 2015 in Taiwan were included in the study. There was a higher cumulative incidence of meniscus tear (1.13%), OA (2.71%) and subsequent TKR (0.91%) among patients with a PCL tear than among patients without one (0.22%, 1.90%, 0.62%; all p < 0.05). PCL reconstruction patients had a decreased cumulative incidence of meniscus tear (0.41%), OA (2.30%) and subsequent TKR (0.48%) compared with non-reconstructed patients (2.44%, 3.46%, 1.69%; all p < 0.05). After adjusting for covariates, PCL-injured patients who underwent reconstruction within one year after PCL injury showed a significantly lower risk of subsequent sequelae than those who never underwent reconstruction (within 1 month: adjusted HR = 0.390, 95% CI = 0.284-0.535; 1 month to 1 year: adjusted HR = 0.546, 95% CI = 0.398-0.748). Conclusions Patients with PCL tears have a significantly higher risk of meniscus tear, OA and subsequent TKR than patients without PCL tears. PCL reconstruction could decrease the cumulative incidence of these outcomes. The results suggest that PCL-injured patients should undergo reconstruction as early as possible (within one year) to reduce the risk of further degeneration.	[Wang, Sheng-Hao; Lin, Leou-Chyr; Pan, Ru-Yu] Triserv Gen Hosp, Natl Def Med Ctr, Dept Orthopaed, Taipei, Taiwan; [Wang, Sheng-Hao; Pan, Ru-Yu] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Wang, Yung-Chih] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Pan, RY (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Orthopaed, Taipei, Taiwan.; Pan, RY (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	chienwu@mail.ndmctsgh.edu.tw; m86010460@ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Wang, Yung-Chih/ABE-9069-2020	Wang, Yung-Chih/0000-0002-8491-8972; Pan, Ru-Yu/0000-0001-9577-820X	Tri-Service General Hospital Research Foundation [TSGHATSGH- C107-080]	Tri-Service General Hospital Research Foundation	This study was funded by Tri-Service General Hospital Research Foundation (TSGHATSGH- C107-080). The funder has no role in the design, concept, data collection and interpretation, analysis, drafting or other process in this paper.	Ahn JH, 2006, AM J SPORT MED, V34, P194, DOI 10.1177/0363546505279915; Aroen A, 2013, KNEE SURG SPORT TR A, V21, P1017, DOI 10.1007/s00167-012-2132-1; Bedi A, 2016, J AM ACAD ORTHOP SUR, V24, P277, DOI 10.5435/JAAOS-D-14-00326; Boynton MD, 1996, AM J SPORT MED, V24, P306, DOI 10.1177/036354659602400310; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Christel P, 2003, KNEE SURG SPORT TR A, V11, P289, DOI 10.1007/s00167-003-0407-2; Cosgarea A J, 2001, J Am Acad Orthop Surg, V9, P297; DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334; FANELLI GC, 1994, ARTHROSCOPY, V10, P673, DOI 10.1016/S0749-8063(05)80067-2; FOWLER PJ, 1987, AM J SPORT MED, V15, P553, DOI 10.1177/036354658701500606; GEISSLER WB, 1993, AM J SPORT MED, V21, P846, DOI 10.1177/036354659302100615; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Granan Lars-Petter, 2004, Tidsskr Nor Laegeforen, V124, P928; Hamada M, 2000, ARTHROSCOPY, V16, P59, DOI 10.1016/S0749-8063(00)90128-2; Hammoud S, 2010, SPORTS MED ARTHROSC, V18, P280, DOI 10.1097/JSA.0b013e3181eaf8b4; Hermans S, 2009, AM J SPORT MED, V37, P1499, DOI 10.1177/0363546509333479; Hewett TE, 1997, AM J SPORT MED, V25, P648, DOI 10.1177/036354659702500510; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Huang YJ, 2017, J THORAC ONCOL, V12, P782, DOI 10.1016/j.jtho.2017.01.021; HUGHSTON JC, 1982, CLIN ORTHOP RELAT R, P59; Jackson WFM, 2008, J BONE JOINT SURG BR, V90B, P1328, DOI 10.1302/0301-620X.90B10.20517; Jung YB, 2008, KNEE SURG SPORT TR A, V16, P729, DOI 10.1007/s00167-008-0531-0; KELLER PM, 1993, AM J SPORT MED, V21, P132, DOI 10.1177/036354659302100122; LaPrade CM, 2015, AM J SPORT MED, V43, P3077, DOI 10.1177/0363546515572770; Lin CL, 2017, J HUM HYPERTENS, V31, P220, DOI 10.1038/jhh.2016.55; Logan M, 2004, AM J SPORT MED, V32, P1915, DOI 10.1177/0363546504265005; Majewski M, 2006, KNEE, V13, P184, DOI 10.1016/j.knee.2006.01.005; Okazaki K, 2015, KNEE SURG SPORT TR A, V23, P3094, DOI 10.1007/s00167-014-3469-4; PAROLIE JM, 1986, AM J SPORT MED, V14, P35, DOI 10.1177/036354658601400107; Patel Dipak V, 2007, HSS J, V3, P137, DOI 10.1007/s11420-007-9058-z; Pearsall AW, 2004, AM J SPORT MED, V32, P1675, DOI 10.1177/0363546504265937; Sanders TL, 2017, KNEE SURG SPORT TR A, V25, P3017, DOI 10.1007/s00167-016-4052-y; Schulz MS, 2003, ARCH ORTHOP TRAUM SU, V123, P186, DOI 10.1007/s00402-002-0471-y; Sekiya JK, 2005, ARTHROSCOPY, V21, P1042, DOI 10.1016/j.arthro.2005.05.023; Shelbourne KD, 2013, AM J SPORT MED, V41, P1526, DOI 10.1177/0363546513486771; Shelbourne KD, 2005, ARTHROSCOPY, V21, P457, DOI 10.1016/j.arthro.2004.11.013; Shelbourne KD, 1999, AM J SPORT MED, V27, P276, DOI 10.1177/03635465990270030201; SHINO K, 1995, J BONE JOINT SURG BR, V77B, P895, DOI 10.1302/0301-620X.77B6.7593102; SKYHAR MJ, 1993, J BONE JOINT SURG AM, V75A, P694, DOI 10.2106/00004623-199305000-00008; Strobel MJ, 2003, ARTHROSCOPY, V19, P262, DOI 10.1053/jars.2003.50037; Van de Velde SK, 2009, J BONE JOINT SURG AM, V91A, P167, DOI [10.2106/JBJS.H.01382, 10.2106/JBJS.H.00177]; Voos JE, 2012, AM J SPORT MED, V40, P222, DOI 10.1177/0363546511416316; Watsend AME, 2009, KNEE SURG SPORT TR A, V17, P140, DOI 10.1007/s00167-008-0632-9; Wind WM, 2004, AM J SPORT MED, V32, P1765, DOI 10.1177/0363546504270481	45	17	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205118	10.1371/journal.pone.0205118	http://dx.doi.org/10.1371/journal.pone.0205118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281658	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400084
J	Acedo-Carmona, C; Munar, E; Gomila, A				Acedo-Carmona, Cristina; Munar, Enric; Gomila, Antoni			Trust-based altruism facing new contexts: The Vyegwa-Gika pygmies from Burundi	PLOS ONE			English	Article							INTERPERSONAL-TRUST; SOCIAL-STRUCTURE; EVOLUTION; COOPERATION; RECIPROCITY; PUNISHMENT; CENTRALITY; SOCIETIES; DIVERSITY; HUMANS	The community of Pygmies settled in Vyegwa-Gika provides an exceptional case study to test the role of trust in the evolution of altruism. The Vyegwa-Gika Pygmies were forced to migrate from rainforests to the savanna, changing quickly their environment, culture, and socio-economic situation. Despite the high level of poverty they suffer in this new settlement, we found evidence of strong altruistic attitudes toward trustees when playing an economic game. In addition, Vyegwa-Gika Pygmies keep small personal trust networks despite the fact they share frequent social interactions within the community. These results indicate the great effectiveness of personal trust in fostering altruism, even if the circumstances make it difficult to establish such kind of affective bonds. A theory of the evolution of altruism should therefore also account for the evolution of psychology of trust, as a key element in the process.	[Acedo-Carmona, Cristina; Munar, Enric; Gomila, Antoni] Univ Balearic Isl, Human Evolut & Cognit Grp EvoCog, IFISC, Associated Unit,CSIC, Cra Valldemossa, Palma De Mallorca, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Acedo-Carmona, C (corresponding author), Univ Balearic Isl, Human Evolut & Cognit Grp EvoCog, IFISC, Associated Unit,CSIC, Cra Valldemossa, Palma De Mallorca, Balearic Island, Spain.	cacedo33@hotmail.com	Munar, Enric/AAK-4175-2021; Gomila, Antoni/I-1342-2012; Munar, Enric/C-7397-2011; Carmona, Cristina Flores Acedo/AAA-4808-2019	Munar, Enric/0000-0001-7330-8389; Acedo-Carmona, Cristina/0000-0001-5615-156X	Ministerio de Ciencia e Innovacion [FFI2010-20759, FFI2013-44007-P]; FPU Fellowship [AP2009-3369]; Ministerio de Educacion, Cultura y Deporte	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FPU Fellowship(Spanish Government); Ministerio de Educacion, Cultura y Deporte(Spanish Government)	Funded by Projects FFI2010-20759 and FFI2013-44007-P. Ministerio de Ciencia e Innovacion (ES). http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid=9fc8603368ce2210VgnVCM1000001d04140aRCRD. FPU Fellowship AP2009-3369. Ministerio de Educacion, Cultura y Deporte (ES). https://www.mecd.gob.es/portada-mecd/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo C, 2013, ANN NY ACAD SCI, V1299, P77, DOI 10.1111/nyas.12142; Acedo-Carmona C., 2012, ASIAN C PSYCHOL BEHA, V5, P492; Acedo-Carmona C, 2015, SPAN J PSYCHOL, V18, DOI 10.1017/sjp.2015.102; Acedo-Carmona C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00661; Acedo-Carmona C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105559; Andreoni J., 2006, HDB EC GIVING ALTRUI, P1201, DOI [10.1016/s1574-0714(06)02018-5, DOI 10.1016/S1574-0714(06)02018-5]; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bambanze V, 2011, RIGHTS SENSITIVE E A; Bastian M., 2009, ICWSM, V3, P361, DOI 10.13140/2.1.1341.1520; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Benzi M, 2013, MATRIX ANAL DIFFEREN; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Chaudhary N, 2016, SCI REP-UK, V6, DOI 10.1038/srep29120; Chretien J P, 1988, HIST AFR, V15, P407; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P162; Daley P, 2006, POLIT GEOGR, V25, P657, DOI 10.1016/j.polgeo.2006.05.007; DALY M, 1988, SCIENCE, V242, P519, DOI 10.1126/science.3175672; De Vries MFRK, 1999, ORGAN DYN, V27, P66, DOI 10.1016/S0090-2616(99)90022-0; Dennison G, 1989, WORLD DIRECTORY COUN, P2; Diestel R., 2015, GRAPH THEORY; Dunbar RIM, 2009, ANN HUM BIOL, V36, P562, DOI 10.1080/03014460902960289; Dyble M, 2015, SCIENCE, V348, P796, DOI 10.1126/science.aaa5139; Dyble M, 2016, CURR BIOL, V26, P2017, DOI 10.1016/j.cub.2016.05.064; Fauna & Flora International, 2013, BATW CULT VAL BWIND; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; Garza P, 2012, PHYSICA A, V391, P849; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Kleinberg J, 1999, ACM COMPUT SURV, V31, P4; Lewis J, 2000, BATWA PYGMIES GREAT; Majamba H, 2011, RIGHTS SENSITIVE E A; Musinguzi B, 2010, NEW AFRICAN, V497, P38; Mworoha E, 1987, HIST BURUNDI ORIGINS; Newbury D, 2001, INT J AFR HIST STUD, V34, P255, DOI 10.2307/3097483; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ntahombaye P, 2007, AFR J CONFL RESOLUT, V7, P239, DOI 10.4314/ajcr.v7i2.39417; Poole P, 2003, CULTURAL MAPPING IND; Richerson P, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X1400106X; Salali GD, 2017, NATURE HUMAN BEHAV, V1, P1; Schotter A, 2003, AM ECON REV, V93, P196, DOI 10.1257/000282803321947047; SILK JB, 1980, AM ANTHROPOL, V82, P799, DOI 10.1525/aa.1980.82.4.02a00050; Smith D, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160131; Sober E., 1998, OTHERS EVOLUTION PSY; Stiller J, 2007, SOC NETWORKS, V29, P93, DOI 10.1016/j.socnet.2006.04.001; Stolle D, 2008, POLIT STUD-LONDON, V56, P57, DOI 10.1111/j.1467-9248.2007.00717.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; WOODBURN J, 1982, MAN, V17, P431, DOI 10.2307/2801707; Wu WL, 2009, SOC BEHAV PERSONAL, V37, P83, DOI 10.2224/sbp.2009.37.1.83; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	56	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204321	10.1371/journal.pone.0204321	http://dx.doi.org/10.1371/journal.pone.0204321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273385	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700018
J	Li, J; Duan, R; Zhang, YY; Zhao, X; Cheng, YX; Chen, YX; Yuan, JG; Li, H; Zhang, JP; Chu, L; Xia, DY; Zhao, SM				Li, Jun; Duan, Ran; Zhang, Yingying; Zhao, Xin; Cheng, Yanxin; Chen, Yongxue; Yuan, Jinge; Li, Hong; Zhang, Jianping; Chu, Li; Xia, Dengyun; Zhao, Senming			Beta-adrenergic activation induces cardiac collapse by aggravating cardiomyocyte contractile dysfunction in bupivacaine intoxication	PLOS ONE			English	Article							STANDARD-DOSE EPINEPHRINE; CARDIORESPIRATORY RESPONSE; INTRAVENOUS BUPIVACAINE; ROPIVACAINE; RESUSCITATION; ARREST; DEPRESSION; TOXICITY; RATS; DOGS	In order to determine the role of the adrenergic system in bupivacaine-induced cardiotoxicity, a series of experiments were performed. In an animal experiment, male Sprague-Dawley (SD) rats under chloral hydrate anesthesia received intravenous bupivacaine, followed by an intravenous injection of adrenalin or isoprenalin, and the electrocardiogram (ECG), left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), the maximum rate of rise of left ventricular pressure (+dP/dtmax) and the maximum rate of pressure decrease (-dP/dtmax) were continually monitored. In a cellular experiment, freshly isolated adult SD rat ventricular myocytes were perfused with bupivacaine at different concentrations in the presence or absence of isoprenalin, with or without esmolol. The percentage of the sarcomere shortening (bl% peak h), departure velocity (dep v) of sarcomere shortening and time to 50% of the peak speed of myocyte contraction (Tp50) was assessed by a video-based edge-detection system. In an additional experiment, Swiss mice pretreated with saline, isoprenalin, esmolol or dexmedetomidine received bupivacaine to determine the 50% lethal dose (LD50) of bupivacaine. Electron microscopy of myocardial mitochondria was performed to assess damage of these structures. To test mitochondrial reactive oxygen species (ROS) production, freshly isolated SD rat ventricular myocytes were incubated with bupivacaine in the presence of isoprenalin, with or without esmolol. First, our results showed that bupivacaine significantly reduced the LVSP and +dP/dtmax, as well as enhanced the LVEDP and -dP/dtmax (P < 0.05, vs. control, and vs. baseline). Adrenalin and isoprenalin induced a further reduction of LVSP and +dP/dtmax (P < 0.05, vs. before adrenalin or isoprenalin delivery, and vs. control). Second, bupivacaine induced a dose-dependent cardiomyocyte contractile depression. While 5.9 mu mol/L or 8.9 mu mol/L of bupivacaine resulted in no change, 30.0 mu mol/L of bupivacaine prolonged the Tp50 and reduced the bl% peak h and dep v (P < 0.05, vs. control and vs. baseline). Isoprenalin aggravated the bupivacaine-induced cardiomyocyte contractile depression, significantly prolonging the Tp50 (P < 0.05, vs. bupivacaine alone) and reducing the dep v (P < 0.05, vs. bupivacaine alone). Third, esmolol and dexmedetomidine significantly enhanced, while isoprenalin significantly reduced, the LD50 of bupivacaine in mice. Fourth, bupivacaine led to significant mitochondrial swelling, and the extent of myocardial mitochondrial swelling in isoprenalin-pretreated mice was significantly higher than that compared with mice pretreated with saline, as reflected by the higher mitochondrial damage score (P< 0.01). Meanwhile, esmolol pretreatment significantly reduced the mitochondrial damage score (P < 0.01). Fifth, bupivacaine significantly increased the ROS in freshly isolated cardiomyocytes, and added isoprenalin induced a further enhancement of ROS production (P< 0.05, vs. bupivacaine alone). Added esmolol significantly decreased ROS production (P < 0.05, vs. bupivacaine + isoprenalin). Our results suggest that bupivacaine depressed cardiac automaticity, conductivity and contractility, but the predominant effect was contractile dysfunction which resulted from the disruption of mitochondrial energy metabolism. beta-adrenergic activation aggravated the cellular metabolism disorder and therefore contractile dysfunction.	[Li, Jun; Duan, Ran; Cheng, Yanxin; Li, Hong; Zhao, Senming] Hebei Med Univ, Pain Med Ctr, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yingying; Xia, Dengyun] Hebei North Univ, Dept Anesthesiol, Zhangjiakou, Hebei, Peoples R China; [Zhao, Xin] Hebei Med Univ, Hepatopathy Dept, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Chen, Yongxue; Yuan, Jinge] Handan Ctr Hosp, Dept Anesthesiol, Handan, Hebei, Peoples R China; [Zhang, Jianping; Chu, Li] Hebei Univ Chinese Med, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei North University; Hebei Medical University; Hebei University of Chinese Medicine	Zhao, SM (corresponding author), Hebei Med Univ, Pain Med Ctr, Hosp 3, Shijiazhuang, Hebei, Peoples R China.	senming63@163.com						Ali B, 2007, ANN INTERN MED, V147, P171, DOI 10.7326/0003-4819-147-3-200708070-00006; Berg RA, 1996, CRIT CARE MED, V24, P1695, DOI 10.1097/00003246-199610000-00016; BERG RA, 1994, CRIT CARE MED, V22, P282, DOI 10.1097/00003246-199402000-00020; BERNARDS CM, 1989, ANESTHESIOLOGY, V71, P711, DOI 10.1097/00000542-198911000-00014; BERNARDS CM, 1991, ANESTHESIOLOGY, V74, P89, DOI 10.1097/00000542-199101000-00015; Cela O, 2010, MITOCHONDRION, V10, P487, DOI 10.1016/j.mito.2010.05.005; Cho HS, 2000, ANESTH ANALG, V91, P1096, DOI 10.1097/00000539-200011000-00010; CLARKSON CW, 1985, ANESTHESIOLOGY, V62, P396, DOI 10.1097/00000542-198504000-00006; El-Tantawy WH, 2014, J PHYSIOL BIOCHEM, V70, P33, DOI 10.1007/s13105-013-0277-0; ELEDJAM JJ, 1989, ANESTH ANALG, V69, P732; Groban L, 2001, ANESTH ANALG, V92, P37; HASSELSTROM LJ, 1984, ANESTH ANALG, V63, P1053; HEAVNER JE, 1995, ANESTH ANALG, V80, P1134, DOI 10.1097/00000539-199506000-00011; Hiller N, 2013, ANESTH ANALG, V116, P83, DOI 10.1213/ANE.0b013e31826c8095; Huske C, 2016, BRAIN RES, V1642, P364, DOI 10.1016/j.brainres.2016.04.019; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Joshi MS, 2000, ANAL CELL PATHOL, V21, P41, DOI 10.1155/2000/201406; KINNEY WW, 1991, CAN J ANAESTH, V38, P533, DOI 10.1007/BF03007595; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; Kulier AH, 1996, ANESTH ANALG, V83, P62, DOI 10.1097/00000539-199607000-00011; Mather LE, 2001, DRUGS, V61, P333, DOI 10.2165/00003495-200161030-00002; Mikusova A, 2009, CAN J PHYSIOL PHARM, V87, P641, DOI [10.1139/Y09-053, 10.1139/y09-053]; ORSER B, 1992, CAN J ANAESTH, V39, P407, DOI 10.1007/BF03009066; Reinikainen M, 2003, ACTA ANAESTH SCAND, V47, P904, DOI 10.1034/j.1399-6576.2003.00188.x; Sandberg KL, 2013, ACTA PAEDIATR, V102, P391, DOI 10.1111/apa.12151; Schwoerer AP, 2015, ANESTH ANALG, V120, P1226, DOI 10.1213/ANE.0000000000000646; Sztark F, 1998, ANESTHESIOLOGY, V88, P1340, DOI 10.1097/00000542-199805000-00026; TAKAHASHI S, 1994, PHARMACOL TOXICOL, V75, P119, DOI 10.1111/j.1600-0773.1994.tb00334.x; Vandycke C, 2000, RESUSCITATION, V45, P161, DOI 10.1016/S0300-9572(00)00188-X; Yu XQ, 1996, BIOL NEONATE, V69, P146, DOI 10.1159/000244290	30	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203602	10.1371/journal.pone.0203602	http://dx.doi.org/10.1371/journal.pone.0203602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273351	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700007
J	Alemao, E; Al, MJ; Boonen, AA; Stevenson, MD; Verstappen, SMM; Michaud, K; Weinblatt, ME; Rutten-van Molken, MPMH				Alemao, Evo; Al, Maiwenn J.; Boonen, Annelies A.; Stevenson, Matthew D.; Verstappen, Suzanne M. M.; Michaud, Kaleb; Weinblatt, Michael E.; Rutten-van Molken, Maureen P. M. H.			Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis	PLOS ONE			English	Article							COLLEGE-OF-RHEUMATOLOGY; RAPID RADIOGRAPHIC PROGRESSION; MODIFYING ANTIRHEUMATIC DRUGS; COST-EFFECTIVENESS ANALYSIS; DISEASE-ACTIVITY; AMERICAN-COLLEGE; TREATMENT STRATEGIES; EXTRAARTICULAR MANIFESTATIONS; METHOTREXATE MONOTHERAPY; SERIOUS INFECTIONS	The objective of this study was to evaluate current approaches to economic modeling in rheumatoid arthritis (RA) and propose a new conceptual model for evaluation of the cost-effectiveness of RA interventions. We followed recommendations from the International Society of Pharmacoeconomics and Outcomes Research-Society of Medical Decision Making (ISPOR-SMDM) Modeling Good Research Practices Task Force-2. The process involved scoping the decision problem by a working group and drafting a preliminary cost-effectiveness model framework. A systematic literature review (SLR) of existing decision-analytic models was performed and analysis of an RA registry was conducted to inform the structure of the draft conceptual model. Finally, an expert panel was convened to seek input on the draft conceptual model. The proposed conceptual model consists of three separate modules: 1) patient characteristic module, 2) treatment module, and 3) outcome module. Consistent with the scope, the conceptual model proposed six changes to current economic models in RA. These changes proposed are to: 1) use composite measures of disease activity to evaluate treatment response as well as disease progression (at least two measures should be considered, one as the base case and one as a sensitivity analysis); 2) conduct utility mapping based on disease activity measures; 3) incorporate subgroups based on guideline-recommended prognostic factors; 4) integrate realistic treatment patterns based on clinical practice/registry datasets; 5) assimilate outcomes that are not joint related (extra-articular outcomes); and 6) assess mortality based on disease activity. We proposed a conceptual model that incorporates the current understanding of clinical and real-world evidence in RA, as well as of existing modeling assumptions. The proposed model framework was reviewed with experts and could serve as a foundation for developing future cost-effectiveness models in RA.	[Alemao, Evo] BMS, Worldwide Hlth Econ & Outcomes Res, Lawrence, NJ 08648 USA; [Alemao, Evo] Erasmus Univ, Rotterdam, Netherlands; [Al, Maiwenn J.; Rutten-van Molken, Maureen P. M. H.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Boonen, Annelies A.] Maastricht Univ, Med Ctr, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands; [Stevenson, Matthew D.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Verstappen, Suzanne M. M.] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol,Ctr Musculoskeletal, Manchester, Lancs, England; [Michaud, Kaleb] Univ Nebraska Med Ctr, Dept Rheumatol & Immunol, Omaha, NE USA; [Weinblatt, Michael E.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Rutten-van Molken, Maureen P. M. H.] Erasmus Univ, iMTA, Rotterdam, Netherlands; [Boonen, Annelies A.] Maastricht Univ, Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Verstappen, Suzanne M. M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	Erasmus University Rotterdam; Erasmus University Rotterdam; Maastricht University; University of Sheffield; University of Manchester; University of Nebraska System; University of Nebraska Medical Center; Harvard University; Brigham & Women's Hospital; Erasmus University Rotterdam; Maastricht University; Maastricht University Medical Centre (MUMC); University of Manchester	Alemao, E (corresponding author), BMS, Worldwide Hlth Econ & Outcomes Res, Lawrence, NJ 08648 USA.; Alemao, E (corresponding author), Erasmus Univ, Rotterdam, Netherlands.	evo.alemao@bms.com	Molken, Maureen PMH Rutten-van/G-8481-2014; Molken, Maureen Rutten-van/X-8712-2019	Molken, Maureen PMH Rutten-van/0000-0001-8706-3159; Molken, Maureen Rutten-van/0000-0001-8706-3159; , Matt/0000-0002-3099-9877				Alava MH, 2013, RHEUMATOLOGY, V52, P944, DOI 10.1093/rheumatology/kes400; Alemao E, 2018, SEMIN ARTHRITIS RHEU, V47, P630, DOI 10.1016/j.semarthrit.2017.10.009; Alemao E, 2018, VALUE HEALTH, V21, P193, DOI 10.1016/j.jval.2017.05.020; Alemao E, 2017, RHEUMATOLOGY, V56, P777, DOI 10.1093/rheumatology/kew440; Alemao E, 2016, RHEUMATOLOGY, V55, P809, DOI 10.1093/rheumatology/kev427; Alemao E, 2016, ARTHRIT CARE RES, V68, P308, DOI 10.1002/acr.22678; Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Allison P.D., 2005, FIXED EFFECTS REGRES; Barnabe C, 2011, ARTHRIT CARE RES, V63, P522, DOI 10.1002/acr.20371; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brennan A, 2007, RHEUMATOLOGY, V46, P1345, DOI 10.1093/rheumatology/kem115; Bruce B, 2003, J RHEUMATOL, V30, P167; Davies A, 2009, J RHEUMATOL, V36, P16, DOI 10.3899/jrheum.080257; de Jong PHP, 2016, RHEUMATOLOGY, V55, P2138, DOI 10.1093/rheumatology/kew321; Emery P, 2015, ANN RHEUM DIS, V74, P19, DOI 10.1136/annrheumdis-2014-206106; Eriksson JK, 2015, ANN RHEUM DIS, V74, P1094, DOI 10.1136/annrheumdis-2013-205060; Feldmann M, 2015, ARTHRITIS RHEUMATOL, V67, P2283, DOI 10.1002/art.39269; Felson D, 2007, ARTHRIT RHEUM-ARTHR, V57, P193, DOI 10.1002/art.22552; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Finckh A, 2009, ANN INTERN MED, V151, P612, DOI 10.7326/0003-4819-151-9-200911030-00006; Gaujoux-Viala C, 2012, JOINT BONE SPINE, V79, P149, DOI 10.1016/j.jbspin.2011.04.008; Geryk LL, 2015, CLIN EXP RHEUMATOL, V33, P366; Gibson L, 2018, PROGR DIS PEOPLE RHE; Gissel C, 2016, Z RHEUMATOL, V75, P1006, DOI 10.1007/s00393-016-0071-9; Gottenberg JE, 2016, ARTHRITIS RHEUMATOL, V68, P1346, DOI 10.1002/art.39595; Hallinen TA, 2010, RHEUMATOLOGY, V49, P767, DOI 10.1093/rheumatology/kep425; Harrold LR, 2016, ANN RHEUM DIS, V75, P505, DOI 10.1136/annrheumdis-2016-eular.1514; Hochberg MC, 2008, CURR MED RES OPIN, V24, P469, DOI [10.1185/030079908X261177, 10.1185/030079908X261177 ]; Jonsson B, 2008, EUR J HEALTH ECON, V8, pS61, DOI 10.1007/s10198-007-0089-7; Kang EH, 2017, ANN RHEUM DIS, V76, P802, DOI 10.1136/annrheumdis-2017-eular.2407; Kelly CA, 2014, RHEUMATOLOGY, V53, P1676, DOI 10.1093/rheumatology/keu165; Kielhorn A, 2008, CURR MED RES OPIN, V24, P2639, DOI [10.1185/03007990802321683, 10.1185/03007990802321683 ]; Kievit W, 2016, ANN RHEUM DIS, V75, P1939, DOI 10.1136/annrheumdis-2015-208317; Kirchhoff T, 2011, RHEUMATOLOGY, V50, P756, DOI 10.1093/rheumatology/keq398; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P1815, DOI 10.1136/ard.2010.149260; Kobelt G, 1999, ARTHRITIS RHEUM-US, V42, P347, DOI 10.1002/1529-0131(199902)42:2<347::AID-ANR18>3.0.CO;2-P; Kobelt G, 2003, RHEUMATOLOGY, V42, P326, DOI 10.1093/rheumatology/keg107; Kobelt G, 2009, SCAND J RHEUMATOL, V38, P409, DOI 10.3109/03009740902865464; Kobelt G, 2011, INT J TECHNOL ASSESS, V27, P193, DOI 10.1017/S0266462311000195; Kubo S, 2016, ANN RHEUM DIS, V75, P1321, DOI 10.1136/annrheumdis-2015-207784; Lekander I, 2010, INT J TECHNOL ASSESS, V26, P54, DOI 10.1017/S0266462309990596; Madan J, 2015, RHEUMATOL THER, V2, P113, DOI 10.1007/s40744-015-0020-0; Manders SHM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0630-5; Meissner Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1077-z; Mennini FS, 2017, CLIN DRUG INVEST, V37, P375, DOI 10.1007/s40261-016-0491-y; Merkesdal S, 2010, EUR J HEALTH ECON, V11, P95, DOI 10.1007/s10198-009-0205-y; Michaud K, 2003, ARTHRITIS RHEUM-US, V48, P2750, DOI 10.1002/art.11439; Moghadam MG, 2016, ARTHRITIS RHEUMATOL, V68, P1810, DOI 10.1002/art.39626; Nam JL, 2017, ANN RHEUM DIS, V76, P1108, DOI 10.1136/annrheumdis-2016-210713; Nikiphorou E, 2012, RHEUMATOLOGY, V51, P385, DOI 10.1093/rheumatology/ker401; Ollendorf Daniel A, 2005, J Manag Care Pharm, V11, P383; Ollendorf DA, 2009, CLIN THER, V31, P825, DOI 10.1016/j.clinthera.2009.04.002; Prete M, 2011, AUTOIMMUN REV, V11, P123, DOI 10.1016/j.autrev.2011.09.001; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Putrik P, 2014, ANN RHEUM DIS, V73, P198, DOI 10.1136/annrheumdis-2012-202603; Roberts M, 2012, MED DECIS MAKING, V32, P678, DOI [10.1177/0272989X12454941, 10.1016/j.jval.2012.06.016]; Russell A, 2009, CLIN RHEUMATOL, V28, P403, DOI 10.1007/s10067-008-1060-4; Ruyssen-Witrand A, 2010, JOINT BONE SPINE, V77, P246, DOI 10.1016/j.jbspin.2010.02.009; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Saraux A, 2010, RHEUMATOLOGY, V49, P733, DOI 10.1093/rheumatology/kep434; Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201; Schipper LG, 2011, RHEUMATOLOGY, V50, P1320, DOI 10.1093/rheumatology/ker084; Schoels M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1346-5; Scholz S, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0018-2; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Silman A., 2001, EPIDEMIOLOGY RHEUMAT, V2nd; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2017-211455; Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; Spalding JR, 2006, PHARMACOECONOMICS, V24, P1221, DOI 10.2165/00019053-200624120-00006; Stephens S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006560; Stevenson MD, 2017, J RHEUMATOL, V44, P973, DOI 10.3899/jrheum.160941; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Tanaka E, 2015, MOD RHEUMATOL, V25, P503, DOI 10.3109/14397595.2014.1001475; Tanno Makoto, 2006, Mod Rheumatol, V16, P77; Taylor PC, 2015, ARTHRITIS RHEUMATOL, V67, P14, DOI 10.1002/art.38893; Turesson C, 2006, ANN RHEUM DIS, V65, P1533, DOI 10.1136/ard.2006.052803; Uhlig T, 2007, J RHEUMATOL, V34, P1241; Valle-Mercado C, 2013, RHEUMATOL INT, V33, P2993, DOI 10.1007/s00296-013-2834-9; van den Hoek J, 2017, RHEUMATOL INT, V37, P487, DOI 10.1007/s00296-016-3638-5; van Haalen HGM, 2014, PHARMACOECONOMICS, V32, P429, DOI 10.1007/s40273-014-0139-9; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Vastesaeger N, 2009, RHEUMATOLOGY, V48, P1114, DOI 10.1093/rheumatology/kep155; Vencovsky J, 2003, ANN RHEUM DIS, V62, P427, DOI 10.1136/ard.62.5.427; Vera-Llonch M, 2008, J RHEUMATOL, V35, P1745; Verhoef LM, 2017, RHEUMATOL THER, V4, P1, DOI 10.1007/s40744-017-0055-5; Vermeer M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-350; Visser K, 2010, ANN RHEUM DIS, V69, P1333, DOI 10.1136/ard.2009.121160; Wailoo AJ, 2008, ARTHRITIS RHEUM-US, V58, P939, DOI 10.1002/art.23374; Widdifield J, 2013, ARTHRIT CARE RES, V65, P353, DOI 10.1002/acr.21812; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yuan Yong, 2010, J Med Econ, V13, P33, DOI 10.3111/13696990903508021	93	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205013	10.1371/journal.pone.0205013	http://dx.doi.org/10.1371/journal.pone.0205013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289926	Green Published, gold, Green Accepted			2022-12-27	WOS:000446545500039
J	Naha, D; Sathyakumar, S; Rawat, GS				Naha, Dipanjan; Sathyakumar, S.; Rawat, G. S.			Understanding drivers of human-leopard conflicts in the Indian Himalayan region: Spatio-temporal patterns of conflicts and perception of local communities towards conserving large carnivores	PLOS ONE			English	Article								Human killing is the decisive and most critical expression of human-leopard conflict and needs to be addressed sensitively to maintain local support for leopard conservation in India. This research was undertaken to investigate the ecological aspects of human killing and injury, spatial characteristic and pattern of such sites, temporal and seasonal trends of attacks and perception of local communities towards leopard in the Indian Himalayan region (IHR). We surveyed two sites i) Pauri Garhwal in the western part and ii) North Bengal (Dooars) in the eastern part of IHR, compiled secondary data on human-leopard conflict records and made field visits to (N = 101) conflict sites. We also conducted (N = 186) semi-structured questionnaire surveys in each of the sites to assess perception of local communities towards leopard. We analyzed the conflict data using rare events model in a binary logistic regression framework to understand spatial patterns of such incidents for Pauri Garhwal and North Bengal. The average number of injuries and deaths to leopard attacks in Pauri was estimated to be 11 (SE 1.13) and 3 (SE 0.6) per year between 2006-2016 whereas in North Bengal it was estimated to be 70 (SE 9.2) and 1.6 (SE 0.3) respectively between 2004-2016. About 97% of the leopard attacks in North Bengal and 60% of the leopard attacks in Pauri resulted in human injuries. Majority of the leopard attack victims in Pauri were children and young people, whereas in North Bengal it was middle aged tea estate workers. Attack on humans in Pauri were recorded mostly near areas with dense scrub cover whereas in North Bengal it was reported within tea-estates. The percentage of human deaths to leopard attacks in Pauri were higher (40%) compared to a mere (3%) in North Bengal. Forty-one percent of respondents in Pauri and 75% in North Bengal were positive towards presence and conservation of leopard. A predictive risk map revealed central and northern regions of Pauri Garhwal and protected areas, peripheral areas in central and south-western dooars (North Bengal) as high "human-leopard conflict risk zones". This analytical procedure can be adopted in other sites to identify potential human-carnivore conflict risk zones.	[Naha, Dipanjan; Sathyakumar, S.] Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India; [Rawat, G. S.] Wildlife Inst India, Dehra Dun, Uttarakhand, India	Wildlife Institute of India; Wildlife Institute of India	Sathyakumar, S (corresponding author), Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India.	ssk@wii.gov.in		SATHYAKUMAR, SAMBANDAM/0000-0003-2027-4706	Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies [NMHS/LG-2016/009/8510-2]	Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies	This study was funded by the Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies NMHS/LG-2016/009/8510-2. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161717; Agarwal M, 2011, INT J SCI ENG RES, V9; Anand Shaurabh, 2017, Journal of Asia-Pacific Biodiversity, V10, P154; Anderson CR, 2005, WILDLIFE SOC B, V33, P179, DOI 10.2193/0091-7648(2005)33[179:EEOPTA]2.0.CO;2; Athreya V, 2007, J BOMBAY NATURAL HIS, V98, P267; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Bath AJ, 1987, THESIS; Bernard HR, 1995, SOCIAL RES METHODS Q; Bhatia S, 2016, HUMAN DIMENSIONS WIL, V22, P30; Bhattacharjee Anushree, 2013, Human Dimensions of Wildlife, V18, P20, DOI 10.1080/10871209.2012.698403; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Carter NH, 2012, ORYX, V46, P525, DOI 10.1017/S0030605312000245; Champion H. G., 1968, REVISED SURVEY FORES, P404; Chatterjee Piya, 2001, TIME TEA WOMEN LABOR; Choirat C, 2017, RARE EVENTS LOGISTIC; Corbett, 1991, J CORBETT OMNIBUS MA; Daly B, 2005, P WORKSH CONS BREDD; Doubleday KF, 2018, SOC ANIM, V26, P148, DOI 10.1163/15685306-12341498; Dutta T, 2016, REG ENVIRON CHANGE, V16, P53, DOI 10.1007/s10113-015-0877-z; Edgaonar A, 1998, PRELIMINARY STUDY EC; Femke Broekhuis, 2017, ECOLOGY EVOLUTION, DOI [10.1002/ece3.3565, DOI 10.1002/ECE3.3565]; Fick S. E., 2017, INT J CLIMATOLOGY; Forest Survey of India, 2017, FOR TREE RES STAT UN; Gaba KM, 2016, 20 YEARS INDIA LIGHT; Gangopadhay S, 2017, THESIS; Garcia KC, 2016, URSUS, V27, P5, DOI 10.2192/URSUS-D-15-00012.1; Ghosal S, 2015, SOC NATUR RESOUR, V28, P1092, DOI 10.1080/08941920.2015.1014597; Goyal S. P., 2007, STATUS ECOLOGY LEOPA; Goyal S. P., 2000, STUDY DISTRIBUTION R; Gubbi S, 2016, ORYX, V50, P336, DOI 10.1017/S0030605314000751; Guha Abhijit, 2000, Journal of Human Ecology, V11, P471; Guha Ramachandra, 2007, INDIA GANDHI HIST WO; Gurung B, 2008, J BIOL CONSERVATION, DOI [10.1017/S0030605316001587, DOI 10.1017/S0030605316001587]; Habib B, 2014, ECOLOGY LEOPARD PAN; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Inskip C, 2013, HUM ECOL, V41, P169, DOI 10.1007/s10745-012-9556-6; Jhamvar-Shingote Ramaa, 2013, Human Dimensions of Wildlife, V18, P32, DOI 10.1080/10871209.2012.694578; Kansky R, 2014, BIOL CONSERV, V179, P93, DOI 10.1016/j.biocon.2014.09.008; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Kaushik M, 2015, MANAGEMENT HUMAN WIL; Kshettry A, 2018, TROP CONSERV SCI, V11, DOI 10.1177/1940082918764635; Kshettry A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177013; Kumar D., 2011, THESIS; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Lumley T, 2006, RELATIVE RISK REGRES; Madden F, 2014, BIOL CONSERV, V178, P97, DOI 10.1016/j.biocon.2014.07.015; Mamgain PR, 2015, OUTMIGRATION HILL RE; Mathur N, 2014, J ROY ANTHROPOL INST, V20, P148, DOI 10.1111/1467-9655.12098; Miller JB, 2015, BIODIVERS CONSERV, DOI [10.1002/ece3.1440, DOI 10.1002/ECE3.1440]; Miller JRB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162685; Naha D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152119; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; OLI MK, 1994, BIOL CONSERV, V68, P63, DOI 10.1016/0006-3207(94)90547-9; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Ramakrishnan U, 1999, BIOL CONSERV, V89, P113, DOI 10.1016/S0006-3207(98)00159-1; Ramkumar K., 2018, INDIAN HOTSPOTS, P359, DOI [10.1007/978-981-10-6605-4_18, DOI 10.1007/978-981-10-6605-4_18]; Rangarajan M., 2006, INDIAS WILDLIFE HIST; Redpath SM, 2015, ORYX, V49, P222, DOI 10.1017/S0030605314000799; Rodgers WA, 1998, PLANNING PROTECTED A, V1; Rodriguez E, 2006, PHOTOGRAMMETRIC ENG; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Sankar K, 2002, MAMMALIA, V66, P285, DOI 10.1515/mamm.2002.66.2.285; Technology Outreach Services D ITOS D University of Georgia, 2013, GLOB ROADS OP ACC DA; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Wegge P., 2016, ORYX, P1; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505; Wilson S, 2015, ORYX, V49, P140, DOI 10.1017/S0030605313000513; Zar JH., 2010, BIOSTAT ANAL, V5th; Zarco-Gonzalez MM, 2013, BIOL CONSERV, DOI [10.1007/s10745-012-9505-4, DOI 10.1007/S10745-012-9505-4]; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005	74	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204528	10.1371/journal.pone.0204528	http://dx.doi.org/10.1371/journal.pone.0204528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289908	gold, Green Published, Green Submitted			2022-12-27	WOS:000446545500017
J	Sheen, M; Yekani, HAK; Jordan, TR				Sheen, Mercedes; Yekani, Hajar Aman Key; Jordan, Timothy R.			Investigating the effect of wearing the hijab: Perception of facial attractiveness by Emirati Muslim women living in their native Muslim country	PLOS ONE			English	Article							BIAS; PREFERENCES; FACES	The Hijab and other forms of Islamic veiling are important social, cultural, and religious symbols that are central to the identity of millions of Muslim women across the world. However, despite the large body of literature that exists on the political and socio-cultural aspects of Islamic veiling, little is known about how the appearance of women wearing the hijab is perceived by other Muslim women within their native Muslim country. To throw light on this important issue, the current study focussed on the effects of the hijab on female facial attractiveness perceived by practising Muslim Emirati women living in their native Muslim country (the United Arab Emirates) who themselves wore the hijab as everyday attire. Participants were shown frontal-head images of women in three different conditions: covered (heads fully covered by the hijab except for the face), partially covered (heads fully covered by the hijab except for the face and the hair around the forehead) and uncovered (heads with no covering). The findings showed that faces in images where heads were covered and partially covered by the hijab were rated as equally attractive but both were rated as significantly less attractive than faces in images where heads were uncovered. These findings suggest that, even for practising Muslim Emirati females living in their native Muslim country for whom wearing the hijab is a normal aspect of everyday life, perception of facial attractiveness is compromised by wearing this garment. We argue that this effect of wearing the hijab is not consistent with a preference for one's own cultural group (cultural endogamy) and may, instead, occur because wearing a hijab occludes external features, such as hair and ears, which normally contribute to the perception of human facial attractiveness. In sum, while wearing the hijab may be dominated by male attitudes towards suppressing female attractiveness towards males, the findings from this study suggest that female Muslims too perceive the negative influence of wearing the hijab on female facial attractiveness.	[Sheen, Mercedes; Yekani, Hajar Aman Key] Zayed Univ, Dept Psychol, Dubai, U Arab Emirates; [Jordan, Timothy R.] Middle East Tech Univ, Dept Psychol, Northern Cyprus Campus, Kapouti, Northern Cyprus, Turkey	Zayed University; Middle East Technical University	Jordan, TR (corresponding author), Middle East Tech Univ, Dept Psychol, Northern Cyprus Campus, Kapouti, Northern Cyprus, Turkey.	ProfTimJordan@gmail.com		Aman key yekani, Hajar/0000-0002-5083-9774	RIF grant by Zayed University	RIF grant by Zayed University	This work was a supported by a RIF grant awarded to Tim Jordan by Zayed University.	Ahmed L., 1992, WOMEN GENDER ISLAM H; Allen C., 2013, EXPERIENCE IMPACT AN; Allen P, 2010, DAILY MAIL; Allen P, 2009, DAILY MAIL; BAILEY IL, 1980, AM J OPTOM PHYS OPT, V57, P378; Bereczkei T., 2006, REV PSYCHOL, V13, P35; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Buss DM, 1998, HANDBOOK OF EVOLUTIONARY PSYCHOLOGY, P405; Chan JPK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00087; Dijkstra W, 2001, QUAL QUANT, V35, P107, DOI 10.1023/A:1004816210439; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; El Guindi Fadwa., 1999, FASH THEORY, V3, P51, DOI [10.2752/136270499779165626, DOI 10.2752/136270499779165626]; Everett JAC, 2015, J APPL SOC PSYCHOL, V45, P90, DOI 10.1111/jasp.12278; Favelle S, 2015, VISION RES, V112, P26, DOI 10.1016/j.visres.2015.05.002; Hydock C, 2018, BEHAV RES METHODS, V50, P1563, DOI 10.3758/s13428-017-0984-5; Jordan TR, 2011, PERCEPTION, V40, P873, DOI 10.1068/p6940; Koenig HG, 2010, RELIGIONS, V1, P78, DOI 10.3390/rel1010078; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Little AC, 2003, P ROY SOC B-BIOL SCI, V270, P1759, DOI 10.1098/rspb.2003.2445; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; LIU JH, 1995, EUR J SOC PSYCHOL, V25, P95, DOI 10.1002/ejsp.2420250108; Mahmud Y, 2010, BODY IMAGE, V7, P90, DOI 10.1016/j.bodyim.2009.09.003; Maitner AT, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00703; Merton RK, 1948, ANTIOCH REV, V8, P193, DOI DOI 10.2307/4609267; Mesko N, 2004, HUM NATURE-INT BIOS, V15, P251, DOI 10.1007/s12110-004-1008-6; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pasha-Zaidi N, 2015, J INT WOMENS STUDIES, V16, P29; Pazhoohi F, 2017, EVOL PSYCHOL SCI, V3, P118, DOI DOI 10.1007/S40806-016-0079-Z; Pazhoohi F, 2014, ARCH SEX BEHAV, V43, P1083, DOI 10.1007/s10508-014-0259-5; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Sheridan LP, 2006, J INTERPERS VIOLENCE, V21, P317, DOI 10.1177/0886260505282885; Swami V, 2012, PSYCHOL WOMEN DIVERS, P128; Taubert J, 2011, VISION RES, V51, P1273, DOI 10.1016/j.visres.2011.04.002; Toseeb U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084754; Toseeb U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034144; Trujillo L, 2014, COGN AFFECT BEHAV NE, V14, P1061, DOI 10.3758/s13415-013-0230-2; Unkelbach C, 2008, J EXP SOC PSYCHOL, V44, P1409, DOI 10.1016/j.jesp.2008.04.003; Unkelbach C, 2010, SOC PSYCHOL PERS SCI, V1, P378, DOI 10.1177/1948550610378381; Wang Y, 2015, PERCEPTION, V44, P328, DOI 10.1068/p7940	40	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0199537	10.1371/journal.pone.0199537	http://dx.doi.org/10.1371/journal.pone.0199537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289895	Green Submitted, Green Published, gold			2022-12-27	WOS:000446545500002
J	Sudirman, S; Hsu, YH; He, JL; Kong, ZL				Sudirman, Sabri; Hsu, Yuan-Hua; He, Jia-Ling; Kong, Zwe-Ling			Dietary polysaccharide-rich extract from Eucheuma cottonii modulates the inflammatory response and suppresses colonic injury on dextran sulfate sodium-induced colitis in mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KAPPAPHYCUS-ALVAREZII; COLORIMETRIC DETERMINATION; MARINE-ALGAE; FIBER; SEAWEEDS; DISEASE; TUMOR; HOST; 3,6-ANHYDROGALACTOSE	Inflammatory bowel disease (IBD) is a known medical burden in most developed countries and a significant cause of morbidity. The IBD label includes Crohn's disease (CD) and ulcerative colitis (UC). Pharmacological and surgical intervention are the two main management approaches for IBD. Some drugs have been developed for IBD therapy, but accessibility is limited due to high costs. Furthermore, these agents have demonstrated inactivity over long-term treatment courses. Therefore, an urgent need is present for new treatment options that are safe, able to sustain clinical remission, and improve mucosal gut healing. Seaweed has received much attention in the pharmacological field owing to its various biomedical properties, including the prolongation of blood clotting time, as well as antitumor, anti-inflammation, and antioxidant effects. This study therefore aimed to examine the effects of a dietary polysaccharide-rich extract obtained from Eucheuma cottonii (EC) on a model of colitis. Colitis was induced in male BALB/c mice by the administration of 2.5% (w/v) dextran sulfate sodium (DSS) for 7 days. DSS-induced mice were treated with either one of three different doses of EC extracts (0.35, 0.70, and 1.75 g/kg body weight) or curcumin as a positive control (0.10 g/kg). Mice were sacrificed post-treatment and blood samples were collected. The disease activity index (DAI) and inflammatory cytokine levels (tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6, IL-10) were measured. After treatment for 7 days, EC extract administration protected against weight loss and decreased the colon weight per length ratio. EC extract administration also decreased pro-inflammatory cytokine expression, increased IL-10 levels, and reduced colonic damage. Therefore, a dietary polysaccharide-rich extract from E. cottonii reduced DSS-induced bowel inflammation, thereby becoming a promising candidate for the treatment of colitis.	[Sudirman, Sabri; Hsu, Yuan-Hua; He, Jia-Ling; Kong, Zwe-Ling] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan	National Taiwan Ocean University	Kong, ZL (corresponding author), Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.	kongzl@mail.ntou.edu.tw	Kong, Zwe-Ling/E-8763-2013; Kong, Zwe-Ling/AAB-5328-2019; Sudirman, Sabri/O-2980-2018; Kong, Zwe-Ling/AAB-5261-2019	Kong, Zwe-Ling/0000-0002-4877-6524; Kong, Zwe-Ling/0000-0002-4877-6524; Sudirman, Sabri/0000-0003-2821-3772; He, Jia-Ling/0000-0002-1194-2533				Abdelali A, 2016, TOXICOL APPL PHARM, V311, P61, DOI 10.1016/j.taap.2016.09.023; Abu Bakar N, 2015, J FUNCT FOODS, V19, P710, DOI 10.1016/j.jff.2015.10.011; Arafa HMM, 2009, FOOD CHEM TOXICOL, V47, P1311, DOI 10.1016/j.fct.2009.03.003; Bakar Nurul'Ain Abu, 2017, J Microsc Ultrastruct, V5, P70, DOI 10.1016/j.jmau.2016.08.001; Barbalho SM, 2018, J MED FOOD, V21, P633, DOI 10.1089/jmf.2017.0120; Bitencourt MAO, 2015, REV BRAS FARMACOGN, V25, P677, DOI 10.1016/j.bjp.2015.10.001; da Matta CBB, 2011, MAR DRUGS, V9, P307, DOI 10.3390/md9030307; Brito TV, 2016, CARBOHYD POLYM, V151, P957, DOI 10.1016/j.carbpol.2016.06.047; Brumatti LV, 2014, MOLECULES, V19, P21127, DOI 10.3390/molecules191221127; Campo VL, 2009, CARBOHYD POLYM, V77, P167, DOI 10.1016/j.carbpol.2009.01.020; Chang VS, 2017, BIOMED PHARMACOTHER, V87, P296, DOI 10.1016/j.biopha.2016.12.092; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Cho EJ, 2011, J ETHNOPHARMACOL, V136, P428, DOI 10.1016/j.jep.2010.04.047; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; D'Orazio N, 2012, MAR DRUGS, V10, P812, DOI 10.3390/md10040812; de Souza ET, 2009, MAR DRUGS, V7, P689, DOI 10.3390/md7040689; Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5; Fard SG, 2011, J ANIM VET ADV, V10, P601, DOI 10.3923/javaa.2011.601.605; Fayaz M, 2005, J AGR FOOD CHEM, V53, P792, DOI 10.1021/jf0493627; Galvez J, 2005, MOL NUTR FOOD RES, V49, P601, DOI 10.1002/mnfr.200500013; Ghani NAA, 2019, ARAB J CHEM, V12, P370, DOI 10.1016/j.arabjc.2018.06.008; Gomez-Ordonez E, 2010, FOOD RES INT, V43, P2289, DOI 10.1016/j.foodres.2010.08.005; Gommeaux J, 2007, MOL CELL BIOL, V27, P2215, DOI 10.1128/MCB.01454-06; Hamamoto N, 1999, CLIN EXP IMMUNOL, V117, P462; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hwang Eun-Sun, 2014, Prev Nutr Food Sci, V19, P40, DOI 10.3746/pnf.2014.19.1.040; Ilott NE, 2016, ISME J, V10, P2389, DOI 10.1038/ismej.2016.40; Jeon YD, 2016, MOLECULES, V21, DOI 10.3390/molecules21040523; Jimenez-Escrig A, 2000, NUTR RES, V20, P585, DOI 10.1016/S0271-5317(00)00149-4; Kai Y, 2005, GASTROENTEROLOGY, V128, P922, DOI 10.1053/j.gastro.2005.01.013; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; KIM DB, 2013, EVID-BASED COMPL ALT, DOI DOI 10.1155/2013/671281; Kim SJ, 2010, MOLECULES, V15, P7208, DOI 10.3390/molecules15107208; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kumar KS, 2008, FOOD CHEM, V107, P289, DOI 10.1016/j.foodchem.2007.08.016; Lean QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128453; Lee J, 2017, ANN PHARM PHARM, V2, P1056; Li MC, 2004, WORLD J GASTROENTERO, V10, P620, DOI 10.3748/wjg.v10.i5.620; Liang WA, 2014, CARBOHYD POLYM, V101, P776, DOI 10.1016/j.carbpol.2013.10.010; Lim C.L., 2015, J MED BIOENG, V4, P461, DOI [10.12720/jomb.4.6.461-465, DOI 10.12720/JOMB.4.6.461-465]; Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012; Matanjun P, 2008, J APPL PHYCOL, V20, P367, DOI 10.1007/s10811-007-9264-6; MATSUHIRO B, 1983, CARBOHYD RES, V118, P276, DOI 10.1016/0008-6215(83)88056-2; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Myers KJ, 2003, J PHARMACOL EXP THER, V304, P411, DOI 10.1124/jpet.102.040329; Namvar F, 2014, INDIAN J CLIN BIOCHE, V29, P13, DOI 10.1007/s12291-013-0313-4; Namvar F, 2012, FOOD CHEM, V130, P376, DOI 10.1016/j.foodchem.2011.07.054; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Park Yo Han, 2015, J Cancer Prev, V20, P260, DOI 10.15430/JCP.2015.20.4.260; Pugliese D, 2017, EXPERT REV CLIN IMMU, V13, P223, DOI 10.1080/1744666X.2017.1243468; Raman M, 2015, J FUNCT FOODS, V15, P354, DOI 10.1016/j.jff.2015.03.037; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Rodriguez-Cabezas ME, 2002, J NUTR, V132, P3263, DOI 10.1093/jn/132.11.3263; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Shamsabadi FT, 2013, NUTR CANCER, V65, P255, DOI 10.1080/01635581.2013.756528; Soriano A, 2000, LAB INVEST, V80, P1541, DOI 10.1038/labinvest.3780164; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Torres FAE, 2014, REV BRAS FARMACOGN, V24, P265, DOI 10.1016/j.bjp.2014.07.001; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Ung VYL, 2010, DIGEST DIS SCI, V55, P1272, DOI 10.1007/s10620-009-0843-z; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Wanyonyi S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111261; Yang Joon-Yeop, 2013, J Cancer Prev, V18, P186; YAPHE W, 1960, ANAL CHEM, V32, P1327, DOI 10.1021/ac60166a030	65	25	25	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205252	10.1371/journal.pone.0205252	http://dx.doi.org/10.1371/journal.pone.0205252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289911	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500059
J	Qiu, LL; Chang, GB; Bi, YL; Liu, XP; Chen, GH				Qiu, Lingling; Chang, Guobin; Bi, Yulin; Liu, Xiangping; Chen, Guohong			Circular RNA and mRNA profiling reveal competing endogenous RNA networks during avian leukosis virus, subgroup J-induced tumorigenesis in chickens	PLOS ONE			English	Article							CELL-GROWTH; CHINA; INFECTION; EFFICIENT; HPRS-103; LEUKEMIA; ABUNDANT; TOPHAT; STRAIN; CANCER	Avian leukosis virus subgroup J (ALV-J) can induce myeloid tumors and hemangiomas in chickens and causes severe economic losses with commercial layer chickens and meat-type chickens. Here, we generated ribominus RNA sequencing data from three normal chicken spleen tissues and three ALV-J-infected chicken spleen tissues. Structure analysis of transcripts showed that, compared to mRNAs and IncRNAs, chicken circRNAs shared relatively shorter transcripts and similar GC content. Differentially expression analysis showed 152 differentially expressed circRNAs with 106 circRNAs up regulated and 46 circRNAs down regulated. Through comparing differentially expressed circRNA host genes and mRNAs and performed ceRNA network analysis, we found several tumor or immune-related genes, in which, there were four genes existed in both differentially expressed mRNAs and circRNA host genes (Dock4, Fmr1, Zfhx3, Ralb) and two genes (Mll, Aoc3) involved in ceRNA network. We further characterized one exon-intron circRNA derived from HRH4 gene in the ceRNA network, termed circHRH4, which is an abundant and stable circRNA expressed in various tissues and cells in chicken and localizes in cytoplasm. Our results provide new insight into the pathology of ALV-J infection and circRNAs may also mediate tumorigenesis in chicken.	[Qiu, Lingling; Chang, Guobin; Bi, Yulin; Chen, Guohong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Liu, Xiangping] Chinese Acad Agr Sci, Poultry Inst, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences	Chang, GB (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	gbchang@yzu.edu.cn			National Science & Technology Pillar Program of China [2015BAD03B03]; priority academic program development of Jiangsu Higher Education Institutions	National Science & Technology Pillar Program of China; priority academic program development of Jiangsu Higher Education Institutions	This work was funded by National Science & Technology Pillar Program of China (2015BAD03B03) and the priority academic program development of Jiangsu Higher Education Institutions. The funders conceived and designed the study.	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Aldoss I, 2018, BLOOD, V131, P2507, DOI 10.1182/blood-2018-02-834911; Arshad SS, 1997, VET PATHOL, V34, P127, DOI 10.1177/030098589703400205; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Cheng ZQ, 2010, J VET MED SCI, V72, P1027, DOI 10.1292/jvms.09-0564; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Cui Z, 2006, J AVIAN LEUKOSIS VIR; Cui ZZ, 2003, AVIAN DIS, V47, P1321, DOI 10.1637/6085; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098965; Devaux Y, 2017, EUR J HEART FAIL, V19, P701, DOI 10.1002/ejhf.801; Ding JiaBo, 2007, Chinese Journal of Veterinary Science, V27, P39; Dong X, 2015, AVIAN PATHOL, V44, P43, DOI 10.1080/03079457.2014.993359; Falsetti SC, 2007, MOL CELLULAR BIOL, V27; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Gao YL, 2012, J CLIN MICROBIOL, V50, P953, DOI 10.1128/JCM.06179-11; Gleicher N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102370; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Ji R.L., 2001, CHIN J VET DRUG, V35, P1; Johnstone RW, 2001, MOL CELL BIOL, V21, P1672, DOI 10.1128/MCB.21.5.1672-1681.2001; Lai HZ, 2011, VET MICROBIOL, V151, P275, DOI 10.1016/j.vetmic.2011.03.037; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Liu D, 2016, SCI REP-UK, V6, DOI 10.1038/srep20188; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mori Y, 2007, INT J CANCER, V121, P241, DOI 10.1002/ijc.22654; Ouyang HJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00172; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; PAYNE LN, 1993, VET REC, V132, P555, DOI 10.1136/vr.132.22.555; Qiu LL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00996; Qiu LL, 2017, DEV COMP IMMUNOL, V76, P292, DOI 10.1016/j.dci.2017.06.015; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sironi G, 2006, J VET MED B, V53, P347, DOI 10.1111/j.1439-0450.2006.00961.x; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang YM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0598-7; Wang Z, 2018, AGING-US, V10, P775, DOI 10.18632/aging.101427; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yu JR, 2015, GENE DEV, V29, P250, DOI 10.1101/gad.248963.114; Zhang S., 2010, CHINA POULT, V32, P11, DOI [10.16372/j.issn.1004-6364.2010.12.003, DOI 10.16372/J.ISSN.1004-6364.2010.12.003]; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang XH, 2017, ONCOTARGET, V8, P34961, DOI 10.18632/oncotarget.16442; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215	50	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204931	10.1371/journal.pone.0204931	http://dx.doi.org/10.1371/journal.pone.0204931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286182	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500062
J	Heinonen, M; Milliat, F; Benadjaoud, MA; Francois, A; Buard, V; Tarlet, G; d'Alche-Buc, F; Guipaud, O				Heinonen, Markus; Milliat, Fabien; Benadjaoud, Mohamed Amine; Francois, Agnes; Buard, Valerie; Tarlet, Georges; d'Alche-Buc, Florence; Guipaud, Olivier			Temporal clustering analysis of endothelial cell gene expression following exposure to a conventional radiotherapy dose fraction using Gaussian process clustering	PLOS ONE			English	Article							IONIZING-RADIATION; NORMAL TISSUE; TIME-SERIES; COEFFICIENT	The vascular endothelium is considered as a key cell compartment for the response to ionizing radiation of normal tissues and tumors, and as a promising target to improve the differential effect of radiotherapy in the future. Following radiation exposure, the global endothelial cell response covers a wide range of gene, miRNA, protein and metabolite expression modifications. Changes occur at the transcriptional, translational and post-translational levels and impact cell phenotype as well as the microenvironment by the production and secretion of soluble factors such as reactive oxygen species, chemokines, cytokines and growth factors. These radiation-induced dynamic modifications of molecular networks may control the endothelial cell phenotype and govern recruitment of immune cells, stressing the importance of clearly understanding the mechanisms which underlie these temporal processes. A wide variety of time series data is commonly used in bioinformatics studies, including gene expression, protein concentrations and metabolomics data. The use of clustering of these data is still an unclear problem. Here, we introduce kernels between Gaussian processes modeling time series, and subsequently introduce a spectral clustering algorithm. We apply the methods to the study of human primary endothelial cells (HUVECs) exposed to a radiotherapy dose fraction (2 Gy). Time windows of differential expressions of 301 genes involved in key cellular processes such as angiogenesis, inflammation, apoptosis, immune response and protein kinase were determined from 12 hours to 3 weeks post-irradiation. Then, 43 temporal clusters corresponding to profiles of similar expressions, including 49 genes out of 301 initially measured, were generated according to the proposed method. Forty-seven transcription factors (TFs) responsible for the expression of clusters of genes were predicted from sequence regulatory elements using the MotifMap system. Their temporal profiles of occurrences were established and clustered. Dynamic network interactions and molecular pathways of TFs and differential genes were finally explored, revealing key node genes and putative important cellular processes involved in tissue infiltration by immune cells following exposure to a radiotherapy dose fraction.	[Heinonen, Markus] Aalto Univ, Dept Informat & Comp Sci, Aalto, Finland; [Milliat, Fabien; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Guipaud, Olivier] Inst Radiol Protect & Nucl Safety IRSN, PSE SANTE, SERAMED, LRMed, Fontenay Aux Roses, France; [Benadjaoud, Mohamed Amine] Inst Radiol Protect & Nucl Safety IRSN, PSE SANTE, SERAMED, Fontenay Aux Roses, France; [d'Alche-Buc, Florence] Univ Paris Saclay, LTCI, Telecom ParisTech, Paris, France	Aalto University; IMT - Institut Mines-Telecom; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Guipaud, O (corresponding author), Inst Radiol Protect & Nucl Safety IRSN, PSE SANTE, SERAMED, LRMed, Fontenay Aux Roses, France.	olivier.guipaud@irsn.fr		Milliat, Fabien/0000-0001-8249-9498; TARLET, Georges/0000-0002-4756-5127	Electricite de France (Groupe Gestion Projet Radioprotection); Institut de Radioprotection et de Surete Nucleaire (programme ROSIRIS)	Electricite de France (Groupe Gestion Projet Radioprotection); Institut de Radioprotection et de Surete Nucleaire (programme ROSIRIS)	This work has been supported by Electricite de France (Groupe Gestion Projet Radioprotection) and Institut de Radioprotection et de Surete Nucleaire (programme ROSIRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijo T, 2009, BIOINFORMATICS, V25, P2937, DOI 10.1093/bioinformatics/btp511; Angelini C, 2007, STAT APPL GENET MOL, V6; Bach FR, 2004, ADV NEUR IN, V16, P305; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Caldas J, 2009, BIOINFORMATICS, V25, pI145, DOI 10.1093/bioinformatics/btp215; Chawla S, 2013, P 2013 SIAM INT C DA; Cheng JD, 2002, BIOCHEM BIOPH RES CO, V297, P1128, DOI 10.1016/S0006-291X(02)02301-X; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; Corre I, 2013, INT J MOL SCI, V14, P22678, DOI 10.3390/ijms141122678; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; DeVita VT, 2011, ROSENBERGS CANC PRIN; Dudoit S, 2002, STAT SINICA, V12, P111; Duong T, 2011, KS KERNEL SMOOTHING; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Gao P, 2008, BIOINFORMATICS, V24, pI70, DOI 10.1093/bioinformatics/btn278; Guipaud O, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170762; Heinonen M, 2015, BIOINFORMATICS, V31, P728, DOI 10.1093/bioinformatics/btu699; Hensman J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-252; Holsclaw T, 2013, TECHNOMETRICS, V55, P57, DOI 10.1080/00401706.2012.723918; INMAN HF, 1989, COMMUN STAT THEORY, V18, P3851, DOI 10.1080/03610928908830127; Jaakkola T, 1999, Proc Int Conf Intell Syst Mol Biol, P149; Jebara T, 2003, LECT NOTES ARTIF INT, V2777, P57, DOI 10.1007/978-3-540-45167-9_6; Kalaitzis AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-180; Karhunen K., 1947, ANN ACAD SCI FENN A1, V37, P1; Kim J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-310; Kirk PDW, 2009, BIOINFORMATICS, V25, P1300, DOI 10.1093/bioinformatics/btp139; Laube M, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5020014; Lawrence N. D., 2007, ADV NEURAL INFORM PR, P785; LEE YJ, 1995, J BIOL CHEM, V270, P28790, DOI 10.1074/jbc.270.48.28790; Liauw SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005148; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Moding EJ, 2013, NAT REV DRUG DISCOV, V12, P526, DOI 10.1038/nrd4003; Moreno PJ, 2004, ADV NEUR IN, V16, P1385; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Potters L, 2010, INT J RADIAT ONCOL, V76, P326, DOI 10.1016/j.ijrobp.2009.09.042; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Rannou E, 2015, SCI REP-UK, V5, DOI 10.1038/srep15738; Rasmussen CE, 2003, BAYESIAN STATISTICS 7, P651; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Riihimaki J., 2010, J MACH LEARN RES, V9, P645; Schliep A, 2005, IEEE ACM T COMPUT BI, V2, P179, DOI 10.1109/TCBB.2005.31; Schmid F, 2006, COMPUT STAT DATA AN, V50, P1583, DOI 10.1016/j.csda.2005.01.014; Simone CB, 2013, CHEST, V143, P1784, DOI 10.1378/chest.12-2580; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Solak E., 2002, P ADV NEUR INF PROC, P1033; Stegle O, 2010, J COMPUT BIOL, V17, P355, DOI 10.1089/cmb.2009.0175; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Tamm I, 1998, CANCER RES, V58, P5315; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Weitzman M.S., 1970, MEASURES OVERLAP INC; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Yang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016229; Yao F., 2015, PACE PACKAGE FUNCTIO; Yuan M, 2006, COMPUT STAT DATA AN, V51, P1754, DOI 10.1016/j.csda.2005.11.017	62	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204960	10.1371/journal.pone.0204960	http://dx.doi.org/10.1371/journal.pone.0204960			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281653	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400072
J	Kodish, SR; Rohner, F; Beauliere, JM; Daffe, M; Ayoya, MA; Wirth, JP; Ngnie-Teta, I				Kodish, Stephen R.; Rohner, Fabian; Beauliere, Jean-Max; Daffe, Mamady; Ayoya, Mohamed Ag; Wirth, James P.; Ngnie-Teta, Ismael			Implications of the Ebola virus disease outbreak in Guinea: Qualitative findings to inform future health and nutrition-related responses (vol 13, e0202468, 2018)	PLOS ONE			English	Correction													Rohner, Fabian/I-5088-2019	Rohner, Fabian/0000-0003-0579-6952				Kodish SR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202468	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204675	10.1371/journal.pone.0204675	http://dx.doi.org/10.1371/journal.pone.0204675			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281637	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400054
J	Rizvi, S; Pagnutti, C; Fraser, E; Bauch, CT; Anand, M				Rizvi, Sarah; Pagnutti, Chris; Fraser, Evan; Bauch, Chris T.; Anand, Madhur			Global land use implications of dietary trends (vol 13, e0200781, 2018)	PLOS ONE			English	Correction														Fraser, Evan/0000-0001-5124-488X				Rizvi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200781	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205312	10.1371/journal.pone.0205312	http://dx.doi.org/10.1371/journal.pone.0205312			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281649	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400089
J	Tesfaye, B; Alebel, A; Gebrie, A; Zegeye, A; Tesema, C; Kassie, B				Tesfaye, Bekele; Alebel, Animut; Gebrie, Alemu; Zegeye, Abriham; Tesema, Cheru; Kassie, Bekalu			The twin epidemics: Prevalence of TB/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis	PLOS ONE			English	Review							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; RISK-FACTORS; TUBERCULOSIS; COHORT; TB; MANIFESTATIONS; DETERMINANTS; REGION; ADULTS	Background Tuberculosis and HIV/AIDS are the major public health problems in many parts of the world particularly in resource limited countries like Ethiopia. Although studies have been conducted on the prevalence and associated factors of TB/HIV co-infection in Ethiopia, there is no comprehensive data on the magnitude and risk factors at a national and regional levels. Therefore, this review is aimed to summarize the prevalence of TB/HIV co-infection in Ethiopia using meta-analysis based on a systematic review of published articles & grey literatures. Methods To conduct this systematic review and meta-analysis, major databases such as Pub Med, Google scholar, CINAHL, Africa Journals Online and Google were systematically searched using search terms. PRISMA guideline was followed in the study. Two authors extracted all necessary data using a standardized data extraction format, and analysis was done using STATA version 11. A Statistical heterogeneity across the studies was evaluated by using Cochran's Q test and I-2 statistic. The pooled effect size was conducted in the form of prevalence and associations were measured using odds ratio. Moreover, the univariate meta regression was performed by considering the sample size to determine potential sources of heterogeneity. The Egger's weighted regression and Begg's rank correlation tests were used to assess potential publication biases. Results This meta-analysis included 21 studies with a total of 12,980 participants. The pooled prevalence of TB/HIV Co-infection was 25.59% (95% CI (20.89% - 30.29%). A significant association was found between low CD4 counts (OR: 3.53; 95% CI: 1.55, 8.06), advanced WHO stage (OR: 6.81; 95% CI: 3.91, 11.88) and TB/HIV/AIDS Co-infection. Conclusion This finding revealed that the magnitude of TB/HIV co-infection in Ethiopia is increasing and deserves special attention. Low CD4 count and advanced WHO stage are contributing factors for dual infection. Establishing mechanisms such as Conducting surveillance to determine HIV burden among TB patients and TB burden among HIV patients, and intensifying the three I's (Intensive case finding, INH Preventive Therapy and Infection control) should be routine work of clinicians. Moreover, early screening & treatment should be provided to those patients with low CD4 count and advanced WHO stage.	[Tesfaye, Bekele; Alebel, Animut] Debre Markos Univ, Coll Hlth Sci, Dept Nursing, Debre Markos, Ethiopia; [Gebrie, Alemu; Zegeye, Abriham] Debre Markos Univ, Coll Med, Dept Biomed Sci, Debre Markos, Ethiopia; [Tesema, Cheru] Debre Markos Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Markos, Ethiopia; [Kassie, Bekalu] Debre Markos Univ, Coll Hlth Sci, Dept Midwifery, Debre Markos, Ethiopia		Tesfaye, B (corresponding author), Debre Markos Univ, Coll Hlth Sci, Dept Nursing, Debre Markos, Ethiopia.	bekeletesfaye76@gmail.com	Alebel, Animut/L-4278-2019; Gebrie, Alemu/AAD-3275-2020; Ayalew, Animut Alebel/U-6092-2019	Alebel, Animut/0000-0003-2822-2062; Gebrie, Alemu/0000-0001-5575-6823; 				Albalak R, 2007, ARCH INTERN MED, V167, P2443, DOI 10.1001/archinte.167.22.2443; Alexander PE, 2007, CAN J INFECT DIS MED, V18, P289, DOI 10.1155/2007/986794; [Anonymous], 2008, NATL TUBERCULOSIS PR; [Anonymous], 2009, UNAIDS REP AIDS EP U; [Anonymous], 2012, GLOB TUB REP 2012; [Anonymous], 2017, AT TEM POHCIAMDROPTA; Ayenew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009702; Belay M, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27949; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Charles Marie, 2002, AIDS Read, V12, P288; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Country/Regional Operational Plan (COP/ROP), 2017, ETHIOPIA        0421; Dalbo M., 2016, ADV INFECT DIS, V06, P70, DOI 10.4236/aid.2016.62010; de Carvalho BM, 2008, BRAZ J INFECT DIS, V12, P281, DOI 10.1590/S1413-86702008000400005; Deribew Amare, 2010, BMC Res Notes, V3, P249, DOI 10.1186/1756-0500-3-249; do Prado TN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-415; Esmael A, 2013, J AIDS CLIN RES, V04; Fekadu S, 2015, J INFECT DEV COUNTR, V9, P898, DOI 10.3855/jidc.5667; Gao J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0421; Gao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064915; Gudina EK, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.126.1907; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kamath R, 2013, LUNG INDIA, V30, P302, DOI 10.4103/0970-2113.120605; Kassu Afework, 2007, Journal of Microbiology Immunology and Infection, V40, P116; Kibret KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064488; Kloos H, 2001, INT C AFR DEV ARCH; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Loney P L, 1998, Chronic Dis Can, V19, P170; Loveday M, 2011, TROP MED INT HEALTH, V16, P431, DOI 10.1111/j.1365-3156.2010.02721.x; Madkan VK, 2006, ARCH DERMATOL, V142, P365, DOI 10.1001/archderm.142.3.365; Megersa Obsa Amente, 2013, RISK FACTORS ASS TB; Mekonnen Daniel, 2015, BMC Res Notes, V8, P666, DOI 10.1186/s13104-015-1664-0; Melkamu H, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/279876; Mitku AA, 2016, AFR HEALTH SCI, V16, P588, DOI 10.4314/ahs.v16i2.29; Mungrue Kameel, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P170, DOI 10.1177/1545109709331471; Osei E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2598-z; Padian NS, 2011, IMPLEMENTATION SCI U; Piggott DA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/103917; Pimpin L, 2011, EUR RESPIR J, V38, P1382, DOI 10.1183/09031936.00198410; Porco T HP, 1993, TUBERCULOSIS HIV COI; San K E, 2001, Malays J Med Sci, V8, P34; Sia D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3783-5; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Simieneh A, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.75.11977; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Staehelin C, 2003, AIDS, V17, P2237, DOI 10.1097/00002030-200310170-00012; Swaminathan S, 2008, J BIOSCIENCES, V33, P527, DOI 10.1007/s12038-008-0071-2; Tadesse S, 2013, J INFECT DIS IMMUN, V5, P29, DOI DOI 10.5897/JIDI2013.0117; Taha M, 2011, ETHIOP J HEALTH SCI, V21, P131; Tarekegne Daniel, 2016, BMC Res Notes, V9, P192, DOI 10.1186/s13104-016-2004-8; Taylor S, 1998, TRTAFASFPBMOTAAFPBIM; WHO, EST WHO TB MORT STAT; WHO, 2009, TB HIV FACTSH; WHO, 2003, TREAT TB HIV HEALTHL; Wondimeneh Yitayih, 2012, BMC Res Notes, V5, P331, DOI 10.1186/1756-0500-5-331; World Health Organization, 2016, WHOHTMTB201522; World Health Organization, TUB HIV; Yassin MA, 2004, SCAND J INFECT DIS, V36, P670, DOI 10.1080/00365540410020848	59	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203986	10.1371/journal.pone.0203986	http://dx.doi.org/10.1371/journal.pone.0203986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281631	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400036
J	Yuan, T; Li, JP; Fl, Y; Xu, T; Li, J; Wang, XQ; Zhou, Y; Dong, YY; Zhao, WG				Yuan, Tao; Li, Jiapei; Fl, Yong; Xu, Tao; Li, Juan; Wang, Xiangqing; Zhou, Ying; Dong, Yingyue; Zhao, Weigang			A cardiac risk score based on sudomotor function to evaluate cardiovascular autonomic neuropathy in asymptomatic Chinese patients with diabetes mellitus	PLOS ONE			English	Article							INDICATOR TEST; SKIN VASOMOTOR; DIAGNOSIS; DYSFUNCTION; TOOL; COMPLICATIONS; PATHOGENESIS; MORTALITY	Backgrounds Cardiac autonomic neuropathy is a common but always overlooked. More convenient diagnostic methods are needed. Hypothesis Cardiac autonomic neuropathy risk score evaluated by SUDOSCAN has a fine diagnostic efficacy detecting cardiac autonomic neuropathy. Methods This is a cross-sectional study among patients with diabetes mellitus. Subjects undertook SUDOSCAN tests and cardiac autonomic reflex tests, including heart rate variability due to Valsalva maneuver, heart rate response due to deep breathing and heart rate response due to standing up. Presenting 2 abnormal results was defined as cardiac autonomic neuropathy. Results Subjects with cardiac autonomic neuropathy has significantly higher cardiac autonomic neuropathy risk score (32.88 +/- 1.60 vs 27.64 +/- 1.24,P = 0.010). Cardiac autonomic neuropathy risk score was correlated significantly with the heart rate response due to deep breathing (P = 0.004). Multiple regression analysis including significant variables showed an independent association of cardiac autonomic neuropathy risk score and heart rate response due to deep breathing (P = 0.031) and age (P = 0.000). In receiver operating characteristic curve analysis evaluating the relationship between cardiac autonomic neuropathy risk score and cardiac autonomic neuropathy, The cut-off value was 20.5, with the sensitivity of 90.48%, the specificity of 29.5%, and the positive predictive value of 46.9%. In two-step diagnostic methods, Setting 20.5 as the cut-off value of cardiac autonomic neuropathy risk score and abnormal heart rate response due to standing up as the second diagnostic step's positive result, and setting 16.5 as the cut-off value of cardiac autonomic neuropathy risk score and abnormal heart rate response due to deep breathing as the second diagnostic step's positive result, both achieved good diagnostic efficacy. Conclusion Cardiac autonomic neuropathy risk score evaluated by SUDOSCAN is a good screening test for cardiac autonomic neuropathy. The two-step diagnostic methods could be considered as surrogate diagnostic methods.	[Yuan, Tao; Li, Jiapei; Fl, Yong; Li, Juan; Wang, Xiangqing; Zhou, Ying; Dong, Yingyue; Zhao, Weigang] Peking Union Med Coll Hosp, Peking Union Med Coll, Key Lab Endocrinol Natl Hlth & Family Planning Co, Dept Endocrinol, Beijing, Peoples R China; [Yuan, Tao; Li, Jiapei; Fl, Yong; Li, Juan; Wang, Xiangqing; Zhou, Ying; Dong, Yingyue; Zhao, Weigang] Chinese Acad Med Sci, Beijing, Peoples R China; [Xu, Tao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Sch Basic Med,Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, WG (corresponding author), Peking Union Med Coll Hosp, Peking Union Med Coll, Key Lab Endocrinol Natl Hlth & Family Planning Co, Dept Endocrinol, Beijing, Peoples R China.; Zhao, WG (corresponding author), Chinese Acad Med Sci, Beijing, Peoples R China.	xiehezhaoweigang@163.com	Li, Jiapei/AAX-7482-2021					Akaogi Y, 2009, NEUROLOGY, V73, P59, DOI 10.1212/WNL.0b013e3181aae83c; American Diabetes Association, 2017, CLIN DIABETES, V35, P5, DOI [10.2337/cd16-0067, DOI 10.2337/CD16-0067]; Aminoff M, 1996, NEUROLOGY, V46, P873; [Anonymous], 1988, DIABETES CARE, V11, P592, DOI 10.2337/diacare.11.7.592; Asahina M, 2008, J DIABETES COMPLICAT, V22, P278, DOI 10.1016/j.jdiacomp.2007.03.009; Balcioglu AS, 2015, WORLD J DIABETES, V6, P80, DOI 10.4239/wjd.v6.i1.80; Bilen H, 2007, ADV THER, V24, P1020, DOI 10.1007/BF02877707; Cameron NE, 1997, DIABETES, V46, pS31, DOI 10.2337/diab.46.2.S31; Casellini CM, 2013, DIABETES TECHNOL THE, V15, P948, DOI 10.1089/dia.2013.0129; Deli G, 2013, NEUROENDOCRINOLOGY, V98, P267, DOI 10.1159/000358728; Eranki VG, 2013, DIABETES RES CLIN PR, V101, pE11, DOI 10.1016/j.diabres.2013.07.003; Freedman BI, 2015, AM J NEPHROL, V41, P438, DOI 10.1159/000437342; GREENE DA, 1988, DIABETES, V37, P688, DOI 10.2337/diabetes.37.6.688; He TY, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8289740; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; Jiang Y, 2002, MODERN MED J, V30, P317; Liatis S, 2007, DIABETIC MED, V24, P1375, DOI 10.1111/j.1464-5491.2007.02280.x; Low PA, 2004, DIABETES CARE, V27, P2942, DOI 10.2337/diacare.27.12.2942; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; Luk AOY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134981; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; Papanas N, 2013, DIABETIC MED, V30, P525, DOI 10.1111/dme.12000; Papanas N, 2014, ENDOCRINE, V47, P690, DOI 10.1007/s12020-014-0285-z; Pop-Busui R, 2012, J CARDIOVASC TRANSL, V5, P463, DOI 10.1007/s12265-012-9367-6; Pop-Busui R, 2010, DIABETES CARE, V33, P1578, DOI 10.2337/dc10-0125; Selvarajah D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138224; Serhiyenko VA, 2015, WORLD J DIABETES, V6, P245, DOI 10.4239/wjd.v6.i2.245; Spallone V, 2009, DIABETIC MED, V26, P686, DOI 10.1111/j.1464-5491.2009.02760.x; Spallone V, 2011, DIABETES-METAB RES, V27, P639, DOI 10.1002/dmrr.1239; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Valensi P, 2003, METABOLISM, V52, P815, DOI 10.1016/S0026-0495(03)00095-7; Veves A, 2001, J CLIN INVEST, V107, P1215, DOI 10.1172/JCI13038; Vinik Aaron I., 2003, Comprehensive Therapy, V29, P130, DOI 10.1007/s12019-003-0017-4; Vinik AI, 2013, CURR DIABETES REP, V13, P517, DOI 10.1007/s11892-013-0392-x; Vinik AI, 2003, SEMIN NEUROL, V23, P365; Yajnik CS, 2013, DIABETES METAB, V39, P126, DOI 10.1016/j.diabet.2012.09.004; ZIEGLER D, 1993, DIABETES METAB, V19, P143	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204804	10.1371/journal.pone.0204804	http://dx.doi.org/10.1371/journal.pone.0204804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281621	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400059
J	Armitage, AD; Lysoe, E; Nellist, CF; Lewis, LA; Cano, LM; Harrison, RJ; Brurberg, MB				Armitage, Andrew D.; Lysoe, Erik; Nellist, Charlotte F.; Lewis, Laura A.; Cano, Liliana M.; Harrison, Richard J.; Brurberg, May B.			Bioinformatic characterisation of the effector repertoire of the strawberry pathogen Phytophthora cactorum	PLOS ONE			English; English	Article							COMBINED TRANSMEMBRANE TOPOLOGY; SIGNAL PEPTIDE PREDICTION; HIDDEN MARKOV MODEL; GENETIC-VARIATION; RXLR EFFECTORS; PARTIAL RESISTANCE; PROTEIN FUNCTION; METHYL-BROMIDE; SILVER BIRCH; WEB SERVER	The oomycete pathogen Phytophthora cactorum causes crown rot, a major disease of cultivated strawberry. We report the draft genome of P. cactorum isolate 10300, isolated from symptomatic Fragaria x ananassa tissue. Our analysis revealed that there are a large number of genes encoding putative secreted effectors in the genome, including nearly 200 RxLR domain containing effectors, 77 Crinklers (CRN) grouped into 38 families, and numerous apoplastic effectors, such as phytotoxins (PcF proteins) and necrosis inducing proteins. As in other Phytophthora species, the genomic environment of many RxLR and CRN genes differed from core eukaryotic genes, a hallmark of the two-speed genome. We found genes homologous to known Phytophthora infestans avirulence genes including Avr1, Avr3b, Avr4, Avrblb1 and AvrSmira2 indicating effector sequence conservation between Phytophthora species of Glade 1a and Glade 1 c. The reported P. cactorum genome sequence and associated annotations represent a comprehensive resource for avirulence gene discovery in other Phytophthora species from Glade 1 and, will facilitate effector informed breeding strategies in other crops.	[Armitage, Andrew D.; Nellist, Charlotte F.; Lewis, Laura A.; Harrison, Richard J.] NIAB EMR, Kent, England; [Lysoe, Erik; Brurberg, May B.] Norwegian Inst Bioecon Res NIBIO, Div Biotechnol & Plant Hlth, As, Norway; [Cano, Liliana M.] Univ Florida, UF IFAS Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Cano, Liliana M.] Sainsbury Lab, Norwich, Norfolk, England; [Brurberg, May B.] Norwegian Univ Life Sci NMBU, Dept Plant Sci, As, Norway	Norwegian Institute of Bioeconomy Research; State University System of Florida; University of Florida; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Norwegian University of Life Sciences	Harrison, RJ (corresponding author), NIAB EMR, Kent, England.	richard.harrison@emr.ac.uk	Brurberg, May Bente/HFI-2864-2022; Lysøe, Erik/AAJ-8894-2020; Cano, Liliana M/O-7041-2016; Harrison, Richard/E-3169-2015	Cano, Liliana M/0000-0002-7996-4181; Lysoe, Erik/0000-0001-5204-2577; Harrison, Richard/0000-0002-3307-3519; Nellist, Charlotte F/0000-0002-7453-3710; Armitage, Andrew/0000-0002-0610-763X	BBSRC [BB/K017071/1, BB/K017071/2]; strategic NIBIO project	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); strategic NIBIO project	AA, CFN, LAL and RJH were funded by BBSRC grant BB/K017071/1 and BB/K017071/2, https://bbsrc.ukri.org/research/grants/grants/AwardDetails.aspx? FundingReference=BB/K017071/1 and https://bbsrc.ukri.org/research/grants/grants/AwardDetails.aspx?FundingReference=BB/K017071/2. MB, EL and sequencing costs were financed by a strategic NIBIO project (basic funding).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amaro TMMM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00099; Anderson RG, 2015, MOL PLANT MICROBE IN, V28, P1063, DOI 10.1094/MPMI-01-15-0022-CR; Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bhat RG, 2006, PLANT DIS, V90, P161, DOI 10.1094/PD-90-0161; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Blackman LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-785; Bouwmeester K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001327; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Champouret N, 2009, MOL PLANT MICROBE IN, V22, P1535, DOI 10.1094/MPMI-22-12-1535; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen XR, 2018, MOL GENET GENOMICS, V293, P541, DOI 10.1007/s00438-017-1400-7; Chen XR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-980; Chen XR, 2011, CURR GENET, V57, P297, DOI 10.1007/s00294-011-0348-0; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Damasceno CMB, 2008, MOL PLANT MICROBE IN, V21, P820, DOI 10.1094/MPMI-21-6-0820; Davik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137746; De Cal A, 2004, PLANT DIS, V88, P210, DOI 10.1094/PDIS.2004.88.2.210; Denoyes-Rothan B, 2004, ACTA HORTIC, P147, DOI 10.17660/ActaHortic.2004.663.19; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005704; Dong SM, 2015, CURR OPIN GENET DEV, V35, P57, DOI 10.1016/j.gde.2015.09.001; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Du Y, 2015, PLANT PHYSIOL, V169, P1975, DOI 10.1104/pp.15.01169; Eikemo H, 2010, HORTSCIENCE; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Feng BZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-126; Fennimore SA, 2008, CALIF AGR, V62, P62, DOI 10.3733/ca.v062n02p62; Franceschetti M, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00066-16, 10.1128/mmbr.00066-16]; Fry WE, 2015, PHYTOPATHOLOGY, V105, P966, DOI 10.1094/PHYTO-01-15-0005-FI; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Gottlieb D, 1978, PHYTOPATHOLOGY; Grenville-Briggs LJ, 2017, GENOM DATA, V12, P155, DOI 10.1016/j.gdata.2017.05.010; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hantula J, 1997, MYCOL RES, V101, P565, DOI 10.1017/S0953756296002900; Hantula J, 2000, MYCOL RES, V104, P1062, DOI 10.1017/S0953756200002999; Hirakawa H, 2014, DNA RES, V21, P169, DOI 10.1093/dnares/dst049; Hoff KJ, 2016, BIOINFORMATICS, V32, P767, DOI 10.1093/bioinformatics/btv661; Huang L, 2018, NUCLEIC ACIDS RES, V46, pD516, DOI 10.1093/nar/gkx894; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jupe J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r63; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lilja A, 1998, EUR J PLANT PATHOL, V104, P529, DOI 10.1023/A:1008644804415; Martin FN, 2014, FUNGAL GENET BIOL, V66, P19, DOI 10.1016/j.fgb.2014.02.006; Nellist C. F., 2018, BIORXIV, DOI [10.1101/249573, DOI 10.1101/249573]; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Orsomando G, 2001, J BIOL CHEM, V276, P21578, DOI 10.1074/jbc.M101377200; Orsomando G, 2011, PROTEIN SCI, V20, P2047, DOI 10.1002/pro.742; Rajput NA, 2015, PLANT CELL PHYSIOL, V56, P2423, DOI 10.1093/pcp/pcv164; Rietman H, 2012, MOL PLANT MICROBE IN, V25, P910, DOI 10.1094/MPMI-01-12-0010-R; Robinson SM, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00797; Shaw DV, 2008, PLANT PATHOL, V57, P210, DOI 10.1111/j.1365-3059.2007.01773.x; Shaw DV, 2006, J AM SOC HORTICULTUR; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Stam R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00387; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stensvand A., 1999, Bulletin OEPP, V29, P155, DOI 10.1111/j.1365-2338.1999.tb00809.x; Sugimoto T, 2011, BREEDING SCI, V61, P511, DOI 10.1270/jsbbs.61.511; Testa AC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1344-4; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Thomas R, 2007, PLANT PHYSIOL, V144, P299, DOI 10.1104/pp.106.091090; Thomidis T, 2003, AUST J EXP AGR, V43, P99, DOI 10.1071/EA01203; Thomidis T, 2001, PHYTOPARASITICA, V29, P47, DOI 10.1007/BF02981813; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vega-Sanchez ME, 2005, PHYSIOL MOL PLANT P, V66, P175, DOI 10.1016/j.pmpp.2005.07.001; Wawra S, 2017, PLANT CELL, V29, P1184, DOI 10.1105/tpc.16.00552; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; WOOD SG, 1978, BIOCHEM J, V170, P355, DOI 10.1042/bj1700355; Xu RQ, 2008, J BACTERIOL, V190, P343, DOI 10.1128/JB.00978-07	97	17	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0202305	10.1371/journal.pone.0202305	http://dx.doi.org/10.1371/journal.pone.0202305			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278048	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000446010200002
J	Dance, KM; Rooker, JR; Shipley, JB; Dance, MA; Wells, RJD				Dance, Kaylan M.; Rooker, Jay R.; Shipley, J. Brooke; Dance, Michael A.; Wells, R. J. David			Feeding ecology of fishes associated with artificial reefs in the northwest Gulf of Mexico	PLOS ONE			English	Article							TRIGGERFISH BALISTES-CAPRISCUS; SNAPPER LUTJANUS-CAMPECHANUS; STABLE-ISOTOPE ANALYSES; RED SNAPPER; GRAY TRIGGERFISH; NORTHEASTERN GULF; TROPHIC ECOLOGY; NATURAL REEFS; FOOD WEBS; HABITAT COMPLEXITY	The feeding ecology of two reef fishes associated with artificial reefs in the northwest Gulf of Mexico (GoM) was examined using gut contents and natural stable isotopes. Reefs were divided into three regions (east, central, west) across an east to west gradient of increasing reef complexity and salinity. Gray triggerfish (Balistes capriscus) primarily consumed reef-associated prey (xanthid crabs, bivalves, barnacles) and pelagic gastropods, while red snapper (Lutjanus campechanus) diets were mainly comprised of non-reef prey (stomato-pods, fishes, portunid crabs). Natural stable isotopes of carbon (delta C-13), nitrogen (delta N-15), and sulfur (delta S-34) were measured in consumer muscle tissue as well as potential primary producers. Gray triggerfish occupied a lower trophic position than red snapper, with lower delta C-13 and delta N-15 values across all size classes and regions, and generally higher delta S-34 values. Red snapper had a smaller range of stable isotope values and corrected standard ellipse areas across all size classes and regions, indicating a smaller isotopic niche. Contribution estimates of particulate organic matter (26 to 54%) and benthic microalgae (BMA, 47 to 74%) for both species were similar, with BMA contributions greater across all three size classes (juveniles, sub-adults, adults) of red snapper and all but the juvenile size class for gray triggerfish. Species gut contents and stable isotopes differed by region, with fishes consuming more crabs in the east region and more gastropods in the central and west regions. delta C-13 and delta N-15 values generally decreased from east to west, while delta S-34 increased across this gradient. Results highlight species-specific feeding differences associated with artificial reefs, where gray triggerfish may be more dependent on the reef structure for foraging opportunities. In addition, results offer further information on the integral role of BMA in primary production at nearshore artificial reefs.	[Dance, Kaylan M.; Rooker, Jay R.; Dance, Michael A.; Wells, R. J. David] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Rooker, Jay R.; Wells, R. J. David] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Shipley, J. Brooke] Artificial Reef Program, Texas Pk & Wildlife Dept, Austin, TX USA; [Dance, Michael A.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Louisiana State University System; Louisiana State University	Dance, KM (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	kaylandance@gmail.com	Shipley, Brooke/T-3045-2019		Texas Parks and Wildlife Departments Artificial Reef Program [443017]	Texas Parks and Wildlife Departments Artificial Reef Program	This work was funded by the Texas Parks and Wildlife Departments Artificial Reef Program (Award #443017) to RJDW and JRR. Funding agency website: https://tpwd.texas.gov/landwater/water/habitats/artificial_reef/. The funders, with exception of the named author, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DT, 2016, N AM J FISH MANAGE, V36, P131, DOI 10.1080/02755947.2015.1084406; Addis DT, 2013, FISH RES, V147, P349, DOI 10.1016/j.fishres.2013.07.011; Ahlbeck I, 2012, CAN J FISH AQUAT SCI, V69, P1184, DOI [10.1139/F2012-051, 10.1139/f2012-051]; Ajemian MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126354; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2016, 43 SEDAR; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Ballard Sarah E., 2012, Gulf and Caribbean Research, V24, P31; Becker A, 2017, ICES J MAR SCI, V74, P277, DOI 10.1093/icesjms/fsw133; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bohnsack J.A., 1991, P61; BOHNSACK JA, 1985, B MAR SCI, V37, P11; Bortone SA, 1998, ITAL J ZOOL, V65, P265, DOI 10.1080/11250009809386830; Bretz F., 2016, MULTIPLE COMP USING; Brickhill MJ, 2005, J FISH BIOL, V67, P53, DOI 10.1111/j.0022-1112.2005.00915.x; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Charbonnel E, 2002, ICES J MAR SCI, V59, pS208, DOI 10.1006/jmsc.2002.1263; Clarke K. R., 2015, PRIMER V7 USER MANUA; Creach V, 1997, ESTUAR COAST SHELF S, V44, P599, DOI 10.1006/ecss.1996.0147; Cresson P, 2014, MAR ECOL PROG SER, V509, P15, DOI 10.3354/meps10866; Daigle ST, 2013, MAR COAST FISH, V5, P53, DOI 10.1080/19425120.2013.774301; Dance MA, 2011, B MAR SCI, V87, P301, DOI 10.5343/bms.2010.1040; Fischer AJ, 2004, FISH B-NOAA, V102, P593; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; FRAZER TK, 1991, B MAR SCI, V48, P159; Frisch AJ, 2014, MAR BIOL, V161, P61, DOI 10.1007/s00227-013-2315-4; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Fry B, 2007, STABLE ISOTOPE ECOLO; Gallaway BJ, 2009, REV FISH SCI, V17, P48, DOI 10.1080/10641260802160717; Gelman A., 1992, BAYESIAN STAT, V4, P625; Goldman SF, 2016, FISH B-NOAA, V114, P317, DOI 10.7755/FB.114.3.5; Gregalis KC, 2012, T AM FISH SOC, V141, P1453, DOI 10.1080/00028487.2012.703154; Grossman GD, 1997, FISHERIES, V22, P17, DOI 10.1577/1548-8446(1997)022<0017:DARIRF>2.0.CO;2; Guzzo MM, 2013, BIOL INVASIONS, V15, P1695, DOI 10.1007/s10530-012-0401-z; Herbig JL, 2016, FISHERIES MANAG ECOL, V23, P418, DOI 10.1111/fme.12190; Herzka SZ, 2000, CAN J FISH AQUAT SCI, V57, P137, DOI 10.1139/cjfas-57-1-137; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Jaxion-Harm J, 2015, N AM J FISH MANAGE, V35, P86, DOI 10.1080/02755947.2014.982332; Karnauskas M, 2017, MAR COAST FISH, V9, P50, DOI 10.1080/19425120.2016.1255684; Koeck B, 2014, AQUAT BIOL, V20, P219, DOI 10.3354/ab00561; Kulaw DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172360; KURZ RC, 1995, B MAR SCI, V56, P150; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lindberg WJ, 1997, FISHERIES, V22, P10; LINDQUIST DG, 1994, B MAR SCI, V55, P308; Lingo ME, 2006, ENVIRON BIOL FISH, V76, P71, DOI 10.1007/s10641-006-9009-4; Lombardi LRA, SEDAR43WP102015; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; McCawley Jessica R., 2006, Gulf of Mexico Science, V24, P14; Melville AJ, 2003, OECOLOGIA, V136, P499, DOI 10.1007/s00442-003-1302-8; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; Morey SL, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001674; Moriarty PE, 2017, CAN J FISH AQUAT SCI, V74, P168, DOI 10.1139/cjfas-2016-0149; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinkas L, 1970, FISH B, V152, P10; Plumlee JD, 2016, MAR ECOL PROG SER, V550, P163, DOI 10.3354/meps11723; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rooker JR, 2004, ESTUAR COAST SHELF S, V59, P653, DOI 10.1016/j.ecss.2003.11.009; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Shipp RL, 2009, REV FISH SCI, V17, P41, DOI 10.1080/10641260802104244; Simmons CM, 2011, T AM FISH SOC, V140, P14, DOI 10.1080/00028487.2011.545002; Simonsen KA, 2015, ENVIRON BIOL FISH, V98, P811, DOI 10.1007/s10641-014-0317-9; Sluis MZ, 2013, ENVIRON TOXICOL CHEM, V32, P434, DOI 10.1002/etc.2077; Stephane C, 2009, J APPL ECOL, V46, P443; Stock B.C., 2013, MIXSIAR GUI USER MAN; Streich MK, 2016, ECOLOGY RED SNAPPER; Strelcheck AJ, 2005, B MAR SCI, V77, P425; Sutton SG, 2007, OCEAN COAST MANAGE, V50, P829, DOI 10.1016/j.ocecoaman.2007.01.003; Szedlmayer ST, 2004, FISH B-NOAA, V102, P366; Tarnecki JH, 2015, MAR COAST FISH, V7, P135, DOI 10.1080/19425120.2015.1020402; Tessier A, 2015, HYDROBIOLOGIA, V753, P1, DOI 10.1007/s10750-015-2213-5; Tolan JM, 2007, ESTUAR COAST SHELF S, V72, P247, DOI 10.1016/j.ecss.2006.10.018; VOSE FE, 1994, B MAR SCI, V55, P1316; Wang XC, 2004, MAR CHEM, V89, P241, DOI 10.1016/j.marchem.2004.02.014; Wells RJD, 2008, MAR ECOL PROG SER, V361, P213, DOI 10.3354/meps07425; [No title captured]	82	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203873	10.1371/journal.pone.0203873	http://dx.doi.org/10.1371/journal.pone.0203873			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278043	Green Submitted, Green Published, gold			2022-12-27	WOS:000446010200007
J	Peikert, T; Duan, FH; Rajagopalan, S; Karwoski, RA; Clay, R; Robb, RA; Qin, ZL; Sicks, J; Bartholmai, BJ; Maldonado, F				Peikert, Tobias; Duan, Fenghai; Rajagopalan, Srinivasan; Karwoski, Ronald A.; Clay, Ryan; Robb, Richard A.; Qin, Ziling; Sicks, JoRean; Bartholmai, Brian J.; Maldonado, Fabien			Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial (vol 13, e0196910, 2018)	PLOS ONE			English	Correction															Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0110]	Office of the Assistant Secretary of Defense for Health Affairs	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Lung Cancer Research Program under Award No. W81XWH-15-1-0110 (Fabien Maldonado). Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Peikert T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196910	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205311	10.1371/journal.pone.0205311	http://dx.doi.org/10.1371/journal.pone.0205311			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278080	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200047
J	Huang, FF; Wang, ZH; Zhang, JG; Du, WW; Su, C; Jiang, HR; Jia, XF; Ouyang, YF; Wang, Y; Li, L; Zhang, B; Wang, HJ				Huang, Feifei; Wang, Zhihong; Zhang, Jiguo; Du, Wenwen; Su, Chang; Jiang, Hongru; Jia, Xiaofang; Ouyang, Yifei; Wang, Yun; Li, Li; Zhang, Bing; Wang, Huijun			Dietary calcium intake and food sources among Chinese adults in CNTCS	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEALTH; DAIRY; RISK; NUTRIENTS; ENERGY; TRENDS; WOMEN	Background Calcium is one of the essential micronutrients in the human body and is well-known for its important role in keeping bones and teeth healthy. However, calcium deficiency is a very common nutritional problem in the world and especially in China. The aim of this research was to determine the dietary calcium intake of Chinese adults and the corresponding food sources based on data from the 2015 China Nutritional Transition Cohort Study. Methods We obtained dietary data from Chinese adults ages 18 to 64 years in 15 provinces, autonomous regions, and municipalities using 3 consecutive days combined with the household weighing method. We used the China Food Composition (book 1, 2nd edition) to calculate the calcium intake from each food category. We regarded the percentage of participants with a calcium intake median below the estimated average requirement as the level of calcium inadequacy in the overall population. Results We divided the participants into 2 age groups, 18-49 years and 50-64 years, which included 6,630 and 5,307 participants, respectively. The groups' dietary calcium intake medians were 324.8 milligrams per day (mg/d) and 332.7 mg/d, respectively, and the calcium inadequacies were 92.9% and 96.0%, correspondingly. The median calcium intake for the whole study population was 328.3 mg/d, and the inadequacy was 94.3%, which improved with higher education, income, and urbanization levels. The main food sources of dietary calcium among the study population were vegetables, legumes, and cereals, which contributed 30.2%, 16.7%, and 14.6%, respectively. Milk and dairy products contributed 6.7% to the study population but varied with the urbanization level to 15.0%, 6.1%, 6.3%, and 2.0% in urban, suburban, county, and rural areas, respectively. Conclusion These findings highlight the importance of nutrition education and intervention for Chinese adults to improve their dietary structures and increase milk and dairy products intake to consume adequate calcium.	[Huang, Feifei; Wang, Zhihong; Zhang, Jiguo; Du, Wenwen; Su, Chang; Jiang, Hongru; Jia, Xiaofang; Ouyang, Yifei; Wang, Yun; Li, Li; Zhang, Bing; Wang, Huijun] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China.	wanghj@ninh.chinacdc.cn			Ministry of Finance of the people's Republic of China [13103110700015005]	Ministry of Finance of the people's Republic of China	Financial support was provided by Ministry of Finance of the people's Republic of China (No. 13103110700015005). The website about this fund is not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidong L, 2012, ACTA NUTRIMENTA SINI, V34, P10; Barr SI, 2002, J AM DIET ASSOC, V102, P780, DOI 10.1016/S0002-8223(02)90177-X; Barr SI, 2006, APPL PHYSIOL NUTR ME, V31, P66, DOI [10.1139/h05-020, 10.1139/H05-020]; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Fan YiOu, 2012, Acta Nutrimenta Sinica, V34, P15; Feifei H, 2018, ACTA NUTRIMENTA SINI; Food and Drug Administration HHS, 2008, Fed Regist, V73, P56477; Jile C, 2016, MONITORING NUTR HLTH, P37; Koyama T, 2017, ASIA PAC J CLIN NUTR, V26, P837, DOI 10.6133/apjcn.072016.11; Manios Y, 2015, NUTRIENTS, V7, P1841, DOI 10.3390/nu7031841; Mensink GBM, 2013, BRIT J NUTR, V110, P755, DOI 10.1017/S000711451200565X; Murphy SP, 2002, PUBLIC HEALTH NUTR, V5, P843, DOI 10.1079/PHN2002389; Murphy SP, 2008, ASIA PAC J CLIN NUTR, V17, P299; Nicklas TA, 2009, J AM COLL NUTR, V28, p73S, DOI 10.1080/07315724.2009.10719807; Nutrition C. S. O, 2013, CHIN DIET REF INT, P31; O'Neil CE, 2012, NUTRIENTS, V4, P2097, DOI 10.3390/nu4122097; Oh JM, 2017, NUTR METAB CARDIOVAS, V27, P1152, DOI 10.1016/j.numecd.2017.10.005; Olza J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020168; Paik JM, 2014, OSTEOPOROSIS INT, V25, P2047, DOI 10.1007/s00198-014-2732-3; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Quann EE, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0057-5; Serra-Majem L, 2007, PUBLIC HEALTH NUTR, V10, P1354, DOI 10.1017/S1368980007000961; Strohle A, 2015, CLIMACTERIC, V18, P702, DOI 10.3109/13697137.2015.1016419; Talaei M, 2017, J NUTR, V147, P235, DOI 10.3945/jn.116.238485; Wang HJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040397; [王美辰 Wang Meichen], 2017, [营养学报, Acta Nutrimenta Sinica], V39, P332; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283; Yuexin Y, CHINA FOOD COMPOSITI, V1, P3	29	24	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205045	10.1371/journal.pone.0205045	http://dx.doi.org/10.1371/journal.pone.0205045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273413	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700062
J	Onodera, Y; Teramura, T; Takehara, T; Itokazu, M; Mori, T; Fukuda, K				Onodera, Yuta; Teramura, Takeshi; Takehara, Toshiyuki; Itokazu, Maki; Mori, Tatsufumi; Fukuda, Kanji			Inflammation-associated miR-155 activates differentiation of muscular satellite cells	PLOS ONE			English	Article							MUSCLE STEM-CELL; BINDING-PROTEIN BETA; SKELETAL-MUSCLE; BONE-MARROW; MICRORNA EXPRESSION; SELF-RENEWAL; ADULT; PROLIFERATION; QUIESCENCE; NICHE	Tissue renewal and muscle regeneration largely rely on the proliferation and differentiation of muscle stem cells called muscular satellite cells (MuSCs). MuSCs are normally quiescent, but they are activated in response to various stimuli, such as inflammation. Activated MuSCs proliferate, migrate, differentiate, and fuse to form multinucleate myofibers. Meanwhile, inappropriate cues for MuSC activation induce premature differentiation and bring about stem cell loss. Recent studies revealed that stem cell regulation is disrupted in various aged tissues. We found that the expression of microRNA (miR)-155, which is an inflammation-associated miR, is upregulated in MuSCs of aged muscles, and this upregulation activates the differentiation process through suppression of C/ebp beta, which is an important molecule for maintaining MuSC self-renewal. We also found that Notch1 considerably repressed miR-155 expression, and loss of Notch1 induced miR-155 overexpression. Our findings suggest that miR-155 can act as an activator of muscular differentiation and might be responsible for accelerating aging-associated premature differentiation of MuSCs.	[Onodera, Yuta; Teramura, Takeshi; Takehara, Toshiyuki; Fukuda, Kanji] Kindai Univ, Inst Adv Clin Med, Div Cell Biol Regenerat Med, Fac Med, Osaka, Japan; [Itokazu, Maki; Fukuda, Kanji] Kindai Univ, Dept Rehabil Med, Fac Med, Osaka, Japan; [Mori, Tatsufumi] Kindai Univ, Life Sci Res Inst, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University)	Teramura, T (corresponding author), Kindai Univ, Inst Adv Clin Med, Div Cell Biol Regenerat Med, Fac Med, Osaka, Japan.	teramura@med.kindai.ac.jp	Itokazu, Maki/T-9417-2019; Teramura, Takeshi/ELU-7591-2022	Itokazu, Maki/0000-0002-6349-6571; Teramura, Takeshi/0000-0002-5310-4749	JSPS KAKENHI Grant [16K01484, 17K01487]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 16K01484 (KF) and 17K01487 (MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Blaya D, 2018, HEPATOLOGY, V68, P691, DOI 10.1002/hep.29833; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen WY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41159; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Costamagna D, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/805172; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dedkov EI, 2003, CELL TISSUE RES, V311, P401, DOI 10.1007/s00441-002-0686-9; Ding SJ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.3; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fu DC, 2015, J BIOL CHEM, V290, P10200, DOI 10.1074/jbc.M115.638577; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liu L, 2015, NAT PROTOC, V10, P1612, DOI 10.1038/nprot.2015.110; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Marchildon F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.4; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; MUSARO A, 1995, EXP CELL RES, V221, P241, DOI 10.1006/excr.1995.1372; Nie M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.165; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Obora K, 2017, SCI REP-UK, V7, DOI 10.1038/srep43604; Onodera Y, 2017, AGING CELL, V16, P1369, DOI 10.1111/acel.12680; Park S, 2013, IMMUNOL INVEST, V42, P179, DOI 10.3109/08820139.2012.717328; Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Sredni Simone T., 2011, Frontiers in Genetics, V2, P49, DOI 10.3389/fgene.2011.00049; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Van Roosbroeck K, 2017, CLIN CANCER RES, V23, P2891, DOI 10.1158/1078-0432.CCR-16-1025; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Woodbury ME, 2015, J NEUROSCI, V35, P9764, DOI 10.1523/JNEUROSCI.4790-14.2015; Yue F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14328; Zhai LL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.128	51	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204860	10.1371/journal.pone.0204860	http://dx.doi.org/10.1371/journal.pone.0204860			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273359	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700043
J	Sajid, A; Lusvarghi, S; Chufan, EE; Ambudkar, SV				Sajid, Andaleeb; Lusvarghi, Sabrina; Chufan, Eduardo E.; Ambudkar, Suresh, V			Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1)	PLOS ONE			English	Article							DRUG-BINDING POCKET; MULTIDRUG-RESISTANCE; ATP HYDROLYSIS; CATALYTIC CYCLE; MAMMALIAN-CELLS; INHIBITION; RESIDUES; POLYSPECIFICITY; EXPRESSION; CANCER	P-glycoprotein (P-gp) is an ABC transporter that exports many amphipathic or hydrophobic compounds, including chemically and functionally dissimilar anticancer drugs, from cells. To understand the role of transmembrane helices (TMH) 1 and 7 in drug-binding and transport, we selected six residues from both TMH1 (V53, 159, I60, L65, M68 and F72) and TMH7 (V713,I719,I720, Q725, F728 and F732); and substituted them with alanine by gene synthesis to generate a variant termed "TMH1,7 mutant P-gp". The expression and function of TMH1,7 mutant P-gp with twelve mutations was characterized using the BacMam baculovirus-HeLa cell expression system. The expression and conformation of TMH1,7 mutant P-gp was not altered by the introduction of the twelve mutations, as confirmed by using the human P-gp-specific antibodies UIC2, MRK16 and 4E3. We tested 25 fluorescently-labeled substrates and found that only three substrates, NBD-cyclosporine A, Rhod-2-AM and X-Rhod-1-AM were transported by the TMH1,7 mutant. The basal ATPase activity of TMH1,7 mutant P-gp was lower (40-50%) compared to wild-type (WT) P-gp, despite similar level of expression. Although most of the substrates modulate ATPase activity of P-gp, the activity of TMH1,7 mutant transporter was not significantly modulated by any of the tested substrates. Docking of selected substrates in homology models showed comparable docking scores for the TMH1,7 mutant and WT P-gp, although the binding conformations were different. Both the ATPase assay and in silico docking analyses suggest that the interactions with residues in the drug-binding pocket are altered as a consequence of the mutations. We demonstrate that it is possible to generate a variant of P-gp with a loss of broad substrate specificity and propose that TMH1 and TMH7 play a critical role in the drug efflux function of this multidrug transporter.	[Sajid, Andaleeb; Lusvarghi, Sabrina; Chufan, Eduardo E.; Ambudkar, Suresh, V] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambudkar, SV (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	ambudkar@mail.nih.gov	Sajid, Andaleeb/AAI-2960-2020	Sajid, Andaleeb/0000-0001-6248-4985; Ambudkar, Suresh/0000-0002-2639-4955; Lusvarghi, Sabrina/0000-0003-1793-0450	National Institutes of Health, the National Cancer Institute, Center for Cancer Research [ZIA BC010030]; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER	National Institutes of Health, the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Center for Cancer Research (project #ZIA BC010030).	Alam A, 2018, P NATL ACAD SCI USA, V115, pE1973, DOI 10.1073/pnas.1717044115; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Callaghan R, 2014, DRUG METAB DISPOS, V42, P623, DOI 10.1124/dmd.113.056176; Cascorbi I, 2011, HANDB EXP PHARMACOL, V201, P261, DOI 10.1007/978-3-642-14541-4_6; Chufan EE, 2016, BIOCHEM PHARMACOL, V101, P40, DOI 10.1016/j.bcp.2015.12.007; Chufan EE, 2015, ADV CANCER RES, V125, P71, DOI 10.1016/bs.acr.2014.10.003; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Egido E, 2015, MOL PHARMACEUT, V12, P4026, DOI 10.1021/acs.molpharmaceut.5b00463; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Kim Y, 2018, SCIENCE, V359, P915, DOI 10.1126/science.aar7389; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Li MJ, 2018, J BIOL CHEM, V293, P6297, DOI 10.1074/jbc.RA118.002190; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; Loo TW, 1996, J BIOL CHEM, V271, P15414, DOI 10.1074/jbc.271.26.15414; LOO TW, 1994, J BIOL CHEM, V269, P28683; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; Martinez L, 2014, FEBS J, V281, P673, DOI 10.1111/febs.12613; Okochi E, 1997, LEUKEMIA, V11, P1119, DOI 10.1038/sj.leu.2400658; Pan LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07880; Pluchino KM, 2016, BIOCHEMISTRY-US, V55, P1010, DOI 10.1021/acs.biochem.5b01064; Pluchino KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136396; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Shukla S, 2012, DRUG METAB DISPOS, V40, P304, DOI 10.1124/dmd.111.042721; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Szollosi D, 2018, BBA-BIOMEMBRANES, V1860, P818, DOI 10.1016/j.bbamem.2017.10.028; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vahedi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30984-8; Vahedi S, 2017, BIOCHEM PHARMACOL, V143, P53, DOI 10.1016/j.bcp.2017.07.014; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Yuan SG, 2016, STRUCTURE, V24, P2041, DOI 10.1016/j.str.2016.11.012	56	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204693	10.1371/journal.pone.0204693	http://dx.doi.org/10.1371/journal.pone.0204693			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265721	gold, Green Submitted, Green Published			2022-12-27	WOS:000446005500045
J	Yen, PS; Amraoui, F; Rua, AV; Failloux, AB				Yen, Pei-Shi; Amraoui, Fadila; Rua, Anubis Vega; Failloux, Anna-Bella			Aedes aegypti mosquitoes from Guadeloupe (French West Indies) are able to transmit yellow fever virus	PLOS ONE			English	Article							VECTOR COMPETENCE; DENGUE; CHIKUNGUNYA; ALBOPICTUS; DIPTERA; ISLANDS	The recent yellow fever epidemic in Brazil has raised the concern of outbreaks in neighboring countries, particularly in the Caribbean region where the vector Aedes aegypti is predominant. This threat comes from the past when in the Americas, this disease caused devastating urban epidemics. We report the vector competence of Ae. aegypti from Guadeloupe for yellow fever virus by determining different parameters describing virus infection, dissemination, and transmission. The results indicate that Ae. aegypti Guadeloupe are susceptible to yellow fever virus with viral particles detected in mosquito saliva at 14 and 21 days post-infection. Local authorities and more broadly, international organizations should maintain the active surveillance of Aedes mosquitoes and the spreading of human cases from South America.	[Yen, Pei-Shi; Amraoui, Fadila; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, Paris, France; [Rua, Anubis Vega] Inst Pasteur Guadeloupe, Environm & Hlth Unit, Lab Vector Control Res, Les Abymes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Yen, PS (corresponding author), Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, Paris, France.	pei-shi.yen@pasteur.fr		Yen, Pei-Shi/0000-0002-2113-7394	French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; FEDER - European Union; Guadeloupe Region, Programme Operationnel FEDER-Guadeloupe-Conseil Regional [2015-FED-192]; Institut Pasteur; National Health Research Institutes in Taiwan	French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); FEDER - European Union(European Commission); Guadeloupe Region, Programme Operationnel FEDER-Guadeloupe-Conseil Regional; Institut Pasteur(European Commission); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	ABF was funded by French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID); AVR was funded by FEDER grant that financed by the European Union and Guadeloupe Region, Programme Operationnel FEDER-Guadeloupe-Conseil Regional 2014-2020 (Grant number 2015-FED-192). P-SY was supported by the Institut Pasteur and the National Health Research Institutes in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Rev Panam Salud Publica, V1, P68; Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Bryan CS, 2004, INFECT DIS CLIN N AM, V18, P275, DOI 10.1016/j.idc.2004.01.007; Cathey JT, 2014, T ROY SOC TROP MED H, V108, P252, DOI 10.1093/trstmh/tru043; Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3; Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046; Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285; Dorleans F, 2018, AM J TROP MED HYG, V98, P1819, DOI 10.4269/ajtmh.16-0719; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Ellis BR, 2012, T ROY SOC TROP MED H, V106, P387, DOI 10.1016/j.trstmh.2012.02.007; Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x; GOODYEAR JD, 1978, B HIST MED, V52, P5; Gustave J, 1996, B SOC PATHOL EXOT, V89, P143; Gustave J, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/249524; Johnson BW, 2002, T ROY SOC TROP MED H, V96, P611, DOI 10.1016/S0035-9203(02)90326-3; Jupp PG, 2002, T ROY SOC TROP MED H, V96, P493, DOI 10.1016/S0035-9203(02)90417-7; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Larrieu S, 2014, ACTA TROP, V131, P37, DOI 10.1016/j.actatropica.2013.11.023; Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P437, DOI 10.1590/S0074-02762002000300031; Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Pan American Health Organization (PAHO), 2018, EP UPD YELL FEV; Pastorino BAM, 2008, VIRUS RES, V131, P293, DOI 10.1016/j.virusres.2007.09.009; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; van den Hurk AF, 2011, AM J TROP MED HYG, V85, P446, DOI 10.4269/ajtmh.2011.11-0061; Vasconcelos PFC, 1999, DENGUE B, V23, P11; Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204710	10.1371/journal.pone.0204710	http://dx.doi.org/10.1371/journal.pone.0204710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265716	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500046
J	Niitsuma, ENA; Fernandes, GD; Lana, FCF				Alvarenga Niitsuma, Eyleen Nabyla; Fernandes, Gabriel da Rocha; Felix Lana, Francisco Carlos			The TLR1 gene is associated with higher protection from leprosy in women	PLOS ONE			English	Article							SEX-DIFFERENCES; SUSCEPTIBILITY; POLYMORPHISM; TUBERCULOSIS; INFECTION; RESPONSES; DISEASE; CELLS; N248S; NOD2	Leprosy is an infectious disease with a complex genetic and immunological background. Polymorphisms in genes that encode cytokines and receptors involved in the immune response, such as the Toll-like receptor 1 (TLR1), may be associated with disease risk. We hypothesized that polymorphisms in innate immunity genes confer susceptibility to leprosy that differs between women and men. In this study, we investigate sex differences in the association between a single nucleotide polymorphism (SNP) in TLR1 and Nucleotide-binding oligomerization domain containing 2 (NOD2) genes and leprosy susceptibility in 256 clinically classified leprosy patients and 233 control subjects in a Brazilian population. Our results showed no association between the SNP rs8057341 in NOD2 and leprosy in this population. However, the heterozygous genotype of the TLR1 SNP (rs4833095) showed a statistically significant association in women (OR = 0.54, P = 0.02). Our findings suggest that the TLR1 polymorphism was associated with an increased protection from leprosy in women.	[Alvarenga Niitsuma, Eyleen Nabyla] IFNMG, Inst Fed Educ Ciencia & Tecnol Norte Minas Gerais, Almenara, MG, Brazil; [Fernandes, Gabriel da Rocha] Fiocruz Minas, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Felix Lana, Francisco Carlos] Univ Fed Minas Gerais, Escola Enfermagem, Dept Maternal & Child Nursing & Publ Hlth, Belo Horizonte, MG, Brazil	Instituto Federal do Norte de Minas Gerais (IFNMG); Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Niitsuma, ENA (corresponding author), IFNMG, Inst Fed Educ Ciencia & Tecnol Norte Minas Gerais, Almenara, MG, Brazil.	eyleen.alvarenga@ifnmg.edu.br	Niitsuma, Eyleen Nabyla Alvarenga/AAQ-9344-2020; Lana, Francisco/AAD-1443-2019; da Rocha Fernandes, Gabriel/A-5383-2010; Lana, Francisco CF/I-1438-2012	Niitsuma, Eyleen Nabyla Alvarenga/0000-0002-5781-6313; Lana, Francisco/0000-0001-9043-3181; da Rocha Fernandes, Gabriel/0000-0002-4897-8521; Lana, Francisco CF/0000-0001-9043-3181	Health Surveillance Secretariat of the Ministry of Health. Government of Brazil [23072.039742 / 2012-29]	Health Surveillance Secretariat of the Ministry of Health. Government of Brazil	This study was funded by Health Surveillance Secretariat of the Ministry of Health. Government of Brazil (Grant number: 23072.039742 / 2012-29) to FCFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P501; Brazil Ministry of Health, 2008, HLTH SURV EP SIT LEP; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Colombini A, 2015, INT J MOL SCI, V16, P3722, DOI 10.3390/ijms16023722; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Geluk A, 2013, LEPROSY REV, V84, P3; Griesbeck M, 2015, J IMMUNOL, V195, P5327, DOI 10.4049/jimmunol.1501684; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; Hart BE, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/415057; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Lastoria JC, 2014, AN BRAS DERMATOL, V89, P205, DOI 10.1590/abd1806-4841.20142450; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Manry J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012450; Marcinek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073103; Marques CD, 2013, J INFECT DIS, V208, P120, DOI 10.1093/infdis/jit133; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001; O'Neill LAJ, 2015, NATURE REV IMMUNOLOG; Pino-Yanes M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013759; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Sales-Marques C, 2014, HUM GENET, V133, P1525, DOI 10.1007/s00439-014-1502-9; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh KD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/538053; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; van Lunzen J, 2014, J INFECT DIS, V209, pS79, DOI 10.1093/infdis/jiu159; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205234	10.1371/journal.pone.0205234	http://dx.doi.org/10.1371/journal.pone.0205234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289892	Green Submitted, Green Published, gold			2022-12-27	WOS:000446545500057
J	Bayati, M; Neher, T; Melchior, J; Diba, K; Wiskott, L; Cheng, S				Bayati, Mehdi; Neher, Torsten; Melchior, Jan; Diba, Kamran; Wiskott, Laurenz; Cheng, Sen			Storage fidelity for sequence memory in the hippocampal circuit	PLOS ONE			English	Article							DENTATE GYRUS; ENTORHINAL CORTEX; PYRAMIDAL CELLS; NEURAL-NETWORK; PLACE CELLS; DOUBLE DISSOCIATION; DORSAL HIPPOCAMPUS; PATTERN COMPLETION; RECURRENT NETWORK; PHASE PRECESSION	Episodic memories have been suggested to be represented by neuronal sequences, which are stored and retrieved from the hippocampal circuit. A special difficulty is that realistic neuronal sequences are strongly correlated with each other since computational memory models generally perform poorly when correlated patterns are stored. Here, we study in a computational model under which conditions the hippocampal circuit can perform this function robustly. During memory encoding, CA3 sequences in our model are driven by intrinsic dynamics, entorhinal inputs, or a combination of both. These CA3 sequences are hetero-associated with the input sequences, so that the network can retrieve entire sequences based on a single cue pattern. We find that overall memory performance depends on two factors: the robustness of sequence retrieval from CA3 and the circuit's ability to perform pattern completion through the feedforward connectivity, including CA3, CA1 and EC. The two factors, in turn, depend on the relative contribution of the external inputs and recurrent drive on CA3 activity. In conclusion, memory performance in our network model critically depends on the network architecture and dynamics in CA3.	[Bayati, Mehdi; Melchior, Jan; Wiskott, Laurenz; Cheng, Sen] Ruhr Univ Bochum, Inst Neuroinformat, Bochum, Germany; [Neher, Torsten] Ruhr Univ Bochum, Fac Psychol, Dept Clin Child & Adolescent Psychol, Mental Hlth Res & Treatment Ctr, Bochum, Germany; [Diba, Kamran] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA	Ruhr University Bochum; Ruhr University Bochum; University of Michigan System; University of Michigan	Cheng, S (corresponding author), Ruhr Univ Bochum, Inst Neuroinformat, Bochum, Germany.	sen.cheng@rub.de	Wiskott, Laurenz/P-7715-2017; Cheng, Sen/A-5722-2009	Wiskott, Laurenz/0000-0001-6237-740X; Cheng, Sen/0000-0002-6719-8029; Axmacher, Nikolai/0000-0002-0475-6492; Bayati, Mehdi/0000-0002-4040-198X	German Research Foundation (DFG) [SFB 874]; Stiftung Mercator; German Federal Ministry of Education and Research (BMBF) [01GQ1506]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088798] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Stiftung Mercator; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the German Research Foundation (DFG) through the SFB 874, projects B2 (S.C.) and B3 (L.W.), from the Stiftung Mercator (S.C.), and from the German Federal Ministry of Education and Research (BMBF), grant 01GQ1506 (S.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agster KL, 2002, J NEUROSCI, V22, P5760; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Amit Daniel J., 1992, MODELING BRAIN FUNCT; Appleby PA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001063; Azizi AH, 2014, HIPPOCAMPUS, V24, P912, DOI 10.1002/hipo.22306; Azizi AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00161; Battaglia FP, 1998, NEURAL COMPUT, V10, P431, DOI 10.1162/089976698300017827; Bayati M, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00069; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cheng S, 2011, NEUROSCIENCE, V197, P293, DOI 10.1016/j.neuroscience.2011.09.002; Cheng S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00088; CHIBA AA, 1994, BEHAV NEURAL BIOL, V61, P123, DOI 10.1016/S0163-1047(05)80065-2; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Cutsuridis V, 2010, SPR SER COMPUT NEURO, V5, P1, DOI 10.1007/978-1-4419-0996-1; de Camargo RY, 2018, PEERJ, V6, DOI 10.7717/peerj.4203; Deshmukh SS, 2003, J NEUROSCI, V23, P1903; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gluck M.A., 2001, GATEWAY MEMORY INTRO; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Guzman SJ, 2016, SCIENCE, V353, P1117, DOI 10.1126/science.aaf1836; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hawkins J, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00023; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P699, DOI 10.1002/hipo.20429; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Itskov V, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00040; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H., 2001, BONN GER GER NATL RE, V148, P2001; Jahnke S, 2015, J NEUROSCI, V35, P16236, DOI 10.1523/JNEUROSCI.3977-14.2015; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerman T, 2006, LEARN MEMORY, V13, P458, DOI 10.1101/lm.246906; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Kloosterman F, 2000, ANN NY ACAD SCI, V911, P459; Kropff Emilio, 2007, Natural Computing, V6, P169, DOI 10.1007/s11047-006-9019-3; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuipers SD, 2015, NEUROBIOL AGING, V36, P365, DOI 10.1016/j.neurobiolaging.2014.07.033; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Lazic SE, 2012, NEUROBIOL AGING, V33, P1664, DOI 10.1016/j.neurobiolaging.2011.03.008; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Leibold C, 2006, NEURAL COMPUT, V18, P904, DOI 10.1162/089976606775774714; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 1998, ADV NEUR IN, V10, P194; Maass W, 1997, NEURAL NETWORKS, V10, P1659, DOI 10.1016/S0893-6080(97)00011-7; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Middleton SJ, 2016, NAT NEUROSCI, V19, P945, DOI 10.1038/nn.4311; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moustafa AA, 2009, BRAIN RES, V1276, P180, DOI 10.1016/j.brainres.2009.04.020; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Neher T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181618; Neher T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004250; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Panzeri S, 2001, NETWORK-COMP NEURAL, V12, P423, DOI 10.1088/0954-898X/12/4/302; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pyka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085016; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rao RPN, 2000, ADV NEUR IN, V12, P164; Renno-Costa C, 2010, NEURON, V68, P1051, DOI 10.1016/j.neuron.2010.11.024; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; Rolls ET, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P51; Romani S, 2015, HIPPOCAMPUS, V25, P94, DOI 10.1002/hipo.22355; Roudi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000012; Salz DM, 2016, J NEUROSCI, V36, P7476, DOI 10.1523/JNEUROSCI.0087-16.2016; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; SOMPOLINSKY H, 1986, PHYS REV LETT, V57, P2861, DOI 10.1103/PhysRevLett.57.2861; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; TAUBE JS, 1990, J NEUROSCI, V10, P420; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TREVES A, 1993, NETWORK-COMP NEURAL, V4, P259, DOI 10.1088/0954-898X/4/3/002; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.0.CO;2-S; Vago DR, 2007, HIPPOCAMPUS, V17, P977, DOI 10.1002/hipo.20329; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; Willshaw David J, 1969, NATURE; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Yoon J, 2012, LEARN MEMORY, V19, P1, DOI 10.1101/lm.024554.111; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	120	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204685	10.1371/journal.pone.0204685	http://dx.doi.org/10.1371/journal.pone.0204685			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286147	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500034
J	Lee, MJ; Park, JH; Moon, YR; Jo, SY; Yoon, D; Park, RW; Jeong, JC; Park, I; Shin, GT; Kim, H				Lee, Min-Jeong; Park, Joo-Han; Moon, Yeo Rae; Jo, Soo-Yeon; Yoon, Dukyong; Park, Rae Woong; Jeong, Jong Cheol; Park, Inwhee; Shin, Gyu-Tae; Kim, Heungsoo			Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?	PLOS ONE			English	Article							NATIONAL-HEALTH; VISUAL-FIELD; RISK SCORES; MODELS; COHORT; KOREA	Purpose We aimed to develop a model of chronic kidney disease (CKD) progression for predicting the probability and time to progression from various CKD stages to renal replacement therapy (RRT), using 6 months of clinical data variables routinely measured at healthcare centers. Methods Data were derived from the electronic medical records of Ajou University Hospital, Suwon, South Korea from October 1997 to September 2012. We included patients who were diagnosed with CKD (estimated glomerular filtration rate [eGFR] < 60 mL.min(-1) -1 .73 m(-2) for >= 3 months) and followed up for at least 6 months. The study population was randomly divided into training and test sets. Results We identified 4,509 patients who met reasonable diagnostic criteria. Patients were randomly divided into 2 groups, and after excluding patients with missing data, the training and test sets included 1,625 and 1,618 patients, respectively. The integral mean was the most powerful explanatory (R-2 = 0.404) variable among the 8 modified values. Ten variables (age, sex, diabetes mellitus[DM], polycystic kidney disease[PKD], serum albumin, serum hemoglobin, serum phosphorus, serum potassium, eGFR (calculated by Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI]), and urinary protein) were included in the final risk prediction model for CKD stage 3 (R-2 = 0.330). Ten variables (age, sex, DM, GN, PKD, serum hemoglobin, serum blood urea nitrogen[BUN], serum calcium, eGFR(calculated by Modification of Diet in Renal Disease[MDRD]), and urinary protein) were included in the final risk prediction model for CKD stage 4 (R-2 = 0.386). Four variables (serum hemoglobin, serum BUN, eGFR(calculated by MDRD) and urinary protein) were included in the final risk prediction model for CKD stage 5 (R-2 = 0.321). Conclusion We created a prediction model according to CKD stages by using integral means. Based on the results of the Brier score (BS) and Harrel's C statistics, we consider that our model has significant explanatory power to predict the probability and interval time to the initiation of RRT.	[Lee, Min-Jeong; Jeong, Jong Cheol; Park, Inwhee; Shin, Gyu-Tae; Kim, Heungsoo] Ajou Univ, Dept Nephrol, Sch Med, Suwon, South Korea; [Lee, Min-Jeong] Ajou Univ, Dept Emergency Med, Sch Med, Suwon, South Korea; [Park, Joo-Han] Ajou Univ, Dept Internal Med, Sch Med, Suwon, South Korea; [Moon, Yeo Rae] Ajou Univ, Dept Biostat, Sch Med, Suwon, South Korea; [Jo, Soo-Yeon; Yoon, Dukyong; Park, Rae Woong] Ajou Univ, Dept Med Informat, Sch Med, Suwon, South Korea	Ajou University; Ajou University; Ajou University; Ajou University; Ajou University	Kim, H (corresponding author), Ajou Univ, Dept Nephrol, Sch Med, Suwon, South Korea.	nephrohs@ajou.ac.kr		Lee, Min-Jeong/0000-0002-2611-7333				BOEGLIN RJ, 1992, AM J OPHTHALMOL, V113, P396, DOI 10.1016/S0002-9394(14)76161-6; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Evans M, 2005, AM J KIDNEY DIS, V46, P863, DOI 10.1053/j.ajkd.2005.07.040; Fink JC, 2009, AM J KIDNEY DIS, V53, P681, DOI 10.1053/j.ajkd.2008.12.016; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Gerds TA, 2006, BIOMETRICAL J, V48, P1029, DOI 10.1002/bimj.200610301; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Iseki K, 1996, KIDNEY INT, V49, P800, DOI 10.1038/ki.1996.111; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Jin DC, 2016, KIDNEY RES CLIN PRAC, V35, P204, DOI 10.1016/j.krcp.2016.09.006; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Malik R, 2012, CLIN EXP OPHTHALMOL, V40, P369, DOI 10.1111/j.1442-9071.2012.02770.x; Park JI, 2016, J KOREAN MED SCI, V31, P915, DOI 10.3346/jkms.2016.31.6.915; Soveri I, 2012, TRANSPLANTATION, V94, P57, DOI 10.1097/TP.0b013e3182516cdc; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Taal MW, 2008, KIDNEY INT, V73, P1216, DOI 10.1038/ki.2008.36; Wilhelm-Leen ER, 2009, AM J MED, V122, P664, DOI 10.1016/j.amjmed.2009.01.026	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204586	10.1371/journal.pone.0204586	http://dx.doi.org/10.1371/journal.pone.0204586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286208	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500026
J	Bradford, BZ; Huseth, AS; Groves, RL				Bradford, Benjamin Z.; Huseth, Anders S.; Groves, Russell L.			Widespread detections of neonicotinoid contaminants in central Wisconsin groundwater	PLOS ONE			English	Article							COMPLEX-MIXTURES; SURFACE WATERS; COATED SEEDS; US STREAMS; INSECTICIDES; PESTICIDES; THIAMETHOXAM; EXPOSURE; CORN; BEES	Neonicotinoids are a popular and widely-used class of insecticides whose heavy usage rates and purported negative impacts on bees and other beneficial insects has led to questions about their mobility and accumulation in the environment. Neonicotinoid compounds are currently registered for over 140 different crop uses in the United States, with commercial growers continuing to rely heavily on neonicotinoid insecticides for the control of key insect pests through a combination of in-ground and foliar applications. In 2008, the Wisconsin Department of Agriculture, Trade and Consumer Protection (DATCP) began testing for neonicotinoids in groundwater test wells in the state, reporting detections of one or more neonicotinoids in dozens of shallow groundwater test wells. In 2011, similar detection levels were confirmed in several high-capacity overhead center-pivot irrigation systems in central Wisconsin. The current study was initiated to investigate the spatial extent and magnitude of neonicotinoid contamination in groundwater in and around areas of irrigated commercial agriculture in central Wisconsin. From 2013-2015 a total of 317 samples were collected from 91 unique high-capacity irrigation wells and tested for the presence of thiamethoxam (TMX), a neonicotinoid, using enzyme-linked immunosorbent assays. 67% of all samples were positive for TMX at a concentration above the analytical limit of quantification (0.05 mu g/L) and 78% of all wells tested positive at least once. Mean detection was 0.28 mu g/L, with a maximum detection of 1.67 mu g/L. Five wells had at least one detection exceeding 1.00 mu g/L. Furthermore, an analysis of the spatial structure of these well detects suggests that contamination profiles vary across the landscape, with differences in mean detection levels observed from landscape (25 km), to farm (5 km), to individual well (500 m) scales. We also provide an update of DATCP's neonicotinoid monitoring in Wisconsin's shallow groundwater test wells and private potable wells for the years 2011-2017.	[Bradford, Benjamin Z.; Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Huseth, Anders S.] North Carolina State Univ, Dept Entomol, Raleigh, NC USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University	Groves, RL (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	groves@entomology.wisc.edu		Huseth, Anders/0000-0002-5273-8555	United States Department of Agriculture Natural Resources Conservation Service Conservation Innovation Grants [69-3A75-11-211]; United States Department of Agriculture Agricultural Marketing Service Specialty Crop Block Grant Program (USDA AMS SCBGP) [12-012]; Wisconsin Potato and Vegetable Growers Association	United States Department of Agriculture Natural Resources Conservation Service Conservation Innovation Grants; United States Department of Agriculture Agricultural Marketing Service Specialty Crop Block Grant Program (USDA AMS SCBGP); Wisconsin Potato and Vegetable Growers Association	This work was supported by United States Department of Agriculture Natural Resources Conservation Service Conservation Innovation Grants, #69-3A75-11-211, https://www.nrcs.usda.gov/wps/portal/nrcs/main/national/programs/financial/cig/, to RLG; United States Department of Agriculture Agricultural Marketing Service Specialty Crop Block Grant Program (USDA AMS SCBGP), # 12-012, https://www.ams.usda.gov/services/grants/scbgp, to RLG.r We thank the cooperating growers for generously allowing us to collect water samples on their farms and for assisting in these efforts. We thank Amy DeBaker, Rick Graham, Jeff Postle, and Stan Senger of Wisconsin DATCP for their support of this project and for sharing DATCP's groundwater monitoring data. We thank Bob Smail and Bill Phelps of Wisconsin DNR for their expertise with regards to high-capacity well issues in Wisconsin. We thank the Wisconsin Potato and Vegetable Growers Association for continued support of our research efforts.	Anderson TA, 2013, CHEMOSPHERE, V92, P84, DOI 10.1016/j.chemosphere.2013.02.054; [Anonymous], R LANG ENV STAT COMP; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Carnemark M, 2015, WATER HAZARD AQUATIC; Chau NDG, 2015, ENVIRON SCI POLLUT R, V22, P9042, DOI 10.1007/s11356-014-4034-x; Chretien F, 2017, ENVIRON POLLUT, V224, P255, DOI 10.1016/j.envpol.2017.02.002; Code A, 2016, XERCES SOC; DeLorenzo ME, 2012, ENVIRON MONIT ASSESS, V184, P343, DOI 10.1007/s10661-011-1972-3; EPA, 2016, PREL AQ RISK ASS SUP, P305; Furlan L, 2021, ENVIRON SCI POLLUT R, V28, P11798, DOI 10.1007/s11356-017-1052-5; Giorio C, 2021, ENVIRON SCI POLLUT R, V28, P11716, DOI 10.1007/s11356-017-0394-3; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gupta S, 2008, B ENVIRON CONTAM TOX, V80, P431, DOI 10.1007/s00128-008-9420-y; Hladik ML, 2017, AGR ECOSYST ENVIRON, V241, P160, DOI 10.1016/j.agee.2017.03.015; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Hladik ML, 2018, YEAR ROUND PRESENCE, DOI [10.1016/j.envpol.2018.01.013, DOI 10.1016/J.ENVPOL.2018.01.013]; Huseth AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097081; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson JD, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2127-2; Klarich KL, 2017, ENVIRON SCI TECH LET, V4, P168, DOI 10.1021/acs.estlett.7b00081; Kraft GJ, 2012, GROUND WATER, V50, P308, DOI 10.1111/j.1745-6584.2011.00836.x; Kraft GJ, 1998, NITRATE LOADING IMPA; Krupke CH, 2015, CURR OPIN INSECT SCI, V10, P8, DOI 10.1016/j.cois.2015.04.005; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kurwadkar S, 2014, J CONTAM HYDROL, V170, P86, DOI 10.1016/j.jconhyd.2014.09.009; Leake SA, 2013, UNDERSTANDING MANAGI; Main AR, 2016, AGR ECOSYST ENVIRON, V215, P76, DOI 10.1016/j.agee.2015.09.011; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; Nowell LH, 2018, SCI TOTAL ENVIRON, V613, P1469, DOI 10.1016/j.scitotenv.2017.06.156; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pinheiro J, 2016, LINEAR NONLINEAR MIX; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Pisa L, 2021, ENVIRON SCI POLLUT R, V28, P11749, DOI 10.1007/s11356-017-0341-3; Samson-Robert O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108443; Sanchez-Bayo F, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00071; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Sur Robin, 2003, Bulletin of Insectology, V56, P35; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; U. S. Environmental Protection Agency, 2016, HUM HLTH BENCHM PEST; US Geological Survey, 2016, PEST NAT SYNTH PROJ; van Lexmond MB, 2015, ENVIRON SCI POLLUT R, V22, P1, DOI 10.1007/s11356-014-3220-1; Van Metre PC, 2017, ENVIRON POLLUT, V220, P431, DOI 10.1016/j.envpol.2016.09.085; Wettstein FE, 2016, J AGR FOOD CHEM, V64, P6407, DOI 10.1021/acs.jafc.6b02619; Wijnja H, 2014, B ENVIRON CONTAM TOX, V93, P228, DOI 10.1007/s00128-014-1251-4; Wisconsin Department of Agriculture Trade and Consumer Protection, 2011, 2011 BUR AGR MAN ANN; Wisconsin Department of Agriculture Trade and Consumer Protection, 2014, 2014 BUR AGR MAN ANN; Xing ZS, 2013, ARCH ENVIRON CON TOX, V64, P208, DOI 10.1007/s00244-012-9833-9	49	29	30	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0201753	10.1371/journal.pone.0201753	http://dx.doi.org/10.1371/journal.pone.0201753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281610	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400007
J	Carro, J; Pueyo, E; Matas, JFR				Carro, Jesus; Pueyo, Esther; Matas, Jose F. Rodriguez			A response surface optimization approach to adjust ionic current conductances of cardiac electrophysiological models. Application to the study of potassium level changes	PLOS ONE			English	Article							TRANSMURAL HETEROGENEITY; ACTION-POTENTIALS; HUMAN HEART; REPOLARIZATION; MECHANISMS; MYOCYTES; ADAPTATION; CONDUCTION	Cardiac electrophysiological computational models are often developed from previously published models. The new models may incorporate additional features to adapt the model to a different species or may upgrade a specific ionic formulation based on newly available experimental data. A relevant challenge in the development of a new model is the estimation of certain ionic current conductances that cannot be reliably identified from experiments. A common strategy to estimate those conductances is by means of constrained non-linear least-squares optimization. In this work, a novel methodology is proposed for estimation of ionic current conductances of cardiac electrophysiological models by using a response surface approximation-based constrained optimization with trust region management. Polynomial response surfaces of a number of electrophysiological markers were built using statistical sampling methods. These markers included action potential duration (APD), triangulation, diastolic and systolic intracellular calcium concentration, and time constants of APD rate adaptation. The proposed methodology was applied to update the Carro et al. human ventricular action potential model after incorporation of intracellular potassium ([K+](i)) dynamics. While the Carro et al. model was well suited for investigation of arrhythmogenesis, it did not allow simulation of [K+](i) changes. With the methodology proposed in this study, the updated Carro et al. human ventricular model could be used to simulate [K+](i) changes in response to varying extracellular potassium ([K+](o)) levels. Additionally, it rendered values of evaluated electrophysiological markers within physiologically plausible ranges. The optimal values of ionic current conductances in the updated model were found in a notably shorter time than with previously proposed methodologies. As a conclusion, the response surface optimization-based approach proposed in this study allows estimating ionic current conductances of cardiac electrophysiological computational models while guaranteeing replication of key electrophysiological features and with an important reduction in computational cost with respect to previously published approaches. The updated Carro et al. model developed in this study is thus suitable for the investigation of arrhythmic risk-related conditions, including those involving large changes in potassium concentration.	[Carro, Jesus] Univ San Jorge, Zaragoza, Spain; [Carro, Jesus; Pueyo, Esther; Matas, Jose F. Rodriguez] Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, Zaragoza, Spain; [Carro, Jesus; Pueyo, Esther] CIBER Bioengn Biomat & Nanomedicne CIBER BBN, Zaragoza, Spain; [Matas, Jose F. Rodriguez] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, LaBS, Milan, Italy	Universidad San Jorge; University of Zaragoza; Polytechnic University of Milan	Carro, J (corresponding author), Univ San Jorge, Zaragoza, Spain.; Carro, J (corresponding author), Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, Zaragoza, Spain.; Carro, J (corresponding author), CIBER Bioengn Biomat & Nanomedicne CIBER BBN, Zaragoza, Spain.	jcarro@usj.es	Carro, Jesús/D-7488-2011; Pueyo, Esther/C-6945-2009; Matas, Jose F Rodriguez/H-4589-2011	Carro, Jesús/0000-0001-7789-2973; Pueyo, Esther/0000-0002-1960-407X; Matas, Jose F Rodriguez/0000-0001-7612-266X	Ministerio de Economia y Competitividad [DPI2016-75458-R]; CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III; Grupo Consolidado BSICoS [T39_17R]; Grupo Consolidado AMB [T24_17R]	Ministerio de Economia y Competitividad(Spanish Government); CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III; Grupo Consolidado BSICoS; Grupo Consolidado AMB	This work was supported by Ministerio de Economia y Competitividad (http://www.mineco.gob.es) under project DPI2016-75458-R, by CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN, http://www.ciber-bbn.es/) through Instituto de Salud Carlos III (http://www.isciii.es/), by Grupo Consolidado BSICoS (T39_17R) and Grupo Consolidado AMB (T24_17R), from DGA (http://www.aragon.es) and European Social Fund (http://ec.europa.eu/esf/home.jsp), and by the European Research Council (ERC, https://erc.europa.eu/) through project ERC-2014-StG 638284.	Bars DM, 2006, J PHARM SCI, V100, P315, DOI [10.1254/johs.C1:506001X, DOI 10.1254/JOHS.C1:506001X]; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bot CT, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00421; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Carro J, 2017, PROG BIOPHYS MOL BIO, V129, P53, DOI 10.1016/j.pbiomolbio.2016.11.006; Carro J, 2011, PHILOS T R SOC A, V369, P4205, DOI 10.1098/rsta.2011.0127; Corsi C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42492; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Dokos S, 2004, PROG BIOPHYS MOL BIO, V85, P407, DOI 10.1016/j.pbiomolbio.2004.02.002; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Drouin E, 1998, J AM COLL CARDIOL, V32, P1063, DOI 10.1016/S0735-1097(98)00330-1; Dutta S, 2017, PROG BIOPHYS MOL BIO, V129, P40, DOI 10.1016/j.pbiomolbio.2017.02.007; Fabbri A, 2017, J PHYSIOL-LONDON, V595, P2365, DOI 10.1113/JP273259; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Groenendaal W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004242; Guo T, 2013, COMP MATH MATH PHYS, V2013, P1, DOI [10.1155/2013/407917, DOI 10.1155/2013/407917]; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; Himeno Y, 2015, BIOPHYS J, V109, P415, DOI 10.1016/j.bpj.2015.06.017; Hondeghem LM, 2001, CIRCULATION, V103, P2004; Jost N, 2013, J PHYSIOL-LONDON, V591, P4189, DOI 10.1113/jphysiol.2013.261198; Kaur J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107984; Krogh-Madsen T, 2016, J PHYSIOL-LONDON, V594, P2525, DOI 10.1113/JP270618; Li GR, 1999, AM J PHYSIOL-HEART C, V276, pH98, DOI 10.1152/ajpheart.1999.276.1.H98; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Livshitz L, 2009, BIOPHYS J, V97, P1265, DOI 10.1016/j.bpj.2009.05.062; Nygren A, 2001, PHILOS T ROY SOC A, V359, P1111, DOI 10.1098/rsta.2001.0819; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Pieske B, 1999, CIRC RES, V85, P38; Pueyo E, 2004, IEEE T BIO-MED ENG, V51, P1511, DOI 10.1109/TBME.2004.828050; Pueyo E, 2010, AM J PHYSIOL-HEART C, V298, pH1577, DOI 10.1152/ajpheart.00936.2009; Rodriguez JF, 1998, J MECH DESIGN, V120, P58, DOI 10.1115/1.2826677; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Schmidt U, 1998, J MOL CELL CARDIOL, V30, P1929, DOI 10.1006/jmcc.1998.0748; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Syed Z, 2005, MED BIOL ENG COMPUT, V43, P561, DOI 10.1007/BF02351029; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Yao A, 1997, CELL CALCIUM, V22, P431, DOI 10.1016/S0143-4160(97)90070-1; Yue LX, 1996, AM J PHYSIOL-HEART C, V270, pH2157, DOI 10.1152/ajpheart.1996.270.6.H2157; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	46	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204411	10.1371/journal.pone.0204411	http://dx.doi.org/10.1371/journal.pone.0204411			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281636	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400049
J	Din, SU; Rahman, FU; Khan, Q				Din, Sami Ud; Rahman, Fazal Ur; Khan, Qudrat			Smooth super-twisting sliding mode control for the class of underactuated systems	PLOS ONE			English	Article							MECHANICAL SYSTEMS; NONLINEAR-SYSTEMS; DESIGN	In this article, Smooth Super-twisting Sliding Mode Control (SSTWSMC) is investigated for the class of underactuated system. In underactuated systems, the control design is not directly applicable as for other systems (known as fully actuated systems). Therefore, at initial step, a nonlinear uncertain model of systems is transformed into the controllable canonical form, and then Smooth Super Twisting (SSTW) based Sliding Mode Control (SMC) is devised for the control design purpose for the considered class. In addition, closed loop stability of the proposed technique is presented in a fascinating way. The effectiveness and supremacy of the proposed control technique is proven by extensive analysis between conventional Sliding Mode Control (SMC), Super twisting (STW) sliding mode control and Smooth Super-twisting Sliding Mode Control (SSTWSMC). The comprehensive analysis evaluates the attributes like robustness enhancement, settling time, control effort, chattering reduction, overshoot, sliding mode convergence, etc. and is supported by simulations as well as practical implementation on ball and beam balancer (which is considered as application example).	[Din, Sami Ud; Rahman, Fazal Ur] Capital Univ Sci & Technol, Dept Elect Engn, Islamabad, Pakistan; [Khan, Qudrat] COMSATS Univ, CAST, Islamabad, Pakistan	Capital University of Science & Technology; COMSATS University Islamabad (CUI)	Din, SU (corresponding author), Capital Univ Sci & Technol, Dept Elect Engn, Islamabad, Pakistan.	samiuddin@ieee.org		ud Din, Sami/0000-0002-3857-4988; Rehman, Fazal ur/0000-0002-4650-8956	Higher Education Commission (HEC) Pakistan	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan)	This research is supported by the Higher Education Commission (HEC) Pakistan. However, HEC had no role in study design, data collection, and analysis, decision to publish, or preparation of this manuscript. However, it is not funded any organization/ institute.	Almutairi NB, 2010, NONLINEAR DYNAM, V59, P221, DOI 10.1007/s11071-009-9534-8; Brockett R. W., 1983, DIFFERENTIAL GEOMETR, P181; Din SU, 2018, IEEE ACCESS, V6, P1927, DOI [10.1109/ACCESS.2017.2712261, 10.1109/ACCESS.2017.2780889]; Din SU, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/5641478; Fang YC, 2012, IEEE T CONTR SYST T, V20, P241, DOI 10.1109/TCST.2011.2107910; Freidovich L, 2009, IEEE T CONTR SYST T, V17, P853, DOI 10.1109/TCST.2008.2005734; Khan I., 2016, THESIS; Khan Q, 2017, ISA T, V66, P241, DOI 10.1016/j.isatra.2016.10.017; Lee H, 2007, ANNU REV CONTROL, V31, P179, DOI 10.1016/j.arcontrol.2007.08.001; Liu Y, 2013, IET CONTROL THEORY A, V7, P921, DOI 10.1049/iet-cta.2012.0505; Mahjoub S, 2015, INT J AUTOM COMPUT, V12, P134, DOI 10.1007/s11633-015-0880-3; McNinch LC, 2010, P AMER CONTR CONF, P5212; Mobayen S, 2017, INT J SYST SCI, V48, P1990, DOI 10.1080/00207721.2017.1299812; Mobayen S, 2016, NONLINEAR DYNAM, V83, P1557, DOI 10.1007/s11071-015-2430-5; Mobayen Saleh, 2015, J VIB CONTROL, P1; Olfati-Saber R, 2002, IEEE T AUTOMAT CONTR, V47, P305, DOI 10.1109/9.983365; Ozguner U., 2008, AUTOMATICA, P44; Yang ECY, 2011, IEEE T CONTR SYST T, V19, P248, DOI 10.1109/TCST.2010.2046902	18	6	6	11	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203667	10.1371/journal.pone.0203667	http://dx.doi.org/10.1371/journal.pone.0203667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281586	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400025
J	Dalton, LA; Benalcazar, ME; Dougherty, ER				Dalton, Lori A.; Benalcazar, Marco E.; Dougherty, Edward R.			Optimal clustering under uncertainty	PLOS ONE			English	Article							MINIMUM EXPECTED ERROR; GRANULOMETRIC MOMENTS; OPTIMAL CLASSIFIERS; BAYESIAN FRAMEWORK; FILTERS; REPRESENTATION; PERFORMANCE; IMAGES; MODELS	Classical clustering algorithms typically either lack an underlying probability framework to make them predictive or focus on parameter estimation rather than defining and minimizing a notion of error. Recent work addresses these issues by developing a probabilistic framework based on the theory of random labeled point processes and characterizing a Bayes clusterer that minimizes the number of misclustered points. The Bayes clusterer is analogous to the Bayes classifier. Whereas determining a Bayes classifier requires full knowledge of the feature-label distribution, deriving a Bayes clusterer requires full knowledge of the point process. When uncertain of the point process, one would like to find a robust clusterer that is optimal over the uncertainty, just as one may find optimal robust classifiers with uncertain feature-label distributions. Herein, we derive an optimal robust clusterer by first finding an effective random point process that incorporates all randomness within its own probabilistic structure and from which a Bayes clusterer can be derived that provides an optimal robust clusterer relative to the uncertainty. This is analogous to the use of effective class-conditional distributions in robust classification. After evaluating the performance of robust clusterers in synthetic mixtures of Gaussians models, we apply the framework to granular imaging, where we make use of the asymptotic granulometric moment theory for granular images to relate robust clustering theory to the application.	[Dalton, Lori A.] Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA; [Benalcazar, Marco E.] Escuela Politec Nacl, Dept Informat & Ciencias Comp, Fac Ingn Sistemas, Quito, Ecuador; [Dougherty, Edward R.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA	University System of Ohio; Ohio State University; Escuela Politecnica Nacional Ecuador; Texas A&M University System; Texas A&M University College Station	Dalton, LA (corresponding author), Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA.	dalton.lori@outlook.com			National Science Foundation [CCF-1422631, 562 CCF-1453563, CCF-1453563]	National Science Foundation(National Science Foundation (NSF))	The work of LAD is supported by the National Science Foundation (CCF-1422631 and 562 CCF-1453563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of LAD is supported by the National Science Foundation (CCF-1422631 and CCF-1453563).	[Anonymous], R LANG ENV STAT COMP; [Anonymous], [No title captured]; BINDER DA, 1978, BIOMETRIKA, V65, P31, DOI 10.2307/2335273; Chiu S. N., 2013, WILEY SERIES PROBABI; Choquet G., 1954, ANN LINSTITUT FOURIE, V5, P131, DOI DOI 10.5802/AIF.53; Chris Fraley TBM, 2012, 597 U WASH DEP STAT; Dalton L, 2009, CURR GENOMICS, V10, P430, DOI 10.2174/138920209789177601; Dalton LA, 2015, IEEE T SIGNAL PROCES, V63, P1605, DOI 10.1109/TSP.2015.2399870; Dalton LA, 2014, IEEE T SIGNAL PROCES, V62, P657, DOI 10.1109/TSP.2013.2291213; Dalton LA, 2013, PATTERN RECOGN, V46, P1288, DOI 10.1016/j.patcog.2012.10.019; Dalton LA, 2013, PATTERN RECOGN, V46, P1301, DOI 10.1016/j.patcog.2012.10.018; DeGroot M.H., 2005, OPTIMAL STAT DECISIO; Dougherty ER, 2005, PATTERN RECOGN, V38, P1520, DOI 10.1016/j.patcog.2005.01.019; DOUGHERTY ER, 1995, J VIS COMMUN IMAGE R, V6, P69, DOI 10.1006/jvci.1995.1006; Dougherty ER, 2004, PATTERN RECOGN, V37, P917, DOI 10.1016/j.patcog.2003.10.003; DOUGHERTY ER, 1991, OPT ENG, V30, P438, DOI 10.1117/12.55823; Dougherty ER, 2001, SIGNAL PROCESS, V81, P1357, DOI 10.1016/S0165-1684(01)00017-2; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fritsch A, 2009, BAYESIAN ANAL, V4, P367, DOI 10.1214/09-BA414; Grigoryan AM, 1999, J MATH IMAGING VIS, V11, P239, DOI 10.1023/A:1008356620614; Grigoryan AM, 2001, SIGNAL PROCESS, V81, P2503, DOI 10.1016/S0165-1684(01)00144-X; KASSAM SA, 1977, J FRANKLIN I, V304, P171, DOI 10.1016/0016-0032(77)90011-4; Kendall DG, 1974, STOCHASTIC GEOMETRY, V3, P322; KUZNETSOV VP, 1976, TELECOMM RADIO ENG+, V30, P58; Matheron G., 1975, RANDOM SETS INTEGRAL; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; POOR HV, 1980, IEEE T AUTOMAT CONTR, V25, P531, DOI 10.1109/TAC.1980.1102349; Quintana FA, 2003, J ROY STAT SOC B, V65, P557, DOI 10.1111/1467-9868.00402; Sand F, 1999, PATTERN RECOGN, V32, P1657, DOI 10.1016/S0031-3203(99)00028-X; Wade S., 2015, MCCLUST EXT POINT ES	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204627	10.1371/journal.pone.0204627	http://dx.doi.org/10.1371/journal.pone.0204627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278063	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200018
J	Zheng, W; Wang, KR; Sun, YJ; Kuo, SM				Zheng, Wei; Wang, Kairui; Sun, Yijun; Kuo, Shiu-Ming			Dietary or supplemental fermentable fiber intake reduces the presence of Clostridium XI in mouse intestinal microbiota: The importance of higher fecal bacterial load and density	PLOS ONE			English	Article							DIFFICILE INFECTION; GUT MICROBIOTA; COLONIZATION RESISTANCE; INULIN; OLIGOSACCHARIDES; TRANSPLANTATION; RECURRENCE; SEQUENCES; PROFILES; THERAPY	Objectives Clostridium difficile infection is a public health concern. C. difficile was found in healthy human intestine as a member of Clostridium XI. Because soluble fermentable fiber ingestion affects intestinal microbiota, we used fiber-containing diets to determine the intestinal microbial condition that could reduce the presence of Clostridium XI. Methods Newly weaned male mice were assigned to three published diets: Control AIN-93G purified diet with only poorly fermented cellulose; Control plus 5% purified fermentable fiber inulin; Chow with wheat, soybean and corn that provide a mixture of unpurified dietary fibers. Methods were developed to quantify 24-hour fecal microbial load and microbial DNA density. The relative abundance of bacterial genera and the bacterial diversity were determined through 16S rRNA sequence-based fecal microbiota analysis. Results Mice adjusted food intake to maintain the same energy intake and body weight under these three moderate-fat (7% w:w) diets. Chow-feeding led to higher food intake but also higher 24-h fecal output. Chow-feeding and 1-8 wk ingestion of inulin-supplemented diet increased daily fecal microbial load and density along with lowering the prevalence of Clostridium XI to undetectable. Clostridium XI remained undetectable until 4 weeks after the termination of inulin-supplemented diet. Fermentable fiber intake did not consistently increase probiotic genera such as Bifidobacterium or Lactobacillus. Chow feeding, but not inulin supplementation, increased the bacterial diversity. Conclusions Increase fecal microbial load/density upon fermentable fiber ingestion is associated with a lower and eventually undetectable presence of Clostridium XI. Higher bacterial diversity or abundance of particular genera is not apparently essential. Future studies are needed to see whether this observation can be translated into the reduction of C. difficile at the species level in at-risk populations.	[Zheng, Wei; Sun, Yijun] Univ Buffalo, Dept Comp Sci & Engn, Buffalo, NY USA; [Wang, Kairui; Kuo, Shiu-Ming] Univ Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Sun, Yijun] Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY USA; [Sun, Yijun] Univ Buffalo, Dept Biostat, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kuo, SM (corresponding author), Univ Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.	smkuo@buffalo.edu			University at Buffalo; National Institute of Health [NIH 1R01AI125982-01, NIH 1R01DE024523]	University at Buffalo; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding sources include University at Buffalo, and National Institute of Health through the following two grant support: NIH 1R01AI125982-01 (YJS); NIH 1R01DE024523-01(YJS).	Adlerberth I, 2014, J CLIN MICROBIOL, V52, P173, DOI 10.1128/JCM.01701-13; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borgia G, 2015, EXPERT OPIN BIOL TH, V15, P1001, DOI 10.1517/14712598.2015.1045872; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dantes R, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv113; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Drenowatz C, 2015, ADV NUTR, V6, P592, DOI 10.3945/an.115.008615; Perez-Cobas AE, 2015, ANTIBIOTICS-BASEL, V4, P337, DOI 10.3390/antibiotics4030337; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ghaffarzadegan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157427; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Hopkins MJ, 2003, APPL ENVIRON MICROB, V69, P1920, DOI 10.1128/AEM.69.4.1920-1927.2003; Hsieh YH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01643; Kirk RE, 2013, EXPERIMENTAL DESIGN, P154; KOCH AL, 1970, ANAL BIOCHEM, V38, P252, DOI 10.1016/0003-2697(70)90174-0; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koleva PT, 2012, BRIT J NUTR, V108, P1633, DOI 10.1017/S0007114511007203; Konstantinov SR, 2003, FEMS MICROBIOL ECOL, V43, P225, DOI 10.1111/j.1574-6941.2003.tb01062.x; Kuo SM, 2018, CURR DEV NUTR, V2, DOI 10.3945/cdn.117.001180; Kuo SM, 2014, J NUTR, V144, P245, DOI 10.3945/jn.113.185249; Kuo SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060270; Kuo SM, 2004, J NUTR, V134, P2216; Liu TW, 2016, J NUTR, V146, P949, DOI 10.3945/jn.115.227504; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Masso-Welch PA, 2012, IMMUNOL INVEST, V41, P521, DOI 10.3109/08820139.2012.684193; Matsumoto K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175406; McClane B. A., 2006, Gram-positive pathogens, P703; McGill CR, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29977; Myint H, 2017, ANIM SCI J; Myllyluoma E, 2007, DIGEST LIVER DIS, V39, P516, DOI 10.1016/j.dld.2007.02.015; Myllyluoma E, 2005, ALIMENT PHARM THER, V21, P1263, DOI 10.1111/j.1365-2036.2005.02448.x; Navarro D, 2018, J ANIM SCI; Niness KR, 1999, J NUTR, V129, p1402S, DOI 10.1093/jn/129.7.1402S; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paul HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20683; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Peretz A, 2016, CURR MED CHEM, V23, P4442, DOI 10.2174/0929867323666161028162018; Razik R, 2016, AM J GASTROENTEROL, V111, P1141, DOI 10.1038/ajg.2016.187; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; So D, 2018, AM J CLIN NUTR, V107, P965, DOI 10.1093/ajcn/nqy041; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sullivan KM, 2010, ANN PHARMACOTHER, V44, P352, DOI 10.1345/aph.1M351; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Swanson KS, 2001, J ANIM SCI, V79, P919; Tschudin-Sutter S, 2014, PEDIATR INFECT DIS J, V33, P414, DOI 10.1097/INF.0000000000000108; Umu OCO, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0078-5; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Yu YJ, 2008, CANCER EPIDEM BIOMAR, V17, P455, DOI 10.1158/1055-9965.EPI-07-2515; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang LH, 2015, ANAEROBE, V34, P1, DOI 10.1016/j.anaerobe.2015.03.008; Zheng W, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0110-9	62	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205055	10.1371/journal.pone.0205055	http://dx.doi.org/10.1371/journal.pone.0205055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278071	Green Submitted, Green Published, gold			2022-12-27	WOS:000446010200037
J	Collignon, O; Han, J; An, H; Oh, S; Lee, Y				Collignon, Olivier; Han, Jeongseop; An, Hyungmi; Oh, Seungyoung; Lee, Youngjo			Comparison of the modified unbounded penalty and the LASSO to select predictive genes of response to chemotherapy in breast cancer	PLOS ONE			English	Article							VARIABLE SELECTION; MODELS	Covariate selection is a fundamental step when building sparse prediction models in order to avoid overfitting and to gain a better interpretation of the classifier without losing its predictive accuracy. In practice the LASSO regression of Tibshirani, which penalizes the likelihood of the model by the L1 norm of the regression coefficients, has become the gold-standard to reach these objectives. Recently Lee and Oh developed a novel random-effect covariate selection method called the modified unbounded penalty (MUB) regression, whose penalization function can equal minus infinity at 0 in order to produce very sparse models. We sought to compare the predictive accuracy and the number of covariates selected by these two methods in several high-dimensional datasets, consisting in genes expressions measured to predict response to chemotherapy in breast cancer patients. These comparisons were performed by building the Receiver Operating Characteristics (ROC) curves of the classifiers obtained with the selected genes and by comparing their area under the ROC curve (AUC) corrected for optimism using several variants of bootstrap internal validation and cross-validation. We found consistently in all datasets that the MUB penalization selected a remarkably smaller number of covariates than the LASSO while offering a similar-and encouraging-predictive accuracy. The models selected by the MUB were actually nested in the ones obtained with the LASSO. Similar findings were observed when comparing these results to those obtained in their first publication by other authors or when using the area under the Precision-Recall curve (AUCPR) as another measure of predictive performance. In conclusion, the MUB penalization seems therefore to be one of the best options when sparsity is required in high-dimension. Further investigation in other datasets is however required to validate these findings.	[Collignon, Olivier] Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, Luxembourg, Luxembourg; [Han, Jeongseop] Korea Mil Acad, Dept Math, Seoul, South Korea; [An, Hyungmi; Oh, Seungyoung; Lee, Youngjo] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul, South Korea	Luxembourg Institute of Health; Seoul National University (SNU)	Lee, Y (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul, South Korea.	youngjo@snu.ac.kr	An, Hyungmi/AAD-9862-2022					Boyd K., 2013, JOINT EUR C MACH LEA; Collignon O, 2016, APPL MATH, V7, P1639, DOI [10.4236/am.2016.715141, DOI 10.4236/AM.2016.715141]; Collignon O, 2014, CLIN EPIDEMIOL, V6, P221, DOI 10.2147/CLEP.S64811; de Ronde JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088551; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fan JQ, 2010, STAT SINICA, V20, P101; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Ishwaran H, 2005, ANN STAT, V33, P730, DOI 10.1214/009053604000001147; Kwon S, 2016, COMPUT STAT DATA AN, V103, P401, DOI 10.1016/j.csda.2016.05.016; Lee Y, 1996, J ROY STAT SOC B MET, V58, P619; Lee Y, 2017, GEN LINEAR MODELS RA; Lee Y, 2009, RANDOM EFFECT MODELS; Lee Y, 2014, J MULTIVARIATE ANAL, V125, P89, DOI 10.1016/j.jmva.2013.11.016; Ng CT, 2016, STAT METHODOL, V32, P147, DOI 10.1016/j.stamet.2016.05.006; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204897	10.1371/journal.pone.0204897	http://dx.doi.org/10.1371/journal.pone.0204897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273405	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700046
J	Kalkowski, L; Malysz-Cymborska, I; Golubczyk, D; Janowski, M; Holak, P; Milewska, K; Kedziorek, D; Adamiak, Z; Maksymowicz, W; Walczak, P				Kalkowski, Lukasz; Malysz-Cymborska, Izabela; Golubczyk, Dominika; Janowski, Miroslaw; Holak, Piotr; Milewska, Kamila; Kedziorek, Dorota; Adamiak, Zbigniew; Maksymowicz, Wojciech; Walczak, Piotr			MRI-guided intracerebral convection-enhanced injection of gliotoxins to induce focal demyelination in swine	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; BRAIN; DELIVERY; CELLS; ENCEPHALOMYELITIS; REMYELINATION; MONKEYS; LESIONS; RESCUE; TISSUE	Demyelinating disorders such as multiple sclerosis (MS) or transverse myelitis are devastating neurological conditions with no effective cure. Prevention of myelin loss or restoration of myelin are key for successful therapy. To investigate the disease and develop cures animal models with good clinical relevance are essential. The goal of the current study was to establish a model of focal demyelination in the brain of domestic pig using MRI-guided gliotoxin delivery. The rationale for developing a new myelin disease model in the domestic pig was based on the fact that the brain in pigs is anatomically and histologically much more similar to that of humans compared to the rodent brain. For MRI-assisted gliotoxin injection, eight 30 kg pigs were subjected to treatment with lysolecithin (20, 30 mg/ml); or with ethidium bromide (0.0125, 0.05, 0.2 mg/ml). Animals were placed in an MRI scanner for intraparenchymal targeting of gliotoxin into the corona radiata (250 mu l over 1 h), with real-time monitoring of toxin distribution on T1 scans and monitoring of lesion evolution over seven days using both T1 and T2 scans. After the last MRI, animals were transcardially perfused and brains were processed for histological and immunofluorescent analysis. Gadolinium-enhanced T1 MRI during injection demonstrated biodistribution of the contrast (as a surrogate marker for toxin distribution) and its diffusion through the brain parenchyma. Lesion induction was confirmed on T2-weighted MRI and histopathology, thus enabling the establishment of optimal doses of gliotoxins. To conclude, MRI-guided focal demyelination in swine is accurate and provides real-time confirmation of gliotoxin, thus facilitating placement of focal lesions with high precision. This new model of focal demyelination can be used for further investigation and development of novel therapeutic approaches.	[Kalkowski, Lukasz; Malysz-Cymborska, Izabela; Golubczyk, Dominika; Milewska, Kamila; Maksymowicz, Wojciech; Walczak, Piotr] Univ Warmia & Mazury, Fac Med Sci, Dept Neurol & Neurosurg, Olsztyn, Poland; [Janowski, Miroslaw] Polish Acad Sci, Mossakowski Med Res Ctr, NeuroRepair Dept, Warsaw, Poland; [Janowski, Miroslaw; Kedziorek, Dorota; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Cellular Imaging Sect, Inst Cell Engn, Baltimore, MD 21218 USA; [Janowski, Miroslaw; Kedziorek, Dorota; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Div Russell H Morgan, Baltimore, MD 21218 USA; [Holak, Piotr; Adamiak, Zbigniew] Univ Warmia & Mazury, Fac Vet Med, Dept Surg & Radiol, Olsztyn, Poland	University of Warmia & Mazury; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Johns Hopkins University; Johns Hopkins University; University of Warmia & Mazury	Walczak, P (corresponding author), Univ Warmia & Mazury, Fac Med Sci, Dept Neurol & Neurosurg, Olsztyn, Poland.; Walczak, P (corresponding author), Johns Hopkins Univ, Sch Med, Cellular Imaging Sect, Inst Cell Engn, Baltimore, MD 21218 USA.; Walczak, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Div Russell H Morgan, Baltimore, MD 21218 USA.	pwalczak@mri.jhu.edu	Adamiak, Zbigniew/ABG-6173-2020; adamiak, zbigniew/ABD-4580-2021	Adamiak, Zbigniew/0000-0001-8350-0198; Walczak, Piotr/0000-0002-3733-3322; Malysz-Cymborska, Izabela/0000-0003-4192-6726; Golubczyk, Dominika/0000-0001-5692-6329; Janowski, Miroslaw/0000-0001-5261-7975; Holak, Piotr/0000-0002-2050-1959	National Institutes of Health [R01 NS091100, R01 NS091110, R01 NS076573, 2017-MSCRFD-3942]; Narodowe Centrum Badan i Rozwoju [1/233209/12/NCBIR/2015]; National Center for Research and Development [1/2352773/19/NCBR/2016, 12-/EuroNanoMed/2016]; NIH/NINDS [R01NS091110, R01NS091100, R01NS076573]; NIH [MSCRFD-3942]; National Centre for Research and Development [1/2352773/19/NCBR/2016, 12-/EuroNanoMed/2016, STRATEGMED1/233205/12/NCBR/2015]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076573, R01NS091100, R01NS091110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Narodowe Centrum Badan i Rozwoju(National Centre for Research & Development, Poland); National Center for Research and Development(National Centre for Research & Development, Poland); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centre for Research and Development(National Centre for Research & Development, Poland); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health- R01 NS091100; Piotr Walczak is reciever, National Institutes of Health- R01 NS091110; Piotr Walczak is reciever, National Institutes of Health- R01 NS076573; Piotr Walczak is reciever, Narodowe Centrum Badan i Rozwoju-Strategmed 1/233209/12/NCBIR/2015; Piotr Walczak is reciever, National Institutes of Health - 2017-MSCRFD-3942, National Center for Research and Development - Strategmed 1/2352773/19/NCBR/2016, National Center for Research and Development - Strategmed 12-/EuroNanoMed/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by NIH/NINDS (R01NS091110, R01NS091100, R01NS076573), NIH (MSCRFD-3942), National Centre for Research and Development (STRATEGMED1/233205/12/NCBR/2015, 1/2352773/19/NCBR/2016, 12-/EuroNanoMed/2016). The authors have declared that no competing interests exist.	Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Ding D, 2010, J NEURO-ONCOL, V98, P1, DOI 10.1007/s11060-009-0046-7; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Gorelik M, 2012, RADIOLOGY, V265, P175, DOI 10.1148/radiol.12112212; HALL SM, 1972, J CELL SCI, V10, P535; Holm IE, 2016, J PATHOL, V238, P267, DOI 10.1002/path.4654; Janowski M, 2016, J CEREBR BLOOD F MET, V36, P569, DOI 10.1177/0271678X15615875; Kalincik T, 2015, NEUROEPIDEMIOLOGY, V44, P199, DOI 10.1159/000382130; Kantorovich S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080606; Kerr DA, 2002, CURR OPIN NEUROL, V15, P339, DOI 10.1097/00019052-200206000-00019; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lyczek A, 2017, EXP NEUROL, V291, P74, DOI 10.1016/j.expneurol.2017.02.005; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Milo R, 2014, AUTOIMMUN REV, V13, P518, DOI 10.1016/j.autrev.2014.01.012; Nduom EK, 2012, J NEUROSURG, V117, P1150, DOI 10.3171/2012.9.JNS12506; Nichols NL, 2013, NEUROSCIENCE, V229, P77, DOI 10.1016/j.neuroscience.2012.10.066; Qin HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169656; Rivers TM, 1933, J EXP MED, V58, P39, DOI 10.1084/jem.58.1.39; Samaranch L, 2016, GENE THER, V23, P393, DOI 10.1038/gt.2015.87; Sampson John H, 2006, Neurosurg Focus, V20, pE14, DOI 10.3171/foc.2006.20.4.9; Sirianni RW, 2014, BIOCONJUGATE CHEM, V25, P2157, DOI 10.1021/bc500315j; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Yin D, 2013, CANCER GENE THER, V20, P336, DOI 10.1038/cgt.2013.25	29	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204650	10.1371/journal.pone.0204650	http://dx.doi.org/10.1371/journal.pone.0204650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273376	gold, Green Submitted, Green Published			2022-12-27	WOS:000446124700030
J	Niwa, H; Ozawa, R; Kurahashi, Y; Kumamoto, T; Nakanishi, Y; Okumura, K; Matsuda, I; Ishida, Y; Hirota, S; Shinohara, H				Niwa, Hirotaka; Ozawa, Rie; Kurahashi, Yasunori; Kumamoto, Tsutomu; Nakanishi, Yasutaka; Okumura, Koichi; Matsuda, Ikuo; Ishida, Yoshinori; Hirota, Seiichi; Shinohara, Hisashi			The eCura system as a novel indicator for the necessity of salvage surgery after non-curative ESD for gastric cancer: A case-control study	PLOS ONE			English	Article							ENDOSCOPIC SUBMUCOSAL DISSECTION; RISK-FACTORS; RESECTION; CRITERIA; OUTCOMES; JAPAN	Endoscopic submucosal dissection (ESD) for early gastric cancer does not always lead to complete cancer resection. The aim of this study was to determine indicators for cancer residue (CR) status in cases of non-curative ESD. We analyzed 47 cases of non-curative ESD followed by salvage surgery and collected data regarding the rates of CR, which included both local CR and lymph node metastasis (LNM). To elucidate the risk factors for CR status, we compared the CR positive and the CR negative groups among surgical specimens according to the following variables obtained from ESD findings: tumor location, tumor size, depth of invasion, lympho-vascular invasion, histological margin, and histological diagnosis. The eCura system, which is an LNM risk scoring system, was also applied and scores were calculated in each case as follows: 3 points for lymphatic invasion and 1 point each for tumor size >30 mm, positive vertical margin, venous invasion, and submucosal invasion >= 500 mu m. There were 9 (19%) CR positive cases, which included 6 cases of local CR and 4 cases of LNM; no cancer was detected in over 80% of the patients. The eCura scoring system was the only significant factor for CR status: the higher the eCura score, the greater the CR positivity (p = 0.0128). In particular, all patients in the low-risk group (score = 0-1 point) had no CR. Although no cancer recurrence was observed during a median follow-up of 4 years, 2 patients died of pneumonia. In conclusion, the eCura system might make it possible to select appropriate cases for salvage surgery.	[Niwa, Hirotaka; Ozawa, Rie; Kurahashi, Yasunori; Kumamoto, Tsutomu; Nakanishi, Yasutaka; Okumura, Koichi; Ishida, Yoshinori; Shinohara, Hisashi] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan; [Matsuda, Ikuo; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine; Hyogo College of Medicine	Niwa, H (corresponding author), Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan.	hironiwa@hyo-med.ac.jp			JSPS KAKENHI [16H05399]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 16H05399. No additional external or internal funding was received for this study other than this grant.	Choi JY, 2015, SURG ENDOSC, V29, P1842, DOI 10.1007/s00464-014-3874-2; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Eom BW, 2017, GASTROINTEST ENDOSC, V85, P155, DOI 10.1016/j.gie.2016.07.036; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Hatta W, 2018, GASTRIC CANCER, V21, P481, DOI 10.1007/s10120-017-0769-7; Hatta W, 2017, AM J GASTROENTEROL, V112, P874, DOI 10.1038/ajg.2017.95; Hatta W, 2017, J GASTROENTEROL, V52, P175, DOI 10.1007/s00535-016-1210-4; Ito H, 2018, SURG ENDOSC, V32, P196, DOI 10.1007/s00464-017-5659-x; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kim ER, 2015, BRIT J SURG, V102, P1394, DOI 10.1002/bjs.9873; Lee JH, 2013, PATHOL RES PRACT, V209, P314, DOI 10.1016/j.prp.2013.02.014; McCall MD, 2016, WORLD J GASTROENTERO, V22, P1101, DOI 10.3748/wjg.v22.i3.1101; Takizawa K, 2013, GASTRIC CANCER, V16, P531, DOI 10.1007/s10120-012-0220-z; Tanabe S, 2017, GASTRIC CANCER, V20, P834, DOI 10.1007/s10120-017-0699-4; Tanabe S, 2017, GASTRIC CANCER, V20, pS45, DOI 10.1007/s10120-016-0664-7; Tomita T, 2012, J GASTROEN HEPATOL, V27, P1441, DOI 10.1111/j.1440-1746.2012.07144.x; Toyokawa T, 2016, SURG ENDOSC, V30, P2404, DOI 10.1007/s00464-015-4491-4; Toyokawa T, 2015, EXP THER MED, V9, P1209, DOI 10.3892/etm.2015.2265; Yamada T, 2014, GASTRIC CANCER, V17, P692, DOI 10.1007/s10120-013-0323-1; Zozumi M, 2010, J CLIN PATHOL, V63, P904, DOI 10.1136/jcp.2010.078980	21	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204039	10.1371/journal.pone.0204039	http://dx.doi.org/10.1371/journal.pone.0204039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273388	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700013
J	Jarman, SK; Haney, AM; Valdez, GR				Jarman, Sorscha K.; Haney, Alison M.; Valdez, Glenn R.			Kappa opioid regulation of depressive-like behavior during acute withdrawal and protracted abstinence from ethanol	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ANXIETY-LIKE BEHAVIOR; DEPENDENT RATS; ENHANCED RESPONSIVENESS; RECEPTOR ANTAGONIST; ANIMAL-MODEL; ALCOHOL; EXPOSURE; DRINKING; ACTIVATION	The dynorphin/kappa opioid receptor (DYN/KOR) system appears to be a key mediator of the behavioral effects of chronic exposure to alcohol. Although KOR opioid receptor antagonists have been shown to decrease stress-related behaviors in animal models during acute ethanol withdrawal, the role of the DYN/KOR system in regulating long-term behavioral changes following protracted abstinence from ethanol is not well understood. The objective of the current study was to further explore the role of the DYN/KOR system in regulating stress-related behavioral changes associated with acute withdrawal and protracted abstinence from ethanol. More specifically, the present experiments sought to examine the ability of the KOR antagonist norbinaltorphimine (nor-BNI) to reverse depressive-like behavior in the forced swim test in rats exposed to chronic ethanol.In the first experiment, rats were fed an ethanol or control liquid diet for 28-30 days, and then 24 hours after removal of the diet, were exposed to inescapable swim stress. Immediately following this procedure, rats were injected with nor-BNI (20 mg/kg) or saline and then tested 24 hours later in the forced swim test. A second experiment used a similar procedure to examine the effects of nor-BNI on behavioral changes during protracted abstinence in rats tested in the forced swim test 3 weeks after exposure to the ethanol liquid diet procedure. Ethanol-dependent rats showed increased immobility, which is thought to indicate a depressive-like state, when examined during acute withdrawal and protracted abstinence compared to controls, an effect attenuated by nor-BNI. These results suggest that the DYN/KOR system plays role in mediating both short- and long-term behavioral changes associated with depression following chronic alcohol exposure.	[Jarman, Sorscha K.; Haney, Alison M.; Valdez, Glenn R.] Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA; [Haney, Alison M.] Purdue Univ, Dept Psychol, W Lafayette, IN 47907 USA	Grand Valley State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Valdez, GR (corresponding author), Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA.	valdezg@gvsu.edu		Valdez, Glenn/0000-0001-8337-1760; Haney, Alison/0000-0002-4257-4593	National Institute on Alcohol Abuse and Alcoholism [R15 AA018213]; Center for Scholarly and Creative Excellence at Grand Valley State University; Grand Valley State University TRIO McNair Scholars Program	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Center for Scholarly and Creative Excellence at Grand Valley State University; Grand Valley State University TRIO McNair Scholars Program	This work was supported by R15 AA018213 from the National Institute on Alcohol Abuse and Alcoholism (GRV), the Center for Scholarly and Creative Excellence at Grand Valley State University (GRV), and the Grand Valley State University TRIO McNair Scholars Program (GRV, SKJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RI, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00045; Annis HM, 1998, ADDICT BEHAV, V23, P127, DOI 10.1016/S0306-4603(97)00024-5; BEGLEITER H, 1979, DRUG ALCOHOL DEPEN, V4, P353, DOI 10.1016/0376-8716(79)90019-X; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Carr GV, 2010, NEUROPSYCHOPHARMACOL, V35, P752, DOI 10.1038/npp.2009.183; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; Cottone P, 2009, PSYCHONEUROENDOCRINO, V34, P38, DOI 10.1016/j.psyneuen.2008.08.010; DESOTO CB, 1989, ALCOHOL CLIN EXP RES, V13, P693; ENDOH T, 1992, ARCH INT PHARMACOD T, V316, P30; Gillett K, 2013, ALCOHOL, V47, P359, DOI 10.1016/j.alcohol.2013.05.001; Harshberger E, 2016, J ADDICT, DOI [10.1155/2016/1084235, DOI 10.1155/2016/1084235]; HERSHON HI, 1977, J STUD ALCOHOL, V38, P953, DOI 10.15288/jsa.1977.38.953; Holleran KM, 2016, NEUROPSYCHOPHARMACOL, V41, P2062, DOI 10.1038/npp.2016.3; JACKISCH R, 1986, J NEUROCHEM, V46, P1802; Kissler JL, 2016, NEUROPSYCHOPHARMACOL, V41, P560, DOI 10.1038/npp.2015.183; Laorden ML, 2000, ENDOCRINOLOGY, V141, P1366, DOI 10.1210/en.141.4.1366; Macey DJ, 1996, ALCOHOL, V13, P163, DOI 10.1016/0741-8329(95)02030-6; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Nealey KA, 2011, NEUROPHARMACOLOGY, V61, P35, DOI 10.1016/j.neuropharm.2011.02.012; Pang TY, 2013, EUR J NEUROSCI, V37, P1803, DOI 10.1111/ejn.12195; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rasmussen DD, 2001, ALCOHOL CLIN EXP RES, V25, P999, DOI 10.1097/00000374-200107000-00008; Reyes BAS, 2008, J COMP NEUROL, V508, P663, DOI 10.1002/cne.21683; Ribeiro-Carvalho A, 2011, BEHAV BRAIN RES, V221, P282, DOI 10.1016/j.bbr.2011.03.014; Roberts AJ, 2000, NEUROPSYCHOPHARMACOL, V22, P581, DOI 10.1016/S0893-133X(99)00167-0; ROELOFS SMGJ, 1985, ALCOHOL, V2, P501, DOI 10.1016/0741-8329(85)90123-5; Rorick-Kehn LM, 2014, NEUROPHARMACOLOGY, V77, P131, DOI 10.1016/j.neuropharm.2013.09.021; ROTH KA, 1983, SCIENCE, V219, P189, DOI 10.1126/science.6129700; Schank JR, 2012, ADDICT BIOL, V17, P634, DOI 10.1111/j.1369-1600.2012.00455.x; Schulteis G, 1996, ALCOHOL CLIN EXP RES, V20, P164, DOI 10.1111/j.1530-0277.1996.tb01060.x; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Valdez GR, 2007, J PHARMACOL EXP THER, V323, P525, DOI 10.1124/jpet.107.125484; Valdez GR, 2012, PHARMACOL BIOCHEM BE, V102, P44, DOI 10.1016/j.pbb.2012.03.019; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Valdez GR, 2003, ALCOHOL, V29, P55, DOI 10.1016/S0741-8329(03)00020-X; Valdez GR, 2004, ALCOHOL CLIN EXP RES, V28, P865, DOI 10.1097/01.ALC.0000128222.29875.40; Walker BM, 2010, ADDICT BIOL, V16; Walker BM, 2008, NEUROPSYCHOPHARMACOL, V33, P643, DOI 10.1038/sj.npp.1301438; Walker BM, 2012, ALCOHOL, V46, P359, DOI 10.1016/j.alcohol.2011.10.006; Walker BM, 2010, ALCOHOL, V44, P487, DOI 10.1016/j.alcohol.2010.06.006; Zorrilla EP, 2001, PSYCHOPHARMACOLOGY, V158, P374, DOI 10.1007/s002130100773	41	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0205016	10.1371/journal.pone.0205016	http://dx.doi.org/10.1371/journal.pone.0205016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265734	Green Published, gold			2022-12-27	WOS:000446005500061
J	Kaur, H; Badaruddoza, B; Bains, V; Kaur, A				Kaur, Harjit; Badaruddoza, Badaruddoza; Bains, Veena; Kaur, Anupam			Genetic association of ADIPOQ gene variants (-3971A > G and+276G > T) with obesity and metabolic syndrome in North Indian Punjabi population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BODY-MASS INDEX; ADIPONECTIN GENE; INSULIN-RESISTANCE; APM1 GENE; PLASMA ADIPONECTIN; PROXIMAL PROMOTER; WAIST/HIP RATIO; COMMON VARIANTS; RISK-FACTORS	Background and aims At present obesity and metabolic syndrome (MetS) in India are the most challenging health problems. It is also well accepted that obesity is a significant risk factor for the development of metabolic syndrome and other degenerative diseases. Many studies have reported that single-nucleotide polymorphisms (SNPs) of the adiponectin (ADIPOQ) gene have been associated with obesity and its related disorders. Here, we aimed to investigate the association of two intronic variants in ADIPOQ gene, -3971A>G (rs822396) and +276G>T (rs1501299) with obesity and metabolic syndrome. Methods Biochemical and anthropometric measurements were obtained from a total of 550 unrelated subjects (obese = 250 and non-obese = 300) of North Indian Punjabi population. Genotyping for the intron variants were performed by polymerase chain reaction based restriction fragment length polymorphism (PCR-RFLP) methods. After genotyping, as a quality control measure 10% of the samples for each polymorphism were confirmed by Sanger Sequencing method. The distributions of genotypic and allelic frequencies among obese and non-obese groups were compared by chi-square test and the corresponding risk was calculated using binary logistic regression. The effects of multiple testing were controlled by applying Bonferroni corrections. Results All the anthropometric and biochemical parameters except triglycerides (TG) and very low-density lipoproteins cholesterol (VLDL-C) have shown significant association with both GG and TT genotypes of -3971A>G (rs822396) and +276G>T (rs1501299) polymorphisms respectively. The frequencies of GG (-3971A>G) and TT (+276G>T) genotypes were higher among obese cases (p = 0.008 and p = 0.035 respectively). However, no significant association was found between allelic frequencies of ADIPOQ rs822396 and obesity, whereas the 16 association of ADIPOQ rs1501299 attenuated and became marginally significant after Bonferroni correction (p>0.025). Both the variant genotypes of ADIPOQ gene polymorphisms (-3971GG and +276TT) significantly increased the risk of development of obesity (OR: 1.52, p = 0.03; OR: 1.58, p = 0.04 respectively) and MetS (OR: 1.42, p = 0.03; OR: 1.57, p = 0.01 respectively) in the present population, after adjusting the various covariates. The G-T haplotype model (possessing -3971G and +276T alleles) was shown to provide similar to 3 fold risk towards the obesity susceptibility (OR: 2.69, p = 0.009) and MetS risk (OR: 2.73, p = 0.009) and the association persisted after adjusting for different confounding variables. Conclusion The present study has confirmed that ADIPOQ -3971A>G (rs822396) and +276G>T (rs1501299) polymorphism may be clinically helpful to estimate obesity and MetS risk in North Indian Punjabi population.	[Kaur, Harjit; Badaruddoza, Badaruddoza; Bains, Veena; Kaur, Anupam] Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India	Guru Nanak Dev University	Badaruddoza, B (corresponding author), Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India.	doza13@yahoo.co.in		, Badaruddoza/0000-0002-8082-1356	University Grants Commission (UGC), New Delhi, under General Development Assistance Scheme during XIIth plan [3-1/2012 (SU)-1]	University Grants Commission (UGC), New Delhi, under General Development Assistance Scheme during XIIth plan	The present work was funded by University Grants Commission (UGC), New Delhi, under General Development Assistance Scheme during XIIth plan (Grant No. F.No.3-1/2012 (SU)-1).	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Apalasamy YD, 2014, MOL BIOL REP, V41, P2917, DOI 10.1007/s11033-014-3147-0; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Badaruddoza, 2015, J ADV RES, V6, P739, DOI 10.1016/j.jare.2014.04.002; Badaruddoza, 2009, ANTHROPOL ANZ, V67, P111, DOI 10.1127/0003-5548/2009/0014; Badaruddoza, 2014, EGYPT J APPL SCI, V2, P13, DOI [10.1016/J.EJBAS.2014.11.002, DOI 10.1016/J.EJBAS.2014.11.002]; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berthier MT, 2005, J LIPID RES, V46, P237, DOI 10.1194/jlr.M400135-JLR200; Bouatia-Naji N, 2006, DIABETES, V55, P545, DOI 10.2337/diabetes.55.02.06.db05-0971; Boumaiza I, 2012, GENET TEST MOL BIOMA, V16, P726, DOI 10.1089/gtmb.2011.0324; Boumaiza I, 2011, METAB SYNDR RELAT D, V9, P419, DOI 10.1089/met.2011.0035; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Cheong MY, 2011, YONSEI MED J, V52, P20, DOI 10.3349/ymj.2011.52.1.20; Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Cummings DE, 2003, ANNU REV MED, V54, P453, DOI 10.1146/annurev.med.54.101601.152403; Deepa M, 2009, EUR J CLIN NUTR, V63, P259, DOI 10.1038/sj.ejcn.1602920; Dolley G, 2008, INT J OBESITY, V32, P669, DOI 10.1038/sj.ijo.0803773; Filippi E, 2005, J MOL MED, V83, P711, DOI 10.1007/s00109-005-0667-z; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gable DR, 2006, ATHEROSCLEROSIS, V188, P231, DOI 10.1016/j.atherosclerosis.2006.02.010; Gotoda T, 1997, HUM MOL GENET, V6, P869, DOI 10.1093/hmg/6.6.869; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; Gupta V, 2012, GENET TEST MOL BIOMA, V16, P948, DOI 10.1089/gtmb.2012.0051; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Jang Y, 2005, AM J CLIN NUTR, V82, P760, DOI 10.1093/ajcn/82.4.760; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kalnina I, 2009, P LAV ACAD SCI, V63, P174, DOI [10.2478/v10046-009-0046-1, DOI 10.2478/V10046-009-0046-1]; Kang ES, 2005, DIABETES CARE, V28, P1139, DOI 10.2337/diacare.28.5.1139; Karmelic I, 2012, ARCH MED RES, V43, P145, DOI 10.1016/j.arcmed.2012.02.004; Krizova J, 2008, PHYSIOL RES, V57, P539, DOI 10.33549/physiolres.931195; Li P, 2015, EUR J CLIN NUTR, V69, P62, DOI 10.1038/ejcn.2014.152; Lu HY, 2007, DIABETES METAB SYND, V1, P259, DOI 10.1016/j.dsx.2007.09.008; Luke A, 2003, DIABETES, V52, P1284, DOI 10.2337/diabetes.52.5.1284; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Misra A, 2009, J Assoc Physicians India, V57, P163; Mohammadzadeh Ghorban, 2016, Iranian Biomedical Journal, V20, P152, DOI 10.7508/ibj.2016.03.004; MOHAN V, 1986, DIABETOLOGIA, V29, P235, DOI 10.1007/BF00454882; Mohan V, 2004, J Assoc Physicians India, V52, P95; Mtiraoui N, 2012, DIABETES RES CLIN PR, V97, P290, DOI 10.1016/j.diabres.2012.02.015; Mullican DR, 2009, DIABETES CARE, V32, P1870, DOI 10.2337/dc09-0328; Newell Astrid, 2007, Prev Chronic Dis, V4, pA31; Ogundele OE., 2018, EGYPT J MED HUM GENE, V19, P123, DOI [DOI 10.1016/J.EJMHG.2017.08.005, 10.1016/j.ejm-hg.2017.08.005]; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Organization WH, 1998, WELLB MEAS PRIM HLTH; Pischon T, 2007, OBESITY, V15, P2051, DOI 10.1038/oby.2007.244; Poitou C, 2005, OBES SURG, V15, P11, DOI 10.1381/0960892052993431; Prakash J, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.154773; Prakash J, 2011, ANN HUM BIOL, V38, P760, DOI 10.3109/03014460.2011.614278; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Ramya K, 2013, GENE, V532, P253, DOI 10.1016/j.gene.2013.09.012; Rohde K, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0449-8; Rosmond R, 2000, J CLIN ENDOCR METAB, V85, P3126, DOI 10.1210/jc.85.9.3126; Salmenniemi U, 2005, J CLIN ENDOCR METAB, V90, P4216, DOI 10.1210/jc.2004-2289; Schwartz MW, 2017, ENDOCR REV, V38, P267, DOI 10.1210/er.2017-00111; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37; Tanko LB, 2005, OBES RES, V13, P2113, DOI 10.1038/oby.2005.262; Toy WC, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000152; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Vimaleswaran KS, 2008, HUM GENET, V123, P599, DOI 10.1007/s00439-008-0506-8; Wakai K, 2013, OBESITY, V21, P2413, DOI 10.1002/oby.20316; Warodomwichit D, 2009, OBESITY, V17, P510, DOI 10.1038/oby.2008.583; Yang WS, 2007, AM J CLIN NUTR, V86, P509, DOI 10.1093/ajcn/86.2.509; Yang WS, 2006, J MOL MED, V84, P112, DOI 10.1007/s00109-005-0011-7; Yang WS, 2003, J MOL MED-JMM, V81, P428, DOI 10.1007/s00109-002-0409-4; Yu ZB, 2012, OBESITY, V20, P396, DOI 10.1038/oby.2011.148; Zaki ME, 2014, INT J PHARM PHARM SC, V6, P226, DOI [10.1016/J.EJMHG.2017.08.005, DOI 10.1016/J.EJMHG.2017.08.005]	75	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204502	10.1371/journal.pone.0204502	http://dx.doi.org/10.1371/journal.pone.0204502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265726	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500036
J	Kavunga-Membo, H; Nkwembe, E; Simulundu, E; Karhemere, S; Babakazo, P; Manya, L; Kabamba, J; Okitolonda, E; Ahuka-Mundeke, S; Muyembe, JJ				Kavunga-Membo, Hugo; Nkwembe, Edith; Simulundu, Edgar; Karhemere, Stomy; Babakazo, Pelagie; Manya, Leonie; Kabamba, Joelle; Okitolonda, Emile; Ahuka-Mundeke, Steve; Muyembe, Jean Jacques			Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015	PLOS ONE			English	Article							SEASONAL INFLUENZA; SOUTH-AFRICA; SURVEILLANCE; NEURAMINIDASE; ALGORITHM; ILLNESS; BURDEN; KENYA; H1N1	Introduction The establishment of the influenza sentinel surveillance system in Kinshasa, Bas Congo, Maniema, Katanga, and Kasai Provinces allowed generation of important data on the molecular epidemiology of human influenza viruses circulating in the Democratic Republic of Congo (DRC). However, some challenges still exist, including the need for extending the influenza surveillance to more provinces. This study describes the pattern of influenza virus circulating in DRC during 2015. Methodology Nasopharyngeal swabs were collected from January to December 2015 from outpatients with influenza-like illness (ILI) and in all hospitalized patients with Severe Acute Respiratory Infection (SARI). Molecular analysis was done to determine influenza type and subtype at the National Reference Laboratory (NRL) in Kinshasa using real time reverse transcription-polymerase chain reaction (rRT-PCR). Analysis of antiviral resistance by enzyme inhibition assay and nucleotide sequencing was performed by the Collaborating center in the USA (CDC, Atlanta). Results Out of 2,376 nasopharyngeal swabs collected from patients, 218 (9.1%) were positive for influenza virus. Among the positive samples, 149 were characterized as influenza virus type A (Flu A), 67 as type B (Flu B) and 2 mixed infections (Flu A and B). Flu A subtypes detected were H3N2 and H1N1. The Yamagata strain of Flu B was detected among patients in the country. Individuals aged between 5 and 14 years accounted for the largest age group affected by influenza virus. All influenza viruses detected were found to be sensitive to antiviral drugs such as oseltamivar, zanamivir, peramivir and laninamivar. Conclusion The present study documented the possible involvement of both circulation of Flu A and B viruses in human respiratory infection in certain DRC provinces during 2015. This study emphasises the need to extend the influenza surveillance to other provinces for a better understanding of the epidemiology of influenza in DRC. It is envisioned that such a system would lead to improved disease control and patient management.	[Kavunga-Membo, Hugo; Nkwembe, Edith; Karhemere, Stomy; Ahuka-Mundeke, Steve; Muyembe, Jean Jacques] INRB, Dept Virol, Kinshasa, DEM REP CONGO; [Kavunga-Membo, Hugo; Simulundu, Edgar] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Babakazo, Pelagie; Okitolonda, Emile] Univ Kinshasa UNIKIN, Ecole Sante Publ, Kinshasa, DEM REP CONGO; [Manya, Leonie; Kabamba, Joelle] Minist Sante Publ, Direct Lutte Malad, Kinshasa, DEM REP CONGO	Institute Nacional de Recherche Biomedical; University of Zambia; Universite de Kinshasa	Kavunga-Membo, H (corresponding author), INRB, Dept Virol, Kinshasa, DEM REP CONGO.; Kavunga-Membo, H (corresponding author), Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia.	hugokavunga@gmail.com	Simulundu, Edgar/H-7331-2019; Babakazo, Pelagie/GLR-3170-2022; Babakazo, PÃ©lagie/Y-5453-2019	Simulundu, Edgar/0000-0001-9423-0816; 				[Anonymous], 2008, Wkly Epidemiol Rec, V83, P366; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P81; [Anonymous], 2016, INFL DIV REP; Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Besselaar TG, 2008, EMERG INFECT DIS, V14, P1809, DOI 10.3201/eid1411.080958; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Gachara G, 2006, J CLIN VIROL, V35, P117, DOI 10.1016/j.jcv.2005.10.004; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Kamps BS, 2006, PREISER J INFLUENZA; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Njouom R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-56; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shepard SS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3030-6; STUDIER JA, 1988, MOL BIOL EVOL, V5, P729; Tamfum JJM, 2012, J INFECT DIS, V206, pS36, DOI 10.1093/infdis/jis537; Theo A, 2012, J INFECT DIS, V206, pS173, DOI 10.1093/infdis/jis599; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; Zhou Bin, 2012, Methods Mol Biol, V865, P175, DOI 10.1007/978-1-61779-621-0_11	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203995	10.1371/journal.pone.0203995	http://dx.doi.org/10.1371/journal.pone.0203995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265699	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500014
J	Wang, XS; Zhang, HH; Chen, Y				Wang, Xiushan; Zhang, Hehu; Chen, Ying			Research on maize canopy center recognition based on nonsignificant color difference segmentation	PLOS ONE			English	Article							MACHINE VISION; AUTOMATED CROP; VEGETATION; ALGORITHM; IMAGES; SVM	Weed control is a substantial challenge in field management. A better weed control method at an earlier growth stage is important for increasing yields. As a promising weed control technique, intelligent weeding based on machine vision can avoid the harm of chemical weeding. For machine vision, it is critical to extract and segment crops from their background. However, there is still no optimal solution for object tracking with occlusion under a similar color background. In this study, it was found that the gray distribution of a maize canopy follows the gradient law. Therefore, the recognition method based on the HLS-SVM (HLS color space and Support Vector Machine) and on the grayscale gradient was developed. First, the HLS color space was used to detect the maize canopy. Second, the SVM method was used to segment the central region of the maize canopy. Finally, the maize canopy center was identified according to the gradient law. The results showed that the average segmentation time was 0.49 s, the average segmentation quality was 87.25%, and the standard deviation of the segmentation was 3.57%. The average recognition rate of the center position was 93.33%. This study provided a machine vision method for intelligent weeding agricultural equipment as well as a theoretical reference for further agricultural machine vision research.	[Wang, Xiushan; Zhang, Hehu] Henan Agr Univ, Coll Mech & Elect Engn, Dept Elect Engn, Zhengzhou, Henan, Peoples R China; [Chen, Ying] Henan Agr Univ, Coll Humanities & Law, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Zhang, HH (corresponding author), Henan Agr Univ, Coll Mech & Elect Engn, Dept Elect Engn, Zhengzhou, Henan, Peoples R China.	henauzhh@163.com	zhang, hehu/AAT-8931-2020; Zhang, Hehu/AAN-5588-2021	Zhang, Hehu/0000-0003-0862-0506	National Natural Science Foundation of China [U1204524]; Henan province science and technology key project [172102210302]; Henan college key scientific research project [18A416002]; Development of key technologies for electrically driven inter robot weeding robot based on machine vision technology [KF1607]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan province science and technology key project; Henan college key scientific research project; Development of key technologies for electrically driven inter robot weeding robot based on machine vision technology	This research is supported by the following projects: the National Natural Science Foundation of China (Grant: U1204524), the Henan province science and technology key project (Grant: 172102210302), the Henan college key scientific research project (Grant: 18A416002), and the Development of key technologies for electrically driven inter robot weeding robot based on machine vision technology (KF1607).; This research is supported by the following projects: the National Natural Science Foundation of China (Grant: U1204524), the Henan province science and technology key project (Grant: 172102210302), the Henan college key scientific research project (Grant: 18A416002), and the Development of key technologies for electrically driven inter robot weeding robot based on machine vision technology (KF1607). The project team heartily expresses their full thanks to above units.	Abbasgholipour M, 2011, EXPERT SYST APPL, V38, P3671, DOI 10.1016/j.eswa.2010.09.023; Bai XF, 2016, NEURAL COMPUT APPL, V27, P45, DOI 10.1007/s00521-013-1544-2; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cordill C, 2011, BIOSYST ENG, V110, P247, DOI 10.1016/j.biosystemseng.2011.07.007; Eizentals P, 2017, SPR PROC ADV ROBOT, V1, P433, DOI 10.1007/978-3-319-50115-4_38; Eyre MD, 2011, EUR J AGRON, V34, P153, DOI 10.1016/j.eja.2011.01.001; Guo W, 2013, COMPUT ELECTRON AGR, V96, P58, DOI 10.1016/j.compag.2013.04.010; Hague T, 2006, PRECIS AGRIC, V7, P21, DOI 10.1007/s11119-005-6787-1; Huang YJ, 2010, COMPUT ELECTRON AGR, V70, P42, DOI 10.1016/j.compag.2009.08.011; Hunt E. Raymond Jr, 2005, Precision Agriculture, V6, P359, DOI 10.1007/s11119-005-2324-5; Kataoka T, 2003, IEEE ASME INT C ADV, P1079, DOI 10.1109/aim.2003.1225492; Kondo N., 2009, ENG AGR ENV FOOD, V2, P60, DOI DOI 10.1016/S1881-8366(09)80017-7; Kovac J, 2003, IEEE REGION 8 EUROCON 2003, VOL B, PROCEEDINGS, P144; Lapin M, 2014, NEURAL NETWORKS, V53, P95, DOI 10.1016/j.neunet.2014.02.002; Li N, 2015, INT J AGR BIOL ENG, V8, P20, DOI 10.3965/j.ijabe.20150806.1932; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; Meyer GE, 2004, COMPUT ELECTRON AGR, V42, P161, DOI 10.1016/j.compag.2003.08.002; Meyer GE, 2008, COMPUT ELECTRON AGR, V63, P282, DOI 10.1016/j.compag.2008.03.009; Moghaddam PA, 2016, COMPUT ELECTRON AGR, V122, P133, DOI 10.1016/j.compag.2016.01.025; Najman L, 2010, MATH MORPHOLOGY, P3, DOI [10.1002/9781118600788.ch1, DOI 10.1002/9781118600788.CH1]; Nuss ET, 2010, COMPR REV FOOD SCI F, V9, P417, DOI 10.1111/j.1541-4337.2010.00117.x; Wali SB, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/250461; Wu TF, 2010, P IEEE COMP SOC C CO, V2, P2301, DOI [10.1016/j.visres.2004.04.006, DOI 10.1016/J.VISRES.2004.04.006]; Zhang JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195223; Zhao JD, 2017, J ADV TRANSPORT, DOI 10.1155/2017/6458495; Zheng LY, 2009, COMPUT ELECTRON AGR, V65, P93, DOI 10.1016/j.compag.2008.08.002	26	2	2	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0202366	10.1371/journal.pone.0202366	http://dx.doi.org/10.1371/journal.pone.0202366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261517	gold, Green Published, Green Submitted			2022-12-27	WOS:000445907400003
J	Atsri, HK; Konko, Y; Cuni-Sanchez, A; Abotsi, KE; Kokou, K				Atsri, Honam Komina; Konko, Yawo; Cuni-Sanchez, Aida; Abotsi, Komla Elikplim; Kokou, Kouami			Changes in the West African forest-savanna mosaic, insights from central Togo	PLOS ONE			English	Article							DYNAMICS; FRAGMENTATION; BIODIVERSITY; INDICATORS; RESERVE; AREA	The West African forest-savanna mosaic, an important habitat for biodiversity and humans, is severely degraded, fragmented and modified by human activities. However, few studies have quantified the land cover changes observed over time and/or analysed the drivers of change. This study focused on Fazao-Malfakassa National Park, the largest in Togo, uses a combination of remote sensing, ground surveys and questionnaires to: (i) quantify vegetation changes, (ii) determine the drivers of change, (iii) compare results with findings elsewhere in the region and (iv) suggest management interventions. The images used were Landsat 5 TM, Landsat 7 ETM and Sentinel-2. Different vegetation indices were computed including: number of fragments, index of dominance, mean area of a vegetation type and mean annual expansion rate. In total, 300 people (including park staff and local populations) were interviewed using a semi-structured questionnaire. Results indicate that between 1987 and 2015 closed-canopy forest and tree-savanna became severely degraded and fragmented, following trends in other parts of the West African forest-savanna mosaic. The main drivers of change were agricultural expansion, bush fires and timber extraction. Observed changes and drivers altered with time: e.g. agricultural expansion was greatest during 1987-2001 (linked with political instability) while illegal timber extraction augmented during 2001-2015 (following increased timber value). Park staff and local populations' perceptions on drivers of change did not differ. Our study highlights that action is urgently needed if we are to preserve this important habitat, the biodiversity it hosts and the services it provides to humans. We suggest several management interventions, learning from successful interventions elsewhere in the region.	[Atsri, Honam Komina; Abotsi, Komla Elikplim; Kokou, Kouami] Univ Lome Togo, Fac Sci, Lab Rech Forestiere, Lome, Togo; [Konko, Yawo] Minist Environm & Ressources Forestieres Togo, Agence Natl Gest Environm, Lome, Togo; [Cuni-Sanchez, Aida] Univ York, Environm Dept, York, N Yorkshire, England	University of York - UK	Atsri, HK (corresponding author), Univ Lome Togo, Fac Sci, Lab Rech Forestiere, Lome, Togo.	atsri.honam@yahoo.com	Atsri, Honam/Q-8052-2019	Atsri, Honam/0000-0001-5594-316X				Achard F, 1990, APPORTS TELEDETECTIO, P1; Adjonou K., 2010, BOIS FOR TROP, V306, P33; Adjoussi P., 2000, CHANGEMENT CLIMATIQU; Amori G, 2016, ZOOSYSTEMA, V38, P201, DOI 10.5252/z2016n2a3; Arouna O., 2012, CARTOGRAPHIE MODELIS; Aubreville A., 1957, Bois et Forets des Tropiques, P23; Banque mondiale, 2014, POPULATION TOTAL BAN; Barima Y.S.S., 2010, T L D TECTION, V9, P129; Barima YSS, 2010, BIOTECHNOL AGRON SOC, V14, P617; Belle EMS, 2016, SUMMARY MAIN OUTPUTS; Blanc-Pamard C., 1984, DEV RURAL QUESTION, V106, P55; BLOT A, 1988, J AFR EARTH SCI, V7, P159, DOI 10.1016/0899-5362(88)90062-0; Bogaert J, 2003, CONSERV ECOL, V7; Bouko BS, 2016, EUR SCI J ESJ, V12; CALOZ R., 1993, TELEDETECTION CARTOG, P17; Camara AA, 2012, CYBERGEO; Campbell G, 2005, PRIMATE BIRD DIVERSI; Carr JA, 2014, EVALUATION VULNERABI; CIBIEN C, 2000, RESERVES BIOSPHERE T; Cibien C, 2008, DEMARCHE MAB VOIE OP; Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x; Commission allemande pour l'UNESCO, 2015, GUID GEST RES UNESCO; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Davidson C, 1998, WILDLIFE SOC B, V26, P32; Denis G., 2015, EUR SCI J ESJ, V11; Diallo Hady, 2011, Secheresse (Montrouge), V22, P97, DOI 10.1684/sec.2011.0306; DibiN'Da H., 2008, TELEDETECTION, V8, P17; Dimobe K, 2015, GLOB ECOL CONSERV, V4, P559, DOI 10.1016/j.gecco.2015.10.006; Diwediga B, 2017, J GEOGR SCI, V27, P579, DOI 10.1007/s11442-017-1394-4; Djibu K.J.-P., 2008, ANN FS AGRON LUNIVER, V1, P12; Djiwa O, 2008, DYNAMIQUE FOERESTIER; Dourma M, 2012, BOIS FOR TROP, V313; FFW, 2013, ET EC INV FOR FAUN E; Gautestad AO, 2010, ECOL MODEL, V221, P2741, DOI 10.1016/j.ecolmodel.2010.08.014; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; GUELLY KA, 2013, ANAL COMPRE HENSION, P88; Heilig GK, 2012, DEP EC SOC AFF DESA; Idbraim S., 2009, THESIS; Inoussa Maman Maarouhi, 2011, Secheresse (Montrouge), V22, P108, DOI 10.1684/sec.2011.0305; IUCN/PACO, 2008, EV EFF GEST AIR PROT; James R, 2013, CLIMATIC CHANGE, V117, P859, DOI 10.1007/s10584-012-0581-7; Jenkins MD, 2002, WORLD ATLAS BIODIVER; Johns Andrew Grieser, 1995, Oryx, V29, P205, DOI 10.1017/S0030605300021141; Kaiser J., 2001, BIOINDICATORS BIOMAR; Kemavo A., 2012, CONTRIBUTION TECHNOL; Kokou K, 2006, PHYTOCOENOLOGIA, V36, P403, DOI 10.1127/0340-269X/2006/0036-0403; Kone M, 2007, REV TELEDETECTION, V7, P3; Kouami K, 2009, SCI RES ESSAYS, V4, P881; Kurtz C., 2009, ANAL MULTIRESOLUTION; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lerman SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043497; Levine J.S., 1999, WILDLAND FIRES ENV G; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lugo E., 2008, J LAND USE ENV LAW, V23, P243; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Masumbuko B, 2014, ANAL LINKS CLIMATE C; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; Ministere de l'Environnement et des Ressources Forestieres, 2016, PLAN NAT AD AUX CHAN, P117; MPTHU, 2001, COMSTABEX9194 MPTHU; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Oloukoi J, 2007, TELEDETECTION, V6, P305; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Osseni Inoussa A., 2009, CONTRIBUTION GESTION; Otto H-J, 1998, ECOLOGIE FORESTIERE; PACO/UICN I, 2012, PAPACO STUD; PNUD, 2016, RAPP DEV HUM AFR 201; Poilecot P, 2009, BOIS FOR TROP, P51; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Prudent P, 2008, 742 ACP RPR; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Rabeil T., 2003, DISTRIBUTION POTENTI; RGPH4, 2011, DIR GEN STAT COMPT N; Robin A, 2007, THESIS; Sambieni K, 2015, VERTIGO REV ELECT SC, V15; Sawadogo L, 2007, ADAPTER APPROCHES AM; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; Sinsin B, 2010, ATLAS BIODIVERSITE A, VI; Smyth RL, 2007, ENVIRON MANAGE, V39, P301, DOI 10.1007/s00267-005-0282-3; Tankoano B., 2015, International Journal of Biological and Chemical Sciences, V9, P1983, DOI 10.4314/ijbcs.v9i4.23; Tchamie T. T. K., 1994, UNASYLVA, V45, P22; Toko Mouhamadou I, 2012, VERTIGO REV ELECT SC, V12; Vergara PM, 2015, ECOL MODEL, V300, P114, DOI 10.1016/j.ecolmodel.2015.01.006; Woegan Y. A., 2013, International Journal of Biological and Chemical Sciences, V7, P1951, DOI 10.4314/ijbcs.v7i5.14; Woegan YA, 2011, ACTA BOT GALLICA, V158, P444	84	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203999	10.1371/journal.pone.0203999	http://dx.doi.org/10.1371/journal.pone.0203999			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289922	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500012
J	Sacreas, A; Yang, JYC; Vanaudenaerde, BM; Sigdel, TK; Liberto, JM; Damm, I; Verleden, GM; Vos, R; Verleden, SE; Sarwal, MM				Sacreas, Annelore; Yang, Joshua Y. C.; Vanaudenaerde, Bart M.; Sigdel, Tara K.; Liberto, Juliane M.; Damm, Izabella; Verleden, Geert M.; Vos, Robin; Verleden, Stijn E.; Sarwal, Minnie M.			The common rejection module in chronic rejection post lung transplantation	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; ALLOGRAFT DYSFUNCTION; EXPRESSION; BIOPSIES	Rationale Recent studies suggest that similar injury mechanisms are in place across different solid organ transplants, resulting in the identification of a common rejection module (CRM), consisting of 11 genes that are overexpressed during acute and, to a lesser extent, chronic allograft rejection. Objectives We wanted to evaluate the usefulness of the CRM module in identifying acute rejection (AR) and different phenotypes of chronic lung transplant rejection (CLAD), i.e., bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS), using transbronchial brushings, broncho-alveolar lavage (BAL) samples, and explant tissue. Methods Gene expression measurements for the 11 CRM genes (CD6, TAP1, CXCL10, CXCL9, INPP5D, ISG20, LCK, NKG7, PSMB9, RUNX3, and BASP1) were performed via qRT-PCR in 14 transbronchial brushings (AR, n = 4; no AR, n = 10), 32 BAL samples (stable, n = 13; AR, n = 8; BOS, n = 9; RAS, n = 10), and 44 tissue specimens (unused donor lungs, n = 15; BOS, n = 13; RAS, n = 16). A geometric mean score was calculated to quantitate overall burden of immune injury and a new computational model was built for the most significant genes in lung transplant injury. Results Acute rejection showed a significant difference in almost every gene analysed, validating previous observations from microarray analysis. RAS tissue demonstrated a higher geometric mean score (6.35) compared to donor tissue (4.09, p = 0.018). Analysis of individual CRM genes showed an increased expression of ISG20, CXCL10 and CXCL9 in RAS. In BAL samples, no differences were detected in gene expression or geometric mean scores between the various groups (stable, 5.15; AR, 5.81; BOS, 5.62; RAS, 7.31). A newly modelled 2-gene tissue CRM score did not demonstrate any difference between BOS and RAS (p>0.05). However, the model was able to discriminate RAS from BOS tissue (AUC = 0.75, 95% CI = 0.55-0.94, p = 0.025). Conclusion Transcriptional tissue analysis for CRM genes in CLAD can identify acute rejection and distinguish RAS from BOS. The immune activation in RAS seems similar to acute rejection after kidney/liver/heart transplantation.	[Sacreas, Annelore; Vanaudenaerde, Bart M.; Verleden, Geert M.; Vos, Robin; Verleden, Stijn E.] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Leuven Lung Transplant Unit, Leuven, Belgium; [Yang, Joshua Y. C.; Sigdel, Tara K.; Liberto, Juliane M.; Damm, Izabella; Sarwal, Minnie M.] Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA	KU Leuven; University of California System; University of California San Francisco	Verleden, SE (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Leuven Lung Transplant Unit, Leuven, Belgium.; Sarwal, MM (corresponding author), Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA.	stijn.verleden@kuleuven.be; minnie.sarwal@ucsf.edu	Liberto, Juliane M/ABA-9675-2020; Yang, Joshua Young Cynming/P-6447-2018; Sigdel, Tara/AAV-5886-2020	Liberto, Juliane M/0000-0003-1927-5058; Yang, Joshua Young Cynming/0000-0003-2410-7817; Sigdel, Tara/0000-0001-8448-0328; Verleden, Stijn/0000-0002-9656-5844; Vanaudenaerde, Bart/0000-0001-6435-6901	Reaseach Foundation - Flanders (FWO) [12G8715N, 1500617N]; UZ Leuven [STG/15/023]; KU Leuven research funding [C24/15/030]; NIH (NIAID); NIH (NIDDK)	Reaseach Foundation - Flanders (FWO); UZ Leuven(KU Leuven); KU Leuven research funding; NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Authors of this work were supported by several funding resources. RV and SEV are senior clinical research fellows sponsored by Reaseach Foundation - Flanders (FWO: 12G8715N and 1500617N). RV is supported by UZ Leuven (STG/15/023). GMV and BMV are supported by KU Leuven research funding C24/15/030. MMS and TKS have research support from the NIH (NIAID and NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angaswamy N, 2013, HUM IMMUNOL, V74, P1478, DOI 10.1016/j.humimm.2013.07.002; Bollmann BA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01844-2016; Davis WA, 2012, AM J TRANSPLANT, V12, P745, DOI 10.1111/j.1600-6143.2011.03849.x; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200; Halloran PF, 2017, J HEART LUNG TRANSPL, V36, P1192, DOI 10.1016/j.healun.2017.05.029; Halloran PF, 2016, NAT REV NEPHROL, V12, P534, DOI 10.1038/nrneph.2016.85; Kennedy VE, 2013, AM J TRANSPLANT, V13, P552, DOI 10.1111/ajt.12091; Keslar KS, 2013, AM J TRANSPLANT, V13, P1891, DOI 10.1111/ajt.12284; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Mengual Lourdes, 2008, BMC Res Notes, V1, P21, DOI 10.1186/1756-0500-1-21; Meyer KC, 2014, EUR RESPIR J, V44, P1479, DOI 10.1183/09031936.00107514; Royer PJ, 2016, TRANSPLANTATION, V100, P1803, DOI 10.1097/TP.0000000000001215; Sato M, 2011, J HEART LUNG TRANSPL, V30, P735, DOI 10.1016/j.healun.2011.01.712; Shino MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180281; Shino MY, 2013, AM J RESP CRIT CARE, V188, P1117, DOI 10.1164/rccm.201305-0861OC; Sigdel T, 2017, AM J TRANSPLANT, V17, DOI [10.1371/journal.pone.0138133, DOI 10.1371/JOURNAL.PONE.0138133]; Sigdel TK, 2018, KIDNEY INT REP, V3, P722, DOI 10.1016/j.ekir.2018.01.014; Sigdel TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138133; Verleden GM, 2014, J HEART LUNG TRANSPL, V33, P127, DOI 10.1016/j.healun.2013.10.022; Verleden SE, 2015, J HEART LUNG TRANSPL, V34, P625, DOI 10.1016/j.healun.2014.11.007; Verleden SE, 2015, TRANSPLANTATION, V99, P86, DOI 10.1097/TP.0000000000000269; Verleden SE, 2014, AM J RESP CRIT CARE, V189, P292, DOI 10.1164/rccm.201310-1894OC; Yang JYC, 2017, NAT REV GENET, V18, P309, DOI 10.1038/nrg.2017.12; Yusen RD, 2016, J HEART LUNG TRANSPL, V35, P1170, DOI 10.1016/j.healun.2016.09.001; Zheng ZW, 2017, INTRACTABLE RARE DIS, V6, P35, DOI 10.5582/irdr.2017.01004	26	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205107	10.1371/journal.pone.0205107	http://dx.doi.org/10.1371/journal.pone.0205107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289917	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000446545500049
J	Sekihara, K; Saitoh, K; Yang, H; Kawashima, H; Kazuno, S; Kikkawa, M; Arai, H; Miida, T; Hayashi, N; Niyonsaba, F; Sasai, K; Tabe, Y				Sekihara, Kazumasa; Saitoh, Kaori; Yang, Haeun; Kawashima, Haruki; Kazuno, Saiko; Kikkawa, Mika; Arai, Hajime; Miida, Takashi; Hayashi, Nobuhiro; Niyonsaba, Francois; Sasai, Keisuke; Tabe, Yoko			Low-dose ionizing radiation exposure represses the cell cycle and protein synthesis pathways in in vitro human primary keratinocytes and U937 cell lines (vol 13, e0199117, 2018)	PLOS ONE			English	Correction									[Niyonsaba, Francois] Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Tokyo, Japan	Juntendo University	Niyonsaba, F (corresponding author), Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Tokyo, Japan.		Hayashi, Nobuhiro/F-6088-2011; Miida, Takashi/A-5589-2012	Hayashi, Nobuhiro/0000-0002-9950-094X; Miida, Takashi/0000-0002-4294-8030	MEXT, Japan [16K19855]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The following information is missing from the Funding section: This study was supported by Grant-in-Aid for Young Scientists (B) (16K19855) from the MEXT, Japan to KS.	Sekihara K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199117	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205581	10.1371/journal.pone.0205581	http://dx.doi.org/10.1371/journal.pone.0205581			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289943	gold, Green Submitted, Green Published			2022-12-27	WOS:000446545500072
J	Wu, KY; Koo, J; Jiang, XJ; Chen, R; Cohen, SN; Nathan, C				Wu, Kangyun; Koo, Jovanka; Jiang, Xiuju; Chen, Ran; Cohen, Stanley N.; Nathan, Carl			Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R (vol 7, e30512, 2012)	PLOS ONE			English	Correction																		Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Mundhra S., 2018, EUR J IMMUNOL; Wu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030512; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	4	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205424	10.1371/journal.pone.0205424	http://dx.doi.org/10.1371/journal.pone.0205424			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289942	Green Published, gold			2022-12-27	WOS:000446545500067
J	Calvopina, M; Romero-Alvarez, D; Diaz, F; Cevallos, W; Sugiyama, H				Calvopina, Manuel; Romero-Alvarez, Daniel; Diaz, Fernanda; Cevallos, William; Sugiyama, Hiromu			A comparison of Kato-Katz technique to three other methods for diagnosis of Amphimerus spp. liver fluke infection and the prevalence of infection in Chachi Amerindians of Ecuador	PLOS ONE			English	Article							GOLD STANDARD; HELMINTH INFECTIONS; ABSENCE; HOOKWORM; DISEASE; HUMANS; TESTS	Background Recently, a high prevalence of infection by the liver fluke Amphimerus spp. has been documented in the Chachi Amerindians of Ecuador. For diagnosis, no studies exist that compare the sensitivity of different coproparasitological detection techniques. The present study compares the Kato-Katz technique with three other coproparasitological methods for detecting eggs of Amphimerus in stools, as well as determines the prevalence of infection in Chachi residents in a Tropical rain forest area in the northwest coast of Ecuador. Methodology/Results total of 105 samples, utilizing the Kato-Katz technique (KK), the spontaneous sedimentation technique in tube (SSTT), the formalin-ether concentration technique (FEC), and direct smear microscopy (DM), were examined. Combining the four methods (fixed "gold" standard), 38 samples were positive with a prevalence of infection of 36.2%. The sensitivities of individual methods were 71%, 58%, 50% and 3% for KK, SSTT, FEC, and DM respectively. Our results indicated that KK alone had the best performance, detecting 27 (71%) of the 38 positive samples. The combination of KK and SSTT detected amphimeriasis in 36 (95%) samples, and KK and FEC in 31 (82%) samples. Conclusions DM showed the lowest sensitivity, which raises concern for its value, because it is the standard technique for stool examination for detection of parasites in both public and private laboratories in Ecuador. SSTT alone detected eggs in 22 samples (58%) and would be recommended for field studies because of its simplicity. Performing two techniques on a single sample enhances the detection of Amphimerus infection. Its sensitivity is relative to a fixed gold" standard, determined as the combined results of the four techniques performed. This study confirms the high prevalence of human infection by Amphimerus in the indigenous Chachi group where the first human cases were described.	[Calvopina, Manuel] UDLA, Fac Ciencias Salud, Carrera Med, OneHlth Grp, Quito, Ecuador; [Romero-Alvarez, Daniel] Univ Kansas, Dept Ecol & Evolutionary Biol, Biodivers Inst, Lawrence, KS 66045 USA; [Diaz, Fernanda; Cevallos, William] Univ Cent Ecuador, Carrera Med, Quito, Ecuador; [Sugiyama, Hiromu] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan	Universidad de Las Americas - Ecuador; University of Kansas; Universidad Central del Ecuador; National Institute of Infectious Diseases (NIID)	Calvopina, M (corresponding author), UDLA, Fac Ciencias Salud, Carrera Med, OneHlth Grp, Quito, Ecuador.	manuelcalvopina@gmail.com	Romero-Alvarez, Daniel/K-2270-2019	Cevallos, William/0000-0003-1519-7275; Romero-Alvarez, Daniel/0000-0002-6762-6046; Calvopina, Manuel/0000-0002-0286-0747	Universidad Central del Ecuador [CUP 91750000.0000.374072]; Japan Society for the Promotion of Science, JSPS (KAKENHI) [16H05820]	Universidad Central del Ecuador; Japan Society for the Promotion of Science, JSPS (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by the grants from the Universidad Central del Ecuador (CUP 91750000.0000.374072) (MCH) (http://www.uce.edu.ec) and in part by the Japan Society for the Promotion of Science, JSPS (KAKENHI: Grant No. 16H05820) (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, SYNOPSIS DIGENETIC T; Assefa LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002843; Calvopina M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003526; Calvopina M, 2011, EMERG INFECT DIS, V17, P2331, DOI 10.3201/eid1712.110373; Centers for Disease Control and Prevention, LAB ID PAR DIS PUBL; Cevallos W, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005672; Cevallos W, 2017, MEM I OSWALDO CRUZ, V112, P364, DOI 10.1590/0074-02760160426; Dendukuri N, 2004, BIOMETRICS, V60, P388, DOI 10.1111/j.0006-341X.2004.00183.x; Eisenberg JNS, 2006, P NATL ACAD SCI USA, V103, P19460, DOI 10.1073/pnas.0609431104; Endris M., 2013, ISRN PARASITOL, V4, P1; EOM K-S, 1984, Korean Journal of Parasitology, V22, P215, DOI 10.3347/kjp.1984.22.2.215; Goodman D, 2007, AM J TROP MED HYG, V76, P725, DOI 10.4269/ajtmh.2007.76.725; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Kaewkes S, 2003, ACTA TROP, V88, P177, DOI 10.1016/j.actatropica.2003.05.001; Keiser J, 2009, CLIN MICROBIOL REV, V22, P466, DOI 10.1128/CMR.00012-09; Maco V, 2001, REV MED HERED, V12, P111; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Orihel TC, 2003, MAN CLIN MICROBIOLOG, P2056; Santos FLN, 2005, REV SOC BRAS MED TRO, V38, P196, DOI 10.1590/S0037-86822005000200016; Sierra R, 1999, ENVIRON CONSERV, V26, P136, DOI 10.1017/S0376892999000181; Steinmann P, 2008, AM J TROP MED HYG, V78, P760, DOI 10.4269/ajtmh.2008.78.760; Tello R., 1988, 5 JORN CIENT U PER C; Tello R, 2012, INT J INFECT DIS, V16, pE414, DOI 10.1016/j.ijid.2011.12.017; Terashima Angélica, 2009, Rev. gastroenterol. Perú, V29, P305; Utzinger J, 2008, T ROY SOC TROP MED H, V102, P84, DOI 10.1016/j.trstmh.2007.09.009; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; World Health Organization, 2002, PREV CONTR SCHIST SO	27	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203811	10.1371/journal.pone.0203811	http://dx.doi.org/10.1371/journal.pone.0203811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286114	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500011
J	Chakravorty, D; Patra, S				Chakravorty, Debamitra; Patra, Sanjukta			RankProt: A multi criteria-ranking platform to attain protein thermostabilizing mutations and its in vitro applications - Attribute based prediction method on the principles of Analytical Hierarchical Process	PLOS ONE			English	Article							STABILITY CHANGES; EVOLUTION; SEQUENCE	Attaining recombinant thermostable proteins is still a challenge for protein engineering. The complexity is the length of time and enormous efforts required to achieve the desired results. Present work proposes a novel and economic strategy of attaining protein thermostability by predicting site-specific mutations at the shortest possible time. The success of the approach can be attributed to Analytical Hierarchical Process and the outcome was a rationalized thermostable mutation(s) prediction tool- RankProt. Briefly the method involved ranking of 17 biophysical protein features as class predictors, derived from 127 pairs of thermostable and mesostable proteins. Among the 17 predictors, ionic interactions and main-chain to main-chain hydrogen bonds were the highest ranked features with eigen value of 0.091. The success of the tool was judged by multi-fold in silico validation tests and it achieved the prediction accuracy of 91% with AUC 0.927. Further, in vitro validation was carried out by predicting thermostabilizing mutations for mesostable Bacillus subtilis lipase and performing the predicted mutations by multi-site directed mutagenesis. The rationalized method was successful to render the lipase thermostable with optimum temperature stability and T m increase by 20 degrees C and 7 degrees C respectively. Conclusively it can be said that it was the minimum number of mutations in comparison to the number of mutations incorporated to render Bacillus subtilis lipase thermostable, by directed evolution techniques. The present work shows that protein stabilizing mutations can be rationally designed by balancing the biophysical pleiotropy of proteins, in accordance to the selection pressure.	[Chakravorty, Debamitra; Patra, Sanjukta] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Patra, S (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, Assam, India.	sanjukta@iitg.ernet.in	Chakravorty, Debamitra/AAO-3550-2020		Department of Biotechnology, Government of India [BT/535/NE/TBP/2013]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study was supported by The Department of Biotechnology, Government of India, is acknowledged for funding the project BT/535/NE/TBP/2013 to SP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Akanuma S, 2017, LIFE-BASEL, V7, DOI 10.3390/life7030033; Bednar D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004556; Bhardwaj A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011347; Bikadi Z, 2007, ARCH BIOCHEM BIOPHYS, V461, P225, DOI 10.1016/j.abb.2007.02.020; Bommarius AS, 2013, CHEM SOC REV, V42, P6534, DOI 10.1039/c3cs60137d; Cang ZX, 2017, BIOINFORMATICS, V33, P3549, DOI 10.1093/bioinformatics/btx460; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chakravorty D, 2015, CURRENT BIOTECHNOL, V61, P39; Chakravorty D, 2011, EXTREMOPHILES, V15, P89, DOI 10.1007/s00792-010-0337-0; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; EIJSINK VGH, 1992, BIOCHEM J, V285, P625, DOI 10.1042/bj2850625; Folkman L, 2016, J MOL BIOL, V428, P1394, DOI 10.1016/j.jmb.2016.01.012; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Huang W, 2013, ECOL INDIC, V25, P180, DOI 10.1016/j.ecolind.2012.09.017; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Ivanov A, 2012, INT CONF ACOUST SPEE, P5125, DOI 10.1109/ICASSP.2012.6289074; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; KOLLMAN PA, 1972, CHEM REV, V72, P283, DOI 10.1021/cr60277a004; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Levner I, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-68; Li YQ, 2012, PROTEINS, V80, P81, DOI 10.1002/prot.23163; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Murakami S, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4931814; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Notomista E, 2001, BIOCHEMISTRY-US, V40, P9097, DOI 10.1021/bi010741s; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Porebski BT, 2016, PROTEIN ENG DES SEL, V29, P245, DOI 10.1093/protein/gzw015; Pucci F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091659; Quan LJ, 2016, BIOINFORMATICS, V32, P2936, DOI 10.1093/bioinformatics/btw361; Rathi PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130289; Reetz MT, 2009, BIOTECHNOL BIOENG, V102, P1712, DOI 10.1002/bit.22202; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Saaty TL, 2000, INT J SERVICES SCI, V11, P83; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Schmidt K, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0234-7; Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031; Sikosek T, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0419; Socha RD, 2013, FEBS J, V280, P5582, DOI 10.1111/febs.12354; Srinivasu P, 2012, ADV INTELLIGENT SOFT, V132; Srivastava A, 2014, PLOS ONE, V98; Su Q, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1645619; Subrahmanyam K., 2013, IOSR J COMPUT ENG, V133, P70; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Torrez M, 2003, BIOPHYS J, V85, P2845, DOI 10.1016/S0006-3495(03)74707-9; Vehlow C, 2011, BIOINFORMATICS, V27, P1573, DOI 10.1093/bioinformatics/btr163; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang ZY, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/btt211; Wijma HJ, 2014, PROTEIN ENG DES SEL, V27, P49, DOI 10.1093/protein/gzt061; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yin S, 2007, MODELING BACKBONE FL, V1512, P1567; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yu JS, 2005, BIOINFORMATICS, V21, P2200, DOI 10.1093/bioinformatics/bti370; Zhu W., 2010, P NESUG P HLTH CAR L, V19, P67	64	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203036	10.1371/journal.pone.0203036	http://dx.doi.org/10.1371/journal.pone.0203036			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286107	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500004
J	Saiphoklang, N; Auttajaroon, J				Saiphoklang, Narongkorn; Auttajaroon, Jeerayuth			Incidence and outcome of weaning from mechanical ventilation in medical wards at Thammasat University Hospital	PLOS ONE			English	Article							EXTUBATION FAILURE; PARAMETERS; TRIAL	Background Weaning from mechanical ventilation is classified as simple, difficult, or prolonged according to weaning process. Theoretically, simple weaning group usually has better clinical outcomes than non-simple group; however, the results of previous studies were still inconsistent. Objectives The purpose of the study was to determine the incidence, predictors, and outcomes of ventilator weaning and causes of weaning failure. Methods A prospective observational study was performed between June and December 2013 in all patients (n = 164) who required mechanical ventilation with endotracheal intubation in medical wards at Thammasat University Hospital, Thailand. Duration of weaning, causes of weaning failure, extubation, reintubation, tracheostomy, number of ventilator-free days within 28 days, length of hospital stay, and hospital mortality were measured. Results 103 patients were eligible for final analysis. Mean +/- SD age was 65.1 +/- 17.5 years and 55.3% were males. The incidences of simple, difficult and prolonged weaning were 46.6%, 36.9% and 16.5%, respectively. The mortality rates for simple, difficult, and prolonged weaning were 0%, 10.5% and 23.5% (p = 0.006), respectively. The 3 causes of weaning failure in non-simple weaning were bronchospasm, pneumonia, and malnutrition. Conclusions Non-simple weaning increased mortality. Bronchospasm, pneumonia, and malnutrition were key risk factors for weaning failure. Strategies are needed to minimize their effects.	[Saiphoklang, Narongkorn; Auttajaroon, Jeerayuth] Thammasat Univ, Div Pulm & Crit Care Med, Dept Med, Fac Med, Pathum Thani, Thailand	Thammasat University	Saiphoklang, N (corresponding author), Thammasat Univ, Div Pulm & Crit Care Med, Dept Med, Fac Med, Pathum Thani, Thailand.	m_narongkorn@hotmail.com	Saiphoklang, Narongkorn/AGA-9282-2022; Saiphoklang, Narongkorn/GPG-4003-2022	Saiphoklang, Narongkorn/0000-0003-2462-9471	Division of Pulmonary and Critical Care Medicine, Thammasat University	Division of Pulmonary and Critical Care Medicine, Thammasat University	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was fully supported by Division of Pulmonary and Critical Care Medicine, Thammasat University. The division supported financial, human resources and statistical analysis. The authors received no income from the division for this study.	Beduneau G, 2017, AM J RESP CRIT CARE, V195, P772, DOI 10.1164/rccm.201602-0320OC; Beuret P, 2009, INTENS CARE MED, V35, P1090, DOI 10.1007/s00134-009-1404-9; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Dalar L, 2013, ANAESTH INTENS CARE, V41, P108, DOI 10.1177/0310057X1304100118; Ely EW, 2001, CHEST, V120, p454S, DOI 10.1378/chest.120.6_suppl.454S; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Funk GC, 2010, EUR RESPIR J, V35, P88, DOI 10.1183/09031936.00056909; Huang CT, 2013, RESP CARE, V58, P1307, DOI 10.4187/respcare.01773; MacIntyre N, 2017, AM J RESP CRIT CARE, V195, P710, DOI 10.1164/rccm.201610-1988ED; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; TOBIN MJ, 1994, NEW ENGL J MED, V330, P1056, DOI 10.1056/NEJM199404143301507; Tonnelier A, 2011, RESP CARE, V56, P583, DOI 10.4187/respcare.00842; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135	15	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205106	10.1371/journal.pone.0205106	http://dx.doi.org/10.1371/journal.pone.0205106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286153	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500086
J	Brennan, AT; Jamieson, L; Crowther, NJ; Fox, MP; George, JA; Berry, KM; Stokes, A; Maskew, M; Sanne, I; Long, L; Cassim, N; Rosen, S				Brennan, Alana T.; Jamieson, Lise; Crowther, Nigel J.; Fox, Matthew P.; George, Jaya A.; Berry, Kaitlyn M.; Stokes, Andrew; Maskew, Mhairi; Sanne, Ian; Long, Lawrence; Cassim, Naseem; Rosen, Sydney			Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; T-CELL-ACTIVATION; BLOOD-PRESSURE; RISK-FACTORS; THERAPY; DISEASE; ASSOCIATION; EPIDEMIC; HEART	Background One of the key risk factors for cardiovascular disease is hypertension. Hypertension, which leads to heart attacks and strokes, already affects one billion people worldwide, making it a global public health issue. Incidence and prevalence of the condition is on the rise in low-and middle-income countries, with the biggest increase in sub-Saharan Africa and South Africa at the forefront. We examined the prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive patients on ART in a large South African observational cohort. Methods We conducted a prospective study of ART naive adults initiating ART at a public sector HIV clinic in South Africa between April 2004-2017. Patients with diagnosed hypertension at ART initiation were excluded from the incidence analysis. Log-binomial regression was used to estimate predictors of hypertension at ART initiation, while competing risks regression was used to evaluate the relationship between predictors of incident hypertension, accounting for death as a competing risk. Results Among 77,696 eligible patients, 22.0% had prevalent hypertension at ART initiation. Of the remaining patients with no hypertension at ART initiation, 8,125 incident hypertension cases were diagnosed over the period of follow-up, corresponding to an incident rate of 5.4 per 100 person-years (95% confidence interval (CI): 5.3-5.6). We found patients >= 40 years of age and patients with a body mass index (BMI) >= 25kg/m(2) were at increased risk of both prevalent and incident hypertension. Male patients and those with pre-hypertension at ART initiation had increased hazards of hypertension over the period of follow-up. When assessing the choice of antiretroviral drug in first-line ART, patients initiated on nevirapine were at 27% increased risk of developing hypertension compared to those initiated on efavirenz, while patients who initiated on either zidovudine or stavudine had a 40% increased risk of developing hypertension compared to patients initiated on tenofovir. Patientswith poorer health status at ART initiation (i.e. WHO III/IV stage, low CD4 count, low hemoglobin levels and low BMI) had a decrease risk of prevalent hypertension. We found an inverse relationship in patients with a CD4 count <50 cells/mm(3) at ART initiation who had a 25% increased risk of incident hypertension compared to those with a CD4 count >= 350 cells/mm(3). Conclusion Over 20% of patients in our cohort had hypertension at ART initiation, and 13% of those with normal blood pressure at ART initiation developed hypertension while on ART. Older patients, males, those on nevirapine, zidovudine or stavudine, and those who are overweight/obese should be targeted for frequent blood pressure monitoring and the identification of other cardiovascular risk factors to encourage lifestyle modifications. Additionally, these groups should be offered pharmaceutical therapy to help prevent myocardial infarction, heart failure, stroke, and kidney disease. Further research is needed to determine the level of access and adherence to pharmaceutical treatment for hypertension in this population. Additionally, an HIV-negative comparison population is needed to assess the association of the HIV virus itself with hypertension.	[Brennan, Alana T.; Fox, Matthew P.; Berry, Kaitlyn M.; Stokes, Andrew; Sanne, Ian; Long, Lawrence; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Brennan, Alana T.; Jamieson, Lise; Fox, Matthew P.; Maskew, Mhairi; Sanne, Ian; Long, Lawrence; Rosen, Sydney] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Crowther, Nigel J.; George, Jaya A.] Univ Witwatersrand, Fac Hlth Sci, Dept Chem Pathol, Johannesburg, South Africa; [Crowther, Nigel J.; George, Jaya A.; Cassim, Naseem] Natl Hlth Lab Serv, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Clin HIV Res Unit,Dept Internal Med, Johannesburg, South Africa; [Sanne, Ian] Right Care, Johannesburg, South Africa; [Cassim, Naseem] Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa	Boston University; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; Boston University; University of Witwatersrand; University of Witwatersrand	Brennan, AT (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.; Brennan, AT (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa.	abrennan@bu.edu	Cassim, Naseem/GLR-4911-2022; Cassim, Naseem/AFU-5522-2022; Fox, Matthew/K-2004-2019; Sanne, Ian/ABH-2231-2020	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Crowther, Nigel/0000-0002-5766-1745; Long, Lawrence/0000-0003-4986-4988; Berry, Kaitlyn/0000-0002-2928-6773; Brennan, Alana/0000-0002-7746-0668; MASKEW, MHAIRI/0000-0003-4238-0200; George, Jaya/0000-0001-8769-3505	National Institutes of Health [5T32AI052074-13]; USAID [674-A-00-08-0000-700, INROADS AID-674-A-12-00029]; United States Agency for International Development; National Institutes of Health; Right to Care, the nongovernmental organization	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID(United States Agency for International Development (USAID)); United States Agency for International Development(United States Agency for International Development (USAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Right to Care, the nongovernmental organization	Funding was provided 5T32AI052074-13 from the National Institutes of Health and by USAID under the terms of the Cooperative Agreement 674-A-00-08-0000-700 to Right to Care and INROADS AID-674-A-12-00029. This study is made possible by the generous support of the American people through the United States Agency for International Development and the National Institutes of Health. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID, the United States government or the Right to Care Clinics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our gratitude to Right to Care, the nongovernmental organization supporting the study site through a partnership with the United States Agency for International Development, and to the staff of the participating clinics. We also thank the provincial and national Departments of Health for providing for the care of the patients under the Comprehensive Care Management and Treatment program and the HIV/AIDS conditional grant. Most of all we thank the patients attending the clinic for their continued trust in the treatment provided at the clinic.	[Anonymous], 2017, S AFR DEM HLTH SURV; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Beckett NS, 2008, NEW ENGL J MED, V358, P2417; Berry KM, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000348; Calza L, 2004, J ANTIMICROB CHEMOTH, V53, P10, DOI 10.1093/jac/dkh013; Cooper RS, 2015, J HYPERTENS, V33, P473, DOI 10.1097/HJH.0000000000000429; Currier J, 2008, JAIDS-J ACQ IMM DEF, V48, P35, DOI 10.1097/QAI.0b013e318164227f; Daniels A, 1999, J HUM HYPERTENS, V13, P689, DOI 10.1038/sj.jhh.1000892; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fernandez S, 2006, CLIN IMMUNOL, V120, P163, DOI 10.1016/j.clim.2006.04.570; Fine Jason P, PROPORTIONAL HAZARDS, P496; Fox MP, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015620; Garenne M, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.32795; Hatleberg CI, 2015, C RETR OPP INF CROI; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kotler DP, 2008, JAIDS-J ACQ IMM DEF, V49, pS79, DOI 10.1097/QAI.0b013e318186519c; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Majane OHL, 2007, J HYPERTENS, V25, P1798, DOI 10.1097/HJH.0b013e3281e6666f; Manner IW, 2013, J CLIN HYPERTENS, V15, P101, DOI 10.1111/jch.12029; Metcalf CA, 1996, J HUM HYPERTENS, V10, P21; Mulenga L, 2014, CLIN INFECT DIS, V58, P1473, DOI 10.1093/cid/ciu117; National Department of Health, 2013, S AFR ANT TREATM GUI; National Department of Health Republic of South Africa, 2004, S AFR ANT TREATM GUI; Noncommunicable Disease, PROGR MON 2017; Pillay Y, 2016, IMPLEMENTATION UNIVE; Rodriguez-Arboli E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172089; Schutte AE, 2012, INT J EPIDEMIOL, V41, P1114, DOI 10.1093/ije/dys106; Seedat YK, 2015, CARDIOVASC J AFR, V26; Shaffer D, 2014, JAIDS-J ACQ IMM DEF, V66, P155, DOI 10.1097/QAI.0000000000000131; Sliwa K, 2012, EUR HEART J, V33, P866, DOI 10.1093/eurheartj/ehr398; South African National Department of Health, 2010, S AFR ANT TREATM GUI; Statistics South Africa, 2016, MORT CAUS DEATH S AF; Stewart S, 2011, INT J CARDIOL, V146, P22, DOI 10.1016/j.ijcard.2009.05.061; Steyn K, 2001, J HYPERTENS, V19, P1717, DOI 10.1097/00004872-200110000-00004; Thiebaut R, 2005, ANTIVIR THER, V10, P811; Timaeus I, 2002, MORTALITY TRENDS S A; van Zoest RA, 2016, CLIN INFECT DIS, V63, P205, DOI 10.1093/cid/ciw285; WHO, ANT THER HIV INF AD; WHO South Africa Country Profile, TUBERCULOSIS	44	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204020	10.1371/journal.pone.0204020	http://dx.doi.org/10.1371/journal.pone.0204020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281618	Green Published, gold			2022-12-27	WOS:000446342400038
J	Sogawa, Y; Nagasu, H; Itano, S; Kidokoro, K; Taniguchi, S; Takahashi, M; Kadoya, H; Satoh, M; Sasaki, T; Kashihara, N				Sogawa, Yuji; Nagasu, Hajime; Itano, Seiji; Kidokoro, Kengo; Taniguchi, Shun'ichiro; Takahashi, Masafumi; Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki			The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice	PLOS ONE			English	Article							NITRIC-OXIDE; BLOOD-PRESSURE; DISEASE; PROMOTES; RISK; MACROPHAGES; SUPEROXIDE; DEFICIENCY; DAMAGE; CELLS	Hypertension causes vascular complications, such as stroke, cardiovascular disease, and chronic kidney disease (CKD). The relationship between endothelial dysfunction and progression of kidney disease is well known. However, the relationship between the eNOS-NO pathway and chronic inflammation, which is a common pathway for the progression of kidney disease, remains unexplored. We performed in vivo experiments to determine the role of the eNOS-NO pathway by using eNOS-deficient mice in a hypertensive kidney disease model. All mice were unilateral nephrectomized (Nx). One week after Nx, the mice were randomly divided into two groups: the aldosterone infusion groups and the vehicle groups. All mice also received a 1% NaCl solution instead of drinking water. The aldosterone infusion groups were treated with hydralazine to correct blood pressure differences. After four weeks of drug administration, all mice were euthanized, and blood and kidney tissue samples were collected. In the results, NLRP3 inflammasome activation was elevated in the kidneys of the eNOS-deficient mice, and tubulointerstitial fibrosis was accelerated. Suppression of inflammasome activation by knocking out ASC prevented tubulointerstitial injury in the eNOS knockout mice, indicating that the eNOS-NO pathway is involved in the development of kidney dysfunction through acceleration of NLRP3 inflammasome in macrophages. We revealed that endothelial function, particularly the eNOS-NO pathway, attenuates the progression of renal tubulointerstitial injury via suppression of inflammasome activation. Clinically, patients who develop vascular endothelial dysfunction have lifestyle diseases, such as hypertension or diabetes, and are known to be at risk for CKD. Our study suggests that the eNOS-NO pathway could be a therapeutic target for the treatment of chronic kidney disease associated with endothelial dysfunction.	[Sogawa, Yuji; Nagasu, Hajime; Itano, Seiji; Kidokoro, Kengo; Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki] Kawasaki Med Sch, Dept Nephrol & Hypertens, Kurashiki, Okayama, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Dept Mol Oncol, Grad Sch Med, Matsumoto, Nagano, Japan; [Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan	Kawasaki Medical School; Shinshu University; Jichi Medical University	Nagasu, H (corresponding author), Kawasaki Med Sch, Dept Nephrol & Hypertens, Kurashiki, Okayama, Japan.	hajimenagasu@med.kawasaki-m.ac.jp		Nagasu, Hajime/0000-0003-2549-4126	Japan Society of The Promotion for Science KAKENHI [24591220]; JSPS KAKENHI [24591220, 18H02828]	Japan Society of The Promotion for Science KAKENHI; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society of The Promotion for Science (http://www.jsps.go.jp/index.html) KAKENHI grant (No. 24591220 to HN).; We thank Etsuko Yorimasa, Yuriko Katayama, and Ayano Higashi for providing animal care, as well as Satomi Hanada, Keiko Shirakiya, and Keiko Satoh for assisting with the in vitro assays. This work was supported in part by a JSPS KAKENHI grant (No. 24591220 to HN and No.18H02828 to NK).	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; Fujimoto S, 2008, HYPERTENS RES, V31, P305, DOI 10.1291/hypres.31.305; Fukumura D, 1997, AM J PATHOL, V150, P713; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Ikeda A, 2009, AM J HYPERTENS, V22, P273, DOI 10.1038/ajh.2008.356; Kadoya H, 2015, FASEB J, V29, P3899, DOI 10.1096/fj.15-271734; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Luther JM, 2012, KIDNEY INT, V82, P643, DOI 10.1038/ki.2012.170; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; McMaster WG, 2015, CIRC RES, V116, P1022, DOI 10.1161/CIRCRESAHA.116.303697; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nagasu H, 2016, LAB INVEST, V96, P25, DOI 10.1038/labinvest.2015.128; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Nakayama T, 2009, AM J PHYSIOL-RENAL, V296, pF317, DOI 10.1152/ajprenal.90450.2008; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Pushpakumar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06484-6; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Ross R, 2001, INT IMMUNOPHARMACOL, V1, P1469, DOI 10.1016/S1567-5769(01)00091-1; Satoh M, 2005, AM J PHYSIOL-RENAL, V288, pF1144, DOI 10.1152/ajprenal.00221.2004; Satoh M, 2010, HYPERTENS RES, V33, P135, DOI 10.1038/hr.2009.190; Seliger SL, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0303-x; Sogawa Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08054-2; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Wassertheil-Smoller S, 2004, JAMA-J AM MED ASSOC, V292, P2849, DOI 10.1001/jama.292.23.2849; Weisheit CK, 2015, CLIN J AM SOC NEPHRO, V10, P1841, DOI 10.2215/CJN.07100714; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111	36	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203823	10.1371/journal.pone.0203823	http://dx.doi.org/10.1371/journal.pone.0203823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281670	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400030
J	Kinouchi, R; Ishiko, S; Hanada, K; Hayashi, H; Mikami, D; Tani, T; Zenimaru, T; Kawai, M; Nakabayashi, S; Kinouchi, M; Yoshida, A				Kinouchi, Reiko; Ishiko, Satoshi; Hanada, Kazuomi; Hayashi, Hiroki; Mikami, Daiki; Tani, Tomofumi; Zenimaru, Tatsuya; Kawai, Motofumi; Nakabayashi, Seigo; Kinouchi, Motoshi; Yoshida, Akitoshi			A low meat diet increases the risk of open-angle glaucoma in women-The results of population-based, cross-sectional study in Japan	PLOS ONE			English	Article							LIFE-STYLE; OCULAR HYPERTENSION; PREVALENCE; CONSUMPTION; DISEASE; ASSOCIATION; HEALTH	Background Studies identifying modifiable lifestyle risk factors related to open-angle glaucoma (OAG) are limited, especially from Asian countries. This study aimed to identify lifestyle risk factors for OAG in a Japanese population. Methods and findings This population-based, cross-sectional study recruited Japanese participants aged 40 years or older from January 2013 to March 2015. We took fundus photographs for OAG screening, determined lifestyle and health characteristics through a questionnaire and performed physical examinations. The participants who had suspect findings in the fundus photographs were sent for a detailed ophthalmic examination to diagnose OAG. Lifestyle and heath characteristics were statistically compared between the OAG and non-OAG participants. A total of 1583 participants were included in the study, of which 42 had OAG and 1541 did not have OAG. The number of days per week that the female participants consumed meat (mean +/- SD; OAG: 1.7 +/- 1.2 days, non-OAG: 2.7 +/- 1.5 days) was negatively associated with OAG (OR = 0.61; 95% CI: 0.43-0.88; p =0.007). Higher intraocular pressure was positively associated with OAG in men (OR = 1.20; 95% CI: 1.05-1.38, p = 0.009). No significant difference between participants with and without OAG was observed for a range of other lifestyle factors and health criteria including self-report of diabetes, number of family living together, body mass index, blood pressure, pulse rate, coffee drinking, tea drinking, alcohol drinking, number of fruits consumed per day and days of fish consumption per week. Conclusions A higher weekly consumption of meat appears to be negatively associated with OAG in Japanese women. Increasing the dietary intake of meat can contribute to reducing the risk of developing OAG.	[Kinouchi, Reiko; Ishiko, Satoshi; Hanada, Kazuomi; Hayashi, Hiroki; Mikami, Daiki] Asahikawa Med Univ, Med & Engn Combined Res Inst, Asahikawa, Hokkaido, Japan; [Kinouchi, Reiko; Ishiko, Satoshi; Hanada, Kazuomi; Kawai, Motofumi; Nakabayashi, Seigo; Yoshida, Akitoshi] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan; [Tani, Tomofumi] Rumoi Municipal Hosp, Dept Ophthalmol, Rumoi, Hokkaido, Japan; [Zenimaru, Tatsuya] Zenimaru Eye Clin, Rumoi, Hokkaido, Japan; [Kinouchi, Motoshi] Red Cross Asahikawa Hosp, Dept Dermatol, Asahikawa, Hokkaido, Japan; [Tani, Tomofumi] Ororon Line Eye Clin, Rumoi, Japan	Asahikawa Medical College; Asahikawa Medical College	Kinouchi, R (corresponding author), Asahikawa Med Univ, Med & Engn Combined Res Inst, Asahikawa, Hokkaido, Japan.; Kinouchi, R (corresponding author), Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan.	rkino@asahikawa-med.ac.jp	Kinouchi, Reiko/R-6833-2019	kinouchi, reiko/0000-0003-1344-1641	Asahikawa Medical University; Rumoi city government	Asahikawa Medical University; Rumoi city government	This study was supported by research funding from the Asahikawa Medical University president.; We would like to thank the Rumoi city government, the staff members of NPO Rumoi Cohotopia for their support and cooperation and all the participants who took part in this study.	Araie Makoto, 2012, Nippon Ganka Gakkai Zasshi, V116; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Bourne RRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162229; Chan EW, 2016, BRIT J OPHTHALMOL, V100, P78, DOI 10.1136/bjophthalmol-2014-306102; Coleman AL, 2008, AM J OPHTHALMOL, V145, P1081, DOI 10.1016/j.ajo.2008.01.022; Daly RM, 2015, TRIALS, V16, DOI [10.1186/s13063-015-0652-y, 10.1186/s13063-015-0884-x]; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Doi Y, 2010, STROKE, V41, P203, DOI 10.1161/STROKEAHA.109.564708; Doshi V, 2008, OPHTHALMOLOGY, V115, P639, DOI 10.1016/j.ophtha.2007.05.032; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Giaconi JA, 2012, AM J OPHTHALMOL, V154, P635, DOI 10.1016/j.ajo.2012.03.048; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jonas JB, 2017, LANCET, DOI 10.1016/s0140-6736(17)31469-1; Kang JH, 2016, JAMA OPHTHALMOL, V134, P294, DOI 10.1001/jamaophthalmol.2015.5601; Kang JH, 2004, AM J CLIN NUTR, V79, P755; Keenan TDL, 2015, BRIT J OPHTHALMOL, V99, P524, DOI 10.1136/bjophthalmol-2014-305863; Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Oliver JE, 2002, AM J OPHTHALMOL, V133, P764, DOI 10.1016/S0002-9394(02)01403-4; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Ramdas WD, 2012, EUR J EPIDEMIOL, V27, P385, DOI 10.1007/s10654-012-9672-z; Ramdas WD, 2011, ARCH OPHTHALMOL-CHIC, V129, P767, DOI 10.1001/archophthalmol.2010.373; Renard JP, 2013, ACTA OPHTHALMOL, V91, P505, DOI 10.1111/j.1755-3768.2011.02356.x; Su CW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002833; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Taniguchi Y, 2014, J GERONTOL A-BIOL, V69, P1276, DOI 10.1093/gerona/glt286; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012	30	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204955	10.1371/journal.pone.0204955	http://dx.doi.org/10.1371/journal.pone.0204955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278082	gold, Green Submitted, Green Published			2022-12-27	WOS:000446010200028
J	Belay, E; Endrias, A; Alem, B; Endris, K				Belay, Ezra; Endrias, Asrat; Alem, Birhane; Endris, Kedir			Hematological responses to iron-folate supplementation and its determinants in pregnant women attending antenatal cares in Mekelle City, Ethiopia	PLOS ONE			English	Article							BIRTH-WEIGHT; ANEMIA; DEFICIENCY; INFLAMMATION; PREVALENCE; DISEASE	Objective To characterize anemia and evaluate hematological responses to universal iron-folic acid (IFA) supplementation in Ethiopian pregnant women. Method A hospital-based prospective follow up study was done between December 2016 and June 2017. Hematological profiles were measured in pregnant women before and after a minimum of one-month IFA supplementation. Mean values and abnormal proportions of hematological profiles were compared before and after supplementation using paired t-test and McNemar test, respectively. Univariate and multivariate analysis were used to analyze the association between independent variables and poor treatment responses. Result Lack of adequate hemoglobin response was found in 48.5%(95/196) of the participants. Prevalence of anemia and low hematocrit value were decreased significantly after IFA supplementation (p = 0.002, and p = 0.001, respectively). Normocytic hypochromic anemia was the commonest form of anemia found in this study followed by normocytic normochromic anemia. There was no statistically significant association between poor hemoglobin responses and all studied factors such as educational level, household size, parity, recent illness, stage of pregnancy, coffee consumption, and duration of iron treatment. Conclusion Our study revealed poor hemoglobin responses in nearly half of the study participants and a high proportion of anemias morphologically atypical of iron deficiency anemia. There is a need to consider anemia attributable to etiologies other than an iron deficiency in anemia intervention programs.	[Belay, Ezra; Endrias, Asrat] Mekelle Univ, Coll Hlth Sci, Dept Med Biochem, Mekelle, Ethiopia; [Alem, Birhane] Mekelle Univ, Coll Hlth Sci, Dept Anat, Mekelle, Ethiopia; [Endris, Kedir] Mekelle Univ, Coll Hlth Sci, Dept Nursing, Mekelle, Ethiopia	Mekelle University; Mekelle University; Mekelle University	Belay, E (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Med Biochem, Mekelle, Ethiopia.	aga.bely@gmail.com		belay, Ezra/0000-0001-6546-0591	Mekelle University [CRPO/CHS/Sm/003/09]	Mekelle University	The project was funded by Mekelle University under grant number:CRPO/CHS/Sm/003/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Allen LH, 2000, AM J CLIN NUTR, V71, P1485; Allen LH, 2002, J NUTR, V132, p813S, DOI 10.1093/jn/132.4.813S; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; [Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2012, GUID DAIL IR FOL AC; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1997, ACTA PAEDIATR, V86, P78; BEATON GH, 1999, EFFICACY INTERMITTEN; Beck KL, 2014, NUTRIENTS, V6, P3747, DOI 10.3390/nu6093747; Brugnara C, 1999, JAMA-J AM MED ASSOC, V281, P2225, DOI 10.1001/jama.281.23.2225; Cappellini MD, 2015, SEMIN HEMATOL, V52, P261, DOI 10.1053/j.seminhematol.2015.07.006; Cascio MJ, 2017, MED CLIN N AM, V101, P263, DOI 10.1016/j.mcna.2016.09.003; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Ethiopian public health institute (EPHI), 2016, NAT MICR SURV REP; Federal Ministry of Health (FMOH) of Ethiopia, 2004, NAT GUID CONTR PREV; FERGUSON BJ, 1992, J LAB CLIN MED, V119, P385; Ganz T, 2018, INT J HEMATOL, V107, P7, DOI 10.1007/s12185-017-2366-2; Gebreegziabher T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184742; Gebreselassie SG, 2013, J HEALTH POPUL NUTR, V31, P185; Ghio AJ, 2012, ANN HEMATOL, V91, P957, DOI 10.1007/s00277-011-1335-8; Gutteridge John M. C., 1996, P239; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; International Social Security Association, 2002, WHO RET WORK WHY EV, P1; Longo DL, 2012, HARRISONS PRINCIPLES; Lonnerdal B, 2004, NESTLE NUTR WORKS SE, V54, P67, DOI 10.1159/000080447; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Micronutrient Initiative, 2009, INV FUT UN CALL ACT; Mori R, 2012, COCHRANE DATABASE SY, V7; Nasreen H, 2010, SERIES 32 RES MONOGR, V32; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; Ross AC, 2017, AM J CLIN NUTR, V106, p1581S, DOI 10.3945/ajcn.117.155838; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; Tahaineh L, 2017, J PHARM HEALTH SERV, V8, P45, DOI 10.1111/jphs.12149; Uche-Nwachi EO, 2010, AFR HEALTH SCI, V10, P66; Wirth JP, 2017, AM J CLIN NUTR, V106, p416S, DOI 10.3945/ajcn.116.143073	39	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204791	10.1371/journal.pone.0204791	http://dx.doi.org/10.1371/journal.pone.0204791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273373	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700035
J	Wang, X; Elksnis, A; Wikstrom, P; Walum, E; Welsh, N; Carlsson, PO				Wang, Xuan; Elksnis, Andris; Wikstrom, Per; Walum, Erik; Welsh, Nils; Carlsson, Per-Ola			The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; MITOCHONDRIAL; NOX4; DYSFUNCTION; SECRETION; CYTOKINES; KINASE	It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study was to evaluate the efficacy of novel Nox inhibitors as protective agents against cytokine- or high glucose + palmitate-induced human beta-cell death. The Nox2 protein was present mainly in the cytoplasm and was induced by cytokines. Nox4 protein immunoreactivity, with some nuclear accumulation, was observed in human islet cells, and was not affected by islet culture in the presence of cytokines or high glucose + palmitate. Nox inhibitors with partial or no isoform selectivity (DPI, dapsone, GLX351322, and GLX481372) all reduced ROS production of human islet cells exposed to high glucose + palmitate. This was paralleled by improved viability and reduced caspase 3 activation. The Nox1 selective inhibitor ML171 failed to reduce human islet cell death in response to both cytokines and high glucose + palmitate. The selective Nox2 inhibitor Phox-12 also failed to protect against cytokines, but protected partially against high glucose + palmitate-induced cellular death. The highly selective Nox4 inhibitor GLX7013114 protected islet cells against both cytokines and high glucose + palmitate. However, as no osmotic control for high glucose was used, we cannot exclude the possibility that the high glucose effect was due to osmosis. It is concluded that Nox4 may participate in stress-induced islet cell death in human islets in vitro. We propose that Nox4 mediates pro-apoptotic effects in intact islets under stressful conditions and that selective Nox4-inhibition may be a therapeutic strategy in type 2 diabetes.	[Wang, Xuan; Elksnis, Andris; Welsh, Nils; Carlsson, Per-Ola] Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden; [Wikstrom, Per; Walum, Erik] Glucox Biotech AB, Stockholm, Sweden	Uppsala University	Wang, X (corresponding author), Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden.	xuan.wang@mcb.uu.se		Welsh, Nils/0000-0001-5926-5407	Olle Engkvist Byggmastare; Swedish Research Council [2017-01343]; Swedish Diabetes Association; Novo Nordisk Foundation; family Ernfors Fund; Swedish Child Diabetes Fund; EXODIAB; Glucox Biotech AB	Olle Engkvist Byggmastare; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); family Ernfors Fund; Swedish Child Diabetes Fund; EXODIAB; Glucox Biotech AB	The present study was supported in part by Olle Engkvist Byggmastare, the Swedish Research Council (2017-01343), the Swedish Diabetes Association, the Novo Nordisk Foundation, the family Ernfors Fund, the Swedish Child Diabetes Fund and EXODIAB. The funder Glucox Biotech AB provided support in the form of salaries for authors EW and PW. Glucox Biotech AB has supported this study by generating, characterizing and providing NOX inhibitors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Anvari E, 2015, FREE RADICAL RES, V49, P1308, DOI 10.3109/10715762.2015.1067697; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Bosco EE, 2012, CHEM BIOL, V19, P228, DOI 10.1016/j.chembiol.2011.12.017; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Chul S, 2011, Patent application EP, Patent No. [2364698A2, 2364698]; de Souza AH, 2017, MOL CELL ENDOCRINOL, V439, P354, DOI 10.1016/j.mce.2016.09.022; Derscheid RJ, 2014, AM J RESP CELL MOL, V50, P389, DOI 10.1165/rcmb.2012-0529OC; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Fred RG, 2015, MOL CELL ENDOCRINOL, V414, P53, DOI 10.1016/j.mce.2015.07.015; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Guichard C, 2008, BIOCHEM SOC T, V36, P920, DOI 10.1042/BST0360920; Guo SH, 2015, J DRUG TARGET, V23, P888, DOI 10.3109/1061186X.2015.1036276; Han CY, 2016, DIABETES METAB J, V40, P272, DOI 10.4093/dmj.2016.40.4.272; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jaquet V, 2011, BRIT J PHARMACOL, V164, P507, DOI 10.1111/j.1476-5381.2011.01439.x; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Krizhanovskii C, 2017, ISLETS, V9, P43, DOI 10.1080/19382014.2017.1296995; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006963; Liang J, 2016, ANTIOXID REDOX SIGN, V24, P419, DOI 10.1089/ars.2014.6135; Moon JS, 2016, NAT MED, V22, P1002, DOI 10.1038/nm.4153; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Przybylska D, 2016, ONCOTARGET, V7, P66429, DOI 10.18632/oncotarget.12079; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rebelato E, 2012, LIFE SCI, V91, P244, DOI 10.1016/j.lfs.2012.07.004; Robertson RP, 2006, CURR OPIN PHARMACOL, V6, P615, DOI 10.1016/j.coph.2006.09.002; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Sato Y, 2014, J DIABETES INVEST, V5, P19, DOI 10.1111/jdi.12124; Shanmugasundaram K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01106-1; Syed I, 2011, DIABETES, V60, P2843, DOI 10.2337/db11-0809; Type Mandrup-Poulsen T., 2013, DERMATOL CLIN, V31, P495, DOI [10.1016/j.det.2013.04.006, DOI 10.1016/J.DET.2013.04.006]; Uchizono Y, 2006, LIFE SCI, V80, P133, DOI 10.1016/j.lfs.2006.08.031; Wagner B, 2014, AM J PHYSIOL-RENAL, V306, pF85, DOI 10.1152/ajprenal.00371.2013; Wang LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118553; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Xiong QB, 1996, BIOL PHARM BULL, V19, P1580, DOI 10.1248/bpb.19.1580	40	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204271	10.1371/journal.pone.0204271	http://dx.doi.org/10.1371/journal.pone.0204271			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265686	Green Submitted, gold, Green Published			2022-12-27	WOS:000446005500024
J	Silva, R; de Almeida, DM; Cabral, BCA; Dias, VHG; Mello, ICDE; Urmenyi, TP; Woerner, AE; Neto, RSD; Budowle, B; Nassar, CAG				Silva, Rosane; de Almeida, Darcy Muniz; Azeredo Cabral, Bianca Catarina; Giordano Dias, Victor Hugo; de Toledo e Mello, Isadora Cristina; Urmenyi, Turan Peter; Woerner, August E.; de Moura Neto, Rodrigo Soares; Budowle, Bruce; Gomes Nassar, Cristina Aparecida			Microbial enrichment and gene functional categories revealed on the walls of a spent fuel pool of a nuclear power plant	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; BACTERIA; USTILAGO; URANIUM; FUNGI; BASIDIOMYCOTA; SPORISORIUM; RADIATION; WASTE; PH	Microorganisms developing in the liner of the spent fuel pool (SFP) and the fuel transfer channel (FTC) of a Nuclear Power Plant (NPP) can form high radiation resistant biofilms and cause corrosion. Due to difficulties and limitations to obtain large samples from SFP and FTC, cotton swabs were used to collect the biofilm from the wall of these installations. Molecular characterization was performed using massively parallel sequencing to obtain a taxonomic and functional gene classification. Also, samples from the drainage system were evaluated because microorganisms may travel over the 12-meter column of the pool water of the Brazilian Nuclear Power Plant (Angra1), which has been functioning since 1985. Regardless of the treatment of the pool water, our data reveal the unexpected presence of Fungi (Basidiomycota and Ascomycota) as the main contaminators of the SFP and FTC. Ustilaginomycetes (Basidiomycota) was the major class contributor (70%) in the SFP and FTC reflecting the little diversity in these sites; nevertheless, Proteobacteria, Actinobacteria, Firmicutes (Bacilli) were present in small proportions. Mapping total reads against six fungal reference genomes indicate that there is, in fact, a high abundance of fungal sequences in samples collected from SFP and FTC. Analysis of the ribosomal internal transcribed spacer (ITS) 1 and 2 regions and the protein found in the mitochondria of eukaryotic cells, cytochrome b (cytb) grouped our sample fungi in the Glade 7 as Ustilago and Pseudozyma. In contrast, in the drainage system, Alphaproteobacteria were present in high abundances (55%). The presence of Sphingopyxis, Mesorhizobium, Erythrobacter, Sphingomonas, Novosphingobium, Sphingobium, Chelativorans, Oceanicaulis, Acidovorax, and Cyanobacteria was observed. Based on genomic annotation data, the assessment of the biological function found a higher proportion of protein-coding sequences related to respiration and protein metabolism in SFP and FTC samples. The knowledge of this biological inventory present in the system may contribute to further studies of potential microorganisms that might be useful for bioremediation of nuclear waste.	[Silva, Rosane; Azeredo Cabral, Bianca Catarina; Giordano Dias, Victor Hugo; de Toledo e Mello, Isadora Cristina; Urmenyi, Turan Peter] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [de Almeida, Darcy Muniz] Univ Fed Rio de Janeiro, Escola Politecn, Rio De Janeiro, Brazil; [de Almeida, Darcy Muniz] Univ Fed Rio de Janeiro, Escola Quim, Rio De Janeiro, Brazil; [Woerner, August E.; Budowle, Bruce] Univ North Texas, Hlth Sci Ctr, Ctr Human Identificat, Ft Worth, TX USA; [de Moura Neto, Rodrigo Soares; Gomes Nassar, Cristina Aparecida] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Budowle, Bruce] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of North Texas System; University of North Texas Denton; Universidade Federal do Rio de Janeiro; King Abdulaziz University	Silva, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.	silvaros@biof.ufrj.br	Moura-Neto, Rodrigo S/F-6770-2012; Nassar, Cristina/AAI-6888-2021; Silva, Rosane/U-6913-2019; Nassar, Cristina/AGZ-0090-2022	Moura-Neto, Rodrigo S/0000-0002-4292-6878; Nassar, Cristina/0000-0003-3306-0862; Silva, Rosane/0000-0002-2998-6999; Nassar, Cristina/0000-0003-3306-0862; Azeredo Cabral, Bianca Catarina/0000-0002-9131-0113; Giordano Dias, Victor Hugo/0000-0003-4113-7639	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 305833/2013-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES PE 99999.000335/2016-09]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by research grants of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq 305833/2013-8 (RS - USD 12,375) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES PE 99999.000335/2016-09 (RS - USD 27,000).	Adachi J, 1996, J MOL EVOL, V42, P459; Aime MC, 2018, IMA FUNGUS, V9, P75, DOI 10.5598/imafungus.2018.09.01.06; Cervantes-Montelongo JA, 2016, J BASIC MICROB, V56, P1222, DOI 10.1002/jobm.201600130; Castelvecchi D., 2009, SCI NEWS, V171, P325, DOI [10.1002/scin.2007.5591712106, DOI 10.1002/SCIN.2007.5591712106]; Chicote E, 2005, J IND MICROBIOL BIOT, V32, P155, DOI 10.1007/s10295-005-0216-3; Chicote E, 2004, BIOFOULING, V20, P35, DOI 10.1080/08927010410001662670; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Fonseca JP, 2018, GENE, V642, P389, DOI 10.1016/j.gene.2017.11.039; HOLLIDAY R, 1971, NATURE-NEW BIOL, V232, P233, DOI 10.1038/newbio232233a0; Holloman WK, 2007, TRENDS MICROBIOL, V15, P525, DOI 10.1016/j.tim.2007.10.007; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalin M, 2005, J ENVIRON RADIOACTIV, V78, P151, DOI 10.1016/j.jenvrad.2004.05.002; Karley D, 2018, ENVIRON SCI POLLUT R, V25, P20518, DOI 10.1007/s11356-017-0376-5; Kip N, 2015, ISME J, V9, P542, DOI 10.1038/ismej.2014.169; LICINA GJ, 1989, JOM-J MIN MET MAT S, V41, P23, DOI 10.1007/BF03220842; Lloyd JR, 2005, CURR OPIN BIOTECH, V16, P254, DOI 10.1016/j.copbio.2005.04.012; Maeda T, 2012, FEBS J, V279, P1407, DOI 10.1111/j.1742-4658.2012.08548.x; Matthies C, 1997, J BASIC MICROB, V37, P335, DOI 10.1002/jobm.3620370506; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; McTaggart AR, 2012, PERSOONIA, V29, P55, DOI 10.3767/003158512X660283; McTaggart AR, 2016, IMA FUNGUS, V7, P309, DOI 10.5598/imafungus.2016.07.02.10; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mumtaz S, 2013, J ENVIRON RADIOACTIV, V120, P39, DOI 10.1016/j.jenvrad.2013.01.007; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pizzorno Lara, 2015, Integr Med (Encinitas), V14, P35; Pollmann K, 2006, BIOTECHNOL ADV, V24, P58, DOI 10.1016/j.biotechadv.2005.06.002; Ragon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021764; Rajasekar A, 2017, ENVIRON SCI POLLUT R, V24, P8120, DOI 10.1007/s11356-017-8501-z; Rivasseau C, 2016, J PHYCOL, V52, P689, DOI 10.1111/jpy.12442; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Ruiz-Gonzalez MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22969; Sarro MI, 2007, J IND MICROBIOL BIOT, V34, P433, DOI 10.1007/s10295-007-0215-7; Sarro MI, 2005, INT MICROBIOL, V8, P223; Sayin Z, 2016, BIOL TRACE ELEM RES, V173, P241, DOI 10.1007/s12011-016-0637-z; Stoll M, 2005, MYCOL RES, V109, P342, DOI 10.1017/S0953756204002229; Stoll M, 2003, CAN J BOT, V81, P976, DOI [10.1139/b03-094, 10.1139/B03-094]; Thines M, 2016, TAXON, V65, P1170, DOI 10.12705/655.20; Vaishampayan P, 2010, INT J SYST EVOL MICR, V60, P1031, DOI 10.1099/ijs.0.008979-0; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Vylkova S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006149; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wang QM, 2015, STUD MYCOL, P55, DOI 10.1016/j.simyco.2015.10.004; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wollenberg T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004218; Zambanini T, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0809-x; Zavilgelsky GB, 1998, J PHOTOCH PHOTOBIO B, V43, P152, DOI 10.1016/S1011-1344(98)00099-2	49	4	4	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205228	10.1371/journal.pone.0205228	http://dx.doi.org/10.1371/journal.pone.0205228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286173	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500099
J	Vitali, M; Dimauro, C; Sirri, R; Zappaterra, M; Zambonelli, P; Manca, E; Sami, D; Lo Fiego, DP; Davoli, R				Vitali, Marika; Dimauro, Corrado; Sirri, Rubina; Zappaterra, Martina; Zambonelli, Paolo; Manca, Elisabetta; Sami, Dalal; Lo Fiego, Domenico Pietro; Davoli, Roberta			Effect of dietary polyunsaturated fatty acid and antioxidant supplementation on the transcriptional level of genes involved in lipid and energy metabolism in swine	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; CONJUGATED LINOLEIC-ACID; RICH PLANT-PRODUCTS; SKELETAL-MUSCLE; FINISHING PIGS; LARGE WHITE; MOLECULAR-MECHANISM; INSULIN-RESISTANCE; CROSSBRED PIGS; PPAR-ALPHA	Porcine fat traits depend mostly on the interaction between nutritional and genetic factors. However, the pathways and biological processes influenced by this interaction are still poorly known in pigs, although they can have a huge impact on meat quality traits. The present research provides new knowledge insight into the effect of four diets (D1 = standard diet; D2 = linseed supplementation; D3 = linseed, vitamin E and selenium supplementation; D4 = linseed and plant-derived polyphenols supplementation) on the expression of 24 candidate genes selected for their role in lipid and energy metabolism. The data indicated that 10 out of 24 genes were differentially expressed among diets, namely ACACA, ADIPOQ, ADIPOR1, CHREBP (MLXPL), ELOVL6, FASN, G6PD, PLIN2, RXRA and SCD. Results from the univariate analysis displayed an increased expression of ACACA, ADIPOQ, ADIPOR1, CHREBP, ELOVL6, FASN, PLIN2, RXRA and SCD in D4 compared to D2. Similarly, ACACA, ADIPOQ, ADIPOR1, ELOVL6 and SCD were highly expressed in D4 compared to D3, while no differences were observed in D2-D3 comparison. Moreover, an increased expression of G6PD and ELOVL6 genes in D4 compared to D1 was observed. Results from the multivariate analysis confirmed that D2 was not different from D3 and that ACACA, SCD and FASN expression made D4 different from D2 and D3. Comparing D4 and D1, the expression levels of ELOVL6 and ACACA were the most influenced. This research provides evidence that the addition of both n-3 PUFA and polyphenols, derived from linseed, grape-skin and oregano supplementation in the diets, stimulates the expression of genes involved in lipogenesis and in oxidative processes. Results evidenced a greater effect on gene expression of the diet added with both plant extracts and n-3 PUFA, resulting in an increased expression of genes coding for fatty acid synthesis, desaturation and elongation in pig Longissimus thoracis muscle.	[Vitali, Marika; Sirri, Rubina; Zambonelli, Paolo; Sami, Dalal; Davoli, Roberta] Univ Bologna, Interdept Ctr Ind Agrifood Res CIRI AGRO, Cesena, Italy; [Dimauro, Corrado; Manca, Elisabetta; Davoli, Roberta] Univ Sassari, Dept Agron, Sassari, Italy; [Zappaterra, Martina; Zambonelli, Paolo] Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy; [Lo Fiego, Domenico Pietro] Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy; [Lo Fiego, Domenico Pietro] Univ Modena & Reggio Emilia, Interdept Res Ctr Agri Food Biol Resource Improve, Reggio Emilia, Italy	University of Bologna; University of Sassari; University of Bologna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Davoli, R (corresponding author), Univ Bologna, Interdept Ctr Ind Agrifood Res CIRI AGRO, Cesena, Italy.; Dimauro, C; Davoli, R (corresponding author), Univ Sassari, Dept Agron, Sassari, Italy.	dimauro@uniss.it; roberta.davoli@unibo.it	Vitali, Marika/P-5927-2019; Sirri, Rubina/O-3903-2019; Zambonelli, Paolo/N-3084-2014; Lo Fiego, Domenico Pietro/H-4811-2013	Vitali, Marika/0000-0002-8373-0898; Zambonelli, Paolo/0000-0002-2532-5528; Sirri, Rubina/0000-0002-8603-8418; Lo Fiego, Domenico Pietro/0000-0002-9154-9888; DAVOLI, ROBERTA/0000-0003-4600-8326; Zappaterra, Martina/0000-0001-5085-4811; Dimauro, Corrado/0000-0002-6588-923X	Bologna University RFO; Regione Emilia-Romagna POR-FESR 2014-2020 [PG/2015/730542]; Emilia Romagna Region	Bologna University RFO; Regione Emilia-Romagna POR-FESR 2014-2020; Emilia Romagna Region(Regione Emilia Romagna)	This research was funded by Bologna University RFO and Regione Emilia-Romagna POR-FESR 2014-2020 (URL: https://fesr.regione.emilia-romagna.it/) "Innovare la filiera suina mediante la valorizzazione di sottoprodotti vegetali e l'impiego di avanzate tecnologie "omiche" e di processo, per la produzione sostenibile di carne e salumi ad impatto positivo sulla salute"-Green Charcuterie grant n. PG/2015/730542. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fundings were received by RD and DPLF.; Authors warmly thank Dr Giacinto Dalla Casa for his time, dedication and assistance in caring the animals during the trial and to Giovanni Ferrari for his valued contribute when participated to the samples collection and laboratory analysis. The work was part of the project entitled "Innovating the pork chain through the valorization of vegetal by-products and the use of advanced "omics" and processing technologies, for the sustainable production of fresh and processed pork meat products with a positive impact on human health-Green Charcuterie". The authors thank Emilia Romagna Region and Bologna University RFO funding for the financial support of the project.	Dominguez-Avila JA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071002; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], R LANG ENV STAT COMP; Bae JS, 2016, BIOCHEM BIOPH RES CO, V478, P1060, DOI 10.1016/j.bbrc.2016.08.061; Barnes KM, 2012, J ANIM SCI, V90, P1142, DOI 10.2527/jas.2011-4642; Bee G, 2002, J ANIM SCI, V80, P1564; Bhaswant M, 2015, J NUTR BIOCHEM, V26, P571, DOI 10.1016/j.jnutbio.2015.02.001; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Braglia S, 2014, LIVEST SCI, V162, P15, DOI [10.1016/j.livsci.2014.01.014, 10.]; Caselli C, 2014, MOL GENET METAB, V113, P155, DOI 10.1016/j.ymgme.2014.09.003; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Davoli R, 2011, MOL BIOL REP, V38, P1575, DOI 10.1007/s11033-010-0266-0; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; de Souza CO, 2017, J CELL PHYSIOL, V232, P2168, DOI 10.1002/jcp.25715; De Tonnac A, 2016, BRIT J NUTR, V116, P7, DOI 10.1017/S0007114516001392; Desert C, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4520-5; Duran-Montge P, 2009, ANIMAL, V3, P535, DOI 10.1017/S1751731108003686; Fiesel A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0196-5; Gessner DK, 2017, J ANIM PHYSIOL AN N, V101, pe185, DOI 10.1111/jpn.12586; Guillot G, 2007, MATH BIOSCI, V205, P195, DOI 10.1016/j.mbs.2006.08.007; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Han XZ, 2007, INT J MOL SCI, V8, P950, DOI 10.3390/i8090950; Ho HY, 2006, J AGR FOOD CHEM, V54, P1638, DOI 10.1021/jf0524372; Huang CW, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0428-3; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Ikuyama S, 2013, FUNCT FOODS HEALTH D, V3, P353, DOI 10.31989/ffhd.v3i9.40; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kamei A, 2015, BIOSCI BIOTECH BIOCH, V79, P1893, DOI 10.1080/09168451.2015.1042833; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Lipinski K, 2017, ANN ANIM SCI, V17, P41, DOI 10.1515/aoas-2016-0042; Madeira MS, 2014, BRIT J NUTR, V111, P1521, DOI 10.1017/S0007114513004029; Madeira MS, 2013, BRIT J NUTR, V110, P216, DOI 10.1017/S0007114512004916; Marette A, 2014, REV ENDOCR METAB DIS, V15, P299, DOI 10.1007/s11154-014-9296-6; Ogluszka M, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0552-8; Park HS, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0922-9; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Ren ZQ, 2008, GENET SEL EVOL, V40, P625, DOI 10.1051/gse:2008024; Revilla M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20473-3; Sabour H, 2015, J SPINAL CORD MED, V38, P599, DOI 10.1179/2045772314Y.0000000251; Schwarz C, 2017, ANIMAL, V11, P345, DOI 10.1017/S1751731116001518; Siriwardhana N, 2013, J NUTR BIOCHEM, V24, P613, DOI 10.1016/j.jnutbio.2012.12.013; Soheila K, 2013, ASIAN PAC J CANCER P, V14, P1629, DOI 10.7314/APJCP.2013.14.3.1629; Straub BK, 2013, HISTOPATHOLOGY, V62, P617, DOI 10.1111/his.12038; Surai PF, 2014, J ANIM PHYSIOL AN N, V98, P19, DOI 10.1111/jpn.12070; Switonski M, 2010, J APPL GENET, V51, P153, DOI 10.1007/BF03195724; Szostak A, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0517-4; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Tous N, 2012, J ANIM SCI, V90, P340, DOI 10.2527/jas.53768; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang C, 2015, MEAT SCI, V102, P15, DOI 10.1016/j.meatsci.2014.11.014; Zhang GH, 2015, GENE, V565, P30, DOI 10.1016/j.gene.2015.03.057	58	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204869	10.1371/journal.pone.0204869	http://dx.doi.org/10.1371/journal.pone.0204869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286141	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500055
J	Grant, M; Salsman, NL; Berking, M				Grant, Michaels; Salsman, Nicholas L.; Berking, Matthias			The assessment of successful emotion regulation skills use: Development and validation of an English version of the Emotion Regulation Skills Questionnaire	PLOS ONE			English	Article							DIALECTICAL BEHAVIOR-THERAPY; BORDERLINE PERSONALITY-DISORDER; TORONTO-ALEXITHYMIA-SCALE; NEGATIVE MOOD REGULATION; REGULATION DIFFICULTIES; EXPERIENTIAL AVOIDANCE; FIT INDEXES; SELF-REPORT; TRANSDIAGNOSTIC TREATMENT; GENERALIZED EXPECTANCIES	Emotion regulation has become an important topic in mental health and psychotherapy research. Skills supposingly relevant for adaptive responses towards emotions include the abilities to be consciously aware of emotions, identify and correctly label emotions, understand what has caused and maintains one's present emotions, modify the intensity or duration of one's emotions, accept and tolerate undesired emotions, confront situations likely to cue negative emotions, and provide effective self-support when working to cope with challenging emotions. To economically assess these abilities, a self-report measure has been developed in German and validated in various studies. To facilitate the use of the measure in English speaking countries, we have developed and validated an English version of the Emotion Regulation Skills Questionnaire (ERSQ) in a student sample (n = 263) and a sample of individual clinical sample (n = 35). Findings from this study provide significant evidence for the reliability and validity of the ERSQ. Thus, the measure can be used to assess a broad range of important emotion regulation skills in an economic way.	[Grant, Michaels] Johannes Gutenberg Univ Mainz, Dept Clin Psychol & Psychotherapy, Mainz, Rhineland Palat, Germany; [Salsman, Nicholas L.] Xavier Univ, Dept Clin Psychol, Cincinnati, OH 45207 USA; [Berking, Matthias] Univ Erlangen Nueremberg, Dept Clin Psychol & Psychotherapy, Erlangen, Bavaria, Germany	Johannes Gutenberg University of Mainz; Xavier University; University of Erlangen Nuremberg	Grant, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Clin Psychol & Psychotherapy, Mainz, Rhineland Palat, Germany.	grant@uni-mainz.de						Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Aldao A, 2012, J ABNORM PSYCHOL, V121, P276, DOI 10.1037/a0023598; Anestis MD, 2010, BEHAV RES THER, V48, P607, DOI 10.1016/j.brat.2010.03.012; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baker R, 2004, BEHAV RES THER, V42, P1271, DOI 10.1016/j.brat.2003.09.002; Berenbaum H, 2003, CLIN PSYCHOL-SCI PR, V10, P206, DOI 10.1093/clipsy/bpg011; Berking M., 2014, SEE GROSS, V2014, P529; Berking M., 2008, TRAINING EMOTIOALER; Berking M, 2008, BEHAV RES THER, V46, P1230, DOI 10.1016/j.brat.2008.08.005; Berking M, 2008, Z PSYCHIATR PSYCH PS, V56, P141, DOI 10.1024/1661-4747.56.2.141; Berking M, 2014, AFFECT REGULATION TRAINING: A PRACTITONERS' MANNUAL, P19, DOI 10.1007/978-1-4939-1022-9_3; Berking M, 2014, BEHAV RES THER, V57, P13, DOI 10.1016/j.brat.2014.03.003; Berking M, 2013, PSYCHOTHER PSYCHOSOM, V82, P234, DOI 10.1159/000348448; Berking M, 2012, J BEHAV THER EXP PSY, V43, P931, DOI 10.1016/j.jbtep.2011.09.009; Berking M, 2012, CURR OPIN PSYCHIATR, V25, P128, DOI 10.1097/YCO.0b013e3283503669; Berking M, 2011, J CONSULT CLIN PSYCH, V79, P307, DOI 10.1037/a0023421; Berking M, 2010, BEHAV THER, V41, P329, DOI 10.1016/j.beth.2009.08.001; Berking M, 2008, J COUNS PSYCHOL, V55, P485, DOI 10.1037/a0013589; Brislin R.W., 1980, HDB CROSS CULTURAL P, P389, DOI DOI 10.3390/HEALTHCARE6030093; Bydlowski S, 2005, INT J EAT DISORDER, V37, P321, DOI 10.1002/eat.20132; CATANZARO SJ, 1990, J PERS ASSESS, V54, P546, DOI 10.1207/s15327752jpa5403&4_11; Catanzaro SJ, 2000, J PERS, V68, P757, DOI 10.1111/1467-6494.00115; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cloitre M, 2002, J CONSULT CLIN PSYCH, V70, P1067, DOI 10.1037//0022-006X.70.5.1067; Clyne Courtney, 2010, Eat Disord, V18, P408, DOI 10.1080/10640266.2010.511930; Conway M, 2000, J PERS ASSESS, V75, P404, DOI 10.1207/S15327752JPA7503_04; Corstorphine E, 2006, EUR EAT DISORD REV, V14, P448, DOI 10.1002/erv.747; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Diedrich A, 2014, BEHAV RES THER, V58, P43, DOI 10.1016/j.brat.2014.05.006; Ebert DD, 2013, DIAGNOSTICA, V59, P17, DOI 10.1026/0012-1924/a000079; Ehring T, 2008, PERS INDIV DIFFER, V44, P1574, DOI 10.1016/j.paid.2008.01.013; Ehring T, 2010, EMOTION, V10, P563, DOI 10.1037/a0019010; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Elices M, 2017, BORDER PERS DIS EMOT, V4, DOI 10.1186/s40479-017-0064-6; Ellison JA, 2009, J CONSULT CLIN PSYCH, V77, P103, DOI 10.1037/a0014653; Fox HC, 2008, ADDICT BEHAV, V33, P388, DOI 10.1016/j.addbeh.2007.10.002; Fox HC, 2007, DRUG ALCOHOL DEPEN, V89, P298, DOI 10.1016/j.drugalcdep.2006.12.026; Garnefski N, 2007, EUR J PSYCHOL ASSESS, V23, P141, DOI 10.1027/1015-5759.23.3.141; Geisinger K. F., 2003, HDB PSYCHOL, V10, P95, DOI DOI 10.1002/0471264385.WEI1005; Ghorbani F, 2017, PSYCHIAT RES, V252, P223, DOI 10.1016/j.psychres.2017.03.005; Giromini L, 2012, J CLIN PSYCHOL, V68, P989, DOI 10.1002/jclp.21876; GOTTMAN JM, 1989, DEV PSYCHOL, V25, P373, DOI 10.1037/0012-1649.25.3.373; Gratz KL, 2006, BEHAV THER, V37, P25, DOI 10.1016/j.beth.2005.03.002; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Greenberg L. S., 2002, J PSYCHOTHERAPY INTE, V12, P154, DOI DOI 10.1037/1053-0479.12.2.154; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2014, HDB EMOTION REGULATI, Vxviii; Harley R, 2008, J NERV MENT DIS, V196, P136, DOI 10.1097/NMD.0b013e318162aa3f; Harrison A, 2009, CLIN PSYCHOL PSYCHOT, V16, P348, DOI 10.1002/cpp.628; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Hilbert A, 2007, INT J EAT DISORDER, V40, P521, DOI 10.1002/eat.20401; Hino T, 2002, COMPR PSYCHIAT, V43, P279, DOI 10.1053/comp.2002.33495; Hofmann SG, 2010, J PSYCHOPATHOL BEHAV, V32, P255, DOI 10.1007/s10862-009-9142-4; Hourigan SE, 2011, J EXP CHILD PSYCHOL, V110, P198, DOI 10.1016/j.jecp.2011.03.002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Kassel JD, 2007, BEHAV RES THER, V45, P939, DOI 10.1016/j.brat.2006.07.014; Kraaij V, 2002, AGING MENT HEALTH, V6, P275, DOI 10.1080/13607860220142387; Kramer U, 2014, CLIN PSYCHOL PSYCHOT, V21, P242, DOI 10.1002/cpp.1832; Kring AM, 1999, COGNITION EMOTION, V13, P575, DOI 10.1080/026999399379195; Larsen RJ, 2000, PSYCHOL INQ, V11, P129, DOI 10.1207/S15327965PLI1103_01; Lavender JM, 2015, CLIN PSYCHOL REV, V40, P111, DOI 10.1016/j.cpr.2015.05.010; LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819; Leahy RL, 2002, COGN BEHAV PRACT, V9, P177, DOI 10.1016/S1077-7229(02)80048-7; LeMoult J, 2014, BIOL PSYCHOL, V100, P50, DOI 10.1016/j.biopsycho.2014.05.001; Linehan M., 1993, COGNITIVE BEHAV TREA; Linehan MM, 2002, DRUG ALCOHOL DEPEN, V67, P13, DOI 10.1016/S0376-8716(02)00011-X; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond S.H., 1995, MANUAL DEPRESSION AN, V2nd; Lynch TR, 2007, ANNU REV CLIN PSYCHO, V3, P181, DOI 10.1146/annurev.clinpsy.2.022305.095229; Lynch TR, 2007, INT J GERIATR PSYCH, V22, P131, DOI 10.1002/gps.1703; Lynch TR, 2003, AM J GERIAT PSYCHIAT, V11, P33, DOI 10.1176/appi.ajgp.11.1.33; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Massah O, 2016, INT J HIGH RISK BEHA, V5, DOI [10.58129jhrba.24327, DOI 10.5812/IJHRBA.24327]; Mennin D, 2007, CLIN PSYCHOL-SCI PR, V14, P329, DOI 10.1111/j.1468-2850.2007.00094.x; Mennin DS, 2004, CLIN PSYCHOL PSYCHOT, V11, P17, DOI 10.1002/cpp.389; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Parker JDA, 2003, J PSYCHOSOM RES, V55, P269, DOI 10.1016/S0022-3999(02)00578-0; Radkovsky A, 2014, J CONSULT CLIN PSYCH, V82, P248, DOI 10.1037/a0035828; Saarni C., 1999, DEV EMOTIONAL COMPET; Safer DL, 2001, AM J PSYCHIAT, V158, P632, DOI 10.1176/appi.ajp.158.4.632; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Salovey P., 1995, EMOTION DISCLOSURE H, P125; Sauer-Zavala S, 2016, J PERS DISORD, V30, P35, DOI 10.1521/pedi_2015_29_179; Selby EA, 2016, MINDFULNESS, V7, P228, DOI 10.1007/s12671-015-0432-5; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Telch CF, 2001, J CONSULT CLIN PSYCH, V69, P1061, DOI 10.1037//0022-006X.69.6.1061; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Tragesser SL, 2007, J PERS DISORD, V21, P603, DOI 10.1521/pedi.2007.21.6.603; Tragesser SL, 2010, J PERS DISORD, V24, P377, DOI 10.1521/pedi.2010.24.3.377; Tull MT, 2007, BEHAV THER, V38, P303, DOI 10.1016/j.beth.2006.10.001; Tull MT, 2007, BEHAV THER, V38, P378, DOI 10.1016/j.beth.2006.10.006; Turk CL, 2005, COGNITIVE THER RES, V29, P89, DOI 10.1007/s10608-005-1651-1; Van de Vijver F, 1996, EUR PSYCHOL, V1, P89, DOI 10.1027/1016-9040.1.2.89; Van Rheenen TE, 2015, PSYCHIAT RES, V225, P425, DOI 10.1016/j.psychres.2014.12.001; Varkovitzky RL, 2018, BEHAV MODIF, V42, P210, DOI 10.1177/0145445517724539; Westermann S, 2012, BEHAV THER, V43, P329, DOI 10.1016/j.beth.2011.07.005; Whiteside Ursula, 2007, Eat Behav, V8, P162, DOI 10.1016/j.eatbeh.2006.04.001; Wirtz CM, 2014, DEPRESS ANXIETY, V31, P87, DOI 10.1002/da.22198	104	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205095	10.1371/journal.pone.0205095	http://dx.doi.org/10.1371/journal.pone.0205095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281666	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400080
J	Limmer, M; Platen, P				Limmer, Mirjam; Platen, Petra			The influence of hypoxia and prolonged exercise on attentional performance at high and extreme altitudes: A pilot study	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; COGNITIVE PERFORMANCE; WORKING-MEMORY; REACTION-TIME; SLEEP; IMPAIRMENT; PSILOCYBIN; PRESSURE; HEADACHE; SCALE	Introduction Exposure to hypoxic conditions is reported to impair cognitive performance. Further, moderate physical exercise improves cognitive function, but little is known about the influence of exercise on cognitive function in hypoxia. Therefore, the current study aimed to examine the influence of hypoxia (HYP) and prolonged exercise (EX) on attentional performance. Methods A total of 80 participants (female: n = 29; male: n = 51) were assigned to four groups: HYP + EX (n = 15), HYP (n = 25), EX (n = 21) and normoxia (NOR) (n = 21). The Frankfurt Attention Inventory-2 (FAIR-2) was performed at four testing points (day 1, 14, 16 and 18) to assess attentional performance. All groups completed a pretest (D1) and a follow-up test (D18). In HYP + EX conditions, the cognitive task was performed in a hypoxic state after prolonged exercise (D14: 3950 m, D16: 5739 m) during a mountain climb on Mt. Kilimanjaro. Participants in HYP were tested under intermittent hypoxia at rest in a hypoxic chamber (D14: 3500 m, D16: 5800 m), and those in EX were tested under normoxia after prolonged exercise during a 7-day backcountry ski hiking tour. NOR was a control group, and participants completed all tests under normoxia and at rest. Results Hypoxia impaired the attentional functions performance value (PV) and continuity value (CV) for the HYP + EX (p = 0.000) and HYP (L: p = 0.025; K: p = 0.043) groups at 5739 m and 5800 m, respectively, but not the function quality value (QV). In contrast, the EX group did not exhibit changes in attentional function. Conclusion The current results suggest that attentional performance is impaired during extreme normobaric and hypobaric hypoxic exposure. We further conclude that greater cognitive impairment under hypobaric hypoxia during a mountain climb compared with normobaric hypoxia at rest is not caused by prolonged exercise, but may be influenced by other factors (e.g. low temperatures, dehydration, or sleep deprivation) that remain to be verified.	[Limmer, Mirjam; Platen, Petra] Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany; [Limmer, Mirjam] German Sports Univ Cologne, Inst Outdoor Sports & Environm Sci, Cologne, Germany	Ruhr University Bochum; German Sport University Cologne	Limmer, M (corresponding author), Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany.; Limmer, M (corresponding author), German Sports Univ Cologne, Inst Outdoor Sports & Environm Sci, Cologne, Germany.	mirjam.limmer@rub.de		Platen, Petra/0000-0002-3440-8245; Limmer, Mirjam/0000-0002-8032-6152	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063630; Ando S, 2010, J APPL PHYSIOL, V108, P1210, DOI 10.1152/japplphysiol.01115.2009; Bartsch P, 2008, SCAND J MED SCI SPOR, V18, P96, DOI 10.1111/j.1600-0838.2008.00837.x; BERRY DTR, 1989, J CLIN EXP NEUROPSYC, V11, P241, DOI 10.1080/01688638908400886; Bonnon M, 2000, AVIAT SPACE ENVIR MD, V71, P678; Chang YK, 2014, PSYCHOL SPORT EXERC, V15, P464, DOI 10.1016/j.psychsport.2014.04.007; Chang YK, 2014, J SCI MED SPORT, V17, P51, DOI 10.1016/j.jsams.2013.02.007; Cohen J., 1992, PSYCHOL B; DiPasquale DM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6245609; Dobashi S, 2016, HIGH ALT MED BIOL, V17, P214, DOI 10.1089/ham.2016.0036; Finnoff JT, 2008, CURR SPORT MED REP, V7, P28, DOI 10.1097/01.CSMR.0000308669.99816.71; Fruhauf A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3313-z; Gao YX, 2015, EUR J NEUROL, V22, P1363, DOI 10.1111/ene.12507; Griva K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174277; Harris GA, 2009, WILD ENVIRON MED, V20, P261, DOI 10.1580/08-WEME-OR-261R.1; Hasler F, 2004, PSYCHOPHARMACOLOGY, V172, P145, DOI 10.1007/s00213-003-1640-6; Hext F, 2011, HIGH ALT MED BIOL, V12, P329, DOI 10.1089/ham.2010.1055; Hill CM, 2014, NEUROPSYCHOLOGY, V28, P752, DOI 10.1037/neu0000065; Hurdiel R, 2015, J SPORT SCI, V33, P670, DOI 10.1080/02640414.2014.960883; Kimoto K, 2011, INTERNAL MED, V50, P1923, DOI 10.2169/internalmedicine.50.5640; Komiyama T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10332-y; Komiyama T, 2015, PHYSIOL BEHAV, V139, P290, DOI 10.1016/j.physbeh.2014.11.057; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Latshang TD, 2013, SLEEP, V36, P1969, DOI 10.5665/sleep.3242; Leach J, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0048-y; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; MacInnis MJ, 2013, HIGH ALT MED BIOL, V14, P334, DOI 10.1089/ham.2013.1030; Malle C, 2016, HIGH ALT MED BIOL, V17, P359, DOI 10.1089/ham.2016.0022; McMorris T, 2017, NEUROSCI BIOBEHAV R, V74, P225, DOI 10.1016/j.neubiorev.2017.01.019; Merz TM, 2013, EUR J APPL PHYSIOL, V113, P2025, DOI 10.1007/s00421-013-2635-6; Moosbrugger H, 2011, FAIR 2 FRANKFURTER A, V2; Niedermeier M, 2017, PHYSIOL BEHAV, V173, P236, DOI 10.1016/j.physbeh.2017.02.018; Ochi G, 2018, J PHYSIOL SCI, V68, P847, DOI 10.1007/s12576-018-0603-y; Ozeki K, 2015, INT J BIOMETEOROL, V59, P447, DOI 10.1007/s00484-014-0859-8; Pavlicek V, 2005, AVIAT SPACE ENVIR MD, V76, P28; Petermann F, 2011, Z PSYCHIATR PSYCH PS, V59, P325, DOI 10.1024/1661-4747/a000088; Petrassi FA, 2012, AVIAT SPACE ENVIR MD, V83, P975, DOI 10.3357/ASEM.3315.2012; Pilmanis AA, 2016, AEROSP MED HUM PERF, V87, P596, DOI 10.3357/AMHP.4558.2016; Pramsohler S, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0362-3; Roach EB, 2014, NEUROREPORT, V25, P814, DOI 10.1097/WNR.0000000000000169; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roach RC, 2018, HIGH ALT MED BIOL, V19, P4, DOI 10.1089/ham.2017.0164; Roeggla G, 1996, J ROY SOC MED, V89, P141, DOI 10.1177/014107689608900307; SAVOUREY G, 1995, AVIAT SPACE ENVIR MD, V66, P963; Seo Y, 2015, HIGH ALT MED BIOL, V16, P298, DOI 10.1089/ham.2015.0027; Sharma VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101448; Singh S B, 2003, Indian J Physiol Pharmacol, V47, P52; Stivalet P, 2000, ERGONOMICS, V43, P474, DOI 10.1080/001401300184350; Tomporowski PD, 2007, INT J SPORTS MED, V28, P891, DOI 10.1055/s-2007-965004; Uebel-von Sandersleben H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178866; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; Vollenweider FX, 2007, NEUROPSYCHOPHARMACOL, V32, P1876, DOI 10.1038/sj.npp.1301324; Wagner DR, 2007, HIGH ALT MED BIOL, V8, P27, DOI 10.1089/ham.2006.0814; Wagner DR, 2012, HIGH ALT MED BIOL, V13, P245, DOI 10.1089/ham.2012.1030; Wang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04443; West JB, 2013, HIGH ALT MED BIOL, V14, P191, DOI 10.1089/ham.2013.1431; West JB, 2011, HIGH ALT MED BIOL, V12, P23, DOI 10.1089/ham.2010.1068; Westhoff K, 2003, DIAGNOSTICA, V49, P110, DOI 10.1026//0012-1924.49.3.110; Wickens C. D., 2015, J HUMAN PERFORMANCE, V12, P1, DOI [10.7771/2327-2937.1065, DOI 10.7771/2327-2937.1065]; Yan XA, 2011, EXP BRAIN RES, V208, P437, DOI 10.1007/s00221-010-2494-x; Zillmer E., 2010, D2 TEST ATTENTION	62	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205285	10.1371/journal.pone.0205285	http://dx.doi.org/10.1371/journal.pone.0205285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281651	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400088
J	Yousseu, FBS; Nemg, FBS; Ngouanet, SA; Mekanda, FMO; Demanou, M				Yousseu, Francine Berlange Sado; Nemg, Fredy Brice Simo; Ngouanet, Sandra Ateutchia; Mekanda, Franck Martin Obam; Demanou, Maurice			Detection and serotyping of dengue viruses in febrile patients consulting at the New-Bell District Hospital in Douala, Cameroon	PLOS ONE			English	Article							CHIKUNGUNYA-VIRUS; ARBOVIRAL INFECTIONS; ANGOLA; SEROPREVALENCE; OUTBREAK	Arboviruses are a major public health problem worldwide and are predominantly present in intertropical areas. Chikungunya, dengue and zika viruses have been implicated in recent epidemics in Asia, America and Africa. In Cameroon, data on these viruses are fragmentary. The purpose of this study was to determine the frequency of detection of these three viruses in febrile patients in Douala, Cameroon. A cross-sectional and descriptive study was conducted from March to April 2017 at the New-Bell District Hospital in Douala. Blood samples were collected from febrile patients and tested for malaria infections using Rapid Diagnostic test. Plasma harvested was later analyzed for the presence of chikungunya, dengue and zika viruses by a Trioplex real-time RT-PCR at Centre Pasteur of Cameroon. A total of 114 participants were included, of which 63.2% were females, reflecting a sex ratio (female/male) of 1.7. The median age was 26 years, range [0.25-81]. Eight (7%) of the 114 participants were infected with Dengue virus (DENV) among which 5 were identified as serotype 1. No cases of infection by either Zika virus or Chikungunya virus were detected. Three cases of dengue-malaria co-infection (13%) were recorded. No association was found between socio-demographic factors and dengue infection. The phylogenetic analysis of the partial envelope E gene showed that all the five DENV serotype 1 samples belonged to sub-type V, similarly to strains from West African countries, particularly those from Nigeria, Senegal and Cote d'Ivoire. This study showed the circulation of DENV serotype 1 in febrile patients and raises the alarm for the establishment of a sustained surveillance system to detect cases and prevent potential outbreaks in Cameroon. The existence of dengue-malaria co-infections suggests that surveillance of arboviruses should not be limited to febrile, non-malarial cases.	[Yousseu, Francine Berlange Sado; Nemg, Fredy Brice Simo; Mekanda, Franck Martin Obam; Demanou, Maurice] CPC, Natl Reference Lab Chikungunya & Dengue, Dept Virol, Yaounde, Centre, Cameroon; [Yousseu, Francine Berlange Sado; Ngouanet, Sandra Ateutchia] Univ Dschang, Dept Biomed Sci, Dschang, West, Cameroon		Demanou, M (corresponding author), CPC, Natl Reference Lab Chikungunya & Dengue, Dept Virol, Yaounde, Centre, Cameroon.	demanou@pasteur-yaounde.org		Demanou, Maurice/0000-0002-9275-0874				Abreu C, 2016, J CLIN VIROL, V79, P77, DOI 10.1016/j.jcv.2016.04.011; Achonduh-Atijegbe OA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1996-y; Ageep AK, 2006, SAUDI MED J, V27, P1711; [Anonymous], CDC TRIOPL REAL TIM; [Anonymous], WEEKL B OUTBR OTH EM; Ayorinde AF, 2016, J INFECT PUBLIC HEAL, V9, P52, DOI 10.1016/j.jiph.2015.06.009; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950; Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128; Epelboin L, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax028; Esposito S, 2012, EUR J CLIN MICROBIOL, V31, P3251, DOI 10.1007/s10096-012-1692-9; Fokam E B, 2010, East Afr Med J, V87, P262; Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631; Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Gulati S, 2012, SCAND J INFECT DIS, V44, P522, DOI 10.3109/00365548.2012.669044; Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182; Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078; Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932; Mamoudou Savadogo, 2016, Pan Afr Med J, V23, P168, DOI 10.11604/pamj.2016.23.168.9234; Masson E, 2018, FIEVRE JAUNE DENGUE; Maurice D, 2015, VIROL SIN, V30, P470, DOI 10.1007/s12250-015-3663-7; Monamele GC, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.227.15316; Ndip LM, 2004, EMERG INFECT DIS, V10, P432, DOI 10.3201/eid1003.020713; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Parreira R, 2014, EUROSURVEILLANCE, V19, P7; Parreira R, 2014, J INFECT DEV COUNTR, V8, P1210, DOI 10.3855/jidc.4910; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Rodhain F, 1996, B SOC PATHOL EXOT, V89, P87; Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496	32	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204143	10.1371/journal.pone.0204143	http://dx.doi.org/10.1371/journal.pone.0204143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281633	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400043
J	Zheng, HT; Fu, ZY; Chen, JY; Sangaiah, AK; Jiang, Y; Zhao, CZ				Zheng, Hai-Tao; Fu, Zuo-You; Chen, Jin-Yuan; Sangaiah, Arun Kumar; Jiang, Yong; Zhao, Cong-Zhi			Novel knowledge-based system with relation detection and textual evidence for question answering research	PLOS ONE			English	Article								With the development of large-scale knowledge bases (KBs), knowledge-based question answering (KBQA) has become an important research topic in recent years. The key task in KBQA is relation detection, which is the process of finding a compatible answer type for a natural language question and generating its corresponding structured query over a KB. However, existing systems often rely on shallow probabilistic methods, which are less expressive than deep semantic representation methods. In addition, since KBs are still far from complete, it is necessary to develop a new strategy that leverages unstructured resources outside of KBs. In this work, we propose a novel Question Answering method with Relation Detection and Textual Evidence (QARDTE). First, to address the semantic gap problem in relation detection, we use bidirectional long-short term memory networks with different levels of abstraction to better capture sentence structures. Our model achieves improved results with robustness against a wide diversity of expressions and questions with multiple relations. Moreover, to help compensate for the incompleteness of KBs, we utilize external unstructured text to extract additional supporting evidence and combine this evidence with relation information during the answer re-ranking process. In experiments on two well-known benchmarks, our system achieves F-1 values of 0.558 (+2.8%) and 0.663 (+5.7%), which are state-of-the-art results that show significant improvement over existing KBQA systems.	[Zheng, Hai-Tao; Fu, Zuo-You; Chen, Jin-Yuan; Jiang, Yong] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen, Peoples R China; [Sangaiah, Arun Kumar] VIT Univ, Sch Comp Sci & Engn, Vellore, Tamil Nadu, India; [Zhao, Cong-Zhi] Giiso Informat Technol Co Ltd, Shenzhen, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Vellore Institute of Technology	Fu, ZY (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Shenzhen, Peoples R China.	fzy15@mails.tsinghua.edu.cn	Sangaiah, Arun Kumar/U-6785-2019	Sangaiah, Arun Kumar/0000-0002-0229-2460; Fu, Zuoyou/0000-0001-8690-7807	National Natural Science Foundation of China [61773229]; Shenzhen Science and Technology Project (Shenzhen Science, Technology and Innovation Commission) [CYZZ20150408152315667]; Basic Scientific Research Program of Shenzhen City (Shenzhen Science, Technology and Innovation Commission) [JCYJ20160331184440545]; Graduate School at Shenzhen, Tsinghua University [JC20140001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Project (Shenzhen Science, Technology and Innovation Commission); Basic Scientific Research Program of Shenzhen City (Shenzhen Science, Technology and Innovation Commission); Graduate School at Shenzhen, Tsinghua University	This research is supported by (1) National Natural Science Foundation of China Grant No. 61773229, Funding Body: National Natural Science Foundation of China, http://www.nsfc.gov.cn/, author received: HTZ; (2) Shenzhen Science and Technology Project Grant No. CYZZ20150408152315667, Funding Body: Shenzhen Science, Technology and Innovation Commission, http://www.szsti.gov.cn, author received: CZZ; (3) Basic Scientific Research Program of Shenzhen City Grant No. JCYJ20160331184440545, Funding Body: Shenzhen Science, Technology and Innovation Commission, http://www.szsti.gov.cn, author received: HTZ; and (4) Cross fund of Graduate School at Shenzhen, Tsinghua University Grant No. JC20140001, http://www.sz.tsinghua.edu.cn/, Funding Body: Graduate School at Shenzhen, Tsinghua University, author received: HTZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of our authors (CZZ) affiliates to Giiso Information Technology Co., Ltd. The funder provided support in the form of salaries for authors HTZ, ZYF, YJ, CZZ and JYC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baldi P., 2012, P ICML WORKSHOP UNSU, V27, P37, DOI DOI 10.1561/2200000006; Berant J., 2015, T ASS COMPUT LINGUIS, V3, P545, DOI DOI 10.1162/tacl_a_00157; Berant J, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1415, DOI 10.3115/v1/p14-1133; Bollacker K., 2008, P 2008 ACM SIGMOD IN, P1247, DOI [10.1145/1376616.1376746, DOI 10.1145/1376616.1376746]; Bordes A., 2014, P 2014 C EMP METH NA, P615, DOI DOI 10.3115/V1/D14-1067; Bordes A., 2015, CORR; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai Qingqing, 2013, P ACL, V1, P423; Cui W., 2016, IJCAI INT JOINT C AR; Dong L, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P260; Graves A, 2005, LECT NOTES COMPUT SC, V3697, P799; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hannah B., 2015, P 24 ACM INT C INF K, P1431, DOI [10.1145/2806416.2806472, DOI 10.1145/2806416.2806472]; Hermann K. M., 2015, NIPS, p1693{1701; Hinton G.E., 2012, COURSERA NEURAL NETW; Joachims T., 2002, P 8 ACM SIGKDD INT C, P133, DOI [10.1145/775047.775067, DOI 10.1145/775047.775067]; Kalchbrenner N, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P655, DOI 10.3115/v1/p14-1062; Liu T.-Y., 2009, FOUND TRENDS INF RET, V3, P225, DOI [DOI 10.1561/1500000016, DOI 10.1007/978-3-642-14267-3]; Mahdisoltani F., 2015, P 7 BIENN C INN DAT; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; Mikolov T., 2013, ADV NEURAL INFORM PR, V26, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Miller Alexander, 2016, P 2016 C EMPIRICAL M, P1400; Nair V, 2010, PROC 27 TH INT C MAC, P807; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pengcheng Yin, 2016, IJCAI; Savenkov D, 2016, SIGIR'16: PROCEEDINGS OF THE 39TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P235, DOI 10.1145/2911451.2911536; Sun H, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1045, DOI 10.1145/2736277.2741651; Xu Kun, 2016, P 54 ANN M ASS COMP, V1; Yao XC, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P956; Yavuz S., 2016, P 2016 C EMPIRICAL M, P149, DOI DOI 10.18653/V1/D16-1; Yin Jun, 2016, P 25 INT JOINT C ART, P2972; Zhou P., 2016, P COLING 2016 26 INT, P3485	35	1	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205097	10.1371/journal.pone.0205097	http://dx.doi.org/10.1371/journal.pone.0205097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281661	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400081
J	Dubljevic, V; Sattler, S; Racine, E				Dubljevic, Veljko; Sattler, Sebastian; Racine, Eric			Deciphering moral intuition: How agents, deeds, and consequences influence moral judgment	PLOS ONE			English	Article							ETHICAL DECISION-MAKING	Moral evaluations occur quickly following heuristic-like intuitive processes without effortful deliberation. There are several competing explanations for this. The ADC-model predicts that moral judgment consists in concurrent evaluations of three different intuitive components: the character of a person (Agent-component, A); their actions (Deed-component, D); and the consequences brought about in the situation (Consequences-component, C). Thereby, it explains the intuitive appeal of precepts from three dominant moral theories (virtue ethics, deontology, and consequentialism), and flexible yet stable nature of moral judgment. Insistence on single-component explanations has led to many centuries of debate as to which moral precepts and theories best describe (or should guide) moral evaluation. This study consists of two large-scale experiments and provides a first empirical investigation of predictions yielded by the ADC model. We use vignettes describing different moral situations in which all components of the model are varied simultaneously. Experiment 1 (within-subject design) shows that positive descriptions of the A-, D-, and C-components of moral intuition lead to more positive moral judgments in a situation with low-stakes. Also, interaction effects between the components were discovered. Experiment 2 further investigates these results in a between-subject design. We found that the effects of the A-, D-, and Ccomponents vary in strength in a high-stakes situation. Moreover, sex, age, education, and social status had no effects. However, preferences for precepts in certain moral theories (PPIMT) partially moderated the effects of the A- and C-component. Future research on moral intuitions should consider the simultaneous three-component constitution of moral judgment.	[Dubljevic, Veljko] North Carolina State Univ, Dept Philosophy & Religious Studies, Raleigh, NC 27695 USA; [Dubljevic, Veljko; Sattler, Sebastian; Racine, Eric] Inst Rech Clin Montreal, Pragmat Hlth Eth Res Unit, Montreal, PQ, Canada; [Sattler, Sebastian] Univ Cologne, Inst Sociol & Social Psychol, Cologne, Germany	University of North Carolina; North Carolina State University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Cologne	Dubljevic, V (corresponding author), North Carolina State Univ, Dept Philosophy & Religious Studies, Raleigh, NC 27695 USA.; Dubljevic, V (corresponding author), Inst Rech Clin Montreal, Pragmat Hlth Eth Res Unit, Montreal, PQ, Canada.	veljko_dubljevic@ncsu.edu	Sattler, Sebastian/Y-3590-2018	Sattler, Sebastian/0000-0002-6491-0754; Dubljevic, Veljko/0000-0003-3606-587X	Banting Postdoctoral Fellowships Programme [201310BAF-327654-235414]; Canadian Institutes of Health Research [EPP114801]	Banting Postdoctoral Fellowships Programme; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Support for this work comes from the Banting Postdoctoral Fellowships Programme (VD, PI; 201310BAF-327654-235414; URL: http://banting.fellowships-bourses.gc.ca/en/home-accueil.html) and a grant from the Canadian Institutes of Health Research (ER, co-PI; EPP114801, URL: http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Aiken L.S., 1991, MULTIPLE REGRESSION; [Anonymous], 2011, ELEMENTS MORAL COGNI, DOI [10.1017/CBO9780511780578, DOI 10.1017/CBO9780511780578]; Atzmuller C., 2015, METHODOLOGY, V6, P128; Berinsky AJ, 2014, AM J POLIT SCI, V58, P739, DOI 10.1111/ajps.12081; Bialek M., 2014, AJOB NEUROSCI, V5, P21, DOI [10.1080/21507740.2014.951790, DOI 10.1080/21507740.2014.951790]; Bocian K, 2014, PERS SOC PSYCHOL B, V40, P898, DOI 10.1177/0146167214529800; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Brady FN, 1996, J BUS ETHICS, V15, P927, DOI 10.1007/BF00705573; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; Craft JL, 2013, J BUS ETHICS, V117, P221, DOI 10.1007/s10551-012-1518-9; Cushman F, 2013, PERS SOC PSYCHOL REV, V17, P273, DOI 10.1177/1088868313495594; Dawson JF, 2006, J APPL PSYCHOL, V91, P917, DOI 10.1037/0021-9010.91.4.917; Dewey J., 1966, EDUC THEORY, V16, P198; DiStefano C., 2009, PRACTICAL ASSESSMENT, V14, P20, DOI [DOI 10.7275/DA8T-4G52, 10.7275/da8t-4g52]; Doris J. M, 2010, MORAL PSYCHOL HDB, DOI DOI 10.1093/ACPROF:OSO/9780199582143.003.0008; Dubljevic V., 2014, AJOB NEUROSCIENCE, V5, P3, DOI [10.1080/21507740.2014.939381, DOI 10.1080/21507740.2014.939381]; Dubljevic V., 2017, DEBATES NEUROETHICS, P129, DOI DOI 10.1007/978-3-319-54651-3_9; Dubljevic V, 2017, BIOETHICS, V31, P338, DOI 10.1111/bioe.12355; Dubljevic V, 2014, BEHAV BRAIN SCI, V37, P487, DOI 10.1017/S0140525X13003701; FORD RC, 1994, J BUS ETHICS, V13, P205, DOI 10.1007/BF02074820; Gilligan Carol, 1993, DIFFERENT VOICE PSYC; Goritz A. S., 2014, MIND SOC, V13, P285, DOI DOI 10.1007/S11299-014-0147-7; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Huebner B, 2009, TRENDS COGN SCI, V13, P1, DOI 10.1016/j.tics.2008.09.006; Jasso G, 2006, SOCIOL METHOD RES, V34, P334, DOI 10.1177/0049124105283121; Kahane G, 2012, SOC COGN AFFECT NEUR, V7, P393, DOI 10.1093/scan/nsr005; Kant Immanuel, 2003, PERPETUAL PEACE PHIL; Kant Immanuel, 1993, GROUNDING METAPHYSIC; Kauppinen Antti., 2015, HDB NEUROETHICS, P169, DOI [DOI 10.1007/978-94-007-4707-4_163, 10.1007/978-94-007-4707-4_163]; Kitcher Philip, 2011, ETHICAL PROJECT; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs Michael, 2012, Soc Cogn Affect Neurosci, V7, P708, DOI 10.1093/scan/nsr048; KOHLBERG L, 1968, PSYCHOL TODAY, V2, P25; Lavrakas PJ., 2008, ENCY SURVEY RES METH, P219, DOI DOI 10.4135/9781412963947; Loe TW, 2000, J BUS ETHICS, V25, P185, DOI 10.1023/A:1006083612239; Mendez MF, 2009, CNS SPECTRUMS, V14, P608, DOI 10.1017/S1092852900023853; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; O'Fallon MJ, 2005, J BUS ETHICS, V59, P375, DOI 10.1007/s10551-005-2929-7; Piaget J., 1932, MORAL JUDGMENT CHILD; Railton P, 2017, COGNITION, V167, P172, DOI 10.1016/j.cognition.2016.08.015; Reynolds SJ, 2006, J APPL PSYCHOL, V91, P233, DOI 10.1037/0021-9010.91.1.233; Riffkin R, 2014, GALLUP NEWS POLITICS; Sattler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071452; Schleim S, 2015, HDB NEUROETHICS, P185; Schwitzgebel E, 2012, MIND LANG, V27, P135, DOI 10.1111/j.1468-0017.2012.01438.x; Sinnott-Armstrong W., 2008, MORAL PSYCHOL, P35; Spring T, 2015, ARCH SCI PSYCHOL, V3, P1, DOI DOI 10.1037/ARC0000011; Sytsma Justin, 2016, THEORY PRACTICE EXPT; Tannenbaum D, 2011, J EXP SOC PSYCHOL, V47, P1249, DOI 10.1016/j.jesp.2011.05.010; Tanner C, 2008, EUR J SOC PSYCHOL, V38, P757, DOI 10.1002/ejsp.493; Tufts J. H., 1909, ETHICS; van Veen F, 2016, SOC SCI COMPUT REV, V34, P333, DOI 10.1177/0894439315585074; Wikstrom POH, 2010, J QUANT CRIMINOL, V26, P55, DOI 10.1007/s10940-009-9083-9; Zizzo Natalie, 2016, J Clin Ethics, V27, P117	57	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204631	10.1371/journal.pone.0204631	http://dx.doi.org/10.1371/journal.pone.0204631			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273370	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700028
J	Ruocco, N; Mutalipassi, M; Pollio, A; Costantini, S; Costantini, M; Zupo, V				Ruocco, Nadia; Mutalipassi, Mirko; Pollio, Antonino; Costantini, Susan; Costantini, Maria; Zupo, Valerio			First evidence of Halomicronema metazoicum (Cyanobacteria) free-living on Posidonia oceanica leaves	PLOS ONE			English	Article							MARINE CYANOBACTERIA; PHYLOGENETIC-RELATIONSHIPS; HOT-SPRINGS; DIVERSITY	Cyanobacteria contribute to the ecology of various marine environments, also for their symbioses, since some of them are common hosts of sponges and ascidians. They are also emerging as an important source of novel bioactive secondary metabolites in pharmacological (as anticancer drugs) and biotechnological applications. In the present work we isolated a cyanobacteria in a free-living state from leaves of the seagrass Posidonia oceanica leaves. This newly collected strain was then cultivated under two laboratory conditions, and then characterized by combining morphological observation and molecular studies based on 16S rRNA gene sequences analysis. The strain showed 99% pairwise sequence identity with Halomicronema metazoicum ITAC101, never isolated before as a free-living organisms, but firstly described as an endosymbiont of the Mediterranean marine spongae Petrosia ficiformis, under the form of a filamentous strain. Further studies will investigate the actual role of this cyanobacterium in the leaf stratum of P. oceanica leaves, given its demonstrated ability to influence the vitality and the life cycle of other organisms. In fact, its newly demonstrated free-living stage, described in this study, indicate that Phormidium-like cyanobacteria could play important roles in the ecology of benthic and planktonic communities.	[Ruocco, Nadia; Costantini, Maria] Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Ruocco, Nadia; Pollio, Antonino] Univ Naples Federico II, Dept Biol, Complesso Univ Monte St Angelo, Naples, Italy; [Ruocco, Nadia] CNR, Inst Biomol Chem, Bioorgan Chem Unit, Naples, Italy; [Mutalipassi, Mirko; Zupo, Valerio] Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Ctr Villa Dohrn Ischia Benth Ecol, Naples, Italy; [Costantini, Susan] Fdn G Pascale, IRCCS, Ist Nazl Tumori, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Stazione Zoologica Anton Dohrn di Napoli; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale	Costantini, M (corresponding author), Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.; Zupo, V (corresponding author), Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Ctr Villa Dohrn Ischia Benth Ecol, Naples, Italy.	maria.costantini@szn.it; vzupo@szn.it	Ruocco, Nadia/HGA-2143-2022; Mutalipassi, Mirko/AAP-2473-2021; Costantini, Maria/AGH-4080-2022; Costantini, Susan/J-9914-2018; pollio, antonino/AAE-6006-2019; Zupo, Valerio/A-5887-2011	Mutalipassi, Mirko/0000-0002-5521-5303; Costantini, Susan/0000-0002-7538-4657; Zupo, Valerio/0000-0001-9766-8784	PhD in Biology, University of Naples Federico II; Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples; Open University-SZN PhD fellowship	PhD in Biology, University of Naples Federico II; Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples; Open University-SZN PhD fellowship	Nadia Ruocco was supported by a PhD (PhD in Biology, University of Naples Federico II) fellowship co-funded by the Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples. Mirko Mutalipassi was supported by an Open University-SZN PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2002, ARCH MICROBIOL, V177, P361, DOI 10.1007/s00203-001-0390-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANAGNOSTIDIS K, 1988, Archiv fuer Hydrobiologie Supplement, V80, P327; Caroppo C, 2012, FOTTEA, V12, P315, DOI 10.5507/fot.2012.022; Carr NG, 1982, BIOL BLUE GREEN ALGA; Castenholz R. W., 1996, NOVA HEDWIGIA, V112, P33; Costa M, 2012, MAR DRUGS, V10, P2181, DOI 10.3390/md10102181; Costantini Susan, 2007, Genomics Proteomics & Bioinformatics, V5, P253, DOI 10.1016/S1672-0229(08)60013-3; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; Diaz Maria Cristina, 2007, V28, P31; Dorador C, 2008, FEMS MICROBIOL ECOL, V64, P419, DOI 10.1111/j.1574-6941.2008.00483.x; Dutta D, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-36; Finsinger K, 2008, ENVIRON MICROBIOL, V10, P460, DOI 10.1111/j.1462-2920.2007.01467.x; Gademann K, 2008, CURR ORG CHEM, V12, P326, DOI 10.2174/138527208783743750; Gantar M, 2008, J PHYCOL, V44, P260, DOI 10.1111/j.1529-8817.2008.00469.x; Garcia-Pichel F, 1998, ARCH MICROBIOL, V169, P469, DOI 10.1007/s002030050599; Geitler L, 1932, KRYPTOGAMEN FLORA DE, P673; Govindjee, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00028; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hoffmann L, 1999, EUR J PHYCOL, V34, P371; Ishida T, 1997, J GEN APPL MICROBIOL, V43, P237, DOI 10.2323/jgam.43.237; Komarek J., 2005, OCEANOLOGICAL HYDROB, V34, P5, DOI DOI 10.1080/09670262.2016.1163738; Lacap DC, 2005, CAN J MICROBIOL, V51, P583, DOI 10.1139/W05-038; Ma ZL, 2009, PLANTA, V230, P329, DOI 10.1007/s00425-009-0947-x; Madamwar D, 2015, EXCLI J, V14, P527, DOI 10.17179/excli2014-696; Marquardt J, 2007, ARCH MICROBIOL, V187, P397, DOI 10.1007/s00203-006-0204-7; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Mugnai G, 2018, BIOL FERT SOILS, V54, P27, DOI 10.1007/s00374-017-1234-9; Mur L., 1999, TOXIC CYANOBACTERIA, P15; Nikam T. D., 2013, Bioremediation, Biodiversity and Bioavailability, V7, P70; Nowruzi B, 2018, J PHARM HEALTH SERV, V9, P5, DOI 10.1111/jphs.12202; Nubel U, 2000, ENVIRON MICROBIOL, V2, P217, DOI 10.1046/j.1462-2920.2000.00094.x; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oren A, 2015, BIODIVERS CONSERV, V24, P781, DOI 10.1007/s10531-015-0882-z; Pagliara P., 2010, RAPP COMM INT MER ME, V39, P392; Pagliara P, 2011, TOXICON, V57, P889, DOI 10.1016/j.toxicon.2011.03.006; Perkerson RB, 2011, J PHYCOL, V47, P1397, DOI 10.1111/j.1529-8817.2011.01077.x; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rastogi RP, 2009, BIOTECHNOL ADV, V27, P521, DOI 10.1016/j.biotechadv.2009.04.009; Rastogi RP, 2011, INT J PHARM BIOSCI, V2, pB271; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Singh SP, 2011, WORLD J MICROB BIOT, V27, P1225, DOI 10.1007/s11274-010-0571-8; Sompong U, 2005, FEMS MICROBIOL ECOL, V52, P365, DOI 10.1016/j.femsec.2004.12.007; Stancheva R, 2013, HYDROBIOLOGIA, V720, P111, DOI 10.1007/s10750-013-1630-6; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Stoyanov P, 2014, EVOL BIOINFORM, V10, P39, DOI 10.4137/EBO.S13748; Strunecky O, 2010, POLAR BIOL, V33, P1419, DOI 10.1007/s00300-010-0834-8; Subramanian G, 1996, J SCI IND RES INDIA, V55, P685; Sundararaman M, 1996, PHYTOTHER RES, V10, P9, DOI 10.1002/(SICI)1099-1573(199602)10:1&lt;9::AID-PTR762&gt;3.0.CO;2-0; Sundararaman M, 2001, ALGAL BIOTECHNOLOGY, P31; Tuo SH, 2017, J PLANKTON RES, V39, P404, DOI 10.1093/plankt/fbx023; Usher KM, 2004, MICROB ECOL, V48, P167, DOI 10.1007/s00248-003-1062-3; Vaishampayan A, 2001, BOT REV, V67, P453, DOI 10.1007/BF02857893; Wang LC, 2017, HARMFUL ALGAE, V61, P56, DOI 10.1016/j.hal.2016.11.010; West NJ, 1997, APPL ENVIRON MICROB, V63, P4479, DOI 10.1128/AEM.63.11.4479-4484.1997; Yamazaki SS, 2008, FT LAUD FLOR P 11 IN, P265; Zhu P, 2008, MICROB ECOL, V55, P406, DOI 10.1007/s00248-007-9285-3; Zi JM, 2018, AQUAT TOXICOL, V194, P78, DOI 10.1016/j.aquatox.2017.11.007	59	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204954	10.1371/journal.pone.0204954	http://dx.doi.org/10.1371/journal.pone.0204954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273387	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700054
J	Allen, JD; Ray, S; Ross, TM				Allen, James D.; Ray, Satyajit; Ross, Ted M.			Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses	PLOS ONE			English	Article							COMPUTATIONALLY OPTIMIZED HEMAGGLUTININ; RESPONSES; IMMUNOGENICITY; INFECTION; CHILDREN; IMMUNITY; VIRION	Development of broadly reactive or universal influenza vaccines will be a paradigm shifting event for the influenza vaccine field. These next generation vaccines could replace the current standard of care with vaccines that elicit broadly cross-protective immune responses. However, a variety of in vitro and in vivo models are necessary to make the best assessments of these vaccine formulations to determine their mechanisms of action, and allow for downselection of candidates prior to human clinical trials. Our group has developed the computationally optimized broadly reactive antigen (COBRA) technology to develop HA head-based strategies to elicit antibodies against H1, H3, and H5 influenza strains. These vaccines elicit broadly reactive antibody responses that neutralize not only historical and contemporary vaccine strains, but also co-circulating variants in mice. In this study, we used H1 and H3 HA antigens in a split, inactivated vaccine (IIV) formulation in combination with the AF03 squalene-in-water emulsion adjuvant in ferrets immunologically naive to influenza virus. The H3 COBRA IIV vaccine T11 elicited antibodies with HAI activity against more H3N2 influenza strains compared to IIV expressing wild-type H3 HA antigens, except for IIV vaccines expressing the HA from A/Texas/50/2012 (Tx/12) virus. H1 COBRA IIV vaccines, P1 and X6, elicited antibodies that recognized a similar number of H1N1 viruses as those antibodies elicited by IIV expressing the A/California/07/2009 (CA/09) HA. Ferrets vaccinated with the P1 or X6 COBRA IIV were protected against CA/09 challege and cleared virus from the lungs of the ferrets, similar to ferrets vaccinated with the CA/09 IIV.	[Allen, James D.; Ross, Ted M.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Ross, Ted M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Ray, Satyajit] Sanofi Pasteur Inc, Cambridge, MA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ross, TM (corresponding author), Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.; Ross, TM (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	tedross@uga.edu		Ross, Ted/0000-0003-1947-7469	University of Georgia (UGA) [UGA-001]; Sanofi Pasteur [CROA UGA 001]; Georgia Research Alliance	University of Georgia (UGA); Sanofi Pasteur; Georgia Research Alliance	This work, including the efforts of TMR, was funded by University of Georgia (UGA) (UGA-001). This work, including the efforts of TMR, was funded by Sanofi Pasteur (CROA UGA 001). In addition, TMR is supported by the Georgia Research Alliance as an Eminent Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Agency EM Use CfMPfH], 2014, EMACHMPVWP4572592014; Allen JD, 2017, VACCINE, V35, P5209, DOI 10.1016/j.vaccine.2017.07.107; Allen JD, 2018, J VIROL UNPUB; Barberis I, 2016, J Prev Med Hyg, V57, pE115; Carter DM, 2017, J VIROL, V91, DOI [10.1128/JVI.01283-17, 10.1128/jvi.01283-17]; Carter DM, 2016, J VIROL, V90, P4720, DOI 10.1128/JVI.03152-15; Crevar CJ, 2015, HUM VACC IMMUNOTHER, V11, P572, DOI 10.1080/21645515.2015.1012013; DAVENPORT FM, 1964, J LAB CLIN MED, V63, P5; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ellebedy AH, 2009, VACCINE, V27, pD65, DOI 10.1016/j.vaccine.2009.08.038; ENNIS FA, 1977, J INFECT DIS, V136, pS397, DOI 10.1093/infdis/136.Supplement_3.S397; Erbelding EJ, 2018, J INFECT DIS, V218, P347, DOI 10.1093/infdis/jiy103; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Giles BM, 2012, J INFECT DIS, V205, P1562, DOI 10.1093/infdis/jis232; Giles BM, 2012, CLIN VACCINE IMMUNOL, V19, P128, DOI 10.1128/CVI.05533-11; Giles BM, 2011, VACCINE, V29, P3043, DOI 10.1016/j.vaccine.2011.01.100; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Kon TC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150700; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lina B, 2000, BIOLOGICALS, V28, P95, DOI 10.1006/biol.2000.0245; Lupulescu E, 1997, Bacteriol Virusol Parazitol Epidemiol, V42, P110; MCELHANEY JE, 1994, J GERONTOL, V49, pM37, DOI 10.1093/geronj/49.2.M37; Monto AS, 2010, VACCINE, V28, pD33, DOI 10.1016/j.vaccine.2010.08.027; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Ross Ted M, 2011, PLoS Curr, V3, pRRN1265, DOI 10.1371/currents.RRN1265; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Song JS, 2011, J VIROL, V85, P2180, DOI 10.1128/JVI.01975-10; VERSLUIS DJ, 1988, NEPHRON, V49, P16, DOI 10.1159/000184979; Wong TM, 2017, J VIROL, V91, DOI 10.1128/JVI.01581-17; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Wu JA, 2010, VACCINE, V28, P6221, DOI 10.1016/j.vaccine.2010.07.008	32	20	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204284	10.1371/journal.pone.0204284	http://dx.doi.org/10.1371/journal.pone.0204284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265682	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500025
J	Bohm, BB; Fehrl, Y; Janczi, T; Schneider, N; Burkhardt, H				Boehm, Beate B.; Fehrl, Yuliya; Janczi, Tomasz; Schneider, Nadine; Burkhardt, Harald			Cell adhesion-induced transient interaction of ADAM15 with poly(A) binding protein at the cell membrane colocalizes with mRNA translation	PLOS ONE			English	Article							POLY(A)-BINDING PROTEIN; INITIATION-FACTOR; EUKARYOTIC TRANSLATION; INTEGRIN BINDING; FOCAL ADHESIONS; DISINTEGRIN; KINASE; DOMAIN; LOCALIZATION; CHONDROCYTES	The regulation of temporo-spatial compartmentalization of protein synthesis is of crucial importance for a variety of physiologic cellular functions. Here, we demonstrate that the cell membrane-anchored disintegrin metalloproteinase ADAM15, upregulated in a variety of aggressively growing tumor cells, in the hyperproliferative synovial membrane of inflamed joints as well as in osteoarthritic chondrocytes, transiently binds to poly(A) binding protein 1 (PABP) in cells undergoing adhesion. The cytoplasmic domain of ADAM15 was shown to selectively interact with the proline-rich linker of PABP. Immunostainings of adhesion-triggered cells demonstrate an ADAM15-dependent recruitment of PABP to cell membrane foci coinciding with ongoing mRNA translation as visualized by the detection of puromycin-terminated polypeptides. Moreover, the increase in cell membrane-associated neosynthesis of puromycylated proteins upon induction of cell adhesion was proven linked to ADAM15 expression in HeLa and ADAM15-transfected chondrocytic cells. Thus, down regulation of ADAM15 by siRNA and/or the use of a cell line transfected with a mutant ADAM15-construct lacking the cytoplasmic tail resulted in a considerable reduction in the amount of cell membrane-associated puromycylated proteins formed during induced cell adhesion. These results provide first direct evidence for a regulatory role of ADAM15 on mRNA translation at the cell membrane that transiently emerges in response to triggering cell adhesion and might have potential implications under pathologic conditions of matrix remodeling associated with ADAM15 upregulation.	[Boehm, Beate B.; Fehrl, Yuliya; Janczi, Tomasz; Burkhardt, Harald] Goethe Univ, Univ Hosp Frankfurt, Div Rheumatol, Frankfurt, Germany; [Schneider, Nadine; Burkhardt, Harald] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Fraunhofer Gesellschaft	Burkhardt, H (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Div Rheumatol, Frankfurt, Germany.; Burkhardt, H (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany.	harald.burkhardt@kgu.de		Janczi, Tomasz/0000-0003-0228-0256	Deutsche Forschungsgemeinschaft DFG grant [DFG BU 584/5-1]	Deutsche Forschungsgemeinschaft DFG grant(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG grant DFG BU 584/5-1.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Beck V, 2005, INT J BIOCHEM CELL B, V37, P590, DOI 10.1016/j.biocel.2004.08.005; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bohm B, 2010, ARTHRITIS RHEUM-US, V62, P1372, DOI 10.1002/art.27387; Bohm BB, 2013, ARTHRITIS RHEUM-US, V65, P2826, DOI 10.1002/art.38109; Bohm BB, 2009, J CELL MOL MED, V13, P2634, DOI 10.1111/j.1582-4934.2008.00490.x; Bohm BB, 2005, ARTHRITIS RHEUM-US, V52, P1100, DOI 10.1002/art.20974; Bohm BB, 2001, ARTHRITIS RHEUM-US, V44, P2046, DOI 10.1002/1529-0131(200109)44:9<2046::AID-ART354>3.0.CO;2-3; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Burdelski C, 2017, NEOPLASIA, V19, P279, DOI 10.1016/j.neo.2017.01.005; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Charrier-Hisamuddin L, 2008, FASEB J, V22, P641, DOI 10.1096/fj.07-8876rev; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Eliseeva IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1377, DOI 10.1134/S0006297913130014; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Fried D, 2012, J BIOL CHEM, V287, P21214, DOI 10.1074/jbc.M112.347120; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Goss DJ, 2013, WIRES RNA, V4, P167, DOI 10.1002/wrna.1151; Gray NK, 2015, BIOCHEM SOC T, V43, P1277, DOI 10.1042/BST20150171; Hiles GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150138; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Hu YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06024; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kleino I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121301; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Lee JH, 2009, STRUCTURE, V17, P833, DOI 10.1016/j.str.2009.04.010; Lin JX, 2012, BIOPHYS J, V102, P1427, DOI 10.1016/j.bpj.2012.02.025; Lu D, 2006, THROMB HAEMOSTASIS, V96, P642, DOI 10.1160/TH06-07-0395; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Najy AJ, 2008, CANCER RES, V68, P1092, DOI 10.1158/0008-5472.CAN-07-2432; Nath D, 1999, J CELL SCI, V112, P579; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Smith RWP, 2010, BIOCHEM J, V426, P1, DOI 10.1042/BJ20091571; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Willett M, 2006, EXP CELL RES, V312, P2942, DOI 10.1016/j.yexcr.2006.05.020; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200; Woods AJ, 2005, MOL CELL BIOL, V25, P3763, DOI 10.1128/MCB.25.9.3763-3773.2005	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203847	10.1371/journal.pone.0203847	http://dx.doi.org/10.1371/journal.pone.0203847			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265671	Green Submitted, gold, Green Published			2022-12-27	WOS:000446005500011
J	Koethe, S; Banysch, S; Alves-dos-Santos, I; Lunau, K				Koethe, Sebastian; Banysch, Sarah; Alves-dos-Santos, Isabel; Lunau, Klaus			Spectral purity, intensity and dominant wavelength: Disparate colour preferences of two Brazilian stingless bee species	PLOS ONE			English	Article							TETRAGONULA-CARBONARIA SM; RECRUITMENT BEHAVIOR; RAIN-FOREST; HONEYBEES; HUMMINGBIRDS; MELIPONINI; FLOWERS; VISION; APIDAE; RED	Bees use floral colour as a major long distance orientation cue. While it is known for bumblebees and honeybees that dominant wavelength ((sic) colour hue), colour contrast and spectral purity ((sic) saturation) are crucial for flower detection and discrimination, only little is known about colour preferences in stingless bees (Meliponini). In this experiment freely flying workers of two Brazilian species of stingless bees-Partamona helleri and Melipona bicolor-were tested for colour preferences concerning the colour parameters dominant wavelength, spectral purity and intensity ((sic) brightness). Each individual bee had to perform 57 tests, in which a definite series of dual choices between colour stimuli varying in intensity, spectral purity or dominant wavelength were presented. The results show that P. helleri chose colours of higher spectral purity and preferred bluish colours, while M. bicolor made generalized colour choices. Intensity did not influence the colour choice of any bee species. The results of P. helleri are consistent with findings for honeybees and bumblebees, while colour preferences in M. bicolor seem to be absent.	[Koethe, Sebastian; Banysch, Sarah; Lunau, Klaus] Heinrich Heine Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany; [Alves-dos-Santos, Isabel] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Lab Abelhas, Sao Paulo, SP, Brazil	Heinrich Heine University Dusseldorf; Universidade de Sao Paulo	Koethe, S (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany.	sebastian.koethe@hhu.de	Alves-dos-Santos, Isabel/C-7624-2012; Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201; Koethe, Sebastian/0000-0003-0489-9909; alves dos santos, isabel/0000-0003-2352-1290	Deutsche Forschungsgemeinschaft [F020511114]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), Grant number: F020511114, Recipient: SK.	AUTRUM H, 1964, Z VERGL PHYSIOL, V48, P357, DOI 10.1007/BF00299270; Avargues-Weber A, 2014, J COMP PHYSIOL A, V200, P449, DOI 10.1007/s00359-014-0909-z; Barth FG, 2008, J COMP PHYSIOL A, V194, P313, DOI 10.1007/s00359-008-0321-7; BENE FRANK, 1941, CONDOR, V43, P237, DOI 10.2307/1364506; Bergamo PJ, 2016, FUNCT ECOL, V30, P710, DOI 10.1111/1365-2435.12537; Biesmeijer JC, 2004, APIDOLOGIE, V35, P143, DOI 10.1051/apido:2004003; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; De Ibarra NH, 2000, J EXP BIOL, V203, P3289; Del Sarto MCL, 2005, J ECON ENTOMOL, V98, P260, DOI 10.1603/0022-0493-98.2.260; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2016, J COMP PHYSIOL A, V202, P603, DOI 10.1007/s00359-016-1101-4; Dyer AG, 2016, J COMP PHYSIOL A, V202, P629, DOI 10.1007/s00359-016-1107-y; FREITAS SW, 2006, MENS DOCE, V86, P1; GILL FB, 1982, IBIS, V124, P44, DOI 10.1111/j.1474-919X.1982.tb03739.x; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; GIURFA M, 1994, J COMP PHYSIOL A, V175, P773, DOI 10.1007/BF00191849; GOLDSMITH TH, 1979, J COMP PHYSIOL, V130, P209, DOI 10.1007/BF00614607; GRANT KA, 1966, AM NAT, V100, P85, DOI 10.1086/282403; Heard TA, 1999, ANNU REV ENTOMOL, V44, P183, DOI 10.1146/annurev.ento.44.1.183; Jarau S, 2003, INSECT SOC, V50, P365, DOI 10.1007/s00040-003-0684-2; Jarau S, 2009, CONTEMP TOP ENTOMOL, P223; Kantsa A, 2017, NAT ECOL EVOL, V1, P1502, DOI 10.1038/s41559-017-0298-0; Koethe S, 2016, J COMP PHYSIOL A, V202, P615, DOI 10.1007/s00359-016-1115-y; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Lunau K, 1996, J COMP PHYSIOL A, V178, P477, DOI 10.1007/BF00190178; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; MCDADE LA, 1983, CONDOR, V85, P360, DOI 10.2307/1367077; MelendezAckerman E, 1997, ECOLOGY, V78, P2532, DOI 10.1890/0012-9658(1997)078[2532:HBAMOS]2.0.CO;2; Michener, 2007, BEES WORLD, P953, DOI DOI 10.1080/00379271.2007.10697535; MICHENER C D, 1974, P404; Michener Charles D., 1946, JOUR NEW YORK ENT SOC, V54, P179; MILLER RS, 1971, CONDOR, V73, P309, DOI 10.2307/1365757; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Murillo Martinez R.M., 1985, Biotica (Mexico), V9, P423; Nagamitsu T, 1997, OECOLOGIA, V110, P432, DOI 10.1007/s004420050178; Ng L, 2018, FACETS, V3, P800, DOI 10.1139/facets-2017-0116; Nieh JC, 2004, APIDOLOGIE, V35, P159, DOI 10.1051/apido:2004007; Papiorek S, 2013, NATURWISSENSCHAFTEN, V100, P633, DOI 10.1007/s00114-013-1060-3; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Porsch O, 1931, BIOL GEN, V2, P647; RAVEN PH, 1972, EVOLUTION, V26, P674, DOI 10.1111/j.1558-5646.1972.tb01975.x; Rhode K, 2013, J COMP PHYSIOL A, V199, P197; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; ROUBIK D W, 1986, Journal of Tropical Ecology, V2, P97, DOI 10.1017/S0266467400000699; Roubik D.W., 1989, ECOLOGY NATURAL HIST; ROUBIK DW, 1978, SCIENCE, V201, P1030, DOI 10.1126/science.201.4360.1030; Sanfiorenzo Andre, 2018, Journal of Pollination Ecology, V22, P1, DOI 10.26786/1920-7603(2018)one; Slaa EJ, 2003, ECOL ENTOMOL, V28, P369, DOI 10.1046/j.1365-2311.2003.00512.x; Slaa EJ, 2006, INSECT SOC, V53, P70, DOI 10.1007/s00040-005-0837-6; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; Spaethe J, 2014, J COMP PHYSIOL A, V200, P485, DOI 10.1007/s00359-014-0886-2; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; STILES FG, 1976, CONDOR, V78, P10, DOI 10.2307/1366912; Streinzer M, 2016, J COMP PHYSIOL A, V202, P643, DOI 10.1007/s00359-016-1118-8; Team RC., 2022, LANG ENV STAT COMP; Valido A, 2011, J EVOLUTION BIOL, V24, P751, DOI 10.1111/j.1420-9101.2010.02206.x; Vorobyev M, 1997, ISRAEL J PLANT SCI, V45, P103, DOI 10.1080/07929978.1997.10676677	62	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204663	10.1371/journal.pone.0204663	http://dx.doi.org/10.1371/journal.pone.0204663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265685	gold, Green Submitted, Green Published			2022-12-27	WOS:000446005500043
J	Carley, S; Yahng, LL				Carley, Sanya; Yahng, Lilian			Willingness-to-pay for sustainable beer	PLOS ONE			English	Article							ORGANIC FOOD; FAIR TRADE; CONSUMPTION; CONSUMERS; PRODUCTS; BEHAVIOR; TRANSPORTATION; PREFERENCES; BREWERIES; PARADIGM	Breweries across the country are investing in energy efficient and low-carbon brewing practices. Drawing insights from the sustainable consumption and ecological economics literature, this analysis evaluates whether consumers are willing to pay more for sustainable beer and what predicts the value of the premium. Based on a survey of beer consumers from across the U.S. that contained one of two willingness-to-pay exercises, we evaluate what respondent attributes are associated with a higher willingness-to-pay for sustainably brewed beer. We find that the majority of beer consumers are willing to pay more for sustainable beer. Consumers who are prepared to pay a premium tend to already pay more per unit of beer, are more aware of their purchasing behavior and the manner in which their consumption patterns may affect the environment, and pursue lifestyles based on professional advancement, helping the environment, and helping other causes.	[Carley, Sanya] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Yahng, Lilian] Indiana Univ, Ctr Survey Res, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Carley, S (corresponding author), Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.	scarley@indiana.edu			Office of the Vice Provost of Research Award for Research Methods and Collaboration at Indiana University	Office of the Vice Provost of Research Award for Research Methods and Collaboration at Indiana University	This research was supported by the Office of the Vice Provost of Research Award for Research Methods and Collaboration at Indiana University.	[Anonymous], 2008, MBAA TQ; Ashenfelter OC, 2015, RAND J ECON, V46, P328, DOI 10.1111/1756-2171.12092; Association Brewers, 2015, BREW ASS DAT 2015; Axsen J, 2012, ECOL ECON, V82, P64, DOI 10.1016/j.ecolecon.2012.07.013; Barlow MA, 2016, J MANAGE, P1; Barr S, 2005, ENERG POLICY, V33, P1425, DOI 10.1016/j.enpol.2003.12.016; Barr S, 2006, GEOFORUM, V37, P906, DOI 10.1016/j.geoforum.2006.05.002; Brewers Association, 2015, 2015 SUST BENCHM REP; Cabuk S, 2014, INT J CONSUM STUD, V38, P337, DOI 10.1111/ijcs.12094; Carroll GR, 2000, AM J SOCIOL, V106, P715, DOI 10.1086/318962; Carrus G, 2008, J ENVIRON PSYCHOL, V28, P51, DOI 10.1016/j.jenvp.2007.09.003; Cordano M., 2003, J ENVIRON EDUC, V34, P22, DOI [10.1080/00958960309603490, DOI 10.1080/00958960309603490]; De Young R, 2000, J SOC ISSUES, V56, P509, DOI 10.1111/0022-4537.00181; Didier T, 2008, INT J CONSUM STUD, V32, P479, DOI 10.1111/j.1470-6431.2008.00714.x; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10, DOI 10.1080/00958964.1978.10801875; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Essoussi LH, 2010, J CONSUM MARK, V27, P458, DOI 10.1108/07363761011063358; Galitsky C, 2001, TECHNICAL Q, V28, P189; Grebitus C, 2013, ECOL ECON, V88, P67, DOI 10.1016/j.ecolecon.2013.01.006; Guyader H, 2017, J RETAIL CONSUM SERV, V34, P319, DOI 10.1016/j.jretconser.2016.07.008; Hansla A, 2011, ENERG EFFIC, V4, P185, DOI 10.1007/s12053-010-9096-0; Harrison J., 2016, MALT HOPS NEW DEMOGR; Hede AM, 2013, J MARKET MANAG-UK, V29, P207, DOI 10.1080/0267257X.2012.762422; Hoalst-Pullen N., 2014, GEOGRAPHY BEER, P109; Huff C, 2015, RES POLITICS, V2, DOI 10.1177/2053168015604648; Krupnikov Yanna., 2014, J EXP POLIT SCI, V1, P59, DOI DOI 10.1017/XPS.2014.7; Krystallis A, 2005, BRIT FOOD J, V107, P320, DOI 10.1108/00070700510596901; Laroche M, 2001, J CONSUM MARK, V18, P503, DOI 10.1108/EUM0000000006155; Levay K. E., 2016, SAGE OPEN, P1, DOI 10.1177/2158244016636433; Loomis JB, 2014, J AGR RESOUR ECON, V39, P34; Loureiro ML, 2005, ECOL ECON, V53, P129, DOI 10.1016/j.ecolecon.2004.11.002; Loureiro ML., 2002, J AGR APPL EC, V34, P477, DOI [DOI 10.1017/S1074070800009251, 10.1017/S1074070800009251]; Munksgaard J, 2000, ENERG ECON, V22, P423, DOI 10.1016/S0140-9883(99)00033-X; Muster-Slawitsch B, 2011, APPL THERM ENG, V31, P2123, DOI 10.1016/j.applthermaleng.2011.03.033; Nixon H, 2009, ENVIRON BEHAV, V41, P101, DOI 10.1177/0013916507310053; Olajire AA, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2012.03.003; ORIORDAN T, 1985, ENVIRON PLANN A, V17, P1431, DOI 10.1068/a171431; Peattie K, 2010, ANNU REV ENV RESOUR, V35, P195, DOI 10.1146/annurev-environ-032609-094328; Ropke I, 2009, ECOL ECON, V68, P2490, DOI 10.1016/j.ecolecon.2009.05.015; Royne MB, 2011, J CONSUM AFF, V45, P329, DOI 10.1111/j.1745-6606.2011.01205.x; SANNE C., 2002, ECOLOGICAL EC, P273; Sheehan Kim Bartel, 2016, AMAZONS MECH TURK AC; Shove Elizabeth, 2003, J CONSUM POLICY DORD, V26, P395, DOI [10.1023/A:1026362829781, 10.1023/a:1026362829781, DOI 10.1023/A:1026362829781]; Toro-Gonzalez D, 2014, J AGR RESOUR ECON, V39, P174; Van Loo EJ, 2015, ECOL ECON, V118, P215, DOI 10.1016/j.ecolecon.2015.07.011; Vlosky RP, 1999, J CONSUM MARK, V16, P122, DOI 10.1108/07363769910260498; Woolverton A. E., 2008, Journal of Food Distribution Research, V39, P50; Young W, 2010, SUSTAIN DEV, V18, P20, DOI 10.1002/sd.394	48	22	22	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204917	10.1371/journal.pone.0204917	http://dx.doi.org/10.1371/journal.pone.0204917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289903	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500027
J	Arepalli, S; Srivastava, SK; Hu, M; Kaiser, PM; Dukles, N; Reese, JL; Ehlers, JP				Arepalli, Sruthi; Srivastava, Sunil K.; Hu, Ming; Kaiser, Peter M.; Dukles, Neeley; Reese, Jamie L.; Ehlers, Justis P.			Assessment of inner and outer retinal layer metrics on the Cirrus HD-OCT Platform in normal eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; 2ND REFLECTIVE BAND; SPECTRAL-DOMAIN OCT; ELLIPSOID ZONE; MACULAR THICKNESS; AXIAL LENGTH; QUANTITATIVE-ANALYSIS; DISEASED RETINA; AGE	Purpose Ellipsoid zone (EZ) and outer retinal integrity are strongly linked to visual prognosis, but quantitative normative data is lacking. This study evaluates the EZ, outer retina, and inner retina in eyes without macular disease across a wide age spectrum. Methods An IRB-approved study was performed for eyes without macular pathology undergoing Spectral Domain Optical Coherence Tomography (SD-OCT) scans on the Cirrus HD-OCT system (Carl Zeiss Meditec, Oberkochen, Germany). Scans were analyzed using a previously described automated EZ mapping tool with line-by-line manual verification. Segmentation included internal limiting membrane (ILM), outer nuclear layer/Henle fiber layer complex (ONUHFL), EZ, and the retinal pigment epithelium (RPE). The output included metrics for the inner retina (ILM-OPUHFL), outer retina (ONUHFL-RPE), EZ-RPE area and volume, and en face EZ mapping. EZ-RPE attenuation on en face mapping was defined as EZ-RPE thickness < 20 um, and total attenuation was 0 um. Imaging parameters were assessed for the group and compared to age, sex, visual acuity and spherical equivalent. Results 167 eyes from 167 subjects were included. Mean age was 49.7 years (range 10-84 years). The mean foveal retinal thickness was 200.58 +/- 19.22 um. Mean inner retinal thickness was 21.47 +/- 13.60 um. Mean outer retinal thickness was 179.11 +/- 18.52 um. Mean EZ-RPE thickness was 50.58 +/- 6.01um. The mean EZ-RPE volume was 1.20 +/- 0.10 mm(3). Mean EZ attenuation percentage per macular map area was 0.87% +/- 1.13% and mean percentage total attenuation was 0.12% +/- 0.14%. Total and inner retinal thickness metrics decreased with age. Mean outer retinal thickness increased with age. EZ-RPE parameters were unchanged with age. However, EZ attenuation was negatively correlated with age. Conclusion This study provides important information for inner and outer retinal parameters. Future research on quantitative EZ integrity can utilize this data for comparison.	[Arepalli, Sruthi; Srivastava, Sunil K.; Hu, Ming; Dukles, Neeley; Reese, Jamie L.; Ehlers, Justis P.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Srivastava, Sunil K.; Hu, Ming; Kaiser, Peter M.; Dukles, Neeley; Reese, Jamie L.; Ehlers, Justis P.] Cleveland Clin, Tony & Leona Campane Ctr Excellence Image Guided, Cleveland, OH 44106 USA; [Hu, Ming] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ehlers, JP (corresponding author), Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.; Ehlers, JP (corresponding author), Cleveland Clin, Tony & Leona Campane Ctr Excellence Image Guided, Cleveland, OH 44106 USA.	ehlersj@ccf.org		Ehlers, Justis/0000-0001-6763-7768; Kaiser, Peter Murano/0000-0002-7814-4552; Srivastava, Sunil/0000-0002-0398-8806	Ohio Department of Development [TECH-13-059]; Research to Prevent Blindness (Cole Eye Institutional);  [NIH/NEI K23-EY022947-01A1]; NATIONAL EYE INSTITUTE [K23EY022947] Funding Source: NIH RePORTER	Ohio Department of Development; Research to Prevent Blindness (Cole Eye Institutional); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided through the following grant mechanisms: NIH/NEI K23-EY022947-01A1 (JPE); Ohio Department of Development TECH-13-059 (JPE); and Research to Prevent Blindness (Cole Eye Institutional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GW, 2013, LIST VIDEO CONTRIBUT, pxxiii; Arepalli S, 2017, ELLIPSOID ZONE MAPPI, DOI [10.1097/iae.0000000000001716, DOI 10.1097/IAE.0000000000001716]; Asefzadeh B, 2007, OPTOMETRY VISION SCI, V84, P941; Asrani S, 1999, OPHTHALMOLOGY, V106, P269, DOI 10.1016/S0161-6420(99)90057-X; Barthelmes D, 2006, INVEST OPHTH VIS SCI, V47, P1161, DOI 10.1167/iovs.05-0783; Birch DG, 2011, INVEST OPHTH VIS SCI, V52, P7141, DOI 10.1167/iovs.11-7509; Bressler NM, 2008, AM J OPHTHALMOL, V145, P894, DOI 10.1016/j.ajo.2007.12.025; Chang LK, 2008, RETINA-J RET VIT DIS, V28, P969, DOI 10.1097/IAE.0b013e3181744165; Channa R, 2012, J OPHTHALMIC INFLAMM, V2, P113, DOI 10.1007/s12348-011-0054-6; Chen J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28013-9; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Eriksson U, 2009, BRIT J OPHTHALMOL, V93, P1448, DOI 10.1136/bjo.2007.131094; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P9703, DOI 10.1167/iovs.11-8650; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P101, DOI 10.1167/iovs.10-5799; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang YJ, 2012, INVEST OPHTH VIS SCI, V53, P2133, DOI 10.1167/iovs.11-8755; Ikram MK, 2013, OPHTHALMOLOGICA, V229, P125, DOI 10.1159/000342158; Inoue M, 2009, GRAEF ARCH CLIN EXP, V247, P325, DOI 10.1007/s00417-008-0999-9; Itoh Y, 2016, RETINA-J RET VIT DIS, V36, P2290, DOI 10.1097/IAE.0000000000001110; Itoh Y, 2016, BRIT J OPHTHALMOL, V100, P295, DOI 10.1136/bjophthalmol-2015-307105; Itoh Y, 2012, AM J OPHTHALMOL, V153, P111, DOI 10.1016/j.ajo.2011.05.039; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P1791, DOI 10.1167/iovs.15-18529; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Kitaguchi Y, 2011, CLIN OPHTHALMOL, V5, P345, DOI 10.2147/OPTH.S17335; Lai WW, 2010, BRIT J OPHTHALMOL, V94, P311, DOI 10.1136/bjo.2009.163584; Lam DSC, 2007, INVEST OPHTH VIS SCI, V48, P376, DOI 10.1167/iovs.06-0426; Lazow MA, 2011, INVEST OPHTH VIS SCI, V52, P9581, DOI 10.1167/iovs.11-8554; Manassakorn A, 2008, JPN J OPHTHALMOL, V52, P450, DOI 10.1007/s10384-008-0538-6; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Massin P, 2002, EUR J OPHTHALMOL, V12, P102, DOI 10.1177/112067210201200205; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Runkle AP, 2017, INVEST OPHTH VIS SCI, V58, P3683, DOI 10.1167/iovs.16-20976; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Sundaram V, 2014, OPHTHALMOLOGY, V121, P234, DOI 10.1016/j.ophtha.2013.08.017; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Tao LW, 2016, CLIN EXP OPHTHALMOL, V44, P422, DOI 10.1111/ceo.12685; Tong KK, 2016, OPTOMETRY VISION SCI, V93, P714, DOI 10.1097/OPX.0000000000000861; Toprak I, 2017, INT OPHTHALMOL, V37, P801, DOI 10.1007/s10792-016-0331-3; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466; Wu ZC, 2013, OPHTHALMOLOGY, V120, P1307, DOI 10.1016/j.ophtha.2012.12.047; Wu ZC, 2013, INVEST OPHTH VIS SCI, V54, P2800, DOI 10.1167/iovs.13-11613; YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4	52	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203324	10.1371/journal.pone.0203324	http://dx.doi.org/10.1371/journal.pone.0203324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286099	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500008
J	Blank, M; Sjogren, KG; Knipper, C; Frei, KM; Stora, J				Blank, Malou; Sjogren, Karl-Goran; Knipper, Corina; Frei, Karin M.; Stora, Jan			Isotope values of the bioavailable strontium in inland southwestern Sweden-A baseline for mobility studies	PLOS ONE			English	Article							FUNNEL BEAKER CULTURE; ORIGIN ASSIGNMENT; SR-87/SR-86 RATIO; BRONZE-AGE; MIGRATION; ISLAND; ARCHAEOLOGY; WATERS; OLAND	The inland area of southwestern Sweden is well known for its well-preserved archaeological animal and human remains dating back to the Mesolithic and Neolithic (10000-4000 and 4000-1700 BC). They allow application of multiple bioarchaeological methods, giving insights into various and complementary aspects of prehistoric human life, as well as economic and social structures. One important aspect concerns human mobility and its relation to social networks and to circulation of objects. Here, strontium isotope analysis plays a crucial role. The present study aims to construct a strontium isotope baseline of southwestern Sweden with considerably greater coverage and higher resolution than previously published data. As the region has been affected by glacial events, the relation between bedrock geology and isotope signals of the bioavailable strontium in such areas is given special attention. We determined strontium isotope ratios for 61 water and five archaeological animal samples, and combined the data with previous measurements of two water and 21 non-domestic faunal samples. The results reveal a complex pattern. Several areas with distinct baseline ranges can be distinguished, although with overlaps between some of them. Overall, the bioavailable strontium isotope signals mirror the basement geology of the region. The highest ratios occur in the geologically oldest eastern parts of the Precambrian terrain, while lower ratios are found in the western part, and the lowest ratios occur in the youngest Paleozoic areas. At the same time, there are minor deviations compared to the underlying bedrock, due to glacial transport, overlying sediments, and local intrusions of younger rocks. The background data set now available allows for more nuanced and detailed interpretations of human and animal mobility in the region, in particular by identification of subregions with differing strontium isotope ratios within the Precambrian province. Also, we can now identify long distance mobility with greater confidence.	[Blank, Malou; Sjogren, Karl-Goran] Univ Gothenburg, Dept Hist Studies, Gothenburg, Sweden; [Knipper, Corina] Curt Engelhorn Ctr Archaeometry gGmbH, Mannheim, Germany; [Frei, Karin M.] Natl Museum Denmark, Environm Archaeol & Mat Sci, Brede, Denmark; [Stora, Jan] Stockholm Univ, Dept Archaeol & Class Studies, Stockholm, Sweden	University of Gothenburg; Stockholm University	Blank, M (corresponding author), Univ Gothenburg, Dept Hist Studies, Gothenburg, Sweden.	malou.blank.backlund@gu.se		Sjogren, Karl-Goran/0000-0003-1791-3175; Blank, Malou/0000-0002-0057-8756; Frei, Karin Margarita/0000-0001-5198-073X	Atlas of Ancient Human Genomes in Sweden; Swedish Research Council [VR 2013-1905]; Swedish Foundation for Humanities and Social Sciences [RJ M13-0904:1]	Atlas of Ancient Human Genomes in Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Humanities and Social Sciences	The analyses were financed by The Atlas of Ancient Human Genomes in Sweden, funded by The Swedish Research Council -VR 2013-1905, and The Swedish Foundation for Humanities and Social Sciences, RJ M13-0904:1.	ABERG F, 1987, NORD HYDROL, V18, P33; ABERG G, 1995, WATER AIR SOIL POLL, V79, P309, DOI 10.1007/BF01100444; Ahlberg P., 2013, RAPPORTER MEDDELANDE, P37; Ahlstrom T., 2009, UNDERJORDISKA DODSRI; Anderbjork JE, 1932, V STERG TLANDS FORNM, VIV, P5; Andersson J, 1999, PRECAMBRIAN RES, V98, P151, DOI 10.1016/S0301-9268(99)00048-0; Andersson M., 2014, GEOKEMISK ATLAS SVER; ANTHONY DW, 1990, AM ANTHROPOL, V92, P895, DOI 10.1525/aa.1990.92.4.02a00030; Arcini C, 2015, ENV SOC BLACK DEATH; Bataille CP, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00155.1; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bergerbrant S., 2017, NEW PERSPECTIVES BRO, P37, DOI [DOI 10.2307/J.CTV1PZK2C1.8, 10.2307/j.ctv1pzk2c1.8]; Blank M, MAKING JOURNEYS ARCH; Blank M, 2018, OPEN ARCHAEOL, V4, P1, DOI 10.1515/opar-2018-0001; Bronnimann D, 2018, J ARCHAEOL SCI-REP, V17, P279, DOI 10.1016/j.jasrep.2017.11.009; Burmeister S, 2000, CURR ANTHROPOL, V41, P539, DOI 10.1086/317383; Cassel Kerstin, 2000, CURR SWED ARCHAEOL, V8, P33; Copeland Sandi R., 2010, Journal of Taphonomy, V8, P115; Crowley BE, 2017, BIOL REV, V92, P43, DOI 10.1111/brv.12217; Cullberg Carl, 1963, MEGALITGRAVEN ROSSBE; Daggers Apel J., 2001, DAGGERS KNOWLEDGE PO; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; Eriksson G, 2018, J ARCHAEOL SCI-REP, V17, P904, DOI 10.1016/j.jasrep.2016.05.052; Evans JA, 2010, J GEOLOGICAL SOC LON, V167, P754; Faure G., 1986, PRINCIPLES ISOTOPE G, V2nd; Faure G., 2004, ISOTOPES PRINCIPLES; Flockhart DTT, 2015, ISOT ENVIRON HEALT S, V51, P372, DOI 10.1080/10256016.2015.1021345; Fornander E, 2015, BAR INT SERIES, V2, P183; Fraser M, 2018, J ARCHAEOL SCI-REP, V20, P324, DOI 10.1016/j.jasrep.2018.02.045; Fraser M, 2018, J ARCHAEOL SCI-REP, V17, P325, DOI 10.1016/j.jasrep.2017.09.002; Frei K., 2015, NATURE SCI REPORTS, V5, DOI [10.1038/srep10431, DOI 10.1038/SREP10431]; Frei K. M., 2009, FORNVANNEN, V104, P313; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; Frei KM, 2012, ARCHAEOL ANTHROP SCI, V4, P103, DOI 10.1007/s12520-011-0087-7; Frei KM, 2009, J ARCHAEOL SCI, V36, P1965, DOI 10.1016/j.jas.2009.05.007; Frei KM, 2014, OPEN J ARCHAEOM, V2, P5239, DOI [10.4081/arc.2014.5239, DOI 10.4081/ARC.2014.5239]; Frei R, 2013, APPL GEOCHEM, V38, P147, DOI 10.1016/j.apgeochem.2013.09.007; Gerling C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180164; Gillberg G., 1965, GEOL FOREN STOCK FOR, V86, P433; Glykou A, 2018, RAPID COMMUN MASS SP, DOI [10.1002/7cm.8158, DOI 10.1002/7CM.8158]; Grimstead DN, 2017, ADV ARCHAEOL PRACT, V5, P184, DOI 10.1017/aap.2017.6; Gron KJ, 2016, J ARCHAEOL SCI-REP, V6, P248, DOI 10.1016/j.jasrep.2016.02.015; Gron KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131267; Gustafsson MER, 2000, ATMOS ENVIRON, V34, P313, DOI 10.1016/S1352-2310(99)00198-3; HILLSON S, 1996, DENT ANTHR; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hodell DA, 2004, J ARCHAEOL SCI, V31, P585, DOI 10.1016/j.jas.2003.10.009; Kirkbride MP, 2002, MODERN PAST GLACIAL, P47; Klassen L, 2015, CONTACT FORSKNINGSPR, P132; Klassen L, E JUTLAND MUSEUM PUB, V5; Knipper C, 2012, MIGRATIONS PREHISTOR, P293; Knipper C., 2011, BAR INTERNATIONAL SE, V2305; Knipper C, 2017, P NATL ACAD SCI USA, V114, P10083, DOI 10.1073/pnas.1706355114; Knipper C, 2014, J ARCHAEOL SCI, V41, P818, DOI 10.1016/j.jas.2013.09.019; Kootker LM, 2016, J ARCHAEOL SCI-REP, V6, P1, DOI 10.1016/j.jasrep.2016.01.015; Larsson SA., 2015, SVERIGES BERGGRUND G; Lewis J, 2017, SCI TECHNOL ARCHAEOL, V3, P45, DOI 10.1080/20548923.2017.1303124; Lewis J, 2014, CHEM GEOL, V390, P173, DOI 10.1016/j.chemgeo.2014.10.021; Lindstrom J., 2009, BRONSALDERSMORDET AR; Lindstrom M., 2000, Sveriges geologi fran urtid till nutid, V2nd; Loberg B., 1999, GEOLOGI MAT PROCESSE, V6; LOFVENDAHL R, 1990, AQUAT SCI, V52, P315, DOI 10.1007/BF00879760; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; Menzies J.M., 2013, TREATISE GEOMORPHOLO, V8, P127; Montgomery J, 2006, APPL GEOCHEM, V21, P1626, DOI 10.1016/j.apgeochem.2006.07.002; Montgomery J., 2014, J N ATLANTIC SPECIAL, V7, P54, DOI [10.3721/037.002.sp705, DOI 10.3721/037.002.SP705]; Montgomery J., 2006, SOCIAL ARCHAEOLOGY F, P122; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Muller-Sohnius D., 2007, GEOLOGICA BAVARICA, V110, P1; Naumann E, 2014, AM J PHYS ANTHROPOL, V155, P322, DOI 10.1002/ajpa.22551; Oelze VM, 2012, ARCHAEOMETRY, V54, P752, DOI 10.1111/j.1475-4754.2011.00644.x; Passe T, 2016, BESKRIVNINGAR JORDAR, P534; Persson P, 2001, ARKEOLOGISKA SKRIFTE, V34; Peschel EM, 2017, J ARCHAEOL SCI-REP, V13, P175, DOI 10.1016/j.jasrep.2017.03.049; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Poszwa A, 2004, BIOGEOCHEMISTRY, V67, P1, DOI 10.1023/B:BIOG.0000015162.12857.3e; Price T.D., 2004, EUR J ARCHAEOL, V7, P9, DOI [DOI 10.1177/1461957104047992, 10.1177/1461957104047992]; Price TD, 2018, J ANTHROPOL ARCHAEOL, V49, P19, DOI 10.1016/j.jaa.2017.10.002; Price TD, 2017, J ARCHAEOL SCI, V80, P1, DOI 10.1016/j.jas.2017.01.013; Price TD, 2011, ANTIQUITY, V85, P476, DOI 10.1017/S0003598X00067880; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Price TD, 2015, J N ATLANTIC, V7, P103; Price TD, 2013, STUDIES UPPAKRA IRON, P157; Rauch E, 2007, FORENSIC SCI INT, V168, P215, DOI 10.1016/j.forsciint.2006.02.011; Retzius G., 1899, CRANIA SUECICA ANTIG; Rossmann A, 2000, EUR FOOD RES TECHNOL, V211, P32, DOI 10.1007/s002170050585; SEALY J, 1995, ANTIQUITY, V69, P290, DOI 10.1017/S0003598X00064693; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Sjogren KG, 2013, J ARCHAEOL SCI, V40, P690, DOI 10.1016/j.jas.2012.08.001; Sjogren K. G, 2015, NEOLITHIC DIVERSITIE, P200; Sjogren K-G, 2003, GOT B; Sjogren K-G, 2008, 200823 VAST MUS, P23; Sjogren KG, 2009, J ANTHROPOL ARCHAEOL, V28, P85, DOI 10.1016/j.jaa.2008.10.001; Tilly C., 1978, HUMAN MIGRATION PATT, P48; Tipple BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21359-0; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; Vretemark M., 2014, MEDELTIDA STORGARDAR, P131; Whiteman MP, 2002, MODERN PAST GLACIAL, P171; WICKMAN FE, 1987, NORD HYDROL, V18, P21; Wilhelmson H, 2017, J ARCHAEOL SCI-REP, V12, P183, DOI 10.1016/j.jasrep.2017.01.031; Wilhelmson H, 2015, J ARCHAEOL SCI, V64, P30, DOI 10.1016/j.jas.2015.09.007; Willmes M, 2014, EARTH SYST SCI DATA, V6, P117, DOI 10.5194/essd-6-117-2014	103	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204649	10.1371/journal.pone.0204649	http://dx.doi.org/10.1371/journal.pone.0204649			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286158	Green Submitted, gold, Green Published			2022-12-27	WOS:000446383500031
J	Blazej, P; Wnetrzak, M; Mackiewicz, D; Mackiewicz, P				Blazej, Pawel; Wnetrzak, Malgorzata; Mackiewicz, Dorota; Mackiewicz, Pawel			Correction: Optimization of the standard genetic code according to three codon positions using an evolutionary algorithm (Vol 13, e0201715, 2018)	PLOS ONE			English	Correction													Mackiewicz, Dorota/AAJ-8963-2020	Mackiewicz, Dorota/0000-0001-8922-8615; Wnetrzak, Malgorzata/0000-0003-3102-6863				Blazej P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201715; WNETRZAK BP, 2018, PLOS ONE, V13, DOI DOI 10.1371/J0URNAL.PONE.0201715	2	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205450	10.1371/journal.pone.0205450	http://dx.doi.org/10.1371/journal.pone.0205450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286199	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500106
J	Ersino, G; Zello, GA; Henry, CJ; Regassa, N				Ersino, Getahun; Zello, Gordon A.; Henry, Carol J.; Regassa, Nigatu			Gender and household structure factors associated with maternal and child undernutrition in rural communities in Ethiopia	PLOS ONE			English	Article							LOW-INCOME; HEALTH; GROWTH; PREGNANCY; OUTCOMES; WEIGHT; SIDAMA	Addressing maternal and child undernutrition is a priority for the National Nutrition Program of Ethiopia. In a cross-sectional design, we selected mother-child pairs (n = 630) from Halaba, south Ethiopia (n = 413, two communities) and Zeway, Oromiya region (n = 217, one community). These communities were previously included in a project to improve agricultural practices. We aimed to estimate the level of maternal and child undernutrition in the two study sites and compare findings to regional/national reports. We also examined associations with gender, household-structure and nutrition/health related variables. Households were selected using simple random sampling based on list of households obtained from local health posts. Mothers were interviewed via questionnaire. Anthropometric measurements were taken from mothers-child pairs. Maternal undernutrition (% BMI<18.5) ranged from moderate (14% Zeway) to high (22% Halaba). In the children, stunting and underweight were very high (54% and 42% stunting, 36% and 21% underweight, in Halaba and Zeway, respectively). Up to 95% of Halaba and 85% of Zeway mothers reported "same as usual" or "less than usual" consumption patterns during their most recent pregnancy compared to periods of non-pregnancy. Mothers reported (61% in Halaba, 18% in Zeway) abstaining from consumption of certain nutritious foods for cultural reasons. Gender and socio-economic-demographic structure of the households, including imbalance of power, control of farm produce, physiological density, household size and dietary habits during pregnancy showed significant associations with maternal and child undernutrition (p<0.05). The levels of child and maternal undernutrition, particularly in children, were unexpected and of concern, given that a national nutrition program has been in place since 2008. The study provides insights for policy makers to improve women's education, reproductive health services for better family planning, and strengthen nutrition/health programs designed to target vulnerable segments of the population in these and other rural communities and districts with similar structure and demographics in Ethiopia.	[Ersino, Getahun; Zello, Gordon A.; Henry, Carol J.; Regassa, Nigatu] Univ Saskatchewan, Coll Pharm & Nutr, Nutr & Dietet, Saskatoon, SK, Canada; [Ersino, Getahun] Hawassa Univ, Sch Nutr Food Sci & Technol, Hawassa, Snnpr, Ethiopia	University of Saskatchewan; Hawassa University	Zello, GA (corresponding author), Univ Saskatchewan, Coll Pharm & Nutr, Nutr & Dietet, Saskatoon, SK, Canada.	gordon.zello@usask.ca		Ersino, Getahun/0000-0002-7341-0030	International Development Research Centre (IDRC); Global Affairs Canada, Government of Canada, through the Canadian International Food Security Research Fund (CIFSRF)	International Development Research Centre (IDRC); Global Affairs Canada, Government of Canada, through the Canadian International Food Security Research Fund (CIFSRF)	The research was supported by the International Development Research Centre (IDRC) and Global Affairs Canada (formerly the Department of Foreign Affairs Trade and Development), Government of Canada, through the Canadian International Food Security Research Fund (CIFSRF), https://www.idrc.ca/en. The funders had no role in the design, analysis or writing of this article.	African Union Commission Nepad Planning and Coordinating Agency Un Economic Commission for Africa Un World Food Programme., 2014, COST HUNG AFR SOC EC; [Anonymous], 2012, UG DEM HLTH SURV 201; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black MM, 2006, NUTR COGN CHILDR UN; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Central Statistical Agency, 2006, ETH DEM HLTH SURV; Central Statistical Agency [Ethiopia], 2014, ETH MIN DEM HLTH SUR; Central Statistical Agency [Ethiopia] ICF, 2016, ETH DEM HLTH SURV 20; Central Statistics Agency (CSA) [Ethiopia] and ORC Macro, 2001, ETH DEM HLTH SURV 20; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; CSA IJAA, 2012, ETH DEM HLTH SURV 20, P430; Dekker M., 2006, ETHIOP J EC, V15, P35; Ethiopia Federal MoH, 2008, PROGR IMPL MAN NAT N; Ethiopian Health Nutrition Research Institute (EHNRI), 2010, NUTR BAS SURV REP NA; FDRE, 2013, NAT NUTR PROGR JUN 2, P45; Gibson R.S, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2009, MATERN CHILD NUTR, V5, P260, DOI 10.1111/j.1740-8709.2008.00179.x; Godfrey K M, 2001, Public Health Nutr, V4, P611; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Groot W., 2002, J HAPPINESS STUD, V3, P153, DOI [DOI 10.1023/A:1019673927286, 10.1023/A:1019673927286]; Guha-Khasnobis B, WOMENS STATUS CHILDR; Hawassa University University of Saskatchewan, 2013, IMPR FOOD SEC HIGHL; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Karlberg J, 1989, Acta Paediatr Scand Suppl, V350, P70; Kebebu A., 2013, African Journal of Food, Agriculture, Nutrition and Development, V13, P7789; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, NAT COUNC POP DEV KE; Kind KL, 2006, REPROD BIOMED ONLINE, V12, P532, DOI 10.1016/S1472-6483(10)61178-9; Kramer M S, 2003, Cochrane Database Syst Rev, pCD000032; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Matanda DJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-5; Miese-Looy G, 2008, STUDIES UNDERGRADUAT, V1; Ministry of Finance and Economic Development, 2010, GROWTH TRANSF PLAN 2, VII, P38; MOSER CON, 1989, WORLD DEV, V17, P1799, DOI 10.1016/0305-750X(89)90201-5; Negash C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142301; Ota E, 2011, B WORLD HEALTH ORGAN, V89, P127, DOI 10.2471/BLT.10.077982; Regassa N, 2012, J BIOSOC SCI, V44, P537, DOI 10.1017/S002193201200017X; Regassa N, 2012, PUBLIC HEALTH NUTR, V15, P1276, DOI 10.1017/S1368980011003119; Roba AC, 2015, ECOL FOOD NUTR, V54, P240, DOI 10.1080/03670244.2014.974593; Teshome G, 2013, AM J EC, V3, P191; Tessema M, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.75.1630; TSE WY, 1989, ACTA PAEDIATR SCAND, P38; United Nations, 2016, SUSTAINABLE DEV GOAL; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; WHO Expert Committee on Physical Status, 1995, PHYS STAT UINT ANT; WHO UNICEF, 2010, PROGR SAN DRINK WAT	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203914	10.1371/journal.pone.0203914	http://dx.doi.org/10.1371/journal.pone.0203914			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286090	Green Submitted, gold, Green Published			2022-12-27	WOS:000446383500012
J	Hege, I; Kononowicz, AA; Kiesewetter, J; Foster-Johnson, L				Hege, Inga; Kononowicz, Andrzej A.; Kiesewetter, Jan; Foster-Johnson, Lynn			Uncovering the relation between clinical reasoning and diagnostic accuracy - An analysis of learner's clinical reasoning processes in virtual patients	PLOS ONE			English	Article							INTEGRATION STRATEGIES; MEDICAL-EDUCATION; REPRESENTATION; STUDENTS; SUPPORT; IMPROVE; FUTURE; ERROR; NEEDS	Background Clinical reasoning is an important topic in healthcare training, assessment, and research. Virtual patients (VPs) are a safe environment to teach, assess and perform research on clinical reasoning and diagnostic accuracy. Our aim was to explore the details of the clinical reasoning process and diagnostic accuracy of undergraduate medical students when working with VPs using a concept mapping tool. Methods Over seven months we provided access to 67 German and 30 English VPs combined with a concept mapping tool to visualize and measure the clinical reasoning process of identifying problems, differential diagnoses, recommended tests and treatment options, and composing a summary statement about a VP. A final diagnosis had to be submitted by the learners in order to conclude the VP scenario. Learners were allowed multiple attempts or could request the correct diagnosis from the system. Results We analyzed 1,393 completed concept maps from 317 learners. We found significant differences between maps with a correct final diagnosis on one or multiple attempts and maps in which learners gave up and requested the solution from the system. These maps had lower scores, fewer summary statements, and fewer problems, differential diagnoses, tests, and treatments. Conclusions The different use patterns and scores between learners who had the correct final diagnosis on one or multiple attempts and those who gave up, indicate that diagnostic accuracy in the form of a correct final diagnosis on the first attempt has to be reconsidered as a sole indicator for clinical reasoning competency. For the training, assessment, and research of clinical reasoning we suggest focusing more on the details of the process to reach a correct diagnosis, rather than whether it was made in the first attempt.	[Hege, Inga; Kiesewetter, Jan] Univ Hosp LMU Munich, Inst Med Educ, Munich, Germany; [Hege, Inga] Univ Augsburg, Sch Med, Augsburg, Germany; [Kononowicz, Andrzej A.] Jagiellonian Univ, Coll Med, Dept Bioinformat & Telemed, Krakow, Poland; [Foster-Johnson, Lynn] Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA	University of Munich; University of Augsburg; Jagiellonian University; Collegium Medicum Jagiellonian University; Dartmouth College	Hege, I (corresponding author), Univ Hosp LMU Munich, Inst Med Educ, Munich, Germany.; Hege, I (corresponding author), Univ Augsburg, Sch Med, Augsburg, Germany.	inga.hege@med.uni-muenchen.de	Kiesewetter, Jan/AFQ-5216-2022; Kononowicz, Andrzej/ABG-8696-2020	Kiesewetter, Jan/0000-0001-8165-402X; Kononowicz, Andrzej/0000-0003-2956-2093; Hege, Inga/0000-0003-4335-5162	European Union [654857]; Jagiellonian University [K/ZDS/006367]	European Union(European Commission); Jagiellonian University	The project receives funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 654857 to IH and from internal funds at Jagiellonian University No. K/ZDS/006367 to AAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman N, 2009, ACAD MED, V84, P942, DOI 10.1097/ACM.0b013e3181a8c668; Berman NB, 2016, ACAD MED, V91, P1217, DOI 10.1097/ACM.0000000000001146; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Bordage G, 1997, ACAD MED, V72, pS37, DOI 10.1097/00001888-199710001-00013; Bordage G, 2007, MED EDUC, V41, P1117, DOI 10.1111/j.1365-2923.2007.02919.x; Braun LT, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1044-7; Braun LT, 2017, MED EDUC, V51, P1118, DOI 10.1111/medu.13355; Charlin B, 2012, MED EDUC, V46, P454, DOI 10.1111/j.1365-2923.2012.04242.x; Connell KJ, 1998, ASSESSING CLIN QUALI; Cook DA, 2010, ACAD MED, V85, P1589, DOI 10.1097/ACM.0b013e3181edfe13; Cook DA, 2009, MED EDUC, V43, P303, DOI 10.1111/j.1365-2923.2008.03286.x; Durning SJ, 2015, J CONTIN EDUC HEALTH, V35, P232, DOI 10.1002/chp.21298; Durning SJ, 2013, ACAD MED, V88, P442, DOI [10.1097/ACM.0b013e3182851b5b, 10.1097/ACM.0b013e3182953763]; Ellaway RH, 2009, MED TEACH, V31, P683, DOI 10.1080/01421590903124765; Eva KW, 2005, MED EDUC, V39, P98, DOI 10.1111/j.1365-2929.2004.01972.x; Friedman CP, 2005, J GEN INTERN MED, V20, P334, DOI 10.1111/j.1525-1497.2005.30145.x; Hege I, 2018, GMS J MED ED, V15; Hege Inga, 2017, JMIR Med Educ, V3, pe21, DOI 10.2196/mededu.8100; Hege I, 2007, MED TEACH, V29, P791, DOI 10.1080/01421590701589193; Kiesewetter J, 2014, MED TEACH, V36, P505, DOI 10.3109/0142159X.2014.891008; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Linsen A, 2018, HLTH PROFESSIONS ED, V4, P86, DOI [10.1016/j.hpe.2017.03.003, DOI 10.1016/J.HPE.2017.03.003]; Posel N, 2015, MED TEACH, V37, P813, DOI 10.3109/0142159X.2014.993951; Schmidt HG, 2015, MED EDUC, V49, P961, DOI 10.1111/medu.12775; Smith S, 2016, ACAD MED, V91, P94, DOI 10.1097/ACM.0000000000000800	25	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204900	10.1371/journal.pone.0204900	http://dx.doi.org/10.1371/journal.pone.0204900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286136	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500060
J	Gagliardi, KB; Cordeiro, I; Demarco, D				Gagliardi, Karina Bertechine; Cordeiro, Ines; Demarco, Diego			Structure and development of flowers and inflorescences in Peraceae and Euphorbiaceae and the evolution of pseudanthia in Malpighiales	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC ANALYSIS; NUCLEAR-DNA SEQUENCES; DALECHAMPIA EUPHORBIACEAE; SYSTEMATICS; EMBRYOLOGY; MORPHOLOGY; SYNOPSIS; CYATHIUM	Pseudanthia are reduced and compact inflorescences which apparently had independent evolution in Euphorbiaceae and Peraceae within Malpighiales. In order to analyze the hypothesis that the different pseudanthia found in Malpighiales have non-homologous developmental steps, we studied the inflorescence and flower development in the three Malpighiales genera that present this type of inflorescence-Dalechampia (Acalyphoideae/Euphorbiaceae), Euphorbia (Euphorbioideae/Euphorbiaceae), and Pera (Peraceae)-and compared them to that of Joannesia (Crotonoideae/Euphorbiaceae), which does not present a pseudanthium. Inflorescences and flowers were analyzed using light microscopy and scanning electron microscopy. Dalechampia and Euphorbia have protogynic bisexual pseudanthia, with unisexual perianthed flowers in Dalechampia, and achlamydeous flowers in Euphorbia. Pera has unisexual pseudanthia and the male flowers have a vestigial calyx and the female flowers are achlamydeous. Joannesia flowers are very distinct when compared to the pseudanthia flowers, as they are composed of all the whorls and there is no reduction. In the early stages of development, the first structures to be formed in the pseudanthia are the different series of bracts, including outer, involucral and involucel bracts. The floral primordia are initiated almost simultaneously with the involucre. Although the different morphology, the early inflorescence followed the same branching pattern in all studied genera, and the number and elongation of the branches were affected by the early female flower development in the terminal position. We suggest that the different pseudanthia evolved via process of floral whorl reduction and reorganization of flowers in the inflorescence axes, especially the position of female and male flowers and elongation or shortening of the branches. The sex of the terminal flower is a developmental key, i.e., the protogynic development deeply affects the pseudanthia growth, reducing the ramification and elongation of the axes.	[Gagliardi, Karina Bertechine; Demarco, Diego] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Cordeiro, Ines] Inst Bot, Nucleo Pesquisa Curadoria Herbario, Ctr Pesquisa Plantes Vasc, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto de Botanica - Sao Paulo	Gagliardi, KB (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	kabertechine3@usp.br	Cordeiro, Ines/C-9556-2012; Demarco, Diego/C-6122-2012	Cordeiro, Ines/0000-0002-2626-5280; Demarco, Diego/0000-0002-8244-2608	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/09755-1, 2017/23882-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305633/2015-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), #2012/09755-1 (to KBG) and #2017/23882-0 (to DD), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (to KBG), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), #305633/2015-5 (to DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMBRUSTER WS, 1979, BIOTROPICA, V11, P278, DOI 10.2307/2387919; ARMBRUSTER WS, 1988, SYST BOT, V13, P303, DOI 10.2307/2419294; Bigio Narcísio Costa, 2010, Rodriguésia, V61, P77, DOI 10.1590/2175-7860201061107; Bigio Narcisio Costa, 2012, Rodriguésia, V63, P163; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cacho NI, 2010, AM J BOT, V97, P493, DOI 10.3732/ajb.0900090; CLASSENBOCKHOFF R, 1990, PLANT SYST EVOL, V171, P57, DOI 10.1007/BF00940596; Croizat L, 1937, B TORREY BOT CLUB, V64, P523; Davis CC, 2008, CURR OPIN PLANT BIOL, V11, P49, DOI 10.1016/j.pbi.2007.11.003; Davis CC, 2007, SCIENCE, V315, P1812, DOI 10.1126/science.1135260; de Freitas JR, 2011, REV ARVORE, V35, P1227, DOI 10.1590/S0100-67622011000700009; Souza Luiz Antonio de, 2010, Acta Bot. Venez., V33, P103; Endress PK, 2013, ANN BOT-LONDON, V111, P969, DOI 10.1093/aob/mct056; Froebe Hans A., 1993, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V115, P27; Gagliardi KB, 2016, FLORA, V220, P52, DOI 10.1016/j.flora.2016.02.003; Gagliardi KB, 2014, PLANT SYST EVOL, V300, P775, DOI 10.1007/s00606-013-0918-3; Gagliardi KB, 2012, ACTA BOT BRAS, V26, P38, DOI 10.1590/S0102-33062012000100005; Gerlach D., 1984, BOT MIKROTECHNIK EIN, V3rd; JOHANSEN DONALD ALEXANDER, 1940; Judd W.S., 2002, PLANT SYSTEMATICS PH, V2nd ed., P55; LILLIE R. D., 1954; Narbona E, 2008, ANN BOT-LONDON, V101, P717, DOI 10.1093/aob/mcn011; Pax F, 1931, Die naturlichen Pflanzenfamilien, V19c, P11; Prenner G, 2008, AUST SYST BOT, V21, P153, DOI 10.1071/SB08010; Prenner G, 2007, AM J BOT, V94, P1612, DOI 10.3732/ajb.94.10.1612; Prenner G, 2011, J EXP BOT, V62, P345, DOI 10.1093/jxb/erq275; Ronse De Craene LP., 2010, FLORAL DIAGRAMS; SAZIMA M, 1985, Revista Brasileira de Biologia, V45, P85; Silveira M, 1989, MANUAL TECNICAS BASI, V1; SOUZA L. A., 2003, MORFOLOGIA ANATOMIA; Steinmann VW, 2002, ANN MO BOT GARD, V89, P453, DOI 10.2307/3298591; Sutter Doris, 1995, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V116, P517; TOKUOKA T, 1995, J PLANT RES, V108, P97, DOI 10.1007/BF02344312; Tokuoka T, 2007, J PLANT RES, V120, P511, DOI 10.1007/s10265-007-0090-3; Tokuoka T, 2006, J PLANT RES, V119, P599, DOI 10.1007/s10265-006-0025-4; Weberling F., 1989, Morphology of flowers and inflorescences.; WEBSTER G L, 1991, Annals of the Missouri Botanical Garden, V78, P255, DOI 10.2307/2399610; WEBSTER GL, 1994, ANN MO BOT GARD, V81, P33, DOI 10.2307/2399909; WEBSTER GL, 1972, AM J BOT, V59, P573, DOI 10.2307/2441021; WEBSTER GL, 1989, BRITTONIA, V41, P1, DOI 10.2307/2807580; Wurdack KJ, 2009, AM J BOT, V96, P1551, DOI 10.3732/ajb.0800207; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397	42	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203954	10.1371/journal.pone.0203954	http://dx.doi.org/10.1371/journal.pone.0203954			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281673	Green Submitted, gold, Green Published			2022-12-27	WOS:000446342400035
J	De la Casa, LG; Carcel, L; Ruiz-Salas, JC; Vicente, L; Mena, A				Gonzalo De la Casa, Luis; Carcel, Lucia; Carlos Ruiz-Salas, Juan; Vicente, Lucia; Mena, Auxiliadora			Conditioned increase of locomotor activity induced by haloperidol	PLOS ONE			English	Article							UNCONDITIONED STIMULUS; DOPAMINERGIC ACTIVITY; AMPHETAMINE; APOMORPHINE; BEHAVIOR; RATS; CATALEPSY; MORPHINE; SENSITIZATION; ACQUISITION	Dopamine antagonist drugs have profound effects on locomotor activity. In particular, the administration of the D2 antagonist haloperidol produces a state that is similar to catalepsy. In order to confirm whether the modulation of the dopaminergic activity produced by haloperidol can act as an unconditioned stimulus, we carried out two experiments in which the administration of haloperidol was repeatedly paired with the presence of distinctive contextual cues that served as a Conditioned Stimulus. Paradoxically, the results revealed a dose-dependent increase in locomotor activity following conditioning with dopamine antagonist (Experiments 1) that was susceptible of extinction when the conditioned stimulus was presented repeatedly by itself after conditioning (Experiment 2). These data are interpreted from an associative perspective, considering them as a result of a classical conditioning process.	[Gonzalo De la Casa, Luis; Carcel, Lucia; Carlos Ruiz-Salas, Juan; Vicente, Lucia; Mena, Auxiliadora] Univ Seville, Dept Expt Psychol, Seville, Spain	University of Sevilla	De la Casa, LG (corresponding author), Univ Seville, Dept Expt Psychol, Seville, Spain.	delacasa@us.es	De la Casa, Luis/E-7128-2010; VICENTE, LIERN/B-6112-2008	De la Casa, Luis/0000-0001-5199-5851; VICENTE, LIERN/0000-0001-5883-9640; RUIZ-SALAS, JUAN CARLOS/0000-0002-4862-2939; Vicente, Lucia/0000-0003-2769-5028	MINECO, FEDER, UE [PSI2015-64965-P]	MINECO, FEDER, UE	This research was supported by PSI2015-64965-P grant (MINECO, FEDER, UE).	Ahmed SH, 1996, PSYCHOPHARMACOLOGY, V123, P325, DOI 10.1007/BF02246642; Ahmed SH, 1998, BEHAV NEUROSCI, V112, P1167; Amtage J, 2003, BEHAV PHARMACOL, V14, P563, DOI 10.1097/00008877-200311000-00009; Banasikowski TJ, 2012, INT J NEUROPSYCHOPH, V15, P1525, DOI 10.1017/S1461145711001696; BARR GA, 1983, LIFE SCI, V33, P1341, DOI 10.1016/0024-3205(83)90817-2; Battisti JJ, 2000, PHARMACOL BIOCHEM BE, V66, P671, DOI 10.1016/S0091-3057(00)00214-8; BENINGER RJ, 1983, SCIENCE, V220, P1304, DOI 10.1126/science.6857251; Bouton ME, 2007, LEARNING BEHAV CONT, V19; Brudzynski SM, 1997, PHYSIOL BEHAV, V62, P635, DOI 10.1016/S0031-9384(97)00189-3; Carey RJ, 2008, PROG BRAIN RES, V172, P347, DOI 10.1016/S0079-6123(08)00917-5; Carrera MP, 2012, PSYCHOPHARMACOLOGY, V220, P281, DOI 10.1007/s00213-011-2474-2; Dias FRC, 2012, BEHAV BRAIN RES, V229, P153, DOI 10.1016/j.bbr.2011.12.042; Dias FRC, 2010, PSYCHOPHARMACOLOGY, V209, P137, DOI 10.1007/s00213-009-1768-0; Damianopoulos E N, 1992, Rev Neurosci, V3, P65, DOI 10.1515/REVNEURO.1992.3.1.65; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; DICKINSON A, 1978, ANNU REV PSYCHOL, V29, P587, DOI 10.1146/annurev.ps.29.020178.003103; EIKELBOOM R, 1981, PSYCHOPHARMACOLOGY, V75, P96, DOI 10.1007/BF00433511; EIKELBOOM R, 1982, PSYCHOL REV, V89, P507, DOI 10.1037/0033-295X.89.5.507; EIKELBOOM R, 1979, PSYCHOPHARMACOLOGY, V61, P31, DOI 10.1007/BF00426807; ELIAS JW, 1983, PHYSIOL BEHAV, V31, P639; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; FUREDY JJ, 1976, BIOL PSYCHOL, V4, P93, DOI 10.1016/0301-0511(76)90010-7; GEYER MA, 1987, PHARMACOL BIOCHEM BE, V28, P393, DOI 10.1016/0091-3057(87)90460-6; GOLD LH, 1988, BEHAV NEUROSCI, V102, P544, DOI 10.1037/0735-7044.102.4.544; Hilgard ER, 1936, PSYCHOL REV, V43, P366, DOI 10.1037/h0058976; KUSCHINSKY K, 1972, EUR J PHARMACOL, V19, P119, DOI 10.1016/0014-2999(72)90086-6; LIDSKY TI, 1993, J PHARMACOL EXP THER, V265, P1193; MartinIverson MT, 1996, BEHAV PHARMACOL, V7, P24; Mena A, 2013, BEHAV BRAIN RES, V252, P188, DOI 10.1016/j.bbr.2013.06.005; MIKSIC S, 1975, Neuropsychobiology, V1, P277, DOI 10.1159/000117501; MOREIRA LFD, 1982, PHARMACOLOGY, V25, P1; Pavlov IP, 2010, ANN NEUROSCI, V17, P136, DOI 10.5214/ans.0972-7531.1017309; PICKENS RW, 1967, PSYCHOPHARMACOLOGIA, V11, P88, DOI 10.1007/BF00401511; POULOS CX, 1982, SCIENCE, V218, P491, DOI 10.1126/science.6889765; Santos BG, 2017, PHARMACOL BIOCHEM BE, V156, P24, DOI 10.1016/j.pbb.2017.04.002; Santos BG, 2015, PHARMACOL BIOCHEM BE, V129, P79, DOI 10.1016/j.pbb.2014.12.003; SCHIFF SR, 1982, BIOL PSYCHIAT, V17, P135; Schmidt WJ, 2006, NEUROTOX RES, V10, P161, DOI 10.1007/BF03033244; SIEGEL S, 1977, J EXP PSYCHOL ANIM B, V3, P1, DOI 10.1037/0097-7403.3.1.1; Siegel S., 1979, PSYCHOPATHOL ANIM RE, P498; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; TILSON HA, 1973, PHARM BIO B, V1, P149; WIKLER A, 1967, PSYCHOPHARMACOLOGIA, V10, P255, DOI 10.1007/BF00401386	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0200178	10.1371/journal.pone.0200178	http://dx.doi.org/10.1371/journal.pone.0200178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281607	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400005
J	Jena, B; Kumar, A; Ravichandran, M; Kern, S				Jena, Babula; Kumar, Avinash; Ravichandran, M.; Kern, Stefan			Mechanism of sea-ice expansion in the Indian Ocean sector of Antarctica: Insights from satellite observation and model reanalysis	PLOS ONE			English	Article							SOUTHERN-OCEAN; ANNULAR MODE; OZONE HOLE; VARIABILITY; TRENDS; TEMPERATURE; ATMOSPHERE; SALINITY; DRIVEN; COVER	In the backdrop of global warming, Antarctic sea-ice variability showed an overall expansion with the regional heterogeneity of increasing and decreasing patterns. Analysis of satellite derived sea-ice extent, during 1979 to 2015, in the Indian Ocean sector of Antarctica (IOA) revealed expansion of 2.4 +/- 1.2% decade(-1). We find strengthening of westerly wind during the austral summer (between 50 degrees S to 62 degrees S) facilitated northward advection of a cool and fresh layer. Also, the strong westerly wind cools the upper ocean due to net heat loss from the ocean surface. The combined effect of northward advection of cold fresh layer and net heat loss from the surface, favours sea-ice expansion in the subsequent seasons, in the IOA region, north of 62 degrees S. However, sea-ice retreat was observed near the Kerguelen Plateau, due to upper ocean warming, and hence a non-annular pattern of sea-ice extent in the IOA was observed.	[Jena, Babula; Kumar, Avinash; Ravichandran, M.] Govt India, Minist Earth Sci, ESSO Natl Ctr Antarctic & Ocean Res, Vasco Da Gama, India; [Kern, Stefan] Univ Hamburg, Ctr Earth Syst Res & Sustainabil, Integrated Climate Data Ctr, Hamburg, Germany	Ministry of Earth Sciences (MoES) - India; National Centre for Polar and Ocean Research (NCPOR); University of Hamburg	Jena, B (corresponding author), Govt India, Minist Earth Sci, ESSO Natl Ctr Antarctic & Ocean Res, Vasco Da Gama, India.	bjena@ncaor.gov.in	Ravichandran, M./AAM-1351-2020	Kern, Stefan/0000-0001-7281-3746; Avinash, Kumar/0000-0002-6511-8435				Balmaseda MA, 2008, MON WEATHER REV, V136, P3018, DOI 10.1175/2008MWR2433.1; Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Bell RE, 2017, NATURE, V544, P344, DOI 10.1038/nature22048; Bintanja R, 2013, NAT GEOSCI, V6, P376, DOI [10.1038/NGEO1767, 10.1038/ngeo1767]; Bitz CM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053393; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053316; Comiso JC, 2017, J CLIMATE, V30, P2251, DOI [10.1175/JCLI-D-16-0408.1, 10.1175/jcli-d-16-0408.1]; Deb P, 2017, INT J CLIMATOL, V37, P648, DOI 10.1002/joc.4730; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; England MH, 2008, T ROYAL SOC VICTORIA, V120, pi; Ferreira D, 2015, J CLIMATE, V28, P1206, DOI 10.1175/JCLI-D-14-00313.1; Good SA, 2013, J GEOPHYS RES-OCEANS, V118, P6704, DOI 10.1002/2013JC009067; Goosse H, 2009, CLIM DYNAM, V33, P999, DOI 10.1007/s00382-008-0500-9; Groh A, 2016, EGU GEN ASS C; Haumann FA, 2016, NATURE, V537, P89, DOI 10.1038/nature19101; Hellmer HH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019506; Helm KP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044222; Hendricks S, 2018, SEA ICE CLIMATE CHAN, DOI [10.5285/b1f1ac03077b4aa784c5a413a2210bf5, DOI 10.5285/B1F1AC03077B4AA784C5A413A2210BF5]; Herraiz-Borreguero L, 2016, J GEOPHYS RES-OCEANS, V121, P4946, DOI 10.1002/2016JC011858; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Jacobs SS, 2002, SCIENCE, V297, P386, DOI 10.1126/science.1069574; Khan SA, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/4/046801; Khazendar A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13243; Kusahara K, 2017, J GEOPHYS RES-OCEANS, V122, P6238, DOI 10.1002/2017JC012911; Kwok R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015415; Lavergne T, 2018, CRYOSPHERE DISCUSSIO, V2018, P1, DOI [10.5194/tc-2018-127, DOI 10.5194/TC-2018-127]; Liu JP, 2010, P NATL ACAD SCI USA, V107, P14987, DOI 10.1073/pnas.1003336107; Liu JP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018732; Marshall GJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019952; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Mayewski PA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000231; Mogensen K., 2012, ECMWF TECHNICAL MEMO, DOI 10.21957/x5y9yrtm; Nitsche FO, 2017, GEOPHYS RES LETT, V44, P8936, DOI 10.1002/2017GL074433; Nowicki S, 2013, J GEOPHYS RES-EARTH, V118, P1002, DOI 10.1002/jgrf.20081; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Parkinson CL, 2012, CRYOSPHERE, V6, P871, DOI 10.5194/tc-6-871-2012; Parkinson CL, 2016, REMOTE SENS ENVIRON, V183, P198, DOI 10.1016/j.rse.2016.05.020; Paul S, 2018, EMPIRICAL PARAMETRIZ, P2437; Pauling AG, 2017, GEOPHYS RES LETT, V44, P10454, DOI 10.1002/2017GL075017; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Previdi M, 2014, Q J ROY METEOR SOC, V140, P2401, DOI 10.1002/qj.2330; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Raphael MN, 2011, CLIM DYNAM, V36, P1403, DOI 10.1007/s00382-010-0892-1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Rintoul SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601610; Santoso A, 2006, J PHYS OCEANOGR, V36, P1523, DOI 10.1175/JPO2930.1; Schlosser E, 2018, CRYOSPHERE, V12, P1103, DOI 10.5194/tc-12-1103-2018; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sigmond M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044301; Sigmond M, 2014, J CLIMATE, V27, P1336, DOI 10.1175/JCLI-D-13-00590.1; Smith WO, 2008, J GEOPHYS RES, V113, P1, DOI [10.1029/2007JCOO4251, DOI 10.1029/2007JC004251]; Spence P, 2010, J CLIMATE, V23, P5332, DOI 10.1175/2010JCLI3098.1; Tamsitt V, 2017, NATURE COMMUNICATION, V8, P1, DOI [10.1038/s41467-016-0009-6, DOI 10.1038/S41467-016-0009-6]; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Tschudi MA, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8060457; Turner J, 2017, GEOPHYS RES LETT, V44, P6868, DOI 10.1002/2017GL073656; Turner J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037524; Williams GD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12577; Wong APS, 1999, NATURE, V400, P440, DOI 10.1038/22733; Zhang JL, 2007, J CLIMATE, V20, P2515, DOI 10.1175/JCLI4136.1; Zhang JL, 2014, J CLIMATE, V27, P202, DOI 10.1175/JCLI-D-12-00139.1; Zwally HJ, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000733; Zwally HJ, 2002, J GEODYN, V34, P405, DOI 10.1016/S0264-3707(02)00042-X	66	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203222	10.1371/journal.pone.0203222	http://dx.doi.org/10.1371/journal.pone.0203222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281612	Green Published, gold			2022-12-27	WOS:000446342400017
J	Zheng, WH; Sun, H; Zhang, PL; Zhou, GJ; Jin, QY; Lu, XQ				Zheng, Wanhui; Sun, Hong; Zhang, Peilin; Zhou, Guojiang; Jin, Quanyu; Lu, Xiaoqin			A four-stage DEA-based efficiency evaluation of public hospitals in China after the implementation of new medical reforms	PLOS ONE			English	Article								This study applied the non-parametric four-stage data envelopment analysis method (Four-Stage DEA) to measure the relative efficiencies of Chinese public hospitals from 2010 to 2016, and to determine how efficiencies were affected by eight factors. A sample of public hospitals (n = 84) was selected from Chongqing, China, including general hospitals and traditional Chinese medicine hospitals graded level 2 or above. The Four-Stage-DEA method was chosen since it enables the control of the impact of environment factors on efficiency evaluation results. Data on the number of staff, government financial subsidies, the number of beds and fixed assets were used as input whereas the number of out-patients and emergency department patients and visits, the number of discharged patients, medical and health service income and hospital bed utilization rate were chosen as study outputs. As relevant environmental variables, we selected GDP per capita, permanent population, population density, number of hospitals and number of available sickbeds in local medical institutions. The relative efficiencies (i.e. technical, pure technical, scale) of sample hospitals were also calculated to analyze the change between the first stage and fourth stage every year. The study found that Four-Stage-DEA can effectively filter the impact of environmental factors on evaluation results, which sets it apart from other models commonly used in existing studies.	[Zheng, Wanhui; Zhou, Guojiang] Cent S Univ, Xiangya Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Zheng, Wanhui; Zhang, Peilin; Lu, Xiaoqin] Ninth Peoples Hosp Chongqing, Hosp Cost Management Res Ctr, Chongqing, Peoples R China; [Sun, Hong] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Zhou, Guojiang] Shanghai Skin Dis Hosp, Dept Human Resource & Performance Appraisal, Shanghai, Peoples R China; [Jin, Quanyu] Yubei Matern & Child Healthcare Hosp, Chongqing, Peoples R China	Central South University; Central South University	Sun, H (corresponding author), Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China.	shjhaj@vip.163.com			World Bank [P126210]; Chongqing Health and Family Planning Commission [2017MXSM159]; Chongqing Institute of Health Economics [YWJK2017-11]; Medical University Chongqing [JW170246]	World Bank(The World Bank India); Chongqing Health and Family Planning Commission; Chongqing Institute of Health Economics; Medical University Chongqing	This study was supported by the World Bank Project (P126210) which is a loan project of the Chongqing Municipal Health and Family Planning Commission using the world bank. This study was also supported by Medical research project of Chongqing Health and Family Planning Commission (2017MXSM159). And Wanhui Zheng is the head of the project. This study was also supported by Bidding Project of Chongqing Institute of Health Economics (YWJK2017-11). And Wanhui Zheng is the head of the project. This study was also supported by an education and teaching project of Medical University Chongqing (JW170246). And Xiaoqing Lu is the head of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao J., 2016, J XINJIANG MED U, V6, P772; Cheng C B, 2014, SCI TECHNOLOGICAL PR, V31, P50; Cheng ZH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007267; Fried HO, 1999, J PROD ANAL, V12, P249, DOI 10.1023/A:1007800306752; Fried HO, 2002, J PROD ANAL, V17, P157, DOI 10.1023/A:1013548723393; Guo X X, 2012, STUDY EFFICIENCY PUB; Hu Z Z, 2017, PRACTICAL PREVENTIVE, V4, P502; Li H, 2014, BMC HEALTH SERV RES, V14, DOI [10.1186/1472-6963-14-158, 10.1186/1471-2229-14-105]; Li K, 2017, CHINESE HOSP MANAGEM, V37, P34; Li M, 2013, METHOD EMPIRICAL STU; Liao C Q, 2015, RES AGR MODERNIZATIO, V5, P876; Liu DM., 2014, MODERN HOSP, V14, P6; Liu Z M, 2014, J CENTRAL U FINANCE, P97; Mao Yan-na, 2015, HLTH EC RES, P15; National Health and Family Planning Commission of the People's Republic of China China, 2016, STUD SUGG CHIN FURTH; Sun Bin, 2016, Transactions of Tianjin University, V22, P182, DOI 10.1007/s12209-016-2725-8; Wei X., 2017, CHINESE HLTH EC, V36, P82; Yunnan Public Health Insurance Information Service, MED FAQS ARCH 2012 0; [张航 Zhang Hang], 2016, [中国公共卫生, China Journal of Public Health], V32, P1195; Zhang XB, 2014, APPL BIOCHEM BIOTECH, V172, P176, DOI 10.1007/s12010-013-0528-0; Zheng T Q, 2015, CHINESE HLTH EC, V34, P79	21	19	19	11	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203780	10.1371/journal.pone.0203780	http://dx.doi.org/10.1371/journal.pone.0203780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281620	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400029
J	Konboon, M; Bani-Yaghoub, M; Pithua, PO; Rhee, N; Aly, SS				Konboon, Malinee; Bani-Yaghoub, Majid; Pithua, Patrick O.; Rhee, Noah; Aly, Sharif S.			A nested compartmental model to assess the efficacy of paratuberculosis control measures on US dairy farms	PLOS ONE			English	Article							AVIUM SUBSP-PARATUBERCULOSIS; LINKED IMMUNOSORBENT ASSAYS; POLYMERASE-CHAIN-REACTION; JOHNES-DISEASE; MYCOBACTERIUM-PARATUBERCULOSIS; REPRODUCTION NUMBERS; INFECTED COWS; CATTLE; HERDS; SENSITIVITY	Paratuberculosis, also known as Johne's disease (JD), is a chronic contagious disease, caused by Mycobacterium avium subsp. paratuberculosis (MAP). The disease is incurable, fatal and causes economic losses estimated to exceed 200 million dollars to the U.S. dairy industry annually. Several preventive and control measures have been recommended; however, only a few of these measures have been validated empirically. Using a nested compartmental (NC) modeling approach, the main objective of this research was to identify the best combination of control and preventive measures that minimizes the prevalence and incidence of JD and the risk of MAP occurrence in a dairy herd. The NC model employs both MAP transmission estimates and data on pen movement of cattle on a dairy to quantify the effectiveness of control and preventive measures. To obtain reasonable ranges of parameter values for between-pen movements, the NC model was fitted to the movement data of four typical California dairy farms. Using the estimated ranges of the movement parameters and those of JD from previous research, the basic reproduction number was calculated to measure the risk of MAP occurrence in each pen environment as well as the entire dairy. Although the interventions evaluated by the NC model were shown to reduce the infection, no single measure alone was capable of eradicating the infection. The numerical simulations suggest that a combination of test and cull with more frequent manure removal is the most effective method in reducing incidence, prevalence and the risk of MAP occurrence. Other control measures such as limiting calf-adult cow contacts, raising calves in a disease-free herd or colostrum management were less effective.	[Konboon, Malinee; Bani-Yaghoub, Majid; Rhee, Noah] Univ Missouri, Dept Math & Stat, Kansas City, MO 64110 USA; [Pithua, Patrick O.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Pithua, Patrick O.] Virginia Maryland Coll Vet Med, Dept Populat Hlth Sci, Blacksburg, VA USA; [Aly, Sharif S.] Univ Calif Davis, Vet Med Teaching & Res Ctr, Sch Vet Med, Tulare, CA USA; [Aly, Sharif S.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Columbia; University of California System; University of California Davis; University of California System; University of California Davis	Konboon, M (corresponding author), Univ Missouri, Dept Math & Stat, Kansas City, MO 64110 USA.	mk880@mail.umkc.edu	Pithua, Patrick/J-2426-2013; Aly, Sharif S./J-6586-2019	Pithua, Patrick/0000-0002-2817-5772; Aly, Sharif S./0000-0003-0330-5013				Aly SS, 2014, INT J APPL RES VET M, V12, P1; Aly SS, 2015, J DAIRY SCI, V98, P1805, DOI 10.3168/jds.2014-8759; Aly SS, 2012, J VET DIAGN INVEST, V24, P821, DOI 10.1177/1040638712452107; Aly SS, 2005, JAVMA-J AM VET MED A, V227, P450, DOI 10.2460/javma.2005.227.450; Angelidou E, 2016, PREV VET MED, V124, P102, DOI 10.1016/j.prevetmed.2015.12.011; Aranaz A, 2006, VET RES, V37, P593, DOI 10.1051/vetres:2006021; Ayele WY, 2004, VET MICROBIOL, V103, P209, DOI 10.1016/j.vetmic.2004.07.011; Bani-Yaghoub M, 2012, EPIDEMIOL INFECT, V140, P542, DOI 10.1017/S0950268811000604; Bani-Yaghoub M, 2012, J BIOL DYNAM, V6, P923, DOI 10.1080/17513758.2012.693206; Bolton MW, 2011, J DAIRY SCI, V94, P4669, DOI 10.3168/jds.2011-4158; Brito BP, 2014, JAVMA-J AM VET MED A, V244, P582, DOI 10.2460/javma.244.5.582; Cho J, 2013, CAN J AGR ECON, V61, P583, DOI 10.1111/j.1744-7976.2012.01270.x; Chowell G., 2009, MATH STAT ESTIMATION, DOI [10.1007/978-90-481-2313-1, DOI 10.1007/978-90-481-2313-1]; Collins M, 2010, WHAT IS JOHNES DIS W; Crossley BM, 2005, VET MICROBIOL, V107, P257, DOI 10.1016/j.vetmic.2005.01.017; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Espejo LA, 2013, AM J VET RES, V74, P1304, DOI 10.2460/ajvr.74.10.1304; Gautam R, 2014, EPIDEMIOL INFECT, V142, P1034, DOI 10.1017/S0950268813001805; Groenendaal H, 2008, JAVMA-J AM VET MED A, V233, P1852, DOI 10.2460/javma.233.12.1852; Heffernan C, 2008, VACCINE, V26, P2433, DOI 10.1016/j.vaccine.2008.02.045; KETTERER PJ, 1981, AUST VET J, V57, P61, DOI 10.1111/j.1751-0813.1981.tb00445.x; Kohler H, 2001, J VET MED B, V48, P185, DOI 10.1046/j.1439-0450.2001.00443.x; LARSEN AB, 1956, AM J VET RES, V17, P549; Lovell R, 1944, J COMP PATHOL, V54, P120, DOI DOI 10.1016/S0368-1742(44)80013-3; Lu Z, 2008, J THEOR BIOL, V254, P135, DOI 10.1016/j.jtbi.2008.05.008; Lu Z, 2013, PREV VET MED, V110, P335, DOI 10.1016/j.prevetmed.2013.01.006; Lu Z, 2013, PREV VET MED, V108, P148, DOI 10.1016/j.prevetmed.2012.08.001; Magombedze G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076636; Martcheva M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0190-3; Massaro T, 2013, J BIOL SYST, V21, DOI 10.1142/S021833901340010X; Mitchell RM, 2015, PREV VET MED, V118, P215, DOI 10.1016/j.prevetmed.2014.12.009; Nielsen SS, 2006, J DAIRY SCI, V89, P4557, DOI 10.3168/jds.S0022-0302(06)72505-X; Pithua P, 2009, J AM VET MED ASSOC, V234; Pithua P, 2011, JAVMA-J AM VET MED A, V238, P94, DOI 10.2460/javma.238.1.94; Sorge US, 2013, VET MICROBIOL, V164, P383, DOI 10.1016/j.vetmic.2013.02.021; STREETER RN, 1995, AM J VET RES, V56, P1322; Sweeney RW, 2012, J VET INTERN MED, V26, P1239, DOI 10.1111/j.1939-1676.2012.01019.x; SWEENEY RW, 1992, AM J VET RES, V53, P477; Sweeney RW, 1996, VET CLIN N AM-FOOD A, V12, P305, DOI 10.1016/S0749-0720(15)30408-4; Tijdschr DT, 1977, PRODUCTIVE LIFE SPAN, V102, P739; Tiwari A, 2006, CAN VET J, V47, P874; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Whitlock RH, 2005, ESTIMATION PARAMETER; Whittington RJ, 2009, VET J, V179, P60, DOI 10.1016/j.tvjl.2007.08.023	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203190	10.1371/journal.pone.0203190	http://dx.doi.org/10.1371/journal.pone.0203190			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278041	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200005
J	van Keulen, D; Pouwer, MG; Pasterkamp, G; van Gool, AJ; Gelpke, MDS; Princen, HMG; Tempel, D				van Keulen, Danielle; Pouwer, Marianne G.; Pasterkamp, Gerard; van Gool, Alain J.; Gelpke, Maarten D. Sollewijn; Princen, Hans M. G.; Tempel, Dennie			Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; RHEUMATOID-ARTHRITIS; TNF-ALPHA; EARLY ATHEROSCLEROSIS; GROWTH-FACTOR; CANCER-CELLS; EXPRESSION; ADHESION; DISEASE	Aims Endothelial activation is involved in many chronic inflammatory diseases, such as atherosclerosis, and is often initiated by cytokines. Oncostatin M (OSM) is a relatively unknown cytokine that has been suggested to play a role in both endothelial activation and atherosclerosis. We comprehensively investigated the effect of OSM on endothelial cell activation from different vascular beds and in APOE*3Leiden.CETP mice. Methods and results Human umbilical vein endothelial cells, human aortic endothelial cells and human microvascular endothelial cells cultured in the presence of OSM express elevated MCP-1, IL-6 and ICAM-1 mRNA levels. Human umbilical vein endothelial cells and human aortic endothelial cells additionally expressed increased VCAM-1 and E-selectin mRNA levels. Moreover, ICAM-1 membrane expression is increased as well as MCP-1, IL-6 and E-selectin protein release. A marked increase was observed in STAT1 and STAT3 phosphorylation indicating that the JAK/STAT pathway is involved in OSM signaling. OSM signals through the LIF receptor alfa (LIFR) and the OSM receptor (OSMR). siRNA knockdown of the LIFR and the OSMR revealed that simultaneous knockdown is necessary to significantly reduce MCP-1 and IL-6 secretion, VCAM-1 and E-selectin shedding and STAT1 and STAT3 phosphorylation after OSM stimulation. Moreover, OSM administration to APOE*3Leiden.CETP mice enhances plasma E-selectin levels and increases ICAM-1 expression and monocyte adhesion in the aortic root area. Furthermore, 11-6 mRNA expression was elevated in the aorta of OSM treated mice. Conclusion OSM induces endothelial activation in vitro in endothelial cells from different vascular beds through activation of the JAK/STAT cascade and in vivo in APOE*3Leiden.CETP mice. Since endothelial activation is an initial step in atherosclerosis development, OSM may play a role in the initiation of atherosclerotic lesion formation.	[van Keulen, Danielle; Pasterkamp, Gerard; Tempel, Dennie] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [van Keulen, Danielle; Pasterkamp, Gerard; Tempel, Dennie] Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands; [van Keulen, Danielle; Tempel, Dennie] Quorics BV, Rotterdam, Netherlands; [van Keulen, Danielle; Pouwer, Marianne G.; Princen, Hans M. G.] TNO Metab Hlth Res, Gaubius Lab, Leiden, Netherlands; [Pouwer, Marianne G.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [van Gool, Alain J.] TNO Microbiol & Syst Biol, Zeist, Netherlands; [van Gool, Alain J.] Radboudumc, Nijmegen, Netherlands; [Gelpke, Maarten D. Sollewijn] Mol Profiling Consulting, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Radboud University Nijmegen	Tempel, D (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.; Tempel, D (corresponding author), Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands.; Tempel, D (corresponding author), Quorics BV, Rotterdam, Netherlands.	d.tempel@umcutrecht.nl	Princen, Hans MG/AID-9392-2022	Princen, Hans MG/0000-0002-7206-1596; van Gool, Alain/0000-0003-0010-5286	European Union Seventh Framework Programme (FP7/2007-2013) [602936]; Quorics B.V; Molecular Profiling Consulting	European Union Seventh Framework Programme (FP7/2007-2013); Quorics B.V; Molecular Profiling Consulting	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) [grant number 602936] (CarTarDis project). https://ec.europa.eu/research/health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Quorics B.V provided support in the form of salaries for authors DVK and DT, and Molecular Profiling Consulting provided salary for MDSG but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Albasanz-Puig A, 2011, ATHEROSCLEROSIS, V216, P292, DOI 10.1016/j.atherosclerosis.2011.02.003; Amin MA, 2010, ANN RHEUM DIS, V69, P2204, DOI 10.1136/ard.2009.127241; BROWN TJ, 1991, J IMMUNOL, V147, P2175; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Camare C, 2017, REDOX BIOL, V12, P18, DOI 10.1016/j.redox.2017.01.007; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Cross A, 2004, ARTHRITIS RHEUM-US, V50, P1430, DOI 10.1002/art.20166; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Dumas A, 2012, J CELL MOL MED, V16, P1274, DOI 10.1111/j.1582-4934.2011.01412.x; Esashi E, 2009, EUR J IMMUNOL, V39, P1664, DOI 10.1002/eji.200839149; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Foglia B, 2017, DIGEST LIVER DIS, V49, pE5, DOI 10.1016/j.dld.2017.01.013; Fossey SL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-125; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hui W, 1997, ANN RHEUM DIS, V56, P184, DOI 10.1136/ard.56.3.184; Jing YY, 2011, CANCER INVEST, V29, P485, DOI 10.3109/07357907.2011.597812; Kang SA, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2366-2; Kapoor D, 2014, ATHEROSCLEROSIS, V237, P623, DOI 10.1016/j.atherosclerosis.2014.10.009; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1442, DOI 10.1152/ajpcell.2001.281.5.C1442; Kim I, 2000, JBC PAPERS; Kisucka J, 2008, CIRC RES, V103, P598, DOI 10.1161/CIRCRESAHA.108.174870; Kuhnast S, 2014, J LIPID RES, V55, P2103, DOI 10.1194/jlr.M051326; Landlinger C, 2017, EUR HEART J, V38, P2499, DOI 10.1093/eurheartj/ehx260; Langenkamp E, 2009, CELL TISSUE RES, V335, P205, DOI 10.1007/s00441-008-0642-4; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; McDonald AI, 2018, CELL STEM CELL, V23, P210, DOI 10.1016/j.stem.2018.07.011; Modur V, 1997, J CLIN INVEST, V100, P158, DOI 10.1172/JCI119508; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Natarelli L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05065-z; Okane CM, 2008, EUR J IMMUNOL, V38, P1321, DOI 10.1002/eji.200737855; PIGOTT R, 1992, BIOCHEM BIOPH RES CO, V187, P584, DOI 10.1016/0006-291X(92)91234-H; Pradeep AR, 2010, BIOMARKERS, V15, P277, DOI 10.3109/13547500903573209; PUGIN J, 1993, J EXP MED, V178, P2193, DOI 10.1084/jem.178.6.2193; Rajashekhar G, 2006, J VASC RES, V43, P193, DOI 10.1159/000090949; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reddy VS, 2011, J CELL PHYSIOL, V226, P3303, DOI 10.1002/jcp.22676; Rega G, 2007, ARTERIOSCL THROM VAS, V27, P1587, DOI 10.1161/ATVBAHA.107.143081; Reynolds HR, 2010, ATHEROSCLEROSIS, V210, P569, DOI 10.1016/j.atherosclerosis.2009.12.007; Ruprecht K, 2001, J NEUROPATH EXP NEUR, V60, P1087, DOI 10.1093/jnen/60.11.1087; Rychli K, 2010, J THROMB HAEMOST, V8, P596, DOI 10.1111/j.1538-7836.2010.03741.x; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schnittker D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/317503; Scott DW, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000263; Shi N, 2014, J BIOMED RES, V28, P40, DOI 10.7555/JBR.28.20130130; Stamatiou R, 2012, ISRN Inflamm, V2012, P731472, DOI 10.5402/2012/731472; Sugaya M, 2006, J IMMUNOL, V177, P7665, DOI 10.4049/jimmunol.177.11.7665; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Tenger C, 2005, ARTERIOSCL THROM VAS, V25, P791, DOI 10.1161/01.ATV.0000153516.02782.65; Tokuhira M, 2000, ARTHRITIS RHEUM, V43, P1122, DOI 10.1002/1529-0131(200005)43:5<1122::AID-ANR23>3.0.CO;2-7; Vasse M, 1999, ARTERIOSCL THROM VAS, V19, P1835, DOI 10.1161/01.ATV.19.8.1835; Wang Q, 2002, AM J RESP CRIT CARE, V166, P872, DOI 10.1164/rccm.2201007; Weiss TW, 2011, ANTICANCER RES, V31, P3273; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; WILDER RL, 1991, J CELL BIOCHEM, V45, P162, DOI 10.1002/jcb.240450207; Wu KK, 1996, ANNU REV MED, V47, P315; Zhang X, 2017, J LIPID RES, V58, P895, DOI 10.1194/jlr.M074112; Zhang YZ, 2014, J MOL CELL CARDIOL, V72, P85, DOI 10.1016/j.yjmcc.2014.02.012; Zhao WW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13072-1; ZWAGINGA JJ, 1990, ARTERIOSCLEROSIS, V10, P49, DOI 10.1161/01.ATV.10.1.49	67	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204911	10.1371/journal.pone.0204911	http://dx.doi.org/10.1371/journal.pone.0204911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273401	Green Published, gold			2022-12-27	WOS:000446124700047
J	Wong, DPW; Ng, MY; Leung, JY; Boh, BK; Lim, EC; Tan, SH; Lim, S; Seah, WH; Hu, CZW; Ho, BC; Ng, DHP; Hagen, T				Wong, Daphne Pei Wen; Ng, Mei Ying; Leung, Jia Yu; Boh, Boon Kim; Lim, Ee Chien; Tan, Shi Hua; Lim, Shuying; Seah, Wen Hui; Hu, Christine Zhiwen; Ho, Boon Chuan; Ng, Daphne Hui Ping; Hagen, Thilo			Regulation of the NRF2 transcription factor by andrographolide and organic extracts from plant endophytes	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; COVALENT MODIFICATION; STRESS-RESPONSE; OXYGENASE 1; KEAP1; ACTIVATION; PROTEIN; CELLS; UBIQUITINATION; INFLAMMATION	The transcription factor NF-E2 Related Factor-2 (NRF2) is an important drug target. Activation of NRF2 has chemopreventive effects in cancer and exerts beneficial effects in a number of diseases, including neurodegenerative diseases, inflammatory diseases, hepatosteatosis, obesity and insulin resistance. Hence, there have been great efforts to discover and characterize novel NRF2 activators. One reported NRF2 activator is the labdane diterpenoid andrographolide. In this study, we identified the mechanism through which andrographolide activates NRF2. We showed that andrographolide inhibits the function of KEAP1, a protein that together with CUL3 and RBX1 forms an E3 ubiquitin ligase that polyu-biquitinates NRF2. Andrographolide partially inhibits the interaction of KEAP1 with CUL3 in a manner dependent on Cys151 in KEAP1. This suggests that andrographolide forms Michael acceptor dependent adducts with Cys151 in KEAP1 in vivo, leading to inhibition of NRF2 ubiquitination and consequently accumulation of the transcription factor. Interestingly, we also showed that at higher concentrations andrographolide increases NRF2 protein expression in a Cys151 independent, but likely KEAP1 dependent manner, possibly through modification of other Cys residues in KEAP1. In this study we also screened secondary metabolites produced by endophytes isolated from non-flowering plants for NRF2-inducing properties. One of the extracts, ORX 41, increased both NRF2 protein expression and transcriptional activity markedly. These results suggest that endophytes isolated from non-flowering or other plants may be a good source of novel NRF2 inducing compounds.	[Wong, Daphne Pei Wen; Ng, Mei Ying; Leung, Jia Yu; Boh, Boon Kim; Lim, Ee Chien; Tan, Shi Hua; Lim, Shuying; Seah, Wen Hui; Hu, Christine Zhiwen; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Tan, Shi Hua] Natl Heart Ctr Singapore, Singapore, Singapore; [Ho, Boon Chuan] Natl Pk Board, Singapore Bot Gardens, Herbarium, Singapore, Singapore; [Ng, Daphne Hui Ping] Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore, Singapore	National University of Singapore; National Heart Centre Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Ng, DHP (corresponding author), Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore, Singapore.	daphneng@ntu.edu.sg; daphneng@ntu.edu.sg; bchth@nus.edu.sg	Ho, Boon-Chuan/ABC-5638-2021	Ho, Boon-Chuan/0000-0003-0530-775X				Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Baird L, 2013, BIOCHEM BIOPH RES CO, V433, P58, DOI 10.1016/j.bbrc.2013.02.065; Bascom-Slack CA, 2012, SCIENCE, V338, P485, DOI 10.1126/science.1215227; Chapla VM, 2014, MOLECULES, V19, P6597, DOI 10.3390/molecules19056597; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; COOPERDRIVER G, 1977, SCIENCE, V198, P1260, DOI 10.1126/science.198.4323.1260; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Li XC, 2014, TURK J BIOCHEM, V39, P30, DOI 10.5505/tjb.2014.65882; Lim JCW, 2012, CLIN EXP PHARMACOL P, V39, P300, DOI 10.1111/j.1440-1681.2011.05633.x; Norhajar Eswani, 2010, Journal of Agricultural Science (Toronto), V2, P189; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Revathi R., 2013, PTERID RES, V2, P1; Stefanson AL, 2014, NUTRIENTS, V6, P3777, DOI 10.3390/nu6093777; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tan WSD, 2017, BIOCHEM PHARMACOL, V139, P71, DOI 10.1016/j.bcp.2017.03.024; Trivedi P.C., 2009, MED PLANTS UTILISATI; Wang XJ, 2008, TOXICOL APPL PHARM, V230, P383, DOI 10.1016/j.taap.2008.03.003; WHO, WHO MON SEL MED PLAN, P12; Wong DPW, 2010, EUR J PHARMACOL, V643, P188, DOI 10.1016/j.ejphar.2010.06.040; Wong SY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0723-3; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Yang CH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081638; Yen TL, 2016, TRANSL RES, V170, P57, DOI 10.1016/j.trsl.2015.12.002; Yuan YL, 2012, FITOTERAPIA, V83, P1506, DOI 10.1016/j.fitote.2012.08.018; Zakaria ZA, 2011, AFR J BIOTECHNOL, V10, P273; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492	32	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204853	10.1371/journal.pone.0204853	http://dx.doi.org/10.1371/journal.pone.0204853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273379	Green Published, gold			2022-12-27	WOS:000446124700042
J	Dehiya, V; Thomas, J; Sael, L				Dehiya, Vasundhara; Thomas, Jaya; Sael, Lee			Impact of structural prior knowledge in SNV prediction: Towards causal variant finding in rare disease	PLOS ONE			English	Article							MISSENSE MUTATIONS; SOMATIC MUTATIONS; PROTEIN FUNCTION; TOOL; P53; ANNOTATION; DISCOVERY; SERVER; EXOMES; SIFT	Can structural information of proteins generate essential features for predicting the deleterious effect of a single nucleotide variant (SNV) independent of the known existence of the SNV in diseases? In this work, we answer the question by examining the performance of features generated from prior knowledge with the goal towards determining the pathogenic effect of rare variants in rare disease. We take the approach of prioritizing SNV loci focusing on protein structure-based features. The proposed structure-based features are generated from geometric, physical, chemical, and functional properties of the variant loci and structural neighbors of the loci utilizing multiple homologous structures. The performance of the structure-based features alone, trained on 80% of HumVar-HumDiv combination (HumVD-train) and tested on 20% of HumVar-HumDiv (HumVD-test), ClinVar and ClinVar rare variant rare disease (ClinVarRVRD) datasets, showed high levels of discernibility in determining the SNV's pathogenic or benign effects on patients. Combined structure- and sequence-based features generated from prior knowledge on a random forest model further improved the F scores to 0.84 (HumVD-test), 0.75 (ClinVar), and 0.75 (ClinVarRVRD). Including features based on the difference between wild-type in addition to the features based on loci information increased the F score slightly more to 0.90 (HumVD-test), 0.78 (ClinVar), and 0.76 (ClinVarRVRD). The empirical examination and high F scores of the results based on loci information alone suggest that location of SNV plays a primary role in determining functional impact of mutation and that structure-based features can help enhance the prediction performance.	[Dehiya, Vasundhara; Thomas, Jaya] State Univ New York Korea, Dept Comp Sci, Incheon, South Korea; [Dehiya, Vasundhara; Thomas, Jaya] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Sael, Lee] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Seoul National University (SNU)	Sael, L (corresponding author), Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea.	saellee@snu.ac.kr	Sael, Lee/AAD-9185-2021	Sael, Lee/0000-0002-9066-5756	Basic Science Research Program through the National Research Foundation of Korea [2015R1C1A2A01055739, 2018R1A1A3A04079531]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	LS was supported by Basic Science Research Program through the National Research Foundation of Korea (2015R1C1A2A01055739, 2018R1A1A3A04079531).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chial H, 2008, NAT ED, V1, P63; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; de Vrueh R, 2013, 619 WHO; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Global Genes, 2017, RAR DIS FACTS STAT; Gress A, 2016, NUCLEIC ACIDS RES, V44, pW463, DOI 10.1093/nar/gkw364; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lo YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116347; Lwin TZ, 2007, J MOL BIOL, V373, P1334, DOI 10.1016/j.jmb.2007.07.080; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pi J, 2013, INT J MOL SCI, V14, P20635, DOI 10.3390/ijms141020635; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Sael L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S7; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Witten I. H., 2016, MORGAN KAUFMANN, DOI 10.1016%2Fb978-0-12-804291-5.00024-6; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhang F, 2013, ARCH BIOCHEM BIOPHYS, V535, P120, DOI 10.1016/j.abb.2013.03.005	42	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204101	10.1371/journal.pone.0204101	http://dx.doi.org/10.1371/journal.pone.0204101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265692	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500018
J	Fullwood, RA; Low, GM; Chase, EP; Grasley, M; Beal, SS; McCrary, IM; Daniels, CW; Ingersoll, K; Berges, BK				Fullwood, R. Amy; Low, Gregory M.; Chase, Emily P.; Grasley, Meagan; Beal, Soren S.; McCrary, Ian M.; Daniels, Christian W.; Ingersoll, Kayleigh; Berges, Bradford K.			The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model	PLOS ONE			English	Article							PRIMARY EFFUSION LYMPHOMA; ACTIVATION; DISEASE; CD30; PROLIFERATION; LATENCY; GROWTH; IL-6; HIV	Kaposi's sarcoma-associated herpesvirus (KSHV) is a cancer-causing virus in humans, primarily affecting AIDS patients. KSHV causes a range of cancers including Kaposi's sarcoma, pleural effusion lymphoma and multicentric Castleman's disease. Current methods available for treating these cancers are relatively ineffective, and new targets for therapy are needed. The KSHV viral homolog of interleukin-6 gene (vIL-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood. Here, a novel animal model was used to study how vIL-6 affects tumor development. Highly immune-deficient Rag2(-/-)yc(-/-) mice were transplanted with an immortalized human B cell line (BJAB) harboring either wild-type (WT) KSHV or a mutant strain lacking vIL-6 Delta vIL-6). Solid tumors developed and total tumor mass and the number of tumors were characterized. The vIL-6 gene had no significant impact on tumor mass, but significantly more tumors were detected when vIL-6 was present. Significant differences in expression of B cell markers in cells from extracted tumors were detected based upon the presence of vIL-6. B cell markers in tumor cells were also compared to the same cell type in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of vIL-6. The only marker that significantly increased in expression during tumor development was CD30. Tumor blood vessels were quantified to determine if more angiogenesis occurred with vIL-6-expressing virus, but there was no significant difference. These data indicate that vIL-6 plays a role in KSHV tumor formation in B cells in vivo. Further investigation into how vIL-6 manipulates CD30 expression may shed insight into KSHV oncogenesis, and may identify how vIL-6 can be targeted.	[Fullwood, R. Amy; Low, Gregory M.; Chase, Emily P.; Grasley, Meagan; Beal, Soren S.; McCrary, Ian M.; Daniels, Christian W.; Ingersoll, Kayleigh; Berges, Bradford K.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	Berges, BK (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	brad.berges@gmail.com	McCrary, Ian/HGB-1627-2022	Chase, Emily/0000-0003-4379-4552; Ingersoll Omdahl, Kayleigh/0000-0003-0255-5547; Berges, Bradford/0000-0003-0711-576X	Simmons Center for Cancer Research Fellowship; Brigham Young University Office of Research and Creative Activities award	Simmons Center for Cancer Research Fellowship; Brigham Young University Office of Research and Creative Activities award	RAF was supported by a Simmons Center for Cancer Research Fellowship. GML was supported by a Brigham Young University Office of Research and Creative Activities award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Areste C, 2009, TRENDS MICROBIOL, V17, P119, DOI 10.1016/j.tim.2008.12.001; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chen DM, 2014, J VIROL, V88, P1025, DOI 10.1128/JVI.02830-13; Chen DM, 2009, J VIROL, V83, P722, DOI 10.1128/JVI.01517-08; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Chen L, 2007, VIROLOGY, V359, P425, DOI 10.1016/j.virol.2006.09.044; Chiarle R, 1999, CLIN IMMUNOL, V90, P157, DOI 10.1006/clim.1998.4636; Cornaby C, 2016, J GEN VIROL, V97, P543, DOI 10.1099/jgv.0.000370; Cousins E, 2013, J VIROL, V87, P10816, DOI 10.1128/JVI.02047-13; DERIE MA, 1989, CELL IMMUNOL, V118, P368, DOI 10.1016/0008-8749(89)90385-7; Gasperini P, 2008, J LEUKOCYTE BIOL, V84, P994, DOI 10.1189/jlb.1107777; Giffin L, 2015, MBIO, V6, DOI 10.1128/mBio.01499-15; Jones KD, 1999, BLOOD, V94, P2871; Klein U, 2003, BLOOD, V101, P4115, DOI 10.1182/blood-2002-10-3090; Knowles DM, 2003, HEMATOL ONCOL CLIN N, V17, P785, DOI 10.1016/S0889-8588(03)00050-9; Lebbe Celeste, 2009, V146, P169, DOI 10.1007/978-0-387-78574-5_15; Mir SS, 2000, BLOOD, V96, P4307; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Pellat-Deceunynck C, 2004, BLOOD CELL MOL DIS, V32, P293, DOI 10.1016/j.bcmd.2003.12.001; Picchio GR, 1997, VIROLOGY, V238, P22, DOI 10.1006/viro.1997.8822; Sakakibara S, 2011, J INTERF CYTOK RES, V31, P791, DOI 10.1089/jir.2011.0043; Sanchez Freddy M, 2013, Methods Mol Biol, V1031, P19, DOI 10.1007/978-1-62703-481-4_2; Staber PB, 2006, LEUKEMIA RES, V30, P343, DOI 10.1016/j.leukres.2005.08.010; Sullivan RJ, 2008, CLIN INFECT DIS, V47, P1209, DOI 10.1086/592298; Suthaus J, 2012, BLOOD, V119, P5173, DOI 10.1182/blood-2011-09-377705; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204947	10.1371/journal.pone.0204947	http://dx.doi.org/10.1371/journal.pone.0204947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265712	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500058
J	Kim, E; Yang, SM; Kwak, SG; Park, S; Bahk, JH; Seo, JH				Kim, Eugene; Yang, Seong Mi; Kwak, Sang Gyu; Park, Seoyeong; Bahk, Jae-Hyon; Seo, Jeong-Hwa			Tracheal tubes lubricated with water to reduce sore throat after intubation: A randomized non-inferiority trial	PLOS ONE			English	Article							ENDOTRACHEAL-TUBE; BENZYDAMINE HYDROCHLORIDE; HOARSENESS; LIDOCAINE; SURGERY; CUFF; INJURIES; COUGH; COLONIZATION; NASENDOSCOPY	Background Sore throat is common after tracheal intubation. Water can be used to lubricate tracheal tubes, but its benefit has not been validated. We thus did a randomised non-inferiority trial to test the hypothesis that a tube lubricated with water does not reduce sore throat after tracheal intubation. Methods We randomized female or male patients (n = 296) undergoing surgery in the ears or eyes to receive either a tube lubricated with water or a tube without lubrication for intubation. We assessed sore throat at 0, 2, 4, and 24 h after surgery; pharyngeal injury at 2 and 24 h after surgery; and respiratory infections within 7 days after surgery. For the incidence of sore throat within 24 h after surgery (primary outcome), the two-sided 90% confidence interval of the risk difference was compared with the prespecified non-inferiority margin of 15%. Other outcomes were analyzed with two-sided superiority tests. Results The incidence of sore throat within 24 h after surgery was 80/147 (54.4%) in the non-lubricated tube group and 83/149 (55.7%) in the water-lubricated tube group (risk difference -1.3%, 90% confidence interval -10.9% to 8.3%). Because the confidence interval was below the non-inferiority margin, the incidence of sore throat was not higher in the non-lubricated tube group than in the water-lubricated tube group. There was no significant association between groups in the sore throat, pharyngeal injury, and respiratory infection at each assessment time. Conclusions The tube lubricated with water did not reduce sore throat and pharyngeal injury after tracheal intubation compared to the tube without lubrication.	[Kim, Eugene; Yang, Seong Mi; Park, Seoyeong; Bahk, Jae-Hyon; Seo, Jeong-Hwa] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kwak, Sang Gyu] Daegu Catholic Univ, Coll Med, Dept Med Stat, Daegu, South Korea; [Kim, Eugene] Daegu Catholic Univ, Coll Med, Med Ctr, Dept Anesthesiol & Pain Med, Daegu, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Daegu; Catholic University of Daegu	Seo, JH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.	eong77@snu.ac.kr	Kwak, Sanggyu/AAG-4341-2021; Kim, Eugene/E-2446-2019	Kim, Eugene/0000-0002-1926-4191; Bahk, Jae-Hyon/0000-0002-3082-5244				Agarwal A, 2006, ANESTH ANALG, V103, P1001, DOI 10.1213/01.ane.0000231637.28427.00; Ayoub CM, 1998, ANESTH ANALG, V87, P714, DOI 10.1097/00000539-199809000-00042; Bottcher A, 2014, EUR ARCH OTO-RHINO-L, V271, P345, DOI 10.1007/s00405-013-2659-x; Borazan H, 2012, ANESTHESIOLOGY, V117, P512, DOI 10.1097/ALN.0b013e3182639d5f; Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196; Cairns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014759; Canbay O, 2008, BRIT J ANAESTH, V100, P490, DOI 10.1093/bja/aen023; Casati A, 1999, ANESTH ANALG, V89, P263; CHRISTENSEN AM, 1994, BRIT J ANAESTH, V73, P786, DOI 10.1093/bja/73.6.786; CONWAY CM, 1960, BRIT J ANAESTH, V32, P219, DOI 10.1093/bja/32.5.219; Domino KB, 1999, ANESTHESIOLOGY, V91, P1703, DOI 10.1097/00000542-199912000-00023; Estebe JP, 2004, BRIT J ANAESTH, V92, P361, DOI 10.1093/bja/aeh078; Feldman C, 1999, EUR RESPIR J, V13, P546, DOI 10.1183/09031936.99.13354699; Gibbs K, 2012, SEMIN PERINATOL, V36, P454, DOI 10.1053/j.semperi.2012.06.008; HARDING CJ, 1987, ANAESTHESIA, V42, P1104, DOI 10.1111/j.1365-2044.1987.tb05179.x; Higgins PP, 2002, BRIT J ANAESTH, V88, P582, DOI 10.1093/bja/88.4.582; Huang YS, 2010, ANESTH ANALG, V111, P887, DOI 10.1213/ANE.0b013e3181e6d82a; Hung NK, 2010, ANESTH ANALG, V111, P882, DOI 10.1213/ANE.0b013e3181d4854e; Kim E, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1699-0; Kim HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17034; Komasawa N, 2017, BRIT J ANAESTH, V119, P171, DOI 10.1093/bja/aex184; Kundra P, 2010, ANZ J SURG, V80, P817, DOI 10.1111/j.1445-2197.2010.05441.x; LOESER EA, 1983, ANESTHESIOLOGY, V58, P376, DOI 10.1097/00000542-198304000-00015; Martini CH, 2014, BRIT J ANAESTH, V112, P498, DOI 10.1093/bja/aet377; Maruyama K, 2004, BRIT J ANAESTH, V92, P541, DOI 10.1093/bja/aeh098; McHardy FE, 1999, ANAESTHESIA, V54, P444, DOI 10.1046/j.1365-2044.1999.00780.x; Ozaki M, 2001, CAN J ANAESTH, V48, P1080, DOI 10.1007/BF03020373; Panman MR, 2013, NAT CHEM, V5, P929, DOI [10.1038/NCHEM.1744, 10.1038/nchem.1744]; Park SH, 2008, ANESTH ANALG, V107, P1814, DOI 10.1213/ane.0b013e318185d093; Pneumatikos IA, 2009, ANESTHESIOLOGY, V110, P673, DOI 10.1097/ALN.0b013e31819868e0; Pothier DD, 2006, CLIN OTOLARYNGOL, V31, P134, DOI 10.1111/j.1749-4486.2006.01173.x; Puyo CA, 2017, MOL PAIN, V13, DOI 10.1177/1744806917731696; Seccia V, 2014, LARYNGOSCOPE, V124, P1648, DOI 10.1002/lary.24535; Seo JH, 2013, BRIT J ANAESTH, V111, P812, DOI 10.1093/bja/aet203; Seo JH, 2016, BRIT J ANAESTH, V116, P282, DOI 10.1093/bja/aev414; Soltani HA, 2002, J CLIN ANESTH, V14, P15, DOI 10.1016/S0952-8180(01)00344-0; SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001; Sumathi PA, 2008, BRIT J ANAESTH, V100, P215, DOI 10.1093/bja/aem341; Sunkaraneni VS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005606.pub2; Thomas S, 2007, CAN J ANAESTH, V54, P897, DOI 10.1007/BF03026793; Yamanaka H, 2009, BRIT J ANAESTH, V103, P452, DOI 10.1093/bja/aep169	41	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204846	10.1371/journal.pone.0204846	http://dx.doi.org/10.1371/journal.pone.0204846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286145	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500049
J	Liu, LF; Zhao, WA; Liu, JX; Gan, Y; Liu, LJ; Tian, J				Liu, Lifei; Zhao, Weian; Liu, Jianxia; Gan, Yi; Liu, Lingjuan; Tian, Jie			Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice	PLOS ONE			English	Article							ADENOVIRAL GENE-TRANSFER; SARCOPLASMIC-RETICULUM CA2+-ATPASE; GREEN TEA POLYPHENOLS; CARDIAC-HYPERTROPHY; RAT HEARTS; CLASS-I; EXPRESSION; EGCG; CATECHINS; (-)-EPIGALLOCATECHIN-3-GALLATE	Heart failure is a common, costly, and potentially fatal condition. The cardiac sarcoplasmic reticulum Ca-ATPase (SERCA2a) plays a critical role in the regulation of cardiac function. Previously, low SERCA2a expression was revealed in mice with heart failure. Epigallocatechin-3-gallate (EGCG) can function as an epigenetic regulator and has been reported to enhance cardiac function. However, the underlying epigenetic regulatory mechanism is still unclear. In this study, we investigated whether EGCG can up-regulate SERCA2a via histone acetylation and play role in preventing heart failure. For this, we generated a mouse model of heart failure by performing a minimally invasive transverse aortic constriction (TAC) operation and used this to test the effects of EGCG. The TAC+EGCG group showed nearly normal cardiac function compared to that in the SHAM group. The expression of SERCA2a was decreased at both the mRNA and protein levels in the TAC group but was enhanced in the TAC+EGCG group. Levels of AcH3 and AcH3K9 were determined to decrease near the promoter region of Atp2a2 (the gene encoding SERCA-2a) in the TAC group, but were elevated in the TAC+EGCG group. Meanwhile, HDAC1 activity and binding near the Atp2a2 promoter were increased in the TAC group but decreased with EGCG addition. Further, binding levels of GATA4 and Mef2c near the Atp2a2 promoter region were reduced in TAC hearts, which might have been caused by histone hypoacetylation; this was reversed by EGCG. Together, upregulation of SERCA2a via the modification of histone acetylation plays a role in EGCG-mediated prevention of pressure overload-induced heart failure, and this might represent a novel pharmacological target for the treatment of heart failure.	[Liu, Lifei; Liu, Jianxia] Chongqing Med Univ, Dept Anesthesiol, Childrens Hosp, Chongqing, Peoples R China; [Zhao, Weian; Tian, Jie] Chongqing Med Univ, Childrens Hosp, Dept Cardiol, Heart Ctr, Chongqing, Peoples R China; [Gan, Yi] Minist Educ, Key Lab Child Dev & Disorders, Beijing, Peoples R China; [Liu, Lingjuan] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Liu, Lingjuan] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Tian, J (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Cardiol, Heart Ctr, Chongqing, Peoples R China.	jietian@cqmu.edu.cn			Natural Science Foundation of China [81670212]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of China (81670212 to JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106024; ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; Bavendiek U, 1998, BASIC RES CARDIOL, V93, P76; Cai Y, 2013, PHYTOMEDICINE, V20, P106, DOI 10.1016/j.phymed.2012.10.002; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eng QY, 2018, J ETHNOPHARMACOL, V210, P296, DOI 10.1016/j.jep.2017.08.035; FELDMAN AM, 1993, CIRC RES, V73, P184, DOI 10.1161/01.RES.73.1.184; Feng W, 2012, MOL PHARMACOL, V82, P993, DOI 10.1124/mol.112.079707; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Hajjar RJ, 1997, CIRC RES, V81, P145, DOI 10.1161/01.RES.81.2.145; Hajjar RJ, 1997, CIRCULATION, V95, P423; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hayward C, 2015, HUM GENE THER, V26, P293, DOI 10.1089/hum.2015.018; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Ikeda I, 2008, ASIA PAC J CLIN NUTR, V17, P273; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin P, 2014, CELL TISSUE RES, V356, P381, DOI 10.1007/s00441-014-1797-9; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; KISS E, 1995, CIRC RES, V77, P759, DOI 10.1161/01.RES.77.4.759; Koh YW, 2011, J NUTR BIOCHEM, V22, P1074, DOI 10.1016/j.jnutbio.2010.09.005; Kondo T, 2002, CANCER LETT, V180, P139, DOI 10.1016/S0304-3835(02)00007-1; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Krum H, 2009, LANCET, V373, P941, DOI 10.1016/S0140-6736(09)60236-1; Li YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-274; Lim YC, 2008, CANCER LETT, V271, P140, DOI 10.1016/j.canlet.2008.05.048; Liu Z, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21932; Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013; Man Y, 2017, BIOMED RES INT, V2017, P1, DOI [DOI 10.1155/2017/5615647, 10.1155/2017/5615647, DOI 10.18632/oncotarget.13723]; MATSUI H, 1995, AM J PHYSIOL-CELL PH, V268, pC252, DOI 10.1152/ajpcell.1995.268.1.C252; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Muller OJ, 2003, CARDIOVASC RES, V59, P380, DOI 10.1016/S0008-6363(03)00429-2; Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285; Pan B, 2017, J CELL MOL MED, V21, P2481, DOI 10.1111/jcmm.13169; Quan JunJun, 2017, Journal of Third Military Medical University, V39, P436; Roychoudhury S, 2017, REPROD BIOMED ONLINE, V34, P487, DOI 10.1016/j.rbmo.2017.02.006; Sakata R, 2004, J HEPATOL, V40, P52, DOI 10.1016/S0168-8278(03)00477-X; Sakata S, 2007, J MOL CELL CARDIOL, V42, P852, DOI 10.1016/j.yjmcc.2007.01.003; Shareef MA, 2014, EUR J PHARMACOL, V724, P1, DOI 10.1016/j.ejphar.2013.12.018; Sheehan A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00243; Sheng R, 2009, PLANTA MED, V75, P113, DOI 10.1055/s-0028-1088387; Smith Robert E, 2016, Diseases, V4, DOI 10.3390/diseases4040034; Thakur VS, 2012, INT J ONCOL, V41, P353, DOI 10.3892/ijo.2012.1449; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zhang QC, 2022, IEEE T BIG DATA, V8, P25, DOI 10.1109/TBDATA.2017.2701816; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205123	10.1371/journal.pone.0205123	http://dx.doi.org/10.1371/journal.pone.0205123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286210	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500090
J	Rusz, D; Bijleveld, E; Kompier, MAJ				Rusz, Dorottya; Bijleveld, Erik; Kompier, Michiel A. J.			Reward-associated distractors can harm cognitive performance	PLOS ONE			English	Article							OCULOMOTOR CAPTURE; WORKING-MEMORY; ATTENTION; SEARCH; DRIVEN; CONFLICT; STIMULI; REVEALS; PURSUIT; HISTORY	When people carry out cognitive tasks, they sometimes suffer from distractions, that is, drops in performance that occur close in time to task-irrelevant stimuli. In this research, we examine how the pursuit of rewards contributes to distractions. In two experiments, participants performed a math task (in which they could earn monetary rewards vs. not) while they were exposed to task-irrelevant stimuli (that were previously associated with monetary rewards vs. not). In Experiment 1, irrelevant cues that were previously associated with rewards (vs. not) impaired performance. In Experiment 2, this effect was only replicated when these reward-associated distractors appeared relatively early during task performance. While the results were thus somewhat mixed, they generally support the idea that reward associations can augment the negative effect of distractors on performance.	[Rusz, Dorottya; Bijleveld, Erik; Kompier, Michiel A. J.] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands	Radboud University Nijmegen	Rusz, D (corresponding author), Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.	d.rusz@psych.ru.nl						Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Anderson BA, 2016, ANN NY ACAD SCI, V1369, P24, DOI 10.1111/nyas.12957; Anderson BA, 2014, BRAIN RES, V1587, P88, DOI 10.1016/j.brainres.2014.08.062; Anderson BA, 2012, ATTEN PERCEPT PSYCHO, V74, P1183, DOI 10.3758/s13414-012-0325-9; Anderson BA, 2012, VIS COGN, V20, P647, DOI 10.1080/13506285.2012.679711; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Asgeirsson AG, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00309; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Bijleveld E, 2012, J EXP PSYCHOL GEN, V141, P728, DOI 10.1037/a0027615; Bijleveld E, 2012, CURR DIR PSYCHOL SCI, V21, P194, DOI 10.1177/0963721412438463; Bijleveld E, 2011, J EXP SOC PSYCHOL, V47, P865, DOI 10.1016/j.jesp.2011.03.002; Bijleveld E, 2009, PSYCHOL SCI, V20, P1313, DOI 10.1111/j.1467-9280.2009.02443.x; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Bourgeois A, 2017, COGNITION EMOTION, V31, P109, DOI 10.1080/02699931.2015.1085366; Caird JK, 2014, ACCIDENT ANAL PREV, V71, P311, DOI 10.1016/j.aap.2014.06.005; Carr N., 2011, SHALLOWS WHAT INTERN; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Chambers CD, 2013, CORTEX, V49, P609, DOI 10.1016/j.cortex.2012.12.016; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; DeStefano D, 2004, EUR J COGN PSYCHOL, V16, P353, DOI 10.1080/09541440244000328; Failing M, 2018, PSYCHON B REV, V25, P514, DOI 10.3758/s13423-017-1380-y; Failing M, 2015, J NEUROPHYSIOL, V114, P2316, DOI 10.1152/jn.00441.2015; Flehmig H. C., 2007, PSYCHOL SCI, V49, P132; Garbers Y, 2014, J OCCUP ORGAN PSYCH, V87, P102, DOI 10.1111/joop.12039; Gazzaley A, 2016, DISTRACTED MIND: ANCIENT BRAINS IN A HIGH-TECH WORLD, P1; Gong MY, 2014, J EXP PSYCHOL HUMAN, V40, P841, DOI 10.1037/a0035131; Guo Y, 2015, AM J ORTHOD DENTOFAC, V147, P146, DOI 10.1016/j.ajodo.2014.10.009; Hassan R., 2011, AGE DISTRACTION READ; Heitz RP, 2008, PSYCHOPHYSIOLOGY, V45, P119, DOI 10.1111/j.1469-8986.2007.00605.x; Hickey C, 2015, J EXP PSYCHOL GEN, V144, P264, DOI 10.1037/a0038627; Hickey C, 2013, VISION RES, V92, P67, DOI 10.1016/j.visres.2013.09.008; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Infanti E, 2015, VISION RES, V107, P22, DOI 10.1016/j.visres.2014.11.008; Inzlicht M, 2014, TRENDS COGN SCI, V18, P127, DOI 10.1016/j.tics.2013.12.009; Jett QR, 2003, ACAD MANAGE REV, V28, P494, DOI 10.5465/amr.2003.10196791; Klink PC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08608-4; Kool W, 2014, J EXP PSYCHOL GEN, V143, P131, DOI 10.1037/a0031048; Krebs RM, 2010, COGNITION, V117, P341, DOI 10.1016/j.cognition.2010.08.018; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P875, DOI 10.1177/1948550617693058; Lakens D, 2014, EUR J SOC PSYCHOL, V44, P701, DOI 10.1002/ejsp.2023; Langner R, 2018, J EXP PSYCHOL HUMAN, V44, P1313, DOI 10.1037/xhp0000561; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; Le Pelley ME, 2016, PSYCHOL BULL, V142, P1111, DOI 10.1037/bul0000064; Le Pelley ME, 2015, J EXP PSYCHOL GEN, V144, P158, DOI 10.1037/xge0000037; Lee J, 2014, PSYCHOL SCI, V25, P466, DOI 10.1177/0956797613509284; Liljeholm M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001272; Los SA, 2017, J EXP PSYCHOL HUMAN, V43, P78, DOI 10.1037/xhp0000279; MacLean MH, 2015, BRAIN RES, V1606, P86, DOI 10.1016/j.brainres.2015.02.016; Miller J, 2002, J EXP PSYCHOL HUMAN, V28, P1364, DOI 10.1037//0096-1523.28.6.1364; Mueller J, 2007, EUR J NEUROSCI, V26, P3661, DOI 10.1111/j.1460-9568.2007.05949.x; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Oulasvirta A, 2012, PERS UBIQUIT COMPUT, V16, P105, DOI 10.1007/s00779-011-0412-2; Pessoa L, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00017; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Samaha M, 2016, COMPUT HUM BEHAV, V57, P321, DOI 10.1016/j.chb.2015.12.045; Sana F, 2013, COMPUT EDUC, V62, P24, DOI 10.1016/j.compedu.2012.10.003; Sanders A.F., 1998, ELEMENTS HUMAN PERFO, DOI 10.4324/9780203774250; Steinborn MB, 2017, PSYCHOL RES-PSYCH FO, V81, P1135, DOI 10.1007/s00426-016-0810-1; Steinborn MB, 2011, ACTA PSYCHOL, V136, P405, DOI 10.1016/j.actpsy.2011.01.008; Sykes ER, 2011, INT J INFORM MANAGE, V31, P385, DOI 10.1016/j.ijinfomgt.2010.10.010; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2012, VISION RES, V74, P80, DOI 10.1016/j.visres.2012.07.024; Henry H, 2016, PSYCHON B REV, V23, P1607, DOI 10.3758/s13423-016-1011-z; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zedelius CM, 2014, COGN AFFECT BEHAV NE, V14, P493, DOI 10.3758/s13415-013-0241-z; Zedelius CM, 2011, CONSCIOUS COGN, V20, P355, DOI 10.1016/j.concog.2010.05.001	71	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205091	10.1371/journal.pone.0205091	http://dx.doi.org/10.1371/journal.pone.0205091			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286146	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500083
J	Szymanski, L; Cios, A; Lewicki, S; Szymanski, P; Stankiewicz, W				Szymanski, Lukasz; Cios, Aleksandra; Lewicki, Slawomir; Szymanski, Pawel; Stankiewicz, Wanda			Fas/FasL pathway and cytokines in keratinocytes in atopic dermatitis - Manipulation by the electromagnetic field	PLOS ONE			English	Article							MAPK SIGNALING PATHWAYS; FAS LIGAND; STEM-CELLS; IN-VITRO; EXPOSURE; LEVEL; SKIN; ACTIVATION; RADIATION; APOPTOSIS	Background Atopic dermatitis (AD) is one of the most frequent skin diseases. Changes of the keratinocytes functionality play a major role in the development of AD. For example, activation of the Fas (CD95)/FasL (CD178) pathway in AD does not lead to extensive apoptosis in skin. Binding of the Fas receptor to its protein ligand-FasL, which are present on the (AD)-modified keratinocytes, should result in the sequential induction of cell death, but there is no evidence of extensive apoptosis of these cells. This suggests that non-apoptotic mechanism of Fas/FasL pathway is commonly encountered, although not examined in the case of AD, phenomenon. An electromagnetic field, which was used to influence cultured cells in this study, can modulate proliferation, apoptosis, differentiation, and metabolism in various cells. Objective Here, we evaluate the possibility to manipulate the immune activation of AD keratinocytes and their response to the electromagnetic field, which was not tested before. Methods Keratinocytes isolated from the skin of healthy subjects (n = 20) and patients with atopic dermatitis (n = 20) as well as HaCaT and PCS-200-010 cell were exposed to the 900 MHz electromagnetic field for 60 minutes. Cytometric analysis of viability, Fas/FasL, p-ERK, p-p38 and p-JNK expression and Luminex analysis of cytokine concentration were performed in two-time points: 4 and 24 hours after the exposition. Results This research has shown upregulated Fas, FasL, p-ERK, p-p38, and p-JNK expression along with increased cytokine secretion (IL-1 beta, IL-4, IL-8, IL-10, IL-12p70, IL-13, IL-17A, IL-31 and TNF alpha) by keratinocytes derived from the skin of patients with the AD when compared with healthy control. Exposure of keratinocyte cultures obtained from AD patients to EMF resulted in a decrease of 1 beta, IL-4, IL-10, IL-12, I L-13, IL-17, IL-31 and TNF alpha levels. Keratinocytes derived from the skin of AD patients are characterized by elevated Fas and FasL expression when compared to healthy control. Conclusion Apoptotic and nonapoptotic activation of the Fas/FasL-dependent signaling pathway may play a significant role in the pathogenesis of AD, by adjusting the local cytokine and chemokine environment at the site of inflammation. Moreover, the electromagnetic field exhibits strong immunomodulatory effects on AD-modified keratinocytes.	[Szymanski, Lukasz; Cios, Aleksandra; Szymanski, Pawel; Stankiewicz, Wanda] Mil Inst Hyg & Epidemiol, Dept Microwave Safety, Warsaw, Poland; [Lewicki, Slawomir] Mil Inst Hyg & Epidemiol, Dept Regenerat Med & Cell Biol, Warsaw, Poland	Military Institute of Hygiene & Epidemiology (MIHE); Military Institute of Hygiene & Epidemiology (MIHE)	Szymanski, L (corresponding author), Mil Inst Hyg & Epidemiol, Dept Microwave Safety, Warsaw, Poland.	lukas91.sz@gmail.com	Szymanski, Lukasz/HDM-8142-2022	Szymanski, Lukasz/0000-0003-0148-541X; Lewicki, Slawomir/0000-0002-0539-0680	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was funded by Polish Ministry of Science and Higher Education grant for Young Scientist.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Bien K, 2017, INFLAMM RES, P1; Boehm I, 2006, CURR MOL MED, V6, P375, DOI 10.2174/156652406777435390; Bort A, 2017, MOL PAIN, V13, P1, DOI 10.1177/1744806916688220; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; D'Angelo C, 2015, SAUDI J BIOL SCI, V22, P75, DOI 10.1016/j.sjbs.2014.07.006; Dabrowski MP, 2003, ELECTROMAGN BIOL MED, V22, P1, DOI 10.1081/JBC-120020347; Farley SM, 2006, J INVEST DERMATOL, V126, P2438, DOI 10.1038/sj.jid.5700477; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Huang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113424; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kennedy NJ, 2010, HDB CELL SIGNALING, P1315, DOI [10.1016/B978-0-12-374145-5.00164-9, DOI 10.1016/B978-0-12-374145-5.00164-9]; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kjellerup RB, 2008, EXP DERMATOL, V17, P498, DOI 10.1111/j.1600-0625.2007.00672.x; Lee SH, 1998, BRIT J DERMATOL, V139, P186; Leshem YA, 2015, BRIT J DERMATOL, V172, P1353, DOI 10.1111/bjd.13662; Lesniak M, 2018, TISSUE ENG REGEN MED, V15, P211, DOI 10.1007/s13770-017-0103-9; Lu B, 2002, AM J PHYSIOL-CELL PH, V283, pC831, DOI 10.1152/ajpcell.00045.2002; Maier E, 2014, J IMMUNOL, V193, P645, DOI 10.4049/jimmunol.1301836; Mutou Y, 2010, J HEALTH SCI, V56, P675, DOI 10.1248/jhs.56.675; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Nylund R, 2004, PROTEOMICS, V4, P1359, DOI 10.1002/pmic.200300773; Patruno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139644; Rosado MM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00085; Sobiech Jaromir, 2015, Przeglad Elektrotechniczny, V91, P218, DOI 10.15199/48.2015.12.56; Stankiewicz W, 2006, ELECTROMAGN BIOL MED, V25, P45, DOI 10.1080/15368370600572961; Sun YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40605; Tan Q, 2017, MOL MED REP, V16, P8863, DOI 10.3892/mmr.2017.7689; Wajant H, 2003, CYTOKINE GROWTH F R, V14, P53, DOI 10.1016/S1359-6101(02)00072-2; Wolf-Goldberg T, 2013, BBA-MOL CELL RES, V1833, P1396, DOI 10.1016/j.bbamcr.2013.02.011; Wu D, 2013, CELL BIOCHEM BIOPHYS, V67, P1115, DOI 10.1007/s12013-013-9615-7; Zhang HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026805; Zhi WJ, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-017-0139-0; Zmyslony M, 2004, BIOELECTROMAGNETICS, V25, P324, DOI 10.1002/bem.10191	34	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205103	10.1371/journal.pone.0205103	http://dx.doi.org/10.1371/journal.pone.0205103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286163	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500085
J	Allen, KD; Regier, MJ; Hsieh, C; Tsokas, P; Barnard, M; Phatarpekar, S; Wolk, J; Sacktor, TC; Fenton, AA; Hernandez, AI				Allen, Kim D.; Regier, Matthew J.; Hsieh, Changchi; Tsokas, Panayiotis; Barnard, Maya; Phatarpekar, Shwetha; Wolk, Jason; Sacktor, Todd C.; Fenton, Andre A.; Hernandez, A. Ivan			Learning-induced ribosomal RNA is required for memory consolidation in mice-Evidence of differentially ex-pressed rRNA variants in learning and memory	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; LONG-TERM FACILITATION; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; GENE-EXPRESSION; NUCLEOLUS; APLYSIA; RDNA; TURNOVER; DISEASE	The transition from short-term to long-term forms of synaptic plasticity requires protein synthesis and new gene expression. Most efforts to understand experience-induced changes in neuronal gene expression have focused on the transcription products of RNA polymerase II-primarily mRNAs and the proteins they encode. We recently showed that nucleolar integrity and activity-dependent ribosomal RNA (rRNA) synthesis are essential for the maintenance of hippocampal long-term potentiation (LTP). Consequently, the synaptic plasticity and memory hypothesis predicts that nucleolar integrity and activity dependent rRNA synthesis would be required for Long-term memory (LTM). We tested this prediction using the hippocampus-dependent, Active Place Avoidance (APA) spatial memory task and found that training induces de novo rRNA synthesis in mouse dorsal hippocampus. This learning-induced increase in nucleolar activity and rRNA synthesis persists at least 24 h after training. In addition, intra-hippocampal injection of the Pol I specific inhibitor, CX-5461 prior to training, revealed that de novo rRNA synthesis is required for 24 h memory, but not for learning. Using qPCR to assess activity-dependent changes in gene expression, we found that of seven known rRNA expression variants (v-rRNAs), only one, v-rRNA IV, is significantly upregulated right after training. These data indicate that learning induced v-rRNAs are crucial for LTM, and constitute the first evidence that differential rRNA gene expression plays a role in memory.	[Allen, Kim D.; Regier, Matthew J.; Barnard, Maya; Phatarpekar, Shwetha; Hernandez, A. Ivan] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Allen, Kim D.] CUNY Medgar Evers Coll, Sch Sci Hlth & Technol, Dept Biol, Brooklyn, NY 11225 USA; [Regier, Matthew J.; Phatarpekar, Shwetha] Suny Downstate Med Ctr, Grad Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Hsieh, Changchi; Tsokas, Panayiotis; Sacktor, Todd C.; Fenton, Andre A.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Tsokas, Panayiotis; Sacktor, Todd C.] Suny Downstate Med Ctr, Dept Anesthesiol, Brooklyn, NY 11203 USA; [Wolk, Jason] NYU, Dept Phys, 4 Washington Pl, New York, NY 10003 USA; [Sacktor, Todd C.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Sacktor, Todd C.; Fenton, Andre A.; Hernandez, A. Ivan] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Hernandez, AI (corresponding author), Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA.; Hernandez, AI (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA.	ivan.hernandez@downstate.edu		Regier, Matthew/0000-0002-4641-3316; Allen, Kim D/0000-0001-9774-5014; Hsieh, Changchi/0000-0003-0488-1565; tsokas, panayiotis/0000-0002-1679-8980	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057068] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH057068] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Allen KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104364; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bellavia D, 2016, GENE, V580, P118, DOI 10.1016/j.gene.2016.01.010; Capitano F, 2016, J NEUROCHEM, V136, P706, DOI 10.1111/jnc.13504; CASTELLUCCI VF, 1986, J PHYSIOL-PARIS, V81, P349; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Dimarco E, 2012, GENE, V508, P21, DOI 10.1016/j.gene.2012.07.067; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; Goosens KA, 2002, HIPPOCAMPUS, V12, P592, DOI 10.1002/hipo.10099; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hernandez A Ivan, 2015, Commun Integr Biol, V8, pe1017163, DOI 10.1080/19420889.2015.1017163; Hernandez AI, 2009, J NEUROSCI, V29, P9553, DOI 10.1523/JNEUROSCI.1512-09.2009; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002; Higa-Nakamine S, 2012, NUCLEIC ACIDS RES, V40, P391, DOI 10.1093/nar/gkr700; HIRSCH CA, 1966, J BIOL CHEM, V241, P5936; Ihara M, 2011, BIOL REPROD, V84, P944, DOI 10.1095/biolreprod.110.089680; JUNERA HR, 1995, J CELL SCI, V108, P3427; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KATZ JOSEPH J., 1950, COMPAR PSYCHOL MONOGR, V20, P1; Kiryk A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00207; Kuo BA, 1996, NUCLEIC ACIDS RES, V24, P4817, DOI 10.1093/nar/24.23.4817; Lee J, 2014, BBA-MOL BASIS DIS, V1842, P785, DOI 10.1016/j.bbadis.2013.09.017; Lesburgueres E, 2016, HIPPOCAMPUS, V26, P1481, DOI 10.1002/hipo.22666; Li DF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04072-4; Mathis AD, 2017, MOL CELL PROTEOMICS, V16, P243, DOI 10.1074/mcp.M116.063255; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; NIKOLOV EN, 1983, INT J BIOCHEM, V15, P1255, DOI 10.1016/0020-711X(83)90215-X; Parks MM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao0665; Parlato R, 2014, BBA-MOL BASIS DIS, V1842, P791, DOI 10.1016/j.bbadis.2013.12.014; Parlato R, 2013, J MOL MED, V91, P541, DOI 10.1007/s00109-012-0981-1; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pavlowsky A, 2017, NEUROBIOL LEARN MEM, V138, P182, DOI 10.1016/j.nlm.2016.08.015; Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585; Pontvianne F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001225; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Shiao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022266; Tseng H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001843; Tsokas P, 2016, ELIFE, V5, DOI 10.7554/eLife.14846; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Waters AP, 1997, J BIOL CHEM, V272, P3583, DOI 10.1074/jbc.272.6.3583; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Zeng JY, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8987928	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203374	10.1371/journal.pone.0203374	http://dx.doi.org/10.1371/journal.pone.0203374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281601	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400020
J	Chen, YM; Tu, YK; Yu, HW; Chiu, TY; Chiang, TL; Chen, DR; Chang, RE				Chen, Ya-Mei; Tu, Yu-Kang; Yu, Hsiao-Wei; Chiu, Tzu-Ying; Chiang, Tung-Liang; Chen, Duan-Rung; Chang, Ray-E			Leisure time activities as mediating variables in functional disability progression: An application of parallel latent growth curve modeling	PLOS ONE			English	Article							LATE-LIFE DISABILITY; OLDER-ADULTS; PHYSICAL-ACTIVITY; UNITED-STATES; FOLLOW-UP; TRENDS; AGE; TRAJECTORIES; PREVALENCE; MORTALITY	Objectives The aims of this study were to investigate (1) whether and (2) the extent to which Taiwanese older adults' leisure time activity (LTA) trajectories mediated the potential association between their sociodemographic factors and their functional disability trajectories. Methods Longitudinal data from four waves of the Taiwan Longitudinal Study on Aging (TLSA), collected between 1996 and 2007, were used for analysis (N = 3,429). Parallel-process latent growth curve modeling was adopted to evaluate the process by which LTA mediated between sociodemographic factors (age, gender, education, self-rated health, comorbidities, and depression) and the outcome process of functional disabilities. Results When mediated by baseline level of LTA, five sociodemographic factors-age, gender, education level, self-rated health, and number of comorbidities-had significant and negative mediating effects on baseline or change in functional disability, thus improving disability outcomes. However, four of the sociodemographic factors (age, education level, and number of comorbidities), when mediated through the rate of change in LTA, were found to have significant and positive mediating effects, which increased disability levels. The proportion of effects mediated by the LTA trajectory ranged from 0% to 194%. Discussion The large proportion of effects mediated through the LTA process underlines the importance of LTA to public health policy and health programs for older adults. The study's findings shed light on how to better target populations of older adults to promote an active lifestyle and achieve more successful aging in late life in Asian countries.	[Chen, Ya-Mei; Chiang, Tung-Liang; Chang, Ray-E] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei, Taiwan; [Tu, Yu-Kang] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Xu Zhou Rd, Taipei, Taiwan; [Yu, Hsiao-Wei] Chang Gung Univ Sci & Technol, Dept Gerontol Care & Management, Taoyuan, Taiwan; [Chiu, Tzu-Ying] Tzu Chi Univ Sci & Technol, Grad Inst Long Term Care, Hualien, Taiwan; [Chen, Duan-Rung] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Behav & Community Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; Chang Gung University of Science & Technology; Tzu Chi University of Science & Technology; National Taiwan University	Chen, YM (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei, Taiwan.; Tu, YK (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Xu Zhou Rd, Taipei, Taiwan.	chenyamei@ntu.edu.tw; yukangtu@ntu.edu.tw		CHANG, RAY-E/0000-0003-3891-5313; CHIANG, TUNG-LIANG/0000-0002-7876-3943; Tu, Yu-Kang/0000-0002-2461-474X	Ministry of Science and Technology; National Science Council of Taiwan [NSC 101-2410-H-002-212-MY2, MOST 103-2410-H-002-146, MOST 106-2811-H-002-018]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study received funding support from the Ministry of Science and Technology and the National Science Council of Taiwan (NSC 101-2410-H-002-212-MY2, MOST 103-2410-H-002-146, MOST 106-2811-H-002-018) to YMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, ADV FACTOR ANAL STRU; Bengtsson S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173659; Bentler PM., 1999, STRUCTURAL EQUATION, V6; Bentler PM, 1990, PSYCHOL BULL, P107; Bishop J, 2015, PSYCHOL METHODS, V20, P43, DOI 10.1037/met0000018; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Chao SF, 2016, GERONTOLOGIST, V56, P397, DOI 10.1093/geront/gnu052; Chen CM, 2015, GERIATR GERONTOL INT, V15, P156, DOI 10.1111/ggi.12243; Chen CM, 2012, J GERONTOL A-BIOL, V67, P1059, DOI 10.1093/gerona/gls074; Chen YM, 2016, INT J BEHAV MED, V23, P697, DOI 10.1007/s12529-016-9554-y; Chen YM, 2015, ARCH GERONTOLOGY GER; Cheong J, 2003, STRUCT EQU MODELING, V10, P238, DOI 10.1207/S15328007SEM1002_5; Chiu YC, 2013, INT J NURS STUD, V50, P1314, DOI 10.1016/j.ijnurstu.2013.01.002; Chou KL, 2008, J AGING HEALTH, V20, P385, DOI 10.1177/0898264308315852; Duncan T, 2006, INTRO LATENT VARIABL; Everard KM, 2000, J GERONTOL B-PSYCHOL, V55, pS208, DOI 10.1093/geronb/55.4.S208; Feng Lei, 2011, J Aging Res, V2011, P960848, DOI 10.4061/2011/960848; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gooloo S, 2009, IMPROVING MEASUREMEN; Hancock GR, 2001, STRUCT EQU MODELING, V8, P470, DOI 10.1207/S15328007SEM0803_7; Hung WW, 2012, MED CARE, V50, P501, DOI 10.1097/MLR.0b013e318245a0e0; Janke MC, 2008, INT J AGING HUM DEV, V67, P231, DOI 10.2190/AG.67.3.c; Kane RA, 1981, ASSESSING ELDERLY PR; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; Kline R.B., 2011, PRINCIPLES PRACTICE; Kmetic A, 2002, EPIDEMIOLOGY, V13, P437, DOI 10.1097/00001648-200207000-00012; Ku PW, 2012, AM J PREV MED, V42, P355, DOI 10.1016/j.amepre.2011.11.010; Liang J, 2010, SOC SCI MED, V71, P1208, DOI 10.1016/j.socscimed.2010.05.007; Lin YP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-428; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Martin LG, 2011, POP STUD-J DEMOG, V65, P289, DOI 10.1080/00324728.2011.604730; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Muthen B, 2011, APPL CAUSALLY DEFINE; Muthen L, GROWTH MODELING LATE, P1; Muthen L.K., 2009, MPLUS USERS GUIDE; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; Paganini-Hill A, 2011, J GERONTOL A-BIOL, V66, P559, DOI 10.1093/gerona/glq237; Palacios-Cena D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-799; Park I, 2005, RES Q EXERCISE SPORT, V76, P176, DOI 10.1080/02701367.2005.10599279; Preacher K.J., 2008, LATENT GROWTH CURVE; Puts MTE, 2008, AGE AGEING, V37, P187, DOI 10.1093/ageing/afm185; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; ROGOSA D, 1982, PSYCHOL BULL, V92, P726, DOI 10.1037/0033-2909.92.3.726; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Schutte H YP, 1997, LEISURE BEHAV ASIA I; Sorman DE, 2014, J GERONTOL B-PSYCHOL, V69, P493, DOI 10.1093/geronb/gbt056; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stenholm S, 2015, J GERONTOL A-BIOL, V70, P330, DOI 10.1093/gerona/glu113; Strain LA, 2002, GERONTOLOGIST, V42, P217, DOI 10.1093/geront/42.2.217; Strobl R, 2014, PREV MED, V62, P8, DOI 10.1016/j.ypmed.2014.01.017; Sulander T, 2006, INT J EPIDEMIOL, V35, P1255, DOI 10.1093/ije/dyl183; Wang HX, 2012, BBA-MOL BASIS DIS, V1822, P482, DOI 10.1016/j.bbadis.2011.09.002; Yu HW, 2018, J APPL GERONTOL, V37, P706, DOI 10.1177/0733464816650800; Zimmer Z, 2014, J GERONTOL B-PSYCHOL, V69, P275, DOI 10.1093/geronb/gbt099	54	9	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203757	10.1371/journal.pone.0203757	http://dx.doi.org/10.1371/journal.pone.0203757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281590	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400027
J	Hirota, Y; Nakagawa, K; Isomoto, K; Sakaki, T; Kubodera, N; Kamao, M; Osakabe, N; Suhara, Y; Okano, T				Hirota, Yoshihisa; Nakagawa, Kimie; Isomoto, Keigo; Sakaki, Toshiyuki; Kubodera, Noboru; Kamao, Maya; Osakabe, Naomi; Suhara, Yoshitomo; Okano, Toshio			Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice	PLOS ONE			English	Article							VITAMIN-D ANALOG; BONE-MINERAL DENSITY; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; OSTEOPOROTIC PATIENTS; POSTMENOPAUSAL WOMEN; CALCIUM-METABOLISM; D-RECEPTOR; RAT MODEL; GENE; ED-71	Calcium (Ca) absorption from the intestinal tract is promoted by active vitamin D (1 alpha,25D(3)). Vitamin D not only promotes Ca homeostasis, but it also inhibits bone resorption and promotes osteogenesis, thus playing a role in the maintenance of normal bone metabolism. Because 1 alpha,25D(3) plays an important role in osteogenesis, vitamin D formulations, such as alfacalcidol (ALF) and eldecalcitol (ELD), are used for treating osteoporosis. While it is known that, in contrast to ALF, ELD is an active ligand that directly acts on bone, the reason for its superior osteogenesis effects is unknown. Cyp27b1-knockout mice (Cyp27b1(-/-)mice) are congenitally deficient in 1 alpha,25D(3) and exhibit marked hypocalcemia and high parathyroid hormone levels, resulting in osteodystrophy involving bone hypocalcification and growth plate cartilage hypertrophy. However, because the vitamin D receptor is expressed normally in Cyp27b1(-/-)mice, they respond normally to 1 alpha,25D(3). Accordingly, in Cyp27b1(-/-)mice, the pharmacological effects of exogenously administered active vitamin D derivatives can be analyzed without being affected by 1 alpha,25D(3). We used Cyp27b1(-/-)mice to characterize and clarify the superior osteogenic effects of ELD on the bone in comparison with ALF. The results indicated that compared to ALF, ELD strongly induces ECaC2, calbindin-D-9k, and CYP24A1 in the duodenum, promoting Ca absorption and decreasing the plasma concentration of 1 alpha,25D(3), resulting in improved osteogenesis. Because bone morphological measurements demonstrated that ELD has stronger effects on bone calcification, trabecular formation, and cancellous bone density than ALF, ELD appears to be a more effective therapeutic agent for treating postmenopausal osteoporosis, in which cancellous bone density decreases markedly. By using Cyp27b1(-/-)mice, this study was the first to succeed in clarifying the osteogenic effect of ELD without any influence of endogenous 1 alpha,25D(3).	[Hirota, Yoshihisa] Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Lab Biochem,Minuma Ku, Saitama, Japan; [Hirota, Yoshihisa; Nakagawa, Kimie; Isomoto, Keigo; Kamao, Maya; Okano, Toshio] Kobe Pharmaceut Univ, Lab Hygien Sci, Higashinada Ku, Motoyamakita Machi, Kobe, Hyogo, Japan; [Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Dept Pharmaceut Engn, Imizu, Toyama, Japan; [Kubodera, Noboru] Int Inst Act Vitamin D Analogs, Mishima, Shizuoka, Japan; [Osakabe, Naomi] Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Food & Nutr Lab,Minuma Ku, Saitama, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Lab Organ Synth & Med Chem,Minuma Ku, Saitama, Japan	Shibaura Institute of Technology; Kobe Pharmaceutical University; Toyama Prefectural University; Shibaura Institute of Technology; Shibaura Institute of Technology	Hirota, Y (corresponding author), Shibaura Inst Technol, Coll Syst Engn & Sci, Dept Biosci & Engn, Lab Biochem,Minuma Ku, Saitama, Japan.; Hirota, Y; Okano, T (corresponding author), Kobe Pharmaceut Univ, Lab Hygien Sci, Higashinada Ku, Motoyamakita Machi, Kobe, Hyogo, Japan.	hirotay@shibaura-it.ac.jp; t-okano@kobepharma-u.ac.jp	Hirota, Yoshihisa/R-6741-2019	Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	JSPS [17K00900, 18K11056, 16K18924]; Precise Measurement Technology Promotion Foundation (PMTP-F)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Precise Measurement Technology Promotion Foundation (PMTP-F)	This work was supported in part by a Grant-in-aid for Scientific Research (C) [grant number 17K00900:https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-17K00900/ and 18K11056:https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-18K11056/] from JSPS and a grant-in-aid for Scientific Research Young Scientists (B) (grant number 16K18924:https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-16K18924/) from JSPS. This work was partly supported by the Precise Measurement Technology Promotion Foundation (PMTP-F)http://www.pmtp-f.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe D, 2005, DRUG METAB DISPOS, V33, P778, DOI 10.1124/dmd.104.003038; Akiyama H, 1996, J BONE MINER RES, V11, P22; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Colnot S, 2000, ENDOCRINOLOGY, V141, P2301, DOI 10.1210/en.141.7.2301; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; Dardenne O, 2004, J STEROID BIOCHEM, V89-90, P327, DOI 10.1016/j.jsbmb.2004.03.026; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Darwish Hisham, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P89; GALANTE L, 1972, NATURE, V238, P271, DOI 10.1038/238271a0; GILL RK, 1993, P NATL ACAD SCI USA, V90, P2984, DOI 10.1073/pnas.90.7.2984; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Hatakeyama S, 2006, BIOORGAN MED CHEM, V14, P8050, DOI 10.1016/j.bmc.2006.07.039; Hayashi Y., 1992, J BONE MINER METAB, V10, P184; Hirota Y, 2017, BIOCHEM BIOPH RES CO, V483, P359, DOI 10.1016/j.bbrc.2016.12.139; IKEDA T, 1992, BIOCHEM BIOPH RES CO, V189, P1231, DOI 10.1016/0006-291X(92)92336-V; Ishizawa M, 2008, J LIPID RES, V49, P763, DOI 10.1194/jlr.M700293-JLR200; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Kubodera N, 2003, J CELL BIOCHEM, V88, P286, DOI 10.1002/jcb.10346; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; MIYAMOTO K, 1993, CHEM PHARM BULL, V41, P1111; MORIMOTO S, 1989, BIOCHEM INT, V19, P1143; MURAYAMA E, 1986, CHEM PHARM BULL, V34, P4410; OHYAMA Y, 1993, BIOCHEMISTRY-US, V32, P76, DOI 10.1021/bi00052a011; OKANO T, 1989, BIOCHEM BIOPH RES CO, V163, P1444, DOI 10.1016/0006-291X(89)91140-6; Okuda N, 2007, BONE, V40, P281, DOI 10.1016/j.bone.2006.08.017; ORIMO H, 1994, CALCIFIED TISSUE INT, V54, P370, DOI 10.1007/BF00305521; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; Parfitt AM, 2002, BONE, V30, P807, DOI 10.1016/S8756-3282(02)00735-4; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Sairanen S, 2000, CALCIFIED TISSUE INT, V67, P122, DOI 10.1007/s00223001118; Saito H, 2013, J STEROID BIOCHEM, V136, P178, DOI 10.1016/j.jsbmb.2012.10.004; Sanford M, 2011, DRUGS, V71, P1755, DOI 10.2165/11206790-000000000-00000; Serizawa K, 2016, J ENDOCRINOL, V228, P75, DOI 10.1530/JOE-15-0332; Shams-White MM, 2017, AM J CLIN NUTR, V105, P1528, DOI 10.3945/ajcn.116.145110; Shiraishi A, 2002, CALCIFIED TISSUE INT, V71, P69, DOI 10.1007/s00223-001-2090-y; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; TSURUKAMI H, 1994, CALCIFIED TISSUE INT, V54, P142, DOI 10.1007/BF00296065; Uchiyama Y, 2002, BONE, V30, P582, DOI 10.1016/S8756-3282(02)00682-8; Vanhooke JL, 2006, P NATL ACAD SCI USA, V103, P75, DOI 10.1073/pnas.0509734103; Yasuda K, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.120	42	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0199856	10.1371/journal.pone.0199856	http://dx.doi.org/10.1371/journal.pone.0199856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281599	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400004
J	Jonas, JB; Wei, WB; Xu, L; Wang, YX				Jonas, Jost B.; Wei, Wen Bin; Xu, Liang; Wang, Ya Xing			Systemic inflammation and eye diseases. The Beijing Eye Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; COMPLEMENT FACTOR-H; POLYPOIDAL CHOROIDAL VASCULOPATHY; TYPE-2 DIABETES-MELLITUS; MACULAR DEGENERATION; COGNITIVE IMPAIRMENT; RISK-FACTORS; RETINOPATHY; ASSOCIATION; PREVALENCE	Purpose Systemic inflammation is potentially associated with ocular diseases such as late age-related macular degeneration (AMD). Using the serum concentration of high-sensitive C-reactive protein (hs-CRP) as surrogate of systemic inflammation, we examined potential associations between the serum hs-CRP concentration and the presence and degree of eye diseases. Methods The population-based Beijing Eye Study included 3468 Chinese individuals. The study participants underwent a standardized interview and a detailed ophthalmic examination. The serum concentration of hs-CRP was determined. Results Out of 3468 participants, 2452 (70.7%) individuals (mean age:63.4 +/- 9.4 year; range:50-91 years) had hs-CRP measurements (mean:1.96 +/- 4.07mg/L). In multivariate analysis, higher serum concentration of hs-CRP was significantly (regression coefficient r: 0.21) associated with a higher level of diabetic retinopathy (P= 0.007; standardized regression coefficient beta:0.06; non-standardized regression coefficient B:1.35; 95% confidence interval (CI):0.37,2.22) and polypoidal choroidal vasculopathy (P= 0.002;beta:0.06;B:6.22;95% CI:2.24,10.2) after adjusting for higher serum concentration of high-density lipoproteins (P<0.001;beta:-0.12;B:-1.31;95%CI:-1.77,-0.85), higher body mass index (P= 0.01; beta:0.06;B:0.06;95%CI:0.01, 0.11), lower level of education (P = 0.04;beta:-0.06;B:0.22;95%CI:-0.42,-0.02), lower cognitive function score (P= 0.01;beta:-0.07;B:-0.08;95% CI:-0.13,-0.02). If the presences of other ocular diseases were added to the model, the presence of glaucoma (P = 0.99), open-angle glaucoma (P = 0.80), angle-closure glaucoma (P= 0.67), pseudoexfoliation (P = 0.18), nuclear cataract (P = 0.30), cortical cataract (P = 0.15), subcapsular cataract (P= 0.59), retinal vein occlusions (P= 0.33), central serous choroidopathy (P = 0.44), early stage of age-related macular degeneration (AMD) (P = 0.46), intermediate stage of AMD (P= 0.20) and late stage of AMD (P= 0.91) including geographic atrophy (P= 0.60) or neovascular AMD (P= 0.68) were not significantly associated with the serum concentration of hs-CRP. Conclusions In Chinese aged 50+ years, higher serum concentration of hs-CRP was significantly associated with a higher level of diabetic retinopathy and higher frequency of polypoidal choroidal vasculopathy. Other major ocular disorders, namely glaucoma including open-angle glaucoma and angle-closure glaucoma, pseudoexfoliation, nuclear, cortical or subcapsular cataract, retinal vein occlusions, central serous choroidopathy, early, intermediate or late stage of AMD including geographic atrophy, were not significantly associated with hs-CRP serum concentrations. It suggests that these diseases, in contrast to diabetic retinopathy and polypoidal choroidal vasculopathy, were not associated with a major systemic inflammatory component.	[Jonas, Jost B.; Xu, Liang; Wang, Ya Xing] Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Tongren Eye Ctr,Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Wang, YX (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Tongren Eye Ctr,Beijing Inst Ophthalmol, Beijing, Peoples R China.; Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	weiwenbintr@163.com; yaxingw@gmail.com	wang, YA XING/K-9671-2016; wei, wei/HHR-8613-2022	wang, YA XING/0000-0003-2749-7793; Jonas, Jost/0000-0003-2972-5227	National Natural Science Foundation of China [81570835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by National Natural Science Foundation of China (grant # 81570835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Aryan Z, 2018, ANN NUTR METAB, V72, P287, DOI 10.1159/000488537; Cheng HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110818; Chirco KR, 2016, J PATHOL, V240, P173, DOI 10.1002/path.4766; Chuengsamarn S, 2017, DIABETES METAB SYND, V11, P103, DOI 10.1016/j.dsx.2016.08.012; Cipriani V, 2017, JAMA OPHTHALMOL, V135, P909, DOI 10.1001/jamaophthalmol.2017.2191; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dong N, 2015, INVEST OPHTH VIS SCI, V56, P4177, DOI 10.1167/iovs.15-16470; Feng XF, 2009, OPHTHALMOLOGY, V116, P1908, DOI 10.1016/j.ophtha.2009.03.011; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Jonas JB, 2009, ACTA OPHTHALMOL, V87, P247, DOI 10.1111/j.1755-3768.2008.01385.x; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kikuchi M, 2007, OPHTHALMOLOGY, V114, P1722, DOI 10.1016/j.ophtha.2006.12.021; Laursen JVN, 2013, CURR EYE RES, V38, P174, DOI 10.3109/02713683.2012.713153; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P4458, DOI 10.1167/iovs.09-4939; Noble JM, 2010, ARCH NEUROL-CHICAGO, V67, P87, DOI 10.1001/archneurol.2009.308; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Peng DF, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0006-5; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Roberts RO, 2009, ALZHEIMERS DEMENT, V5, P398, DOI 10.1016/j.jalz.2009.01.025; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; Sakurada Y, 2015, OPHTHALMIC RES, V53, P2, DOI 10.1159/000365487; Sasongko MB, 2015, DIABETIC MED, V32, P686, DOI 10.1111/dme.12640; Schaumberg DA, 2006, INVEST OPHTH VIS SCI, V47, P2336, DOI 10.1167/iovs.05-1456; Seddon JM, 2010, OPHTHALMOLOGY, V117, P1560, DOI 10.1016/j.ophtha.2009.11.020; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Song J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144406; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; Yan YN, 2015, OPHTHALMOLOGY, V122, P1873, DOI 10.1016/j.ophtha.2015.05.031; Yang HS, 2014, INVEST OPHTH VIS SCI, V55, P5989, DOI 10.1167/iovs.14-14864; Yang XF, 2016, INT J OPHTHALMOL-CHI, V9, P111, DOI 10.18240/ijo.2016.01.19; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhou JQ, 2013, OPHTHALMOLOGY, V120, P803, DOI 10.1016/j.ophtha.2012.09.033; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	39	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204263	10.1371/journal.pone.0204263	http://dx.doi.org/10.1371/journal.pone.0204263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281641	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400046
J	Malik, NA				Malik, Nadeem A.			Turbulent particle pair diffusion: A theory based on local and non-local diffusional processes	PLOS ONE			English	Article							RELATIVE DISPERSION; 2-PARTICLE DISPERSION; HOMOGENEOUS TURBULENCE; ISOTROPIC TURBULENCE; TRACKING VELOCIMETRY; 3-DIMENSIONAL FLOWS; FLUID; SIMULATION	A re-appraisal of the Richardson's 1926 dataset [Richardson, L. F. Proc. Roy. Soc. Lond. A 100, 709-737, (1926)] displays an unequivocal non-local scaling for the pair diffusion coefficient, K similar to sigma(1.564)(l), quite different to the previously assumed locality scaling law similar to sigma(4/3)(l), where sigma(l) is the pair separation. Consequently, the foundations of turbulent pair diffusion theory are re-examined here and it is shown that pair diffusion is governed by both local and non-local diffusional processess inside the inertial subrange. In the context of generalised energy spectra, E(k) similar to K-p for 1 < p <= 3, the new theory predicts two non-Richardson regimes depending on the size of the inertial subrange: (1) in the limit of asymptotically infinite subrange, non-local scaling laws is obtained, K similar to sigma(gamma)(l), with y intermediate between the purely local and the purely non-local scalings, i.e. (1 +p)/2 < y <= 2; and (2) for finite (short) inertial subrange, local scaling laws are obtained, K similar to sigma l((1+p)/2). The theory features a novel mathematical approach expressing the pair diffusion coefficient through a Fourier integral decomposition.	[Malik, Nadeem A.] King Fand Univ Petr & Minerals, Dept Math & Stat, POB 5046, Dhahran 31261, Saudi Arabia; [Malik, Nadeem A.] Florida Atlantic Univ, Charles E Schmidt Coll Sci, Dept Math & Stat, Boca Raton, FL 33431 USA	King Fahd University of Petroleum & Minerals; State University System of Florida; Florida Atlantic University	Malik, NA (corresponding author), King Fand Univ Petr & Minerals, Dept Math & Stat, POB 5046, Dhahran 31261, Saudi Arabia.; Malik, NA (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Sci, Dept Math & Stat, Boca Raton, FL 33431 USA.	nadeem_malik@cantab.net	Malik, Nadeem/D-4883-2015	Malik, Nadeem/0000-0001-5053-9360	Saudi Arabian Basic Industries Corporation (SABIC) [SB101011]; SABIC [SB101011]	Saudi Arabian Basic Industries Corporation (SABIC); SABIC	Saudi Arabian Basic Industries Corporation (SABIC). SB101011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank SABIC for funding this work through project number SB101011, and the ITC Department at KFUPM for making available the High Performance Computing facility for this project.	Akerblom F., 1908, NOVA ACTA REG SOC UP; Batchelor G. K., 1953, THEORY HOMOGENEOUS T; BATCHELOR GK, 1952, P CAMB PHILOS SOC, V48, P345, DOI 10.1017/S0305004100027687; Benzi R., 2011, VOAYAGE TURBULENCE; Berg J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016304; Berloff PS, 2002, J PHYS OCEANOGR, V32, P764, DOI 10.1175/1520-0485(2002)032<0764:MTIOGP>2.0.CO;2; Biferale L, 2014, J FLUID MECH, V757, P550, DOI 10.1017/jfm.2014.515; Bitane R, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.045302; Boffetta G, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/36/363001; Boffetta G, 2002, PHYS FLUIDS, V14, P3224, DOI 10.1063/1.1498121; Boffetta G, 2000, PHYSICA A, V280, P1, DOI 10.1016/S0378-4371(99)00613-5; Boradwell J. F., 1988, J FLUID MECH, V125, P397, DOI [10.1017/S0022112082003401, DOI 10.1017/S0022112082003401]; Bourgoin M, 2006, SCIENCE, V311, P835, DOI 10.1126/science.1121726; Defant A., GEOGAF ANN, V3, P209; Defant A., 1921, WIEN AKAD WISS SI 2A, V130, P401; DURBIN PA, 1980, J FLUID MECH, V100, P279, DOI 10.1017/S0022112080001152; EuHIT, DAT TRAJ; Eyink GL, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.023011; Falkovich G, 2001, REV MOD PHYS, V73, P913, DOI 10.1103/RevModPhys.73.913; FUNG JCH, 1992, J FLUID MECH, V236, P281, DOI 10.1017/S0022112092001423; Fung JCH, 1996, FLUID MEC A, V36, P617; Huber M, 2001, J ATMOS SCI, V58, P2377, DOI 10.1175/1520-0469(2001)058<2377:ACOTDI>2.0.CO;2; Ishihara T, 2002, PHYS FLUIDS, V14, pL69, DOI 10.1063/1.1508443; Ishihara T, 2009, ANNU REV FLUID MECH, V41, P165, DOI 10.1146/annurev.fluid.010908.165203; Johns Hopkins University, TURB DAT; Jorgensen JB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1863259; Julian P., 1977, Bulletin of the American Meteorological Society, V58, P936, DOI 10.1175/1520-0477(1977)058<0936:TTE>2.0.CO;2; Jullien MC, 1999, PHYS REV LETT, V82, P2872, DOI 10.1103/PhysRevLett.82.2872; Kay G. W. C., 1982, PHYS CHEM CONSTANTS, VI; KLAFTER J, 1987, PHYS REV A, V35, P3081, DOI 10.1103/PhysRevA.35.3081; Klafter J., 1987, REV GEOPHYS, V58, P1101; KOLMOGOROV AN, 1991, P ROY SOC LOND A MAT, V434, P9, DOI 10.1098/rspa.1991.0075; Koszalka I, 2009, J MAR RES, V67, P411, DOI 10.1357/002224009790741102; La Porta A, 2001, NATURE, V409, P1017, DOI 10.1038/35059027; LaCasce JH, 2003, J MAR RES, V61, P285, DOI 10.1357/002224003322201205; Lacorata G, 2004, J ATMOS SCI, V61, P2936, DOI 10.1175/JAS-3292.1; MAAS HG, 1993, EXP FLUIDS, V15, P133, DOI 10.1007/BF00190953; MALIK NA, 1993, EXP FLUIDS, V15, P279; Malik NA, 1996, FLUID MEC A, V36, P619; Malik NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202940; MOREL P, 1974, J ATMOS SCI, V31, P2189, DOI 10.1175/1520-0469(1974)031<2189:RDOCBI>2.0.CO;2; Obukhov A., 1941, DOKL AKAD NAUK SSSR, V5, P453; Ogasawara T, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.104402; Ollitrault M, 2005, J FLUID MECH, V533, P381, DOI 10.1017/S0022112005004556; Ouellette NT, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/6/109; Peters N., 1988, P S COMB SEATTL, P163; POPE SB, 1994, ANNU REV FLUID MECH, V26, P23, DOI 10.1146/annurev.fl.26.010194.000323; Richardson L. F., 1922, WEATHER PREDICTION N, P221; RICHARDSON LF, 1948, J METEOROL, V5, P238, DOI 10.1175/1520-0469(1948)005<0238:NOEDIT>2.0.CO;2; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Richardson LF, 1926, MEM R METROL SOC, V1, P1; Salazar JPLC, 2009, ANNU REV FLUID MECH, V41, P405, DOI 10.1146/annurev.fluid.40.111406.102224; Sawford BL, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2946442; Scatamacchia R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.144501; Schmidt W., 1917, WIEN AKAD SITZB 2A, V126, P773; Shlesinger M. F., 1993, LECT NOTES PHYS, V450; Shraiman BI, 2000, NATURE, V405, P639, DOI 10.1038/35015000; Sokolov IM, 1999, PHYS REV E, V60, P5528, DOI 10.1103/PhysRevE.60.5528; STOMMEL H, 1949, J MAR RES, V8, P199; SULLIVAN PJ, 1971, J FLUID MECH, V47, P601, DOI 10.1017/S0022112071001253; Sverdrup H. U, 1915, LEIPZIG GEOPHYS I 2; Tatarski V. I., 1960, IZV VYSSH UCHEBN ZAV, V4, P551; Taylor G. I., 1915, PHILOS T R SOC A, V215, P1, DOI DOI 10.1098/RSTA.1915.0001; THOMSON DJ, 1987, J FLUID MECH, V180, P529, DOI 10.1017/S0022112087001940; Thomson DJ, 2005, J FLUID MECH, V526, P277, DOI 10.1017/S0022112004002915; Vaillancourt PA, 2000, B AM METEOROL SOC, V81, P285, DOI 10.1175/1520-0477(2000)081<0285:ROPIAC>2.3.CO;2; Virant M, 1997, MEAS SCI TECHNOL, V8, P1539, DOI 10.1088/0957-0233/8/12/017; WILKINS EM, 1958, J METEOROL, V15, P324, DOI 10.1175/1520-0469(1958)015<0324:OOTSOP>2.0.CO;2; Wolf MC, 2004, J CHEM ECOL, V30, P501, DOI 10.1023/B:JOEC.0000018625.83906.95; YEUNG PK, 1994, PHYS FLUIDS, V6, P3416, DOI 10.1063/1.868399; Yeung PK, 2004, J FLUID MECH, V503, P93, DOI 10.1017/S0022112003007584	73	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202940	10.1371/journal.pone.0202940	http://dx.doi.org/10.1371/journal.pone.0202940			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281611	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400016
J	Zhang, QB; Yu, K; Liu, ZK; Wang, DW; Zhao, YY; Yin, SJ; Liu, ZX				Zhang, Qing-bin; Yu, Kai; Liu, Zekun; Wang, Dawei; Zhao, Yuanyuan; Yin, Sanjun; Liu, Zexian			Prediction of prkC-mediated protein serine/threonine phosphorylation sites for bacteria	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; KINASE; PHOSPHOPROTEOME; SER/THR/TYR; LOGO	As an abundant post-translational modification, reversible phosphorylation is critical for the dynamic regulation of various biological processes. prkC, a critical serine/threonine-protein kinase in bacteria, plays important roles in regulation of signaling transduction. Identification of prkC-specific phosphorylation sites is fundamental for understanding the molecular mechanism of phosphorylation-mediated signaling. However, experimental identification of substrates for prkC is time-consuming and labor-intensive, and computational methods for kinase-specific phosphorylation prediction in bacteria have yet to be developed. In this study, we manually curated the experimentally identified substrates and phosphorylation sites of prkC from the published literature. The analyses of the sequence preferences showed that the substrate recognition pattern for prkC might be miscellaneous, and a complex strategy should be employed to predict potential prkC-specific phosphorylation sites. To develop the predictor, the amino acid location feature extraction method and the support vector machine algorithm were employed, and the methods achieved promising performance. Through 10-fold cross validation, the predictor reached a sensitivity of 91.67% at the specificity of 95.12%. Then, we developed freely accessible software, which is provided at http://free.cancerbio.info/prkc/. Based on the predictor, hundreds of potential prkC-specific phosphorylation sites were annotated based on the known bacterial phosphorylation sites. prkC-PSP was the first predictor for prkC-specific phosphorylation sites, and its prediction performance was promising. We anticipated that these analyses and the predictor could be helpful for further studies of prkC-mediated phosphorylation.	[Zhang, Qing-bin] Guangzhou Med Univ, Key Lab Oral Med, Guangzhou Inst Oral Dis, Stomatol Hosp, Guangzhou, Guangdong, Peoples R China; [Yu, Kai; Liu, Zekun; Liu, Zexian] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Liu, Zekun] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hepatobiliary Surg, Wuhan, Hubei, Peoples R China; [Wang, Dawei] China Meitan Gen Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Zhao, Yuanyuan] Hefei Normal Univ, Sch Arts & Media, Hefei, Anhui, Peoples R China; [Yin, Sanjun] Healthtimegene Inst, Shenzhen, Peoples R China	Guangzhou Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Huazhong University of Science & Technology; Hefei Normal University	Zhang, QB (corresponding author), Guangzhou Med Univ, Key Lab Oral Med, Guangzhou Inst Oral Dis, Stomatol Hosp, Guangzhou, Guangdong, Peoples R China.; Liu, ZX (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr, Guangzhou, Guangdong, Peoples R China.	doctorqingbin@hotmail.com; liuzx@sysucc.org.cn	Liu, Zexian/D-1153-2011	Liu, Zexian/0000-0001-9698-0610; Yu, Kai/0000-0003-3343-2902; Qing-bin, Zhang/0000-0002-8523-9293	Natural Science Foundation of China [31501069]; Fundamental Research Funds for the Central Universities [SYSU:16ykzd06]; Science and Technology Planning Project of Guangdong Province [201511013, 2016ZC0147]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Planning Project of Guangdong Province	This work was supported by grants from the Natural Science Foundation of China (31501069), the Fundamental Research Funds for the Central Universities (SYSU:16ykzd06), and the Science and Technology Planning Project of Guangdong Province (201511013, 2016ZC0147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181966; Butt AH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8370132; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Cousin C, 2013, FEMS MICROBIOL LETT; COZZONE AJ, 1988, ANNU REV MICROBIOL, V42, P97, DOI 10.1146/annurev.mi.42.100188.000525; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Ehsan A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19491-y; Eymann C, 2007, PROTEOMICS, V7, P3509, DOI 10.1002/pmic.200700232; FERNLEY RT, 1981, BIOSCIENCE REP, V1, P497, DOI 10.1007/BF01121583; Fry B, 2000, APPL ENVIRON MICROB, V66, P4045, DOI 10.1128/AEM.66.9.4045-4049.2000; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; He ZY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S22; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Khan YD, 2018, ANAL BIOCHEM, V550, P109, DOI 10.1016/j.ab.2018.04.021; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Lakshminarayan H, 2008, PROTEIN EXPRES PURIF, V58, P309, DOI 10.1016/j.pep.2007.12.012; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Miller ML, 2009, PROTEOMICS, V9, P116, DOI 10.1002/pmic.200800285; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Page CA, 2013, J BACTERIOL, V195, P1750, DOI 10.1128/JB.02277-12; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Raju TNK, 2000, LANCET, V356, P81, DOI 10.1016/S0140-6736(05)73417-6; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Squeglia F, 2011, J AM CHEM SOC, V133, P20676, DOI 10.1021/ja208080r; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zou L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-247	40	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203840	10.1371/journal.pone.0203840	http://dx.doi.org/10.1371/journal.pone.0203840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278050	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200006
J	Lee, JK; Bloom, J; Zubeldia-Plazaola, A; Garbe, JC; Stampfer, MR; LaBarge, MA				Lee, Jonathan K.; Bloom, Jessica; Zubeldia-Plazaola, Arantzazu; Garbe, James C.; Stampfer, Martha R.; LaBarge, Mark A.			Different culture media modulate growth, heterogeneity, and senescence in human mammary epithelial cell cultures	PLOS ONE			English	Article							HUMAN BREAST-CANCER; CATALYTIC SUBUNIT; TRANSFORMATION; INACTIVATION; MYC; TUMORIGENESIS; METHYLATION; PROGENITORS; TELOMERASE; EXPRESSION	The ability to culture normal human mammary epithelial cells (HMEC) greatly facilitates experiments that seek to understand both normal mammary cell biology and the many differences between normal and abnormal human mammary epithelia. To maximize in vivo relevance, the primary cell culture conditions should maintain cells in states that resemble in vivo as much as possible. Towards this goal, we compared the properties of HMEC strains from two different reduction mammoplasty tissues that were grown in parallel using different media and culture conditions. Epithelial organoids were initiated into three different media: two commonly used serum-free-media, MCDB 170-type (e.g. MEGM) and WIT-P, and a low stress media, M87A. Growth, lineage heterogeneity, p16 protein expression, and population doublings to senescence were measured for each culture condition. MCDB 170 caused rapid senescence and loss of heterogeneity within 2 to 3 passages, but some cultures went through the 1 to 2 month process of selection to generate clonal finite post-selection post-stasis cells. WIT-P caused impressive expansion of luminal cells in 2nd passage followed by their near complete disappearance by passage 4 and senescence shortly thereafter. M87A supported as much as twice the number of population doublings compared to either serum-free medium, and luminal and myoepithelial cells were present for as many as 8 passages. Thus, of the three media compared, WIT-P and MCDB 170 imposed rapid senescence and loss of lineage heterogeneity, phenotypes consistent with cells maintained in high-stress conditions, while M87A supported cultures that maintained multiple lineages and robust growth for up to 60 population doublings. In conjunction with previous studies examining the molecular properties of cultures grown in these media, we conclude that M87A medium is most able to support long-term culture of multiple lineages similar to in vivo conditions, thereby facilitating investigations of normal HMEC biology relevant to the mammary gland in situ.	[Lee, Jonathan K.; Garbe, James C.; Stampfer, Martha R.; LaBarge, Mark A.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Bloom, Jessica; LaBarge, Mark A.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Zubeldia-Plazaola, Arantzazu] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; City of Hope; Beckman Research Institute of City of Hope; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Stampfer, MR; LaBarge, MA (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.; LaBarge, MA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA.	mrstampfer@lbl.gov; mlabarge@coh.org		LaBarge, Mark/0000-0003-2405-4719	National Institutes of Aging [R01AG040081]; Era of Hope Scholar Award from the Congressionally Directed Medical Research Program's Breast Cancer Research Program [BC141351]; U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE ON AGING [R01AG040081] Funding Source: NIH RePORTER	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Era of Hope Scholar Award from the Congressionally Directed Medical Research Program's Breast Cancer Research Program; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Aging (R01AG040081), and the Era of Hope Scholar Award from the Congressionally Directed Medical Research Program's Breast Cancer Research Program (BC141351). MRS and JCG are supported by U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Chanson L, 2011, P NATL ACAD SCI USA, V108, P3264, DOI 10.1073/pnas.1019556108; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elster D, 2016, CELL CYCLE, V15, P2551, DOI 10.1080/15384101.2016.1207837; Feijoo P, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0667-z; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Garbe JC, 2012, CANCER RES, V72, P3687, DOI 10.1158/0008-5472.CAN-12-0157; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; HERMAN JG, 1995, CANCER RES, V55, P4525; Holst CR, 2003, CANCER RES, V63, P1596; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kim H, 2002, BIOCHEM J, V365, P765, DOI 10.1042/BJ20011848; LaBarge MA, 2013, JOVE-J VIS EXP, DOI 10.3791/50011; LaBarge MA, 2009, INTEGR BIOL-UK, V1, P70, DOI 10.1039/b816472j; Lee JK, 2015, FRONTIERS CELL DEV B; Li YZ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-7; Miyano M, 2017, AGING-US, V9, P2025, DOI 10.18632/aging.101298; Moumen M, 2011, INT J DEV BIOL, V55, P763, DOI 10.1387/ijdb.113385mm; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Pelissier FA, 2014, CELL REP, V7, P1926, DOI 10.1016/j.celrep.2014.05.021; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; Stampfer M, 1985, J TISSUE CULTURE MET, V9, P107; STAMPFER MR, 1982, IN VITRO CELL DEV B, V18, P531; Stampfer MR, 2001, P NATL ACAD SCI USA, V98, P4498, DOI 10.1073/pnas.071483998; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Stampfer MR, 2013, CELL MOL BIOL BREAST, P323, DOI [10.1007/978-1-62703-634-4_15, DOI 10.1007/978-1-62703-634-4_15]; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Vatter FAP, 2018, CELL REP, V23, P1205, DOI 10.1016/j.celrep.2018.03.114; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204645	10.1371/journal.pone.0204645	http://dx.doi.org/10.1371/journal.pone.0204645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273377	Green Published, gold			2022-12-27	WOS:000446124700029
J	Richtig, G; Hoeller, C; Wolf, M; Wolfe, I; Rainer, BM; Schulter, G; Richtig, M; Grubler, MR; Gappmayer, A; Haidn, T; Kofler, J; Huegel, R; Lange-Asschenfeldt, B; Pichler, M; Pilz, S; Heinemann, A; Richtig, E				Richtig, Georg; Hoeller, Christoph; Wolf, Martin; Wolfe, Ingrid; Rainer, Barbara M.; Schulter, Guenter; Richtig, Markus; Gruebler, Martin R.; Gappmayer, Anna; Haidn, Thomas; Kofler, Julian; Huegel, Rainer; Lange-Asschenfeldt, Bernhard; Pichler, Martin; Pilz, Stefan; Heinemann, Akos; Richtig, Erika			Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; CANCER-IMMUNOTHERAPY; GUT MICROBIOTA; OBESITY; THERAPY; SURVIVAL; NEUTROPHIL; TOXICITY; CRITERIA; DISEASE	Introduction Immunotherapy is a well-established treatment option in patients with metastatic melanoma. However, biomarkers that can be used to predict a response in these patients have not yet been found, putting patients at risk of severe side effects. Methods In this retrospective analysis, we investigated the association between the body mass index and ipilimumab treatment response in patients with metastatic melanoma. Patients with metastatic melanoma who received a monotherapy of up to 4 doses of ipilimumab (3 mg/kg) every 3 weeks from 2011 to 2014 in three major hospitals in Austria were included. Patients were classified into two groups: normal group (BMI<25) and overweight group (BMI >= 25). Results 40 patients had a normal BMI, and 36 had a BMI above normal. Patients with a BMI that was above normal showed significantly higher response rates (p = 0.024, chi(2)), and lower likelihood of brain metastases (p = 0.012, chi(2)). No differences were found between both groups with respect to gender (p = 0.324, chi(2)), T-stage (p = 0.197, chi(2)), or the occurrence of side effects (p= 0.646, chi(2)). Patients with a BMI above normal showed a trend towards longer overall survival (p = 0.056, Log-Rank), but no difference was found regarding progression-free survival (p= 0.924, Log-Rank). Conclusions The BMI correlated with the response to ipilimumab treatment in a cohort of metastatic melanoma patients.	[Richtig, Georg; Heinemann, Akos] Med Univ Graz, Otto Loewi Res Ctr, Pharmacol Sect, Graz, Austria; [Richtig, Georg; Wolf, Martin; Wolfe, Ingrid; Rainer, Barbara M.; Richtig, Markus; Richtig, Erika] Med Univ Graz, Dept Dermatol, Graz, Austria; [Hoeller, Christoph] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Wolf, Martin; Gappmayer, Anna; Haidn, Thomas] State Hosp Wiener Neustadt, Dept Dermatol, Wiener Neustadt, Austria; [Schulter, Guenter] Karl Franzens Univ Graz, Dept Psychol, Biol Psychol Unit, Graz, Austria; [Gruebler, Martin R.] Bern Univ Hosp, Swiss Cardiovasc Ctr Bern, Dept Cardiol, Bern, Switzerland; [Gruebler, Martin R.; Pilz, Stefan] Med Univ Graz, Dept Internal Med, Div Endocrinol & Diabetol, Graz, Austria; [Kofler, Julian; Huegel, Rainer; Lange-Asschenfeldt, Bernhard] State Hosp Klagenfurt, Dept Dermatol & Venereol, Klagenfurt Am Worthersee, Austria; [Lange-Asschenfeldt, Bernhard] Charite Univ Med Berlin, Skin Canc Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany; [Pichler, Martin] Med Univ Graz, Div Oncol, Graz, Austria; [Pichler, Martin] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Medical University of Graz; Medical University of Graz; Medical University of Vienna; University of Graz; University of Bern; University Hospital of Bern; Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Graz; University of Texas System; UTMD Anderson Cancer Center	Richtig, G (corresponding author), Med Univ Graz, Otto Loewi Res Ctr, Pharmacol Sect, Graz, Austria.; Richtig, G (corresponding author), Med Univ Graz, Dept Dermatol, Graz, Austria.	georg.richtig@medunigraz.at	Rainer, Barbara/N-2613-2016	Rainer, Barbara/0000-0002-8643-7507; Pilz, Stefan/0000-0002-7959-1311; Richtig, Georg/0000-0002-4437-4413; Pichler, Martin/0000-0002-8701-9462	Austrian Science Fund FWF [W1241]; Medical University Graz through the PhD Program Molecular Fundamentals of Inflammation (DK-MOLIN)	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Medical University Graz through the PhD Program Molecular Fundamentals of Inflammation (DK-MOLIN)	Georg Richtig received funding from the Austrian Science Fund FWF (W1241) and the Medical University Graz through the PhD Program Molecular Fundamentals of Inflammation (DK-MOLIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Cassidy MR, 2017, EBIOMEDICINE, V18, P56, DOI 10.1016/j.ebiom.2017.03.029; Daly LE, 2017, BRIT J CANCER, V116, P310, DOI 10.1038/bjc.2016.431; Delyon J, 2013, ANN ONCOL, V24, P1697, DOI 10.1093/annonc/mdt027; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferrucci PF, 2016, ANN ONCOL, V27, P732, DOI 10.1093/annonc/mdw016; Ferrucci PF, 2015, BRIT J CANCER, V112, P1904, DOI 10.1038/bjc.2015.180; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Ligibel JA, 2014, J CLIN ONCOL, V32, P3568, DOI 10.1200/JCO.2014.58.4680; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; McQuade JL, 2018, LANCET ONCOL, V19, P310, DOI 10.1016/S1470-2045(18)30078-0; Mirsoian A, 2015, IMMUNOTHERAPY-UK, V7, P319, DOI [10.2217/IMT.15.12, 10.2217/imt.15.12]; O'Day SJ, 2007, CANCER-AM CANCER SOC, V110, P2614, DOI 10.1002/cncr.23086; Richtig G, 2017, EBIOMEDICINE, V18, P13, DOI 10.1016/j.ebiom.2017.03.032; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Skowron F, 2015, J EUR ACAD DERMATOL, V29, P262, DOI 10.1111/jdv.12515; Snyder A, 2015, SCIENCE, V350, P1031, DOI 10.1126/science.aad7706; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tsang NM, 2016, CANCER MED-US, V5, P665, DOI 10.1002/cam4.634; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	25	53	53	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204729	10.1371/journal.pone.0204729	http://dx.doi.org/10.1371/journal.pone.0204729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273398	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700034
J	Ugarte-Berzal, E; Berghmans, N; Boon, L; Martens, E; Vandooren, J; Cauwe, B; Thijs, G; Proost, P; Van Damme, J; Opdenakker, G				Ugarte-Berzal, Estefania; Berghmans, Nele; Boon, Lise; Martens, Erik; Vandooren, Jennifer; Cauwe, Benedicte; Thijs, Greet; Proost, Paul; Van Damme, Jo; Opdenakker, Ghislain			Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; MATRIX METALLOPROTEINASES; DEFICIENT MICE; MMP-9; DISEASES; CLEAVAGE; BIOLOGY; BRAIN	Gelatinase B/matrix metalloproteinase-9 (MMP-9) triggers multiple sclerosis (MS) and the animal model of experimental autoimmune encephalomyelitis (EAE) by the breakdown of the blood-brain barrier. Interestingly, MMP-9 is beneficial in systemic autoimmunity caused by Fas-deficiency. Fas-deficient (fas(lpr)) and Fas-ligand-deficient mice are protected against EAE. We here investigated the interaction between Fas and MMP-9 in the setting of induction of EAE and compared short- and long-term effects. We provoked EAE with myelin oligodendrocyte glycoprotein (MOG) peptide and compared EAE development in four genotypes (wild-type (WT), single knockout mmp-9(-/-), fas(lpr), and mmp-9(-/-)/fas(lpr)) and monitored leukocytes, cytokines and chemokines as immunological parameters. As expected, fas(lpr) mice were resistant against EAE induction, whereas MMP-9 single knockout mice were not. In the double mmp-9(-/-)/fas(lpr) mice the effects on disease scores pointed to independent rather than interrelated disease mechanisms. On a short term, after EAE induction leukocytes infiltrated into the brain and cytokine and chemokine levels were significantly higher in all the four genotypes studied, even in the fas(lpr) and mmp-9(-/-)/fas(lpr), which did not develop clinical disease. The levels of MMP-9 but not of MMP-2 were increased in the brain and in the peripheral organs after EAE induction. After 40 days all the animals recovered and did not show signs of EAE. However, the absence of MMP-9 in the remission phase suggested a protective role of MMP-9 in the late phase of the disease, because single mmp-9(-/-) mice presented a delayed remission in comparison with WT animals suggesting a phase-dependent role of MMP-9 in the disease. Nevertheless, the levels of some cytokines and chemokines remained higher than in control animals even 100 days after EAE induction, attesting to a prolonged state of immune activation. We thus yielded new insights and useful markers to monitor this activated immune status. Furthermore, MMP-9 but not MMP-2 levels remained increased in the brains and, to a higher extend, in the spleens of the WT mice even during the remission phase, which is in line with the role of MMP-9 as a useful marker and a protective factor for EAE in the remission phase.	[Ugarte-Berzal, Estefania; Boon, Lise; Martens, Erik; Vandooren, Jennifer; Cauwe, Benedicte; Thijs, Greet; Opdenakker, Ghislain] Univ Leuven, KU Leuven, Lab Immunol, Dept Microbiol & Immunol,Rega Inst Med Res, Leuven, Belgium; [Berghmans, Nele; Proost, Paul; Van Damme, Jo] Univ Leuven, KU Leuven, Lab Mol Immunol, Dept Microbiol & Immunol,Rega Inst Med Res, Leuven, Belgium	KU Leuven; KU Leuven	Opdenakker, G (corresponding author), Univ Leuven, KU Leuven, Lab Immunol, Dept Microbiol & Immunol,Rega Inst Med Res, Leuven, Belgium.	Ghislain.opdenakker@kuleuvan.be	Vandooren, Jennifer/H-5318-2019; Vandooren, Jennifer/O-6424-2018; Martens, Erik/F-9214-2015; Proost, Paul/V-3052-2017; Opdenakker, Ghislain/Q-3130-2017; Opdenakker, Ghislain/V-8562-2019	Vandooren, Jennifer/0000-0002-7157-3370; Martens, Erik/0000-0002-7947-6567; Proost, Paul/0000-0002-0133-5545; Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Van Damme, Jo/0000-0002-6707-1167	Geconcerteerde OnderzoeksActies [GOA 2013/015, C16/17/010]; Foundation for Scientific Research of Flanders (FWO-Vlaanderen); Charcot Foundation (Belgium)	Geconcerteerde OnderzoeksActies; Foundation for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Charcot Foundation (Belgium)	The present study was possible thanks to funding by the Geconcerteerde OnderzoeksActies (GOA 2013/015) and (C16/17/010), the Foundation for Scientific Research of Flanders (FWO-Vlaanderen) and the Charcot Foundation (Belgium).	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Agrawal SM, 2007, INT REV NEUROBIOL, V79, P99, DOI 10.1016/S0074-7742(07)79005-0; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Berghmans N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-243; Brandle SM, 2016, P NATL ACAD SCI USA, V113, P7864, DOI 10.1073/pnas.1522730113; Cauwe B, 2011, J AUTOIMMUN, V36, P239, DOI 10.1016/j.jaut.2011.02.002; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Cauwe B, 2009, INTEGR BIOL-UK, V1, P404, DOI 10.1039/b904701h; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; de Bruyn M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15384; Descamps FJ, 2002, LAB INVEST, V82, P1607, DOI 10.1097/01.LAB.0000038556.54069.73; Dittel BN, 1999, J IMMUNOL, V162, P6392; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Dubois B, 2000, J CLIN INVEST, V106, P627, DOI 10.1172/JCI10910; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Ethell DW, 2003, J CLIN IMMUNOL, V23, P363, DOI 10.1023/A:1025317516396; Fainardi E, 2006, MULT SCLER J, V12, P294, DOI 10.1191/135248506ms1274oa; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gerwien H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8020; GIJBELS K, 1993, J NEUROSCI RES, V36, P432, DOI 10.1002/jnr.490360409; GIJBELS K, 1992, J NEUROIMMUNOL, V41, P29, DOI 10.1016/0165-5728(92)90192-N; GRABAR P, 1974, LANCET, V1, P1320; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Kallaur AP, 2013, MOL MED REP, V7, P1010, DOI 10.3892/mmr.2013.1256; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Legroux L, 2015, J NEUROSCI METH, V247, P23, DOI 10.1016/j.jneumeth.2015.03.021; Loma I, 2011, CURR NEUROPHARMACOL, V9, P409, DOI 10.2174/157015911796557911; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Metz LM, 2017, NEW ENGL J MED, V376, P2122, DOI 10.1056/NEJMoa1608889; Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8; OPDENAKKER G, 1994, IMMUNOL TODAY, V15, P103, DOI 10.1016/0167-5699(94)90151-1; Opdenakker G, 2016, TRENDS MOL MED, V22, P746, DOI 10.1016/j.molmed.2016.07.002; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Paemen L, 1996, BIOCHEM PHARMACOL, V52, P105, DOI 10.1016/0006-2952(96)00168-2; PROOST P, 1993, BIOCHEM BIOPH RES CO, V192, P1175, DOI 10.1006/bbrc.1993.1540; Proost P, 2017, J AUTOIMMUN, V85, P45, DOI 10.1016/j.jaut.2017.06.009; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Sabelko-Downes KA, 1999, J EXP MED, V189, P1195, DOI 10.1084/jem.189.8.1195; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Waldner H, 1997, J IMMUNOL, V159, P3100	52	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0197944	10.1371/journal.pone.0197944	http://dx.doi.org/10.1371/journal.pone.0197944			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273366	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700001
J	Ataguba, JEO				Ataguba, John Ele-Ojo			A reassessment of global antenatal care coverage for improving maternal health using sub-Saharan Africa as a case study	PLOS ONE			English	Article							PRENATAL-CARE; BIRTH-WEIGHT; QUALITY; OUTCOMES; CONTEXT; DEMAND	Background Antenatal period is an opportunity for reaching pregnant women with vital interventions. In fact, antenatal care (ANC) coverage was an indicator for assessing progress towards the Millennium Development Goals. This paper applies a novel index of service coverage using ANC, which accounts for every ANC visit. An index of service coverage gap is also proposed. These indices are additively decomposable by population groups and they are sensitive to the receipt of more ANC visits below a defined threshold. These indices have also been generalised to account for the quality of services. Methods Data from recent rounds of the Demographic and Health Survey (DHS) are used to reassess ANC service coverage in 35 sub-Saharan African countries. An index of ANC coverage was estimated. These countries were ranked, and their ranks are compared with those based on attaining at least four ANC visits (ANC4+). Findings The index of ANC coverage reflected the level of service coverage in countries. Further, disparities exist in country ranking as some countries, e.g. Cameroon, Benin Republic and Nigeria are ranked better using the ANC4+ indicator but poorly using the proposed index. Also, Rwanda and Malawi are ranked better using the proposed index. Conclusion The proposed ANC index allows for the assessment of progressive realisation, rooted in the move towards universal health coverage. In fact, the index reflects progress that countries make in increasing service coverage. This is because every ANC visit counts. Beyond ANC coverage, the proposed index is applicable to assessing service coverage generally including quality education.	[Ataguba, John Ele-Ojo] Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Hlth Sci Fac, Cape Town, South Africa	University of Cape Town	Ataguba, JEO (corresponding author), Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Hlth Sci Fac, Cape Town, South Africa.	John.Ataguba@uct.ac.za		Ataguba, John Ele-Ojo/0000-0002-7746-3826	National Research Foundation [103687]	National Research Foundation	The work is supported by the National Research Foundation (Fund number: 103687). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MDG REP ASS PROGR AF; Arunda M, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1328796; BACKE B, 1993, BRIT J OBSTET GYNAEC, V100, P727, DOI 10.1111/j.1471-0528.1993.tb14263.x; Beeckman K, 2013, EUR J PUBLIC HEALTH, V23, P366, DOI 10.1093/eurpub/cks123; Boller C, 2003, B WORLD HEALTH ORGAN, V81, P116; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Diamond-Smith N, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0208-y; Evans WN, 2005, J ECONOMETRICS, V125, P207, DOI 10.1016/j.jeconom.2004.04.007; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Habibov NN, 2011, ECON HUM BIOL, V9, P56, DOI 10.1016/j.ehb.2010.08.003; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hosseinpoor AR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001727; Izugbara CO, 2018, HEALTH POLICY PLANN, V33, P1, DOI 10.1093/heapol/czx131; Koroma MM, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0218-4; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Linard M, 2018, BJOG-INT J OBSTET GY, V125, P587, DOI 10.1111/1471-0528.14794; Ng M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001730; ROSENZWEIG MR, 1983, J POLIT ECON, V91, P723, DOI 10.1086/261179; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Uganda Bureau of Statistics (UBOS) and ICF, 2018, UG DEM HLTH SURV 201; United Nations Development Programme, 2015, SUST DEV GOALS; Wehby GL, 2009, ECON HUM BIOL, V7, P84, DOI 10.1016/j.ehb.2008.10.001; WHO, 2022, WHO RECOMMENDATIONS; *WHO, COUNTD 2015 DEC REP; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2014, EV NEWB ACT PLAN END	29	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204822	10.1371/journal.pone.0204822	http://dx.doi.org/10.1371/journal.pone.0204822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289886	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500024
J	Cheek, M; Lebbie, A				Cheek, Martin; Lebbie, Aiah			Lebbiea (Podostemaceae-Podostemoideae), a new, nearly extinct genus with foliose tepals, in Sierra Leone	PLOS ONE			English	Article							SP-NOV PODOSTEMACEAE; WEST-AFRICA; LEDERMANNIELLA PODOSTEMACEAE; CAMEROON; GUINEA; RUBIACEAE	Lebbiea grandiflora (Podostemaceae), a rheophytic herb from the Sewa River rapids in Sierra Leone, is described as a new species. It is the first new African genus of Podostemaceae published for 30 years. First collected in May 2017, the species is assessed as Critically Endangered using the IUCN 2012 standard. It is on the edge of extinction with a small population at a single site threatened by deposition of gravel and sand from alluvial gold and diamond mining upstream, and a planned hydro-electric dam. The new genus is unique in Podostemaceae in a) its highly developed and robust style-stigma structure in which the bases of the two style-stigmas unite to form a bifurcate funneliform-cylindrical structure, with a reflexed, blade-like apex that extends half-way around the perimeter of the ovary-fruit towards the base of the ovary-fruit, b) a specialised andropodium, with robust, self-supporting capacity, having differentiated thickened central, and angled, thinner marginal areas (in other Podostemaceae the andropodial structures are undifferentiated), c) the pillar-like haptera which completely elevate the crustose root above the substrate. Lebbiea is placed in Podostemoideae, necessitating amplification of the delimitation of that subfamily in which it is additionally unique in having the foliose tepals characteristic of the basal subfamilies Wed-dellinoideae and Tristichoideae.	[Cheek, Martin] Royal Bot Gardens, Sci, Richmond, Surrey, England; [Lebbie, Aiah] Njala Univ, Natl Herbarium Sierra Leone, Dept Biol Sci, Freetown, Sierra Leone	Royal Botanic Gardens, Kew; Njala University	Cheek, M (corresponding author), Royal Bot Gardens, Sci, Richmond, Surrey, England.	m.cheek@kew.org		LEBBIE, AIAH/0000-0001-8725-3593	Joule Engineering as part of baseline studies for a hydroelectric dam at Bumbuna-Yiben, Sierra Leone	Joule Engineering as part of baseline studies for a hydroelectric dam at Bumbuna-Yiben, Sierra Leone	The fieldwork which produced the specimen which triggered this study was funded by Joule Engineering as part of baseline studies for a hydroelectric dam at Bumbuna-Yiben, Sierra Leone. Joule had no role in study design, data-collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Beentje H., 2005, FLORA TROPICAL E AFR; Bogner J, 2011, WILLDENOWIA, V41, P57, DOI 10.3372/wi.41.41106; Cheek M, 2017, BLUMEA, V62, P125, DOI 10.3767/blumea.2017.62.02.07; Cheek M, 2016, KEW B, V17, P2, DOI DOI 10.1007/S12225-016-9634-9; Cheek M, 2018, PEERJ, V6, DOI 10.7717/peerj.4666; Cheek M, 2017, KEW BULL, V72, DOI 10.1007/S12225-017-9699-0; Cheek M, 2016, KEW BULL, V71, DOI 10.1007/S12225-016-9673-2; Cheek M, 2016, KEW BULL, V71, DOI [10.1007/S12225-016-9638-5, 10.1007/s12225-016-9638-5]; Cheek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152110; Cheek M, 2015, KEW BULL, V70, DOI 10.1007/S12225-015-9559-8; Cheek Martin, 2010, Kew Bulletin, V65, P83, DOI 10.1007/s12225-010-9180-9; Cheek M, 2008, NORD J BOT, V26, P214, DOI 10.1111/j.1756-1051.2008.00162.x; Cheek Martin, 2003, Kew Bulletin, V58, P733, DOI 10.2307/4111153; Clark Ruth, 2011, Kew Bulletin, V66, P589; COOK CDK, 2007, FAMILIES GENERA VASC, V9, P304, DOI DOI 10.1007/978-3-540-32219-1_40; CUSSET C, 1973, Adansonia, V13, P307; CUSSET C, 1974, Adansonia, V14, P271; CUSSET C, 1978, ADANSONIA, V17, P293; Cusset C, 1984, ADANSONIA, V3, P249; Cusset C., 1987, FLORE CAMEROUN; CUSSET C, 1997, FLORA ZAMBEZIACA, V9, P1; Cusset C, 1983, ADANSONIA, V4, P361; Darbyshire Iain, 2011, Kew Bulletin, V66, P425; Davis PH, 1963, PRINCIPLES ANGIOSPER; de la Estrella M, 2012, NORD J BOT, V30, P136, DOI 10.1111/j.1756-1051.2012.01357.x; Fischer Eberhard, 2011, Kew Bulletin, V66, P441, DOI 10.1007/s12225-011-9296-6; Goyder D. J., 2008, Kew Bulletin, V63, P473, DOI 10.1007/s12225-008-9059-1; Jongkind CCH, 2012, PLANT ECOL EVOL, V145, P126, DOI 10.5091/plecevo.2012.594; Jongkind Carel C. H., 2003, Systematics and Geography of Plants, V73, P95; Kita Yoko, 2008, APG Acta Phytotaxonomica et Geobotanica, V59, P223; Koi S, 2012, BOT J LINN SOC, V169, P461, DOI 10.1111/j.1095-8339.2012.01258.x; McNeill J, 2012, INT CODE NOMENCLATUR; Pfeifer E, 2009, NOVON, V19, P102, DOI 10.3417/2007080; Philbrick C.T., 2004, SYST BOT MONOGR, V70, P1; Phillips SM, 2015, KEW BULL, V70, DOI 10.1007/S12225-014-9557-2; Phillips Sylvia M., 2012, Kew Bulletin, V67, P273, DOI 10.1007/s12225-012-9353-9; Prance GT, 2015, KEW BULL, V70, DOI [10.1007/s12225-014-9547-4, 10.1007/S12225-014-9547-4]; Rial Anabel, 2002, Adansonia (Paris), V24, P295; Ruhfel BR, 2011, AM J BOT, V98, P306, DOI 10.3732/ajb.1000354; Rutishauser R., 2004, PODOSTEMACEAE AFRICA; Schenk JJ, 2004, NOVON, V14, P227; Schenk JJ, 2015, SYST BOT, V40, P539, DOI 10.1600/036364415X688330; Thiers B., INDEX HERBARIORUM GL	44	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203603	10.1371/journal.pone.0203603	http://dx.doi.org/10.1371/journal.pone.0203603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289915	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500006
J	Al Baki, MA; Jung, JK; Maharjan, R; Yi, H; Ahn, JJ; Gu, XJ; Kim, Y				Al Baki, Md. Abdullah; Jung, Jin Kyo; Maharjan, Rameswor; Yi, Hwijong; Ahn, Jeong Joon; Gu, Xiaojun; Kim, Yonggyun			Application of insulin signaling to predict insect growth rate in Maruca vitrata (Lepidoptera: Crambidae)	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; LEGUME POD BORER; PROTHORACICOTROPIC HORMONE; BOMBYX-MORI; DROSOPHILA; IDENTIFICATION; PEPTIDES; EXPRESSION; SECRETION; EVOLUTION	Insect growth is influenced by two major environmental factors: temperature and nutrient. These environmental factors are internally mediated by insulin/insulin-like growth factor signal (I IS) to coordinate tissue or organ growth. Maruca vitrata, a subtropical lepidopteran insect, migrates to different climate regions and feeds on various crops. The objective of this study was to determine molecular tools to predict growth rate of M. vitrata using IIS components. Four genes [insulin receptor (InR), Forkhead Box O (FOXO), Target of Rapamycin (TOR), and serine-threonine protein kinase (Akt)] were used to correlate their expression levels with larval growth rates under different environmental conditions. The functional association of IIS and larval growth was confirmed because RNA interference of these genes significantly decreased larval growth rate and pupal weight. Different rearing temperatures altered expression levels of these four IIS genes and changed their growth rate. Different nutrient conditions also significantly changed larval growth and altered expression levels of IIS components. Different local populations of M. vitrata exhibited significantly different larval growth rates under the same nutrient and temperature conditions along with different expression levels of IIS components. Under a constant temperature (25 degrees C), larval growth rates showed significant correlations with IIS gene expression levels. Subsequent regression formulas of expression levels of four IIS components against larval growth rate were applied to predict growth patterns of M. vitrata larvae reared on different natural hosts and natural local populations reared on the same diet. All four formulas well predicted larval growth rates with some deviations. These results indicate that the IIS expression analysis explains the growth variation at the same temperature due to nutrient and genetic background.	[Al Baki, Md. Abdullah; Kim, Yonggyun] Andong Natl Univ, Dept Plant Med, Andong, South Korea; [Jung, Jin Kyo] Rural Dev Adm, Div Crop Cultivat & Environm Res, Dept Cent Area Crop Sci, Natl Inst Crop Sci, Suwon, South Korea; [Maharjan, Rameswor; Yi, Hwijong] Rural Dev Adm, Dept Southern Area Crop Sci, Natl Inst Crop Sci, Miryang, South Korea; [Ahn, Jeong Joon] Rural Dev Adm, Res Inst Climate Change & Agr, Natl Inst Hort & Herbal Sci, Jeju, South Korea; [Gu, Xiaojun] Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Fujian, Peoples R China	Andong National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Fujian Agriculture & Forestry University	Kim, Y (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	hosanna@anu.ac.kr		Kim, Yonggyun/0000-0002-6840-2167	Agenda Research Grant - Rural Development Administration, Republic of Korea [PJ01182003]	Agenda Research Grant - Rural Development Administration, Republic of Korea	This study was supported by an Agenda Research Grant (Project number: PJ01182003) funded by the Rural Development Administration, Republic of Korea.	Agunbiade TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092072; Al Baki MA, 2018, PEPTIDES, V106, P28, DOI 10.1016/j.peptides.2018.06.006; Antonova Y., 2012, INSECT ENDOCRINOL, P63, DOI DOI 10.1016/B978-0-12-384749-2.10002-0; Aslam AFM, 2011, ZOOL SCI, V28, P609, DOI 10.2108/zsj.28.609; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dabour N, 2011, DEV GROWTH DIFFER, V53, P857, DOI 10.1111/j.1440-169X.2011.01291.x; Das R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109530; Ding BY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020357; Dobens LL, 2012, DEV DYNAM, V241, P1239, DOI 10.1002/dvdy.23822; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Ghosh A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004750; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Iga M, 2011, PEPTIDES, V32, P531, DOI 10.1016/j.peptides.2010.10.033; Jung Jin Kyo, 2016, Korean Journal of Applied Entomology, V55, P439, DOI 10.5656/KSAE.2016.11.0.060; Jung Jin Kyo, 2009, Korean Journal of Applied Entomology, V48, P29; Kim Y, 2017, ENVIRON ENTOMOL, V46, P1432, DOI 10.1093/ee/nvx153; Koyama T, 2018, CURR OPIN INSECT SCI, V25, P1, DOI 10.1016/j.cois.2017.11.002; Koyama T, 2014, ELIFE, V3, DOI 10.7554/eLife.03091; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Liu Y, 2010, J INSECT PHYSIOL, V56, P1436, DOI 10.1016/j.jinsphys.2010.02.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HL, 2011, INSECT MOL BIOL, V20, P637, DOI 10.1111/j.1365-2583.2011.01094.x; Mattila J, 2009, MOL CELL BIOL, V29, P5357, DOI 10.1128/MCB.00302-09; NAGASAWA H, 1984, SCIENCE, V226, P1344, DOI 10.1126/science.226.4680.1344; NAGASAWA H, 1986, P NATL ACAD SCI USA, V83, P5840, DOI 10.1073/pnas.83.16.5840; Nijhout HF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00245; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Okamoto N, 2015, CURR OPIN INSECT SCI, V11, P21, DOI 10.1016/j.cois.2015.08.001; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sang M, 2016, GENE, V585, P196, DOI 10.1016/j.gene.2016.02.034; Sano H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005209; SAS Institute Inc, 1989, SAS STAT USERS GUIDE; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Sureshan CS, 2015, APPL TRANSL GENOM, V7, P2, DOI 10.1016/j.atg.2015.10.003; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Van de Velde S, 2007, GEN COMP ENDOCR, V153, P72, DOI 10.1016/j.ygcen.2007.05.001; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Wen ZM, 2010, MOL CELL ENDOCRINOL, V328, P47, DOI 10.1016/j.mce.2010.07.003; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011	46	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204935	10.1371/journal.pone.0204935	http://dx.doi.org/10.1371/journal.pone.0204935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286156	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500064
J	Breen, NE; Loewenstein, J; Metivier, R; Andrade, L; Rhyne, AL				Breen, Nancy E.; Loewenstein, Julie; Metivier, Rebecca; Andrade, Lawrence; Rhyne, Andrew L.			Can excreted thiocyanate be used to detect cyanide exposure in live reef fish? (vol 13, e0196841, 2018)	PLOS ONE			English	Correction														Rhyne, Andrew/0000-0001-7252-3431; Loewenstein, Julie/0000-0003-4618-5277				Breen NE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196841	1	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205552	10.1371/journal.pone.0205552	http://dx.doi.org/10.1371/journal.pone.0205552			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286202	gold, Green Submitted, Green Published			2022-12-27	WOS:000446383500112
J	Kumar, S; Mahajan, S; Jain, S				Kumar, Santhust; Mahajan, Saurabh; Jain, Sanjay			Feedbacks from the metabolic network to the genetic network reveal regulatory modules in E. coli and B. subtilis	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; HIERARCHICAL STRUCTURE; ORGANIZATION; EVOLUTION; CONSERVATION; PRINCIPLES; MODELS; MOTIFS	The genetic regulatory network (GRN) plays a key role in controlling the response of the cell to changes in the environment. Although the structure of GRNs has been the subject of many studies, their large scale structure in the light of feedbacks from the metabolic network (MN) has received relatively little attention. Here we study the causal structure of the GRNs, namely the chain of influence of one component on the other, taking into account feedback from the MN. First we consider the GRNs of E. coli and B. subtilis without feedback from MN and illustrate their causal structure. Next we augment the GRNs with feedback from their respective MNs by including (a) links from genes coding for enzymes to metabolites produced or consumed in reactions catalyzed by those enzymes and (b) links from metabolites to genes coding for transcription factors whose transcriptional activity the metabolites alter by binding to them. We find that the inclusion of feedback from MN into GRN significantly affects its causal structure, in particular the number of levels and relative positions of nodes in the hierarchy, and the number and size of the strongly connected components (SCCs). We then study the functional significance of the SCCs. For this we identify condition specific feedbacks from the MN into the GRN by retaining only those enzymes that are essential for growth in specific environmental conditions simulated via the technique of flux balance analysis (FBA). We find that the SCCs of the GRN augmented by these feedbacks can be ascribed specific functional roles in the organism. Our algorithmic approach thus reveals relatively autonomous subsystems with specific functionality, or regulatory modules in the organism. This automated approach could be useful in identifying biologically relevant modules in other organisms for which network data is available, but whose biology is less well studied.	[Kumar, Santhust; Jain, Sanjay] Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India; [Mahajan, Saurabh] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Jain, Sanjay] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA	University of Delhi; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); The Santa Fe Institute	Jain, S (corresponding author), Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India.; Jain, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	jain@physics.du.ac.in			Department of Biotechnology, Government of India [BT/COE/34/SP15246/2015]; Science and Engineering Research Board, Government of India [SR/S4/MS:791/12]; University Grants Commission, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Science and Engineering Research Board, Government of India; University Grants Commission, Government of India(University Grants Commission, India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, Government of India (http://www.dbtindia.nic.in/), grant no. BT/COE/34/SP15246/2015 to SJ; and Science and Engineering Research Board, Government of India (www.serb.gov.in), grant no. SR/S4/MS:791/12 to SJ. SK acknowledges a Junior Research Fellowship and Senior Research Fellowship from the University Grants Commission, Government of India. SM acknowledges a Senior Research Fellowship from the Department of Biotechnology, Government of India. SJ acknowledges the Addie and Harold Broitman Membership of the Simons Center for Systems Biology, Institute of Advanced Study, Princeton, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Axelsen JB, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/01/P01018; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Bhardwaj N, 2010, P NATL ACAD SCI USA, V107, P6841, DOI 10.1073/pnas.0910867107; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Corominas-Murtra B, 2013, P NATL ACAD SCI USA, V110, P13316, DOI 10.1073/pnas.1300832110; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farkas IJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-478; Freyre-Gonzalez JA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r154; Freyre-Gonzalez JA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-127; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69; Herrgard MJ, 2006, GENOME RES, V16, P627, DOI 10.1101/gr.4083206; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Klosik DF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00587-4; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Kumar S, 2015, MOL BIOSYST, V11, P930, DOI 10.1039/c4mb00298a; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Ma HW, 2004, BIOINFORMATICS, V20, P1870, DOI 10.1093/bioinformatics/bth167; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Robison K, 1998, J MOL BIOL, V284, P241, DOI 10.1006/jmbi.1998.2160; Rodriguez-Caso C, 2009, MOL BIOSYST, V5, P1617, DOI [10.1039/b904960f, 10.1039/B904960f]; Salgado H, 2001, NUCLEIC ACIDS RES, V29, P72, DOI 10.1093/nar/29.1.72; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Samal A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-21; Santillan M, 2004, J THEOR BIOL, V231, P287, DOI 10.1016/j.jtbi.2004.06.023; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal Eran, 2003, Genome Biol, V4, P317, DOI 10.1186/gb-2003-4-5-317; Seshasayee ASN, 2009, GENOME RES, V19, P79, DOI 10.1101/gr.079715.108; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Yeang CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-332; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	61	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203311	10.1371/journal.pone.0203311	http://dx.doi.org/10.1371/journal.pone.0203311			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286091	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500007
J	Prasannan, CB; Jaiswal, D; Davis, R; Wangikar, PP				Prasannan, Charulata B.; Jaiswal, Damini; Davis, Rose; Wangikar, Pramod P.			An improved method for extraction of polar and charged metabolites from cyanobacteria	PLOS ONE			English	Article							C-13 FLUX ANALYSIS; METABOLOMICS; YEAST; IDENTIFICATION; TOOLS	A key requirement for C-13 Metabolic flux analysis (C-13-MFA), a widely used technique to estimate intracellular metabolic fluxes, is an efficient method for the extraction of intermediate metabolites for analysis via liquid chromatography mass spectrometry (LC/MS). The C-13 isotopic labeling results in further distribution of an already sparse pool of intermediate metabolites into isotopologues, each appearing as a separate chromatographic feature. We examined some of the reported solvent systems for the extraction of polar intracellular metabolites from three strains of cyanobacteria of the genus Synechococcus, viz., Synechococcus sp. PCC 7002, Synechococcus elongatus PCC 7942, and a newly isolated Synechococcus elongatus PCC 11801 (manuscript under review). High resolution-LC/MS was used to assess the relative abundance of the extracted metabolites. The different solvent systems used for extraction led to statistically significant changes in the extraction efficiency for a large number of metabolites. While a few hundred m/z features or potential metabolites were detected with different solvent systems, the abundance of over a quarter of all metabolites varied significantly from one solvent system to another. Further, the extraction methods were evaluated for a targeted set of metabolites that are important in C-13-MFA studies of photosynthetic organisms. While for the strain PCC 7002, the reported method using methanol-chloroform-water system gave satisfactory results, a mild base in the form of NH4OH had to be used in place of water to achieve adequate levels of extraction for PCC 7942 and PCC 11801. While minor changes in extraction solvent resulted in dramatic changes in the extraction efficiency of a number of compounds, certain metabolites such as amino acids and organic acids were adequately extracted in all the solvent systems tested. Overall, we present a new improved method for extraction using a methanol-chloroform-NH4OH system. Our method improves the extraction of polar compounds such as sugar phosphates, bisphosphates, that are central to C-13-MFA studies.	[Prasannan, Charulata B.; Jaiswal, Damini; Davis, Rose; Wangikar, Pramod P.] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India; [Prasannan, Charulata B.; Wangikar, Pramod P.] Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Bombay, Maharashtra, India; [Wangikar, Pramod P.] Indian Inst Technol, Wadhwani Res Ctr Bioengn, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; DBT-Pan IIT Centre for Bioenergy; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Wangikar, PP (corresponding author), Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India.; Wangikar, PP (corresponding author), Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Bombay, Maharashtra, India.; Wangikar, PP (corresponding author), Indian Inst Technol, Wadhwani Res Ctr Bioengn, Bombay, Maharashtra, India.	wangikar@iitb.ac.in		Wangikar, Pramod/0000-0003-0108-7585; Jaiswal, Damini/0000-0002-5822-2541				Alagesan S, 2013, PHOTOSYNTH RES, V118, P191, DOI 10.1007/s11120-013-9911-5; Baran R, 2011, MOL BIOSYST, V7, P3200, DOI 10.1039/c1mb05196b; Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Cassier-Chauvat C, 2017, APPL MICROBIOL BIOT, V101, P1359, DOI 10.1007/s00253-017-8105-z; Crown SB, 2013, METAB ENG, V20, P42, DOI 10.1016/j.ymben.2013.08.005; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Dempo Y, 2014, METABOLITES, V4, P499, DOI 10.3390/metabo4020499; ENTIAN KD, 1977, MOL GEN GENET, V156, P99, DOI 10.1007/BF00272258; Faijes M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-27; Folch J, 1987, J BIOL CHEM, V55, P999, DOI DOI 10.1016/J.ULTRASMEDBIO.2011.03.005; Forsberg EM, 2018, NAT PROTOC, V13, P633, DOI 10.1038/nprot.2017.151; GALE EF, 1958, BIOCHEM J, V69, P611, DOI 10.1042/bj0690611; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Hendry JI, 2017, BIOTECHNOL BIOENG, V114, P2298, DOI 10.1002/bit.26350; Hendry JI, 2016, BIORESOURCE TECHNOL, V213, P190, DOI 10.1016/j.biortech.2016.02.128; Jaiswal D, 2018, ANAL CHEM, V90, P6486, DOI 10.1021/acs.analchem.7b05329; Jazmin LJ, 2017, METAB ENG, V42, P9, DOI 10.1016/j.ymben.2017.05.001; Jazmin LJ, 2013, METHOD MOL BIOL, V985, P149, DOI [10.1007/978-1-62703-299-5_9, DOI 10.1007/978-1-62703-299-5_9]; Kalisiak J, 2009, J AM CHEM SOC, V131, P378, DOI 10.1021/ja808172n; Lai MC, 2015, METABOLITES, V5, P636, DOI 10.3390/metabo5040636; LELOIR LF, 1957, METHOD ENZYMOL, V3, P840, DOI 10.1016/S0076-6879(57)03459-X; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Li X, 2013, J MICROBIOL METH, V94, P61, DOI 10.1016/j.mimet.2013.04.006; Lu WY, 2017, ANNU REV BIOCHEM, V86, P277, DOI 10.1146/annurev-biochem-061516-044952; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; Mathe EA, 2014, CANCER RES, V74, P3259, DOI 10.1158/0008-5472.CAN-14-0109; Misra BB, 2018, ELECTROPHORESIS, V39, P909, DOI 10.1002/elps.201700441; Mosier AC, 2013, MBIO, V4, DOI 10.1128/mBio.00484-12; Narainsamy K, 2013, METABOLOMICS, V9, P21, DOI 10.1007/s11306-011-0382-4; Noh K, 2006, BIOTECHNOL BIOENG, V94, P234, DOI 10.1002/bit.20803; Noh K, 2006, METAB ENG, V8, P554, DOI 10.1016/j.ymben.2006.05.006; Park C, 2012, APPL BIOCHEM BIOTECH, V167, P425, DOI 10.1007/s12010-012-9685-9; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Pinu FR, 2017, METABOLITES, V7, DOI 10.3390/metabo7040053; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Riekeberg Eli, 2017, F1000Res, V6, P1148, DOI 10.12688/f1000research.11495.1; Sana T, 2007, 59897407EN AG TECHN, P5989; Sengupta A., 2018, APPL MICROBIOL BIOT, P1, DOI DOI 10.1007/S00253-017-8535-7; SHRYOCK JC, 1986, ANAL BIOCHEM, V159, P73, DOI 10.1016/0003-2697(86)90309-X; Silipo A, 2002, J LIPID RES, V43, P2188, DOI 10.1194/jlr.D200021-JLR200; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Villas-Boas SG, 2005, BIOCHEM J, V388, P669, DOI 10.1042/BJ20041162; Wu C, 2015, PLANT PHYSIOL, V167, P586, DOI 10.1104/pp.114.250688; Xiong W, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.53; Yang FF, 2014, MAR DRUGS, V12, P1258, DOI 10.3390/md12031258; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zamboni N, 2015, MOL CELL, V58, P699, DOI 10.1016/j.molcel.2015.04.021; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004; Zur Y., 2000, PROC 2 INT C GEOSPAT, P1	55	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204273	10.1371/journal.pone.0204273	http://dx.doi.org/10.1371/journal.pone.0204273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286115	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500016
J	Schafer, N; Friedrich, M; Jorgensen, ME; Kollert, S; Koepsell, H; Wischmeyer, E; Lesch, KP; Geiger, D; Doring, F				Schaefer, Nadine; Friedrich, Maximilian; Jorgensen, Morten Egevang; Kollert, Sina; Koepsell, Hermann; Wischmeyer, Erhard; Lesch, Klaus-Peter; Geiger, Dietmar; Doering, Frank			Functional analysis of a triplet deletion in the gene encoding the sodium glucose transporter 3, a potential risk factor for ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NA+/GLUCOSE COTRANSPORTER; MOLECULAR-GENETICS; RENAL GLUCOSURIA; SUGAR-BINDING; LINKAGE; MODELER; FAMILY; SGLT1	Sodium-glucose transporters (SGLT) belong to the solute carrier 5 family, which is characterized by sodium dependent transport of sugars and other solutes. In contrast, the human SGLT3 (hSGLT3) isoform, encoded by SLC5A4, acts as a glucose sensor that does not transport sugar but induces membrane depolarization by Na+ currents upon ligand binding. Whole-exome sequencing (WES) of several extended pedigrees with high density of attention-deficit/hyperactivity disorder (ADHD) identified a triplet ATG deletion in SLC5A4 leading to a single amino acid loss (Delta M500) in the hSGLT3 protein imperfectly co-segregating with the clinical phenotype of ADHD. Since mutations in homologous domains of hSGLT1 and hSGLT2 were found to affect intestinal and renal function, respectively, we analyzed the functional properties of hSGLT3[wt] and [Delta M500] by voltage clamp and current clamp recordings from cRNA-injected Xenopus laevis oocytes. The cation conductance of hSGLT3[wt] was activated by application of glucose or the specific agonist 1-desoxpojirimycin (DNJ) as revealed by inward currents in the voltage clamp configuration and cell depolarization in the current clamp mode. Almost no currents and changes in membrane potential were observed when glucose or DNJ were applied to hSGLT3 [Delta M500]-injected oocytes, demonstrating a loss of function by this amino acid deletion in hSGLT3. To monitor membrane targeting of wt and mutant hSGLT3, fusion constructs with YFP were generated, heterologously expressed in Xenopus laevis oocytes and analyzed for membrane fluorescence by confocal microscopy. In comparison to hSGLT3[wt] the fluorescent signal of mutant [Delta M500] was reduced by 43% indicating that the mutant phenotype might mainly result from inaccurate membrane targeting. As revealed by homology modeling, residue M500 is located in TM11 suggesting that in addition to the core structure (TM1-TM10) of the transporter, the surrounding TMs are equally crucial for transport/sensor function. In conclusion, our findings indicate that the deletion [Delta M500] in hSGLT3 inhibits membrane targeting and thus largely disrupts glucose-induced sodium conductance, which may, in interaction with other ADHD risk-related gene variants, influence the risk for ADHD in deletion carriers.	[Schaefer, Nadine; Jorgensen, Morten Egevang; Koepsell, Hermann; Geiger, Dietmar] Univ Wurzburg, Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, Wurzburg, Germany; [Friedrich, Maximilian; Kollert, Sina; Lesch, Klaus-Peter] Univ Hosp Wurzburg, Div Mol Psychiat, Ctr Mental Hlth, Wurzburg, Germany; [Kollert, Sina; Wischmeyer, Erhard; Doering, Frank] Univ Wurzburg, Inst Physiol, Div Mol Electrophysiol, Wurzburg, Germany; [Kollert, Sina; Lesch, Klaus-Peter] Sechenov First Moscow State Med Univ, Inst Mol Med, Lab Psychiat Neurobiol, Moscow, Russia; [Wischmeyer, Erhard; Doering, Frank] Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Ctr Mental Hlth, Wurzburg, Germany; [Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Neurosci, Maastricht, Netherlands	University of Wurzburg; University of Wurzburg; University of Wurzburg; Sechenov First Moscow State Medical University; University of Wurzburg; Maastricht University	Doring, F (corresponding author), Univ Wurzburg, Inst Physiol, Div Mol Electrophysiol, Wurzburg, Germany.; Doring, F (corresponding author), Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Ctr Mental Hlth, Wurzburg, Germany.	fdoering@uni-wuerzburg.de	Geiger, Dietmar/AAH-8140-2019; Lesch, Klaus-Peter/J-4906-2013; Jorgensen, Morten Egevang/A-2795-2016	Geiger, Dietmar/0000-0003-0715-5710; Lesch, Klaus-Peter/0000-0001-8348-153X; Jorgensen, Morten Egevang/0000-0001-6503-0495; Doring, Frank/0000-0003-1017-1498	King Saud University, Saudi Arabia; Danish Council for Independent Research [DFF-6108-00122]; German Research Foundation [SFB TRR58-A05]; European Union [602805]; Horizon 2020 Research and Innovation Programme (grant Eat2beNICE) [728018]; 5-100 Russian Academic Excellence Project; German Research Foundation; University of Wuerzburg	King Saud University, Saudi Arabia(King Saud University); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); Horizon 2020 Research and Innovation Programme (grant Eat2beNICE); 5-100 Russian Academic Excellence Project(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation); German Research Foundation(German Research Foundation (DFG)); University of Wuerzburg	NS and DG were supported by the King Saud University, Saudi Arabia. MEJ was supported by a grant from the Danish Council for Independent Research (grant DFF-6108-00122). KPL was supported by the German Research Foundation (grant SFB TRR58-A05), the European Union's Seventh Framework Programme (grant FP7/2007-2013/No. 602805), the Horizon 2020 Research and Innovation Programme (grant Eat2beNICE/No. 728018), and the 5-100 Russian Academic Excellence Project. Publication was supported by the German Research Foundation and the Open Access Publication Fund of the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Calado J, 2008, NEPHROL DIAL TRANSPL, V23, P3874, DOI 10.1093/ndt/gfn386; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; Chapman NH, 2015, HUM GENET, V134, P1055, DOI 10.1007/s00439-015-1585-y; Chen Jian, 2010, Diabetes Ther, V1, P57, DOI 10.1007/s13300-010-0006-4; Corominas J, 2020, MOL PSYCHIATR, V25, P2047, DOI 10.1038/s41380-018-0210-6; Cristino AS, 2014, MOL PSYCHIATR, V19, P294, DOI 10.1038/mp.2013.16; Cross-Disorder Group of Psychiatric Genomics Consortium, 2013, GEN REL 5 PSYCH DIS, V45, P984; Dahmen B, 2012, J NEURAL TRANSM, V119, P1023, DOI 10.1007/s00702-012-0809-8; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; Diez-Sampedro A, 2011, J BIOL CHEM, V286, P7975, DOI 10.1074/jbc.M110.187880; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Franke B, 2012, MOL PSYCHIATR, V17, P960, DOI 10.1038/mp.2011.138; Hawi Z, 2015, MOL PSYCHIATR, V20, P289, DOI 10.1038/mp.2014.183; Hirayama BA, 2007, BIOCHEMISTRY-US, V46, P13391, DOI 10.1021/bi701562k; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Killeen PR, 2013, NEUROSCI BIOBEHAV R, V37, P625, DOI 10.1016/j.neubiorev.2013.02.011; Klaassen P, 2016, AM J MED GENET B, V171, P790, DOI 10.1002/ajmg.b.32441; Koepsell H, 2017, PHARMACOL THERAPEUT, V170, P148, DOI 10.1016/j.pharmthera.2016.10.017; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Lyon GJ, 2011, DISCOV MED, V11, P41; Martin MG, 1996, NAT GENET, V12, P216, DOI 10.1038/ng0296-216; Merker S, 2017, J CHILD PSYCHOL PSYC, V58, P798, DOI 10.1111/jcpp.12702; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Romanos M, 2008, MOL PSYCHIATR, V13, P522, DOI 10.1038/mp.2008.12; Santer R., 2000, Journal of Inherited Metabolic Disease, V23, P178; Santer R, 2003, J AM SOC NEPHROL, V14, P2873, DOI 10.1097/01.ASN.0000092790.89332.D2; Sotak M, 2017, ESP PHYSL, V103, P5; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Vrhovac I, 2015, PFLUG ARCH EUR J PHY, V467, P1881, DOI 10.1007/s00424-014-1619-7; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2013, MOL ASPECTS MED, V34, P183, DOI 10.1016/j.mam.2012.11.002; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205109	10.1371/journal.pone.0205109	http://dx.doi.org/10.1371/journal.pone.0205109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286162	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500087
J	Stasiak, A; Sayles, M; Winter, IM				Stasiak, Arkadiusz; Sayles, Mark; Winter, Ian M.			Perfidious synaptic transmission in the guinea-pig auditory brainstem	PLOS ONE			English	Article							ANTEROVENTRAL COCHLEAR NUCLEUS; SPHERICAL BUSHY CELLS; CAT TRAPEZOID BODY; NERVE FIBERS; TEMPORAL REPRESENTATION; REGULARITY ANALYSIS; DISCHARGE PATTERNS; MONGOLIAN GERBIL; HELD SYNAPSE; WAVE-FORMS	The presence of 'giant' synapses in the auditory brainstem is thought to be a specialization designed to encode temporal information to support perception of pitch, frequency, and sound-source localisation. These 'giant' synapses have been found in the ventral cochlear nucleus, the medial nucleus of the trapezoid body and the ventral nucleus of the lateral lemniscus. An interpretation of these synapses as simple relays has, however, been challenged by the observation in the gerbil that the action potential frequently fails in the ventral cochlear nucleus. Given the prominence of these synapses it is important to establish whether this phenomenon is unique to the gerbil or can be observed in other species. Here we examine the responses of units, thought to be the output of neurons in receipt of 'giant' synaptic endings, in the ventral cochlear nucleus and the medial nucleus of the trapezoid body in the guinea pig. We found that failure of the action-potential component, recorded from cells in the ventral cochlear nucleus, occurred in similar to 60% of spike waveforms when recording spontaneous activity. In the medial nucleus of the trapezoid body, we did not find evidence for actionpotential failure. In the ventral cochlear nucleus action-potential failures transform the receptive field between input and output of bushy cells. Additionally, the action-potential failures result in "non-primary-like" temporal-adaptation patterns. This is important for computational models of the auditory system, which commonly assume the responses of ventral cochlear nucleus bushy cells are very similar to their "primary like" auditory-nerve-fibre inputs.	[Stasiak, Arkadiusz; Sayles, Mark; Winter, Ian M.] Ctr Neural Basis Hearing, Physiol Lab, Downing St, Cambridge, England; [Sayles, Mark] Purdue Univ, Brainstem Neurophysiol Lab, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	University of Cambridge; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Winter, IM (corresponding author), Ctr Neural Basis Hearing, Physiol Lab, Downing St, Cambridge, England.	imw1001@cam.ac.uk	Stasiak, Arkadiusz/AAI-1325-2020	Stasiak, Arkadiusz/0000-0002-7953-4739; Sayles, Mark/0000-0002-4313-6878	BBSRC; Wellcome Trust; University of Cambridge MD PhD program	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Cambridge MD PhD program	This work was supported by the BBSRC and the Wellcome Trust. M. S. was supported by a scholarship from the University of Cambridge MD PhD program.	BANKS MI, 1991, J NEUROPHYSIOL, V65, P606, DOI 10.1152/jn.1991.65.3.606; BLACKBURN CC, 1990, J NEUROPHYSIOL, V63, P1191, DOI 10.1152/jn.1990.63.5.1191; BLACKBURN CC, 1989, J NEUROPHYSIOL, V62, P1303, DOI 10.1152/jn.1989.62.6.1303; Borst JGG, 2012, SPRINGER HANDB AUDIT, V41, P95, DOI 10.1007/978-1-4419-9517-9_5; Bourk TR, 1976, THESIS; BROWNELL WE, 1975, BRAIN RES, V94, P413, DOI 10.1016/0006-8993(75)90226-7; Campagnola L, 2014, J NEUROSCI, V34, P2214, DOI 10.1523/JNEUROSCI.4669-13.2014; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Dehmel S, 2010, HEARING RES, V268, P234, DOI 10.1016/j.heares.2010.06.005; Englitz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007014; Galambos R, 1943, J NEUROPHYSIOL, V6, P39, DOI 10.1152/jn.1943.6.1.39; Gleich O, 1998, AUDIOL NEURO-OTOL, V3, P1, DOI 10.1159/000013775; HACKNEY C M, 1986, British Journal of Audiology, V20, P215, DOI 10.3109/03005368609079018; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Joris PX, 2016, ADV EXP MED BIOL, V894, P347, DOI 10.1007/978-3-319-25474-6_36; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1037, DOI 10.1152/jn.1994.71.3.1037; Keine C, 2017, ELIFE, V6, DOI [10.7554/eLife.29639.001, 10.7554/eLife.29639]; Keine C, 2016, ELIFE, V5, DOI 10.7554/eLife.19295; Keine C, 2015, J NEUROSCI, V35, P8579, DOI 10.1523/JNEUROSCI.0133-15.2015; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; Kuenzel T, 2011, J NEUROSCI, V31, P4260, DOI 10.1523/JNEUROSCI.5433-10.2011; Lloyd M.E.A., 2002, INT J AUDIOL, V41, P263; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Louage DHG, 2005, J NEUROSCI, V25, P1560, DOI 10.1523/JNEUROSCI.4742-04.2005; Manis PB, 2012, SPRINGER HANDB AUDIT, V41, P61, DOI 10.1007/978-1-4419-9517-9_4; Mc Laughlin M, 2008, J NEUROSCI, V28, P10206, DOI 10.1523/JNEUROSCI.2735-08.2008; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Nerlich J, 2014, J NEUROSCI, V34, P11604, DOI 10.1523/JNEUROSCI.0719-14.2014; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; Palmer AR, 1996, ADVANCES IN SPEECH H, V3; PFEIFFER RR, 1966, SCIENCE, V154, P667, DOI 10.1126/science.154.3749.667; Rhode WS, 2008, NEUROSCIENCE, V154, P87, DOI 10.1016/j.neuroscience.2008.03.013; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Sayles M, 2008, J NEUROSCI, V28, P11925, DOI 10.1523/JNEUROSCI.3137-08.2008; Sayles M, 2008, NEURON, V58, P789, DOI 10.1016/j.neuron.2008.03.029; Sayles M, 2017, SPRINGER HANDB AUDIT, V62, P215, DOI 10.1007/978-3-319-52073-5_8; Sayles M, 2015, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00248; Sayles M, 2013, J PHYSIOL-LONDON, V591, P3401, DOI 10.1113/jphysiol.2013.253062; SHOFNER WP, 1985, J NEUROPHYSIOL, V54, P917, DOI 10.1152/jn.1985.54.4.917; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; Smith PH, 2005, J COMP NEUROL, V482, P349, DOI 10.1002/cne.20407; Spirou GA, 2005, NEUROSCIENCE, V136, P843, DOI 10.1016/j.neuroscience.2005.08.068; SPIROU GA, 1990, J NEUROPHYSIOL, V63, P1169, DOI 10.1152/jn.1990.63.5.1169; Typlt M, 2010, EUR J NEUROSCI, V31, P1574, DOI 10.1111/j.1460-9568.2010.07188.x; Verschooten E, 2013, ASSESSMENT NEURAL PH; WICKESBERG RE, 1990, J NEUROSCI, V10, P1762; WINTER IM, 1990, J ACOUST SOC AM, V88, P1437, DOI 10.1121/1.399720; WINTER IM, 1990, HEARING RES, V44, P161, DOI 10.1016/0378-5955(90)90078-4	50	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203712	10.1371/journal.pone.0203712	http://dx.doi.org/10.1371/journal.pone.0203712			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286113	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500010
J	Theurer, CP; Tumasjan, A; Welpe, IM				Theurer, Christian P.; Tumasjan, Andranik; Welpe, Isabell M.			Contextual work design and employee innovative work behavior: When does autonomy matter?	PLOS ONE			English	Article							LEADER-MEMBER EXCHANGE; JOB DESIGN; CONJOINT-ANALYSIS; ORGANIZATIONAL-BEHAVIOR; PSYCHOLOGICAL CLIMATE; VENTURE CAPITALISTS; PRODUCT INNOVATION; DECISION-MAKING; MODERATING ROLE; CREATIVITY	In environments experiencing fast technological change in which innovative performance is expected, work design research has found that the degree of autonomy positively predicts behavioral and attitudinal work outcomes. Because extant work design research has tended to examine the direct and mediating effects of autonomy on work outcomes such as job satisfaction, examinations of more situational elements and the degree to which the organizational context strengthens or weakens this relationship has been neglected. This study, therefore, takes a context-contingent perspective to investigate the degree to which psychological climate dimensions such as supervisor support, organizational structure and organizational innovation moderate the effects of autonomy (work scheduling autonomy, work methods autonomy, decision-making autonomy) on employee perceived innovative work behavior (IWB). Using a conjoint experiment based on 9,440 assessments nested within 1,180 employees, it was found that all autonomy dimensions had a significant direct effect on employee perceived IWB. Contrary to the Hypotheses, the multi-level analysis did not reveal any moderating effect of the climate dimensions on the relationship between autonomy and employee IWB. This study provides a context-contingent view for the features of work design and gives a more detailed analysis of autonomy, which has previously been seen primarily as a unidimensional construct.	[Theurer, Christian P.; Welpe, Isabell M.] Tech Univ Munich, TUM Sch Management, Chair Strategy & Org, Munich, Bavaria, Germany; [Tumasjan, Andranik] Johannes Gutenberg Univ Mainz, Gutenberg Sch Management & Econ, Chair Management & Digital Transformat, Mainz, Germany; [Welpe, Isabell M.] Bavarian State Inst Higher Educ Res & Planning, Munich, Germany	Technical University of Munich; Johannes Gutenberg University of Mainz	Theurer, CP (corresponding author), Tech Univ Munich, TUM Sch Management, Chair Strategy & Org, Munich, Bavaria, Germany.	christian.theurer@tum.de		Theurer, Christian/0000-0003-0011-7594	HAYS AG (Mannheim) - Recruiting Experts Worldwide	HAYS AG (Mannheim) - Recruiting Experts Worldwide	This work received funding through HAYS AG (Mannheim) - Recruiting Experts Worldwide: https://www.hays.de/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PS, 1996, ADMIN SCI QUART, V41, P61, DOI 10.2307/2393986; Aguinis H, 2013, J MANAGE, V39, P1490, DOI 10.1177/0149206313478188; Ahmed P.K., 1998, EUR J INNOV MANAG, V1, P30, DOI DOI 10.1108/14601069810199131; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Amabile TM, 2004, LEADERSHIP QUART, V15, P5, DOI 10.1016/j.leaqua.2003.12.003; AMABILE TM, 1988, RES ORGAN BEHAV, V10, P123; AMABILE TM, 1983, J PERS SOC PSYCHOL, V45, P357, DOI 10.1037/0022-3514.45.2.357; [Anonymous], 2015, DIGITAL TRANSFORMATI; Axtell CM, 2000, J OCCUP ORGAN PSYCH, V73, P265, DOI 10.1348/096317900167029; Baum M, 2013, J WORLD BUS, V48, P175, DOI 10.1016/j.jwb.2012.07.002; Baum M, 2013, INT J HUM RESOUR MAN, V24, P1393, DOI 10.1080/09585192.2012.712542; Behrens J, 2014, J PROD INNOVAT MANAG, V31, P144, DOI 10.1111/jpim.12085; Benzer J, 2015, HUM RESOUR MANAGE-US, V54, P457, DOI 10.1002/hrm.21645; Bertels HMJ, 2011, J PROD INNOVAT MANAG, V28, P757, DOI 10.1111/j.1540-5885.2011.00836.x; Bradshaw T., 2017, FINANCIAL TIMES; Breaugh JA, 1999, J BUS PSYCHOL, V13, P357, DOI 10.1023/A:1022926416628; BREAUGH JA, 1989, HUM RELAT, V42, P1033, DOI 10.1177/001872678904201105; BREAUGH JA, 1985, HUM RELAT, V38, P551, DOI 10.1177/001872678503800604; Briggs Christian., 2012, DIGITAL FLUENCY BUIL; Brock D.M., 2003, INT J BUSINESS EC, V2, P57; Brundin E, 2008, J BUS VENTURING, V23, P221, DOI 10.1016/j.jbusvent.2006.10.009; Brynjolfsson E., 2011, RACE MACHINE DIGITAL; Carnabuci G, 2015, ACAD MANAGE J, V58, P881, DOI 10.5465/amj.2013.1042; Carnoy M, 1997, INT LABOUR REV, V136, P27; Carr JZ, 2003, J APPL PSYCHOL, V88, P605, DOI 10.1037/0021-9010.88.4.605; Castells M., 2011, INFORM AGE EC SOC CU; Chang S, 2014, J APPL PSYCHOL, V99, P665, DOI 10.1037/a0035679; Choi YR, 2004, J MANAGE, V30, P377, DOI 10.1016/j.jm.2003.04.002; Colbert A, 2016, ACAD MANAGE J, V59, P731, DOI 10.5465/amj.2016.4003; CONNOR PE, 1992, ACAD MANAGE J, V35, P218, DOI 10.2307/256480; Cooper RG, 1999, J PROD INNOVAT MANAG, V16, P115, DOI 10.1016/S0737-6782(98)00061-7; DAMANPOUR F, 1991, ACAD MANAGE J, V34, P555, DOI 10.2307/256406; Dawis R.V., 1984, PSYCHOL THEORY WORK; de Jong JPJ, 2007, EUR J INNOV MANAG, V10, P41, DOI 10.1108/14601060710720546; Dedrick J, 2003, ACM COMPUT SURV, V35, P1, DOI 10.1145/641865.641866; Donaldson SI, 2002, J BUS PSYCHOL, V17, P245, DOI 10.1023/A:1019637632584; Dorenbosch L., 2005, CREATIVITY INNOVATIO, V14, P129, DOI [DOI 10.1111/J.1476-8691.2005.00333.X, 10.1111/j.1476-8691.2005.00333.x]; DRAZIN R, 1986, ADMIN SCI QUART, V30, P514; Dul J, 2014, J PROD INNOVAT MANAG, V31, P1254, DOI 10.1111/jpim.12149; Eisenberger R, 2002, J APPL PSYCHOL, V87, P565, DOI 10.1037//0021-9010.87.3.565; EVANS DS, 1995, J HUM RESOUR, V30, P386, DOI 10.2307/146125; Fiedler F. E., 1967, THEORY LEADERSHIP EF; Flores LG, 2012, J MANAGE, V38, P640, DOI 10.1177/0149206310384631; Ford CM, 2000, J MANAGE, V26, P705, DOI 10.1177/014920630002600406; FRIED Y, 1987, PERS PSYCHOL, V40, P287, DOI 10.1111/j.1744-6570.1987.tb00605.x; Fried Y., 2008, OXFORD HDB PERSONNEL, P586; FRY LW, 1984, ACAD MANAGE J, V27, P221, DOI 10.2307/255923; FRY LW, 1987, ACAD MANAGE REV, V12, P117, DOI 10.2307/257998; Gottlieb J., 2014, DIGITAL TIPPING POIN; GRAEN G, 1982, ORGAN BEHAV HUM PERF, V30, P109, DOI 10.1016/0030-5073(82)90236-7; Grant A. M., 2011, APA HDB IND ORG PSYC, V1, P417; Grant AM, 2009, ACAD MANAG ANN, V3, P317, DOI 10.1080/19416520903047327; GREEN PE, 1978, J CONSUM RES, V5, P103, DOI 10.1086/208721; Green PE, 2001, INTERFACES, V31, pS56, DOI 10.1287/inte.31.3s.56.9676; Hackman J.R., 1980, WORK REDESIGN; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; HACKMAN JR, 1975, J APPL PSYCHOL, V60, P159, DOI 10.1037/h0076546; Hahn G.J., 1966, CATALOGING COMPUTER; Hartnell CA, 2011, J APPL PSYCHOL, V96, P677, DOI 10.1037/a0021987; Holland J.L., 1985, MAKING VOCATIONAL CH; Humphrey SE, 2007, J APPL PSYCHOL, V92, P1332, DOI 10.1037/0021-9010.92.5.1332; Hurt H.T., 1977, HUM COMMUN RES, V4, P58, DOI DOI 10.1111/J.1468-2958.1977.TB00597.X; Ilies R, 2007, J APPL PSYCHOL, V92, P269, DOI 10.1037/0021-9010.92.1.269; Janssen O, 2000, J OCCUP ORGAN PSYCH, V73, P287, DOI 10.1348/096317900167038; Janz BD, 1997, PERS PSYCHOL, V50, P877, DOI 10.1111/j.1744-6570.1997.tb01486.x; Johns G, 2006, ACAD MANAGE REV, V31, P386, DOI 10.5465/amr.2006.20208687; Johns G, 2010, J ORGAN BEHAV, V31, P361, DOI 10.1002/job.669; Johns T, 2013, HARVARD BUS REV, V91, P66; JONES AP, 1979, ORGAN BEHAV HUM PERF, V23, P201, DOI 10.1016/0030-5073(79)90056-4; Judge WQ, 1997, CALIF MANAGE REV, V39, P72, DOI 10.2307/41165899; Juillerat TL, 2010, J ORGAN BEHAV, V31, P216, DOI 10.1002/job.654; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Kirkman BL, 2004, ACAD MANAGE J, V47, P175, DOI 10.2307/20159571; Lammers J, 2016, PERS SOC PSYCHOL B, V42, P498, DOI 10.1177/0146167216634064; Langfred CW, 2004, ACAD MANAGE J, V47, P385, DOI 10.2307/20159588; Langfred CW, 2000, J ORGAN BEHAV, V21, P563, DOI 10.1002/1099-1379(200008)21:5<563::AID-JOB31>3.0.CO;2-H; Lawrence PR, 1986, ORG ENV MANAGING DIF; Litwin G.H., 1968, MOTIVATION ORG CLIMA; Lofquist L. H., 1969, ADJUSTMENT WORK; Lohrke FT, 2010, ORGAN RES METHODS, V13, P16, DOI 10.1177/1094428109341992; Lumpkin GT, 2009, ENTREP THEORY PRACT, V33, P47, DOI 10.1111/j.1540-6520.2008.00280.x; Mankins M., 2017, HARVARD BUSINESS REV; Martins EC., 2003, EUR J INNOV MANAG, V6, P64, DOI [10.1108/14601060310456337, DOI 10.1108/14601060310456337]; Mathieu JE, 2012, J APPL PSYCHOL, V97, P951, DOI 10.1037/a0028380; Mazmanian M, 2013, ORGAN SCI, V24, P1337, DOI 10.1287/orsc.1120.0806; McAdam R., 2002, EUR J INNOV MANAG, V5, P86, DOI [DOI 10.1108/14601060210428186, 10.1108/14601060210428186]; McCord P, 2014, HARVARD BUS REV, V92, P70; Morgeson F.P., 2003, HDB PSYCHOL IND ORG, VVol. 12, P423, DOI [DOI 10.1002/0470048204.CH16, DOI 10.1002/0471264385.WEI1217]; Morgeson FP, 2006, J APPL PSYCHOL, V91, P1321, DOI 10.1037/0021-9010.91.6.1321; Morgeson FP, 2013, PERS PSYCHOL, V66, P805, DOI 10.1111/peps.12055; Morgeson FP, 2010, J ORGAN BEHAV, V31, P351, DOI 10.1002/job.642; Morgeson FP, 2008, RES PERS H, V27, P39, DOI 10.1016/S0742-7301(08)27002-7; Moy JW, 2004, PERS REV, V33, P521, DOI 10.1108/00483480410550134; Nayir DZ, 2014, INT J INNOV TECHNOL, V11, DOI 10.1142/S0219877014500291; Oldham GR, 1996, ACAD MANAGE J, V39, P607, DOI 10.2307/256657; Oldham GR, 2010, J ORGAN BEHAV, V31, P463, DOI 10.1002/job.678; OREILLY C, 1989, CALIF MANAGE REV, V31, P9, DOI 10.2307/41166580; OSTROFF C, 1993, ORGAN BEHAV HUM DEC, V56, P56, DOI 10.1006/obhd.1993.1045; Parker CP, 2003, J ORGAN BEHAV, V24, P389, DOI 10.1002/job.198; Parker SK, 2006, J APPL PSYCHOL, V91, P636, DOI 10.1037/0021-9010.91.3.636; Parker SK, 2003, J APPL PSYCHOL, V88, P620, DOI 10.1037/0021-9010.88.4.620; Parker SK, 2001, J OCCUP ORGAN PSYCH, V74, P413, DOI 10.1348/096317901167460; Patterson MG, 2005, J ORGAN BEHAV, V26, P379, DOI 10.1002/job.312; Patzelt H, 2008, J MANAGE STUD, V45, P1217, DOI 10.1111/j.1467-6486.2008.00791.x; Patzelt H, 2009, ENTREP THEORY PRACT, V33, P319, DOI 10.1111/j.1540-6520.2008.00291.x; Pierce JL, 1977, ACAD MANAGE REV, V2, P27, DOI DOI 10.5465/AMR.1977.4409154; PUGH DS, 1968, ADMIN SCI QUART, V13, P65, DOI 10.2307/2391262; Ramamoorthy N., 2005, CREAT INNOV MANAG, V14, P142, DOI [DOI 10.1111/J.1467-8691.2005.00334.X, 10.1111/j.1467-8691.2005.00334.x]; Rao Vithala R., 2014, APPL CONJOINT ANAL, DOI DOI 10.1007/978-3-540-87753-0; Raub S, 2008, INT J HOSP MANAG, V27, P179, DOI 10.1016/j.ijhm.2007.07.018; Raudenbush SW, 2004, HIERARCHICAL LINEAR; Schroeder R.G., 1989, RES MANAGEMENT INNOV, P107; SCOTT SG, 1994, ACAD MANAGE J, V37, P580, DOI 10.2307/256701; Shalley CE, 2000, ACAD MANAGE J, V43, P215, DOI 10.2307/1556378; Shepherd D., 1999, VENTURE CAPITAL INT, V1, P197, DOI DOI 10.1080/136910699295866; Shepherd D.A., 1997, ADV ENTREPRENEURSHIP, VVol. 3, P203, DOI DOI 10.1177/0149206310369940; Shepherd DA, 1999, MANAGE SCI, V45, P621, DOI 10.1287/mnsc.45.5.621; Shepherd DA, 2013, ACAD MANAGE J, V56, P1251, DOI 10.5465/amj.2011.0776; Smith GF, 1998, J CREATIVE BEHAV, V32, P107, DOI 10.1002/j.2162-6057.1998.tb00810.x; SPECTOR PE, 1986, HUM RELAT, V39, P1005, DOI 10.1177/001872678603901104; Svyantek D, 2004, COMPREHENSIVE HDB PS, V4, P507; Uy MA, 2015, J BUS VENTURING, V30, P375, DOI 10.1016/j.jbusvent.2014.02.001; Van der Vegt GS, 2003, J MANAGE, V29, P729, DOI 10.1016/S0149-2063(03)00033-3; Volmer J, 2012, LEADERSHIP QUART, V23, P456, DOI 10.1016/j.leaqua.2011.10.005; Wang AC, 2010, J ORGAN BEHAV, V31, P106, DOI 10.1002/job.634; Wayne SJ, 1999, J ORGAN BEHAV, V20, P577, DOI 10.1002/(SICI)1099-1379(199909)20:5<577::AID-JOB958>3.0.CO;2-0; Wegman LA, 2018, J MANAGE, V44, P352, DOI 10.1177/0149206316654545; WEST MA, 1989, SOC BEHAV, V4, P15; World Economic Forum, 2016, FUTURE JOBS EMPLOYME; Wullenweber K, 2008, INFORM SYST FRONT, V10, P211, DOI 10.1007/s10796-008-9063-x; Xiao ZX, 2007, ADMIN SCI QUART, V52, P1, DOI 10.2189/asqu.52.1.1; Yuan FR, 2010, ACAD MANAGE J, V53, P323, DOI 10.5465/AMJ.2010.49388995; Yun S, 2005, J APPL PSYCHOL, V90, P1288, DOI 10.1037/0021-9010.90.6.1288; Zacharakis AL, 1998, J BUS VENTURING, V13, P57, DOI 10.1016/S0883-9026(97)00004-9; Zaltman G., 1973, INNOVATIONS ORG	135	15	15	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204089	10.1371/journal.pone.0204089	http://dx.doi.org/10.1371/journal.pone.0204089			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286104	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500014
J	Wang, J; Duan, Y; Meng, QH; Gong, R; Guo, C; Zhao, Y; Zhang, YL				Wang, Juan; Duan, Yong; Meng, Qing-He; Gong, Rong; Guo, Chong; Zhao, Ying; Zhang, Yanliang			Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China	PLOS ONE			English	Article							SHOCK-PROTEIN 20; FUNCTIONAL TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; AIR-POLLUTION; BETA-CATENIN; BCL6B; PATTERNS; METASTASIS; ACTIVATION	Background Aberrant DNA methylation occurs frequently in cancer. The aim of this study was to identify novel methylation markers in lung cancer in Xuanwei, China, through integrated genome-wide DNA methylation and gene expression studies. Methods Differentially methylated regions (DMRs) and differentially expressed genes (DEGs) were detected on 10 paired lung cancer tissues and noncancerous lung tissues by methylated DNA immunoprecipitation combined with microarray (MeDIP-chip) and gene expression microarray analyses, respectively. Integrated analysis of DMRs and DEGs was performed to screen out candidate methylation-related genes. Both methylation and expression changes of the candidate genes were further validated and analyzed. Results Compared with normal lung tissues, lung cancer tissues expressed a total of 6,899 DMRs, including 5,788 hypermethylated regions and 1,111 hypomethylated regions. Integrated analysis of DMRs and DEGs identified 45 tumor-specific candidate genes: 38 genes whose DMRs were hypermethylated and expression was downregulated, and 7 genes whose DMRs were hypomethylated and expression was upregulated. The methylation and expression validation results identified 4 candidate genes (STXBP6, BCL6B, FZD10, and HSPB6) that were significantly hypermethylated and downregulated in most of the tumor tissues compared with the noncancerous lung tissues. Conclusions This integrated analysis of genome-wide DNA methylation and gene expression in lung cancer in Xuanwei revealed several genes regulated by promoter methylation that have not been described in lung cancer before. These results provide new insight into the carcinogenesis of lung cancer in Xuanwei and represent promising new diagnostic and therapeutic targets.	[Wang, Juan; Duan, Yong; Gong, Rong; Guo, Chong; Zhao, Ying; Zhang, Yanliang] Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Wang, Juan; Duan, Yong; Gong, Rong; Guo, Chong; Zhao, Ying; Zhang, Yanliang] Yunnan Inst Expt Diag, Kunming, Yunnan, Peoples R China; [Wang, Juan; Duan, Yong; Gong, Rong; Guo, Chong; Zhao, Ying; Zhang, Yanliang] Yunnan Key Lab Lab Med, Kunming, Yunnan, Peoples R China; [Meng, Qing-He] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA	Kunming Medical University; University of Texas System; UTMD Anderson Cancer Center	Zhang, YL (corresponding author), Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.; Zhang, YL (corresponding author), Yunnan Inst Expt Diag, Kunming, Yunnan, Peoples R China.; Zhang, YL (corresponding author), Yunnan Key Lab Lab Med, Kunming, Yunnan, Peoples R China.	zylyh2007@163.com			National Natural Science Foundation of China [81160292, 81460325]; Key Project of Science and Technology Department of Yunnan Province-Kunming Medical University Union Found [2014FA014]; High Level Talents of Health Technology in Yunnan Province [L-201202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology Department of Yunnan Province-Kunming Medical University Union Found; High Level Talents of Health Technology in Yunnan Province	This study was supported by the National Natural Science Foundation of China (Grant number: 81160292,Yanliang Zhang), the National Natural Science Foundation of China (Grant number: 81460325,Yong Duan), the Key Project of Science and Technology Department of Yunnan Province-Kunming Medical University Union Found (Grant number: 2014FA014,Yong Duan) and High Level Talents of Health Technology in Yunnan Province (Grant number: L-201202,Yong Duan). Yanliang Zhang:preparation manuscript. Yong Duan:decision to publish.	Ambrosone CB, 2014, ONCOTARGET, V5, P237, DOI 10.18632/oncotarget.1599; Bind MA, 2014, EPIGENETICS-US, V9, P448, DOI 10.4161/epi.27584; Bjaanaes MM, 2016, MOL ONCOL, V10, P330, DOI 10.1016/j.molonc.2015.10.021; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Bu FF, 2015, ONCOTARGET, V6, P2120, DOI 10.18632/oncotarget.2940; Chen C, 2009, CANCER INVEST, V27, P582, DOI 10.1080/07357900802620869; Chen GB, 2015, LUNG CANCER, V90, P155, DOI 10.1016/j.lungcan.2015.08.006; Deng JY, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140067; Fernandez SV, 2010, MUTAT RES-FUND MOL M, V688, P28, DOI 10.1016/j.mrfmmm.2010.02.007; Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467; Gaedcke J, 2014, ONCOTARGET, V5, P8123, DOI 10.18632/oncotarget.2347; Gong C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6406; Hashimoto Y, 2016, EPIGENOMICS-UK, V8, P685, DOI 10.2217/epi-2015-0013; Hu S, 2015, AM J CANCER RES, V5, P651; Ju YT, 2015, J CELL BIOCHEM, V116, P277, DOI 10.1002/jcb.24966; Kawano H, 2014, ANN SURG ONCOL, V21, pS696, DOI 10.1245/s10434-014-3818-z; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kun W, 2017, SOFT SCI HLTH, V31, P7; Li X, 2015, ONCOTARGET, V6, P11547, DOI 10.18632/oncotarget.3413; Liu WB, 2015, ONCOTARGET, V6, P21225, DOI 10.18632/oncotarget.4237; Matsushima-Nishiwaki R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151907; Matsushima-Nishiwaki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078440; Min ZH, 2016, MODERN PREVENTIVE ME, V43, P6; Mullapudi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143826; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; Nagasawa T, 2015, ARCH BIOCHEM BIOPHYS, V565, P1, DOI 10.1016/j.abb.2014.10.010; Nagasawa T, 2014, ONCOL REP, V32, P1291, DOI 10.3892/or.2014.3278; Nagayama S, 2005, ONCOGENE, V24, P6201, DOI 10.1038/sj.onc.1208780; Nagayama S, 2009, CANCER SCI, V100, P405, DOI 10.1111/j.1349-7006.2008.01052.x; Qiao NA, 2014, EUR J GYNAECOL ONCOL, V35, P576; Spisak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046215; Terasaki H, 2002, INT J MOL MED, V9, P107; Wang BX, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-11; Wang J, 2014, CANCER LETT, V355, P192, DOI 10.1016/j.canlet.2014.08.025; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wang WL, 2015, ONCOTARGET, V6, P20252, DOI 10.18632/oncotarget.3857; Wu HF, 2016, EUR J CANCER PREV, V25, P508, DOI 10.1097/CEJ.0000000000000214; Xu LX, 2012, GUT, V61, P977, DOI 10.1136/gutjnl-2011-300411; Yang QF, 2013, BIOMARKERS, V18, P721, DOI 10.3109/1354750X.2013.853839; Zahnow CA, 2016, ADV CANCER RES, V130, P55, DOI 10.1016/bs.acr.2016.01.007; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032765; Zheng RS, 2016, THORAC CANCER, V7, P94, DOI 10.1111/1759-7714.12286; Zhu C., 2008, THE THIRD CHINESE NA	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0203155	10.1371/journal.pone.0203155	http://dx.doi.org/10.1371/journal.pone.0203155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286088	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500005
J	Noureini, SK; Fatemi, L; Wink, M				Noureini, Sakineh Kazemi; Fatemi, Leili; Wink, Michael			Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine	PLOS ONE			English	Article							CATALYTIC SUBUNIT GENE; HTERT TRANSCRIPTION; LENGTH REGULATION; G-QUADRUPLEX; TUMOR-CELLS; MAJUS; ASSAY; INHIBITION; SENESCENCE; DYNAMICS	Telomeres, the specialized dynamic structures at chromosome ends, regularly shrink with every replication. Thus, they function as an internal molecular clock counting down the number of cell divisions. However, most cancer cells escape this limitation by activating telomerase, which can maintain telomere length. Previous studies showed that the benzylisoquinoline alkaloid chelidonine stimulates multiple modes of cell death and strongly down-regulates telomerase. It is still unknown if down-regulation of telomerase by chelidonine boosts substantial telomere shortening. The breast cancer cell line MCF7 was sequentially treated with very low concentrations of chelidonine over several cell passages. Telomere length and telomerase activity were measured by a monochrome multiplex quantitative PCR and a q-TRAP assay, respectively. Changes in population size and doubling time correlated well with telomerase inhibition and telomere shortening. MCF7 cell growth was arrested completely after three sequential treatments with 0.1 mu M chelidonine, each ending after 48 h, while telomere length was reduced to almost 10% of the untreated control. However, treatment with 0.01 mu M chelidonine did not have any apparent consequence. In addition to dose and time dependent telomerase inhibition, chelidonine changed the splicing pattern of hTERT towards non-enzyme coding isoforms of the transcript. In conclusion, telomere length and telomere stability are strongly affected by chelidonine in addition to microtubule formation.	[Noureini, Sakineh Kazemi; Fatemi, Leili] Hakim Sabzevari Univ, Fac Basic Sci, Dept Biol, Sabzevar, Iran; [Wink, Michael] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Noureini, SK (corresponding author), Hakim Sabzevari Univ, Fac Basic Sci, Dept Biol, Sabzevar, Iran.	Kazemibio@gmail.com	Noureini, Sakineh Kazemi/AAD-4340-2020; Wink, Michael/E-3803-2012	Noureini, Sakineh Kazemi/0000-0001-5876-3295; Wink, Michael/0000-0002-7875-4510	Hakim Sabzevari University	Hakim Sabzevari University	The authors received a limited grant budget by Hakim Sabzevari University, who had no role in the design of the study, in the collection, analyses, or interpretation of data, or in the writing of the manuscript.	Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Allegra A, 2017, LEUKEMIA RES, V56, P60, DOI 10.1016/j.leukres.2017.02.002; Bolzan A.D, 2016, TELOMERE TELOMERASE, V3; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chuaire Lilian, 2006, Colomb. Med., V37, P332; Collins K, 1996, CURR OPIN CELL BIOL, V8, P374, DOI 10.1016/S0955-0674(96)80013-5; Colombo ML, 1996, PHARMACOL RES, V33, P127, DOI 10.1006/phrs.1996.0019; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Deng YB, 2007, LAB INVEST, V87, P1071, DOI 10.1038/labinvest.3700673; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HOHENWARTER O, 1992, DRUG EXP CLIN RES, V18, P1; Hou M, 2001, CLIN CHEM, V47, P519; Jafri MA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0324-x; Kaminskyy V, 2008, CELL BIOL INT, V32, P271, DOI 10.1016/j.cellbi.2007.09.004; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Kong F, 2014, SCI CHINA LIFE SCI, V57, P564, DOI 10.1007/s11427-014-4666-6; Lan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059230; Li AYJ, 2011, MOL CELL BIOL, V31, P2605, DOI 10.1128/MCB.05447-11; Lu LG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2893; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Mazzanti G, 2009, J ETHNOPHARMACOL, V126, P518, DOI 10.1016/j.jep.2009.09.004; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neumann AA, 2002, NAT REV CANCER, V2, P879, DOI 10.1038/nrc929; Noureini SK, 2017, BBA-GEN SUBJECTS, V1861, P2020, DOI 10.1016/j.bbagen.2017.05.002; Noureini SK, 2014, CHEM-BIOL INTERACT, V223, P141, DOI 10.1016/j.cbi.2014.09.013; Noureini SK, 2009, WORLD J GASTROENTERO, V15, P3603, DOI 10.3748/wjg.15.3603; Panzer A, 2001, EUR J CELL BIOL, V80, P111, DOI 10.1078/0171-9335-00135; Paul Avijit, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1025, DOI 10.3736/jcim20120912; Qu SM, 2013, AM J EPIDEMIOL, V177, P617, DOI 10.1093/aje/kws291; RHODES D, 1995, CURR OPIN STRUC BIOL, V5, P311, DOI 10.1016/0959-440X(95)80092-1; Rodriguez-Brenes IA, 2010, P NATL ACAD SCI USA, V107, P5387, DOI 10.1073/pnas.0914502107; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Strahl C, 1996, MOL CELL BIOL, V16, P53; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Tian XP, 2010, APPL BIOCHEM BIOTECH, V160, P1460, DOI 10.1007/s12010-009-8633-9; Ulaner GA, 1998, CANCER RES, V58, P4168; Ulaner GA, 2001, INT J CANCER, V91, P644, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.3.CO;2-M; Van Wyk B.-E., 2015, PHYTOMEDICINES HERBA; Van Wyk B.-E., 2017, MED PLANTS WORLD; Wang XJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21070906; Ward RJ, 2005, MOL PHARMACOL, V68, P779, DOI 10.1124/mol.105.011494; Wong MS, 2014, TRENDS GENET, V30, P430, DOI 10.1016/j.tig.2014.07.006; Yi XM, 2000, NEOPLASIA, V2, P433, DOI 10.1038/sj.neo.7900113; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579; Zou CS, 2017, PESTIC BIOCHEM PHYS, V142, P123, DOI 10.1016/j.pestbp.2017.04.009; Zvereva MI, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1563, DOI 10.1134/S0006297910130055	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204901	10.1371/journal.pone.0204901	http://dx.doi.org/10.1371/journal.pone.0204901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281650	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400065
J	Rubab, M; Chellia, R; Saravanakumar, K; Mandava, S; Khan, I; Tango, CN; Hussain, MS; Daliri, EBM; Kim, SH; Ramakrishnan, SR; Wang, MH; Lee, J; Kwon, JH; Chandrashekar, S; Oh, DH				Rubab, Momna; Chellia, Ramachandran; Saravanakumar, Kandasamy; Mandava, Suresh; Khan, Imran; Tango, Charles Nkufi; Hussain, Mohammad Shakhawat; Daliri, Eric Banan-Mwine; Kim, Se-Hun; Ramakrishnan, Sudha Rani; Wang, Myeong-Hyeon; Lee, Jongkook; Kwon, Joong-Ho; Chandrashekar, Sangeeta; Oh, Deog-Hwan			Preservative effect of Chinese cabbage (Brassica rapa subsp pekinensis) extract on their molecular docking, antioxidant and antimicrobial properties	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANTIBACTERIAL ACTIVITY; CRYSTAL-STRUCTURE; VAR. CAPITATA; SOUTH-KOREA; IN-VIVO; BIOSYNTHESIS; AGENTS; PLANTS; LPXC	This study aimed at investigating the antimicrobial activity of different solvent extracts of Chinese cabbage Brassica rapa subsp. pekinensis (BRARP) and their antioxidant and cytotoxicity properties. Of the different solvents extracts, the chloroform extracts (CE) were significantly inhibited the bacterial pathogens at minimum inhibitory concentration (MIC) of 16.5 mg.mL(-1). Biochemical analysis revealed that total phenol (62.6 +/- 0.05 mg GAE.g(-1)) and flavonoids (27.6 +/- 0.04 mg QE.g(-1)) were higher in the extracts of BRARP, which resulted in enhanced antioxidant activity in CE. A total of eight dominant compounds were detected in the potent antimicrobial extract from BRARP based on GC-MS analysis. The molecular interactions study revealed that, among the screened compounds the 1,2-benzenedicarboxylic acid and 2,3-dicyanopropionamide interacted with the active site of pathogenicity and survival related protein with lipopolysaccharide (LpxC) with higer binding energy. This work concluded that the 1, 2-Benzenedicarboxylic acid and 2, 3-Dicyanopropionamide from BRARP was reported to be good non-cytotoxic and antioxidant antimicrobials against bacterial pathogens.	[Rubab, Momna; Chellia, Ramachandran; Khan, Imran; Tango, Charles Nkufi; Hussain, Mohammad Shakhawat; Daliri, Eric Banan-Mwine; Kim, Se-Hun; Oh, Deog-Hwan] Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, South Korea; [Saravanakumar, Kandasamy; Wang, Myeong-Hyeon] Kangwon Natl Univ, Coll Biomed Sci, Dept Med Biotechnol, Chunchon, South Korea; [Mandava, Suresh; Lee, Jongkook] Kangwon Natl Univ, Coll Pharm, Chunchon, South Korea; [Ramakrishnan, Sudha Rani; Kwon, Joong-Ho] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu, South Korea; [Chandrashekar, Sangeeta] Sri Venkateshwara Dent Coll, Madras, Tamil Nadu, India	Kangwon National University; Kangwon National University; Kangwon National University; Kyungpook National University	Oh, DH (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, South Korea.	deoghwa@kangwon.ac.kr	Saravanakumar, Kandasamy/P-6745-2018; Ramakrishnan, Sudha Rani/V-6342-2017; Khan, Imran/S-3149-2018	Saravanakumar, Kandasamy/0000-0002-4465-4378; Ramakrishnan, Sudha Rani/0000-0002-4460-416X; Khan, Imran/0000-0001-9802-0429; Lee, Jongkook/0000-0003-0739-7963; Kwon, Joong-Ho/0000-0002-3875-1438; Myeong-Hyeon, Wang/0000-0003-1760-1622	Brain Korea (BK) 21 Plus Project [22A20153713433]; National Research Foundation of Korea, Ministry of Science [2018007551]; National Research Foundation of Korea (NRF) [2017H1D3A1A01052610]; Brain Korea (BK) 21 Plus Project - Korean Government, Republic of Korea [22A20153713433]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT [2017H1D3A1A01052610]; Young Researchers Program [2018007551]	Brain Korea (BK) 21 Plus Project; National Research Foundation of Korea, Ministry of Science; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Brain Korea (BK) 21 Plus Project - Korean Government, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Science, ICT; Young Researchers Program	Funded by Brain Korea (BK) 21 Plus Project 22A20153713433 to Ms Momna Rubab. Korea Research Fellowship Program, National Research Foundation of Korea, Ministry of Science, Young Researchers Program for 2018007551 to Dr Ramachandran Chelliah. Korea Research Fellowship Program through the National Research Foundation of Korea (NRF) 2017H1D3A1A01052610 to Dr Kandasamy Saravanakumar.; We thank Mr. Park-Yong IK (Kangwon National University, Central laboratory) for technical support for GC-MS and CLSM analysis. This work was supported by a grant from the Brain Korea (BK) 21 Plus Project (Grant No. 22A20153713433) Funded by the Korean Government, Republic of Korea. The part of this work was supported by Korea Research Fellowship Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT (2017H1D3A1A01052610) and Young Researchers Program for (2018007551) (http://www.nrf.re.kr/eng/main).	Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002; [Anonymous], 1994, HERBALGRAM; Arabshahi-D S, 2007, FOOD CHEM, V100, P1100, DOI 10.1016/j.foodchem.2005.11.014; Armesto J, 2019, INT J FOOD SCI NUTR, V70, P136, DOI 10.1080/09637486.2018.1482530; Arora S., 2018, J PHARMACOGNOSY PHYT, V7, P1445; Ashraf S, 2018, ENVIRON TOXICOL PHAR, V58, P54, DOI 10.1016/j.etap.2017.12.017; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Borges A, 2015, J FOOD SCI TECH MYS, V52, P4737, DOI 10.1007/s13197-014-1533-1; Brown MF, 2012, J MED CHEM, V55, P914, DOI 10.1021/jm2014748; Chalannavar RK, 2014, J ESSENT OIL BEAR PL, V17, P1293, DOI 10.1080/0972060X.2014.892840; Cho JI, 2014, FOOD SCI BIOTECHNOL, V23, P209, DOI 10.1007/s10068-014-0028-1; CLSI, 2012, PERF STAND ANT DISK; DICKERMAN JM, 1952, FOOD RES, V17, P438; Ding C, 2017, STUD NAT PROD CHEM, V54, P141, DOI 10.1016/B978-0-444-63929-5.00005-X; El-Hefny M, 2017, BIORESOURCES, V12, P1835, DOI 10.15376/biores.12.1.1835-1849; Elshouny WAF, 2017, J MICROB BIOTEC FOOD, V6, P1203, DOI 10.15414/jmbfs.2017.6.5.1203-1208; Gersnoviez A., 2018, 2018 13 TECHN APPL E, P1, DOI [10.1007/s00425-017-2798-1, DOI 10.1007/S00425-017-2798-1]; Gogo L. A., 2010, Journal of Applied Sciences Research, P1807; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; Gyawali R, 2014, FOOD CONTROL, V46, P412, DOI 10.1016/j.foodcont.2014.05.047; Hanschen FS, 2018, FOOD CHEM, V263, P240, DOI 10.1016/j.foodchem.2018.04.069; HarborneJB, 1984, PHYTOCHEMICAL METHOD, P1, DOI [DOI 10.1007/978-94-009-5570-7_1, 10.1007/978-94-009-5570-7_1]; Hariharan B, 2013, MICROBIAL BIOCH TECH, V6; Hong Eunyoung, 2013, Prev Nutr Food Sci, V18, P218, DOI 10.3746/pnf.2013.18.3.218; Hu Shu-Hui, 2004, Kaohsiung Journal of Medical Sciences, V20, P591, DOI 10.1016/S1607-551X(09)70264-5; Igwe K.K., 2016, INT J SCI TECH RES E, V1, P9; Igwe KK, 2016, INT J ADV RES SCI EN, V3, P1765; Jackman JE, 2000, J BIOL CHEM, V275, P11002, DOI 10.1074/jbc.275.15.11002; Jaiswal AK, 2012, J FOOD BIOCHEM, V36, P344, DOI 10.1111/j.1745-4514.2011.00545.x; Jang Dai-Ja, 2015, Journal of Ethnic Foods, V2, P126; Kalinin DV, 2017, EXPERT OPIN THER PAT, V27, P1227, DOI 10.1080/13543776.2017.1360282; Kim GH, 2015, J FOOD SCI, V80, pM2257, DOI 10.1111/1750-3841.12996; Koncic MZ, 2010, FOOD CHEM TOXICOL, V48, P1537, DOI 10.1016/j.fct.2010.03.021; LIU J Y, 1986, Annals of the Phytopathological Society of Japan, V52, P669, DOI 10.3186/jjphytopath.52.669; Males E, 2004, JPC-J PLANAR CHROMAT, V17, P280, DOI 10.1556/JPC.17.2004.4.7; Mataragas M, 2015, MEAT SCI, V103, P39, DOI 10.1016/j.meatsci.2015.01.002; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Mochalkin I, 2008, PROTEIN SCI, V17, P450, DOI 10.1110/ps.073324108; Mollica A, 2018, BIOMED PHARMACOTHER, V107, P129, DOI 10.1016/j.biopha.2018.07.169; Mudzengi CP, 2017, PHARM BIOL, V55, P1054, DOI 10.1080/13880209.2017.1287744; Nabavi SM, 2015, FOOD CHEM, V173, P339, DOI 10.1016/j.foodchem.2014.10.042; Oliveira DA, 2013, J BIOTECHNOL, V164, P423, DOI 10.1016/j.jbiotec.2012.09.014; Ortega-Ramirez Luis Alberto, 2014, J Food Sci, V79, pR129, DOI 10.1111/1750-3841.12341; Parashar S., 2014, J PHARMACOGN PHYTOCH, V3; Pederson CS, 1944, NEW YORK STATE AGR E, V237; Perez IA, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/284213; Pirbalouti AG, 2014, J MED FOOD, V17, P1151, DOI 10.1089/jmf.2013.0057; Prasanna G, 2014, MED CHEM RES, V23, P2651, DOI 10.1007/s00044-013-0858-z; Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x; Rokayya S, 2013, ASIAN PAC J CANCER P, V14, P6657, DOI 10.7314/APJCP.2013.14.11.6657; Shen XJ, 2017, IND CROP PROD, V96, P110, DOI 10.1016/j.indcrop.2016.11.053; Shen ZH, 2017, CURR ORG CHEM, V21, P1626, DOI 10.2174/1385272821666170410145554; Shenoy N, 2017, LAB INVEST, V97, P494, DOI 10.1038/labinvest.2017.18; Sherman J. M., 1936, J BACTERIOL, V31; Shin J, 2016, FOODBORNE PATHOG DIS, V13, P535, DOI 10.1089/fpd.2016.2147; Soengas P., 2018, J AGR FOOD CHEM; Soengas P, 2018, ACS OMEGA, V3, P5237, DOI 10.1021/acsomega.8b00242; Thangam R, 2013, PHYTOTHER RES, V27, P1664, DOI 10.1002/ptr.4908; Thielmann J, 2017, INT J FOOD MICROBIOL, V251, P48, DOI 10.1016/j.ijfoodmicro.2017.03.019; Thiruvengadam M, 2015, SCI HORTIC-AMSTERDAM, V193, P136, DOI 10.1016/j.scienta.2015.07.007; Tomaras AP, 2014, MBIO, V5, DOI 10.1128/mBio.01551-14; Varghese P., 2015, J STUDENT RES, V4, P87; Vijayan A., 2017, J NATURAL PRODUCTS R, V3, P125; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Wu Q, 2013, ARCH PHARM RES, V36, P423, DOI 10.1007/s12272-013-0068-8; Yee LW, 2007, MALAYSIAN J NUTR, V13, P71; YILDIZ F, 1981, J FOOD SCI, V46, P962, DOI 10.1111/j.1365-2621.1981.tb15397.x; [周璐 Zhou Lu], 2017, [机械传动, Journal of Mechanical Transmission], V41, P1	68	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203306	10.1371/journal.pone.0203306	http://dx.doi.org/10.1371/journal.pone.0203306			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281596	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400018
J	Gokmen-Polar, Y; True, JD; Vieth, E; Gu, Y; Gu, XP; Qi, GD; Mosley, AL; Badve, SS				Gokmen-Polar, Yesim; True, Jason D.; Vieth, Edyta; Gu, Yuan; Gu, Xiaoping; Qi, Guihong D.; Mosley, Amber L.; Badve, Sunil S.			Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; METASTASIS SUPPRESSOR; GENE; PROTEIN; LIVER; EXPRESSION; METHYLATION; ECT2; PHOSPHORYLATION; GROWTH	Deleted in Liver Cancer-1 (DLC1), a member of the RhoGAP family of proteins, functions as a tumor suppressor in several cancers including breast cancer. However, its clinical relevance is unclear in breast cancer. In this study, expression of DLC1 was correlated with prognosis using publicly available breast cancer gene expression datasets and quantitative Reverse Transcription PCR in cohorts of Estrogen Receptor-positive (ER+) breast cancer. Low expression of DLC1 correlates with poor prognosis in patients with ER+ breast cancer with further decrease in metastatic lesions. The Cancer Genome Atlas (TCGA) data showed that down regulation of DLC1 is not due to methylation or mutations. To seek further insights in understanding the role of DLC1 in ER+ breast cancer, we stably overexpressed DLC1-full-length (DLC1-FL) in T-47D breast cancer cells; this inhibited cell colony formation significantly in vitro compared to its control counterpart. Label-free global proteomic and TiO2 phosphopeptide enrichment assays (ProteomeXchange identifier PXD008220) showed that 205 and 122 phosphopeptides were unique to DLC1-FL cells and T-47D-control cells, respectively, whereas 6,726 were quantified by phosphoproteomics analysis in both conditions. The top three significant clusters of differentially phosphopeptides identified by DAVID pathway analysis represent cell-cell adhesion, mRNA processing and splicing, and transcription regulation. Phosphoproteomics analysis documented an inverse relation between DLC1 expression and several phosphopeptides including epithelial cell transforming sequence 2 (ECT2). Decreased phosphorylation of ECT2 at the residue T359, critical for its active conformational change, was validated by western blot. In addition, the ECT2 T359-containing phosphopeptide was detected in both basal and luminal patient-derived breast cancers breast cancer phosphoproteomics data on the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay portal. Together, for the first time, this implicates ECT2 phosphorylation in breast cancer, which has been proposed as a therapeutic target in lung cancer. In conclusion, this data suggests that low expression of DLC1 is associated with poor prognosis. Targeting ECT2 phosphopeptides could provide a promising mechanism for controlling poor prognosis seen in DLC1(low) ER+ breast cancer.	[Gokmen-Polar, Yesim; Vieth, Edyta; Gu, Yuan; Gu, Xiaoping; Badve, Sunil S.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [True, Jason D.; Qi, Guihong D.; Mosley, Amber L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Badve, Sunil S.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Badve, Sunil S.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [True, Jason D.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Ball State University	Gokmen-Polar, Y (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	ypolar@iu.edu	Gokmen-Polar, Yesim/AAX-4001-2021	Gokmen-Polar, Yesim/0000-0001-9927-4893; Vieth, Edyta/0000-0002-7413-9078; Badve, Sunil/0000-0001-8861-9980	Susan G. Komen for the Cure(R); Joshua Edwards Professor of Pathology & Laboratory Medicine Funds	Susan G. Komen for the Cure(R)(Susan G. Komen Breast Cancer Foundation); Joshua Edwards Professor of Pathology & Laboratory Medicine Funds	This work was partly supported by the Susan G. Komen for the Cure (R) and Joshua Edwards Professor of Pathology & Laboratory Medicine Funds to Sunil Badve.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2015, CARDIOVASC DIABETOL, V14, P1, DOI DOI 10.1016/J.JHEP.2015.01.014; Dai XF, 2015, G3-GENES GENOM GENET, V5, P81, DOI 10.1534/g3.114.014894; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; El-Sitt S, 2013, J RECEPT SIG TRANSD, V33, P10, DOI 10.3109/10799893.2012.752002; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gokmen-Polar Y, 2015, MODERN PATHOL, V28, P677, DOI 10.1038/modpathol.2014.146; Gokmen-Polar Y, 2011, BREAST CANCER RES TR, V127, P375, DOI 10.1007/s10549-010-1004-y; Gokmen-Polar Y, 2010, BREAST CANCER RES TR, V124, P327, DOI 10.1007/s10549-010-0733-2; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Guo ZH, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0872-3; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Huff Lauren P, 2013, Genes Cancer, V4, P460, DOI 10.1177/1947601913514851; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Justilien Verline, 2019, Small GTPases, V10, P388, DOI 10.1080/21541248.2017.1335274; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kim TY, 2003, ONCOGENE, V22, P3943, DOI 10.1038/sj.onc.1206573; Ko FCF, 2014, INT J CANCER, V135, P264, DOI 10.1002/ijc.28505; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Lukasik D, 2011, ONCOL LETT, V2, P763, DOI 10.3892/ol.2011.345; Mansour M, 2016, CANCER RES, V76, P4236, DOI 10.1158/0008-5472.CAN-15-1553; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Mosley AL, 2009, J PROTEOMICS, V72, P110, DOI 10.1016/j.jprot.2008.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perez-Riverol Y, 2016, MOL CELL PROTEOMICS, V15, P305, DOI 10.1074/mcp.O115.050229; Plaumann M, 2003, J CANCER RES CLIN, V129, P349, DOI 10.1007/s00432-003-0440-z; Popescu NC, 2014, MOL DIAGN THER, V18, P293, DOI 10.1007/s40291-014-0086-3; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Song YF, 2006, J CLIN PATHOL, V59, P947, DOI 10.1136/jcp.2005.031377; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Teramoto A, 2004, ONCOL REP, V12, P141; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang HB, 2016, CLIN TRANSL ONCOL, V18, P735, DOI 10.1007/s12094-015-1428-2; Wang X, 2018, CANCER RES, V78; Wang YF, 2014, J CLIN INVEST, V124, P1646, DOI 10.1172/JCI71812; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhang T, 2009, UROL INT, V82, P380, DOI 10.1159/000218524	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204658	10.1371/journal.pone.0204658	http://dx.doi.org/10.1371/journal.pone.0204658			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278072	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200019
J	Egieyeh, S; Syce, J; Malan, SF; Christoffels, A				Egieyeh, Samuel; Syce, James; Malan, Sarel F.; Christoffels, Alan			Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach	PLOS ONE			English	Article							APPLICABILITY DOMAIN; DRUG DEVELOPMENT; ATTRITION; MALARIA; VIRULENCE	In view of the vast number of natural products with potential antiplasmodial bioactivity and cost of conducting antiplasmodial bioactivity assays, it may be judicious to learn from previous antiplasmodial bioassays and predict bioactivity of these natural products before experimental bioassays. This study set out to harness antimalarial bioactivity data of natural products to build accurate predictive models, utilizing classical machine learning approaches, which can find potential antimalarial hits from new sets of natural products. Classical machine learning approaches were used to build four classifier models (Naive Bayesian, Voted Perceptron, Random Forest and Sequence Minimization Optimization of Support Vector Machines) from bioactivity data of natural products with in-vitro antiplasmodial activity (NAA) using a combination of the molecular descriptors and two-dimensional molecular fingerprints of the compounds. Models were evaluated with an independent test dataset. Possible chemical features associated with reported antimalarial activities of the compounds were also extracted. From the results, Random Forest (accuracy 82.81%, Kappa statistics 0.65 and Area under Receiver Operating Characteristics curve 0.91) and Sequential Minimization Optimization (accuracy 85.93%, Kappa statistics 0.72 and Area under Receiver Operating Characteristics curve 0.86) showed good predictive performance for the NAA dataset. The amine chemical group (specifically alkyl amines and basic nitrogen) was confirmed to be essential for antimalarial activity in active NAA dataset. This study built and evaluated classifier models that were used to predict the antiplasmodial bioactivity class (active or inactive) of a set of natural products from interBioScreen chemical library.	[Egieyeh, Samuel; Christoffels, Alan] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council Bioinformat Unit, Cape Town, South Africa; [Egieyeh, Samuel; Syce, James; Malan, Sarel F.] Univ Western Cape, Sch Pharm, Cape Town, South Africa	University of the Western Cape; University of the Western Cape	Egieyeh, S (corresponding author), Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council Bioinformat Unit, Cape Town, South Africa.; Egieyeh, S (corresponding author), Univ Western Cape, Sch Pharm, Cape Town, South Africa.	segieyeh@uwc.ac.za	Malan, Sarel/AAA-4189-2020	Malan, Sarel/0000-0002-1640-6457	South African Research Chairs Initiative of the Department of Science and Technology (DST); National Research Foundation (NRF) of South Africa [UID-64751]; National Research Foundation (NRF) of South Africa	South African Research Chairs Initiative of the Department of Science and Technology (DST); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This work was supported by South African Research Chairs Initiative of the Department of Science and Technology (DST) and the National Research Foundation (NRF) of South Africa http://www.nrf.ac.za. Grant number: UID-64751. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge William Jose, Godinez Navarro and Azzaoui Kamal all of Novartis Institute for Biomedical Research (NIBR), Basel Switzerland for reading this paper and making valuable contributions. The South African Research Chairs Initiative of the Department of Science and Technology (DST) and the National Research Foundation (NRF) of South Africa supported this work.	[Anonymous], 2005, P 1 INT WORKSH OP SO; Barnes PJ, 2015, EUR RESPIR J, V45, P1197, DOI 10.1183/09031936.00007915; Bathurst I, 2006, TRENDS PARASITOL, V22, P301, DOI 10.1016/j.pt.2006.05.011; Batista R, 2009, MOLECULES, V14, P3037, DOI 10.3390/molecules14083037; Berthold M., 2009, ACM SIGKDD EXPLOR NE, V11, P26, DOI [10.1145/1656274.1656280, DOI 10.1145/1656274.1656280]; Berthold M. R., 2008, KNIME KONSTANZ INFOR; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Burgess D., 2014, NAT REV GENET, V15, P147; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Christensen SB, 2001, BIOACTIVE COMPOUNDS FROM NATURAL SOURCES: ISOLATION CHARACTERISATION AND BIOLOGICAL PROPERTIES, P379; Chu W, 2007, NEURAL COMPUT, V19, P792, DOI 10.1162/neco.2007.19.3.792; Davis RA, 2012, J MED CHEM, V55, P5851, DOI 10.1021/jm3002795; Drummond C, 2006, COST CURVES IMPROVED; Fang, 2015, MESOZOIC CENOZOIC IN, P1, DOI DOI 10.1007/S11517-014-1207-1; Ferri N, 2013, PHARMACOL THERAPEUT, V138, P470, DOI 10.1016/j.pharmthera.2013.03.005; Frederich M, 2008, T ROY SOC TROP MED H, V102, P11, DOI 10.1016/j.trstmh.2007.10.002; GUPTA S, 1994, P NATL ACAD SCI USA, V91, P3715, DOI 10.1073/pnas.91.9.3715; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Jamal S, 2013, BMC BIOINFORMATICS, V14; Jamal S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-329; James G., 2017, INTRO STAT LEARNING; Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508; Ji SH, 2007, PATTERN RECOGN, V40, P1474, DOI 10.1016/j.patcog.2006.11.008; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kaur K, 2009, BIOORGAN MED CHEM, V17, P3229, DOI 10.1016/j.bmc.2009.02.050; Klein EY, 2013, INT J ANTIMICROB AG, V41, P311, DOI 10.1016/j.ijantimicag.2012.12.007; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Landrum G, 2014, OPEN SOURCE CHEMINFO; Landrum G, 2013, RELEASE, V1, P4; Loukeris N, 2015, INT J FINANCE EC; Martisius Ignas, 2013, International Journal of Artificial Intelligence, V10, P41; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Mazanetz MP, 2012, CURR TOP MED CHEM, V12, P1965; Meinl T, 2009, KONSTANZ INFORM MINE; Mojab F, 2012, AVICENNA J PHYTOMEDI, V2, P52; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Nogueira CR, 2011, MOLECULES, V16, P2146, DOI 10.3390/molecules16032146; NUR EM, 1993, SOC SCI MED, V37, P1115, DOI 10.1016/0277-9536(93)90250-8; Periwal V, 2011, BMC RES NOTES, V4; Roberts RA, 2014, DRUG DISCOV TODAY, V19, P341, DOI 10.1016/j.drudis.2013.11.014; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Sahigara F, 2012, MOLECULES, V17, P4791, DOI 10.3390/molecules17054791; Severini C, 2015, J GLOBAL ANTIMICROBI; Sharma I, 2015, ANTIMICROB AGENTS CH; Sheridan RP, 2012, J CHEM INF MODEL, V52, P814, DOI 10.1021/ci300004n; Singh H, 2015, BIOL DIRECT, V10; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Xu YJ, 2013, MINI-REV MED CHEM, V13, P1056, DOI 10.2174/1389557511313070009	52	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204644	10.1371/journal.pone.0204644	http://dx.doi.org/10.1371/journal.pone.0204644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265702	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500042
J	Porter, MM; Niksiar, P				Porter, Michael M.; Niksiar, Pooya			Multidimensional mechanics: Performance mapping of natural biological systems using permutated radar charts	PLOS ONE			English	Article							DARWINS FINCHES; ECOSYSTEM MULTIFUNCTIONALITY; HIERARCHICAL STRUCTURE; CORTICAL BONE; DESIGN; TENDON; VISUALIZATION; BIODIVERSITY; ADAPTATION; TOUGHNESS	Comparing the functional performance of biological systems often requires comparing multiple mechanical properties. Such analyses, however, are commonly presented using orthogonal plots that compare N <= 3 properties. Here, we develop a multidimensional visualization strategy using permutated radar charts (radial, multi-axis plots) to compare the relative performance distributions of mechanical systems on a single graphic across N >= 3 properties. Leveraging the fact that radar charts plot data in the form of closed polygonal profiles, we use shape descriptors for quantitative comparisons. We identify mechanical property-function correlations distinctive to rigid, flexible, and damage-tolerant biological materials in the form of structural ties, beams, shells, and foams. We also show that the microstructures of dentin, bone, tendon, skin, and cartilage dictate their tensile performance, exhibiting a trade-off between stiffness and extensibility. Lastly, we compare the feeding versus singing performance of Darwin's finches to demonstrate the potential of radar charts for multidimensional comparisons beyond mechanics of materials.	[Porter, Michael M.; Niksiar, Pooya] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA	Clemson University	Porter, MM (corresponding author), Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.	mmporte@clemson.edu	Porter, Michael/A-4895-2016	Porter, Michael/0000-0002-1607-6531				Achrai B, 2017, J MECH BEHAV BIOMEDI; Albo Y, 2016, IEEE T VIS COMPUT GR, V22, P569, DOI 10.1109/TVCG.2015.2467322; Albuquerque G., 2010, 2010 Proceedings of IEEE Symposium on Visual Analytics Science and Technology (VAST 2010), P19, DOI 10.1109/VAST.2010.5652433; Ankerst M, 1998, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION - PROCEEDINGS, P52, DOI 10.1109/INFVIS.1998.729559; Ashby M. F., 2017, MAT SELECTION MECH D; Ashby MF, 2000, ACTA MATER, V48, P359, DOI 10.1016/S1359-6454(99)00304-3; ASKEW MJ, 1978, J BIOMECH ENG-T ASME, V100, P105, DOI 10.1115/1.3426200; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Barthelat F, 2011, J MECH PHYS SOLIDS, V59, P829, DOI 10.1016/j.jmps.2011.01.001; Bechthold M, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.82; Byrnes JEK, 2014, METHODS ECOL EVOL, V5, P111, DOI 10.1111/2041-210X.12143; Campas O, 2010, P NATL ACAD SCI USA, V107, P3356, DOI 10.1073/pnas.0911575107; CHAMBERLAIN JA, 1978, PALEOBIOLOGY, V4, P419, DOI 10.1017/S0094837300006163; Chandrasekaran P, 2017, J BIOMECH, V60, P134, DOI 10.1016/j.jbiomech.2017.06.031; Claessen JHT, 2011, IEEE T VIS COMPUT GR, V17, P2310, DOI 10.1109/TVCG.2011.201; Clemmer J, 2010, J BIOMECH, V43, P2785, DOI 10.1016/j.jbiomech.2010.06.009; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Draper GM, 2009, IEEE T VIS COMPUT GR, V15, P759, DOI 10.1109/TVCG.2009.23; EASTERLING KE, 1982, P ROY SOC LOND A MAT, V383, P31, DOI 10.1098/rspa.1982.0118; ELLIOTT DH, 1965, BIOL REV, V40, P392, DOI 10.1111/j.1469-185X.1965.tb00808.x; Feldman R, 2013, SOC INDIC RES, V111, P709, DOI 10.1007/s11205-012-0028-6; Floater MS, 2003, COMPUT AIDED GEOM D, V20, P19, DOI 10.1016/S0167-8396(03)00002-5; Flusser J., 2009, MOMENTS MOMENT INVAR; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Fratzl P., 2008, COLLAGEN STRUCTURE M, DOI 10.1007/978-0-387-73906-9; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; George WT, 2005, J ORTHOP RES, V23, P1047, DOI 10.1016/j.orthres.2005.02.008; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hamed E, 2012, ACTA BIOMATER, V8, P1080, DOI 10.1016/j.actbio.2011.11.010; Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; Herrel A, 2010, EMU, V110, P39, DOI 10.1071/MU09034; Herrel A, 2009, FUNCT ECOL, V23, P119, DOI 10.1111/j.1365-2435.2008.01494.x; Hoffman P., 1997, P VISUALIZATION, V97, P437; Huang W, 2017, ACTA BIOMATER, V64, P1, DOI 10.1016/j.actbio.2017.09.043; Jaccard P., 1902, B SOC VAUD SCI NAT, V38, P69, DOI [DOI 10.5169/SEALS-266762, 10.5169/seals-266762]; Kandogan E., 2000, P IEEE INF VIS S, V650, P22, DOI DOI 10.1145/502512.502530; Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Krzywinski M, 2013, NAT METHODS, V10, P595, DOI 10.1038/nmeth.2531; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Lehmann DJ, 2016, COMPUT GRAPH FORUM, V35, P443, DOI 10.1111/cgf.12845; LEU JG, 1991, PATTERN RECOGN, V24, P949, DOI 10.1016/0031-3203(91)90092-J; Liu SS, 2017, IEEE T VIS COMPUT GR, V23, P1249, DOI 10.1109/TVCG.2016.2640960; Liu WY, 2008, PROCEEDINGS OF 2008 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P857, DOI 10.1109/ICMLC.2008.4620524; McKittrick J, 2010, MAT SCI ENG C-MATER, V30, P331, DOI 10.1016/j.msec.2010.01.011; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Miettinen K., 2014, OR SPECTRUM, P1; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Montagna W., 2012, STRUCTURE FUNCTION S; Naleway SE, 2015, ADV MATER, V27, P5455, DOI 10.1002/adma.201502403; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; Peng W, 2004, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2004, PROCEEDINGS, P89; Peura M., 1997, P 3 INT WORKSH VIS F, V443, P451; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]; Rosario GE, 2003, INFOVIS 2002: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2003, PROCEEDINGS, P113, DOI 10.1109/INFVIS.2003.1249016; Sacha D, 2016, IEEE T VIS COMPUT GR, V22, P240, DOI 10.1109/TVCG.2015.2467591; Sedlmair M, 2014, IEEE T VIS COMPUT GR, V20, P2161, DOI 10.1109/TVCG.2014.2346321; Sherman VR, 2015, J MECH BEHAV BIOMED, V52, P22, DOI 10.1016/j.jmbbm.2015.05.023; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Soons J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129479; Sullivan TN, 2017, MAT TODAY; Tan T, 2011, ACTA BIOMATER, V7, P3796, DOI 10.1016/j.actbio.2011.06.008; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Long TV, 2015, PROC INT CONF ADV, P297, DOI 10.1109/ATC.2015.7388338; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wong B, 2012, NAT METHODS, V9, P1131, DOI 10.1038/nmeth.2258; Wong B, 2010, NAT METHODS, V7, P665, DOI 10.1038/nmeth0910-665; Yang W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7649; Yaraghi NA, 2018, ANNU REV PHYS CHEM, V69, P23, DOI 10.1146/annurev-physchem-040215-112621; Zhang DS, 2004, PATTERN RECOGN, V37, P1, DOI 10.1016/j.patcog.2003.07.008	78	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204309	10.1371/journal.pone.0204309	http://dx.doi.org/10.1371/journal.pone.0204309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265707	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500029
J	Huang, DL; Wang, L; Talbot, NC; Huang, C; Pu, LP; Zhao, XL; Tian, XC; Zhang, M; Tang, Y				Huang, Delun; Wang, Ling; Talbot, Neil C.; Huang, Chang; Pu, Liping; Zhao, Xiuling; Tian, Xiuchun; Zhang, Ming; Tang, Young			Analyzing bovine OCT4 and NANOG enhancer activity in pluripotent stem cells using fluorescent protein reporters	PLOS ONE			English	Article							MOUSE EPIBLAST; GROUND-STATE; SELF-RENEWAL; GENERATION; LINES; MAINTENANCE; EXPRESSION; DERIVATION; INDUCTION; NAIVE	Green fluorescent protein (GFP) reporters controlled by the regulatory region of OCT4 and NANOG-two master regulators for pluripotency are widely used in studies of pluripotent stem cell establishment and embryo development. Alongside the challenge in establishing bovine pluripotent stem cells, the application of bovine-specific gene reporters has rarely been explored. Using lentivirus-based GFP reporter, we investigated the upstream regulatory regions of bovine OCT4 and NANOG. These reporters show activity in both naive- and primed-state pluripotency when infected into mouse and human embryonic stem cells (ESCs), respectively. Consistent with what is found in humans and mice, the bovine OCT4-distal enhancer (bOCT4-DE) but not the proximal enhancer (bOCT4-PE) region is preferentially activated in naive-state pluripotency. Furthermore, the bOCT4-DE region is silenced upon conversion of naive-state ESCs into primed-state epiblast stem cells (EpiSCs). Co-infection of mouse fibroblasts with the reprograming factors for induced pluripotent stem cell (iPSC) induction leads to the generation of GFP positive colonies, demonstrating that these GFP reporters can serve as live indicators for induced pluripotent cell establishment. We further proved that the bovine OCT4 distal enhancer is active in bovine blastocysts. We established the lentiviral-based fluorescent reporters controlled by bovine OCT4 and NANOG enhancer sequences. These reporter constructs show activity in naive- and primed-pluripotent states. These reporters may serve as versatile tools for bovine ESC/iPSC generation and identification, as well as for developmental studies of bovine embryos.	[Huang, Delun; Pu, Liping; Zhao, Xiuling; Zhang, Ming] Guangxi Univ, Anim Reprod Inst, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Huang, Delun; Wang, Ling; Huang, Chang; Tian, Xiuchun; Tang, Young] Univ Connecticut, Inst Syst Genom, Dept Anim Sci, Storrs, CT 06269 USA; [Talbot, Neil C.] ARS, USDA, Anim Biosci & Biotechnol Lab, Beltsville, MD USA	Guangxi University; University of Connecticut; United States Department of Agriculture (USDA)	Zhang, M (corresponding author), Guangxi Univ, Anim Reprod Inst, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China.; Tang, Y (corresponding author), Univ Connecticut, Inst Syst Genom, Dept Anim Sci, Storrs, CT 06269 USA.	mingzhang@gxu.edu.cn; yong.tang@uconn.edu	Tang, Young/GXF-6129-2022	Huang, Delun/0000-0002-7449-0386; Wang, Ling/0000-0002-0787-3352; Huang, Chang/0000-0002-9836-8166	United States Department of Agriculture (USDA) [W2171]; Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2016-67016-24894]; Chinese Scholarship Council	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; Chinese Scholarship Council(China Scholarship Council)	This work was supported by the United States Department of Agriculture (USDA) W2171 regional project to Y.T., the Agriculture and Food Research Initiative Competitive Grant no. 2016-67016-24894 to Y.T. from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov/), and the Chinese Scholarship Council for Study Abroad for D.H. and M.Z. (https://www.csc.edu.cn/chuguo).	Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Deng YF, 2012, STEM CELLS DEV, V21, P2485, DOI 10.1089/scd.2012.0018; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Han XP, 2011, CELL RES, V21, P1509, DOI 10.1038/cr.2011.125; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang YL, 2018, THERIOGENOLOGY, V110, P1, DOI 10.1016/j.theriogenology.2017.12.040; Kawaguchi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135403; Lei L, 2013, MOL REPROD DEV, V80, P193, DOI 10.1002/mrd.22147; Maruotti J, 2012, MOL REPROD DEV, V79, P461, DOI 10.1002/mrd.22051; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Neely MD, 2011, NEUROMETHODS, V56, P27, DOI 10.1007/978-1-61779-077-5_2; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stice SL, 1996, BIOL REPROD, V54, P100, DOI 10.1095/biolreprod54.1.100; Sumer H, 2011, J ANIM SCI, V89, P2708, DOI 10.2527/jas.2010-3666; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot NC, 2017, MOL REPROD DEV, V84, P468, DOI 10.1002/mrd.22797; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Eijk MJT, 1999, BIOL REPROD, V60, P1093, DOI 10.1095/biolreprod60.5.1093; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Wu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep28343; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	41	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203923	10.1371/journal.pone.0203923	http://dx.doi.org/10.1371/journal.pone.0203923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289916	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500008
J	Song, J; Han, K; Lee, D; Kim, SW				Song, Junho; Han, Kyungsik; Lee, Dongwon; Kim, Sang-Wook			"Is a picture really worth a thousand words?": A case study on classifying user attributes on Instagram	PLOS ONE			English	Article							GENDER-DIFFERENCES; PERSONALITY; MODEL	Because using social media has become a major part of people's daily lives, many of their personal characteristics are often implicitly or explicitly reflected in the content they share. We present a study of two personal characteristics-age and gender-related to user engagement on Instagram that can be determined through the characterization of images and tags. We demonstrate the strong influence of age and gender on Instagram use in terms of topical and content differences. We then build age and gender classification models that yield F1 scores of up to 88% and 74% in the detection of age and gender, respectively, and that better characterize users by images than by tags. We further demonstrate the robustness of our models using a new set of test data, with which the models exhibit greater overall performance than human raters. Our study highlights that future research should look to exploit images to a greater degree because they complement text and there are many unexamined images with no embedded text available.	[Song, Junho; Kim, Sang-Wook] Hanyang Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Han, Kyungsik] Ajou Univ, Dept Software & Comp Engn, Suwon, South Korea; [Lee, Dongwon] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA	Hanyang University; Ajou University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Han, K (corresponding author), Ajou Univ, Dept Software & Comp Engn, Suwon, South Korea.	kyungsikhan@ajou.ac.kr	Han, Kyungsik/D-3010-2017; Han, Kyungsik/O-2416-2019	Han, Kyungsik/0000-0001-5535-0081; Song, Junho/0000-0003-3592-7669	Ajou University [S-2017-G0001-00040]; National Research Foundation of Korea [NRF-2017R1A2B3004581, NRF-2017R1C1B5017391, NRF-2017M3C4A7069440, NRF-2017M3C4A7083529]; National Science Foundation [NSF CNS-1422215, NSF CNS-1742702, NSF IUSE-1525601]; Samsung GRO 2015 awards	Ajou University; National Research Foundation of Korea(National Research Foundation of Korea); National Science Foundation(National Science Foundation (NSF)); Samsung GRO 2015 awards(Samsung)	This work was supported by S-2017-G0001-00040: Ajou University (Kyungsik Han, https://www.ajou.ac.kr/); NRF-2017R1A2B3004581: National Research Foundation of Korea (Sang-Wook Kim, https://nrf.re.kr/); NRF-2017R1C1B5017391: National Research Foundation of Korea (Kyungsik Han, https://nrf.re.kr/); NRF-2017M3C4A7069440: National Research Foundation of Korea (Sang-Wook Kim; https://nrf.re.kr/); NRF-2017M3C4A7083529: National Research Foundation of Korea (Kyungsik Han, https://nrf.re.kr/); NSF CNS-1422215: National Science Foundation (Dongwon Lee, https://www.nsf.gov/); NSF CNS-1742702: National Science Foundation (Dongwon Lee, https://www.nsf.gov/); NSF IUSE-1525601: National Science Foundation (Dongwon Lee, https://www.nsf.gov/); and Samsung GRO 2015 awards (Dongwon Lee).	Al Zamal F, 2012, P INT C WEB SOC MED; Almeida V., 2015, P 2015 ACM C ONLINE, P221, DOI DOI 10.1145/2817946.2817948; Andalibi N, 2015, P ACM C COMPUTER SUP, P231, DOI [10.1145/2685553.2699014, DOI 10.1145/2685553.2699014]; Argamon Shlomo, 2007, First Monday, V12; Bakhshi S, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P965, DOI 10.1145/2556288.2557403; Bamman D, 2014, J SOCIOLING, V18, P135, DOI 10.1111/josl.12080; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Blei D, 2014, J MACHINE LEARNING R; Boyd Danah, 2008, MACARTHUR FDN SERIES, P119; Burger John D., 2011, P C EMP METH NAT LAN, P1301, DOI DOI 10.1007/S00256-005-0933-8; Chua THH, 2016, COMPUT HUM BEHAV, V55, P190, DOI 10.1016/j.chb.2015.09.011; Deeb-Swihart J., 2017, P INT C WEB SOCIAL, P42; Dhir A, 2016, COMPUT HUM BEHAV, V63, P549, DOI 10.1016/j.chb.2016.05.053; Doring N, 2016, COMPUT HUM BEHAV, V55, P955, DOI 10.1016/j.chb.2015.10.001; Duggan M., 2016, SOCIAL MEDIA UPDATE; ehrek R., 2010, P 2010 WORKSH NEW CH, P45, DOI DOI 10.13140/2.1.2393.1847; Ellison NB, 2011, NEW MEDIA SOC, V13, P873, DOI 10.1177/1461444810385389; Erikson E., 1980, IDENTITY LIFE CYCLE; Filippova K, 2012, P 2012 JOINT C EMP M, P1478; Flekova L, 2013, CLEF 2012 LAB WORKSH; Flekova L, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2016), VOL 2, P313; Goffman E., 2006, PRESENTATION SELF LI; Han K., 2015, P INT C HUM FACT COM, P1941; Han K, 2016, PROCEEDINGS OF THE 2016 ACM WEB SCIENCE CONFERENCE (WEBSCI'16), P35, DOI 10.1145/2908131.2908160; Hollenstein L., 2010, J SPATIAL INFORM SCI, V1; Hu Y., 2014, P INT C WEB SOC MED; Jang J.Y., 2015, P 26 ACM C HYPERTEXT, P273, DOI DOI 10.1145/2700171.2791043; Juvonen J, 2008, J SCHOOL HEALTH, V78, P496, DOI 10.1111/j.1746-1561.2008.00335.x; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Krcmar M, 2008, COMMUN Q, V56, P111, DOI 10.1080/01463370802031844; Le Q., 2014, INT C MACH LEARN, P1188; Lenhart A, 2011, KINDNESS CRUELTY SOC; Levy O, 2014, ADV NEUR IN, V27; Li XH, 2008, IEEE T SIGNAL PROCES, V56, P675, DOI 10.1109/TSP.2007.907820; Mukherjee A., 2010, P 2010 C EMPIRICAL M, P207, DOI DOI 10.5555/1870658.1870679; Newman ML, 2008, DISCOURSE PROCESS, V45, P211, DOI 10.1080/01638530802073712; Ottoni R, 2013, P INT C WEB SOC MED; Page D., 2015, MOBILE MESSAGING SOC; Park H, P INT C WEB SERV; Pedregosa F., 2011, J MACHINE LEARNING R, P12; Peersman C., 2011, P 3 INT WORKSHOP SEA, P37, DOI [10.1145/2065023.2065035, DOI 10.1145/2065023.2065035]; Pfeil U, 2016, J COMPUTERS HUMAN BE, V25, P634; Popescu A, 2010, P INT C WEB SOC MED; Quinn D., 2011, Proceedings of the 2011 IEEE International Conference on Internet of Things and 4th IEEE International Conference on Cyber, Physical and Social Computing (iThings/CPSCom 2011), P266, DOI 10.1109/iThings/CPSCom.2011.86; Ramage D, 2010, P INT C WEB SOC MED; Reece AG, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0118-4; Rosenthal S., 2011, P 49 ANN M ASS COMP, P763; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Simonyan K., 2014, COMPUTER SCI; Smith A., 2018, SOCIAL MEDIA USE 201; Sorokowska A, 2016, PERS INDIV DIFFER, V90, P119, DOI 10.1016/j.paid.2015.10.037; Sorokowski P, 2016, COMPUT HUM BEHAV, V59, P368, DOI 10.1016/j.chb.2016.02.033; Stefanone MA, 2010, J BROADCAST ELECTRON, V54, P508, DOI 10.1080/08838151.2010.498851; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P190, DOI 10.1002/asi.21180; Wisniewski P, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P302, DOI 10.1145/2675133.2675293; Zhang Y, 2016, C INF COMM TECHN TOU	56	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204938	10.1371/journal.pone.0204938	http://dx.doi.org/10.1371/journal.pone.0204938			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289937	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500029
J	Agbana, TE; Diehl, JC; van Pul, F; Khan, SM; Patlan, V; Verhaegen, M; Vdovin, G				Agbana, Temitope E.; Diehl, Jan-Carel; van Pul, Fiona; Khan, Shahid M.; Patlan, Vsevolod; Verhaegen, Michel; Vdovin, Gleb			Imaging & identification of malaria parasites using cellphone microscope with a ball lens	PLOS ONE			English	Article							DIAGNOSIS	We have optimized the design and imaging procedures, to clearly resolve the malaria parasite in Giemsa-stained thin blood smears, using simple low-cost cellphone-based microscopy with oil immersion. The microscope uses a glass ball as the objective and the phone camera as the tube lens. Our optimization includes the optimal choice of the ball lens diameter, the size and the position of the aperture diaphragm, and proper application of immersion, to achieve diagnostic capacity in a wide field of view. The resulting system is potentially applicable to low-cost in-the-field optical diagnostics of malaria as it clearly resolves micron-sized features and allows for analysis of parasite morphology in the field of 50 x 50 mu m, and parasite detection in the field of at least 150 x 150 mu m.	[Agbana, Temitope E.; Verhaegen, Michel; Vdovin, Gleb] Delft Univ Technol, Delft Ctr Syst & Controls, Delft, Netherlands; [Diehl, Jan-Carel] Delft Univ Technol, Design Sustainabil, Ind Design Engn, Delft, Netherlands; [van Pul, Fiona; Khan, Shahid M.] Leiden Univ, Med Ctr, Parasitol & Immunologyparasitol Grp, Leiden, Netherlands; [Patlan, Vsevolod; Vdovin, Gleb] Flexible Opt BV, Rijswijk, Netherlands; [Verhaegen, Michel] Delft Univ Technol, Fac 3ME, Delft Ctr Syst & Control, Delft, Netherlands; [Vdovin, Gleb] Delft Univ Technol, Fac 3ME, Precis & Microsyst Engn, Delft, Netherlands	Delft University of Technology; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Delft University of Technology	Agbana, TE (corresponding author), Delft Univ Technol, Delft Ctr Syst & Controls, Delft, Netherlands.	t.e.agbana@tudelft.nl	Diehl, Jan Carel/L-6621-2013	Diehl, Jan Carel/0000-0002-4007-2282; Khan, Shahid/0000-0002-0533-4670	Delft Global Initiative of TU Delft [P70370]; European Research Council under the European Union [339681]; Russian Ministry of Education; Flexible Optical B.V.	Delft Global Initiative of TU Delft; European Research Council under the European Union(European Research Council (ERC)); Russian Ministry of Education(Ministry of Education and Science, Russian Federation); Flexible Optical B.V.	The research leading to these results has received funding from Delft Global Initiative of TU Delft (P70370), http://globalstories.tudelft.nl/. Michel Verhaegen's work is funded by the European Research Council (https://erc.europa.eu/) under the European Unions Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement n. 339681. The work of G. Vdovin is partially funded by the program 5 in 100 of the Russian Ministry of Education (en.russia.edu.ru/), and by Flexible Optical B.V. (www.okotech.com/). The funders provided support in the form of salaries for authors [Temitope Agbana & Gleb Vdovin], but did not have any additional role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbana TE, 2017, OPT LETT, V42, P2271, DOI 10.1364/OL.42.002271; Bell S., 2010, INTRO MICROSCOPY; Bogoch II, 2017, AM J TROP MED HYG, V96, P1468, DOI 10.4269/ajtmh.16-0912; Bogoch II, 2013, AM J TROP MED HYG, V88, P626, DOI 10.4269/ajtmh.12-0742; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Butykai A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01431; Dendere R, 2015, J MICROSC-OXFORD, V260, P248, DOI 10.1111/jmi.12307; GOLDBERG O, 1980, MICROSCOPE, V28, P15; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; KAWAMOTO F, 1991, LANCET, V337, P200, DOI 10.1016/0140-6736(91)92159-Y; Kobori Y, 2016, FERTIL STERIL, V106, P574, DOI 10.1016/j.fertnstert.2016.05.027; Koydemir HC, 2015, LAB CHIP, V15, P1284, DOI 10.1039/c4lc01358a; Mogollon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168362; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mudanyali O, 2010, LAB CHIP, V10, P2419, DOI 10.1039/c004829a; Pirnstill CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13368; Seo S, 2009, LAB CHIP, V9, P777, DOI 10.1039/b813943a; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Switz NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095330; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; WHO, 2010, BAS MAL MICR; World Health Organisation, MAL FACTSH 2016; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524	25	21	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205020	10.1371/journal.pone.0205020	http://dx.doi.org/10.1371/journal.pone.0205020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286150	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500076
J	Koohkanzade, M; Zakiaghl, M; Dhami, MK; Fekrat, L; Namaghi, HS				Koohkanzade, Marzieh; Zakiaghl, Mohammad; Dhami, Manpreet K.; Fekrat, Lida; Namaghi, Hussein Sadeghi			Rapid identification of Bactrocera zonata (Dip.: Tephritidae) using TaqMan real-time PCR assay	PLOS ONE			English	Article							FRUIT-FLIES DIPTERA; MOLECULAR-IDENTIFICATION; MICROSATELLITE MARKERS; PEST; SEQUENCES; FLY; INFORMATION; PHYLOGENY; SELECTION; RFLP	Tephritid fruit flies are ranked as one of the most damaging groups of insect pests. Morphological identification of fruit flies is mainly performed on adults due to the lack of adequate identification keys for immature stages. The peach fruit fly, Bactrocera zonata (Saunders), infests some of the principal commercial fruits and vegetables. It is, therefore important to avert its global dispersal, particularly by accurately identifying this species at ports of entry. In this study, a TaqMan real-time polymerase chain reaction (PCR) was developed for the accurate identification and sensitive detection of the peach fruit fly. A novel set of primers and probe were designed to specifically identify the mitochondrial cytochrome oxidase I (COI) gene. All specimens of peach fruit fly (including various life stages) were detected, and no cross reactivity with other tested tephritids were observed. Since this assay performed equally well with crushed insects and purified DNA, we note added efficiency by eliminating DNA extraction step. Considering the speed, specificity as well as sensitivity of the assay, Taqman real-time PCR can be used as a swift and specific method for pest species at ports of entry.	[Koohkanzade, Marzieh; Zakiaghl, Mohammad; Fekrat, Lida; Namaghi, Hussein Sadeghi] Ferdowsi Univ Mashhad, Dept Plant Protect, Fac Agr, Mashhad, Iran; [Dhami, Manpreet K.] Manaaki Whenua Landcare Res, Biodivers & Conservat, Lincoln, New Zealand	Ferdowsi University Mashhad; Landcare Research - New Zealand	Fekrat, L (corresponding author), Ferdowsi Univ Mashhad, Dept Plant Protect, Fac Agr, Mashhad, Iran.	fekrat@ferdowsi.um.ac.ir	namaghi, hussein sadeghi/M-6394-2018; fekrat, Lida/A-2693-2016; zakiaghl, mohammad/AAC-7177-2022	fekrat, Lida/0000-0002-5189-9488; , mohammad/0000-0001-5032-8344	Ferdowsi University of Mashhad [3/40358]	Ferdowsi University of Mashhad	This work was supported by Ferdowsi University of Mashhad [grant number 3/40358].	[Anonymous], 1992, FRUIT FLIES EC SIGNI; Armstrong K, 1997, P NZ PLANT PROT C; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Asokan R, 2011, FLA ENTOMOL, V94, P1026, DOI 10.1653/024.094.0441; Barr NB, 2012, ANN ENTOMOL SOC AM, V105, P339, DOI 10.1603/AN11100; Barr NB, 2011, J ECON ENTOMOL, V104, P1706, DOI 10.1603/EC11093; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P428, DOI 10.1111/j.1755-0998.2012.03124.x; Bonants P., 2013, Bulletin OEPP, V43, P211, DOI 10.1111/epp.12030; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Choudhary JS, 2018, MITOCHONDRIAL DNA A, V29, P727, DOI 10.1080/24701394.2017.1350952; Chua TH, 2010, PEST MANAG SCI, V66, P379, DOI 10.1002/ps.1886; Dai SM, 2004, MOL ECOL NOTES, V4, P629, DOI 10.1111/j.1471-8286.2004.00732.x; Delatte H, 2014, CONSERV GENET RESOUR, V6, P9, DOI 10.1007/s12686-013-0026-2; Dhami MK, 2016, J APPL ENTOMOL, V140, P536, DOI 10.1111/jen.12286; Dhami MK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00005; Dhami MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098934; Diamantidis AD, 2008, J APPL ENTOMOL, V132, P695, DOI 10.1111/j.1439-0418.2008.01325.x; Gilligan TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142912; Huang KS, 2010, BIOL LETTERS, V6, P555, DOI 10.1098/rsbl.2009.1060; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; Leblanc L, 2015, ZOOKEYS, P339, DOI 10.3897/zookeys.540.9786; Ledezma LA, 2016, J ECON ENTOMOL, V109, P1957, DOI 10.1093/jee/tow111; Li D, 2019, B ENTOMOL RES, V109, P102, DOI 10.1017/S0007485318000251; Logan JMJ, 2004, REAL TIME PCR ESSENT; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Naaum AM, 2014, J APPL ENTOMOL, V138, P485, DOI 10.1111/jen.12114; Naaum AM, 2012, J APPL ENTOMOL, V136, P704, DOI 10.1111/j.1439-0418.2012.01706.x; Onah IE, 2015, AFR ENTOMOL, V23, P342, DOI 10.4001/003.023.0225; Parubrub A, 2015, J ECON ENTOMOL, V108, P301, DOI 10.1093/jee/tou027; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Shearman DCA, 2006, MOL ECOL NOTES, V6, P4, DOI 10.1111/j.1471-8286.2006.01024.x; Smit J, 2013, ZOOKEYS, P279, DOI 10.3897/zookeys.365.5819; Stonehouse J, 2002, CROP PROT, V21, P651, DOI 10.1016/S0261-2194(02)00019-4; Vargas RI, 2008, AREAWIDE PEST MANAGEMENT: THEORY AND IMPLEMENTATION, P300, DOI 10.1079/9781845933722.0300; Vargas RI, 2015, INSECTS, V6, P297, DOI 10.3390/insects6020297; Walsh K, 2005, J APPL ENTOMOL, V129, P272, DOI 10.1111/j.1439-0418.2005.00960.x; Yu DJ, 2005, RAFFLES B ZOOL, V53, P73; Yu DJ, 2004, J APPL ENTOMOL, V128, P670, DOI 10.1111/j.1439-0418.2004.00907.x; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308; Zhang QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37549	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205136	10.1371/journal.pone.0205136	http://dx.doi.org/10.1371/journal.pone.0205136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286152	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500091
J	Sesser, KA; Iglecia, M; Reiter, ME; Strum, KM; Hickey, CM; Kelsey, R; Skalos, DA				Sesser, Kristin A.; Iglecia, Monica; Reiter, Matthew E.; Strum, Khara M.; Hickey, Catherine M.; Kelsey, Rodd; Skalos, Daniel A.			Waterbird response to variable-timing of drawdown in rice fields after winter-flooding	PLOS ONE			English	Article							MANAGED WETLANDS; CENTRAL VALLEY; HABITAT; WATERFOWL; COMMUNITIES; GEESE; BIRDS	Wetland loss and degradation have been extensive across the world, especially in California's Central Valley where over 90% of the natural wetlands have been converted to agricultural and urban uses. In the Central Valley today, a much smaller network of managed wetlands and flooded agricultural fields supports almost five million waterfowl and half a million shorebirds. Over 50% of waterbird habitat in the Central Valley is provided by flooded agricultural land, primarily rice (Oryza sativa). Each year non-breeding waterbird habitat decreases in the late winter as flooded agricultural fields are drained after waterfowl hunting season in late-January to prepare for the next crop. This study evaluated a practice called 'variable drawdown' that involves delaying the removal of water from rice fields by 1, 2, and 3 weeks to extend the availability of flooded habitat later into February and March. We studied waterbird response to variable drawdown in 2012 and 2013 at twenty rice farms throughout the northern half of the Central Valley. The staggered drawdown created a mosaic of water depths throughout the six-week study period. The 3-week delay in drawdown supported more dabbling ducks than earlier drawdowns in the first half of the study and more shorebirds and long-legged wading birds during the second half of the study. The timing of highest use of each drawdown treatment differed for each waterbird guild; dabbling ducks, geese and swans benefited at the beginning, then long-legged wading birds, followed by shorebirds. Despite the presence of appropriate water depths for shorebirds across the treatments during the entire study period, shorebird densities were highest near the end of the study when the 3-week-delayed drawdown was providing the majority of the habitat on the landscape. This suggests that shorebirds may have concentrated in our study fields due to decreasing availability of shallow water habitat elsewhere. The practice of variable drawdown successfully extended the availability of waterbird habitat provided by post-harvest flooded rice fields later into winter.	[Sesser, Kristin A.; Reiter, Matthew E.; Strum, Khara M.; Hickey, Catherine M.; Skalos, Daniel A.] Point Blue Conservat Sci, Petaluma, CA 94954 USA; [Iglecia, Monica; Strum, Khara M.; Kelsey, Rodd] Audubon Calif, Sacramento, CA USA; [Iglecia, Monica] Manomet, Plymouth, MA USA; [Kelsey, Rodd] Nature Conservancy, Sacramento, CA USA; [Skalos, Daniel A.] Calif Dept Fish & Wildlife, Sacramento, CA USA	Nature Conservancy	Sesser, KA (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	ksesser@pointblue.org		Kelsey III, Thomas Rodd/0000-0002-3187-1971; Sesser, Kristin/0000-0003-2761-7388	S. D. Bechtel, Jr. Foundation; U.S. Department of Agriculture Natural Resources Conservation Service [NRCS 68-9104-5-265]; NRCS	S. D. Bechtel, Jr. Foundation; U.S. Department of Agriculture Natural Resources Conservation Service(United States Department of Agriculture (USDA)); NRCS	Funding for this research was provided to the Migratory Bird Conservation Partnership (Point Blue Conservation Science, Audubon California, The Nature Conservancy) by the S. D. Bechtel, Jr. Foundation http://sdbjrfoundation.org/ and by a U.S. Department of Agriculture Natural Resources Conservation Service http://www.nrcs.usda.gov Regional Conservation Partnership Program grant (NRCS 68-9104-5-265). The funding sources had no additional role in study design, data collection and analysis, in the decision to submit the article for publication, or in the preparation of the manuscript.; This study would not have been possible without the participation and support of the U.S. Department of Agriculture Natural Resources Conservation Service and our rice farming partners: Don Bransford, Sean Doherty, Chris and Anna O'Sullivan, John Brennan, Mark Galentine, Montna Farms, Brett Perry, Robbins Rice Company, and six anonymous rice growers. We are also grateful for the support of Paul Buttner at the California Rice Commission. Jennifer Dhundale, Corey Shake, Karen Velas, and Brent Campos provided essential field support. B. Campos provided help with data analysis and interpretation. Tom Gardali and B. Campos provided valuable comments on earlier drafts. Funding was provided by the S. D. Bechtel, Jr. Foundation with some assistance for writing and analysis by a NRCS Regional Conservation Partnership Program grant. This is contribution No. 2203 of Point Blue Conservation Science.	Ackerman JT, 2006, J WILDLIFE MANAGE, V70, P965, DOI 10.2193/0022-541X(2006)70[965:SUBWGW]2.0.CO;2; Amano T, 2008, BIOL CONSERV, V141, P1704, DOI 10.1016/j.biocon.2008.04.012; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Barbaree BA, 2018, LANDSCAPE ECOL, DOI [10.1007/s10980-017-0605-9, DOI 10.1007/S10980-017-0605-9]; Barbaree BA, 2015, WATERBIRDS, V38, P40, DOI 10.1675/063.038.0106; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Bird JA, 2000, J APPL ECOL, V37, P728, DOI 10.1046/j.1365-2664.2000.00539.x; Burnham KP, 2002, MODEL SELECTION MULT, DOI [10.1007/978-3-319-02868-2_3, DOI 10.1007/978-3-319-02868-2_3]; Central Valley Joint Venture, 2006, CENTRAL VALLEY JOINT; Colwell MA, 2000, WATERBIRDS, V23, P45; Corline NJ, 2017, WETL ECOL MANAG, V25, P533, DOI 10.1007/s11273-017-9534-2; Dahl T. E., 1990, WETLANDS LOSSES US 1, V53, DOI [10.2144/000113917, DOI 10.2144/000113917]; Day JH, 1998, COLON WATERBIRD, V21, P185, DOI 10.2307/1521905; Dybala Kristen E., 2017, San Francisco Estuary & Watershed Science, V15, P2; Eadie J.M., 2008, CONSERVATION RICELAN, P7; Elphick CS, 2008, WATERBIRDS, V31, P62, DOI 10.1675/1524-4695(2008)31[62:LEOWDI]2.0.CO;2; Elphick CS, 2010, WATERBIRDS, V33, P181, DOI 10.1675/063.033.s114; Elphick CS, 1998, J APPL ECOL, V35, P95, DOI 10.1046/j.1365-2664.1998.00274.x; Elphick CS, 2000, CONSERV BIOL, V14, P181, DOI 10.1046/j.1523-1739.2000.98314.x; ESRI, 2014, ARCGIS DESKTOP RELEA; Fleskes JP, 2005, CALIF FISH GAME, V91, P207; Frayer WE, 1989, WETLANDS OF THE CALI; Garr JD, 2014, THE STATUS OF RICE F; Golet GH, 2018, ECOL APPL, V28, P409, DOI 10.1002/eap.1658; Gosselink J.G., 2000, WETLANDS; Isola CR, 2000, WATERBIRDS, V23, P196; Johnston A, 2015, ECOL APPL, V25, P1749, DOI 10.1890/14-1826.1; King S, 2010, WATERBIRDS, V33, P151, DOI 10.1675/063.033.s111; Lourenco PM, 2009, IBIS, V151, P196, DOI 10.1111/j.1474-919X.2008.00881.x; MCNEIL R, 1992, BIOL REV, V67, P381, DOI 10.1111/j.1469-185X.1992.tb01188.x; Miller MR, 2010, WETLANDS, V30, P939, DOI 10.1007/s13157-010-0090-2; Moser M., 1996, P 6 M C CONTR PART B, P21; Nam HK, 2015, WATERBIRDS, V38, P173, DOI 10.1675/063.038.0206; Nolet BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147340; Olson S.M., 2014, PACIFIC FLYWAY DATA; Pernollet CA, 2017, J WILDLIFE MANAGE, V81, P96, DOI 10.1002/jwmg.21167; Pernollet CA, 2015, AGR ECOSYST ENVIRON, V214, P118, DOI 10.1016/j.agee.2015.08.018; Petrie MJ, 2016, J FISH WILDL MANAG, V7, P408, DOI 10.3996/082015-JFWM-082; R Development Core Team, 2011, R A LANGUAGE AND ENV; Reiter ME, 2018, PEERJ, V6, DOI 10.7717/peerj.5147; Reiter ME, 2015, J FISH WILDL MANAG, V6, P29, DOI [10.3996/012014-JFWM-003, 1]; Schaffer-Smith D, 2017, REMOTE SENS ENVIRON, V193, P180, DOI 10.1016/j.rse.2017.02.016; Sesser KA, 2016, BIOL CONSERV, V197, P69, DOI 10.1016/j.biocon.2016.02.021; Shaskey L., 2012, LOCAL AND LANDSCAPE; Shuford WD, 1998, CONDOR, V100, P227, DOI 10.2307/1370264; Stafford JD, 2010, WATERBIRDS, V33, P133, DOI 10.1675/063.033.s110; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stralberg D, 2011, BIODIVERS CONSERV, V20, P19, DOI 10.1007/s10531-010-9943-5; Strum KM, 2013, AGR ECOSYST ENVIRON, V179, P116, DOI 10.1016/j.agee.2013.08.003; Taft OW, 2006, LANDSCAPE ECOL, V21, P169, DOI 10.1007/s10980-005-0146-5; Tajiri H, 2013, ORNITHOL SCI, V12, P127, DOI 10.2326/osj.12.127; Taylor IR, 2010, WATERBIRDS, V33, P71, DOI 10.1675/063.033.s105; Toral GM, 2011, IBIS, V153, P684, DOI 10.1111/j.1474-919X.2011.01147.x; Wald A, 1942, ANN MATH STAT, V13, P127, DOI 10.1214/aoms/1177731601; WHSRN, 2016, WESTERN HEMISPHERE S; Zuur Alain F., 2009, P1	57	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204800	10.1371/journal.pone.0204800	http://dx.doi.org/10.1371/journal.pone.0204800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286116	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500045
J	Baltazar, CS; Rafael, F; Langa, JPM; Chicumbe, S; Cavailler, P; Gessner, BD; Pezzoli, L; Barata, A; Zaina, D; Inguane, DL; Mengel, MA; Munier, A				Baltazar, Cynthia Sema; Rafael, Florentina; Langa, Jose Paulo M.; Chicumbe, Sergio; Cavailler, Philippe; Gessner, Bradford D.; Pezzoli, Lorenzo; Barata, Americo; Zaina, Dores; Inguane, Dorteia L.; Mengel, Martin A.; Munier, Aline			Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique	PLOS ONE			English	Article							MALAWI	Background In addition to improving water, sanitation and hygiene (WASH) measures and optimal case management, the introduction of Oral cholera vaccine (OCV) is a complementary strategy for cholera prevention and control for vulnerable population groups. In October 2016, the Mozambique Ministry of Health implemented a mass vaccination campaign using a two-dose regimen of the Shanchol (TM) OCV in six high-risk neighborhoods of Nampula city, in Northern Mozambique. Overall 193,403 people were targeted by the campaign, which used a door-to-door strategy. During campaign follow-up, a population survey was conducted to assess: (1) OCV coverage; (2) frequency of adverse events following immunization; (3) vaccine acceptability and (4) reasons for non-vaccination. Methodology/Principal findings In the absence of a household listing and clear administrative neighborhood delimitations, we used geospatial technology to select households from satellite images and used the support of community leaders. One person per household was randomly selected for interview. In total, 636 individuals were enrolled in the survey. The overall vaccination coverage with at least one dose (including card and oral reporting) was 69.5% (95%CI: 51.2-88.2) and the two-dose coverage was 51.2% (95%CI: 37.9-64.3). The campaign was well accepted. Among the 185 non-vaccinated individuals, 83 (44.6%) did not take the vaccine because they were absent when the vaccination team visited their houses. Among the 451 vaccinated individuals, 47 (10%) reported minor and non-specific complaints, and 78 (17.3%) mentioned they did not receive any information before the campaign. Conclusions/Significance In spite of overall coverage being slightly lower than expected, the use of a mobile door-to-door strategy remains a viable option even in densely-populated urban settings. Our results suggest that campaigns can be successfully implemented and well accepted in Mozambique in non-emergency contexts in order to prevent cholera outbreaks. These findings are encouraging and complement the previous Mozambican experience related to OCV.	[Baltazar, Cynthia Sema; Langa, Jose Paulo M.; Chicumbe, Sergio; Inguane, Dorteia L.] Minist Hlth, Inst Nacl Saude, Maputo, Mozambique; [Rafael, Florentina] Agence Med Prevent, Abidjan, Cote Ivoire; [Cavailler, Philippe] Agence Med Prevent, Ferney Voltaire, France; [Gessner, Bradford D.; Mengel, Martin A.; Munier, Aline] Agence Med Prevent, Paris, France; [Pezzoli, Lorenzo] WHO, Geneva, Switzerland; [Barata, Americo] Minist Hlth, Direccao Prov Saude, Nampula, Mozambique; [Zaina, Dores] Minist Hlth, Direccao Saude Cidade, Nampula, Mozambique	Agence de Medecine Preventive; Agence de Medecine Preventive; World Health Organization	Rafael, F (corresponding author), Agence Med Prevent, Abidjan, Cote Ivoire.	florentina.rafael@hotmail.fr	Pezzoli, Lorenzo/AAA-9894-2019; Chicumbe, Sergio Antonio Rodrigues/GXA-1921-2022	Chicumbe, Sergio Antonio Rodrigues/0000-0002-2498-9373; Sema Baltazar, Cynthia/0000-0001-8901-2240	Bill & Melinda Gates Foundation [OPP 1106078]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) through the project "Cholera Targeted Investments to Answer Endemic Use" (OPP 1106078), which granted funding to reinforce control and prevention of cholera in Africa by assessing the use of oral cholera vaccines and potentially integrating it into the list of measures used in endemic countries. The funding source had no role in study design, data collection, analysis or interpretation, or in the preparation of the manuscript and the decision to submit the paper for publication.	Abubakar A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001901; Admiraal R, 2014, J WATER SANIT HYG DE, V4, P410, DOI 10.2166/washdev.2014.145; Ali M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002120; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; Desai SN, 2016, LANCET GLOB HEALTH, V4, pE223, DOI 10.1016/S2214-109X(16)00037-1; Desai SN, 2016, HUM VACCINES IMMUNOT; Dimitrov DT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003343; Gujral L, 2013, J INFECT DIS, V208, pS107, DOI 10.1093/infdis/jit212; Ivers LC, 2013, AM J TROP MED HYG, V89, P617, DOI 10.4269/ajtmh.13-0183; Lam E, 2017, EMERG INFECT DIS, V23, P38, DOI 10.3201/eid2301.160881; Langa JP, 2015, J INFECT DEV COUNTR, V9, P635, DOI 10.3855/jidc.6943; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Luquero FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002465; Mengel MA, 2014, T ROY SOC TROP MED H, V108, P391, DOI 10.1093/trstmh/tru077; Msyamboza Kelias Phiri, 2016, Pan Afr Med J, V23, P203, DOI 10.11604/pamj.2016.23.203.8346; Msyamboza KP, 2014, J INFECT DEV COUNTR, V8, P720, DOI 10.3855/jidc.3506; Ngwa MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005105; Phares CR, 2016, VACCINE, V34, P128, DOI 10.1016/j.vaccine.2015.10.112; Rafael F, 2017, VACCINE, V35, P6041, DOI 10.1016/j.vaccine.2017.07.033; Sauvageot D, 2017, VACCINE, V35, P5194, DOI 10.1016/j.vaccine.2017.07.104; Schaetti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041527; Verma R, 2012, HUM VACC IMMUNOTHER, V8, P682, DOI 10.4161/hv.19083; WHO, 2017, 92 WHO, P477	26	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0198592	10.1371/journal.pone.0198592	http://dx.doi.org/10.1371/journal.pone.0198592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281604	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400003
J	Bartlow, CM; Mann, KA; Damron, TA; Oest, ME				Bartlow, Christopher M.; Mann, Kenneth A.; Damron, Timothy A.; Oest, Megan E.			Limited field radiation therapy results in decreased bone fracture toughness in a murine model	PLOS ONE			English	Article							HUMAN CORTICAL BONE; GLYCATION END-PRODUCTS; COLLAGEN CROSS-LINKS; SOFT-TISSUE SARCOMA; AGE-RELATED-CHANGES; X-RAY-IRRADIATION; BIOMECHANICAL PROPERTIES; NONENZYMATIC GLYCATION; IONIZING-RADIATION; GAMMA-IRRADIATION	Fragility fractures are a well-known complication following oncologic radiotherapy, and it is suspected that radiation-induced embrittlement of bone within the treatment field may contribute to fracture risk. To explore this phenomenon, a mouse model (BALB/cJ) of fractionated, limited field, bilateral hindlimb irradiation (4x5 Gy) was used. The effects of radiation on femoral (cortical) bone fracture toughness, morphology, and biochemistry-including advanced glycation end products (AGEs)-were quantified and compared to Sham group samples prior to irradiation and at 0, 4, 8, and 12 weeks post-irradiation. Additionally, alterations to bone fracture toughness mediated directly by radiation (independent of cellular mechanisms) were determined using devitalized mouse cadaver femurs. Finally, the contribution of AGEs to reduced fracture toughness was examined by artificially ribosylating mouse femurs ex vivo. These data demonstrate that in vivo irradiation results in an immediate (-42% at 0 weeks, p < 0.001) and sustained (-28% at 12 weeks, p < 0.001) decrease in fracture toughness with small changes in morphology (-5% in cortical area at 12 weeks), and minimal changes in bone composition (tissue mineral density, mineral:matrix ratio, and AGE content). Irradiation of devitalized femurs also reduced fracture toughness (-29%, p < 0.001), but to a lesser extent than was seen in vivo. While artificial ribosylation decreased fracture toughness with time, the extent of glycation needed to induce this effect exceeded the AGE accumulation that occurred in vivo. Overall, hindlimb irradiation induced a substantial and sustained decrease in bone fracture toughness. Approximately half of this decrease in fracture toughness is due to direct radiation damage, independent of cellular remodeling. Collagen glycation in vivo was not substantially altered, suggesting other matrix changes may contribute to post-radiotherapy bone embrittlement.	[Bartlow, Christopher M.; Mann, Kenneth A.; Damron, Timothy A.; Oest, Megan E.] SUNY Upstate Med Univ, Dept Orthoped Surg, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Oest, ME (corresponding author), SUNY Upstate Med Univ, Dept Orthoped Surg, Syracuse, NY 13210 USA.	oestm@upstate.edu	Damron, Timothy A./AAE-5816-2020		National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR065419, R01AR070142]; David G. Murray Endowment; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070142, R01AR065419] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); David G. Murray Endowment; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under awards R01AR065419 (TAD) & R01AR070142 (MEO), and by the David G. Murray Endowment (TAD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding agency URLS: https://www.niams.nih.gov David G. Murray endowment has no url The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo C, 2018, NAT BIOMED ENG, V2, P62, DOI 10.1038/s41551-017-0183-9; Akkus O, 2001, J ORTHOP RES, V19, P927, DOI 10.1016/S0736-0266(01)00004-3; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Bandstra ER, 2008, RADIAT RES, V169, P607, DOI 10.1667/RR1310.1; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Barth HD, 2010, BONE, V46, P1475, DOI 10.1016/j.bone.2010.02.025; Baxter NN, 2005, JAMA-J AM MED ASSOC, V294, P2587, DOI 10.1001/jama.294.20.2587; Bierhaus A, 1998, CARDIOVASC RES, V37, P586, DOI 10.1016/S0008-6363(97)00233-2; Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3; Burton B, 2014, BONE, V61, P71, DOI 10.1016/j.bone.2014.01.006; Carriero A, 2014, J MECH BEHAV BIOMED, V39, P38, DOI 10.1016/j.jmbbm.2014.06.017; Chandra A, 2015, J BIOL CHEM, V290, P157, DOI 10.1074/jbc.M114.608158; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Chen HHW, 2002, RADIOTHER ONCOL, V62, P239, DOI 10.1016/S0167-8140(02)00002-6; Currey JD, 1997, J ORTHOP RES, V15, P111, DOI 10.1002/jor.1100150116; DARLEYUSMAR VM, 1992, FREE RADICAL RES COM, V17, P9, DOI 10.3109/10715769209061085; Dhakal S, 2011, INT J RADIAT ONCOL, V80, P1158, DOI 10.1016/j.ijrobp.2010.04.012; Dickie CI, 2009, INT J RADIAT ONCOL, V75, P1119, DOI 10.1016/j.ijrobp.2008.12.006; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; FIDELER BM, 1995, AM J SPORT MED, V23, P643, DOI 10.1177/036354659502300521; Garnero P, 2006, BONE, V38, P300, DOI 10.1016/j.bone.2005.09.014; GIBBONS MJ, 1991, J ORTHOPAED RES, V9, P209, DOI 10.1002/jor.1100090209; Gong B, 2013, BONE, V57, P252, DOI 10.1016/j.bone.2013.08.014; Gortzak Y, 2010, CANCER-AM CANCER SOC, V116, P1553, DOI 10.1002/cncr.24949; Green DE, 2014, BONE, V63, P87, DOI 10.1016/j.bone.2014.02.018; Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Hamer AJ, 1999, J BONE JOINT SURG BR, V81B, P342, DOI 10.1302/0301-620X.81B2.9083; Hamer AJ, 1996, J BONE JOINT SURG BR, V78B, P363, DOI 10.1302/0301-620X.78B3.0780363; Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; Inoue Yasuhiro, 2003, Int J Clin Oncol, V8, P336, DOI 10.1007/s10147-003-0340-x; Katsamenis OL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055641; Kondo H, 2010, J APPL PHYSIOL, V108, P152, DOI 10.1152/japplphysiol.00294.2009; Kondo H, 2009, RADIAT RES, V171, P283, DOI 10.1667/RR1463.1; Konski A, 1996, INT J RADIAT ONCOL, V35, P361, DOI 10.1016/0360-3016(95)02139-6; Kwon JW, 2008, AM J ROENTGENOL, V191, P987, DOI 10.2214/AJR.07.3634; McCormack J, 2012, BONE, V50, P1275, DOI 10.1016/j.bone.2012.02.018; Morales A, 1998, INT J RADIAT ONCOL, V42, P191, DOI 10.1016/S0360-3016(98)00185-0; Nalla RK, 2005, J BIOMECH, V38, P1517, DOI 10.1016/j.jbiomech.2004.07.010; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Nyaruba MM, 1998, ACTA RADIOL, V39, P43; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Oest ME, 2018, J BONE MINER RES, V33, P99, DOI 10.1002/jbmr.3289; Oest ME, 2016, CALCIFIED TISSUE INT, V98, P619, DOI 10.1007/s00223-016-0111-0; Oest ME, 2016, BONE, V86, P91, DOI 10.1016/j.bone.2016.03.003; Oest ME, 2015, J ORTHOP RES, V33, P334, DOI 10.1002/jor.22761; Oest ME, 2014, RADIAT RES, V181, P439, DOI 10.1667/RR13451.1; Oh D, 2008, INT J RADIAT ONCOL, V70, P1183, DOI 10.1016/j.ijrobp.2007.08.005; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Park SH, 2011, RADIAT ONCOL J, V29, P269, DOI 10.3857/roj.2011.29.4.269; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Paulino AC, 2004, INT J RADIAT ONCOL, V60, P265, DOI 10.1016/j.ijrobp.2004.02.001; Poundarik AA, 2015, J MECH BEHAV BIOMED, V50, P82, DOI 10.1016/j.jmbbm.2015.05.025; Poundarik AA, 2015, J MECH BEHAV BIOMED, V52, P120, DOI 10.1016/j.jmbbm.2015.08.012; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Reisz JA, 2014, ANTIOXID REDOX SIGN, V21, P260, DOI 10.1089/ars.2013.5489; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; Saito M, 2011, CALCIFIED TISSUE INT, V88, P314, DOI 10.1007/s00223-011-9472-6; Salehpour A, 1995, J ORTHOP RES, V13, P898, DOI 10.1002/jor.1100130614; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SINGH A, 1983, PROG BIOPHYS MOL BIO, V39, P69, DOI 10.1016/0079-6107(83)90014-7; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Sroga GE, 2012, CURR OSTEOPOROS REP, V10, P141, DOI 10.1007/s11914-012-0103-6; Sternheim A, 2013, BONE JOINT J, V95B, P1144, DOI [10.1302/0301-620X.9588.31832, 10.1302/0301-620X.95B8.31832]; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2011, J BIOMECH, V44, P330, DOI 10.1016/j.jbiomech.2010.10.016; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Wernle JD, 2010, J BIOMECH, V43, P2738, DOI 10.1016/j.jbiomech.2010.06.017; Willey JS, 2008, RADIAT RES, V170, P388, DOI 10.1667/RR1388.1; Willey JS, 2010, BONE, V46, P101, DOI 10.1016/j.bone.2009.09.002; Wright LE, 2015, J BONE MINER RES, V30, P1268, DOI 10.1002/jbmr.2458; Yumoto K, 2010, RADIAT RES, V173, P494, DOI 10.1667/RR1754.1; Zimmermann EA, 2011, P NATL ACAD SCI USA, V108, P14416, DOI 10.1073/pnas.1107966108; Zioupos P, 2001, J BIOMATER APPL, V15, P187, DOI 10.1106/5JUJ-TFJ3-JVVA-3RJ0; Zou Q, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-015-0339-9	78	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204928	10.1371/journal.pone.0204928	http://dx.doi.org/10.1371/journal.pone.0204928			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281657	gold, Green Submitted, Green Published			2022-12-27	WOS:000446342400068
J	Kahle, P; Ludolphy, C; Kierdorf, H; Kierdorf, U				Kahle, Patricia; Ludolphy, Catharina; Kierdorf, Horst; Kierdorf, Uwe			Dental anomalies and lesions in Eastern Atlantic harbor seals, Phoca vitulina vitulina (Carnivora, Phocidae), from the German North Sea	PLOS ONE			English	Article							TEMPOROMANDIBULAR-JOINT PATHOLOGY; HYPOHIDROTIC ECTODERMAL DYSPLASIA; CANINE-DISTEMPER VIRUS; CALLORHINUS-URSINUS; ENAMEL HYPOPLASIA; SKULL LESIONS; MARION ISLAND; FERAL CATS; DENTITION; TEETH	Skulls of 1,901 Eastern Atlantic harbor seals (Phoca vitulina vitulina) were systematically studied for externally visible dental anomalies and lesions. The sample comprised 927 males and 974 female individuals, with age at death ranging between 1 week and 25 years. Most of the skulls originated from animals collected in 1988, when the population suffered from a mass mortality event caused by the phocine distemper virus (PDV). Mean age (+/- SD) of females (6.7 +/- 6.4 years) was higher (p = 0.002) than that of males (5.9 +/- 5.2 years). In 264 individuals, one or more teeth were missing either congenitally (n = 26 animals, 1.4%) or due to intravital loss (n = 238 animals, 12.5%). One male exhibited congenital absence of all teeth (anodontia). As this animal had been reported to be almost hairless, the condition was tentatively diagnosed as a case of hypohidrotic ectodermal dysplasia. Males were more frequently (p = 0.002) affected by intravital tooth loss (15.0%) than females (10.2%). Supernumerary teeth were found in 3.4% of the skulls, with females (4.7%) showing hyperodontia more frequently (p < 0.001) than males (1.9%). Fifty-nine individuals (3.1%; 28 males, 31 females, p = 0.84) exhibited abnormal tooth morphology. Tooth fractures were noted in 40 seals (2.1%), with males being more frequently affected than females (p = 0.017). Periapical lesions were diagnosed in 143 skulls, with a tendency (p = 0.05) for males (8.7%) to be more frequently affected than females (6.4%). Enamel hypoplasia was not observed in the study sample. Analyzing the occurrence of dental anomalies and lesions in wild mammals can substantially contribute to an assessment of population health and thereby broaden the basis for effective species conservation and informed management decisions.	[Kahle, Patricia; Ludolphy, Catharina; Kierdorf, Horst; Kierdorf, Uwe] Univ Hildesheim, Dept Biol, Hildesheim, Germany	University of Hildesheim	Kierdorf, U (corresponding author), Univ Hildesheim, Dept Biol, Hildesheim, Germany.	uwe.kierdorf@uni-hildesheim.de	Kierdorf, Uwe/F-2539-2012	Kierdorf, Uwe/0000-0003-0531-2460; Kahle, Patricia/0000-0001-7012-7507; Kierdorf, Horst/0000-0001-6411-9631	Volkswagen Foundation [Az. 89911, AZ 89 911]	Volkswagen Foundation(Volkswagen)	This study was funded by the Volkswagen Foundation (https://www.volkswagenstiftung.de/; grant number Az. 89911) within the program "Research in museums". The funder is supportive of publication, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their sincere thanks to Prof. Dr. Gunther B. Hartl and Mrs. Renate Lucht (Zoological Institute of Kiel University) for making the harbor seal skeletal collection available for this study. Renate is also thanked for her kind hospitality during our stays at the Institute in Kiel. We are much indebted to the two reviewers for their valuable comments and suggestions that helped to improve the manuscript. We further gratefully acknowledge the financial support of our study by the Volkswagen Foundation (AZ 89 911) within the framework of the program "Research in Museums".	Aalderink MT, 2015, J COMP PATHOL, V152, P325, DOI 10.1016/j.jcpa.2015.02.002; Aalderink MT, 2015, J COMP PATHOL, V152, P335, DOI 10.1016/j.jcpa.2015.02.003; Abbott C, 2005, J COMP PATHOL, V132, P169, DOI 10.1016/j.jcpa.2004.09.007; Abt KF, 2002, THESIS; Aghashani A, 2016, J COMP PATHOL, V154, P329, DOI 10.1016/j.jcpa.2016.03.001; AVDC (American Veterinary Dental College), 2015, DENT FRACT CLASS; Beineke A, 2015, ONE HEALTH, V1, P49, DOI 10.1016/j.onehlt.2015.09.002; Bhat M, 1989, Adv Dent Res, V3, P132; Bjorge A, 2010, NAMMCO SCI PUBLICATI, V8, P7, DOI [DOI 10.7557/3.2668, 10.7557/3.2668]; BODINGBAUER J, 1949, Schweiz Arch Tierheilkd, V91, P84; BRIGGS KT, 1974, J MAMMAL, V55, P158, DOI 10.2307/1379264; Brook AH, 2014, AUST DENT J, V59, P131, DOI 10.1111/adj.12160; Burns JJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P533; Casal ML, 1997, J HERED, V88, P513, DOI 10.1093/oxfordjournals.jhered.a023146; Clark EJ, 2017, J COMP PATHOL, V156, P240, DOI 10.1016/j.jcpa.2016.11.267; Cowan DF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P836; Cruwys L, 2006, POLAR REC, V42, P83, DOI 10.1017/S0032247405004869; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Doring S, 2018, J COMP PATHOL, V160, P56, DOI 10.1016/j.jcpa.2018.03.001; Drehmer Cesar Jaeger, 2004, Latin American Journal of Aquatic Mammals, V3, P7; Drehmer CJ, 2015, ZOOMORPHOLOGY, V134, P325, DOI 10.1007/s00435-015-0255-x; Drogemuller C, 2003, GENET SEL EVOL, V35, pS137, DOI 10.1051/gse:2003022; Drogemuller C, 2002, VET DERMATOL, V13, P307, DOI 10.1046/j.1365-3164.2002.00313.x; DUBIELZIG RR, 1981, VET PATHOL, V18, P684, DOI 10.1177/030098588101800513; DUBIELZIG RR, 1979, VET PATHOL, V16, P268, DOI 10.1177/030098587901600216; Duguy R, 1992, HDB SAUGETIERE EUROP, V6, P18; Duignan PJ, 2014, VIRUSES-BASEL, V6, P5093, DOI 10.3390/v6125093; Ehlers K., 1962, Zeitschrift fuer Saugietierkunde, V27, P184; Evenhuis JV, 2018, J COMP PATHOL, V158, P39, DOI 10.1016/j.jcpa.2017.11.002; Galatius A, 2017, ANN REPORT; Garrott RA, 2002, ECOSYSTEMS, V5, P659, DOI 10.1007/s10021-002-0211-8; Gelberg H. B., 2001, THOMSONS SPECIAL VET, P1; GOODMAN AH, 1990, YEARB PHYS ANTHROPOL, V33, P59; HARKONEN T, 1990, OPHELIA, V32, P211; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Higashino T, 2017, EXPERT OPIN ORPHAN D, V5, P967, DOI 10.1080/21678707.2017.1405806; Hillson S, 2014, TOOTH DEVELOPMENT IN HUMAN EVOLUTION AND BIOARCHAEOLOGY, P1, DOI 10.1017/CBO9780511894916; Hillson S., 2005, TEETH; Hillson S., 2010, BIOL ANTHR HUMAN SKE, P301; Janssens L, 2016, J MAMMAL, V97, P1111, DOI 10.1093/jmammal/gyw058; Jo WK, 2018, CURR OPIN VIROL, V28, P133, DOI 10.1016/j.coviro.2017.12.005; Kierdorf H, 2012, J ANAT, V220, P484, DOI 10.1111/j.1469-7580.2012.01482.x; Kierdorf H, 1997, CELL TISSUE RES, V289, P125, DOI 10.1007/s004410050858; Klein OD, 2013, AM J MED GENET C, V163, P318, DOI 10.1002/ajmg.c.31382; Konemann S, 1997, Z SAUGETIERKD, V62, P71; KUBOTA K, 1964, ANAT REC, V150, P487, DOI 10.1002/ar.1091500417; KUBOTA K, 1970, J DENT RES, V49, P325, DOI 10.1177/00220345700490022201; Lan Y, 2014, SEMIN CELL DEV BIOL, V25, P61, DOI 10.1016/j.semcdb.2013.12.003; Loch C, 2010, ZOOLOGIA-CURITIBA, V27, P477, DOI 10.1590/S1984-46702010005000001; Lowry L., IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-1.RLTS.T17013A45229114.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T17013A45229114.EN]; Ludolphy C, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1473-5; Matzke T, 2001, THESIS; Mauldin E.A., 2016, JUBB KENNEDY PALMERS, V6, P509, DOI DOI 10.1016/B978-0-7020-5317-7.00006-0; Merrick R, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P368; Meyer W, 2004, MAMM BIOL, V69, P401, DOI 10.1078/1616-5047-00162; Miles AEW, 1990, COLYERS VARIATIONS D; MORTENSEN P, 1992, AMBIO, V21, P520; NLWKN (Niedersachsischer Landesbetrieb fur Wasserwirtschaft Kusten-und Naturschutz), 2011, VOLLZ SCH SAUG NIED; POHLMEYER G, 1993, J COMP PATHOL, V109, P57, DOI 10.1016/S0021-9975(08)80240-X; Reeves R. R., 2002, SEA MAMMALS WORLD CO; Reijnders PJH, 1992, HDB SAUGETIERE EUROP, V6, P120; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Sadier A, 2014, TRENDS GENET, V30, P24, DOI 10.1016/j.tig.2013.08.006; Sasaki H, 2012, SELTZER AND BENDER'S DENTAL PULP, SECOND EDITION, P277; Schandorff S, 1997, ANN ZOOL FENN, V34, P151; SCHROEDER HE, 1991, PATHOBIOLOGIE ORALER; Schumacher G.H., 1990, ANATOMIE BIOCHEMIE Z; SEOW WK, 1991, J DENT CHILD, V58, P441; Sinai NL, 2014, J COMP PATHOL, V151, P113, DOI 10.1016/j.jcpa.2014.02.004; Siqueira JF, 2012, SELTZER AND BENDER'S DENTAL PULP, SECOND EDITION, P205; Slootweg, 2013, DENT PATHOLOGY PRACT; Starck D., 1995, LEHRBUCH SPEZIELLE 5, V2, P848; Suzuki M., 1990, Japanese Journal of Oral Biology, V32, P323; Thenius, 1989, HDB ZOOLOGIE, V8; Trzeciak WH, 2016, J APPL GENET, V57, P51, DOI 10.1007/s13353-015-0307-4; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Van Valkenburgh B, 2009, BIOL J LINN SOC, V96, P68, DOI 10.1111/j.1095-8312.2008.01108.x; Verstraete FJM, 1996, J COMP PATHOL, V115, P265, DOI 10.1016/S0021-9975(96)80084-3; Verstraete FJM, 1996, J COMP PATHOL, V115, P283, DOI 10.1016/S0021-9975(96)80085-5; Winer JN, 2016, J COMP PATHOL, V155, P231, DOI 10.1016/j.jcpa.2016.07.004; Winer JN, 2016, J COMP PATHOL, V155, P242, DOI 10.1016/j.jcpa.2016.07.005; WOLSAN M, 1984, ACTA THERIOL, V29, P128, DOI 10.4098/AT.arch.84-11; Xu MG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15397	84	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204079	10.1371/journal.pone.0204079	http://dx.doi.org/10.1371/journal.pone.0204079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281623	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400040
J	Chen, YQ; Song, QY; Pan, L; Jia, MQ; Li, CW; Hu, BB; Wu, GH				Chen, Yueqin; Song, Qiuyang; Pan, Ling; Jia, Meiqing; Li, Congwei; Hu, Beibei; Wu, Guanghong			Trace metals, organic carbon and nutrients in the Beidagang Wetland Nature Reserve, northern China	PLOS ONE			English	Article							FIRED POWER-PLANTS; ATMOSPHERIC PARTICULATE MERCURY; HEAVY-METALS; URBAN SOILS; MATTER; SEDIMENTS; MOBILITY; NITROGEN; TIANJIN; FRACTIONATION	This study aimed to determine sediment contamination in the Beidagang Wetland Nature Reserve to describe atmospheric deposition of trace metals. We analyzed Hg, Cd, Pb, TOC, TN, TP, delta C-13, and delta N-15, and studied their variations in surface sediments and in the vertical profiles of sediment cores collected from the reserve. Evaluation of environmental trace metal contamination using sediment quality guidelines and geochemical background values indicated that the risk of metal pollution in the reserve sediments was relatively low. Concentrations of Hg, Cd, and Pb in the sediments were much lower than concentrations in sediment samples from Bohai Bay and polluted rivers in Tianjin. Enrichment factors indicate that samples are moderately contaminated with Hg, Cd, and Pb; whereas the geo-accumulation index results classify the sediments as uncontaminated to moderately contaminated with Hg, Cd, and Pb. The distribution patterns of trace metal concentrations in the three core samples were uniform. delta C-13 and delta N-15 were used to track the sources of TOC and TN in sediments. Results show that TOC mainly originated from the residue and decaying matter of aquatic plants (e.g., algae, reeds, and Typha), while TN was derived from soil N and elevated atmospheric N deposition. Because domestic and industrial waste is not discharged into the Beidagang Wetland Nature Reserve, trace metals found in sediments mainly originate from atmospheric deposition. The results provide baseline data for analysis of trace metal accumulation in Beijing-Tianjin-Hebei, a region subject to atmospheric deposition in northern China.	[Chen, Yueqin; Song, Qiuyang; Pan, Ling; Jia, Meiqing; Wu, Guanghong] Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China; [Li, Congwei; Hu, Beibei] Tianjin Normal Univ, Coll Urban & Environm Sci, Tianjin, Peoples R China	Tianjin Normal University; Tianjin Normal University	Wu, GH (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China.	wuguanghong@hotmail.com		wu, guanghong/0000-0003-2779-3306	Discipline Construction Projects from the Tianjin Municipal Commission of Education [ZX110GG019]; Open Research Fund of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin [IWHR-SKL-201418]	Discipline Construction Projects from the Tianjin Municipal Commission of Education; Open Research Fund of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin	This work was financially supported by the Discipline Construction Projects from the Tianjin Municipal Commission of Education (ZX110GG019) and the Open Research Fund of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin (IWHR-SKL-201418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuduwaili J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120001; Acosta JA, 2011, CHEMOSPHERE, V85, P1318, DOI 10.1016/j.chemosphere.2011.07.046; Chen Qing, 2015, Chinese Journal of Plant Ecology, V39, P1044, DOI 10.17521/cjpe.2015.0101; Chen X, 2010, ENVIRON POLLUT, V158, P48, DOI 10.1016/j.envpol.2009.08.028; Cheng HX, 2013, J GEOCHEM EXPLOR, V124, P195, DOI 10.1016/j.gexplo.2012.09.007; Deng S, 2014, FUEL PROCESS TECHNOL, V126, P469, DOI 10.1016/j.fuproc.2014.06.009; Driscoll CT, 2013, ENVIRON SCI TECHNOL, V47, P4967, DOI 10.1021/es305071v; Du Laing G, 2008, ESTUAR COAST SHELF S, V77, P589, DOI 10.1016/j.ecss.2007.10.017; ElBishlawi H, 2015, CHEMOSPHERE, V127, P144, DOI 10.1016/j.chemosphere.2014.12.080; Emerson S, 1988, PALEOCEANOGRAPHY, V3, P621, DOI 10.1029/PA003i005p00621; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; Fellman JB, 2008, BIOGEOCHEMISTRY, V88, P169, DOI 10.1007/s10533-008-9203-x; Feng HA, 2011, J ENVIRON MANAGE, V92, P1185, DOI 10.1016/j.jenvman.2010.11.020; Guentzel JL, 2009, SCI TOTAL ENVIRON, V407, P1344, DOI 10.1016/j.scitotenv.2008.09.030; Hogberg P, 1999, NEW PHYTOL, V142, P569, DOI 10.1046/j.1469-8137.1999.00404.x; Hyun Sangmin, 2011, Ocean Science Journal, V46, P289, DOI 10.1007/s12601-011-0022-y; LEDGARD SF, 1985, AUST J PLANT PHYSIOL, V12, P631, DOI 10.1071/PP9850631; Liu JH, 2000, J ENVIRON SCI, V12, P77; Liu MD, 2016, ENVIRON SCI TECHNOL, V50, P6224, DOI 10.1021/acs.est.5b04999; [刘明 Liu Ming], 2016, [海洋学报, Acta Oceanologica Sinica], V38, P36; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Middelburg JJ, 1998, MAR CHEM, V60, P217, DOI 10.1016/S0304-4203(97)00104-7; Okuda T, 2008, CHEMOSPHERE, V72, P917, DOI 10.1016/j.chemosphere.2008.03.033; Pacyna Jozef M., 1995, Environmental Reviews, V3, P145, DOI 10.1139/a95-006; Pavageau MP, 2002, ENVIRON SCI TECHNOL, V36, P1561, DOI 10.1021/es015595s; Qiao Jun, 2010, Research of Environmental Sciences, V23, P1343; Sanei H, 2006, APPL GEOCHEM, V21, P1900, DOI 10.1016/j.apgeochem.2006.08.015; Schleicher NJ, 2016, ATMOS ENVIRON, V124, P396, DOI 10.1016/j.atmosenv.2015.09.040; Schleicher NJ, 2015, ATMOS ENVIRON, V109, P251, DOI 10.1016/j.atmosenv.2015.03.018; Schleicher NJ, 2011, ATMOS ENVIRON, V45, P7248, DOI 10.1016/j.atmosenv.2011.08.067; SHI GT, 2010, ATMOS ENVIRON, V8, P39, DOI DOI 10.1016/j.atmosenv.2010.08.039; Shi GT, 2008, ENVIRON POLLUT, V156, P251, DOI 10.1016/j.envpol.2008.02.027; Shi JB, 2005, ENVIRON INT, V31, P357, DOI 10.1016/j.envint.2004.08.008; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Streets DG, 2005, ATMOS ENVIRON, V39, P7789, DOI 10.1016/j.atmosenv.2005.08.029; Sun CH, 2017, MAR POLLUT BULL, V115, P451, DOI 10.1016/j.marpolbul.2016.10.066; Tang RL, 2013, APPL GEOCHEM, V35, P88, DOI 10.1016/j.apgeochem.2013.03.016; Tang SL, 2016, FUEL, V180, P194, DOI 10.1016/j.fuel.2016.04.037; Tian HZ, 2011, SCI TOTAL ENVIRON, V409, P3078, DOI 10.1016/j.scitotenv.2011.04.039; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Wei Q, 2017, HYDROL RES, V48, P1058, DOI 10.2166/nh.2016.142; Wei X., 2015, ECOTOX ENVIRON SAFE, V112, P186, DOI [10. 1016/j. ecoenv. 2014. 11. 005 25463870, DOI 10.1016/J.EC0ENV.2014.11.005]; Wei Z, 2011, ENVIRON TOXICOL CHEM, V30, P1997, DOI 10.1002/etc.605; Wu GH, 2010, B ENVIRON CONTAM TOX, V84, P336, DOI 10.1007/s00128-010-9939-6; Wu GH, 2016, AIR QUAL ATMOS HLTH, V9, P687, DOI 10.1007/s11869-015-0375-y; Wu GH, 2014, MAR POLLUT BULL, V82, P194, DOI 10.1016/j.marpolbul.2014.02.033; Xing JW, 2017, CHEMOSPHERE, V174, P428, DOI 10.1016/j.chemosphere.2017.02.004; Xue DM, 2009, WATER RES, V43, P1159, DOI 10.1016/j.watres.2008.12.048; You Ping, 2006, Acta Ecologica Sinica, V26, P999, DOI 10.1016/S1872-2032(06)60018-8; Zhang L, 2015, ENVIRON SCI TECHNOL, V49, P3185, DOI 10.1021/es504840m; Zhang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135182; Zhao L, 2014, SCI TOTAL ENVIRON, V468, P654, DOI 10.1016/j.scitotenv.2013.08.094	53	2	2	9	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204812	10.1371/journal.pone.0204812	http://dx.doi.org/10.1371/journal.pone.0204812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278089	gold, Green Submitted, Green Published			2022-12-27	WOS:000446010200023
J	Vanderoost, J; Janssen, R; Eggermont, J; Callens, R; De Laet, T				Vanderoost, Jef; Janssen, Rianne; Eggermont, Jan; Callens, Riet; De Laet, Tinne			Elimination testing with adapted scoring reduces guessing and anxiety in multiple- choice assessments, but does not increase grade average in comparison with negative marking	PLOS ONE			English	Article							ASSESSING PARTIAL KNOWLEDGE; GENDER-DIFFERENCES; OPTIMAL NUMBER; OPTIONS; RELIABILITY; VALIDITY; SCORES; EXAMS; ITEM	Background and hypotheses This study is the first to offer an in-depth comparison of elimination testing with the scoring rule of Arnold & Arnold (hereafter referred to as elimination testing with adapted scoring) and negative marking. As such, this study is motivated by the search for an alternative for negative marking that still discourages guessing, but is less disadvantageous for non-relevant student characteristics such a risk-aversion and does not result in grade inflation. The comparison is structured around seven hypotheses: in comparison with negative marking, elimination testing with adapted scoring leads to (1) a similar average score (no grade inflation); (2) students expressing their partial knowledge; (3) a decrease in the number of blank answers; (4) no gender bias in the number of blank answers; (5) a reduction in guessing; (6) a decrease in self-reported test anxiety; and finally (7) students preferring elimination testing with adapted scoring over negative marking. Methodology To investigate the above hypotheses, this study implemented elimination testing with adapted scoring and negative marking in real exam settings in two courses in a Faculty of Medicine at a large university. Due to changes in the master of medicine the same two courses were taught to both students of the 1st and 2nd master in the same semester. Given that both student groups could take the same exam with different test instructions and scoring methods, a unique opportunity occurred in which elimination testing with adapted scoring and negative marking could be compared in a high-stakes testing situation. After receiving the grades on the exams, students received a questionnaire to assess their experiences. Findings The statistical analysis taking into account student ability and gender showed that elimination testing with adapted scoring is a valuable alternative for negative marking when looking for a scoring method that discourages guessing. In contrast to traditional scoring of elimination testing, elimination testing with adapted scoring does not result in grade inflation in comparison with negative marking. This study showed that elimination testing with adapted scoring reduces blank answers and finds strong indications for the reduction of guessing in comparison with negative marking. Finally, students preferred elimination testing with adapted scoring over negative marking and reported lower stress levels in elimination testing with adapted scoring in comparison with negative marking.	[Vanderoost, Jef; Callens, Riet; De Laet, Tinne] Katholieke Univ Leuven, Fac Engn Sci, Tutorial Serv, Leuven, Belgium; [Vanderoost, Jef; Callens, Riet; De Laet, Tinne] Katholieke Univ Leuven, Leuven Engn & Sci Educ Ctr, Leuven, Belgium; [Janssen, Rianne] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Ctr Educ Effectiveness & Evaluat, Leuven, Belgium; [Eggermont, Jan] Katholieke Univ Leuven, Fac Med, Lab Cellular Transport Syst, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	De Laet, T (corresponding author), Katholieke Univ Leuven, Fac Engn Sci, Tutorial Serv, Leuven, Belgium.; De Laet, T (corresponding author), Katholieke Univ Leuven, Leuven Engn & Sci Educ Ctr, Leuven, Belgium.	Tinne.DeLaet@kuleuven.be	De Laet, Tinne/AAK-8612-2020	De Laet, Tinne/0000-0003-0624-3305; Vanderoost, Jef/0000-0001-8741-0851; Eggermont, Jan/0000-0002-8497-1159	KU Leuven [IMP15-08]; KU Leuven Educational council	KU Leuven(KU Leuven); KU Leuven Educational council	This project was funded by KU Leuven within the grant IMP15-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We gratefully acknowledge the support of KU Leuven Educational council during this study. Special thanks to members of our project team: Lisa Dejonghe, Anneleen Claassen, Wilfried Lemahieu, Monique Snoeck, Wim Dehaene, Geert Dhaene and Stefan Rummens. We thank all participating students, teachers, and the program advisory committees for their collaboration. Finally, we thank LSTAT (Leuven Statics Research Centre) for their valuable advice.	Akyol SP, 2016, HIT MISS TEST TAKING, DOI [10.3386/w22401, DOI 10.3386/W22401]; ARNOLD JC, 1970, J EXP EDUC, V39, P8, DOI 10.1080/00220973.1970.11011223; Bacon DR, 2006, J MARKET EDUC, V28, P35, DOI 10.1177/0273475305284638; Baldiga K, 2014, MANAGE SCI, V60, P434, DOI 10.1287/mnsc.2013.1776; Bar-Hillel M., 2005, MIND SOC, V4, P3, DOI DOI 10.1007/S11299-005-0001-Z; BenSimon A, 1997, APPL PSYCH MEAS, V21, P65, DOI 10.1177/0146621697211006; Bereby-Meyer Y, 2003, ACTA PSYCHOL, V112, P207, DOI 10.1016/S0001-6918(02)00085-9; Bereby-Meyer Y, 2002, J BEHAV DECIS MAKING, V15, P313, DOI 10.1002/bdm.417; Bond AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055956; Borghans L, J EUROPEAN EC ASS, P649, DOI [10.2307/40282781, DOI 10.2307/40282781]; BRADBARD DA, 1986, J EXP EDUC, V54, P68, DOI 10.1080/00220973.1986.10806400; Bradbard DA, 2004, DECISION SCI J INNOV, V2, P11, DOI [10.1111/dsji.2004.2.issue-1, DOI 10.1111/DSJI.2004.2.ISSUE-1, 10.1111/j.0011-7315.2004.00016.x]; BUDESCU D, 1993, J EDUC MEAS, V30, P277, DOI 10.1111/j.1745-3984.1993.tb00427.x; BUDESCU DV, 1985, J EDUC MEAS, V22, P183, DOI 10.1111/j.1745-3984.1985.tb01057.x; Burton R. F., 2004, ASSESS EVAL HIGH EDU, V29, P585, DOI DOI 10.1080/02602930410001689153; Burton R.F., 2001, ASSESS EVAL HIGH EDU, V26, P41, DOI [DOI 10.1080/02602930020022273, 10.1080/02602930020022273]; Bush M., 2001, J FURTHER HIGHER ED, V25, P157, DOI [10.1080/03098770120050828, DOI 10.1080/03098770120050828]; Campbell ML, MULTIPLE CHOICE EXAM, DOI [10.1021/ed500465q, DOI 10.1021/ED500465Q]; COOMBS CH, 1956, EDUC PSYCHOL MEAS, V16, P13, DOI 10.1177/001316445601600102; De Laet T, 2015, P 43 ANN SEFI C ORL, P2; Delame T, 2016, P 8 ADV SAT MULT SYS, P1; Eckel CC., 2008, HDB EXPT EC RESULTS, DOI 10.1016/S1574-0722(07)00113-8; Farooqi Y.N., 2012, INT J PSYCHOL BEHAV, V2, P38, DOI DOI 10.5923/J.IJPBS.20120202.06; Fowell S, 2000, MED EDUC, V34, P785, DOI 10.1046/j.1365-2923.2000.00796.x; HAKSTIAN AR, 1975, J EDUC MEAS, V12, P231, DOI 10.1111/j.1745-3984.1975.tb01024.x; HALADYNA TM, 1993, EDUC PSYCHOL MEAS, V53, P999, DOI 10.1177/0013164493053004013; Haladyna TM, 2004, DEV VALIDATING MULTI, V3; JARADAT D, 1988, EDUC PSYCHOL MEAS, V48, P627, DOI 10.1177/0013164488483006; Jennings S, 2006, PRACTICAL ASSESSMENT, V11, P1; KANSUP W, 1975, J EDUC MEAS, V12, P219, DOI 10.1111/j.1745-3984.1975.tb01023.x; Kilgour JM, 2016, ADV HEALTH SCI EDUC, V21, P571, DOI 10.1007/s10459-015-9652-7; Kubinger KD, 2010, INT J SELECT ASSESS, V18, P111, DOI 10.1111/j.1468-2389.2010.00493.x; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; Lesage E, 2013, STUD EDUC EVAL, V39, P188, DOI 10.1016/j.stueduc.2013.07.001; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; Muijtjens AMM, 1999, MED EDUC, V33, P267; Ng AWY, 2009, LECT NOTES ENG COMP, P1958; Espinosa MP, 2010, J MATH PSYCHOL, V54, P415, DOI 10.1016/j.jmp.2010.06.001; Pekkarinen T, 2015, J ECON BEHAV ORGAN, V115, P94, DOI 10.1016/j.jebo.2014.08.007; Prieto G, 1999, PERS INDIV DIFFER, V27, P1067, DOI 10.1016/S0191-8869(99)00049-5; Ricketts C, 2010, ADV HEALTH SCI EDUC, V15, P265, DOI 10.1007/s10459-009-9197-8; Riener G, 2017, ECON EDUC REV, V59, P43, DOI 10.1016/j.econedurev.2017.06.005; RODRIGUEZ M. C., 2005, EDUC MEAS-ISSUES PRA, V24, P3, DOI [10.1111/J.1745-3992.2005.00006.X, DOI 10.1111/J.1745-3992.2005.00006.X]; TREVISAN MS, 1991, EDUC PSYCHOL MEAS, V51, P829, DOI 10.1177/001316449105100404	44	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203931	10.1371/journal.pone.0203931	http://dx.doi.org/10.1371/journal.pone.0203931			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278049	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200008
J	Lee, SH; Hong, SH; Tang, CH; Ling, YS; Chen, KH; Liang, HJ; Lin, CY				Lee, Sheng-Han; Hong, Si-Han; Tang, Chuan-Ho; Ling, Yee Soon; Chen, Ke-Han; Liang, Hao-Jan; Lin, Ching-Yu			Mass spectrometry-based lipidomics to explore the biochemical effects of naphthalene toxicity or tolerance in a mouse model	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; DIALLYL TRISULFIDE; ORGANIC-COMPOUNDS; FATTY-ACIDS; CLARA CELLS; MICE; RAT; MEMBRANES; INJURY; DISCRIMINATION	Naphthalene causes mouse airway epithelial injury. However, repeated exposures of naphthalene result in mouse airway tolerance. Previous results showed that toxicity or tolerance was correlated with changes of phosphorylcholine-containing lipids. In this study, a mass spectrometry-based lipidomic approach was applied to examine the effects of naphthalene-induced injury or tolerance in the male ICR mice. The injury model was vehicle x 7 plus 300 mg/kg naphthalene while the tolerant one was 200 mg/kg daily x 7 followed by 300 mg/kg naphthalene on day 8. The lung, liver, kidney, and serum samples were collected for profiles of phosphorylcholine-containing lipids including phosphatidylcholines (PCs) and sphingomyelins (SMs). A partial least-square-discriminate analysis model showed different lung phosphorylcholine-containing lipid profiles from the injured, tolerant, and control groups. Perturbation of diacyl-PCs and plasmenylcholines may be associated with enhanced membrane flexibility and anti-oxidative mechanisms in the lungs of tolerant mice. Additionally, alterations of lyso-PCs and SMs may be responsible for pulmonary dysfunction and inflammation in the lungs of injured mice. Moreover, serum PC(16:0/18:1) has potential to reflect naphthalene-induced airway injuries. Few phosphorylcholine-containing lipid alterations were found in the mouse livers and kidneys across different treatments. This study revealed the changes in lipid profiles associated with the perturbations caused by naphthalene tolerance and toxicity; examination of lipids in serum may assist biomarker development with the potential for application in the human population.	[Lee, Sheng-Han; Hong, Si-Han; Ling, Yee Soon; Chen, Ke-Han; Liang, Hao-Jan; Lin, Ching-Yu] Natl Taiwan Univ, Inst Environm Hlth, Coll Publ Hlth, Taipei, Taiwan; [Tang, Chuan-Ho] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Tang, Chuan-Ho] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Pingtung, Taiwan; [Ling, Yee Soon] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei, Taiwan; [Ling, Yee Soon] Univ Malaysia Sabah, Biotechnol Res Inst, Jalan UMS, Kota Kinabalu, Sabah, Malaysia	National Taiwan University; National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Taiwan University; Universiti Malaysia Sabah	Lin, CY (corresponding author), Natl Taiwan Univ, Inst Environm Hlth, Coll Publ Hlth, Taipei, Taiwan.	chingyulin@ntu.edu.tw	Ling, Yee_Soon/H-6815-2016	Ling, Yee_Soon/0000-0002-1042-7820; LIN, CHING-YU/0000-0002-7144-0383	Ministry of Science and Technology of Taiwan [MST 102-2628-B-002-048-MY3, MST 105-2628-B-002-026-MY3]; National Health Research Institutes of Taiwan [NHRI-EX102-9915EC]; National Taiwan University, Taiwan [NTU-CDP-107L7730]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This study was funded by Ministry of Science and Technology of Taiwan, Grant/Award Numbers: MST 102-2628-B-002-048-MY3 and MST 105-2628-B-002-026-MY3), National Health Research Institutes of Taiwan, Grant/Award Numbers: NHRI-EX102-9915EC, and National Taiwan University, Taiwan, Grant/Award Numbers: NTU-CDP-107L7730.	ATSDR, 2005, TOX PROF NAPHTH 1 ME; Bagchi M, 1998, FREE RADICAL BIO MED, V25, P137, DOI 10.1016/S0891-5849(98)00063-X; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bowler RP, 2015, AM J RESP CRIT CARE, V191, P275, DOI 10.1164/rccm.201410-1771OC; Chen WL, 2014, MOL BIOSYST, V10, P3163, DOI 10.1039/c4mb00435c; Dong J, 2010, METABOLOMICS, V6, P478, DOI 10.1007/s11306-010-0215-x; EISELE GR, 1985, B ENVIRON CONTAM TOX, V34, P549, DOI 10.1007/BF01609774; Evans CR, 2014, J PROTEOME RES, V13, P640, DOI 10.1021/pr4007624; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Ghidoni R, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/487508; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; Hong JH, 2014, J APPL TOXICOL, V34, P1379, DOI 10.1002/jat.2970; Hull MC, 2004, J PHYS CHEM B, V108, P15890, DOI 10.1021/jp049845d; Kang DH, 2012, ATMOS ENVIRON, V50, P79, DOI 10.1016/j.atmosenv.2011.12.060; Kang YP, 2014, J PROTEOME RES, V13, P3919, DOI 10.1021/pr5002059; Khaselev N, 2000, J LIPID RES, V41, P564; Kidd PM, 2005, ALTERN MED REV, V10, P268; Lessig J, 2009, CURR MED CHEM, V16, P2021; Li X, 2011, OMICS, V15, P655, DOI 10.1089/omi.2011.0027; Lin CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120429; Ling YS, 2014, MOL BIOSYST, V10, P1918, DOI 10.1039/c4mb00090k; Ma DWL, 2004, J NUTR BIOCHEM, V15, P700, DOI 10.1016/j.jnutbio.2004.08.002; Mander A, 2002, AM J RESP CELL MOL, V27, P714, DOI 10.1165/rcmb.4746; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; Miyamoto S, 2016, EBIOMEDICINE, V7, P121, DOI 10.1016/j.ebiom.2016.03.033; OBRIEN KAF, 1985, CHEM-BIOL INTERACT, V55, P109, DOI 10.1016/S0009-2797(85)80122-8; PELLIZZARI ED, 1982, B ENVIRON CONTAM TOX, V28, P322, DOI 10.1007/BF01608515; Pierson DJ, 2006, RESP CARE, V51, P413; PLOPPER CG, 1992, J PHARMACOL EXP THER, V261, P353; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; Ravipati S, 2015, METABOLOMICS, V11, P1600, DOI 10.1007/s11306-015-0811-x; Shoemaker SD, 2002, IND ENG CHEM RES, V41, P324, DOI 10.1021/ie010049t; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smith HL, 2009, J AM CHEM SOC, V131, P3631, DOI 10.1021/ja807680m; Stanley JS, 1986, BROAD SCAN ANAL FY82, V1; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Tang C.-S., 2011, CHINA CIV ENG J, V44, P5, DOI [DOI 10.15951/J.TMGCXB.2011.S2.040, 10.1016/j.geotexmem.2006.11.002]; Tang CH, 2012, ANAL BIOANAL CHEM, V404, P2949, DOI 10.1007/s00216-012-6414-8; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; THIES F, 1992, J NEUROCHEM, V59, P1110, DOI 10.1111/j.1471-4159.1992.tb08353.x; TINGLE MD, 1993, BIOCHEM PHARMACOL, V46, P1529, DOI 10.1016/0006-2952(93)90319-R; Todd DA, 2010, PEDIATR CRIT CARE ME, V11, P82, DOI 10.1097/PCC.0b013e3181ae5a4c; Tokumura A, 2011, J HEALTH SCI, V57, P115, DOI 10.1248/jhs.57.115; Van Winkle LS, 1999, AM J RESP CELL MOL, V21, P44, DOI 10.1165/ajrcmb.21.1.3630; Vuchetich PJ, 1996, FREE RADICAL BIO MED, V21, P577, DOI 10.1016/0891-5849(96)00161-X; West JAA, 2000, J PHARMACOL EXP THER, V294, P516; West JAA, 2003, TOXICOL SCI, V75, P161, DOI 10.1093/toxsci/kfg156; West JAA, 2002, AM J PATHOL, V160, P1115, DOI 10.1016/S0002-9440(10)64932-2; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Xu Yi, 2014, Biomed J, V37, P112, DOI 10.4103/2319-4170.131378; YOUNES M, 1980, RES COMMUN CHEM PATH, V27, P119; Zhang F, 2016, INT J IMMUNOPATH PH, V29, P205, DOI 10.1177/0394632015627160; Zhang F, 2015, INT IMMUNOPHARMACOL, V29, P326, DOI 10.1016/j.intimp.2015.10.033	59	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204829	10.1371/journal.pone.0204829	http://dx.doi.org/10.1371/journal.pone.0204829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273358	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700038
J	Fang, W; Ren, YF; Liu, X; Jiao, XQ; Chu, CQ				Fang, Wei; Ren, Yongfeng; Liu, Xin; Jiao, Xinquan; Chu, Chengqun			Parameter extraction method for the twisted pair cable with rectangular connectors	PLOS ONE			English	Article								Cables play an important role in transmitting energy and information. In this article, in order to obtain the S-parameters of the special twisted pair cable with rectangular connectors, a de-embedding method of the transmission matrix is proposed to deal with the two adapters ends of the cable. According to the frequency-dependent RLGC(f) model, the cable characteristics are extracted in the frequency range of 10 MHz to 200 MHz through conventional and modified methods respectively. The frequency-domain analysis shows that the inherent capacity of modified method can decrease the errors especially due to the discontinuities of hyperbolic functions. This research supplies an advantageous modelling approach for the cable to improve its robustness against disturbances in the S-parameters measurement that cannot be decreased with the calibration procedure.	[Fang, Wei; Ren, Yongfeng; Liu, Xin; Jiao, Xinquan; Chu, Chengqun] North Univ China, Natl Key Lab Elect Measurement Technol, Taiyuan, Shanxi, Peoples R China; [Fang, Wei] North Univ China, Sch Elect & Control Engn, Taiyuan, Shanxi, Peoples R China; [Liu, Xin] Taiyuan Univ Sci & Technol, Coll Elect & Informat Engn, Taiyuan, Shanxi, Peoples R China	North University of China; North University of China; Taiyuan University of Science & Technology	Fang, W (corresponding author), North Univ China, Natl Key Lab Elect Measurement Technol, Taiyuan, Shanxi, Peoples R China.; Fang, W (corresponding author), North Univ China, Sch Elect & Control Engn, Taiyuan, Shanxi, Peoples R China.	huoweifw@163.com		Fang, Wei/0000-0002-1403-9024	National Natural Science Foundation of China [61771343]; National Major Scientific Research Instrument Development Project of National Natural Science Foundation of China [61727804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific Research Instrument Development Project of National Natural Science Foundation of China	This work was financially supported by National Natural Science Foundation of China (No.61771343) and National Major Scientific Research Instrument Development Project of National Natural Science Foundation of China (No. 61727804).	Acatauassu D, 2013, IEEE GLOB COMM CONF, P2834, DOI 10.1109/GLOCOM.2013.6831504; [Anonymous], 1998, ETSI STC TM6 M; Chen WY, 1998, MACMILLAN TECHNOLOGY, P123; Daniel ES, 2004, ARFTG: AUTOMATIC RF TECHNIQUES GROUP, CONFERENCE DIGEST, SPRING 2004, P61, DOI 10.1109/ARFTG.2004.1387856; Degerstrom MJ, 2008, 2008 IEEE-EPEP ELECTRICAL PERFORMANCE OF ELECTRONIC PACKAGING, P69; Deutsch A., 1992, IEEE Microwave and Guided Wave Letters, V2, P25, DOI 10.1109/75.109132; EISENSTADT WR, 1992, IEEE T COMPON HYBR, V15, P483, DOI 10.1109/33.159877; FERRARI P, 1994, IEEE MICROW GUIDED W, V4, P177, DOI 10.1109/75.294284; GOLDBERG SB, 1991, IEEE T COMPON HYBR, V14, P761, DOI 10.1109/33.105130; Guang Chen, 2005, Electrical Performance of Electronic Packaging (IEEE Cat. No. 05TH8817), P25; Issakov V, 2009, IET CIRC DEVICE SYST, V3, P91, DOI 10.1049/iet-cds.2008.0276; Jaisson D, 2016, IEEE T ELECTROMAGN C, V58, P1151, DOI 10.1109/TEMC.2016.2544952; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kim JH, 2003, ELECTRICAL PERFORMANCE OF ELECTRONIC PACKAGING, P239, DOI 10.1109/EPEP.2003.1250040; Kim W., 2002, 59 ARFTG C SPRING 20, P119, DOI [DOI 10.1109/ARFTGS.2002.1214689, 10.1109/ARFTGS.2002.1214689]; Kim W, 2006, ELECTRICAL PERFORMANCE OF ELECTRONIC PACKAGING, P79; Papazyan R, 2004, IEEE T DIELECT EL IN, V11, P461; Rodrigues RM, 2012, IEEE T INSTRUM MEAS, V61, P43, DOI 10.1109/TIM.2011.2157431; Sampath MK, 2008, 2008 IEEE-EPEP ELECTRICAL PERFORMANCE OF ELECTRONIC PACKAGING, P241; Williams DF, 1999, IEEE T MICROW THEORY, V47, P403, DOI 10.1109/22.754872; Yan YJ, 2018, IEEE T ELECTROMAGN C, V60, P435, DOI 10.1109/TEMC.2017.2729662; Zhang JM, 2010, IEEE T ELECTROMAGN C, V52, P189, DOI 10.1109/TEMC.2009.2035055; Zhang J, 2008, IEEE INT CON AUTO SC, P1, DOI 10.1109/COASE.2008.4626431; Zhang JM, 2004, 2004 INTERNATIONAL SYMPOSIUM ON ELECTROMAGNETIC COMPATIBILITY, SYMPOSIUM RECORD 1-3, P572	24	1	1	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205072	10.1371/journal.pone.0205072	http://dx.doi.org/10.1371/journal.pone.0205072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289924	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500045
J	Kattelus, H; Kesaniemi, YA; Huikuri, H; Ukkola, O				Kattelus, Helena; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi			Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study)	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; PREVALENCE; SURGERY; SOCIETY	Introduction Relation between atrial fibrillation (AF) and cancer is known but not very well understood. The purpose of this prospective study was to find out whether subjects with cancer were at greater risk of AF than subjects without cancer. Materials and methods The study was based on the OPERA (Oulu Project Elucidating Risk of Atherosclerosis) material and had 1045 subjects and the mean follow-up time of 16.3 years. During the follow-up AF and cancer diagnosis were made (atrial flutter included) if these events were listed in the National Death Registry and/or hospital discharge registry. Results In this study 130 subjects (12%) had cancer and 19% of these had AF, whereas only 9% of those without cancer experienced AF during the follow-up (p<0.001). Subjects in the cancer group had greater probability of developing atrial fibrillation during the follow-up time in comparison to the subjects without cancer (Hazard ratio (HR) 2.47 (95%CI) 1.57-3.88) in multi-variate model including relevant confounding factors. Conclusion The main finding of this OPERA study was that cancer is an independent risk factor of atrial fibrillation. Still it remains unclear whether this association is causative or whether cancer and atrial fibrillation just share the same pathophysiologic mechanisms.	[Ukkola, Olavi] Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland; Univ Oulu, Oulu, Finland	University of Oulu; University of Oulu	Ukkola, O (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland.	olavi.ukkola@oulu.fi						Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Erichsen R, 2012, INTERN EMERG MED, V7, P431, DOI 10.1007/s11739-011-0701-9; Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026; Ferreira C, 2015, ARQ BRAS CARDIOL, V105, P519, DOI 10.5935/abc.20150142; Garner M, 2017, INTERACT CARDIOV TH, V24, P260, DOI 10.1093/icvts/ivw348; Guzzetti S, 2008, INTERN EMERG MED, V3, P227, DOI 10.1007/s11739-008-0124-4; Hu YF, 2013, INT J CARDIOL, V165, P355, DOI 10.1016/j.ijcard.2012.08.036; Iwata T, 2016, SURG TODAY, V46, P877, DOI 10.1007/s00595-015-1258-4; Karajamaki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Krawczuk-Rybak M, 2017, J MED IMAG RADIAT ON, V61, P85, DOI 10.1111/1754-9485.12510; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Melichar B, 2012, ANTICANCER RES, V32, P4077; Mery B, 2017, INT J CARDIOL, V240, P196, DOI 10.1016/j.ijcard.2017.03.132; Muranishi Y, 2017, SURG TODAY, V47, P252, DOI 10.1007/s00595-016-1380-y; O'Neal WT, 2015, AM J CARDIOL, V115, P1090, DOI 10.1016/j.amjcard.2015.01.540; Onaitis M, 2010, ANN THORAC SURG, V90, P368, DOI 10.1016/j.athoracsur.2010.03.100; Ostenfeld EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102861; Perkiomaki J, 2014, J CARDIOVASC ELECTR, V25, P719, DOI 10.1111/jce.12402; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Siu CW, 2005, PACE, V28, pS120, DOI 10.1111/j.1540-8159.2005.00024.x; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Suter TM, 2013, EUR HEART J, V34, P1102, DOI 10.1093/eurheartj/ehs181	25	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205454	10.1371/journal.pone.0205454	http://dx.doi.org/10.1371/journal.pone.0205454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289944	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500068
J	Lee, D; Kim, P				Lee, Dongryul; Kim, Pilwon			Isolation and exploitation of minority: Game theoretical analysis	PLOS ONE			English	Article							DISCRIMINATION; COOPERATION; PROPERTY	We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size difference between groups. Our work focuses on the cases where the entire community isolates a small group or even an individual to maximize its gain. While people's basic motivation to form a group can be understood based on the group-size effect on multi-plying a collective asset, sensitive factors that induce a asymmetric group distribution are the group efficiency and the ratio of secured assets to assets pending in a competition. We show that social rejection to a minor group may occur when the group efficiency is relatively low and their asset is severely exposed to possible appropriation.	[Lee, Dongryul] Sungshin Univ, Dept Econ, Seoul 136742, South Korea; [Kim, Pilwon] UNIST, Sch Nat Sci, Dept Math Sci, Ulsan 689798, South Korea	Sungshin Women's University; Ulsan National Institute of Science & Technology (UNIST)	Kim, P (corresponding author), UNIST, Sch Nat Sci, Dept Math Sci, Ulsan 689798, South Korea.	pwkim@unist.ac.kr		Kim, Pilwon/0000-0003-2230-7815	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2015S1A5A2A03049830, 2017R1D1A1B04032921]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2015S1A5A2A03049830, 2017R1D1A1B04032921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altonji J, 1999, HDB LABOR EC C, V3C, P3143, DOI DOI 10.1016/S1573-4463(99)30039-0; Arrow K., 1973, DISCRIMINATION LABOR, V3, P3; Aumann R. J., 1974, International Journal of Game Theory, V3, P217, DOI 10.1007/BF01766876; Becker G. S., 2010, EC DISCRIMINATION; BLANZ M, 1995, EUR J SOC PSYCHOL, V25, P231, DOI 10.1002/ejsp.2420250208; Demange G, 2005, GROUP FORMATION IN ECONOMICS: NETWORKS, CLUBS, AND COALITIONS, P1, DOI 10.1017/CBO9780511614385; Fix Michael E., 1993, CLEAR CONVINCING EVI; Garfinkel M.R., 2007, HDB DEFENSE EC, V2, P649; GROSSMAN HI, 1995, J POLIT ECON, V103, P1275, DOI 10.1086/601453; HIRSHLEIFER D, 1989, J ECON BEHAV ORGAN, V12, P87, DOI 10.1016/0167-2681(89)90078-4; Hirshleifer J., 1991, ECON POLIT-OXFORD, V3, P177, DOI [10.1111/j.1468-0343.1991.tb00046.x, DOI 10.1111/J.1468-0343.1991.TB00046.X]; Hirshleifer Jack, 1995, HDB DEFENSE EC, V1, P165, DOI DOI 10.1016/S1574-0013(05)80009-2; Kim P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094333; Maier-Rigaud FP, 2010, J ECON BEHAV ORGAN, V73, P387, DOI 10.1016/j.jebo.2009.11.001; Myerson R. B., 1977, Mathematics of Operations Research, V2, P225, DOI 10.1287/moor.2.3.225; Neumark D, 1996, Q J ECON, V111, P915, DOI 10.2307/2946676; Ouwerkerk J.W., 2005, SOCIAL OUTCAST OSTRA, P321, DOI DOI 10.4324/978020; Owen G., 1977, Mathematical economics and game thoery, P76; PHELPS ES, 1972, AM ECON REV, V62, P659; Ray D., 2007, GAME THEORETIC PERSP; Seyranian V, 2008, GROUP PROCESS INTERG, V11, P21, DOI 10.1177/1368430207084843; Shenoy P. P., 1979, International Journal of Game Theory, V8, P133, DOI 10.1007/BF01770064; SKAPERDAS S, 1992, AM ECON REV, V82, P720; Tavoni A, 2012, J THEOR BIOL, V299, P152, DOI 10.1016/j.jtbi.2011.07.003	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205241	10.1371/journal.pone.0205241	http://dx.doi.org/10.1371/journal.pone.0205241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289913	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500058
J	Zapata, C; Puente, A; Garcia, A; Garcia-Alba, J; Espinoza, J				Zapata, Carlos; Puente, Araceli; Garcia, Andres; Garcia-Alba, Javier; Espinoza, Jorge			Assessment of ecosystem services of an urbanized tropical estuary with a focus on habitats and scenarios	PLOS ONE			English	Article							GUAYAS RIVER ESTUARY; PROTECTED AREA; LAND-USE; MANAGEMENT; MODEL; GULF	Tropical estuaries are one of the most valuable ecosystems on the planet because of the number of ecosystem services they provide. The increasing anthropogenic pressure to which these estuaries are subject has caused a reduction in their natural capital stock. Therefore, the application of a pragmatic and rational ecosystem-based management approach to sustainably manage the multiple ecosystem services provided by this ecosystem is necessary. The aim of our study is to present an approach that combines prospective scenarios with habitat-based perspective to assess the supply capacity of ecosystem services, plus determine the impact of protected areas in an urbanized tropical estuary. The current situation and two scenarios were generated to evaluate the capacity of habitats to supply ecosystem services. This type of assessment will allow the decision makers to visualize the effect of their choices or the occurrence of events which might produce significant changes in the estuary. Thus, over time, measures can be taken to sustain the supply of ecosystem services. We determined that the establishment of protected areas have a positive impact; however, the effect is not the same for all of them. Consequently, indicating that actions such as community participation, research, education, management planning and infrastructure development must accompany the development of a protected area.	[Zapata, Carlos; Espinoza, Jorge] Inst Oceanog Armada INOCAR, Dept Hydrog, Guayaquil, Guayas, Ecuador; [Zapata, Carlos; Puente, Araceli; Garcia, Andres; Garcia-Alba, Javier] Univ Cantabria, Enviromental Hydraul Inst, Santander, Cantabria, Spain	Universidad de Cantabria	Zapata, C (corresponding author), Inst Oceanog Armada INOCAR, Dept Hydrog, Guayaquil, Guayas, Ecuador.; Zapata, C (corresponding author), Univ Cantabria, Enviromental Hydraul Inst, Santander, Cantabria, Spain.	carlos.zapata@inocar.mil.ec	Alba, Javier García/I-1614-2015; Puente, Araceli/H-3163-2015; Alba, Javier García/O-9743-2019; Gómez, Andrés García/I-2409-2015; Puente, Araceli/ABG-9362-2021	Alba, Javier García/0000-0003-3693-3753; Puente, Araceli/0000-0001-7627-4743; Alba, Javier García/0000-0003-3693-3753; Gómez, Andrés García/0000-0002-2658-7765; Puente, Araceli/0000-0001-7627-4743; zapata, carlos/0000-0001-7823-5342	Oceanographic Institute of the Ecuadorian Navy	Oceanographic Institute of the Ecuadorian Navy	This article is part of my research to obtain my phd degree. My studies are financed by the Oceanographic Institute of the Ecuadorian Navy.	Amer M, 2013, FUTURES, V46, P23, DOI 10.1016/j.futures.2012.10.003; angela Rodriguez L, 2014, VISIONES DESARROLLO; Arcade J, 2004, ANALISIS ESTRUCTURAL, P165; Arkema KK, 2012, AM FISH S S, V79, P9; Balbi ER, 2014, CONSTRUYENDO FUTURO; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Berg C, 2016, FUTURES, V81, P68, DOI 10.1016/j.futures.2015.10.014; Bitar S., 2016, SERIE GESTION PUBLIC, V85, P70; Bradfield R, 2005, FUTURES, V37, P795, DOI 10.1016/j.futures.2005.01.003; Brochier T, 2013, AQUAT LIVING RESOUR, V26, P147, DOI 10.1051/alr/2012028; Cabral P, 2015, ECOSYST SERV, V16, P306, DOI 10.1016/j.ecoser.2014.09.007; Hernandez JJC, 2010, LECT NOTES COMPUT SC, V6134, P113, DOI 10.1007/978-3-642-13681-8_14; Cardenas M., 2016, COMMUNITY STRUCTURE; Carvalho TM, 2013, LAND USE POLICY, V34, P134, DOI 10.1016/j.landusepol.2013.02.007; Castro T., 2016, SISTEMA PORTUARIO EC; CEPLAN, 2016, FAS AN LIS PROSP SEC; Chua T-E, 1990, EVALUACION CULTIVO C; CIIFEN, 2010, INF FIN MED AD RES M; CLIRSEN PMRC; MAE, 2006, ACT EST MULT MANGL C; Costanza R, 1998, ECOL ECON, V25, P67, DOI 10.1016/S0921-8009(98)00019-6; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Cruz Manuel, 2003, Gayana (Concepc.), V67, P232; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; Escobar J., 2002, CONTAMINACION RIOS S, DOI [10.3989/arbor.2000.i653.1000, DOI 10.3989/ARBOR.2000.I653.1000]; Fares I., 2016, COMERCIALIZACION CAM; Flores J., 2012, CADENA VALOR CANGREJ; FONTELA E, 1993, FUTURES, V25, P139, DOI 10.1016/0016-3287(93)90160-U; Gibbes B, 2014, ESTUARIES AUST 2050, V296, DOI [10.1007/978-94-007-7019-5, DOI 10.1007/978-94-007-7019-5]; Godet M., 2007, PROSPECTIVA ESTRATEG, V2; Godet Michael, 1993, ANTICIPACION ACCION; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hazen Sawyer, 2015, ESTUDIO IMPACTO AMBI, DOI [10.15713/ins.mmj.3, DOI 10.15713/INS.MMJ.3]; Helmut Anheier K, 2009, GLOBAL CIVIL SOC 200, P238; Hemingway KL, 2013, TIDE TOOL CONFLICT M; Herbeck LS., 2011, THESIS; Huang SL, 2009, ENVIRON IMPACT ASSES, V29, P116, DOI 10.1016/j.eiar.2008.03.003; Iturralde G, 2016, ECUADOR RESERVA ECOL, P36; Jacobs S., 2013, ECOSYSTEM SERVICE AS; Jacobs S, 2015, ECOSYST SERV, V16, P378, DOI 10.1016/j.ecoser.2014.10.006; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lindgren M., 2003, SCENARIO PLANNING LI, DOI DOI 10.1057/9780230511620; Logan B, 2011, J PALEOLIMNOL, V46, P597, DOI 10.1007/s10933-010-9457-x; Lopoukhine N., 2012, SAPIENS, V5, p117?131, DOI DOI 10.1017/CBO9781107415324.004; Lund K., 2007, HABITAT CLASSIFICATI; MAE, 2008, PLAN MAN RES PROD FA; Martinez-Harms MJ, 2017, ECOSYST SERV, V25, P56, DOI 10.1016/j.ecoser.2017.03.021; Mascarenhas A, 2016, ECOSYST SERV, V18, P87, DOI 10.1016/j.ecoser.2016.02.011; McCann MJ, 2017, FRONT ECOL ENVIRON, V15, P142, DOI 10.1002/fee.1474; McLusky D.S., 2005, ESTUARINE ECOSYSTEM; MEA, 2005, EC HUM WELL BEING SY, DOI [10.1196/annals.1439.003, DOI 10.1196/ANNALS.1439.003]; Mukul SA, 2017, ECOSYST SERV, V26, P355, DOI 10.1016/j.ecoser.2017.04.001; Palaima A., 2013, ECOL CONSERV RESTOR, P207; Potschin M, 2013, LANDSCAPE ECOL, V28, P1053, DOI 10.1007/s10980-012-9756-x; Robinson D., 2009, ACCLIMATING NEW BAY; Rodriguez A., 2005, ACTA OCEAN PACIFICO, V103, P2005; Sadio O, 2015, OCEAN COAST MANAGE, V116, P257, DOI 10.1016/j.ocecoaman.2015.08.004; Schonig D., 2014, RESILIENCE BASED RES; SENPLADES, 2016, PLAN ESP MAR COST; Stevenson M., 1981, BOLETN CIENTFICO TEC, V4, P1; Templado J., 2012, GUIA INTERPRETATIVA; Thrush SF, 2013, ECOSYST SERV NZ; Thrush SF, 2010, ANNU REV MAR SCI, V2, P419, DOI 10.1146/annurev-marine-120308-081129; Torres G., 2014, ESTRATEGIAS PREVENTI; Twilley RR, 1997, OECOLOGIA, V111, P109, DOI 10.1007/s004420050214; Twilley RR, 2001, ECOL STU AN, V144, P245; TWILLEY RR, 1998, ENVIRON SCI POLICY, V1, P271, DOI DOI 10.1016/S1462-9011(98)00012-4; USAID, 2009, SIT ACT CONC MANGL R; Vester F., 1988, SYST PRACTICE, V1, P399	70	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203927	10.1371/journal.pone.0203927	http://dx.doi.org/10.1371/journal.pone.0203927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289936	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500009
J	Albanna, W; Kotliar, K; Luke, JN; Alpdogan, S; Conzen, C; Lindauer, U; Clusmann, H; Hescheler, J; Vilser, W; Schneider, T; Schubert, GA				Albanna, Walid; Kotliar, Konstantin; Lueke, Jan Niklas; Alpdogan, Serdar; Conzen, Catharina; Lindauer, Ute; Clusmann, Hans; Hescheler, Juergen; Vilser, Walthard; Schneider, Toni; Schubert, Gerrit Alexander			Non-invasive evaluation of neurovascular coupling in the murine retina by dynamic retinal vessel analysis	PLOS ONE			English	Article							SUBARACHNOID HEMORRHAGE; CEREBRAL AUTOREGULATION; FLICKERING LIGHT; BLOOD-FLOW; AGE; VASODILATION; DIAMETER; RAT	Background Impairment of neurovascular coupling (NVC) was recently reported in the context of subarachnoid hemorrhage and may correlate with disease severity and outcome. However, previous techniques to evaluate NVC required invasive procedures. Retinal vessels may represent an alternative option for non-invasive assessment of NVC. Methods A prototype of an adapted retinal vessel analyzer was used to assess retinal vessel diameter in mice. Dynamic vessel analysis (DVA) included an application of monochromatic flicker light impulses in predefined frequencies for evaluating NVC. All retinae were harvested after DVA and electroretinograms were performed. Results A total of 104 retinal scans were conducted in 21 male mice (90 scans). Quantitative arterial recordings were feasible only in a minority of animals, showing an emphasized reaction to flicker light impulses (8 mice; 14 scans). A characteristic venous response to flicker light, however, could observed in the majority of animals. Repeated measurements resulted in a significant decrease of baseline venous diameter (7 mice; 7 scans, p < 0.05). Ex-vivo electroretinograms, performed after in-vivo DVA, demonstrated a significant reduction of trans-retinal signaling in animals with repeated DVA (n = 6, p < 0.001). Conclusions To the best of our knowledge, this is the first non-invasive study assessing murine retinal vessel response to flicker light with characteristic changes in NVC. The imaging system can be used for basic research and enables the investigation of retinal vessel dimension and function in control mice and genetically modified animals.	[Albanna, Walid; Lueke, Jan Niklas; Alpdogan, Serdar; Hescheler, Juergen; Schneider, Toni] Univ Cologne, Inst Neurophysiol, Cologne, Germany; [Albanna, Walid; Conzen, Catharina; Lindauer, Ute; Clusmann, Hans; Schubert, Gerrit Alexander] Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany; [Kotliar, Konstantin] FH Aachen Univ Appl Sci, Dept Med Engn & Technomath, Aachen, Germany; [Lindauer, Ute] Rhein Westfal TH Aachen, Tranlat Neurosurg & Neurobiol, Aachen, Germany; [Vilser, Walthard] IMEDOS Syst UG, Jena, Germany	University of Cologne; RWTH Aachen University; RWTH Aachen University	Albanna, W (corresponding author), Univ Cologne, Inst Neurophysiol, Cologne, Germany.; Albanna, W (corresponding author), Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany.	walbanna@ukaachen.de	Schubert, Gerrit Alexander/Q-9192-2017; Alpdogan, Serdar/AAA-4233-2022	Schubert, Gerrit Alexander/0000-0001-9135-6042; Alpdogan, Serdar/0000-0002-5188-9925; Kotliar, Konstantin/0000-0003-2087-957X; Albanna, Walid/0000-0001-9986-8739	START-Program of the Faculty of Medicine, RWTH Aachen University	START-Program of the Faculty of Medicine, RWTH Aachen University	This research program is supported by the START-Program of the Faculty of Medicine, RWTH Aachen University. One of the authors (WV), is affiliated to IMEDOS Systems, employed as CEO of the company. IMEDOS Systems gave technical instruction and support for the imaging device. The funder provided support in the form of research material, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Albanna W, 2017, CURR EYE RES, V42, P1518, DOI 10.1080/02713683.2017.1339807; Albanna W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158781; Aschinger GC, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20598; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Balbi M, 2017, J CEREB BLOOD FLOW M; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Conzen C, 2017, TRANSL STROKE RES; Filosa JA, 2016, NEUROSCIENCE, V323, P96, DOI 10.1016/j.neuroscience.2015.03.064; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Kneser M, 2009, MED SCI MONITOR, V15, pCR436; Koide M, 2013, ACTA NEUROCHIR SUPPL, V115, P167, DOI 10.1007/978-3-7091-1192-5_32; Kornfield TE, 2014, J NEUROSCI, V34, P11504, DOI 10.1523/JNEUROSCI.1971-14.2014; Kotliar KE, 2004, GRAEF ARCH CLIN EXP, V242, P377, DOI 10.1007/s00417-003-0847-x; Kotliar K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13349-5; Kotliar KE, 2011, MICROVASC RES, V81, P123, DOI 10.1016/j.mvr.2010.11.007; Lanzl IM, 2011, ACTA OPHTHALMOL, V89, P472, DOI 10.1111/j.1755-3768.2009.01718.x; Link D, 2011, BIOMED OPT EXPRESS, V2, P3094, DOI 10.1364/BOE.2.003094; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Nagel E, 2004, INVEST OPHTH VIS SCI, V45, P1486, DOI 10.1167/iovs.03-0667; Newman EA, 2013, J CEREBR BLOOD F MET, V33, P1685, DOI 10.1038/jcbfm.2013.145; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Pappas AC, 2015, J NEUROSCI, V35, P13375, DOI 10.1523/JNEUROSCI.1551-15.2015; Polak K, 2002, INVEST OPHTH VIS SCI, V43, P2721; Sharifizad M, 2016, INVEST OPHTH VIS SCI, V57, P3306, DOI 10.1167/iovs.16-19261; Szel A, 1996, MICROSC RES TECHNIQ, V35, P445	31	9	9	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204689	10.1371/journal.pone.0204689	http://dx.doi.org/10.1371/journal.pone.0204689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286110	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500035
J	Chen, X; Zhu, QY; Yu, F; Zhang, W; Wang, RN; Ye, XF; Jin, LF; Liu, YC; Li, SF; Chen, Y				Chen, Xiao; Zhu, Qiaoyun; Yu, Fei; Zhang, Wen; Wang, Ruonan; Ye, Xianfei; Jin, Linfeng; Liu, Yanchao; Li, Shufei; Chen, Yu			Serology, virulence and molecular characteristics of Vibrio parahaemolyticus isolated from seafood in Zhejiang province	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; CLINICAL STRAINS; PREVALENCE; DIVERSITY; THAILAND; WATERS; MEXICO; O3-K6; CHINA; CLONE	Vibrio parahaemolyticus is a leading foodborne pathogen in southeastern China. In this study, 105 strains of V. parahaemolyticus were isolated from fresh seafood in 2013 and 2014. The serotypes, virulence-associated genes and sequence types (STs) of these strains were analyzed. 26 defined serotypes were identified and 69 strains (65.7%) had untypeable O or K antigen. 8 strains (7.6%) had the virulence-associated gene tdh and no strain carried the trh gene. 45.7% (48/105) of isolates contained all four T3SS1 genes and 50% (4/8) tdh(+) trh(-) V. parahaemolyticus isolates lacked at least one of the four tested T3SS2a genes. 105 strains could be categorized into 84 STs and only 3 STs (ST3, ST8, ST675) had appeared in clinical strains. V. parahaemolyticus strains from seafood have more diverse and untypeable serotypes, less virulence-associated genes and more STs than strains from clinical sources.	[Chen, Xiao; Jin, Linfeng; Chen, Yu] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiao; Zhu, Qiaoyun; Yu, Fei; Zhang, Wen; Wang, Ruonan; Ye, Xianfei; Liu, Yanchao; Li, Shufei; Chen, Yu] Zhejiang Univ, Key Lab Clin Vitro Diagnost Tech Zhejiang Prov, Dept Clin Lab, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University	Chen, Y (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China.; Chen, Y (corresponding author), Zhejiang Univ, Key Lab Clin Vitro Diagnost Tech Zhejiang Prov, Dept Clin Lab, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China.	chenyuzy@zju.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022		National Key Programs for Infectious Diseases of China [2012ZX10004210, 2017ZX10103008]	National Key Programs for Infectious Diseases of China	This work was supported by the National Key Programs for Infectious Diseases of China (2012ZX10004210, 2017ZX10103008)(YC,XC).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee SK, 2014, J CLIN MICROBIOL, V52, P1081, DOI 10.1128/JCM.03047-13; Caburlotto G, 2008, EURO SURVEILLANCE B, V13; Chao GX, 2010, FOODBORNE PATHOG DIS, V7, P649, DOI 10.1089/fpd.2009.0441; Chen Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.003; Hernandez-Diaz LD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00221; DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; Ellis CN, 2012, APPL ENVIRON MICROB, V78, P3778, DOI 10.1128/AEM.07794-11; Gavilan RG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002210; Jones JL, 2012, J CLIN MICROBIOL, V50, P2343, DOI 10.1128/JCM.00196-12; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; Laohaprertthisan V, 2003, EPIDEMIOL INFECT, V130, P395, DOI 10.1017/S0950268803008458; Letchumanan V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00705; Li JJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00787; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nordstrom JL, 2007, J CARDIOVASCULAR ELE, V14, P616; Noriea NF, 2010, J APPL MICROBIOL, V109, P953, DOI 10.1111/j.1365-2672.2010.04722.x; Ottaviani D, 2013, ENVIRON MICROBIOL, V15, P1377, DOI 10.1111/j.1462-2920.2012.02839.x; Powell A, 2013, MICROB ECOL, V65, P924, DOI 10.1007/s00248-013-0201-8; Raghunath P, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00805; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Theethakaew C, 2013, APPL ENVIRON MICROB, V79, P2358, DOI 10.1128/AEM.03067-12; Tsai SE, 2013, INT J FOOD MICROBIOL, V165, P18, DOI 10.1016/j.ijfoodmicro.2013.04.017; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; Velazquez-Roman J, 2012, APPL ENVIRON MICROB, V78, P1794, DOI 10.1128/AEM.06953-11; Vengadesh L, 2015, FRONTIERS MICROBIOLO, V6; Yan WX, 2015, EPIDEMIOL INFECT, V143, P1020, DOI 10.1017/S0950268814001599; Yan YF, 2011, INT J FOOD MICROBIOL, V145, P106, DOI 10.1016/j.ijfoodmicro.2010.11.038	28	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204892	10.1371/journal.pone.0204892	http://dx.doi.org/10.1371/journal.pone.0204892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286209	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500058
J	Singh, R; Kalra, MK; Nitiwarangkul, C; Patti, JA; Homayounieh, F; Padole, A; Rao, P; Putha, P; Muse, VV; Sharma, A; Digumarthy, SR				Singh, Ramandeep; Kalra, Mannudeep K.; Nitiwarangkul, Chayanin; Patti, John A.; Homayounieh, Fatemeh; Padole, Atul; Rao, Pooja; Putha, Preetham; Muse, Victorine V.; Sharma, Amita; Digumarthy, Subba R.			Deep learning in chest radiography: Detection of findings and presence of change	PLOS ONE			English	Article							TUBERCULOSIS	Background Deep learning (DL) based solutions have been proposed for interpretation of several imaging modalities including radiography, CT, and MR. For chest radiographs, DL algorithms have found success in the evaluation of abnormalities such as lung nodules, pulmonary tuberculosis, cystic fibrosis, pneumoconiosis, and location of peripherally inserted central catheters. Chest radiography represents the most commonly performed radiological test for a multitude of non-emergent and emergent clinical indications. This study aims to assess accuracy of deep learning (DL) algorithm for detection of abnormalities on routine frontal chest radiographs (CXR), and assessment of stability or change in findings over serial radiographs. Methods and findings We processed 874 de-identified frontal CXR from 724 adult patients (> 18 years) with DL (Qure Al). Scores and prediction statistics from DL were generated and recorded for the presence of pulmonary opacities, pleural effusions, hilar prominence, and enlarged cardiac silhouette. To establish a standard of reference (SOR), two thoracic radiologists assessed all CXR for these abnormalities. Four other radiologists (test radiologists), unaware of SOR and DL findings, independently assessed the presence of radiographic abnormalities. A total 724 radiographs were assessed for detection of findings. A subset of 150 radiographs with follow up examinations was used to asses change over time. Data were analyzed with receiver operating characteristics analyses and post-hoc power analysis. Results About 42% (305/ 724) CXR had no findings according to SOR; single and multiple abnormalities were seen in 23% (168/724) and 35% (251/724) of CXR. There was no statistical difference between DL and SOR for all abnormalities (p = 0.2-0.8). The area under the curve (AUC) for DL and test radiologists ranged between 0.837-0.929 and 0.693-0.923, respectively. DL had lowest AUC (0.758) for assessing changes in pulmonary opacities over follow up CXR. Presence of chest wall implanted devices negatively affected the accuracy of DL algorithm for evaluation of pulmonary and hilar abnormalities. Conclusions DL algorithm can aid in interpretation of CXR findings and their stability over follow up CXR. However, in its present version, it is unlikely to replace radiologists due to its limited specificity for categorizing specific findings.	[Singh, Ramandeep; Kalra, Mannudeep K.; Nitiwarangkul, Chayanin; Patti, John A.; Homayounieh, Fatemeh; Padole, Atul; Muse, Victorine V.; Sharma, Amita; Digumarthy, Subba R.] Massachusetts Gen Hosp, Dept Radiol, 32 Fruit St, Boston, MA 02114 USA; [Singh, Ramandeep; Kalra, Mannudeep K.; Nitiwarangkul, Chayanin; Patti, John A.; Homayounieh, Fatemeh; Padole, Atul; Muse, Victorine V.; Sharma, Amita; Digumarthy, Subba R.] Harvard Med Sch, Boston, MA 02115 USA; [Nitiwarangkul, Chayanin] Mahidol Univ, Ramathibodi Hosp, Div Diagnost Radiol, Dept Diagnost & Therapeut Radiol,Fac Med, Bangkok, Thailand; [Rao, Pooja; Putha, Preetham] Qure Ai, 101 Raheja Titanium, Bombay, Maharashtra, India	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mahidol University	Digumarthy, SR (corresponding author), Massachusetts Gen Hosp, Dept Radiol, 32 Fruit St, Boston, MA 02114 USA.; Digumarthy, SR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	sdigumarthy@mgh.harvard.edu	Singh, Ramandeep/AAI-8987-2020	Nitiwarangkul, Chayanin/0000-0001-7018-2012; Singh, Ramandeep/0000-0001-5840-9907; Rao, Pooja/0000-0002-4846-7895				Becker AS, 2018, INT J TUBERC LUNG D, V22, P328, DOI 10.5588/ijtld.17.0520; Dagunts Dmitry, 2017, ARXIV171010501CS; FORREST JV, 1981, WESTERN J MED, V134, P485; He K., 2016, PROC IEEE COMPUT SOC; Huang G., ARXIV160806993; Hwang S., 2016, P SPIE MED IMAGING 2, V9785; Jaeger S, 2014, IEEE T MED IMAGING, V33, P233, DOI 10.1109/TMI.2013.2284099; Lakhani P, 2017, DEEP LEARNING CHEST, V2, P574; Lee MZ, 2013, IEEE ENG MED BIO, P3965, DOI 10.1109/EMBC.2013.6610413; Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325; Melendez J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25265; Pande T, 2016, INT J TUBERC LUNG D, V20, P1226, DOI 10.5588/ijtld.15.0926; Quekel LGBA, 1999, CHEST, V115, P720, DOI 10.1378/chest.115.3.720; Rajpurkar P, 2017, RADIOLOGIST LEVEL PN; SHWACHMAN H, 1958, AMA J DIS CHILD, V96, P6, DOI 10.1001/archpedi.1958.02060060008002; Tudor GR, 1997, CLIN RADIOL, V52, P235, DOI 10.1016/S0009-9260(97)80280-2; van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004; Wang X, 2017, IEEE CVPR; Xu H, 2010, COMPUTER AIDED DETEC, V9, P129; Yu PC, 2011, J DIGIT IMAGING, V24, P382, DOI 10.1007/s10278-010-9276-7; Zhu BY, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-141	21	81	84	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204155	10.1371/journal.pone.0204155	http://dx.doi.org/10.1371/journal.pone.0204155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286097	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500015
J	Yasuda, S; Kusakawa, S; Kuroda, T; Miura, T; Tano, K; Takada, N; Matsuyama, S; Matsuyama, A; Nasu, M; Umezawa, A; Hayakawa, T; Tsutsumi, H; Sato, Y				Yasuda, Satoshi; Kusakawa, Shinji; Kuroda, Takuya; Miura, Takumi; Tano, Keiko; Takada, Nozomi; Matsuyama, Satoko; Matsuyama, Akifumi; Nasu, Michiyo; Umezawa, Akihiro; Hayakawa, Takao; Tsutsumi, Hideki; Sato, Yoji			Tumorigenicity-associated characteristics of human iPS cell lines	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN FIBROBLASTS; GENETIC-VARIATION; TERATOMAS; PROLIFERATION; EXPRESSION; THERAPIES; PROGRAM; MICE	Human induced pluripotent stem cells (hiPSCs) represent promising raw materials of human cell-based therapeutic products (hCTPs). As undifferentiated hiPSCs exhibit intrinsic tumorigenicity properties that enable them to form teratomas, hCTPs containing residual undifferentiated hiPSCs may cause tumor formation following transplantation. We first established quantitative and sensitive tumorigenicity testing of hiPSCs dissociated into single cells using NOD/Shi-scid IL2Ry(null) (NOG) mice by inhibiting apoptosis of hiPSCs with a Rho kinase inhibitor. To examine different features in tumorigenicity of various hiPSCs, 10 commonly available hiPSC lines were subjected to in vivo tumorigenicity testing. Transplanted hiPSC lines showed remarkable variation in tumor incidence, formation latency, and volumes. Most of the tumors formed were classified as immature teratomas. However, no signs of malignancies, such as carcinoma and sarcoma, were recognized in the tumors. Characteristics associated tumorigenicity of hiPSCs were investigated with microarray analysis, karyotype analysis, and whole exome sequencing. Gene expression profiling and pathway analysis supported different features of hiPSC lines in tumorigenicity. hiPSC lines showed chromosomal abnormalities in some lines and 61-77 variants of cancer-related genes carrying effective nonsynonymous mutations, which were confirmed in the COSMIC databases. In this study, the chromosomal abnormalities and cancer-related gene mutations observed in hiPSC lines did not lead to the malignancy of tumors derived from hiPSCs. Our results suggest that the potential tumorigenicity risk of hCTPs containing residual undifferentiated hiPSCs is dependent on not only amounts of undifferentiated hiPSCs but also features of the cell lines used as raw materials, a finding that should be considered from the perspective of quality of hCTPs used.	[Yasuda, Satoshi; Kusakawa, Shinji; Kuroda, Takuya; Miura, Takumi; Tano, Keiko; Matsuyama, Satoko; Sato, Yoji] Natl Inst Hlth Sci, Div Cell Based Therapeut Prod, Kawasaki, Kanagawa, Japan; [Takada, Nozomi; Matsuyama, Satoko; Matsuyama, Akifumi] Natl Inst Biomed Innovat Hlth & Nutr, Ctr Rare Dis Res, Osaka, Japan; [Nasu, Michiyo; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Ctr Regenerat Med, Tokyo, Japan; [Hayakawa, Takao] Kindai Univ, Pharmaceut Res & Technol Inst, Osaka, Japan; [Tsutsumi, Hideki] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Sato, Yoji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Qual Assurance Sci Pharmaceut, Nagoya, Aichi, Japan; [Sato, Yoji] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Cellular & Gene Therapy Prod, Osaka, Japan; [Sato, Yoji] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Fukuoka, Fukuoka, Japan	National Institute of Health Sciences - Japan; National Center for Child Health & Development - Japan; Kindai University (Kinki University); Nagoya City University; Osaka University; Kyushu University	Sato, Y (corresponding author), Natl Inst Hlth Sci, Div Cell Based Therapeut Prod, Kawasaki, Kanagawa, Japan.; Sato, Y (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Qual Assurance Sci Pharmaceut, Nagoya, Aichi, Japan.; Sato, Y (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Dept Cellular & Gene Therapy Prod, Osaka, Japan.; Sato, Y (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Fukuoka, Fukuoka, Japan.	yoji@nihs.go.jp		YASUDA, Satoshi/0000-0002-1011-0815	Japanese Ministry of Health, Labour and Welfare [H25-JITSUYOKA(SAISEI)-IPPAN-008]; Japan Agency for Medical Research and Development [15bk0104014h0103, 15bk0104014h0203, 16bk0104006h0104, 16bk0104006h0204, 17bk0104006j0105, 17bk0104006j0205]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The present work was supported by a Research Grant from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/) (H25-JITSUYOKA(SAISEI)-IPPAN-008) and the Japan Agency for Medical Research and Development (https://www.amed.go.jp/en/) (15bk0104014h0103 to YS, 15bk0104014h0203 to SY, 16bk0104006h0104 to YS, 16bk0104006h0204 to SY, 17bk0104006j0105 to YS, and 17bk0104006j0205 to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu H, 2016, REGEN THER, V5, P31, DOI 10.1016/j.reth.2016.06.003; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Andrews PW, 2017, STEM CELL REP, V9, P1, DOI 10.1016/j.stemcr.2017.05.029; [Anonymous], 1987, LAB ANIMAL SCI, V37; Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Chang YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41913; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329; Damjanov I, 2016, INT J DEV BIOL, V60, P337, DOI 10.1387/ijdb.160274id; Glantz S.A., 2002, PRIMER BIOSTATISTICS; Gropp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045532; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Kusakawa S, 2015, REGEN THER, V1, P30, DOI 10.1016/j.reth.2014.12.001; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, ARXIV PREPRINT; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lorenz R. J., 1973, Laboratory techniques in rabies. WHO Monograph Series No.23., P321; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; OCONNOR DM, 1994, INT J GYNECOL PATHOL, V13, P283, DOI 10.1097/00004347-199410000-00001; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; WHO Expert Committee on Biological Standardization, 2013, WHO TECHN REP SER, P79; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013	32	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205022	10.1371/journal.pone.0205022	http://dx.doi.org/10.1371/journal.pone.0205022			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286143	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500077
J	Basurko, C; Everhard, S; Matheus, S; Restrepo, M; Hilderal, H; Lambert, V; Boukhari, R; Duvernois, JP; Favre, A; Valmy, L; Nacher, M; Carles, G				Basurko, Celia; Everhard, Sibille; Matheus, Severine; Restrepo, Marion; Hilderal, Helene; Lambert, Veronique; Boukhari, Rachida; Duvernois, Jean-Pierre; Favre, Anne; Valmy, Larissa; Nacher, Mathieu; Carles, Gabriel			A prospective matched study on symptomatic dengue in pregnancy	PLOS ONE			English	Article							TRANSMISSION; DEPRIVATION; OUTCOMES	Dengue fever is an increasing problem worldwide, but consequences during pregnancy remain unclear. Much of the available literature suffers from methodological biases that compromise the validity of clinical recommendations. We conducted a matched cohort study during an epidemic in French Guiana to compare events and pregnancy outcomes between two paired groups of pregnant women: women having presented with symptomatic dengue during pregnancy (n = 73) and women having had neither fever nor dengue during pregnancy (n = 219). Women in each arm were matched by place of follow up, gestation weeks at inclusion, and place of residence. Dengue infection was considered to be confirmed if viral RNA, N S1 antigen, the seroconversion of IgM antibodies or the presence of IgM was detected in collected samples. According to the 2009 WHO classification, 27% of the women with symptomatic dengue had at least one clinical or biological warning sign. These complications occurred after the 28th week of gestation in 55% of cases. The medical history, socioeconomic status and demographic characteristics were included in multivariate analysis. Exposure to dengue during pregnancy was not significantly associated with prematurity, small for gestational age infants, hypertension or emergency caesarian section. Maternal dengue with warning signs was a risk factor for peripartum hemorrhage with adjusted relative risk = 8.6(95% CI = 1.2-62). There was a near significant association between dengue and in utero death (p = 0.09). This prospective comparative study underlined the importance of taking into account potential confounders between exposure to dengue and the occurrence of obstetrical events. It also confirms the need for increased vigilance for pregnant women with dengue, particularly for women who present with severe dengue.	[Basurko, Celia; Everhard, Sibille; Restrepo, Marion; Hilderal, Helene; Valmy, Larissa; Nacher, Mathieu] Ctr Hosp Cayenne, Ctr Invest Clin Antilles Guyane, Inserm CIC1424, Cayenne, French Guiana; [Basurko, Celia; Nacher, Mathieu] Univ Guyane, Equipe EA3593, Ecosyst Amazoniens & Pathol Trop, Cayenne, French Guiana; [Matheus, Severine] Inst Pasteur Guyane Cayenne, Lab Virol, Ctr Natl Reference Arbovirus, Cayenne, French Guiana; [Restrepo, Marion; Lambert, Veronique; Carles, Gabriel] Ctr Hosp Ouest Guyanais, Serv Gynecol & Obstet, St Laurent Du Maroni, French Guiana; [Restrepo, Marion] Ctr Hosp Ouest Guyanais, Pole Sante Publ, St Laurent Du Maroni, French Guiana; [Boukhari, Rachida] Ctr Hosp Ouest Guyanais, Serv Anal Med, St Laurent Du Maroni, French Guiana; [Duvernois, Jean-Pierre] Croix Rouge Francaise, Serv Gynecol & Obstet, Ctr Medicochirurg Kourou, Kourou, French Guiana; [Favre, Anne] Reseau Perinat Guyane, Cayenne, French Guiana		Basurko, C; Nacher, M (corresponding author), Ctr Hosp Cayenne, Ctr Invest Clin Antilles Guyane, Inserm CIC1424, Cayenne, French Guiana.; Basurko, C; Nacher, M (corresponding author), Univ Guyane, Equipe EA3593, Ecosyst Amazoniens & Pathol Trop, Cayenne, French Guiana.	cbasurko@gmail.com; mathieu.nacher66@gmail.com	Basurko, Célia/AAM-8297-2021; amsalu, ribka/G-8780-2019; nacher, mathieu/AAH-4796-2021	nacher, mathieu/0000-0001-9397-3204; LAMBERT, veronique/0000-0001-6453-8983; Matheus, Severine/0000-0001-9171-1964	European public funds (PO-FEDER 2007-2013 program) [31257]; Pasteur Institute; Cayenne General Hospital	European public funds (PO-FEDER 2007-2013 program); Pasteur Institute; Cayenne General Hospital	This work was supported by European public funds (PO-FEDER 2007-2013 program; presage number 31257), by Pasteur Institute, and by Cayenne General Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam I, 2010, PARITY, V2, P2; [Anonymous], 2012, WHO REC PREV POSTP H; Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028; Boussemart T, 2001, J Perinatol, V21, P255, DOI 10.1038/sj.jp.7200530; Bunyavejchevin S, 1997, J Obstet Gynaecol Res, V23, P445; Carles G, 2016, LANCET INFECT DIS, V16, P765, DOI 10.1016/S1473-3099(16)00130-4; Carroll I Dale, 2007, Travel Med Infect Dis, V5, P183, DOI 10.1016/j.tmaid.2006.11.002; Convers M, 2012, GYNECOL OBSTET FERTI, V40, P208, DOI 10.1016/j.gyobfe.2011.10.014; Cummings P, 2003, EPIDEMIOL REV, V25, P43, DOI 10.1093/epirev/mxg002; Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06; Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Ismail Nor Azlin Mohamed, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P681; Janjindamai Waricha, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P793; Kerdpanich Angkool, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P488; Labbe E, 2015, EUR J PUBLIC HEALTH, V25, P604, DOI 10.1093/eurpub/cku231; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lumbiganon P, 2014, BJOG-INT J OBSTET GY, V121, P32, DOI 10.1111/1471-0528.12647; Machain-Williams C, 2018, BIOMED RES INT, V2018, DOI [10.1155/2018/9643083, 10.1016/j.bjp.2018.10.005]; Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Phillips B, 2011, BJU INT, V107, P348, DOI DOI 10.1111/J.1464-410X.2011.10141.X; Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc; Restrepo Berta N, 2003, Biomedica, V23, P416; Ribeiro CF, 2012, INT J INFECT DIS, V16, pE72, DOI 10.1016/j.ijid.2011.09.005; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Tagore S, 2007, Singapore Med J, V48, pe281; Talarmin A, 1998, J CLIN MICROBIOL, V36, P1189, DOI 10.1128/JCM.36.5.1189-1192.1998; Tan PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001637; THAITHUMYANON P, 1994, CLIN INFECT DIS, V18, P248, DOI 10.1093/clinids/18.2.248; Waduge R, 2006, J CLIN VIROL, V37, P27, DOI 10.1016/j.jcv.2006.06.002; WHO, 2009, WHO TECH REP SER, V958, P1; Wiwanitkit V, 2010, J INFECT DEV COUNTR, V4, P51, DOI 10.3855/jidc.145; Woodward M., 2013, EPIDEMIOLOGY STUDY D	34	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202005	10.1371/journal.pone.0202005	http://dx.doi.org/10.1371/journal.pone.0202005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281605	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400009
J	Martin-Frances, L; Martinon-Torres, M; de Pinillos, MM; Garcia-Campos, C; Modesto-Mata, M; Zanolli, C; Rodriguez, L; de Castro, JMB				Martin-Frances, Laura; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Modesto-Mata, Mario; Zanolli, Clement; Rodriguez, Laura; Bermudez de Castro, Jose Maria			Tooth crown tissue proportions and enamel thickness in Early Pleistocene Homo antecessor molars (Atapuerca, Spain)	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRIC-ANALYSIS; DENTAL DEVELOPMENTAL PATTERN; PALEOLITHIC HUMAN REMAINS; BRIEF COMMUNICATION; MIDDLE PLEISTOCENE; MODERN HUMANS; GRAN DOLINA; ENDOSTRUCTURAL CHARACTERIZATION; MORPHOLOGICAL DESCRIPTION; HUMAN SETTLEMENT	Tooth crown tissue proportions and enamel thickness distribution are considered reliable characters for inferring taxonomic identity, phylogenetic relationships, dietary and behavioural adaptations in fossil and extant hominids. While most Pleistocene hominins display variations from thick to hyper-thick enamel, Neanderthals exhibit relatively thinner. However, the chronological and geographical origin for the appearance of this typical Neanderthal condition is still unknown. The European late Early Pleistocene species Homo antecessor (Gran Dolina-TD6 site, Sierra de Atapuerca) represents an opportunity to investigate the appearance of the thin condition in the fossil record. In this study, we aim to test the hypothesis if H. antecessor molars approximates the Neanderthal condition for tissue proportions and enamel thickness. To do so, for the first time we characterised the molar inner structural organization in this Early Pleistocene hominin taxon (n = 17) and compared it to extinct and extant populations of the genus Homo from African, Asian and European origin (n = 355). The comparative sample includes maxillary and mandibular molars belonging to H. erectus, East and North African Homo, European Middle Pleistocene Homo, Neanderthals, and fossil and extant H. sapiens. We used high-resolution images to investigate the endostructural configuration of TD6 molars (tissue proportions, enamel thickness and distribution). TD6 permanent molars tend to exhibit on average thick absolute and relative enamel in 2D and 3D estimates, both in the complete crown and the lateral enamel. This condition is shared with the majority of extinct and extant hominin sample, except for Neanderthals and some isolated specimens. However, while the total crown percentage of dentine in TD6 globally resembles the low modern values, the lateral crown percentage of dentine tends to be much higher, closer to the Neanderthal signal. Similarly, the H. antecessormolar enamel distribution maps reveal a relative distribution pattern that is more similar to the Neanderthal condition (with the thickest enamel more spread at the periphery of the occlusal basin) rather than that of other fossil specimens and modern humans (with thicker cuspal enamel). Future studies on European Middle Pleistocene populations will provide more insights into the evolutionary trajectory of the typical Neanderthal dental structural organization.	[Martin-Frances, Laura] Univ Bordeaux, CNRS, MCC, PACEA,UMR 5199, F-33615 Pessac, France; [Martin-Frances, Laura; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Modesto-Mata, Mario; Bermudez de Castro, Jose Maria] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Modesto-Mata, Mario; Bermudez de Castro, Jose Maria] UCL, Anthropol Dept, London, England; [Zanolli, Clement] Univ Toulouse III Paul Sabatier, UMR CNRS 5288, Lab AMIS, Toulouse, France; [Rodriguez, Laura] Univ Burgos, Lab Evoluc Humana, Dept Ciencias Hist & Geog, Edificio I D I, Burgos, Spain; [Rodriguez, Laura] Univ Isabel I, Fac Ciencias Salud, Burgos, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universidad de Burgos	Martin-Frances, L (corresponding author), Univ Bordeaux, CNRS, MCC, PACEA,UMR 5199, F-33615 Pessac, France.; Martin-Frances, L (corresponding author), Ctr Nacl Invest Evoluc Humana, Burgos, Spain.	lauramartinfrancesmf@gmail.com	Rodriguez, Laura/AAO-4864-2020; de Pinillos, Marina Martínez/N-7595-2019; Garcia-Campos, Cecilia/L-3757-2016; Martínez de Pinillos, Marina/D-9631-2018; Rodriguez, Laura/H-4774-2015	Rodriguez, Laura/0000-0002-5090-1582; de Pinillos, Marina Martínez/0000-0002-8035-337X; Garcia-Campos, Cecilia/0000-0002-0310-6973; Martínez de Pinillos, Marina/0000-0002-8035-337X; Rodriguez, Laura/0000-0002-5090-1582; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Martin-Frances Martin de la Fuente, Laura/0000-0001-5853-5014; Zanolli, Clement/0000-0002-5617-1613	Ministerio de Economia y Competitividad (MINECO) [CGL2015-65387-C3-3-P]; British Academy [PM160019]; French State in the frame of the "Investments for the future" Programme IdEx Bordeaux [ANR-10-IDEX-03-02]; Leakey Foundation; IdEx Post-Doctoral Research Grant; Fundacion Atapuerca; Junta de Castilla y Leon - European Social Funds through the Consejeria de Educacion [BOCYL-D-02102014-14]; Junta de Castilla y Leon - European Social Funds through the Consejeria de Educacion	Ministerio de Economia y Competitividad (MINECO); British Academy; French State in the frame of the "Investments for the future" Programme IdEx Bordeaux; Leakey Foundation; IdEx Post-Doctoral Research Grant; Fundacion Atapuerca; Junta de Castilla y Leon - European Social Funds through the Consejeria de Educacion; Junta de Castilla y Leon - European Social Funds through the Consejeria de Educacion	This study was part of the Ministerio de Economia y Competitividad (MINECO), project CGL2015-65387-C3-3-P (JMBdC). This study received financial support from the British Academy (International Partnership and Mobility Scheme PM160019), the French State in the frame of the "Investments for the future" Programme IdEx Bordeaux, reference ANR-10-IDEX-03-02 (LM-F) and the Leakey Foundation through the personal support of Gordon Getty (2013) and Dub Crook (2014-2017) (MM-T). LM-F is beneficiary of an IdEx Post-Doctoral Research Grant, MMdP is beneficiary of a Fundacion Atapuerca Post-Doctoral Research Grant. CG-C and MMdP have a predoctoral contract of the Junta de Castilla y Leon (BOCYL-D-02102014-14) co-financed by the European Social Funds through the Consejeria de Educacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge all members of the Atapuerca Research Team for their dedication and effort. To Pilar Fernandez Colon and Elena Lacasa Marquina, from the CENIEH Conservation and Restoration Laboratory for their work with the conservation of the specimens. The authors are grateful to Dr. Priscilla Bayle (PACEA Lab. Universite A de Bordeaux, France) for her valuable comments and scientific discussion that greatly improved the study and to Dr. Santos (PACEA Lab. Universite A de Bordeaux, France) for his advice and discussion for the statistic analysis. Moreover, the authors are grateful to Dr. Tanya Smith (Griffith University, Australia) for kindly providing part of the modern human data. We also acknowledge The Leakey Foundation through the personal support of Gordon Getty (2013) and Dub Crook (2014-2017) to one of the authors (MM-T). L MF is a beneficiary of IdEx Post-Doctoral Research Grant, MM-P is beneficiary of a Fundacion Atapuerca Post-Doctoral Research Grant, whereas CG and MM have Predoctoral contracts of the Junta de Castilla y Leon financed by European Social Funds through the Consejeria de Educacion. Part of this research was done at the ICTS-Cenieh and with the collaboration of CENIEH staff. Thanks to the Conservation and Restauration area for the manipulation of the TD6 sample and the Microscopy lab for the mCT.	Arnaud J, 2016, QUATERN INT, V425, P437, DOI 10.1016/j.quaint.2016.09.009; Arnold LJ, 2015, QUATERN INT, V389, P167, DOI 10.1016/j.quaint.2014.08.010; Arsuaga JL, 1999, NATURE, V399, P255, DOI 10.1038/20430; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bayle P., 2017, PEOPLE PALOMAS NEAND, P115; Bayle P, SPY CAVE 125 YEARS M; Bayle P, 2009, AM J PHYS ANTHROPOL, V138, P493, DOI 10.1002/ajpa.21000; Bayle P, 2009, J HUM EVOL, V56, P66, DOI 10.1016/j.jhevol.2008.09.002; Been E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03025-z; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P305, DOI 10.1002/ajpa.22421; Benazzi S, 2013, AM J PHYS ANTHROPOL, V152, P300, DOI 10.1002/ajpa.22355; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; de Castro JMB, 2017, EVOL ANTHROPOL, V26, P157, DOI 10.1002/evan.21540; de Castro JMB, 2016, QUATERNARY SCI REV, V153, P51, DOI 10.1016/j.quascirev.2016.10.010; de Castro JMB, 2012, AM J PHYS ANTHROPOL, V147, P604, DOI 10.1002/ajpa.22020; Bermudez-de-Castro JM, 2017, QUATERN INT, V433, P22, DOI 10.1016/j.quaint.2015.03.049; Buti L, 2017, J HUM EVOL, V113, P162, DOI 10.1016/j.jhevol.2017.08.009; Carbonell E, 1999, J HUM EVOL, V37, P313, DOI 10.1006/jhev.1999.0282; Carretero JM, 1999, J HUM EVOL, V37, P459, DOI 10.1006/jhev.1999.0342; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; de Castro JMB, 1999, J HUM EVOL, V37, P523, DOI 10.1006/jhev.1999.0323; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; deCastro JMB, 1997, SCIENCE, V276, P1392; Duval M, 2018, QUAT GEOCHRONOL, V47, P120, DOI 10.1016/j.quageo.2018.05.001; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; Gomez-Robles A, 2015, J HUM EVOL, V82, P34, DOI 10.1016/j.jhevol.2015.02.013; Gomez-Robles A, 2013, P NATL ACAD SCI USA, V110, P18196, DOI 10.1073/pnas.1302653110; Gomez-Robles A, 2012, J HUM EVOL, V63, P512, DOI 10.1016/j.jhevol.2012.06.002; Gomez-Robles A, 2011, J HUM EVOL, V61, P688, DOI 10.1016/j.jhevol.2011.09.004; Grine FE, 2005, AM J PHYS ANTHROPOL, V126, P14, DOI 10.1002/ajpa.10277; Grine FE, 2002, S AFR J SCI, V98, P503; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Le Luyer M, 2015, REDUCTION DENTS HUMA; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; Macchiarelli R., 2013, ANTHR PERSPECTIVES T, P250, DOI DOI 10.1017/CBO9780511984464.011; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Margherita C, 2017, J HUM EVOL, V113, P83, DOI 10.1016/j.jhevol.2017.07.011; Margherita C, 2016, J HUM EVOL, V93, P120, DOI 10.1016/j.jhevol.2016.01.007; Castro JMB, 2013, QUATERNARY SCI REV, V76, P53, DOI 10.1016/j.quascirev.2013.06.023; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin LB, 1983, RELATIONSHIPS LATE M; Martinez de Pinillos M., 2017, THESIS; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2014, CR PALEVOL, V13, P223, DOI 10.1016/j.crpv.2013.12.002; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Maureille B, 2001, PALEO, V13, P183, DOI DOI 10.4000/PALEO.1043; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak AJ, 2005, S AFR J SCI, V101, P219; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Pablos A, 2017, QUATERN INT, V433, P103, DOI 10.1016/j.quaint.2015.08.044; Pablos A, 2012, J HUM EVOL, V63, P610, DOI 10.1016/j.jhevol.2012.06.008; Pares JM, 2013, J ARCHAEOL SCI, V40, P4586, DOI 10.1016/j.jas.2013.06.013; Scolan HF, 2012, B MEMOIRES SOC ANTHR, V24; Skinner MM, 2016, J HUM EVOL, V93, P63, DOI 10.1016/j.jhevol.2016.01.010; Skinner MM, 2015, J HUM EVOL, V85, P35, DOI 10.1016/j.jhevol.2015.03.012; Skinner MM, 2010, AM J PHYS ANTHROPOL, V142, P157, DOI 10.1002/ajpa.21248; Smith TM, 2006, ARCH ORAL BIOL, V51, P974, DOI 10.1016/j.archoralbio.2006.04.012; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2008, AM J PHYS ANTHROPOL, V136, P237, DOI 10.1002/ajpa.20796; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith Tanya M., 2009, Paleoanthropology, V2009, P117; Suwa G, 2005, ANTHROPOL SCI, V113, P273, DOI 10.1537/ase.050118; Toussaint M, 2010, J HUM EVOL, V58, P56, DOI 10.1016/j.jhevol.2009.09.006; Vialet A, 2010, CR PALEVOL, V9, P331, DOI 10.1016/j.crpv.2010.07.017; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Xing S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114265; Zanolli C, PLOSONE; Zanolli C, 2018, J HUM EVOL, V116, P1, DOI 10.1016/j.jhevol.2017.11.002; Zanolli C, 2017, CR PALEVOL, V16, P702, DOI 10.1016/j.crpv.2017.05.002; Zanolli C, 2015, AM J PHYS ANTHROPOL, V157, P666, DOI 10.1002/ajpa.22748; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004	80	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203334	10.1371/journal.pone.0203334	http://dx.doi.org/10.1371/journal.pone.0203334			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281589	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400019
J	Bottino, FD; Gardinali, NR; Salvador, SBS; Figueiredo, AS; Cysne, LB; Francisco, JS; de Oliveira, JM; Machado, MP; Pinto, MA				Bottino, Fernanda de Oliveira; Gardinali, Noemi Rovaris; Salamene Salvador, Sarah Beatrizv; Figueiredo, Andreza Soriano; Cysne, Lynn Barwick; Francisco, Juliane Siqueira; de Oliveira, Jaqueline Mendes; Machado, Marcelo Pelajo; Pinto, Marcelo Alves			Cynomolgus monkeys (Macaca fascicularis) experimentally and naturally infected with hepatitis E virus: The bone marrow as a possible new viral target	PLOS ONE			English	Article							KIDNEY-TRANSPLANT RECIPIENTS; STEM-CELL TRANSPLANTATION; APLASTIC-ANEMIA; TACROLIMUS; TRANSMISSION; GENOTYPE; CAMELS; DONOR; JAPAN; RISK	Hepatitis E virus (HEV) transmission through infected blood and blood products has already been described. However, little is known about the bone marrow (BM) as source of HEV infection. Our study aimed to investigate the presence of HEV antigen (Ag) and histological changes in BM of cynomolgus monkeys (Macaca fascicularis) experimentally and naturally infected with HEV. Four cynomolgus monkeys with acute, and two with chronic hepatitis E - after immunosuppressive therapy with tacrolimus - were compared with one colony-bred animal naturally infected. Both, natural and experimental infections were characterized by anti-HEV IgG seroconversion detected by ELISA, and viral RNA isolation confirmed by RT-qPCR and qualitative nested RT-PCR. BM biopsies were collected from all animals, submitted to histology and indirect immunofluorescence techniques and observed, respectively, by light and confocal microscopy. The HEV Ag-fluorescent-labeled cells were detected from BM biopsies obtained from three monkeys with acute and one with chronic hepatitis E, and also from the naturally infected monkey. In the experimentally infected animals with acute hepatitis, HEV Ag detection occurred at 160 days post-infection, even after viral clearance in serum, feces, and liver. Double-stranded RNA, a replicative marker, was detected in BM cells from both acute and chronically infected animals. Major histological findings included vacuolization in mononuclear and endosteal cells, an absence of organized inflammatory infiltrates, and also some fields suggesting displasic focal BM disease. These findings support the hypothesis of BM cells as secondary target sites of HEV persistence. Further experimental studies should be carried out to confirm the assumption of HEV transmission through BM transplantation.	[Bottino, Fernanda de Oliveira; Gardinali, Noemi Rovaris; Salamene Salvador, Sarah Beatrizv; Figueiredo, Andreza Soriano; de Oliveira, Jaqueline Mendes; Pinto, Marcelo Alves] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Technol Dev Virol, Rio De Janeiro, Brazil; [Cysne, Lynn Barwick] Fundacao Oswaldo Cruz, Inst Sci & Technol Biomodels, Rio De Janeiro, Brazil; [Francisco, Juliane Siqueira; Machado, Marcelo Pelajo] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Pathol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Bottino, FD; Pinto, MA (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Technol Dev Virol, Rio De Janeiro, Brazil.	fernanda_bottino4@hotmail.com; marcelop@ioc.fiocruz.br	Pinto, Marcelo Alves/ABA-3312-2020; Machado, Marcelo Pelajo/I-5359-2012; Figueiredo, Andreza/O-3096-2019; Pinto, Marcelo/G-7503-2012	Figueiredo, Andreza/0000-0002-4222-223X; Pinto, Marcelo/0000-0003-3462-7277; de Oliveira, Jaqueline/0000-0002-6759-4574; de Oliveira Bottino, Fernanda/0000-0002-6682-9845	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302367/2014-4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grants awarded to MAP (302367/2014-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2001, J INFECT DIS, V184, P1380, DOI 10.1086/324376; [Anonymous], HEP E; da Silva SGC, 2016, TRANSFUS MED HEMOTH, V43, P137, DOI 10.1159/000441910; Dalton HR, 2018, COLD SPRING HARB PER; Danesi R, 2004, TRANSPL P, V36, P703, DOI 10.1016/j.transproceed.2004.03.016; de Carvalho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-495; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duarte D, 2018, CELL STEM CELL, V22, P64, DOI 10.1016/j.stem.2017.11.006; Frange P, 2015, J INFECTION, V71, P141, DOI 10.1016/j.jinf.2015.02.008; Galan-Diez Marta, 2017, Curr Mol Biol Rep, V3, P53, DOI 10.1007/s40610-017-0055-9; Gardinali NR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174070; Griffin SP, 2016, PROG TRANSPLANT, V26, P314, DOI 10.1177/1526924816667950; Halac U, 2012, J PEDIATR-US, V160, P871, DOI 10.1016/j.jpeds.2012.01.028; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Jaber M, 2014, BONE MARROW TRANSPL, V49, P857, DOI 10.1038/bmt.2014.27; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kamar N, 2008, N ENGL J MED; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kannegieter NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170806; Kannegieter NM, 2016, THER DRUG MONIT, V38, P280, DOI 10.1097/FTD.0000000000000264; Kawatani T, 2001, EUR J HAEMATOL, V67, P45, DOI 10.1034/j.1600-0609.2001.067001045.x; Kinugasa F, 2008, J PHARMACOL SCI, V108, P529, DOI 10.1254/jphs.08142FP; Koenecke C, 2014, BONE MARROW TRANSPL, V49, P159, DOI 10.1038/bmt.2013.148; le Coutre P, 2009, GUT, V58, P699, DOI 10.1136/gut.2008.165571; Matthews KA, 2015, COMPARATIVE MED, V65, P352; Mayer P., 1903, Z WISSENSCHAFTLICHE, V20; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Mirazo S, 2014, HEPATIC MED-EVID RES, V6, P45, DOI 10.2147/HMER.S63417; O'Donghaile D, 2017, BONE MARROW TRANSPL, V52, P1471, DOI 10.1038/bmt.2017.163; Pischke S, 2016, J HEPATOL; Pischke S, 2016, CLIN INFECT DIS, V63, P569, DOI 10.1093/cid/ciw309; Purdy MA, 2017, J GEN VIROL, V98, P2645, DOI 10.1099/jgv.0.000940; Rauff B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-87; Rivero-Juarez A, 2017, CLIN INFECT DIS, V64, P964, DOI 10.1093/cid/cix004; Safadi R, 2001, BONE MARROW TRANSPL, V27, P183, DOI 10.1038/sj.bmt.1702749; Shah SAR, 2012, J CLIN VIROL, V54, P96, DOI 10.1016/j.jcv.2012.02.002; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Takahashi M, 2014, VIRUS RES, V180, P59, DOI 10.1016/j.virusres.2013.12.014; Tatapudi VS, 2018, CASE REP NEPHROL DIA, V8, P10, DOI 10.1159/000486158; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Versluis J, 2013, BLOOD, V122, P1079, DOI 10.1182/blood-2013-03-492363; Wang YJ, 2014, GASTROENTEROLOGY, V146, P1775, DOI 10.1053/j.gastro.2014.02.036; Weiler-Normann C, 2018, Z GASTROENTEROL, V56, P51, DOI 10.1055/s-0043-121737; Woo PCY, 2016, EMERG INFECT DIS, V22, P2219, DOI 10.3201/eid2212.160979; Woo PCY, 2014, EMERG INFECT DIS, V20, P1044, DOI 10.3201/eid2006.140140; Woolson KL, 2014, ALIMENT PHARM THER, V40, P1282, DOI 10.1111/apt.12986; Yamamoto H, 2012, EMERG INFECT DIS, V18, P2032, DOI 10.3201/eid1812.120884; Zylberman M, MEDICINA B AIRES, V75, P175	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205039	10.1371/journal.pone.0205039	http://dx.doi.org/10.1371/journal.pone.0205039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278075	Green Submitted, Green Published, gold			2022-12-27	WOS:000446010200035
J	In, HJ; Lim, H; Lee, JA; Lee, SR; Jin, YB; Jeong, KJ; Hyeon, JY; Yoo, JS; Lee, JW; Choi, YK; Lee, SW				In, Hyun Ju; Lim, Heeji; Lee, Jung-Ah; Lee, Sang-Rae; Jin, Yeung Bae; Jeong, Kang-Jin; Hyeon, Ji-Yeon; Yoo, Jung Sik; Lee, June-Woo; Choi, Young Ki; Lee, Sang-Won			Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; POLIO ERADICATION; NEWBORN MICE; DOUBLE-BLIND; PHASE-I; VACCINE; INFECTION; SAFETY; IMMUNOGENICITY; TAIWAN	Enterovirus 71 (EV71) is a major etiological agent of various public health issues, particularly in the Asia-Pacific region. EV71 causes hand-foot-and-mouth disease (HFMD) and is associated with serious neurological disorders in young children. A formalin-inactivated EV71 candidate vaccine (KCDC-HFMDV1-EV71) based on the C4 subgenotype was previously developed and confirmed to be a potential candidate vaccine for prevention of EV71 infection in mice. In this study, an inactivated EV71 vaccine was used for analysis of long-term immunogenicity and efficacy in cynomolgus monkeys, a common nonhuman primate model. The vaccine was immunized three times at 0, 4, and 8 weeks with either 20-mu g doses of EV71 candidate vaccine formulated with aluminum hydroxide gel adjuvant or phosphate-buffered saline as a control. The group immunized with the inactivated EV71 showed significantly increased EV71-specific antibody and serum neutralizing antibody titers at 3 weeks after vaccination and maintained these elevated titers until the end of the experiment (54 weeks after vaccination). The sera from vaccinated cynomolgus monkeys showed a crossreactive neutralizing antibody response to the heterologous subtype of EV71 (B1-4, C1, and C2). These findings suggest that the inactivated EV71 candidate vaccine may be a potential vaccine candidate and valuable tool for the control of HFMD.	[In, Hyun Ju; Lim, Heeji; Lee, Jung-Ah; Hyeon, Ji-Yeon; Yoo, Jung Sik; Lee, June-Woo; Lee, Sang-Won] Ctr Dis Control & Prevent, Natl Res Inst Hlth, Div Vaccine Res, Cheongju, Chungcheongbuk, South Korea; [In, Hyun Ju; Lim, Heeji; Choi, Young Ki] Chungbuk Natl Univ, Coll Med & Med Res Inst, Cheongju, Chungcheongbuk, South Korea; [Lee, Sang-Rae; Jin, Yeung Bae; Jeong, Kang-Jin] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongju, Chungcheongbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, SW (corresponding author), Ctr Dis Control & Prevent, Natl Res Inst Hlth, Div Vaccine Res, Cheongju, Chungcheongbuk, South Korea.	epilsw@korea.kr	IN, HYUN JU/A-5623-2017	IN, HYUN JU/0000-0002-7783-4877	Korea National Institute of Health [NIH4800-4859-300]	Korea National Institute of Health	This study was supported by grant from the Korea National Institute of Health (Grant no. NIH4800-4859-300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Cheng A, 2013, VACCINE, V31, P2471, DOI 10.1016/j.vaccine.2013.03.015; Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chung CY, 2010, VACCINE, V28, P6951, DOI 10.1016/j.vaccine.2010.08.052; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Diamanti E, 1998, VACCINE, V16, P940, DOI 10.1016/S0264-410X(98)80025-X; Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; In HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178259; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Lim PY, 2015, VACCINE, V33, P6017, DOI 10.1016/j.vaccine.2015.05.108; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin YL, 2012, VACCINE, V30, P1305, DOI 10.1016/j.vaccine.2011.12.081; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; Liu CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106756; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Wagner BG, 2008, B MATH BIOL, V70, P253, DOI 10.1007/s11538-007-9255-4; Wang YF, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-31; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Zhang YJ, 2015, CURR CHIN ECON REPOR, P33, DOI 10.1007/978-3-662-46205-8_2; Zhou XB, 2013, HUM VACC IMMUNOTHER, V9, P1430, DOI 10.4161/hv.24395; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0202552	10.1371/journal.pone.0202552	http://dx.doi.org/10.1371/journal.pone.0202552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278051	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200003
J	Ford, K; Latic, N; Slavic, S; Zeitz, U; Dolezal, M; Andrukhov, O; Erben, RG; Andrukhova, O				Ford, Kristopher; Latic, Nejla; Slavic, Svetlana; Zeitz, Ute; Dolezal, Marlies; Andrukhov, Oleh; Erben, Reinhold G.; Andrukhova, Olena			Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; PARATHYROID-HORMONE LEVELS; D-RECEPTOR; PRIMARY HYPERPARATHYROIDISM; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; D SUPPLEMENTATION; D DEFICIENCY; ARTERIAL STIFFNESS; CONTROLLED-TRIAL	Epidemiological studies have linked vitamin D deficiency to an increased incidence of myocardial infarction and support a role for vitamin D signalling in the pathophysiology of myocardial infarction. Vitamin D deficiency results in the development of secondary hyperparathyroidism, however, the role of secondary hyperparathyroidism in the pathophysiology of myocardial infarction is not known. Here, we aimed to explore further the secondary hyperparathyroidism independent role of vitamin D signalling in the pathophysiology of myocardial infarction by inducing experimental myocardial infarction in 3-month-old, male, wild-type mice and in mice lacking a functioning vitamin D receptor. In order to prevent secondary hyperparathyroidism in vitamin D receptor mutant mice, all mice were maintained on a rescue diet enriched with calcium, phosphorus, and lactose. Surprisingly, survival rate, cardiac function as measured by echocardiography and intra-cardiac catheterisation and cardiomyocyte size were indistinguishable between normocalcaemic vitamin D receptor mutant mice and wild-type controls, 2 and 8 weeks post-myocardial infarction. In addition, the myocardial infarction-induced inflammatory response was similar in vitamin D receptor mutants and wild-type mice, as evidenced by a comparable upregulation in cardiac interleukin-1-beta and tumor-necrosis-factor-alpha mRNA abundance and similar elevations in circulating interleukin-1-beta and tumor-necrosis-factor-alpha. Our data suggest that the lack of vitamin D signalling in normocalcaemic vitamin D receptor mutants has no major detrimental effect on cardiac function and outcome post-myocardial infarction. Our study may have important clinical implications because it suggests that the secondary hyperparathyroidism induced by vitamin D deficiency, rather than the lack of vitamin D signalling per se, may negatively impact cardiac function post-myocardial infarction.	[Ford, Kristopher; Latic, Nejla; Slavic, Svetlana; Zeitz, Ute; Dolezal, Marlies; Erben, Reinhold G.; Andrukhova, Olena] Univ Vet Med Vienna, Dept Biomed Sci, Vienna, Austria; [Andrukhov, Oleh] Med Univ Vienna, Sch Dent, Div Conservat Dent & Periodontol, Vienna, Austria	University of Veterinary Medicine Vienna; Medical University of Vienna	Erben, RG (corresponding author), Univ Vet Med Vienna, Dept Biomed Sci, Vienna, Austria.	Reinhold.Erben@vetmeduni.ac.at	Andrukhov, Oleh/H-9851-2018; Erben, Reinhold/AAG-8007-2020	Andrukhov, Oleh/0000-0002-0485-2142; Erben, Reinhold/0000-0003-0801-6958; Latic, Nejla/0000-0001-5635-5175	Austrian Science Fund [FWF P 26534-B13]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Fund (FWF P 26534-B13) to Olena Andrukhova.	Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; Almqvist EG, 2002, SURGERY, V132, P1126, DOI 10.1067/msy.2002.128692; AMANN K, 1994, J AM SOC NEPHROL, V4, P1814; AMANN K, 1995, NEPHROL DIAL TRANSPL, V10, P2043; Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252; [Anonymous], 2017, R LANG ENV STAT COMP; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Azizieh F, 2016, J INFLAMM RES, V9, P51, DOI 10.2147/JIR.S103298; Bae S, 2013, J APPL PHYSIOL, V114, P979, DOI 10.1152/japplphysiol.01506.2012; Bikdeli B, 2012, CIRC-CARDIOVASC QUAL, V5, P580, DOI 10.1161/CIRCOUTCOMES.111.964072; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; BOGIN E, 1981, J CLIN INVEST, V67, P1215, DOI 10.1172/JCI110137; BOGIN E, 1982, MINER ELECTROL METAB, V7, P151; Bouillon Roger, 2014, Bonekey Rep, V3, P480, DOI 10.1038/bonekey.2013.214; Calton EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141770; Cannell JJ, 2014, DERM-ENDOCRINOL, V6, DOI 10.4161/19381980.2014.983401; Carroll WW, 2016, INT FORUM ALLERGY RH, V6, P605, DOI 10.1002/alr.21704; Chen S, 2008, HYPERTENSION, V52, P1106, DOI 10.1161/HYPERTENSIONAHA.108.119602; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; CRAN, 2015, VIS PAIR COMP; CRAN, 2017, LEAST SQUAR MEANS VE; Dadabhai AS, 2017, WORLD J HEPATOL, V9, P278, DOI 10.4254/wjh.v9.i5.278; DOMINICZAK AF, 1990, CLIN SCI, V78, P127, DOI 10.1042/cs0780127; Erben RG, 2002, MOL ENDOCRINOL, V16, P1524, DOI 10.1210/me.16.7.1524; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Gardner DG, 2013, AM J PHYSIOL-REG I, V305, pR969, DOI 10.1152/ajpregu.00322.2013; GUILLEN I, 1995, AM J PHYSIOL-REG I, V269, pR229, DOI 10.1152/ajpregu.1995.269.2.R229; Gunta SS, 2013, NAT REV NEPHROL, V9, P337, DOI 10.1038/nrneph.2013.74; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Kamycheva E, 2004, EUR J CARDIOV PREV R, V11, P69, DOI 10.1097/01.hjr.0000114706.27531.01; Kendrick J, 2011, ADV CHRONIC KIDNEY D, V18, P113, DOI 10.1053/j.ackd.2010.12.003; Khalili H, 2012, CLIN RES CARDIOL, V101, P321, DOI 10.1007/s00392-011-0394-0; LAFFERTY FW, 1981, ARCH INTERN MED, V141, P1761, DOI 10.1001/archinte.141.13.1761; Lee JH, 2011, AM J CARDIOL, V107, P1636, DOI 10.1016/j.amjcard.2011.01.048; LEMIRE JM, 1995, J STEROID BIOCHEM, V53, P599, DOI 10.1016/0960-0760(95)00106-A; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Manousaki D, 2016, CIRC-CARDIOVASC GENE, V9, P349, DOI 10.1161/CIRCGENETICS.116.001396; MCCARTHY DM, 1984, LANCET, V1, P78; Meems LMG, 2012, J STEROID BIOCHEM, V132, P282, DOI 10.1016/j.jsbmb.2012.06.004; Milazzo V, 2017, WORLD J CARDIOL, V9, P14, DOI 10.4330/wjc.v9.i1.14; Nappi S, 2000, CARDIOLOGY, V93, P229, DOI 10.1159/000007031; Ni W, 2014, HYPERTENSION, V64, DOI 10.1161/HYPERTENSIONAHA.114.03971; Nuzzo V, 2002, EUR J ENDOCRINOL, V147, P453, DOI 10.1530/eje.0.1470453; Oliveira Gustavo B F, 2015, Front Cardiovasc Med, V2, P32, DOI 10.3389/fcvm.2015.00032; Park CW, 1999, AM J KIDNEY DIS, V33, P73, DOI 10.1016/S0272-6386(99)70260-X; Piovesan A, 1999, CLIN ENDOCRINOL, V50, P321, DOI 10.1046/j.1365-2265.1999.00651.x; Saleh FN, 2003, EUR HEART J, V24, P2054, DOI 10.1016/j.ehj.2003.09.010; Sandmann S, 2006, BLOOD PRESSURE, V15, P116, DOI 10.1080/08037050600586593; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098; Simpson RU, 2011, CIRCULATION, V124, P1808, DOI 10.1161/CIRCULATIONAHA.111.061234; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; STEFENELLI T, 1990, AM HEART J, V120, P590, DOI 10.1016/0002-8703(90)90016-Q; Stefenelli T, 1997, J CLIN ENDOCR METAB, V82, P106, DOI 10.1210/jc.82.1.106; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tishkoff DX, 2008, ENDOCRINOLOGY, V149, P558, DOI 10.1210/en.2007-0805; Turner NA, 2007, CARDIOVASC RES, V76, P81, DOI 10.1016/j.cardiores.2007.06.003; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; van Ballegooijen AJ, 2013, AM HEART J, V165, P655, DOI 10.1016/j.ahj.2013.02.014; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Willett AM, 2005, P NUTR SOC, V64, P193, DOI 10.1079/PNS2005420; Witham MD, 2013, INT J CARDIOL, V167, P745, DOI 10.1016/j.ijcard.2012.03.054; YANG SL, 1993, ARCH BIOCHEM BIOPHYS, V303, P98, DOI 10.1006/abbi.1993.1260; Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898	68	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204803	10.1371/journal.pone.0204803	http://dx.doi.org/10.1371/journal.pone.0204803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273386	Green Submitted, gold, Green Published			2022-12-27	WOS:000446124700036
J	Ding, ZF; Jin, M; Ren, Q				Ding, Zhengfeng; Jin, Min; Ren, Qian			Transcriptome analysis of Macrobrachium rosenbergii intestines under the white spot syndrome virus and poly (I:C) challenges	PLOS ONE			English	Article							RNA-SEQ; WSSV; SPLICEOSOME; TOOL	Intestine is a primary site of the white spot syndrome virus (WSSV) infection in most crustaceans. To date, little is known about its role in the anti-viral immune response in the freshwater prawn Macrobrachium rosenbergii. In this study, next-generation sequencing was employed to investigate the M. rosenbergii intestine transcriptomes following WSSV or poly I:C challenges. A total of 41.06 M, 39.58 M and 47.00 M clean reads were generated and assembled into 65,340, 71,241 and 70,614 transcripts from the negative control group (NG), WSSV challenge group (WG) and poly I:C treatment group (PG) respectively. Based on homology searches, functional annotation with 7 databases (NR, NT, GO, COG, KEGG, Swissprot and Interpro) for 88,412 transcripts was performed. After WSSV or poly (I:C) challenge, the numbers of up-regulated differentially expressed genes (DEGs) were greater than the down-regulated DEGs. Gene Ontology (GO) classification of the DEGs also distributed similarly, with the same top 10 annotations and were all assigned to the signaling pathways, including spliceosome, Rap1 signaling pathway, proteoglycans, PI3K-Akt signaling pathway, ECM receptor interaction. Results could contribute to a better understanding of the intestinal immune response to viral pathogens.	[Ding, Zhengfeng] Jiangsu Second Normal Univ, Coll Life Sci & Chem, Inst Aquat Biol, Nanjing, Jiangsu, Peoples R China; [Ding, Zhengfeng] Jiangsu Second Normal Univ, Coll Life Sci & Chem, Jiangsu Key Lab Biofunct Mol, Nanjing, Jiangsu, Peoples R China; [Jin, Min] SOA, State Key Lab Breeding Base Marine Genet Resource, Inst Oceanog 3, Xiamen, Peoples R China; [Ren, Qian] Coinnovat Ctr Marine Bioind Technol Jiangsu Prov, Lianyungang, Peoples R China; [Ren, Qian] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Aquat Crustacean Dis, Nanjing, Jiangsu, Peoples R China	Jiangsu Second Normal University; Jiangsu Second Normal University; State Oceanic Administration; Nanjing Normal University	Ren, Q (corresponding author), Coinnovat Ctr Marine Bioind Technol Jiangsu Prov, Lianyungang, Peoples R China.; Ren, Q (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Aquat Crustacean Dis, Nanjing, Jiangsu, Peoples R China.	renqian0402@126.com			Natural Sciences Foundation of Jiangsu Province [BK20171406]; Natural Science Fund of Colleges and Universities in Jiangsu Province [16KJA180005, 16KJB180006]; innovation of agricultural science [CX (17) 2008]; project for aquaculture of Jiangsu Province [Y2016-29, Y2017-28]; China Scholarship Council	Natural Sciences Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Fund of Colleges and Universities in Jiangsu Province; innovation of agricultural science; project for aquaculture of Jiangsu Province; China Scholarship Council(China Scholarship Council)	This work was supported by grants from Natural Sciences Foundation of Jiangsu Province (BK20171406), Natural Science Fund of Colleges and Universities in Jiangsu Province (16KJA180005, 16KJB180006), innovation of agricultural science (CX (17) 2008), project for aquaculture of Jiangsu Province (Y2016-29, Y2017-28) and China Scholarship Council (2018).	Baranski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085413; Bonami JR, 2011, J INVERTEBR PATHOL, V106, P131, DOI 10.1016/j.jip.2010.09.007; Cao J, 2017, FISH SHELLFISH IMMUN, V67, P27, DOI 10.1016/j.fsi.2017.05.059; Citarasu T, 2010, AQUACULT INT, V18, P403, DOI 10.1007/s10499-009-9253-7; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding ZF, 2017, AQUAC RES, V48, P2528, DOI 10.1111/are.13089; Ding ZF, 2015, J VIROL METHODS, V220, P49, DOI 10.1016/j.jviromet.2015.04.011; Du Z., 2016, SCI REP, V6; Du ZQ, 2017, GENET MOL BIOL, V40, P168, DOI [10.1590/1678-4685-GMB-2016-0133, 10.1590/1678-4685-gmb-2016-0133]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green TJ, 2013, FISH SHELLFISH IMMUN, V35, P382, DOI 10.1016/j.fsi.2013.04.051; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049711; Li M, 2014, DEV COMP IMMUNOL, V46, P231, DOI 10.1016/j.dci.2014.04.014; Li ZP, 2016, J VIROL, V90, P842, DOI 10.1128/JVI.02357-15; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oidtmann B, 2011, TRANSBOUND EMERG DIS, V58, P469, DOI 10.1111/j.1865-1682.2011.01231.x; Rao R, 2016, J INVERTEBR PATHOL, V136, P10, DOI 10.1016/j.jip.2016.01.002; Santos CA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00298; Shen HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110548; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Verma AK, 2017, FISH SHELLFISH IMMUN, V67, P141, DOI 10.1016/j.fsi.2017.06.007; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wu JL, 2001, DIS AQUAT ORGAN, V47, P129, DOI 10.3354/dao047129; Yang L, 2007, MOL CELL, V27, P861, DOI 10.1016/j.molcel.2007.09.003; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087218; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047038; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	31	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204626	10.1371/journal.pone.0204626	http://dx.doi.org/10.1371/journal.pone.0204626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265693	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500041
J	Price, CA; Green-Thompson, L; Mammen, VG; Madhim, SA; Lala, SG; Dangor, Z				Price, Caris A.; Green-Thompson, Lionel; Mammen, Vijay G.; Madhim, Shabir A.; Lala, Sanjay G.; Dangor, Ziyaad			Knowledge gaps among South African healthcare providers regarding the prevention of neonatal group B streptococcal disease	PLOS ONE			English	Article							UNITED-STATES; SEPSIS; METAANALYSES; GUIDELINES; MORTALITY; VACCINE; INFANTS	Objective To evaluate obstetric healthcare provider knowledge regarding the prevention of group B streptococcal disease in South African infants. Methods Questionnaires exploring knowledge, attitudes and beliefs around group B streptococcal prevention were administered to consenting doctors and maternity nurses in a tertiary academic hospital. Qualitative assessments (focus groups) were undertaken with junior doctors and nurses. Results 238 participants completed the questionnaire: 150 (63.0%) doctors and 88 (37.0%) nurses. Overall, 22.7% of participants correctly identified the risk-based prevention protocol recommended at this hospital. Most doctors (68.0%) and nurses (94.3%) could not correctly list a single risk factor. A third of doctors did not know the correct antibiotic protocols, and most (80.0%) did not know the recommended timing of antibiotics in relation to delivery. Focus group discussions highlighted the lack of knowledge, awareness and effective implementation of protocols regarding disease prevention. Conclusions Our study highlighted knowledge gaps on the risk-based prevention strategy in a setting which has consistently reported among the highest incidence of invasive group B streptococcal disease globally. In these settings, education and prioritization of the risk-based intrapartum antibiotic strategy is warranted, but an alternative vaccine-based strategy may prove more effective in preventing invasive group B streptococcal disease in the long-term.	[Price, Caris A.; Mammen, Vijay G.; Lala, Sanjay G.; Dangor, Ziyaad] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa; [Green-Thompson, Lionel] Univ Witwatersrand, Fac Hlth Sci, Off Teaching & Learning, Johannesburg, South Africa; [Madhim, Shabir A.; Dangor, Ziyaad] Univ Witwatersrand, Fac Hlth Sci, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa; [Madhim, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis Res Chair, Johannesburg, South Africa; [Lala, Sanjay G.] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Price, CA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa.	caris.ronan@outlook.com		Dangor, Ziyaad/0000-0003-4089-147X				Bianchi-Jassir F, 2017, CLIN INFECT DIS, V65, pS133, DOI 10.1093/cid/cix661; Buchmann EJ, 2015, BJOG-INT J OBSTET GY, V122, P220, DOI 10.1111/1471-0528.13064; Cutland CL, 2012, PEDIATRICS, V130, pE581, DOI 10.1542/peds.2011-1548; Dangor Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169101; Dangor Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123014; Darlow BA, 2016, AUST NZ J OBSTET GYN, V56, P69, DOI 10.1111/ajo.12378; [Department of Economic Development Department of Economic Development], 2012, 5 YEAR SOW EC DEV PL; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Heath PT, 2009, ARCH DIS CHILD, V94, P674, DOI 10.1136/adc.2008.148874; Kim SY, 2014, VACCINE, V32, P1954, DOI 10.1016/j.vaccine.2014.01.062; Kwatra G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098778; Le Doare K, 2017, CLIN INFECT DIS, V65, pS143, DOI 10.1093/cid/cix654; Madhi SA, 2017, VACCINE, V35, P4457, DOI 10.1016/j.vaccine.2017.02.025; Madrid L, 2017, CLIN INFECT DIS, V65, pS160, DOI 10.1093/cid/cix656; Motsohi T, 2015, POVERTY INEQUALITY B; Oster G, 2014, VACCINE, V32, P4778, DOI 10.1016/j.vaccine.2014.06.003; Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Seale AC, 2017, CLIN INFECT DIS, V65, pS125, DOI 10.1093/cid/cix585; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Vergnano S, 2010, ARCH DIS CHILD-FETAL, V95, pF72, DOI 10.1136/adc.2009.160333; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205157	10.1371/journal.pone.0205157	http://dx.doi.org/10.1371/journal.pone.0205157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289900	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500053
J	Ashrafzadeh, MR; Djan, M; Szendrei, L; Paulauskas, A; Scandura, M; Bagi, Z; Ilie, DE; Kerdikoshvili, N; Marek, P; Soos, N; Kusza, S				Ashrafzadeh, Mohammad Reza; Djan, Mihajla; Szendrei, Laszlo; Paulauskas, Algimantas; Scandura, Massimo; Bagi, Zoltan; Ilie, Daniela Elena; Kerdikoshvili, Nikoloz; Marek, Panek; Soos, Noemi; Kusza, Szilvia			Large-scale mitochondrial DNA analysis reveals new light on the phylogeography of Central and Eastern-European Brown hare (Lepus europaeus Pallas, 1778)	PLOS ONE			English	Article							POSTGLACIAL RANGE EXPANSION; EVOLUTIONARY RELATIONSHIPS; GENETIC DIFFERENTIATION; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; VOJVODINA SERBIA; INTROGRESSION; TIMIDUS; MTDNA; COLONIZATION	European brown hare, Lepus europaeus, from Central and Eastern European countries (Hungary, Poland, Serbia, Lithuania, Romania, Georgia and Italy) were sampled, and phylogenetic analyses were carried out on two datasets: 1.) 137 sequences (358 bp) of control region mtDNA; and 2.) 105 sequences of a concatenated fragment (916 bp), including the cytochrome b, tRNA-Thr, tRNA-Pro and control region mitochondrial DNA. Our sequences were aligned with additional brown hare sequences from GenBank. A total of 52 and 51 haplotypes were detected within the two datasets, respectively, and assigned to two previously described major lineages: Anatolian/Middle Eastern (AME) and European (EUR). Furthermore, the European lineage was divided into two subclades including South Eastern European (SEE) and Central European (CE). Sympatric distribution of the lineages of the brown hare in South-Eastern and Eastern Europe revealed contact zones there. BAPS analysis assigned sequences from L. europaeus to five genetic clusters, whereas CE individuals were assigned to only one cluster, and AME and SEE sequences were each assigned to two clusters. Our findings uncover numerous novel haplotypes of Anatolian/Middle Eastern brown hare outside their main range, as evidence for the combined influence of Late Pleistocene climatic fluctuations and anthropogenic activities in shaping the phylogeographic structure of the species. Our results support the hypothesis of a postglacial brown hare expansion from Anatolia and the Balkan Peninsula to Central and Eastern Europe, and suggest some slight introgression of individual haplotypes from L. timidus to L. europaeus.	[Ashrafzadeh, Mohammad Reza] Shahrekord Univ, Fac Nat Resources & Earth Sci, Dept Fisheries & Environm Sci, Shahrekord, Iran; [Djan, Mihajla] Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia; [Szendrei, Laszlo; Soos, Noemi; Kusza, Szilvia] Univ Debrecen, Inst Anim Husb Biotechnol & Nat Conservat, Debrecen, Hungary; [Paulauskas, Algimantas] Vytautas Magnus Univ, Fac Nat Sci, Dept Biol, Kaunas, Lithuania; [Scandura, Massimo] Univ Sassari, Dept Vet Med, Sassari, Italy; [Bagi, Zoltan] Univ Debrecen, Inst Agr Res & Educ Farm, Debrecen, Hungary; [Ilie, Daniela Elena] Acad Agr & Forestry Sci, Res & Dev Stn Bovine Arad, Arad, Romania; [Kerdikoshvili, Nikoloz] Tbilisi Zoo, Tbilisi, Georgia; [Marek, Panek] Polish Hunting Assoc, Res Stn, Czempin, Poland	Shahrekord University; University of Novi Sad; University of Debrecen; Vytautas Magnus University; University of Sassari; University of Debrecen	Kusza, S (corresponding author), Univ Debrecen, Inst Anim Husb Biotechnol & Nat Conservat, Debrecen, Hungary.	kusza@agr.unideb.hu	Ashrafzadeh, Mohammad Reza/AAZ-8065-2021; Ilie, Daniela Elena/D-7257-2015; Bagi, Zoltán/GPX-7288-2022	Ashrafzadeh, Mohammad Reza/0000-0003-2968-906X; Ilie, Daniela Elena/0000-0002-0464-3199; Djan, Mihajla/0000-0002-2427-0676	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; European Union; European Social Fund;  [EFOP-3.6.3-VEKOP-16-2017-00008]	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); European Social Fund(European Social Fund (ESF)); 	This work was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The publication is supported by the EFOP-3.6.3-VEKOP-16-2017-00008 project. The project is co-financed by the European Union and the European Social Fund.	Alexandri P, 2012, J BIOGEOGR, V39, P713, DOI 10.1111/j.1365-2699.2011.02636.x; Alves PC, 2008, MOL PHYLOGENET EVOL, V46, P1191, DOI 10.1016/j.ympev.2007.11.010; Alves PC, 2003, MOL PHYLOGENET EVOL, V27, P70, DOI 10.1016/S1055-7903(02)00417-7; Antoniou A, 2013, GENETICA, V141, P23, DOI 10.1007/s10709-013-9703-z; Ashrafzadeh MR, 2016, MAMM BIOL, V81, P1, DOI 10.1016/j.mambio.2015.09.001; Avise JC, 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Ben Slimen H, 2006, J ZOOL SYST EVOL RES, V44, P88, DOI 10.1111/j.1439-0469.2005.00345.x; Ben Slimen H, 2008, BIOCHEM SYST ECOL, V36, P22, DOI 10.1016/j.bse.2007.06.014; Bilgin R, 2011, INT J MOL SCI, V12, P4080, DOI 10.3390/ijms12064080; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Canu A, 2013, EUR J WILDLIFE RES, V59, P783, DOI 10.1007/s10344-013-0731-x; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; CORBET GB, 1986, MAMMAL REV, V16, P105, DOI 10.1111/j.1365-2907.1986.tb00029.x; Djan M, 2015, BALKAN J WILDLIFE RE, V2, P18, DOI [10.15679/bjwr.v2i1.22, DOI 10.15679/BJWR.V2I1.22]; Djan M, 2006, EUR J WILDLIFE RES, V52, P288, DOI 10.1007/s10344-006-0050-6; Djan M, 2017, HYSTRIX, V28, P186, DOI 10.4404/hystrix-28.2-12202; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fickel J, 2005, J WILDLIFE MANAGE, V69, P760, DOI 10.2193/0022-541X(2005)069[0760:GSOPOE]2.0.CO;2; Fickel J, 2008, EUR J WILDLIFE RES, V54, P495, DOI 10.1007/s10344-008-0175-x; Flux J.E.C., 1990, P61; Fontanesi L, 2016, J HERED, V107, P295, DOI 10.1093/jhered/esw010; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Fu YX, 1997, GENETICS, V147, P915; Giannoulis T, 2018, MITOCHONDRIAL DNA A, V29, P353, DOI 10.1080/24701394.2016.1278540; Gissi C, 1998, GENOMICS, V50, P161, DOI 10.1006/geno.1998.5282; Gokasan E, 1997, MAR GEOL, V140, P183, DOI 10.1016/S0025-3227(97)00022-4; Guberti V, 2000, P 5 INT C EUR SOC VE, V8, P27; HARTL GB, 1993, ACTA THERIOL, V38, P33, DOI 10.4098/AT.arch.93-41; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V34, P55, DOI 10.1016/j.ympev.2004.09.007; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Levanen R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191790; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mamuris Z, 2001, BIOL CONSERV, V101, P187, DOI 10.1016/S0006-3207(01)00065-9; Mamuris Z, 2010, MAMM BIOL, V75, P233, DOI 10.1016/j.mambio.2009.01.004; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Melo-Ferreira J, 2012, SYST BIOL, V61, P367, DOI 10.1093/sysbio/syr114; Melo-Ferreira J, 2009, MOL ECOL, V18, P2643, DOI 10.1111/j.1365-294X.2009.04221.x; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Ojeda AA, 2010, J MAMMAL, V91, P302, DOI 10.1644/09-MAMM-A-177.1; Pierpaoli M, 1999, MOL ECOL, V8, P1805, DOI 10.1046/j.1365-294x.1999.00766.x; Pietri C., 2007, CONSERVAZIONE LEPUS, P52; Pietri C, 2011, EUR J WILDLIFE RES, V57, P313, DOI 10.1007/s10344-010-0430-9; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Schmitt T, 2006, MOL ECOL, V15, P1889, DOI 10.1111/j.1365-294X.2006.02900.x; SLATKIN M, 1991, GENETICS, V129, P555; Smith Andrew T., 2008, P297, DOI 10.1007/978-3-540-72446-9_20; Stamatis C, 2009, J BIOGEOGR, V36, P515, DOI 10.1111/j.1365-2699.2008.02013.x; Suchentrunk F, 2006, HUM EVOL, V21, P151, DOI DOI 10.1007/S11598-006-9016-7; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thulin C.-G., 1997, Gibier Faune Sauvage, V14, P463; Thulin CG, 2006, HEREDITAS, V143, P68, DOI 10.1111/j.2006.0018-0661.01952.x; Vapa L, 2007, ACTA ZOOL ACAD SCI H, V53, P75; Vapa L, 2002, Z JAGDWISS, V48, P261, DOI 10.1007/BF02192416; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Zhou TC, 2014, MITOCHONDRION, V18, P70, DOI 10.1016/j.mito.2014.07.012	65	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204653	10.1371/journal.pone.0204653	http://dx.doi.org/10.1371/journal.pone.0204653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286121	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000446383500033
J	Ji, TY; Corbalan-Garcia, S; Hubbard, SR				Ji, Tianyang; Corbalan-Garcia, Senena; Hubbard, Stevan R.			Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1 (vol 13, e0199942, 2018)	PLOS ONE			English	Correction													Corbalan-Garcia, Senena/C-6477-2009	Corbalan-Garcia, Senena/0000-0003-1840-5578	Fundacion Seneca Region de Murcia [19409/PI/14]	Fundacion Seneca Region de Murcia(Fundacion Seneca)	The following information is missing from the Funding section: This study was supported in part by Fundacion Seneca Region de Murcia, Grant# 19409/PI/14 (SCG).	CORBALANGARCIA JT, 2018, PLOS ONE, V13, DOI DOI 10.1371/J0URNAL.PONE.0199942; Ji TY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199942	2	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205540	10.1371/journal.pone.0205540	http://dx.doi.org/10.1371/journal.pone.0205540			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286164	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500109
J	Martinecz, A; Niitsuma, M				Martinecz, Antal; Niitsuma, Mihoko			Fractional integral-like processing in retinal cones reduces noise and improves adaptation	PLOS ONE			English	Article							HORIZONTAL CELL FEEDBACK; DARK-ADAPTATION; VISUAL PIGMENT; GANGLION-CELLS; MOUSE RETINA; PHOTOTRANSDUCTION; PHOTORECEPTORS; RHODOPSIN; ARRESTIN; BINDING	In the human retina, rod and cone cells detect incoming light with a molecule called rhodopsin. After rhodopsin molecules are activated (by photon impact), these molecules activate the rest of the signalling process for a brief period of time until they are deactivated by a multistage process. First, active rhodopsin is phosphorylated multiple times. Following this, they are further inhibited by the binding of molecules called arrestins. Finally, they decay into opsins. The time required for each of these stages becomes progressively longer, and each stage further reduces the activity of rhodopsin. However, while this deactivation process itself is well researched, the roles of the above stages in signal (and image) processing are poorly understood. In this paper, we will show that the activity of rhodopsin molecules during the deactivation process can be described as the fractional integration of an incoming signal. Furthermore, we show how this affects an image; specifically, the effect of fractional integration in video and signal processing and how it reduces noise and the improves adaptability under different lighting conditions. Our experimental results provide a better understanding of vertebrate and human vision, and why the rods and cones of the retina differ from the light detectors in cameras.	[Martinecz, Antal; Niitsuma, Mihoko] Chuo Univ, Dept Precis Mech, Tokyo, Japan; [Martinecz, Antal] Univ Tromso, Dept Pharm, Tromso, Norway	Chuo University; UiT The Arctic University of Tromso	Martinecz, A (corresponding author), Chuo Univ, Dept Precis Mech, Tokyo, Japan.; Martinecz, A (corresponding author), Univ Tromso, Dept Pharm, Tromso, Norway.	antal.martinecz@uit.no						ANASTASIO TJ, 1994, BIOL CYBERN, V72, P69, DOI 10.1007/BF00206239; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Ascano M, 2006, BIOCHEMISTRY-US, V45, P2398, DOI 10.1021/bi052021h; Atangana A, 2017, NUMERICAL METHODS PA; Atangana A, 2016, ADV DIFFER EQU-NY, DOI 10.1186/s13662-016-0871-x; Atangana A, 2015, ADV MECH ENG, V7, DOI 10.1177/1687814015613758; Babai N, 2009, J PHYSIOL-LONDON, V587, P2353, DOI 10.1113/jphysiol.2009.169656; Bai J, 2007, IEEE T IMAGE PROCESS, V16, P2492, DOI 10.1109/TIP.2007.904971; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Chevalier A, 2013, MED C CONTR AUTOMAT, P206, DOI 10.1109/MED.2013.6608723; Coronel-Escamilla A, 2017, MULTIBODY SYSTEM DYN; Coronel-Escamilla A, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19020055; Cuesta E, 2012, SIGNAL PROCESS, V92, P553, DOI 10.1016/j.sigpro.2011.09.001; Das S, 2012, SPRINGERBR APPL SCI, P13, DOI 10.1007/978-3-642-23117-9_2; Dell'Orco D, 2009, MOL BIOSYST, V5, P1232, DOI 10.1039/b908123b; Devillard F, 2014, J COMPUTER COMMUNICA, V2, P78, DOI [10.4236/jcc.2014.214008, DOI 10.4236/JCC.2014.214008]; Morales-Delgado VF, 2016, ADV DIFFER EQU-NY, DOI 10.1186/s13662-016-0891-6; GLOCKLE WG, 1995, BIOPHYS J, V68, P46, DOI 10.1016/S0006-3495(95)80157-8; Golobokova EY, 2006, VISION RES, V46, P2287, DOI 10.1016/j.visres.2005.12.017; Gomez-Aguilar JF, 2017, ADV DIFFER EQU-NY, DOI 10.1186/s13662-017-1120-7; Gould S, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2115; Gross OP, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00006; Hamer RD, 2005, VISUAL NEUROSCI, V22, P417, DOI 10.1017/S0952523805224045; Hu ZH, 2013, ADV INTEL SYS RES, V41, P692; Ichinose T, 2014, J NEUROSCI, V34, P8761, DOI 10.1523/JNEUROSCI.3965-13.2014; Ingram NT, 2016, J PHYSIOL-LONDON, V594, P5415, DOI 10.1113/JP272556; Korenbrot JI, 2012, PROG RETIN EYE RES, V31, P442, DOI 10.1016/j.preteyeres.2012.05.002; Korenbrot JI, 2012, J GEN PHYSIOL, V139, P31, DOI 10.1085/jgp.201110654; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Marc RE, 2012, CURR OPIN NEUROBIOL, V22, P568, DOI 10.1016/j.conb.2012.03.011; Martinecz A, 2015, ICIMCO 2015 PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON INFORMATICS IN CONTROL, AUTOMATION AND ROBOTICS, VOL. 1, P481; Podlubny I, 1999, IEEE T AUTOMAT CONTR, V44, P208, DOI 10.1109/9.739144; Reuter T, 2011, VISION RES, V51, P2243, DOI 10.1016/j.visres.2011.08.021; Shah P, 2016, MECHATRONICS, V38, P29, DOI 10.1016/j.mechatronics.2016.06.005; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Sinha A, 2014, BIOCHEMISTRY-US, V53, P3294, DOI 10.1021/bi401534y; Tatler BW, 2010, I-PERCEPTION, V1, P7, DOI 10.1068/i0382; van Hateren H, 2005, J VISION, V5, P331, DOI 10.1167/5.4.5; Vinagre B.M., 2000, J FRACTIONAL CALCULU, P231; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Wang JS, 2011, CONE SPECIFIC VISUAL; Werblin FS, 2011, J PHYSIOL-LONDON, V589, P3691, DOI 10.1113/jphysiol.2011.210617; Yang KF, 2013, PROC CVPR IEEE, P2810, DOI 10.1109/CVPR.2013.362; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Yepez-Martinez H, 2016, REV MEX FIS, V62, P310; Zilany MSA, 2010, J NEUROSCI, V30, P10380, DOI 10.1523/JNEUROSCI.0647-10.2010	50	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205099	10.1371/journal.pone.0205099	http://dx.doi.org/10.1371/journal.pone.0205099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286168	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500084
J	Paudyal, V; Cunningham, S; Smith, KG; MacLure, K; Ryan, C; Cordina, M				Paudyal, Vibhu; Cunningham, Scott; Smith, Kathrine Gibson; MacLure, Katie; Ryan, Cristin; Cordina, Maria			Methodological considerations in clinical outcomes assessment of pharmacy-based minor ailments management: A systematic review	PLOS ONE			English	Review							COMMUNITY PHARMACY; SELF-MEDICATION; SYMPTOMS; QUALITY; IMPACT; USAGE; CARE	Background The accessibility of services within community pharmacies provides an ideal opportunity to manage minor ailments, yet over 1.1 pound billion is spent by the National Health Service (NHS) in the United Kingdom (UK) in managing minor ailments in high cost settings. There is a need to review the evidence base around clinical effectiveness of pharmacy- based management of minor ailments since the absence of such may lead to under- utilisation of pharmacy services and non- implementation of available pharmacy service models. This study aimed to systematically review the methodological approaches used to assess clinical outcomes of pharmacy- based management of minor ailments in the research literature. Methods A systematic review was conducted to identify relevant literature using the following databases: Medline, EMBASE, CINAHL, IPA, CRD, CDSR, and Google Scholar from publication year 2000 onwards. Studies were included if they evaluated clinical outcomes of pharmacybased management of any minor ailments, with or without a comparator setting such as Emergency Departments (EDs) or general practices. Screening and selection of titles, abstracts and full texts followed by data extraction and quality assessment (QA) was conducted. Paired researchers, from the team, reviewed papers using a protocol based on the Preferred Reporting Items for Systematic Review and Meta- Analysis Protocols (PRISMAP). QA was undertaken using the Critical Appraisal Skills Programme (CASP). Reporting was conducted in accordance with PRISMA checklist and statements. Results A total of 19 studies were included. The majority of studies were observational, conducted in community pharmacies, and did not use a comparator participant group nor a comparator setting. Interventions included counselling, medicines supply and provision of advice on the management of minor ailments. One study used the randomised controlled trial (RCT) design with majority of the study utilising observational design. A range of clinical outcomes including symptom severity, pattern, resolution, and quality of life were reported. Methods used for the assessment of clinical outcomes were, overall, poorly reported. This included a lack of information on the development and validation of the data collection tools and the timing of baseline and follow-up data collection. Adverse clinical outcomes data were collected by only seven studies. Conclusions Currently, there are methodological limitations in the studies that have sought to assess clinical outcomes of pharmacy-based management of minor ailments. Such lack of high quality evidence may contribute to failings to shift care from high cost settings, such as EDs and general practices. Generation of high quality evidence is likely to influence public choices when seeking care for minor ailments. There is scope for development of a core outcomes set specific to minor ailments management and development of a validated methodology for measuring such outcomes in a research study.	[Paudyal, Vibhu] Univ Birmingham, Inst Clin Sci, Sch Pharm, Birmingham, W Midlands, England; [Cunningham, Scott; Smith, Kathrine Gibson; MacLure, Katie] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland; [Ryan, Cristin] Trinity Coll Dublin, Sch Pharm, Dublin, Ireland; [Cordina, Maria] Univ Malta, Fac Med & Surg, Msida, Malta	University of Birmingham; Robert Gordon University; Trinity College Dublin; University of Malta	Paudyal, V (corresponding author), Univ Birmingham, Inst Clin Sci, Sch Pharm, Birmingham, W Midlands, England.	v.paudyal@bham.ac.uk	MacLure, Katie/GRJ-8912-2022	Paudyal, Vibhu/0000-0002-4173-6490; Ryan, Cristin/0000-0002-6037-4413; MacLure, Katie/0000-0003-0686-948X	European Society of Clinical Pharmacy Research Grant	European Society of Clinical Pharmacy Research Grant	This study was funded by the European Society of Clinical Pharmacy Research Grant award 2016. The funding body had no role in the design of the study, data collection, analysis, and interpretation of data and in writing the manuscript.	Bello S. I., 2013, DHAKA U J PHARM SCI, V12, P1; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Birring SS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014112; Bosse N, 2012, J AM PHARM ASSOC, V52, P535, DOI 10.1331/JAPhA.2012.10093; Cernasev A, 2014, J PHARM PHARMACOL, V5, P462; Coelho R. B., 2014, PHARM PRACT, V12; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Danno K, 2014, HOMEOPATHY, V103, P239, DOI 10.1016/j.homp.2014.04.001; Fielding S, 2015, FAM PRACT, V32, P165, DOI 10.1093/fampra/cmv003; Hacker F, 2012, INT J CLIN PHARM TH, V50, P87, DOI 10.5414/CP201576; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; Klimek L, 2016, INT J CLIN PRACT; Krishnan HS, 2000, PHARM WORLD SCI, V22, P102, DOI 10.1023/A:1008733207854; Lambert R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-300; Lineberry N, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5078; Mansell K, 2015, INT J PHARM PRACT, V23, P95, DOI 10.1111/ijpp.12128; Mehuys E, 2009, ANN PHARMACOTHER, V43, P890, DOI 10.1345/aph.1L647; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; NHS England, COMM PHARM HELP PROV; Paudyal V, 2016, TYPES CLIN OUTCOMES; Paudyal V, 2013, BRIT J GEN PRACT, V63, pE472, DOI 10.3399/bjgp13X669194; Paudyal V, 2011, HEALTH POLICY, V101, P253, DOI 10.1016/j.healthpol.2011.05.010; Paudyal Vibhu, 2010, Int J Pharm Pract, V18, P194, DOI 10.1111/j.2042-7174.2010.00042.x; Pharmacy Association of Nova Scotia, 2013, EV PROV MIN AILM SER; Pillay N, 2010, SELFCARE, V1, P105; Plunkett A, 2001, INT J PHARM PRACT, V9, P9; Royal Pharmaceutical Society, NAT MIN AILM SERV NE; Schulz M, 2006, INT J CLIN PHARM TH, V44, P409; Sinclair Hazel K., 2001, Drug Safety, V24, P929, DOI 10.2165/00002018-200124120-00006; Taylor J.G., 2017, INNOV PHARM, V8, P1, DOI [10.24926/iip.v8i1.497, DOI 10.24926/IIP.V8I1.497]; Vogler S, 2014, HEALTH POLICY, V117, P311, DOI 10.1016/j.healthpol.2014.06.001; Watson MC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006261; Westerlund T, 2003, AM J HEALTH-SYST PH, V60, P1336, DOI 10.1093/ajhp/60.13.1336; WHITTINGTON Z, 2001, PHARM J, V266, P425	34	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205087	10.1371/journal.pone.0205087	http://dx.doi.org/10.1371/journal.pone.0205087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286166	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500082
J	Takahashi, A; Moriya, K; Ohira, H; Arinaga-Hino, T; Zeniya, M; Torimura, T; Abe, M; Takaki, A; Kang, JH; Inui, A; Fujisawa, T; Yoshizawa, K; Suzuki, Y; Nakamoto, N; Koike, K; Yoshiji, H; Goto, A; Tanaka, A; Younossi, ZM; Takikawa, H				Takahashi, Atsushi; Moriya, Kei; Ohira, Hiromasa; Arinaga-Hino, Teruko; Zeniya, Mikio; Torimura, Takuji; Abe, Masanori; Takaki, Akinobu; Kang, Jong-Hon; Inui, Ayano; Fujisawa, Tomoo; Yoshizawa, Kaname; Suzuki, Yoshiyuki; Nakamoto, Nobuhiro; Koike, Kazuhiko; Yoshiji, Hitoshi; Goto, Aya; Tanaka, Atsushi; Younossi, Zobair M.; Takikawa, Hajime		Japan AIH Study Grp	Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; MANAGEMENT	Aim Health-related quality of life is impaired in patients with autoimmune hepatitis, but the association between health-related quality of life and patients' backgrounds remains unknown. We assessed health-related quality of life in patients with autoimmune hepatitis and identified factors associated with its impairment. Methods We assessed health-related quality of life in patients with autoimmune hepatitis, patients with chronic hepatitis C, and healthy subjects using the Japanese version of the Chronic Liver Disease Questionnaire and the 36-Item Short Form Survey. We compared health-related quality of life in patients with autoimmune hepatitis with that of patients with chronic hepatitis C and healthy subjects. Results A total of 265 patients with autoimmune hepatitis, 88 patients with chronic hepatitis C, and 97 healthy subjects were enrolled; most patients were women. The median ages of patients were 65, 66, and 57 years, respectively. Of these patients with autoimmune hepatitis, 10.6% and 57.0% had cirrhosis and comorbid diseases, respectively. The overall Chronic Liver Disease Questionnaire scores (5.5 vs. 6.2, P < 0.001) and physical (48.1 vs. 54.2, P < 0.001) and mental (51.8 vs. 55.0, P= 0.004) component summaries of 36-Item Short Form Survey were significantly lower in patients with autoimmune hepatitis than in healthy subjects, and similar to scores in patients with chronic hepatitis C. Having cirrhosis, comorbid diseases, and treatment for autoimmune hepatitis were associated with impaired health-related quality of life among patients with autoimmune hepatitis. In particular, prednisolone use was associated with lower scores on the worry domain of the Chronic Liver Disease Questionnaire. Conclusions Patients with autoimmune hepatitis showed impairment in health-related quality of life, which was associated with not only disease progression, but also comorbid diseases and treatment. Ways to improve health-related quality of life should be considered in patients with AIH when disease outcome is not favorable and when using prednisolone.	[Takahashi, Atsushi; Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan; [Moriya, Kei; Yoshiji, Hitoshi] Nara Med Univ, Sch Med, Dept Gastroenterol & Hepatol, Kashihara, Nara, Japan; [Arinaga-Hino, Teruko; Torimura, Takuji] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka, Japan; [Zeniya, Mikio] Int Univ Hlth & Welf, Sanno Med Ctr, Minato Ku, Tokyo, Japan; [Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Takaki, Akinobu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, Okayama, Japan; [Kang, Jong-Hon] Teine Keijinkai Hosp, Ctr Gastroenterol, Teine Ku, Sapporo, Hokkaido, Japan; [Inui, Ayano; Fujisawa, Tomoo] Saiseikai Yokohama Tobu Hosp, Dept Pediat Hepatol & Gastroenterol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Yoshizawa, Kaname] Natl Hosp Org, Shinshu Ueda Med Ctr, Dept Gastroenterol, Ueda, Nagano, Japan; [Suzuki, Yoshiyuki] Toranomon Gen Hosp, Dept Hepatol, Minato Ku, Tokyo, Japan; [Nakamoto, Nobuhiro] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan; [Koike, Kazuhiko] Jikei Univ, Sch Med, Hosp 3, Dept Gastroenterol & Hepatol, Komae, Tokyo, Japan; [Goto, Aya] Fukushima Med Univ, Ctr Integrated Sci & Humanities, Fukushima, Japan; [Tanaka, Atsushi; Takikawa, Hajime] Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo, Japan; [Younossi, Zobair M.] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA	Fukushima Medical University; Nara Medical University; Kurume University; International University of Health & Welfare; Ehime University; Okayama University; Teine Keijinkai Hospital; Toranomon Hospital; Keio University; Jikei University; Fukushima Medical University; Teikyo University; Inova Health System	Takahashi, A (corresponding author), Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan.	junior@fmu.ac.jp		Takahashi, Atsushi/0000-0003-0568-8361; Yoshiji, Hitoshi/0000-0002-5243-8544	Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan	Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan	This study was conducted and supported by Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dan AA, 2007, ALIMENT PHARM THER, V26, P815, DOI 10.1111/j.1365-2036.2007.03426.x; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Gao F, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-131; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Onji M, 2014, HEPATOL RES, V44, P368, DOI 10.1111/hepr.12300; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Schramm C, 2014, J HEPATOL, V60, P618, DOI 10.1016/j.jhep.2013.10.035; Sockalingam S, 2012, J HEPATOL, V57, P1299, DOI 10.1016/j.jhep.2012.07.032; Suzukamo Y, 2011, J CLIN EPIDEMIOL, V64, P301, DOI 10.1016/j.jclinepi.2010.04.017; Tanaka A, 2016, HEPATOL RES, V46, pE45, DOI 10.1111/hepr.12524; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; van der Plas SM, 2007, QUAL LIFE RES, V16, P375, DOI 10.1007/s11136-006-9131-y; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658; Younossi ZM, 2000, AM J GASTROENTEROL, V95, P497; Younossi ZM, 1999, GUT, V45, P295, DOI 10.1136/gut.45.2.295; Younossi ZM, 2016, LIVER INT, V36, P42, DOI 10.1111/liv.12886	16	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204772	10.1371/journal.pone.0204772	http://dx.doi.org/10.1371/journal.pone.0204772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286131	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500040
J	Cherairia, M; Adler, PH				Cherairia, Mouna; Adler, Peter H.			Genetic variation in a colonization specialist, Simulium ruficorne (Diptera: Simuliidae), the world's most widely distributed black fly	PLOS ONE			English	Article							VITTATUM COMPLEX DIPTERA; SAHARA; FLIES; BIODIVERSITY; DISPERSAL; EVOLUTION; ISLAND; PHYLOGEOGRAPHY; EPIDEMIOLOGY; ASSEMBLAGES	The ability of aquatic insects to colonize Earth's most remote freshwater habitats, such as those of islands and deserts, is limited to select taxa. Among black flies, the premiere colonization specialist is Simulium ruficorne Macquart, the only species known from both the Afrotropical and Palearctic regions. We investigated the cytogenetics of S. ruficorne to gain insight into its wide geographic distribution and ability to colonize oceanic islands and deserts. On the basis of larval polytene chromosomes from 14 locations, we documented 17 novel and previously known chromosomal rearrangements and established five cytoforms (A1, A2, B, C, and D), of which probably four (A1/A2, B, C, and D) are distinct species and two (A1 and A2) represent sex-chromosome polymorphism involving a heteroband in the long arm of chromosome III. The chromosome restructuring phenomena associated with the five cytoforms are consistent with the trend in the Simuliidae that one and the same rearrangement can assume different functions in the various descendants of a common ancestor in which the rearrangement was polymorphic. The most widely distributed cytoforms are A1 and A2, which are found in North Africa, the Canary Islands, and Majorca. Simulium ruficorne, the only known black fly in the Hoggar Mountains of the central Sahara Desert, represents a cohesive population of cytoform A1 little differentiated from other North African populations of A1 and A2. Cytoform B inhabits the West African mainland, cytoform C is on Tenerife, and cytoform D is on Cape Verde. We suggest that dispersal and colonization specialists, such as S. ruficorne, are multivoltine inhabitants of temporary streams, and must relocate as their habitats deteriorate. Simulium ruficorne, therefore, should have adaptations that contribute to successful dispersal and colonization, perhaps largely physiological in nature, such as tolerance of high temperatures and droughts.	[Cherairia, Mouna] Univ 8 Mai 1945 Guelma, Lab Rech & Conservat Zones Humides, Guelma, Algeria; [Adler, Peter H.] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC USA	Universite 8 Mai 1945 de Guelma; Clemson University	Cherairia, M (corresponding author), Univ 8 Mai 1945 Guelma, Lab Rech & Conservat Zones Humides, Guelma, Algeria.	cherairia.mouna@univ-guelma.dz		CHERAIRIA, MOUNA/0000-0003-4463-4489				Adler PH, 2015, MED VET ENTOMOL, V29, P276, DOI 10.1111/mve.12115; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158272; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147673; Adler PH, 2015, ZOOTAXA, V3975, P1, DOI 10.11646/zootaxa.3975.1.1; Adler PH, 2015, BIOL J LINN SOC, V114, P163, DOI 10.1111/bij.12403; Adler PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070765; Adler Peter H., 1997, American Entomologist, V43, P153; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; ADLER PH, 1984, CAN J ZOOL, V62, P1308, DOI 10.1139/z84-188; Adler PH, 2005, J BIOGEOGR, V32, P211, DOI 10.1111/j.1365-2699.2004.01156.x; Adler PH, 2004, BLACK FLIES SIMULIID; Alacs EA, 2011, CONSERV GENET, V12, P297, DOI 10.1007/s10592-010-0140-6; ANDERSEN NM, 1993, OIKOS, V67, P433, DOI 10.2307/3545355; Ayadi A, 2000, PHYS EARTH PLANET IN, V118, P111, DOI 10.1016/S0031-9201(99)00134-X; BEDO DG, 1989, GENOME, V32, P570, DOI 10.1139/g89-484; Beebe NW, 2002, INT J PARASITOL, V32, P563, DOI 10.1016/S0020-7519(01)00359-9; BELAZZOUG S, 1980, Archives de l'Institut Pasteur d'Algerie, V54, P107; Belqat B, 2018, ZOOTAXA, V4442, P201, DOI 10.11646/zootaxa.4442.2.1; Ben Faleh AR, 2012, J ZOOL, V286, P208, DOI 10.1111/j.1469-7998.2011.00868.x; Bouzid A, 2015, GEOL SOC AM SPEC PAP, V514, P239, DOI 10.1130/2015.2514(15); Bradley E, 2017, NEW ZEAL J ECOL, V41, P245, DOI 10.20417/nzjeco1.41.21; Charalambous M, 1996, MED VET ENTOMOL, V10, P111, DOI 10.1111/j.1365-2915.1996.tb00716.x; Cherairia M, 2014, ZOOTAXA, V3796, P166, DOI 10.11646/zootaxa.3796.1.8; CLASTRIER J, 1961, Arch Inst Pasteur Alger, V39, P106; COYNE JA, 1987, AM NAT, V129, P847, DOI 10.1086/284679; Craig DA, 1999, CAN J ZOOL, V77, P610, DOI 10.1139/cjz-77-4-610; CROSSKEY R W, 1987, Entomologist's Gazette, V38, P143; Crosskey R.W., 1982, Fauna of Saudi Arabia, V4, P398; Crosskey R.W., 1990, NATURAL HIST BLACKFL; Crosskey Roger W., 2002, V19, P419; Crosskey RW, 2004, J NAT HIST, V38, P2085, DOI 10.1080/0022293032000140958; CROSSKEY RW, 1981, ANN TROP MED PARASIT, V75, P647, DOI 10.1080/00034983.1981.11687496; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Foley JA, 2003, ECOSYSTEMS, V6, P524, DOI 10.1007/s10021-002-0227-0; Forsman A, 2011, P ROY SOC B-BIOL SCI, V278, P225, DOI 10.1098/rspb.2010.1325; Gomard Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202015; GRENIER P, 1960, Arch Inst Pasteur Alger, V38, P329; Khadem M, 2015, J MED ENTOMOL, V52, P1175, DOI 10.1093/jme/tjv094; Kroepelin S, 2006, SCIENCE, V312, P1138; LAZELL J., 2005, ISLAND FACT THEORY N; Le Houerou HN, 1997, J ARID ENVIRON, V37, P619, DOI 10.1006/jare.1997.0315; Low VL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0911-5; Lytle DA, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P951, DOI 10.1016/B978-0-12-385026-3.00037-1; MacArthur R, 1967, THEORY ISLAND BIOGEO; McCreadie JW, 2006, ECOGRAPHY, V29, P603, DOI 10.1111/j.0906-7590.2006.04541.x; Myers A.A., 1988, ANAL BIOGEOGRAPHY; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicolas V, 2018, J ZOOL SYST EVOL RES, V56, P102, DOI 10.1111/jzs.12185; Pramual P, 2009, HYDROBIOLOGIA, V625, P173, DOI 10.1007/s10750-009-9706-z; PROCUNIER WS, 1989, GENOME, V32, P559, DOI 10.1139/g89-483; PROCUNIER WS, 1982, CAN J ZOOL, V60, P2852, DOI 10.1139/z82-364; ROFF D, 1977, J ANIM ECOL, V46, P443, DOI 10.2307/3822; ROTHFELS K. H., 1956, JOUR HEREDITY, V47, P113; Rothfels K.H., 1980, Symposia of the Royal Entomological Society of London, P207; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Seitz Gunther, 2012, Lauterbornia, V74, P1; Takaoka H., 1988, Japanese Journal of Tropical Medicine and Hygiene, V16, P221; Tierney JE, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601503; Vaillant F, 1955, MEMOIRES MUSEUM NATL, V11; World Wildlife Federation, 2018, WILDF; Zettler JA, 1998, INVERTEBR BIOL, V117, P245, DOI 10.2307/3226989; Zhang ZS, 2014, NATURE, V513, P401, DOI 10.1038/nature13705	62	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205137	10.1371/journal.pone.0205137	http://dx.doi.org/10.1371/journal.pone.0205137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281665	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400085
J	Amadori, M; Soares-Filipe, JF; Riva, F; Vitali, A; Ruggeri, J; Lacetera, N				Amadori, Massimo; Soares-Filipe, Joel Fernando; Riva, Federica; Vitali, Andrea; Ruggeri, Jessica; Lacetera, Nicola			Characterization of the blastogenic response to LPS of bovine peripheral blood mononuclear cells	PLOS ONE			English	Article							PERIPARTURIENT DAIRY-COWS; MONOCLONAL-ANTIBODIES; LIPOPOLYSACCHARIDE; RECEPTOR; EXPRESSION; IDENTIFICATION; STRESS; ALPHA	Mitogens are diverse compounds of plant and microbial origin, widely employed to test immunocompetence in animals. The blastogenic response of bovine Peripheral Blood Mononuclear Cells (PBMC) to lypopolysaccharides (LPS) has been investigated in our laboratories for a long time. In particular, a possible correlation between blastogenic response to LPS and disease resistance of periparturient dairy cows had been observed in previous studies. Most important, low responder cows presented a higher frequency of disease cases after calving, compared with high responder animals. Owing to the above, different aspects of the blastogenic response to LPS were investigated on PBMC of healthy Friesian cows, using a 72-hour Bromodeoxyuridin (BrDU) cell proliferation assay. Stimulation with LPS induced little if any replication of bovine PBMC over 72 hours despite consistent BrDU detection in all the PBMC samples under study. Poor replication of LPS-stimulated PBMC was confirmed by cell cycle and cell growth flow cytometry analyses. In particular, LPS stimulation gave rise to very low percentages of S phase cells, sometimes lower than in control, unstimulated cells, as opposed to Concanavalin A-stimulated PBMC. Magnetic separation and analysis of BrDU-treated bovine PBMC after exposure to LPS showed that both B and CD4 T cells are involved in the blastogenic response to LPS, in contrast with current data based on human and murine models. Finally, LPS caused an early, specific up-regulation of TNF-alpha and TLR4 genes in bovine PBMC, and significant correlations were shown between the expression of inflammatory cytokine and Indoleamine-pyrrole 2,3-dioxygenase (IDO1) genes. On the whole, our data indicate that differences in the blastogenic response to LPS could be partly accounted for by heterogenicity of responding cells (B and T lymphocytes), which might also have an impact on induction and regulation of inflammatory responses and endotoxin tolerance.	[Amadori, Massimo; Ruggeri, Jessica] IZSLER, Lab Cellular Immunol, Brescia, Italy; [Soares-Filipe, Joel Fernando; Riva, Federica] UNIMI, Dept Vet Med DIMEVET, Milan, Italy; [Vitali, Andrea; Lacetera, Nicola] Univ Tuscia, Dept Agr & Forestry Sci DAFNE, Viterbo, Italy	IZS Lombardia e Emilia; Tuscia University	Amadori, M (corresponding author), IZSLER, Lab Cellular Immunol, Brescia, Italy.	massimo.amadori@izsler.it	Lacetera, Nicola/GLV-1404-2022; Vitali, Andrea/AAA-6423-2020; Filipe, Joel/U-7718-2017; Amadori, Massimo/J-2511-2014	Vitali, Andrea/0000-0002-4739-9077; Filipe, Joel/0000-0001-8849-2051; Amadori, Massimo/0000-0002-7562-0322	MIUR (Ministry for Education, University and Research) [Law 232/216]	MIUR (Ministry for Education, University and Research)(Ministry of Education, Universities and Research (MIUR))	The research was partially supported by MIUR (Ministry for Education, University and Research), Law 232/216 (Department of excellence): Dr. Nicola Lacetera, and partially by internal resources (manpower and consumables) of our organizations. There was no additional external funding received for this study.	ABRAHAM C, 1977, EUR J IMMUNOL, V7, P301, DOI 10.1002/eji.1830070512; ADAMS JL, 1990, J LEUKOCYTE BIOL, V48, P549, DOI 10.1002/jlb.48.6.549; Amadori M., 2016, INNATE IMMUNE RESPON; BALDWIN CL, 1986, J IMMUNOL, V136, P4385; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; CALDER PC, 1990, BIOCHEM SOC T, V18, P904, DOI 10.1042/bst0180904; Catalani E, 2013, J DAIRY SCI, V96, P7077, DOI 10.3168/jds.2013-6854; Darzynkiewicz Zbigniew, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0703s30; DAVIS WC, 1993, VET IMMUNOL IMMUNOP, V39, P85, DOI 10.1016/0165-2427(93)90167-3; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Duvigneau JC, 2007, J IMMUNOL METHODS, V324, P38, DOI 10.1016/j.jim.2007.04.012; Duvigneau JC, 2003, J IMMUNOL METHODS, V272, P11, DOI 10.1016/S0022-1759(02)00372-1; HOWARD CJ, 1991, VET IMMUNOL IMMUNOP, V27, P21, DOI 10.1016/0165-2427(91)90072-K; Komai-Koma M, 2009, EUR J IMMUNOL, V39, P1564, DOI 10.1002/eji.200838866; Lacetera N, 2002, INT J BIOMETEOROL, V46, P33, DOI 10.1007/s00484-001-0115-x; Li FX, 2017, INT IMMUNOPHARMACOL, V47, P70, DOI 10.1016/j.intimp.2017.03.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Collazo E, 2013, CRIT CARE, V17, DOI 10.1186/cc13110; Muul L. M., 2011, CURRENT PROTOCOLS IM, DOI DOI 10.1002/0471142735.IM0710S94; NAESSENS J, 1988, IMMUNOLOGY, V63, P569; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Rath PC, 2001, J INTERF CYTOK RES, V21, P523, DOI 10.1089/10799900152434402; Riva F, 2010, VET IMMUNOL IMMUNOP, V136, P65, DOI 10.1016/j.vetimm.2010.02.009; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008	24	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204827	10.1371/journal.pone.0204827	http://dx.doi.org/10.1371/journal.pone.0204827			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278079	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200025
J	Brown, B; Marg, L; Leon, S; Chen, C; Siu, JNY; Calvo, G; Sanchez, H; Galea, JT				Brown, Brandon; Marg, Logan; Leon, Segundo; Chen, Cynthia; Siu, Junice Ng Yi; Calvo, Gino; Sanchez, Hugo; Galea, Jerome T.			The relationship between anogenital HPV types and incident HIV infection among men who have sex with men and transgender women in Lima, Peru: Findings from a prospective cohort study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HUMAN-PAPILLOMAVIRUS INFECTION; GENITAL WARTS; HIGH-RISK; IMMUNODEFICIENCY; PREVALENCE; ACQUISITION; PREVENTION; TRANSWOMEN	Although it is known that individuals living with HIV have a higher HPV prevalence, the impact of individual HPV types on HIV acquisition is less clear. In this prospective cohort study we investigated the relationship between HPV types and incident HIV infection among men who have sex with men (MSM) and transgender women (TW) in Lima, Peru. Six hundred HIV-negative Peruvian MSM and TW participated in a 2-year study with biannual visits. At baseline, participants completed a computerized, self-administered questionnaire on sexual behavior and HPV knowledge and underwent a physical exam including anogenital swabs for HPV DNA (37 genotypes via linear array testing) and HIV testing; follow-up visits included the questionnaire and HIV testing. Participant mean age was 25 years (range = 18-40), with 48.9% self-identifying as gay and 86.5% reporting having sex exclusively with men. At baseline, 530 participants had HPV DNA present (61.1% with high-risk HPV, 84.9% with low-risk HPV). Among 571 participants who returned for any study visit, 73 (12.8%) became infected with HIV during the 2-year follow-up (6% HIV incidence). Compared to those without HIV, more participants with HIV had any HPV type present (97.3% vs. 87.6%, respectively, p = .01), more than one HPV type (79.5% vs. 58.2%, p< .01), or high-risk HPV (72.6% vs. 51.4%, p< .01). Some participants lost to follow-up could have been HIV-positive, which would have affected the relationship of HPV and HIV infection. Our prospective study showed that participants with any HPV type, more than one HPV type, or high-risk HPV were more likely to test positive for HIV. Although most studies have shown HPV-HIV coinfection, our findings illustrate the strong relationship between individual HPV types and HIV infection. This further illustrates the potential utility of HPV vaccine for MSM and TW, not only for HPV prevention but also possibly for HIV prevention.	[Brown, Brandon; Marg, Logan] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA; [Leon, Segundo] Socios Salud, Lima, Peru; [Chen, Cynthia; Siu, Junice Ng Yi] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Calvo, Gino; Sanchez, Hugo; Galea, Jerome T.] Epictr Salud, Lima, Peru; [Galea, Jerome T.] Univ S Florida, Coll Behav & Community Sci, Sch Social Work, Tampa, FL USA	University of California System; University of California Riverside; National University of Singapore; State University System of Florida; University of South Florida	Brown, B (corresponding author), Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA.	brandon.brown@medsch.ucr.edu	Galea, Jerome T/HGV-0203-2022; Galea, Jerome T./AAF-2172-2019; Leon, Segundo Ramos/J-3058-2019	Galea, Jerome T/0000-0001-8732-6959; Galea, Jerome T./0000-0001-8732-6959; Leon, Segundo Ramos/0000-0002-5630-5714; Brown, Brandon/0000-0002-6348-4108; Calvo Moreno, Gino Mauricio/0000-0002-4838-1960	Merck MISP [39619]; Foundation for the National Institutes of Health NIH [T32 MH080634]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER	Merck MISP; Foundation for the National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Merck MISP 39619: http://www.merck.com/index.html; and Foundation for the National Institutes of Health NIH T32 MH080634: https://grants.nih.gov/grants/guide/pa-files/PA-16-152.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048017; Beyrer C, 2008, SEX TRANSM INFECT, V84, P410, DOI 10.1136/sti.2008.033290; Bingham A, 2009, ARCH PEDIAT ADOL MED, V163, P455, DOI 10.1001/archpediatrics.2009.50; Blas MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139524; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brown B, 2015, CALIF J HLTH PROMOT, V13, pvi; Brown B, 2017, LGBT HEALTH, V4, P315, DOI 10.1089/lgbt.2016.0142; Brown Brandon, 2016, Transgend Health, V1, P94, DOI 10.1089/trgh.2016.0001; Brown B, 2015, SEX TRANSM DIS, V42, P198, DOI 10.1097/OLQ.0000000000000258; Brown B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005687; Brown B, 2012, VIRUSES-BASEL, V4, P3851, DOI 10.3390/v4123851; Centers for Disease Control and Prevention, 2016, AN SEX HIV RISK; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Clark JL, 2010, SEX TRANSM INFECT, V86, P545, DOI 10.1136/sti.2010.042697; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Galea JT, 2015, SEX TRANSM DIS, V42, P202, DOI 10.1097/OLQ.0000000000000253; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; KENT C, 1987, JAMA-J AM MED ASSOC, V258, P3385, DOI 10.1001/jama.1987.03400230045017; Ministerio de Salud del Peru, 2013, NORM TECN SAL EST ES; Moscicki AB, 2011, J LOW GENIT TRACT DI, V15, P231, DOI 10.1097/LGT.0b013e318203ae61; Muller EE, 2010, SEX TRANSM INFECT, V86, P175, DOI 10.1136/sti.2009.037598; Palefsky J, 2006, Adv Dent Res, V19, P99; Quinn R, 2012, AIDS RES HUM RETROV, V28, P1734, DOI [10.1089/aid.2011.0307, 10.1089/AID.2011.0307]; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Silverberg MJ, 2002, SEX TRANSM DIS, V29, P427, DOI 10.1097/00007435-200208000-00001; Smits PHM, 2005, J CLIN MICROBIOL, V43, P5936, DOI 10.1128/JCM.43.12.5936-5939.2005; Solomon MM, 2014, CLIN INFECT DIS, V59, P1020, DOI 10.1093/cid/ciu450; Steen R, 2004, J CLIN VIROL, V29, P143, DOI 10.1016/j.jcv.2003.05.001; UNAIDS, 2015, PERU HIV AIDS EST; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2008, REP GLOB AIDS EP; van Aar F, 2013, AIDS, V27, P2921, DOI 10.1097/01.aids.0000432541.67409.3c	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204996	10.1371/journal.pone.0204996	http://dx.doi.org/10.1371/journal.pone.0204996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278061	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200033
J	Mamach, M; Kessler, M; Bankstahl, JP; Wilke, F; Geworski, L; Bengel, FM; Kurt, S; Berding, G				Mamach, Martin; Kessler, Mariella; Bankstahl, Jens P.; Wilke, Florian; Geworski, Lilli; Bengel, Frank M.; Kurt, Simone; Berding, Georg			Visualization of the auditory pathway in rats with F-18-FDG PET activation studies based on different auditory stimuli and reference conditions including cochlea ablation	PLOS ONE			English	Article							BRAIN; NOISE; IMPLANTATION	Activation studies with positron emission tomography (PET) in auditory implant users explained some of the mechanisms underlying the variability of achieved speech comprehension. Since future developments of auditory implants will include studies in rodents, we aimed to inversely translate functional PET imaging to rats. In normal hearing rats, activity in auditory and non-auditory regions was studied using F-18-fluorodeoxyglucose (F-18-FDG) PET with 3 different acoustic conditions: sound attenuated laboratory background, continuous white noise and rippled noise. Additionally, bilateral cochlea ablated animals were scanned. 3D image data were transferred into a stereotaxic standard space and evaluated using volume of interest (VOI) analyses and statistical parametric mapping (SPM). In normal hearing rats alongside the auditory pathway consistent activations of the nucleus cochlearis (NC), olivary complex (OC) and inferior colliculus (IC) were seen comparing stimuli with background. In this respect, no increased activation could be detected in the auditory cortex (AC), which even showed deactivation with white noise stimulation. Nevertheless, higher activity in the AC in normal hearing rats was observed for all 3 auditory conditions against the cochlea ablated status. Vice versa, in ablated status activity in the olfactory nucleus (ON) was higher compared to all auditory conditions in normal hearing rats. Our results indicate that activations can be demonstrated in normal hearing animals based on F-18-FDG PET in nuclei along the central auditory pathway with different types of noise stimuli. However, in the AC missing activation with respect to the background advises the need for more rigorous background noise attenuation for non-invasive reference conditions. Finally, our data suggest cross-modal activation of the olfactory system following cochlea ablation-underlining, that F-18-FDG PET appears to be well suited to study plasticity in rat models for cochlear implantation.	[Mamach, Martin; Wilke, Florian; Geworski, Lilli] Hannover Med Sch, Dept Med Phys & Radiat Protect, Hannover, Germany; [Mamach, Martin; Kessler, Mariella; Kurt, Simone; Berding, Georg] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany; [Kessler, Mariella; Bankstahl, Jens P.; Bengel, Frank M.; Berding, Georg] Hannover Med Sch, Dept Nucl Med, Hannover, Germany; [Kurt, Simone] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Kurt, Simone] Saarland Univ, CIPMM, Dept Biophys, Homburg, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Universitatsklinikum des Saarlandes	Mamach, M (corresponding author), Hannover Med Sch, Dept Med Phys & Radiat Protect, Hannover, Germany.; Mamach, M (corresponding author), Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany.	mamach.martin@mh-hannover.de	Bengel, Frank/AAR-7353-2020	Mamach, Martin/0000-0002-3461-2668; Kurt, Simone/0000-0002-1820-2597; Bengel, Frank/0000-0003-4529-7963	public "Deutsche Forschungsgemeinschaft" (DFG) [EXC 1077]	public "Deutsche Forschungsgemeinschaft" (DFG)	This research was executed within the Cluster of Excellence EXC 1077 "Hearing for all: Models, technology and solutions for diagnostics, restoration and support of hearing", funded by the public "Deutsche Forschungsgemeinschaft" (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SD, 1999, NEUROSCIENCE, V93, P1375, DOI 10.1016/S0306-4522(99)00300-0; Ahn SH, 2004, HEARING RES, V196, P33, DOI 10.1016/j.heares.2004.05.012; Arno P, 2001, NEUROIMAGE, V13, P632, DOI 10.1006/nimg.2000.0731; Berding G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128743; Blamey PJ, 2015, EAR HEARING, V36, P408, DOI 10.1097/AUD.0000000000000150; Chonde DB, 2013, INVEST RADIOL, V48, P302, DOI 10.1097/RLI.0b013e3182839fbc; CLARK WW, 1991, J ACOUST SOC AM, V90, P155, DOI 10.1121/1.401309; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; Dedeurwaerdere S, 2009, EUR J NUCL MED MOL I, V36, P958, DOI 10.1007/s00259-009-1066-4; Deutscher A, 2006, NEUROREPORT, V17, P853, DOI 10.1097/01.wnr.0000221837.20255.62; Giraud AL, 2001, AUDIOL NEURO-OTOL, V6, P381, DOI 10.1159/000046847; Hsu WC, 2009, ACTA OTO-LARYNGOL, V129, P423, DOI 10.1080/00016480802593497; Jang DP, 2012, NEUROREPORT, V23, P228, DOI 10.1097/WNR.0b013e32835022c7; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Knoop BO, 2002, PHYS MED BIOL, V47, P1237, DOI 10.1088/0031-9155/47/8/302; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laudanski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050539; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Lu W, 2005, HEARING RES, V205, P115, DOI 10.1016/j.heares.2005.03.010; Mamach M, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0362-z; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Parellada E, 2008, NUCL MED COMMUN, V29, P894, DOI 10.1097/MNM.0b013e328302cd10; Paul AK, 2009, NEUROIMAGE, V44, P312, DOI 10.1016/j.neuroimage.2008.09.024; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pietrini P, 2000, J NUCL MED, V41, P575; Rao DB, 2000, HEARING RES, V150, P206, DOI 10.1016/S0378-5955(00)00202-1; Rausch I, 2015, EJNMMI PHYS, V2, DOI 10.1186/s40658-015-0132-1; Ruytjens L, 2006, ACTA OTO-LARYNGOL, V126, P1236, DOI 10.1080/00016480600801373; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Smith JJ, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/754014; Soto-Montenegro M, 2009, MOL IMAGING BIOL, V11, P94, DOI 10.1007/s11307-008-0179-7; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Willmore BDB, 2009, CURR BIOL, V19, pR1123, DOI 10.1016/j.cub.2009.11.003; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Zhou Y, 2017, BIOCHEM BIOPH RES CO, V486, P833, DOI 10.1016/j.bbrc.2017.03.140; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	39	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205044	10.1371/journal.pone.0205044	http://dx.doi.org/10.1371/journal.pone.0205044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278068	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200036
J	Hu, XL; Wei, YT; Huang, SL; Liu, G; Wang, YH; Hu, DF; Liu, SQ				Hu, Xiaolong; Wei, Yuting; Huang, Songlin; Liu, Gang; Wang, Yihua; Hu, Defu; Liu, Shuqiang			Effects of breeding center, age and parasite burden on fecal triiodothyronine levels in forest musk deer	PLOS ONE			English	Article							THYROID-HORMONE; SEX; THYROXINE; MORTALITY; FLOTATION; IMMUNITY; GENDER; HORSES; FECES	The objective of this study was to evaluate the effects of sex, breeding center and age on fecal triiodothyronine levels in captive forest musk deer Moschus berezovskii, and to explore the age-intensity model of gastrointestinal parasites. Furthermore, the association between fecal triiodothyronine levels and parasite egg shedding was also analyzed. We collected musk deer fecal samples from two breeding centers located in Shaanxi and Sichuan province, China. Enzyme-linked immunosorbent assays were utilized to estimate the fecal triiodothyronine concentrations and profiles, and fecal parasite eggs or oocysts were counted using the McMaster technique. Female deer from both breeding centers consistently showed higher triiodothyronine concentrations than those observed in males, which indicates that a distinct physiology pattern occurs by sex. The triiodothyronine concentration in Sichuan breeding center was significantly higher than that in Shaanxi center for both sexes, suggesting that differences in environment, diet and management practices are likely to affect the metabolism. In addition, a negative relationship between triiodothyronine concentrations and age was found (r = - 0.75, p < 0.001), and parasite egg shedding was also negatively associated with age (r = - 0.51, p < 0.001), by which we can infer that older animals evolves a more developed immune system. Finally, a positive association between parasite egg shedding and triiodothyronine levels was found, which could be explained by the additional energy metabolism resulting from parasitic infection. Results from this study might suggest metabolic and immunological adaptations in forest musk deer. These baseline data could be used to unveil metabolic status and establish parasite control strategies, which has great potential in captive population management as well as their general health evaluations.	[Hu, Xiaolong; Wei, Yuting; Wang, Yihua; Hu, Defu; Liu, Shuqiang] Beijing Forestry Univ, Coll Nat Conservat, Lab Noninvas Res Technol Endangered Species, Beijing, Peoples R China; [Huang, Songlin] Chinese Acad Forestry, China Wildlife Mark Ctr, Beijing, Peoples R China; [Liu, Gang] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Forestry; Chinese Academy of Forestry; Institute of Wetland Research, CAF	Hu, DF; Liu, SQ (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Lab Noninvas Res Technol Endangered Species, Beijing, Peoples R China.	hudefu2016@163.com; liushuqiang76@sina.com	Hu, Xiaolong/GRR-4875-2022; Liu, Gang/AAE-4197-2022	Hu, Xiaolong/0000-0001-9071-0177; Liu, Gang/0000-0002-3614-0561	State Forestry Administration of China; Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd [2015HXFWBHQ-HDF-001]	State Forestry Administration of China; Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd	DH was funded by the State Forestry Administration of China (http://www.forestry.gov.cn/; musk deer 2016), and Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd (http://www.zzpzh.cn/; 2015HXFWBHQ-HDF-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Chethan G. E., 2016, Comparative Clinical Pathology, V25, P987, DOI 10.1007/s00580-016-2291-4; Cringoli G, 2004, VET PARASITOL, V123, P121, DOI 10.1016/j.vetpar.2004.05.021; da Costa VMC, 2001, J ENDOCRINOL, V171, P193, DOI 10.1677/joe.0.1710193; Eshratkhah B., 2010, Comparative Clinical Pathology, V19, P15, DOI 10.1007/s00580-009-0904-x; Flower JE, 2015, J ZOO WILDLIFE MED, V46, P456, DOI 10.1638/2014-0127.1; Fukuhara K, 1996, J NEUROENDOCRINOL, V8, P533, DOI 10.1046/j.1365-2826.1996.04877.x; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; He L, 2014, APPL ANIM BEHAV SCI, V156, P1, DOI 10.1016/j.applanim.2014.03.011; Herbert DR, 2000, J IMMUNOL, V165, P4544, DOI 10.4049/jimmunol.165.8.4544; Hu XL, 2016, J HELMINTHOL, V90, P680, DOI 10.1017/S0022149X15000942; Hubl W, 2002, CLIN CHEM LAB MED, V40, P165, DOI 10.1515/CCLM.2002.028; Ingole S.D., 2012, J BUFFALO SCI, V1, P39; Kahl S, 2015, DOMEST ANIM ENDOCRIN, V52, P43, DOI 10.1016/j.domaniend.2015.02.001; Keech AL, 2010, GEN COMP ENDOCR, V166, P180, DOI 10.1016/j.ygcen.2009.11.014; Khalil B., 2011, Comparative Clinical Pathology, V20, P115, DOI 10.1007/s00580-010-0962-0; Klei TR, 1999, VET PARASITOL, V85, P123, DOI 10.1016/S0304-4017(99)00093-X; Kohel KA, 2001, GEN COMP ENDOCR, V121, P214, DOI 10.1006/gcen.2000.7595; Kuzmina TA, 2016, VET PARASITOL, V227, P56, DOI 10.1016/j.vetpar.2016.07.024; Kyriacou A, 2015, EUR J INTERN MED, V26, P563, DOI 10.1016/j.ejim.2015.07.017; Lind EO, 1999, EQUINE VET J, V31, P68, DOI 10.1111/j.2042-3306.1999.tb03793.x; Matijatko V, 2009, VET PARASITOL, V162, P263, DOI 10.1016/j.vetpar.2009.03.011; Morganti S, 2004, J ENDOCRINOLOGICAL S, V28, P101; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Myers MJ, 2006, COMP BIOCHEM PHYS A, V145, P90, DOI 10.1016/j.cbpa.2006.05.004; Nicassio M, 2008, ANIM REPROD SCI, V107, P335, DOI 10.1016/j.anireprosci.2008.05.112; Norman A.W., 1997, HORMONES; Novoselec J, 2009, ITAL J ANIM SCI, V8, P208, DOI 10.4081/ijas.2009.s3.208; Olifiers N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143997; Oppenheimer JH, 1999, BIOCHIMIE, V81, P539, DOI 10.1016/S0300-9084(99)80107-2; Petkov P., 2008, Trakia Journal of Sciences, V6, P16; Pit DSS, 2001, PARASITOL RES, V87, P722, DOI 10.1007/s004360100419; Polat H, 2014, J ANIM PLANT SCI, V24, P445; Roth GS, 2002, HORM METAB RES, V34, P378, DOI 10.1055/s-2002-33469; Sheng HL, 2007, MUSK DEER CHINA, P188; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; StAubin DJ, 1996, MAR MAMMAL SCI, V12, P1, DOI 10.1111/j.1748-7692.1996.tb00301.x; Suzuki S, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-1; TOMASI TE, 1991, COMP BIOCHEM PHYS A, V100, P503, DOI 10.1016/0300-9629(91)90363-H; van Oers K, 2010, J ORNITHOL, V151, P69, DOI 10.1007/s10336-009-0427-x; Wasser SK, 2010, GEN COMP ENDOCR, V168, P1, DOI 10.1016/j.ygcen.2010.04.004; West KL, 2014, GEN COMP ENDOCR, V197, P73, DOI 10.1016/j.ygcen.2013.11.021; Yang QS, 2003, BIOL CONSERV, V109, P333, DOI 10.1016/S0006-3207(02)00159-3	44	7	9	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205080	10.1371/journal.pone.0205080	http://dx.doi.org/10.1371/journal.pone.0205080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273412	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700064
J	De Wolfe, TJ; Eggers, S; Barker, AK; Kates, AE; Dill-McFarland, KA; Suen, G; Safdar, N				De Wolfe, T. J.; Eggers, S.; Barker, A. K.; Kates, A. E.; Dill-McFarland, K. A.; Suen, G.; Safdar, N.			Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection	PLOS ONE			English	Article							FECAL MICROBIOTA; SEQUENCE DATA; RESISTANCE; KEGG	Perturbations in the gastrointestinal microbiome caused by antibiotics are a major risk factor for Clostridium difficile infection (CDI). Probiotics are often recommended to mitigate CDI symptoms; however, there exists only limited evidence showing probiotic efficacy for CDI. Here, we examined changes to the GI microbiota in a study population where probiotic treatment was associated with significantly reduced duration of CDI diarrhea. Subjects being treated with standard of care antibiotics for a primary episode of CDI were randomized to probiotic treatment or placebo for 4 weeks. Probiotic treatment consisted of a daily multi-strain capsule (Lactobacillus acidophilus NCFM, ATCC 700396; Lactobacillus paracasei Lpc-37, ATCC SD5275; Bifidobacterium lactis Bi-07, ATCC SC5220; Bifidobacterium lactis B1-04, ATCC SD5219) containing 1.7 x 10(10) CFUs. Stool was collected and analyzed using 16S rRNA sequencing. Microbiome analysis revealed apparent taxonomic differences between treatments and timepoints. Subjects administered probiotics had reduced Verrucomicrobiaceae at week 8 compared to controls. Bacteroides were significantly reduced between weeks 0 to 4 in probiotic treated subjects. Ruminococcus (family Lachnospiraceae), tended to be more abundant at week 8 than week 4 within the placebo group and at week 8 than week 0 within the probiotic group. Similar to these results, previous studies have associated these taxa with probiotic use and with mitigation of CDI symptoms. Compositional prediction of microbial community function revealed that subjects in the placebo group had microbiomes enriched with the iron complex transport system, while probiotic treated subjects had microbiomes enriched with the antibiotic transport system. Results indicate that probiotic use may impact the microbiome function in the face of a CDI; yet, more sensitive methods with higher resolution are warranted to better elucidate the roles associated with these changes. Continuing studies are needed understand probiotic effects on microbiome structure and function and the resulting impacts on CDI.	[De Wolfe, T. J.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [De Wolfe, T. J.; Kates, A. E.; Safdar, N.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Infect Dis, Madison, WI 53706 USA; [Eggers, S.; Barker, A. K.] Univ Wisconsin, Madison Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Kates, A. E.; Safdar, N.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Dill-McFarland, K. A.; Suen, G.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison	De Wolfe, TJ (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.; De Wolfe, TJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Infect Dis, Madison, WI 53706 USA.	tjdewolfe@gmail.com	De Wolfe, Travis J/C-6827-2013; Suen, Garret/AAF-2080-2019	De Wolfe, Travis J/0000-0001-6261-1235; Suen, Garret/0000-0002-6170-711X; Eggers, Shoshannah/0000-0002-4321-9219	National Institute of Food and Agriculture, United States Department of Agriculture [WIS01729]; National Institutes of Health [1R03AG040669-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Food and Agriculture, United States Department of Agriculture, ID #WIS01729 to G.S. and by the National Institutes of Health, ID #1R03AG040669-01A1 to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Abujamel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076269; [Anonymous], R LANG ENV STAT COMP; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Barker AK, 2017, J ANTIMICROB CHEMOTH, V72, P1; Bassis CM, 2014, ANTIMICROB AGENTS CH, V58, P2767, DOI 10.1128/AAC.02262-13; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4; Butler M., 2016, EARLY DIAGNOSIS PREV; Cammarota G, 2014, INTERN EMERG MED, V9, P365, DOI 10.1007/s11739-014-1069-4; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC, P1; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Engelbrektson A, 2009, J MED MICROBIOL, V58, P663, DOI 10.1099/jmm.0.47615-0; Goldenberg JZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub3; Grehan MJ, 2010, J CLIN GASTROENTEROL, V44, P551, DOI 10.1097/MCG.0b013e3181e5d06b; Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05184-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M., 2000, KEGG KYOTO ENCY GENE; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Mathur H, 2014, GUT MICROBES, V5, P696, DOI 10.4161/19490976.2014.983768; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Miller M, 2009, ANAEROBE, V15, P281, DOI 10.1016/j.anaerobe.2009.08.005; Noguchi K, 2012, J STAT SOFTWARE; Oksanen J., 2017, VEGAN COMMUNITY ECOL, P1; OLSON MM, 1994, INFECT CONT HOSP EP, V15, P371; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; ROLFE RD, 1981, J INFECT DIS, V143, P470, DOI 10.1093/infdis/143.3.470; Sanders ME, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0629-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013	47	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204253	10.1371/journal.pone.0204253	http://dx.doi.org/10.1371/journal.pone.0204253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265691	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500021
J	Romano, MR; Cennamo, G; Montorio, D; Del Prete, S; Ferrara, M; Cennamo, G				Romano, Mario R.; Cennamo, Gilda; Montorio, Daniela; Del Prete, Salvatore; Ferrara, Mariantonia; Cennamo, Giovanni			Correlation between various trace elements and ultramicroscopic structure of epiretinal macular membranes and glial cells	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; PROLIFERATIVE DIABETIC-RETINOPATHY; FIBRILLARY ACIDIC PROTEIN; PATHOPHYSIOLOGICAL CONDITIONS; VITREOMACULAR TRACTION; DNA-SYNTHESIS; VITREORETINOPATHY; FIBRONECTIN; EXPRESSION; DETACHMENT	Introduction Elements such as zinc, iron, copper, sulphur and phosphorus have been identified in retinal layers and implicated in vital retinal functions. Regarding mineral composition of epiretinal membranes (ERMs), literature is lacking. This study aimed to analyze both mineral composition and anatomical ultrastructure of ERMs to clarify the pathophysiology of this disease. Methods Twenty ERMs (10 diabetic ERMs and 10 idiopathic ERMs) from 20 patients were harvested during pars plana vitrectomy. Scanning Electron Microscopy (SEM) was used to investigate the anatomical ultrastructure of the peeled ERMs. Mineral composition was analyzed using energy-dispersive spectrometry (EDS). The most frequent elements were evaluated in relation to appearance of ERMs analyzed at SEM and at OCT images. Results Sulphur was the most frequent element found (in 80% of the samples), followed by sodium (50%) and phosphorus (45%). The presence of these elements was not significantly different between diabetic and idiopathic ERMs (P >0.05). Using SEM we found a folded tissue in all ERMs, except in 4 ERMs, where we observed only a smooth tissue. There was a trend of sodium to be more frequent in ERMs with folded layers at SEM examination. Conclusions Several elements were identified in ERMs, and sulphur, sodium and phosphorus were the most frequent ones. This finding may help to understand their role in the physiopatology of epiretinal proliferation and in glial activation.	[Romano, Mario R.] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele Milan, Italy; [Cennamo, Gilda] Univ Federico II, Dept Publ Hlth, Naples, Italy; [Montorio, Daniela; Ferrara, Mariantonia; Cennamo, Giovanni] Univ Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Del Prete, Salvatore] Univ Federico II, Interdept Electron Microscope Ctr, Naples, Italy	Humanitas University; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Romano, MR (corresponding author), Humanitas Univ, Dept Biomed Sci, Pieve Emanuele Milan, Italy.	mario.romano.md@gmail.com	Ferrara, Mariantonia/AEC-7557-2022; Del Prete, Salvatore/AAC-7867-2020; Montorio, Daniela/AAJ-8687-2020; Del Prete, Salvatore/AAW-7149-2021	Ferrara, Mariantonia/0000-0002-1191-4989; Del Prete, Salvatore/0000-0001-6004-7781; Romano, Mario R/0000-0003-0348-0532; Montorio, Daniela/0000-0003-1423-9621				Armstrong D, 1998, OPHTHALMOLOGICA, V212, P410, DOI 10.1159/000027378; Azzolini C, 2017, EUR J OPHTHALMOL, V19, DOI [10.5301/ejo, DOI 10.5301/EJO]; Boscia F, 2016, GLIA, V64, P1677, DOI 10.1002/glia.23030; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P2317, DOI 10.1097/IAE.0000000000000349; Charteris DG, 2007, GRAEF ARCH CLIN EXP, V245, P93, DOI 10.1007/s00417-006-0323-5; ERICKSON PA, 1987, EXP EYE RES, V44, P37, DOI 10.1016/S0014-4835(87)80023-4; Erie JC, 2009, AM J OPHTHALMOL, V147, P276, DOI 10.1016/j.ajo.2008.08.014; Gandorfer A, 2005, AM J OPHTHALMOL, V139, P638, DOI 10.1016/j.ajo.2004.11.035; Gass JDM., 1997, DIAGNOSIS TREATMENT, V4th edition; GRIERSON I, 1994, EYE, V8, P255, DOI 10.1038/eye.1994.54; GRISANTI S, 1993, BRIT J OPHTHALMOL, V77, P238, DOI 10.1136/bjo.77.4.238; Heidenkummer H.-P., 1996, Ophthalmologe, V93, P675, DOI 10.1007/s003470050057; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Hiscott P, 2002, EYE, V16, P393, DOI 10.1038/sj.eye.6700196; HISCOTT PS, 1983, T OPHTHAL SOC UK, V103, P89; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P698, DOI 10.1136/bjo.68.10.698; Joshi M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/192582; KAMPIK A, 1981, ARCH OPHTHALMOL-CHIC, V99, P1445, DOI 10.1001/archopht.1981.03930020319025; Kenawy N, 2010, OPHTHALMOLOGY, V117, P320, DOI 10.1016/j.ophtha.2009.07.024; Kodal H, 2000, INVEST OPHTH VIS SCI, V41, P4262; LEWIS GP, 1994, AM J OPHTHALMOL, V118, P368, DOI 10.1016/S0002-9394(14)72962-9; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; MARANO RPC, 1994, INVEST OPHTH VIS SCI, V35, P2791; MAZURE A, 1992, INVEST OPHTH VIS SCI, V33, P3407; Moll V, 2002, INVEST OPHTH VIS SCI, V43, P766; Newbury DE, 2013, SCANNING, V35, P141, DOI 10.1002/sca.21041; NISHIMURA H, 1991, HISTOCHEMISTRY, V95, P535, DOI 10.1007/BF00266738; Rose CR, 2016, NEUROSCIENCE, V323, P121, DOI 10.1016/j.neuroscience.2015.03.002; Rose CR, 2016, GLIA, V64, P1611, DOI 10.1002/glia.22964; Rose CR, 2013, GLIA, V61, P1191, DOI 10.1002/glia.22492; Scavelli K, 2015, J OCUL PHARMACOL TH, V31, P396, DOI 10.1089/jop.2015.0057; Schumann RG, 2006, AM J OPHTHALMOL, V141, P1112, DOI 10.1016/j.ajo.2006.01.074; Schumann RG, 2011, INVEST OPHTH VIS SCI, V52, P7822, DOI 10.1167/iovs.11-7514; Ugarte M, 2013, SURV OPHTHALMOL, V58, P585, DOI 10.1016/j.survophthal.2012.12.002; Ugarte M, 2012, METALLOMICS, V4, P1245, DOI 10.1039/c2mt20157g; VINORES SA, 1990, INVEST OPHTH VIS SCI, V31, P2529; VINORES SA, 1990, INVEST OPHTH VIS SCI, V31, P14; Yoon HS, 1996, AM J OPHTHALMOL, V122, P67, DOI 10.1016/S0002-9394(14)71965-8; Zhao F, 2013, RETINA-J RET VIT DIS, V33, P77, DOI 10.1097/IAE.0b013e3182602087	40	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204497	10.1371/journal.pone.0204497	http://dx.doi.org/10.1371/journal.pone.0204497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265684	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500035
J	Trost, N; Rempel, E; Ermakova, O; Tamirisa, S; Parcalabescu, L; Boutros, M; Lohmann, JU; Lohmann, I				Trost, Nils; Rempel, Eugen; Ermakova, Olga; Tamirisa, Srividya; Parcalabescu, Letitia; Boutros, Michael; Lohmann, Jan U.; Lohmann, Ingrid			WEADE: A workflow for enrichment analysis and data exploration	PLOS ONE			English	Article							LARGE GENE LISTS; ONTOLOGY; NETWORKS; UPDATE; SERVER	Data analysis based on enrichment of Gene Ontology terms has become an important step in exploring large gene or protein expression datasets and several stand-alone or web tools exist for that purpose. However, a comprehensive and consistent analysis downstream of the enrichment calculation is missing so far. With WEADE we present a free web application that offers an integrated workflow for the exploration of genomic data combining enrichment analysis with a versatile set of tools to directly compare and intersect experiments or candidate gene lists of any size or origin including cross-species data. Lastly, WEADE supports the graphical representation of output data in the form of functional interaction networks based on prior knowledge, allowing users to go from plain expression data to functionally relevant candidate sub-lists in an interactive and consistent manner.	[Trost, Nils; Rempel, Eugen; Ermakova, Olga; Tamirisa, Srividya; Parcalabescu, Letitia; Lohmann, Jan U.; Lohmann, Ingrid] COS, Heidelberg, Germany; [Boutros, Michael] DKFZ, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Lohmann, I (corresponding author), COS, Heidelberg, Germany.	ingrid.lohmann@cos.uni-heidelberg.de	Boutros, Michael/C-3566-2008; Lohmann, Jan/T-3776-2019; Tamirisa, Srividya/C-9789-2018; Tamirisa-Suddapalli, Srividya/P-9339-2019	Boutros, Michael/0000-0002-9458-817X; Lohmann, Jan/0000-0003-3667-187X; Tamirisa, Srividya/0000-0003-0725-8867; Tamirisa-Suddapalli, Srividya/0000-0003-0725-8867; Trost, Nils/0000-0002-5171-018X; Parcalabescu, Letitia/0000-0002-3892-5629	Deutsche Forschungsgemeinschaft [SFB873]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB873.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Montojo J, 2014, F1000RESEARCH; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Voolstra CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020392; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wright RM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1540-2; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	17	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204016	10.1371/journal.pone.0204016	http://dx.doi.org/10.1371/journal.pone.0204016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265728	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500016
J	Chen, C; Ao, YB; Wang, Y; Li, JY				Chen, Chuan; Ao, Yibin; Wang, Yan; Li, Jiayue			Performance appraisal method for rural infrastructure construction based on public satisfaction	PLOS ONE			English	Article							SOCIAL MULTICRITERIA EVALUATION; SUSTAINABILITY; SYSTEMS; MODELS	Rural infrastructure has rather fixed users compared to urban infrastructure. This study evaluated the effect of rural infrastructure construction from the perspective of farmers. First, this study revised the American Customer Satisfaction Index (ACSI) model and selected a performance appraisal index for rural infrastructure based on this revised model. Then, the study adopted an interpretive structural model (ISM), analyzed the influence of each index factor, and developed a hierarchical directed graph. Finally, based on the mutual-influence relationships among the index factors in the hierarchical directed graph, a performance appraisal analytic network process (ANP) model was established. Based on discussions with rural college students and rural households in Sichuan, China, 246 questionnaires were obtained pertaining to rural infrastructure, and an empirical analysis was conducted. The results indicated that the performance of rural infrastructure construction is not very good. In particular, the full use of infrastructure and its role in improving the environment were found to be the worst. Meanwhile, the possibility of building information transparency and the longitudinal comparison of perceived performance appraisal results were the best. The performance of rural infrastructure construction was evaluated based on the perceptions of the direct users of rural infrastructure, and the relationship between the factors and the weight was measured reasonably. The proposed method was found to be workable and the analysis results reliable and effective.	[Chen, Chuan; Ao, Yibin] Sichuan Univ, Sch Business, Chengdu, Sichuan, Peoples R China; [Ao, Yibin; Li, Jiayue] Chengdu Univ Technol, Coll Environm & Civil Engn, Chengdu, Sichuan, Peoples R China; [Wang, Yan] Sichuan Coll Architectural Technol, Dept Engn Management, Deyang, Sichuan, Peoples R China	Sichuan University; Chengdu University of Technology	Ao, YB (corresponding author), Sichuan Univ, Sch Business, Chengdu, Sichuan, Peoples R China.; Ao, YB (corresponding author), Chengdu Univ Technol, Coll Environm & Civil Engn, Chengdu, Sichuan, Peoples R China.	aoyibin10@mail.cdut.edu.cn		Ao, Yibin/0000-0001-7288-638X	Fundamental Research Funds for the Central Universities [2012017yjsy215]; Natural Science Key Project from Sichuan Provincial Department of Education [18ZA0048]; Government of Sichuan Province; Social Capital [0050205502123]; Fundamental Philosophy and Social Science Research Fund for Chengdu University of Technology [YJ2017-NS011]; Research on BIM Technology Resource Sharing Platform Construction and Cooperation Mechanism [CHJK{2017}119]; Development Research Center of Oil and Gas, Sichuan [CYQK-SKB17-04]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Key Project from Sichuan Provincial Department of Education; Government of Sichuan Province; Social Capital; Fundamental Philosophy and Social Science Research Fund for Chengdu University of Technology; Research on BIM Technology Resource Sharing Platform Construction and Cooperation Mechanism; Development Research Center of Oil and Gas, Sichuan	This work was funded by the Fundamental Research Funds for the Central Universities (2012017yjsy215) and The Natural Science Key Project from Sichuan Provincial Department of Education (18ZA0048). The authors appreciate the financial support from (JianQi 666) Promoting the Cooperation 24 between the Government of Sichuan Province and Social Capital (0050205502123), The Fundamental Philosophy and Social Science Research Fund for Chengdu University of Technology (YJ2017-NS011), The Research on BIM Technology Resource Sharing Platform Construction and Cooperation Mechanism (CHJK{2017}119), Development Research Center of Oil and Gas, Sichuan (CYQK-SKB17-04).	Anagnostopoulos K, 2012, J WATER RES PL-ASCE, V138, P125, DOI 10.1061/(ASCE)WR.1943-5452.0000155; Ariaratnam ST, 2013, J CONSTR ENG M, V139, DOI 10.1061/(ASCE)CO.1943-7862.0000763; Bacior S, 2018, ECOL INFORM, V44, P82, DOI 10.1016/j.ecoinf.2018.02.001; Bassioni HA, 2004, J MANAGE ENG, V20, P42, DOI 10.1061/(ASCE)0742-597X(2004)20:2(42); Bocchini P, 2014, J INFRASTRUCT SYST, V20, DOI 10.1061/(ASCE)IS.1943-555X.0000177; Boz MA, 2015, J CONSTR ENG M, V141, DOI 10.1061/(ASCE)CO.1943-7862.0000911; CARDOZO RN, 1965, J MARKETING RES, V2, P244, DOI 10.2307/3150182; Chunchao W, 2010, SHANGHAI J EC, V3; Day RL, 1977, CONSUMER SATISFACTIO, P64; Domingo N, 2015, BUILDINGS-BASEL, V5, P860, DOI 10.3390/buildings5030860; Fan LM, 2009, ISS AGRI EC, V9, P51; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gan J., 2011, INQUIRY EC ISSUES, V11, P153; Glick S, 2013, J CONSTR ENG M, V139, DOI 10.1061/(ASCE)CO.1943-7862.0000762; Hao E. H., 2015, RURAL EC, V4, P64; Howard J. A., 1969, THEORY BUYER BEHAV; Hsu SH, 2008, EXPERT SYST APPL, V34, P3033, DOI 10.1016/j.eswa.2007.06.036; HUNT HK, 1991, J SOC ISSUES, V47, P107, DOI 10.1111/j.1540-4560.1991.tb01814.x; Jeong JS, 2013, LAND USE POLICY, V32, P108, DOI 10.1016/j.landusepol.2012.09.018; Lai IKW, 2010, CONSTR MANAG ECON, V28, P377, DOI 10.1080/01446190903521515; Liu Hong-yu, 2006, Journal of China Universities of Posts and Telecommunications, V13, P109, DOI 10.1016/S1005-8885(07)60093-4; Ma J. Q., 2013, RES LOCAL GOVT PROJE, P15; Ma L. J., 2009, FINANCE TRADE RES, V3, P38; Medagama A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192679; Munda G, 2006, LAND USE POLICY, V23, P86, DOI 10.1016/j.landusepol.2004.08.012; Munda G, 2008, ENVIRON PLANN C, V26, P712, DOI 10.1068/c06105s; National Bureau of Statistics of China, CHIN STAT YB 2015; Parrish K., 2013, PRACTICE PERIODICAL, V19, P89; Ramani TL, 2011, J TRANSP ENG-ASCE, V137, P404, DOI 10.1061/(ASCE)TE.1943-5436.0000255; Reza B, 2014, CLEAN TECHNOL ENVIR, V16, P251, DOI 10.1007/s10098-013-0615-5; SAATY RW, 1987, MATH MODELLING, V9, P161, DOI 10.1016/0270-0255(87)90473-8; Saaty T. L., 2004, Journal of Systems Science and Systems Engineering, V13, P129, DOI 10.1007/s11518-006-0158-y; Shen LY, 2013, J CONSTR ENG M, V139, P591, DOI 10.1061/(ASCE)CO.1943-7862.0000628; Sierra LA, 2018, J CLEAN PROD, V187, P496, DOI 10.1016/j.jclepro.2018.03.022; Sierra LA, 2018, J CLEAN PROD, V176, P521, DOI 10.1016/j.jclepro.2017.12.140; Sierra LA, 2017, ENVIRON IMPACT ASSES, V67, P61, DOI 10.1016/j.eiar.2017.08.003; Sierra LA, 2017, ENVIRON IMPACT ASSES, V65, P41, DOI 10.1016/j.eiar.2017.02.004; Sierra LA, 2016, J CONSTR ENG M, V142, DOI 10.1061/(ASCE)CO.1943-7862.0001099; Torres-Machi C, 2014, REV CONSTR, V13, P49, DOI 10.4067/S0718-915X2014000200006; WARFIELD JN, 1973, IEEE T SYST MAN CYB, VSMC3, P441, DOI 10.1109/TSMC.1973.4309270; Wen-yia L, 2011, J HUBEI U ED, V5; Wenyi L, 2012, J CHONGQING U SOCIAL, V4; Yi H., 2008, CHINA SOFT SCI, V11, P106; Zhang KH, 2009, J ZHONGNAN U EC LAW, V176, P36; Zhang S. B., 2012, STAT DECISION, V1, P175; Zhou J, 2015, J IND ENG MANAG-JIEM, V8, P1002, DOI 10.3926/jiem.1496	46	5	5	12	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204563	10.1371/journal.pone.0204563	http://dx.doi.org/10.1371/journal.pone.0204563			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286101	gold, Green Submitted, Green Published			2022-12-27	WOS:000446383500024
J	Chen, YY; Lin, KH; Huang, HK; Chang, H; Lee, SC; Huang, TW				Chen, Ying-Yi; Lin, Kuan-Hsun; Huang, Hsu-Kai; Chang, Hung; Lee, Shih-Chun; Huang, Tsai-Wang			The beneficial application of preoperative 3D printing for surgical stabilization of rib fractures	PLOS ONE			English	Article							FLAIL CHEST; FIXATION; INJURY; TRAUMA	Objectives The beneficial application of three-dimensional (3D) printing for surgical stabilization of rib fractures (SSRF) has never been proposed in the literature before. The aim of this study was to verify patients' surgical outcomes when utilizing preoperative three-dimensional printing for SSRF. Methods We retrospectively reviewed the records of all consecutive patients who were treated at our hospital for SSRF from July 2015 to December 2017. The patients were divided into two groups according to whether or not 3D printing was utilized. Results Forty-eight patients who underwent SSRF at our hospital were enrolled. Of them, three patients underwent bilateral surgeries. The patients with application of preoperative 3D printing for SSRF had statistically significant associations with shorter operation time per fixed plate (p < 0.001), and a smaller incision length (p < 0.001). Conclusions We present an useful technique involving 3D printing for promoting SSRF significantly with shorter operation time and an appropriate incision length.	[Chen, Ying-Yi; Lin, Kuan-Hsun; Huang, Hsu-Kai; Chang, Hung; Lee, Shih-Chun; Huang, Tsai-Wang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Chen, Ying-Yi; Huang, Tsai-Wang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Huang, TW (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan.; Huang, TW (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	chi-wang@yahoo.com.tw	Chen, Ying Yi/AAF-6765-2022; Chen, Ying Yi/AFJ-9705-2022; Chen, Ying-Yi/AAN-7880-2020	Chen, Ying Yi/0000-0003-3753-4877; Chen, Ying Yi/0000-0003-3753-4877; 				Althausen PL, 2011, J ORTHOP TRAUMA, V25, P641, DOI 10.1097/BOT.0b013e318234d479; Baskaran V, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00069; BEAL SL, 1985, AM J SURG, V150, P324, DOI 10.1016/0002-9610(85)90071-6; Berman B, 2012, BUS HORIZONS, V55, P155, DOI 10.1016/j.bushor.2011.11.003; Bhatnagar A, 2012, J AM COLL SURGEONS, V215, P201, DOI 10.1016/j.jamcollsurg.2012.02.023; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; Majercik S, 2014, AM J SURG, V208, P88, DOI 10.1016/j.amjsurg.2013.08.051; Marasco SF, 2013, J AM COLL SURGEONS, V216, P924, DOI 10.1016/j.jamcollsurg.2012.12.024; McMenamin PG, 2014, ANAT SCI EDUC, V7, P479, DOI 10.1002/ase.1475; Nickerson TP, 2015, WORLD J SURG, V39, P789, DOI 10.1007/s00268-014-2862-y; Nirula R, 2006, AM SURGEON, V72, P307; Schots JPM, 2017, ANN THORAC SURG, V103, P940, DOI 10.1016/j.athoracsur.2016.09.036; Tanaka H, 2002, J TRAUMA, V52, P727, DOI 10.1097/00005373-200204000-00020; Tarng YW, 2016, SURG ENDOSC, V30, P388, DOI 10.1007/s00464-015-4207-9	14	7	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204652	10.1371/journal.pone.0204652	http://dx.doi.org/10.1371/journal.pone.0204652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286120	gold, Green Submitted, Green Published			2022-12-27	WOS:000446383500032
J	Dey, A; Hay, K; Afroz, B; Chandurkar, D; Singh, K; Dehingia, N; Raj, A; Silverman, JG				Dey, Arnab; Hay, Katherine; Afroz, Bilal; Chandurkar, Dharmendra; Singh, Kultar; Dehingia, Nabamallika; Raj, Anita; Silverman, Jay G.			Understanding intersections of social determinants of maternal healthcare utilization in Uttar Pradesh, India	PLOS ONE			English	Article							INEQUALITIES	Objective To explore intersections of social determinants of maternal healthcare utilization using the Classification and Regression Trees (CART) algorithm which is a machine-learning method used to construct prediction models. Methods Institutional review board approval for this study was granted from Public Health Service- Ethical Review Board (PHS-ERB) and from the Health Ministry Screening Committee (HMSC) facilitated by Indian Council for Medical Research (ICMR). IRB review and approval for the current analyses was obtained from University of California, San Diego. Cross-sectional data were collected from women with children aged 0-11 months (n = 5,565) from rural households in 25 districts of Uttar Pradesh, India. Participants were surveyed on maternal healthcare utilization including registration of pregnancy (model-1), receipt of antenatal care (ANC) during pregnancy (model-2), and delivery at health facilities (model -3). Social determinants of health including wealth, social group, literacy, religion, and early age at marriage were captured during the survey. The Classification and Regression Tree (CART) algorithm was used to explore intersections of social determinants of healthcare utilization. Results CART analyses highlight the intersections, particularly of wealth and literacy, in maternal healthcare utilization in Uttar Pradesh. Model-1 documents that women who are poorer, illiterate and Muslim are less likely to have their pregnancies registered (71.4% vs. 86.0% in the overall sample). Model-2 documents that poorer, illiterate women had the lowest ANC coverage (37.7% vs 45% in the overall sample). Model-3, developed for deliveries at health facilities, highlighted that illiterate and poor women have the lowest representation among facility deliveries (59.6% vs. 69% in the overall sample). Conclusion This paper explores the interactions between determinants of maternal healthcare utilization indicators. The findings in this paper highlights that the interaction of wealth and literacy can play a very strong role in accentuating or diminishing healthcare utilization among women. The study also reveals that religion and women's age at marriage also interact with wealth and literacy to create substantial disparities in utilization. The study provides insights into the effect of intersections of determinants, and highlights the importance of using a more nuanced understanding of the impact of co-occurring forms of marginalization to effectively tackle inequities in healthcare utilization.	[Dey, Arnab; Afroz, Bilal; Chandurkar, Dharmendra; Singh, Kultar; Dehingia, Nabamallika] Sambodhi Res & Commun Pvt Ltd, Noida, India; [Hay, Katherine] Bill & Melinda Gates Fdn, Seattle, WA USA; [Raj, Anita; Silverman, Jay G.] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, Ctr Gender Equ & Hlth, La Jolla, CA 92093 USA	Bill & Melinda Gates Foundation; University of California System; University of California San Diego	Dey, A (corresponding author), Sambodhi Res & Commun Pvt Ltd, Noida, India.	arnab@sambodhi.co.in	Dehingia, Nabamallika/AAY-5588-2021; Dehingia, Nabamallika/AAF-1639-2021; Hay, Katherine/ABB-7795-2021	Dehingia, Nabamallika/0000-0003-1787-9050; Dey, Arnab K./0000-0003-4585-3130	Bill and Melinda Gates Foundation [OPP1083531]; Sambodhi Research and Communications Pvt. Ltd.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Sambodhi Research and Communications Pvt. Ltd.	This study was funded by the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/) Grant No. OPP1083531. Sambodhi Research and Communications Pvt. Ltd. provided support in the form of salaries for authors AD, BA, DC, KS and ND but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Breiman L., 1984, CLASSIFICATION REGRE; CALDWELL JC, 1993, SOC SCI MED, V36, P125, DOI 10.1016/0277-9536(93)90204-H; Census of India, 2011, MMR B 2011 2013; Census of India, PRIM CENS ABSTR 2011; Census of India, UTT PRAD REL CENS 20; International Institute of Population Sciences, 2014, NAT FAM HLTH SURV IN; Iyer A, 2008, Glob Public Health, V3 Suppl 1, P13, DOI 10.1080/17441690801892174; Joe W, 2015, MATERNAL MORTALITY I; Joe W, 2015, HEALTH POLICY PLANN, V30, P407, DOI 10.1093/heapol/czu023; Kapilashrami A, 2015, SOC THEOR HEALTH, V13, P288, DOI 10.1057/sth.2015.16; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Montgomery AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083331; Open Working Group, OP WORK GROUP PROP S; Ostlin P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001115; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sanneving L, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19145; Sciences IIfP, 2007, IND NAT FAM HLTH SUR; Sen G, 2009, J HUM DEV CAPABIL, V10, P397, DOI 10.1080/19452820903048894; Seth A, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0538-6; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Sridharan S, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1287493; SUBBARAO K, 1995, ECON DEV CULT CHANGE, V44, P105, DOI 10.1086/452202; Tan P.-N., 2006, INTRO DATA MINING, P145; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development/The World Bank, 2020, LEVELS TRENDS CHILD; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Weber L, 2003, ADV GEND RES, V7, P181	27	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204810	10.1371/journal.pone.0204810	http://dx.doi.org/10.1371/journal.pone.0204810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286134	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500046
J	Favre, B; Begre, N; Bouameur, JE; Lingasamy, P; Conover, GM; Fontao, L; Borradori, L				Favre, Bertrand; Begre, Nadja; Bouameur, Jamal-Eddine; Lingasamy, Prakash; Conover, Gloria M.; Fontao, Lionel; Borradori, Luca			Desmoplakin interacts with the coil 1 of different types of intermediate filament proteins and displays high affinity for assembled intermediate filaments	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; DESMOSOMAL PROTEINS; HUMAN VIMENTIN; KERATIN; DOMAINS; BINDING; PLECTIN; CELLS; HEART; SKIN	The interaction of intermediate filaments (IFs) with the cell-cell adhesion complexes desmosomes is crucial for cytoskeletal organization and cell resilience in the epidermis and heart. The intracellular desmosomal protein desmoplakin anchors IFs to the cell adhesion complexes predominantly via its four last carboxy-terminal domains (C-terminus). However, it remains unclear why the C-terminus of desmoplakin interacts with different IF types or if there are different binding affinities for each type of IFs that may influence the stability of cell-specific adhesion complexes. By yeast three-hybrid and fluorescence binding assays, we found that the coiled-coil 1 of the conserved central rod domain of the heterodimeric cyto-keratins (Ks) 5 and 14 (K5/K14) was required for their interaction with the C-terminus of desmoplakin, while their unique amino head- and C-tail domains were dispensable. Similar findings were obtained in vitro with K1/K10, and the type III IF proteins desmin and vimentin. Binding assays testing the C-terminus of desmoplakin with assembled K5/K14 and desmin IFs yielded an apparent affinity in the nM range. Our findings reveal that the same conserved domain of IF proteins binds to the C-terminus of desmoplakin, which may help explain the previously reported broad binding IF-specificity to desmoplakin. Our data suggest that desmoplakin high-affinity binding to diverse IF proteins ensures robust linkages of IF cytoskeleton and desmosomes that maintain the structural integrity of cellular adhesion complexes. In summary, our results give new insights into the molecular basis of the IF-desmosome association.	[Favre, Bertrand; Begre, Nadja; Bouameur, Jamal-Eddine; Lingasamy, Prakash; Borradori, Luca] Bern Univ Hosp, Dept Dermatol, Inselspital, Bern, Switzerland; [Favre, Bertrand; Begre, Nadja; Bouameur, Jamal-Eddine; Lingasamy, Prakash] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Conover, Gloria M.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA; [Fontao, Lionel] Geneva Univ Hosp, Dept Dermatol, Geneva, Switzerland; [Bouameur, Jamal-Eddine] Univ Leipzig, SIKT, Leipzig, Germany; [Bouameur, Jamal-Eddine] Univ Leipzig, Inst Biol, Leipzig, Germany; [Lingasamy, Prakash] Univ Tartu, Inst Biomed & Translat Med, Lab Canc Biol, Tartu, Estonia	University of Bern; University Hospital of Bern; University of Bern; Texas A&M University System; Texas A&M University College Station; University of Geneva; Leipzig University; Leipzig University; University of Tartu	Borradori, L (corresponding author), Bern Univ Hosp, Dept Dermatol, Inselspital, Bern, Switzerland.	Luca.Borradori@insel.ch	Lionel, Fontao/AGN-3640-2022; Lingasamy, Prakash/H-5010-2013; Conover, Gloria M/L-2279-2019	Lingasamy, Prakash/0000-0002-8826-4531; Fontao, Lionel/0000-0002-5950-564X; Conover, Gloria/0000-0001-7129-4403	Swiss National Foundation for Research [3100A0-121966]; Swiss Foundation for Research on Muscle Diseases; University of Bern	Swiss National Foundation for Research(Swiss National Science Foundation (SNSF)); Swiss Foundation for Research on Muscle Diseases; University of Bern	This work was supported by the Swiss National Foundation for Research (3100A0-121966 to L.B.), www.snf.ch; the Swiss Foundation for Research on Muscle Diseases (to L.B.), www.fsrmm.ch; and University of Bern (to L.B.), www.unibe.ch.	Akat K, 2003, ACTA NEUROPATHOL, V106, P337, DOI 10.1007/s00401-003-0736-8; Albrecht LV, 2015, J CELL BIOL, V208, P597, DOI 10.1083/jcb.201406020; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Block J, 2015, BBA-MOL CELL RES, V1853, P3053, DOI 10.1016/j.bbamcr.2015.05.009; Bouameur JE, 2017, SUBCELL BIOCHEM, V82, P171, DOI 10.1007/978-3-319-49674-0_7; Bouameur JE, 2014, J INVEST DERMATOL, V134, P2776, DOI 10.1038/jid.2014.255; Bouameur JE, 2014, J INVEST DERMATOL, V134, P885, DOI 10.1038/jid.2013.498; Bouameur JE, 2013, J CELL SCI, V126, P4195, DOI 10.1242/jcs.127779; Choi HJ, 2002, NAT STRUCT BIOL, V9, P612, DOI 10.1038/nsb818; Christensen AH, 2010, J MED GENET, V47, P736, DOI 10.1136/jmg.2010.077891; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Favre B, 2018, BRIT J DERMATOL, V179, P797, DOI 10.1111/bjd.16832; Favre B, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002241; Favre B, 2016, METHOD ENZYMOL, V569, P117, DOI 10.1016/bs.mie.2015.06.017; Favre B, 2011, EUR J CELL BIOL, V90, P390, DOI 10.1016/j.ejcb.2010.11.013; Fogl C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10827; Fontao L, 2003, MOL BIOL CELL, V14, P1978, DOI 10.1091/mbc.e02-08-0548; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; Gallicano GI, 2001, DEVELOPMENT, V128, P929; GREEN KJ, 1988, P NATL ACAD SCI USA, V85, P2613, DOI 10.1073/pnas.85.8.2613; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hudson TY, 2004, METHOD CELL BIOL, V78, P757; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; Lapouge K, 2006, J CELL SCI, V119, P4974, DOI 10.1242/jcs.03255; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Panagopoulou P, 2008, J CELL BIOL, V181, P761, DOI 10.1083/jcb.200710049; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Portet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121090; Puzzi L, 2018, MICRON, V106, P27, DOI 10.1016/j.micron.2017.12.005; QUINLAN RA, 1986, J MOL BIOL, V192, P337, DOI 10.1016/0022-2836(86)90369-4; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Robert A, 2015, P NATL ACAD SCI USA, V112, pE3505, DOI 10.1073/pnas.1505303112; Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069; Sakiyama T, 2016, J DERMATOL, V43, P264, DOI 10.1111/1346-8138.13219; Samuelov L, 2015, CELL TISSUE RES, V360, P457, DOI 10.1007/s00441-014-2062-y; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205038	10.1371/journal.pone.0205038	http://dx.doi.org/10.1371/journal.pone.0205038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286183	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500080
J	Naruse, M; Yamamoto, E; Nakao, T; Akimoto, T; Saigo, H; Okamura, K; Ojima, I; Northoff, G; Hori, H				Naruse, Makoto; Yamamoto, Eiji; Nakao, Takashi; Akimoto, Takuma; Saigo, Hayato; Okamura, Kazuya; Ojima, Izumi; Northoff, Georg; Hori, Hirokazu			Why is the environment important for decision making? Local reservoir model for choice-based learning	PLOS ONE			English	Article							SINGLE-PHOTON; DISSONANCE; BRAIN; SELF	Decision making based on behavioral and neural observations of living systems has been extensively studied in brain science, psychology, neuroeconomics, and other disciplines. Decision-making mechanisms have also been experimentally implemented in physical processes, such as single photons and chaotic lasers. The findings of these experiments suggest that there is a certain common basis in describing decision making, regardless of its physical realizations. In this study, we propose a local reservoir model to account for choice-based learning (CBL). CBL describes decision consistency as a phenomenon where making a certain decision increases the possibility of making that same decision again later. This phenomenon has been intensively investigated in neuroscience, psychology, and other related fields. Our proposed model is inspired by the viewpoint that a decision is affected by its local environment, which is referred to as a local reservoir. If the size of the local reservoir is large enough, consecutive decision making will not be affected by previous decisions, thus showing lower degrees of decision consistency in CBL. In contrast, if the size of the local reservoir decreases, a biased distribution occurs within it, which leads to higher degrees of decision consistency in CBL. In this study, an analytical approach for characterizing local reservoirs is presented, as well as several numerical demonstrations. Furthermore, a physical architecture for CBL based on single photons is discussed, and the effects of local reservoirs are numerically demonstrated. Decision consistency in human decision-making tasks and in recruiting empirical data is evaluated based on the local reservoir. This foundation based on a local reservoir offers further insights into the understanding and design of decision making.	[Naruse, Makoto] Natl Inst Informat & Commun Technol, Network Syst Res Inst, Koganei, Tokyo, Japan; [Yamamoto, Eiji] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa, Japan; [Nakao, Takashi] Hiroshima Univ, Grad Sch Educ, Dept Psychol, Hiroshima, Japan; [Akimoto, Takuma] Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, Noda, Chiba, Japan; [Saigo, Hayato] Nagahama Insitute Biosci & Technol, Nagahama, Shiga, Japan; [Okamura, Kazuya] Nagoya Univ, Grad Sch Informat, Nagoya, Aichi, Japan; [Northoff, Georg] Univ Ottawa, Royals Inst Mental Hlth Res, Mind Brain Imaging & Neuroeth Res Unit, Ottawa, ON, Canada; [Hori, Hirokazu] Univ Yamanashi, Interdisciplinary Grad Sch, Kofu, Yamanashi, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Keio University; Hiroshima University; Tokyo University of Science; Nagoya University; University of Ottawa; University of Yamanashi	Naruse, M (corresponding author), Natl Inst Informat & Commun Technol, Network Syst Res Inst, Koganei, Tokyo, Japan.	naruse@nict.go.jp	nakao, takashi/U-7188-2017; Okamura, Kazuya/GNM-8339-2022; Yamamoto, Eiji/E-4926-2013; Naruse, Makoto/F-7400-2014	nakao, takashi/0000-0002-2227-4526; Okamura, Kazuya/0000-0001-9223-5920; Naruse, Makoto/0000-0001-8982-9824; Yamamoto, Eiji/0000-0002-8813-5297; akimoto, takuma/0000-0002-7647-2309	CREST program from Japan Science and Technology Agency; Core-to-Core Program A. Advanced Research Networks; Japan Society for the Promotion of Science [JP17H01277]; MEXT (Ministry of Education, Culture, Sports, Science and Technology); CREST from the Japan Science and Technology Agency [JPMJCR17N2]	CREST program from Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Core-to-Core Program A. Advanced Research Networks; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by the CREST program from Japan Science and Technology Agency and the Core-to-Core Program A. Advanced Research Networks and the Grants-in-Aid for Scientific Research (A) (JP17H01277) from the Japan Society for the Promotion of Science. E. Y. were supported by MEXT (Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for the "Building of Consortia for the Development of Human Resources in Science and Technology".; This work was supported in part by the CREST (JPMJCR17N2) from the Japan Science and Technology Agency, and by the Core-to-Core Program A. Advanced Research Networks and Grants-in-Aid for Scientific Research (A) (JP17H01277) from the Japan Society for the Promotion of Science. E.Y. received support from MEXT (Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for the "Building of Consortia for the Development of Human Resources in Science and Technology".	Akaishi R, 2014, NEURON, V81, P195, DOI 10.1016/j.neuron.2013.10.018; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Deco G, 2013, PROG NEUROBIOL, V103, P194, DOI 10.1016/j.pneurobio.2012.01.010; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Iversen B., 2012, COHOMOLOGY SHEAVES; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Martino M, 2016, P NATL ACAD SCI USA, V113, P4824, DOI 10.1073/pnas.1517558113; Mihana T, 2018, COMPLEXITY, DOI 10.1155/2018/4318127; Miyagi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180041; Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072071; Nakao T, 2016, SCI REP-UK, V6, DOI 10.1038/srep32477; Nakao T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00031; Naruse M, 2018, INT J INF TECH DECIS, V17, P1305, DOI 10.1142/S0219622018500268; Naruse M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08585-8; Naruse M, 2016, ACS PHOTONICS, V3, P2505, DOI 10.1021/acsphotonics.6b00742; Naruse M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13253; Northoff, 2014, UNLOCKING BRAIN, DOI 10.1093/ACPROF:OSO/9780199826988.001.0001; Northoff G., 2014, UNLOCKING BRAIN; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2017, NEUROSCI BIOBEHAV R, V80, P630, DOI 10.1016/j.neubiorev.2017.07.013; O'Doherty JP, 2017, ANNU REV PSYCHOL, V68, P73, DOI 10.1146/annurev-psych-010416-044216; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Urayama J, 2001, PHYS REV LETT, V86, P4930, DOI 10.1103/PhysRevLett.86.4930	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205161	10.1371/journal.pone.0205161	http://dx.doi.org/10.1371/journal.pone.0205161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286186	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500093
J	Madan, C; Chopra, KK; Satyanarayana, S; Surie, D; Chadha, V; Sachdeva, KS; Khanna, A; Deshmukh, R; Dutte, L; Namdeo, A; Shukla, A; Sagili, K; Chauhan, LS				Madan, Chandravali; Chopra, Kamal Kishore; Satyanarayana, Srinath; Surie, Diya; Chadha, Vineet; Sachdeva, Kuldeep Singh; Khanna, Ashwani; Deshmukh, Rajesh; Dutte, Lopamudra; Namdeo, Amit; Shukla, Ajay; Sagili, Karuna; Chauhan, Lakhbir Singh			Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India	PLOS ONE			English	Article							HIV; CARE	Background Tuberculosis (TB) patients with human immunodeficiency virus (HIV) co-infection have worse TB treatment outcomes compared to patients with TB alone. The distribution of unfavourable treatment outcomes differs by socio-demographic and clinical characteristics, allowing for early identification of patients at risk. Objective To develop a statistical model that can provide individual probabilities of unfavourable outcomes based on demographic and clinical characteristics of TB-HIV co-infected patients. Methodology We used data from all TB patients with known HIV-positive test results (aged >15 years) registered for first-line anti-TB treatment (ATT) in 2015 under the Revised National TB Control Programme (RNTCP) in Delhi, India. We included variables on demographics and pretreatment clinical characteristics routinely recorded and reported to RNTCP and the National AIDS Control Organization. Binomial logistic regression was used to develop a statistical model to estimate probabilities of unfavourable TB treatment outcomes (i.e., death, loss to follow-up, treatment failure, transfer out of program, and a switch to drug-resistant regimen). Results Of 55,260 TB patients registered for ATT in 2015 in Delhi, 928 (2%) had known HIV-positive test results. Of these, 816 (88%) had drug-sensitive TB and were >= 15 years. Among 816 TB-HIV patients included, 157 (19%) had unfavourable TB treatment outcomes. We developed a model for predicting unfavourable outcomes using age, sex, disease classification (pulmonary versus extra-pulmonary), TB treatment category (new or previously treated case), sputum smear grade, known HIV status at TB diagnosis, antiretroviral treatment at TB diagnosis, and CD4 cell count at ATT initiation. The chi-square p-value for model calibration assessed using the Hosmer-Lemeshow test was 0.15. The model discrimination, measured as the area under the receiver operator characteristic (ROC) curve, was 0.78. Conclusion The model had good internal validity, but should be validated with an independent cohort of TB HIV co-infected patients to assess its performance before clinical or programmatic use.	[Madan, Chandravali] Evidence Act Deworm World Initiat, New Delhi, India; [Chopra, Kamal Kishore] New Delhi TB Ctr, New Delhi, India; [Satyanarayana, Srinath; Sagili, Karuna] Int Union TB & Lung Dis, New Delhi, India; [Surie, Diya] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Chadha, Vineet] Natl TB Inst, Bangalore, Karnataka, India; [Sachdeva, Kuldeep Singh; Deshmukh, Rajesh] Natl AIDS Control Org, New Delhi, India; [Khanna, Ashwani] Lok Nayak Chest Clin, New Delhi, India; [Dutte, Lopamudra; Namdeo, Amit] United Nat Childrens Fund UNICEF, New Delhi, India; [Shukla, Ajay] Uttar Pradesh State AIDS Control Soc, Lucknow, Uttar Pradesh, India; [Chauhan, Lakhbir Singh] TB Assoc India, New Delhi, India	Centers for Disease Control & Prevention - USA	Madan, C (corresponding author), Evidence Act Deworm World Initiat, New Delhi, India.	madan.chandravali@gmail.com		Chadha, Vineet/0000-0003-4457-4842; Satyanarayana, Srinath/0000-0002-5420-2551	Tuberculosis Association of India [TAI/ORP/2016]; President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	Tuberculosis Association of India; President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	This work was supported by Tuberculosis Association of India (Grant number- TAI/ORP/2016). This research has also been supported in part by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Ambadekar NN, 2015, PUBLIC HEALTH, V129, P783, DOI 10.1016/j.puhe.2015.03.006; [Anonymous], 2010, TREATM TUB GUID; Bastanlar Y, 2014, METHODS MOL BIOL, V1107, P105, DOI 10.1007/978-1-62703-748-8_7; Central TB Division, 2013, J CHEM INF MODEL, V53, P1689, DOI DOI 10.1021/CI400128M; Central TB Division, 2016, TB IND 2016 ANN REP; Central TB Division, 2012, SUP MON STRAT REV NA; Gupta S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004007; India [Internet]. Ministry of Health & Family Welfare Government of India, 2016, REV NAT TB CONTR PRO; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Parchure R, 2016, INT J TUBERC LUNG D, V20, P1348, DOI 10.5588/ijtld.16.0098; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Reddy Satti Siva Balaji, 2016, Indian J Community Med, V41, P120, DOI 10.4103/0970-0218.177529; Sachdeva KS, 2015, POTENTIAL IMPACT UP, P1; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Sharma SK, 2014, INDIAN J MED RES, V139, P154; Shastri S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-838; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; Sudharsan Bharath, 2015, J Diabetes Sci Technol, V9, P86, DOI 10.1177/1932296814554260; *WHO, INT POL COLL TB HIV; World Health Organization, 2016, GLOB REP DIAB 2016; World Health Organization (WHO), 2015, GUID MON EV COLL TB	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204982	10.1371/journal.pone.0204982	http://dx.doi.org/10.1371/journal.pone.0204982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281679	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400073
J	Moffett, BS; Morris, J; Kam, C; Galati, M; Dutta, A; Akcan-Arikan, A				Moffett, Brady S.; Morris, Jennifer; Kam, Charissa; Galati, Marianne; Dutta, Ankhi; Akcan-Arikan, Ayse			Vancomycin associated acute kidney injury in pediatric patients	PLOS ONE			English	Article							LOW-DOSE DOPAMINE; SERUM TROUGH CONCENTRATIONS; PIPERACILLIN-TAZOBACTAM; CRITICALLY-ILL; HOSPITALIZED CHILDREN; RETROSPECTIVE COHORT; RENAL DYSFUNCTION; RISK-FACTORS; NEPHROTOXICITY; METAANALYSIS	Introduction Vancomycin associated acute kidney injury (vAKI) is a well known complication in pediatric patients. Identification and characterization of the incidence and risk factors for vAKI in the pediatric population would assist clinicians in potentially preventing or mitigating vAKI. Methods and materials A 6 year retrospective cohort study was designed. Patients were included if they were < 19 years of age, received vancomycin as inpatients, and had a baseline SCr and one other SCr drawn during and up to 72 hours after the discontinuation of vancomycin. Data collection included patient demographics, vancomycin doses and length of therapy, vancomycin serum concentrations, and concomitant medications. The Kidney Disease Improving Global Outcomes (KDIGO) criteria were used to characterize acute kidney injury. Descriptive statistical methods were used and ordinal logistic regression was employed to determine variables significantly associated with vAKI. Results A total of 7,095 patients met study criteria (55.4% male, median age 4.1 years (IQR 0.671-1.2 years)). Mechanical ventilation was used in 7.9% (n = 563) and mortality was 4.9% (n = 344). A total of 153 concomitant medications were identified. A median of 5 (IQR 3-7) SCr values were obtained and median SCr prior to vancomycin was 0.39 (IQR 0.28-0.57) mg/dL (CrCl 134 +/- 58 mL/min/1.73m(2)). Vancomycin was administered for a median of 2 (IQR 1-3) days (14.9 +/- 1.6 mg/kg/dose). vAKI was present in 12.2% (n = 862: KDIGO stage 1 (8.30%, n = 589), KDIGO stage 2 (1.94%, n = 138) KDIGO stage 3 (1.89%, n = 134)). Mean vancomycin serum concentration at 6-8 hours after a dose for patients with vAKI (10.7 +/- 8.9 mg/L) was significantly, but not clinically different for patients with no vAKI (7.5 +/- 6.3 mg/L). (p<0.05) Ordinal logistic regression identified total dose of vancomycin, vancomycin administration in the intensive care unit, and concomitant medication administration as significant for vAKI. In particular, concomitant administration of several different medications, including nafcillin, clindamycin, and acetazolamide, were noted for strong associations with vAKI. (p<0.05) Conclusions Moderate to severe acute kidney injury due to vancomycin is infrequent in children and associated with concomitant medication use and total dose of vancomycin. Serum vancomycin concentrations are not useful predictors of vAKI in the pediatric population.	[Moffett, Brady S.; Morris, Jennifer; Kam, Charissa; Dutta, Ankhi; Akcan-Arikan, Ayse] Texas Childrens Hosp, Dept Pharm, Houston, TX 77030 USA; [Moffett, Brady S.; Morris, Jennifer; Kam, Charissa; Dutta, Ankhi; Akcan-Arikan, Ayse] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Galati, Marianne] Texas Med Ctr Lib, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Moffett, BS (corresponding author), Texas Childrens Hosp, Dept Pharm, Houston, TX 77030 USA.; Moffett, BS (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	bsmoffet@texaschildrens.org	Kam, Charissa/AAE-1980-2021	Akcan Arikan, Ayse/0000-0002-5123-6713				Bamgbola O, 2016, THER ADV ENDOCRINOL, V7, P136, DOI 10.1177/2042018816638223; Bellomo R, 2000, LANCET, V356, P2139; Benefield Emily C, 2016, J Pediatr Pharmacol Ther, V21, P66, DOI 10.5863/1551-6776-21.1.66; Bennett WM, 2016, AM J NEPHROL, V44, P454, DOI 10.1159/000452430; Bonazza Sarah, 2016, J Pediatr Pharmacol Ther, V21, P486, DOI 10.5863/1551-6776-21.6.486; Constance JE, 2016, ARCH DIS CHILD-FETAL, V101, pF236, DOI 10.1136/archdischild-2015-308459; Davies SW, 2015, SURG INFECT, V16, P684, DOI 10.1089/sur.2014.198; Downes KJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3219; Filippone EJ, 2017, CLIN PHARMACOL THER, V102, P459, DOI 10.1002/cpt.726; Fisher BT, 2010, PEDIATR BLOOD CANCER, V55, P655, DOI 10.1002/pbc.22601; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Gupta A, 2011, NETH J MED, V69, P379; Hammoud K, 2016, AM J NEPHROL, V44, P456, DOI 10.1159/000452427; Hanrahan TP, 2015, ANAESTH INTENS CARE, V43, P594, DOI 10.1177/0310057X1504300507; Hanrahan TP, 2014, CRIT CARE MED, V42, P2527, DOI 10.1097/CCM.0000000000000514; Heble DE, 2016, AM J THER, V23, pE1469, DOI 10.1097/MJT.0000000000000147; Ibach Bethany W, 2016, J Pediatr Pharmacol Ther, V21, P169, DOI 10.5863/1551-6776-21.2.169; Jeon N, 2017, INT J ANTIMICROB AG, V50, P63, DOI 10.1016/j.ijantimicag.2017.02.023; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Knoderer CA, 2015, ANN PHARMACOTHER, V49, P1113, DOI 10.1177/1060028015594190; Knoderer CA, 2014, J PEDIATR INFECT DIS, V3, P127, DOI 10.1093/jpids/pit076; Le J, 2013, PEDIATR INFECT DIS J, V32, pE155, DOI 10.1097/INF.0b013e318286378e; LeCleir LK, 2017, PEDIATR PULM, V52, P1000, DOI 10.1002/ppul.23718; Luther MK, 2018, CRIT CARE MED, V46, P12, DOI 10.1097/CCM.0000000000002769; Marik PE, 2002, INTENS CARE MED, V28, P877, DOI 10.1007/s00134-002-1346-y; McGregor TL, 2016, AM J KIDNEY DIS, V67, P384, DOI 10.1053/j.ajkd.2015.07.019; McKamy S, 2011, J PEDIATR-US, V158, P422, DOI 10.1016/j.jpeds.2010.08.019; McNeil JC, 2016, PEDIATR INFECT DIS J, V35, P263, DOI 10.1097/INF.0000000000000991; Moffett BS, 2008, PEDIATR CRIT CARE ME, V9, P403, DOI 10.1097/PCC.0b013e3181728c25; Moffett BS, 2015, CONGENIT HEART DIS, V10, pE6, DOI 10.1111/chd.12187; Moffett BS, 2011, CLIN PEDIATR, V50, P442, DOI 10.1177/0009922810393500; Moffett BS, 2011, J PEDIATR-US, V158, P865, DOI 10.1016/j.jpeds.2010.12.018; Moffett BS, 2011, CLIN J AM SOC NEPHRO, V6, P856, DOI 10.2215/CJN.08110910; Nolin TD, 2016, CLIN J AM SOC NEPHRO, V11, P2101, DOI 10.2215/CJN.11011016; O'Donnell JN, 2018, INT J ANTIMICROB AG, V51, P239, DOI 10.1016/j.ijantimicag.2017.08.012; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Patel A, 2015, PEDIATR INFECT DIS J, V34, P849, DOI 10.1097/INF.0000000000000748; Prabaker KK, 2012, J HOSP MED, V7, P91, DOI 10.1002/jhm.946; Pritchard L, 2010, AM J MED, V123, P1143, DOI 10.1016/j.amjmed.2010.07.025; RYBAK MJ, 1990, J ANTIMICROB CHEMOTH, V25, P679, DOI 10.1093/jac/25.4.679; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Sinclair EA, 2014, ANN PHARMACOTHER, V48, P1555, DOI 10.1177/1060028014549185; Slater MB, 2017, PEDIATR DRUGS, V19, P59, DOI 10.1007/s40272-016-0205-1; Sutherland SM, 2015, CLIN J AM SOC NEPHRO, V10, P554, DOI 10.2215/CJN.01900214; van Hal SJ, 2013, ANTIMICROB AGENTS CH, V57, P734, DOI 10.1128/AAC.01568-12; Zappitelli M, 2008, CLIN J AM SOC NEPHRO, V3, P948, DOI 10.2215/CJN.05431207	47	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202439	10.1371/journal.pone.0202439	http://dx.doi.org/10.1371/journal.pone.0202439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281600	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400012
J	Sun, JZ; Vu, H; Ellerbroek, J; Hoekstra, JM				Sun, Junzi; Vu, Huy; Ellerbroek, Joost; Hoekstra, Jacco M.			Weather field reconstruction using aircraft surveillance data and a novel meteo-particle model	PLOS ONE			English	Article								Wind and temperature data are important parameters in aircraft performance studies. The lack of accurate measurements of these parameters forces researchers to rely on numerical weather prediction models, which are often filtered for a larger area with decreased local accuracy. Aircraft, however, also transmit information related to weather conditions, in response to interrogation by air traffic controller surveillance radars. Although not intended for this purpose, aircraft surveillance data contains information that can be used for weather models. This paper presents a method that can be used to reconstruct a weather field from surveillance data that can be received with a simple 1090 MHz receiver. Throughout the paper, we answer two main research questions: how to accurately infer wind and temperature from aircraft surveillance data, and how to reconstruct a real-time weather grid efficiently. We consider aircraft as moving sensors that measure wind and temperature conditions indirectly at different locations and flight levels. To address the first question, aircraft barometric altitude, ground velocity, and airspeed are decoded from down-linked surveillance data. Then, temperature and wind observations are computed based on aeronautical speed conversion equations. To address the second question, we propose a novel Meteo-Particle (MP) model for constructing the wind and temperature fields. Short-term local prediction is also possible by employing a predictor layer. Using an unseen observation test dataset, we are able to validate that the mean absolute errors of inferred wind and temperature using MP model are 67% and 26% less than using the interpolated model based on GFS reanalysis data.	[Sun, Junzi; Vu, Huy; Ellerbroek, Joost; Hoekstra, Jacco M.] Delft Univ Technol, Fac Aerosp Engn, Control & Simulat, Kluyverweg 1, NL-2629 HS Delft, Netherlands	Delft University of Technology	Sun, JZ (corresponding author), Delft Univ Technol, Fac Aerosp Engn, Control & Simulat, Kluyverweg 1, NL-2629 HS Delft, Netherlands.	j.sun-1@tudelft.nl		Ellerbroek, Joost/0000-0002-2232-8299; Vu, Huy/0000-0001-6707-3595; Sun, Junzi/0000-0003-3888-1192				Barker DM, 2004, MON WEATHER REV, V132, P897, DOI 10.1175/1520-0493(2004)132<0897:ATVDAS>2.0.CO;2; Dalmau R, 2017, DIG AV SYST C DASC 2, P1; de Haan S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015264; de Haan S., 2014, 201401 KNMI IR; de Jong PMA, 2014, J AIRCRAFT, V51, P1852, DOI 10.2514/1.C032550; de Leege AMP, 2013, J AIRCRAFT, V50, P249, DOI 10.2514/1.C031901; Delahaye D, 2009, DIG AV SYST C 2009 D, P2; Delahaye D, 2003, DIG AV SYST C 2003 D, V1, P5; Delahaye D, 2008, 2008 10TH INTERNATIONAL CONFERENCE ON CONTROL AUTOMATION ROBOTICS & VISION: ICARV 2008, VOLS 1-4, P1033, DOI 10.1109/ICARCV.2008.4795661; Hollister W. M., 1989, Lincoln Laboratory Journal, V2, P555; Houtekamer PL, 1998, MON WEATHER REV, V126, P796, DOI 10.1175/1520-0493(1998)126<0796:DAUAEK>2.0.CO;2; Hrastovec M, 2013, IEEE AERO EL SYS MAG, V28, P12, DOI 10.1109/MAES.2013.6693664; Hurter C, 2014, COMPUT ENVIRON URBAN, V47, P28, DOI 10.1016/j.compenvurbsys.2014.01.005; Kanamitsu M, 1989, WEA FORECASTING, p[4, 335], DOI [10.1175/1520-0434(1989)004&LT;0335:DOTNGD&GT;2.0.CO;2, DOI 10.1175/1520-0434(1989)004<0335:D0TNGD>2.0.C0;2, 10.1175/1520-0434(1989)0042.0.CO;2]; Kapoor A, 2014, PROCEEDINGS OF THE 13TH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN' 14), P25, DOI 10.1109/IPSN.2014.6846738; Lin J, 2013, LAGRANGIAN MODELING, V200; Moninger WR, 2003, B AM METEOROL SOC, V84, P203, DOI 10.1175/BAMS-84-2-203; Moradkhani H, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003604; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rasmussen CE, 2004, LECT NOTES ARTIF INT, V3176, P63, DOI 10.1007/978-3-540-28650-9_4; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Sondij J., 2013, TR336 KNMI; Stone EK, 2015, J ATMOS OCEAN TECH, V32, P736, DOI 10.1175/JTECH-D-14-00192.1; Sun J, 2018, JUNZI PYMODES PYTHON, DOI [10.5281/zenodo.894419, DOI 10.5281/ZENODO.894419]; Sun J., 2018, SUPPLEMENTAL DATASET, DOI [10.6084/m9.figshare.6970403, DOI 10.6084/M9.FIGSHARE.6970403]; Sun J, 2018, 8 INT C RES AIR TRAN; Sun J, 2018, JUNZIS METEOPARTICLE, DOI [10.5281/zenodo.1319564, DOI 10.5281/ZENODO.1319564]; Williams CKI, 1998, NATO ADV SCI I D-BEH, V89, P599	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205029	10.1371/journal.pone.0205029	http://dx.doi.org/10.1371/journal.pone.0205029			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281667	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400078
J	Lu, DL; Ren, ZJ; Zhang, Q; Ren, PW; Yang, B; Liu, LR; Dong, Q				Lu, Dong-Liang; Ren, Zheng-Ju; Zhang, Qin; Ren, Peng-Wei; Yang, Bo; Liu, Liang-Ren; Dong, Qiang			Meta-analysis of the association between the inflammatory potential of diet and urologic cancer risk	PLOS ONE			English	Article							PROSTATE-CANCER; ENDOTHELIAL FUNCTION; PHYSICAL-ACTIVITY; CELL-CARCINOMA; INDEX; NUTRITION; MORTALITY; PREVENTION; FAT	Background The inflammatory potential of diet has been shown to have an association with the risk of several cancer types, but the evidence is inconsistent regarding the related risk of urologic cancer (UC). Therefore, we conducted the present meta-analysis to investigate the association between the inflammatory potential of diet and UC. Methods PubMed, Embase and Web of Science were searched up to July 31, 2018. Two reviewers independently selected the studies and extracted the data. The pooled risk ratio (RR) and its 95% confidence interval (CI) were calculated using the Stata12.0 software package. Results Nine case-control studies and three cohort studies including 83,197 subjects met the inclusion criteria. The overall meta-analysis results showed that individuals with the highest category of DII (dietary inflammatory index) were associated with an increased risk of prostate cancer (RR = 1.62, 95% CI: 1.30-2.02); subgroup analysis showed consistent results. For kidney and bladder cancer, significant positive associations were found in individuals with the highest category of DII score; however, no significant association was found between DII and the risk of urothelial cell carcinoma (UCC). Conclusion Available data suggest that more pro-inflammatory diets are associated with an increased risk of prostate cancer, kidney cancer and bladder cancer. However, further well designed large-scaled cohort studies are warranted to provide more conclusive evidence.	[Lu, Dong-Liang; Ren, Zheng-Ju; Yang, Bo; Liu, Liang-Ren; Dong, Qiang] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu, Sichuan, Peoples R China; [Zhang, Qin] Chongqing Tradit Chinese Med Hosp, Dept Radiol, Chongqing, Peoples R China; [Ren, Peng-Wei] Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Dong, Q (corresponding author), Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu, Sichuan, Peoples R China.	dong_qiang@mcwcums.com			Science and Technology Support Project of Science and Technology Department of Sichuan Province [2016FZ0103]; Key Research and Development Project of Science and Technology Department of Sichuan Province [2017SZ0067]; 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University [ZY2016104]	Science and Technology Support Project of Science and Technology Department of Sichuan Province; Key Research and Development Project of Science and Technology Department of Sichuan Province; 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University	This work was supported by Science and Technology Support Project of Science and Technology Department of Sichuan Province, Grant ID: 2016FZ0103; and Key Research and Development Project of Science and Technology Department of Sichuan Province, Grant ID: 2017SZ0067; and 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University; Grant ID: ZY2016104. The study sponsor had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the article; and decision to submit the article for publication.	Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Cavicchia PP, 2009, J NUTR, V139, P2365, DOI 10.3945/jn.109.114025; Dugue PA, 2016, INT J CANCER, V139, P1251, DOI 10.1002/ijc.30175; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Golabek T, 2015, ARCH MED SCI, V11, P411, DOI 10.5114/aoms.2015.50973; Graffouillere L, 2016, J NUTR, V146, P785, DOI 10.3945/jn.115.225623; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johansson-Persson Anna, 2014, Eur J Nutr, V53, P39, DOI 10.1007/s00394-013-0496-8; Keibel A, 2009, CURR PHARM DESIGN, V15, P1949, DOI 10.2174/138161209788453167; Khoo J, 2011, J SEX MED, V8, P2868, DOI 10.1111/j.1743-6109.2011.02417.x; King DE, 2003, AM J CARDIOL, V92, P1335, DOI 10.1016/j.amjcard.2003.08.020; Kristal AR, 2010, AM J EPIDEMIOL, V172, P566, DOI 10.1093/aje/kwq148; Li P, 2012, OCCUP MED-OXFORD, V62, P281, DOI 10.1093/occmed/kqs016; Markozannes G, 2016, EUR J CANCER, V69, P61, DOI 10.1016/j.ejca.2016.09.026; Nelson D, 2006, J LEUKOCYTE BIOL, V80, P685, DOI 10.1189/jlb.1105646; Sharma JD, 2016, INDIAN J CANCER, V53, P600, DOI 10.4103/0019-509X.204764; Shivappa N, 2016, INT J VITAM NUTR RES, V86, P161, DOI 10.1024/0300-9831/a000395; Shivappa N, 2018, CANCER CAUSE CONTROL, V29, P803, DOI 10.1007/s10552-018-1056-6; Shivappa Nitin, 2018, Asian Pac J Cancer Prev, V19, P415; Shivappa N, 2018, EUR J NUTR, V57, P1207, DOI 10.1007/s00394-017-1403-5; Shivappa N, 2017, NUTR CANCER, V69, P825, DOI 10.1080/01635581.2017.1339095; Shivappa N, 2017, EUR J NUTR, V56, P683, DOI 10.1007/s00394-015-1112-x; Shivappa N, 2017, UROLOGY, V100, P84, DOI 10.1016/j.urology.2016.09.026; Shivappa N, 2015, NUTR CANCER, V67, P941, DOI 10.1080/01635581.2015.1062117; Shivappa N, 2015, BRIT J NUTR, V113, P278, DOI 10.1017/S0007114514003572; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tabung FK, 2017, BRIT J CANCER, V117, P907, DOI 10.1038/bjc.2017.246; Tang JY, 2017, ONCOTARGET, V8, P50034, DOI 10.18632/oncotarget.17293; Touvier M, 2013, AM J EPIDEMIOL, V177, P3, DOI 10.1093/aje/kws359; Vazquez-Salas RA, 2016, BRIT J NUTR, V116, P1945, DOI 10.1017/S0007114516003986; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Yang HY, 2016, EUR J CANCER, V58, P130, DOI 10.1016/j.ejca.2015.12.032; Zucchetto A, 2016, INT J CANCER, V139, P2398, DOI 10.1002/ijc.30208	35	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204845	10.1371/journal.pone.0204845	http://dx.doi.org/10.1371/journal.pone.0204845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273380	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700041
J	Simard, S; Shail, P; MacGregor, J; El Sayed, M; Duman, RS; Vaccarino, FM; Salmaso, N				Simard, Stephanie; Shail, Pragya; MacGregor, Jessica; El Sayed, Maha; Duman, Ronald S.; Vaccarino, Flora M.; Salmaso, Natalina			Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine	PLOS ONE			English	Article							FACTOR SYSTEM; RAT-BRAIN; MAJOR DEPRESSION; ANXIETY; FGF2; DISORDERS; RECEPTORS; BEHAVIOR; FIBROBLAST-GROWTH-FACTOR-2; PREVALENCE	Previous research has shown that fibroblast growth factor 2 protein (FGF2) can act as an anxiolytic and anti-depressive agent in rodents. Levels of hippocampal FGF2 and FGF2 receptors are decreased in post-mortem brains of individuals with mood disorders. No changes in FGF2 were noted in the post-mortem brains of individuals with mood disorders that were successfully treated with anti-depressant medication prior to death. Mutations in the FGF2 gene in humans have been shown to predict non-responsiveness to the therapeutic effects of selective serotonin reuptake inhibitors (SSRIs). These findings suggest that FGF2 may potentially be a target of and/or required for the therapeutic effects of antidepressant medications. To test this, we employed a rodent model of depressive behaviour, chronic variable stress (CVS) in conjunction with antidepressant treatment (fluoxetine) in wild-type (WT) and FGF2 knockout mice (FGF2KO) and examined depressive and anxiety behaviors. Results showed that fluoxetine reversed the effects of CVS on depressive and anxiety behaviours in wild-type mice only, suggesting that the FGF2 gene is indeed necessary for the therapeutic effects of fluoxetine. Interestingly, CVS decreased hippocampal FGF2 levels and fluoxetine partially reversed this effect. Because FGF2 has been previously shown to modify HPA activity through hippocampal glucocorticoid receptors (GR), we examined levels of glucocorticoid receptors and found a decrease in GR in response to CVS, with a further decrease in FGF2KO. No effect of fluoxetine on GR was observed in either WT or FGF2KO mice. This suggests that further changes in glucocorticoid receptors are not necessary for the anti-depressant effects of fluoxetine in WT mice, although decreased glucocorticoid receptors in response to FGF2 deletion may preclude the therapeutic actions of fluoxetine in FGF2KO. Whether astroglia, astroglial functions, or HPA changes are the downstream target of FGF2-mediated changes induced by fluoxetine remains to be determined, however, the current study reaffirms the potential of FGF2 as a novel therapeutic target in the treatment of depression and anxiety disorders.	[Simard, Stephanie; Shail, Pragya; MacGregor, Jessica; Salmaso, Natalina] Carleton Univ, Dept Neurosci, Ottawa, ON, Canada; [El Sayed, Maha; Duman, Ronald S.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Vaccarino, Flora M.; Salmaso, Natalina] Yale Univ, Child Study Ctr, New Haven, CT 06520 USA	Carleton University; Yale University; Yale University	Salmaso, N (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON, Canada.; Salmaso, N (corresponding author), Yale Univ, Child Study Ctr, New Haven, CT 06520 USA.	Natalina.salmaso@carleton.ca		Simard, Stephanie/0000-0001-7770-2295; Salmaso, Natalina/0000-0002-9661-5194	Canadian Institute of Health Research Canada Research Chair Award; Canadian Funds for Innovation; Ontario Small Infrastructure award; Carleton University iCUREUS award; iCUREUS award; Ontario Small Infrastructure Funds	Canadian Institute of Health Research Canada Research Chair Award; Canadian Funds for Innovation; Ontario Small Infrastructure award; Carleton University iCUREUS award; iCUREUS award; Ontario Small Infrastructure Funds	This work was supported by Canadian Institute of Health Research Canada Research Chair Award to N.S.; Canadian Funds for Innovation to N.S.; Ontario Small Infrastructure award to N.S.; Carleton University iCUREUS award to J.M.; We would like to thank Dr. Michael Schlossmacher and Dr. Julianna Tomlinson for allowing us to use their facilities at the University of Ottawa during the transitory period of our facilities relocation. This work was supported by and iCUREUS award to J.M. in addition to the Canadian Funds for Innovation, Ontario Small Infrastructure Funds and a Canadian Institute of Health Research Canada Research Chair award to N.S.	Akil H, 2008, Novartis Found Symp, V289, P94; Akil H, 2008, NOVART FDN SYMP, V289, P93; Akil H, 2008, NOVART FDN SYMP, V289, p[7, 93]; Audet MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00068; Bachis A, 2008, NEUROPHARMACOLOGY, V55, P1114, DOI 10.1016/j.neuropharm.2008.07.014; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; CADAY CG, 1990, DEV BRAIN RES, V52, P241, DOI 10.1016/0165-3806(90)90240-Y; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Di Liberto V, 2014, CURR PROTEIN PEPT SC, V15, P691, DOI 10.2174/1389203715666140901112245; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Eren-Kocak E, 2011, BIOL PSYCHIAT, V69, P534, DOI 10.1016/j.biopsych.2010.11.020; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Flores C, 2000, PSYCHOPHARMACOLOGY, V151, P152, DOI 10.1007/s002130000417; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Guilloux JP, 2011, J NEUROSCI METH, V197, P21, DOI 10.1016/j.jneumeth.2011.01.019; Haj-Mirzaian A, 2016, CAN J PHYSIOL PHARM, V94, P599, DOI 10.1139/cjpp-2015-0429; Hercher C, 2009, J PSYCHIATR RES, V43, P947, DOI 10.1016/j.jpsychires.2009.01.006; Kato M, 2009, EUR NEUROPSYCHOPHARM, V19, P718, DOI 10.1016/j.euroneuro.2009.06.006; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Mallei A, 2002, MOL PHARMACOL, V61, P1017, DOI 10.1124/mol.61.5.1017; Maragnoli ME, 2004, BIOL PSYCHIAT, V55, P1095, DOI 10.1016/j.biopsych.2004.02.003; Paradiso B, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00152; Peng L, 2015, EXPERT REV NEUROTHER, V15, P1299, DOI 10.1586/14737175.2015.1095094; Perez JA, 2009, J NEUROSCI, V29, P6379, DOI 10.1523/JNEUROSCI.4829-08.2009; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rial D, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00521; Salmaso N, 2016, BIOL PSYCHIAT, V80, P479, DOI 10.1016/j.biopsych.2016.02.026; SIMARD S, 2018, NEUROPSYCHOPHARMACOL; Smialowska M, 2013, PHARMACOL REP, V65, P1572; Torres-Platas SG, 2016, MOL PSYCHIATR, V21, P509, DOI 10.1038/mp.2015.65; Torres-Platas SG, 2011, NEUROPSYCHOPHARMACOL, V36, P2650, DOI 10.1038/npp.2011.154; Tumer C.A., 2015, SEMIN CELL DEV BIOL; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Turner CA, 2008, NEUROSCI LETT, V430, P147, DOI 10.1016/j.neulet.2007.10.041; Turner CA, 2006, BIOL PSYCHIAT, V59, P1128, DOI 10.1016/j.biopsych.2006.02.026; Turner CA, 2012, NEURON, V76, P160, DOI 10.1016/j.neuron.2012.08.037; Turner CA, 2011, P NATL ACAD SCI USA, V108, P8021, DOI 10.1073/pnas.1103732108; Vaccarino FM, 2007, NEUROSCIENTIST, V13, P173, DOI 10.1177/1073858406298336; Webster MJ, 2005, NEUROSCIENCE, V133, P453, DOI 10.1016/j.neuroscience.2005.02.037; Zechel S, 2010, NEUROSCIENTIST, V16, P357, DOI 10.1177/1073858410371513; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	42	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204980	10.1371/journal.pone.0204980	http://dx.doi.org/10.1371/journal.pone.0204980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273396	Green Published, gold			2022-12-27	WOS:000446124700056
J	Hoffman, LK; Tomalin, LE; Schultz, G; Howell, MD; Anandasabapathy, N; Alavi, A; Suarez-Farinas, M; Lowes, MA				Hoffman, Lauren K.; Tomalin, Lewis E.; Schultz, Gregory; Howell, Michael D.; Anandasabapathy, Niroshana; Alavi, Afsaneh; Suarez-Farinas, Mayte; Lowes, Michelle A.			Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature	PLOS ONE			English	Article							METABOLISM PATHWAYS; GENE-EXPRESSION; MICROBIOME; PSORIASIS; DISEASES; SUBSETS	Hidradenitis suppurativa (HS) is a chronic skin disease of the pilo-sebaceous apocrine unit characterized by significant inflammation and an impaired quality of life. The pathogenesis of HS remains unclear. To determine the HS skin and blood transcriptomes and HS blood proteome, patient data from previously published studies were analysed and integrated from a cohort of patients with moderate to severe HS (n = 17) compared to healthy volunteers (n = 10). The analysis utilized empirical Bayes methods to determine differentially expressed genes (DEGs) (fold change (FCH) >2.0 and false discovery rate (FDR) <0.05), and differentially expressed proteins (DEPs) (FCH>1.5, FDR<0.05). In the HS skin transcriptome (lesional skin compared to non-lesional skin), there was an abundance of immunoglobulins, antimicrobial peptides, and an interferon signature. Gene-sets related to Notch signalling and Interferon pathways were differentially activated in lesional compared to non-lesional skin. CIBERSORT analysis of the HS skin transcriptome revealed a significantly increased proportion of plasma cells in lesional skin. In the HS skin and blood transcriptomes and HS blood proteome, gene-sets related to the complement system changed significantly (FDR<0.05), with dysregulation of complement-specific DEGs and DEPs. These data point towards an exaggerated immune response in lesional skin that may be responding to commensal cutaneous bacterial presence and raise the possibility that this may be an important driver of HS disease progression.	[Hoffman, Lauren K.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Tomalin, Lewis E.; Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Populat Hlth & Sci Policy, Dept Genet & Genom, New York, NY 10029 USA; [Schultz, Gregory] Univ Florida, Dept Obstet & Gynecol, Miami, FL USA; [Howell, Michael D.] Incyte Corp, Wilmington, DE USA; [Anandasabapathy, Niroshana] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA; [Alavi, Afsaneh] Univ Toronto, Womens Coll Hosp, Dept Med, Div Dermatol, Toronto, ON, Canada; [Lowes, Michelle A.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; State University System of Florida; University of Florida; Incyte; Cornell University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Rockefeller University	Lowes, MA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	lowesm@rockefeller.edu	Lowes, Michelle A/G-9585-2016	Lowes, Michelle A/0000-0003-4256-478X; Anandasabapathy, Niroshana/0000-0002-0473-8358	NIAMS NIH HHS [R01 AR070234] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070234] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blok JL, 2016, BRIT J DERMATOL, V174, P1392, DOI 10.1111/bjd.14371; Blok JL, 2016, BRIT J DERMATOL, V174, P839, DOI 10.1111/bjd.14338; Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110; Chyou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032828; Dany M, 2017, J AM ACAD DERMATOL, V77, P268, DOI 10.1016/j.jaad.2017.03.016; Ewald DA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0133-x; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Guet-Revillet H, 2017, CLIN INFECT DIS, V65, P282, DOI 10.1093/cid/cix285; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Hess C, 2016, IMMUNITY, V45, P240, DOI 10.1016/j.immuni.2016.08.003; Hoffman LK, 2018, BRIT J DERMATOL, V178, pE134, DOI 10.1111/bjd.15958; Hoffman LK, 2017, SEMIN CUTAN MED SURG, V36, P47, DOI 10.12788/j.sder.2017.017; Hotz C, 2016, J INVEST DERMATOL, V136, P1768, DOI 10.1016/j.jid.2016.04.036; Jimenez-Gallo D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2450401; Kanni T, 2018, BRIT J DERMATOL, V179, P413, DOI 10.1111/bjd.16428; Kim Soohyun, 2014, Immune Netw, V14, P123, DOI 10.4110/in.2014.14.3.123; Kuo KY, 2018, J INVEST DERMATOL, V138, P1209, DOI 10.1016/j.jid.2017.12.002; Lima AL, 2016, BRIT J DERMATOL, V174, P514, DOI 10.1111/bjd.14214; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Matusiak L, 2017, J AM ACAD DERMATOL, V76, P670, DOI 10.1016/j.jaad.2016.10.042; Matusiak L, 2009, ACTA DERM-VENEREOL, V89, P601, DOI 10.2340/00015555-0749; Moran B, 2017, J INVEST DERMATOL, V137, P2389, DOI 10.1016/j.jid.2017.05.033; Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Olsen I, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1340085; Ribeiro-Dias F, 2017, J LEUKOCYTE BIOL, V101, P39, DOI [10.1189/jlb.4ru0416-175rr, 10.1189/jlb.4RU0416-175RR]; Riis PT, 2018, EXPERT OPIN INV DRUG, V27, P43, DOI 10.1080/13543784.2018.1412430; Ring HC, 2017, JAMA DERMATOL, V153, P897, DOI 10.1001/jamadermatol.2017.0904; Takahashi K, 2018, J DERMATOL, V45, pE116, DOI 10.1111/1346-8138.14144; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Thomi R, 2017, BRIT J DERMATOL, V177, P1358, DOI 10.1111/bjd.15458; van der Zee HH, 2012, BRIT J DERMATOL, V166, P98, DOI 10.1111/j.1365-2133.2011.10643.x; Wang J, 2017, CLIN EXP ALLERGY, V47, P1456, DOI 10.1111/cea.12979; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xu HX, 2017, POSTEP DERM ALERGOL, V34, P82, DOI 10.5114/ada.2017.65626	38	45	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203672	10.1371/journal.pone.0203672	http://dx.doi.org/10.1371/journal.pone.0203672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265680	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500009
J	Beckmann, N; Pugh, AM; Caldwell, CC				Beckmann, Nadine; Pugh, Amanda M.; Caldwell, Charles C.			Burn injury alters the intestinal microbiome's taxonomic composition and functional gene expression	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; GUT; MICROFLORA; INFECTION; ALIGNMENT; SCALD; ACID	Burn patients have a high risk of sepsis-related mortality even after surviving the initial injury. Immunosuppression increases the risk of sepsis after burn injury, as does the disruption of the intestinal epithelial barrier, which allows the translocation of bacteria and bacterial products into the circulation. The integrity of the intestinal epithelial barrier is largely maintained by the intestinal microbiota. Burn injury has been reported to result in significant changes in the intestinal microbiome composition. In this mouse study, we confirm these taxonomic differences in a full-thickness scald injury model using CF-1 mice. For the first time, we also address alterations in functional gene expression of the intestinal microbiota after burn injury to assess the microbiome's physiological capabilities for overgrowth and pathogenic invasion: 38 pathways were differentially abundant between the sham and burn injury mice, including bacterial invasion of epithelial cells and gap- and adherens junction pathways.	[Beckmann, Nadine; Pugh, Amanda M.; Caldwell, Charles C.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Caldwell, Charles C.] Shriners Hosp Children, Div Res, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati	Caldwell, CC (corresponding author), Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA.; Caldwell, CC (corresponding author), Shriners Hosp Children, Div Res, Cincinnati, OH 45229 USA.	Charles.caldwell@uc.edu		Caldwell, Charles/0000-0003-1692-4550	Shriner's of North America - Cincinnati	Shriner's of North America - Cincinnati	This study was supported by the Hardisty Pilot Grant from the Shriner's of North America - Cincinnati awarded to Charles C. Caldwell (https://www.shrinershospitalsforchildren.org/shc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadel-Kariem FM, 2010, ANAEROBE, V16, P223, DOI 10.1016/j.anaerobe.2010.01.001; Bar K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-145; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bien J, 2013, THER ADV GASTROENTER, V6, P53, DOI 10.1177/1756283X12454590; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cummings JH, 1997, NUTRITION, V13, P476, DOI 10.1016/S0899-9007(97)00114-7; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; Faunce DE, 1999, BURNS, V25, P403, DOI 10.1016/S0305-4179(99)00014-5; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hanschen M, 2011, SHOCK, V35, P252, DOI 10.1097/SHK.0b013e3181f489c5; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kuethe JW, 2016, SHOCK, V45, P647, DOI 10.1097/SHK.0000000000000551; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen PE, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0084-3; Lichtman SM, 2001, J PEDIATR GASTR NUTR, V33, P1, DOI 10.1097/00005176-200107000-00001; MacConmara MP, 2011, J LEUKOCYTE BIOL, V89, P137, DOI 10.1189/jlb.0210082; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; MOSS NM, 1988, SURGERY, V104, P882; Namazi MR, 2004, AUTOIMMUNITY, V37, P73, DOI 10.1080/08916930310001637968; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Rice TC, 2017, CELL IMMUNOL, V313, P25, DOI 10.1016/j.cellimm.2016.12.004; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sydenham TV, 2014, J CLIN MICROBIOL, V52, P1304, DOI 10.1128/JCM.03128-13; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Tschop J, 2009, SHOCK, V31, P157, DOI 10.1097/SHK.0b013e31817fbf4d; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	36	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205307	10.1371/journal.pone.0205307	http://dx.doi.org/10.1371/journal.pone.0205307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289947	Green Submitted, Green Published, gold			2022-12-27	WOS:000446545500064
J	Feiner, ZS; Foley, CJ; Bootsma, HA; Czesny, SJ; Janssen, J; Rinchard, J; Hook, TO				Feiner, Zachary S.; Foley, Carolyn J.; Bootsma, Harvey A.; Czesny, Sergiusz J.; Janssen, John; Rinchard, Jacques; Hook, Tomas O.			Species identity matters when interpreting trophic markers in aquatic food webs	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; STABLE-ISOTOPES; NEOGOBIUS-MELANOSTOMUS; LAKE-MICHIGAN; ROUND GOBY; FUNCTIONAL-CHARACTERIZATION; PREY FISH; DIET; MARINE; CARBON	In aquatic systems, food web linkages are often assessed using diet contents, stable isotope ratios, and, increasingly, fatty acid composition of organisms. Some correlations between different trophic metrics are assumed to be well-supported; for example, particular stable isotope ratios and fatty acids seem to reflect reliance on benthic or pelagic energy pathways. However, understanding whether the assumed correlations between different trophic metrics are coherent and consistent across species represents a key step toward their effective use in food web studies. To assess links among trophic markers, we compared relationships between major diet components, fatty acids, and stable isotope ratios in three fishes: yellow perch (Perca flavescens), round goby (Neogobius melanostomus), and spottail shiner (Notropis hudsonius) collected from nearshore Lake Michigan. Yellow perch and spottail shiner are native in this system, while round goby are a relatively recent invader. We found some evidence for agreement between different trophic metrics, especially between diet components, n-3:n-6 fatty acid ratios, and stable isotope ratios (delta C-13 and delta N-15). However, we also observed significant variation in observed relationships among markers and species, potentially due to taxonomic variation in the specific diet items consumed (e.g., chydorid microcrustaceans and Dreissena mussels) and species-specific biochemical processes. In many of these latter cases, the invasive species differed from the native species. Understanding the effects of taxonomic variation on prey and predator signatures could significantly improve the usefulness of fatty acids in food web studies, whereas diet contents and stable isotopes appear to be reliable indicators of trophic niche in aquatic food webs.	[Feiner, Zachary S.; Foley, Carolyn J.; Hook, Tomas O.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Foley, Carolyn J.; Hook, Tomas O.] Purdue Univ, Illinois Indiana Sea Grant, W Lafayette, IN 47907 USA; [Bootsma, Harvey A.; Janssen, John] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA; [Czesny, Sergiusz J.] Univ Illinois, Lake Michigan Biol Stn, Illinois Nat Hist Survey, Zion, IL USA; [Rinchard, Jacques] SUNY Coll Brockport, Dept Environm Sci & Ecol, Brockport, NY 14420 USA; [Feiner, Zachary S.] Wisconsin Dept Nat Resources, Sci Operat Ctr, Off Appl Sci, Madison, WI USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Milwaukee; Illinois Natural History Survey; University of Illinois System; State University of New York (SUNY) System	Foley, CJ (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.; Foley, CJ (corresponding author), Purdue Univ, Illinois Indiana Sea Grant, W Lafayette, IN 47907 USA.	cfoley@purdue.edu	Feiner, Zachary S/A-2117-2009	Feiner, Zachary S/0000-0001-7880-0778	NOAA Sea Grant State Programs Illinois-Indiana Sea Grant [NA10OAR4170068]; Michigan Sea Grant [NA05OAR4171045]; Wisconsin Sea Grant [R/RegHCE-4]; US Environmental Protection Agency Great Lakes National Program Office through the Great Lakes Restoration Initiative [EPA GL-00E00720]; National Park Service; Purdue University Department of Forestry and Natural Resources	NOAA Sea Grant State Programs Illinois-Indiana Sea Grant; Michigan Sea Grant; Wisconsin Sea Grant; US Environmental Protection Agency Great Lakes National Program Office through the Great Lakes Restoration Initiative; National Park Service; Purdue University Department of Forestry and Natural Resources	Funding for this project was provided by NOAA Sea Grant State Programs Illinois-Indiana Sea Grant (www.iiseagrant.org grant no. NA10OAR4170068), Michigan Sea Grant (www.miseagrant.umich.edu/ grant no. NA05OAR4171045), Wisconsin Sea Grant (www.seagrant.wisc.edu/ grant no. R/RegHCE-4), the US Environmental Protection Agency Great Lakes National Program Office through the Great Lakes Restoration Initiative (https://www.glri.us/ grant no. EPA GL-00E00720), the National Park Service (www.nps.gov), and the Purdue University Department of Forestry and Natural Resources (www.ag.purdue.edu/fnr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Ayad SMEA, 2000, FISH PHYSIOL BIOCHEM, V23, P233, DOI 10.1023/A:1007891922182; Ahlgren G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P147, DOI 10.1007/978-0-387-89366-2_7; [Anonymous], R LANG ENV STAT COMP; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; BELL MV, 1986, COMP BIOCHEM PHYS B, V83, P711, DOI 10.1016/0305-0491(86)90135-5; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Brush JM, 2012, CAN J FISH AQUAT SCI, V69, P573, DOI 10.1139/F2012-001; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Czesny S, 1999, AQUACULTURE, V178, P103, DOI 10.1016/S0044-8486(99)00120-9; Czesny SJ, 2011, CAN J FISH AQUAT SCI, V68, P1211, DOI 10.1139/F2011-048; Dethier MN, 2013, MAR ECOL PROG SER, V478, P1, DOI 10.3354/meps10310; Foley C.J., 2017, FOOD WEBS, V10, P26, DOI [10.1016/j.fooweb.2016.10.001, DOI 10.1016/J.FOOWEB.2016.10.001]; FRY B., 2006, STABLE ISOTOPE ECOLO; Galvan DE, 2012, OECOLOGIA, V169, P1083, DOI 10.1007/s00442-012-2273-4; Ghioni C, 1996, COMP BIOCHEM PHYS B, V114, P161, DOI 10.1016/0305-0491(96)00019-3; Ghomi MR, 2014, J APPL ICHTHYOL, V30, P527, DOI 10.1111/jai.12312; Gu B, 1996, J FISH BIOL, V49, P1233, DOI 10.1111/j.1095-8649.1996.tb01792.x; Hanson CE, 2010, AQUAT BOT, V93, P114, DOI 10.1016/j.aquabot.2010.04.004; Happel A, 2016, CAN J FISH AQUAT SCI, V73, P1222, DOI 10.1139/cjfas-2015-0328; Happel A, 2015, J GREAT LAKES RES, V41, P172, DOI 10.1016/j.jglr.2015.03.025; Happel A, 2015, J GREAT LAKES RES, V41, P179, DOI 10.1016/j.jglr.2015.04.013; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Henderson RJ, 1996, ARCH ANIM NUTR, V49, P5, DOI 10.1080/17450399609381859; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Kirsch PE, 1998, CAN J FISH AQUAT SCI, V55, P1378, DOI 10.1139/cjfas-55-6-1378; Li CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199713; Masclaux H, 2014, AQUAT SCI, V76, P73, DOI 10.1007/s00027-013-0314-7; McMeans BC, 2016, ECOL MONOGR, V86, P4, DOI 10.1890/15-0288.1; Moles MD, 2008, CAN J FISH AQUAT SCI, V65, P600, DOI 10.1139/F07-186; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nakano S, 1999, ECOLOGY, V80, P2435; Napolitano GE, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P21; Nielsen JM, 2018, METHODS ECOL EVOL, V9, P278, DOI 10.1111/2041-210X.12869; Paterson G, 2014, FRESHWATER BIOL, V59, P2150, DOI 10.1111/fwb.12418; Perga ME, 2005, OECOLOGIA, V144, P598, DOI 10.1007/s00442-005-0069-5; Persson J, 2006, FRESHWATER BIOL, V51, P887, DOI 10.1111/j.1365-2427.2006.01540.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Roswell CR, 2013, ECOL FRESHW FISH, V22, P479, DOI 10.1111/eff.12041; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Smyntek PM, 2008, FRESHWATER BIOL, V53, P1768, DOI 10.1111/j.1365-2427.2008.02001.x; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Torres-Ruiz M, 2007, J N AM BENTHOL SOC, V26, P509, DOI 10.1899/06-070.1; Turschak BA, 2014, ECOLOGY, V95, P1243, DOI 10.1890/13-0329.1; Vander Zanden MJ, 2006, CAN J FISH AQUAT SCI, V63, P2608, DOI 10.1139/F06-148; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Vanderploeg HA, 2010, J GREAT LAKES RES, V36, P50, DOI 10.1016/j.jglr.2010.04.005; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; West JM, 2003, ENVIRON BIOL FISH, V67, P297, DOI 10.1023/A:1025843300415; Wiegand MD, 2004, CAN J FISH AQUAT SCI, V61, P110, DOI 10.1139/F03-146	62	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204767	10.1371/journal.pone.0204767	http://dx.doi.org/10.1371/journal.pone.0204767			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289888	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500023
J	Martinkova, P; Goldhaber, D; Erosheva, E				Martinkova, Patricia; Goldhaber, Dan; Erosheva, Elena			Disparities in ratings of internal and external applicants: A case for model-based inter-rater reliability	PLOS ONE			English	Article							HUMAN-RESOURCE MANAGEMENT; IMPACT; PRODUCTIVITY; ACHIEVEMENT; RECRUITMENT; TEACHERS; VALIDITY	Ratings are present in many areas of assessment including peer review of research proposals and journal articles, teacher observations, university admissions and selection of new hires. One feature present in any rating process with multiple raters is that different raters often assign different scores to the same assessee, with the potential for bias and inconsistencies related to rater or assessee covariates. This paper analyzes disparities in ratings of internal and external applicants to teaching positions using applicant data from Spokane Public Schools. We first test for biases in rating while accounting for measures of teacher applicant qualifications and quality. Then, we develop model-based inter-rater reliability (IRR) estimates that allow us to account for various sources of measurement error, the hierarchical structure of the data, and to test whether covariates, such as applicant status, moderate IRR. We find that applicants external to the district receive lower ratings for job applications compared to internal applicants. This gap in ratings remains significant even after including measures of qualifications and quality such as experience, state licensure scores, or estimated teacher value added. With model-based IRR, we further show that consistency between raters is significantly lower when rating external applicants. We conclude the paper by discussing policy implications and possible applications of our model-based IRR estimate for hiring and selection practices in and out of the teacher labor market.	[Martinkova, Patricia] Czech Acad Sci, Dept Stat Modelling, Inst Comp Sci, Prague, Czech Republic; [Martinkova, Patricia] Charles Univ Prague, Fac Educ, Inst Res & Dev Educ, Prague, Czech Republic; [Goldhaber, Dan] Univ Washington, Sch Social Work, Ctr Educ Data & Res, Seattle, WA 98195 USA; [Goldhaber, Dan; Erosheva, Elena] Univ Washington, Ctr Stat Social Sci, Seattle, WA 98195 USA; [Erosheva, Elena] Univ Washington, Sch Social Work, Dept Stat, Seattle, WA 98195 USA; [Erosheva, Elena] Univ Cote dAzur, Lab JA Dieudonne, CNRS, Nice, France	Czech Academy of Sciences; Institute of Computer Science of the Czech Academy of Sciences; Charles University Prague; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Martinkova, P (corresponding author), Czech Acad Sci, Dept Stat Modelling, Inst Comp Sci, Prague, Czech Republic.; Martinkova, P (corresponding author), Charles Univ Prague, Fac Educ, Inst Res & Dev Educ, Prague, Czech Republic.	martinkova@cs.cas.cz	Martinkova, Patricia/E-5090-2014	Martinkova, Patricia/0000-0003-4754-8543	Czech Science Foundation [JG15-15856Y]; COST Action by the EU Framework Programme Horizon 2020 [TD1306]; Institutes of Education Sciences, U.S. Department of Education [R305H130030]; National Science Foundation [1759825]	Czech Science Foundation(Grant Agency of the Czech Republic); COST Action by the EU Framework Programme Horizon 2020; Institutes of Education Sciences, U.S. Department of Education; National Science Foundation(National Science Foundation (NSF))	PM was supported by Grant #JG15-15856Y from the Czech Science Foundation, https://gacr.cz/en/, and by COST Action TD1306 supported by the EU Framework Programme Horizon 2020, www.cost.eu. DG was supported by Grant #R305H130030 from the Institutes of Education Sciences, U.S. Department of Education, https://ies.ed.gov/. EE was supported by Grant #1759825 from the National Science Foundation, https://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERA APA NCME, 2014, STAND ED PSYCH TEST, V2014 ed.; Agresti A, 2002, CATEGORICAL DATA ANA; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker B, 1996, ACAD MANAGE J, V39, P779, DOI 10.2307/256712; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennan R.L., 2001, GEN THEORY; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Casabianca JM, 2017, HDB MODERN ITEM RESP, P449; Casabianca JM, 2013, EDUC PSYCHOL MEAS, V73, P757, DOI 10.1177/0013164413486987; Chan W, 1996, J LABOR ECON, V14, P555, DOI 10.1086/209822; Chetty R, 2014, AM ECON REV, V104, P2633, DOI 10.1257/aer.104.9.2633; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CONWAY JM, 1995, J APPL PSYCHOL, V80, P565, DOI 10.1037/0021-9010.80.5.565; DeVaro J, 2015, 4 SOLE EALE WORLD M; DeVaro J, 2013, J LABOR ECON, V31, P227, DOI 10.1086/667814; Dowle M, 2017, DATA TABLE EXTENSION; Goldhaber D, 2017, ECON EDUC REV, V61, P112, DOI 10.1016/j.econedurev.2017.09.002; Goldhaber D, 2017, EDUC FINANC POLICY, V12, P197, DOI 10.1162/EDFP_a_00200; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Hill HC, 2012, EDUC RESEARCHER, V41, P56, DOI 10.3102/0013189X12437203; Ho A.D., 2013, RELIABILITY CLASSROO; HUSELID MA, 1995, ACAD MANAGE J, V38, P635, DOI 10.2307/256741; Jayasinghe UW, 2003, J R STAT SOC A STAT, V166, P279, DOI 10.1111/1467-985X.00278; Katko NJ, 2013, J PERS ASSESS, V91, pS1; Koch MJ, 1996, STRATEGIC MANAGE J, V17, P335; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lazear EP, 2009, J POLIT ECON, V117, P914, DOI 10.1086/648671; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; MARSH HW, 1989, J EXP EDUC, V57, P151, DOI 10.1080/00220973.1989.10806503; Mutz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048509; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Pinheiro JC, 2000, MIXED EFFECTS MODELS; R Development Core Team, 2009, R LANG ENV STAT COMP; Rockoff JE, 2004, AM ECON REV, V94, P247, DOI 10.1257/0002828041302244; Sandstrom U, 2008, SCIENTOMETRICS, V74, P175, DOI 10.1007/s11192-008-0211-3; Sattler DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130450; Schmidt FL, 1996, PSYCHOL METHODS, V1, P199, DOI 10.1037/1082-989X.1.2.199; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; van den Besselaar P, 2012, J INFORMETR, V6, P580, DOI 10.1016/j.joi.2012.05.003; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Ziv A, 2008, MED EDUC, V42, P991, DOI 10.1111/j.1365-2923.2008.03161.x	43	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203002	10.1371/journal.pone.0203002	http://dx.doi.org/10.1371/journal.pone.0203002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289923	Green Submitted, Green Published, gold			2022-12-27	WOS:000446545500004
J	Morellato, J; Chik, W; Barry, MA; Lu, JT; Thiagalingam, A; Kovoor, P; Pouliopoulos, J				Morellato, John; Chik, William; Barry, M. A.; Lu, Juntang; Thiagalingam, Aravinda; Kovoor, Pramesh; Pouliopoulos, Jim			Quantitative spectral assessment of intracardiac electrogram characteristics associated with post infarct fibrosis and ventricular tachycardia	PLOS ONE			English	Article							SIGNAL-AVERAGED ELECTROCARDIOGRAMS; MYOCARDIAL-INFARCTION; OVINE MODEL; FRACTIONATED ELECTROGRAMS; ARRHYTHMOGENIC SUBSTRATE; PROGNOSTIC-SIGNIFICANCE; RECORDING TECHNIQUES; ELECTRICAL-ACTIVITY; TRANSFORM ANALYSIS; CATHETER ABLATION	Background Post-myocardial infarction (MI) remodeling contributes to increased electrophysiological and structural heterogeneity and arrhythmogenesis. Utilising the post-infarct ovine model our aim was to determine unipolar electrogram frequency characteristics consequent to this remodeling and the development of Ventricular Tachycardia (VT). Methods and results Mapping studies were performed on 14 sheep at > 1 month post-MI induction. Sheep were divided into VT inducible (n = 7) and non-inducible (n = 7) groups. Multielectrode needles (n = 20) were deployed within and surrounding ventricular scar for electrophysiological assessment of electrogram amplitude and width. Spectral analysis of electrograms was undertaken using wavelet and fast fourier transformations (WFFT) to calculate root mean square (RMS) power intervals spanning 0-300Hz in 20Hz intervals. Quantitative assessment between electrophysiological and histological parameters including collagen density, and structural organization of the myocardium was performed. Increasing myocardial scar density resulted in attenuation of electrogram amplitude and RMS values. (all p<0.01). Between groups there were no differences in electrogram amplitude (p = 0.37), however WFFT analysis revealed significantly higher RMS values in the VT group (p<0.05) in association with high frequency fractional components of the electrogram. As scar density increased, greater between-group differences in RMS were observed spanning this high frequency (200-280Hz) spectrum and which were proportionally dependent on the degree of structural disorganisation of the myocardium (p<0.001) and number of extrastimuli required to induce VT (p<0.05). Conclusion High frequency unipolar electrogram spectral characteristics were quantitatively co-influenced by the presence of fibrosis and degree of myocardial structural dissorganisation and were associated with the propensity for development of VT.	[Morellato, John; Chik, William; Thiagalingam, Aravinda; Kovoor, Pramesh; Pouliopoulos, Jim] Univ Sydney, Sydney, NSW, Australia; [Chik, William; Barry, M. A.; Lu, Juntang; Thiagalingam, Aravinda; Kovoor, Pramesh; Pouliopoulos, Jim] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; University of Sydney	Pouliopoulos, J (corresponding author), Univ Sydney, Sydney, NSW, Australia.; Pouliopoulos, J (corresponding author), Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia.	jim.pouliopoulos@gmail.com		Pouliopoulos, Jim/0000-0002-9160-8630	Sydney Medical School - Early Career Researcher Grant; University of Sydney; National Health and Medical Research Council, Australia [402669]	Sydney Medical School - Early Career Researcher Grant; University of Sydney(University of Sydney); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a project grant from a Sydney Medical School - Early Career Researcher Grant, the University of Sydney [J.P], and The National Health and Medical Research Council, Australia [grant #402669 to P.K].	AbdelWahab A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1181, DOI 10.1161/CIRCEP.115.002940; Aliot EM, 2009, HEART RHYTHM, V6, P886, DOI 10.1016/j.hrthm.2009.04.030; Bogun F, 2005, J AM COLL CARDIOL, V46, P667, DOI 10.1016/j.jacc.2005.01.064; BOURKE JP, 1995, AM J CARDIOL, V75, P431, DOI 10.1016/S0002-9149(99)80576-1; CABO C, 1990, IEEE T BIO-MED ENG, V37, P500, DOI 10.1109/10.55640; CAIN ME, 1984, CIRCULATION, V69, P711, DOI 10.1161/01.CIR.69.4.711; Campos B, 2015, HEART RHYTHM, V12, P95, DOI 10.1016/j.hrthm.2014.10.002; Chen LS, 2007, J CARDIOVASC ELECTR, V18, P123, DOI 10.1111/j.1540-8167.2006.00590.x; DEBAKKER JMT, 1988, CIRCULATION, V77, P589, DOI 10.1161/01.CIR.77.3.589; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; DENNISS AR, 1986, CIRCULATION, V74, P731, DOI 10.1161/01.CIR.74.4.731; ELLIS WS, 1995, CIRCULATION, V92, P1619, DOI 10.1161/01.CIR.92.6.1619; GARAN H, 1987, CIRC RES, V60, P879, DOI 10.1161/01.RES.60.6.879; GARDNER PI, 1985, CIRCULATION, V72, P596, DOI 10.1161/01.CIR.72.3.596; Hsieh CH, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1010, DOI 10.1161/CIRCEP.113.000348; IDEKER RE, 1983, PACE, V6, P908, DOI 10.1111/j.1540-8159.1983.tb04412.x; JOSEPHSON ME, 1978, CIRCULATION, V57, P659, DOI 10.1161/01.CIR.57.4.659; Kapela A, 2004, IEEE T BIO-MED ENG, V51, P1915, DOI 10.1109/TBME.2004.834277; Klein HU, 2005, J AM COLL CARDIOL, V46, P675, DOI 10.1016/j.jacc.2005.05.026; Kovoor P, 2003, PACE, V26, P1979, DOI 10.1046/j.1460-9592.2003.00305.x; Kucera JP, 1998, CIRC RES, V83, P795, DOI 10.1161/01.RES.83.8.795; Mekkaoui C, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-70; Popescu M, 1998, PHYSIOL MEAS, V19, P77, DOI 10.1088/0967-3334/19/1/007; Pouliopoulos J, 2010, EUROPACE, V12, P881, DOI 10.1093/europace/euq098; Reek S, 1999, PACE, V22, P605, DOI 10.1111/j.1540-8159.1999.tb00502.x; RICHARDS DAB, 1991, CIRCULATION, V83, P756, DOI 10.1161/01.CIR.83.3.756; Sasaki T, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1081, DOI 10.1161/CIRCEP.112.970699; SENHADJI L, 1995, IEEE ENG MED BIOL, V14, P167, DOI 10.1109/51.376755; SPACH MS, 1990, ANN NY ACAD SCI, V591, P62; SPACH MS, 1985, INT J CARDIOL, V7, P167, DOI 10.1016/0167-5273(85)90361-4; Stevenson WG, 2005, J CARDIOVASC ELECTR, V16, P1017, DOI 10.1111/j.1540-8167.2005.50155.x; Takayama H, 2006, CIRC J, V70, P69, DOI 10.1253/circj.70.69; Takayama H, 1997, J ELECTROCARDIOL, V30, P145, DOI 10.1016/S0022-0736(98)80062-9; Tsiachris D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P863, DOI 10.1161/CIRCEP.114.002551; Turner I, 2005, J CARDIOVASC ELECTR, V16, P151, DOI 10.1046/j.1540-8167.2005.30490.x; WAXMAN HL, 1980, CIRCULATION, V62, P1349, DOI 10.1161/01.CIR.62.6.1349; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; WITKOWSKI FX, 1993, CIRC RES, V72, P424, DOI 10.1161/01.RES.72.2.424; Yao JA, 2003, CIRC RES, V92, P437, DOI 10.1161/01.RES.0000059301.81035.06; Zaman S, 2012, J WORKING GROUPS CAR	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204997	10.1371/journal.pone.0204997	http://dx.doi.org/10.1371/journal.pone.0204997			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289934	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500036
J	Neumann, MS; Plant, A; Margolis, AD; Borkowf, CB; Malotte, CK; Rietmeijer, CA; Flores, SA; O'Donnell, L; Robilotto, S; Myint-U, A; Montoya, JA; Javanbakht, M; Klausner, JD				Neumann, Mary Spink; Plant, Aaron; Margolis, Andrew D.; Borkowf, Craig B.; Malotte, C. Kevin; Rietmeijer, Cornelis A.; Flores, Stephen A.; O'Donnell, Lydia; Robilotto, Susan; Myint-U, Athi; Montoya, Jorge A.; Javanbakht, Marjan; Klausner, Jeffrey D.			Effects of a brief video intervention on treatment initiation and adherence among patients attending human immunodeficiency virus treatment clinics	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; WAITING ROOMS; INFECTION; PREVENTION; TRIAL; COST; SAFE	Background Persons with human immunodeficiency virus (HIV) who get and keep a suppressed viral load are unlikely to transmit HIV. Simple, practical interventions to help achieve HIV viral suppression that are easy and inexpensive to administer in clinical settings are needed. We evaluated whether a brief video containing HIV-related health messages targeted to all patients in the waiting room improved treatment initiation, medication adherence, and retention in care. Methods and findings In a quasi-experimental trial all patients (N = 2,023) attending two HIV clinics from June 2016 to March 2017 were exposed to a theory-based, 29-minute video depicting persons overcoming barriers to starting treatment, taking medication as prescribed, and keeping medical appointments. New prescriptions at index visit, HIV viral load test results, and dates of return visits were collected through review of medical records for all patients during the 10 months that the video was shown. Those data were compared with the same variables collected for all patients (N = 1,979) visiting the clinics during the prior 10 months (August 2015 to May 2016). Among patients exposed to the video, there was an overall 10.4 percentage point increase in patients prescribed treatment (60.3% to 70.7%, p<0.01). Additionally, there was an overall 6.0 percentage point improvement in viral suppression (56.7% to 62.7%, p<0.01), however mixed results between sites was observed. There was not a significant change in rates of return visits (77.5% to 78.8%). A study limitation is that, due to the lack of randomization, the findings may be subject to bias and secular trends. Conclusions Showing a brief treatment-focused video in HIV clinic waiting rooms can be effective at improving treatment initiation and may help patients achieve viral suppression. This feasible, low resource-reliant video intervention may be appropriate for adoption by other clinics treating persons with HIV.	[Neumann, Mary Spink; Margolis, Andrew D.; Borkowf, Craig B.; Flores, Stephen A.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD &TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Plant, Aaron; Montoya, Jorge A.] Sentient Res, West Covina, CA USA; [Malotte, C. Kevin] Calif State Univ Long Beach, Long Beach, CA 90840 USA; [Rietmeijer, Cornelis A.] Univ Colorado, Colorado Sch Publ Hlth, Denver, CO 80202 USA; [O'Donnell, Lydia; Myint-U, Athi] Educ Dev Ctr, Waltham, MA USA; [Robilotto, Susan] Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD USA; [Javanbakht, Marjan; Klausner, Jeffrey D.] Univ Calif Los Angeles, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA; California State University System; California State University Long Beach; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; United States Health Resources & Service Administration (HRSA); University of California System; University of California Los Angeles	Margolis, AD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD &TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	avm8@cdc.gov	Javanbakht, Marjan/Q-2183-2019	Javanbakht, Marjan/0000-0003-0088-3803	Health and Human Services Secretary's Minority AIDS Initiative; Centers for Disease Control and Prevention [200-2013-57577]; Secretary's Minority AIDS Initiative; Centers for Disease Control and Prevention	Health and Human Services Secretary's Minority AIDS Initiative; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Secretary's Minority AIDS Initiative; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The data collected and used for this study were funded by the Health and Human Services Secretary's Minority AIDS Initiative and by the Centers for Disease Control and Prevention through contract number 200-2013-57577 awarded to Sentient Research. The Secretary's Minority AIDS Initiative provided direct funding. The Centers for Disease Control and Prevention provided direct funding and support in the form of salaries for authors MSN, ADM, CBB and SAF, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section. The four authors who are employees of the Centers for Disease Control and Prevention had roles in study design, data collection and analyses, decision to publish, and preparation of the manuscript. Two authors are employees of the commercial company, Sentient Research (AP and JAM), and had roles in study design, data collection, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.	[Anonymous], COMP EV BAS INT BEST; [Anonymous], 2011, HIGH IMP HIV PREV CD; Besera GT, 2016, HEALTH PROMOT PRACT, V17, P731, DOI 10.1177/1524839916631537; Carey MP, 2015, AIDS BEHAV, V19, P1228, DOI 10.1007/s10461-014-0960-3; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Gift TL, 2016, SEX TRANSM DIS, V43, P61, DOI 10.1097/OLQ.0000000000000388; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Harshbarger C, 2006, AIDS EDUC PREV, V18, P184, DOI 10.1521/aeap.2006.18.supp.184; Harshbarger CL, 2012, AM J PREV MED, V42, P468, DOI 10.1016/j.amepre.2012.01.029; Health Resources & Services Administration, RYAN WHIT HIV AIDS P; ITTC-Recommended Procedures and Guidelines, 2017, GUID US RANS TOOLS M; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Myint-U A, 2010, HEALTH PROMOT PRACT, V11, P408, DOI 10.1177/1524839908318830; Neumann MS, 2011, SEX TRANSM DIS, V38, P133, DOI 10.1097/OLQ.0b013e3181f0c051; Neumann MS, 2017, AM PUBL HLTH ASS GLO; O'Donnell CR, 1998, SEX TRANSM DIS, V25, P161, DOI 10.1097/00007435-199803000-00010; Office of National AIDS Policy WHDPC, 2015, NAT HIV AIDS STRAT U; Sweat M, 2001, AIDS, V15, P781, DOI 10.1097/00002030-200104130-00014; Warner L, 2008, PLOS MED, V5, P919, DOI 10.1371/journal.pmed.0050135; World Health Organization, 2014, CONS GUID HIV PREV D	20	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204599	10.1371/journal.pone.0204599	http://dx.doi.org/10.1371/journal.pone.0204599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289884	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500020
J	van Rooij, J; Lucas, EH; Geerards, AJ; Remeijer, L; Wubbels, R				van Rooij, Jeroen; Lucas, Elsina H.; Geerards, Annette J.; Remeijer, Lies; Wubbels, Rene			Corneal transplantation for Fuchs' endothelial dystrophy: A comparison of three surgical techniques concerning 10 year graft survival and visual function	PLOS ONE			English	Article							POSTERIOR LAMELLAR KERATOPLASTY; PENETRATING KERATOPLASTY; OUTCOMES; REJECTION; FAILURE	Objective Comparison of conventional Penetrating Keratoplasty (PKP), posterior mushroom PKP and Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) regarding overall graft survival of primary corneal transplants for Fuchs' endothelial dystrophy (FED), best spectacle-corrected visual acuity (BSCVA) and astigmatism. Methods Single centre study using prospectively collected data from the national database for follow-up of corneal transplants. Main outcome parameters: 10 years graft survival, astigmatism at 24 months, pre- and post-operative BSCVA. Results In total, 721 cases were included: PKP, n =171; posterior mushroom PKP, n = 91; and DSAEK, n = 459. There was no significant difference in graft survival between PKP, posterior mushroom PKP and the DSAEK technique (log-rank test, P = 0.12). The overall postoperative BSCVA improvement in all treatment groups was significant (paired t-test, P<0.001). Pre-operative BSCVA was better for the DSAEK group (0.68 +/- 0.41 logMAR) as compared to the PKP (0.89 +/- 0.53) and posterior mushroom PKP group (0.90 +/- 0.58); ANOVA, P<0.001. After 24 months, BSCVA was significantly better for the DSAEK group (0.25 +/- 0.26 log-MAR) compared to the PKP (0.35 +/- 0.29) and posterior mushroom PKP group (0.41 +/- 0.42); ANOVA, P<0.001. A significant difference in astigmatism was found (median test, P<0.001) between the DSAEK (1.7 +/- 1.1 D), PKP (4.6 +/- 2.7 D) and posterior mushroom PKP group (4.5 +/- 3.3 D). The significantly lower DSAEK-induced astigmatism was confirmed by vector analysis. Conclusion There was no difference in graft survival and BSCVA improvement between conventional PKP, inverted mushroom PKP and DSAEK in this study. The significantly lower changes in astigmatism, wound stability and faster visual rehabilitation with DSAEK surgery are favourable aspects of this technique. The benefits of posterior lamellar keratoplasty warrant earlier intervention, which may contribute to preserve better vision for a prolonged period of remaining lifetime.	[van Rooij, Jeroen; Lucas, Elsina H.; Geerards, Annette J.; Remeijer, Lies; Wubbels, Rene] Rotterdam Eye Hosp, Rotterdam, Netherlands	Rotterdam Eye Hospital	van Rooij, J (corresponding author), Rotterdam Eye Hosp, Rotterdam, Netherlands.	drjoe403@xs4all.nl	Rooij, Jeroen/GPG-0810-2022	Wubbels, Rene J./0000-0002-0058-3643	TopZorg ZonMW, Laan van Nieuw Oost-Indie CE Den Haag, the Netherlands [842005006]; Rotterdam Ophthalmological Institute	TopZorg ZonMW, Laan van Nieuw Oost-Indie CE Den Haag, the Netherlands; Rotterdam Ophthalmological Institute	This study was financially supported by TopZorg ZonMW, Laan van Nieuw Oost-Indie 334, 2593 CE Den Haag, the Netherlands; email info@zonmw.nl; URL www.zonmw.nl, Grant nr 842005006, Funding receiver: The Rotterdam Ophthalmological Institute, Project leader: JvR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari NA, 2006, ARCH OPHTHALMOL-CHIC, V124, P777, DOI 10.1001/archopht.124.6.777; Akanda ZZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119934; Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Bahar I, 2009, CORNEA, V28, P485, DOI 10.1097/ICO.0b013e3181901df4; Busin M, 2003, ARCH OPHTHALMOL-CHIC, V121, P260; Cheng YYY, 2011, AM J OPHTHALMOL, V152, P556, DOI 10.1016/j.ajo.2011.03.012; Cheng YYY, 2009, TRANSPLANTATION, V88, P1294, DOI 10.1097/TP.0b013e3181bc419c; Coster DJ, 2014, OPHTHALMOLOGY, V121, P979, DOI 10.1016/j.ophtha.2013.12.017; Fuest M, 2017, AM J OPHTHALMOL, V182, P62, DOI 10.1016/j.ajo.2017.07.014; Greenrod EB, 2014, AM J OPHTHALMOL, V158, P957, DOI 10.1016/j.ajo.2014.07.037; Hjortdal J, 2013, CORNEA, V32, pE60, DOI 10.1097/ICO.0b013e3182687ff3; Hjortdal J, 2009, ACTA OPHTHALMOL, V87, P310, DOI 10.1111/j.1755-3768.2008.01492.x; Holladay JT, 2001, J CATARACT REFR SURG, V27, P61, DOI 10.1016/S0886-3350(00)00796-3; Ishiyama S, 2016, CORNEA, V35, P1526, DOI 10.1097/ICO.0000000000001003; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; Lehman RE, 2015, CORNEA, V34, P1358, DOI 10.1097/ICO.0000000000000617; McLaren JW, 2009, AM J OPHTHALMOL, V147, P959, DOI 10.1016/j.ajo.2008.12.039; Nanavaty MA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008420.pub3; Park CY, 2015, OPHTHALMOLOGY, V122, P2432, DOI 10.1016/j.ophtha.2015.08.017; Patel SV, 2008, AM J OPHTHALMOL, V145, P97, DOI 10.1016/j.ajo.2007.09.002; Pedersen IB, 2015, ACTA OPHTHALMOL, V93, P172, DOI 10.1111/aos.12518; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2013, OPHTHALMOLOGY, V120, P246, DOI 10.1016/j.ophtha.2012.08.007	23	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203993	10.1371/journal.pone.0203993	http://dx.doi.org/10.1371/journal.pone.0203993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289925	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500011
J	Al-Bashiri, H; Abdulgabber, MA; Romli, A; Kahtan, H				Al-Bashiri, Hael; Abdulgabber, Mansoor Abdullateef; Romli, Awanis; Kahtan, Hasan			An improved memory-based collaborative filtering method based on the TOPSIS technique	PLOS ONE			English	Article							RECOMMENDER SYSTEMS; SIMILARITY MEASURE; PERFORMANCE; ACCURACY	This paper describes an approach for improving the accuracy of memory-based collaborative filtering, based on the technique for order of preference by similarity to ideal solution (TOPSIS) method. Recommender systems are used to filter the huge amount of data available online based on user-defined preferences. Collaborative filtering (CF) is a commonly used recommendation approach that generates recommendations based on correlations among user preferences. Although several enhancements have increased the accuracy of memory-based CF through the development of improved similarity measures for finding successful neighbors, there has been less investigation into prediction score methods, in which rating/preference scores are assigned to items that have not yet been selected by a user. A TOPSIS solution for evaluating multiple alternatives based on more than one criterion is proposed as an alternative to prediction score methods for evaluating and ranking items based on the results from similar users. The recommendation accuracy of the proposed TOPSIS technique is evaluated by applying it to various common CF baseline methods, which are then used to analyze the MovieLens 100K and 1M benchmark datasets. The results show that CF based on the TOPSIS method is more accurate than baseline CF methods across a number of common evaluation metrics.	[Al-Bashiri, Hael; Abdulgabber, Mansoor Abdullateef; Romli, Awanis; Kahtan, Hasan] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Pahang, Malaysia	Universiti Malaysia Pahang	Al-Bashiri, H (corresponding author), Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Pahang, Malaysia.	hailealbashiri1@gmail.com	al-bashiri, hael abdullah hussein/J-6729-2019; romli, awanis/T-2707-2019; Kahtan, Hasan/AAC-5991-2020; Kahtan, Hasan/L-8500-2016	al-bashiri, hael abdullah hussein/0000-0002-2973-1638; Kahtan, Hasan/0000-0001-6521-7081; Kahtan, Hasan/0000-0001-6521-7081	Department of Research and Innovation of University Malaysia Pahang [RDU170318]; Fundamental Research Grant Scheme (FRGS) [RDU170102]	Department of Research and Innovation of University Malaysia Pahang; Fundamental Research Grant Scheme (FRGS)	This research is supported by the Department of Research and Innovation of University Malaysia Pahang under RDU170318 to MAA and Fundamental Research Grant Scheme (FRGS) RDU170102 to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achakulvisut T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158423; Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Aggarwal C. C., 2016, CONTENT BASED RECOMM, P139, DOI DOI 10.1007/978-3-319-29659-3_4; Ahn HJ, 2008, INFORM SCIENCES, V178, P37, DOI 10.1016/j.ins.2007.07.024; Al-bashiri H, 2017, P INT C ADV IM PROC, DOI [10.1166/asl.2017.10020, DOI 10.1166/ASL.2017.10020]; Al-bashiri H, 2018, INT J ADV COMPUT SC, V9, P135; Al-Bashiri H, 2017, ADV SCI LETT, V23, P9045, DOI 10.1166/asl.2017.10020; Alper B., 2017, ANADOLU U J SCI TECH, V18, P225; BAEZAYATES R, 1999, MODERN INFORMATION R; Basu C., 1998, RECOMMENDATION CLASS; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; Bobadilla J, 2010, KNOWL-BASED SYST, V23, P520, DOI 10.1016/j.knosys.2010.03.009; Bobadilla J, 2012, INFORM PROCESS MANAG, V48, P204, DOI 10.1016/j.ipm.2011.03.007; Bobadilla J, 2011, EXPERT SYST APPL, V38, P14609, DOI 10.1016/j.eswa.2011.05.021; Breese J S, 1998, P 14 C UNC ART INT; BURKE R, 2007, ADAPTIVE WEB, P377, DOI DOI 10.1007/978-3-540-72079-9_12; Cai G, 2014, DATA MINING WORKSHOP; Cantador I., 2011, 2 WORKSH INF HET FUS; Chen L, 2015, USER MODEL USER-ADAP, V25, P99, DOI 10.1007/s11257-015-9155-5; Cheng WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155739; Choi K, 2013, KNOWL-BASED SYST, V37, P146, DOI 10.1016/j.knosys.2012.07.019; Ekstrand Michael D., 2010, Foundations and Trends in Human-Computer Interaction, V4, P81, DOI 10.1561/1100000009; Gan MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114662; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Guo G, 2013, INT JOINT C ART INT; Han J, 2012, MOR KAUF D, P1; Haruna K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184516; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Herlocker JL, 1999, PROCEEDINGS OF THE 2; Hill W., 1995, P SIGCHI C HUM FACT; Huang BH, 2015, IEEE INT CONF MOB DA, P104, DOI 10.1109/MDM.2015.43; Hwang C.L., 2012, MULTIPLE ATTRIBUTE D, V186; Hwang C.L., 1981, MULTIPLE ATTRIBUTE D, DOI [DOI 10.1007/978-3-642-48318, 10.1007/978-3-642-48318-9, DOI 10.1007/978-3-642-48318-9]; Ic YT, 2010, EXPERT SYST APPL, V37, P567, DOI 10.1016/j.eswa.2009.05.038; Iijima J, 2007, ELECTRON COMMER R A, V6, P139, DOI 10.1016/j.elerap.2006.11.002; Ishizaka A., 2013, MULTICRITERIA DECISI, P1; Jamali M., 2009, P 15 ACM SIGKDD INT, P394, DOI 10.1145/1557019.1557067; Kahraman C, 2008, SPRINGER SER OPTIM A, V16, P1; Kim HN, 2010, ELECTRON COMMER R A, V9, P73, DOI 10.1016/j.elerap.2009.08.004; Konstan J. A., 1998, REC SYST 1998 WORKSH; Konstan JA, 1997, COMMUN ACM, V40, P77, DOI 10.1145/245108.245126; Koohi H, 2017, EXPERT SYST APPL, V83, P30, DOI 10.1016/j.eswa.2017.04.027; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Koutrika G, 2009, ACM SIGMOD/PODS 2009 CONFERENCE, P745; Liao CL, 2016, ELECTRON COMMER R A, V18, P1, DOI 10.1016/j.elerap.2016.05.001; Liu HF, 2014, KNOWL-BASED SYST, V56, P156, DOI 10.1016/j.knosys.2013.11.006; Liu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113457; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Mooney R. J., 2000, ACM 2000. Digital Libraries. Proceedings of the Fifth ACM Conference on Digital Libraries, P195, DOI 10.1145/336597.336662; Murti YR, 2016, ADV SCI LETT, V22, P1892, DOI 10.1166/asl.2016.7770; Olson DL, 2004, MATH COMPUT MODEL, V40, P721, DOI 10.1016/j.mcm.2004.10.003; Parkan C, 1997, INT J PROD RES, V35, P2963, DOI 10.1080/002075497194246; Patra BK, 2015, KNOWL-BASED SYST, V82, P163, DOI 10.1016/j.knosys.2015.03.001; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Polatidis N, 2016, EXPERT SYST APPL, V48, P100, DOI 10.1016/j.eswa.2015.11.023; Resnick P., 1994, Transcending Boundaries, CSCW '94. Proceedings of the Conference on Computer Supported Cooperative Work, P175, DOI 10.1145/192844.192905; Ricci F., 2011, INTRO RECOMMENDER SY; Salton G, 1986, INTRO MODERN INFORM; Saranya KG, 2017, APPL MATH INFORM SCI, V11, P317, DOI [DOI 10.18576/AMIS/110137, 10.18576/amis/110137]; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Sarwar B., 2000, P ACM E COMM EC 2000, DOI DOI 10.1145/352871.352887; Sarwar B., 2000, ACM WEBKDD 2000 WORK; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Shardanand U., 1995, Human Factors in Computing Systems. CHI'95 Conference Proceedings, P210, DOI 10.1145/223904.223931; Sharma L., 2013, INT J ENG TRENDS TEC, V4, P1989; Shen L, 2010, COMP MOD SIM 2010 IC; Shih HS, 2007, MATH COMPUT MODEL, V45, P801, DOI 10.1016/j.mcm.2006.03.023; Su X., 2009, ADV ARTIF INTELL, V2009, DOI DOI 10.1155/2009/421425; Suryakant, 2016, PROCEDIA COMPUT SCI, V89, P450, DOI 10.1016/j.procs.2016.06.099; Ungar LH, 1998, AAAI WORKSHOP ON REC; Van Den Oord Aaron, 2013, NEURAL INFORM PROCES, V26; Xu L, 2001, INTRO MULTICRITERIA, P1; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049126; Yang XW, 2014, COMPUT COMMUN, V41, P1, DOI 10.1016/j.comcom.2013.06.009; Zang X, 2016, NEW WEIGHTED SIMILAR; Zeng W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111005; Zha Y, 2013, INF SCI CLOUD COMP C; Zhang R, 2014, ADV CLOUD BIG DAT CB	81	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204434	10.1371/journal.pone.0204434	http://dx.doi.org/10.1371/journal.pone.0204434			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286123	gold, Green Submitted, Green Published			2022-12-27	WOS:000446383500020
J	Debniak, T; Scott, RJ; Gorski, B; Masojc, B; Kram, A; Maleszka, R; Cybulski, C; Paszkowska-Szczur, K; Kashyap, A; Murawa, D; Malinska, K; Kiedrowicz, M; Rogoza-Janiszewska, E; Rudnicka, H; Deptula, J; Domagala, P; Kluzniak, W; Lener, MR; Lubinski, J				Debniak, Tadeusz; Scott, Rodney J.; Gorski, Bohdan; Masojc, Bartlomiej; Kram, Andrzej; Maleszka, Romuald; Cybulski, Cezary; Paszkowska-Szczur, Katarzyna; Kashyap, Aniruddh; Murawa, Dawid; Malinska, Karolina; Kiedrowicz, Magdalena; Rogoza-Janiszewska, Emilia; Rudnicka, Helena; Deptula, Jakub; Domagala, Pawel; Kluzniak, Wojciech; Lener, Marcin R.; Lubinski, Jan			BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population	PLOS ONE			English	Article							BREAST-CANCER RISK; CUTANEOUS MELANOMA; PROSTATE-CANCER; MC1R VARIANTS; FOUNDER BRCA1; REPAIR GENES; CARRIERS; FAMILIES; SUSCEPTIBILITY; CARCINOMA	The association of BRCA1/2 mutations with melanoma is not completely determined; the interpretation of variants of unknown significance is also problematic. To evaluate these issues we explored the molecular basis of melanoma risk by performing whole-exome sequencing on a cohort of 96 unrelated Polish early-onset melanoma patients and targeted sequencing of BRCA1/2 genes on additional 30 melanoma patients with familial aggregation of breast and other cancers. Sequencing was performed on peripheral blood. We evaluated Mutation Taster, Polyphen2, SIFT, PROVEAN algorithms, analyzed segregation with cancer disease (in both families with identified BRCA2 variants) and in one family performed LOH (based on 2 primary tumors). We found neither pathogenic mutations nor variants of unknown significance within BRCA1. We identified two BRCA2 variants of unknown significance: c.9334G>A and c.4534 C>T. Disease allele frequency was evaluated by genotyping of 1230 consecutive melanoma cases, 5000 breast cancer patients, 3500 prostate cancers and 9900 controls. Both variants were found to be absent among unselected cancer patients and healthy controls. The Mutation Taster, Polyphen2 and SIFT algorithms indicate that c.9334G>A is a damaging variant. Due to lack of tumour tissue LOH analysis could not be performed for this variant. The variant segregated with the disease. The c.4534 C>T variant did not segregate with disease, there was no LOH of the variant. The c.9334G>A variant, classified as a rare variant of unknown significance, on current evidence may predisposes to cancers of the breast, prostate and melanoma. Functional studies to describe how the DNA change affects the protein function and a large multi-center study to evaluate its penetrance are required.	[Debniak, Tadeusz; Gorski, Bohdan; Cybulski, Cezary; Paszkowska-Szczur, Katarzyna; Kashyap, Aniruddh; Malinska, Karolina; Rogoza-Janiszewska, Emilia; Rudnicka, Helena; Deptula, Jakub; Kluzniak, Wojciech; Lener, Marcin R.; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathomorphol, Szczecin, Poland; [Scott, Rodney J.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Newcastle, NSW, Australia; [Scott, Rodney J.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Masojc, Bartlomiej; Kram, Andrzej] West Pomeranian Oncol Ctr, Szczecin, Poland; [Maleszka, Romuald; Kiedrowicz, Magdalena] Dept Skin Dis & Venerol PUM, Police, Poland; [Murawa, Dawid] Greater Poland Canc Ctr, Dept Oncol & Gen Surg 1, Poznan, Poland; [Domagala, Pawel] Pomeranian Med Univ, Dept Pathol, Szczecin, Poland	Pomeranian Medical University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Wielkopolskie Centrum Onkologii; Pomeranian Medical University	Debniak, T (corresponding author), Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathomorphol, Szczecin, Poland.	debniak@pum.edu.pl	Domagala, Pawel/AAW-2296-2021; Maleszka, Romuald/C-3157-2017; Kashyap, Aniruddh/AAE-5053-2022; Scott, Rodney/B-2827-2013	Domagala, Pawel/0000-0002-7810-5289; Maleszka, Romuald/0000-0001-5975-2045; Lubinski, Jan/0000-0003-2931-3003; Kashyap, Aniruddh/0000-0001-7374-7912; Kram, Andrzej/0000-0003-0621-0204; Scott, Rodney/0000-0001-7724-3404	Polish National Science Centre [2014/13/B/NZ2/03888]	Polish National Science Centre	This research was supported by the Polish National Science Centre grant number 2014/13/B/NZ2/03888 to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbari MR, 2008, ONCOGENE, V27, P1290, DOI 10.1038/sj.onc.1210739; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; Debniak T, 2008, EUR J CANCER, V44, P110, DOI 10.1016/j.ejca.2007.10.006; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Gerstenblith MR, 2007, HUM MUTAT, V28, P495, DOI 10.1002/humu.20476; Goldstein AM, 2005, CANCER EPIDEM BIOMAR, V14, P2208, DOI 10.1158/1055-9965.EPI-05-0321; Gorski B, 2004, INT J CANCER, V110, P683, DOI 10.1002/ijc.20162; Gumaste PV, 2015, BRIT J DERMATOL, V172, P1498, DOI 10.1111/bjd.13626; Hou W, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0163-6; Iqbal J, 2016, BRIT J CANCER, V114, P1160, DOI 10.1038/bjc.2016.58; Johannsson O, 1999, EUR J CANCER, V35, P1248, DOI 10.1016/S0959-8049(99)00135-5; Kadouri L, 2009, FAM CANCER, V8, P29, DOI 10.1007/s10689-008-9206-8; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Kirchhoff T, 2004, CLIN CANCER RES, V10, P2918, DOI 10.1158/1078-0432.CCR-03-0604; Kote-Jarai Z, 2011, BRIT J CANCER, V105, P1230, DOI 10.1038/bjc.2011.383; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landi MT, 2004, J MED GENET, V41, P557, DOI 10.1136/jmg.2003.016907; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin ST, 2005, ONCOGENE, V24, P3652, DOI 10.1038/sj.onc.1208411; Mersch J, 2015, CANCER-AM CANCER SOC, V121, P269, DOI 10.1002/cncr.29041; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Monnerat C, 2007, FAM CANCER, V6, P453, DOI 10.1007/s10689-007-9143-y; Moran A, 2012, FAM CANCER, V11, P235, DOI 10.1007/s10689-011-9506-2; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Potrony M, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.08.11; Read J, 2016, J MED GENET, V53, P1, DOI 10.1136/jmedgenet-2015-103150; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Tuominen R, 2016, GENE CHROMOSOME CANC, V55, P601, DOI 10.1002/gcc.22363; van Asperen CJ, 2005, J MED GENET, V42, P711, DOI 10.1136/jmg.2004.028829; Wang Y, 2017, NAT GENET, V49, P651, DOI 10.1038/ng0417-651a; Warden CD, 2014, PEERJ, V2, DOI 10.7717/peerj.600; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yin JY, 2015, J INVEST DERMATOL, V135, P542, DOI 10.1038/jid.2014.416	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204768	10.1371/journal.pone.0204768	http://dx.doi.org/10.1371/journal.pone.0204768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286154	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500038
J	Mudrak, J; Slepicka, P; Slepickova, I				Mudrak, Jiri; Slepicka, Pavel; Slepickova, Irena			Sport motivation and doping in adolescent athletes	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; ANABOLIC-ANDROGENIC STEROIDS; DRUG-CONTROL MODEL; INTRINSIC MOTIVATION; EGO ORIENTATION; EXTRINSIC MOTIVATION; FIT INDEXES; ATTITUDES; ACHIEVEMENT; PERFORMANCE	Background Although performance-enhancing drugs appear to be prevalent in adolescent sports, relatively little attention has been paid to why adolescent athletes decide to use these drugs. In this study, we examine doping among adolescents from a motivational perspective and explore how motivational variables, such as achievement goal orientations and the perceived self-determination of sports activities, may be related to moral attitudes, doping intentions and doping behavior in adolescents who participate in competitive sports. Methodology The study included 1035 adolescents participating in competitive sports from all regions of the Czech Republic (mean age = 16.3 years). The respondents completed a battery of questionnaires assessing their achievement goal orientations (task, ego), sports motivation at various levels of self-determination (intrinsic motivation, external regulation, amotivation), moral attitudes toward sport competition (acceptance of cheating, keeping winning in proportion, attitudes toward doping), doping intentions and doping behavior. A structural equation model was used to test the relations among motivational variables, attitudes, intentions and doping behavior. Principal results Our analyses indicated a good fit with the proposed model, which explained 59% of the variance in doping intentions and 17.6% of the variance in doping behavior. Within the model, task orientation was positively associated with intrinsic motivation and lower amotivation, whereas ego orientation was positively associated with extrinsic regulation and amotivation. Furthermore, intrinsic motivation was positively associated with keeping winning in proportion and negatively associated with acceptance of cheating and attitudes toward doping; the less self-determined forms of motivation showed opposite relationships. However, only the acceptance of cheating and attitudes toward doping were related to doping intention, which subsequently predicted doping behavior. Conclusions/Significance The results provide further evidence that sports motivation represents a psychological variable that should be considered in anti-doping policies, programs, and interventions aimed at the adolescent population because motivation was linked to the doping-related attitudinal variables and also partially mediated the effect of achievement goal orientations in this regard. On the basis of these results, we may argue that the focus on intrinsic enjoyment, self-referenced criteria of success and self-improvement may be related to more negative attitudes toward doping and cheating, lower doping intentions and less frequent doping behavior, whereas the emphasis on competition, comparison with others and external motivation appear to be related to the opposite outcomes.	[Mudrak, Jiri; Slepicka, Pavel] Charles Univ Prague, Fac Phys Educ & Sport, Dept Pedag Psychol & Didact, Prague, Czech Republic; [Slepickova, Irena] Charles Univ Prague, Fac Phys Educ & Sport, Dept Kinanthropol & Humanities, Prague, Czech Republic	Charles University Prague; Charles University Prague	Mudrak, J (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Dept Pedag Psychol & Didact, Prague, Czech Republic.	mudrak@ftvs.cuni.cz	Mudrak, Jiri/I-9956-2016	Mudrak, Jiri/0000-0002-9457-566X	World Anti-Doping Agency; PROGRES Q19 program	World Anti-Doping Agency; PROGRES Q19 program	The article was written with the support of a research grant from the World Anti-Doping Agency and the PROGRES Q19 program.	Alderman M. Kay, 2013, MOTIVATION ACHIEVEME; Allen J, 2015, J SPORT SCI, V33, P899, DOI 10.1080/02640414.2014.976588; Anderson SJ, 1997, PEDIATRICS, V99, P904; [Anonymous], 2015, 2015 PROH LIST; Barkoukis V, 2013, SCAND J MED SCI SPOR, V23, pE330, DOI 10.1111/sms.12068; Barkoukis V, 2011, PSYCHOL SPORT EXERC, V12, P205, DOI 10.1016/j.psychsport.2010.10.003; Blatny A M, 2006, CESK PSYCHOL, V50, P297; Chan DKC, 2015, J SCI MED SPORT, V18, P315, DOI 10.1016/j.jsams.2014.04.001; Chan DKC, 2015, J SPORT EXERCISE PSY, V37, P199, DOI 10.1123/jsep.2014-0250; Coakley J. J., 1997, SPORT SOC ISSUES CON; Czech Anti-doping Comittee, 2017, EDUCATION; Derenne JL, 2006, ACAD PSYCHIATR, V30, P257, DOI 10.1176/appi.ap.30.3.257; DUDA JL, 1995, INT J SPORT PSYCHOL, V26, P40; DUDA JL, 1991, RES Q EXERCISE SPORT, V62, P79, DOI 10.1080/02701367.1991.10607522; Dweck C.S., 2006, MINDSET NEW PSYCHOL; Ehrnborg C, 2009, GROWTH HORM IGF RES, V19, P285, DOI 10.1016/j.ghir.2009.04.003; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x; Gucciardi DF, 2011, J SCI MED SPORT, V14, P469, DOI 10.1016/j.jsams.2011.03.009; Hodge K, 2013, J SPORT EXERCISE PSY, V35, P419, DOI 10.1123/jsep.35.4.419; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Irving LM, 2002, J ADOLESCENT HEALTH, V30, P243, DOI 10.1016/S1054-139X(01)00414-1; Jalleh G, 2014, J SCI MED SPORT, V17, P574, DOI 10.1016/j.jsams.2013.10.249; JOHNSON MD, 1989, PEDIATRICS, V83, P921; Kanayama G, 2008, DRUG ALCOHOL DEPEN, V98, P1, DOI 10.1016/j.drugalcdep.2008.05.004; Kavussanu M, 2003, J SPORT EXERCISE PSY, V25, P501, DOI 10.1123/jsep.25.4.501; Kindlundh AMS, 1998, SCAND J SOC MED, V26, P71, DOI 10.1177/14034948980260010201; Kindlundh AMS, 2001, EUR J PUBLIC HEALTH, V11, P322, DOI 10.1093/eurpub/11.3.322; Knop PD., 1996, EUR J PHYS ED, V1, P36, DOI [10.1080/1740898960010104, DOI 10.1080/1740898960010104]; Laure P, 2007, BRIT J SPORT MED, V41, P660, DOI 10.1136/bjsm.2007.035733; Lazuras L, 2015, J SPORT EXERCISE PSY, V37, P37, DOI 10.1123/jsep.2013-0232; Lee MJ, 2007, PSYCHOL SPORT EXERC, V8, P369, DOI 10.1016/j.psychsport.2006.12.002; Lentillon-Kaestner V, 2010, SCAND J MED SCI SPOR, V20, P336, DOI 10.1111/j.1600-0838.2009.00885.x; Lucidi F, 2008, J SPORT SCI, V26, P447, DOI 10.1080/02640410701579370; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Mallett C, 2007, PSYCHOL SPORT EXERC, V8, P600, DOI 10.1016/j.psychsport.2006.12.005; Maravelias C, 2005, TOXICOL LETT, V158, P167, DOI 10.1016/j.toxlet.2005.06.005; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Morente-Sanchez J, 2013, SPORTS MED, V43, P395, DOI 10.1007/s40279-013-0037-x; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Ntoumanis N, 2001, J SPORT SCI, V19, P397, DOI 10.1080/026404101300149357; Ntoumanis N, 2009, J APPL SPORT PSYCHOL, V21, P365, DOI 10.1080/10413200903036040; Ntoumanis N, 2014, SPORTS MED, V44, P1603, DOI 10.1007/s40279-014-0240-4; Pedersen W, 2001, J INTERPERS VIOLENCE, V16, P808, DOI 10.1177/088626001016008005; Pedersen W, 2001, J DRUG ISSUES, V31, P517, DOI 10.1177/002204260103100208; PELLETIER LG, 1995, J SPORT EXERCISE PSY, V17, P35, DOI 10.1123/jsep.17.1.35; Petroczi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010457; Petroczi A, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-34; Petroczi A, 2009, PSYCHOL SPORT EXERC, V10, P390, DOI 10.1016/j.psychsport.2008.11.001; Pintrich PR, 2000, J EDUC PSYCHOL, V92, P544, DOI 10.1037/0022-0663.92.3.544; Pluim B, 2008, BRIT J SPORT MED, V42, P549; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1080/10705519909540118, DOI 10.1080/10705519909540118]; Roberts GC, 1998, J SPORT SCI, V16, P337, DOI 10.1080/02640419808559362; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sas-Nowosielski K, 2008, INT J SPORTS MED, V29, P607, DOI 10.1055/s-2007-965817; Sas-Nowosielski K, 2006, BIOL SPORT, V23, P225; Slepicka P., 1996, ACTA U CAROLINAE KIN, V32, P23; Standage M, 2003, J EDUC PSYCHOL, V95, P97, DOI 10.1037/0022-0663.95.1.97; Vallerand RJ, 1999, J APPL SPORT PSYCHOL, V11, P142, DOI 10.1080/10413209908402956; Vealey RS, 1998, J SPORT EXERCISE PSY, V20, P54, DOI 10.1123/jsep.20.1.54; World Anti-Doping Agency, 2014, 2014 ANT TEST FIG RE; World Anti-Doping Agency, 2017, DANG DOP GET FACTS; Yesalis CE, 2000, BEST PRACT RES CL EN, V14, P25, DOI 10.1053/beem.2000.0051; Zelli A, 2010, PSYCHOL SPORT EXERC, V11, P304, DOI 10.1016/j.psychsport.2010.02.008; Zucchetti G, 2015, INT J DRUG POLICY, V26, P162, DOI 10.1016/j.drugpo.2014.07.021	66	21	22	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205222	10.1371/journal.pone.0205222	http://dx.doi.org/10.1371/journal.pone.0205222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286200	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500098
J	Bover, O; Justo, T; Pereira, PNG; Facucho-Oliveira, J; Inacio, JM; Ramalho, JS; Domian, IJ; Belo, JA				Bover, Oriol; Justo, Tiago; Pereira, Paulo N. G.; Facucho-Oliveira, Joao; Inacio, Jose M.; Ramalho, Jose S.; Domian, Ibrahim J.; Belo, Jose Antonio			Loss of Ccbe1 affects cardiac-specification and cardiomyocyte differentiation in mouse embryonic stem cells	PLOS ONE			English	Article							CCBE1; LYMPHANGIOGENESIS; PROGENITORS; INDUCTION; MUTATIONS; DYSPLASIA; LINEAGES; VEGFC	Understanding the molecular pathways regulating cardiogenesis is crucial for the early diagnosis of heart diseases and improvement of cardiovascular disease. During normal mammalian cardiac development, collagen and calcium-binding EGF domain-1 (Ccbe1) is expressed in the first and second heart field progenitors as well as in the proepicardium, but its role in early cardiac commitment remains unknown. Here we demonstrate that during mouse embryonic stem cell (ESC) differentiation Ccbe1 is upregulated upon emergence of Isl1- and Nkx2.5- positive cardiac progenitors. Ccbe1 is markedly enriched in Isl1-positive cardiac progenitors isolated from ESCs differentiating in vitro or embryonic hearts developing in vivo. Disruption of Ccbe1 activity by shRNA knockdown or blockade with a neutralizing antibody results in impaired differentiation of embryonic stem cells along the cardiac mesoderm lineage resulting in a decreased expression of mature cardiomyocyte markers. In addition, knockdown of Ccbe1 leads to smaller embryoid bodies. Collectively, our results show that CCBE1 is essential for the commitment of cardiac mesoderm and consequently, for the formation of cardiac myocytes in differentiating mouse ESCs.	[Bover, Oriol; Justo, Tiago; Pereira, Paulo N. G.; Inacio, Jose M.; Belo, Jose Antonio] Univ NOVA Lisboa, Fac Ciencias Med, NOVA Med Sch, Stem Cells & Dev Lab,CEDOC,Chron Dis Res Ctr, Lisbon, Portugal; [Justo, Tiago; Facucho-Oliveira, Joao] Univ Algarve, Ctr Biomed Res, Campus Gambelas, Faro, Portugal; [Ramalho, Jose S.] Univ NOVA Lisboa, Fac Ciencias Med, NOVA Med Sch, CEDOC,Chron Dis Res Ctr, Lisbon, Portugal; [Domian, Ibrahim J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Domian, Ibrahim J.] Harvard Stem Cell Inst, Cambridge, MA USA	Universidade Nova de Lisboa; Universidade do Algarve; Universidade Nova de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University	Belo, JA (corresponding author), Univ NOVA Lisboa, Fac Ciencias Med, NOVA Med Sch, Stem Cells & Dev Lab,CEDOC,Chron Dis Res Ctr, Lisbon, Portugal.	jose.belo@nms.unl.pt	Pereira, Paulo/AAD-8375-2022; Inacio, Jose M/O-1455-2018; Belo, José A. A/F-4444-2012; Ramalho, Jose/M-6415-2015	Pereira, Paulo/0000-0002-9908-2290; Inacio, Jose M/0000-0002-9790-8335; Belo, José A. A/0000-0001-7384-0949; Facucho-Oliveira, Joao/0000-0003-2940-7915; Ramalho, Jose/0000-0002-1927-164X; Pereira, Paulo N G/0000-0002-0930-0902	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/82280/2011]; FCT [SFRH/BPD/46506/2008, CEDOC/2015/36/iNOVA4Health/Multi/04462, SFRH/BPD/87114/2012, PTDC/SAU-ENB/121095/2010, HMSP-ICT/0039/2013]; Fundacao para a Ciencia e Tecnologia / Ministerio da Educacao e Ciencia [UID/Multi/04462/2013]; FEDER under the PT2020 Partnership Agreement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130391] Funding Source: NIH RePORTER; Fundação para a Ciência e a Tecnologia [HMSP-ICT/0039/2013, PTDC/SAU-ENB/121095/2010] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia / Ministerio da Educacao e Ciencia; FEDER under the PT2020 Partnership Agreement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fundação para a Ciência e a Tecnologia	TJ was a pre-doctoral fellow of Fundacao para a Ciencia e Tecnologia (FCT; SFRH/BD/82280/2011), JFO (SFRH/BPD/46506/2008), JI (CEDOC/2015/36/iNOVA4Health/Multi/04462) and PNGP (SFRH/BPD/87114/2012) are FCT post-doctoral fellows. This work was supported by FCT grants (PTDC/SAU-ENB/121095/2010 and HMSP-ICT/0039/2013) to JA Belo. iNOVA4Health - UID/Multi/04462/2013, a program financially supported by Fundacao para a Ciencia e Tecnologia / Ministerio da Educacao e Ciencia, through national funds and co-funded by FEDER under the PT2020 Partnership Agreement is acknowledged.	Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Astin JW, 2014, DEVELOPMENT, V141, P2680, DOI 10.1242/dev.106591; Bento M, 2011, GENE EXPR PATTERNS, V11, P437, DOI 10.1016/j.gep.2011.07.002; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Bratt-Leal AM, 2009, BIOTECHNOL PROGR, V25, P43, DOI 10.1002/btpr.139; Burger NB, 2015, PRENATAL DIAG, V35, P1278, DOI 10.1002/pd.4687; Connell FC, 2012, CLIN GENET, V81, P191, DOI 10.1111/j.1399-0004.2011.01731.x; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Facucho-Oliveira J, 2011, INT J DEV BIOL, V55, P1007, DOI 10.1387/ijdb.113394jf; Furtado J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115481; Goh SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061856; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Higuchi S, 2013, J BIOSCI BIOENG, V115, P320, DOI 10.1016/j.jbiosc.2012.10.004; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Jakus Z, 2014, J EXP MED, V211, P815, DOI 10.1084/jem.20132308; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Le Guen L, 2014, DEVELOPMENT, V141, P1239, DOI 10.1242/dev.100495; Liersch R, 2006, BLOOD, V107, P1214, DOI 10.1182/blood-2005-08-3400; Mishima K, 2007, MOL BIOL CELL, V18, P1421, DOI 10.1091/mbc.E06-09-0780; Mommersteeg MTM, 2010, CARDIOVASC RES, V87, P92, DOI 10.1093/cvr/cvq033; Roukens MG, 2015, CIRC RES, V116, P1660, DOI 10.1161/CIRCRESAHA.116.304949; Taylor-Weiner H, 2013, STEM CELLS, V31, P2084, DOI 10.1002/stem.1453; Zeng D, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-5; Zhou B, 2008, BIOCHEM BIOPH RES CO, V375, P450, DOI 10.1016/j.bbrc.2008.08.044	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205108	10.1371/journal.pone.0205108	http://dx.doi.org/10.1371/journal.pone.0205108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281646	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400083
J	Freeman, SE; Freeman, LA; Giorli, G; Haas, AF				Freeman, Simon E.; Freeman, Lauren A.; Giorli, Giacomo; Haas, Andreas F.			Photosynthesis by marine algae produces sound, contributing to the daytime soundscape on coral reefs	PLOS ONE			English	Article							SEA; EXTINCTION; ACOUSTICS; PATTERNS; BUBBLES	We have observed that marine macroalgae produce sound during photosynthesis. The resultant soundscapes correlate with benthic macroalgal cover across shallow Hawaiian coral reefs during the day, despite the presence of other biological noise. Likely ubiquitous but previously overlooked, this source of ambient biological noise in the coastal ocean is driven by local supersaturation of oxygen near the surface of macroalgal filaments, and the resultant formation and release of oxygen-containing bubbles into the water column. During release, relaxation of the bubble to a spherical shape creates a monopole sound source that 'rings' at the Minnaert frequency. Many such bubbles create a large, distributed sound source over the sea floor. Reef soundscapes contain vast quantities of biological information, making passive acoustic ecosystem evaluation a tantalizing prospect if the sources are known. Our observations introduce the possibility of a general, volumetrically integrative, noninvasive, rapid and remote technique for evaluating algal abundance and rates of primary productivity in littoral aquatic communities. Increased algal cover is one of the strongest indicators for coral reef ecosystem stress. Visually determining variations in algal abundance is a time-consuming and expensive process. This technique could therefore provide a valuable tool for ecosystem management but also for industrial monitoring of primary production, such as in algae-based biofuel synthesis.	[Freeman, Simon E.; Freeman, Lauren A.] Naval Undersea Warfare Ctr, Newport, RI 02841 USA; [Freeman, Simon E.] US Naval Res Lab, Underwater Acoust & Signal Proc Div, Washington, DC 20375 USA; [Giorli, Giacomo] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Haas, Andreas F.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, Texel, Netherlands; [Haas, Andreas F.] Univ Utrecht, Texel, Netherlands	United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command; United States Department of Defense; United States Navy; Naval Research Laboratory; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	Freeman, SE (corresponding author), Naval Undersea Warfare Ctr, Newport, RI 02841 USA.; Freeman, SE (corresponding author), US Naval Res Lab, Underwater Acoust & Signal Proc Div, Washington, DC 20375 USA.	simon.freeman@navy.mil		Giorli, Giacomo/0000-0003-1230-4901	NSF IGERT [0903551]; U.S. Naval Research Laboratory section 219 program funds; National Research Council; American Society for Engineering Education; NASA [NASA-14HYSP14-0003]	NSF IGERT(National Science Foundation (NSF)); U.S. Naval Research Laboratory section 219 program funds; National Research Council(Consiglio Nazionale delle Ricerche (CNR)); American Society for Engineering Education; NASA(National Aeronautics & Space Administration (NASA))	Work was supported by NSF IGERT grant no. 0903551, U.S. Naval Research Laboratory section 219 program funds, National Research Council and American Society for Engineering Education postdoctoral fellowships and NASA grant no. NASA-14HYSP14-0003.	Ainslie MA, 2011, J ACOUST SOC AM, V130, P3184, DOI 10.1121/1.3628321; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; [Anonymous], 2017, SENSORS SONDES MONIT, V11, P20; Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Bohnenstiehl DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143691; Boyd JWR, 2001, CHEM ENG SCI, V56, P1749, DOI 10.1016/S0009-2509(00)00540-6; Chapman NR, 2011, J ACOUST SOC AM, V129, pE161, DOI 10.1121/1.3567084; Dahl P.H., 2007, ACOUST TODAY, V3, P23, DOI [10.1121/1.2961145, DOI 10.1121/1.2961145]; Deane GB, 2002, NATURE, V418, P839, DOI 10.1038/nature00967; Dunlop RA, 2010, P ROY SOC LOND B BIO; Freeman LA, 2016, MAR ECOL PROG SER, V561, P69, DOI 10.3354/meps11938; Freeman SE, 2015, J ACOUST SOC AM, V137, P30, DOI 10.1121/1.4904523; Freeman SE, 2014, J ACOUST SOC AM, V135, P1775, DOI 10.1121/1.4865922; Giorli G, 2016, DEEP-SEA RES PT I, V107, P1, DOI 10.1016/j.dsr.2015.10.002; Giorli G, 2015, J ACOUST SOC AM, V137, P2495, DOI 10.1121/1.4919291; Haas AF, 2015, PEERJ, V3, DOI 10.7717/peerj.1390; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; KEELING RF, 1993, J MAR RES, V51, P237, DOI 10.1357/0022240933223800; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Kraines S, 1996, LIMNOL OCEANOGR, V41, P1790, DOI 10.4319/lo.1996.41.8.1790; Leighton T.G., 1994, ACOUSTIC BUBBLE, DOI DOI 10.1121/1.410082; Lillis A, 2014, MAR ECOL PROG SER, V505, P1, DOI 10.3354/meps10805; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; McCauley RD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0195; MEDWIN H, 1970, J GEOPHYS RES, V75, P599, DOI 10.1029/JC075i003p00599; Minnaert M, 1933, PHILOS MAG, V16, P235; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; Radford C, 2008, MAR ECOL PROG SER, V362, P37, DOI 10.3354/meps07444; Radford CA, 2011, MAR ECOL PROG SER, V438, P167, DOI 10.3354/meps09312; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Staaterman E, 2013, CORAL REEFS, V32, P553, DOI 10.1007/s00338-012-1007-8; Staaterman E, 2014, MAR ECOL PROG SER, V508, P17, DOI 10.3354/meps10911; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Vargas-Angel B, 2017, BASELINE ASSESSMENTS; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; Wilson CJ, 2012, MAR BIOL, V159, P2311, DOI 10.1007/s00227-012-2016-4; Wilson PS, 2009, J ACOUST SOC AM, V125, P1951, DOI 10.1121/1.3086272; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3	41	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0201766	10.1371/journal.pone.0201766	http://dx.doi.org/10.1371/journal.pone.0201766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281593	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400008
J	Greenberg, DM; Baron-Cohen, S; Rosenberg, N; Fonagy, P; Rentfrow, PJ				Greenberg, David M.; Baron-Cohen, Simon; Rosenberg, Nora; Fonagy, Peter; Rentfrow, Peter J.			Elevated empathy in adults following childhood trauma	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MECHANICAL TURK; QUOTIENT; GROWTH	Traumatic events increase the risk of depression, but there is also evidence that adversity can lead to posttraumatic growth, including increased compassion and prosocial behavior. To date there is no empirical research pinpointing childhood trauma to an increase in trait empathy in adulthood. Although somewhat counter-intuitive, this might be predicted if trauma not only increases fear of future threat but also renders the individual more sensitive to suffering in others. We explored this possible link using multiple studies, self-report measures, and non-clinical samples. Results across samples and measures showed that, on average, adults who reported experiencing a traumatic event in childhood had elevated empathy levels compared to adults who did not experience a traumatic event. Further, the severity of the trauma correlated positively with various components of empathy. These findings suggest that the experience of a childhood trauma increases a person's ability to take the perspective of another and to understand their mental and emotional states, and that this impact is long-standing. Future research needs to test if this is seen on performance measures, and how these findings extend to clinical populations.	[Greenberg, David M.] CUNY City Coll, New York, NY 10031 USA; [Greenberg, David M.] CUNY, Grad Ctr, New York, NY 10016 USA; [Greenberg, David M.; Baron-Cohen, Simon] Univ Cambridge, Autism Res Ctr, Dept Psychiat, Cambridge, England; [Rosenberg, Nora; Rentfrow, Peter J.] Univ Cambridge, Dept Psychol, Cambridge, England; [Fonagy, Peter] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Fonagy, Peter] Anna Freud Ctr, London, England	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; University of Cambridge; University of Cambridge; University of London; University College London; The Anna Freud Centre	Greenberg, DM (corresponding author), CUNY City Coll, New York, NY 10031 USA.; Greenberg, DM (corresponding author), CUNY, Grad Ctr, New York, NY 10016 USA.; Greenberg, DM (corresponding author), Univ Cambridge, Autism Res Ctr, Dept Psychiat, Cambridge, England.	dmg39@cam.ac.uk	Rentfrow, Peter Jason/ABB-9257-2021	Rentfrow, Peter Jason/0000-0002-9068-2118; Baron-Cohen, Simon/0000-0001-9217-2544; Fonagy, Peter/0000-0003-0229-0091; Greenberg, David/0000-0003-1560-1418	Cambridge Commonwealth, European and International Trust; Medical Research Council UK; Autism Research Trust; MRC [G0600977] Funding Source: UKRI	Cambridge Commonwealth, European and International Trust; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autism Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DMG was funded by the Cambridge Commonwealth, European and International Trust during this period of work. SBC was supported by the Medical Research Council UK and the Autism Research Trust during the period of this work.	Allison C, 2011, PERS INDIV DIFFER, V51, P829, DOI 10.1016/j.paid.2011.07.005; [Anonymous], 1999, POSTTRAUMATIC STRESS; Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 1995, MINDBLINDNESS ESSAY, DOI [10.1027//0269-8803.13.1.57, DOI 10.1027//0269-8803.13.1.57]; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Berthelot N, 2015, INFANT MENT HEALTH J, V36, P200, DOI 10.1002/imhj.21499; Bevilacqua L, 2012, ARCH GEN PSYCHIAT, V69, P62, DOI 10.1001/archgenpsychiatry.2011.152; Bonanno GA, 2002, PERS SOC PSYCHOL B, V28, P184, DOI 10.1177/0146167202282005; Bonanno GA, 2001, AM BEHAV SCI, V44, P798, DOI 10.1177/00027640121956502; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Borderline Krohn A., 1974, INT J PSYCHOANAL PSY, DOI [10.1017/S003329170900600X, DOI 10.1017/S003329170900600X]; Brockhouse R, 2011, J TRAUMA STRESS, V24, P735, DOI 10.1002/jts.20704; Brodsky BS, 2001, AM J PSYCHIAT, V158, P1871, DOI 10.1176/appi.ajp.158.11.1871; Brune M, 2016, COMPR PSYCHIAT, V64, P29, DOI 10.1016/j.comppsych.2015.08.003; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Bussey M.C., 2007, TRAUMA TRANSFORMED E; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Daniels JK, 2012, J CLIN PSYCHIAT, V73, P327, DOI 10.4088/JCP.10m06293; Davis MH, 1980, CAT SEL DOC PSYCHOL; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Ensink K, 2015, BRIT J DEV PSYCHOL, V33, P203, DOI 10.1111/bjdp.12074; Etain B, 2013, J CLIN PSYCHIAT, V74, P991, DOI 10.4088/JCP.13m08353; Fonagy P, 2004, ANN NY ACAD SCI, V1036, P181, DOI 10.1196/annals.1330.012; FONAGY P, 1994, J CHILD PSYCHOL PSYC, V35, P231, DOI 10.1111/j.1469-7610.1994.tb01160.x; Fonagy P., 2002, AFFECT REGULATION ME; Fonagy P, 2017, BORDER PERS DIS EMOT, V4, DOI 10.1186/s40479-017-0062-8; Fonagy P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158678; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Franzen N, 2011, PSYCHIAT RES, V187, P224, DOI 10.1016/j.psychres.2010.11.012; Frazzetto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000486; Freeman JB, 2000, J CLIN CHILD PSYCHOL, V29, P245, DOI 10.1207/S15374424jccp2902_10; Harari H, 2010, PSYCHIAT RES, V175, P277, DOI 10.1016/j.psychres.2009.03.002; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lim D, 2016, EMOTION, V16, P175, DOI 10.1037/emo0000144; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Lynch TR, 2006, EMOTION, V6, P647, DOI 10.1037/1528-3542.6.4.647; McNally RJ, 2006, TRENDS COGN SCI, V10, P271, DOI 10.1016/j.tics.2006.04.007; Muncer SJ, 2006, PERS INDIV DIFFER, V40, P1111, DOI 10.1016/j.paid.2005.09.020; OGATA SN, 1990, AM J PSYCHIAT, V147, P1008; Outcalt J, 2016, COMPR PSYCHIAT, V64, P22, DOI 10.1016/j.comppsych.2015.10.002; PENNEBAKER JW, 1988, SOC SCI MED, V26, P327, DOI 10.1016/0277-9536(88)90397-8; Perroud N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.60; Pessoa Luiz, 2004, Prog Brain Res, V144, P171; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Sharp C., 2015, J INFANT CHILD ADOLE, V14, P33, DOI [10.1080/15289168.2015.1004890, DOI 10.1080/15289168.2015.1004890]; Sharp C, 2016, COMPR PSYCHIAT, V64, P4, DOI 10.1016/j.comppsych.2015.07.008; Sharp C, 2013, J PERS DISORD, V27, P3, DOI 10.1521/pedi.2013.27.1.3; Vollhardt JR, 2011, AM J ORTHOPSYCHIAT, V81, P307, DOI 10.1111/j.1939-0025.2011.01099.x; Vollhardt JR, 2009, SOC JUSTICE RES, V22, P53, DOI 10.1007/s11211-009-0088-1; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Vythilingam M, 2007, PSYCHOL MED, V37, P1445, DOI 10.1017/S003329170700092X; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Whitelock CF, 2013, CLIN PSYCHOL SCI, V1, P351, DOI 10.1177/2167702613480136; Wiersma JE, 2009, J CLIN PSYCHIAT, V70, P983, DOI 10.4088/JCP.08m04521; Wilson J., 2004, EMPATHY TREATMENT TR; Zanarini MC, 1997, AM J PSYCHIAT, V154, P1101; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	62	48	48	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203886	10.1371/journal.pone.0203886	http://dx.doi.org/10.1371/journal.pone.0203886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281628	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400032
J	Gregori, J; Soria, ME; Gallego, I; Guerrero-Murillo, M; Esteban, JI; Quer, J; Perales, C; Domingo, E				Gregori, Josep; Soria, Maria Eugenia; Gallego, Isabel; Guerrero-Murillo, Mercedes; Esteban, Juan Ignacio; Quer, Josep; Perales, Celia; Domingo, Esteban			Rare haplotype load as marker for lethal mutagenesis	PLOS ONE			English	Article							HEPATITIS-C VIRUS; FAVIPIRAVIR T-705; CELL-CULTURE; VIRAL-RNA; FITNESS; RIBAVIRIN; REPLICATION; MUTATIONS; SPECTRUM; INFECTIVITY	RNA viruses replicate with a template-copying fidelity, which lies close to an extinction threshold. Increases of mutation rate by nucleotide analogues can drive viruses towards extinction. This transition is the basis of an antiviral strategy termed lethal mutagenesis. We have introduced a new diversity index, the rare haplotype load (RHL), to describe NS5B (polymerase) mutant spectra of hepatitis C virus (HCV) populations passaged in absence or presence of the mutagenic agents favipiravir or ribavirin. The increase in RHL is more prominent in mutant spectra whose expansions were due to nucleotide analogues than to multiple passages in absence of mutagens. Statistical tests for paired mutagenized versus non-mutagenized samples with 14 diversity indices show that RHL provides consistently the highest standardized effect of mutagenic treatment difference for ribavirin and favipiravir. The results indicate that the enrichment of viral quasispecies in very low frequency minority genomes can serve as a robust marker for lethal mutagenesis. The diagnostic value of RHL from deep sequencing data is relevant to experimental studies on enhanced mutagenesis of viruses, and to pharmacological evaluations of inhibitors suspected to have a mutagenic activity.	[Gregori, Josep; Soria, Maria Eugenia; Guerrero-Murillo, Mercedes; Esteban, Juan Ignacio; Quer, Josep; Perales, Celia] Hosp Univ Vall dHebron HUVH, VHIR, Internal Med Dept, Liver Dis Lab Viral Hepatitis,Liver Unit, Barcelona, Spain; [Gregori, Josep; Gallego, Isabel; Esteban, Juan Ignacio; Quer, Josep; Perales, Celia; Domingo, Esteban] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Gregori, Josep] Roche Diagnost SL, Barcelona, Spain; [Gallego, Isabel; Perales, Celia; Domingo, Esteban] CSIC, Ctr Biol Mol Severo Ochoa CSIC UAM, Campus Cantoblanco, Madrid, Spain; [Esteban, Juan Ignacio; Quer, Josep] Univ Autonoma Barcelona, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Roche Holding; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Barcelona	Quer, J; Perales, C (corresponding author), Hosp Univ Vall dHebron HUVH, VHIR, Internal Med Dept, Liver Dis Lab Viral Hepatitis,Liver Unit, Barcelona, Spain.; Quer, J; Perales, C (corresponding author), Inst Salud Carlos III, CIBERehd, Madrid, Spain.; Perales, C (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa CSIC UAM, Campus Cantoblanco, Madrid, Spain.; Quer, J (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.	josep.quer@vhir.org; celia.perales@vhir.org	Quer, Josep/A-6741-2012; Gregori, Josep/J-2586-2015; Domingo, Esteban/K-3937-2014	Quer, Josep/0000-0003-0014-084X; Gregori, Josep/0000-0002-4253-8015; Domingo, Esteban/0000-0002-0573-1676; GALLEGO, ISABEL/0000-0002-7338-1778; Guerrero Murillo, Mercedes/0000-0002-5556-2460; Perales Viejo, Celia Belen/0000-0003-1618-1937; Soria Benito, Maria Eugenia/0000-0002-4719-3351	Instituto de Salud Carlos III; European Regional Development Fund (ERDF) [PI13/00456, PI15/00829, PI16/00337]; CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Economics and Competitiveness (MINECO) [IDI-20151125]; Miguel Servet program of the Instituto de Salud Carlos III - European Regional Development Fund (ERDF) [CP14/00121]; Spanish Ministry of Economics and Competitiveness (MINECO) [BFU-2011-23604, SAF2014-52400-R, SAF2017-87846-R, S2013/ABI-2906]; Fundacion Ramon Areces; Banco Santander	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Economics and Competitiveness (MINECO); Miguel Servet program of the Instituto de Salud Carlos III - European Regional Development Fund (ERDF); Spanish Ministry of Economics and Competitiveness (MINECO); Fundacion Ramon Areces; Banco Santander	Work in Barcelona was funded by Instituto de Salud Carlos III; by grants PI13/00456, PI15/00829, and PI16/00337 cofinanced by the European Regional Development Fund (ERDF); and by CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Economics and Competitiveness (MINECO), IDI-20151125. CP is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CP14/00121) cofinanced by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investigacion en Red de Enfermedades Hepaticas y Digestivas) is funded by Instituto de Salud Carlos III. The work in Madrid was supported by Spanish Ministry of Economics and Competitiveness (MINECO) grants number BFU-2011-23604, SAF2014-52400-R, SAF2017-87846-R and S2013/ABI-2906 (PLATESA from Comunidad de Madrid/FEDER). Institutional grants from the Fundacion Ramon Areces and Banco Santander to the CBMSO are also acknowledged.	Abdelnabi R, 2017, J VIROL, V91, DOI 10.1128/JVI.00487-17; Agol VI, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00067-17; Arias A, 2014, ELIFE, V3, DOI 10.7554/eLife.03679; Arias A, 2013, J GEN VIROL, V94, P817, DOI 10.1099/vir.0.049171-0; Arribas M, 2016, VIROLOGY, V497, P163, DOI 10.1016/j.virol.2016.07.007; Baranovich T, 2013, J VIROL, V87, P3741, DOI 10.1128/JVI.02346-12; Beaucourt S, 2014, CURR OPIN VIROL, V8, P10, DOI 10.1016/j.coviro.2014.04.011; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Borderia AV, 2016, CURR TOP MICROBIOL, V392, P303, DOI 10.1007/82_2015_483; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Crowder S, 2005, NAT GENET, V37, P701, DOI 10.1038/ng1583; de Avilla AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164691; Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003; Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209; DELATORRE JC, 1990, J VIROL, V64, P6278, DOI 10.1128/JVI.64.12.6278-6281.1990; Diaz-Martinez L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19829-6; Domingo E, 2018, EUR BIOPHYS J; Domingo E, 2016, QUASISPECIES THEORY; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Eigen M, 1979, THE HYPERCYCLE, P60; Escribano-Romero E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01400-17, 10.1128/AAC.01400-17]; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027; Gallego I, 2016, ANTIMICROB AGENTS CH, V60, P3786, DOI 10.1128/AAC.00581-16; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Grande-Perez A, 2005, J VIROL, V79, P10451, DOI 10.1128/JVI.79.16.10451-10459.2005; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Gregori J, 2016, VIROLOGY, V493, P227, DOI 10.1016/j.virol.2016.03.017; Gregori J, 2014, BIOINFORMATICS, V30, P1104, DOI 10.1093/bioinformatics/btt768; Gregori J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083361; Gregory MT, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv915; Guedj J, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002535; Hastie T., 2009, UNSUPERVISED LEARNIN; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; Iranzo J, 2011, P NATL ACAD SCI USA, V108, P16008, DOI 10.1073/pnas.1110489108; de Avila AI, 2017, VIRUS RES, V233, P105, DOI 10.1016/j.virusres.2017.03.014; Jee J, 2016, NATURE, V534, P693, DOI 10.1038/nature18313; Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Moreno E, 2017, J VIROL, V91, DOI 10.1128/JVI.02505-16; Moreno H, 2012, VIRUSES-BASEL, V4, P2786, DOI 10.3390/v4112786; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Mullins JGL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020973; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; Ortega-Prieto AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071039; Pages H, BIOSTRINGS STRING OB; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perales C, 2007, J MOL BIOL, V369, P985, DOI 10.1016/j.jmb.2007.03.074; Perales C, 2016, CURR TOP MICROBIOL, V392, P323, DOI 10.1007/82_2015_459; Perales C, 2013, J VIROL, V87, P7593, DOI 10.1128/JVI.02824-12; Perales C, 2012, TRENDS MICROBIOL, V20, P595, DOI 10.1016/j.tim.2012.08.010; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Qiu L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006421; R Core Team, 2017, R LANGUAGE ENV STAT; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Rawson JMO, 2015, ANTIMICROB AGENTS CH, V59, P6834, DOI 10.1128/AAC.01644-15; Schuster P, 2016, CURR TOP MICROBIOL, V392, P61, DOI 10.1007/82_2015_469; Seifert D, 2016, CURR TOP MICROBIOL, V392, P181, DOI 10.1007/82_2015_462; Sheldon J, 2014, J VIROL, V88, P12098, DOI 10.1128/JVI.01860-14; Sidwell OW, 1974, PROG CHEMOTHERAPY, V2, P889; Smith R. A., 1980, RIBAVIRIN BROAD SPEC	69	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204877	10.1371/journal.pone.0204877	http://dx.doi.org/10.1371/journal.pone.0204877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281674	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400062
J	Ingrand, I; Paccalin, M; Liuu, E; Gil, R; Ingrand, P				Ingrand, Isabelle; Paccalin, Marc; Liuu, Evelyne; Gil, Roger; Ingrand, Pierre			Positive perception of aging is a key predictor of quality-of-life in aging people	PLOS ONE			English	Article							SELF-PERCEPTIONS; DEPRESSIVE SYMPTOMS; SOCIAL SUPPORT; OLD-AGE; HEALTH; MODEL; SATISFACTION; INDIVIDUALS	Objective We conducted a cross-sectional survey in France in a cohort over 55 years of age to characterize the impact of psychological dimensions on quality-of-life (QoL). Methods The predictors of QoL in relation with aging were studied using an adapted quality-of-life model, based on emotional, cognitive and physical symptoms, functional status, and general health perception. Adding psychological dimensions such as self-esteem, psychological distress, perceptions of ageing and coping, was hypothesized to improve the QoL model. Responses were analyzed using structural equation modeling and path analysis. Results The study involved 258 participants, mean age 66.9 +/- 7.9 years. Psychological distress and positive perception of aging exhibited the strongest direct impact on QoL (p<0.0001). Psychological distress also appeared to be mediator on QoL for perceived health status, self-esteem and negative perception of aging. Coping centred on emotion exhibited direct impact on self-esteem and so, indirect impact on QoL (p = 0.0002). Perception of personal financial situation (p = 0.0007) and coping centred on social support (p = 0.02) appeared as direct mediators influencing QoL. Conclusions Psychological dimensions are predictors of QOL and have to be taken into account to maximize the resources with a view to successful aging. Further interventions targeting successful aging should focus on positive perception aging.	[Ingrand, Isabelle; Ingrand, Pierre] Univ Poitiers, CHU Poitiers, Pharm & Sante Publ, Pole Biol, Poitiers, France; [Ingrand, Isabelle; Paccalin, Marc; Liuu, Evelyne; Ingrand, Pierre] Univ Poitiers, INSERM, CHU Poitiers, CIC 1402, Poitiers, France; [Paccalin, Marc] Univ Poitiers, Mol Targets & Therapeut Alzheimers Dis EA3808, Poitiers, France; [Paccalin, Marc; Liuu, Evelyne] Univ Poitiers, CHU Poitiers, Pole Geriatrie, Poitiers, France; [Paccalin, Marc; Gil, Roger] Univ Poitiers, CHU Poitiers, Ctr Memoire Ressources & Rech, Poitiers, France	CHU Poitiers; Universite de Poitiers; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Paccalin, M (corresponding author), Univ Poitiers, INSERM, CHU Poitiers, CIC 1402, Poitiers, France.; Paccalin, M (corresponding author), Univ Poitiers, Mol Targets & Therapeut Alzheimers Dis EA3808, Poitiers, France.; Paccalin, M (corresponding author), Univ Poitiers, CHU Poitiers, Pole Geriatrie, Poitiers, France.; Paccalin, M (corresponding author), Univ Poitiers, CHU Poitiers, Ctr Memoire Ressources & Rech, Poitiers, France.	marc.paccalin@chu-poitiers.fr			French Ministry of Research; Poitou-Charentes Region (CPER funding)	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Poitou-Charentes Region (CPER funding)	This work was sponsored by the French Ministry of Research and the Poitou-Charentes Region (CPER funding).	Bakas T, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-134; Barker M., 2007, BMC GERIATR, V7, P9, DOI [10.1186/1471-2318-7-9, DOI 10.1186/1471-2318-7-9]; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Bilotta C, 2012, HEALTH SOC CARE COMM, V20, P32, DOI 10.1111/j.1365-2524.2011.01011.x; Blazer DG, 2008, GERONTOLOGIST, V48, P415, DOI 10.1093/geront/48.4.415; Bollen K., 1989, STRUCTURAL EQUATIONS; Bowling A., 2005, AGEING WELL QUALITY; Bowling A, 2006, AGE AGEING, V35, P607, DOI 10.1093/ageing/afl100; Bowling A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-13; Cantarero R, 2014, INT J AGING HUM DEV, V78, P299, DOI 10.2190/AG.78.4.a; Melendez JC, 2009, ARCH GERONTOL GERIAT, V48, P291, DOI 10.1016/j.archger.2008.02.008; Carver LF, 2016, CLIN INTERV AGING, V11, P1623, DOI 10.2147/CIA.S117202; Dragomirecka E, 2008, CLIN PSYCHOL PSYCHOT, V15, P193, DOI 10.1002/cpp.571; European Commission, 2014, POP AG EUR FACTS IMP; Feeney BC, 2015, PERS SOC PSYCHOL REV, V19, P113, DOI 10.1177/1088868314544222; Fernandez-Ballesteros R, 2001, AGEING SOC, V21, P25, DOI 10.1017/S0144686X01008078; Fernandez-Ballesteros R, 2015, EXP AGING RES, V41, P410, DOI 10.1080/0361073X.2015.1053757; Garin Noe, 2014, Clin Pract Epidemiol Ment Health, V10, P103, DOI 10.2174/1745017901410010103; Hickey A, 2010, IRISH J PSYCHOL, V31, P135, DOI [10.1080/03033910.2010.10446331, DOI 10.1080/03033910.2010.10446331]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Ingrand I, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-17; Koher-Gruhn D, 2012, J GERONTOL B-PSYCHOL, V67, P563, DOI 10.1093/geronb/gbr153; KOP JL, 1993, EUR REV APPL PSYCHOL, V43, P271; Kunzmann U, 2002, J GERONTOL B-PSYCHOL, V57, pP484, DOI 10.1093/geronb/57.6.P484; Lazarus R., 1987, STRESS APPRAISAL COP, V1, P141, DOI https://doi.org/10.1002/per.2410010304; Levy BR, 2014, PSYCHOL SCI, V25, P2127, DOI 10.1177/0956797614551970; Levy BR, 2002, J PERS SOC PSYCHOL, V83, P261, DOI 10.1037//0022-3514.83.2.261; Low G, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-146; Meeks S, 2001, J AGING HEALTH, V13, P92, DOI 10.1177/089826430101300105; Melchior M, 2003, SOC SCI MED, V56, P1817, DOI 10.1016/S0277-9536(02)00181-8; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Netuveli G, 2008, BRIT MED BULL, V85, P113, DOI 10.1093/bmb/ldn003; O'Shea DM, 2017, INT J GERIATR PSYCH, V32, P1217, DOI 10.1002/gps.4584; Pinquart M, 2002, EXP AGING RES, V28, P317, DOI 10.1080/03610730290080353; Reichstadt J, 2010, AM J GERIAT PSYCHIAT, V18, P567, DOI 10.1097/JGP.0b013e3181e040bb; Sorokowski P, 2017, J GERONTOL B-PSYCHOL, V72, P561, DOI 10.1093/geronb/gbv080; Tarlow EM, 1996, J RES PERS, V30, P120, DOI 10.1006/jrpe.1996.0008; Thomas PA, 2010, J GERONTOL B-PSYCHOL, V65, P351, DOI 10.1093/geronb/gbp113; Tkatch Rifky, 2016, Gerontol Geriatr Med, V2, p2333721416667877, DOI 10.1177/2333721416667877; Tkatch R, 2017, GERIATR NURS, V38, P485, DOI 10.1016/j.gerinurse.2017.02.009; Tyrovolas S, 2015, J AGING HEALTH, V27, P1375, DOI 10.1177/0898264315583053; VALLIERES EF, 1990, INT J PSYCHOL, V25, P305, DOI 10.1080/00207599008247865; Wiggins RD, 2004, AGEING SOC, V24, P693, DOI 10.1017/S0144686X04002284; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204044	10.1371/journal.pone.0204044	http://dx.doi.org/10.1371/journal.pone.0204044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281672	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400039
J	Maurer, T; Stoffel, MH; Belyaev, Y; Stiefel, NG; Vidondo, B; Kuker, S; Mogel, H; Schafer, B; Balmer, J				Maurer, Thimo; Stoffel, Michael H.; Belyaev, Yury; Stiefel, Niklaus G.; Vidondo, Beatriz; Kueker, Susanne; Mogel, Helga; Schaefer, Birgit; Balmer, Jasmin			Structural characterization of four different naturally occurring porcine collagen membranes suitable for medical applications	PLOS ONE			English	Article							DIAPHRAGMATIC CENTRAL TENDON; EXTRACELLULAR-MATRIX; ELECTRON-MICROSCOPY; FIBER ARCHITECTURE; SCANNING ELECTRON; FIBRIL STRUCTURE; 3-DIMENSIONAL ORGANIZATION; TISSUE RECONSTRUCTION; INTESTINAL SUBMUCOSA; PARIETAL PERICARDIUM	Collagen is the main structural element of connective tissues, and its favorable properties make it an ideal biomaterial for regenerative medicine. In dental medicine, collagen barrier membranes fabricated from naturally occurring tissues are used for guided bone regeneration. Since the morphological characteristics of collagen membranes play a crucial role in their mechanical properties and affect the cellular behavior at the defect site, in-depth knowledge of the structure is key. As a base for the development of novel collagen membranes, an extensive morphological analysis of four porcine membranes, including centrum tendineum, pericardium, plica venae cavae and small intestinal submucosa, was performed. Native membranes were analyzed in terms of their thickness. Second harmonic generation and two-photon excitation microscopy of the native membranes showed the 3D architecture of the collagen and elastic fibers, as well as a volumetric index of these two membrane components. The surface morphology, fiber arrangement, collagen fibril diameter and Dperiodicity of decellularized membranes were investigated by scanning electron microscopy. All the membrane types showed significant differences in thickness. In general, undulating collagen fibers were arranged in stacked layers, which were parallel to the membrane surface. Multiphoton microscopy revealed a conspicuous superficial elastic fiber network, while the elastin content in deeper layers varied. The elastin/collagen volumetric index was very similar in the investigated membranes and indicated that the collagen content was clearly higher than the elastin content. The surface of both the pericardium and plica venae cavae and the cranial surface of the centrum tendineum revealed a smooth, tightly arranged and crumpled morphology. On the caudal face of the centrum tendineum, a compact collagen arrangement was interrupted by clusters of circular discontinuities. In contrast, both surfaces of the small intestinal submucosa were fibrous, fuzzy and irregular. All the membranes consisted of largely uniform fibrils displaying the characteristic D-banding. This study reveals similarities and relevant differences among the investigated porcine membranes, suggesting that each membrane represents a unique biomaterial suitable for specific applications.	[Maurer, Thimo; Stoffel, Michael H.; Belyaev, Yury; Mogel, Helga; Balmer, Jasmin] Univ Bern, Vetsuisse Fac, Div Vet Anat, Bern, Switzerland; [Stiefel, Niklaus G.; Schaefer, Birgit] Geistlich Pharma AG, Wolhusen, Switzerland; [Vidondo, Beatriz; Kueker, Susanne] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Bern, Switzerland	University of Bern; University of Bern	Balmer, J (corresponding author), Univ Bern, Vetsuisse Fac, Div Vet Anat, Bern, Switzerland.	jasmin.balmer@vetsuisse.unibe.ch	Stoffel, Michael Hubert/I-6939-2015	Stoffel, Michael Hubert/0000-0002-4699-5125; Belyaev, Yury/0000-0001-8318-2951	Geistlich Pharma AG, Wolhusen, Switzerland; Geistlich Pharma AG	Geistlich Pharma AG, Wolhusen, Switzerland; Geistlich Pharma AG	This study was partly funded by Geistlich Pharma AG, Wolhusen, Switzerland. The funding company had a role as well in data analysis and manuscript proofreading. Geistlich Pharma AG provided the salary of TM and covered the costs related to 2-photonmicroscopy. Geistlich (BS, NS) was further involved in the experimental design, data analysis, decision to publish and in the preparation of the manuscript. Internal institutional resources (government funding) covered personnel costs (JB, MHS, HM, BV, SK) as well as the expenses for laboratory consumables and scanning electron microscopy. There was no additional external funding received for this study.	Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Baldwin SJ, 2014, BIOPHYS J, V107, P1794, DOI 10.1016/j.bpj.2014.09.003; Bear RS, 1944, J AM CHEM SOC, V66, P1297, DOI 10.1021/ja01236a027; Bianchini P, 2008, J BIOPHOTONICS, V1, P443, DOI 10.1002/jbio.200810060; Bottino MC, 2012, DENT MATER, V28, P703, DOI 10.1016/j.dental.2012.04.022; Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215; CHUONG CJ, 1991, J BIOMECH, V24, P563, DOI 10.1016/0021-9290(91)90289-Y; Cicchi R, 2013, J BIOPHOTONICS, V6, P129, DOI 10.1002/jbio.201200092; Deeken CR, 2011, J BIOMED MATER RES B, V96B, P199, DOI 10.1002/jbm.b.31753; Deeken CR, 2012, J MATER SCI-MATER M, V23, P537, DOI 10.1007/s10856-011-4486-1; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072; FENTIE IH, 1986, J SUBMICR CYTOL PATH, V18, P53; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gauvin R, 2013, J BIOMATER APPL, V28, P552, DOI 10.1177/0885328212465482; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T; Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x; Hoit BD, 2017, CARDIOL CLIN, V35, P481, DOI 10.1016/j.ccl.2017.07.002; Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8; ISHIHARA T, 1981, J THORAC CARDIOV SUR, V81, P747; Kielty CM, 2002, J CELL SCI, V115, P2817; KNUDSEN PJT, 1991, J ANAT, V177, P41; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Lee CH, 2001, INT J PHARMACEUT, V221, P1, DOI 10.1016/S0378-5173(01)00691-3; LI JC, 1991, ACTA ANAT, V141, P26; Liu ZZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37089; Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017; MARCHINI M, 1986, CONNECT TISSUE RES, V15, P269, DOI 10.3109/03008208609001985; Megerle K, 2016, PLAST RECONSTR SURG, V138, p630E, DOI 10.1097/PRS.0000000000002459; Michailova K, 1999, ANN ANAT, V181, P253, DOI 10.1016/S0940-9602(99)80040-5; Mienaltowski MJ, 2014, ADV EXP MED BIOL, V802, P5, DOI 10.1007/978-94-007-7893-1_2; Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Miura T, 2000, J THORAC CARDIOV SUR, V120, P437, DOI 10.1067/mtc.2000.108906; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Murali R, 2010, SEMIN RESP CRIT CARE, V31, P649, DOI 10.1055/s-0030-1269826; Naik Ronak, 2017, Cardiol Young, P1, DOI 10.1017/S1047951117000646; Nakatani T, 1996, ANAT REC, V244, P529, DOI 10.1002/(SICI)1097-0185(199604)244:4<529::AID-AR11>3.0.CO;2-R; OHTANI O, 1987, ARCH HISTOL CYTOL, V50, P557, DOI 10.1679/aohc.50.557; ORBERG JW, 1982, CONNECT TISSUE RES, V9, P187, DOI 10.3109/03008208209160260; Ortolani E, 2015, ANN I SUPER SANITA, V51, P229, DOI 10.4415/ANN_15_03_11; Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1; Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N; Parry DA, 1984, ULTRASTRUCTURE CONNE, P34; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Pattabhi SR, 2014, DIFFERENTIATION, V88, P131, DOI 10.1016/j.diff.2014.12.005; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Rao RAR, 2009, OPT LETT, V34, P3779, DOI 10.1364/OL.34.003779; Raspanti M, 2007, BIOMACROMOLECULES, V8, P2087, DOI 10.1021/bm070091t; Raspanti M, 2018, INT J BIOL MACROMOL, V107, P1668, DOI 10.1016/j.ijbiomac.2017.10.037; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x; Braga-Vilela AS, 2008, J MEMBRANE BIOL, V221, P15, DOI 10.1007/s00232-007-9081-5; Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7; SACKS MS, 1992, J BIOMECH ENG-T ASME, V114, P183, DOI 10.1115/1.2891370; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheikh Z., 2017, BIOMATER RES, V21, P9, DOI [10.1186/s40824-017-0095-5 28593053, DOI 10.1186/S40824-017-0095-5]; Sizeland KH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189197; Starborg T, 2008, METHOD CELL BIOL, V88, P319, DOI 10.1016/S0091-679X(08)00417-2; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Tilbury K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086014; Toshima M, 2004, ARCH HISTOL CYTOL, V67, P31, DOI 10.1679/aohc.67.31; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; Wang ZB, 2010, ANAT REC, V293, P754, DOI 10.1002/ar.21101; Yamamoto S, 2000, ARCH HISTOL CYTOL, V63, P127, DOI 10.1679/aohc.63.127	70	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205027	10.1371/journal.pone.0205027	http://dx.doi.org/10.1371/journal.pone.0205027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281664	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400077
J	Radford, CA; Putland, RL; Mensinger, AF				Radford, Craig A.; Putland, Rosalyn L.; Mensinger, Allen F.			Barking mad: The vocalisation of the John Dory, Zeus faber	PLOS ONE			English	Article							ACOUSTIC-SIGNALS; SOUNDS; AMPLITUDE; TOADFISH; DEFENSE; SONG	Studies on the behavioural function of sounds are very rare within heterospecific interactions. John Dory (Zeus faber) is a solitary, predatory fish that produces sound when captured, but has not been documented to vocalize under natural conditions (i.e. in the wild). The present study provides the first in-situ recordings of John Dory vocalisations and correlates them to behavioural response of snapper (Pagrus auratus) a common species found through New Zealand. Vocalisations or 'barks', ranged between 200-600 Hz, with a peak frequency of 312 +/- 10 Hz and averaged 139 +/- 4 milliseconds in length. Baited underwater video (BUV) equipped with hydrophones determined that under natural conditions a John Dory vocalization induced an escape response in snapper present, causing them to exit the area opposite to the position of the John Dory. We speculate that the John Dory vocalisation may be used for territorial display towards both conspecifics and heterospecifics, asserting dominance in the area or heightening predatory status.	[Radford, Craig A.; Putland, Rosalyn L.; Mensinger, Allen F.] Univ Auckland, Inst Marine Sci, Leigh Marine Lab, Warkworth, New Zealand; [Mensinger, Allen F.] Univ Minnesota, Biol Dept, Duluth, MN 55812 USA	University of Auckland; University of Minnesota System; University of Minnesota Duluth	Radford, CA (corresponding author), Univ Auckland, Inst Marine Sci, Leigh Marine Lab, Warkworth, New Zealand.	c.radford@auckland.ac.nz		Radford, Craig/0000-0001-7949-9497	Rutherford Discovery Fellowship from the Royal Society of New Zealand [RDF-UOA1302]; NSF [IOS-1354745 NSF]; University of Minnesota travel grant; University of Minnesota Duluth Biology Department grant	Rutherford Discovery Fellowship from the Royal Society of New Zealand(Royal Society of New Zealand); NSF(National Science Foundation (NSF)); University of Minnesota travel grant; University of Minnesota Duluth Biology Department grant	CAR is funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand (RDF-UOA1302). RLP is funded by a PhD scholarship from the above mentioned funding. Funding for AFM was provided by a NSF grant IOS-1354745 NSF grant, a University of Minnesota travel grant and aUniversity of Minnesota Duluth Biology Department grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim MCP, 2010, J EXP BIOL, V213, P2997, DOI 10.1242/jeb.044586; Amorim Maria Clara P., 2006, P71; Bradbury Jack W., 1998, pi; Chabert T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15547; CHOAT JH, 1982, J EXP MAR BIOL ECOL, V60, P129, DOI 10.1016/0022-0981(82)90155-1; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Conti C, 2015, J EXP BIOL, V218, P893, DOI 10.1242/jeb.116673; Davies NB, 1978, DEEP CROAKS FIGHTING; Krebs J, 1978, SONG REPERTOIRES TER; LADICH F, 1992, ETHOLOGY, V90, P307; Ladich F, 1998, ETHOLOGY, V104, P517; Ladich F., 2006, COMMUNICATION FISHES, P122; Maravelias CD, 2007, ESTUAR COAST SHELF S, V72, P703, DOI 10.1016/j.ecss.2006.12.002; Mensinger AF., 2016, P M AC, V27, DOI [10.1121/2.0000234, DOI 10.1121/2.0000234]; Mirjany M, 2011, J EXP BIOL, V214, P3358, DOI 10.1242/jeb.052894; Myrberg AA, 1997, B MAR SCI, V60, P1017; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; Onuki A, 2004, J MAR BIOL ASSOC UK, V84, P843, DOI 10.1017/S0025315404010045h; Parvulescu A., 1963, MARINE BIOACOUSTICS, P413; Pereira R, 2014, ETHOLOGY, V120, P53, DOI 10.1111/eth.12180; Raffinger E, 2009, J ETHOL, V27, P239, DOI 10.1007/s10164-008-0109-9; Reichard DG, 2015, ANIM BEHAV, V105, P253, DOI 10.1016/j.anbehav.2015.04.017; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Slabbekoorn Hans, 2004, P178, DOI 10.1016/B978-012473070-0/50009-8; Thorson RF, 2002, ENVIRON BIOL FISH, V63, P321, DOI 10.1023/A:1014334425821; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	28	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204647	10.1371/journal.pone.0204647	http://dx.doi.org/10.1371/journal.pone.0204647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281630	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400052
J	Bandason, T; Dauya, E; Dakshina, S; McHugh, G; Chonzi, P; Munyati, S; Weiss, HA; Simms, V; Kranzer, K; Ferrand, RA				Bandason, Tsitsi; Dauya, Ethel; Dakshina, Subathira; McHugh, Grace; Chonzi, Prosper; Munyati, Shungu; Weiss, Helen A.; Simms, Victoria; Kranzer, Katharina; Ferrand, Rashida Abbas			Screening tool to identify adolescents living with HIV in a community setting in Zimbabwe: A validation study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CARE; METAANALYSIS; CHILDREN	Introduction A simple cost-effective strategy to pre-screen for targeted HIV testing can have substantial benefit in high burden and resource limited settings. A 4-item (previous hospitalisation, orphanhood, poor health status, and recurring skin problems) screening tool to identify adolescents living with HIV has previously shown high sensitivity in healthcare facility settings. We validated this screening tool in a community setting, in Harare, Zimbabwe in a community-based HIV prevalence survey. Methods A community-based HIV prevalence survey was conducted among individuals aged 8-17 years with guardian consent and child assent and residing in 7 communities during the period February 2015 to December 2015. Participants without previously diagnosed HIV were evaluated for the probability of having HIV using the screening tool. HIV status was defined using an anonymous HIV test which was done using Oral Mucosal Transudate (OMT). A questionnaire was also administered to ascertain self-reported HIV status and screening tool items. The validity of a 4-item screening tool was tested. Sensitivity and specificity of the screening tool was assessed against the HIV status based on OMT result. Results Prevalence survey participants were 5386 children who had an HIV test result, aged 8-17 years. However, 5384, who did not report testing HIV positive and responded to all screening tool item questions were included in the validation. Their median age was 12 (IQR: 10-15) years, 2515 (46.7%) were male. HIV prevalence was 1.3% (95% CI:1.0-1.8%). The 4-item screening tool had poor accuracy with an area under the receiver operating curve of 0.65(95% CI: 0.60-0.72) at a cut-off score >= 1. Its sensitivity was 56.3% (95% CI:44.0-68.1) and specificity of 75.1% (95% CI:73.9-76.3%), PPV of 2.9% (95% CI:2.1-3.9%) and a NPV of 99.2% (95% CI:98.9-99.5%). The number needed to test to diagnose one child using the screening tool was 55% lower than universal testing for HIV. Conclusion Use of the 4-item screening tool could be a strategy that can be adopted to identify children living with HIV in a community setting in resource limited settings by reducing the number needed to test compared to universal testing since it is inexpensive, easy to administer and not harmful. However, screening items adapted to a community setting need to be explored to improve the performance of the screening tool.	[Bandason, Tsitsi; Dauya, Ethel; Dakshina, Subathira; McHugh, Grace; Munyati, Shungu; Ferrand, Rashida Abbas] Biomed Res & Training Inst, Harare, Zimbabwe; [Chonzi, Prosper] Harare City Hlth, Harare, Zimbabwe; [Weiss, Helen A.; Simms, Victoria] LSHTM, MRC Trop Epidemiol Grp, London, England; [Kranzer, Katharina; Ferrand, Rashida Abbas] London Sch Hyg & Trop Med, London, England; [Kranzer, Katharina] Res Ctr Borstel, Borstel, Germany	Biomedical Research Training Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Forschungszentrum Borstel	Bandason, T (corresponding author), Biomed Res & Training Inst, Harare, Zimbabwe.	tbandason@brti.co.zw	weiss, helen/ABC-7823-2021; Simms, Victoria/AAU-4134-2021; Simms, Victoria/C-3278-2009; Kranzer, Katharina/O-8845-2014	weiss, helen/0000-0003-3547-7936; Simms, Victoria/0000-0002-4897-458X; Kranzer, Katharina/0000-0001-5691-7270; Bandason, Tsitsi/0000-0003-0066-8345	Wellcome Trust [095878/Z/11Z]; Medical Research Council [MR/K012126/1]	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Wellcome Trust (grant number 095878/Z/11Z to Dr Rashida Abbas Ferrand), Medical Research Council (grant number MR/K012126/1 to Dr Helen A Weiss, Dr Victoria Simms).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLON UPD HLTH SECT R; Bandason T, 2016, AIDS, V30, P779, DOI 10.1097/QAD.0000000000000959; Bandason T, 2013, AIDS CARE, V25, P1520, DOI 10.1080/09540121.2013.780120; Dakshina S, 2016, 21 INT AIDS C DURB S; Ferrand RA, 2011, TROP MED INT HEALTH, V16, P349, DOI 10.1111/j.1365-3156.2010.02708.x; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Govindasamy D, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20182; Kayigamba FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095459; Kranzer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001649; Mwinga A., 2008, Morbidity and Mortality Weekly Report, V57, P285; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Pufall EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113415; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; UNAIDS, 2014, 90 90 90 AMB TREATM; WHO UNAIDS, 2007, GUID PROV IN TEST CO; World Health Organization, 2015, GUID START ANT THER	18	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204891	10.1371/journal.pone.0204891	http://dx.doi.org/10.1371/journal.pone.0204891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278064	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000446010200026
J	Mubaiwa, J; Fogliano, V; Chidewe, C; Bakker, EJ; Linnemann, AR				Mubaiwa, Juliet; Fogliano, Vincenzo; Chidewe, Cathrine; Bakker, Evert Jan; Linnemann, Anita R.			Utilization of bambara groundnut (Vigna subterranea (L.) Verdc.) for sustainable food and nutrition security in semi-arid regions of Zimbabwe	PLOS ONE			English	Article							BEANS PHASEOLUS-VULGARIS; KANWA ALKALINE SALT; PHYSICAL-PROPERTIES; FUNCTIONAL-PROPERTIES; CHEMICAL-COMPOSITION; L THOUARS; UNGUICULATA; QUALITY; AFRICA; SEEDS	Bambara groundnut (Vigna subterranea (L.) Verdc.) is an indigenous legume crop, cultivated by subsistence farmers throughout sub-Saharan countries. Research findings indicate that the crop has great nutritional and agronomic potential, but it remains scientifically neglected. A baseline study was conducted in seven districts in semi-arid regions of rural Zimbabwe to gather knowledge on current production and utilization of bambara groundnut, assess its role in providing sustainable food and nutrition security for rural populations and determine priorities for follow-up research. Results revealed a variety of bambara groundnut processing techniques, which included boiling, soaking, roasting and milling across the surveyed districts. Reported constraints to processing and consumption included long cooking time, difficulties with milling and high firewood and water requirements. Fifty to eighty percent of respondents in all districts consumed bambara groundnut once or twice weekly from August to December. Preferred consumer attributes were taste, the satiating effect, nutritional benefits or a combination of these. Current, culturally acceptable processing techniques need improvement to support sustainable bambara groundnut processing while optimising nutrient bio-accessibility. Ultimately, community resilience to food and nutrition insecurity can be promoted by exchange of bambara groundnut processing knowledge amongst the production areas, involving the different stakeholders in the food supply chains.	[Mubaiwa, Juliet] Chinhoyi Univ Technol, Dept Food Sci & Technol, Chinhoyi, Zimbabwe; [Mubaiwa, Juliet; Fogliano, Vincenzo; Linnemann, Anita R.] Food Qual & Design, Wageningen, Netherlands; [Chidewe, Cathrine] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe; [Bakker, Evert Jan] Wageningen Univ, Math & Stat Methods, Wageningen, Netherlands	Wageningen University & Research; University of Zimbabwe; Wageningen University & Research	Linnemann, AR (corresponding author), Food Qual & Design, Wageningen, Netherlands.	anita.linnemann@wur.nl	fogliano, vincenzo/W-6885-2019; Fogliano, Vincenzo/M-8166-2019; fogliano, vincenzo/A-1419-2009; Mubaiwa, Juliet/K-8392-2019; Linnemann, Anita/O-7509-2014	fogliano, vincenzo/0000-0001-8786-9355; fogliano, vincenzo/0000-0001-8786-9355; Mubaiwa, Juliet/0000-0001-9553-5830; Linnemann, Anita/0000-0003-3201-3343	Netherlands Fellowship Programmes [CF9152/2013]	Netherlands Fellowship Programmes	This research was supported by the Netherlands Fellowship Programmes (grant award CF9152/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKPAPUNAM MA, 1994, PLANT FOOD HUM NUTR, V46, P147, DOI 10.1007/BF01088767; Amarteifio J. O., 1998, Journal of Food Composition and Analysis, V11, P329, DOI 10.1006/jfca.1998.0595; Amarteifio JO, 2006, AFR J BIOTECHNOL, V5, P2408; Amarteifio J. O., 2002, Tropical Science, V42, P188; Ani D, 2013, BAMBARA GROUNDNUT PA; Annan NT, 2003, DESSEMINATION IMPROV; Asiedu R, 2010, FOOD SECUR, V2, P305, DOI 10.1007/s12571-010-0085-0; Azam-Ali S., 2001, GLOBAL MAPPING SYSTE; Azam-Ali SN, 2001, EXP AGR, V37, P433, DOI 10.1017/S0014479701000412; Berchie J. N., 2010, Journal of Agronomy, V9, P111, DOI 10.3923/ja.2010.111.118; Bisnath S., 1996, GENDER POVERTY ANAL; Boyd H.K.R., 1981, MARKETING RES TEXT C; Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003; BRESSANI R, 1993, FOOD REV INT, V9, P237, DOI 10.1080/87559129309540960; Browne K., 2005, INT J SOC RES METHOD, V8, P47, DOI DOI 10.1080/1364557032000081663; Burchi F, 2011, INT J ENV RES PUB HE, V8, P358, DOI 10.3390/ijerph8020358; Cavendish W, 1999, 991 U OXF; Chazovachii B, 2013, BANGLADESH E J SOCIO, V10; Clover J., 2003, AFR SECUR REV, V12, P5, DOI [10.1080/10246029.2003.9627566, DOI 10.1080/10246029.2003.9627566]; CTDT, CONS IND FOODS ZIMB; De Kock C., 2013, BAMBARA GROUNDNUT; Drechsel P, 2001, ECOL ECON, V38, P251, DOI 10.1016/S0921-8009(01)00167-7; Enwere N, 1986, TROPICAL SCI; Enwere NJ, 1996, INT J FOOD SCI NUTR, V47, P469, DOI 10.3109/09637489609031875; Garcia E, 1998, J AGR FOOD CHEM, V46, P2110, DOI 10.1021/jf970848f; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Gomez M.I., 1989, RESOURCE INVENTORY I; Gunjal K, 2009, SPECIAL REPORT, P22; Hill LD., 1990, GRAIN GRADES STANDAR; Hillocks R. J., 2012, African Crop Science Journal, V20, P1; Jideani VA, 2009, J FOOD ENG, V92, P182, DOI 10.1016/j.jfoodeng.2008.10.040; Johnston JL, 2014, ADV NUTR, V5, P418, DOI 10.3945/an.113.005553; Kaptso KG, 2008, J FOOD ENG, V86, P91, DOI 10.1016/j.jfoodeng.2007.09.014; Linnemann AR, 1987, BAMBARA GROUNDNUT VI, V12; Mabhena C, 2012, J CONTEMP AFR STUD, V30, P219, DOI 10.1080/02589001.2012.664416; Madebwe C, 2005, PAKISTAN J SOCIAL SC, V3, P868; Madode YE, 2011, ECOL FOOD NUTR, V50, P115, DOI 10.1080/03670244.2011.552371; Madode YE, 2013, LWT-FOOD SCI TECHNOL, V54, P186, DOI 10.1016/j.lwt.2013.04.010; Makanda I., 2008, African Crop Science Journal, V16, P175; Makate C, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2802-4; Manda J, 2010, AGR HUM VALUES, V27, P85, DOI 10.1007/s10460-008-9171-8; Massawe FJ, 2005, AFR J BIOTECHNOL, V4, P463; Mataruka D., 1985, ZIMBABWE AGR J; Matsa W, 2013, TRADITIONAL SCI SEED; Mbata T. I., 2009, African Journal of Food Science (ACFS), V3, P107; Minka SR, 1999, FOOD CHEM, V64, P145, DOI 10.1016/S0308-8146(98)00166-6; Mpotokwane SM, 2008, J FOOD ENG, V89, P93, DOI 10.1016/j.jfoodeng.2008.04.006; Mubaiwa J, 2017, FOOD REV INT, V33, P167, DOI 10.1080/87559129.2016.1149864; Muimba-Kankolongo A, 2018, FOOD CROP PRODUCTION BY SMALLHOLDER FARMERS IN SOUTHERN AFRICA: CHALLENGES AND OPPORTUNITIES FOR IMPROVEMENT, P173, DOI 10.1016/B978-0-12-814383-4.00010-4; Mupawaenda AC, 2009, TROP ANIM HEALTH PRO, V41, P1017, DOI 10.1007/s11250-008-9268-5; Murevanhema YY, 2013, CRIT REV FOOD SCI, V53, P954, DOI 10.1080/10408398.2011.574803; Mwangela A, BAMBARA GROUNDNUT SI; Mwaniki A., 2006, ACHIEVING FOOD SECUR; Nhamo N., 2003, GRAIN LEGUMES GREEN, P119; Nti CA, 2009, INT J FOOD SCI TECH, V44, P2234, DOI 10.1111/j.1365-2621.2009.02064.x; Oniang'o RK, 2004, J FOOD SCI, P69; Padulosi S., 2013, FIGHTING POVERTY HUN; Phillips JG, 1998, AGR FOREST METEOROL, V90, P39, DOI 10.1016/S0168-1923(97)00095-6; PLAHAR WA, 1996, EVALUATION SOYBEAN C; Plahar WA, 2002, CROP POSTHARVEST PRO; POULTER NH, 1980, J SCI FOOD AGR, V31, P1158, DOI 10.1002/jsfa.2740311106; POULTER NH, 1981, J SCI FOOD AGR, V32, P44, DOI 10.1002/jsfa.2740320108; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Proctor S, 2000, FACILITATING EFFECTI; QGIS Development Team, QGIS GEOGR INF SYST; Quaye W, 2003, SOCIOECONOMIC SURVEY; Quaye W, 2004, BAMBARA MARKETING MA, V26; Schaafsma G, 2012, BRIT J NUTR, V108, pS333, DOI 10.1017/S0007114512002541; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Sreerama YN, 2009, J FOOD ENG, V92, P389, DOI 10.1016/j.jfoodeng.2008.12.008; Swanevelder CJ., 1998, BAMBARA FOOD AFRICA; UZOGARA SG, 1988, FOOD CHEM, V30, P1, DOI 10.1016/0308-8146(88)90019-2; Verbeke W, 2006, FOOD QUAL PREFER, V17, P126, DOI 10.1016/j.foodqual.2005.03.003; Vermeulen SJ, 1996, HUM ECOL, V24, P479, DOI 10.1007/BF02168863; Weiss W, 2015, TRAINING COURSE SCOP; Winniefridah M., 2013, International Journal of Humanities and Social Science, V3, P234; Yadav N, 2018, INT J FOOD PROP, V21, P437, DOI 10.1080/10942912.2018.1431659	77	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204817	10.1371/journal.pone.0204817	http://dx.doi.org/10.1371/journal.pone.0204817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278086	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200024
J	Ongun, N				Ongun, Nedim			Does nutritional status affect Parkinson's Disease features and quality of life?	PLOS ONE			English	Article							SUBJECTIVE GLOBAL ASSESSMENT; PHYSICAL FUNCTION; DEPRESSION SCALE; CHINESE PATIENTS; OLDER-ADULTS; SHORT-FORM; MALNUTRITION; PREVALENCE; RISK; IMPAIRMENT	Objectives The aim of this study was to determine the relationship between nutritional status and Parkinson's Disease (PD) features in association with depression, anxiety and quality of life in people with PD. Materials and methods This study was conducted on 96 patients with idiopathic PD to whom the following scales were applied: Unified Parkinson's Disease Rating Scale (UPDRS), 39-item PD questionnaire (PDQ-39), Hospital Anxiety and Depression Score (HADS), Mini Nutritional Assessment (MNA). The scales and measurements were applied to patients at their first assessment. Patients with malnutrition or at risk of malnutrition were assessed by the dietitian and nutrition nurse. These patients received nutritional support through personalized diet recommendations and appropriate enteral nutritional products, considering factors such as age, comorbidity, socioeconomic and cultural conditions. At the end of 6 weeks, the scales and measurements applied during the first visit were again applied to the patients. Results A significant and inverse correlation was determined between mental (Spearman r:-0.510, p<0.001), activities of daily living (Spearman r:-0.520, p<0.001), motor (Spearman r:-0.480, p<0.001), complications (Spearman r:-0.346, p<0.001) UPDRS subdivisions and total scores (Spearman r:-0.644, p<0.001) and total MNA score. A significant and inverse correlation was found between all PDQ-39 subdomains and total MNA score (p<0.05). The highest inverse correlations were found in mobility (Spearman r:-0.690, p<0.001) and stigma (Spearman r:-0.570, p<0.001). Both depression (Spearman r:-0.631, p<0.001) and anxiety (Spearman r:-0.333, p<0.001) scores were determined to be inversely correlated with total MNA score. At the 6-week control visit, significantly lower scores were found in all subdivisions and in the total UPDRS score, PDQ-39 score and in the patients' anxiety and depression scores (p<0.05). MNA scores were found to be significantly higher in the assessment performed after 6 weeks of support for patients who had abnormal nutritional status at inception (p<0.001). Conclusion PD motor and nonmotor functions, disease duration and severity are related to nutritional status. Quality of life was also shown to be affected by changes in the nutritional status. These results show that nutritional status assessment should be a standard approach in the PD treatment and follow-up processes.	[Ongun, Nedim] Burdur State Hosp, Dept Neurol, Burdur, Turkey	Burdur State Hospital	Ongun, N (corresponding author), Burdur State Hosp, Dept Neurol, Burdur, Turkey.	nedimongun@yahoo.com						Afsar B, 2006, J RENAL NUTR, V16, P277, DOI 10.1053/j.jrn.2006.01.012; Bannerman E, 2002, PUBLIC HEALTH NUTR, V5, P655, DOI 10.1079/PHN2002336; Barichella M, 2003, EUR J CLIN NUTR, V57, P543, DOI 10.1038/sj.ejcn.1601581; Barichella M, 2008, NUTR NEUROSCI, V11, P128, DOI 10.1179/147683008X301441; Bauer JM, 2006, DEUT MED WOCHENSCHR, V131, P223, DOI 10.1055/s-2006-924953; Burgos R, 2018, CLIN NUTR, V37, P354, DOI 10.1016/j.clnu.2017.09.003; Dereli EE, 2015, ARCH NEUROPSYCHIATR, V52, P128; Fereshtehnejad SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137081; Fereshtehnejad SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Grosset KA, 2005, MOVEMENT DISORD, V20, P616, DOI 10.1002/mds.20393; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Hickson M, 2004, CLIN NUTR, V23, P213, DOI 10.1016/S0261-5614(03)00127-4; Hinnell C, 2012, MOVEMENT DISORD, V27, P236, DOI 10.1002/mds.23961; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jaafar A, 2010, MOVEMENT DISORD, V25, pS424; Keller HH, 2004, J GERONTOL A-BIOL, V59, P68; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Lorefalt B, 2004, ACTA NEUROL SCAND, V110, P180, DOI 10.1111/j.1600-0404.2004.00307.x; Mackenzie AE, 2002, DISABIL REHABIL, V24, P259, DOI 10.1080/09638380110081805; MARKUS HS, 1993, J NEURAL TRANSM-PARK, V5, P117, DOI 10.1007/BF02251202; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Neumann SA, 2005, J HUM NUTR DIET, V18, P129, DOI 10.1111/j.1365-277X.2005.00596.x; Olin AO, 2005, EUR J CLIN NUTR, V59, P263, DOI 10.1038/sj.ejcn.1602067; Persson MD, 2002, J AM GERIATR SOC, V50, P1996, DOI 10.1046/j.1532-5415.2002.50611.x; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Sarikaya D, 2015, ARCH GERONTOL GERIAT, V61, P56, DOI 10.1016/j.archger.2015.04.006; Serrano-Urrea R, 2013, GERONTOLOGY, V59, P490, DOI 10.1159/000351763; Sheard JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0212-1; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057986; Sheard JM, 2011, NUTR REV, V69, P520, DOI 10.1111/j.1753-4887.2011.00413.x; Shearer J, 2012, J NEUROL, V259, P462, DOI 10.1007/s00415-011-6202-y; Starkstein SE, 2008, MOVEMENT DISORD, V23, P538, DOI 10.1002/mds.21866; Tsai AC, 2011, INT J NURS STUD, V48, P1429, DOI 10.1016/j.ijnurstu.2011.05.004; Tumas V, 2008, ARQ NEURO-PSIQUIAT, V66, P152, DOI 10.1590/S0004-282X2008000200002; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; Vailas LI, 1998, J AM DIET ASSOC, V98, P548, DOI 10.1016/S0002-8223(98)00123-0; Visser M, 2008, J NEUROL, V255, P1580, DOI 10.1007/s00415-008-0994-4; Visvanathan R, 2003, J AM GERIATR SOC, V51, P1007, DOI 10.1046/j.1365-2389.2003.51317.x; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009; Winter Y, 2010, J NEUROL, V257, P638, DOI 10.1007/s00415-009-5389-7; Wu Y, 2014, J NEUROL SCI, V340, P144, DOI 10.1016/j.jns.2014.03.014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	22	23	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205100	10.1371/journal.pone.0205100	http://dx.doi.org/10.1371/journal.pone.0205100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278074	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200038
J	Takahara, B; Takahashi, KH				Takahara, Baku; Takahashi, Kazuo H.			Genome-Wide Association Study on Male Genital Shape and Size in Drosophila melanogaster (vol 10, e132846, 2015)	PLOS ONE			English	Correction																		Takahara B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132846	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205301	10.1371/journal.pone.0205301	http://dx.doi.org/10.1371/journal.pone.0205301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278085	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200046
J	Jun, DY; Jang, WY; Kim, KY; Woo, MH; Kim, YH				Jun, Do Youn; Jang, Won Young; Kim, Ki Yun; Woo, Mi Hee; Kim, Young Ho			Cytoprotective effect of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) is mediated by the inhibition of BAK-dependent mitochondrial apoptosis pathway	PLOS ONE			English	Article							OXYGEN SPECIES ROS; PROMETAPHASE ARREST; OXIDATIVE STRESS; CANCER-CELLS; GLUCOCORTICOIDS ACTIVATE; DRUG-RESISTANCE; SUICIDE PROCESS; KEY ROLE; MCL-1; PHOSPHORYLATION	The inhibitory mechanism of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) against apoptosis induced by the microtubule-damaging agents (MDAs), noco-dazole (NOC) and 2-methoxyestradiol (2-MeO-E-2), or a DNA-damaging agent (DDA), camptothecin (CPT) were investigated in human Jurkat T cell clones (J/Neo and J/BCL-XL cells). Treatment of J/Neo cells with NOC, 2-MeO-E-2, or CPT caused cytotoxicity and apoptotic DNA fragmentation but these events were significantly attenuated in the presence of CMEP-NQ. Although not only MDA (NOC or 2-MeO-E-2)-induced mitotic arrest, CDK1 activation, and BCL-2, BCL-XL and BIM phosphorylation, but also DDA (CPT)-induced S-phase arrest and ATM-CHK1/CHK2-p53 pathway activation were not or were barely affected in the presence of CMEP-NQ, the levels of anti-apoptotic BAG3 and MCL-1, which were markedly downregulated after MDA- or DDA-treatment, were rather elevated by CMEP-NQ. Under the same conditions, MDA- or DDA-induced mitochondrial apoptotic events including BAK activation, mitochondrial membrane potential (Delta psi m) loss, caspase-9 activation, and PARP cleavage were significantly inhibited by CMEP-NQ. While MDA- or DDA-induced sub-G(1) peak and Delta psi m loss were abrogated in J/BCL-XL cells, MDA-induced mitotic arrest and DDA-induced S-arrest were more apparent in J/BCL-XL cells than in J/Neo cells. Simultaneously, the induced cell cycle arrest in J/BCL-XL cells was not significantly disturbed by CMEP-NQ. MDA- or DDA-treatment caused intracellular reactive oxygen species (ROS) production; however, MDA- or DDA-induced ROS production was almost completely abrogated in J/BCL-XL cells. MDA- or DDA-induced ROS production in J/Neo cells was significantly suppressed by CMEP-NQ, but the suppressive effect was hardly observed in J/BCL-XL cells. Together, these results show that CMEP-NQ efficiently protects Jurkat T cells from apoptotic cell death via the elevation of BAG3 and MCL-1 levels, which results in the inhibition of intrinsic BAK-dependent mitochondrial apoptosis pathway, as does the overexpression of BCL-XL.	[Jun, Do Youn; Jang, Won Young; Kim, Ki Yun; Kim, Young Ho] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Lab Immunobiol, Daegu, South Korea; [Woo, Mi Hee] Daegu Catholic Univ, Coll Pharmacol, Gyongsan, South Korea	Kyungpook National University; Catholic University of Daegu	Kim, YH (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Lab Immunobiol, Daegu, South Korea.	ykim@knu.ac.kr		Kim, Ki Yun/0000-0003-2909-7056	National Research Foundation of Korea - Korean government [NRF-2016R1A2B4016101]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This study was supported by a grant from the National Research Foundation of Korea funded by the Korean government (NRF-2016R1A2B4016101). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the National Research Foundation of Korea funded by the Korean government (NRF-2016R1A2B4016101).	Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Boiani M, 2013, J BIOL CHEM, V288, P6980, DOI 10.1074/jbc.M112.414177; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Habata S, 2016, INT J ONCOL, V49, P402, DOI 10.3892/ijo.2016.3494; Han CR, 2014, APOPTOSIS, V19, P224, DOI 10.1007/s10495-013-0928-1; Han CR, 2013, BBA-MOL CELL RES, V1833, P2220, DOI 10.1016/j.bbamcr.2013.05.016; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hu QS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0060-6; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jun DY, 2007, CARCINOGENESIS, V28, P1303, DOI 10.1093/carcin/bgm028; Jun DY, 2011, J MED FOOD, V14, P454, DOI 10.1089/jmf.2010.1385; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Lee ST, 2015, BIOCHEM PHARMACOL, V94, P257, DOI 10.1016/j.bcp.2015.02.011; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; MIGLIORATI G, 1992, CELL IMMUNOL, V143, P348, DOI 10.1016/0008-8749(92)90031-J; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; RIEBER MS, 1994, BIOCHEM BIOPH RES CO, V203, P1629, DOI 10.1006/bbrc.1994.2373; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Rudolf E, 2011, APOPTOSIS, V16, P1165, DOI 10.1007/s10495-011-0635-8; Samraj AK, 2006, ONCOGENE, V25, P186, DOI 10.1038/sj.onc.1209034; Sastre J, 2000, IUBMB LIFE, V49, P427; Schulz JB, 1996, J NEUROSCI, V16, P4696; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Son JK, 2008, CHEM PHARM BULL, V56, P213, DOI 10.1248/cpb.56.213; Sugio A, 2014, GYNECOL ONCOL, V134, P615, DOI 10.1016/j.ygyno.2014.06.024; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; Tewari M, 1997, CANCER RES, V57, P4063; Tse WP, 2007, INT J MOL MED, V20, P663; UCKER DS, 1987, NATURE, V327, P62, DOI 10.1038/327062a0; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; Virador VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005136; Wallach D, 1997, FEBS LETT, V410, P96, DOI 10.1016/S0014-5793(97)00553-X; Wang HQ, 2010, J CELL PHYSIOL, V224, P94, DOI 10.1002/jcp.22097; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Woo HJ, 2017, J ETHNOPHARMACOL, V205, P103, DOI 10.1016/j.jep.2017.04.029; Xu Y, 2015, BIOMOLECULES, V5, P1652, DOI 10.3390/biom5031652; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	58	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204585	10.1371/journal.pone.0204585	http://dx.doi.org/10.1371/journal.pone.0204585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273361	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700026
J	Kassa, A; Human, SP; Gemeda, H				Kassa, Andargachew; Human, Sarie Petronella; Gemeda, Hirut			Knowledge of preconception care among healthcare providers working in public health institutions in Hawassa, Ethiopia	PLOS ONE			English	Article							RECOMMENDATIONS; DETERMINANTS; WOMEN	Background Preconception care (PCC) is an evidence-based health promotion intervention to prevent adverse pregnancy outcomes. Nevertheless, it is one of the missing elements within the continuum of maternal and child healthcare. Despite the WHO's recommendation, most of the developing countries have not yet started implementing preconception care. Objective To determine the knowledge level of healthcare providers about PCC and to identify predictors of effective knowledge of preconception care. Method This is a cross-sectional study conducted among 634 healthcare providers (HCP) working in public health institutions of Hawassa. A pilot-tested and validated self-administered survey tool was used to collect data from individual healthcare providers who were selected randomly using a multistage sampling technique. The data entry and analysis were conducted using SPSS version 20 software. Frequency, proportions, means and standard deviations were used to describe the data. Bivariate and multivariate logistic regression models were implemented to determine the predictors of HCP's PCC knowledge. Results Only a few (31%) of the healthcare providers demonstrated a good level of knowledge on preconception care. The odds of having good PCC knowledge was high among HCPs working in hospitals (AOR = 1.8, 95% C.I. 1.3-2.6), HCPs using their smart phone to access clinical resources (AOR = 1.4, 95% C.I. 1.1-2.0), among those HCPs ever have read PCC guideline prepared by organization outside of Ethiopia (AOR = 1.9, 95% C.I. 1.4-2.7), among those who claimed practicing PCC (AOR = 3.4, 95% C.I. 2.0-5.9), and among those who earn salary of >= 146.0 $(AOR = 1.5, 95% C.I. 1.1-2.1). Conclusion There is an unacceptably low level of knowledge about PCC among most of the healthcare providers in public health facilities in Ethiopia. The predictors identified in this study can be used to enhance the knowledge of healthcare providers about preconception care.	[Kassa, Andargachew; Gemeda, Hirut] Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Hawassa, Ethiopia; [Human, Sarie Petronella] Univ South Africa, Coll Human Sci, Dept Hlth Sci, UNISA, Pretoria, South Africa	Hawassa University; University of South Africa	Kassa, A (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Hawassa, Ethiopia.	akandkassa@gmail.com		Biratu, Andargachew Kassa/0000-0003-4696-2582				ACP-ACOG, 2007, GUID PER CAR; Ajayi GO, 2013, CLIN EXP OBSTET GYN, V40, P359; Al-Darzi W, 2014, E MEDITERR HEALTH J, V20, P561, DOI 10.26719/2014.20.9.561; Asemahagn MA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-431; Ayalew Y, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0279-4; Bradley EH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000987; Braspenningx S, 2013, FACTS VIEWS VIS OBGY, V5, P13; BSRC, 2009, PREC HLTH PHYS PRACT; Ebrahimipour Bayram, 2013, J RES HLTH, V3; Fleuren M, 2004, INT J QUAL HEALTH C, V16, P107, DOI 10.1093/intqhc/mzh030; Fleuren MAH, 2014, INT J QUAL HEALTH C, V26, P501, DOI 10.1093/intqhc/mzu060; FMOH, 2015, FED DEM REP ETH MIN; ICF CSACEa, 2016, ETH DEM HLTH SURV 20; Kassa A, 2017, ADDRESSING HIGH ADVE; Kitamura Kazuya, 2005, BMC Fam Pract, V6, P31, DOI 10.1186/1471-2296-6-31; McCluskey A., 2003, AUST OCCUP THER J, V50, P3, DOI [10.1046/j.1440-1630.2003.00303.x, DOI 10.1046/J.1440-1630.2003.00303.X]; MOH, 2015, GUIDL MAT CAR S AFR; Moos MK, 2008, AM J OBSTET GYNECOL, V199, pS280, DOI 10.1016/j.ajog.2008.08.060; Mosale F. A., 2012, EL MINIA MED B, V23, P14; National AIDS and STI Control Programme, 2014, GUIDELINES USE ANTIR; Sanders Lorraine B, 2009, Policy Polit Nurs Pract, V10, P129, DOI 10.1177/1527154409338494; Sardasht FG, 2013, J MIDWIFERY REPROD H, V1, P10; World Health Organisation, 2013, M DEV GLOB CONS PREC; World Health Organization, 2013, PREC HLTH MAX GAINS	24	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204415	10.1371/journal.pone.0204415	http://dx.doi.org/10.1371/journal.pone.0204415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273381	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700021
J	Liu, LB; Guo, YD; Xu, AD; Zhong, JX; Zhuo, WY				Liu, Li-Bin; Guo, Ya-Dong; Xu, An-Ding; Zhong, Jie-Xi; Zhuo, Wen-Yan			Diagnostic value of STAF score in combination with D-dimer in cardioembolism	PLOS ONE			English	Article							LEFT ATRIAL SIZE; ISCHEMIC-STROKE; FIBRILLATION STAF; RISK; ECHOCARDIOGRAPHY; CLASSIFICATION; DILATATION; PREVENTION; PREDICTORS; SUBTYPE	The aim of this study was to evaluate the diagnostic value of the Score for the Targeting of Atrial Fibrillation (STAF) in combination with the serum D-dimer (DD) levels in cardioembolism(CE).This study was a retrospective case-onlystudy, consecutively including patients with acute ischemic stroke. All patients were evaluated following the STAF scoring criteria and were classified according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) etiology classification criteria. A total of 317 patients were enrolled, including 37 CE cases (11.67%). STAF >= 5 showed a sensitivity of 89% and a specificity of 91% for the diagnosis of CE, whereas DD >791.30 ng/mL had a sensitivity of 58% and a specificity of 78%. When the STAF was used in combination with the DD level, the sensitivity was 95%, and the specificity was 100%.STAF score is an excellent tool for the diagnosis of CE when combined with DD, and can facilitate the etiological classification of acute ischemic stroke.	[Liu, Li-Bin; Guo, Ya-Dong; Zhong, Jie-Xi; Zhuo, Wen-Yan] Jinan Univ, Zhuhai Hosp, Dept Neurol, Zhuhai, Peoples R China; [Guo, Ya-Dong; Xu, An-Ding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Zhuo, WY (corresponding author), Jinan Univ, Zhuhai Hosp, Dept Neurol, Zhuhai, Peoples R China.	zhuhaizwy@163.com		Zhuo, Wen-Yan/0000-0001-9003-4041	Medical Scientific Research Fund of Zhuhai, China [20181117A010020]	Medical Scientific Research Fund of Zhuhai, China	This study was supported by the Medical Scientific Research Fund of Zhuhai, China (Project No. 20181117A010020).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ageno W, 2002, ARCH INTERN MED, V162, P2589, DOI 10.1001/archinte.162.22.2589; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Arauz A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166091; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Castellano Jose Maria, 2014, Card Electrophysiol Clin, V6, P5, DOI 10.1016/j.ccep.2013.10.007; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; Ferro JM, 2003, J NEUROL, V250, P139, DOI 10.1007/s00415-003-1017-0; Gardin JM, 2002, J AM SOC ECHOCARDIOG, V15, P275, DOI 10.1067/mje.2002.121536; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Hong KS, 2013, J STROKE CEREBROVASC, V22, pE373, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.008; Horstmann S, 2013, EUR J NEUROL, V20, P147, DOI 10.1111/j.1468-1331.2012.03816.x; Isenegger J, 2010, CEREBROVASC DIS, V29, P82, DOI 10.1159/000256652; Jaroch J, 2016, POL ARCH MED WEWN, V126, P25, DOI 10.20452/pamw.3261; Kim TW, 2015, J NEUROL SCI, V354, P97, DOI 10.1016/j.jns.2015.05.008; Lai CL, 2011, ECHOCARDIOGR-J CARD, V28, P1054, DOI 10.1111/j.1540-8175.2011.01489.x; Lee MJ, 2016, J STROKE, V18, P304, DOI 10.5853/jos.2016.00290; Lin SP, 2016, INT J NEUROSCI, V25, P1; Liu LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118301; Liu XY, 2017, J STROKE CEREBROVASC, V26, P1280, DOI 10.1016/j.jstrokecerebrovasdis.2017.01.022; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Pritchett AM, 2002, J AM COLL CARDIOL, V39, p276A; Shin Hye-Young, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P131, DOI 10.7461/jcen.2013.15.3.131; Suissa L, 2011, CEREBROVASC DIS, V31, P442, DOI 10.1159/000323852; Suissa L, 2009, STROKE, V40, P2866, DOI 10.1161/STROKEAHA.109.552679; Takoglu A, 2013, TURK J MED SCI, V43, P957, DOI 10.3906/sag-1208-60; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yaghi S, 2015, STROKE, V46, P1488, DOI 10.1161/STROKEAHA.115.008711	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204838	10.1371/journal.pone.0204838	http://dx.doi.org/10.1371/journal.pone.0204838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273382	gold, Green Submitted, Green Published			2022-12-27	WOS:000446124700039
J	Asberg, AN; Hagen, K; Stovner, LJ; Heuch, I; Zwart, JA; Winsvold, BS				Asberg, Anders Nikolai; Hagen, Knut; Stovner, Lars Jacob; Heuch, Ingrid; Zwart, John-Anker; Winsvold, Bendik Slagsvold			Do incident musculoskeletal complaints influence mortality? The Nord-Trondelag Health study	PLOS ONE			English	Article							POPULATION-BASED COHORT; CHRONIC WIDESPREAD PAIN; FOLLOW-UP; GLOBAL BURDEN; OLDER-ADULTS; BACK-PAIN; BODY PAIN; HUNT; EPIDEMIOLOGY; PREVALENCE	Background Musculoskeletal complaints (MSC) are common in the general population, causing a major disease burden to the individual and society. The association between MSC and mortality is still unclear. To our knowledge, no study has hitherto evaluated the association between MSC onset within the last month (incident MSC) on the one hand, and all-cause and cause-specific mortality on the other. Methods This prospective population-based cohort study was done using data from the second Nord-Trondelag Health Study (HUNT2) linked with data from a comprehensive national registry of cause of death. A total of 25,931 participants at risk for incident MSC were included. Hazard ratios (HR) of mortality were estimated for participants with incident MSC using Cox regression based on a mean of 14.1 years of follow-up. Results Participants who reported incident MSC did not have an excess mortality compared to those with no MSC in the analyses of all-cause mortality (HR 0.99, 95% CI 0.89-1.10) and cause specific mortality. This was true also after adjustment for several potential confounding factors. No clear association between the number of MSC body sites and mortality was found. Conclusion Incident MSC were not associated with an increased mortality, neither for all-cause mortality, nor cause-specific mortality.	[Asberg, Anders Nikolai; Hagen, Knut; Stovner, Lars Jacob] NTNU Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Hagen, Knut; Stovner, Lars Jacob] St Olays Univ Hosp, Norwegian Advisory Unit Headache, Trondheim, Norway; [Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, Div Clin Neurosci, Dept Res Innovat & Educ, Oslo, Norway; [Zwart, John-Anker; Winsvold, Bendik Slagsvold] Univ Oslo, Inst Clin Med, Oslo, Norway; [Winsvold, Bendik Slagsvold] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Winsvold, Bendik Slagsvold] Oslo Univ Hosp, FORMI, Oslo, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; University of Oslo	Asberg, AN (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway.	anders.n.asberg@ntnu.no	Winsvold, Bendik/ABF-7839-2021	Winsvold, Bendik/0000-0003-4171-8919				Ahacic K, 2010, PAIN, V151, P206, DOI 10.1016/j.pain.2010.07.011; Alfsen G Cecilie, 2012, Tidsskr Nor Laegeforen, V132, P147, DOI 10.4045/tidsskr.11.0427; Andersson HI, 2009, DISABIL REHABIL, V31, P1980, DOI 10.3109/09638280902874154; Andorsen OF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181417; Andorsen OF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164341; Asberg AN, 2016, PAIN, V157, P1443, DOI 10.1097/j.pain.0000000000000537; Bergman S, 2005, DISABIL REHABIL, V27, P675, DOI 10.1080/09638280400009030; Bergman S, 2001, J RHEUMATOL, V28, P1369; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; Docking RE, 2015, EUR J PAIN, V19, P466, DOI 10.1002/ejp.568; Ekholm O, 2014, PAIN, V155, P2486, DOI 10.1016/j.pain.2014.07.006; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Gustavsson A, 2012, EUR J PAIN, V16, P289, DOI 10.1016/j.ejpain.2011.07.006; Hagen K, 2006, SPINE, V31, P2146, DOI 10.1097/01.brs.0000231734.56161.6b; Hagen K, 2011, PAIN MED, V12, P1657, DOI 10.1111/j.1526-4637.2011.01240.x; Hartvigsen J, 2014, SCAND J PUBLIC HEALT, V42, P698, DOI 10.1177/1403494814542263; Holley AL, 2017, PAIN, V158, P794, DOI 10.1097/j.pain.0000000000000817; Holley AL, 2017, CLIN J PAIN, V33, P28, DOI 10.1097/AJP.0000000000000371; Holmen JM K., 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI [10.5324/nje.v13i1.305, DOI 10.1093/eurheartj/eht019]; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Jimenez-Sanchez S, 2010, J PAIN, V11, P612, DOI 10.1016/j.jpain.2009.09.015; Kvalheim S, 2013, PAIN, V154, P1073, DOI 10.1016/j.pain.2013.03.015; Macfarlane GJ, 2007, RHEUMATOLOGY, V46, P805, DOI 10.1093/rheumatology/kel403; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P1815, DOI 10.1136/annrheumdis-2017-211476; Macfarlane GJ, 2001, BRIT MED J, V323, P662, DOI 10.1136/bmj.323.7314.662; McBeth J, 2009, RHEUMATOLOGY, V48, P74, DOI 10.1093/rheumatology/ken424; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; MONTO AS, 1974, JAMA-J AM MED ASSOC, V227, P164, DOI 10.1001/jama.227.2.164; Moradi-Lakeh M, 2017, ANN RHEUM DIS, V76, P1365, DOI 10.1136/annrheumdis-2016-210146; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Nitter AK, 2013, SCAND J PAIN, V4, P86, DOI 10.1016/j.sjpain.2012.12.002; Pedersen AG, 2015, TIDSSKR NORSKE LAEGE, V135, P768, DOI 10.4045/tidsskr.14.1065; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Scott WK, 1997, J CLIN EPIDEMIOL, V50, P291, DOI 10.1016/S0895-4356(96)00365-4; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; Smith D, 2017, ARTHRITIS CARE RES, DOI 10.1002/acr.23268; Smith D, 2018, PAIN, V159, P1112, DOI 10.1097/j.pain.0000000000001193; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; Videm V, 2017, J RHEUMATOL, V44, P1134, DOI 10.3899/jrheum.161396; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weiner DK, 2003, PAIN MED, V4, P311, DOI 10.1111/j.1526-4637.2003.03042.x; Wolfe F, 2011, ARTHRIT CARE RES, V63, P94, DOI 10.1002/acr.20301; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203925	10.1371/journal.pone.0203925	http://dx.doi.org/10.1371/journal.pone.0203925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265708	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500013
J	Droste, N; D'Amato, D; Goddard, JJ				Droste, Nils; D'Amato, Dalia; Goddard, Jessica J.			Where communities intermingle, diversity grows - The evolution of topics in ecosystem service research	PLOS ONE			English	Article							SCIENCE; BIODIVERSITY; VALUATION; ECONOMICS; CASCADE; VALUES; WORLDS	We analyze how the content of ecosystem service research has evolved since the early 1990s. Conducting a computational bibliometric content analysis we process a corpus of 14,118 peer-reviewed scientific article abstracts on ecosystem services (ES) from Web of Science records. To provide a comprehensive content analysis of ES research literature, we employ a latent Dirichlet allocation algorithm. For three different time periods (1990-2000, 2001-2010, 2011-2016), we derive nine main ES topics arising from content analysis and elaborate on how they are related over time. The results show that natural science-based ES research analyzes oceanic, freshwater, agricultural, forest, and soil ecosystems. Pollination and land cover emerge as traceable standalone topics around 2001. Social science ES literature demonstrates a reflexive and critical lens on the role of ES research and includes critiques of market-oriented perspectives. The area where social and natural science converge most is about land use systems such as agriculture. Overall, we provide evidence of the strong natural science foundation, the highly interdisciplinary nature of ES research, and a shift in social ES research towards integrated assessments and governance approaches. Furthermore, we discuss potential reasons for observable topic developments.	[Droste, Nils] UFZ Helmholtz Ctr Environm Res, Dept Econ, Leipzig, Germany; [Droste, Nils] Martin Luther Univ Halle Wittenberg, Dept Econ, Halle, Seale, Germany; [Droste, Nils] FLACSO Fac Latinoamer Ciencias Sociales, Dept Dev Environm & Terr, Quito, Ecuador; [D'Amato, Dalia] Univ Helsinki, Helsinki Inst Sustainabil Sci, Dept Forest Sci, Helsinki, Finland; [Goddard, Jessica J.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Droste, Nils] Lund Univ, Ctr Environm & Climate Res, Lund, Sweden	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg; University of Helsinki; University of California System; University of California Berkeley; Lund University	Droste, N (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Econ, Leipzig, Germany.; Droste, N (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Econ, Halle, Seale, Germany.; Droste, N (corresponding author), FLACSO Fac Latinoamer Ciencias Sociales, Dept Dev Environm & Terr, Quito, Ecuador.; Droste, N (corresponding author), Lund Univ, Ctr Environm & Climate Res, Lund, Sweden.	nils.droste@cec.lu.se	D'Amato, Dalia/AAJ-6538-2020; Droste, Nils/I-2449-2019	D'Amato, Dalia/0000-0002-3992-7263; Droste, Nils/0000-0003-4357-9115; Goddard, Jessica J./0000-0001-9174-2832	Heinrich-Boll-Foundation [P118873]; Academy of Finland [315912]; Center for European Studies at UC Berkeley	Heinrich-Boll-Foundation; Academy of Finland(Academy of Finland); Center for European Studies at UC Berkeley	ND is grateful for a scholarship of the Heinrich-Boll-Foundation (https://www.boell.de/en), grant no. P118873. DD is grateful to Metsateollisuustuotteiden Vientikaupan Edistamissaatio (https://www.mves.info/), Jenny ja Antti Wihurin rahasto (https://wihurinrahasto.fi/) and the Academy of Finland (funding decision 315912). JJG is grateful for a scholarship from the Center for European Studies at UC Berkeley (https://ies.berkeley.edu/cges). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ, 2014, ECOL ECON, V103, P29, DOI 10.1016/j.ecolecon.2014.04.012; Aggestam F, 2015, CONSERV BIOL, V29, P1052, DOI 10.1111/cobi.12516; Arun R, 2010, LECT NOTES ARTIF INT, V6118, P391; Balmford A, 2011, ENVIRON RESOUR ECON, V48, P161, DOI 10.1007/s10640-010-9413-2; Barnaud C, 2014, GEOFORUM, V56, P113, DOI 10.1016/j.geoforum.2014.07.003; Bennett EM, 2015, CURR OPIN ENV SUST, V14, P76, DOI 10.1016/j.cosust.2015.03.007; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blei DM, 2006, INT C MACH LEARN ICM, V148, P113, DOI [10.1145/1143844.1143859, DOI 10.1145/1143844.1143859]; BouchetValat M, 2014, R PACKAGE VERSION 0; Braat LC, 2012, ECOSYST SERV, V1, P4, DOI 10.1016/j.ecoser.2012.07.011; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Cao J, 2009, NEUROCOMPUTING, V72, P1775, DOI 10.1016/j.neucom.2008.06.011; Castree N, 2003, PROG HUM GEOG, V27, P273, DOI 10.1191/0309132503ph428oa; Chan KMA, 2016, P NATL ACAD SCI USA, V113, P1462, DOI 10.1073/pnas.1525002113; Chang J., 2015, R PACKAGE VERSION 1; Chaudhary S, 2015, ENVIRON SCI POLICY, V54, P25, DOI 10.1016/j.envsci.2015.04.025; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2017, ECOSYST SERV, V28, P1, DOI 10.1016/j.ecoser.2017.09.008; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Csardi G, 2015, R PACKAGE VERSION 1; D'Amato D, 2017, J CLEAN PROD, V168, P716, DOI 10.1016/j.jclepro.2017.09.053; Dempsey J, 2012, PROG HUM GEOG, V36, P758, DOI 10.1177/0309132512437076; Deveaud Romain, 2014, DOCUMENT NUMERIQUE, V17, P61, DOI [10.3166/dn.17.1.61-84, DOI 10.3166/DN.17.1.61-84]; Diaz S, 2015, CURR OPIN ENV SUST, V14, P1, DOI 10.1016/j.cosust.2014.11.002; EHRLICH PR, 1983, BIOSCIENCE, V33, P248, DOI 10.2307/1309037; Feinerer I, 2015, R PACKAGE VERSION 0; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Gomez-Baggethun E, 2011, PROG PHYS GEOG, V35, P613, DOI 10.1177/0309133311421708; Gomez-Baggethun E, 2010, ECOL ECON, V69, P1209, DOI 10.1016/j.ecolecon.2009.11.007; GRI, 2011, APPR REP EC SERV INC; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Haines-Young R, 2018, COMMON INT CLASSIFIC; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Heink U, 2016, ECOL INDIC, V61, P18, DOI 10.1016/j.ecolind.2015.09.031; IPBES, 2015, PREL GUID REG DIV CO; IPBES, 2016, SUMMARY POLICYMAKERS; Jacobs S, 2016, ECOSYST SERV, V22, P213, DOI 10.1016/j.ecoser.2016.11.007; Knutas A., 2015, P 16 INT C COMP SYST, P184, DOI [10.1145/2812428.2812442, DOI 10.1145/2812428.2812442]; La Notte A, 2017, ECOL INDIC, V74, P392, DOI 10.1016/j.ecolind.2016.11.030; Lafferty JohnD., 2006, ADV NEURAL INFORM PR, P147; Lele S., 2013, JUSTICES INJUSTICES, P119; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Millennium Ecosystem Assessment, 2005, SYNTHESIS REPORT; Mooney H.A., 1997, NATURES SERVICES SOC, P11; Murzintcev N, 2016, R PACKAGE VERSION 0; Naeem S, 2015, SCIENCE, V347, P1206, DOI 10.1126/science.aaa1403; Natural Capital Coalition, 2015, DRAFT NAT CAP PROT P; Norgaard RB, 2010, ECOL ECON, V69, P1219, DOI 10.1016/j.ecolecon.2009.11.009; Pascual U, 2017, CURR OPIN ENV SUST, V26-27, P7, DOI 10.1016/j.cosust.2016.12.006; Polyakov M, 2018, ENVIRON RESOUR ECON, V71, P217, DOI 10.1007/s10640-017-0147-2; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2017, R LANG ENV STAT COMP; Raymond CM, 2013, BIOSCIENCE, V63, P536, DOI 10.1525/bio.2013.63.7.7; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Robertson MM, 2000, ANTIPODE, V32, P463, DOI 10.1111/1467-8330.00146; Saarikoski H, 2018, ECOSYST SERV, V29, P579, DOI 10.1016/j.ecoser.2017.07.019; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Sievert C., 2014, P WORKSHOP INTERACTI, P63, DOI [10.3115/v1/W14-3110, DOI 10.3115/V1/W14-3110]; Silvertown J, 2015, TRENDS ECOL EVOL, V30, P641, DOI 10.1016/j.tree.2015.08.007; South A, 2011, R J, V3, P35; Spangenberg JH, 2014, ECOL ECON, V104, P22, DOI 10.1016/j.ecolecon.2014.04.025; Spash CL, 2015, BIOL CONSERV, V192, P541, DOI 10.1016/j.biocon.2015.07.037; ten Brink P., 2011, EC ECOSYSTEMS BIODIV; van den Belt M, 2016, ECOSYST SERV, V22, P60, DOI 10.1016/j.ecoser.2016.09.006; Vatn A, 2015, ECOL ECON, V117, P225, DOI 10.1016/j.ecolecon.2014.07.017; Waage B, 2014, PRIVATE SECTOR ENGAG; Weinberger K., 2009, P 26 ANN INT C MACH, P1113, DOI DOI 10.1145/1553374.1553516; WESTMAN WE, 1977, SCIENCE, V197, P960, DOI 10.1126/science.197.4307.960; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wunder S, 2015, ECOL ECON, V117, P234, DOI 10.1016/j.ecolecon.2014.08.016	71	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204749	10.1371/journal.pone.0204749	http://dx.doi.org/10.1371/journal.pone.0204749			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265733	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500048
J	Puzo, Q; Mehlum, L; Qin, P				Puzo, Quirino; Mehlum, Lars; Qin, Ping			Rates and characteristics of suicide by immigration background in Norway	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; MENTAL-HEALTH; OSLO HEALTH; SOCIAL INTEGRATION; INCOME COUNTRIES; AUSTRALIA; POPULATION; MORTALITY; SWEDEN; 1ST-GENERATION	Suicide mortality among immigrant groups is an important health issue, particularly in countries with growing segments of immigrant populations such as Norway. Through linkage of Norwegian national registers we wanted to estimate suicide rates (per 100,000 population) in immigrant groups and to profile characteristics of suicide by immigration background with respect to sex, age, method and seasonality of suicide as well as time since immigrating to Norway. Among all 11,409 suicides during 1992-2012, 1,139 (10%) were individuals with an immigration background. Suicide rate was lower in first-generation immigrants (foreign-born persons to two foreign-born parents) than native Norwegians (9.53 vs 12.22, P < 0.01), with a significant difference confined to male rates only. Foreign-born persons with at least one Norwegian-born parent had significantly higher suicide rates than natives in both sexes (22.42 vs 18.03 in males, 11.67 vs 6.54 in females, P < 0.01). The most frequently used suicide method in all the population groups was hanging; this method accounted for 44.0% of all suicides of first-generation immigrants, 45.2% of all suicides of foreign-born persons with at least one Norwegian-born parent, and 35.4% of all suicides of natives. Suicide by firearms accounted for a much smaller proportion of cases of first-generation immigrants (6.7%) and foreign-born persons with at least one Norwegian-born parent (6.8%) than cases of native Norwegians (20.7%). In terms of monthly distribution, suicides of first-generation immigrants displayed two peaks, in May and in November (P= 0.01). More than 25% of all first-generation immigrant suicides occurred in the first five years after immigration; but differences in time since immigration were observed by sex and country group of origin, in particular among those aged 35 years or less when moving to Norway. In conclusion, there are notable differences in characteristics of suicides by immigration background. Knowledge of immigrant mortality according to suicide method, seasonality of suicide, and time since immigration may be useful when planning suicide preventive measures.	[Puzo, Quirino; Mehlum, Lars; Qin, Ping] Univ Oslo, Natl Ctr Suicide Res & Prevent, Inst Clin Med, Oslo, Norway	University of Oslo	Puzo, Q (corresponding author), Univ Oslo, Natl Ctr Suicide Res & Prevent, Inst Clin Med, Oslo, Norway.	quirino.puzo@medisin.uio.no	Mehlum, Lars/AAV-9241-2021					Abebe DS, 2014, J IMMIGR MINOR HEALT, V16, P60, DOI 10.1007/s10903-012-9745-9; Alpers P, 2018, NORWAY GUN FACTS FIG; [Anonymous], 2006, SOCIAL EC DIMENSIONS; Ashwood JS, 2017, RAND HLTH Q, V6; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bhugra D, 2004, ACTA PSYCHIAT SCAND, V109, P243, DOI 10.1046/j.0001-690X.2003.00246.x; Bhugra Dinesh, 2005, World Psychiatry, V4, P18; Bramness JG, 2015, AM J EPIDEMIOL, V182, P244, DOI 10.1093/aje/kwv064; Burvill PW, 1998, PSYCHOL MED, V28, P201, DOI 10.1017/S0033291797005850; Christodoulou C., 2012, ENCEPHALOS, V49, P9; Dalgard OS, 2006, SCAND J PSYCHOL, V47, P551, DOI 10.1111/j.1467-9450.2006.00546.x; Dalgard Odd Steffen, 2007, Clin Pract Epidemiol Ment Health, V3, P24, DOI 10.1186/1745-0179-3-24; De La Rica S., 2015, OXFORD EC INT MIGR B, V1B, P1303; De Leo D, 2003, SUICIDE LIFE-THREAT, V33, P151, DOI 10.1521/suli.33.2.151.22775; Ekblad S, 2013, TRANSCULT PSYCHIATRY, V50, P841, DOI 10.1177/1363461513511181; Erlangsen A, 2018, STUDIES SUICIDAL BEH; GABENNESCH H, 1988, SOC FORCES, V67, P129, DOI 10.2307/2579103; Gjertsen F, 2014, INT J ENV RES PUB HE, V11, P487, DOI 10.3390/ijerph110100487; Hakko H, 1998, ACTA PSYCHIAT SCAND, V98, P92, DOI 10.1111/j.1600-0447.1998.tb10048.x; Hanigan IC, 2012, P NATL ACAD SCI USA, V109, P13950, DOI 10.1073/pnas.1112965109; Henriksen K, 2011, IMMIGRATION IMMIGRAN; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; Hjern A, 2002, SOC PSYCH PSYCH EPID, V37, P423, DOI 10.1007/s00127-002-0564-5; Holopainen J, 2013, ENVIRON HEALTH PREV, V18, P494, DOI 10.1007/s12199-013-0348-4; Ide N, 2012, SOC PSYCH PSYCH EPID, V47, P1917, DOI 10.1007/s00127-012-0499-4; Johansson LM, 1997, SOC PSYCH PSYCH EPID, V32, P165; Johansson LM, 1997, SOC SCI MED, V44, P181, DOI 10.1016/S0277-9536(96)00142-6; Karasouli E, 2014, JMIR MENT HEALTH, V1, DOI 10.2196/mental.3708; Kliewer E, 1991, J Aust Popul Assoc, V8, P111; KLIEWER EV, 1988, AM J EPIDEMIOL, V127, P640, DOI 10.1093/oxfordjournals.aje.a114839; Kolves K, 2018, PSYCHIAT RES, V260, P67, DOI 10.1016/j.psychres.2017.11.035; Kposowa AJ, 2008, ARCH SUICIDE RES, V12, P82, DOI 10.1080/13811110701801044; Makinen I. H., 2003, ARCH SUICIDE RES, V7, P93, DOI DOI 10.1080/13811110301574; Marie N, 2010, INT J PUBLIC HEALTH, V55, P413, DOI [10.1007/s00038-010-0162-3, 10.1007/s00038-010-0190-z]; MARMOT MG, 1984, LANCET, V1, P1455, DOI 10.1016/S0140-6736(84)91943-3; Mirsky J, 2008, J CLIN PSYCHIAT, V69, P1715, DOI 10.4088/JCP.v69n1106; Mirsky J, 2011, SOC PSYCH PSYCH EPID, V46, P1133, DOI 10.1007/s00127-010-0280-5; NIPH, 2016, CAUS DEATH STAT; Nystadnes T., 2010, 100012010 KITH; Ostby L., 2013, CHANGE INTEGRATION; Park S, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-22; Patel K, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0463-1; Pedersen AG, 2015, TIDSSKR NORSKE LAEGE, V135, P768, DOI 10.4045/tidsskr.14.1065; Pedersen CB, 2006, DAN MED BULL, V53, P441; Petridou E, 2002, EPIDEMIOLOGY, V13, P106, DOI 10.1097/00001648-200201000-00017; Population Statistics, 2022, IMM NORW BORN IMM PA; Postolache TT, 2010, J AFFECT DISORDERS, V121, P88, DOI 10.1016/j.jad.2009.05.015; Puzo Q, 2017, ACTA PSYCHIAT SCAND, V135, P584, DOI 10.1111/acps.12732; Puzo Q, 2018, J PSYCHIAT RES; Puzo Q, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2919-y; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Ratkowska KA, 2013, OPEN J MED PSYCHOL, V2, P10; RCoreTeam, 2017, R LANG ENV STAT COMP; Reneflot A, 2018, SUICIDE SUICIDE ATTE; Sandnes Toril., 2017, INNVANDRERE NORGE 20; SSB, 2017, TABL 05182 PERS IMM; SSB, 2016, EMPL IMM STAT NORW; SSB, 2008, LIV COND IMM STAT NO; SSB, 2016, IMM REAS IMM STAT NO; SSB, 2011, IMM CAT 2008 STAT NO; SSB, 2018, REG UN IMM STAT NORW; SSB, 2017, TABL 05196 POP SEX A; Stack S., 2000, MEDIA IMPACTS SUICID, P957; Straiton M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-341; Sumarokov YA, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0601-z; Syed HR, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-182; Thapa SB, 2005, SOC PSYCH PSYCH EPID, V40, P78, DOI 10.1007/s00127-005-0855-8; Thapa SB, 2007, NORD J PSYCHIAT, V61, P459, DOI 10.1080/08039480701773261; Tollefsen IM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009120; UN, 2017, INT MIGR REP 2017 UN; WHO, 2014, SUIC RAT PER 100 000; Yamaguchi S, 2013, J NERV MENT DIS, V201, P490, DOI 10.1097/NMD.0b013e31829480df	72	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0205035	10.1371/journal.pone.0205035	http://dx.doi.org/10.1371/journal.pone.0205035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265720	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500063
J	Rozycka-Tran, J; Alessandri, G; Jurek, P; Olech, M				Rozycka-Tran, Joanna; Alessandri, Guido; Jurek, Pawel; Olech, Michal			A test of construct isomorphism of the Belief in a Zero-Sum Game scale: A multilevel 43-nation study	PLOS ONE			English	Article							SOCIAL AXIOMS; MEASUREMENT INVARIANCE; DIMENSIONS; BIAS; CONFLICT; VALUES	Background We examined the equivalence of the individual and the country-level factor structure of the Belief in a Zero-Sum Game (BZSG) scale, a tool designed to measure antagonistic beliefs about social relations (i.e., perceived social antagonism) in the struggle for limited resources. Aims In this article we focused on a test of construct isomorphism in a multilevel modeling approach. It was hypothesized that the BZSG measure satisfies all requirements for a strong level of configural isomorphism, and thus that it is useful to investigate BZSG at both the individual and the country levels. The relationships between the BZSG at a country level with other macro-socio-economic indicators were also investigated. Method Multilevel confirmatory factor analysis (MCFA) was carried out on a cross-country sample composed of 11,368 participants from 43 different countries. We also used the country-level latent BZSG factor in each country as an indicator of a property that we attributed to a particular culture: cultural dimension (collectivism-individualism), macroeconomic indicators (GDP per capita and GNI per capita) and macrosocial indicators (Human Development Index and Democracy Index) describing societies. Results The results revealed an isomorphic factor structure of perceived social antagonism (measured by BZSG scale), defined in terms of the equivalence factor structure at the both individual and country levels. Furthermore, the relationship between the perceived social antagonism, gross national income per capita, and collectivism were confirmed. Conclusions Our study supports the usefulness of the BZSG scale for cross-cultural comparison, in the case of its isomorphic structure. At the country level, antagonistic beliefs emerge in hierarchical collectivist societies with lower income. The main contribution of this article is the presentation of the test of construct isomorphism. We made an effort to present a full perspective on construct isomorphism putting together two different but very recent approaches.	[Rozycka-Tran, Joanna; Jurek, Pawel; Olech, Michal] Univ Gdansk, Inst Psychol, Gdansk, Poland; [Alessandri, Guido] Sapienza Univ Rome, Dept Psychol, Rome, Italy	Fahrenheit Universities; University of Gdansk; Sapienza University Rome	Rozycka-Tran, J (corresponding author), Univ Gdansk, Inst Psychol, Gdansk, Poland.	psyjrt@ug.edu.pl	Jurek, Paweł/AAS-6674-2020; Różycka-Tran, Joanna/O-1336-2015; Różycka-Tran, Joanna/ABE-5992-2020	Jurek, Paweł/0000-0002-9958-3941; Olech, Michal/0000-0003-3612-0568; Rozycka-Tran, Joanna/0000-0003-1131-3910	National Science Center (Poland) [2017/01/X/HS6/00082]	National Science Center (Poland)	National Science Center (Poland) funded the costs of publication (2017/01/X/HS6/00082). Michal Olech previously received employment-related income from Implicit Explicit Training & Consulting. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN TA, 1992, J EDUC MEAS, V29, P67, DOI 10.1111/j.1745-3984.1992.tb00368.x; [Anonymous], 2008, INDIVIDUALS CULTURES; Bliese P.D., 2000, MULTILEVEL THEORY RE, P349; Bond MH, 2004, J CROSS CULT PSYCHOL, V35, P548, DOI 10.1177/0022022104268388; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Burleigh T., 2016, THESIS; Byrne BM, 2014, INT J TEST, V14, P168, DOI 10.1080/15305058.2013.870903; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cheung MWL, 2006, J CROSS CULT PSYCHOL, V37, P522, DOI 10.1177/0022022106290476; Dyer NG, 2005, LEADERSHIP QUART, V16, P149, DOI 10.1016/j.leaqua.2004.09.009; Esses VM, 1998, J SOC ISSUES, V54, P699, DOI 10.1111/0022-4537.911998091; Feskens R., 2011, CROSS CULTURAL ANAL, P341; Fischer R, 2010, J CROSS CULT PSYCHOL, V41, P135, DOI 10.1177/0022022109354377; FOSTER GM, 1965, AM ANTHROPOL, V67, P293, DOI 10.1525/aa.1965.67.2.02a00010; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd ed.; Hoftede G., 2010, CULTURES ORG SOFTWAR; Hox J.J., 2017, MULTILEVEL ANAL TECH, V3rd ed., P1, DOI [10.4324/9781315650982, DOI 10.4324/9781315650982]; Hui CM, 2009, INT CULT PSYCHOL, P13, DOI 10.1007/978-0-387-09810-4_2; JACKSON JW, 1993, PSYCHOL REC, V43, P395; Jak S, 2017, J CROSS CULT PSYCHOL, V48, P75, DOI 10.1177/0022022116674599; Jak S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00745; Jak S, 2013, STRUCT EQU MODELING, V20, P265, DOI 10.1080/10705511.2013.769392; Kline R., 2016, PRINCIPLES PRACTICE; Kozlowski S.W.J, 2000, MULTILEVEL THEORY RE; Kurman J, 2004, J CROSS CULT PSYCHOL, V35, P192, DOI 10.1177/0022022103262244; LEUNG K, 1989, J CROSS CULT PSYCHOL, V20, P133, DOI 10.1177/0022022189202002; Leung K, 2002, J CROSS CULT PSYCHOL, V33, P286, DOI 10.1177/0022022102033003005; Leung K., 2004, ADV EXPT SOCIAL PSYC, V36, P122; Leung K, 2009, INT CULT PSYCHOL, P1, DOI 10.1007/978-0-387-09810-4_1; Louis WR, 2010, MED EDUC, V44, P1241, DOI 10.1111/j.1365-2923.2010.03769.x; Meredith W, 2006, MED CARE, V44, pS69, DOI 10.1097/01.mlr.0000245438.73837.89; MUTHEN BO, 1994, SOCIOL METHOD RES, V22, P376, DOI 10.1177/0049124194022003006; Ray D, 2017, ANNU REV ECON, V9, P263, DOI 10.1146/annurev-economics-061109-080205; Roycka J., 2010, STUDIA PSYCHOL, V48, P33; Rozycka-Tran J, 2017, J INT PSYCHOL, DOI [10.1002/ijop.12470, DOI 10.1002/IJOP.12470]; Rozycka-Tran J, 2015, J CROSS CULT PSYCHOL, V46, P525, DOI 10.1177/0022022115572226; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; SCHWARTZ SH, 1987, J PERS SOC PSYCHOL, V53, P550, DOI 10.1037/0022-3514.53.3.550; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; Steinel W, 2007, GROUP PROCESS INTERG, V10, P533, DOI 10.1177/1368430207081541; Tay L, 2014, ORGAN RES METHODS, V17, P77, DOI 10.1177/1094428113517008; THOMPSON L, 1990, ORGAN BEHAV HUM DEC, V47, P98, DOI 10.1016/0749-5978(90)90048-E; Von Neumann J., 1944, THEORY GAMES EC BEHA; Wright R., 2001, NONZERO LOGIC HUMAN; Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078	46	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203196	10.1371/journal.pone.0203196	http://dx.doi.org/10.1371/journal.pone.0203196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265677	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500007
J	Finsterwalder, R; Ganesan, MK; Leb, H; Habertheuer, A; Basilio, J; Lang, I; Krunic, M; Wiedemann, D; Petzelbauer, P				Finsterwalder, Richard; Ganesan, Minu Karthika; Leb, Heide; Habertheuer, Andreas; Basilio, Jose; Lang, Irene; Krunic, Milica; Wiedemann, Dominik; Petzelbauer, Peter			Hypoxia/reperfusion predisposes to atherosclerosis	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; GENE-EXPRESSION; MOUSE MODEL; CELL-PROLIFERATION; ORPHAN-RECEPTOR; MECHANISMS; INJURY; PATHOPHYSIOLOGY; POLYPLOIDY; MODULATION	Surgical interventions on blood vessels bear a risk for intimal hyperplasia and atherosclerosis as a consequence of injury. A specific feature of intimal hyperplasia is the loss of vascular smooth muscle cell (VSMC) differentiation gene expression. We hypothesized that immediate responses following injury induce vascular remodeling. To differentiate injury due to trauma, reperfusion and pressure changes we analyzed vascular responses to carotid artery bypass grafting in mice compared to transient ligation. As a control, the carotid artery was surgically laid open only. In both, bypass or ligation models, the inflammatory responses were transient, peaking after 6h, whereas the loss of VSMC differentiation gene expression persisted. Extended time kinetics showed that transient carotid artery ligation was sufficient to induce a persistent VSMC phenotype change throughout 28 days. Transient arterial ligation in ApoE knockout mice resulted in atherosclerosis in the transiently ligated vascular segment but not on the not-ligated contralateral side. The VSMC phenotype change could not be prevented by anti-TNF antibodies, Sorafenib, Cytosporone B or N-acetylcysteine treatment. Surgical interventions involving hypoxia/reperfusion are sufficient to induce VSMC phenotype changes and vascular remodeling. In situations of a perturbed lipid metabolism this bears the risk to precipitate atherosclerosis.	[Finsterwalder, Richard; Ganesan, Minu Karthika; Leb, Heide; Petzelbauer, Peter] Med Univ Vienna, Dept Dermatol, SERD, Vienna, Austria; [Habertheuer, Andreas] Hosp Univ Penn, Div Cardiovasc Surg, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Basilio, Jose] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Lang, Irene] Med Univ Vienna, Vienna Gen Hosp, Dept Internal Med 2, Div Cardiol, Vienna, Austria; [Krunic, Milica] Univ Vienna, Med Univ Vienna, Ctr Integrat Bioinformat Vienna, Max F Perutz Labs, Vienna, Austria; [Wiedemann, Dominik] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria	Medical University of Vienna; University of Pennsylvania; Pennsylvania Medicine; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna	Petzelbauer, P (corresponding author), Med Univ Vienna, Dept Dermatol, SERD, Vienna, Austria.	peter.petzelbauer@meduniwien.ac.at	Wiedemann, Dominik/AAH-2649-2020; petzelbauer, peter/GLU-3941-2022	Wiedemann, Dominik/0000-0002-2055-8293; Basilio, Jose/0000-0001-7380-2942; Lang, Irene/0000-0003-0485-2692; Habertheuer, Andreas/0000-0001-7310-8838; Petzelbauer, Peter/0000-0001-7080-5259	SFB grant Austrian Science Foundation [F 5408-B21, F 5411-B21]	SFB grant Austrian Science Foundation	This work was supported by SFB grant Austrian Science Foundation F 5408-B21 and F 5411-B21. www.fwf.ac.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Ali MS, 2013, J CEREBR BLOOD F MET, V33, P1564, DOI 10.1038/jcbfm.2013.109; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrienko TN, 2017, J MOL CELL CARDIOL, V110, P1, DOI 10.1016/j.yjmcc.2017.06.016; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bonta PI, 2010, CARDIOVASC RES, V87, P561, DOI 10.1093/cvr/cvq064; Borel CO, 2003, STROKE, V34, P427, DOI 10.1161/01.STR.0000053848.06436.AB; Chang M, 2016, AM J CARDIOL, V118, P17, DOI 10.1016/j.amjcard.2016.04.009; Cui ML, 2016, HYPERTENSION, V67, P153, DOI 10.1161/HYPERTENSIONAHA.115.06114; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; de Vries MR, 2016, NAT REV CARDIOL, V13, P451, DOI 10.1038/nrcardio.2016.76; De Wilde D, 2016, J BIOMECH, V49, P2135, DOI 10.1016/j.jbiomech.2015.11.048; De Wilde D, 2015, MOL IMAGING, V14, DOI 10.2310/7290.2015.00009; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fang H, 2014, EXP THER MED, V7, P970, DOI 10.3892/etm.2014.1510; Getz GS, 2016, J LIPID RES, V57, P758, DOI 10.1194/jlr.R067249; Gorla GR, 2001, J CELL SCI, V114, P2943; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Jeffery TK, 2002, PROG CARDIOVASC DIS, V45, P173, DOI 10.1053/pcad.2002.130041; Jia ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137782; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Katsuumi G, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00018; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Kijani S, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13334; Lacolley P, 2017, PHYSIOL REV, V97, P1555, DOI 10.1152/physrev.00003.2017; Lilly B, 2014, PHYSIOLOGY, V29, P234, DOI 10.1152/physiol.00047.2013; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Sasso G, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0901-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu P, 2007, MAMM GENOME, V18, P617, DOI 10.1007/s00335-007-9048-y; Mccrann DJ, 2008, J CELL PHYSIOL, V215, P588, DOI 10.1002/jcp.21363; McCrann DJ, 2009, CELL CYCLE, V8, P902, DOI 10.4161/cc.8.6.7900; Mitra AK, 2006, IMMUNOL CELL BIOL, V84, P115, DOI 10.1111/j.1440-1711.2005.01407.x; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murgai M, 2017, NAT MED, V23, P1176, DOI 10.1038/nm.4400; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Roostalu U, 2018, DEV BIOL, V435, P109, DOI 10.1016/j.ydbio.2018.01.018; Shimamura N, 2014, TRANSL STROKE RES, V5, P357, DOI 10.1007/s12975-013-0310-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tange O., 2018, USENIX MAGAZINE, V36, P42; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yildiz G, 2007, ANN NY ACAD SCI, V1100, P353, DOI 10.1196/annals.1395.038; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163; Zimna A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/549412; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205067	10.1371/journal.pone.0205067	http://dx.doi.org/10.1371/journal.pone.0205067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289932	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500044
J	Alkhouri, N; Johnson, C; Adams, L; Kitajima, S; Tsuruno, C; Colpitts, TL; Hatcho, K; Lawitz, E; Lopez, R; Feldstein, AE				Alkhouri, Naim; Johnson, Casey; Adams, Leon; Kitajima, Sachiko; Tsuruno, Chikayuki; Colpitts, Tracey L.; Hatcho, Kazuki; Lawitz, Eric; Lopez, Rocio; Feldstein, Ariel E.			Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis (vol 13, e0202226, 2018)	PLOS ONE			English	Correction																		Alkhouri N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202226	1	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205541	10.1371/journal.pone.0205541	http://dx.doi.org/10.1371/journal.pone.0205541			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286196	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500110
J	Cheng, YF; Yang, TH; Wu, CS; Huang, CC; Lin, HC				Cheng, Yen-Fu; Yang, Tzong-Han; Wu, Chuan-Song; Huang, Chung-Chien; Lin, Herng-Ching			Association between mitral valve prolapse and sudden sensorineural hearing loss: A case-control population-based study	PLOS ONE			English	Article							MARFAN-SYNDROME; DISEASE; GENES	This study aimed to evaluate the relationship between sudden sensorineural hearing loss (SSNHL) and MVP using a population-based dataset. Data for this case-control study were retrieved from the Taiwan Longitudinal Health Insurance Database. In total, 3399 cases of newly diagnosed SSNHL were identified. We used propensity score matching to select 3399 comparison patients (one for every case) from the same dataset. The selected matching variables included age, sex, monthly income, geographical location, urbanization level of the patient's residence, hypertension, diabetes, and hyperlipidemia. Chi-squared tests were used to compare differences in sociodemographic characteristics, while conditional logistic regression analyses were used to examine the association of SSNHL with previously diagnosed MVP. Of the 6798 sampled subjects, 131 (1.93%) patients had received a diagnosis of MVP prior to the index date. A significant difference in the prevalence of prior MVP between cases and controls (2.41% vs. 1.44%, p =0.004) was observed. The conditional logistic regression analysis conditioned on gender, age, monthly income, urbanization level, geographic region, hyperlipidemia, diabetes, and hypertension suggested that the odds ratio of prior MVP for cases was 1.69 (95% confidence interval (CI): 1.18-2.42) compared to controls. Our study found that patients with MVP had a 1.69-fold higher risk of getting SSNHL compared to patients without MVP.	[Cheng, Yen-Fu] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Cheng, Yen-Fu] Taipei Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Cheng, Yen-Fu] Natl Yang Ming Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Cheng, Yen-Fu] Natl Taipei Univ Nursing & Hlth Sci, Dept Speech Language & Audiol, Taipei, Taiwan; [Cheng, Yen-Fu; Lin, Herng-Ching] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan; [Yang, Tzong-Han; Wu, Chuan-Song] Taipei City Hosp, Dept Otolaryngol, Taipei, Taiwan; [Huang, Chung-Chien; Lin, Herng-Ching] Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; Taipei City Hospital; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan.; Lin, HC (corresponding author), Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan.	henry11111@tmu.edu.tw	Huang, CC/AAX-5872-2021	Huang, CC/0000-0003-0818-7175; Cheng, Yen-Fu/0000-0003-1995-5854				Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Calabrese V, 2010, NEUROCHEM RES, V35, P2208, DOI 10.1007/s11064-010-0304-2; CALTRIDER ND, 1980, AM J OPHTHALMOL, V90, P534, DOI 10.1016/S0002-9394(14)75024-X; Di Stadio A, 2017, J INT MED RES, V45, P1470, DOI 10.1177/0300060516688600; Freed LA, 1999, PREVALENCE CLIN OUTC; Graff J, 2005, SEMIN THROMB HEMOST, V31, P482, DOI 10.1055/s-2005-916685; Icli A, 2013, CLIN APPL THROMB-HEM, V19, P608, DOI 10.1177/1076029612461847; Le Tourneau T, 2018, HEART BRIT CARDIAC S, DOI [10.1136/heartjnl-2016-311028, DOI 10.1136/HEARTJNL-2016-311028]; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Levine RA, 2015, NAT REV CARDIOL, V12, P689, DOI 10.1038/nrcardio.2015.161; MAYAHARA T, 1972, LARYNGOSCOPE, V82, P578, DOI 10.1288/00005537-197204000-00003; Moulonguet H, 1985, Ann Otolaryngol Chir Cervicofac, V102, P415; Murillo-Cuesta S, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/fnagi.2015.00032, 10.5589/fnagi.2015.00032]; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Olivetto E, 2015, HEARING RES, V327, P58, DOI 10.1016/j.heares.2015.05.004; PERLOFF JK, 1987, AM HEART J, V113, P1324, DOI 10.1016/0002-8703(87)90961-6; PERLOFF JK, 1989, CIRCULATION, V80, P710, DOI 10.1161/01.CIR.80.3.710; Solanellas J, 1996, Ann Otolaryngol Chir Cervicofac, V113, P430; VANRHEE F, 1991, BRIT J OPHTHALMOL, V75, P436, DOI 10.1136/bjo.75.7.436; Vazquez R, 2008, INT J CARDIOL, V124, P370, DOI 10.1016/j.ijcard.2006.11.240; WALSH PN, 1981, CIRCULATION, V63, P552, DOI 10.1161/01.CIR.63.3.552; Walsh T, 2010, AM J HUM GENET, V87, P101, DOI 10.1016/j.ajhg.2010.05.011; Yoshikawa S, 2004, AURIS NASUS LARYNX, V31, P361, DOI 10.1016/j.anl.2004.07.007	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205199	10.1371/journal.pone.0205199	http://dx.doi.org/10.1371/journal.pone.0205199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286192	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500097
J	Mano, S; Nishihama, R; Ishida, S; Hikino, K; Kondo, M; Nishimura, M; Yamato, KT; Kohchi, T; Nakagawa, T				Mano, Shoji; Nishihama, Ryuichi; Ishida, Sakiko; Hikino, Kazumi; Kondo, Maki; Nishimura, Mikio; Yamato, Katsuyuki T.; Kohchi, Takayuki; Nakagawa, Tsuyoshi			Novel gateway binary vectors for rapid tripartite DNA assembly and promoter analysis with various reporters and tags in the liverwort Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GLYOXYSOMAL CITRATE SYNTHASE; GREEN FLUORESCENT PROTEIN; ARABIDOPSIS-THALIANA; GENE ORGANIZATION; PLASTID TRANSFORMATION; COMPLETE SEQUENCE; PLANT BIOLOGY; PEROXISOMES; CELLS	The liverwort Marchantia polymorpha is an emerging model species for basal lineage plant research. In this study, two Gateway cloning-compatible binary vector series, R4pMpGWB and R4L1pMpGWB, were generated to facilitate production of transgenic M. polymorpha. The R4pMpGWB series allows tripartite recombination of any promoter and any coding sequence with a specific reporter or tag. Reporters/tags for the R4pMpGWB series are GUS, ELuc(PEST), FLAG, 3xHA, 4xMyc, mRFP1, Citrine, mCitrine, ER-targeted mCitrine and nucleus-targeted mCitrine. The R4L1pMpGWB series is suitable for promoter analysis. R4L1 pMpGWB vector structure is the same as that of R4pMpGWB vectors, except that the attR2 site is replaced with attL1, enabling bipartite recombination of any promoter with a reporter or tag. Reporters/tags for the R4L1pMpGWB series are GUS, G3GFP-GUS, LUC, ELuc(PEST), Citrine, mCitrine, ER-targeted mCitrine and mCitrine-NLS. Both vector series were functional in M. polymorpha cells. These vectors will facilitate the design and assembly of plasmid constructs and generation of transgenic M. polymorpha.	[Mano, Shoji; Hikino, Kazumi; Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan; [Mano, Shoji] SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan; [Nishihama, Ryuichi; Ishida, Sakiko; Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Kondo, Maki] Natl Inst Basic Biol, Spectrog & Bioimaging Facil, NIBB Core Res Facil, Okazaki, Aichi, Japan; [Yamato, Katsuyuki T.] Kindai Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan; [Nakagawa, Tsuyoshi] Shimane Univ, Dept Mol & Funct Genom, Interdisciplinary Ctr Sci Res, Org Res, Matsue, Shimane, Japan; [Nishimura, Mikio] Konan Univ, Dept Biol, Fac Sci & Engn, Kobe, Hyogo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Shimane University; Konan University	Mano, S (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan.; Mano, S (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan.	mano@nibb.ac.jp	YAMATO, Katsuyuki T/Q-7263-2016	YAMATO, Katsuyuki T/0000-0002-7130-0911; Mano, Shoji/0000-0003-1323-3308; Nishimura, Mikio/0000-0001-7960-9721	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI] [26440157, 17K07457]; Japan Agency for Medical Research and development, AMED; NIBB Research Project for the Development of New Model Organisms	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); NIBB Research Project for the Development of New Model Organisms	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI Grant-in-Aid for Scientific Research (C) (grant Nos. 26440157 and 17K07457 to S.M), and Research Program on Hepatitis from Japan Agency for Medical Research and development, AMED, and NIBB Research Project for the Development of New Model Organisms.	Aboulela M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177889; Aboulela M, 2017, PLASMID, V92, P1, DOI 10.1016/j.plasmid.2017.05.001; Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Bowman JL, 2016, PLANT CELL PHYSIOL, V57, P257, DOI 10.1093/pcp/pcv193; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Chiyoda S, 2007, TRANSGENIC RES, V16, P41, DOI 10.1007/s11248-006-9027-1; Chiyoda S, 2014, METHODS MOL BIOL, V1132, P439, DOI 10.1007/978-1-62703-995-6_30; Chytilova E, 1999, ANN BOT-LONDON, V83, P645, DOI 10.1006/anbo.1999.0866; Era A, 2009, PLANT CELL PHYSIOL, V50, P1041, DOI 10.1093/pcp/pcp055; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Goto-Yamada S, 2015, PLANT CELL PHYSIOL, V56, P1264, DOI 10.1093/pcp/pcv081; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Higo A, 2016, PLANT CELL PHYSIOL, V57, P325, DOI 10.1093/pcp/pcw005; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2016, PLANT CELL PHYSIOL, V57, P262, DOI 10.1093/pcp/pcv097; Ishizaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138876; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kamada T, 2003, PLANT CELL PHYSIOL, V44, P1275, DOI 10.1093/pcp/pcg173; Kamigaki A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160717; KATO A, 1995, PLANT MOL BIOL, V27, P377, DOI 10.1007/BF00020191; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Mano S, 2011, PLANT CELL PHYSIOL, V52, P2157, DOI 10.1093/pcp/pcr147; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nakamura S, 2009, BIOSCI BIOTECH BIOCH, V73, P2556, DOI 10.1271/bbb.90720; Nishihama R, 2016, PLANT CELL PHYSIOL, V57, P271, DOI 10.1093/pcp/pcv102; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; Ogasawara Y, 2013, PLANT CELL ENVIRON, V36, P1520, DOI 10.1111/pce.12085; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Ridge RW, 1999, PLANT CELL PHYSIOL, V40, P1253, DOI 10.1093/oxfordjournals.pcp.a029513; Takenaka M, 2000, TRANSGENIC RES, V9, P179, DOI 10.1023/A:1008963410465; Tanaka D, 2016, PLANT CELL PHYSIOL, V57, P300, DOI 10.1093/pcp/pcv173; Tanaka Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1795, DOI 10.1271/bbb.130405; Tsuboyama S, 2014, PLANT CELL PHYSIOL, V55, P229, DOI 10.1093/pcp/pct168; Tsuboyama-Tanaka S, 2015, J PLANT RES, V128, P337, DOI 10.1007/s10265-014-0695-2; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204964	10.1371/journal.pone.0204964	http://dx.doi.org/10.1371/journal.pone.0204964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286137	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500067
J	Schifano, F; Chiappini, S				Schifano, Fabrizio; Chiappini, Stefania			Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports	PLOS ONE			English	Article							P-GLYCOPROTEIN; CARDIAC DYSRHYTHMIAS; ABUSE; MISUSE; DRUG; CARDIOMYOPATHY; INHIBITION; MEDICATION; TRENDS	Background Among over-the-counter (OTC) drugs, loperamide has recently emerged for its potential of misuse and cardiotoxicity issues. Hence, we aimed here at assessing the loperamiderelated cases being reported to the EMA's EudraVigilance (EV) database. Methods All spontaneous EV reports relating to loperamide misuse/abuse/dependence/withdrawal and cardiotoxicity issues were here retrieved, performing a descriptive analysis. Findings During the years 2005-2017, EV collected a number of 1,983 (out of a total of 7,895; 25.11%) loperamide-related misuse/abuse/dependence/withdrawal adverse drug reaction (ADR) reports, with a progressively increasing trend since 2014. Most cases were classified as drug use disorder (37.4%) or intentional overdose (25.4%). Loperamide was used on its own in 41.9% of cases; remaining, polydrug, cases included antidepressants; benzodiazepines; and other OTCs. Some 1,085 (1,085/7,895 = 13.7%) cardiovascular ADRs were reported, being conduction abnormalities and EKG alterations the most frequently identified. Conclusions EV data may support the levels of concern relating to loperamide potential of abuse and associated cardiotoxicity issues.	[Schifano, Fabrizio; Chiappini, Stefania] Univ Hertfordshire, Sch Life & Med Sci, Psychopharmacol Drug Misuse & Novel Psychoact Sub, Hatfield, Herts, England; [Chiappini, Stefania] Casa Cura Villa Rosa, Viterbo, VT, Italy	University of Hertfordshire	Chiappini, S (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Psychopharmacol Drug Misuse & Novel Psychoact Sub, Hatfield, Herts, England.; Chiappini, S (corresponding author), Casa Cura Villa Rosa, Viterbo, VT, Italy.	stefaniachiappini9@gmail.com	CHIAPPINI, STEFANIA/ABC-3831-2020	CHIAPPINI, STEFANIA/0000-0002-6810-1540; Schifano, Fabrizio/0000-0002-4178-5401				Akel T, 2018, ANN NONINVAS ELECTRO, V23, DOI 10.1111/anec.12505; Amin ML, 2013, DRUG TARGET INSIGHT, V7, P27, DOI 10.4137/DTI.S12519; [Anonymous], 2012, GREY PAGES MERITS HI; [Anonymous], 2016, NY TIMES; Baker DE, 2007, REV GASTROENTEROL DI, V7, pS11; Bhatti Z, 2017, CLIN TOXICOL, V55, P659, DOI 10.1080/15563650.2017.1304555; Bishop-Freeman SC, 2016, J ANAL TOXICOL, V40, P677, DOI 10.1093/jat/bkw069; Bluelight.org, LOP; Borron SW, 2017, J EMERG MED, V53, P73, DOI 10.1016/j.jemermed.2017.03.018; CHURCH J, 1994, MOL PHARMACOL, V45, P747; Cooper RJ, 2013, J SUBST USE, V18, P82, DOI 10.3109/14659891.2011.615002; Council of Europe, 2014, AG MED PROD MED DEV; Daniulaityte R, 2013, DRUG ALCOHOL DEPEN, V130, P241, DOI 10.1016/j.drugalcdep.2012.11.003; Drugs-forum, LOP; Eggleston W, 2016, MMWR-MORBID MORTAL W, V65, P1276, DOI 10.15585/mmwr.mm6545a7; Eggleston W, 2017, ANN EMERG MED, V69, P83, DOI 10.1016/j.annemergmed.2016.03.047; Eggleston W, 2015, CLIN TOXICOL, V53, P495, DOI 10.3109/15563650.2015.1026971; Eichenberg C, 2017, GESUNDHEITSWESEN, V79, P80, DOI 10.1055/s-0035-1549970; Enakpene EO, 2015, AM J MED, V128, P1083, DOI 10.1016/j.amjmed.2015.05.019; Erowid, 2016, LOP; Erowid, 2010, WOULDNT SAY THIS IS; Erowid, 2007, ABS AW LOP; Erowid, 2014, MY NEW FAV OTC HIGH; Erowid, 2012, REC WITHDR; EudraVigilance, EUR DAT SUSP ADV DRU; European Medicines Agency (EMA), 2015, BUYING MED ONL; Finch M., 2015, USE LOPERAMIDE OPIAT; Finkelstein Y, 2017, PEDIATR EMERG CARE, V33, P451, DOI 10.1097/PEC.0000000000000571; Food and Drug Administration, 2018, PUBL DASHB; Food and Drug Administration (FDA), 2016, IM LAB; Fox N, 2005, SOC SCI MED, V61, P1474, DOI 10.1016/j.socscimed.2005.03.011; Heads of Medicines Agencies (HMA) European Medicines Agency (EMA), 2017, GUID GOOD PHARM PRAC; JAFFE JH, 1980, CLIN PHARMACOL THER, V28, P812, DOI 10.1038/clpt.1980.239; Kang JS, 2016, N-S ARCH PHARMACOL, V389, P1133, DOI 10.1007/s00210-016-1286-7; Karami S., 2017, CLIN TOXICOL, V20, P1; Kozak PM, 2017, J ELECTROCARDIOL, V50, P355, DOI 10.1016/j.jelectrocard.2017.01.011; Lasoff DR, 2017, PHARMACOTHERAPY, V37, P249, DOI 10.1002/phar.1885; Le V.T., 2016, J AM COLL HEALTH, V16, P1; Leo RJ, 2017, J ADDICT MED, V11, P402, DOI 10.1097/ADM.0000000000000325; Levine DA, 2007, CURR OPIN PEDIATR, V19, P270, DOI 10.1097/MOP.0b013e32814b09cf; MacDonald R., 2015, BMJ CASE REP; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P287; Marraffa JM, 2014, CLIN TOXICOL, V52, P952, DOI 10.3109/15563650.2014.969371; MedDRA, 2017, INTR GUID VERS 20 1; MedDRA, 2017, INTR GUID STAND MEDD; Medicines and Healthcare products Regulatory Agency (MHRA), 2018, YELL CARD SCHEM LOP; Miller H, 2017, J AM PHARM ASSOC, V57, pS45, DOI 10.1016/j.japh.2016.12.079; Mukarram O, 2016, CASE REP MED, V2016, DOI 10.1155/2016/4061980; National Association of Boards of Pharmacy (NABP), 2012, INT DRUG OUTL ID PRO; Nguyen L, 2016, PHARMACOL THERAPEUT, V159, P1, DOI 10.1016/j.pharmthera.2016.01.016; Nielsen S, 2017, CURR TOP BEHAV NEURO, V34, P59, DOI 10.1007/7854_2015_422; Nozaki-Taguchi N, 1999, ANESTHESIOLOGY, V90, P225, DOI 10.1097/00000542-199901000-00029; Rasla Somwail, 2017, R I Med J (2013), V100, P33; Reeves RR, 2015, SOUTH MED J, V108, P151, DOI 10.14423/SMJ.0000000000000256; Riaz IB, 2017, AM J THER; Rose B.J., 2016, PHARM TODAY, P34; Schifano F, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00239; Stanciu CN, 2017, J PSYCHOACTIVE DRUGS, V49, P18, DOI 10.1080/02791072.2016.1260188; Swank KA, 2017, J AM PHARM ASSOC, V57, pS63, DOI 10.1016/j.japh.2016.11.011; U.S. Food and Drug Administration, 2020, FDA WARNS SER PROBL; Upadhyay A, 2016, CASE REP CARDIOL, V2016, DOI 10.1155/2016/5040176; Vakkalanka JP, 2017, ANN EMERG MED, V69, P73, DOI 10.1016/j.annemergmed.2016.08.444; Vaughn P, 2016, J CARDIOVASC ELECTR, V27, P1230, DOI 10.1111/jce.13052; Wightman RS, 2016, CLIN TOXICOL, V54, P454, DOI 10.3109/15563650.2016.1159310; Wright J, 2016, J PUBLIC HEALTH-UK, V38, P793, DOI 10.1093/pubmed/fdv169; Wu PE, 2017, ANN EMERG MED, V70, P245, DOI 10.1016/j.annemergmed.2017.04.008; Zaprutko T, 2016, HEALTH POLICY, V120, P875, DOI 10.1016/j.healthpol.2016.06.008; Zhang Y, 2013, BIOMED PHARMACOTHER, V67, P757, DOI 10.1016/j.biopha.2013.04.012; Zhou SF, 2004, DRUG METAB REV, V36, P57, DOI 10.1081/DMR-120028427	69	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204443	10.1371/journal.pone.0204443	http://dx.doi.org/10.1371/journal.pone.0204443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286103	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500021
J	Bouzouggar, A; Humphrey, LT; Barton, N; Parfitt, SA; Balzan, LC; Schwenninger, JL; El Hajraoui, MA; Nespoulet, R; Bello, SM				Bouzouggar, Abdeljalil; Humphrey, Louise T.; Barton, Nick; Parfitt, Simon A.; Balzan, Laine Clark; Schwenninger, Jean-Luc; El Hajraoui, Mohammed Abdeljalil; Nespoulet, Roland; Bello, Silvia M.			90,000 year-old specialised bone technology in the Aterian Middle Stone Age of North Africa	PLOS ONE			English	Article							MODERN HUMAN-BEHAVIOR; EL HARHOURA 2; SOUTH-AFRICA; SHELL BEADS; BLOMBOS CAVE; SIBUDU CAVE; ADDITIONAL EVIDENCE; UPPER PLEISTOCENE; CUT-MARKS; MOROCCO	The question of cognitive complexity in early Homo sapiens in North Africa is intimately tied to the emergence of the Aterian culture (similar to 145 ka). One of the diagnostic indicators of cognitive complexity is the presence of specialised bone tools, however significant uncertainty remains over the manufacture and use of these artefacts within the Aterian techno-complex. In this paper we report on a bone artefact from Aterian Middle Stone Age (MSA) deposits in Dar es-Soltan 1 cave on the Atlantic coast of Morocco. It comes from a layer that can be securely dated to similar to 90 ka. The typological characteristics of this tool, which suggest its manufacture and use as a bone knife, are comparatively similar to other bone artefacts from dated Aterian levels at the nearby site of El Mnasra and significantly different from any other African MSA bone technology. The new find from Dar es-Soltan 1 cave combined with those from El Mnasra suggest the development of a bone technology unique to the Aterian.	[Bouzouggar, Abdeljalil; El Hajraoui, Mohammed Abdeljalil] Rabat Inst, Madinat Al Irfane, Inst Natl Sci Archeol Patrimoine, Origin & Evolut Homo Sapiens Morocco Res Grp, Rabat, Morocco; [Bouzouggar, Abdeljalil] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Humphrey, Louise T.; Parfitt, Simon A.; Bello, Silvia M.] Nat Hist Museum, Dept Earth Sci, London, England; [Barton, Nick] Univ Oxford, Inst Archaeol, Oxford, England; [Parfitt, Simon A.] UCL, Inst Archaeol, Gordon Sq, London, England; [Balzan, Laine Clark] Albert Ludwigs Univ Freiburg, Sedimentary Geol & Quaternary Res, Freiburg, Germany; [Schwenninger, Jean-Luc] Univ Oxford, Luminescence Dating Lab, Res Lab Archaeol & Hist Art, Oxford, England; [Nespoulet, Roland] Musee Homme Paris, Museum Natl Hist Nat, UMR 7194, HNHP, Paris, France	Max Planck Society; Natural History Museum London; University of Oxford; University of London; University College London; University of Freiburg; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Bouzouggar, A (corresponding author), Rabat Inst, Madinat Al Irfane, Inst Natl Sci Archeol Patrimoine, Origin & Evolut Homo Sapiens Morocco Res Grp, Rabat, Morocco.; Bouzouggar, A (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.; Bello, SM (corresponding author), Nat Hist Museum, Dept Earth Sci, London, England.	abdeljalil_bouzouggar@eva.mpg.de; s.bello@nhm.ac.uk	Bello, Silvia/ABW-5535-2022; Bello, Silvia/GZK-9069-2022; Bouzouggar, Abdeljalil/AAD-3608-2022	Bouzouggar, Abdeljalil/0000-0002-4332-4385	University of Oxford; Calleva Foundation; Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine; Oxford University; Institut National des Sciences de l'Archeologie et du Patrimoine, Rabat	University of Oxford; Calleva Foundation; Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine; Oxford University; Institut National des Sciences de l'Archeologie et du Patrimoine, Rabat	Excavations at Dar es-Soltan were supported by Institut National des Sciences de l'Archeologie et du Patrimloine, Rabat, Morocco, University of Oxford (Fell Fund) and Calleva Foundation. The study of the bone tool was supported by the Calleva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research program at Dar es-Soltan 1 cave is jointly conducted and supported by the Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine, and the University of Oxford. We thank Simon Collcutt for his lithostratigraphic description and interpretation of the cave sediment taphonomy and Cath Price for her expert processing and sorting of the micro-vertebrate samples, Lu-Allington-Jones and Arianna Bernucci for preparation and conservation of the bone tool, Laura Buck for CT-scanning the bone tool, Shaymae Iken for providing fauna information, Michel Grenet for the lithic drawings and Julia Galway-Witham for assistance. Excavations at Dar es-Soltan and study of the bone tool were supported by the Calleva Foundation. Additional funding for the excavations came from Oxford University (Fell Fund) and the Institut National des Sciences de l'Archeologie et du Patrimoine, Rabat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS P, 1985, MAN, V20, P675, DOI 10.2307/2802756; Arrighi S, 2016, QUATERN INT, V423, P143, DOI 10.1016/j.quaint.2015.11.114; Backwell LR., 2014, ENCY GLOBAL ARCHAEOL, P950, DOI [10.1007/978-1-4419-0465-2_702, DOI 10.1007/978-1-4419-0465-2_702]; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Backwell L, 2016, VERTEBR PALEOBIOL PA, P15, DOI 10.1007/978-94-024-0899-7_2; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Bello SM, 2013, J ARCHAEOL SCI, V40, P2464, DOI 10.1016/j.jas.2012.12.016; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Bello SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182127; Bello SM, 2006, AM J PHYS ANTHROPOL, V129, P24, DOI 10.1002/ajpa.20243; Boulestin B, 1999, BRIT ARCHAEOLOGICAL, V776, P398; Bouzouggar A., 2012, MODERN ORIGINS N AFR, P93; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V65, P359, DOI 10.1002/ajpa.1330650404; Campmas E, 2016, QUATERN INT, V413, P5, DOI 10.1016/j.quaint.2015.11.136; Campmas E, 2015, J HUM EVOL, V78, P122, DOI 10.1016/j.jhevol.2014.08.008; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F., 1993, OXFORD J ARCHAEOL, V12, P145; d'Errico F, 2008, J ARCHAEOL SCI, V35, P2675, DOI 10.1016/j.jas.2008.04.023; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Debenath A, 2000, ANTHROPOLOGIE, V104, P131; Debenath A, 2012, PREHISTORIE REGION R, VIII, P179; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; El Hajraoui MA, 1994, PREHISTOIRE ANTHR ME, V3, P91; Greenfield HJ, 1999, J ARCHAEOL SCI, V26, P797, DOI 10.1006/jasc.1998.0348; Hallett-Desguez E, 2014, PALEOANTHROPOLOGY, pA10; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Hublin J.J., 2001, HUMAN ROOTS AFRICA A, P99; Idrissi NJ, 2012, QUATERNAIRE, V23, P25; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; MOREL J, 1974, ANTHROPOLOGIE, V78, P53; Oudouche H, 2012, VILLES SITES ARCHEOL, VIII, P191; Ruhlmann A., 1951, COLLECTION HESPERIS, P210; Schwenninger J.L., 2010, S E MEDITERRANEAN PE, P18; SHIPMAN P, 1981, ANN NY ACAD SCI, V376, P357, DOI 10.1111/j.1749-6632.1981.tb28179.x; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Wadley L, 2010, CURR ANTHROPOL, V51, pS111, DOI 10.1086/649836; White T.D., 1992, PREHISTORIC CANNIBAL; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100; Zou Y, 2004, PHYS MED BIOL, V49, P2365, DOI 10.1088/0031-9155/49/11/017	49	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202021	10.1371/journal.pone.0202021	http://dx.doi.org/10.1371/journal.pone.0202021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281602	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400010
J	Kim, JH; Baek, MJ; Sun, HY; Lee, B; Li, SF; Khandwala, Y; Del Giudice, F; Chung, BI				Kim, Jae Heon; Baek, Min Jung; Sun, Hwa Yeon; Lee, Bora; Li, Shufeng; Khandwala, Yash; Del Giudice, Francesco; Chung, Benjamin, I			Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; SEXUAL DYSFUNCTION; 5-ALPHA-REDUCTASE INHIBITORS; COMBINATION THERAPY; CLINICAL-TRIALS; MEN; FINASTERIDE; DUTASTERIDE; HIPPOCAMPUS; DEPRESSION	Background Although combination therapy with 5 alpha-reductase inhibitor (5ARI) and alpha-blocker is one of the standard interventions in symptomatic benign prostatic hyperplasia (BPH), 5ARI monotherapy is seldom the focus of attention. Adverse events associated with 5ARI include depression and suicidal attempts in addition to persistent erectile dysfunction. The aim of this study is to update our knowledge of clinical efficacy and incidence of adverse events associated with 5ARI treatment in symptomatic BPH. Methods and findings A meta-analysis of randomized controlled clinical trials (RCTs) from 1966 until March, 2017 was performed using database from PubMed, Cochrane Collaboration and Embase. A total of 23395 patients were included in this study and the inclusion criteria were: RCTs with 5ARI and placebo in symptomatic BPH patients. Parameters included prostate specific antigen (PSA), prostate volume (PV), International Prostate Symptom Score (IPPS), post-void residual urine (PVR), voiding symptoms of IPSS (voiding IPSS), maximum urinary flow rate (Qmax), and adverse events (AEs). A meta-analysis with meta-regression was performed for each effect size and adverse events, sensitivity analysis, cumulative analysis along with the analysis of ratio of means (ROM) in the placebo group. A total of 42 studies were included in this study for review, and a total of 37 studies were included in the meta-analysis, including a total of 23395 patients (treatment group: 11392, placebo group: 12003). The effect size of all variables except PVR showed a significant improvement following 5ARI treatment compared with placebo. However, the effect size of differences showed declining trend in PV, IPSS and Qmax according to recent years of publication. In ROM analysis, PV showed no significant increase in the placebo group, with a ROM of 1.00 (95% CI, 0.88, 1.14). The 5ARI treatment resulted in a significantly higher incidence of decreased libido (OR = 1.7; 95% CI, 1.36, 2.13), ejaculatory disorder (OR = 2.94; 95% CI, 2.15, 4.03), gynecomastia (OR = 2.32; 95% CI, 1.41, 3.83), and impotence (OR = 1.74; 95% CI, 1.32, 2.29). Our study has the following limitations: included studies were heterogeneous and direct comparison of efficacy between alpha blocker and 5ARI was not performed. Adverse events including depression or suicidal attempt could not be analyzed in this meta-analysis setting. Conclusions Although there was a significant clinical benefit of 5ARI monotherapy compared with placebo, the effective size was small. Moreover, the risk of adverse events including sexually related complications were high. Additional head-to-head studies are needed to re-evaluate the clinical efficacy of 5ARI compared with alpha-adrenergic receptor blockers.	[Kim, Jae Heon; Khandwala, Yash; Chung, Benjamin, I] Stanford Univ, Med Ctr, Div Cardiol, Stanford, CA 94305 USA; [Kim, Jae Heon; Sun, Hwa Yeon] Soonchuhyang Univ, Soonchunhyang Univ Hosp, Dept Urol, Med Coll, Seoul, South Korea; [Baek, Min Jung] CHA Bundang Med Ctr, Dept Obstet & Gynecol, Seongnam, South Korea; [Lee, Bora] Chung Ang Univ, Dept Stat, Grad Sch, Seoul, South Korea; [Li, Shufeng] Stanford Univ, Med Ctr, Dept Urol & Dermatol, Stanford, CA 94305 USA; [Khandwala, Yash] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Del Giudice, Francesco] Sapienza Univ Rome, Dept Urol, Rome, Italy	Stanford University; Soonchunhyang University; Soonchunhyang University Hospital; Chung Ang University; Stanford University; University of California System; University of California San Diego; Sapienza University Rome	Kim, JH (corresponding author), Stanford Univ, Med Ctr, Div Cardiol, Stanford, CA 94305 USA.; Kim, JH (corresponding author), Soonchuhyang Univ, Soonchunhyang Univ Hosp, Dept Urol, Med Coll, Seoul, South Korea.; Lee, B (corresponding author), Chung Ang Univ, Dept Stat, Grad Sch, Seoul, South Korea.	piacekjh@hanmail.net; mintbora0125@gmail.com	Del Giudice, Francesco/ABF-8842-2021	Lee, Bora/0000-0002-6322-5712; Chung, Benjamin/0000-0001-9660-2732; Kim, Jae Heon/0000-0002-4490-3610; DEL GIUDICE, FRANCESCO/0000-0003-3865-5988	Soonchunhyang University Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007357] Funding Source: NIH RePORTER	Soonchunhyang University Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Soonchunhyang University Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Belknap SM, 2015, JAMA DERMATOL, V151, P600, DOI 10.1001/jamadermatol.2015.36; Budoff MJ, 2017, JAMA-J AM MED ASSOC, V317, P708, DOI 10.1001/jama.2016.21043; Corona G, 2017, ANDROLOGY-US, V5, P671, DOI 10.1111/andr.12353; Corona G, 2012, J ENDOCRINOL INVEST, V35, P915, DOI 10.3275/8510; Debruyne F, 2004, EUR UROL, V46, P488, DOI 10.1016/j.eururo.2004.05.008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Faraone Stephen V, 2008, P T, V33, P700; Feng Y, 2015, MEDICINE, V94, DOI [10.1097/MD.0000000000000974, 10.1097/MD.0000000000001973]; Finn DA, 2004, PHARMACOL BIOCHEM BE, V78, P435, DOI 10.1016/j.pbb.2004.04.016; Friedrich JO, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-32; Frye CA, 2002, HORM BEHAV, V41, P306, DOI 10.1006/hbeh.2002.1763; Fullhase C, 2015, CURR OPIN UROL, V25, P19, DOI 10.1097/MOU.0000000000000126; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Fusco F, 2018, NEUROUROL URODYNAM, V37, P1865, DOI 10.1002/nau.23554; Fusco F, 2015, WORLD J UROL, V33, P685, DOI 10.1007/s00345-014-1460-9; Goldstein I, 2011, J SEX MED, V8, P1829, DOI 10.1111/j.1743-6109.2011.02368.x; Gur S, 2013, EXPERT OPIN DRUG SAF, V12, P81, DOI 10.1517/14740338.2013.742885; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Irwig MS, 2012, J CLIN PSYCHIAT, V73, P1220, DOI 10.4088/JCP.12m07887; Jacobsen SJ, 1996, J UROLOGY, V155, P595, DOI 10.1016/S0022-5347(01)66461-9; Loeb S, 2008, J UROLOGY, V180, P1314, DOI 10.1016/j.juro.2008.06.033; Loeb S, 2009, J UROLOGY, V182, P1458, DOI 10.1016/j.juro.2009.06.047; McConnell JD, 1998, NEW ENGL J MED, V338, P557, DOI 10.1056/NEJM199802263380901; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McVary KT, 2006, AM J MANAG CARE, V12, pS122; Rhodes ME, 2001, COGN AFFECT BEHAV NE, V1, P287, DOI 10.3758/CABN.1.3.287; Roehrborn CG, 2002, UROLOGY, V60, P434, DOI 10.1016/S0090-4295(02)01905-2; Roehrborn CG, 2008, J UROLOGY, V179, P616, DOI 10.1016/j.juro.2007.09.084; Tacklind J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006015.pub3; Traish AM, 2011, J SEX MED, V8, P872, DOI 10.1111/j.1743-6109.2010.02157.x; Trost Landon, 2013, Sex Med Rev, V1, P24, DOI 10.1002/smrj.3; Welk B, 2017, JAMA INTERN MED, V177, P683, DOI 10.1001/jamainternmed.2017.0089	35	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203479	10.1371/journal.pone.0203479	http://dx.doi.org/10.1371/journal.pone.0203479			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281615	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400022
J	Meyer, C; Bowers, A; Wayant, C; Checketts, J; Scott, J; Musuvathy, S; Vassar, M				Meyer, Chase; Bowers, Aaron; Wayant, Cole; Checketts, Jake; Scott, Jared; Musuvathy, Sanjeev; Vassar, Matt			Scientific evidence underlying the American College of Gastroenterology's clinical practice guidelines	PLOS ONE			English	Article							DIGESTIVE DISEASES; RECOMMENDATIONS; CHALLENGES; WASTE	Background Clinical practice guidelines contain recommendations for physicians to determine the most appropriate care for patients. These guidelines systematically combine scientific evidence and clinical judgment, culminating in recommendations intended to optimize patient care. The recommendations in CPGs are supported by evidence which varies in quality. We aim to survey the clinical practice guidelines created by the American College of Gastroenterology, report the level of evidence supporting their recommendations, and identify areas where evidence can be improved with additional research. Methods We extracted 1328 recommendations from 39 clinical practice guidelines published by the American College of Gastroenterology. Several of the clinical practice guidelines used the differing classifications of evidence for their recommendations. To standardize our results, we devised a uniform system for evidence. Results A total of 39 clinical practice guidelines were surveyed in our study. Together they account for 1328 recommendations. 693 (52.2%) of the recommendations were based on low evidence, indicating poor evidence or expert opinion. Among individual guidelines, 13/39 (33.3%) had no recommendations based on high evidence. Conclusion Very few recommendations made by the American College of Gastroenterology are supported by high levels of evidence. More than half of all recommendations made by the American College of Gastroenterology are based on low-quality evidence or expert opinion.	[Meyer, Chase; Bowers, Aaron; Wayant, Cole; Checketts, Jake; Scott, Jared; Musuvathy, Sanjeev; Vassar, Matt] Oklahoma State Univ, Ctr Hlth Sci, Tulsa, OK 74106 USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences	Bowers, A (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Tulsa, OK 74106 USA.	Aaron.Bowers@okstate.edu	Meyer, Chase/AAG-1081-2022; Meyer, Chase/AFK-2760-2022; Wayant, Cole/X-3972-2018; Meyer, Chase/R-7291-2019; Vassar, Matt/AAD-5385-2020	Wayant, Cole/0000-0001-8829-8179; Vassar, Ben Matthew/0000-0003-2859-6152				American College of Gastroenterology, CLIN GUID; American College of Gastroenterology, 2017, CLIN GUID SORT LIST; [Anonymous], RES AW; [Anonymous], UNN OV MED CAR CAUS; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Duenas M, 2018, PAIN PRACT, V18, P38, DOI 10.1111/papr.12579; Elmunzer BJ, 2015, GASTROENTEROLOGY, V149, P521, DOI 10.1053/j.gastro.2015.07.022; Everhart JE, 2009, GASTROENTEROLOGY, V136, P376, DOI 10.1053/j.gastro.2008.12.015; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Heath I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2254; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; James SP, 2007, GASTROENTEROLOGY, V132, P1219, DOI 10.1053/j.gastro.2007.02.025; Koh C, 2013, HEPATOLOGY, V58, P2142, DOI 10.1002/hep.26578; Marras TK, 2015, RESPIROLOGY, V20, P348, DOI 10.1111/resp.12440; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037413; Pl Y., 2011, HEALTHCARE IMPERATIV; Shah S, 2014, CHEST J, V146, p821A, DOI DOI 10.1378/CHEST.1995242; Silberstein SD, 2005, CEPHALALGIA, V25, P765, DOI 10.1111/j.1468-2982.2005.01014.x; Szentesi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165244; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Venkatesh AK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178456; Wright JD, 2011, OBSTET GYNECOL, V118, P505, DOI 10.1097/AOG.0b013e3182267f43; Yang VW, 2007, GASTROENTEROLOGY, V133, P1761, DOI 10.1053/j.gastro.2007.08.065	25	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204720	10.1371/journal.pone.0204720	http://dx.doi.org/10.1371/journal.pone.0204720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281671	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400055
J	Starlard-Davenport, A; Allman, R; Dite, GS; Hopper, JL; Tuff, ES; Macleod, S; Kadlubar, S; Preston, M; Henry-Tillman, R				Starlard-Davenport, Athena; Allman, Richard; Dite, Gillian S.; Hopper, John L.; Tuff, Erika Spaeth; Macleod, Stewart; Kadlubar, Susan; Preston, Michael; Henry-Tillman, Ronda			Validation of a genetic risk score for Arkansas women of color	PLOS ONE			English	Article							BREAST-CANCER RISK; GENOME-WIDE ASSOCIATION; AFRICAN-AMERICAN; SUSCEPTIBILITY LOCI; PREDICTION; MODEL; GAIL; SUBTYPES; RACE	African American women in the state of Arkansas have high breast cancer mortality rates. Breast cancer risk assessment tools developed for African American underestimate breast cancer risk. Combining African American breast cancer associated single-nucleotide polymorphisms (SNPs) into breast cancer risk algorithms may improve individualized estimates of a woman's risk of developing breast cancer and enable improved recommendation of screening and chemoprevention for women at high risk. The goal of this study was to confirm with an independent dataset consisting of Arkansas women of color, whether a genetic risk score derived from common breast cancer susceptibility SNPs can be combined with a clinical risk estimate provided by the Breast Cancer Risk Assessment Tool (BCRAT) to produce a more accurate individualized breast cancer risk estimate. A population-based cohort of African American women representative of Arkansas consisted of 319 cases and 559 controls for this study. Five-year and lifetime risks from the BCRAT were measured and combined with a risk score based on 75 independent susceptibility SNPs in African American women. We used the odds ratio (OR) per adjusted standard deviation to evaluate the improvement in risk estimates produced by combining the polygenic risk score (PRS) with 5-year and lifetime risk scores estimated using BCRAT. For 5-year risk OR per standard deviation increased from 1.84 to 2.08 with the addition of the polygenic risk score and from 1.79 to 2.07 for the lifetime risk score. Reclassification analysis indicated that 13% of cases had their 5-year risk increased above the 1.66% guideline threshold (NRI = 0.020 (95% CI -0.040, 0.080)) and 6.3% of cases had their lifetime risk increased above the 20% guideline threshold by the addition of the polygenic risk score (NRI = 0.034 (95% CI 0.000, 0.070)). Our data confirmed that discriminatory accuracy of BCRAT is improved for African American women in Arkansas with the inclusion of specific SNP breast cancer risk alleles.	[Starlard-Davenport, Athena] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Allman, Richard] Genet Technol Ltd, Fitzroy, Vic, Australia; [Dite, Gillian S.; Hopper, John L.] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Tuff, Erika Spaeth] Phenogen Sci Inc, Charlotte, NC USA; [Macleod, Stewart] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Genom Core, Little Rock, AR 72205 USA; [Kadlubar, Susan] Univ Arkansas Med Sci, Div Med Genet, Little Rock, AR 72205 USA; [Preston, Michael] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Ctr Divers Affairs & Inclus, Little Rock, AR 72205 USA; [Henry-Tillman, Ronda] Univ Arkansas Med Sci, Coll Med, Dept Surg, Little Rock, AR 72205 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Melbourne; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Starlard-Davenport, A (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Genet Genom & Informat, Memphis, TN 38163 USA.	astarlar@uthsc.edu	Starlard-Davenport, Athena/Q-3866-2017	Starlard-Davenport, Athena/0000-0002-8938-237X; Spaeth, Erika/0000-0002-5397-3493; Allman, Richard/0000-0002-8635-5237	Genetic Technologies Ltd.	Genetic Technologies Ltd.	A. Starlard-Davenport and R. Henry-Tillman report receiving commercial research support from Genetic Technologies Ltd. who provided support in the form of salaries for author AS-D, but did not have any additional role in the study design, data collection and analysis, or decision to publish. Phenogen Sciences Inc. did not provide any financial support, but did have an additional role in preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams-Campbell LL, 2007, BREAST J, V13, P332, DOI 10.1111/j.1524-4741.2007.00439.x; Adams-Campbell LL, 2009, BREAST J, V15, pS72, DOI 10.1111/j.1524-4741.2009.00824.x; Allman R, 2015, BREAST CANCER RES TR, V154, P583, DOI 10.1007/s10549-015-3641-7; Bondurant KL, 2011, BREAST J, V17, P281, DOI 10.1111/j.1524-4741.2011.01082.x; Brentnall AR, 2013, J GENET SYNDR GENE T, V4, P202; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Comen E, 2011, BREAST CANCER RES TR, V127, P479, DOI 10.1007/s10549-010-1215-2; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Dite GS, 2016, CANCER EPIDEM BIOMAR, V25, P359, DOI 10.1158/1055-9965.EPI-15-0838; Dite GS, 2013, BREAST CANCER RES TR, V139, P887, DOI 10.1007/s10549-013-2610-2; Dite GS, 2003, J NATL CANCER I, V95, P448, DOI 10.1093/jnci/95.6.448; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Feng Y, 2017, CANCER EPIDEM BIOMAR, V26, P1016, DOI [10.1158/1055-9965.EPI-16-0567, 10.1158/1055-9965.epi-16-0567]; Feng Y, 2014, HUM MOL GENET, V23, P5518, DOI 10.1093/hmg/ddu252; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Hopper JL, 2015, AM J EPIDEMIOL, V182, P863, DOI 10.1093/aje/kwv193; Maas P, 2016, JAMA ONCOL; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Murphy ME, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0007-9; Palmer JR, 2013, CANCER EPIDEM BIOMAR, V22, P127, DOI 10.1158/1055-9965.EPI-12-0769; Perez CA, 2013, BREAST CANCER RES TR, V139, P497, DOI 10.1007/s10549-013-2550-x; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Society AC, 2016, CANC FACTS FIG FRIC; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; StataCorp, 2013, STATA STAT SOFTW REL; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204834	10.1371/journal.pone.0204834	http://dx.doi.org/10.1371/journal.pone.0204834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281645	Green Published, gold			2022-12-27	WOS:000446342400061
J	Leon, I; Tascon, L; Ortells-Pareja, JJ; Cimadevilla, JM				Leon, Irene; Tascon, Laura; Jose Ortells-Pareja, Juan; Manuel Cimadevilla, Jose			Virtual reality assessment of walking and non-walking space in men and women with virtual reality-based tasks	PLOS ONE			English	Article							SPATIAL MEMORY ALTERATIONS; TEMPORAL-LOBE EPILEPSY; GENDER-DIFFERENCES; SEX-DIFFERENCES; RECOGNITION; PLACE; ORIENTATION; HIPPOCAMPUS; STRATEGIES; CHILDREN	Far space and near space refer to different spatial features in which we unfold our behaviour. On the one hand, classical visuospatial neuropsychological tests assess spatial abilities in the near space; on the other, far space typically involves new spatial memory tasks in which participants display their behaviour in an environment, either interacting with objects or searching for targets. The Boxes Room Task is a virtual test that assesses spatial memory in the far space. Based upon this task, a new test was developed in which participants could not move about within the context, but they could actually perceive it from a specific viewpoint. In this work, both versions of the task were compared with one another. Furthermore, they were also compared with the results of 10/36 spatial recall test, a task assessing spatial memory in the near space. Two conditions were applied in all tasks, both in stable and rotated contexts. Our study included one hundred and twenty healthy young participants who were divided into two groups. The first group performed the Walking Space Boxes Room Task. A second group performed the Non-Walking Space Boxes Room Task as well as another traditional neuropsychological test for near space assessment, the 10/36 spatial recall test. Results proved that orientation in the non-walking space was more difficult than in the walking space. Additionally, our test also showed that men outperformed women in both virtual reality-based tasks, although they did not do it in the traditional 10/36 spatial recall test. In short, this work exposes that virtual-reality technologies provide tools to assess spatial memory, being more sensitive than traditional tests in the detection of small performance changes.	[Leon, Irene; Tascon, Laura; Jose Ortells-Pareja, Juan; Manuel Cimadevilla, Jose] Univ Almeria, Dept Psychol, Almeria, Spain	Universidad de Almeria	Cimadevilla, JM (corresponding author), Univ Almeria, Dept Psychol, Almeria, Spain.	cimadevilla@ual.es	leon, i/GZL-2093-2022; Leon, Irene/AAJ-6829-2020; Tascón, Laura/K-8748-2014; Cimadevilla, Jose Manuel/K-3249-2014	Leon, Irene/0000-0002-3558-8831; Tascón, Laura/0000-0003-3656-699X; Cimadevilla, Jose Manuel/0000-0002-0557-5546	MINECO [PSI2015-67442-P]; Ministry of Education, Culture and Sport of Spain [FPU2013/02655]	MINECO(Spanish Government); Ministry of Education, Culture and Sport of Spain(Spanish Government)	Authors declare no conflict of interest. This investigation was supported by MINECO (PSI2015-67442-P) and by the Ministry of Education, Culture and Sport of Spain [FPU2013/02655].	Amorim MA, 2003, VIS COGN, V10, P157, DOI 10.1080/13506280244000078; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Brain WR, 1941, BRAIN, V64, P244, DOI 10.1093/brain/64.4.244; Canovas R, 2008, BEHAV BRAIN RES, V190, P112, DOI 10.1016/j.bbr.2008.02.024; Canovas R, 2011, BEHAV BRAIN RES, V216, P116, DOI 10.1016/j.bbr.2010.07.026; Canovas R, 2009, RHEUMATOLOGY, V48, P1273, DOI 10.1093/rheumatology/kep218; Chua KP, 2003, PERCEPT PSYCHOPHYS, V65, P72, DOI 10.3758/BF03194784; Cimadevilla JM, 2001, BEHAV NEUROSCI, V115, P695, DOI 10.1037//0735-7044.115.3.695; Cimadevilla JM, 1999, BEHAV PROCESS, V46, P159, DOI 10.1016/S0376-6357(99)00034-0; Coluccia E, 2004, J ENVIRON PSYCHOL, V24, P329, DOI 10.1016/j.jenvp.2004.08.006; DOHLER KD, 1984, PROG BRAIN RES, V61, P99; Gerstenecker A, 2016, INT J GERIATR PSYCH, V31, P410, DOI 10.1002/gps.4346; Gorski R A, 1973, Prog Brain Res, V39, P149; Igloi K, 2009, HIPPOCAMPUS, V19, P1199, DOI 10.1002/hipo.20595; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Leon I, 2016, BEHAV BRAIN RES, V306, P8, DOI 10.1016/j.bbr.2016.03.008; Leon I, 2014, NEUROPSYCHOLOGY, V28, P485, DOI 10.1037/neu0000054; Cimadevilla JM, 2014, EPILEPTIC DISORD, V16, P203, DOI 10.1684/epd.2014.0661; Nemmi F, 2013, NEUROPSYCHOLOGIA, V51, P1561, DOI 10.1016/j.neuropsychologia.2013.03.031; Nori R, 2015, COMPUT HUM BEHAV, V48, P72, DOI 10.1016/j.chb.2015.01.035; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Persson J, 2013, BEHAV BRAIN RES, V256, P219, DOI 10.1016/j.bbr.2013.07.050; Piccardi L, 2014, NEUROSCI LETT, V566, P226, DOI 10.1016/j.neulet.2014.03.005; Piccardi L, 2011, LEARN INDIVID DIFFER, V21, P114, DOI 10.1016/j.lindif.2010.11.003; Piccardi L, 2010, EXP BRAIN RES, V206, P171, DOI 10.1007/s00221-010-2234-2; Postma A, 1999, PSYCHONEUROENDOCRINO, V24, P175, DOI 10.1016/S0306-4530(98)00073-0; Canovas MR, 2011, PSICOTHEMA, V23, P752; Rosas K, 2013, EPILEPSY BEHAV, V28, P227, DOI 10.1016/j.yebeh.2013.05.010; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; Tascon L, 2016, LEARN INDIVID DIFFER, V50, P270, DOI 10.1016/j.lindif.2016.08.007; Wolbers T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00571	31	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204995	10.1371/journal.pone.0204995	http://dx.doi.org/10.1371/journal.pone.0204995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278083	gold, Green Published, Green Submitted			2022-12-27	WOS:000446010200032
J	Biswal, MR; Justis, BD; Han, PY; Li, H; Gierhart, D; Dorey, CK; Lewin, AS				Biswal, Manas R.; Justis, Bradley D.; Han, Pingyang; Li, Hong; Gierhart, Dennis; Dorey, Cheryl K.; Lewin, Alfred S.			Daily zeaxanthin supplementation prevents atrophy of the retinal pigment epithelium (RPE) in a mouse model of mitochondrial oxidative stress	PLOS ONE			English	Article							MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; CHOROIDAL NEOVASCULARIZATION; BETA-CAROTENE; RAT MODEL; HUMAN EYE; AGE; LUTEIN; CELLS; ACCUMULATION	Oxidative damage is implicated in the pathogenesis of age-related macular degeneration (AMD). The dry form of AMD (geographic atrophy) is characterized by loss of RPE, photoreceptors, and macular pigments. The cumulative effects of oxidative stress impact mitochondrial function in RPE. In Sod2(flox/flox)VMD2-cre mice, the RPE specific deletion of Sod2, the gene for mitochondrial manganese superoxide dismutase (MnSOD), leads to elevated oxidative stress in retina and RPE, and causes changes in the RPE and underlying Bruch's membrane that share some features of AMD. This study tested the hypothesis that zeaxanthin supplementation would reduce oxidative stress and preserve RPE structure and function in these mice. Zeaxanthin in retina/RPE/choroid and liver was quantified by LC/MS, retinal function and structure were evaluated by electroretinogram (ERG) and spectral domain optical coherence tomography (SD-OCT), and antioxidant gene expression was measured by RT-PCR. After one month of supplementation, zeaxanthin levels were 5-fold higher in the retina/RPE/choroid and 12-fold higher in liver than in unsupplemented control mice. After four months of supplementation, amplitudes of the ERG a-wave (function of rod photoreceptors) and b-wave (function of the inner retina) were not different in supplemented and control mice. In contrast, the c-wave amplitude (a measure of RPE function) was 28% higher in supplemented mice than in control mice. Higher RPE/choroid expression of antioxidant genes (Cat, Gstm1, Hmox1, Nqo1) and scaffolding protein Sqstm1 were found in supplemented mice than in unsupplemented controls. Reduced nitrotyrosine content in the RPE/choroid was demonstrated by ELISA. Preliminary assessment of retinal ultrastructure indicated that supplementation supported better preservation of RPE structure with more compact basal infoldings and intact mitochondria. We conclude that daily zeaxanthin supplementation protected RPE cells from mitochondrial oxidative stress associated with deficiency in the MnSOD and thereby improved RPE function early in the disease course.	[Biswal, Manas R.; Justis, Bradley D.; Han, Pingyang; Li, Hong; Lewin, Alfred S.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Biswal, Manas R.; Lewin, Alfred S.] Univ Florida, Ctr Vis Res, Gainesville, FL 32611 USA; [Biswal, Manas R.] Univ S Florida, Coll Pharm, Tampa, FL 33620 USA; [Gierhart, Dennis] ZeaVision, Chesterfield, MO USA; [Dorey, Cheryl K.] Virginia Tech Carilion Sch Med, Roanoke, VA USA; [Lewin, Alfred S.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Biswal, MR (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.; Biswal, MR (corresponding author), Univ Florida, Ctr Vis Res, Gainesville, FL 32611 USA.; Biswal, MR (corresponding author), Univ S Florida, Coll Pharm, Tampa, FL 33620 USA.	biswal@ufl.edu		Biswal, Manas/0000-0002-9685-2923; Lewin, Alfred/0000-0002-4192-9727	National Eye Institute (NEI) [R01EY020825, R01EY026268, 1K99EY027013]; NEI core grant [P30 EY02172]; ZeaVision LLC; Bright Focus Foundation; Shaler Richardson Professorship endowment; NATIONAL EYE INSTITUTE [R01EY026268] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI core grant; ZeaVision LLC; Bright Focus Foundation(BrightFocus Foundation); Shaler Richardson Professorship endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants from the National Eye Institute (NEI) (R01EY020825 [ASL]; R01EY026268 [ASL]; 1K99EY027013 [MRB]), an NEI core grant to the University of Florida (P30 EY02172 [ASL]), a pilot grant from ZeaVision LLC (MRB), a grant from Bright Focus Foundation (ASL & MRB) and the Shaler Richardson Professorship endowment (ASL). None of the funding organization had any role in the design, data collection, analysis or preparation of the manuscript for publication. The funder provided support in the form of salaries for authors [MRB, ASL, HL, PH] and resources for research, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D, 1998, Angiogenesis, V2, P93, DOI 10.1023/A:1009010628371; Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Bernstein PS, 1998, INVEST OPHTH VIS SCI, V39, P2003; Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954; Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200; Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024; Biswal MR, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-21272; Biswal MR, 2015, EXP EYE RES, V140, P94, DOI 10.1016/j.exer.2015.07.022; Brightfocus Foundation, 2016, FACTS FIG; Chew EY, 2014, JAMA OPHTHALMOL, V132, P142, DOI 10.1001/jamaophthalmol.2013.7376; Chew EY, 2013, OPHTHALMOLOGY, V120, P1604, DOI 10.1016/j.ophtha.2013.01.021; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; Ding JD, 2015, AM J PATHOL, V185, P29, DOI 10.1016/j.ajpath.2014.08.026; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Guo JH, 2016, CHEM RES TOXICOL, V29, P2125, DOI 10.1021/acs.chemrestox.6b00233; Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Leung IYF, 2004, INVEST OPHTH VIS SCI, V45, P3244, DOI 10.1167/iovs.02-1233; Li BX, 2017, EXP EYE RES, V159, P123, DOI 10.1016/j.exer.2017.02.016; Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mao HY, 2014, INVEST OPHTH VIS SCI, V55, P4613, DOI 10.1167/iovs.14-14633; Murdaugh LS, 2010, EXP EYE RES, V90, P564, DOI 10.1016/j.exer.2010.01.014; Olchawa MM, 2017, FREE RADICAL RES, V51, P799, DOI 10.1080/10715762.2017.1380307; Olk R Joseph, 2015, Int J Retina Vitreous, V1, P22, DOI 10.1186/s40942-015-0019-2; Orhan C, 2016, J OCUL PHARMACOL TH, V32, P631, DOI 10.1089/jop.2015.0154; Pinto LH, 2007, DOC OPHTHALMOL, V115, P127, DOI 10.1007/s10633-007-9064-y; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rex TS, 2004, HUM GENE THER, V15, P960, DOI 10.1089/hum.2004.15.960; Rosen R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/687386; Rudd LP, 2011, CHEM-BIOL INTERACT, V194, P113, DOI 10.1016/j.cbi.2011.08.012; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Schutt F, 2003, INVEST OPHTH VIS SCI, V44, P3663, DOI 10.1167/iovs.03-0172; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; Sommerburg O, 1999, CURR EYE RES, V19, P491, DOI 10.1076/ceyr.19.6.491.5276; Sommerburg Olaf, 2000, Biofactors, V11, P3; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Thomson LR, 2002, INVEST OPHTH VIS SCI, V43, P3538; Thomson LR, 2002, EXP EYE RES, V75, P529, DOI 10.1006/exer.2002.2050; Toyoda Y, 2002, INVEST OPHTH VIS SCI, V43, P1210; Veerappan M, 2016, OPHTHALMOLOGY, V123, P2554, DOI 10.1016/j.ophtha.2016.08.047; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009; Zou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.190	51	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203816	10.1371/journal.pone.0203816	http://dx.doi.org/10.1371/journal.pone.0203816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265681	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500010
J	Conceicao, LB; Baggio, JAO; Mazin, SC; Edwards, DJ; Santos, TEG				Conceicao, Laila B.; Baggio, Jussara A. O.; Mazin, Suleimy C.; Edwards, Dylan J.; Santos, Taiza E. G.			Normative data for human postural vertical: A systematic review and meta-analysis	PLOS ONE			English	Review							VESTIBULAR DYSFUNCTION; BODY VERTICALITY; PUSHER SYNDROME; PERCEPTION; STROKE; ORIENTATION; SENSE	Perception of verticality is required for normal daily function, yet the typical human detection error range has not been well characterized. Vertical misperception has been correlated with poor postural control and functionality in patients after stroke and after vestibular disorders. Until now, all the published studies that assessed Subjective Postural Vertical (SPV) in the seated position used small groups to establish a reference value. However, this sample size does not represent the healthy population for comparison with conditions resulting in pathological vertical. Therefore, the primary objective was to conduct a systematic review with meta-analyses of Subjective Postural Vertical (SPV) data in seated position in healthy adults to establish the reference value with a representative sample. The secondary objective was to investigate the methodological characteristics of different assessment protocols of SPV described in the literature. A systematic literature search was conducted using Medline, EMBASE, and Cochrane libraries. Mean and standard deviation of SPV in frontal and sagittal planes were considered as effect size measures. Sixteen of 129 identified studies met eligibility criteria for our systematic review (n = 337 subjects in the frontal plane; n = 187 subjects in sagittal plane). The meta-analyses measure was estimated using the pooled mean as the estimator and its respective error. Mean reference values were 0.12 degrees +/- 1.49 degrees for the frontal plane and 0.02 degrees +/- 1.82 degrees for the sagittal plane. There was a small variability of the results and this systematic review resulted in representative values for SPV. The critical analysis of the studies and observed homogeneity in the sample suggests that the methodological differences used in the studies did not influence SPV assessment of directional bias in healthy subjects. These data can serve as a reference for clinical studies in disorders of verticality.	[Conceicao, Laila B.] Mae de Deus Hosp, Porto Alegre, RS, Brazil; [Baggio, Jussara A. O.; Mazin, Suleimy C.; Santos, Taiza E. G.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, Ribeirao Preto, SP, Brazil; [Baggio, Jussara A. O.] Univ Fed Alagoas, Arapiraca, Alagoas, Brazil; [Mazin, Suleimy C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Ribeirao Preto, SP, Brazil; [Edwards, Dylan J.] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Edwards, Dylan J.] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, Australia	Universidade de Sao Paulo; Universidade Federal de Alagoas; Universidade de Sao Paulo; Edith Cowan University	Santos, TEG (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, Ribeirao Preto, SP, Brazil.	taiza@fmrp.usp.br	Edwards, Taiza GS/F-9214-2012; de Oliveira Baggio, Jussara Almeida/H-7251-2012; Baggio, Jussara Almeida de Oliveira/AGK-7651-2022	Edwards, Taiza GS/0000-0003-3033-2981; de Oliveira Baggio, Jussara Almeida/0000-0003-2508-1364; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (TEGS)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (TEGS)	This study was funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (TEGS).	Anastasopoulos D, 1997, NEUROSCI LETT, V233, P151, DOI 10.1016/S0304-3940(97)00639-3; Anastasopoulos D, 1997, MOVEMENT DISORD, V12, P561, DOI 10.1002/mds.870120413; Anastasopoulos D, 1999, ANN NY ACAD SCI, V871, P379, DOI 10.1111/j.1749-6632.1999.tb09199.x; [Anonymous], 2012, ASSESSING RISK BIAS; Aoki M, 1999, AM J OTOL, V20, P741; Baccini M, 2014, ATTEN PERCEPT PSYCHO, V76, P112, DOI 10.3758/s13414-013-0551-9; Baggio JAO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150754; Baier B, 2012, NEUROLOGY, V78, P728, DOI 10.1212/WNL.0b013e318248e544; Barbieri G, 2008, EXP BRAIN RES, V185, P545, DOI 10.1007/s00221-007-1177-8; Barbieri G, 2010, AGE, V32, P51, DOI 10.1007/s11357-009-9112-5; Barra J, 2012, NEUROPSYCHOLOGIA, V50, P2492, DOI 10.1016/j.neuropsychologia.2012.06.021; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Bergmann J, 2015, ATTEN PERCEPT PSYCHO, V77, P953, DOI 10.3758/s13414-014-0815-z; Bisdorff A, 1996, BRAIN RES BULL, V40, P413, DOI 10.1016/0361-9230(96)00135-9; Bisdorff AR, 1996, BRAIN, V119, P1523, DOI 10.1093/brain/119.5.1523; Cakrt O, 2011, J VESTIBUL RES-EQUIL, V21, P161, DOI 10.3233/VES-2011-0414; Caparelli-Daquer EM, 2009, BRAIN COGNITION, V69, P116, DOI 10.1016/j.bandc.2008.06.001; Dodds RM, 2016, AGE AGEING, V45, P209, DOI 10.1093/ageing/afv192; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Faralli M, 2009, ACTA OTORHINOLARYNGO, V29, P245; Fiori F, 2015, J NEUROPHYSIOL, V114, P2983, DOI 10.1152/jn.00289.2015; Fukata Kazuhiro, 2017, J Phys Ther Sci, V29, P1950, DOI 10.1589/jpts.29.1950; Funabashi M, 2012, CLINICS, V67, P1127, DOI 10.6061/clinics/2012(10)02; Santos-Pontelli TEG, 2011, ARQ NEURO-PSIQUIAT, V69, P914, DOI 10.1590/S0004-282X2011000700013; Hartung J., 2008, STAT METAANALYSIS AP; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Israel I, 2012, J VESTIBUL RES-EQUIL, V22, P173, DOI 10.3233/VES-2012-0450; Joassin R., 2010, Annals of Physical and Rehabilitation Medicine, V53, P568, DOI 10.1016/j.rehab.2010.07.005; Johannsen L, 2006, J NEUROL, V253, P1367, DOI 10.1007/s00415-006-0216-x; Karnath HO, 2005, NEUROLOGY, V64, P1014, DOI 10.1212/01.WNL.0000154527.72841.4A; Kheradmand A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00552; LOTT JA, 1992, CLIN CHEM, V38, P648; Mansfield A, 2015, NEUROSCI LETT, V590, P172, DOI 10.1016/j.neulet.2015.02.007; Mazibrada G, 2008, GAIT POSTURE, V27, P202, DOI 10.1016/j.gaitpost.2007.03.006; MITTELSTAEDT H, 1992, ANN NY ACAD SCI, V656, P124, DOI 10.1111/j.1749-6632.1992.tb25204.x; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Perennou D, 2014, NEUROPHYSIOL CLIN, V44, P25, DOI 10.1016/j.neucli.2013.10.131; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Perennou DA, 1998, NEUROSCI LETT, V252, P75, DOI 10.1016/S0304-3940(98)00501-1; Piscicelli C, 2017, ANN PHYS REHABIL MED, V60, P208, DOI 10.1016/j.rehab.2016.02.004; REED AH, 1971, CLIN CHEM, V17, P275; Saeys W, 2012, DISABIL REHABIL, V34, P1965, DOI 10.3109/09638288.2012.671883; Saeys W, 2010, EUR J APPL PHYSIOL, V109, P297, DOI 10.1007/s00421-010-1355-4; Schindlbeck KA, 2018, ACTA NEUROL SCAND, V137, P212, DOI 10.1111/ane.12859; Sharpe JA, 2003, NEUROLOGY, V61, P1172, DOI 10.1212/WNL.61.9.1172; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Ticini LF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005737; Veroniki AA, 2016, RES SYNTH METHODS, V7, P55, DOI 10.1002/jrsm.1164; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9	50	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204122	10.1371/journal.pone.0204122	http://dx.doi.org/10.1371/journal.pone.0204122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265701	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500019
J	Stewart, D; Thomas, B; MacLure, K; Pallivalapila, A; El Kassem, W; Awaisu, A; McLay, JS; Wilbur, K; Wilby, K; Ryan, C; Dijkstra, A; Singh, R; Al Hail, M				Stewart, Derek; Thomas, Binny; MacLure, Katie; Pallivalapila, Abdulrouf; El Kassem, Wessam; Awaisu, Ahmed; McLay, James S.; Wilbur, Kerry; Wilby, Kyle; Ryan, Cristin; Dijkstra, Andrea; Singh, Rajvir; Al Hail, Moza			Perspectives of healthcare professionals in Qatar on causes of medication errors: A mixed methods study of safety culture	PLOS ONE			English	Article							IN-HOSPITAL INPATIENTS; OF-THE-LITERATURE; ADMINISTRATION ERRORS; PREVALENCE	Background There is a lack of robust, rigorous mixed methods studies of patient safety culture generally and notably those which incorporate behavioural theories of change. The study aimed to quantify and explain key aspects of patient safety culture which were of most concern to healthcare professionals in Qatar. Methods A sequential explanatory mixed methods design of a cross-sectional survey followed by focus groups in Hamad Medical Corporation, Qatar. All doctors, nurses and pharmacists were invited to complete the Hospital Survey on Patient Safety Culture (HSOPS). Respondents expressing interest in focus group participation were sampled purposively, and discussions based on survey findings using the Theoretical Domains Framework (TDF) to explain behavioural determinants. Results One thousand, six hundred and four questionnaires were received (67.9% nurses, 13.3% doctors, 12.9% pharmacists). HSOPS composites with the lowest levels of positive responses were non-punitive response to errors (24.0% positive) and staffing (36.2%). Specific TDF determinants potentially associated with these composites were social/professional role and identity, emotions, and environmental context and resources. Thematic analysis identified issues of doctors relying on pharmacists to correct their errors and being reluctant to alter the prescribing of fellow doctors. There was a lack of recognition of nurses' roles and frequent policy non-adherence. Stress, workload and lack of staff at key times were perceived to be major contributors to errors. Conclusions This study has quantified areas of concern relating to patient safety culture in Qatar and suggested important behavioural determinants. Rather than focusing on changing behaviour at the individual practitioner level, action may be required at the organisational strategic level to review policies, structures (including resource allocation and distribution) and processes which aim to promote patient safety culture.	[Stewart, Derek; Thomas, Binny; MacLure, Katie] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland; [Thomas, Binny; Pallivalapila, Abdulrouf; El Kassem, Wessam; Al Hail, Moza] Womens Hosp Med Ctr, Hamad Med Corp, Doha, Qatar; [Awaisu, Ahmed; Wilbur, Kerry; Wilby, Kyle] Qatar Univ, Coll Pharm, Doha, Qatar; [McLay, James S.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Ryan, Cristin] Royal Coll Surgeons Ireland, Sch Pharm, Dublin, Ireland; [Dijkstra, Andrea; Singh, Rajvir] Hamad Med Corp, Doha, Qatar	Robert Gordon University; Hamad Medical Corporation; Qatar University; University of Aberdeen; Royal College of Surgeons - Ireland; Hamad Medical Corporation	Stewart, D (corresponding author), Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland.	d.stewart@rgu.ac.uk	MacLure, Katie/GRJ-8912-2022; Thomas, Binny/AFT-6887-2022; Awaisu, Ahmed/AAU-3959-2020; Elkassem, Wessam/H-9989-2019; Thomas, Binny/H-6129-2017; Wilby, Kyle/R-3018-2018	Awaisu, Ahmed/0000-0002-9029-8925; Elkassem, Wessam/0000-0003-2145-7555; MacLure, Katie/0000-0003-0686-948X; Alhail, Moza/0000-0002-7442-3773; Thomas, Binny/0000-0003-1065-8343; Stewart, Derek/0000-0001-7360-8592; Ryan, Cristin/0000-0002-6037-4413; Wilbur, Kerry/0000-0002-5936-4429; Wilby, Kyle/0000-0002-1670-2512	NPRP from Qatar National Research Fund (a member of Qatar Foundation) [NPRP 7-388-3-095]	NPRP from Qatar National Research Fund (a member of Qatar Foundation)	This publication was made possible by NPRP grant NPRP 7-388-3-095 from Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors.	Alsulami Z, 2013, EUR J CLIN PHARMACOL, V69, P995, DOI 10.1007/s00228-012-1435-y; [Anonymous], 1993, STUDY GROUP HUMAN FA; Bartlett JE, 2000, INFORM TECHNOLOGY LE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494; Brown CL, 2017, J AM MED INFORM ASSN, V24, P432, DOI 10.1093/jamia/ocw119; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Craig P, 2008, BMJ-BRIT MED J, V337, pa1665; Creswell J, 2006, CHOOSING MIXED METHO; Donaldson LJ, 2017, LANCET, V389, P1680, DOI 10.1016/S0140-6736(17)31047-4; Duncan EM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-86; Elmontsri M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013487; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Franklin BD, 2011, POSTGRAD MED J, V87, P739, DOI 10.1136/pgmj.2011.117879; Fusch PI, 2015, QUAL REP, V20, P1408; James K Lynette, 2009, Int J Pharm Pract, V17, P9; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Keers RN, 2013, DRUG SAFETY, V36, P1045, DOI 10.1007/s40264-013-0090-2; Keers RN, 2013, ANN PHARMACOTHER, V47, P237, DOI 10.1345/aph.1R147; Lewis PJ, 2009, DRUG SAFETY, V32, P379, DOI 10.2165/00002018-200932050-00002; Michie S, 2015, HEALTH TECHNOL ASSES, P19; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Morello RT, 2013, BMJ QUAL SAF, V22, P11, DOI 10.1136/bmjqs-2011-000582; Pluye P, 2014, ANNU REV PUBL HEALTH, V35, P29, DOI 10.1146/annurev-publhealth-032013-182440; Ritchie J, 2002, QUALITATIVE RES COMP, P305, DOI DOI 10.4135/9781412986274; Ross S, 2009, BRIT J CLIN PHARMACO, V67, P629, DOI 10.1111/j.1365-2125.2008.03330.x; Sears Kim, 2012, JBI Libr Syst Rev, V10, P2350; Shenton A. K., 2004, ED INFORM, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Sorra J, AHRQ PUBL; Tully MP, 2009, DRUG SAFETY, V32, P819, DOI 10.2165/11316560-000000000-00000; Weaver SJ, 2013, ANN INTERN MED, V158, P369, DOI 10.7326/0003-4819-158-5-201303051-00002; World Health Organization, 2017, MED HARM WHO GLOB PA	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204801	10.1371/journal.pone.0204801	http://dx.doi.org/10.1371/journal.pone.0204801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265732	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500049
J	Hattori, H; Ishikawa, Y; Kawashima, N; Akashi, A; Yamaguchi, Y; Harada, Y; Hirano, D; Adachi, Y; Miyao, K; Ushijima, Y; Terakura, S; Nishida, T; Matsushita, T; Kiyoi, H				Hattori, Hikaru; Ishikawa, Yuichi; Kawashima, Naomi; Akashi, Akimi; Yamaguchi, Yohei; Harada, Yasuhiko; Hirano, Daiki; Adachi, Yoshiya; Miyao, Kotaro; Ushijima, Yoko; Terakura, Seitaro; Nishida, Tetsuya; Matsushita, Tadashi; Kiyoi, Hitoshi			Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia	PLOS ONE			English	Article							ARSENIC TRIOXIDE; MISSENSE MUTATIONS; THERAPY; ALPHA; TRANSLOCATION; CELLS; TRIAL; CHEMOTHERAPY; INHIBITOR; T(15-17)	All-trans retinoic acid (ATRA) and arsenic trioxide (ATO) are essential for acute promyelocytic leukemia (APL) treatment. It has been reported that mutations in PML-RARA confer resistance to ATRA and ATO, and are associated with poor prognosis. Although most PML-RARA mutations were point mutations, we identified a novel seven amino acid deletion mutation (p.K227_T233del) in the RARA region of PML-RARA in a refractory APL patient. Here, we analyzed the evolution of the mutated clone and demonstrated the resistance of the mutated clone to retinoic acid (RA). Mutation analysis of PML-RARA was performed using samples from a chemotherapy-and ATRA-resistant APL patient, and the frequencies of mutated PML-RARA transcript were analyzed by targeted deep sequencing. To clarify the biological significance of the identified PML-RARA mutations, we analyzed the ATRA-induced differentiation and PML nuclear body formation in mutant PML-RARA-transduced HL-60 cells. At molecular relapse, the p.K227_T233del deletion and the p.R217S point-mutation in the RARA region of PML-RARA were identified, and their frequencies increased after re-induction therapy with another type of retinoiec acid (RA), tamibarotene. In deletion PML-RARA-transduced cells, the CD11b expression levels and NBT reducing ability were significantly decreased compared with control cells and the formation of PML nuclear bodies was rarely observed after RA treatment. These results indicate that this deletion mutation was closely associated with the disease progression during RA treatment.	[Hattori, Hikaru; Ishikawa, Yuichi; Kawashima, Naomi; Akashi, Akimi; Yamaguchi, Yohei; Harada, Yasuhiko; Hirano, Daiki; Adachi, Yoshiya; Miyao, Kotaro; Ushijima, Yoko; Terakura, Seitaro; Nishida, Tetsuya; Kiyoi, Hitoshi] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan; [Hattori, Hikaru] Nagoya Univ Hosp, Dept Med Tech, Nagoya, Aichi, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Ishikawa, Y (corresponding author), Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan.	yishikaw@med.nagoya-u.ac.jp	Terakura, Seitaro/A-6188-2011	Kawashima, Naomi/0000-0002-9914-739X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17K09921]; Japan Agency for Medical Research and Development, AMED [17ck0106251]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by Grants-in-Aid from the Scientific Research Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (URL: https://www.jsps.go.jp/english/index.html), grant number 17K09921, and from the Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development, AMED (URL: https://www.amed.go.jp/en/index.html), grant number 17ck0106251 for study design, data collection, and analysis.	Beaumont M, 2003, J CLIN ONCOL, V21, P2123, DOI 10.1200/JCO.2003.09.072; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Chen FL, 2016, ONCOTARGET, V7, P47018, DOI 10.18632/oncotarget.10147; Dayyani F, 2011, CANCER-AM CANCER SOC, V117, P110, DOI 10.1002/cncr.25585; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Ding W, 1998, BLOOD, V92, P1172, DOI 10.1182/blood.V92.4.1172.416k02_1172_1183; Elliott MA, 2012, EUR J HAEMATOL, V88, P237, DOI 10.1111/j.1600-0609.2011.01727.x; Gallagher RE, 2006, LEUKEMIA, V20, P556, DOI 10.1038/sj.leu.2404118; Goto E, 2011, BLOOD, V118, P1600, DOI 10.1182/blood-2011-01-329433; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kayser S, 2017, LEUKEMIA, V31, P2347, DOI 10.1038/leu.2017.92; Kitamura K, 1997, LEUKEMIA, V11, P1950, DOI 10.1038/sj.leu.2400837; Kiyoi H, 1997, LEUKEMIA, V11, P1447, DOI 10.1038/sj.leu.2400756; Kudo K, 1998, LEUKEMIA, V12, P1171, DOI 10.1038/sj.leu.2401089; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lo-Coco F, 2010, BLOOD, V116, P3171, DOI 10.1182/blood-2010-03-276196; Lou YJ, 2015, ANN HEMATOL, V94, P1829, DOI 10.1007/s00277-015-2477-x; Ma YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158760; OHNO R, 1993, LEUKEMIA, V7, P1722; Osumi K, 2002, LEUKEMIA LYMPHOMA, V43, P2291, DOI 10.1080/1042819021000040206; Platzbecker U, 2017, J CLIN ONCOL, V35, P605, DOI 10.1200/JCO.2016.67.1982; Pulsoni A, 2002, BLOOD, V100, P1972, DOI 10.1182/blood-2001-12-0312; Ravandi F, 2011, HAEMATOL-HEMATOL J, V96, P493, DOI 10.3324/haematol.2011.041970; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Schachter-Tokarz E, 2010, LEUKEMIA, V24, P473, DOI 10.1038/leu.2009.220; Shinagawa K, 2014, J CLIN ONCOL, V32, P3729, DOI 10.1200/JCO.2013.53.3570; Shiotsu Y, 2009, BLOOD, V114, P1607, DOI 10.1182/blood-2009-01-199307; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973; Tomita A, 2013, INT J HEMATOL, V97, P717, DOI 10.1007/s12185-013-1354-4; Yoshida H, 1996, CANC RES; Zhu HH, 2014, NEW ENGL J MED, V370, P1864, DOI 10.1056/NEJMc1316382	32	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204850	10.1371/journal.pone.0204850	http://dx.doi.org/10.1371/journal.pone.0204850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289902	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500026
J	Lee, JH; Park, WY; Kim, YS; Choi, BS; Park, CW; Yang, CW; Kim, YS; Jin, K; Han, S; Chung, BH				Lee, Jong Hoon; Park, Woo Yeong; Kim, Young Soo; Choi, Bum Soon; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Jin, Kyubok; Han, Seungyeup; Chung, Byung Ha			Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort study	PLOS ONE			English	Article							CADAVERIC RENAL-TRANSPLANTATION; EXPANDED CRITERIA DONORS; DELAYED GRAFT FUNCTION; RISK INDEX; REJECTION; PATHOLOGY; IMPACT; INJURY	Background We investigated whether the Kidney Donor Profile Index (KDPI) system is useful in predicting clinical outcomes in deceased donor kidney transplantation (DDKT). Methods Four hundred sixty-nine kidney transplant recipients (KTRs) receiving kidneys from 359 deceased donors were included in this study, which involved three transplant centers. KTRs were divided into high and low KDPI KTR groups based on the median KDPI score of 67%. We compared clinical outcomes between the high KDPI and low KDPI groups. Results There were no significant differences in the incidence of delayed graft function and acute rejection between high and low KDPI KTR groups. In comparison with histologic findings in allograft tissues obtained within three months from KT, the proportion of glomerulosclerosis was significantly higher in the high KDPI KTR group than in the low KDPI KTR group. With Kaplan-Meier analysis, the graft survival rate was significantly lower in the high KDPI KTR group than in the low KDPI KTR group (Log rank, P = 0.017), and multivariate analysis also demonstrated that a high KDPI score was a significant risk factor for death censored allograft failure (HR 2.62, 95% CI, 1.29 +/- 5.33, P = 0.008). Conclusion The KDPI scoring system is useful in predicting allograft outcomes in a Korean DDKT cohort.	[Lee, Jong Hoon; Yang, Chul Woo; Kim, Yong-Soo; Chung, Byung Ha] Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea; [Lee, Jong Hoon; Choi, Bum Soon; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Chung, Byung Ha] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea; [Park, Woo Yeong; Jin, Kyubok; Han, Seungyeup] Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Park, Woo Yeong; Jin, Kyubok; Han, Seungyeup] Keimyung Univ, Kidney Inst, Daegu, South Korea; [Kim, Young Soo] Catholic Univ Korea, Coll Med, Uijeongbu St Marys Hosp, Div Nephrol,Dept Internal Med, Uijongbu, South Korea	Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Keimyung University; Keimyung University; Catholic University of Korea	Chung, BH (corresponding author), Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea.; Chung, BH (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea.	chungbh@catholic.ac.kr		Chung, Byung Ha/0000-0003-0048-5717	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [NRF-2017R1D1A1B03029140]; Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), and funded by the Ministry of Education, Science, and Technology (NRF-2017R1D1A1B03029140) and it was also supported by Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunnapradist S, 2003, J AM SOC NEPHROL, V14, P1031, DOI 10.1097/01.ASN.0000054494.85680.1C; De Serres SA, 2016, AM J TRANSPLANT, V16, P1516, DOI 10.1111/ajt.13624; Escofet X, 2003, TRANSPLANTATION, V75, P344, DOI 10.1097/01.TP.0000044361.74625.E7; Farney AC, 2013, J AM COLL SURGEONS, V216, P645, DOI 10.1016/j.jamcollsurg.2012.12.020; Gandolfini I, 2014, AM J TRANSPLANT, V14, P2515, DOI 10.1111/ajt.12928; Gonzalez-Segura C, 1998, TRANSPLANTATION, V65, P1465, DOI 10.1097/00007890-199806150-00010; Hara S, 2015, NEPHROLOGY, V20, P2, DOI 10.1111/nep.12474; Heaphy ELG, 2013, AM J TRANSPLANT, V13, P1001, DOI 10.1111/ajt.12154; Jin DC, 2016, KIDNEY RES CLIN PRAC, V35, P204, DOI 10.1016/j.krcp.2016.09.006; Keith DS, 2016, CLIN J AM SOC NEPHRO, V11, P684, DOI 10.2215/CJN.05930615; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kim JH, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0461-5; Klein R, 2013, TRANSPLANTATION, V95, P611, DOI 10.1097/TP.0b013e318279153c; Lee MH, 2014, J CRIT CARE, V29, P432, DOI 10.1016/j.jcrc.2013.12.016; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Loupy A, 2017, AM J TRANSPLANT, V17, P28, DOI 10.1111/ajt.14107; Morales JM, 2012, NEPHROL DIAL TRANSPL, V27, piv39, DOI 10.1093/ndt/gfs544; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Nankivell BJ, 2001, TRANSPLANTATION, V71, P515, DOI 10.1097/00007890-200102270-00006; Ojo AO, 2005, SEMIN DIALYSIS, V18, P463, DOI 10.1111/j.1525-139X.2005.00090.x; Park WY, 2016, KIDNEY RES CLIN PRAC, V35, P50, DOI 10.1016/j.krcp.2015.11.001; Querard AH, 2016, TRANSPL INT, V29, P403, DOI 10.1111/tri.12736; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Said MR, 1998, J AM SOC NEPHROL, V9, P2148; Sampaio Marcelo, 2015, Clin Transpl, V31, P1; Savoye E, 2007, TRANSPLANTATION, V84, P1618, DOI 10.1097/01.tp.0000295988.28127.dd; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; van Ittersum FJ, 2017, TRANSPL INT, V30, P14, DOI 10.1111/tri.12863; Watson CJE, 2012, TRANSPLANTATION, V93, P314, DOI 10.1097/TP.0b013e31823f14d4; Woodle ES, 2005, AM J TRANSPLANT, V5, P2740, DOI 10.1111/j.1600-6143.2005.01090.x; Yarlagadda G, 2008, NEPHROL DIAL TRANSPL, V23, P2995, DOI 10.1093/ndt/gfn158; Yeo SM, 2017, TRANSPL P, V49, P997, DOI 10.1016/j.transproceed.2017.03.057	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205011	10.1371/journal.pone.0205011	http://dx.doi.org/10.1371/journal.pone.0205011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289927	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500038
J	Im, JH; Lazzaro, BP				Im, Joo Hyun; Lazzaro, Brian P.			Population genetic analysis of autophagy and phagocytosis genes in Drosophila melanogaster and D. simulans	PLOS ONE			English	Article							BALANCING SELECTION; IMMUNE-RESPONSE; SOFT SWEEPS; RNAI SCREEN; EVOLUTION; PROTEIN; POLYMORPHISM; DIVERGENCE; RESISTANCE; ADAPTATION	Autophagy and phagocytosis are cellular immune mechanisms for internalization and elimination of intracellular and extracellular pathogens. Some pathogens have evolved the ability to inhibit or manipulate these processes, raising the prospect of adaptive reciprocal co-evolution by the host. We performed population genetic analyses on phagocytosis and autophagy genes in Drosophila melanogasterand D. simulans to test for molecular evolutionary signatures of immune adaptation. We found that phagocytosis and autophagy genes as a whole exhibited an elevated level of haplotype homozygosity in both species. In addition, we detected signatures of recent selection, notably in the Atg14 and Ykt6 genes in D. melanogasterand a pattern of elevated sequence divergence in the genderblind (gb) gene on the D. simulans lineage. These results suggest that the evolution of the host cellular immune system as a whole may be shaped by a dynamic conflict between Drosophila and its pathogens even without pervasive evidence of strong adaptive evolution at the individual gene level.	[Im, Joo Hyun; Lazzaro, Brian P.] Cornell Univ, Inst Host Microbe Interact & Dis, Ithaca, NY 14853 USA; [Im, Joo Hyun; Lazzaro, Brian P.] Cornell Univ, Grad Field Genet Genom & Dev, Ithaca, NY 14853 USA; [Im, Joo Hyun; Lazzaro, Brian P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Im, JH (corresponding author), Cornell Univ, Inst Host Microbe Interact & Dis, Ithaca, NY 14853 USA.; Im, JH (corresponding author), Cornell Univ, Grad Field Genet Genom & Dev, Ithaca, NY 14853 USA.; Im, JH (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	ji72@cornell.edu			NIH [AI064950, AI083932]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064950, R56AI083932] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI064950 and AI083932 to BPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cadwell K, 2013, IMMUNITY, V39, P425, DOI 10.1016/j.immuni.2013.08.027; Capy P, 2004, GENETICA, V120, P5, DOI 10.1023/B:GENE.0000017626.41548.97; Casillas S, 2017, GENETICS, V205, P1003, DOI 10.1534/genetics.116.196493; Chaumorcel M, 2012, J VIROL, V86, P2571, DOI 10.1128/JVI.05746-11; CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Corbett-Detig RB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003056; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P153, DOI 10.1016/0040-5809(72)90024-X; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fiston-Lavier AS, 2010, GENE, V463, P18, DOI 10.1016/j.gene.2010.04.015; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Garud NR, 2016, GENETICS, V203, P863, DOI 10.1534/genetics.115.184002; Garud NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005004; Gonzalez EA, 2013, CURR BIOL, V23, P2319, DOI 10.1016/j.cub.2013.09.061; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HART K, 1993, J MOL BIOL, V234, P249, DOI 10.1006/jmbi.1993.1580; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jiggins FM, 2006, J MOL EVOL, V63, P769, DOI 10.1007/s00239-006-0005-2; Juneja P, 2010, MOL BIOL EVOL, V27, P2284, DOI 10.1093/molbev/msq114; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Lack JB, 2015, GENETICS, V199, P1229, DOI 10.1534/genetics.115.174664; Langley CH, 2012, GENETICS, V192, P533, DOI 10.1534/genetics.112.142018; Lazzaro BP, 2005, GENETICS, V169, P2023, DOI 10.1534/genetics.104.034249; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000442; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Moy RH, 2013, J INNATE IMMUN, V5, P444, DOI 10.1159/000350326; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nonaka S, 2013, J BIOL CHEM, V288, P10374, DOI 10.1074/jbc.M113.451427; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Palmer WH, 2018, GENETICS, V208, P1585, DOI 10.1534/genetics.117.300567; Peltan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051831; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Piyankarage SC, 2008, ANAL CHEM, V80, P1201, DOI 10.1021/ac701785z; Pool JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003080; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramarao N, 2000, MOL MICROBIOL, V37, P1389, DOI 10.1046/j.1365-2958.2000.02089.x; Rogers RL, 2014, MOL BIOL EVOL, V31, P1750, DOI 10.1093/molbev/msu124; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Salazar-Jaramillo L, 2014, GENOME BIOL EVOL, V6, P273, DOI 10.1093/gbe/evu012; Sanjuan MA, 2008, AUTOPHAGY, V4, P607, DOI 10.4161/auto.6397; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; TAJIMA F, 1989, GENETICS, V123, P585; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Unckless RL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0291; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; WATTERSON GA, 1977, THEOR POPUL BIOL, V12, P179, DOI 10.1016/0040-5809(77)90041-7; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Zeng K, 2007, MOL BIOL EVOL, V24, P1562, DOI 10.1093/molbev/msm078; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231; Zirin J, 2010, SEMIN IMMUNOPATHOL, V32, P363, DOI 10.1007/s00281-010-0223-y	80	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205024	10.1371/journal.pone.0205024	http://dx.doi.org/10.1371/journal.pone.0205024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281656	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400076
J	Nguyen, KCT; Pacheco-Pereira, C; Kaipatur, NR; Cheung, J; Major, PW; Le, LH				Nguyen, Kim-Cuong T.; Pacheco-Pereira, Camila; Kaipatur, Neelambar R.; Cheung, June; Major, Paul W.; Le, Lawrence H.			Comparison of ultrasound imaging and cone-beam computed tomography for examination of the alveolar bone level: A systematic review	PLOS ONE			English	Review							PERIODONTAL-DISEASE; IMPLANT; ULTRASONOGRAPHY; DIAGNOSIS; IDENTIFICATION; DEHISCENCES; RELIABILITY; THICKNESS; MAXILLARY; ACCURACY	Background and objective The current methods to image alveolar bone in humans include intraoral 2D radiography and cone-beam computed tomography (CBCT). However, these methods expose the subject to ionizing radiation. Therefore, ultrasound imaging has been investigated as an alternative technique, as it is both non-invasive and free from ionizing radiation. In order to assess the validity and reliability of ultrasonography in visualizing alveolar bone, a systematic review was conducted comparing ultrasound imaging to CBCT for examination of the alveolar bone level. Study design Seven databases were searched. Studies addressing examination of alveolar bone level via CBCT and ultrasound were selected. Risk of bias under Cochrane guidelines was used as a methodological quality assessment tool. Results All the four included studies were ex vivo studies that used porcine or human cadaver samples. The alveolar bone level was measured by the distance from the alveolar bone crest to certain landmarks such as cemento-enamel junction or gingival margin. The risk of bias was found as low. The mean difference between ultrasound and CBCT measurements ranged from 0.07 mm to 0.68 mm, equivalent to 1.6% - 8.8%. Conclusions There is currently preliminary evidence to support the use of ultrasonography as compared to CBCT for the examination of alveolar bone level. Further studies comparing ultrasound to gold standard methods would be necessary to help validate the accuracy of ultrasonography as a diagnostic technique in periodontal imaging.	[Nguyen, Kim-Cuong T.; Le, Lawrence H.] Univ Alberta, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada; [Nguyen, Kim-Cuong T.; Le, Lawrence H.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Pacheco-Pereira, Camila; Kaipatur, Neelambar R.; Major, Paul W.] Univ Alberta, Sch Dent, Edmonton, AB, Canada; [Pacheco-Pereira, Camila] UT Hlth San Antonio, Dept Comprehens Dent, San Antonio, TX USA; [Cheung, June] Univ Alberta, Dept Commun Sci & Disorders, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Texas System; University of Texas Health San Antonio; University of Alberta	Le, LH (corresponding author), Univ Alberta, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada.; Le, LH (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.; Kaipatur, NR (corresponding author), Univ Alberta, Sch Dent, Edmonton, AB, Canada.	kaipatur@ualberta.ca; lawrence.le@ualberta.ca		Le, Lawrence/0000-0003-1907-1258	Alberta Innovates-Technology Futures; Women and Children's Health Research Institute (WCHRI), Canada [530]	Alberta Innovates-Technology Futures; Women and Children's Health Research Institute (WCHRI), Canada	Ms. Nguyen acknowledges the support from the Alberta Innovates-Technology Futures for the PhD fellowship. The authors thank the Women and Children's Health Research Institute (WCHRI), Canada for the financial support through a Seed grant (530).	Agrawal P, 2012, INT DENT J, V62, P57, DOI 10.1111/j.1875-595X.2011.00099.x; Agueda A, 2008, MED ORAL PATOL ORAL, V13, pE609; Anter Enas, 2016, J Indian Soc Periodontol, V20, P235, DOI 10.4103/0972-124X.176389; BAUM G, 1963, SCIENCE, V139, P495, DOI 10.1126/science.139.3554.495; Brand JW, 2003, RAD PROTECTION DENTI, P145; Bushberg J.T., 2011, ESSENTIAL PHYS MED I; Chan HL, 2017, CLIN ORAL IMPLAN RES, V28, P341, DOI 10.1111/clr.12805; Chan HL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171237; Chan HL, 2010, IMPLANT DENT, V19, P288, DOI 10.1097/ID.0b013e3181e59ebd; Chen W, 2013, J CHILD ORTHOP, V7, P521, DOI 10.1007/s11832-013-0539-y; Chifor R, 2015, MED ULTRASON, V17, P273, DOI 10.11152/mu.2013.2066.173.rch; Chifor R, 2015, ROM J MORPHOL EMBRYO, V56, P149; Chifor R, 2011, MED ULTRASON, V13, P120; Choi M, 2012, J PROSTHET DENT, V108, P344, DOI 10.1016/S0022-3913(12)60190-5; Chu TMG, 2014, BASIC AND APPLIED BONE BIOLOGY, P225, DOI 10.1016/B978-0-12-416015-6.00011-3; Coatney R W, 2001, ILAR J, V42, P233; Cotti E, 2002, INT ENDOD J, V35, P148, DOI 10.1046/j.1365-2591.2002.00458.x; Culjat MO, 2010, ULTRASOUND MED BIOL, V36, P861, DOI 10.1016/j.ultrasmedbio.2010.02.012; Degen K, 2017, CLIN ORAL IMPLAN RES, V28, P520, DOI 10.1111/clr.12829; Evans CA, 2013, OR SURG OR MED OR PA, V116, P238, DOI 10.1016/j.oooo.2013.06.002; Grimard BA, 2009, J PERIODONTOL, V80, P48, DOI 10.1902/jop.2009.080289 ; Guo YJ, 2016, DENTOMAXILLOFAC RAD, V45, DOI 10.1259/dmfr.20150265; Haas LF, 2018, DENTOMAXILLOFAC RAD, V47, DOI 10.1259/dmfr.20170084; Hamano N, 2003, DENT MATER J, V22, P66, DOI 10.4012/dmj.22.66; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; JEFFCOAT MK, 1993, J BONE MINER RES, V8, pS467; Kaneko T, 2011, DENT TRAUMATOL, V27, P478, DOI 10.1111/j.1600-9657.2011.01021.x; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Nguyen K, 2016, ANN TELECOMMUN, V71, P639, DOI 10.1007/s12243-016-0502-2; Klein MO, 2008, ULTRASOUND MED BIOL, V34, P1966, DOI 10.1016/j.ultrasmedbio.2008.04.016; Kook YA, 2012, ANGLE ORTHOD, V82, P645, DOI 10.2319/070111-424.1; Kumar G.S., 2014, ORBANS ORAL HISTOLOG; Le LH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3300474; Leung CC, 2010, AM J ORTHOD DENTOFAC, V137, pS109, DOI 10.1016/j.ajodo.2009.07.013; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Lin C, 2017, J DENT RES; LISTGARTEN MA, 1980, J CLIN PERIODONTOL, V7, P165, DOI 10.1111/j.1600-051X.1980.tb01960.x; LOST C, 1989, J CLIN PERIODONTOL, V16, P539, DOI 10.1111/j.1600-051X.1989.tb02333.x; Ludlow J, 2014, DENTOMAXILLOFAC RAD, V44; Machtei EE, 2010, J PERIODONTOL, V81, P1051, DOI 10.1902/jop.2010.090621; Marotti J, 2013, OR SURG OR MED OR PA, V115, P819, DOI 10.1016/j.oooo.2013.03.012; Mazza D, 2006, Minerva Stomatol, V55, P523; Merheb J, 2010, CLIN ORAL IMPLAN RES, V21, P612, DOI 10.1111/j.1600-0501.2009.01880.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mol A, 2004, PERIODONTOL 2000, V34, P34, DOI 10.1046/j.0906-6713.2003.003423.x; Musu D, 2016, OR SURG OR MED OR PA, V122, pE19, DOI 10.1016/j.oooo.2016.03.022; Needleman IG, 2002, J CLIN PERIODONTOL, V29, P6, DOI 10.1034/j.1600-051X.29.s3.15.x; Nguyen KCT, 2014, ULTRASONICS, V54, P1178, DOI 10.1016/j.ultras.2013.08.004; Nicolosi L, 2016, J PERIODONTAL RES; PALOU ME, 1987, J PERIODONTOL, V58, P262, DOI 10.1902/jop.1987.58.4.262; Pascual A, 2017, INT J PERIODONT REST, V37, P533, DOI 10.11607/prd.2848; PINSON M, 1995, J CLIN PERIODONTOL, V22, P118; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Salmon B, 2012, CLIN ORAL INVEST, V16, P643, DOI 10.1007/s00784-011-0533-z; Sawada K, 1984, Nihon Shishubyo Gakkai Kaishi, V26, P88; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Sun LY, 2015, AM J ORTHOD DENTOFAC, V147, P313, DOI 10.1016/j.ajodo.2014.10.032; Szopinski KT, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130289; Theodorakou C, 2012, BRIT J RADIOL, V85, P153, DOI 10.1259/bjr/19389412; Todescan JH, 1994, C PAULISTA ODONTOLOG, V16; Tsiolis FI, 2003, J CLIN PERIODONTOL, V30, P849, DOI 10.1034/j.1600-051X.2003.00380.x; Vasconcelos KD, 2012, DENTOMAXILLOFAC RAD, V41, P64, DOI 10.1259/dmfr/13676777; Walter C, 2015, QUINTESSENCE INT, V46, P81, DOI 10.3290/j.qi.a32513; Xiang XM, 2010, J PERIODONTOL, V81, P186, DOI 10.1902/jop.2009.090419; Zigdon-Giladi H, 2016, CLIN IMPLANT DENT R, V18, P1034, DOI 10.1111/cid.12362	66	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0200596	10.1371/journal.pone.0200596	http://dx.doi.org/10.1371/journal.pone.0200596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281591	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400006
J	Zhou, PP; Ding, QH; Luo, HB; Hou, XL				Zhou, Peipei; Ding, Qinghai; Luo, Haibo; Hou, Xinglin			Violence detection in surveillance video using low-level features	PLOS ONE			English	Article								It is very important to automatically detect violent behaviors in video surveillance scenarios, for instance, railway stations, gymnasiums and psychiatric centers. However, the previous detection methods usually extract descriptors around the spatiotemporal interesting points or extract statistic features in the motion regions, leading to limited abilities to effectively detect video-based violence activities. To address this issue, we propose a novel method to detect violence sequences. Firstly, the motion regions are segmented according to the distribution of optical flow fields. Secondly, in the motion regions, we propose to extract two kinds of low-level features to represent the appearance and dynamics for violent behaviors. The proposed low-level features are the Local Histogram of Oriented Gradient (LHOG) descriptor extracted from RGB images and the Local Histogram of Optical Flow (LHOF) descriptor extracted from optical flow images. Thirdly, the extracted features are coded using Bag of Words (BoW) model to eliminate redundant information and a specific-length vector is obtained for each video clip. At last, the video-level vectors are classified by Support Vector Machine (SVM). Experimental results on three challenging benchmark datasets demonstrate that the proposed detection approach is superior to the previous methods.	[Zhou, Peipei; Ding, Qinghai; Luo, Haibo; Hou, Xinglin] Chinese Acad Sci, Shenyang Inst Automat, Shenyang, Liaoning, Peoples R China; [Zhou, Peipei; Hou, Xinglin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Peipei; Luo, Haibo; Hou, Xinglin] Chinese Acad Sci, Key Lab Optoelect Informat Proc, Shenyang, Liaoning, Peoples R China; [Zhou, Peipei; Luo, Haibo; Hou, Xinglin] Key Lab Image Understanding & Comp Vis, Shenyang, Liaoning, Peoples R China; [Ding, Qinghai] Space Star Technol Co Ltd, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Zhou, PP (corresponding author), Chinese Acad Sci, Shenyang Inst Automat, Shenyang, Liaoning, Peoples R China.; Zhou, PP (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Zhou, PP (corresponding author), Chinese Acad Sci, Key Lab Optoelect Informat Proc, Shenyang, Liaoning, Peoples R China.; Zhou, PP (corresponding author), Key Lab Image Understanding & Comp Vis, Shenyang, Liaoning, Peoples R China.	zhoupeipei@sia.cn						Andrade EL, 2006, ICPR; Nievas EB, 2011, LECT NOTES COMPUT SC, V6855, P332, DOI 10.1007/978-3-642-23678-5_39; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen M, 2009, MOSIFT RECOGNIZING H; Cheng W.H, 2003, P 5 ACM SIGMM INT WO, P109, DOI DOI 10.1145/973264.973282; Clarin C., 2005, PCSC, V6, P150; DALAL N, 2005, PROC CVPR IEEE, P886, DOI DOI 10.1109/CVPR.2005.177; Datta A, 2002, INT C PATT RECOG, P433, DOI 10.1109/ICPR.2002.1044748; de Souza FDM, 2010, SIBGRAPI; Deniz O, 2014, PROCEEDINGS OF THE 2014 9TH INTERNATIONAL CONFERENCE ON COMPUTER VISION, THEORY AND APPLICATIONS (VISAPP 2014), VOL 2, P478; Dong ZH, 2016, COMM COM INF SC, V662, P517, DOI 10.1007/978-981-10-3002-4_43; Fang ZJ, 2016, MULTIMED TOOLS APPL, V75, P14617, DOI 10.1007/s11042-016-3316-3; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Fu EY, 2017, INT J PERVASIVE COMP, V13, P130, DOI 10.1108/IJPCC-02-2017-0018; Fu EY, 2015, IEEE INT SYM MULTIM, P57, DOI 10.1109/ISM.2015.98; Gao Y, 2016, IMAGE VISION COMPUT, V48-49, P37, DOI 10.1016/j.imavis.2016.01.006; Hassner T., 2012, P 2012 IEEE COMPUTER, P1, DOI DOI 10.1109/CVPRW.2012.6239348; He KM, 2013, IEEE T PATTERN ANAL, V35, P1397, DOI 10.1109/TPAMI.2012.213; Huang JF, 2014, 2014 11TH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (FSKD), P565, DOI 10.1109/FSKD.2014.6980896; Lam V., 2016, MULTIMED TOOLS APPL, V76, P1; Laptev I, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P432, DOI 10.1109/iccv.2003.1238378; Liang-Hua Chen, 2011, Proceedings of the 2011 Eighth International Conference on Computer Graphics, Imaging and Visualization (CGIV 2011), P119, DOI 10.1109/CGIV.2011.14; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Peng XJ, 2016, COMPUT VIS IMAGE UND, V150, P109, DOI 10.1016/j.cviu.2016.03.013; Scheider Marion, 2015, CIDADES, P1, DOI 10.7749/citiescommunitiesterritories.jun2015.030.art03; Senst T, 2015, LOCAL FEATURE BASED, P1; Senst T, 2017, IEEE T INF FOREN SEC, V12, P2945, DOI 10.1109/TIFS.2017.2725820; Gracia IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120448; Soomro K., 2012, ARXIV12120402; Sudhakaran S, 2017, LEARNING DETECT VIOL; Wang LM, 2016, LECT NOTES COMPUT SC, V9912, P20, DOI 10.1007/978-3-319-46484-8_2; Xu Dan, 2015, ARXIV151001553; Xu L, 2014, INT CONF ACOUST SPEE; Zach C, 2007, LECT NOTES COMPUT SC, V4713, P214, DOI 10.1007/978-3-540-74936-3_22; Zhang T, 2017, MULTIMED TOOLS APPL, V76, P1419, DOI 10.1007/s11042-015-3133-0; Zhang T, 2016, MULTIMED TOOLS APPL, V75, P7327, DOI 10.1007/s11042-015-2648-8; Zhou PP, 2017, J PHYS CONF SER, V844, DOI 10.1088/1742-6596/844/1/012044	37	36	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203668	10.1371/journal.pone.0203668	http://dx.doi.org/10.1371/journal.pone.0203668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281588	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400026
J	Yu, SQ; Frueh, BE; Steinmair, D; Ebneter, A; Wolf, S; Zinkernagel, MS; Munk, MR				Yu, Siqing; Frueh, Beatrice E.; Steinmair, Dagmar; Ebneter, Andreas; Wolf, Sebastian; Zinkernagel, Martin S.; Munk, Marion R.			Cataract significantly influences quantitative measurements on swept-source optical coherence tomography angiography imaging	PLOS ONE			English	Article							FOVEAL AVASCULAR ZONE; DIABETIC-RETINOPATHY; CAPILLARY PLEXUSES; OXYGEN-SATURATION; VASCULAR DENSITY; RETINAL-VESSELS; SPECTRAL-DOMAIN; ARTIFACTS; EYES; MICROANGIOGRAPHY	Purpose To analyze retinal blood flow before and after cataract surgery using swept-source optical coherence tomography angiography (SS-OCTA). Methods Prospective observational study. Consecutive patients were recruited and scanned using SS-OCTA before and after cataract surgery. Laser flare photometry were performed post-surgery. Perfusion and vessel density of superficial (SCP) and deep capillary plexuses (DCP) of the 3 x 3 mm images as well as foveal avascular zone (FAZ) measurements were assessed. Vessel continuity, vessel visibility and presence of artefacts were evaluated by two blinded graders using a predefined grading protocol. Results Thirteen eyes of 12 patients met the inclusion criteria. There was a significant increase of perfusion and vessel densities in both the SCP and the DCP after cataract surgery within the 3 x 3 mm images. Significantly better distinguishability of FAZ border was observed postoperatively in both SCP and DCP, however, FAZ area and perimeter measurements did not significantly change after cataract surgery. Mean number of motion artifacts in SCP and DCP numerically decreased by 37% (P = .089) and 42% (P = .080). Conclusions Lens opacities have a significant influence on retinal blood flow measurements in SS-OCTA and should be considered in quantitative vessel analysis. Inflammation may also impact the assessment of density parameters. FAZ measurements seems to be the most robust parameters in terms of media opacity.	[Munk, Marion R.] Univ Bern, Inselspital, Bern Univ Hosp, Dept Ophthalmol, Bern, Switzerland; Univ Bern, Inselspital, Bern Univ Hosp, Dept Clin Res, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Munk, MR (corresponding author), Univ Bern, Inselspital, Bern Univ Hosp, Dept Ophthalmol, Bern, Switzerland.	marion_munk@hotmail.com	Wolf, Sebastian/B-8782-2008; Ebneter, Andreas/C-5226-2017	Wolf, Sebastian/0000-0002-7467-7028; Yu, Siqing/0000-0002-8360-5552; Ebneter, Andreas/0000-0001-6666-2558				Al-Sheikh Mayss, 2017, Int J Retina Vitreous, V3, P13, DOI 10.1186/s40942-017-0068-9; Al-Sheikh M, 2017, BRIT J OPHTHALMOL, V101, P449, DOI 10.1136/bjophthalmol-2016-308764; Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; Chen FK, 2016, CLIN EXP OPHTHALMOL, V44, P388, DOI 10.1111/ceo.12683; Chen H, 2017, ACTA OPHTHALMOL, V95, pE436, DOI 10.1111/aos.13332; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Coscas F, 2016, INVEST OPHTH VIS SCI, V57, pOCT211, DOI 10.1167/iovs.15-18793; De Vitis LA, 2016, OPHTHALMIC RES, V56, P155, DOI 10.1159/000447094; Falavarjani KG, 2017, BRIT J OPHTHALMOL, V101, P564, DOI 10.1136/bjophthalmol-2016-309104; Fenner B. J., 2017, BR J OPHTHALMOL; Ferrara D, 2016, CLIN EXP OPHTHALMOL, V44, P367, DOI 10.1111/ceo.12781; Garrity ST, 2017, INVEST OPHTH VIS SCI, V58, P5548, DOI 10.1167/iovs.17-22036; Grieshaber MC, 2007, SURV OPHTHALMOL, V52, pS144, DOI 10.1016/j.survophthal.2007.08.010; Hwang TS, 2015, RETINA-J RET VIT DIS, V35, P2371, DOI 10.1097/IAE.0000000000000716; Kuehlewein L, 2015, INVEST OPHTH VIS SCI, V56, P3984, DOI 10.1167/iovs.15-16510; La Mantia A, 2018, RETINA; La Spina C, 2017, RETINA-J RET VIT DIS, V37, P1636, DOI 10.1097/IAE.0000000000001426; Mo S, 2016, INVEST OPHTH VIS SCI, V57, pOCT130, DOI 10.1167/iovs.15-18932; Munk MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177059; Nakano Y, 2017, CLIN OPHTHALMOL, V11, P759, DOI 10.2147/OPTH.S132392; Povazay B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2773728; Ramm L, 2014, GRAEF ARCH CLIN EXP, V252, P1803, DOI 10.1007/s00417-014-2766-4; Rebhun CB, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.6.4; Sambhav K, 2017, SURV OPHTHALMOL, V62, P838, DOI 10.1016/j.survophthal.2017.05.006; Say EAT, 2017, RETINA-J RET VIT DIS, V37, P1660, DOI 10.1097/IAE.0000000000001414; Shahlaee A, 2016, AM J OPHTHALMOL, V165, P39, DOI 10.1016/j.ajo.2016.02.018; Spaide RF, 2017, PROG RETIN EYE RES; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Sullu Y, 2005, CLIN EXP OPHTHALMOL, V33, P246, DOI 10.1111/j.1442-9071.2005.01013.x; Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849; Told R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38132; Yagi T, 2012, GRAEF ARCH CLIN EXP, V250, P459, DOI 10.1007/s00417-011-1618-8; Zhang QQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.6.066008	33	39	39	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204501	10.1371/journal.pone.0204501	http://dx.doi.org/10.1371/journal.pone.0204501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278057	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200014
J	Komi, D; Kitani, T; Nakamura, A; Wakui, N; Mizutani, R; Ohue, M; Kametani, F; Akimitsu, N; Gojo, S				Komi, Daisuke; Kitani, Tomoya; Nakamura, Akihiro; Wakui, Naoki; Mizutani, Rena; Ohue, Masahito; Kametani, Fuyuki; Akimitsu, Nobuyoshi; Gojo, Satoshi			The DEAD-box RNA-binding protein DDX6 regulates parental RNA decay for cellular reprogramming to pluripotency	PLOS ONE			English	Article							TO-ZYGOTIC TRANSITION; MAGNETIC NANOPARTICLES; GENOME ACTIVATION; QUALITY-CONTROL; RO AUTOANTIGEN; MESSENGER-RNAS; Y RNAS; INSIGHTS; COMPLEX; LOCALIZATION	Cellular transitions and differentiation processes require mRNAs supporting the new phenotype but also the clearance of existing mRNAs for the parental phenotype. Cellular reprogramming from fibroblasts to induced pluripotent stem cells (iPSCs) occurs at the early stage of mesenchymal epithelial transition (MET) and involves drastic morphological changes. We examined the molecular mechanism for MET, focusing on RNA metabolism. DDX6, an RNA helicase, was indispensable for iPSC formation, in addition to RO60 and RNY1, a non-coding RNA, which form complexes involved in intracellular nucleotide sensing. RO60/RNY1/DDX6 complexes formed prior to processing body formation, which is central to RNA metabolism. The abrogation of DDX6 expression inhibited iPSC generation, which was mediated by RNA decay targeting parental mRNAs supporting mesenchymal phenotypes, along with microRNAs, such as miR-302b-3p. These results show that parental mRNA clearance is a prerequisite for cellular reprogramming and that DDX6 plays a central role in this process.	[Komi, Daisuke; Gojo, Satoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Regenerat Med, Kyoto, Japan; [Kitani, Tomoya] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Japan; [Nakamura, Akihiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat Cardiol & Nephrol, Kyoto, Japan; [Wakui, Naoki; Ohue, Masahito] Tokyo Inst Technol, Sch Comp, Dept Comp Sci, Tokyo, Japan; [Mizutani, Rena; Akimitsu, Nobuyoshi] Univ Tokyo, Radioisotope Ctr, Tokyo, Japan; [Kametani, Fuyuki] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Tokyo Institute of Technology; University of Tokyo; Tokyo Metropolitan Institute of Medical Science	Gojo, S (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Regenerat Med, Kyoto, Japan.	gojos@koto.kpu-m.ac.jp	Kametani, Fuyuki/G-4752-2011	Kametani, Fuyuki/0000-0001-9125-7001; Kami, Daisuke/0000-0002-9862-5513	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K15260]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a grant, Grant-in-Aid for challenging Exploratory Research 16K15260, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our sincere thanks to Ms. Sayuri Shikata, Ms. Yoshie Koyama, and Mr. Takanori Hayashi for their technical assistance. This research was supported by a grant, Grant-in-Aid for challenging Exploratory Research 16K15260, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Benoit B, 2009, DEVELOPMENT, V136, P923, DOI 10.1242/dev.031815; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; CLARK G, 1969, J IMMUNOL, V102, P117; Ernoult-Lange M, 2012, RNA, V18, P1702, DOI 10.1261/rna.034314.112; Giraldez AJ, 2010, CURR OPIN GENET DEV, V20, P369, DOI 10.1016/j.gde.2010.04.003; Hall Adam E, 2013, Biomol Concepts, V4, P103, DOI 10.1515/bmc-2012-0050; Han JW, 2011, ANTIOXID REDOX SIGN, V15, P1799, DOI 10.1089/ars.2010.3814; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hogg JR, 2007, GENE DEV, V21, P3067, DOI 10.1101/gad.1603907; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42853; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kami D, 2014, NANOMED-NANOTECHNOL, V10, P1165, DOI 10.1016/j.nano.2014.03.018; Kami D, 2011, J ARTIF ORGANS, V14, P215, DOI 10.1007/s10047-011-0568-6; Kami D, 2011, INT J MOL SCI, V12, P3705, DOI 10.3390/ijms12063705; Krude T, 2009, J CELL SCI, V122, P2836, DOI 10.1242/jcs.047563; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu X, 2018, CELL, V174, P187, DOI 10.1016/j.cell.2018.04.017; Maekawa S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1358-y; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; MITSUI Y, 1980, EXP CELL RES, V126, P289, DOI 10.1016/0014-4827(80)90267-0; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Nishimura T, 2015, CELL REP, V11, P1425, DOI 10.1016/j.celrep.2015.04.065; Ohue M, 2014, BIOINFORMATICS, V30, P3281, DOI 10.1093/bioinformatics/btu532; Ohue M, 2014, PROTEIN PEPTIDE LETT, V21, P766; Ostareck DH, 2014, WIRES RNA, V5, P659, DOI 10.1002/wrna.1237; Ozgur S, 2015, CELL REP, V13, P703, DOI 10.1016/j.celrep.2015.09.033; Perreault J, 2007, MOL BIOL EVOL, V24, P1678, DOI 10.1093/molbev/msm084; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Rutjes SA, 2001, RNA, V7, P741, DOI 10.1017/S1355838201002503; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sim S, 2009, MOL BIOL CELL, V20, P1555, DOI 10.1091/mbc.E08-11-1094; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Sultana Azmiri, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps1925s79; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; VANVENROOIJ WJ, 1993, MOL BIOL REP, V18, P113, DOI 10.1007/BF00986765; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Webb Benjamin, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0506s47; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wolin SL, 2013, RNA BIOL, V10, P1602, DOI 10.4161/rna.26166; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Yartseva V, 2015, CURR TOP DEV BIOL, V113, P191, DOI 10.1016/bs.ctdb.2015.07.020	60	8	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203708	10.1371/journal.pone.0203708	http://dx.doi.org/10.1371/journal.pone.0203708			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273347	gold, Green Published, Green Submitted			2022-12-27	WOS:000446124700008
J	Callister, SJ; McCue, LA; Boaro, AA; LaMarche, B; White, RA; Brown, JM; Ahring, BK				Callister, Stephen J.; McCue, Lee Ann; Boaro, Amy A.; LaMarche, Brian; White, Richard A., III; Brown, Joseph M.; Ahring, Birgitte K.			Identification of metabolite and protein explanatory variables governing microbiome establishment and re-establishment within a cellulose-degrading anaerobic bioreactor	PLOS ONE			English	Article							MUNICIPAL SOLID-WASTE; COMMUNITY STRUCTURE; MIXING CONDITIONS; ESCHERICHIA-COLI; SEQUENCE DATA; DEGRADATION; ACETATE; ADAPTATION; PROPIONATE; PERFORMANCE	Proteins, metabolites, and 16S rRNA measurements were used to examine the community structure and functional relationships within a cellulose degrading anaerobic bioreactor. The bioreactor was seeded with bovine rumen fluid and operated with a 4 day hydraulic retention time on cellulose (avicel) as sole carbon and energy source. The reactor performance and microbial community structure was monitored during the establishment of the cellulose-degrading community. After stable operation was established in the bioreactor, the mixing intensity was increased in order to investigate the effect of a physical disruption of the microbial community structure. Finally, the original conditions were re-established to understand the stability of the microbial community after a perturbation. All factors measured were found to be inter-correlated during these three distinct phases of operation (establishment, perturbation and re-establishment). In particular, the return of community structure and function to pre-perturbed conditions suggests that propionate fermentation and acetate utilization were the explanatory factors for community establishment and re-establishment.	[Callister, Stephen J.; LaMarche, Brian; White, Richard A., III; Brown, Joseph M.] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA USA; [Callister, Stephen J.; Ahring, Birgitte K.] Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA; [McCue, Lee Ann] Pacific Northwest Natl Lab, Environm Mol Sci Div, Richland, WA USA; [Boaro, Amy A.; Ahring, Birgitte K.] Washington State Univ Tri Cities, Bioprod Sci & Engn Lab, Richland, WA 99354 USA; [Ahring, Birgitte K.] Washington State Univ, Gene & Linda Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University; Washington State University	Ahring, BK (corresponding author), Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA.; Ahring, BK (corresponding author), Washington State Univ Tri Cities, Bioprod Sci & Engn Lab, Richland, WA 99354 USA.; Ahring, BK (corresponding author), Washington State Univ, Gene & Linda Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.	bka@tricity.wsu.edu	White, Richard Allen/H-5142-2019	White III, Richard Allen/0000-0002-6292-5936	Microbial Communities Initiative (MCI); Microbiomes in Transition Initiative (MinT); Department of Energy Office of Biological and Environmental Research under the Pan-omics project; EMSL [grid.436923.9]; Office of Biological and Environmental Research	Microbial Communities Initiative (MCI); Microbiomes in Transition Initiative (MinT); Department of Energy Office of Biological and Environmental Research under the Pan-omics project(United States Department of Energy (DOE)); EMSL; Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Partial support for this research was provided by the Microbial Communities Initiative (MCI), Microbiomes in Transition Initiative (MinT), and by the Department of Energy Office of Biological and Environmental Research under the Pan-omics project. Research was performed at the Bioproducts, Sciences & Engineering Laboratory (BSEL) located on the campus of Washington State University Tri-cities, Richland, WA. And, a portion of this research was performed using EMSL (grid.436923.9), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research and located on the campus of Pacific Northwest National Laboratory (PNNL) in Richland, WA.	Ahn S, 2016, J BIOL CHEM, V291, P11928, DOI 10.1074/jbc.M115.708149; AHRING BK, 1995, APPL MICROBIOL BIOT, V43, P559, DOI 10.1007/BF00218466; ANGELIDAKI I, 1990, APPL MICROBIOL BIOT, V33, P469, DOI 10.1007/BF00176668; Ayala-del-Rio HL, 2004, APPL ENVIRON MICROB, V70, P4950, DOI 10.1128/AEM.70.8.4950-4960.2004; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Boaro AA, 2014, FEMS MICROBIOL ECOL, V90, P802, DOI 10.1111/1574-6941.12435; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Callister SJ, 2006, J PROTEOME RES, V5, P1940, DOI 10.1021/pr060050o; Chang D-H, 2015, GENOME ANNOUNC, V3, P1; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EPA US, 2001, 1684 EPA US; FUKUZAKI S, 1990, APPL ENVIRON MICROB, V56, P719, DOI 10.1128/AEM.56.3.719-723.1990; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; GORRIS LGM, 1989, BIOTECHNOL LETT, V11, P61, DOI 10.1007/BF01026788; Guieysse B, 2001, APPL MICROBIOL BIOT, V56, P780, DOI 10.1007/s002530100676; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HILL DT, 1989, BIOL WASTE, V28, P33, DOI 10.1016/0269-7483(89)90047-5; HILL DT, 1988, BIOL WASTE, V23, P195, DOI 10.1016/0269-7483(88)90034-1; Hoffmann RA, 2008, BIOTECHNOL BIOENG, V100, P38, DOI 10.1002/bit.21730; HOLMS WH, 1971, J GEN MICROBIOL, V65, P57, DOI 10.1099/00221287-65-1-57; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Jumas-Bilak E, 2007, INT J SYST EVOL MICR, V57, P2314, DOI 10.1099/ijs.0.64883-0; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Konwar KM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-202; Krumholz LR, 2015, APPL ENVIRON MICROB, V81, P2339, DOI 10.1128/AEM.03358-14; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Maharjan RP, 2005, RES MICROBIOL, V156, P178, DOI 10.1016/j.resmic.2004.09.004; Mao SY, 2013, ANAEROBE, V24, P12, DOI 10.1016/j.anaerobe.2013.08.003; MAWSON AJ, 1991, WATER RES, V25, P1549, DOI 10.1016/0043-1354(91)90187-U; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McMahon KD, 2001, WATER RES, V35, P1817, DOI 10.1016/S0043-1354(00)00438-3; MUCHA H, 1988, APPL MICROBIOL BIOT, V27, P581, DOI 10.1007/BF00451636; NOIKE T, 1985, BIOTECHNOL BIOENG, V27, P1482, DOI 10.1002/bit.260271013; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; PAVLOSTATHIS SG, 1991, CRIT REV ENV CONTR, V21, P411, DOI 10.1080/10643389109388424; PAVLOSTATHIS SG, 1991, WATER SCI TECHNOL, V24, P35, DOI 10.2166/wst.1991.0217; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Robidart J, 2013, ENVIRON SCI TECHNOL, V47, P4399, DOI 10.1021/es3037302; Perez JAS, 2006, CHEM ENG J, V124, P1, DOI 10.1016/j.cej.2006.07.002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seshan H, 2014, WATER RES, V53, P282, DOI 10.1016/j.watres.2014.01.015; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Speece RE, 2006, WATER ENVIRON RES, V78, P460, DOI 10.2175/106143006X95492; Stroot PG, 2001, WATER RES, V35, P1804, DOI 10.1016/S0043-1354(00)00439-5; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Vanwonterghem I, 2014, ISME J, V8, P2015, DOI 10.1038/ismej.2014.50; Vavilin VA, 2005, BIOTECHNOL BIOENG, V89, P113, DOI 10.1002/bit.20323; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; White RA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00045-16; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wu YW, 2016, BIOINFORMATICS, V32, P605, DOI 10.1093/bioinformatics/btv638	57	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204831	10.1371/journal.pone.0204831	http://dx.doi.org/10.1371/journal.pone.0204831			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289885	Green Submitted, Green Published, gold			2022-12-27	WOS:000446545500025
J	Ghobrial, C; Mogahed, EA; El-Karaksy, H				Ghobrial, Carolyne; Mogahed, Engy Adel; El-Karaksy, Hanaa			Routine analysis of ascitic fluid for evidence of infection in children with chronic liver disease: Is it mandatory?	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; C-REACTIVE PROTEIN; RISK-FACTORS; DIAGNOSIS; CIRRHOSIS; PROFILE	Ascitic fluid infection is a major cause of morbidity and mortality in cirrhotic patients, requiring early diagnosis and therapy. We aimed to determine predictors of ascitic fluid infection in children with chronic liver disease. The study included 45 children with chronic liver disease and ascites who underwent 66 paracentesis procedures. Full history taking and clinical examination of all patients were obtained including fever, abdominal pain and tenderness and respiratory distress. Investigations included: complete blood count, C-reactive protein, full liver function tests, ascitic fluid biochemical analysis, cell count and culture. Our results showed that patients' ages ranged between 3 months to 12 years. Prevalence of ascitic fluid infection was 33.3%. Gram-positive bacteria were identified in six cases, and Gram-negative bacteria in five. Fever and abdominal pain were significantly more associated with infected ascites (p value = 0.004, 0.006). Patients with ascitic fluid infection had statistically significant elevated absolute neutrophilic count and C-reactive protein. Logistic regression analysis showed that fever, abdominal pain, elevated absolute neutrophilic count and positive C-reactive protein are independent predictors of ascitic fluid infection. Fever, elevated absolute neutrophilic count and positive C-reactive protein raise the probability of ascitic fluid infection by 3.88, 9.15 and 4.48 times respectively. The cut-off value for C-reactive protein for ascitic fluid infection was 7.2 with sensitivity 73% and specificity of 71%. In conclusion, prevalence of ascitic fluid infection in pediatric patients with chronic liver disease and ascites was 33.3%. Fever, abdominal pain, positive C-reactive protein and elevated absolute neutrophilic count are strong predictors of ascitic fluid infection. Therefore an empirical course of first-line antibiotics should be immediately started with presence of any of these predictors after performing ascitic fluid tapping for culture and sensitivity. In absence of these infection parameters, routine ascitic fluid analysis could be spared.	[Ghobrial, Carolyne; Mogahed, Engy Adel; El-Karaksy, Hanaa] Kasr Alainy Sch Med, Pediat Dept, Pediat Hepatol Unit, Cairo, Egypt		Mogahed, EA (corresponding author), Kasr Alainy Sch Med, Pediat Dept, Pediat Hepatol Unit, Cairo, Egypt.	engy.mogahed@kasralainy.edu.eg	El-Karaksy, Hanaa/ABG-6674-2020; Mogahed, Engy/ABD-2616-2021	El-Karaksy, Hanaa/0000-0002-8479-2847; 				ANDREU M, 1993, GASTROENTEROLOGY, V104, P1133, DOI 10.1016/0016-5085(93)90284-J; Bibi S, 2015, JCPSP-J COLL PHYSICI, V25, P95, DOI 02.2015/JCPSP.9599; Bruce BR, 2008, HARRISONS PRINCIPLES, P1979; Cadranel JF, 2013, WORLD J HEPATOL, V5, P104, DOI 10.4254/wjh.v5.i3.104; Caruntu Florin Alexandru, 2006, J Gastrointestin Liver Dis, V15, P51; Chinnock B, 2008, ANN EMERG MED, V52, P268, DOI 10.1016/j.annemergmed.2008.02.016; CROSSLEY IR, 1985, GUT, V26, P325, DOI 10.1136/gut.26.4.325; Dever JB, 2015, ALIMENT PHARM THER, V41, P1116, DOI 10.1111/apt.13172; Di Giorgio A, 2017, J PEDIATR GASTR NUTR, V64, P171, DOI 10.1097/MPG.0000000000001389; El-Shabrawi MHF, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-26; Evans LT, 2003, HEPATOLOGY, V37, P897, DOI 10.1053/jhep.2003.50119; Farahmand Fatemeh, 2013, Acta Med Iran, V51, P125; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Haghighat M, 2006, WORLD J GASTROENTERO, V12, P5890, DOI 10.3748/wjg.v12.i36.5890; HOEFS JC, 1985, DM-DIS MON, V31, P1, DOI 10.1016/0011-5029(85)90002-1; Kalvandi G, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.38973; Karnsakul W, 2017, J PEDIATR GASTR NUTR, V64, P83, DOI 10.1097/MPG.0000000000001209; Koulaouzidis A, 2008, ANN HEPATOL, V7, P255, DOI 10.1016/S1665-2681(19)31857-5; Koulaouzidis A, 2009, WORLD J GASTROENTERO, V15, P1042, DOI 10.3748/wjg.15.1042; Lata J, 2009, WORLD J GASTROENTERO, V15, P5505, DOI 10.3748/wjg.15.5505; LLOVET JM, 1993, AM J GASTROENTEROL, V88, P388; Natarajan SK, 2007, J GASTROEN HEPATOL, V22, P177, DOI 10.1111/j.1440-1746.2006.04400.x; Navasa M, 2004, LIVER INT, V24, P277, DOI 10.1111/j.1478-3231.2004.0934.x; Parsi MA, 2004, CLEV CLIN J MED, V71, P569, DOI 10.3949/ccjm.71.7.569; Paul K, 2015, J CLIN DIAGN RES, V9, pOJ1, DOI 10.7860/JCDR/2015/14326.6391; Preto-Zamperlini M, 2014, J PEDIATR GASTR NUTR, V58, P96, DOI 10.1097/MPG.0000000000000177; Rerknimitr R, 2006, WORLD J GASTROENTERO, V12, P7183, DOI 10.3748/wjg.v12.i44.7183; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Runyon BA, 2012, PRACTICE GUIDELINE M; Song KH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-41; Srivastava A, 2017, J PEDIATR GASTR NUTR, V64, P194, DOI 10.1097/MPG.0000000000001348; Thanopoulou Anastasia C., 2002, Eur J Intern Med, V13, P194, DOI 10.1016/S0953-6205(02)00027-4; Vieira SMG, 2005, J PEDIATR GASTR NUTR, V40, P289, DOI 10.1097/01.MPG.0000154659.54735.1D; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879; Yuan LY, 2013, ANN LAB MED, V33, P449, DOI 10.3343/alm.2013.33.6.449	35	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0203808	10.1371/journal.pone.0203808	http://dx.doi.org/10.1371/journal.pone.0203808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289914	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500007
J	Koshio, K; Arai, K; Waku, T; Wilson, PW; Hagiwara, Y				Koshio, Kazuya; Arai, Kazuhide; Waku, Tomonori; Wilson, Peter W.; Hagiwara, Yoshimichi			Suppression of droplets freezing on glass surfaces on which antifreeze polypeptides are adhered by a silane coupling agent	PLOS ONE			English	Article							ICE ADHESION; ANTIICING COATINGS; WINTER FLOUNDER; WATER DROPLETS; ANTI-ICE; PROTEIN; WETTABILITY; PERFORMANCE; IONS	The development of ice-phobic, glass-substrate surfaces is important for many reasons such as poor visibility through the ice-covered windshields of vehicles. The present authors have developed new glass surfaces coated with a silane coupling agent and polypeptides whose amino-acid sequence is identical to a partial sequence of winter flounder antifreeze protein. We have conducted experiments on the freezing of sessile water droplets on the glass surfaces, and measured the droplet temperature, contact angle, contact area and surface roughness. The results show that the supercooling temperature decreased noticeably in the case where a higher concentration solution of polypeptide was used for the coating. The adhesion strength of frozen droplets was lowest in the same case. In addition, we observed many nanoscale humps on the coated surface, which were formed by polypeptide aggregates in the solution. We argue that the combination of the hydrophilic humps and the hydrophobic base surfaces causes water molecules adjacent to the surfaces to have a variety of orientations in that plane, even after the ice layer started to grow. This then induces a misfit of water-molecule spacing in the ice layers and consequent formation of fragile polycrystalline structure. This explains the lower values of ice adhesion strength and supercooling enhancement in the cases of the polypeptide-coated glass plates.	[Koshio, Kazuya; Arai, Kazuhide] Kyoto Inst Technol, Grad Sch Sci & Technol, Div Mechanophys, Sakyo Ku, Kyoto, Japan; [Waku, Tomonori] Kyoto Inst Technol, Fac Mol Chem & Engn, Sakyo Ku, Kyoto, Japan; [Wilson, Peter W.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Wilson, Peter W.] Univ S Florida, Honors Coll, Tampa, FL USA; [Hagiwara, Yoshimichi] Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology; University of Tasmania; State University System of Florida; University of South Florida; Kyoto Institute of Technology	Hagiwara, Y (corresponding author), Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto, Japan.	yoshi@kit.ac.ip	Wilson, Peter/AAT-6428-2020	Wilson, Peter/0000-0002-1535-6398; Hagiwara, Yoshimichi/0000-0002-1425-2431	Japan Society for the Promotion of Science [15H02220]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	YH acknowledges the financial support of the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research (A) (No. 15H02220). https://www.jsps.go.jp/, https://www.jsps.go.jp/english/index.html.	Agui H, FROST FORMATIO UNPUB; Charpentier TVJ, 2013, J BIONIC ENG, V10, P139, DOI 10.1016/S1672-6529(13)60208-5; Chaudhary G, 2014, EXP THERM FLUID SCI, V57, P86, DOI 10.1016/j.expthermflusci.2014.04.007; Chen J, 2014, SMALL, V10, P4693, DOI 10.1002/smll.201401557; Chen J, 2013, ACS APPL MATER INTER, V5, P4026, DOI 10.1021/am401004t; Chernyy S, 2014, ACS APPL MATER INTER, V6, P6487, DOI 10.1021/am500046d; Eberle P, 2014, NANOSCALE, V6, P4874, DOI 10.1039/c3nr06644d; Esser-Kahn AP, 2010, J AM CHEM SOC, V132, P13264, DOI 10.1021/ja103038p; Evans RP, 2001, BBA-PROTEIN STRUCT M, V1547, P235, DOI 10.1016/S0167-4838(01)00190-X; Graeber G, 2017, P NATL ACAD SCI USA, V114, P11040, DOI 10.1073/pnas.1705952114; Gwak Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12019; Hayakari K, 2012, MOL SIMULAT, V38, P26, DOI 10.1080/08927022.2011.600759; Jung S, 2011, LANGMUIR, V27, P3059, DOI 10.1021/la104762g; Kim M., 2017, MAR DRUGS, V15; Kim P, 2012, ACS NANO, V6, P6569, DOI 10.1021/nn302310q; Kreder MJ, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.3; Kun H, 2007, BIOPOLYMERS, V88, P807, DOI 10.1002/bip.20844; Marshall CB, 2005, J BIOL CHEM, V280, P17920, DOI 10.1074/jbc.M500622200; Matsumoto K, 2007, INT J REFRIG, V30, P851, DOI 10.1016/j.ijrefrig.2006.11.009; Meuler AJ, 2010, ACS APPL MATER INTER, V2, P3100, DOI 10.1021/am1006035; Miyamoto T, 2018, HEAT MASS TRANSFER, V54, P2415, DOI 10.1007/s00231-018-2315-5; NAKAMURA M, 1986, NIPPON SERAM KYO GAK, V94, P1239; Nishi N., 2016, THESIS; Nishi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154782; Oberli L, 2014, ADV COLLOID INTERFAC, V210, P47, DOI 10.1016/j.cis.2013.10.018; Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538; Petrenko VF, 2003, CAN J PHYS, V81, P387, DOI 10.1139/P03-014; Sonnichsen FD, 1996, STRUCTURE, V4, P1325, DOI 10.1016/S0969-2126(96)00140-2; Subramanyam SB, 2013, LANGMUIR, V29, P13414, DOI 10.1021/la402456c; Wang CY, 2014, LANGMUIR, V30, P12819, DOI 10.1021/la5030444; Wang YL, 2015, SCI CHINA MATER, V58, P559, DOI 10.1007/s40843-015-0069-7; Wang YY, 2013, ACS APPL MATER INTER, V5, P3370, DOI 10.1021/am400429q; Wilson PW, 2013, PHYS CHEM CHEM PHYS, V15, P581, DOI 10.1039/c2cp43586a; Yin XY, 2015, ADV FUNCT MATER, V25, P4237, DOI 10.1002/adfm.201501101	34	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204686	10.1371/journal.pone.0204686	http://dx.doi.org/10.1371/journal.pone.0204686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289883	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000446545500022
J	Dirbaba, NB; Li, S; Wu, HJ; Yan, X; Wang, J				Dirbaba, Niguse Bekele; Li, Sen; Wu, Hongjuan; Yan, Xue; Wang, Jun			Organochlorine pesticides, polybrominated diphenyl ethers and polychlorinated biphenyls in surficial sediments of the Awash River Basin, Ethiopia	PLOS ONE			English	Article							RISK-ASSESSMENT; SURFACE SEDIMENTS; HONG-KONG; PERFLUOROALKYL SUBSTANCES; QUALITY GUIDELINES; SOUTH CHINA; EAST CHINA; BALTIC SEA; PCBS; RESIDUES	This study was initiated to document information on the levels of sediment contamination with organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs). Moreover, it was intended to identify compounds which impose major ecological risks to aquatic organisms. Surficial sediments were collected from 46 locations within the streams and rivers of the Awash River Basin. In total 30 compounds were included in this study: 16 OCPs, 7 PCBs and 7 PBDEs. The total concentrations of OCPs, PCBs, and PBDEs ranged from 6.63 to 206.13 ng g(-1)-dry weight (dw), 0.85 to 26.56 ng g(-1)-dw and 3.71 to 18.95 ng g(-1)-dw respectively. Out of all the tested OCPs, heptachlor, heptachlor epoxide, p,p'-dichlorodiphenyltrichloroethane (p,p'-DDT) and 8-hexachlorocyclohexane ((3-HCH) were the most abundant in the study area. The ratio of ((3-HCH/ZHCHs) indicated that HCHs were originally from earlier usage of HCH in the area whereas the ratio of (p,p'-DDT/p,p'-DDE) showed that the majority of DDT components were recently introduced into most of the sampling locations. Even though there were relatively low concentrations of PBDEs and PCBs across the sampling sites, substantial amounts of PCBs were observed in Addis Ababa City. According to the established ecological risk indices, p,p'DDT and y-HCH are the major concerns for potential adverse ecological impacts. This study provided the first comprehensive information on organohalogenated compounds' (OCs') occurrences, spatial distributions, and ecological risks in sediments of the Awash River Basin. Thus, the report will be very useful background information for further studies on sediment contamination with OCs' in the region. It also adds important first-hand data to the field of fresh water ecology and provides useful empirical evidence for setting pollution control priorities for an ecologically important, yet largely understudied region.	[Dirbaba, Niguse Bekele; Li, Sen; Wu, Hongjuan] Huazhong Univ Sci & Technol, Sch Environm & Sci & Engn, Wuhan, Hubei, Peoples R China; [Dirbaba, Niguse Bekele; Yan, Xue; Wang, Jun] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China; [Yan, Xue; Wang, Jun] Chinese Acad Sci, Sinoafrica Joint Res Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences	Wu, HJ (corresponding author), Huazhong Univ Sci & Technol, Sch Environm & Sci & Engn, Wuhan, Hubei, Peoples R China.; Yan, X; Wang, J (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China.; Yan, X; Wang, J (corresponding author), Chinese Acad Sci, Sinoafrica Joint Res Ctr, Wuhan, Hubei, Peoples R China.	hongjuanwu@mail.hust.edu.cn; yanx@wbgcas.cn; wangjun@wbgcas.cn	Wang, Jun/AAN-4446-2021	Wang, Jun/0000-0002-7574-9468; Li, Sen/0000-0002-1177-7339; Yan, Xue/0000-0003-4460-8117	Sino-Africa Joint Research Center; Chinese Academy of Sciences [Y623321K01]; Hundred Talents Program of the Chinese Academy of Sciences [Y329671K01]; Natural Science Key Foundation of Hubei Province of China; Sino-Africa Joint Research Center, Chinese Academy of Sciences [Y623321K01]	Sino-Africa Joint Research Center; Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Key Foundation of Hubei Province of China; Sino-Africa Joint Research Center, Chinese Academy of Sciences	This work was supported by Funding Project of Sino-Africa Joint Research Center (JW), Chinese Academy of Sciences (Y623321K01); the Hundred Talents Program of the Chinese Academy of Sciences (Y329671K01) (JW).; The authors are grateful to Natural Science Key Foundation of Hubei Province of China, Funding Project of Sino-Africa Joint Research Center, Chinese Academy of Sciences (Y623321K01), and the Hundred Talents Program of the Chinese Academy of Sciences (Y329671K01).	Aamir M, 2016, ECOTOX ENVIRON SAFE, V125, P128, DOI 10.1016/j.ecoenv.2015.12.005; Ali U, 2015, CHEMOSPHERE, V134, P172, DOI 10.1016/j.chemosphere.2015.03.020; Asante KA, 2011, ENVIRON INT, V37, P921, DOI 10.1016/j.envint.2011.03.011; Bai JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17624; Barakat AO, 2002, MAR POLLUT BULL, V44, P1426, DOI 10.1016/S0025-326X(02)00313-2; Bian CW, 2010, CONT SHELF RES, V30, P1189, DOI 10.1016/j.csr.2010.03.008; Binelli A, 2008, CHEMOSPHERE, V73, P1129, DOI 10.1016/j.chemosphere.2008.07.019; Binelli A, 2007, MAR POLLUT BULL, V54, P1220, DOI 10.1016/j.marpolbul.2007.03.021; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P181, DOI 10.1016/S0048-9697(01)01075-0; Carriger JF, 2011, ARCH ENVIRON CON TOX, V60, P281, DOI 10.1007/s00244-010-9623-1; Chen LG, 2009, CHEMOSPHERE, V76, P226, DOI 10.1016/j.chemosphere.2009.03.033; De Roma A, 2017, J VET DIAGN INVEST, V29, P122, DOI 10.1177/1040638716681389; Deribe E, 2011, SCI TOTAL ENVIRON, V410, P136, DOI 10.1016/j.scitotenv.2011.09.008; Doong RA, 2002, MAR POLLUT BULL, V45, P246, DOI 10.1016/S0025-326X(02)00102-9; Eljarrat E, 2004, ENVIRON SCI TECHNOL, V38, P2603, DOI 10.1021/es0301424; Environmental Protection Authority (EPA), 2004, DRAFT ENV IMP ASS GU; FAO, 2013, AWASH RIV BAS WAT AU; Forstner U., 1989, CONTAMINATED SEDIMEN; Gakuba E, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4790-1; Gao J, 2013, SCI TOTAL ENVIRON, V443, P7, DOI 10.1016/j.scitotenv.2012.10.086; Hallare AV, 2005, SCI TOTAL ENVIRON, V347, P254, DOI 10.1016/j.scitotenv.2004.12.002; Haylamicheal ID, 2009, ENVIRON INT, V35, P667, DOI 10.1016/j.envint.2008.11.004; HITCH RK, 1992, B ENVIRON CONTAM TOX, V48, P259, DOI 10.1007/BF00194381; Hong HS, 1999, MAR POLLUT BULL, V39, P376, DOI 10.1016/S0025-326X(99)00081-8; Hong SH, 2003, MAR POLLUT BULL, V46, P244, DOI 10.1016/S0025-326X(02)00399-5; Iwata H., 1995, ENVIRON SCI TECHNOL, V29, P272, DOI DOI 10.1021/ES00001A036; Kanzari F, 2014, SCI TOTAL ENVIRON, V478, P141, DOI 10.1016/j.scitotenv.2014.01.065; KOOPMANESSEBOOM C, 1994, PEDIATR RES, V36, P468, DOI 10.1203/00006450-199410000-00009; Lammel G, 2011, J ENVIRON MONITOR, V13, P3358, DOI 10.1039/c1em10479a; Li JP, 2016, APPL MATER TODAY, V3, P63, DOI 10.1016/j.apmt.2016.03.003; Li QZ, 2011, B ENVIRON CONTAM TOX, V87, P372, DOI 10.1007/s00128-011-0385-x; Liu RX, 2015, ENVIRON EARTH SCI, V73, P5007, DOI 10.1007/s12665-015-4317-7; Liu Y, 2005, MAR POLLUT BULL, V50, P1173, DOI 10.1016/j.marpolbul.2005.04.025; Long E.R., 1991, 52 NOAA NOS OMA; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Long ER, 2000, ECOL APPL, V10, P338, DOI 10.1890/1051-0761(2000)010[0338:DSQIUS]2.0.CO;2; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; MacDonald DD, 1994, DEV EVALUATION APPRO, V3; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Malik RN, 2014, SCI TOTAL ENVIRON, V481, P343, DOI 10.1016/j.scitotenv.2014.02.042; Manirakiza P, 2003, ARCH ENVIRON CON TOX, V44, P171, DOI 10.1007/s00244-002-2006-5; Mansour SA, 2009, HUM EXP TOXICOL, V28, P531, DOI 10.1177/0960327109347048; Meng J, 2014, J ENVIRON SCI-CHINA, V26, P2198, DOI 10.1016/j.jes.2014.09.002; Miglioranza KSB, 1999, ENVIRON POLLUT, V105, P91, DOI 10.1016/S0269-7491(98)00200-0; Ministry of Agriculture (MoA), 2007, REP 12 YEARS PEST IM; Newman MC, 2010, FUNDAMENTALS ECOTOXI, P5; Niu LL, 2013, ENVIRON SCI TECHNOL, V47, P12140, DOI 10.1021/es401630w; Omar WA, 2017, ENVIRON GEOCHEM HLTH, V39, P125, DOI 10.1007/s10653-016-9814-4; Parker H., 2016, THIRSTY FUTURE WATER; Perez F, 2014, ENVIRON RES, V135, P181, DOI 10.1016/j.envres.2014.08.004; Rajendran RB, 2005, ENVIRON INT, V31, P503, DOI 10.1016/j.envint.2004.10.009; Salo S, 2008, CHEMOSPHERE, V73, P1675, DOI 10.1016/j.chemosphere.2008.07.085; Samara F, 2006, ENVIRON POLLUT, V139, P489, DOI 10.1016/j.envpol.2005.06.001; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Sikrbic BD, 2017, ENVIRON SCI POLLUT R, V25, P260; Song WL, 2004, ENVIRON SCI TECHNOL, V38, P3286, DOI 10.1021/es035297q; Strandberg B, 1998, ENVIRON SCI TECHNOL, V32, P1754, DOI 10.1021/es970789m; Sun HW, 2016, ENVIRON POLLUT, V209, P177, DOI 10.1016/j.envpol.2015.11.040; [孙剑辉 SUN Jianhui], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P342; Taddese G, 2004, WATER AWASH RIVER BA; Tan L, 2009, ESTUAR COAST SHELF S, V84, P119, DOI 10.1016/j.ecss.2009.06.013; Teklu BM, 2016, CHEMOSPHERE, V161, P280, DOI 10.1016/j.chemosphere.2016.07.031; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; UN University/ StEP Initiative, 2013, SOLV E WAST PROBL ST; Wang W, 2017, ENVIRON POLLUT, V230, P1062, DOI 10.1016/j.envpol.2017.06.068; Westbom R, 2008, CHEMOSPHERE, V72, P1181, DOI 10.1016/j.chemosphere.2008.03.041; Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530; Wu CW, 2013, CHEMOSPHERE, V90, P2341, DOI 10.1016/j.chemosphere.2012.10.023; Wu YL, 2016, ENVIRON POLLUT, V219, P519, DOI 10.1016/j.envpol.2016.05.081; Yang RQ, 2005, CHEMOSPHERE, V61, P347, DOI 10.1016/j.chemosphere.2005.02.091; Yun XY, 2015, ECOTOXICOLOGY, V24, P172, DOI 10.1007/s10646-014-1370-z; Zacharewski T, 1998, ENVIRON HEALTH PERSP, V106, P577, DOI 10.2307/3433808; Zhang G, 2002, ENVIRON SCI TECHNOL, V36, P3671, DOI 10.1021/es0102888; Zhang HB, 2006, CHEMOSPHERE, V63, P633, DOI 10.1016/j.chemosphere.2005.08.006; Zhang ZL, 2004, ENVIRON POLLUT, V130, P249, DOI 10.1016/j.envpol.2003.12.002; Zhou HY, 1999, ARCH ENVIRON CON TOX, V36, P424, DOI 10.1007/PL00006615; Zhou RB, 2006, J HAZARD MATER, V137, P68, DOI 10.1016/j.jhazmat.2006.02.005; Zhou SS, 2014, CHEMOSPHERE, V114, P26, DOI 10.1016/j.chemosphere.2014.03.100	78	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205026	10.1371/journal.pone.0205026	http://dx.doi.org/10.1371/journal.pone.0205026			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286178	Green Submitted, gold, Green Published			2022-12-27	WOS:000446383500078
J	McKone, E; Robbins, RA; He, XM; Barnes, N				McKone, Elinor; Robbins, Rachel A.; He, Xuming; Barnes, Nick			Caricaturing faces to improve identity recognition in low vision simulations: How effective is current-generation automatic assignment of landmark points?	PLOS ONE			English	Article								Purpose Previous behavioural studies demonstrate that face caricaturing can provide an effective image enhancement method for improving poor face identity perception in low vision simulations (e.g., age-related macular degeneration, bionic eye). To translate caricaturing usefully to patients, assignment of the multiple face landmark points needed to produce the caricatures needs to be fully automatised. Recent development in computer science allows automatic face landmark detection of 68 points in real time and in multiple viewpoints. However, previous demonstrations of the behavioural effectiveness of caricaturing have used higher-precision caricatures with 147 landmark points per face, assigned by hand. Here, we test the effectiveness of the auto-assigned 68-point caricatures. We also compare this to the hand-assigned 147-point caricatures. Method We assessed human perception of how different in identity pairs of faces appear, when veridical (uncaricatured), caricatured with 68-points, and caricatured with 147-points. Across two experiments, we tested two types of low-vision images: a simulation of blur, as experienced in macular degeneration (testing two blur levels); and a simulation of the phos-phenised images seen in prosthetic vision (at three resolutions). Results The 68-point caricatures produced significant improvements in identity discrimination relative to veridical. They were approximately 50% as effective as the 147-point caricatures. Conclusion Realistic translation to patients (e.g., via real time caricaturing with the enhanced signal sent to smart glasses or visual prosthetic) is approaching feasibility. For maximum effectiveness software needs to be able to assign landmark points tracing out all details of feature and face shape, to produce high-precision caricatures.	[McKone, Elinor; Robbins, Rachel A.] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [McKone, Elinor] Australian Natl Univ, ARC Ctr Excellence Cognit & Its Disorders, Canberra, ACT, Australia; [He, Xuming] ShanghaiTech Univ, Sch Informat Sci & Technol, Shanghai, Peoples R China; [Barnes, Nick] Australian Natl Univ, Res Sch Engn, Canberra, ACT, Australia; [Barnes, Nick] CSIRO, Data61, Canberra, ACT, Australia; [Barnes, Nick] Bion Vis Australia, Carlton, Vic, Australia	Australian National University; Australian National University; ShanghaiTech University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	McKone, E (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.; McKone, E (corresponding author), Australian Natl Univ, ARC Ctr Excellence Cognit & Its Disorders, Canberra, ACT, Australia.	Elinor.McKone@anu.edu.au	Barnes, Nick/Y-2744-2018; Robbins, Rachel A/A-5542-2008	Barnes, Nick/0000-0002-9343-9535; McKone, Elinor/0000-0003-1655-4297; Robbins, Rachel/0000-0001-9363-4528	Australian Research Council [DP150100684]; National Health and Medical Research Council [1082358]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian Research Council (http://www.arc.gov.au/) grant DP150100684 to EM and National Health and Medical Research Council (https://www.nhmrc.gov.au/) 1082358 to NB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, OPHTHALMIC PHYSIOLOG; Ayton LN, 2014, PLOS ONE, DOI 10.1371/journal.pone.0115239; BARNES N, 2016, DS, V13, P3; BENSON P J, 1991, European Journal of Cognitive Psychology, V3, P105, DOI 10.1080/09541449108406222; Benson PJ, 1991, J NEURAL ENG, V3, P105; BRUCE V, 1994, Q J EXP PSYCHOL-A, V47, P119, DOI 10.1080/14640749408401146; BULLIMORE MA, 2007, INVEST OPHTHALMOL, V2020, P2020; CALDER AJ, 1997, PROCEEDINGS OF THE R, V127, P5191; CALDER AJ, 2003, COGNITION; CHANG M, 2010, KIM; CHANG M, 2011, JOURNAL OF NEURAL EN; CHANG M, 2009, JOURNAL OF NEURAL EN, V366, P5228; CHANG M, 2006, JOURNAL OF NEURAL EN, V3, P2; CHANG M, 2004, JOURNAL OF NEURAL EN; CHEN SC, 2015, JOURNAL OF NEURAL EN; Chen SC, 2009, VISION RES, V49, P1493, DOI 10.1016/j.visres.2009.02.003; Cimarolli VR, 2011, CLIN REHABILITATION, V26, P748, DOI 10.1177/0269215511429162; Davis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028800; DAWEL A, 2018, JOURNAL OF EXPERIMEN, P19; DUNCAN JL, 1944, CLIN EXP OPTOM; FACE, DD; Humayun MS, 2003, VISION RES, V43, P2573, DOI 10.1016/S0042-6989(03)00457-7; IRONS J, 2012, JOURNAL OF VISION; IRONS JL, 2017, VISION RES, V6, P2; ITZ ML, 2014, NEUROIMAGE, V8, P42; Johnston RA, 1997, VIS COGN, V4, P59, DOI 10.1080/713756748; Jourabloo A, 2016, PROC CVPR IEEE, P4188, DOI 10.1109/CVPR.2016.454; Kaufmann JM, 2012, BIOL PSYCHOL, V89, P21, DOI 10.1016/j.biopsycho.2011.08.011; LEE K, 1974, PSYCHOLOGICAL SCIENC; Lee KH, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046001; LEWIS MB, 1958, QUARTERLY JOURNAL OF; Li RN, 2005, PROCEEDINGS OF THE 2, V5, P5219, DOI 10.1109/IEMBS.2005.1615655; Lieby P, 2011, IEEE ENG MED BIO, P8017, DOI 10.1109/IEMBS.2011.6091977; Liu W., 2016, SSD SINGLE SHOT MULT, V21, P37; MCCARTHY C, 2003, J NEURAL ENG; McIntyre AH, 2013, APPL COGNITIVE PSYCH, V27, P725, DOI 10.1002/acp.2966; MCKONE E, 2014, VISION RES, V1, P7; MCKONE E, 2008, VISION RES, V10, P20; PELI E, 1991, INVEST OPHTH VIS SCI, V32, P2337; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; STEVENAGE S, 1995, BRITISH JOURNAL OF P, V2550; Stingl K, 2013, P ROYAL SOC B, V280, DOI 10.1098/rspb.2013.0077; Tejeria L, 2002, FACE RECOGNITION IN, V86, P1019, DOI 10.1136/bjo.86.9.1019; THOMPSON RW, 2010, INVEST OPHTHALMOL, V1167, P3; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; VALENTINE T, 2000, PERCEPTION; Valentine T, 2016, Q J EXP PSYCHOL, V69, P1996, DOI 10.1080/17470218.2014.990392; VANRHEEDE JJ, 1932, JOURNAL OF VISION; WANG N, 2017, NEUROCOMPUTING, V5, P13; Yang H, 2015, IEEE T IMAGE PROCESS, V24, P2393, DOI 10.1109/TIP.2015.2421438; YARDLEY L, 2008, JOURNAL OF PSYCHOSOM, V3, P13; Zhu SZ, 2015, PROC CVPR IEEE, P4998, DOI 10.1109/CVPR.2015.7299134; ZRENNER E, 2010, PROCEEDINGS OF THE R, V1747, P1098; ARCHIVES OF OPHTHALM, P117; JOURNAL OF NEURAL EN	55	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204361	10.1371/journal.pone.0204361	http://dx.doi.org/10.1371/journal.pone.0204361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286112	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500018
J	Shim, JS; Park, DS; Baek, DH; Jha, N; Park, SI; Yun, HJ; Kim, WJ; Ryu, JJ				Shim, Ji Suk; Park, Dong-sik; Baek, Dong-Heon; Jha, Nayansi; Park, Serk In; Yun, Hyoung Jin; Kim, Won Jong; Ryu, Jae Jun			Antimicrobial activity of NO-releasing compounds against periodontal pathogens	PLOS ONE			English	Article							NITRIC-OXIDE; POTENTIAL APPLICATION; ANTIBACTERIAL AGENTS; DELIVERY; DISEASES; NANOPARTICLES; TETRACYCLINE; DENDRIMERS; EFFICACY	This study describes the successful synthesis of nitric oxide (NO)-releasing compounds with biodegradable and injectable properties and demonstrates that the kinetics of NO release vary according to the type of NO donor. The antimicrobial activity of NO-releasing compounds against three common periodontal pathogens, i.e., Aggregatibacter actinomy-cetemcomitans, Porphyromonas gingivalis, and Actinomyces israelii, was investigated using a susceptibility assay. Human gingival fibroblasts were treated with NO-releasing compounds at the minimum concentrations required for bacterial growth and cytotoxicity was evaluated using the MTT cell proliferation assay. Our results suggest that NO-releasing compounds can be used topically to treat both gram-negative and gram-positive periodontal pathogens. Comparison of the antimicrobial activity and cytotoxicity assay results between the NO-releasing compounds revealed that an NO donor comprising a macromolecule without surface charge, a lower instantaneous NO concentration, and an adequate supply of NO were associated with a strong bactericidal effect and low cytotoxicity. NO-releasing compounds with these properties may be suitable for treatment of periodontitis.	[Shim, Ji Suk] Korea Univ, Dept Dent, Ansan Hosp, Ansan, South Korea; [Park, Dong-sik; Kim, Won Jong] Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang, South Korea; [Baek, Dong-Heon; Yun, Hyoung Jin] Dankook Univ, Dept Oral Microbiol & Immunol, Coll Dent, Cheonan, South Korea; [Jha, Nayansi] Korea Univ, Grad Sch, Seoul, South Korea; [Park, Serk In] Korea Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Ryu, Jae Jun] Korea Univ, Dept Dent, Anam Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Pohang University of Science & Technology (POSTECH); Dankook University; Korea University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, WJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang, South Korea.; Ryu, JJ (corresponding author), Korea Univ, Dept Dent, Anam Hosp, Seoul, South Korea.	wkim@postech.ac.kr; koprosth@unitel.co.kr	Park, Serk In/D-2840-2011; Ryu, Jae-Jun/AAL-6362-2020	Park, Serk In/0000-0001-8643-5096; Ryu, Jae-Jun/0000-0001-6903-5955; Shim, Ji Suk/0000-0002-4112-6051	National Research Foundation of Korea(NRF) grant - Korea government(MSIP; Ministry of Science, ICT & Future Planning) [2017R1D1A1B03036033]	National Research Foundation of Korea(NRF) grant - Korea government(MSIP; Ministry of Science, ICT & Future Planning)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP; Ministry of Science, ICT & Future Planning) (No. 2017R1D1A1B03036033).	Al-Ani B, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000025; Azevedo MM, 2014, J MED MICROBIOL, V63, P1167, DOI 10.1099/jmm.0.069609-0; Backlund CJ, 2015, J DENT RES, V94, P1092, DOI 10.1177/0022034515589314; Backlund CJ, 2014, J DENT RES, V93, P1089, DOI 10.1177/0022034514529974; Backlund CJ, 2016, ACTA BIOMATER, V29, P198, DOI 10.1016/j.actbio.2015.10.021; Cha MH, 2011, J COLLOID INTERF SCI, V360, P78, DOI 10.1016/j.jcis.2011.04.041; Da Rocha Huberth Alexandre Junior, 2015, J Int Acad Periodontol, V17, P82; De Ceulaer J, 2014, EUR J CLIN MICROBIOL, V33, P1873, DOI 10.1007/s10096-014-2160-5; De Colli M, 2015, CLIN ORAL INVEST, V19, P1269, DOI 10.1007/s00784-014-1344-9; Emtiazi Giti, 1994, Biodegradation, V5, P83, DOI 10.1007/BF00700633; Esposito E, 1997, J MICROENCAPSUL, V14, P175, DOI 10.3109/02652049709015331; Fukada SY, 2008, J DENT RES, V87, P1155, DOI 10.1177/154405910808701207; GENCO RJ, 1981, J PERIODONTOL, V52, P545, DOI 10.1902/jop.1981.52.9.545; Ghaffari A, 2006, NITRIC OXIDE-BIOL CH, V14, P21, DOI 10.1016/j.niox.2005.08.003; GOODSON JM, 1983, J PERIODONTOL, V54, P575, DOI 10.1902/jop.1983.54.10.575; Hecht DW, 2007, METHODS ANTIMICROBIA; Hetrick EM, 2008, ACS NANO, V2, P235, DOI 10.1021/nn700191f; HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030; Jain N, 2008, DRUG DISCOV TODAY, V13, P932, DOI 10.1016/j.drudis.2008.07.010; Jones ML, 2010, APPL MICROBIOL BIOT, V88, P401, DOI 10.1007/s00253-010-2733-x; Kang Y, 2015, J CONTROL RELEASE, V220, P624, DOI 10.1016/j.jconrel.2015.08.057; Kaplish V, 2013, PHARMACOPHORE, V4, P39; Katsarelis H, 2015, J DENT RES, V94, P534, DOI 10.1177/0022034515572021; Kim J, 2014, J MATER CHEM B, V2, P341, DOI 10.1039/c3tb21259a; Lu Y, 2015, ACTA BIOMATER, V12, P62, DOI 10.1016/j.actbio.2014.10.028; MARLETTA M A, 1990, Biofactors, V2, P219; Mastiholimath V. S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P68; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; NI PH, 1995, J MEMBRANE SCI, V103, P51; Park JS, 2013, SUPERLATTICE MICROST, V64, P7, DOI 10.1016/j.spmi.2013.09.019; Rams TE, 2014, J PERIODONTOL, V85, P160, DOI 10.1902/jop.2013.130142; Soskolne WA, 1997, CRIT REV ORAL BIOL M, V8, P164, DOI 10.1177/10454411970080020501; Sun B, 2012, BIOMACROMOLECULES, V13, P3343, DOI 10.1021/bm301109c; Tomasi C, 2004, J CLIN PERIODONTOL, V31, P589, DOI 10.1111/j.1600-051X.2004.00524.x; Vyas SP, 2000, J CLIN PHARM THER, V25, P21, DOI 10.1046/j.1365-2710.2000.00261.x; Yang L, 2018, BIOCONJUGATE CHEM, V29, P35, DOI 10.1021/acs.bioconjchem.7b00537; Zhou ZR, 2006, BIOMACROMOLECULES, V7, P2565, DOI 10.1021/bm060361s	37	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0199998	10.1371/journal.pone.0199998	http://dx.doi.org/10.1371/journal.pone.0199998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286117	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500002
J	Dancak, M; Hrones, M; Sochor, M; Sochorova, Z				Dancak, Martin; Hrones, Michal; Sochor, Michal; Sochorova, Zuzana			Thismia kelabitiana (Thismiaceae), a new unique Fairy Lantern from Borneo potentially threatened by commercial logging	PLOS ONE			English	Article							TRIURIDACEAE; KALIMANTAN	Thismia kelabitiana, a new unique species from the Sarawak state of Malaysia in the island of Borneo is described and illustrated. This new species is not similar to any species of Thismia described so far especially by having a unique form of mitre and outer perianth lobes deeply divided into 8-10 acute lobes and forming striking fringe around perianth tube opening. The species appears to be critically endangered due to ongoing logging activities in the region. It may potentially become a surrogate species for lower montane forests of the region and thus help protect them against further destruction.	[Dancak, Martin] PalackY Univ, Dept Ecol & Environm Sci, Olomouc, Czech Republic; [Hrones, Michal; Sochorova, Zuzana] Palacky Univ, Dept Bot, Olomouc, Czech Republic; [Sochor, Michal] Crop Res Inst, Dept Genet Resources Vegetables Med & Special Pla, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Crop Research Institute (CRI)	Dancak, M (corresponding author), PalackY Univ, Dept Ecol & Environm Sci, Olomouc, Czech Republic.	martin.dancak@upol.cz	Sochor, Michal/AAF-7666-2020; Sochor, Michal/G-7270-2016; Dančák, Martin/AAB-9537-2019; Sochor, Michal/AAE-2042-2022; Sochorová, Zuzana/ABG-7697-2020	Dančák, Martin/0000-0002-3851-4969; Sochor, Michal/0000-0002-6525-1295; Sochorová, Zuzana/0000-0003-0022-9780; Hrones, Michal/0000-0002-0380-929X	Internal Grant Agency of the Palacky University [IGA PrF-2018-001]; (Sustainable development of research in the Centre of the Region Hana) from the National Program of Sustainability I, MEYS [LO1204]; Ministry of Education, Youth and Sports of the Czech Republic [INTER-TRANSFER LTT17017]	Internal Grant Agency of the Palacky University; (Sustainable development of research in the Centre of the Region Hana) from the National Program of Sustainability I, MEYS; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Michal Hrones was supported by the project no. IGA PrF-2018-001 from the Internal Grant Agency of the Palacky University. Michal Sochor was supported by grant No. LO1204 (Sustainable development of research in the Centre of the Region Hana) from the National Program of Sustainability I, MEYS. Martin Dancak was supported by a grant from the Ministry of Education, Youth and Sports of the Czech Republic (grant number: INTER-TRANSFER LTT17017). Zuzana Sochorova was supported by the project no. IGA PrF-2018-001 from the Internal Grant Agency of the Palacky University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Berger J, 1997, CONSERV BIOL, V11, P69, DOI 10.1046/j.1523-1739.1997.95481.x; Budiharta S, 2011, ORYX, V45, P172, DOI 10.1017/S0030605310001092; Caro T. M, 2010, CONSERVATION PROXY I; Fleishman E, 2000, ECOL APPL, V10, P569, DOI 10.1890/1051-0761(2000)010[0569:ANMFSO]2.0.CO;2; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Global Forest Watch, 2010, SAR LOGG CONC 2010 2; Hrones M, 2018, PLANT ECOL EVOL, V151, P110, DOI 10.5091/plecevo.2018.1387; Hrones M, 2015, PHYTOTAXA, V234, P172; Jonker F. P., 1948, FLORA MALESIANA 1, P13; Jonker FP., 1938, MEDEDEELINGEN BOT MU, V51, P1; Kiew Ruth, 1999, Gardens' Bulletin (Singapore), V51, P179; Kumar P, 2017, PHYTOTAXA, V319, P225, DOI 10.11646/phytotaxa.319.3.2; Lhota S, 2012, AM J PRIMATOL, V74, P193, DOI 10.1002/ajp.21983; Luu HT, 2014, PHYTOTAXA, V164, P190; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Smets EF, 2013, MYCOHETEROTROPHY BIO, P103, DOI DOI 10.1007/978-1-4614-5209-63; Sochor M, 2018, PLANT SYST EVOL, V304, P699, DOI 10.1007/s00606-018-1504-5; Sochor M, 2017, PHYTOTAXA, V295, P263, DOI 10.11646/phytotaxa.295.3.7; Thiele K, 2012, TELOPEA, V9, P765; Tsukaya H, 2016, PHYTOTAXA, V266, P146, DOI 10.11646/phytotaxa.266.2.9; Tsukaya H, 2014, PHYTOTAXA, V170, P283, DOI 10.11646/phytotaxa.170.4.6; Tsukaya H, 2013, SYST BOT, V38, P600, DOI 10.1600/036364413X670476; Tsukaya H, 2012, SYST BOT, V37, P53, DOI 10.1600/036364412X616639	25	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203443	10.1371/journal.pone.0203443	http://dx.doi.org/10.1371/journal.pone.0203443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281609	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400021
J	Gibbs, A; Jewkes, R; Willan, S; Washington, L				Gibbs, Andrew; Jewkes, Rachel; Willan, Samantha; Washington, Laura			Associations between poverty, mental health and substance use, gender power, and intimate partner violence amongst young (18-30) women and men in urban informal settlements in South Africa: A cross-sectional study and structural equation model	PLOS ONE			English	Article							PREVALENCE; MULTICOUNTRY; PERPETRATION; INCOME; RISK; ASIA	Research suggests that poverty is a key driver of intimate partner violence (IPV), however detailed analysis suggests that this relationship is not clear, either for women's experience or men's perpetration of IPV. We explored associations between poverty and IPV using cross-sectional data from the Stepping Stones and Creating Futures cluster randomized control trial, in urban informal settlements in Durban, South Africa, with young (18-30) people. Using logistic regression and structural equation modelling we assess associations between poverty and women's experience and men's perpetration of physical and/or sexual IPV in the past 12 months. 680 women and 677 men were recruited into the study between September 2015 and September 2016. The analyses highlight how specific forms or measures of poverty intersecting with gender identities shape IPV. For men we found indicators of economic provision were associated with IPV perpetration, while for women food-insecurity was key to IPV experience. We also found similarities between women and men. First, food-insecurity and childhood traumas shaped pathways to substance misuse and poor mental health that increased IPV. Second, there was a resilience pathway in both models, whereby those with more education had increased gender equitable attitudes and fewer controlling behaviours, which reduced IPV. Interventions to reduce IPV need to work to reduce household food insecurity, but these need to be combined with gender transformative interventions. Interventions should also focus on reducing the impact of mental health and substance misuse. Finally, working to increase educational attainment is a long-term critical intervention to reduce IPV.	[Gibbs, Andrew] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa; [Gibbs, Andrew; Jewkes, Rachel; Willan, Samantha] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Washington, Laura] Project Empower, Durban, South Africa	University of Kwazulu Natal; South African Medical Research Council	Gibbs, A (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa.; Gibbs, A (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.	andrew.gibbs@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267; Gibbs, Andrew/0000-0003-2812-5377	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research is funded through the What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) funded by the UK Government's Department for International Development (DFID). However, the views expressed do not necessarily reflect the department's official policies and the funders had no role in study design; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the paper for publication. Funding was managed by the South African Medical Research Council.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; [Anonymous], 2011, WORKING PAPER; [Anonymous], 2015, 22 UN HAB; Bhatla N, 2010, SOCIAL PROTECTION AS DEVELOPMENT POLICY: ASIAN PERSPECTIVES, P219; Bingham N.H., 2010, REGRESSION LINEAR MO; Buller AM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3129-3; Decker MR, 2014, J ADOLESCENT HEALTH, V55, pS58, DOI 10.1016/j.jadohealth.2014.08.022; Deitchler M., 2010, VALIDATION MEASURE H; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Fleming PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118639; Fong S, 2016, INT J GYNECOLOGY OBS; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gibbs A, 2017, GLOB HLTH ACTION, P1; Gibbs A, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23676; Gibbs A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4223-x; Gibbs A, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17362; Groes-Green C., 2009, NORDIC J AFRICAN STU, V18, P286; HDA, 2012, KWAZULU NAT INF SETT; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Hidrobo M, 2013, EFFECT CASH VOUCHERS; Huchzermeyer M, 2006, INFORMAL SETTLEMENTS; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002381; Jewkes R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1325; Jewkes R, 2013, LANCET GLOB HEALTH, V1, pE208, DOI 10.1016/S2214-109X(13)70069-X; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Johnson M.P., 2010, TYPOLOGY DOMESTIC VI; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Lagdon S, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.24794; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Machisa MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175240; Machisa MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150986; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Patel V, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002257; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peterman A, 2017, AM J PUBLIC HEALTH, V107, P747, DOI 10.2105/AJPH.2017.303694; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ricks JL, 2016, PUBLIC HEALTH NUTR, V19, P914, DOI 10.1017/S1368980015001986; Tsai AC, 2012, SOCIAL SCI MED, V74; Vyas S, 2009, J INT DEV, V21, P577, DOI 10.1002/jid.1500; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	46	72	72	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204956	10.1371/journal.pone.0204956	http://dx.doi.org/10.1371/journal.pone.0204956			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281677	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400071
J	Randles, D; Benjamin, R; Martens, JP; Heine, SJ				Randles, Daniel; Benjamin, Rachele; Martens, Jason P.; Heine, Steven J.			Searching for answers in an uncertain world: Meaning threats lead to increased working memory capacity	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; GENERAL FLUID INTELLIGENCE; SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; COMPENSATORY AFFIRMATION; STEREOTYPE THREAT; SELF-ESTEEM; PAIN; SYSTEM; MAINTENANCE	The Meaning Maintenance Model posits that individuals seek to resolve uncertainty by searching for patterns in the environment, yet little is known about how this is accomplished. Four studies investigated whether uncertainty has an effect on people's cognitive functioning. In particular, we investigated whether meaning threats lead to increased working memory capacity. In each study, we exposed participants to either an uncertain stimulus used to threaten meaning in past studies, or a control stimulus. Participants then completed a working memory measure, where they either had to recall lists of words (Studies 1, 2), or strings of digits (Studies 3, 4). We used both a frequentist approach and Bayesian analysis to evaluate our findings. Across the four studies, we find a small but consistent effect, where participants in the meaning threat condition show improved performance on the working memory tasks. Overall, our findings were consistent with the hypothesis that working memory capacity increases when people experience a meaning threat, which may help to explain improved pattern recognition. Additionally, our results highlight the value of using a Bayesian analytic approach, particularly when studying phenomena with high variance.	[Randles, Daniel] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Benjamin, Rachele; Heine, Steven J.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Martens, Jason P.] Birmingham City Univ, Sch Social Sci, Birmingham, W Midlands, England	University of Toronto; University of British Columbia; Birmingham City University	Heine, SJ (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	heine@psych.ubc.ca			Social Sciences and Humanities Research Council of Canada Doctoral Fellowship; Social Sciences and Humanities Research Council of Canada Banting Postdoctoral Fellowship [RN242784-BFP-SSHRC-01045]; Social Sciences and Humanities Research Council of Canada [435-2014-0025]	Social Sciences and Humanities Research Council of Canada Doctoral Fellowship(Social Sciences and Humanities Research Council of Canada (SSHRC)); Social Sciences and Humanities Research Council of Canada Banting Postdoctoral Fellowship; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Support was provided by a Social Sciences and Humanities Research Council of Canada Doctoral Fellowship and Social Sciences and Humanities Research Council of Canada Banting Postdoctoral Fellowship (RN242784-BFP-SSHRC-01045), D.R. The following is the URL of the funder's website: http://www.sshrc-crsh.gc.ca/funding-financement/programs-programmes/fellowships/banting-eng.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by the Social Sciences and Humanities Research Council of Canada (435-2014-0025), S.J.H. The following is the URL for the funder's website: http://www.sshrc-crsh.gc.ca/funding-financement/umbrella_programs-programme_cadre/insight-savoir-eng.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport GW, 1943, PSYCHOL REV, V50, P451, DOI 10.1037/h0055375; Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; Amodio DM, 2008, J PERS SOC PSYCHOL, V94, P60, DOI 10.1037/0022-3514.94.1.60; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barros-Loscertales A, 2006, NEUROIMAGE, V33, P1011, DOI 10.1016/j.neuroimage.2006.07.025; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRUNER JS, 1949, J PERS, V18, P206, DOI 10.1111/j.1467-6494.1949.tb01241.x; Carlin B, 2000, BAYES EMPIRICAL BAYE, V20000622, DOI [10.1201/9781420057669, DOI 10.1201/9781420057669]; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Corr PJ, 2013, SOC PERSONAL PSYCHOL, V7, P158, DOI 10.1111/spc3.12016; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DeWall CN, 2015, J EXP SOC PSYCHOL, V56, P117, DOI 10.1016/j.jesp.2014.09.006; DeWall CN, 2010, PSYCHOL SCI, V21, P931, DOI 10.1177/0956797610374741; DeWall CN, 2009, J PERS SOC PSYCHOL, V96, P729, DOI 10.1037/a0014634; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dienes Z, 2016, J MATH PSYCHOL, V72, P78, DOI 10.1016/j.jmp.2015.10.003; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Foster JL, 2015, MEM COGNITION, V43, P226, DOI 10.3758/s13421-014-0461-7; FOWLES DC, 1980, PSYCHOPHYSIOLOGY, V17, P87, DOI 10.1111/j.1469-8986.1980.tb00117.x; Gable SL, 2000, J PERS SOC PSYCHOL, V78, P1135, DOI 10.1037//0022-3514.78.6.1135; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Heidegger M, 1983, GESAMTAUSGABE; Heidegger M., QUESTION TECHNOLOGY; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Hogg M.A., 1999, SOCIAL IDENTITY SOCI, P249; Holbrook C, 2011, J PERS SOC PSYCHOL, V101, P451, DOI 10.1037/a0024033; Inzlicht M, 2009, PSYCHOL SCI, V20, P385, DOI 10.1111/j.1467-9280.2009.02305.x; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Jackman S., 2009, BAYESIAN ANAL SOCIAL; Jonas E, 2014, ADV EXP SOC PSYCHOL, V49, P219, DOI 10.1016/B978-0-12-800052-6.00004-4; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; Kuhn TS, 1962, STRUCTURE SCI REVOLU, V2, DOI [10.1111/j.1468-0149, DOI 10.1111/J.1468-0149]; Kuhn TS, 1996, STRUCTURE SCI REVOLU, V57; Larson MJ, 2011, COGN AFFECT BEHAV NE, V11, P159, DOI 10.3758/s13415-010-0018-6; Lee K, 2000, PIAGETS THEORY, P33; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lerner MJ, 1980, BELIEF JUST WORLD FU, P9, DOI [10. 1007/978-1-4899-0448-5_2, DOI 10.1007/978-1-4899-0448-5]; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th ed.; Lieberman MD, 2015, P NATL ACAD SCI USA, V112, P15250, DOI 10.1073/pnas.1515083112; Lieberman MD, 2002, ADV EXP SOC PSYCHOL, V34, P199, DOI 10.1016/S0065-2601(02)80006-5; Light AE, 2018, PERS SOC PSYCHOL B, V44, P24, DOI 10.1177/0146167217730368; MARSHALL BJ, 1984, LANCET, V1, P1311; McElreath R, 2016, STAT RETHINKING R PA; McGregor I, 2003, J PERS SOC PSYCHOL, V85, P838, DOI 10.1037/0022-3514.85.5.838; McGregor I, 2001, J PERS SOC PSYCHOL, V80, P472, DOI 10.1037//0022-3514.80.3.472; McGregor I, 2010, J PERS SOC PSYCHOL, V99, P133, DOI 10.1037/a0019701; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Nash K, 2012, BIOL PSYCHOL, V91, P96, DOI 10.1016/j.biopsycho.2012.05.005; Nash K, 2010, PSYCHOPHYSIOLOGY, V47, P979, DOI 10.1111/j.1469-8986.2010.00999.x; Navarrete CD, ANXIETY INTERGROUP B, DOI [10.1177/1368430204046144, DOI 10.1177/1368430204046144]; Park C.L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037/1089-2680.1.2.115, DOI 10.1037/1089-2680.1.2.115, 10.1037//1089-2680.1.2.115, DOI 10.1037//1089-2680.1.2.115]; Piaget J, 1937, CONSTRUCTION REALITY; Proulx T, 2006, PSYCHOL INQ, V17, P309, DOI 10.1080/10478400701366985; Proulx T, 2013, J SOC ISSUES, V69, P455, DOI 10.1111/josi.12024; Proulx T, 2012, PSYCHOL INQ, V23, P386, DOI 10.1080/1047840X.2012.734912; Proulx T, 2012, TRENDS COGN SCI, V16, P285, DOI 10.1016/j.tics.2012.04.002; Proulx T, 2010, SOC PERSONAL PSYCHOL, V4, P889, DOI 10.1111/j.1751-9004.2010.00304.x; Proulx T, 2010, PERS SOC PSYCHOL B, V36, P817, DOI 10.1177/0146167210369896; Proulx T, 2009, PSYCHOL SCI, V20, P1125, DOI 10.1111/j.1467-9280.2009.02414.x; Proulx T, 2008, PSYCHOL SCI, V19, P1294, DOI 10.1111/j.1467-9280.2008.02238.x; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Quirin M, 2012, SOC COGN AFFECT NEUR, V7, P193, DOI 10.1093/scan/nsq106; Randles D, 2016, SOC COGN AFFECT NEUR, V11, P899, DOI 10.1093/scan/nsw023; Randles D, 2015, J PERS SOC PSYCHOL, V108, P697, DOI 10.1037/a0038933; Randles D, 2013, PSYCHOL SCI, V24, P966, DOI 10.1177/0956797612464786; Randles D, 2011, J EXP SOC PSYCHOL, V47, P246, DOI 10.1016/j.jesp.2010.07.020; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Schmader T, 2003, J PERS SOC PSYCHOL, V85, P440, DOI 10.1037/0022-3514.85.3.440; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shipstead Z, 2014, J MEM LANG, V72, P116, DOI 10.1016/j.jml.2014.01.004; THOMPSON SC, 1988, J SOC CLIN PSYCHOL, V7, P260, DOI 10.1521/jscp.1988.7.2-3.260; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; van den Bos K, 2009, PSYCHOL INQ, V20, P197, DOI 10.1080/10478400903333411; van Harreveld F, 2014, J EXP PSYCHOL GEN, V143, P1666, DOI 10.1037/a0036099; Wechsler D., 2003, WECHSLER INTELLIGENC, V4th; Whitson JA, 2008, SCIENCE, V322, P115, DOI 10.1126/science.1159845; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	93	5	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204640	10.1371/journal.pone.0204640	http://dx.doi.org/10.1371/journal.pone.0204640			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281622	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000446342400051
J	Riang'a, RM; Nangulu, AK; Broerse, JEW				Riang'a, Roselyter Monchari; Nangulu, Anne Kisaka; Broerse, Jacqueline E. W.			"I should have started earlier, but I was not feeling ill!" Perceptions of Kalenjin women on antenatal care and its implications on initial access and differentials in patterns of antenatal care utilization in rural Uasin Gishu County Kenya	PLOS ONE			English	Article							DETERMINANTS; BOOKING	Aim The aim of this study was to explore how Kalenjin women in rural Uasing Gishu County in Kenya perceive antenatal care and how their perceptions impede or motivate earlier access and continuous use of antenatal care services. Methods A study was conducted among 188 pregnant and post-natal mothers seeking care in 23 rural public health facilities. Gestational age at the initial antenatal care booking was established from their medical cards. Further researcher-administered questionnaire with closed and open-ended questions was used. Key informant interviews with traditional birth attendants (n = 6) and maternal and child health nursing officers (n = 6) were also conducted for triangulation. Descriptive statistics were applied using SPSS programme. The interviews of women who gave consent to be audio recorded (n = 52) were transcribed and thematically analysed using MAXQDA program, based on Andersen and Newman's (1973) behavioural model of health services utilization. Results The mean gestational age at booking initial biomedical care was 23.36 weeks. Only 18 patients (10%) booked before 13 weeks and 45% made four or more visits. The main reasons given for early booking were: illness in index pregnancy (42%) checking the foetus position and monitoring foetus progress (7%). The main reasons given for late booking were: no reason (31%), was not feeling sick (16%), fear or shame due to unexpected pregnancy (13%). Almost half of the respondents (44%) used both biomedical and traditional antenatal care services. Main reasons for visiting traditional care were to: check foetus position and reposition it (63%), collect medicinal herbs (31%), relief discomforts through massage (18%). Conclusion Early antenatal care booking is meant for women with unpleasant physical signs and symptoms. Later ANC is meant to check foetus position and reposition it to cephalic presentation and monitor its progress and this is only possible if the foetus is large.	[Riang'a, Roselyter Monchari] Moi Univ, Sch Arts & Social Sci, Dept Sociol & Psychol, Eldoret, Kenya; [Riang'a, Roselyter Monchari; Broerse, Jacqueline E. W.] Vrije Univ Amsterdam, Fac Sci, Athena Inst, Amsterdam, Netherlands; [Nangulu, Anne Kisaka] Commiss Univ Educ, Nairobi, Kenya; [Nangulu, Anne Kisaka] Moi Univ, Sch Arts & Social Sci, Dept Hist, Eldoret, Kenya	Moi University; Vrije Universiteit Amsterdam; Moi University	Riang'a, RM (corresponding author), Moi Univ, Sch Arts & Social Sci, Dept Sociol & Psychol, Eldoret, Kenya.; Riang'a, RM (corresponding author), Vrije Univ Amsterdam, Fac Sci, Athena Inst, Amsterdam, Netherlands.	monchari2002@yahoo.com	Riang'a, Roselyter/AAW-7541-2021		A Sustainable Approach to Livelihood Improvement (ASALI) project	A Sustainable Approach to Livelihood Improvement (ASALI) project	The authors acknowledge the financial support by A Sustainable Approach to Livelihood Improvement (ASALI) project (https://acwfs.vu.nl/en/research/themes/inequality-in-food-security/projects/sustainable-livelihood/index.aspx). ASALI is a joint collaboration project of Moi University Kenya, South Eastern Kenya University (SEKU) and Vrije Universiteit Amsterdam (VU) that is being implemented in Kenya. The project is coordinated by: Prof. Ann Nangulu - Moi University, Prof. Mary Mburu - South Eastern Kenya University, Dr. Denyse Snelder - Vrije Universiteit Amsterdam. The funding was granted to RMR. This financial support proved fundamental to the design of the study, the collection and analysis of data, and the writing of this manuscript. Only one coordinator (Prof. Anne Nangulu) of ASALI project who participated in this study. Prof. Anne Nangulu contributed to design, analysis, supervision, methodology, prove-reading,review, and decision to publish.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Adekanle DA, 2008, ONLINE J HLTH ALLIED, V7, P1; Amna A., 2015, ISRA MED J, V7, P38; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Banda I., 2012, MED J AUSTRALIA, V39, P29; Blomberg M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005840; Bourbonnais B., 2013, IMPLEMENTING FREE MA; Braun V., 2022, THEMATIC ANAL PRACTI; Brown CA, 2008, BMC PREGNANCY CHILDB, V8, P1, DOI [10.1186/1471-2393-8-1, DOI 10.1186/1471-2393-8-1]; Central Statistical Agency and ICF International, 2012, ETH DEM HLTH SURV, P452; Cheptum J., 2014, Developing Country Studies, V4, P48; Chorongo D, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.2.10520; County Government of Uasin Gishu Department of Health Services, 2013, COUNT HLTH STRAT INV; Ebeigbe P N, 2010, Ghana Med J, V44, P47; Essendi H, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0078-8; Fisher C, 2015, ASSESSING ENHANCING, DOI [10.1207/S1532480XADS0701, DOI 10.1207/S1532480XADS0701]; Floridia M, 2014, HIV CLIN TRIALS, V15, P104, DOI 10.1310/hct1503-104; Government of Uasin Gishu County, 2013, UAS GISH COUNT INT D; Grinnel RM, 2007, SOCIAL WORK RES EVAL; Gross J, 2015, AFR J MIDWIFERY WOME, V9; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Helman CG, 2007, CUTURE HLTH ILLINESS; Izugbara CO, 2009, PUBLIC HEALTH REP, V124, P585, DOI 10.1177/003335490912400416; Jebet CJ, 2013, FACTORS CONTRIBUTING; Jebet J, 2015, POOR PREGNANCY OUTCO, P4, DOI [10.12968/ajmw.2012.6.4.183, DOI 10.12968/AJMW.2012.6.4.183]; Kaingu CK, 2011, J ETHNOPHARMACOL, V137, P495, DOI 10.1016/j.jep.2011.05.044; Kanogo Tabitha, 2005, AFRICAN WOMANHOOD CO; Kenya M, 2013, MATERNAL INFANT YOUN; Kenya National Bureau of Statistics, 2014, KEN DEM HLTH SURV 20; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kisuule I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-121; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Lincetto O, ANTENATAL CARE, P51; Magadi M, 2000, SOC BIOL, V47, P164; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Mothupi MC, 2014, BMC COMPLEM ALTERN M, P1, DOI [10.1186/1472-6882-14-1, DOI 10.1186/1472-6882-14-1]; Ngom P, 2000, INTRA HOUSEHOLD DECI; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Okunlola M A, 2006, J Obstet Gynaecol, V26, P195, DOI 10.1080/01443610500508220; Olungah CO, 2006, THESIS; Onoh RC, 2012, ANN MED HEALTH SCI R, V2, P169, DOI 10.4103/2141-9248.105666; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Riang'a RM, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0130-0; Riang'a RM, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0157-8; Rono AK., 2015, THESIS, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; Severinski NS, 2009, INT J GYNECOL OBSTET, V107, P63, DOI 10.1016/j.ijgo.2009.05.011; Shah AT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170415; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Verschuren P., 2010, DESIGNING RES PROJEC, V2; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202895	10.1371/journal.pone.0202895	http://dx.doi.org/10.1371/journal.pone.0202895			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281594	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400015
J	Rock, CG; Wurdeman, SR; Stergiou, N; Takahashi, KZ				Rock, Chase G.; Wurdeman, Shane R.; Stergiou, Nicholas; Takahashi, Kota Z.			Stride-to-stride fluctuations in transtibial amputees are not affected by changes in push-off mechanics from using different prostheses	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; NONLINEAR DYNAMICS; ENERGY PROFILES; HUMAN GAIT; WALKING; VARIABILITY; FOOT; STABILITY; INTERVAL; SYSTEM	Stride-to-stride fluctuations of joint kinematics during walking reflect a highly structured organization that is characteristic of healthy gait. The organization of stride-to-stride fluctuations is disturbed in lower-limb prosthesis users, yet the factors contributing to this difference are unclear. One potential contributor to the changes in stride-to-stride fluctuations is the altered push-off mechanics experienced by passive prosthesis users. The purpose of our study was to determine if changes in push-off mechanics affect stride-to-stride fluctuations in transtibial amputees. Twenty-two unilateral transtibial amputees were enrolled in the 6-week cross-over study, where High and Low Activity (based on the Medicare Functional Classification System) prostheses were worn for three weeks each. Data collection took place at the end of the third week. Participants walked on a treadmill in a motion capture laboratory to quantify stride-to-stride fluctuations of the lower extremity joint angle trajectories using the largest Lyapunov Exponent, and over floor-embedded force platforms to enable calculating push-off work from the prosthesis and the sound limb. Push-off work was 140% greater in the High Activity prosthesis compared to the Low Activity prosthesis (p < 0.001), however no significant change was observed in stride-to-stride fluctuations of the ankle between the two prosthesis types (p = 0.576). There was no significant correlation between changes in prosthesis push-off work and the largest Lyapunov exponent. Though differences in push-off work were observed between the two prosthesis types, stride-to-stride fluctuations remained similar, indicating that prosthesis propulsion mechanics may not be a strong determinant of stride-to-stride fluctuations in unpowered transtibial prosthesis users.	[Rock, Chase G.; Stergiou, Nicholas; Takahashi, Kota Z.] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA; [Wurdeman, Shane R.] Hanger Clin, Dept Clin & Sci Affairs, Houston, TX USA; [Stergiou, Nicholas] Univ Nebraska Med Ctr, Dept Environm Agr & Occupat Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center	Takahashi, KZ (corresponding author), Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA.	ktakahashi@unomaha.edu	Rock, Chase G/AAG-9072-2019	Rock, Chase/0000-0001-7598-759X	Center for Research in Human Movement Variability; National Institute of Health [P20GM109090, R15HD086828]; Office of Research and Creative Activity at the University of Nebraska at Omaha; NASA Nebraska Space Grant Fellowship; NIH [P20GM109090, R15HD086828]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	Center for Research in Human Movement Variability; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Creative Activity at the University of Nebraska at Omaha; NASA Nebraska Space Grant Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Center for Research in Human Movement Variability and the National Institute of Health (P20GM109090 and R15HD086828), the Office of Research and Creative Activity at the University of Nebraska at Omaha, and the NASA Nebraska Space Grant Fellowship.; This work has been supported by the Center for Research in Human Movement Variability and the NIH (P20GM109090 and R15HD086828), the Office of Research and Creative Activity at the University of Nebraska at Omaha, and the NASA Nebraska Space Grant Fellowship.	Adamczyk PG, 2015, IEEE T NEUR SYS REH, V23, P776, DOI 10.1109/TNSRE.2014.2356722; BARR AE, 1992, PHYS THER, V72, P344, DOI 10.1093/ptj/72.5.344; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cignetti F, 2012, ANN BIOMED ENG, V40, P1122, DOI 10.1007/s10439-011-0474-3; D'Alonzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050756; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Franz JR, 2016, EXERC SPORT SCI REV, V44, P129, DOI 10.1249/JES.0000000000000086; Franz JR, 2013, J BIOMECH, V46, P535, DOI 10.1016/j.jbiomech.2012.09.032; Goldberg EJ, 2008, J BIOMECH, V41, P1805, DOI 10.1016/j.jbiomech.2008.03.009; Hafner BJ, 2002, J REHABIL RES DEV, V39, P1; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Kararizou E, 2006, INT J NEUROSCI, V116, P629, DOI 10.1080/00207450600592180; Kurz MJ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-30; Lee MY, 2007, IEEE SYS MAN CYBERN, P2909; LEHMANN JF, 1993, ARCH PHYS MED REHAB, V74, P853, DOI 10.1016/0003-9993(93)90013-Z; Look N, 2013, CHAOS, V23, DOI 10.1063/1.4837095; Malcolm P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0014-8; Myers SA, 2009, J VASC SURG, V49, P924, DOI 10.1016/j.jvs.2008.11.020; Nishikawa K, 2007, INTEGR COMP BIOL, V47, P16, DOI 10.1093/icb/icm024; Plauche A, 2016, IEEE T HAPTICS, V9, P421, DOI 10.1109/TOH.2016.2580507; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Quesada RE, 2016, J BIOMECH, V49, P3452, DOI 10.1016/j.jbiomech.2016.09.015; Scott-Okafor HR, 2001, ANGIOLOGY, V52, P7, DOI 10.1177/000331970105200102; Shull PB, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0055-z; Silverman AK, 2012, J BIOMECH, V45, P2271, DOI 10.1016/j.jbiomech.2012.06.008; Stergiou N., 2016, NONLINEAR ANAL HUMAN; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stergiou UH, 2004, INNOVATIVE ANAL HUMA, P63; Takahashi KZ, 2015, PROSTHET ORTHOT INT, V39, P150, DOI 10.1177/0309364613513298; Takahashi KZ, 2013, GAIT POSTURE, V38, P818, DOI 10.1016/j.gaitpost.2013.04.002; Takahashi KZ, 2012, J BIOMECH, V45, P2662, DOI 10.1016/j.jbiomech.2012.08.017; WINTER DA, 1988, J BIOMECH, V21, P361, DOI 10.1016/0021-9290(88)90142-X; WINTER DA, 1984, HUM MOVEMENT SCI, V3, P51, DOI 10.1016/0167-9457(84)90005-8; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wurdeman SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100125; Wurdeman SR, 2013, J REHABIL RES DEV, V50, P671, DOI 10.1682/JRRD.2012.06.0104; Wurdeman SR, 2013, ANN BIOMED ENG, V41, P806, DOI 10.1007/s10439-012-0705-2; Wurdeman SR, 2012, MED ENG PHYS, V34, P1421, DOI 10.1016/j.medengphy.2012.01.004; Zelik KE, 2016, J EXP BIOL, V219, P3676, DOI 10.1242/jeb.140376	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205098	10.1371/journal.pone.0205098	http://dx.doi.org/10.1371/journal.pone.0205098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281652	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400082
J	Dennis, RA; Long, DE; Landes, RD; Padala, KP; Padala, PR; Garner, KK; Wise, JN; Peterson, CA; Sullivan, DH				Dennis, Richard A.; Long, Douglas E.; Landes, Reid D.; Padala, Kalpana P.; Padala, Prasad R.; Garner, Kimberly K.; Wise, James N.; Peterson, Charlotte A.; Sullivan, Dennis H.			Tutorial for using SliceOmatic to calculate thigh area and composition from computed tomography images from older adults	PLOS ONE			English	Article							HYDROXY-BETA-METHYLBUTYRATE; RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; BODY-COMPOSITION; MUSCLE; SUPPLEMENTATION; EXERCISE; HEALTH; MECHANISMS; GLUTAMINE	Objective Area of muscle, fat, and bone is often measured in thigh CT scans when tissue composition is a key outcome. SliceOmatic software is commonly referenced for such analysis but published methods may be insufficient for new users. Thus, a quick start guide to calculating thigh composition using SliceOmatic has been developed. Methods CT images of the thigh were collected from older (69 +/- 4 yrs, N = 24) adults before and after 12-weeks of resistance training. SliceOmatic was used to segment images into seven density regions encompassing fat, muscle, and bone from -190 to +2000 Hounsfield Units [HU]. The relative contributions to thigh area and the effects of tissue density overlap for skin and marrow with muscle and fat were determined. Results The largest contributors to the thigh were normal fat (-190 to -30 HU, 29.1 +/- 7.4%) and muscle (35 to 100 HU, 48.9 +/- 8.2%) while the smallest were high density (101 to 150 HU, 0.79 +/- 0.50%) and very high density muscle (151 to 200 HU, 0.07 +/- 0.02%). Training significantly (P<0.05) increased area for muscle in the very low (-29 to -1 HU, 5.5 +/- 7.9%), low (0 to 34 HU, 9.6 +/- 16.8%), normal (35 to 100 HU, 4.2 +/- 7.9%), and high (100 to 150 HU, 70.9 +/- 80.6%) density ranges for muscle. Normal fat, very high density muscle and bone did not change (P>0.05). Contributions to area were altered by similar to 1% or less and the results of training were not affected by accounting for skin and marrow. Conclusions When using SliceOmatic to calculate thigh composition, accounting for skin and marrow may not be necessary. We recommend defining muscle as -29 to +200 HU but that smaller ranges (e.g. low density muscle, 0 to 34 HU) can easily be examined for relationships with the health condition and intervention of interest.	[Dennis, Richard A.; Padala, Kalpana P.; Padala, Prasad R.; Garner, Kimberly K.; Sullivan, Dennis H.] Cent Arkansas Vet Healthcare Syst, Geriatr Res Educ & Clin Ctr, North Little Rock, AR 72205 USA; [Dennis, Richard A.; Padala, Kalpana P.; Padala, Prasad R.; Garner, Kimberly K.; Sullivan, Dennis H.] Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA; [Long, Douglas E.; Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Lexington, KY USA; [Long, Douglas E.; Peterson, Charlotte A.] Univ Kentucky, Ctr Muscle Biol, Lexington, KY USA; [Landes, Reid D.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Padala, Prasad R.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA; [Wise, James N.] Univ Arkansas Med Sci, Dept Radiol, Coll Med, Little Rock, AR 72205 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Kentucky; University of Kentucky; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Dennis, RA (corresponding author), Cent Arkansas Vet Healthcare Syst, Geriatr Res Educ & Clin Ctr, North Little Rock, AR 72205 USA.; Dennis, RA (corresponding author), Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA.	richard.dennis2@va.gov		Padala, Prasad/0000-0003-1921-9806	United States Department of Veterans Affairs, Rehabilitation Research and Development Service [RX0012030]; Veterans Affairs [I01RX001203] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Rehabilitation Research and Development Service; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Award RX0012030 to RAD from the United States Department of Veterans Affairs, Rehabilitation Research and Development Service (https://www.research.va.gov/services/rrd.cfm) but does not represent the views of the VA or US Government. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Argiles JM, 2015, CURR OPIN PHARMACOL, V22, P100, DOI 10.1016/j.coph.2015.04.003; Aubrey J, 2014, ACTA PHYSIOL, V210, P489, DOI 10.1111/apha.12224; Chale A, 2013, J GERONTOL A-BIOL, V68, P682, DOI 10.1093/gerona/gls221; Chomentowski P, 2009, J GERONTOL A-BIOL, V64, P575, DOI 10.1093/gerona/glp007; Clark RH, 2000, JPEN-PARENTER ENTER, V24, P133, DOI 10.1177/0148607100024003133; Dennis RA, 2018, TUTORIAL USING SLICE; Dennis RA, 2008, J AM GERIATR SOC, V56, P1270, DOI 10.1111/j.1532-5415.2008.01789.x; Dennis RA, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0631-3; Distefano G, 2018, COLD SPRING HARB PER, V8; Goodpaster BH, 1985, J APPL PHYSIOL, P89; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; Hirani V, 2017, AGE AGEING, V46, P413, DOI 10.1093/ageing/afw214; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Irving BA, 2007, OBESITY, V15, P370, DOI 10.1038/oby.2007.573; Maddocks M, 2014, EUR RESPIR J, V44, P1188, DOI 10.1183/09031936.00066414; May PE, 2002, AM J SURG, V183, P471, DOI 10.1016/S0002-9610(02)00823-1; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Stefanaki C, 2018, HORM-INT J ENDOCRINO, V17, P33, DOI 10.1007/s42000-018-0023-7; Strandberg Soren, 2010, BMC Med Imaging, V10, P18, DOI 10.1186/1471-2342-10-18; Weitzel Lindsay-Rae B, 2009, Crit Care Med, V37, pS400, DOI 10.1097/CCM.0b013e3181b6f2e6; Zanchi NE, 2011, AMINO ACIDS, V40, P1015, DOI 10.1007/s00726-010-0678-0	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204529	10.1371/journal.pone.0204529	http://dx.doi.org/10.1371/journal.pone.0204529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278056	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200015
J	Oh, WS; Yoon, S; Noh, J; Sohn, J; Kim, C; Heo, J				Oh, Won Seob; Yoon, Sanghyun; Noh, Juhwan; Sohn, Jungwoo; Kim, Changsoo; Heo, Joon			Geographical variations and influential factors in prevalence of cardiometabolic diseases in South Korea	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; CANCER INCIDENCE; BLOOD-PRESSURE; LYME-DISEASE; STROKE; ASSOCIATION; POPULATION; MORTALITY	Geographical variations and influential factors of disease prevalence are crucial information enabling optimal allocation of limited medical resources and prioritization of appropriate treatments for each regional unit. The purpose of this study was to explore the geographical variations and influential factors of cardiometabolic disease prevalence with respect to 230 administrative districts in South Korea. Global Moran's I was calculated to determine whether the standardized prevalences of cardiometabolic diseases (hypertension, stroke, and diabetes mellitus) were spatially clustered. The CART algorithm was then applied to generate decision tree models that could extract the diseases' regional influential factors from among 101 demographic, economic, and public health data variables. Finally, the accuracies of the resulting model-hypertension (67.4%), stroke (62.2%), and diabetes mellitus (56.5%)-were assessed by ten-fold cross-validation. Marriage rate was the main determinant of geographic variation in hypertension and stroke prevalence, which has the possibility that married life could have positive effects in lowering disease risks. Additionally, stress-related variables were extracted as factors positively associated with hypertension and stroke. In the opposite way, the wealth status of a region was found to have an influence on the prevalences of stroke and diabetes mellitus. This study suggested a framework for provision of novel insights into the regional characteristics of diseases and the corresponding influential factors. The results of the study are anticipated to provide valuable information for public health practitioners' cost-effective disease management and to facilitate primary intervention and mitigation efforts in response to regional disease outbreaks.	[Oh, Won Seob; Yoon, Sanghyun; Heo, Joon] Yonsei Univ, Coll Engn, Sch Civil & Environm Engn, Seoul, South Korea; [Noh, Juhwan; Sohn, Jungwoo; Kim, Changsoo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Heo, J (corresponding author), Yonsei Univ, Coll Engn, Sch Civil & Environm Engn, Seoul, South Korea.	jheo@yonsei.ac.kr	Noh, Juhwan/Q-9902-2019; Heo, Joon/J-8399-2012	Noh, Juhwan/0000-0003-0657-0082; a, gokul/0000-0003-2226-4691; Kim, Changsoo/0000-0002-5940-5649	MOLIT (The Ministry of Land, Infrastructure and Transport), Korea, under the national spatial information research program [18NSIP-B081011-05]; Fire Fighting Safety & 119 Rescue Technology Research and Development Program - National Fire Agency [MPSS-2015-80]	MOLIT (The Ministry of Land, Infrastructure and Transport), Korea, under the national spatial information research program; Fire Fighting Safety & 119 Rescue Technology Research and Development Program - National Fire Agency	This research, 'Geospatial Big Data Management, Analysis and Service Platform Technology Development', was supported by the MOLIT (The Ministry of Land, Infrastructure and Transport), Korea, under the national spatial information research program supervised by the KAIA (Korea Agency for Infrastructure Technology Advancement)"(18NSIP-B081011-05). Also, this research was supported by the Fire Fighting Safety & 119 Rescue Technology Research and Development Program funded by National Fire Agency (MPSS-2015-80).	Al-Ahmadi K, 2013, INT J ENV RES PUB HE, V10, P7207, DOI 10.3390/ijerph10127207; Attig A., 2011, T CASE BASED REASONI, V4, P3; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chen ZY, 2012, AM J MED, V125, P568, DOI 10.1016/j.amjmed.2011.10.034; Darnaud C, 2015, AM J HYPERTENS, V28, P1257, DOI 10.1093/ajh/hpv025; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; ESRI (Environmental Systems Research Institute), 2016, SPATIAL AUTOCORRELAT; ESRI (Environmental Systems Research Institute), 2016, A Z SCOR; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gehlke CE, 1934, J AM STAT ASSOC, V29, P169, DOI 10.2307/2277827; GLASS GE, 1995, AM J PUBLIC HEALTH, V85, P944, DOI 10.2105/AJPH.85.7.944; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Gou FX, 2017, INT J BIOMETEOROL, V61, P137, DOI 10.1007/s00484-016-1197-9; Griffith DA, 1987, A PRIMER; Hanchette CL, 2003, HLTH INFORMAT SER, P431; Hassarangsee S, 2015, INT J ENV RES PUB HE, V12, P16005, DOI 10.3390/ijerph121215040; Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413; Khalili H, 2012, GUT, V61, P1686, DOI 10.1136/gutjnl-2011-301574; Kitron U, 1997, AM J EPIDEMIOL, V145, P558, DOI 10.1093/oxfordjournals.aje.a009145; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KOSIS (Korean Statistical Information Service), 2016, STAT ANN REP; Lee DS, 2009, CAN MED ASSOC J, V181, pE55, DOI 10.1503/cmaj.081629; Li P, 2015, EUR UROL, V67, P1134, DOI 10.1016/j.eururo.2014.11.001; Lipowicz A, 2005, EUR J EPIDEMIOL, V20, P421, DOI 10.1007/s10654-005-1752-x; Longley PA., 2005, GEOGRAPHIC INFORM SY; Madsen KA, 2015, AM J PREV MED, V48, P292, DOI 10.1016/j.amepre.2014.09.033; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Parrish G B, 2000, PRINCIPLES PRACTICE, V2000, P76; SGIS (Statistical Geographic Information Service), 2016, KOR DISTR MAP; Suzumori N, 2014, PRENATAL DIAG, V34, P1055, DOI 10.1002/pd.4427; Timofeev R., 2004, CLASSIFICATION REGRE, P1; Tomines A, 2014, HEALTH INFORM SER, P329, DOI 10.1007/978-1-4471-4237-9_18; Wang A, 2012, MILBANK Q, V90, P592, DOI 10.1111/j.1468-0009.2012.00675.x; Wang C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1560-9; Xu M, 2016, EPIDEMIOL INFECT, V144, P940, DOI 10.1017/S095026881500223X; Yun Jeong Mi, 2015, [journal of Korean Society for Geospatial Information Science, 대한공간정보학회지], V23, P77, DOI 10.7319/kogsis.2015.23.3.077; Zhou M, 2014, DIABETES CARE	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205005	10.1371/journal.pone.0205005	http://dx.doi.org/10.1371/journal.pone.0205005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278073	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200034
J	Isaacs, AM; Riva-Cambrin, J; Yavin, D; Hockley, A; Pringsheim, TM; Jette, N; Lethebe, BC; Lowerison, M; Dronyk, J; Hamilton, MG				Isaacs, Albert M.; Riva-Cambrin, Jay; Yavin, Daniel; Hockley, Aaron; Pringsheim, Tamara M.; Jette, Nathalie; Lethebe, Brendan Cord; Lowerison, Mark; Dronyk, Jarred; Hamilton, Mark G.			Age-specific global epidemiology of hydrocephalus: Systematic review, metanalysis and global birth surveillance	PLOS ONE			English	Review							NORMAL-PRESSURE HYDROCEPHALUS; NEURAL-TUBE DEFECTS; SHUNT-DEPENDENT HYDROCEPHALUS; CONGENITAL HYDROCEPHALUS; INFANTILE HYDROCEPHALUS; FOLIC-ACID; PRENATAL-DIAGNOSIS; NATIONAL REGISTRY; NATURAL-HISTORY; CHILDREN BORN	Background Hydrocephalus is a debilitating disorder, affecting all age groups. Evaluation of its global epidemiology is required for healthcare planning and resource allocation. Objectives To define age-specific global prevalence and incidence of hydrocephalus. Methods Population-based studies reporting prevalence of hydrocephalus were identified (MEDLINE, EMBASE, Cochrane, and Google Scholar (1985-2017)). Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Two authors reviewed abstracts, full text articles and abstracted data. Metanalysis and meta-regressions were used to assess associations between key variables. Heterogeneity and publication bias were assessed. Main outcome of interest was hydrocephalus prevalence among pediatric (<= 18 years), adults (19-64 years), and elderly (>= 65) patients. Annual hydrocephalus incidence stratified by country income level and folate fortification requirements were obtained (2003-2014) from the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR). Results Of 2,460 abstracts, 52 met review eligibility criteria (aggregate population 171,558,651). Mean hydrocephalus prevalence was 85/100,000 [95% CI 62, 116]. The prevalence was 88/100,000 [95% CI 72, 107] in pediatrics; 11/100,000 [95% CI 5, 25] in adults; and 175/100,000 [95% CI 67, 458] in the elderly. The ICBDSR-based incidence of hydrocephalus diagnosed at birth remained stable over 11 years: 81/100,000 [95% CI 69, 96]. A significantly lower incidence was identified in high-income countries. Conclusion This systematic review established age-specific global hydrocephalus prevalence. While high-income countries had a lower hydrocephalus incidence according to the ICBDSR registry, folate fortification status was not associated with incidence. Our findings may inform future healthcare resource allocation and study.	[Isaacs, Albert M.; Riva-Cambrin, Jay; Yavin, Daniel; Hockley, Aaron; Dronyk, Jarred; Hamilton, Mark G.] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Calgary, AB, Canada; [Isaacs, Albert M.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO USA; [Riva-Cambrin, Jay] Univ Calgary, Alberta Childrens Hosp, Dept Neurosurg, Calgary, AB, Canada; [Hockley, Aaron] NYU, Dept Orthoped Surg, New York, NY USA; [Pringsheim, Tamara M.; Jette, Nathalie] Univ Calgary, Dept Clin Neurosci, Div Neurol, Calgary, AB, Canada; [Pringsheim, Tamara M.] Univ Calgary, Alberta Childrens Hosp, Dept Neurol, Calgary, AB, Canada; [Jette, Nathalie] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Lethebe, Brendan Cord; Lowerison, Mark] Univ Calgary, Clin Res Unit, Calgary, AB, Canada	University of Calgary; Washington University (WUSTL); Alberta Childrens Hospital; University of Calgary; New York University; University of Calgary; Alberta Childrens Hospital; University of Calgary; Icahn School of Medicine at Mount Sinai; University of Calgary	Hamilton, MG (corresponding author), Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Calgary, AB, Canada.	mghamilton.hydro@gmail.com	Jette, Nathalie/HCH-4827-2022; Pringsheim, Tamara/L-5955-2019	Jette, Nathalie/0000-0003-1351-5866; Pringsheim, Tamara/0000-0002-8229-8431; Hockley, Aaron/0000-0002-9348-503X	Public Health Agency of Canada	Public Health Agency of Canada	This study has been sponsored by the Public Health Agency of Canada. Funding was received by Drs. Mark Hamilton, Tamara Pringsheim and Nathalie Jette. However, the funder had no role in study design, data collection, data analysis, data interpretation, writing of the report, or decision to submit the findings for publication.	Abdullah J, 2001, PEDIATR NEUROSURG, V34, P13, DOI 10.1159/000055987; Ahrens K, 2011, EPIDEMIOLOGY, V22, P731, DOI 10.1097/EDE.0b013e3182227887; Al Salloum AA, 2011, J CHILD NEUROL, V26, P21, DOI 10.1177/0883073810371510; Al-Jama F, 2001, J Obstet Gynaecol, V21, P595, DOI 10.1080/01443610120085546; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; Baer RJ, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.025; Balogun OO, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004073.pub4; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bekelis K, 2014, J NEUROINTERV SURG, V6, P342, DOI 10.1136/neurintsurg-2013-010815; Bodilsen J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-321; Botto LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069077; Boyle MH, 1998, EVID-BASED MENT HEAL, V1, P37; Brean A, 2009, ACTA NEUROL SCAND, V120, P314, DOI 10.1111/j.1600-0404.2009.01250.x; Cavalcanti Denise P., 2003, J. Pediatr. (Rio J.), V79, P135, DOI 10.1590/S0021-75572003000200008; Chang CJ, 2004, BRAIN DEV-JPN, V26, P168, DOI 10.1016/S0387-7604(03)00122-0; Cherian AG, 2016, J TROP PEDIATRICS, V62, P361, DOI 10.1093/tropej/fmw019; Ciurea AV, 2004, PEDIATRIC HYDROCEPHALUS, P201; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; de Oliveira JG, 2007, NEUROSURGERY, V61, P924, DOI 10.1227/01.neu.0000303188.72425.24; De-Regil Luz Maria, 2015, Cochrane Database Syst Rev, pCD007950, DOI 10.1002/14651858.CD007950.pub3; Del Bigio MR, 1998, CAN J NEUROL SCI, V25, P123; Delshad S, 2009, TROP DOCT, V39, P156, DOI 10.1258/td.2008.070434; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Edwards RJ, 2004, BRAIN PATHOL, V14, P325; Egbe A, 2015, PEDIATR NEONATOL, V56, P25, DOI 10.1016/j.pedneo.2014.03.010; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Gaidi MA, 2015, J NEUROSURG-PEDIATR, V15, P4, DOI 10.3171/2014.8.PEDS14146; ELAWAD ME, 1992, ANN TROP PAEDIATR, V12, P335; Espay AJ, 2017, ANN NEUROL, V82, P503, DOI 10.1002/ana.25046; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Fernell E, 1998, ACTA PAEDIATR, V87, P392; Fleetwood IG, 2005, CAN J NEUROL SCI, V32, P57, DOI 10.1017/S0317167100016887; Garne E, 2010, EUR J PAEDIATR NEURO, V14, P150, DOI 10.1016/j.ejpn.2009.03.005; Glinianaia SV, 1999, EUR J PEDIATR SURG, V9, P46; Gonzalez-Andrade F, 2010, APPL CLIN GENET, V3, P29; GRAFFRADFORD NR, 1989, NEUROLOGY, V39, P1596, DOI 10.1212/WNL.39.12.1596; Groisman B, 2013, ARCH ARGENT PEDIATR, V111, P484, DOI [10.5546/aap.2013.484, 10.5546/aap.2013.eng.484]; Group TWB, COUNTR EC 2017; Guardiola A, 2009, ARQ NEURO-PSIQUIAT, V67, P807, DOI 10.1590/S0004-282X2009000500005; Haider BA, 2017, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD004905.pub5, DOI 10.1002/14651858.CD004905.PUB5]; Hamilton MG, 2009, SEMIN PEDIATR NEUROL, V16, P34, DOI 10.1016/j.spen.2009.02.001; Hannon T, 2012, OBSTET GYNECOL, V120, P1345, DOI [http://10.1097/AOG.0b013e3182732b53, 10.1097/AOG.0b013e3182732b53]; Harmat G, 2001, Eur J Ultrasound, V12, P209, DOI 10.1016/S0929-8266(00)00120-8; Hiraoka K, 2008, NEUROL MED-CHIR, V48, P197, DOI 10.2176/nmc.48.197; Hoh BL, 2011, WORLD NEUROSURG, V76, P548, DOI 10.1016/j.wneu.2011.05.054; Inamasu J, 2003, CLIN NEUROL NEUROSUR, V106, P9, DOI 10.1016/S0303-8467(03)00060-X; Initiative FF, COUNTR PROF 2017; Isaacs A, 2016, GLOBAL PREVALENCE IN; Isaacs AM, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.6.FOCUS16193; Iseki C, 2014, J NEUROL SCI, V339, P108, DOI 10.1016/j.jns.2014.01.033; Iseki C, 2009, J NEUROL SCI, V277, P54, DOI 10.1016/j.jns.2008.10.004; Jaraj D, 2017, ALZHEIMERS DEMENT, V13, P850, DOI 10.1016/j.jalz.2017.01.013; Jaraj D, 2014, NEUROLOGY, V82, P1449, DOI 10.1212/WNL.0000000000000342; Jeng S, 2011, PEDIATR NEUROL, V45, P67, DOI 10.1016/j.pediatrneurol.2011.03.009; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kasanmoentalib ES, 2010, NEUROLOGY, V75, P918, DOI 10.1212/WNL.0b013e3181f11e10; Klassen BT, 2011, NEUROLOGY, V77, P118, DOI 10.1212/WNL.0b013e318224af8d; Kulkarni AV, 2013, J NEUROSURG-PEDIATR, V12, P235, DOI 10.3171/2013.6.PEDS12535; Kumar R, 2008, ACTA NEUROPSYCHIATR, V20, P87, DOI 10.1111/j.1601-5215.2008.00273.x; Kuriyama N, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.635; Loney PL, 1999, PHYS THER, V79, P384, DOI 10.1093/ptj/79.4.384; Mahmoud Mustafa Z, 2014, Glob J Health Sci, V6, P1, DOI 10.5539/gjhs.v6n5p1; Martin-Laez R, 2016, WORLD NEUROSURG, V87, P298, DOI 10.1016/j.wneu.2015.10.069; Martin-Laez R, 2015, WORLD NEUROSURG, V84, P2002, DOI 10.1016/j.wneu.2015.07.005; McAllister JP, 2015, J NEUROSURG, V123, P1427, DOI 10.3171/2014.12.JNS132352; Miyakoshi A, 2013, ACTA NEUROCHIR, V155, P1271, DOI 10.1007/s00701-013-1742-9; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moussa HN, 2016, FUTUR SCI OA, V2, DOI 10.4155/fsoa-2015-0015; Movafagh A, 2008, PAK J MED SCI, V24, P80; Msamati B C, 2000, Cent Afr J Med, V46, P292; Munch TN, 2012, BRAIN, V135, P2409, DOI 10.1093/brain/aws158; Murshid WR, 2000, PEDIATR NEUROSURG, V32, P119, DOI 10.1159/000028915; Nakling J, 2005, ACTA OBSTET GYN SCAN, V84, P1042, DOI 10.1111/j.0001-6349.2005.00785.x; NOGUEIRA GJ, 1992, CHILD NERV SYST, V8, P40, DOI 10.1007/BF00316561; Ogunyemi D, 2000, J Matern Fetal Med, V9, P219; Persson EK, 2005, ACTA PAEDIATR, V94, P726, DOI 10.1080/08035250510027336; Persson EK, 2007, CHILD NERV SYST, V23, P1111, DOI 10.1007/s00381-007-0324-7; R Development Core Team, 2009, R LANG ENV STAT COMP; Rajab A, 1998, J TROP PEDIATRICS, V44, P300, DOI 10.1093/tropej/44.5.300; Raut T, 2013, J INFECTION, V66, P330, DOI 10.1016/j.jinf.2012.12.009; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Research ICfBDSa, ANN REP 2017; Rintoul NE, 2002, PEDIATRICS, V109, P409, DOI 10.1542/peds.109.3.409; Saper CB, 2017, ANN NEUROL, V82, P514, DOI 10.1002/ana.25053; Schneider C, 2015, J NEUROSURG-PEDIATR, V15, P236, DOI 10.3171/2014.9.PEDS14280; Sethna F, 2011, OBSTET GYNECOL, V117, P867, DOI 10.1097/AOG.0b013e3182117471; Shawky RM., 2011, EJMHG, V12, P69, DOI [10.1016/j.ejmhg.2011.02.016, DOI 10.1016/J.EJMHG.2011.02.016]; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Smith ER, 2004, J NEUROSURG, V100, P90, DOI 10.3171/ped.2004.100.2.0090; Sun G, 2011, WORLD J PEDIATR, V7, P331, DOI 10.1007/s12519-011-0328-y; Synnes AR, 2004, AM J PERINAT, V21, P199, DOI 10.1055/s-2004-828604; Tanaka N, 2009, NEUROEPIDEMIOLOGY, V32, P171, DOI 10.1159/000186501; Tang YW, 2006, MATERN CHILD HLTH J, V10, P75, DOI 10.1007/s10995-005-0031-5; Tisell M, 2005, ACTA NEUROL SCAND, V112, P72, DOI 10.1111/j.1600-0404.2005.00451.x; Toriello HV, 2011, GENET MED, V13, P593, DOI 10.1097/GIM.0b013e31821d4188; Tso MK, 2016, WORLD NEUROSURG, V86, P226, DOI 10.1016/j.wneu.2015.09.056; Tulipan N, 2003, PEDIATR NEUROSURG, V38, P27, DOI 10.1159/000067560; Vinchon M, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-18; Viswanathan M, 2017, US PREVENTIVE SERVIC; Viswanathan M, 2017, JAMA-J AM MED ASSOC, V317, P190, DOI 10.1001/jama.2016.19193; Wald NJ, 2001, LANCET, V358, P2069, DOI 10.1016/S0140-6736(01)07104-5; Waller DK, 2000, FETAL DIAGN THER, V15, P348, DOI 10.1159/000021035; Wang SS, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-59; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P502, DOI 10.3171/2011.8.PEDS11221; Warf BC, 2010, WORLD NEUROSURG, V73, P296, DOI 10.1016/j.wneu.2010.02.009; Wilson CD, 2017, J NEUROSURG, V126, P586, DOI 10.3171/2015.11.JNS152094; Wilson RK, 2007, J NEUROL NEUROSUR PS, V78, P508, DOI 10.1136/jnnp.2006.108761; Wolf HT, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.029; Xie DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147280; Zhang XG, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-125	112	87	88	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204926	10.1371/journal.pone.0204926	http://dx.doi.org/10.1371/journal.pone.0204926			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273390	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700051
J	Nielsen, SH; Rasmussen, DGK; Brix, S; Fenton, A; Jesky, M; Ferro, CJ; Karsdal, M; Genovese, F; Cocicwell, P				Nielsen, Signe Holm; Rasmussen, Daniel Guldager Kring; Brix, Susanne; Fenton, Anthony; Jesky, Mark; Ferro, Charles J.; Karsdal, Morten; Genovese, Federica; Cocicwell, Paul			A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; POPULATION COHORTS; BASEMENT-MEMBRANES; LIGHT-CHAINS; ALBUMINURIA; NEPHROPATHY; PROTEINS	Background Patients with chronic kidney disease (CKD) have increased risk of development of end-stage renal disease (ESRD) and early mortality. Fibrosis is the central pathogenic process in CKD and is caused by dysregulated extracellular matrix (ECM) remodeling. The laminin gamma 1 chain (LAMC1) is a core structural protein present in the basement membrane of several organs, including the kidneys. We hypothesized that dysregulation of LAMC1 remodeling could be associated with a higher risk of adverse clinical outcomes in patients with CKD. Methods A novel immunoassay targeting LG1M, a specific MMP-9-generated neo-epitope fragment of LAMC1, was developed and used to measure the levels of the fragment in urine and serum from 492 patients from the Renal Impairment in Secondary Care (RIISC) study, a prospective cohort of patients with high-risk CKD. Patients were monitored for a median followup time of 3.5 years. Associations between serum and urine LG1M levels and progression of CKD at 12 months were assessed by a multivariable logistic regression model. The association with ESRD or mortality was assessed by Kaplan-Meier survival curves and Cox proportional hazards regression. Results Forty-six (11%) of the 416 patients who reached 12-month follow-up had progression of CKD; during the study follow-up, 125 patients (25.4%) developed ESRD and 71 patients (14.4%) died. Serum and urine levels of LG1 M correlated with baseline eGFR (r = -0.43, p<0.0001 and r = -0.17, p = 0.0002, respectively). Serum levels of LG1M were higher in patients with one-year progression of CKD compared to those who did not progress (p<0.01). Baseline serum levels of LG1 M were associated with development of ESRD (HR 3.2, 95% CI 1.99-5.2 for patients in the highest LG1 M tertile compared to patient in the lowest tertile). Baseline urinary levels of LG1M (uLG1 M) were significantly associated with mortality (HR 5.0, 95% CI 2.8-8.9, p<0.0001 for patients in the highest LG1M tertile compared to patients in the lowest tertile). Urine LG1M was retained in the model for prediction of mortality (HR per standard deviation of uLG1 M: 1.01, 95% CI 1.00-1.02, p = 0.001). Conclusions LG1M, a marker of basement membrane remodeling, is increased in serum and urine of patients with CKD and levels are associated with one-year disease progression, development of ESRD, and mortality.	[Nielsen, Signe Holm; Rasmussen, Daniel Guldager Kring; Karsdal, Morten; Genovese, Federica] Nord Biosci Biomarkers & Res, Herlev, Denmark; [Nielsen, Signe Holm; Brix, Susanne] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Rasmussen, Daniel Guldager Kring] Univ Southern Denmark, Inst Mol Med Cardiovasc & Renal Res, Inst Clin Res, Odense, Denmark; [Fenton, Anthony; Jesky, Mark; Ferro, Charles J.; Cocicwell, Paul] Queen Elizabeth Hosp, Dept Renal Med, Birmingham, W Midlands, England; [Fenton, Anthony; Ferro, Charles J.; Cocicwell, Paul] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England	Nordic Bioscience; Technical University of Denmark; University of Southern Denmark; University of Birmingham; University of Birmingham	Nielsen, SH (corresponding author), Nord Biosci Biomarkers & Res, Herlev, Denmark.; Nielsen, SH (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	shn@nordicbio.com	ferro, charles/L-7250-2019; Ferro, Charles J./O-8912-2016; Holm, Signe/GLT-8793-2022; Pedersen, Susanne Brix/B-3484-2009	ferro, charles/0000-0003-0577-7081; Ferro, Charles J./0000-0003-0577-7081; Holm, Signe/0000-0002-4612-1014; Pedersen, Susanne Brix/0000-0001-8951-6705; Fenton, Anthony/0000-0003-2665-6924; Karsdal, Morten/0000-0001-5026-8740; Cockwell, Paul/0000-0003-1975-266X	Danish Research Fund (Den Danske Forskningsfond); Binding Site Ltd (Birmingham, UK)	Danish Research Fund (Den Danske Forskningsfond); Binding Site Ltd (Birmingham, UK)	This work was supported by the Danish Research Fund (Den Danske Forskningsfond) to SHN. The Binding Site Ltd (Birmingham, UK) is acknowledged for the funding of the research fellowship of AF. The funder Nordic Bioscience provided support in the form of salaries for authors SHN, DGKR, MK and FGE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Binding Site Ltd. provided support in the form of salaries for author AF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the Danish Research Fund (Den Danske Forskningsfond). The Binding Site Ltd (Birmingham, UK) is acknowledged for the funding of the research fellowship of AF.	ABRAHAMSON DR, 1993, KIDNEY INT, V43, P73, DOI 10.1038/ki.1993.13; Altemtam N, 2012, NEPHRON EXTRA, V2, P219, DOI 10.1159/000339645; BOHLE A, 1987, AM J NEPHROL, V7, P421, DOI 10.1159/000167514; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Herrera G A, 2000, Ann Diagn Pathol, V4, P174; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Macy EM, 1997, CLIN CHEM, V43, P52; Malinda KM, 1996, INT J BIOCHEM CELL B, V28, P957, DOI 10.1016/1357-2725(96)00042-8; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563; Montseny JJ, 1998, NEPHROL DIAL TRANSPL, V13, P1438, DOI 10.1093/ndt/13.6.1438; National Institute for Health and Clinical Excellence, 2008, CHRON KIDN DIS EARL; Pote A, 2000, AM J KIDNEY DIS, V36, P735, DOI 10.1053/ajkd.2000.17620; RISDON RA, 1968, LANCET, V2, P363; SANDERS PW, 1992, J CLIN INVEST, V89, P630, DOI 10.1172/JCI115629; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Setty S, 2012, MODERN PATHOL, V25, P859, DOI 10.1038/modpathol.2011.216; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; Willem M, 2002, DEVELOPMENT, V129, P2711; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204239	10.1371/journal.pone.0204239	http://dx.doi.org/10.1371/journal.pone.0204239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273365	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700016
J	Osorno, T; Arenas, O; Ramirez-Suarez, NJ; Echeverry, FA; Gomez, MD; Nasi, E				Osorno, Tomas; Arenas, Oscar; Ramirez-Suarez, Nelson J.; Echeverry, Fabio A.; del Pilar Gomez, Maria; Nasi, Enrico			Light control of G protein signaling pathways by a novel photopigment	PLOS ONE			English	Article							CILIARY INVERTEBRATE PHOTORECEPTORS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; VISUAL PIGMENT; IN-VIVO; HYPERPOLARIZING PHOTORECEPTORS; COUPLED RECEPTORS; CALCIUM-CHANNELS; CHLORIDE CHANNEL; BOVINE RHODOPSIN; OPTICAL CONTROL	Channelopsins and photo-regulated ion channels make it possible to use light to control electrical activity of cells. This powerful approach has lead to a veritable explosion of applications, though it is limited to changing membrane voltage of the target cells. An enormous potential could be tapped if similar opto-genetic techniques could be extended to the control of chemical signaling pathways. Photopigments from invertebrate photoreceptors are an obvious choice-as they do not bleach upon illumination -however, their functional expression has been problematic. We exploited an unusual opsin, pScop2, recently identified in ciliary photoreceptors of scallop. Phylogenetically, it is closer to vertebrate opsins, and offers the advantage of being a bi-stable photopigment. We inserted its coding sequence and a fluorescent protein reporter into plasmid vectors and demonstrated heterologous expression in various mammalian cell lines. HEK 293 cells were selected as a heterologous system for functional analysis, because wild type cells displayed the largest currents in response to the G-protein activator, GTP-gamma-S. A line of HEK cells stably transfected with pScop2 was generated; after reconstitution of the photopigment with retinal, light responses were obtained in some cells, albeit of modest amplitude. In native photoreceptors pScop2 couples to G(center dot); HEK cells express poorly this G-protein, but have a prominent Gq/PLC pathway linked to internal Ca mobilization. To enhance pScop2 competence to tap into this pathway, we swapped its third intracellular loop-important to confer specificity of interaction between 7TMDRs and G-proteins-with that of a G(q)-linked opsin which we cloned from microvillar photoreceptors present in the same retina. The chimeric construct was evaluated by a Ca fluorescence assay, and was shown to mediate a robust mobilization of internal calcium in response to illumination. The results project pScop2 as a potentially powerful optogenetic tool to control signaling pathways.	[Osorno, Tomas; Arenas, Oscar; Ramirez-Suarez, Nelson J.; Echeverry, Fabio A.; del Pilar Gomez, Maria] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; [del Pilar Gomez, Maria; Nasi, Enrico] Marine Biol Lab, Woods Hole, MA 02543 USA; [Nasi, Enrico] Univ Nacl Colombia, Inst Genet, Bogota, Colombia; [Osorno, Tomas] Harvard Med Sch, Dept Neurobiol, Boston, MA USA; [Arenas, Oscar] Northwestern Univ, Dept Neurosci, Chicago, IL 60611 USA; [Ramirez-Suarez, Nelson J.; Echeverry, Fabio A.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA	Universidad Nacional de Colombia; Marine Biological Laboratory - Woods Hole; Universidad Nacional de Colombia; Harvard University; Harvard Medical School; Northwestern University; Yeshiva University	Nasi, E (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.; Nasi, E (corresponding author), Univ Nacl Colombia, Inst Genet, Bogota, Colombia.	enasil@unal.edu.co	Echeverry, Fabio/AAS-2830-2021	Echeverry, Fabio/0000-0002-4200-4080; Ramirez, Nelson/0000-0001-7394-860X	Colciencias grant [FP44842-010-2015]; Connecticut Fund for Science	Colciencias grant(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Connecticut Fund for Science	This work was funded by Colciencias grant FP44842-010-2015 and Connecticut Fund for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE R, 1994, METHOD ENZYMOL, V238, P348; Arenas O, 2018, J GEN PHYSIOL, V150, P401, DOI 10.1085/jgp.201711938; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Brydon L, 1999, MOL ENDOCRINOL, V13, P2025, DOI 10.1210/me.13.12.2025; CHAN T, 1992, J BIOL CHEM, V267, P9478; Chen YM, 2003, VISION RES, V43, P3037, DOI 10.1016/j.visres.2003.08.001; Colecraft HM, 2001, J NEUROSCI, V21, P1137; CONE RA, 1967, SCIENCE, V155, P1128, DOI 10.1126/science.155.3766.1128; CORNWALL MC, 1983, J PHYSIOL-LONDON, V340, P307, DOI 10.1113/jphysiol.1983.sp014764; CORNWALL MC, 1983, CELL MOL NEUROBIOL, V3, P311, DOI 10.1007/BF00734713; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; Gomez MD, 2011, J NEUROSCI, V31, P1811, DOI 10.1523/JNEUROSCI.3320-10.2011; Gomez MD, 2009, J GEN PHYSIOL, V134, P177, DOI 10.1085/jgp.200910214; Erster O, 2010, METHODS MOL BIOL, V634, P157, DOI 10.1007/978-1-60761-652-8_12; FEILER R, 1992, J NEUROSCI, V12, P3862; Francken BJB, 2000, MOL PHARMACOL, V57, P1034; Giesbers ME, 2008, PHOTOCHEM PHOTOBIOL, V84, P990, DOI 10.1111/j.1751-1097.2008.00347.x; Gomez MD, 2005, J BIOL CHEM, V280, P16784, DOI 10.1074/jbc.M414538200; GOMEZ MD, 1995, NEURON, V15, P607, DOI 10.1016/0896-6273(95)90149-3; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Greasley PJ, 2001, J BIOL CHEM, V276, P46485, DOI 10.1074/jbc.M105791200; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; HILLMAN P, 1972, SCIENCE, V175, P1486, DOI 10.1126/science.175.4029.1486; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Horn F, 2000, PROTEINS, V41, P448, DOI 10.1002/1097-0134(20001201)41:4<448::AID-PROT30>3.0.CO;2-C; Hsu SH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1021, DOI 10.1152/ajpendo.00003.2007; Jansen V, 2017, CURR OPIN BIOTECH, V48, P15, DOI 10.1016/j.copbio.2017.02.014; Jiang MS, 2009, NEUROSIGNALS, V17, P23, DOI 10.1159/000186688; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Knox BE, 2003, J BIOL CHEM, V278, P40493, DOI 10.1074/jbc.M304567200; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kramarenko II, 2009, BIOCHEM PHARMACOL, V77, P269, DOI 10.1016/j.bcp.2008.09.027; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Ma JX, 1999, FEBS LETT, V452, P199, DOI 10.1016/S0014-5793(99)00606-7; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; MINKE B, 1975, J COMP PHYSIOL, V98, P345, DOI 10.1007/BF00709805; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NOLTE J, 1972, J GEN PHYSIOL, V59, P186, DOI 10.1085/jgp.59.2.186; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Parry JWL, 2000, VISION RES, V40, P2241, DOI 10.1016/S0042-6989(00)00101-2; PEPPERBERG DR, 1978, J GEN PHYSIOL, V71, P369, DOI 10.1085/jgp.71.4.369; RASMUSSEN T, 1947, FED PROC, V6, P184; Reiner A, 2013, TRENDS NEUROSCI, V36, P557, DOI 10.1016/j.tins.2013.08.005; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Sexton TJ, 2012, J BIOL CHEM, V287, P20888, DOI 10.1074/jbc.M111.325969; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Shichida Y, 2003, PHOTOCH PHOTOBIO SCI, V2, P1237, DOI 10.1039/b300434a; Spoida K, 2016, CURR BIOL, V26, P1206, DOI 10.1016/j.cub.2016.03.007; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zheng LL, 2010, J NEUROSCI, V30, P7187, DOI 10.1523/JNEUROSCI.0852-10.2010; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5	69	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205015	10.1371/journal.pone.0205015	http://dx.doi.org/10.1371/journal.pone.0205015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273391	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700059
J	Perez, PA; DiPatrizio, NV				Perez, Pedro A.; DiPatrizio, Nicholas, V			Impact of maternal western diet-induced obesity on offspring mortality and peripheral endocannabinoid system in mice	PLOS ONE			English	Article							CANNABINOID RECEPTORS; INSULIN-SECRETION; UNITED-STATES; FOOD; HYPERPHAGIA; PREVALENCE; MECHANISMS; PREGNANCY; GUT; ANTAGONIST	Over two-thirds of adults in the United States are obese or overweight, which is largely due to chronic overconsumption of diets high in fats and sugars (i.e., Western diet). Recent studies reveal that maternal obesity may predispose offspring to development of obesity and other metabolic diseases; however, the molecular underpinnings of these outcomes are largely unknown. The endocannabinoid system is an important signaling pathway that controls feeding behavior and energy homeostasis, and its activity becomes upregulated in the upper small intestinal epithelium of Western diet-induced obese mice, which drives overeating. In the current investigation, we examined the impact of chronic maternal consumption of Western diet on the expression and function of the endocannabinoid system in several peripheral organs important for food intake and energy homeostasis in offspring. Female C57BU6Tac mice were fed a Western diet or low-fat/no-sucrose control chow for 10 weeks, then males were introduced for mating. Dams were maintained on their respective diets through weaning of pups, at which time pups were maintained on low-fat/nosucrose chow for 10 weeks. Neonates born from dams fed Western diet, when compared to those born from mice fed control chow, unexpectedly displayed increases in mortality that occurred exclusively within six days following birth (greater than 50% mortality). Males comprised a larger fraction of surviving offspring from obese dams. Furthermore, surviving offspring displayed transient increases in body mass for first two days post weaning, and no marked changes in feeding patterns and endocannabinoid levels in upper small intestinal epithelium, pancreas, and plasma, or in expression of key endocannabinoid system genes in the upper small intestinal epithelium and pancreas at 10 weeks post-weaning. Collectively, these results suggest that maternal diet composition greatly influences survival of neonate C57BL/6Tac mice, and that surviving offspring from dams chronically fed a Western diet do not display marked changes in body mass, eating patterns, or expression and function of the endocannabinoid system in several peripheral organs important for feeding behavior and energy homeostasis.	[Perez, Pedro A.; DiPatrizio, Nicholas, V] Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	DiPatrizio, NV (corresponding author), Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA.	ndipatri@ucr.edu	DiPatrizio, NIcholas/AAV-1865-2021	DiPatrizio, NIcholas/0000-0001-8423-0695; Perez, Pedro/0000-0002-2480-552X	National Institutes of Health [DA034009, DK114978]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants DA034009 and DK114978 to NVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2018, CRIT REV CL LAB SCI, V55, P71, DOI 10.1080/10408363.2017.1422109; Almeida MM, 2017, BRIT J NUTR, V118, P788, DOI 10.1017/S0007114517002884; Angelini R, 2017, CANNABIS CANNABINOID, V2, P123, DOI 10.1089/can.2017.0019; Argueta DA, 2017, PHYSIOL BEHAV, V171, P32, DOI 10.1016/j.physbeh.2016.12.044; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Buchanan TA, 2012, NAT REV ENDOCRINOL, V8, P639, DOI 10.1038/nrendo.2012.96; Cristino L, 2014, BIOFACTORS, V40, P389, DOI 10.1002/biof.1168; De Petrocellis L, 2007, EXP CELL RES, V313, P2993, DOI 10.1016/j.yexcr.2007.05.012; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; DiPatrizio NV, 2016, CANNABIS CANNABINOID, V1, P67, DOI 10.1089/can.2016.0001; DiPatrizio NV, 2015, AM J PHYSIOL-REG I, V309, pR805, DOI 10.1152/ajpregu.00239.2015; DiPatrizio NV, 2015, J CLIN INVEST, V125, P891, DOI 10.1172/JCI76302; DiPatrizio NV, 2013, FASEB J, V27, P2513, DOI 10.1096/fj.13-227587; DiPatrizio NV, 2012, TRENDS NEUROSCI, V35, P403, DOI 10.1016/j.tins.2012.04.006; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Dotsey E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42584; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Fride E, 2001, EUR J PHARMACOL, V419, P207, DOI 10.1016/S0014-2999(01)00953-0; Fryar C.D., 2014, PREVALENCE OVERWEIGH; Hiramatsu L, 2017, PHYSIOL BEHAV, V179, P235, DOI 10.1016/j.physbeh.2017.06.008; Izzo AA, 2010, PHARMACOL THERAPEUT, V126, P21, DOI 10.1016/j.pharmthera.2009.12.005; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Jarbe TUC, 2005, BEHAV PHARMACOL, V16, P373; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Kim HY, 2018, MOL ASPECTS MED, DOI [10.1016/j.mam, DOI 10.1016/J.MAM]; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Li C, 2010, ISLETS, V2, P293, DOI 10.4161/isl.2.5.12729; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Malenczyk K, 2015, P NATL ACAD SCI USA, V112, pE6185, DOI 10.1073/pnas.1519040112; Malenczyk K, 2013, J BIOL CHEM, V288, P32685, DOI 10.1074/jbc.M113.478354; Masuyama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092805; Medina-Remon A, 2018, CRIT REV FOOD SCI, V58, P262, DOI 10.1080/10408398.2016.1158690; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Nivoit P, 2017, ESTABLISHED DIET IND, P1432, DOI [10.1017/S0007114517002884, DOI 10.1017/S0007114517002884]; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Park T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0751-z; Pertwee RG, 2015, HANDB EXP PHARMACOL, V231, P1, DOI 10.1007/978-3-319-20825-1_1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pirkola J, 2010, DIABETES CARE, V33, P1115, DOI 10.2337/dc09-1871; Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.113.071928; Ramirez-Lopez M. T., 2016, FRONT BEHAV NEUROSCI, V10, P1, DOI DOI 10.3389/; Shin H, 2018, J CELL MOL MED, V22, P2337, DOI 10.1111/jcmm.13523; Simon V, 2017, EUR J ENDOCRINOL, V176, pR309, DOI 10.1530/EJE-16-1044; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Ramirez-Lopez MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165432; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00339; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Vahratian A, 2009, MATERN CHILD HLTH J, V13, P268, DOI 10.1007/s10995-008-0340-6	56	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205021	10.1371/journal.pone.0205021	http://dx.doi.org/10.1371/journal.pone.0205021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273406	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700061
J	Paterson, TSE; O'Rourke, N; Shapiro, RJ; Thornton, WL				Paterson, Theone S. E.; O'Rourke, Norm; Shapiro, R. Jean; Thornton, Wendy Loken			Medication adherence in renal transplant recipients: A latent variable model of psychosocial and neurocognitive predictors	PLOS ONE			English	Article							SELF-EFFICACY SCALE; QUALITY-OF-LIFE; KIDNEY-TRANSPLANT; EFFECTS QUESTIONNAIRE; INTELLECTUAL ABILITY; EVERYDAY COGNITION; AGE-DIFFERENCES; DEPRESSION; NONADHERENCE; VALIDATION	Objective Estimates indicate that 20-70% of renal transplant recipients are medication non-adherent, significantly increasing the risk of organ rejection. Medication adherence is negatively impacted by lower everyday problem solving ability, and associations between depressive symptoms, self-efficacy, and adherence are reported in renal transplant recipients. Nonetheless, to date, these associations have not been examined concurrently. Given the relationship between non-adherence and organ rejection, it is critical to gain a better understanding of the predictors of adherence in renal transplant recipients. To this end, we modeled relationships among cognitive abilities, depressive symptoms, self-efficacy, and adherence in this group. Methods Participants (N = 211) underwent renal transplant at least one year prior to participation. Adherence was measured via self-report, medication possession ratio, and immunosuppressant blood-level. Traditionally-measured neurocognitive and everyday problem-solving abilities were assessed. Depressive symptoms were measured via self-report, as were general and medication adherence related self-efficacy. Structural equation modeling was used to assess the fit of the model to available data. Results Everyday problem solving and self-efficacy had direct positive associations with adherence. Depressive symptoms were negatively associated with self-efficacy, but not adherence. Traditionally-measured neurocognitive abilities were positively associated with self-efficacy, and negatively associated with depressive symptoms. Conclusions We present a comprehensive investigation of relationships between cognitive and psychosocial factors and adherence in medically stable renal transplant recipients. Findings confirm the importance of everyday problem solving and self-efficacy in predicting adherence and suggest that influences of depressive symptoms and neurocognitive abilities are indirect. Findings have important implications for future development of interventions to improve medication adherence in renal transplant recipients.	[Paterson, Theone S. E.; Thornton, Wendy Loken] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [O'Rourke, Norm] Ben Gurion Univ Negev, Beer Sheva, Israel; [Shapiro, R. Jean] Univ British Columbia, Vancouver, BC, Canada	Simon Fraser University; Ben Gurion University; University of British Columbia	Thornton, WL (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.	wthornto@sfu.ca	O'Rourke, Norm/AAP-5428-2020	O'Rourke, Norm/0000-0001-5100-427X; Paterson, Theone/0000-0002-5876-1991	SFU/Social Sciences and Humanities Research Council [R631729, R631828]; Krescent Allied Health Doctoral Scholarship [KRES110008]; Michael Smith Foundation for Health Research [ST-SGS-02284]	SFU/Social Sciences and Humanities Research Council; Krescent Allied Health Doctoral Scholarship; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by SFU/Social Sciences and Humanities Research Council grants (R631729; R631828) awarded to Dr. Wendy Loken Thornton. Dr. Theone Paterson was supported by a Krescent Allied Health Doctoral Scholarship (KRES110008) and a Michael Smith Foundation for Health Research Senior Graduate Studentship (ST-SGS-02284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire JC, 2002, PSYCHOL AGING, V17, P101, DOI [10.1037//0882-7974.17.1.101, 10.1037/0882-7974.17.1.101]; Allaire JC, 1999, PSYCHOL AGING, V14, P627, DOI 10.1037/0882-7974.14.4.627; Andrade ASA, 2013, JAIDS-J ACQ IMM DEF, V62, P282, DOI 10.1097/QAI.0b013e31827ed678; Annema C, 2013, RES NURS HEALTH, V36, P203, DOI 10.1002/nur.21530; Arbuckle J.L., 2014, AMOS; Axelrod BN, 2002, ASSESSMENT, V9, P17, DOI 10.1177/1073191102009001003; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Barclay TR, 2007, HEALTH PSYCHOL, V26, P40, DOI 10.1037/0278-6133.26.1.40; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Butler JA, 2004, TRANSPLANTATION, V77, P769, DOI 10.1097/01.TP.0000110408.83054.88; Caspar S, 2009, AGEING INT, V34, P33, DOI 10.1007/s12126-009-9033-8; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chapman JR, 2004, TRANSPLANTATION, V77, P782, DOI 10.1097/01.TP.0000110411.23547.D4; Chen G, 2001, ORGAN RES METHODS, V4, P62, DOI 10.1177/109442810141004; Cheng CY, 2012, TRANSPL P, V44, P746, DOI 10.1016/j.transproceed.2011.11.030; Chisholm-Burns M, 2012, CLIN TRANSPLANT, V26, P706, DOI 10.1111/j.1399-0012.2011.01589.x; Chisholm-Burns MA, 2012, J AM PHARM ASSOC, V52, P816, DOI 10.1331/JAPhA.2012.11083; De Pasquale C, 2014, TRANSPL P, V46, P2235, DOI 10.1016/j.transproceed.2014.07.035; DeGeest S, 1996, WESTERN J NURS RES, V18, P595, DOI 10.1177/019394599601800509; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Denhaerynck K, 2005, TRANSPL INT, V18, P1121, DOI 10.1111/j.1432-2277.2005.00176.x; Denhaerynck K, 2014, INT J TRANSPLANT MED, V5, P7; Dew MA, 2007, TRANSPLANTATION, V83, P858, DOI 10.1097/01.tp.0000258599.65257.a6; Dobbels F, 2010, TRANSPLANTATION, V90, P205, DOI 10.1097/TP.0b013e3181e346cd; Dobbels F, 2010, PEDIATR TRANSPLANT, V14, P216, DOI 10.1111/j.1399-3046.2009.01197.x; Fernandez S, 2008, J BEHAV MED, V31, P453, DOI 10.1007/s10865-008-9170-7; Fiorina P, 2012, DIABETES CARE, V35, P367, DOI 10.2337/dc11-1697; FRAZIER PA, 1994, CLIN TRANSPLANT, V8, P550; Gelb S, 2008, NEPHROL DIAL TRANSPL, V23, P1032, DOI 10.1093/ndt/gfm659; Gelb SR, 2010, NEUROPSYCHOLOGY, V24, P514, DOI 10.1037/a0018670; Goldfarb-Rumyantzev AS, 2011, NEPHRON CLIN PRACT, V117, pC33, DOI 10.1159/000319645; Gonzalez JS, 2013, DIABETES CARE, V36, P831, DOI 10.2337/dc12-0410; Griva K, 2002, NEPHROL DIAL TRANSPL, V17, P2204, DOI 10.1093/ndt/17.12.2204; Griva K, 2012, ANN BEHAV MED, V44, P85, DOI 10.1007/s12160-012-9359-4; Hain Debra J, 2008, Nephrol Nurs J, V35, P23; Hertzog C., 1990, PSYCHOL ASSESSMENT, V2, P64, DOI DOI 10.1037/1040-3590.2.1.64; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jean-Baptiste R., 2002, DISS ABSTR INT B, V62; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Jerusalem M., 1992, SELF EFFICACY THOUGH, P195, DOI DOI 10.4324/9781315800820; Johnson MO, 2007, J BEHAV MED, V30, P359, DOI 10.1007/s10865-007-9118-3; Kasahara H., 2006, PSYCHOGERIATRICS, V6, P128; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; Lindberg M, 2010, J CLIN NURS, V19, P2997, DOI 10.1111/j.1365-2702.2010.03372.x; Liu J, 2015, CLIN THER, V37, P2572, DOI 10.1016/j.clinthera.2015.09.014; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Massey EK, 2013, J PSYCHOSOM RES, V75, P229, DOI 10.1016/j.jpsychores.2013.07.006; McDonald JH, 2014, HDB BIOL STAT, P255; National Institute of Mental Health, USA NAT I MENT HLTH; O'Rourke N, 2004, EDUC PSYCHOL MEAS, V64, P973, DOI 10.1177/0013164404268668; O'Rourke N., 2013, STEP BY STEP APPROAC; Oh HS, 2013, J ADV NURS, V69, P2041, DOI 10.1111/jan.12071; Ozcan H, 2015, TRANSPL P, V47, P1348, DOI 10.1016/j.transproceed.2015.04.032; Palmer S, 2013, KIDNEY INT, V84, P179, DOI 10.1038/ki.2013.77; Paterson TSE, 2011, CAN J BEHAV SCI, V43, P318, DOI 10.1037/a0025104; Paterson TSE, 2016, J INT NEUROPSYCH SOC, V22, P62, DOI [10.1016/j.transproceed.2014.07.035, DOI 10.1016/J.TRANSPROCEED.2014.07.035]; Pereira AA, 2005, AM J KIDNEY DIS, V45, P448, DOI 10.1053/j.ajkd.2004.10.024; Prihodova L, 2014, J ADV NURS, V70, P2871, DOI 10.1111/jan.12447; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rudman LA, 1999, J APPL SOC PSYCHOL, V29, P834, DOI 10.1111/j.1559-1816.1999.tb02028.x; Scherbaum CA, 2006, EDUC PSYCHOL MEAS, V66, P1047, DOI 10.1177/0013164406288171; Schoenthaler A, 2009, HEALTH EDUC BEHAV, V36, P127, DOI 10.1177/1090198107309459; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Stewart K, 2014, INT J CLIN PHARM-NET, V36, P15, DOI 10.1007/s11096-013-9877-6; Sukhpreet, 2007, INDIAN J PHARMACOL, V39, P66; The kindney foundation on canada &VERBAR; La Fondation canadienne du rein, WHAT IS KIDN DIS; Thornton AE, 2010, J CLIN EXP NEUROPSYC, V32, P299, DOI 10.1080/13803390903002209; Thornton WL, 2007, J INT NEUROPSYCH SOC, V13, P344, DOI 10.1017/S1355617707070361; Thornton WL, 2007, PSYCHOL AGING, V22, P470, DOI 10.1037/0882-7974.22.3.470; Thornton WL, 2013, INT J BEHAV DEV, V37, P13, DOI 10.1177/0165025412454028; Thornton WJL, 2005, PSYCHOL AGING, V20, P85, DOI 10.1037/0882-7974.20.1.85; Troen AM, 2012, J RENAL NUTR, V22, P268, DOI 10.1053/j.jrn.2011.07.009; Tucker CM, 2001, J PEDIATR PSYCHOL, V26, P455, DOI 10.1093/jpepsy/26.8.455; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Weng LC, 2008, J CLIN NURS, V17, P1786, DOI 10.1111/j.1365-2702.2007.02035.x; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th; Yeung SE, 2011, AGING NEUROPSYCHOL C, V18, P733, DOI 10.1080/13825585.2011.609882; Yochim B, 2007, J INT NEUROPSYCH SOC, V13, P704, DOI 10.1017/S1355617707070907; Yount SE, 1998, J CLIN PSYCHOL MED S, V5, P497, DOI 10.1023/A:1026215129503; Zalai D, 2012, SEMIN DIALYSIS, V25, P428, DOI 10.1111/j.1525-139X.2012.01100.x; Ziegelmann JP, 2002, BRIT J HEALTH PSYCH, V7, P393, DOI 10.1348/135910702320645381	83	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204219	10.1371/journal.pone.0204219	http://dx.doi.org/10.1371/journal.pone.0204219			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265697	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500020
J	Yoneda, S; Okubo, H; Linderman, SW; Kusano, N; Silva, MJ; Thomopoulos, S; Kanaya, F; Gelberman, RH				Yoneda, Susumu; Okubo, Hirotaka; Linderman, Stephen W.; Kusano, Nozomu; Silva, Matthew J.; Thomopoulos, Stavros; Kanaya, Fuminori; Gelberman, Richard H.			The effect of modified locking methods and suture materials on Zone II flexor tendon repair-An ex vivo study	PLOS ONE			English	Article							EARLY ACTIVE MOBILIZATION; CORE SUTURE; GLIDING RESISTANCE; GAP FORMATION; STRENGTH; EXCURSION; CADAVER; CANINES; MOTION; LOOPS	The failure rate of intrasynovial tendon repair is high due to substantial elongation at the repair site and to the development of adhesions between the tendon's surface and the surrounding digital sheath. To minimize these complications, we sought to reduce the incidence of gapping and to facilitate the initiation of early motion by improving the time zero structural properties of repair. The Winters-Gelberman 8-strand repair technique was modified by adding surface lock loops and by using Fiberwire suture material. Forty-eight canine flexor digitorum profundus tendons were transected and repaired with one of three 8-strand techniques (Pennington modified Kessler, half hitch loops, or surface locking Kessler) using either 3-0 Supramid or 4-0 Fiberwire suture. Biomechanical testing was performed to determine the physiologic and failure mode properties of the repairs. The surface locking Kessler technique improved repair maximum load, load necessary to create a 2 mm repair site gap, and yield force compared to the modified Kessler and half hitch loop techniques. Fiberwire suture improved maximum load, the load necessary to create a 2 mm repair site gap, stiffness, and yield force compared to Supramid suture. Failure occurred by both suture pull out and by suture breakage in the modified Kessler, Supramid suture repair group. Failure occurred consistently by suture breakage in the surface locking Kessler, Supramid suture repair group. These results reveal that a novel locking Kessler repair is significantly stronger than the current state-of-the art flexor tendon suture repair technique. The use of a surface locking Kessler technique with Fiberwire suture markedly improves the mechanical properties of intrasynovial tendon repair by reducing the risk of post-operative gapping and rupture.	[Yoneda, Susumu; Linderman, Stephen W.; Silva, Matthew J.; Gelberman, Richard H.] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Yoneda, Susumu; Okubo, Hirotaka; Kanaya, Fuminori] Univ Ryukyus, Grad Sch Med, Dept Orthoped Surg, Okinawa, Japan; [Kusano, Nozomu] Tominaga Kusano Hosp, Dept Orthoped Surg, Niigata, Japan; [Thomopoulos, Stavros] Columbia Univ, Dept Orthoped Surg, New York, NY USA; [Thomopoulos, Stavros] Columbia Univ, Dept Biomed Engn, New York, NY USA	Washington University (WUSTL); University of the Ryukyus; Columbia University; Columbia University	Yoneda, S (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.; Yoneda, S (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Orthoped Surg, Okinawa, Japan.	susumuyoneda@wustl.edu	Linderman, Stephen/GQB-4770-2022	Silva, Matthew/0000-0001-7375-4522; Linderman, Stephen/0000-0002-1797-5870	National Institutes of Health (NIH) [R01-AR062947]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR060719, R01AR062947] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was funded in part by a grant from the National Institutes of Health (NIH) R01-AR062947 (to RHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio Peter C, 2005, J Hand Ther, V18, P112, DOI 10.1197/j.jht.2005.01.005; Boyer MI, 2001, J BONE JOINT SURG AM, V83A, P891, DOI 10.2106/00004623-200106000-00011; Gan AWT, 2012, J HAND SURG-AM, V37A, P1830, DOI 10.1016/j.jhsa.2012.06.008; Gelberman RH, 1999, J BONE JOINT SURG AM, V81A, P975, DOI 10.2106/00004623-199907000-00010; Gelberman RH, 2007, J HAND SURG-AM, V32A, P373, DOI 10.1016/j.jhsa.2006.12.009; Hotokezaka S, 1997, J HAND SURG-AM, V22A, P995, DOI 10.1016/S0363-5023(97)80038-X; Karjalainen T, 2012, J HAND SURG-AM, V37A, P217, DOI 10.1016/j.jhsa.2011.10.039; Kormpakis I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153822; MASHADI ZB, 1991, J HAND SURG-BRIT EUR, V16B, P35, DOI 10.1016/0266-7681(91)90124-7; Miller B, 2007, J HAND SURG-AM, V32A, P591, DOI 10.1016/j.jhsa.2007.03.003; Mistry R, 2016, J HAND SURG-ASIAN-PA, V21, P333, DOI 10.1142/S2424835516500302; Moriya K, 2015, J HAND SURG-EUR VOL, V40, P250, DOI 10.1177/1753193414551682; Moriya T, 2012, J HAND SURG-EUR VOL, V37E, P316, DOI 10.1177/1753193411422793; Moriya T, 2010, J ORTHOP RES, V28, P1475, DOI 10.1002/jor.21177; Nelson GN, 2012, J ORTHOP RES, V30, P1652, DOI 10.1002/jor.22108; Osei DA, 2014, J HAND SURG-AM, V39, P262, DOI 10.1016/j.jhsa.2013.11.001; Peltz TS, 2015, J HAND SURG-ASIAN-PA, V20, P369, DOI 10.1142/S0218810415400092; PENNINGTON DG, 1979, PLAST RECONSTR SURG, V63, P648, DOI 10.1097/00006534-197905000-00007; Sandow MJ, 2011, J HAND SURG-EUR VOL, V36E, P467, DOI 10.1177/1753193411405937; SAVAGE R, 1989, J HAND SURG-BRIT EUR, V14B, P396, DOI 10.1016/0266-7681(89)90154-X; SCHUIND F, 1992, J HAND SURG-AM, V17A, P291, DOI 10.1016/0363-5023(92)90408-H; Silva Matthew J, 2002, J Orthop Sci, V7, P508, DOI 10.1007/s007760200090; Strickland, 1995, J Am Acad Orthop Surg, V3, P44; Strickland JW, 2000, J HAND SURG-AM, V25A, P214; Thomopoulos S, 2009, J ORTHOP RES, V27, P1209, DOI 10.1002/jor.20875; Walbeehm ET, 2009, J HAND SURG-EUR VOL, V34E, P190, DOI 10.1177/1753193408098479; Wang B, 2003, J HAND SURG-BRIT EUR, V28B, P347, DOI 10.1016/S0266-7681(03)00019-6; Winters SC, 1998, J HAND SURG-AM, V23A, P97, DOI 10.1016/S0363-5023(98)80096-8; Wu YF, 2014, J HAND SURG-EUR VOL, V39, P6, DOI 10.1177/1753193413492914; Wu YF, 2012, J HAND SURG-AM, V37A, P906, DOI 10.1016/j.jhsa.2012.01.004	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205121	10.1371/journal.pone.0205121	http://dx.doi.org/10.1371/journal.pone.0205121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289887	Green Submitted, gold, Green Published			2022-12-27	WOS:000446545500050
J	Boonyarittichaikij, R; Verbrugghe, E; Dekeukeleire, D; Strubbe, D; Van Praet, S; De Beelde, R; Rouffaer, L; Pasmans, F; Bonte, D; Verheyen, K; Lens, L; Martel, A				Boonyarittichaikij, Roschong; Verbrugghe, Elin; Dekeukeleire, Daan; Strubbe, Diederik; Van Praet, Sarah; De Beelde, Robbe; Rouffaer, Lieze; Pasmans, Frank; Bonte, Dries; Verheyen, Kris; Lens, Luc; Martel, An			Mitigating the impact of microbial pressure on great (Parus major) and blue (Cyanistes caeruleus) tit hatching success through maternal immune investment	PLOS ONE			English	Article							REAL-TIME PCR; BACTERIAL COMMUNITIES; BROOD PARASITISM; ESSENTIAL OIL; FECES; EGGS; QUANTIFICATION; CONTAMINATION	The hatching success of a bird's egg is one of the key determinants of avian reproductive success, which may be compromised by microbial infections causing embryonic death. During incubation, outer eggshell bacterial communities pose a constant threat of pathogen translocation and embryo infection. One of the parental strategies to mitigate this threat is the incorporation of maternal immune factors into the egg albumen and yolk. It has been suggested that habitat changes like forest fragmentation can affect environmental factors and life-history traits that are linked to egg contamination. This study aims at investigating relationships between microbial pressure, immune investment and hatching success in two abundant forest bird species and analyzing to what extent these are driven by extrinsic (environmental) factors. We here compared (1) the bacterial load and composition on eggshells, (2) the level of immune defenses in eggs, and (3) the reproductive success between great (Parus major) and blue (Cyanistes caeruleus) tits in Belgium and examined if forest fragmentation affects these parameters. Analysis of 70 great tit and 34 blue tit eggshells revealed a similar microbiota composition (Enterobacteriaceae, Lactobacillus spp., Firmicutes and Bacteroidetes), but higher bacterial loads in great tits. Forest fragmentation was not identified as an important explanatory variable. Although a significant negative correlation between hatching success and bacterial load on the eggshells in great tits corroborates microbial pressure to be a driver of embryonic mortality, the overall hatching success was only marginally lower than in blue tits. This may be explained by the significantly higher levels of lysozyme and IgY in the eggs of great tits, protecting the embryo from increased infection pressure. Our results show that immune investment in eggs is suggested to be a species-specific adaptive trait that serves to protect hatchlings from pathogen pressure, which is not directly linked to habitat fragmentation.	[Boonyarittichaikij, Roschong; Verbrugghe, Elin; Van Praet, Sarah; Rouffaer, Lieze; Pasmans, Frank; Martel, An] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Ghent, Belgium; [Boonyarittichaikij, Roschong] Mahidol Univ, Dept Clin Sci & Publ Hlth, Fac Vet Sci, Phuttamonthon, Nakhon Pathom, Thailand; [Dekeukeleire, Daan; Strubbe, Diederik; De Beelde, Robbe; Bonte, Dries; Lens, Luc] Univ Ghent, Dept Biol, Terr Ecol Unit, Ghent, Belgium; [De Beelde, Robbe; Verheyen, Kris] Univ Ghent, Dept Forest & Water Management, Forest & Nat Lab, Gontrode, Belgium	Ghent University; Mahidol University; Ghent University; Ghent University	Verbrugghe, E (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Ghent, Belgium.	Elin.Verbrugghe@ugent.be	Bonte, Dries/AAH-3913-2021; Pasmans, Frank/D-3667-2014	Bonte, Dries/0000-0002-3320-7505; Verheyen, Kris/0000-0002-2067-9108; Lens, Luc/0000-0002-0241-2215	UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB); Marie Sklodowska-Curie Action [H2020-MSCA-IF-2015, 706318]; Danish National Research Foundation [DNRF96]; Research Foundation Flanders (FWO) [12E6616N, 11L7514N]	UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB); Marie Sklodowska-Curie Action; Danish National Research Foundation(Danmarks Grundforskningsfond); Research Foundation Flanders (FWO)(FWO)	Financial support for this research was provided via the UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB). D. S. is currently funded by a Marie Sklodowska-Curie Action (H2020-MSCA-IF-2015, 706318) and acknowledges the Danish National Research Foundation for support to CMEC (grant number DNRF96). E. V. and L. R. are supported by the Research Foundation Flanders (FWO grant 12E6616N and 11L7514N, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulamir AS, 2010, AFR J BIOTECHNOL, V9, P1481; Adelman JS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1429; [Anonymous], 2010, BIODIVERS CONSERV, V19, P223, DOI [10.1007/s10531-009-9718-z, DOI 10.1007/S10531-009-9718-Z]; Baggott GK, 2002, OX ORN SER, V13, P179; Barrientos R, 2015, BEHAV ECOL SOCIOBIOL, V69, P1603, DOI 10.1007/s00265-015-1972-3; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Board R.G., 1995, EGG SCI TECHNOLOGY, V4th, P81; Boonyarittichaikij R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187640; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; D'Alba L, 2010, BEHAV ECOL SOCIOBIOL, V64, P1037, DOI 10.1007/s00265-010-0919-y; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; De Groote SRE, 2017, PLANT ECOL EVOL, V150, P229, DOI 10.5091/plecevo.2017.1331; De Maesschalck C, 2015, APPL ENVIRON MICROB, V81, P5880, DOI 10.1128/AEM.01616-15; Dorrestein Gerry M, 2009, Vet Clin North Am Exot Anim Pract, V12, P433, DOI 10.1016/j.cvex.2009.07.005; Gan ZB, 1999, J BIOCHEM BIOPH METH, V39, P1, DOI 10.1016/S0165-022X(98)00051-7; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Garcia-Mazcorro JF, 2017, MICROB ECOL, V73, P224, DOI 10.1007/s00248-016-0840-7; Goodenough AE, 2010, MICROB ECOL, V59, P221, DOI 10.1007/s00248-009-9591-z; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Latimer CE, 2018, OIKOS, V127, P1069, DOI 10.1111/oik.05111; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Mazerolle MJ, 2017, ALCOMODAVG MODEL SEL; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Morosinotto C, 2013, J AVIAN BIOL, V44, P427, DOI 10.1111/j.1600-048X.2013.00084.x; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; PINOWSKI J, 1994, J BIOSCIENCES, V19, P441, DOI 10.1007/BF02703180; Rogers KH, 2006, THESIS; Ruiz-de-Castaneda R, 2011, J FIELD ORNITHOL, V82, P215, DOI 10.1111/j.1557-9263.2011.00324.x; Ruuskanen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025360; Shawkey MD, 2008, BEHAV ECOL, V19, P920, DOI 10.1093/beheco/arn019; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Skaltsa HD, 2003, PHYTOCHEMISTRY, V64, P743, DOI 10.1016/S0031-9422(03)00386-8; Soler JJ, 2011, BIOL J LINN SOC, V103, P836, DOI 10.1111/j.1095-8312.2011.01672.x; Sparks N. H. C., 1994, P25; Yamanishi H, 2002, CLIN CHEM, V48, P1565; Zeng WC, 2012, J FOOD SCI, V77, pC824, DOI 10.1111/j.1750-3841.2012.02767.x	40	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204022	10.1371/journal.pone.0204022	http://dx.doi.org/10.1371/journal.pone.0204022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286089	gold, Green Published			2022-12-27	WOS:000446383500013
J	Bouyssou, JM; Liu, CJ; Bustoros, M; Sklavenitis-Pistofidis, R; Aljawai, Y; Manier, S; Yosef, A; Sacco, A; Kokubun, K; Tsukamoto, S; Glen, AP; Huynh, D; Castillo, JJ; Treon, SP; Leblond, V; Hermine, O; Roccaro, AM; Ghobrial, IM; Capelletti, M				Bouyssou, Juliette M.; Liu, Chia-Jen; Bustoros, Mark; Sklavenitis-Pistofidis, Romanos; Aljawai, Yosra; Manier, Salomon; Yosef, Amir; Sacco, Antonio; Kokubun, Katsutoshi; Tsukamoto, Shokichi; Glen, Adriana Perilla; Huynh, Daisy; Castillo, Jorge J.; Treon, Steven P.; Leblond, Veronique; Hermine, Olivier; Roccaro, Aldo M.; Ghobrial, Irene M.; Capelletti, Marzia			Profiling of circulating exosomal miRNAs in patients with Waldenstrom Macroglobulinemia	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; L265P SOMATIC MUTATION; IN-VIVO; MICRORNA SIGNATURES; MULTIPLE-MYELOMA; DRUG-RESISTANCE; CELL-LINE; CANCER; METASTASIS; PROGRESSION	Waldenstrom Macroglobulinemia (WM) is a low-grade B-cell lymphoma characterized by disease progression from IgM MGUS to asymptomatic and then symptomatic disease states. We profiled exosomes from the peripheral blood of patients with WM at different stages (30 smoldering/asymptomatic WM, 44 symptomatic WM samples and 10 healthy controls) to define their role as potential biomarkers of disease progression. In this study, we showed that circulating exosomes and their miRNA content represent unique markers of the tumor and its microenvironment. We observed similar levels of miRNAs in exosomes from patients with asymptomatic (smoldering) and symptomatic WM, suggesting that environmental and clonal changes occur in patients at early stages of disease progression before symptoms occur. Moreover, we identified a small group of miRNAs whose expression correlated directly or inversely with the disease status of patients, notably the known tumor suppressor miRNAs let-7d and the oncogene miR-21 as well as miR-192 and miR-320b. The study of these miRNAs' specific effect in WM cells could help us gain further insights on the mechanisms underlying WM pathogenesis and reveal their potential as novel therapeutic targets for this disease.	[Bouyssou, Juliette M.; Liu, Chia-Jen; Bustoros, Mark; Sklavenitis-Pistofidis, Romanos; Aljawai, Yosra; Manier, Salomon; Yosef, Amir; Sacco, Antonio; Kokubun, Katsutoshi; Tsukamoto, Shokichi; Glen, Adriana Perilla; Huynh, Daisy; Castillo, Jorge J.; Treon, Steven P.; Roccaro, Aldo M.; Ghobrial, Irene M.; Capelletti, Marzia] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bouyssou, Juliette M.] Univ Paris Saclay, Hop Necker Enfants Malad, Paris, France; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Leblond, Veronique] Hop La Pitie Salpetriere, Dept Hematol, Paris, France; [Hermine, Olivier] INSERM, UMR 1163, Lab Cellular & Mol Mech Hematol Disorders & Thera, Paris, France	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ghobrial, IM; Capelletti, M (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	irene_ghobrial@dfci.harvard.edu; marzia_capelletti@dfci.harvard.edu	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Hermine, Olivier/Q-7072-2018; Sacco, Antonio/AAG-7676-2022; Sacco, Antonio/AFL-7734-2022; Sacco, Antonio/K-4681-2016	Bouyssou, Juliette/0000-0002-2301-0426; Liu, Chia-Jen/0000-0001-7945-9292; Yosef, Amir/0000-0002-9322-1798; Sacco, Antonio/0000-0003-2945-9416	International Waldenstrom's Macroglobulinemia Foundation	International Waldenstrom's Macroglobulinemia Foundation	This work was supported by a grant awarded by the International Waldenstrom's Macroglobulinemia Foundation, https://www.iwmf.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Besse LK, 2015, AM J HEMATOL, V90, pE51, DOI 10.1002/ajh.23910; Bhome R, 2018, CANCER LETT, V420, P228, DOI 10.1016/j.canlet.2018.02.002; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Boyiadzis M, 2017, LEUKEMIA, V31, P1259, DOI 10.1038/leu.2017.91; Braggio E, 2012, HAEMATOL-HEMATOL J, V97, P1281, DOI 10.3324/haematol.2012.068478; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Correa JG, 2017, BRIT J HAEMATOL, V179, P849, DOI 10.1111/bjh.14266; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Hodge LS, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.25; Hodge LS, 2011, BLOOD, V117, pE190, DOI 10.1182/blood-2010-12-326868; Hui LL, 2015, CANCER LETT, V368, P7, DOI 10.1016/j.canlet.2015.07.039; Kapoor P, 2017, JAMA ONCOL, V3, P1257, DOI 10.1001/jamaoncol.2016.5763; Kasi Pashtoon Murtaza, 2015, Clin Adv Hematol Oncol, V13, P56; Leleu X, 2007, BLOOD, V110, P4417, DOI 10.1182/blood-2007-05-092098; Li YQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006183; Lian JW, 2016, ONCOTARGET, V7, P2672, DOI 10.18632/oncotarget.6603; Lv GY, 2018, ONCOL RES, V26, P837, DOI 10.3727/096504017X14920318811721; Manier S, 2017, LEUKEMIA, V31, P853, DOI 10.1038/leu.2016.296; Manier S, 2017, BLOOD, V129, P2429, DOI 10.1182/blood-2016-09-742296; Matsumura T, 2015, BRIT J CANCER, V113, P275, DOI 10.1038/bjc.2015.201; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Muz B, 2015, MOL CANCER RES, V13, P263, DOI 10.1158/1541-7786.MCR-14-0150; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pfeffer SR, 2015, DRUG DEVELOP RES, V76, P270, DOI 10.1002/ddr.21257; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Roccaro AM, 2014, BLOOD, V123, P4120, DOI 10.1182/blood-2014-03-564583; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Roccaro AM, 2010, BLOOD, V116, P1506, DOI 10.1182/blood-2010-01-265686; Roccaro AM, 2009, BLOOD, V113, P4391, DOI 10.1182/blood-2008-09-178228; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sacco A, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-38; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; Sasaki CT, 2016, NEOPLASIA, V18, P329, DOI 10.1016/j.neo.2016.04.007; SATSANGI J, 1994, LANCET, V343, P1509, DOI 10.1016/S0140-6736(94)92622-0; Suchorska WM, 2016, ONCOL REP, V35, P1237, DOI 10.3892/or.2015.4507; Sun JT, 2016, INT J MOL MED, V37, P485, DOI 10.3892/ijmm.2016.2449; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varettoni M, 2013, BLOOD, V121, P2522, DOI 10.1182/blood-2012-09-457101; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang HT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1728-5; Wang JH, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15016892; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Wu SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11169; Xu YJ, 2015, CLIN TRANSL ONCOL, V17, P34, DOI 10.1007/s12094-014-1194-6; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhao L, 2015, CANCER LETT, V356, P339, DOI 10.1016/j.canlet.2014.10.027	57	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204589	10.1371/journal.pone.0204589	http://dx.doi.org/10.1371/journal.pone.0204589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286096	Green Submitted, Green Published, gold			2022-12-27	WOS:000446383500027
J	Dupuis, LJ; Lumens, J; Arts, T; Delhaas, T				Dupuis, Lauren J.; Lumens, Joost; Arts, Theo; Delhaas, Tammo			High tension in sarcomeres hinders myocardial relaxation: A computational study	PLOS ONE			English	Article							RAT CARDIAC TRABECULAE; COOPERATIVE ACTIVATION; DEPENDENT CHANGES; MUSCLE; CALCIUM; TROPONIN; LENGTH; CONTRACTION; FORCE; MODEL	Experiments have shown that the relaxation phase of cardiac sarcomeres during an isometric twitch is prolonged in muscles that reached a higher peak tension. However, the mechanism is not completely understood. We hypothesize that the binding of calcium to troponin is enhanced by the tension in the thin filament, thus contributing to the prolongation of contraction upon higher peak tension generation. To test this hypothesis, we developed a computational model of sarcomere mechanics that incorporates tension-dependence of calcium binding. The model was used to simulate isometric twitch experiments with time dependency in the form of a two-state cross-bridge cycle model and a transient intracellular calcium concentration. In the simulations, peak isometric twitch tension appeared to increase linearly by 51.1 KPa with sarcomere length from 1.9 mu m to 2.2 mu m. Experiments showed an increase of 47.3 KPa over the same range of sarcomere lengths. The duration of the twitch also increased with both sarcomere length and peak intracellular calcium concentration, likely to be induced by the inherently coupled increase of the peak tension in the thin filament. In the model simulations, the time to 50% relaxation (t(R50)) increased over the range of sarcomere lengths from 1.9 mu m to 2.2 mu m by 0.11s, comparable to the increased duration of 0.12s shown in experiments. Model simulated t(R50) increased by 0.12s over the range of peak intracellular calcium concentrations from 0.87 mu M to 1.45 mu M. Our simulation results suggest that the prolongation of contraction at higher tension is a result of the tighter binding of Ca2+ to troponin in areas under higher tension, thus delaying the deactivation of the troponin.	[Dupuis, Lauren J.; Lumens, Joost; Arts, Theo; Delhaas, Tammo] Maastricht Univ, Dept Biomed Engn, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Lumens, Joost] Univ Bordeaux, LIRYC Inst Rythmol & Modelisat Cardiaque, Bordeaux, France	Maastricht University; UDICE-French Research Universities; Universite de Bordeaux	Dupuis, LJ (corresponding author), Maastricht Univ, Dept Biomed Engn, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.	l.dupuis@maastrichtuniversity.nl		Dupuis, Lauren/0000-0003-2606-3045; Lumens, Joost/0000-0001-8129-7384	Dutch Heart Foundation [2015T082]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was funded through a personal grant within the Dr. E. Dekker framework of the Dutch Heart Foundation to J. Lumens (grant 2015T082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1982, J PHYSIOL-LONDON, V327, P79, DOI 10.1113/jphysiol.1982.sp014221; BACKX PH, 1993, AM J PHYSIOL, V264, pH1098, DOI 10.1152/ajpheart.1993.264.4.H1098; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Biesiadecki Brandon J, 2014, Biophys Rev, V6, P273, DOI 10.1007/s12551-014-0143-5; Briston SJ, 2014, CARDIOVASC RES, V104, P347, DOI 10.1093/cvr/cvu201; Campbell SG, 2010, BIOPHYS J, V98, P2254, DOI 10.1016/j.bpj.2010.02.010; Daniel TL, 1998, BIOPHYS J, V74, P1611, DOI 10.1016/S0006-3495(98)77875-0; Desai R, 2015, J BIOL CHEM, V290, P1915, DOI 10.1074/jbc.M114.609743; Dobesh DP, 2002, AM J PHYSIOL-HEART C, V282, pH1055, DOI 10.1152/ajpheart.00667.2001; Dupuis LJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005126; Heinzel FR, 2002, CIRC RES, V91, P1023, DOI 10.1161/01.RES.0000045940.67060.DD; IZAKOV VY, 1991, CIRC RES, V69, P1171; JANSSEN PML, 1995, AM J PHYSIOL-HEART C, V269, pH676, DOI 10.1152/ajpheart.1995.269.2.H676; Janssen PML, 2002, AM J PHYSIOL-HEART C, V282, pH499, DOI 10.1152/ajpheart.00595.2001; Kassiri Z, 2000, J PHYSIOL-LONDON, V524, P221, DOI 10.1111/j.1469-7793.2000.t01-3-00221.x; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Kurihara S, 1995, J PHYSIOL-LONDON, V489, P617, DOI 10.1113/jphysiol.1995.sp021077; LANDESBERG A, 1994, AM J PHYSIOL, V267, pH779, DOI 10.1152/ajpheart.1994.267.2.H779; Niederer SA, 2006, BIOPHYS J, V90, P1697, DOI 10.1529/biophysj.105.069534; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Schonleitner P, 2017, PROG BIOPHYS MOL BIO, V130, P288, DOI 10.1016/j.pbiomolbio.2017.06.013; Solaro J, 2001, HEART PHYSL PATHOPHY, P519; Solaro RJ, 1998, CIRC RES, V83, P471, DOI 10.1161/01.RES.83.5.471; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; ter Keurs HEDJ, 2008, PROG BIOPHYS MOL BIO, V97, P312, DOI 10.1016/j.pbiomolbio.2008.02.013; Wannenburg T, 1997, AM J PHYSIOL-HEART C, V273, pH2428, DOI 10.1152/ajpheart.1997.273.5.H2428; Williams CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0697	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204642	10.1371/journal.pone.0204642	http://dx.doi.org/10.1371/journal.pone.0204642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286135	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500030
J	Fierro, J; Haynes, DR; Washbourne, P				Fierro, Javier, Jr.; Haynes, Dylan R.; Washbourne, Philip			4.1 Ba is necessary for glutamatergic synapse formation in the sensorimotor circuit of developing zebrafish	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; FUNCTIONAL-CHARACTERIZATION; PROTEIN 4.1B; EXPRESSION; FAMILY; CYTOSKELETAL; ASSOCIATION; EVOLUTION; NEURONS; GENOME	During the process of synapse formation, thousands of proteins assemble at prospective sites of cell-cell communication. Although many of these proteins have been identified, the roles they play in generating functional connections during development remain unknown. 4.1 scaffolding proteins have been implicated in synapse formation and maturation in vitro, but in vivo studies for some family members have suggested these proteins are not important for this role. We examined the role of family member 4.1B because it has been implicated in glutamatergic synaptogenesis, but has not been described in vivo. We identified two 4.1B genes in zebrafish, 4.1Ba and 4.16b, by sequence comparisons and synteny analysis. In situ hybridization shows these genes are differentially expressed, with 4.1Ba expressed primarily in the nervous system and 4.1Bb expressed in the nervous system and muscle, but not the spinal cord. We focused our studies on 4.1Ba in the spinal cord. 4.1Ba knockdown reduced the number of glutamatergic synapses at caudal primary motor neurons and caused an increase in the duration of touch-evoked coiling. These results suggest 4.1Ba is important for the formation of functional glutamatergic synapses in the developing zebrafish spinal cord.	[Fierro, Javier, Jr.; Haynes, Dylan R.; Washbourne, Philip] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Washbourne, P (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	pwash@uoneuro.uoregon.edu			NINDS [R01 NS065795]; NICHD [P01 HD022486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NINDS: R01 NS065795 and NICHD: P01 HD022486.	An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; Baines AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-85; Baines AJ, 2014, BBA-BIOMEMBRANES, V1838, P605, DOI 10.1016/j.bbamem.2013.05.030; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Easley-Neal C, 2013, CELL REP, V3, P1199, DOI 10.1016/j.celrep.2013.03.031; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Escudero I, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0502-8; Fowler DK, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00024; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Hauptmann G, 2000, METH MOL B, V137, P139; Hoy JL, 2009, MOL CELL NEUROSCI, V42, P466, DOI 10.1016/j.mcn.2009.09.010; Ippolito D.M., 2010, J VIS EXP; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Kutzing M.K., 2010, J VIS EXP; Meyer MP, 2005, J NEUROBIOL, V63, P91, DOI 10.1002/neu.20118; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Pietri T, 2009, DEV NEUROBIOL, V69, P780, DOI 10.1002/dneu.20741; Postlethwait J, 2004, METHOD CELL BIOL, V77, P255; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; Saint-Amant L, 2001, NEURON, V31, P1035, DOI 10.1016/S0896-6273(01)00416-0; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Scott C, 2001, EUR J BIOCHEM, V268, P3709, DOI 10.1046/j.1432-1327.2001.02276.x; Scott C, 2001, EUR J BIOCHEM, V268, P1084, DOI 10.1046/j.1432-1327.2001.01968.x; Shen L, 2000, J NEUROSCI, V20, P7932; Subramaniam S, 1998, PROTEINS, V32, P1; Sun CX, 2002, J CELL SCI, V115, P3991, DOI 10.1242/jcs.00094; Terada N, 2007, J HISTOCHEM CYTOCHEM, V55, P1199, DOI 10.1369/jhc.7A7266.2007; Wells S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021559; Welten MCM, 2006, ZEBRAFISH, V3, P465, DOI 10.1089/zeb.2006.3.465; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Wozny C, 2009, J CELL SCI, V122, P735, DOI 10.1242/jcs.037382; Yageta M, 2002, CANCER RES, V62, P5129; Yin J, 2016, AUTISM GENETICS OVER; Zelenchuk TA, 2011, GENESIS, V49, P546, DOI 10.1002/dvg.20766	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205255	10.1371/journal.pone.0205255	http://dx.doi.org/10.1371/journal.pone.0205255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286167	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500103
J	Magwood, O; Kpade, V; Afza, R; Oraka, C; McWhirter, J; Oliver, S; Pottie, K				Magwood, Olivia; Kpade, Victoire; Afza, Ruh; Oraka, Chinedu; McWhirter, Jennifer; Oliver, Sandy; Pottie, Kevin			Understanding women's, caregivers', and providers' experiences with home-based records: A systematic review of qualitative studies	PLOS ONE			English	Review							CHILD HEALTH; PREGNANT-WOMEN; PERCEPTIONS; PERSPECTIVE; PROMOTION; FAMILIES; HANDBOOK; BEHAVIOR; STAFF; CARE	Mothers, caregivers, and healthcare providers in 163 countries have used paper and electronic home-based records (HBRs) to facilitate primary care visit. These standardized records have the potential to empower women, improve the quality of care for mothers and children and reduce health inequities. This review examines experiences of women, caregivers and providers with home-based records for maternal and child health and seeks to explore the feasibility, acceptability, affordability and equity of these interventions. We systematically searched MEDLINE, MEDLINE In-Process, MEDLINE Ahead of Print, Embase, CINAHL, ERIC, and PsycINFO for articles that were published between January 1992 and December 2017. We used the CASP checklist to assess study quality, a framework analysis to support synthesis, and GRADE-CERQual to assess the confidence in the key findings. Of 7,904 citations, 19 studies met our inclusion criteria. In these studies, mothers, caregivers and children shared HBR experiences in relation to maternal and child health which facilitated the monitoring of immunisations and child growth and development. Participants' reports of HBRs acting as a point of commonality between patient and provider offer an explanation for their perceptions of improved communication and patient-centered care, and enhanced engagement and empowerment during pregnancy and childcare. Healthcare providers and nurses reported that the home-based record increased their feeling of connection with their patients. Although there were concerns around electronic records and confidentiality, there were no specific concerns reported for paper records. Mothers and other caregivers see home based records as having a pivotal role in facilitating primary care visits and enhancing healthcare for their families. The records' potential could be limited by users concerns over confidentiality of electronic home-based records, or shortcomings in their design. Health systems should seize the opportunity HBRs provide in empowering women, especially in the contexts of lower literacy levels and weak health care delivery systems.	[Magwood, Olivia; Kpade, Victoire; Afza, Ruh; Pottie, Kevin] CT Lamont Primary Hlth Care Res Ctr, Bruyere Res Inst, Ottawa, ON, Canada; [Oraka, Chinedu] Univ Ottawa, Ottawa, ON, Canada; [McWhirter, Jennifer] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Oliver, Sandy] UCL, Dept Social Sci, London, England; [Oliver, Sandy] Univ Johannesburg, Johannesburg, South Africa; [Pottie, Kevin] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Pottie, Kevin] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Guelph; University of London; University College London; University of Johannesburg; University of Ottawa; University of Ottawa	Pottie, K (corresponding author), CT Lamont Primary Hlth Care Res Ctr, Bruyere Res Inst, Ottawa, ON, Canada.; Pottie, K (corresponding author), Univ Ottawa, Dept Family Med, Ottawa, ON, Canada.; Pottie, K (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	kpottie@uottawa.ca	Oraka, Chinedu/AAG-4997-2019; Pottie, Kevin/ABC-4385-2020	Oliver, Sandy/0000-0001-9571-269X; Magwood, Olivia/0000-0003-0262-5621; Oraka, Chinedu/0000-0002-3035-899X	World Health Organization; Japan International Cooperation Agency; World Health Organization Department of Maternal, Newborn, Child and Adolescent Health through Japan International Cooperation Agency	World Health Organization(World Health Organization); Japan International Cooperation Agency; World Health Organization Department of Maternal, Newborn, Child and Adolescent Health through Japan International Cooperation Agency	This work was supported by World Health Organization and Japan International Cooperation Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the funding received from the World Health Organization Department of Maternal, Newborn, Child and Adolescent Health through a grant received from the Japan International Cooperation Agency. They would like to acknowledge Sarah Crispo and Alain Mayhew of the Cochrane Equity Methods Group for their technical support of this review, as well as Joanna Vogel of WHO/MCA for coordinating the project and Helen Smith, of International Health Consulting Services Ltd, for review of key findings.	Akl EA, 2017, J CLIN EPIDEMIOL, V90, P68, DOI 10.1016/j.jclinepi.2017.01.017; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Busza J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17373; Byczkowski TL, 2014, HEALTH INFORM J, V20, P151, DOI 10.1177/1460458213489054; Carroll C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-37; CASP, 2017, CASP CHECKL 2017; Clendon J, 2010, J ADV NURS, V66, P968, DOI 10.1111/j.1365-2648.2010.05285.x; Ehrhardt AA, 2009, JAIDS J ACQUIRED IMM, V51; Elena Broaddus SM, 2018, FRAMEWORK ANAL FACIL; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Hagiwara A, 2013, J PUBLIC HEALTH POL, V34, P31, DOI 10.1057/jphp.2012.56; Hamilton L, 2012, EDUC DEV PSYCHOL, V29, P66, DOI 10.1017/edp.2012.2; Harrison D, 1998, S AFR MED J, V88, P1424; Hayward MD, SIGNIFICANCE SOCIOEC; Hunter D, 2008, ADOPT FOSTER, V32, P57; KAZAK AE, 1989, J CONSULT CLIN PSYCH, V57, P25, DOI 10.1037/0022-006X.57.1.25; Kelly MM, 2017, J AM MED INFORM ASSN, V24, P153, DOI 10.1093/jamia/ocw070; Kim SS, 2007, AM J PUBLIC HEALTH, V97, P259, DOI 10.2105/AJPH.2005.076661; King G, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6811; Kitayama K, 2014, CLIN PEDIATR, V53, P238, DOI 10.1177/0009922813506608; Lee LK, 2016, ACAD PEDIATR, V16, P460, DOI 10.1016/j.acap.2015.12.008; Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0688-3; Lewin S, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001895; Maeve Hully JH, 1993, NURSING CHILDREN YOU, V5, P14; Magwood O, 2018, PLOS MED UNPUB; Magwood O, 2017, PERSPECTIVES WOMEN C; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nakamura Y, 2010, JPN MED ASS J, V53, P259; O'Connor S, 2016, STUD HEALTH TECHNOL, V225, P971, DOI 10.3233/978-1-61499-658-3-971; Organization WH, 2017, HOM BAS REC WHO; Phipps H, 2001, AUST NZ J OBSTET GYN, V41, P398, DOI 10.1111/j.1479-828X.2001.tb01316.x; Quinlivan JA, 2014, TELEMED E-HEALTH, V20, P810, DOI 10.1089/tmj.2013.0342; Ritchie JS, 1994, QUALITATIVE RES COMP; Roberts NJ, 2013, HEALTH SERV INSIGHTS, V6, P79, DOI 10.4137/HSI.S11092; Ronquillo Jeremiah Geronimo, 2012, Yale Journal of Biology and Medicine, V85, P379; Schofield T., 1995, BMJ-BRIT MED J, V311, P1580, DOI DOI 10.1136/BMJ.311.7019.1580]; Schunemann H, GRADE HDB; Shah AT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170415; Sharp LK, 2014, J ADOLESC YOUNG ADUL, V3, P117, DOI 10.1089/jayao.2013.0039; Shaw E, 2008, J OBSTET GYNAECOL CA, V30, P38, DOI 10.1016/S1701-2163(16)32711-6; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Turner KE, 2011, ONLINE J PUBLIC HLTH, V3; Grippo MLVS, 2008, REV ESC ENFERM USP, V42, P429, DOI 10.1590/S0080-62342008000300003; Whitford HM, 2014, BIRTH-ISS PERINAT C, V41, P283, DOI 10.1111/birt.12109; WHO, 2008, WORLD HLTH REPORT 20; WHO, 2011, SEX REPR HLTH COR CO; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Women, 2011, WOM EMP PRINC EQ MEA; World Health Organization, 2015, GLOB STRAT WOM CHILD; Yanagisawa S, 2015, HEALTH POLICY PLANN, V30, P1184, DOI 10.1093/heapol/czu133	52	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204966	10.1371/journal.pone.0204966	http://dx.doi.org/10.1371/journal.pone.0204966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286161	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500068
J	Bayray, A; Meles, KG; Sibhatu, Y				Bayray, Alemayehu; Meles, Kidanu Gebremariam; Sibhatu, Yosef			Magnitude and risk factors for hypertension among public servants in Tigray, Ethiopia: A cross-sectional study	PLOS ONE			English	Article							PREVALENCE	Background Hypertension is a globally recognized threat to social and economic development with premature morbidity and mortality. In middle and low-income countries hypertension appears to be increasing. However, sufficient data on this silent-killer is not available in Ethiopia. Therefore, this study examined the magnitude and risk factors for hypertension among public servants in Tigray, Ethiopia. Methods We used a cross-sectional survey from May-June 2016 among 1525 public servants in Tigray region. Field workers collected data using a pre-tested, standardized questionnaire. A multivariate logistic regression analysis conducted to identify risk factors for hypertension. Statistical significance was declared using a p-value<0.05 and 95% of confidence interval (CI) for an adjusted odds ratio (AOR). Results The overall prevalence of hypertension was 16% (95% CI: 13.10-21.9) and the proportion of awareness (96.7%), treatment (31.3%) and control of hypertension (40.1%) among employees. Being male [AOR = 2.06, 95%CI:1.49, 2.84], ages groups of 30-49 years [AOR = 2.21, 95%CI:1.25, 3.89] and >50years [AOR = 3.61, 95% CI:1.93, 6.69], Body Mass Index(BMI); underweight [AOR = 0.40, 95% CI; 0.20, 0.78], overweight [AOR = 1.70, 95% CI; 1.22, 2.33] and obesity [AOR = 3.20, 95% CI; 1.78, 5.78] were determinants for hypertension. Conclusion The prevalence of hypertension is relatively high in Mekelle city compared with previous reports. This study revealed that male sex, age-group, and BMI were evidenced as risk factors for hypertension. Policy makers need to consider sector wise integrating prevention and control of hypertension. Skilled based information, education and communication strategies should be designed and implemented to avoid unhealthy lifestyles, investing in workforces to eliminate the modifiable risk factors for non-communicable diseases and promote healthy practices.	[Bayray, Alemayehu; Meles, Kidanu Gebremariam; Sibhatu, Yosef] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Meles, KG (corresponding author), Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.	kidanumeles2008@gmail.com		Gebremariam, kidanu/0000-0002-7880-6907; Gebregiorgis, Yosef/0000-0003-1329-7782				Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210; Angaw K, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0062-9; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Daniel C, 2013, BMC PUBLIC HEALTH, V13, P732; David Bloom, 2011, REDUCING EC IMPACT N; Gebreyes YF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194819; Gebrihet TA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176904; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Kayima J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2146-y; Mengistu MD, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-33; Mion Jr. Decio, 2004, Rev. Hosp. Clin., V59, P329, DOI 10.1590/S0041-87812004000600004; Misganaw A, 2017, POPUL HEALTH METR, V15, P1, DOI [10.1186/s12963, DOI 10.1186/S12963-016-0118-9, 10.1186/s12963-016-0118-9]; Onyango MJ, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.178.13073; Tadesse T, 2014, HYPERTENSION ASS FAC, P2; Tesfaye F, 2007, ASS BODY MASS INDEX, P28; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; WHO, 2015, NCD FACT SHEET; World Health Organization, NCDS STEPS MAN	21	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204879	10.1371/journal.pone.0204879	http://dx.doi.org/10.1371/journal.pone.0204879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281660	Green Submitted, gold, Green Published			2022-12-27	WOS:000446342400063
J	Kazmierczak, PM; Burton, NC; Keinrath, G; Hirner-Eppeneder, H; Schneider, MJ; Eschbach, RS; Heimer, M; Solyanik, O; Todica, A; Reiser, MF; Ricke, J; Cyran, CC				Kazmierczak, Philipp M.; Burton, Neal C.; Keinrath, Georg; Hirner-Eppeneder, Heidrun; Schneider, Moritz J.; Eschbach, Ralf S.; Heimer, Maurice; Solyanik, Olga; Todica, Andrei; Reiser, Maximilian F.; Ricke, Jens; Cyran, Clemens C.			Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma	PLOS ONE			English	Article							GUIDED SURGERY; BREAST-CANCER; TOMOGRAPHY; FLUORESCENCE; VEMURAFENIB; SURVIVAL; TISSUE; RGD	Purpose To investigate alpha(v)beta(3)-integrin-targeted optoacoustic imaging and MRI for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma. Materials and methods Human BRAF V600E-positive melanoma xenograft (A375)-bearing Balb/c nude mice (n = 10) were imaged before (day 0) and after (day 7) a BRAF/MEK inhibitor combination therapy (encorafenib, 1.3 mg/kg/d; binimetinib, 0.6 mg/kg/d, n = 5) or placebo (n = 5), respectively. Optoacoustic imaging was performed on a preclinical system unenhanced and 5 h after i. v. injection of an alpha(v)beta(3)-integrin-targeted fluorescent probe. The alpha(v)beta(3)-integrin-specific tumor signal was derived by spectral unmixing. For morphology-based tumor response assessments, T2w MRI data sets were acquired on a clinical 3 Tesla scanner. The imaging results were validated by multiparametric immunohistochemistry (beta 3 -integrin expression, CD31 -microvascular density, Ki-67 -proliferation). Results The alpha(v)beta(3)-integrin-specific tumor signal was significantly reduced under therapy, showing a unidirectional decline in all animals (from 7.98 +/- 2.22 to 1.67 +/- 1.30; p = 0.043). No significant signal change was observed in the control group (from 6.60 +/- 6.51 to 3.67 +/- 1.93; p = 0.500). Immunohistochemistry revealed a significantly lower integrin expression (beta(3) : 0.20 +/- 0.02 vs. 0.39 +/- 0.05; p = 0.008) and microvascular density (CD31: 119 +/- 15 vs. 292 +/- 49; p = 0.008) in the therapy group. Tumor volumes increased with no significant intergroup difference (therapy: +107 +/- 42 mm(3); control +112 +/- 44mm(3), p = 0.841). In vivo blocking studies with alpha(v)beta(3-)integrin antagonist cilengitide confirmed the target specificity of the fluorescent probe. Conclusions alpha(v)beta(3)-integrin-targeted optoacoustic imaging allowed for the early non-invasive monitoring of a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma, adding molecular information on tumor receptor status to morphology-based tumor response criteria.	[Kazmierczak, Philipp M.; Keinrath, Georg; Hirner-Eppeneder, Heidrun; Schneider, Moritz J.; Eschbach, Ralf S.; Heimer, Maurice; Solyanik, Olga; Reiser, Maximilian F.; Ricke, Jens; Cyran, Clemens C.] Ludwig Maximilians Univ Munchen, Univ Hosp, Lab Expt Radiol, Dept Radiol, Munich, Germany; [Burton, Neal C.] iThera Med GmbH, Munich, Germany; [Schneider, Moritz J.] German Ctr Lung Res, Comprehens Pneumol Ctr, Munich, Germany; [Todica, Andrei] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany	University of Munich; University of Munich	Kazmierczak, PM (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Lab Expt Radiol, Dept Radiol, Munich, Germany.	philipp.kazmierczak@med.lmu.de			FoErderprogramm fur Forschung und Lehre (FoEFoLe), Medizinische FakultaEt, Ludwig-Maximilians-Universitat MuEnchen [907]	FoErderprogramm fur Forschung und Lehre (FoEFoLe), Medizinische FakultaEt, Ludwig-Maximilians-Universitat MuEnchen	This work was supported by FoErderprogramm fur Forschung und Lehre (FoEFoLe), Medizinische FakultaEt, Ludwig-Maximilians-Universitat MuEnchen (FoEFoLe-Reg.Nr. 907); https://www.med.uni-muenchen.de/forschung/foerderprogramme/foefole/index.html (PMK). NCB is an employee of iThera Medical GmbH (Munich, Germany; https://www.itheramedical.com/). The funder provided support in the form of salary for author NCB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Amaral T, 2017, EUR J CANCER, V73, P85, DOI 10.1016/j.ejca.2016.12.010; Arrieta O, 2017, J NUCL MED; Borchmann P, 2017, LANCET; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen HJ, 2016, THERANOSTICS, V6, P78, DOI 10.7150/thno.13242; Cui YF, 2016, INT J NANOMED, V11, P5671, DOI 10.2147/IJN.S115357; Desar IME, 2009, CANCER TREAT REV, V35, P309, DOI 10.1016/j.ctrv.2008.12.001; Dima A, 2016, PHOTOACOUSTICS, V4, P65, DOI 10.1016/j.pacs.2016.05.003; Diot G., 2017, CLIN CANC RES; Gaertner FC, 2010, Q J NUCL MED MOL IM, V54, P309; Georgieva M, 2017, CANC MED; Gibbs SL, 2012, QUANT IMAGING MED SU, V2, P177, DOI 10.3978/j.issn.2223-4292.2012.09.04; Gujrati V, 2017, CHEM COMMUN, V53, P4653, DOI 10.1039/c6cc09421j; Haedicke K, 2017, PHOTOACOUSTICS, V6, P1, DOI 10.1016/j.pacs.2017.03.001; Harlaar NJ, 2016, LANCET GASTROENTEROL, V1, P283, DOI 10.1016/S2468-1253(16)30082-6; Herzog E, 2012, RADIOLOGY, V263, P461, DOI 10.1148/radiol.11111646; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Hudson SV, 2014, CANCER RES, V74, P6271, DOI 10.1158/0008-5472.CAN-14-1656; Joseph J, 2017, J NUCL MED, V58, P807, DOI 10.2967/jnumed.116.182311; Kazmierczak PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168248; Kazmierczak PM, 2016, INVEST RADIOL, V51, P746, DOI 10.1097/RLI.0000000000000278; Kimbrough CW, 2015, J SURG RES, V193, P246, DOI 10.1016/j.jss.2014.06.045; Knieling F, 2017, NEW ENGL J MED, V376, P1292, DOI 10.1056/NEJMc1612455; Lee JH, 2016, LANCET GASTROENTEROL, V1, P147, DOI 10.1016/S2468-1253(16)30027-9; Mahabeleshwar GH, 2007, SEMIN ONCOL, V34, P555, DOI 10.1053/j.seminoncol.2007.09.009; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; Martelli C, 2016, ONCOTARGET, V7, P48753, DOI 10.18632/oncotarget.9066; Morscher S, 2014, PHOTOACOUSTICS, V2, P103, DOI 10.1016/j.pacs.2014.06.001; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Riedl CC, 2017, EUR J NUCL MED MOL I, V44, P1428, DOI 10.1007/s00259-017-3703-7; Sarantopoulos A, 2011, MOL IMAGING BIOL, V13, P874, DOI 10.1007/s11307-010-0416-8; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Stoffels I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1278; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Teng Fei-Fei, 2013, Int J Nanomedicine, V8, P3703, DOI 10.2147/IJN.S51264; Tummers QRJG, 2016, ONCOTARGET, V7, P32144, DOI 10.18632/oncotarget.8282; Tzoumas S, 2014, IEEE T MED IMAGING, V33, P48, DOI 10.1109/TMI.2013.2279994; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Wang DP, 2017, BIOMED OPT EXPRESS, V8, P112, DOI 10.1364/BOE.8.000112; Xie B, 2017, CLIN CANC RES; Yadav V, 2015, PHARMACOL THERAPEUT, V149, P139, DOI 10.1016/j.pharmthera.2014.12.003	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204930	10.1371/journal.pone.0204930	http://dx.doi.org/10.1371/journal.pone.0204930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281669	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400069
J	Vina-Cervantes, V; Coscia, M; Lambiotte, R				Vina-Cervantes, Viviana; Coscia, Michele; Lambiotte, Renaud			The struggle for existence in the world market ecosystem	PLOS ONE			English	Article							COMPARATIVE ADVANTAGE; COUNTRIES; NETWORKS; GROWTH	The global trade system can be viewed as a dynamic ecosystem in which exporters struggle for resources: the markets in which they export. We can think that the aim of an exporter is to gain the entirety of a market share (say, car imports from the United States). This is similar to the objective of an organism in its attempt to monopolize a given subset of resources in an ecosystem. In this paper, we adopt a multilayer network approach to describe this struggle. We use longitudinal, multiplex data on trade relations, spanning several decades. We connect two countries with a directed link if the source country's appearance in a market correlates with the target country's disappearing, where a market is defined as a country-product combination in a given decade. Each market is a layer in the network. We show that, by analyzing the countries' network roles in each layer, we are able to classify them as out-competing, transitioning or displaced. This classification is a meaningful one: when testing the future export patterns of these countries, we show that out-competing countries have distinctly stronger growth rates than the other two classes.	[Vina-Cervantes, Viviana; Coscia, Michele; Lambiotte, Renaud] Univ Namur, Naxys Dept Math, Namur, Belgium; [Coscia, Michele] Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA; [Coscia, Michele] IT Univ Copenhagen, Copenhagen, Denmark; [Lambiotte, Renaud] Univ Oxford, Math Inst, Oxford, England	University of Namur; Harvard University; IT University Copenhagen; University of Oxford	Coscia, M (corresponding author), Univ Namur, Naxys Dept Math, Namur, Belgium.; Coscia, M (corresponding author), Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA.; Coscia, M (corresponding author), IT Univ Copenhagen, Copenhagen, Denmark.	michele_coscia@hks.harvard.edu	Coscia, Michele/AGJ-5531-2022; Lambiotte, Renaud/HDO-4530-2022	Coscia, Michele/0000-0001-5984-5137; Lambiotte, Renaud/0000-0002-0583-4595	FNRS [24927961]	FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by FNRS #24927961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ARXIV10122726; Bachi G, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P552, DOI 10.1109/SocialCom-PASSAT.2012.115; Bahar D, 2014, J INT ECON, V92, P111, DOI 10.1016/j.jinteco.2013.11.001; BALASSA B, 1977, MANCH SCH ECON SOC, V45, P327, DOI 10.1111/j.1467-9957.1977.tb00701.x; Berlingerio M, 2013, WORLD WIDE WEB, V16, P567, DOI 10.1007/s11280-012-0190-4; Blondel VD, 2004, SIAM REV, V46, P647, DOI 10.1137/S0036144502415960; Burger M, 2009, SPAT ECON ANAL, V4, P167, DOI 10.1080/17421770902834327; Bustos S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049393; Coscia Michele, 2011, Statistical Analysis and Data Mining, V4, P514, DOI 10.1002/sam.10133; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; DAVIS JA, 1967, HUM RELAT, V20, P181, DOI 10.1177/001872676702000206; FISEK MH, 1991, AM J SOCIOL, V97, P114, DOI 10.1086/229742; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hanhij?rvi S., 2009, P 2009 SIAM INT C DA, P780, DOI DOI 10.1137/1.9781611972795.67; Hartmann D, 2015, ARXIV150507907; Hausmann R., 2014, ATLAS EC COMPLEXITY; Henderson Keith, 2012, P 18 ACM SIGKDD INT, P1231, DOI DOI 10.1145/2339530.2339723; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Klimek P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038924; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Martin R, 2015, TERRIT POLIT GOV, V3, P235, DOI 10.1080/21622671.2015.1064825; MAYER T, 2008, TRADEPROD CEPII TRAD; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Neffke F, 2011, ECON GEOGR, V87, P237, DOI 10.1111/j.1944-8287.2011.01121.x; Poncet S, 2013, WORLD DEV, V51, P104, DOI 10.1016/j.worlddev.2013.05.010; Pugliese E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168540; Saviotti PP, 2008, J EVOL ECON, V18, P201, DOI 10.1007/s00191-007-0081-5; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Stein E., 2014, RETHINKING PRODUCTIV; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Willer D., 1999, NETWORK EXCHANGE THE; Zenka J, 2014, EUR PLAN STUD, V22, P164, DOI 10.1080/09654313.2012.731042	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203915	10.1371/journal.pone.0203915	http://dx.doi.org/10.1371/journal.pone.0203915			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281627	Green Submitted, Green Published, gold			2022-12-27	WOS:000446342400033
J	Yan, XY; Li, Q; Luo, BX; You, TH; Wang, HJ				Yan, Xiao-Ying; Li, Qin; Luo, Bing-Xian; You, Tian-Hui; Wang, Hai-Jun			Trend in the nutritional status of children aged 2-7 years in Luoding city, China: A panel study from 2004 to 2013	PLOS ONE			English	Article							DOUBLE BURDEN; PHYSICAL-ACTIVITY; OVERWEIGHT; UNDERNUTRITION; OVERNUTRITION; OBESITY; GROWTH; INCOME; DIET; CONSEQUENCES	To examine trends in the prevalence of wasting, stunting, overweight, and obesity among children in Luoding, a lower-middle-income city in southern China, we collected height, weight and other information on 65,908 pre-school children aged 2 to 7 years from 23 kindergartens, in which health examinations were conducted annually between 2004 and 2013. We used the growth standards of the World Health Organization (WHO) to calculate Z-scores for height and body mass index (BMI), and used the cut-offs recommended by WHO to define wasting, stunting, overweight, and obesity for each child. From 2004 to 2013, the prevalence of overweight increased from 3.70% to 7.27% and of obesity increased from 1.04% to 2.08%. Meanwhile, the prevalence of wasting decreased from 0.91% to 0.72% and of stunting decreased from 9.29% to 5.22%. These trends suggest there was still a double burden of nutritional status there. The nutritional interventions focusing on pre-school children should be comprehensively elaborated in lower-middle-income areas such as Luoding.	[Yan, Xiao-Ying; You, Tian-Hui] Guangdong Pharmaceut Univ, Sch Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Qin; Wang, Hai-Jun] Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China; [Luo, Bing-Xian] Luoding City Maternal & Child Hlth Care Hosp, Yunfu, Peoples R China	Guangdong Pharmaceutical University; Peking University	Wang, HJ (corresponding author), Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China.	whjun1@bjmu.edu.cn	Li, Qin/M-1155-2018; Li, Qin/AAS-9349-2021; Wang, Haijun/AAD-1302-2021	Li, Qin/0000-0002-8633-8859; Li, Qin/0000-0002-8633-8859; Wang, Haijun/0000-0003-0849-2903; You, Tianhui/0000-0002-8499-3809	National Natural Science Foundation of China [81573170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Data analyses of the present study were supported by a grant from National Natural Science Foundation of China (grant number 81573170) to H-JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2014, OBES REV, V15, P49, DOI 10.1111/obr.12123; Baird J, 2005, BMJ-BRIT MED J, V331, DOI [10.1136/bmj.38586.411273.EO, DOI 10.1136/BMJ.38586.411273.EO]; Nguyen BKL, 2013, BRIT J NUTR, V110, pS45, DOI 10.1017/S0007114513002080; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Li Xiao-Qiang, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P289; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Olsen EO, 2017, AM J PUBLIC HEALTH, V107, P1116, DOI 10.2105/AJPH.2017.303761; Piernas C, 2015, EUR J CLIN NUTR, V69, P1323, DOI 10.1038/ejcn.2015.106; Skouteris H, 2010, OBES REV, V11, P757, DOI 10.1111/j.1467-789X.2010.00806.x; Song Y, 2012, ZHONGHUA YU FANG YI, V46, P789; Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210; United Nations Children's Fund World Health Organization The World Bank, 2012, UNICEF WHO WORLD BAN; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wang ZH, 2008, ASIA PAC J CLIN NUTR, V17, P123; World Health Organization, 2006, WHO CHILD GROWTH STA; Xiao YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134466; Zhai FY, 2014, OBES REV, V15, P16, DOI 10.1111/obr.12124; Zhang C, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0157000, 10.1371/journal.pone.0162830, 10.1371/journal.pone.0158119]; Zhang Xin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P781; Zhang YQ, 2017, AM J PHYS ANTHROPOL, V163, P497, DOI 10.1002/ajpa.23224; Zhang YX, 2015, INT J CARDIOL, V184, P380, DOI 10.1016/j.ijcard.2015.02.076; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0205163	10.1371/journal.pone.0205163	http://dx.doi.org/10.1371/journal.pone.0205163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281659	gold, Green Submitted, Green Published			2022-12-27	WOS:000446342400086
J	Learmonth, G; Gallagher, A; Gibson, J; Thut, G; Harvey, M				Learmonth, Gemma; Gallagher, Aodhan; Gibson, Jamie; Thut, Gregor; Harvey, Monika			Intra- and Inter-Task Reliability of Spatial Attention Measures in Pseudoneglect (vol 10, e0138379, 2015)	PLOS ONE			English	Correction													Learmonth, Gemma/J-7227-2019	Learmonth, Gemma/0000-0003-4061-4464; Thut, Gregor/0000-0003-1313-4262				Learmonth G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138379	1	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205269	10.1371/journal.pone.0205269	http://dx.doi.org/10.1371/journal.pone.0205269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278070	Green Published, gold, Green Submitted			2022-12-27	WOS:000446010200040
J	Manzouri, A; Savic, I				Manzouri, Amirhossein; Savic, Ivanka			Multimodal MRI suggests that male homosexuality may be linked to cerebral midline structures	PLOS ONE			English	Article								The neurobiology of sexual preference is often discussed in terms of cerebral sex dimorphism. Yet, our knowledge about possible cerebral differences between homosexual men (HoM), heterosexual men (HeM) and heterosexual women (HeW) are extremely limited. In the present MRI study, we addressed this issue investigating measures of cerebral anatomy and function, which were previously reported to show sex difference. Specifically, we asked whether there were any signs of sex atypical cerebral dimorphism among HoM, if these were widely distributed (providing substrate for more general 'female' behavioral characteristics among HoM), or restricted to networks involved in self-referential sexual arousal. Cortical thickness (Cth), surface area (SA), subcortical structural volumes, and resting state functional connectivity were compared between 30 (HoM), 35 (HeM) and 38 (HeW). HoM displayed a significantly thicker anterior cingulate cortex (ACC), precuneus, and the left occipito-temporal cortex compared to both control groups. These differences seemed coordinated, since HoM also displayed stronger cortico-cortical covariations between these regions. Furthermore, functional connections within the default mode network, which mediates self- referential processing, and includes the ACC and precuneus were significantly weaker in HoM than HeM and HeW, whereas their functional connectivity between the thalamus and hypothalamus (important nodes for sexual behavior) was stronger. In addition to these singular features, HoM displayed 'female' characteristics, with a similar Cth in the left superior parietal and cuneus cortices as HeW, but different from HeM. These data suggest both singular and sex atypical features and motivate further investigations of cerebral midline structures in relation to male homosexuality.	[Manzouri, Amirhossein; Savic, Ivanka] Karolinska Inst & Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Manzouri, Amirhossein; Savic, Ivanka] Karolinska Inst & Hosp, Neurol Clin, Stockholm, Sweden; [Manzouri, Amirhossein] Stockholm Univ, Dept Psychol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Stockholm University	Savic, I (corresponding author), Karolinska Inst & Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden.; Savic, I (corresponding author), Karolinska Inst & Hosp, Neurol Clin, Stockholm, Sweden.	ivanka.savic-berglund@ki.se		Savic, Ivanka/0000-0003-4275-0689	Swedish Science Council [2007-3107]; Stockholm Brain Institute; FORTE; AFA	Swedish Science Council; Stockholm Brain Institute; FORTE(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); AFA	This work was supported by the Swedish Science Council (I.S Dnr 2007-3107); Stockholm Brain Institute (I.S.); FORTE (I.S. and A.M.); AFA (I.S.); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114721; ALLEN LS, 1991, J COMP NEUROL, V312, P97, DOI 10.1002/cne.903120108; Bellec P, 2006, NEUROIMAGE, V29, P1231, DOI 10.1016/j.neuroimage.2005.08.044; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Burrows CA, 2016, DEVELOPMENTAL SCI, V19, P564, DOI 10.1111/desc.12400; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Doyle-Thomas KAR, 2013, RES AUTISM SPECT DIS, V7, P141, DOI 10.1016/j.rasd.2012.08.004; Feusner JD, 2017, BRAIN IMAGING BEHAV, V11, P964, DOI 10.1007/s11682-016-9578-6; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Golkar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104550; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Griffanti L, 2017, NEUROIMAGE, V154, P188, DOI 10.1016/j.neuroimage.2016.12.036; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Herting MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119774; Hu SH, 2008, AM J NEURORADIOL, V29, P1890, DOI 10.3174/ajnr.A1260; Hu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059426; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kim SW, 2006, INT J IMPOT RES, V18, P452, DOI 10.1038/sj.ijir.3901449; Kinsey AC, 1948, SEXUAL BEHAV HUMAN M, DOI [10.2105/AJPH.93.6.894, DOI 10.2105/AJPH.93.6.894]; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; Lentini E, 2013, CEREB CORTEX, V23, P2322, DOI 10.1093/cercor/bhs222; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Liem F, 2015, NEUROIMAGE, V108, P95, DOI 10.1016/j.neuroimage.2014.12.035; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Lv B, 2010, NEUROIMAGE, V53, P373, DOI 10.1016/j.neuroimage.2010.05.020; Manzouri A, 2017, CEREB CORTEX, V27, P998, DOI 10.1093/cercor/bhv278; Metzler-Baddeley C, 2016, NEUROIMAGE, V130, P48, DOI 10.1016/j.neuroimage.2016.01.007; Motofei IG, 2014, BJU INT, V113, P296, DOI 10.1111/bju.12399; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Northoff G, 2011, TRENDS COGN SCI, V15, P186, DOI 10.1016/j.tics.2011.03.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Paul T, 2008, HUM BRAIN MAPP, V29, P726, DOI 10.1002/hbm.20435; Paus T, 2010, PROG BRAIN RES, V186, P13, DOI 10.1016/B978-0-444-53630-3.00002-6; Pletzer B, 2010, BRAIN RES, V1348, P55, DOI 10.1016/j.brainres.2010.06.019; Poeppl TB, 2016, FRONT NEUROENDOCRIN, V43, P28, DOI 10.1016/j.yfrne.2016.10.001; Ponseti J, 2006, NEUROIMAGE, V33, P825, DOI 10.1016/j.neuroimage.2006.08.002; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Safron A, 2007, BEHAV NEUROSCI, V121, P237, DOI 10.1037/0735-7044.121.2.237; Savic I, 2018, CEREB CORTEX, V28, P894, DOI 10.1093/cercor/bhw413; Savic I, 2014, CEREB CORTEX, V24, P3246, DOI 10.1093/cercor/bht180; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Savic I, 2017, HUM BRAIN MAPP, V38, P1801, DOI 10.1002/hbm.23483; Savic I, 2015, CEREB CORTEX, V25, P1554, DOI 10.1093/cercor/bht348; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sylva D, 2013, HORM BEHAV, V64, P673, DOI 10.1016/j.yhbeh.2013.08.003; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Verhagen L., 2006, NEUROIMAGE, V31, pS45; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Witelson SF, 2008, ARCH SEX BEHAV, V37, P857, DOI 10.1007/s10508-007-9276-y; Zhou W, 2014, CURR BIOL, V24, P1091, DOI 10.1016/j.cub.2014.03.035	67	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203189	10.1371/journal.pone.0203189	http://dx.doi.org/10.1371/journal.pone.0203189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278046	Green Published, Green Submitted, gold			2022-12-27	WOS:000446010200004
J	Sasaki, N; Sato, S; Yamaguchi, S; Shimodaira, M; Kawakami, N				Sasaki, Natsuki; Sato, Sayaka; Yamaguchi, Sosei; Shimodaira, Michiyo; Kawakami, Norito			Development of a scale to assess motivation for competitive employment among persons with severe mental illness	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NEGATIVE SYNDROME SCALE; SUPPORTED EMPLOYMENT; INDIVIDUAL PLACEMENT; INTRINSIC MOTIVATION; PEOPLE; SCHIZOPHRENIA; DISORDERS; EXPERIENCES; PREDICTORS	Background The employment rate among people with severe mental illness has recently increased, though it is still low. The motivation to work appears to be an important role as an intermediate outcome measure in vocational rehabilitation programs. In addition, measuring the work motivation for people with severe mental illness appears to be essential to identify candidates who are likely to benefit and monitor candidates' motivation in a supported employment program. This study aimed to develop a new measure for assessing both intrinsic and extrinsic motivation to work among people with severe mental illness, as there are currently no well-established instruments of this kind. Methods A focus group interview and review of previous qualitative research were used to identify possible items for inclusion in the new scale. A provisional scale was constructed and further refined for content and format based on feedback from a researcher and also three peer workers with severe mental illness. The resulting provisional 38-item version of the scale was completed by 136 respondents with severe mental illness, and we performed exploratory factor analysis to identify latent constructs within the new measure. The finalized scale was analyzed for test-retest reliability, internal consistency, and convergent validity. Result An exploratory factor analysis yielded a four-factor scale with 23 items. The finalized 23 items had high internal consistency (Cronbach's alpha = 0.91) and relatively high test-retest reliability (ICC = 0.83). The four subscales had fair internal consistency (Cronbach's alpha >= 0.69) and good test-retest reliability (ICC >= 0.61). Convergent validity was weakly supported by the significant positive correlations with the overall question on motivation to work (r >= 0.19, p < 0.01). Besides these correlations, only the "Pressure from others" subscale was negatively and significantly correlated with the negative symptoms evaluated using the Positive and Negative Syndrome Scale (r = -0.18, p = 0.04). Conclusions This study used factor analysis to develop a new multidimensional scale assessing motivation for competitive employment among persons with severe mental illness. The scale showed acceptable levels of reliability and factor-based and convergent validity. The new measure can be used for measuring the motivation for competitive employment among people with severe mental illness, and it would be useful to identify candidates who are likely to benefit from a certain supported employment program, and to monitor interim progress of the state of participants' motivation in a program.	[Sasaki, Natsuki; Sato, Sayaka; Yamaguchi, Sosei] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Community Mental Hlth & Law, Kodaira, Tokyo, Japan; [Shimodaira, Michiyo; Kawakami, Norito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; University of Tokyo	Sasaki, N (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Community Mental Hlth & Law, Kodaira, Tokyo, Japan.	natsuki.sasaki2018@gmail.com	Yamaguchi, Sosei/T-9439-2019	Yamaguchi, Sosei/0000-0002-0579-4431; Sasaki, Natsuki/0000-0001-8813-1432	Ministry of Health, Labour and Welfare in Japan - Policy research for improving the quality of community life of people with mental disorders [H28-001, H26-002]; Japan Society for the Promotion of Science KAKENHI [25871175]	Ministry of Health, Labour and Welfare in Japan - Policy research for improving the quality of community life of people with mental disorders; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 1. Ministry of Health, Labour and Welfare in Japan - Policy research for improving the quality of community life of people with mental disorders [no. H28-001] (S.S received the funding); - A study on facilitating employment for people with mental illness [no. H26-002] (S.Y received the funding), URL: https://mhlw-grants.niph.go.jp/; 2. Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Young Scientists [B]: Development of assessment tools and collecting of fundamental data which would be helpful for vocational services to support people with severe mental illness in community settings [no. 25871175] (S.S received the funding), URL: https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-25871175/.	[Anonymous], 2016, ZENK ZAIT SHOUG SHA; [Anonymous], 2017, SYOG NO SYUG JYOK TO; [Anonymous], 2013, LAB FORC SURV JAP; [Anonymous], 2016, COMPREHENSIVE SUPPOR; Areberg C, 2013, SCAND J OCCUP THER, V20, P420, DOI 10.3109/11038128.2013.765911; Asahi M, 2009, THOUGHTS USERS STAFF; Auerbach ES, 2005, PSYCHIATR REHABIL J, V28, P267, DOI 10.2975/28.2005.267.273; Bedell JR, 1998, PSYCHIATR REHABIL J, V21, P279, DOI 10.1037/h0095301; Bejerholm U, 2017, J AFFECT DISORDERS, V207, P212, DOI 10.1016/j.jad.2016.08.028; Bond GR, 2012, WORLD PSYCHIATRY, V11, P32, DOI 10.1016/j.wpsyc.2012.01.005; Braveman B, 2005, WORKER ROLE INTERVIE; Burns JK, 2008, SOC PSYCH PSYCH EPID, V43, P331, DOI 10.1007/s00127-008-0308-2; Choi J, 2010, SCHIZOPHRENIA BULL, V36, P966, DOI 10.1093/schbul/sbp030; Choi KH, 2013, J NERV MENT DIS, V201, P173, DOI 10.1097/NMD.0b013e3182848bd4; Corson TR, 2017, IMPACT PERCEIVED MEN; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crowther R, 2001, Cochrane Database Syst Rev, pCD003080, DOI 10.1002/14651858.CD003080; Davidson M, 2016, SCHIZOPHRENIA BULL, V42, P443, DOI 10.1093/schbul/sbv023; Drake RE, 2008, PSYCHIATR REHABIL J, V31, P367, DOI 10.2975/31.4.2008.367.376; Dunn EC, 2008, PSYCHIATR REHABIL J, V32, P59, DOI 10.2975/32.1.2008.59.62; Dunn EC, 2010, AM J ORTHOPSYCHIAT, V80, P185, DOI 10.1111/j.1939-0025.2010.01022.x; Fukuhara S., 2004, MANUAL SF 8 JAPANESE; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Howard LM, 2010, BRIT J PSYCHIAT, V196, P404, DOI 10.1192/bjp.bp.108.061465; Igarashi Y, 1998, PSYCHIAT CLIN NEUROS, V52, P467, DOI 10.1046/j.1440-1819.1998.00425.x; Japanese Ministry of Health LaW, 2013, SURV EMPL STAT PERS; Kageyama M, 2016, ARCH PSYCHIAT NURS, V30, P614, DOI 10.1016/j.apnu.2016.02.003; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kinoshita Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008297.pub2; Knaeps J, 2015, J MENT HEALTH, V24, P196, DOI 10.3109/09638237.2015.1036972; McQuilken M., 2003, J VOCAT REHABIL, V18, P59; Metcalfe JD, 2018, SCHIZOPHRENIA BULL, V44, P22, DOI 10.1093/schbul/sbx132; Metcalfe JD, 2017, ADM POLICY MENT HLTH, V44, P345, DOI 10.1007/s10488-016-0774-x; Nakatogawa S, 2009, JAPAN ACAD PSYCHIAT, V18, P70; Oshima I, 2014, PSYCHIATR REHABIL J, V37, P137, DOI 10.1037/prj0000085; Reddy LF, 2016, SCHIZOPHR RES, V176, P462, DOI 10.1016/j.schres.2016.08.006; Salkever DS, 2007, PSYCHIAT SERV, V58, P315, DOI 10.1176/appi.ps.58.3.315; Saperstein AM, 2011, J NERV MENT DIS, V199, P672, DOI 10.1097/NMD.0b013e318229d0eb; Scupin R., 1997, HUM ORGAN, V56, P2; Suzuki Y, 2008, WORK, V30, P185; Tremblay MA, 2009, CAN J BEHAV SCI, V41, P213, DOI 10.1037/a0015167; Waghorn G, 2007, BIPOLAR DISORD, V9, P166, DOI 10.1111/j.1399-5618.2007.00417.x; Ware JE, 2001, GLAXOSMITHKLINE SC S; Yamaguchi S, 2017, PSYCHOL MED, V47, P53, DOI 10.1017/S0033291716002063	44	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204809	10.1371/journal.pone.0204809	http://dx.doi.org/10.1371/journal.pone.0204809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278081	Green Submitted, Green Published, gold			2022-12-27	WOS:000446010200022
J	Kim, NH; Youn, YA; Choi, SJ; Hwang, JH; Kim, EK; Kim, EAR; Lee, SM				Kim, Nam Hyo; Youn, Young Ah; Choi, Su Jin; Hwang, Jong-Hee; Kim, Ee-Kyung; Kim, Ellen Ai-Rhan; Lee, Soon Min		Korean Neonatal Network	The predictors for the non-compliance to follow-up among very low birth weight infants in the Korean neonatal network	PLOS ONE			English	Article							UNITED-STATES; NEURODEVELOPMENTAL OUTCOMES; EARLY-CHILDHOOD; PRETERM BIRTH; CARE; CHILDREN; ATTENDANCE; DIFFICULTY; DISCHARGE; PROGRAMS	The critical need to emphasize preterm infant follow-up after neonatal intensive care unit (NICU) discharge assures early identification of and intervention for neurodevelopmental disability. The aims of this study were to observe the follow-up rates in high-risk follow-up clinics, and analyze factors associated with non-compliance to follow-up among very low birth weight (VLBW) infants. The data was prospectively collected for 3063 VLBW infants between January 2013 and December 2014 from 57 Korean neonatal network (KNN) centers at a corrected age of 18-24 months. Correlations among demographic data, clinical variables, and neonatal intensive care unit (NICU) volume (divided into 4 quartiles) with the occurrence of non-compliance were analyzed. The overall follow-up rate at the corrected age of 18-24 month was 65.4%. The follow-up rates were inversely related to birth weight and gestational age. Apgar score, hospital stay, maternal age, and maternal education were significantly different between the compliance and non-compliance groups. The follow-up rate was higher for mothers with chorioamnionitis, abnormal amniotic fluid, multiple pregnancy, and in vitro fertilization. Infants with respiratory distress syndrome, bronchopulmonary dysplasia, patent ductus arteriosus ligation, periventricular leukomalacia, and retinopathy of prematurity were more common in the compliance group. Follow-up rates showed significant differences according to NICU volume. Using multivariate logistic regression, high birth weight, low NICU volume, siblings, foreign maternal nationality and high 5 min APGAR scores were significant independent factors associated with the non-compliance of VLBW infants for follow-up at 18-24 months of age. This is the first nation-wide analysis of follow-up for VLBW infants in Korea. Understanding factors associated with failure of compliance could help improve the long-term follow-up rates and neurodevelopmental outcomes through early intervention.	[Kim, Nam Hyo] CHA Univ, CHA Gangnam Med Ctr, Dept Pediat, Seoul, South Korea; [Youn, Young Ah] Catholic Univ, Coll Med, Seoul St Marys Hosp, Dept Pediat, Seoul, South Korea; [Choi, Su Jin] Ewha Womans Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Hwang, Jong-Hee] Inje Univ, Ilsan Paik Hosp, Dept Pediat, Coll Med, Goyang, South Korea; [Kim, Ee-Kyung] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea; [Kim, Ellen Ai-Rhan] Univ Ulsan, Asan Med Ctr, Dept Pediat, Coll Med,Childrens Hosp, Seoul, South Korea; [Lee, Soon Min] Yonsei Univ, Gangnam Severance Hosp, Dept Pediat, Coll Med, Seoul, South Korea	Pochon Cha University; Catholic University of Korea; Seoul St. Mary's Hospital; Ewha Womans University; Inje University; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System	Lee, SM (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Pediat, Coll Med, Seoul, South Korea.	smlee@yuhs.ac	Cho, Su Jin/AAJ-5195-2020	Cho, Su Jin/0000-0002-3851-9073; Lee, Soon Min/0000-0003-0174-1065	Korea Centers for Disease Control and Prevention [2016-ER6307-02]	Korea Centers for Disease Control and Prevention	This work was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (2016-ER6307-02#).	Ballantyne M, 2014, CHILD CARE HLTH DEV, V40, P250, DOI 10.1111/cch.12015; Ballantyne M, 2012, J PERINAT NEONAT NUR, V26, P90, DOI 10.1097/JPN.0b013e31823f900b; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bockli K, 2014, J PERINATOL, V34, P71, DOI 10.1038/jp.2013.136; Callanan C, 2001, J PAEDIATR CHILD H, V37, P152, DOI 10.1046/j.1440-1754.2001.00621.x; CAMPBELL MK, 1993, AM J EPIDEMIOL, V138, P704, DOI 10.1093/oxfordjournals.aje.a116908; Castro L, 2004, PEDIATRICS, V114, P404, DOI 10.1542/peds.114.2.404; CATLETT AT, 1993, PUBLIC HEALTH REP, V108, P589; Chang YS, 2013, NEONATAL MED, V20, P169, DOI DOI 10.5385/NM.2013.20.2.169; Chang YS, 2015, J KOREAN MED SCI, V30, pS3, DOI 10.3346/jkms.2015.30.S1.S3; Choi SH, 2010, J KOREAN MED SCI, V25, P1191, DOI 10.3346/jkms.2010.25.8.1191; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; Doyle LW, 2010, J PEDIATR-US, V156, P49, DOI 10.1016/j.jpeds.2009.07.013; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Ferris TG, 2001, PEDIATRICS, V107, P143, DOI 10.1542/peds.107.1.143; Greene M, 2016, RES DEV DISABIL, V53-54, P287, DOI 10.1016/j.ridd.2016.02.016; Harmon SL, 2013, CLIN PEDIATR, V52, P389, DOI 10.1177/0009922813477237; Hintz SR, 2008, ARCH PEDIAT ADOL MED, V162, P748, DOI 10.1001/archpedi.162.8.748; Hintz SR, 2015, J PEDIATR-US, V166, P289, DOI 10.1016/j.jpeds.2014.10.038; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Kuppala VS, 2012, J PERINATOL, V32, P293, DOI 10.1038/jp.2011.97; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Nehra V, 2009, J PERINAT MED, V37, P677, DOI 10.1515/JPM.2009.135; Network TECoKN, 2015, 2014 KOR NEON NETW A; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Perenyi A, 2010, J DEV ORIG HLTH DIS, V1, P396, DOI 10.1017/S2040174410000590; Stark AR, 2008, PEDIATRICS, V122, P1119, DOI 10.1542/peds.2008-2174; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sunderam S, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6606a1; Synnes Anne R, 2006, Paediatr Child Health, V11, P271; Tin W, 1998, ARCH DIS CHILD-FETAL, V79, pF83, DOI 10.1136/fn.79.2.F83; Verma RP, 2003, CLIN PEDIATR, V42, P299, DOI 10.1177/000992280304200403; WOLKE D, 1995, LANCET, V345, P447, DOI 10.1016/S0140-6736(95)90425-5	34	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204421	10.1371/journal.pone.0204421	http://dx.doi.org/10.1371/journal.pone.0204421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273357	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700022
J	Mishra, MV; Ray, SB; Srinivasan, N				Mishra, Maruti Vijayshankar; Ray, Sonia Baloni; Srinivasan, Narayanan			Cross-cultural emotion recognition and evaluation of Radboud faces database with an Indian sample	PLOS ONE			English	Article							FACIAL EXPRESSIONS; DISPLAY RULES; UNIVERSAL; JAPANESE; SIMILARITIES; RELIABILITY; VALIDATION; JUDGMENTS; ACCURACY; VALENCE	Emotional databases are important tools to study emotion recognition and their effects on various cognitive processes. Since, well-standardized large-scale emotional expression database is not available in India, we evaluated Radboud faces database (RaFD)-a freely available database of emotional facial expressions of adult Caucasian models, for Indian sample. Using the pictures from RaFD, we investigated the similarity and differences in self-reported ratings on emotion recognition accuracy as well as parameters of valence, clarity, genuineness, intensity and arousal of emotional expression, by following the same rating procedure as used for the validation of RaFD. We also systematically evaluated the universality hypothesis of emotion perception by analyzing differences in accuracy and ratings for different emotional parameters across Indian and Dutch participants. As the original Radboud database lacked arousal rating, we added this as a emotional parameter along with all other parameters. The results show that the overall accuracy of emotional expression recognition by Indian participants was high and very similar to the ratings from Dutch participants. However, there were significant cross-cultural differences in classification of emotion categories and their corresponding parameters. Indians rated certain expressions comparatively more genuine, higher in valence, and less intense in comparison to original Radboud ratings. The misclassifications/confusion for specific emotional categories differed across the two cultures indicating subtle but significant differences between the cultures. In addition to understanding the nature of facial emotion recognition, this study also evaluates and enables the use of RaFD within Indian population.	[Mishra, Maruti Vijayshankar; Ray, Sonia Baloni; Srinivasan, Narayanan] Univ Allahabad, CBCS, Allahabad, Uttar Pradesh, India	University of Allahabad	Mishra, MV; Srinivasan, N (corresponding author), Univ Allahabad, CBCS, Allahabad, Uttar Pradesh, India.	maruti.mishra07@gmail.com; nsrini@cbcs.ac.in	Srinivasan, Narayanan/E-7882-2010	Srinivasan, Narayanan/0000-0001-5342-0381				Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2014, PSYCHO SOCIAL ANAL I; [Anonymous], 2012, MATLAB2012B; Beaupre MG, 2005, J CROSS CULT PSYCHOL, V36, P355, DOI 10.1177/0022022104273656; Becker DV, 2007, J PERS SOC PSYCHOL, V92, P179, DOI 10.1037/0022-3514.92.2.179; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1986, MOTIV EMOTION, V10, P159, DOI 10.1007/BF00992253; Ekman P., 1994, STRONG EVIDENCE UNIV; Ekman P, 1978, TECHNIQUE MEASUREMEN, P22; Ekman P, 1972, EMOTION HUMAN FACE G; Elfenbein H. A, 2002, IS THERE IN GROUP AD; Elfenbein HA, 2003, J PERS SOC PSYCHOL, V85, P276, DOI 10.1037/0022-3514.85.2.276; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Elfenbein HA, 2007, EMOTION, V7, P131, DOI 10.1037/1528-3542.7.1.131; Elfenbein HA, 2002, EMOTION, V2, P75, DOI 10.1037/1528-3542.2.1.75; Fernandes MA, 2011, VIS COGN, V19, P1191, DOI 10.1080/13506285.2011.618151; Flykt A., 1998, KAROLINSKA DIRECTED, P91, DOI [10.1017/S0048577299971664, DOI 10.1017/S0048577299971664, 10.1037/t27732-000]; Fridlund A.J., 1987, FACIAL EXPRESSIONS E; Gendron M, 2014, EMOTION, V14, P251, DOI 10.1037/a0036052; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Hwang H., 2015, UNDERSTANDING FACIAL, P41; Ihssen N, 2009, COGNITION EMOTION, V23, P296, DOI 10.1080/02699930801987504; Izard C. E., 1979, MAXIMALLY DISCRIMINA; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jack RE, 2012, J EXP PSYCHOL GEN, V141, P19, DOI 10.1037/a0023463; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Kim U.E., 1994, INDIVIDUALISM COLLEC; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lundqvist D, 2014, COGNITION EMOTION, V28, P1012, DOI 10.1080/02699931.2013.867479; MATSUMOTO D, 1992, J CROSS CULT PSYCHOL, V23, P72, DOI 10.1177/0022022192231005; MATSUMOTO D, 1990, MOTIV EMOTION, V14, P195, DOI 10.1007/BF00995569; MATSUMOTO D, 1989, J CROSS CULT PSYCHOL, V20, P92, DOI 10.1177/0022022189201006; Matsumoto D, 2004, J PERS SOC PSYCHOL, V87, P529, DOI 10.1037/0022-3514.87.4.529; Matsumoto D, 2002, COGNITION EMOTION, V16, P721, DOI 10.1080/02699930143000608; Matsumoto D., 2002, METHODOLOGICAL REQUI; Matsumoto D, 2008, J CROSS CULT PSYCHOL, V39, P55, DOI 10.1177/0022022107311854; Nelson NL, 2013, EMOT REV, V5, P8, DOI 10.1177/1754073912457227; Oyserman D, 2002, RETHINKING INDIVIDUA; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Prado C, 2014, MOTIV EMOTION, V38, P420, DOI 10.1007/s11031-013-9383-0; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Samuelsson H, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2196; Schneider W., 2002, E PRIME VERSION 20 C; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinha D, 1994, INDIVIDUALISM COLLEC; Stephan WG, 1996, J CROSS CULT PSYCHOL, V27, P147, DOI 10.1177/0022022196272001; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; Yan XQ, 2016, J EXP PSYCHOL HUMAN, V42, P423, DOI 10.1037/xhp0000114; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	54	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203959	10.1371/journal.pone.0203959	http://dx.doi.org/10.1371/journal.pone.0203959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273355	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700010
J	Vollbehr, NK; Bartels-Velthuis, AA; Nauta, MH; Castelein, S; Steenhuis, LA; Hoenders, HJR; Ostafin, BD				Vollbehr, Nina K.; Bartels-Velthuis, Agna A.; Nauta, Maaike H.; Castelein, Stynke; Steenhuis, Laura A.; Hoenders, H. J. Rogier; Ostafin, Brian D.			Hatha yoga for acute, chronic and/or treatment-resistant mood and anxiety disorders: A systematic review and meta-analysis	PLOS ONE			English	Review							COGNITIVE-BEHAVIORAL THERAPY; REPETITIVE NEGATIVE THINKING; RANDOMIZED CONTROLLED-TRIAL; REDUCE PRENATAL DEPRESSION; MAJOR DEPRESSION; DSM-IV; INDIVIDUAL PSYCHOTHERAPY; COMPLEMENTARY THERAPY; MINDFULNESS; WOMEN	Background The aim of this study was to systematically investigate the effectiveness of hatha yoga in treating acute, chronic and/or treatment-resistant mood and anxiety disorders. Methods Medline, Cochrane Library, Current Controlled Trials, Clinical Trials. gov, NHR Centre for Reviews and Dissemination, PsycINFO and CINAHL were searched through June 2018. Randomized controlled trials with patients with mood and anxiety disorders were included. Main outcomes were continuous measures of severity of mood and anxiety symptoms. Cohen's d was calculated as a measure of effect size. Meta-analyses using a random effects model was applied to estimate direct comparisons between yoga and control conditions for depression and anxiety outcomes. Publication bias was visually inspected using funnel plots. Results Eighteen studies were found, fourteen in acute patients and four in chronic patients. Most studies were of low quality. For depression outcomes, hatha yoga did not show a significant effect when compared to treatment as usual, an overall effect size of Cohen's d -0.64 (95% CI = -1.41, 0.13) or to all active control groups, Cohen's d -0.13 (95% CI = -0.49, 0.22). A sub-analysis showed that yoga had a significant effect on the reduction of depression compared to psychoeducation control groups, Cohen's d -0.52 (95% CI = -0.96, -0.08) but not to other active control groups, Cohen's d 0.28 (95% CI = -0.07, 0.63) For studies using a follow-up of six months or more, hatha yoga had no effect on the reduction of depression compared to active control groups, Cohen's d -0.14 (95% CI = -0.60, 0.33). Regarding anxiety, hatha yoga had no significant effect when compared to active control groups, Cohen's d -0.09 (95% CI = -0.47, 0.30). The I-2 and Q-statistic revealed heterogeneity amongst comparisons. Qualitative analyses suggest some promise of hatha yoga for chronic populations. Conclusions The ability to draw firm conclusions is limited by the notable heterogeneity and low quality of most of the included studies. With this caveat in mind, the results of the current meta-analysis suggest that hatha yoga does not have effects on acute, chronic and/or treatment-resistant mood and anxiety disorders compared to treatment as usual or active control groups. However, when compared to psychoeducation, hatha yoga showed more reductions in depression. It is clear that more high-quality studies are needed to advance the field.	[Vollbehr, Nina K.; Bartels-Velthuis, Agna A.; Hoenders, H. J. Rogier] Lentis Psychiat Inst, Ctr Integrat Psychiat, Groningen, Netherlands; [Vollbehr, Nina K.; Nauta, Maaike H.; Castelein, Stynke; Steenhuis, Laura A.; Ostafin, Brian D.] Univ Groningen, Fac Behav & Social Sci, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Bartels-Velthuis, Agna A.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Rob Giel Res Ctr, Groningen, Netherlands; [Castelein, Stynke] Lentis Psychiat Inst, Lentis Res, Groningen, Netherlands	University of Groningen; University of Groningen	Vollbehr, NK (corresponding author), Lentis Psychiat Inst, Ctr Integrat Psychiat, Groningen, Netherlands.; Vollbehr, NK (corresponding author), Univ Groningen, Fac Behav & Social Sci, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	n.vollbehr@lentis.nl		Castelein, Stynke/0000-0002-8419-568X; Hoenders, Rogier/0000-0001-5069-0239				Abrantes Ana M, 2012, Ment Health Phys Act, V5, P155; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1952, DIAGN STAT MAN MENT; American Psychiatric Association, 1968, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angermeyer MC, 2005, SOC PSYCH PSYCH EPID, V40, P855, DOI 10.1007/s00127-005-0958-x; Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Balasubramaniam Meera, 2012, Front Psychiatry, V3, P117, DOI 10.3389/fpsyt.2012.00117; Barnes PM, 2008, NATL HLTH STAT REPOR, P1; Baxter AJ, 2014, PSYCHOL MED, V44, P2363, DOI 10.1017/S0033291713003243; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; Berlim MT, 2007, EUR NEUROPSYCHOPHARM, V17, P696, DOI 10.1016/j.euroneuro.2007.03.009; Borenstein M, 2009, INTRO META ANAL; Boyd RC, 2005, ARCH WOMEN MENT HLTH, V8, P141, DOI 10.1007/s00737-005-0096-6; Broota A, 1990, J PERS CLIN STUD, V6, P83; Brown TA, 1998, J ABNORM PSYCHOL, V107, P179, DOI 10.1037/0021-843X.107.2.179; Butler LD, 2008, J CLIN PSYCHOL, V64, P806, DOI 10.1002/jclp.20496; Bystritsky A, 2006, MOL PSYCHIATR, V11, P805, DOI 10.1038/sj.mp.4001852; Campbell-Sills L, 2006, EMOTION, V6, P587, DOI 10.1037/1528-3542.6.4.587; Carson JW, 2007, J PAIN SYMPTOM MANAG, V33, P331, DOI 10.1016/j.jpainsymman.2006.08.009; Carson JW, 2010, PAIN, V151, P530, DOI 10.1016/j.pain.2010.08.020; Carson JW, 2009, SUPPORT CARE CANCER, V17, P1301, DOI 10.1007/s00520-009-0587-5; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cooper AA, 2015, CLIN PSYCHOL REV, V40, P57, DOI 10.1016/j.cpr.2015.05.001; Cramer H, 2018, DEPRESS ANXIETY, V35, P830, DOI 10.1002/da.22762; Cramer H, 2017, J AFFECT DISORDERS, V213, P70, DOI 10.1016/j.jad.2017.02.006; Cramer H, 2013, DEPRESS ANXIETY, V30, P1068, DOI 10.1002/da.22166; Crocq MA, 2015, DIALOGUES CLIN NEURO, V17, P319; Cuijpers P, 2016, PSYCHOL MED, V46, P3451, DOI 10.1017/S0033291716002348; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Cuijpers P, 2010, CLIN PSYCHOL REV, V30, P51, DOI 10.1016/j.cpr.2009.09.003; Cusin C, 2010, CURR CLIN PSYCHIAT, P7, DOI 10.1007/978-1-59745-387-5_2; da Silva TL, 2009, ASIAN J PSYCHIATR, V2, P6, DOI 10.1016/j.ajp.2008.12.002; de Graaf R, 2012, SOC PSYCH PSYCH EPID, V47, P203, DOI 10.1007/s00127-010-0334-8; Dhananjai S, 2013, Int J Yoga, V6, P66, DOI 10.4103/0973-6131.105949; Drost J, 2014, BEHAV RES THER, V63, P177, DOI 10.1016/j.brat.2014.06.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ehring T, 2008, INT J COGN THER, V1, P192, DOI 10.1680/ijct.2008.1.3.192; Evans S, 1996, J AFFECT DISORDERS, V38, P73, DOI 10.1016/0165-0327(95)00045-3; Falsafi N, 2016, J AM PSYCHIAT NURSES, V22, P483, DOI 10.1177/1078390316663307; Fava M, 1996, PSYCHIAT CLIN N AM, V19, P179, DOI 10.1016/S0193-953X(05)70283-5; Field T, 2013, J BODYW MOV THER, V17, P397, DOI 10.1016/j.jbmt.2013.03.010; Field T, 2012, J BODYW MOV THER, V16, P204, DOI 10.1016/j.jbmt.2011.08.002; First MB, 2002, STRUCTURED CLIN INTE; Gersh E, 2017, J ANXIETY DISORD, V52, P25, DOI 10.1016/j.janxdis.2017.10.001; Gilmer WS, 2005, ACTA PSYCHIAT SCAND, V112, P425, DOI 10.1111/j.1600-0447.2005.00633.x; Goldberg DP, 2009, PSYCHOL MED, V39, P2043, DOI 10.1017/S0033291709990298; Gupta K, 2013, INT J RES AYURVEDA P, V4, P858, DOI [10.7897/2277-4343.04616, DOI 10.7897/2277-4343.04616]; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hawley LL, 2014, COGNITIVE THER RES, V38, P1, DOI 10.1007/s10608-013-9586-4; Helgadottir B, 2017, PREV MED, V105, P37, DOI 10.1016/j.ypmed.2017.08.008; Helgadottir B, 2016, PREV MED, V91, P123, DOI 10.1016/j.ypmed.2016.08.011; Hellerstein DJ, 2002, J AFFECT DISORDERS, V71, P85, DOI 10.1016/S0165-0327(01)00371-8; Herring MP, 2012, PSYCHOTHER PSYCHOSOM, V81, P21, DOI 10.1159/000327898; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hofmann SG, 2009, INT J COGN THER, V2, P160, DOI 10.1521/ijct.2009.2.2.160; JACOBS KW, 1993, PSYCHOL REP, V73, P431, DOI 10.2466/pr0.1993.73.2.431; Kessler R.C., 2002, NEUROPSYCHOPHARMACOL, V67, P981; Kessler RC, 2001, AM J PSYCHIAT, V158, P289, DOI 10.1176/appi.ajp.158.2.289; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kinser PA, 2014, ARCH PSYCHIAT NURS, V28, P377, DOI 10.1016/j.apnu.2014.08.014; Kinser PA, 2013, ARCH PSYCHIAT NURS, V27, P137, DOI 10.1016/j.apnu.2013.01.003; Kirkwood G, 2005, BRIT J SPORT MED, V39, P884, DOI 10.1136/bjsm.2005.018069; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Mehta P, 2010, J EVID-BASED INTEGR, V15, P156, DOI 10.1177/1533210110387405; Mitchell J., 2012, PSYCHOLOGY, V3, P782, DOI DOI 10.4236/PSYCH.2012.329118; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Moher David, 2009, Open Med, V3, pe123; Orwin R.G., 1994, HDB RES SYNTHESIS; Parthasarathy S, 2014, W INDIAN MED J, V63, P78, DOI 10.7727/wimj.2012.054; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Prathikanti S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173869; Ruhe HG, 2012, J AFFECT DISORDERS, V137, P35, DOI 10.1016/j.jad.2011.02.020; Sahasi G., 1989, J PERSONALITY CLIN S, V5, P51; Salmon P, 2009, COGN BEHAV PRACT, V16, P59, DOI 10.1016/j.cbpra.2008.07.002; SANTOR DA, 1995, PSYCHOL ASSESSMENT, V7, P131, DOI 10.1037/1040-3590.7.2.131; Sarubin N, 2014, J PSYCHIATR RES, V53, P76, DOI 10.1016/j.jpsychires.2014.02.022; Schuver KJ, 2016, COMPLEMENT THER MED, V26, P85, DOI 10.1016/j.ctim.2016.03.003; Sharma M, 2013, J EVID-BASED INTEGR, V18, P15, DOI 10.1177/2156587212460046; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shohani M, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_242_16; Spijker J., 2012, MULTIDISCIPLINARY GU; Spinhoven P, 2015, J ANXIETY DISORD, V33, P45, DOI 10.1016/j.janxdis.2015.05.001; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; Tarrier N, 2004, BEHAV RES THER, V42, P1377, DOI 10.1016/j.brat.2004.06.020; Taylor S, 2012, J ANXIETY DISORD, V26, P583, DOI 10.1016/j.janxdis.2012.02.010; Tolahunase MR, 2018, RESTOR NEUROL NEUROS, V36, P423, DOI 10.3233/RNN-170810; Tsang HWH, 2008, BRIT J CLIN PSYCHOL, V47, P303, DOI 10.1348/014466508X279260; Uebelacker LA, 2017, PSYCHOL MED, V47, P2130, DOI 10.1017/S0033291717000575; Uebelacker LA, 2016, ARCH WOMEN MENT HLTH, V19, P543, DOI 10.1007/s00737-015-0571-7; Vahia N. S., 1973, INDIAN J PSYCHIAT, V15, P32; Viechtbauer W., 2010, METAFOR METAANALYSIS; Vollestad J, 2012, BRIT J CLIN PSYCHOL, V51, P239, DOI 10.1111/j.2044-8260.2011.02024.x; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; WHO, 2012, ICD 10 CLASS MENT BE; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114	106	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204925	10.1371/journal.pone.0204925	http://dx.doi.org/10.1371/journal.pone.0204925			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273409	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700050
J	Han, N; Han, SH; Chu, H; Kim, J; Rhew, KY; Yoon, JH; Je, NK; Rhie, SJ; Ji, E; Lee, E; Kim, YS; Oh, JM				Han, Nayoung; Han, Seung Hee; Chu, Hyuneun; Kim, Jaehyun; Rhew, Ki Yon; Yoon, Jeong-Hyun; Je, Nam Kyung; Rhie, Sandy Jeong; Ji, Eunhee; Lee, Euni; Kim, Yon Su; Oh, Jung Mi		DrugTEAM Study Grp	Service design oriented multidisciplinary collaborative team care service model development for resolving drug related problems	PLOS ONE			English	Article							MEDICATION THERAPY MANAGEMENT; SOUTH-KOREA; PROGRAM; ADHERENCE; APPROPRIATENESS; IMPACT; NEEDS	Our goal was to help prevent drug-related morbidity and mortality by developing a collaborative multidisciplinary team care (MTC) service model using a service design framework that addressed the unmet needs and perspectives of diverse stakeholders. Our service model was based on a "4D" framework that included Discover, Define, Design, and Develop phases. In the "discover" phase, we conducted desk research and field research of stakeholders to identify the unmet needs in existing patient care services. We used service design tools, including service safaris, user shadowing, and customer journey maps to identify pain and opportunity points in the current services. We also performed focus group discussions and in-depth interviews with stakeholders to explore the needs for improved services. In the "define" phase, we generated the service concept by mind mapping and brainstorming about the needs of stakeholders. The service concept was defined to be a Patient-oriented, Collaborative, Advanced, Renovated, and Excellent (P-CARE) service. We named the service "DrugTEAM" (Drug Therapy Evaluation And Management). In the "design" phase, we designed and refined four prototypes based on results from validation tests for their application towards following services: 1) medication reconciliation, 2) medication evaluation and management, 3) evidence-based drug information, and 4) pharmaceutical care transition services. During the "develop" phase, we implemented four services in a longitudinal chronic care model, considering the time spent by patients for each inpatient and outpatient setting. In conclusion, this is a study to develop a collaborative MTC service model using service design framework, focused on managing the unmet needs of patients and healthcare providers. As a result of implementing this service model, we expect to strengthen the professional relationship between pharmacists and stakeholders to ultimately create better patient outcomes.	[Han, Nayoung; Han, Seung Hee; Chu, Hyuneun; Kim, Jaehyun; Lee, Euni; Oh, Jung Mi] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Rhew, Ki Yon] Dongduk Womens Univ, Coll Pharm, Seoul, South Korea; [Yoon, Jeong-Hyun; Je, Nam Kyung] Pusan Natl Univ, Coll Pharm, Busan, South Korea; [Rhie, Sandy Jeong] Ewha Womans Univ, Grad Sch, Div Life & Pharmaceut Sci, Seoul, South Korea; [Ji, Eunhee] Gachon Univ, Coll Pharm, Incheon, South Korea; [Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Coll Med, Seoul, South Korea	Seoul National University (SNU); Dongduk Women's University; Pusan National University; Ewha Womans University; Gachon University; Seoul National University (SNU)	Oh, JM (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	jmoh@snu.ac.kr			National Research Foundation of Korea [21A20132100004]; Korea Health Industry Development Institute [HI13C0731]; Korea Health Technology RD Project	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Korea Health Technology RD Project	This work was supported by the National Research Foundation of Korea, http://dx.doi.org/10.13039/501100003725, 21A20132100004; and Korea Health Industry Development Institute, http://dx.doi.org/10.13039/501100003710, HI13C0731. Jung Mi Oh was supported by a grant of the Korea Health Technology R&D Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Health-System Pharmacists, 2014, ASHP STAT PHARM CAR, P266; American Society of Hospital Pharmacists, 1993, AM J HOSP PHARM, V50, P126; Bauters T., 2014, ROLE PHARMACIST MULT; Bond CA, 2001, PHARMACOTHERAPY, V21, P1023, DOI 10.1592/phco.21.13.1023.34617; CARDONI AA, 1978, AM J HOSP PHARM, V35, P1233, DOI 10.1093/ajhp/35.10.1233; Chamberlain JJ, 2017, ANN INTERN MED, V166, P572, DOI 10.7326/M16-2937; Dolin Robert H, 2007, AMIA Annu Symp Proc, P186; Elliott RA, 2008, PHARM WORLD SCI, V30, P17, DOI 10.1007/s11096-007-9134-y; Enninga T., 2013, SERVICE DESIGN INSIG; Epstein NE, 2014, SURG NEUROL INT S7, V5, pS295, DOI [10.4103/2152-7806.139612, DOI 10.4103/2152-7806.139612]; Griffiths J, 2008, STAKEHOLDER INVOLVEM, P1; Guest G., 2012, INTRO APPL THEMATIC, P3; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Isetts BJ, 2008, J AM PHARM ASSOC, V48, P203, DOI 10.1331/JAPhA.2008.07108; Jodar-Sanchez F, 2015, PHARMACOECONOMICS, V33, P599, DOI 10.1007/s40273-015-0270-2; Kang J, 2017, PATIENT PREFER ADHER, V11, P1381, DOI 10.2147/PPA.S141562; Karine Freire DS, 2010, NORD SERV DES C, P1; Kovell LC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002315; Lauffenburger JC, 2012, AM J GERIATR PHARMAC, V10, P129, DOI 10.1016/j.amjopharm.2012.01.002; Lee IH, 2016, INT J CLIN PHARM-NET, V38, P1219, DOI 10.1007/s11096-016-0355-9; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162; McLean William, 2003, Can Respir J, V10, P195; Mekonnen AB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010003; Moore JM, 2013, J MANAGE CARE PHARM, V19, P228, DOI 10.18553/jmcp.2013.19.3.228; National Centre for Social Research, FRAM QUAL DAT AN TOO; Ndoro Samuel, 2014, Br J Nurs, V23, P724, DOI 10.12968/bjon.2014.23.13.724; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Polaine A., 2013, TURNING RES INSIGHT, P58; Reason B, 2016, CUSTOMER STORY UNDER, P58; Reinke Thomas, 2011, Manag Care, V20, P17; Rhew K, 2017, INT J CLIN PHARM TH, V55, P866, DOI 10.5414/CP202964; Ritchie J, 2002, QUALITATIVE RES COMP, P305, DOI DOI 10.4135/9781412986274; Ross LA, 2012, J AM PHARM ASSOC, V52, P802, DOI 10.1331/JAPhA.2012.10192; SAMSA GP, 1994, J CLIN EPIDEMIOL, V47, P891, DOI 10.1016/0895-4356(94)90192-9; Sehgal Vishal, 2013, J Family Med Prim Care, V2, P194, DOI 10.4103/2249-4863.117423; Smith M, 2011, HEALTH AFFAIR, V30, P646, DOI 10.1377/hlthaff.2011.0002; Tan ECK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003214; van Boven JFM, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-66; WHO, 1988, ROL PHARM HLTH CAR S; Wiedenmayer K, 2006, HDB DEV PHARM PRACTI, P7; Wolf C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142011; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030856	43	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0201705	10.1371/journal.pone.0201705	http://dx.doi.org/10.1371/journal.pone.0201705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265678	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500004
J	Segura-Garcia, I; Tun, TY; Box, SJ				Segura-Garcia, Iris; Tun, Thu Yain; Box, Stephen J.			Genetic characterization of the artisanal mud crab fishery in Myanmar	PLOS ONE			English	Article							SPECIES GENUS SCYLLA; MITOCHONDRIAL-DNA; ANDAMAN SEA; BRACHYURA PORTUNIDAE; MANGROVE ECOSYSTEM; POPULATION SIZES; OLIVACEA; SPP.; BAY; CONFIRMATION	Fish are important for food supply, especially in developing countries. In Southeast Asia, including Myanmar, the mud crab fishery is an important livelihood that represents a valuable source of income and food to coastal communities. However, the increasing demand for mud crab in domestic and international markets and poor management has generated concern about the status of this fishery across Southeast Asia. In this region, at least four species of mud crab in the genus Scylla are recognised but their correct identification and occurrence remain to be fully explained. Relying on accurate taxonomic identification of mud crab species represents the cornerstone of the successful implementation of management plans as life history biology and relative exploitation rates may vary by species due to gear susceptibility. Toward this aim, tissue samples from mud crabs were collected from four fishing communities of the Mergui archipelago, in the Tanintharyi region of southern Myanmar. All crab samples were DNA barcoded for species identification through sequencing. This study is the first genetic characterization of the mud crab fishery in Myanmar and revealed that Scylla olivacea was the only species found in the sampled fisheries of the Tanintharyi region. The populations studied across the Mergui archipelago did not show evidence of genetic structure, but gene flow appeared to be limited among conspecifics from neighbouring countries.	[Segura-Garcia, Iris; Box, Stephen J.] Natl Museum Nat Hist, Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA; [Tun, Thu Yain; Box, Stephen J.] Rare, Global Fisheries, Arlington, VA USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Segura-Garcia, I (corresponding author), Natl Museum Nat Hist, Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA.	SeguraGarciaI@si.edu		Segura-Garcia, Iris/0000-0003-3688-3557; Box, Stephen/0000-0001-5265-0556	Helmsley Charitable Trust [504604- 2017]	Helmsley Charitable Trust	This study was funded by the Helmsley Charitable Trust (grant number 504604- 2017) awarded to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bucklin A, 1998, J HERED, V89, P383, DOI 10.1093/jhered/89.5.383; Chatterjee A, 2017, J GEOPHYS RES-OCEANS, V122, P3200, DOI 10.1002/2016JC012300; ESTAMPADOR EULOGIO P., 1949, PHILIPPINE JOUR SCI, V78, P95; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO, 2003, MYANM AQ INL FISH MY; Fratini S, 2002, J EXP MAR BIOL ECOL, V272, P103, DOI 10.1016/S0022-0981(02)00052-7; FU YX, 1993, GENETICS, V133, P693; Fuseya R, 1996, FISHERIES SCI, V62, P705, DOI 10.2331/fishsci.62.705; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gopurenko D, 2003, MAR FRESHWATER RES, V54, P833, DOI 10.1071/MF03033; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; HILL BJ, 1994, MAR BIOL, V120, P379, DOI 10.1007/BF00680211; Imai H, 2004, AQUAT LIVING RESOUR, V17, P31, DOI 10.1051/alr:2004007; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jirapunpipat Kanchana, 2008, Kasetsart Journal Natural Sciences, V42, P31; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keenan CP, 1998, RAFFLES B ZOOL, V46, P217; Keenan CP, 2003, JOND C CTR BRIB ISL, P42; Koolkalya S, 2006, FISHERIES MANAG ECOL, V13, P391, DOI 10.1111/j.1365-2400.2006.00518.x; Lebata MJHL, 2007, B MAR SCI, V80, P891; Ma LB, 2006, AQUAC RES, V37, P1694, DOI 10.1111/j.1365-2109.2006.01603.x; MacIntosh DJ, 2002, J SHELLFISH RES, V21, P259; Macnae W., 1969, ADV MAR BIOL, V6; Mandal A, 2014, J SHELLFISH RES, V33, P503, DOI 10.2983/035.033.0219; Mandal A, 2014, BIOCHEM GENET, V52, P338, DOI 10.1007/s10528-014-9651-z; Moser S, 2005, FISH RES, V71, P27, DOI 10.1016/j.fishres.2004.07.008; Ng P., 1998, FAO SPECIES IDENTIFI, P1397; Ogawa CY, 2012, J CRUSTACEAN BIOL, V32, P762, DOI 10.1163/193724012X649787; Ong KS, 1964, IPFC P, P135; Overton JL, 2002, J CRUSTACEAN BIOL, V22, P790, DOI 10.1651/0278-0372(2002)022[0790:ESASMF]2.0.CO;2; Rizal Syamsul, 2012, American Journal of Environmental Sciences, V8, P479, DOI 10.3844/ajessp.2012.479.488; Roehrdanz R.L., 1993, Insect Molecular Biology, V2, P89, DOI 10.1111/j.1365-2583.1993.tb00129.x; Rosly HAAM, 2013, MOL BIOL REP, V40, P6407, DOI 10.1007/s11033-013-2755-4; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rumisha C., 2017, GENETIC DIVERSITY CO, V2017, P1; Sangthong Pradit, 2006, Kasetsart Journal Natural Sciences, V40, P958; Sarower MG, 2017, MITOCHONDRIAL DNA A, V28, P935, DOI 10.1080/24701394.2016.1214726; Serene R., 1952, INDO PACIFIC FISHERI, P132; Shukla M., 2013, RES J MAR SCI, V1, P2321; Slatkin M, 1999, GENETICS, V152, P775; Slatkin M, PAIRWISE COMPARISONS; Stamatis C, 2004, MOL ECOL, V13, P1377, DOI 10.1111/j.1365-294X.2004.02165.x; Stepien CA, 1999, MOL PHYLOGENET EVOL, V13, P31, DOI 10.1006/mpev.1999.0666; Supmee V, 2012, ZOOL STUD, V51, P1040; Wee AKS, 2014, J BIOGEOGR, V41, P954, DOI 10.1111/jbi.12263	48	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204905	10.1371/journal.pone.0204905	http://dx.doi.org/10.1371/journal.pone.0204905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265718	Green Published, gold, Green Submitted			2022-12-27	WOS:000446005500053
J	Teng, F; Ye, H; Xue, TJ				Teng, Fei; Ye, Huan; Xue, Tianjiao			Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease	PLOS ONE			English	Article							COPD; DIAGNOSIS; MORTALITY; BURDEN	Objective This study aimed to determine the predictive value of the neutrophil to lymphocyte ratio (NLR) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods A retrospective study was conducted from March 2012 to May 2016 in Fuxing Hospital, Capital University of Medical Science. We collected 906 cases (525 males, 381 females, mean age 81.86 +/- 9.75 years) diagnosed with AECOPD. The NLR was calculated from their white blood cell (WBC), neutrophil (NEU), and lymphocyte (LYM) counts, which were obtained at laboratory examination. Result After treatment, 698 patients with AECOPD improved. The NLR was higher at admission (6.89 +/- 6.82) than after treatment (4.19 +/- 5.11) (P = 0.000). The area under the receiver operating characteristic curve (AUC) of the NLR for predicting the 28-day mortality rate was 0.737. Using 8.130 as the critical NLR value, the sensitivity was 60.5%, and the specificity was 74.8%. The AUC of the NLR for predicting the frequency of the need for invasive mechanical ventilation was 0.732. Using 10.345 as the critical NLR value, the sensitivity was 54.3%, and the specificity was 84.8%. The AUC of WBC, NEU and LYM for predicting 28-day mortality and the need for invasive mechanical ventilation in these patients were all less than 0.7. An increased NLR was an independent risk factor for 28-day mortality (OR = 1.067, 95% CI = 1.039 to 1.095, P = 0.000), intensive care unit occupancy (OR = 1.046, 95% CI = 1.023 to 1.068, P = 0.000), and the need for invasive mechanical ventilation (OR = 1.042, 95% CI = 1.019 to 1.066, P = 0.000). Compared with those patients without comorbidities, patients with renal dysfunction or upper gastrointestinal bleeding had an increased risk of death within 28 days (OR = 3.102, 95% CI = 1.525 to 6.312; OR = 4.598, 95% CI = 1.825 to 11.583, respectively), ICU admission (OR = 2.228, 95% CI = 1.286 to 3.860; OR = 3.103, 95% CI = 1.402 to 6.866, respectively), and the need for invasive mechanical ventilation (OR = 3.572, 95% CI = 1.822 to 7.000; OR = 4.279, 95% CI = 1.823 to 10.045, respectively). Conclusion In patients with AECOPD, the accuracy of the NLR for predicting the 28-day mortality rate and frequency of the need for mechanical ventilation was significantly higher than the accuracy of WBC, NEU and LYM counts. AECOPD patients with an NLR >= 8.130 had higher 28-day mortality rate, while those with an NLR >= 10.345 were more likely to need invasive mechanical ventilation.	[Teng, Fei; Ye, Huan; Xue, Tianjiao] Capital Med Univ, Fuxing Hosp, Dept Infect Dis, Beijing, Peoples R China	Capital Medical University	Ye, H (corresponding author), Capital Med Univ, Fuxing Hosp, Dept Infect Dis, Beijing, Peoples R China.	yedahuan@yeah.net		Ye, Huan/0000-0001-9285-1504				[Anonymous], GLOB STRAT DIAFN MAN; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Hurst JR, 2007, THORAX, V62, P198, DOI 10.1136/thx.2007.077883; Lee H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156511; Liu CL, 2013, J SURG ONCOL, V107, P493, DOI 10.1002/jso.23270; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Papi Alberto, 2006, Proc Am Thorac Soc, V3, P245, DOI 10.1513/pats.200512-125SF; Perera PN, 2012, COPD, V9, P131, DOI 10.3109/15412555.2011.650239; Rahimirad S, 2017, TUBERK TORAK, V65, P25, DOI 10.5578/tt.27626; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sorensen AK, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0064-5; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Stefan MS, 2015, CRIT CARE MED, V43, P1386, DOI 10.1097/CCM.0000000000000945; Taylan M, 2017, CLIN RESPIR J, V11, P311, DOI 10.1111/crj.12336; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042860; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335; Yin P, 2016, CHEST, V150, P1269, DOI 10.1016/j.chest.2016.08.1474; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	28	14	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204377	10.1371/journal.pone.0204377	http://dx.doi.org/10.1371/journal.pone.0204377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265703	Green Submitted, gold, Green Published			2022-12-27	WOS:000446005500031
J	Murai, R; Itoh, Y; Kageyama, S; Nakayama, M; Ishigaki, H; Teramoto, K; Narita, M; Yoshida, T; Tomita, K; Kobayashi, K; Wada, A; Nagasawa, M; Kubota, S; Ogasawara, K; Kawauchi, A				Murai, Ryosuke; Itoh, Yasushi; Kageyama, Susumu; Nakayama, Misako; Ishigaki, Hirohito; Teramoto, Kazuo; Narita, Mitsuhiro; Yoshida, Tetsuya; Tomita, Keiji; Kobayashi, Ken-ichi; Wada, Akinori; Nagasawa, Masayuki; Kubota, Shigehisa; Ogasawara, Kazumasa; Kawauchi, Akihiro			Prediction of intravesical recurrence of nonmuscle-invasive bladder cancer by evaluation of intratumoral Foxp3(+) T cells in the primary transurethral resection of bladder tumor specimens	PLOS ONE			English	Article							IMMUNE TOLERANCE; CARCINOMA; RELAPSE	Patients with a history of non-muscle-invasive bladder cancer sometimes have recurrence of tumors after transurethral resection of bladder tumor treatment. To find factors related to the recurrence of non-muscle-invasive bladder cancer, we examined tissue specimens taken at transurethral resection of bladder tumor as an initial treatment. We revealed the association between prognosis of non-muscle-invasive bladder cancer and infiltration of Foxp3(+) T cells that suppress anti-tumor immunity in 115 primary non-muscle-invasive bladder cancer patients retrospectively identified and followed for at least 3 months after primary transurethral resection. In immunohistological staining, we counted the number of cells positive for CD3 and positive for CD3 and Foxp3 together and calculated the percentage of Foxp3(+) T cells among the CD3(+) T cells. The recurrence-free survival rate was calculated by the Kaplan-Meier method, and a Cox regression analysis of recurrence factors was performed. The median (interquartile range) percentage of Foxp3(+) T cells in all cases was 17.1% (11.9, 11.4-23.3%). Compared by risk stratification, it was 11.4% (10.4, 7.8-18.2%) in the low-risk group (n = 32), 16.8% (12.6, 11.6-24.2%) in the intermediate-risk group (n = 45), and 22.0% (9.7, 16.4-26.1%) in the high-risk group (n = 38). The Kaplan-Meier survival analysis indicated that the Foxp3(+) T cell high group (>= 17.1%) had a worse RFS rate than did the low group (< 17.1%) (P = 0.006). In multivariate analysis, the percentage of Foxp3(+) T cells was an independent risk factor for intravesical recurrence (hazard ratio 2.25). Thus, peritumoral Foxp3(+) T cell infiltration was correlated to risk stratification and recurrence-free survival. Therefore, the percentage of Foxp3(+) T cells in tumor specimens may predict a risk for intravesical recurrence.	[Murai, Ryosuke; Itoh, Yasushi; Nakayama, Misako; Ishigaki, Hirohito; Teramoto, Kazuo; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga, Japan; [Murai, Ryosuke; Kageyama, Susumu; Narita, Mitsuhiro; Yoshida, Tetsuya; Tomita, Keiji; Kobayashi, Ken-ichi; Wada, Akinori; Nagasawa, Masayuki; Kubota, Shigehisa; Kawauchi, Akihiro] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Itoh, Y (corresponding author), Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga, Japan.	yasushii@belle.shiga-med.ac.jp	Nagasawa, Masayuki/CAI-8101-2022; Ishigaki, Hirohito/AAO-7458-2020	Ishigaki, Hirohito/0000-0002-5249-8598; Nakayama, Misako/0000-0001-8611-0662; Kobayashi, Kenichi/0000-0002-6618-5664; Kageyama, Susumu/0000-0001-7150-647X; Itoh, Yasushi/0000-0001-7462-2193	Japan Society for the Promotion of Science [26462409]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (26462409) to Mitsuhiro Narita. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Boer MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094192; Chang SS, 2016, J UROLOGY, V196, P1021, DOI 10.1016/j.juro.2016.06.049; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Horn T, 2016, WORLD J UROL, V34, P181, DOI 10.1007/s00345-015-1615-3; Kamat AM, 2016, LANCET, V388, P2796, DOI 10.1016/S0140-6736(16)30512-8; Kang MJ, 2013, TRANSL ONCOL, V6, P282, DOI 10.1593/tlo.13256; Lee NR, 2008, LEUKEMIA LYMPHOMA, V49, P247, DOI 10.1080/10428190701824536; Li L, 2011, IMMUNOBIOLOGY, V216, P477, DOI 10.1016/j.imbio.2010.09.003; Lipscomb MW, 2010, EUR J IMMUNOL, V40, P480, DOI 10.1002/eji.200939667; Miyake M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102186; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Noh J, 2012, CELL IMMUNOL, V274, P109, DOI 10.1016/j.cellimm.2012.01.005; Parodi A, 2016, ONCOTARGET, V7, P6424, DOI 10.18632/oncotarget.7024; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x	19	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204745	10.1371/journal.pone.0204745	http://dx.doi.org/10.1371/journal.pone.0204745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261082	Green Published, Green Submitted, gold			2022-12-27	WOS:000445907400101
J	Bai, XF; Ewins, D; Crocombe, AD; Xu, W				Bai, Xuefei; Ewins, David; Crocombe, Andrew David; Xu, Wei			A biomechanical assessment of hydraulic ankle-foot devices with and without micro-processor control during slope ambulation in trans-femoral amputees	PLOS ONE			English	Article							PROSTHETIC FOOT; LEVEL WALKING; GAIT; LOCOMOTION; SURFACES; DOWNHILL; FEET	Slope ambulation is a challenge for trans-femoral amputees due to a relative lack of knee function. The assessment of prosthetic ankles on slopes is required for supporting the design, optimisation, and selection of prostheses. This study assessed two hydraulic ankle-foot devices (one of the hydraulic ankles is controlled by a micro-processor that allows real-time adjustment in ankle resistance and range of motion) used by trans-femoral amputees in ascending and descending a 5-degree slope walking, against a rigid ankle-foot device. Five experienced and active unilateral trans-femoral amputees performed ascending and descending slope tests with their usual prosthetic knee and socket fitted with a rigid ankle-foot, a hydraulic ankle-foot without a micro-processor, and a hydraulic ankle-foot with a micro-processor optimised for ascending and descending slopes. Peak values in hip, knee and ankle joint angles and moments were collected and the normalcy Trend Symmetry Index of the prosthetic ankle moments (as an indication of bio-mimicry) were calculated and assessment. Particular benefits of the hydraulic ankle-foot devices were better bio-mimicry of ankle resistance moment, greater range of motion, and improved passive prosthetic knee stability according to the greater mid-stance external knee extensor moment (especially in descending slope) compared to the rigid design. The micro-processor controlled device demonstrated optimised ankle angle and moment patterns for ascending and descending slope respectively, and was found to potentially further improve the ankle moment bio-minicry and prosthetic knee stability compared to the hydraulic device without a micro-processor. However the difference between the micro-processor controlled device and the one without a micro-processor does not reach a statistically significant level.	[Bai, Xuefei] Natl Res Ctr Rehabil Tech Aids, Beijing, Peoples R China; [Bai, Xuefei] Beijing Key Lab Rehabil Tech Aids Old Age Disabil, Beijing, Peoples R China; [Bai, Xuefei] Minist Civil Affairs, Key Lab Human Mot Anal & Rehabil Technol, Beijing, Peoples R China; [Ewins, David; Crocombe, Andrew David; Xu, Wei] Univ Surrey, Dept Mech Engn Sci, Guildford, Surrey, England; [Ewins, David] Queen Marys Hosp, Gait Lab, London, England	University of Surrey; University of London; Queen Mary University London	Xu, W (corresponding author), Univ Surrey, Dept Mech Engn Sci, Guildford, Surrey, England.	w.xu@surrey.ac.uk			Henry Lester Trust Ltd.	Henry Lester Trust Ltd.	Xuefei Bai was supported by the Henry Lester Trust Ltd. for her doctoral research and publications. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Bai XF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180836; Collins TD, 2009, GAIT POSTURE, V30, P173, DOI 10.1016/j.gaitpost.2009.04.004; Crenshaw SJ, 2006, GAIT POSTURE, V24, P515, DOI 10.1016/j.gaitpost.2005.12.002; De Asha AR, 2014, CLIN BIOMECH, V29, P728, DOI 10.1016/j.clinbiomech.2014.06.009; De Asha AR, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-107; De Asha AR, 2013, CLIN BIOMECH, V28, P218, DOI 10.1016/j.clinbiomech.2012.11.013; Goldberg EJ, 2008, J BIOMECH, V41, P695, DOI 10.1016/j.jbiomech.2007.10.002; Hansen AH, 2004, HUM MOVEMENT SCI, V23, P807, DOI 10.1016/j.humov.2004.08.023; Koehler-McNicholas SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173423; KUSTER M, 1995, CLIN BIOMECH, V10, P79, DOI 10.1016/0268-0033(95)92043-L; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Pitkin Mark R, 1997, J Prosthet Orthot, V9, P113, DOI 10.1097/00008526-199700930-00005; Pitkin Mark R, 1995, J Prosthet Orthot, V7, P114, DOI 10.1097/00008526-199507040-00003; Pitkin MR, 2010, BIOMECHANICS OF LOWER LIMB PROSTHETICS, P1, DOI 10.1007/978-3-642-03016-1; Portnoy S, 2012, GAIT POSTURE, V35, P121, DOI 10.1016/j.gaitpost.2011.08.021; Prince F., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P247, DOI 10.1109/86.340873; Redfern MS, 1997, GAIT POSTURE, V6, P119; Sedki I, 2013, PROSTHET ORTHOT INT, V37, P250, DOI 10.1177/0309364612458448; Simon J, 2007, GAIT POSTURE, V26, P11; Struchkov V, 2016, CLIN BIOMECH, V32, P164, DOI 10.1016/j.clinbiomech.2015.11.015; Su PF, 2010, AM J PHYS MED REHAB, V89, P34, DOI 10.1097/PHM.0b013e3181c55ad4; van der Linden ML, 1999, J BIOMECH, V32, P877, DOI 10.1016/S0021-9290(99)00086-X; Villa C, 2015, CLIN BIOMECH, V30, P623, DOI 10.1016/j.clinbiomech.2015.03.022; Vrieling AH, 2008, GAIT POSTURE, V28, P235, DOI 10.1016/j.gaitpost.2007.12.006; Wanamaker AB, 2017, PROSTHET ORTHOT INT, V41, P431, DOI 10.1177/0309364616682385	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205093	10.1371/journal.pone.0205093	http://dx.doi.org/10.1371/journal.pone.0205093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289921	Green Submitted, gold, Green Published			2022-12-27	WOS:000446545500048
J	Forcina, G; Guerrini, M; Khaliq, I; Khan, AA; Barbanera, F				Forcina, Giovanni; Guerrini, Monica; Khaliq, Imran; Khan, Aleem Ahmed; Barbanera, Filippo			Human-modified biogeographic patterns and conservation in game birds: The dilemma of the black francolin (Francolinus francolinus, Phasianidae) in Pakistan	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; BIOTIC HOMOGENIZATION; PASSERINE BIRDS; COMMON QUAIL; RAPD MARKERS; WILD; GALLIFORMES; HYBRIDIZATION; CONSEQUENCES	The ever-increasing human-mediated wildlife reshuffling is raising concern for the conservation of biodiversity. The loss of biological distinctiveness among regions lessens the genetic diversity and consequently the evolutionary potential of local biotas to tackle present-day global change and human disturbance. This process may be sometimes cryptic unless investigated by means of a molecular approach. In this respect, game birds are a paradigmatic case. The black francolin (Francolinus francolinus, Phasianidae) is a medium-sized galliform whose distribution range stretches from Cyprus to the Gulf of Bengal. Six morphologic subspecies are known, with three of which occurring in Pakistan, where the species is heavily hunted and used as pet for chirping competitions. We genotyped 98 samples (feathers) at both the entire mitochondrial DNA Control Region gene and nine microsatellite loci to get a deeper insight into the genetic diversity of the black francolin in Pakistan in order to offer cogent recommendations for its conservation management. We identified several mtDNA lineages that were consistent with the currently described subspecies/taxonomy whose pattern of co-occurrence is compatible with the geological history and the faunal movement routes of the region under study. However, the biparentally inherited micro-satellites returned a quite discordant picture of an extensive, sex-biased genetic mixing due to the intensive relocations of already overharvested male individuals for chirping competitions. Our results indicated that the genetic integrity of the black francolin in Pakistan could be seriously at risk and call for monitoring and limiting its trade other than enhancing the public awareness of the importance of local biodiversity resources.	[Forcina, Giovanni; Guerrini, Monica; Barbanera, Filippo] Univ Pisa, Dept Biol, Pisa, Italy; [Khaliq, Imran; Khan, Aleem Ahmed] Ghazi Univ, Dept Zool, Dera Ghazi Khan, Punjab, Pakistan; [Forcina, Giovanni; Guerrini, Monica; Barbanera, Filippo] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	University of Pisa; National University of Singapore	Barbanera, F (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	filippo.barbaner@unipi.it	Forcina, Giovanni/O-5179-2017	Forcina, Giovanni/0000-0001-5727-7770				Ali S., 1983, HDB BIRDS INDIA PAKI; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Altaf M, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0253-4; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baker E. C. S., 1923, Journal of the Bombay Natural History Society, V29, P9; Baldacci Ugo, 1964, FRANCOLINO SUA REINT; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbanera F, 2005, BIOL CONSERV, V122, P275, DOI 10.1016/j.biocon.2004.07.017; Barbanera F, 2010, BIOL CONSERV, V143, P1259, DOI 10.1016/j.biocon.2010.02.035; Barbanera F, 2009, BIOL INVASIONS, V11, P333, DOI 10.1007/s10530-008-9251-0; Behbash R, 2010, AFR J BIOTECHNOL, V9, P3847; Bird Life International, 2004, BIRD LIF CONS SER, V12; Boivin N, 2017, HUMAN DISPERSAL AND SPECIES MOVEMENT: FROM PREHISTORY TO THE PRESENT, P1; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Casas F, 2012, BIOL INVASIONS, V14, P295, DOI 10.1007/s10530-011-0062-3; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Clements JF, 2007, CLEMENTS CHECKLIST B; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Dementiev GP, 1952, BIRDS TURKMENISTAN, V1, DOI [10.1111/brv.12107, DOI 10.1111/BRV.12107]; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ericson PGP, 2002, MOL PHYLOGENET EVOL, V25, P53, DOI 10.1016/S1055-7903(02)00215-4; Ericson PGP, 2002, P ROY SOC B-BIOL SCI, V269, P235, DOI 10.1098/rspb.2001.1877; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Finlayson C., 2011, AVIAN SURVIVORS HIST; Flockhart DTT, 2017, WILDLIFE SOC B, V41, P231, DOI 10.1002/wsb.759; Forcina G, 2012, MOL PHYLOGENET EVOL, V65, P523, DOI 10.1016/j.ympev.2012.07.006; Forcina G, 2015, P NATL ACAD SCI USA, V112, P3296, DOI 10.1073/pnas.1500677112; Forcina G, 2014, J NAT CONSERV, V22, P15, DOI 10.1016/j.jnc.2013.07.004; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Fuller R.A., 2000, PARTRIDGES QUAILS FR, P63; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Goudet J., 2002, FSTAT VERSION 2 9 3; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guerrini M, 2009, BIOCHEM GENET, V47, P873, DOI 10.1007/s10528-009-9288-5; Gummer H, 2003, DEP CONSERVATION SCI, V150; HALL B. P., 1963, BRIT MUS [NAT HIST] ZOOL, V10, P105; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hufbauer RA, 2015, P NATL ACAD SCI USA, V112, P10557, DOI 10.1073/pnas.1504732112; Islam K., 1993, P131; ISLAM K, 1999, BIRDS N AM, P394; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnsgard PA, 1988, QUAILS PARTRIDGES FR; Jonsson KA, 2012, P NATL ACAD SCI USA, V109, P6620, DOI 10.1073/pnas.1115835109; Karanth KP, 2003, CURR SCI INDIA, V85, P1276; Khan MF, 2015, J ANIM PLANT SCI, V25, P101; Khan WA, 2013, PAK J ZOOL, V45, P949; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Madge S., 2002, PHEASANTS PARTRIDGES; Mahmoud Sajid, 2010, Podoces, V5, P42; Mani MS., 1974, ECOLOGY BIOGEOGRAPHY, P698, DOI DOI 10.1007/978-94-010-2331-3_24; Mann M. Anwar, 2000, Pakistan Veterinary Journal, V20, P118; Ogawa A, 1997, CHROMOSOME RES, V5, P93, DOI 10.1023/A:1018461906913; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; Perez T, 1998, MOL ECOL, V7, P1347, DOI 10.1046/j.1365-294x.1998.00484.x; PERGAMS ORW, 2009, PRINCETON GUIDE ECOL, P642; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; Pritchard JK, 2000, GENETICS, V155, P945; Qureshi JI, 1972, PAK J AGR SCI, V12, P103; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Riaz M, 2011, PAK J ZOOL, V43, P889; Roberts T.J., 1992, BIRDS PAKISTAN, V1; Romagosa CM, 2009, CONSERV BIOL, V23, P1001, DOI 10.1111/j.1523-1739.2009.01194.x; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Sanchez-Donoso I, 2018, ANIM BEHAV, V136, P107, DOI 10.1016/j.anbehav.2017.12.012; Sanchez-Donoso I, 2014, EVOL ECOL RES, V16, P493; Sanchez-Donoso Ines, 2014, Frontiers in Ecology and Evolution, V2, P15; Sclater PL, 1858, J P LINNEAN SOC ZOOL, V2, P130, DOI DOI 10.1111/J.1096-3642.1858.TB02549.X; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Soderquist P, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1156-8; Templeton A.R., 1986, P105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vazquez-Reyes LD, 2017, CONDOR, V119, P275, DOI 10.1650/CONDOR-16-116.1; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Whistler H., 1949, POPULAR HDB INDIAN B; Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009; *WORLD PHEAS ASS I, 2009, GUID REINTR GALL CON; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	90	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205059	10.1371/journal.pone.0205059	http://dx.doi.org/10.1371/journal.pone.0205059			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289901	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500042
J	Glaspie, CN; Seitz, RD				Glaspie, Cassandra N.; Seitz, Rochelle D.			Habitat complexity and benthic predator-prey interactions in Chesapeake Bay	PLOS ONE			English	Article							CALLINECTES-SAPIDUS RATHBUN; SOFT-SHELL CLAM; DENSITY-DEPENDENT PREDATION; MYA-ARENARIA L.; BLUE-CRAB; FUNCTIONAL-RESPONSES; FORAGING BEHAVIOR; HARD CLAMS; POPULATION; SIZE	In Chesapeake Bay, the soft-shell clam Mya arenaria (thin-shelled, deep-burrowing) exhibits population declines when predators are active, and it persists at low densities. In contrast, the hard clam Mercenaria mercenaria (thick-shelled, shallow-burrowing) has a stable population and age distribution. We examined the potential for habitat and predators to control densities and distributions of bivalves in a field caging experiment (Mya only) and laboratory mesocosm experiments (both species). In the field, clams exposed to predators experienced 76.3% greater mortality as compared to caged individuals, and blue crabs were likely responsible for most of the mortality of juvenile Mya. In mesocosm experiments, Mya had lower survival in sand and seagrass than in shell hash or oyster shell habitats. However, crabs often missed one or more prey items in seagrass, shell, and oyster shell habitats. Predator search times and encounter rates declined when prey were at low densities, likely due to the added cost of inefficient foraging; however, this effect was more pronounced for Mya than for Mercenaria. Mercenaria had higher survival than Mya in mesocosm experiments, likely because predators feeding on Mercenaria spent less time foraging than those feeding on Mya. Mya may retain a low-density refuge from predation even with the loss of structurally complex habitats, though a loss of habitat refuge may result in clam densities that are not sustainable. A better understanding of density-dependent predator-prey interactions is necessary to prevent loss of food-web integrity and to conserve marine resources.	[Glaspie, Cassandra N.; Seitz, Rochelle D.] Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA; [Glaspie, Cassandra N.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	William & Mary; Virginia Institute of Marine Science; Louisiana State University System; Louisiana State University	Glaspie, CN (corresponding author), Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA.; Glaspie, CN (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	cglaspie1@lsu.edu			National Oceanic and Atmospheric Administration Chesapeake Bay Office [NA11NMF4570218]; Environmental Protection Agency EPA STAR Fellowship [FP91767501]; National Science Foundation Administration GK-12 program [DGE-0840804]	National Oceanic and Atmospheric Administration Chesapeake Bay Office(National Oceanic Atmospheric Admin (NOAA) - USA); Environmental Protection Agency EPA STAR Fellowship; National Science Foundation Administration GK-12 program	This material is based upon work supported by the National Oceanic and Atmospheric Administration Chesapeake Bay Office (https://chesapeakebay.noaa.gov/) grant number NA11NMF4570218 (RDS); the Environmental Protection Agency EPA STAR Fellowship (https://www.epa.gov/research-fellowships/science-achieve-results-star-graduate-fellowships) under grant number FP91767501 (CNG); and the National Science Foundation Administration GK-12 program (http://www.vims.edu/education/graduate/gk12/fellows/index.php) under grant number DGE-0840804 (CNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1982, AM NAT, V120, P382, DOI 10.1086/283996; [Anonymous], R LANG ENV STAT COMP; ARNOLD WS, 1984, J EXP MAR BIOL ECOL, V80, P207, DOI 10.1016/0022-0981(84)90150-3; Beal BF, 2002, AQUACULTURE, V208, P81, DOI 10.1016/S0044-8486(01)00900-0; Beal BF, 2006, J EXP MAR BIOL ECOL, V336, P1, DOI 10.1016/j.jembe.2006.04.006; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bellmore JR, 2015, ECOLOGY, V96, P274, DOI 10.1890/14-0733.1; BLUNDON JA, 1982, J EXP MAR BIOL ECOL, V65, P47, DOI 10.1016/0022-0981(82)90175-7; BLUNDON JA, 1982, J EXP MAR BIOL ECOL, V65, P67, DOI 10.1016/0022-0981(82)90176-9; Boukal DS, 2007, THEOR POPUL BIOL, V72, P136, DOI 10.1016/j.tpb.2006.12.003; CRONIN TW, 1988, J COMP PHYSIOL A, V162, P463, DOI 10.1007/BF00612512; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Dungan CF, 2002, DIS AQUAT ORGAN, V50, P67, DOI 10.3354/dao050067; EGGLESTON DB, 1992, MAR ECOL PROG SER, V85, P55, DOI 10.3354/meps085055; Fisher R.A, 2010, LIFE HIST TROPHIC EC; Fisher RA, 2011, J SHELLFISH RES, V30, P187, DOI 10.2983/035.030.0126; GARRITY SD, 1981, ECOL MONOGR, V51, P267, DOI 10.2307/2937274; Gascoigne JC, 2004, J APPL ECOL, V41, P801, DOI 10.1111/j.0021-8901.2004.00944.x; Glaspie CN, 2018, MAR ECOL PROG SER, V603, P117, DOI 10.3354/meps12706; Glaspie CN, 2017, MAR ECOL PROG SER, V570, P113, DOI 10.3354/meps12103; Glaspie CN, 2017, J EXP MAR BIOL ECOL, V489, P58, DOI 10.1016/j.jembe.2016.11.010; Glaspie CN, 2017, KNOWLEDGE NETWORK BI; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; Hassell MP., 1978, DYNAMICS ARTHROPOD P; HINES AH, 1990, MAR ECOL PROG SER, V67, P105, DOI 10.3354/meps067105; Homer ML, 2011, ASSESSMENT CHESAPEAK; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Kramer AM, 2010, J ANIM ECOL, V79, P633, DOI 10.1111/j.1365-2656.2009.01657.x; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Lipcius RN, 1998, MAR FRESHWATER RES, V49, P807, DOI 10.1071/MF97094; LIPCIUS RN, 1986, ECOLOGY, V67, P1361, DOI 10.2307/1938692; Lipcius Romuald N., 2007, BLUE CRAB CALLINECTE, P535; Long WC, 2013, J EXP MAR BIOL ECOL, V449, P142, DOI 10.1016/j.jembe.2013.09.004; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Madadi H, 2011, J PEST SCI, V84, P447, DOI 10.1007/s10340-011-0387-9; Micheli F, 1997, ECOL MONOGR, V67, P203, DOI 10.1890/0012-9615(1997)067[0203:EOPFBO]2.0.CO;2; MURDOCH W W, 1975, P1; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; QUAMMEN ML, 1984, ECOLOGY, V65, P529, DOI 10.2307/1941415; RANDALL JE, 1961, ECOLOGY, V42, P812, DOI 10.2307/1933510; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Sinclair ARE, 2006, J ANIM ECOL, V75, P64, DOI 10.1111/j.1365-2656.2006.01036.x; SKILLETER GA, 1994, MAR ECOL PROG SER, V109, P29, DOI 10.3354/meps109029; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; SPONAUGLE S, 1990, MAR ECOL PROG SER, V67, P43, DOI 10.3354/meps067043; Stoner AW, 2009, J EXP MAR BIOL ECOL, V382, P54, DOI 10.1016/j.jembe.2009.10.003; Taylor DL, 2000, MAR ECOL PROG SER, V196, P221, DOI 10.3354/meps196221; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Uszko W, 2015, ECOLOGY, V96, P3243, DOI 10.1890/15-0055.1; Vermeij G.J., 1987, EVOLUTION ESCALATION; WHETSTONE JM, 1981, ESTUARIES, V4, P153, DOI 10.2307/1351680; WRIGHT LD, 1987, ESTUAR COAST SHELF S, V24, P765, DOI 10.1016/0272-7714(87)90151-X	58	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205162	10.1371/journal.pone.0205162	http://dx.doi.org/10.1371/journal.pone.0205162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289889	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500054
J	Ernst, J; Faller, H; Koch, U; Brahler, E; Harter, M; Schulz, H; Weis, J; Kohler, N; Hinz, A; Mehnert, A				Ernst, Jochen; Faller, Hermann; Koch, Uwe; Braehler, Elmar; Haerter, Martin; Schulz, Holger; Weis, Joachim; Koehler, Norbert; Hinz, Andreas; Mehnert, Anja			Doctor's recommendations for psychosocial care: Frequency and predictors of recommendations and referrals	PLOS ONE			English	Article							CANCER-PATIENTS; ONCOLOGISTS RECOGNITION; EMOTIONAL DISTRESS; MENTAL-DISORDERS; BREAST-CANCER; PREVALENCE; DEPRESSION; PATIENT; SUPPORT; NEEDS	Background A significant number of oncological patients are heavily burdened by psychosocial stress. Doctors recommending or referring their patients to psycho-oncologists in the course of routine consultations can positively influence psycho-oncological care. The aim of this study was to analyze the frequency and predictors of such recommendations and to examine the use of these services by patients. Methods 4,020 cancer patients (mean age 58 years; 51% women) were evaluated in a multicenter, cross-sectional study in Germany. Data was gathered about doctors' referral practices, patients' utilization of psycho-oncological care services, and disease-related symptoms. The PHQ-9 depression scale and the GAD-7 anxiety scale were used to measure psychological burden. Descriptive data analysis was conducted on the basis of subgroup comparisons and multivariable analysis was done using binary logistical regression. Results 21.9% of the respondents reported having been given a recommendation or referral for psycho-oncological care by a doctor within the course of their cancer diagnosis and treatment. This comprises 29.5% of the patients identified by screening as being psychologically burdened. Nearly half of the patients who received a recommendation or referral (49.8%) acted on it. Predictors for seeking out psycho-oncological care included: patient desire (OR = 2.0), previous experience with psycho-oncological care (OR = 1.59), and female gender (OR = 1.57). Multivariable analysis indicated that patients' level of psychological burden (depression, anxiety) had no effect on whether doctors gave them a recommendation or referral. Conclusions Along with examining the degree to which patients are burdened (e.g. using screening instruments), determining whether or not patients would like to receive psycho-oncological care is an important aspect of improving referral practices and, by extension, will allow important progress in the field of psycho-oncological care to be made.	[Ernst, Jochen; Braehler, Elmar; Hinz, Andreas; Mehnert, Anja] Univ Med Ctr Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Faller, Hermann] Univ Wurzburg, Dept Med Psychol & Psychotherapy, Med Sociol & Rehabil Sci, Klin Str 3, Wurzburg, Germany; [Faller, Hermann] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Klin Str 3, Wurzburg, Germany; [Koch, Uwe; Haerter, Martin; Schulz, Holger] Univ Med Ctr Hamburg Eppendorf, Dept & Outpatient Clin Med Psychol, Martinistr 52, Hamburg, Germany; [Braehler, Elmar] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Untere Zahlbacherstr 8, Mainz, Germany; [Weis, Joachim] Univ Med Ctr Freiburg, Dept Psychooncol, Clin Oncol Rehabil, Freiburg, Germany; [Koehler, Norbert] Univ Leipzig, Clin Trial Ctr, Leipzig, Germany	Leipzig University; University of Wurzburg; University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; University of Freiburg; Leipzig University	Ernst, J (corresponding author), Univ Med Ctr Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany.	jochen.ernst@medizin.uni-leipzig.de	Ernst, Jochen/ABA-6999-2021; Braehler, Elmar/C-6535-2009; Mehnert-Theuerkauf, Anja/A-1177-2008	Ernst, Jochen/0000-0002-2374-3232; Braehler, Elmar/0000-0002-2648-2728; Mehnert-Theuerkauf, Anja/0000-0002-6872-9805	German Research Foundation (DFG); Leipzig University; Deutsche Krebshilfe [107465]	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University; Deutsche Krebshilfe(Deutsche Krebshilfe)	We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing, and Deutsche Krebshilfe (107465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal JM, 2016, PSYCHO-ONCOLOGY, V25, P1363, DOI 10.1002/pon.4067; Baker-Glenn EA, 2011, PSYCHO-ONCOLOGY, V20, P525, DOI 10.1002/pon.1759; Basch E, 2006, LANCET ONCOL, V7, P903, DOI 10.1016/S1470-2045(06)70910-X; Bauwens S, 2014, PSYCHO-ONCOLOGY, V23, P804, DOI 10.1002/pon.3484; Beraldi A, 2016, ONKOLOGE, V22, P121, DOI 10.1007/s00761-015-3059-1; Book K, 2013, PSYCHO-ONCOLOGY, V22, P2789, DOI 10.1002/pon.3347; Brosius F., 2018, SPSS UMFASSENDES HDB; Buchhold B, 2017, J DTSCH DERMATOL GES, V15, P791, DOI 10.1111/ddg.13294; Carlson LE, 2012, J CLIN ONCOL, V30, P1160, DOI 10.1200/JCO.2011.39.5509; Clover KA, 2015, PSYCHO-ONCOLOGY, V24, P812, DOI 10.1002/pon.3729; Dubruille S, 2015, PSYCHO-ONCOLOGY, V24, P294, DOI 10.1002/pon.3636; Ernstmann N, 2009, SUPPORT CARE CANCER, V17, P1417, DOI 10.1007/s00520-009-0605-7; Faller H, 2017, PSYCHO-ONCOLOGY, V26, P537, DOI 10.1002/pon.4197; Faller H, 2016, J PSYCHOSOM RES, V81, P24, DOI 10.1016/j.jpsychores.2015.12.004; Grafe K, 2004, DIAGNOSTICA, V50, P171, DOI 10.1026/0012-1924.50.4.171; Krebber AMH, 2014, PSYCHO-ONCOLOGY, V23, P121, DOI 10.1002/pon.3409; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kuhnt S, 2016, PSYCHOTHER PSYCHOSOM, V85, P289, DOI 10.1159/000446991; Lee JY, 2016, PSYCHO-ONCOLOGY, V25, P170, DOI 10.1002/pon.3879; Li WWY, 2013, PSYCHO-ONCOLOGY, V22, P792, DOI 10.1002/pon.3068; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Mehnert A, 2014, J CLIN ONCOL, V32, P3540, DOI 10.1200/JCO.2014.56.0086; Mehnert A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-70; Merckaert I, 2010, PSYCHO-ONCOLOGY, V19, P141, DOI 10.1002/pon.1568; Mitchell Alex J, 2013, Lancet Oncol, V14, P721, DOI 10.1016/S1470-2045(13)70244-4; Mosher CE, 2014, PSYCHO-ONCOLOGY, V23, P812, DOI 10.1002/pon.3488; Nekolaichuk CL, 2011, PSYCHO-ONCOLOGY, V20, P326, DOI 10.1002/pon.1765; Okuyama T, 2011, JPN J CLIN ONCOL, V41, P1251, DOI 10.1093/jjco/hyr146; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; Plass A, 2001, PSYCHO-ONCOL, V10, P511, DOI 10.1002/pon.543; Schmacke N., 2011, SHARED DECISION MAKI; Singer S, 2011, PSYCHOTHERAPEUT, V56, P386, DOI 10.1007/s00278-011-0859-7; Tuinman MA, 2015, PSYCHO-ONCOLOGY, V24, P699, DOI 10.1002/pon.3712; Werner A, 2012, PSYCHO-ONCOLOGY, V21, P818, DOI 10.1002/pon.1975; Zeissig SR, 2015, PSYCHOTHER PSYCH MED, V65, P177, DOI 10.1055/s-0034-1395627	36	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205160	10.1371/journal.pone.0205160	http://dx.doi.org/10.1371/journal.pone.0205160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286172	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500092
J	Huruy, K; Mulu, A; Liebert, UG; Melanie, M				Huruy, Kahsay; Mulu, Andargachew; Liebert, Uwe Gerd; Melanie, Maier			HIV-1 C proviral DNA for detection of drug resistance mutations	PLOS ONE			English	Article							GENOTYPIC RESISTANCE; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; CELLULAR RESERVOIRS; NAIVE INDIVIDUALS; PLASMA RNA; BLOOD DNA; EPIDEMIOLOGY; PREVALENCE; VARIANTS	Background Using HIV proviral DNA as a template may be suitable for initial detection of transmitted drug resistance mutations (TDRMs) as it is easy to handle and less expensive compared to RNA. However, existing literatures which are mainly focused on HIV-1B subtypes DNA extracted from PBMCs revealed controversial findings ranging from the detection of significantly lower or higher mutations in proviral DNA compared to historic viral RNA. Thus, to verify whether viral RNA or proviral DNA has improved sensitivity in detecting transmitted genotypic drug resistance mutations paired viral RNA and proviral DNA (which is directly extracted from stored whole blood) samples were tested from Ethiopian antiretroviral naive HIV-1C infected subjects. Methods In the present comparative study the frequency of TDR mutations was assessed in paired samples of viral RNA and proviral DNA (extracted directly from stored whole blood) of HIV1C infected treatment naive patients and interpreted using the 2009 WHO drug resistance surveillance mutation lists, Stanford University drug resistance data base and International Antiviral Society-USA mutation lists. Results High agreement in rate of TDR between the two compartments was observed using the WHO mutation lists. While mutations G190A and E138A were concurrently found in both compartments, others such as G735 on PR and A62V, M1841, M2301 on RT were identified in proviral DNA only. All signature mutations seen in viral RNA were not missed in proviral DNA. Conclusions The concordance of major genotype drug resistance mutation between RNA and proviral DNA in treatment naive patients suggests that proviral DNA might be an alternative approaches for an initial assessment of drug resistance prior to initiation of antiretroviral therapy using the WHO mutations lists in resource-limited countries. However, the clinical importance of TDRMs observed only in proviral DNA in terms of being a risk factor for virologic failure and whether they limit future treatment options needs additional investigation using more sensitive sequencing approaches such as Next Generation Sequencing (NGS).	[Huruy, Kahsay] Univ Gondar, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia; [Mulu, Andargachew] AHRI, Addis Ababa, Ethiopia; [Liebert, Uwe Gerd; Melanie, Maier] Univ Leipzig, Inst Virol, Leipzig, Germany	University of Gondar; Leipzig University	Mulu, A (corresponding author), AHRI, Addis Ababa, Ethiopia.	andargachewmulu@yahoo.com	Mulu, Andargachew/GMW-4823-2022	Mulu, Andargachew/0000-0003-2862-0175				Abdissa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-181; Abegaz WE, 2008, ANTIVIR THER, V13, P89; Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Bansode V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-52; Bon I, 2007, J CLIN VIROL, V38, P313, DOI 10.1016/j.jcv.2006.12.018; Casabianca A, 2007, MOL CELL PROBE, V21, P368, DOI 10.1016/j.mcp.2007.05.005; Chew CB, 2005, J CLIN VIROL, V33, P206, DOI 10.1016/j.jcv.2004.11.006; d'Ettorre G, 2010, NEW MICROBIOL, V33, P1; Demetriou VL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010976; Derache A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117430; Fourati S, 2012, AIDS, V26, P1619, DOI 10.1097/QAD.0b013e3283560703; Frentz D, 2012, AIDS REV, V14, P17; Geretti AM, 2014, J ANTIMICROB CHEMOTH, V69, P1090, DOI 10.1093/jac/dkt474; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Huruy K, 2015, J MED VIROL, V87, P978, DOI 10.1002/jmv.24110; Imaz A, 2011, AIDS REV, V13, P180; Kabamba-Mukadi B, 2010, HIV MED, V11, P483, DOI 10.1111/j.1468-1293.2009.00814.x; Kassu A, 2007, AIDS RES HUM RETROV, V23, P564, DOI 10.1089/aid.2006.0270; Leal-Klevezas DS, 2000, CLIN DIAGN LAB IMMUN, V7, P945, DOI 10.1128/CDLI.7.6.945-946.2000; Lee GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046181; Mulu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141318; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-158; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; Parisi SG, 2007, J CLIN MICROBIOL, V45, P1783, DOI 10.1128/JCM.00056-07; Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552; Saracino A, 2008, J MED VIROL, V80, P1695, DOI 10.1002/jmv.21261; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turriziani O, 2010, CLIN MICROBIOL INFEC, V16, P1518, DOI 10.1111/j.1469-0691.2010.03329.x; Turriziani O, 2007, JAIDS-J ACQ IMM DEF, V44, P518, DOI 10.1097/QAI.0b013e3180315515; Venturi G, 2002, ANTIVIR THER, V7, P245; Vicenti I, 2007, CLIN INFECT DIS, V44, P1657, DOI 10.1086/518287; Wainberg MA, 2011, VIRUSES, V1, P2493; Wang YM, 2007, CURR HIV RES, V5, P235; Wensing AM, 2017, TOP ANTIVIR MED, V24; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010	39	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205119	10.1371/journal.pone.0205119	http://dx.doi.org/10.1371/journal.pone.0205119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286160	gold, Green Submitted, Green Published			2022-12-27	WOS:000446383500088
J	Schnell, G; Krishnan, P; Tripathi, R; Beyer, J; Reisch, T; Irvin, M; Dekhtyar, T; Lu, LJ; Ng, TI; Xie, WG; Pilot-Matias, T; Collins, C				Schnell, Gretja; Krishnan, Preethi; Tripathi, Rakesh; Beyer, Jill; Reisch, Thomas; Irvin, Michelle; Dekhtyar, Tatyana; Lu, Liangjun; Ng, Teresa I.; Xie, Wangang; Pilot-Matias, Tami; Collins, Christine			Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir	PLOS ONE			English	Article							VIVO ANTIVIRAL ACTIVITY; HISTORICAL EPIDEMIOLOGY; 6 INFECTION; SELECT COUNTRIES; GLOBAL EPIDEMIOLOGY; RESISTANCE PROFILE; HCV GENOTYPES; FULL-LENGTH; IN-VITRO; SOFOSBUVIR	Hepatitis C virus (HCV) is genetically diverse and includes 7 genotypes and 67 confirmed subtypes, and the global distribution of each HCV genotype (GT) varies by geographic region. In this report, we utilized a large dataset of NS3/4A and NS5A sequences isolated from 2348 HCV GT1-6-infected patients treated with the regimen containing glecaprevir/pibrentasvir (GLE/PIB) to assess genetic diversity within HCV subtypes by geographic region using phylogenetic analyses, and evaluated the prevalence of baseline amino acid polymorphisms in NS3 and NS5A by region/country and phylogenetic cluster. Among 2348 NS3/4A and NS5A sequences, phylogenetic analysis identified 6 genotypes and 44 subtypes, including 3 GT1, 8 GT2, 3 GT3, 13 GT4, 1 GT5, and 16 GT6 subtypes. Phylogenetic analysis of HCV subtype la confirmed the presence of two clades, which differed by geographic region distribution and NS3 080K prevalence. We detected phylogenetic clustering by country in HCV subtypes 1a, 1 b, 2a, 2b, and 5a, suggesting that genetically distinct virus lineages are circulating in different countries. In addition, two clades were detected in HCV GT4a and GT6e, and NS5A amino acid polymorphisms were differentially distributed between the 2 clades in each subtype. The prevalence of NS3 and NS5A baseline polymorphisms varied substantially by genotype and subtype; therefore, we also determined the activity of GLE or PIB against replicons containing NS3/4A or NS5A from HCV GT1-6 clinical samples representing 6 genotypes and 21 subtypes overall. GLE and PIB retained activity against the majority of HCV replicons containing NS3/4A or NS5A from HCV GT1-6 clinical samples, with a median EC50 of 0.29 nM for GLE and 1.1 pM for PIB in a transient replicon assay. The data presented in this report expands the available data on HCV epidemiology, subtype diversity by geographic region, and NS3 and NS5A baseline polymorphism prevalence.	[Schnell, Gretja; Krishnan, Preethi; Tripathi, Rakesh; Beyer, Jill; Reisch, Thomas; Irvin, Michelle; Dekhtyar, Tatyana; Lu, Liangjun; Ng, Teresa I.; Xie, Wangang; Pilot-Matias, Tami; Collins, Christine] AbbVie Inc, Res & Dev, N Chicago, IL 60064 USA	AbbVie	Schnell, G (corresponding author), AbbVie Inc, Res & Dev, N Chicago, IL 60064 USA.	gretja.schnell@abbvie.com	Irvin, Michelle/AAR-9177-2020; Zhou, Linjie/E-7874-2013	Irvin, Michelle/0000-0001-5712-1100; Zhou, Linjie/0000-0002-2792-2959; Ng, Teresa/0000-0001-8333-2446	AbbVie, Inc.; AbbVie	AbbVie, Inc.(AbbVie); AbbVie(AbbVie)	The study was funded by AbbVie, Inc. All authors are employees of AbbVie and may hold AbbVie stock or stock options. The design, study conduct, and financial support for these studies were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	Abergel A, 2007, ALIMENT PHARM THER, V26, P1437, DOI 10.1111/j.1365-2036.2007.03530.x; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2017, MAV GLEC PIBR PRESCR; [Anonymous], 2017, MAV GLEC PIBR; Asselah T, 2018, J HEPATOL, V68, pS39, DOI 10.1016/S0168-8278(18)30294-0; Asselah T, 2018, J HEPATOL, V68, P814, DOI 10.1016/j.jhep.2017.11.037; Asselah T, 2018, CLIN GASTROENTEROL H, V16, P417, DOI 10.1016/j.cgh.2017.09.027; Asselah T, 2018, LIVER INT, V38, P7, DOI 10.1111/liv.13673; Babatin MA, 2018, J CLIN GASTROENTEROL, V52, P452, DOI 10.1097/MCG.0000000000000896; Bourliere M, 2017, NEW ENGL J MED, V376, P2134, DOI 10.1056/NEJMoa1613512; Brown A, 2018, J VIRAL HEPATITIS, V25, P457, DOI 10.1111/jvh.12801; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; De Luca A, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv043; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Flisiak R, 2011, EUR J GASTROEN HEPAT, V23, P1213, DOI 10.1097/MEG.0b013e32834d173c; Forns X, 2017, LANCET INFECT DIS, V17, P1062, DOI 10.1016/S1473-3099(17)30496-6; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gane E, 2017, NEW ENGL J MED, V377, P1448, DOI 10.1056/NEJMoa1704053; Gane E, 2016, GASTROENTEROLOGY, V151, P651, DOI 10.1053/j.gastro.2016.07.020; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Harrington PR, 2018, HEPATOLOGY, V67, P2430, DOI 10.1002/hep.29693; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Henquell C, 2011, INFECT GENET EVOL, V11, P496, DOI 10.1016/j.meegid.2010.12.015; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Krishnan P, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01249-18; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Kwo P, 2016, HEPATOLOGY, V64, P370, DOI 10.1002/hep.28467; Kwo PY, 2017, J HEPATOL, V67, P263, DOI 10.1016/j.jhep.2017.03.039; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Liakina V, 2015, J VIRAL HEPATITIS, V22, P4, DOI 10.1111/jvh.12475; Lim SG, 2017, LANCET GASTROENTEROL, V2, P52, DOI 10.1016/S2468-1253(16)30080-2; Maaroufi A, 2017, J VIRAL HEPATITIS, V24, P8, DOI 10.1111/jvh.12762; McCloskey RM, 2015, J INFECT DIS, V211, P1288, DOI 10.1093/infdis/jiu613; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Murphy DG, 2015, J CLIN MICROBIOL, V53, P967, DOI 10.1128/JCM.02831-14; Ng TI, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01620-17; Ng TI, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02558-16, 10.1128/aac.02558-16]; Panasiuk Anatol, 2013, Przegl Epidemiol, V67, P11; Pham VH, 2011, JPN J INFECT DIS, V64, P537; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rehman Irshad-Ur, 2011, Genet Vaccines Ther, V9, P2, DOI 10.1186/1479-0556-9-2; Rodrigo C, 2017, J VIRAL HEPATITIS, V24, P43, DOI 10.1111/jvh.12616; Rodrigo C, 2016, J INFECT DIS, V214, P1383, DOI 10.1093/infdis/jiw389; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Santos AF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31780; Saraswat V, 2015, J VIRAL HEPATITIS, V22, P6, DOI 10.1111/jvh.12350; Schnell G, 2018, J VIRAL HEPATITIS, V25, P1078, DOI 10.1111/jvh.12906; Schnell G, 2018, J MED VIROL, V90, P109, DOI 10.1002/jmv.24923; Schnell G, 2015, ANTIMICROB AGENTS CH, V59, P6807, DOI 10.1128/AAC.01229-15; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Tanaka Y, 2004, J MOL EVOL, V58, P191, DOI 10.1007/s00239-003-2541-3; Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176; Verbeeck J, 2006, J VIROL, V80, P4220, DOI 10.1128/JVI.80.9.4220-4226.2006; Verbeeck J, 2010, EUR J CLIN MICROBIOL, V29, P1427, DOI 10.1007/s10096-010-1021-0; Thong VD, 2014, WORLD J GASTROENTERO, V20, P2927, DOI 10.3748/wjg.v20.i11.2927; Welzel TM, 2017, J HEPATOL, V67, P224, DOI 10.1016/j.jhep.2017.03.014; WHO, 2017, WHO PUBLISHES LIST B; Wyles D, 2018, HEPATOLOGY, V67, P514, DOI 10.1002/hep.29541; Wyles DL, 2017, CURR HIV-AIDS REP, V14, P229, DOI 10.1007/s11904-017-0369-5; Zeuzem S, 2018, NEW ENGL J MED, V378, P354, DOI 10.1056/NEJMoa1702417; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	75	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205186	10.1371/journal.pone.0205186	http://dx.doi.org/10.1371/journal.pone.0205186			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286205	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500095
J	Su, TC; Chen, CY; Tsai, WC; Hsu, HT; Yen, HH; Sung, WW; Chen, CJ				Su, Tzu-Cheng; Chen, Chun-Yu; Tsai, Wen-Che; Hsu, Hui-Ting; Yen, Hsu-Heng; Sung, Wen-Wei; Chen, Chih-Jung			Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays	PLOS ONE			English	Article							ORIGINATED PROTEIN-KINASE; MITOTIC KINASE; PHOSPHATASE; METASTASIS; PHOSPHORYLATION	Objective PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) regulates components of the cell cycle, including cell growth, immune responses, DNA damage repair, apoptosis, and inflammation. PBK/TOPK may also accelerate tumorigenesis in colorectal cancer. Methods We investigated the impact of PBK/TOPK on the clinical outcome of colorectal cancer patients to further identify its role in colorectal cancer. PBK/TOPK immunoreactivity was analyzed by immunohistochemistry in 162 cancer specimens from primary colorectal cancer patients. Results The mean follow-up time after surgery was 5.4 years (medium: 3.9 years; range 0.01 to 13.1 years). The prognostic value of PBK/TOPK on overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. PBK/TOPK was expressed in both the cytoplasm and nucleus. High PBK/TOPK expression in tumor cells was significantly associated with advanced T value. The 5-year survival rate was greater for patients with high total PBK/TOPK expression than with low PBK/TOPK expression (58.3% vs 34.4%, P = 0.005). Multivariate analyses showed that low-scoring cytoplasmic PBK/TOPK, negative nuclear PBK/TOPK, low total PBK/TOPK, and advanced tumor stage were correlated with poor overall patient survival. Conclusions We suggest that PBK/TOPK expression, detected by IHC staining, could be used as an independent prognostic marker for colorectal cancer patients.	[Su, Tzu-Cheng; Hsu, Hui-Ting; Chen, Chih-Jung] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan; [Chen, Chun-Yu] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Tsai, Wen-Che] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Hsu, Hui-Ting; Yen, Hsu-Heng; Sung, Wen-Wei; Chen, Chih-Jung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsu, Hui-Ting; Sung, Wen-Wei] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yen, Hsu-Heng] Changhua Christian Hosp, Dept Gastroenterol, Changhua, Taiwan; [Sung, Wen-Wei] Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Chen, Chih-Jung] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan	Changhua Christian Hospital; National Taiwan University; National Taiwan University Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, CJ (corresponding author), Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan.; Sung, WW; Chen, CJ (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Sung, WW (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Sung, WW (corresponding author), Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan.; Chen, CJ (corresponding author), Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan.	flutewayne@gmail.com; 132540@cch.org.tw	Sung, Wen-Wei/P-5053-2019	Sung, Wen-Wei/0000-0002-2375-0029	 [102-CCH-IRP-064];  [104-CCH-IRP-088]	; 	This work was jointly supported by grants from 102-CCH-IRP-064 and 104-CCH-IRP-088 (Dr. CJ Chen. Changhua Christian Hospital, Changhua, Taiwan). URL: http://www2.cch.org.tw/cch_english/.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Abe Y, 2007, J MOL BIOL, V370, P231, DOI 10.1016/j.jmb.2007.04.067; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bradbury J, 2001, LANCET, V358, P1245, DOI 10.1016/S0140-6736(01)06385-1; Chen TC, 2009, J PROTEOME RES, V8, P4943, DOI 10.1021/pr900325f; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; He FR, 2010, HUM PATHOL, V41, P415, DOI 10.1016/j.humpath.2009.05.016; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hu F, 2010, ONCOGENE, V29, P5464, DOI 10.1038/onc.2010.275; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin KT, 2012, ONCOL LETT, V3, P11, DOI 10.3892/ol.2011.432; Kim DJ, 2012, CANCER RES, V72, P3060, DOI 10.1158/0008-5472.CAN-11-3851; Layer G, 2008, RADIOLOGE, V48, P26, DOI 10.1007/s00117-007-1584-7; Matsumoto S, 2004, BIOCHEM BIOPH RES CO, V325, P997, DOI 10.1016/j.bbrc.2004.10.133; Onodera H, 2015, EBIOMEDICINE, V2, P495, DOI 10.1016/j.ebiom.2015.05.019; Park JH, 2010, CANCER SCI, V101, P403, DOI 10.1111/j.1349-7006.2009.01400.x; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Sung WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-951; Sung WW, 2013, CLIN CANCER RES, V19, P4092, DOI 10.1158/1078-0432.CCR-12-3439; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Vlajnic T, 2011, MODERN PATHOL, V24, P1404, DOI 10.1038/modpathol.2011.96; Wang Z, 2015, BRIT J CANCER, V112, P572, DOI 10.1038/bjc.2014.598; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zlobec I, 2010, BRIT J CANCER, V102, P151, DOI 10.1038/sj.bjc.6605452; Zykova TA, 2006, CLIN CANCER RES, V12, P6884, DOI 10.1158/1078-0432.CCR-06-0410	29	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204866	10.1371/journal.pone.0204866	http://dx.doi.org/10.1371/journal.pone.0204866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286126	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500054
J	Temiye, EO; Adeniyi, OF; Fajolu, IB; Ogbenna, AA; Ladapo, TA; Esezobor, CI; Akinsulie, AO; Mabogunje, CA				Temiye, Edamisan Olusoji; Adeniyi, Oluwafunmilayo Funke; Fajolu, Iretiola Bamikeolu; Ogbenna, Ann Abiola; Ladapo, Taiwo Augustine; Esezobor, Christopher Imokhuede; Akinsulie, Adebola Olumide; Mabogunje, Cecilia Abimbola			Human immunodeficiency virus status in malnourished children seen at Lagos	PLOS ONE			English	Article							PEDIATRIC HIV-INFECTION; HEMATOLOGICAL ABNORMALITIES; MALNUTRITION; HEALTH; IMPACT	Introduction Human immunodeficiency virus and protein energy malnutrition are still prevalent in Nigeria and the occurrence of the two conditions together confers a poor prognosis. The aim of this study was to determine the current categories of malnutrition amongst under-5 children in Lagos, document their HIV status and determine any peculiarities in the clinical features, haematological and some biochemical profile in these children. Methods The study was a cross-sectional study conducted at the Paediatric departments of the Lagos University Teaching Hospital and the Massey Street Children's Hospital, both in Lagos, over a 6-month period. All the subjects had anthropometry, HIV testing, full blood count and serum proteins done. The factors associated with HIV status were determined with the logistic regression analysis. Results Two hundred and fourteen (214) malnourished children <= 5 years, including 25 (11.7%) with HIV were recruited in the study. Among the study participants, 150 (70.1%) and 54 (29.9%) had moderate and severe malnutrition, respectively. Fever, cough and diarrhea were the most common symptoms in the study participants. The haematological indices were comparable in the two groups, the serum globulin levels though higher in the HIV infected group was not statistically significantly different from the non-infected group.(p = 0.66). None of the factors explored on multivariate analysis was able to predict the occurrence of the infection in this cohort. Conclusion Malnourished children remain a high risk group for HIV infection and the prevalence of the infection obtained in this group of children is still unacceptably high. Discriminatory features between malnutrition and HIV remains difficult. The presence of hyperglobulinaemia on laboratory analysis in a malnourished child may heighten the suspicion of possible underlying associated HIV infection. Screening of malnourished children for HIV infection and further longitudinal studies on malnourished children with HIV is advocated	[Temiye, Edamisan Olusoji; Adeniyi, Oluwafunmilayo Funke; Fajolu, Iretiola Bamikeolu; Ladapo, Taiwo Augustine; Esezobor, Christopher Imokhuede; Akinsulie, Adebola Olumide] Univ Lagos, Lagos Univ Teaching Hosp, Coll Med, Dept Paediat, Lagos, Nigeria; [Ogbenna, Ann Abiola] Univ Lagos, Lagos Univ Teaching Hosp, Coll Med, Dept Haematol, Lagos, Nigeria; [Mabogunje, Cecilia Abimbola] Massey St Childrens Hosp, Lagos, Nigeria	University of Lagos; University of Lagos	Adeniyi, OF (corresponding author), Univ Lagos, Lagos Univ Teaching Hosp, Coll Med, Dept Paediat, Lagos, Nigeria.	layo_funke@yahoo.co.uk	Fajolu, Iretiola Bamikeolu/P-5759-2019; Ogbenna, Ann A/D-1656-2015; Adeniyi, Oluwafunmilayo/CAF-6583-2022; Adeniyi, Oluwafunmilayo/ABA-2009-2020; Esezobor, Christopher Imokhuede/AAP-2230-2020	Fajolu, Iretiola Bamikeolu/0000-0003-3045-9616; Adeniyi, Oluwafunmilayo/0000-0003-2564-6118; Esezobor, Christopher Imokhuede/0000-0003-1736-4794; Ladapo, Taiwo/0000-0002-9969-6233; Akinsulie, Adebola/0000-0003-2543-5871	Central Research Committee of University of Lagos, Lagos, Nigeria [CRC. 2015/09]; Central research Committee of the University of Lagos	Central Research Committee of University of Lagos, Lagos, Nigeria; Central research Committee of the University of Lagos	This study received some funding from the Central Research Committee of University of Lagos, Lagos, Nigeria; Grant number: CRC.NO. 2015/09.; We acknowledge the contribution of the Central research Committee of the University of Lagos for the support for the study. We are also grateful to Mr Niyi and the resident doctors in the department of Paediatrics Lagos University Teaching Hospital who assisted with the recruitment of the subjects and the collection of the data for the study.	Achadi E, 2016, GLOBAL NUTR REPORT 2; Adeleke SI, 2004, NIGERIAN J PHARM MED, V1, P23; Adetifa IMO, 2006, ANN TROP PAEDIATR, V26, P121, DOI 10.1179/146532806X107467; Bachou H, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-27; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bugaje M. A., 2006, Annals of African Medicine, V5, P73; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Emodi IJ, 1998, J TROP PEDIATRICS, V44, P73, DOI 10.1093/tropej/44.2.73; Ezeonwu BU, 2014, NIGER J CLIN PRACT, V17, P303, DOI 10.4103/1119-3077.130230; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; FISCHER GD, 1993, EPIDEMIOL INFECT, V110, P373, DOI 10.1017/S095026880006831X; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Kessler L, 2000, ANN TROP PAEDIATR, V20, P50, DOI 10.1080/02724930092075; LESBORDES JL, 1986, LANCET, V2, P337; Madec Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022787; Merchant R H, 2001, Indian Pediatr, V38, P239; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Ogubosi BO, 2011, ITAL J PEDIATR, V37, P29, DOI [10.1186/1824-7288-37-29, DOI 10.1186/1824-7288-37-29]; Okonko, 2013, J MICROBIOL RES, V3, P107; Senbanjo Idowu O, 2016, Niger Med J, V57, P307, DOI 10.4103/0300-1652.193854; Sudawa A, 2013, WORLD J AIDS, V3, P350; Ticklay IMH, 1997, E AFR MED J, V74, P217; Tindyebwa D, 2006, INTRO HDB PAEDIAT AI; United Nations Children's Fund World Health Organization The World Bank, 2012, UNICEFWHO WORLD BANK; van Gend CL, 2003, J TROP PEDIATRICS, V49, P143, DOI 10.1093/tropej/49.3.143; Yeung S, 2000, J TROP PEDIATRICS, V46, P107, DOI 10.1093/tropej/46.2.107	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0200435	10.1371/journal.pone.0200435	http://dx.doi.org/10.1371/journal.pone.0200435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286087	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500003
J	Goncalves, GMR; da Silva, EN				Reis Goncalves, Gabriela Maria; da Silva, Everton Nunes			Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System	PLOS ONE			English	Article							STAGE RENAL-DISEASE; UNITED-STATES; NATIONAL-HEALTH; MORTALITY; IMPACT; CARE; ASSOCIATION; PROGRESSION; POPULATION; DIALYSIS	Introduction Diabetes is the most common cause of chronic kidney disease, with a high economic impact on health systems. Objective To estimate the cost of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) attributable to diabetes, stratified by sex, race/skin color, and age, from the perspective of the Brazilian public health system between 2010 and 2016. Methods Population attributable risk (PAR) was calculated from the Brazilian prevalence of diabetes and the relative risk (or odds ratio) of persons with diabetes developing CKD and ESKD as compared to non-diabetic subjects. The variables of interest were sex, race/skin color, and age. A top-down approach was used to measure the direct costs of the disease reimbursed by the Brazilian Ministry of Health, using data from outpatient and inpatient records. Results The cost of CKD and ESKD attributable to diabetes in the period 2010-2016 was US$1.2 billion (US$180 million per year) and trending upward. Female sex, age 65-75, and black race/skin color contributed substantially to the costs of CKD and ESKD (US$475 million, US $63 million, and US$25 million respectively). The clinical procedures accounting for the greatest share of disease-attributable costs are hemodialysis and peritoneal dialysis. Conclusion Diabetes accounted for 22% of the costs of CKD and ESKD. Female sex, age 65-75 years, and black race/skin color were the variables which contributed most to disease-related expenditure. The economic burden of CKD may increase gradually in the coming years, with serious implications for the financial sustainability of the Brazilian public health system.	[Reis Goncalves, Gabriela Maria; da Silva, Everton Nunes] Univ Brasilia, Brasilia, DF, Brazil; [da Silva, Everton Nunes] CNPq, Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil	Universidade de Brasilia	Goncalves, GMR (corresponding author), Univ Brasilia, Brasilia, DF, Brazil.	gabimaria.nut@gmail.com		Reis Goncalves, Gabriela Maria/0000-0003-0544-3831; Silva, Everton/0000-0001-8747-4185				Atkins Robert C., 2010, Arch. Cardiol. Méx., V80, P44; Barreto SM, 2016, J EPIDEMIOL COMMUN H, V70, P380, DOI 10.1136/jech-2015-205834; Barros MBDA, 2017, REV SAUDE PUBL, V51; Brasil Ipea I de PEA, 2011, RETR DES GEN RAC, P39; Carrero JJ, 2011, NEPHROL DIAL TRANSPL, V26, P270, DOI 10.1093/ndt/gfq386; Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181; Cherchiglia ML, 2010, CAD SAUDE PUBLICA, V26, P1627, DOI 10.1590/S0102-311X2010000800016; Collins AJ, 2015, KIDNEY INT SUPPL, V5, P2, DOI 10.1038/kisup.2015.2; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; da BRASILM S, 2011, PLANO ACOES ESTRATEG; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; De Cosmo S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004007; de Moura L, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-111; de Oliveira ML, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0112217, 10.1371/journal.pone.0121160]; de Oliveira ML, 2014, REV NUTR, V27, DOI 10.1590/1415-52732014000500007; Ene-Iordache B, 2016, LANCET GLOB HEALTH, V4, pE307, DOI 10.1016/S2214-109X(16)00071-1; Goes F, 2011, MULHERES NEGRAS BRAN, P571; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hemmelgarn BR, 2012, JAMA-J AM MED ASSOC, V307, P2507, DOI 10.1001/jama.2012.6455; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2014, PESQ NAC SAUD; *INT ORG MIGR, 2017, WORLD MIGR REP 2018, P1, DOI DOI 10.1093/ESR/JCN046; Jha V, 2016, KIDNEY INT, V90, P1164, DOI 10.1016/j.kint.2016.09.009; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Lewis EF, 2015, AM HEART J, V170, P322, DOI 10.1016/j.ahj.2015.05.008; Lipworth L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048407; Lorenzo V, 2010, NEPHROL DIAL TRANSPL, V25, P2283, DOI 10.1093/ndt/gfp761; Marinho Ana Wanda Guerra Barreto, 2017, Cad. saúde colet., V25, P379, DOI 10.1590/1414-462x201700030134; Martins D, 2006, AM J KIDNEY DIS, V47, P965, DOI 10.1053/j.ajkd.2006.02.179; Morton RL, 2016, NEPHROL DIAL TRANSPL, V31, P46, DOI 10.1093/ndt/gfu394; Moura L, 2013, REV BRAS EPIDEMIO S2, V18, P181; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; Narres M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147329; Ng BL, 2011, INTERN MED J, V41, P761, DOI 10.1111/j.1445-5994.2011.02590.x; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pinheiro Rejane Sobrino, 2002, Ciênc. saúde coletiva, V7, P687; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Scialla JJ, 2012, KIDNEY INT, V82, P106, DOI 10.1038/ki.2012.82; Sesso Ricardo Cintra, 2017, Braz. J. Nephrol., V39, P261, DOI 10.5935/0101-2800.20170049; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Shen YJ, 2017, ENDOCRINE, V55, P75, DOI 10.1007/s12020-016-1014-6; Silva Junior Geraldo Bezerra da, 2017, Braz. J. Nephrol., V39, P65, DOI 10.5935/0101-2800.20170011; Tsai WC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003013; van den Beukel TO, 2013, CLIN J AM SOC NEPHRO, V8, P1540, DOI 10.2215/CJN.10761012; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Xavier DB, 2017, OBES SURG, V27, P641, DOI 10.1007/s11695-016-2327-5; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524; Yu MK, 2015, NEPHROLOGY, V20, P451, DOI 10.1111/nep.12468; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	54	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203992	10.1371/journal.pone.0203992	http://dx.doi.org/10.1371/journal.pone.0203992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273345	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700011
J	Huertas-Delgado, FJ; Mertens, L; Chillon, P; Van Dyck, D				Javier Huertas-Delgado, Francisco; Mertens, Lieze; Chillon, Palma; Van Dyck, Delfien			Parents' and adolescents' perception of traffic- and crime-related safety as correlates of independent mobility among Belgian adolescents	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; NEIGHBORHOOD ENVIRONMENT; ACTIVE-TRANSPORT; SCHOOL; CHILDREN; WALKING; HEALTH; YOUTH; PLAY; FEAR	The independent mobility (IM), defined as the freedom of young people to travel without adult supervision, has been related to the physical activity time, the acquisition of personal autonomy, to less intense fear of crime, and to a stronger feeling of being part of their community and other health and social benefits. The aims of this study were to compare parents' and adolescents' traffic- and crime-related safety perceptions of their neighborhood and to analyze the associations of these perceptions with adolescents' IM. A total of 291 adolescents and their parents completed the Neighborhood Environment Walkability Scale (NEWS) questionnaire. Multilevel (two-level models: individual level-neighborhood level) regression analyses were conducted to examine whether the environmental perceptions differed between parents and adolescents and the association between the parental and adolescents' perception to the IM and the active independent mobility (AIM). Parents reported a more negative perception of traffic (except for amount and speed) and crime-related safety. Adolescents' environmental perceptions were not associated with their IM but parental perceptions of traffic- and crime-related safety were associated with IM and with active IM, although not all associations were in the expected direction. Future urban policy efforts should address environments where parents perceive sufficient levels of safety to increase the levels of IM in adolescents.	[Javier Huertas-Delgado, Francisco] Univ Granada, Teaching Ctr La Inmaculada, PA Help Phys Act Hlth Promot Res Grp, Granada, Spain; [Mertens, Lieze; Van Dyck, Delfien] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci, Ghent, Belgium; [Mertens, Lieze; Van Dyck, Delfien] Res Fdn Flanders, Brussels, Belgium; [Chillon, Palma] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, PROFITH Promoting FITness & Hlth Phys Act Res Grp, Granada, Spain	University of Granada; Ghent University; University of Granada	Huertas-Delgado, FJ (corresponding author), Univ Granada, Teaching Ctr La Inmaculada, PA Help Phys Act Hlth Promot Res Grp, Granada, Spain.	fjhuertas@ugr.es	Huertas-Delgado, Francisco Javier/AAT-7550-2020; Van Dyck, Delfien/AAO-8981-2020; Chillon, Palma/E-5634-2014; Huertas-Delgado, Francisco Javier/G-7664-2015; Mertens, Lieze/AAG-3340-2020	Huertas-Delgado, Francisco Javier/0000-0001-9957-4802; Chillon, Palma/0000-0003-0862-8989; Huertas-Delgado, Francisco Javier/0000-0001-9957-4802; 	Spanish Ministry of Education, Culture and Sport [CAST17/00072]; Research Foundation Flanders (FWO) [FWO12/PDO/158]; University of Granada, Plan Propio de Investigacion 2016, Excellence actions: Excellence Units, Scientific Excellence Unit on Exercise and Health (UCEES)	Spanish Ministry of Education, Culture and Sport; Research Foundation Flanders (FWO)(FWO); University of Granada, Plan Propio de Investigacion 2016, Excellence actions: Excellence Units, Scientific Excellence Unit on Exercise and Health (UCEES)	This study was supported by a grant from the Spanish Ministry of Education, Culture and Sport [CAST17/00072] and by a grant from the Research Foundation Flanders (FWO) [FWO12/PDO/158]. Additional support was obtained from the University of Granada, Plan Propio de Investigacion 2016, Excellence actions: Excellence Units, Scientific Excellence Unit on Exercise and Health (UCEES).	Ahern S., 2015, 11 ANN SCI M BIOL BE; Armstrong N, 2012, J SPORT HEALTH SCI, V1, P131, DOI 10.1016/j.jshs.2012.05.003; Bates B, 2015, J SCI MED SPORT, V18, P545, DOI 10.1016/j.jsams.2014.07.006; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Carver A, 2005, AM J HEALTH PROMOT, V20, P139, DOI 10.4278/0890-1171-20.2.139; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Carver A, 2014, J TRANSP HEALTH, V1, P25, DOI 10.1016/j.jth.2013.12.003; Carver A, 2014, J TRANSP HEALTH, V1, P267, DOI 10.1016/j.jth.2014.01.004; Carver A, 2012, J SCI MED SPORT, V15, P505, DOI 10.1016/j.jsams.2012.03.005; Carver A, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-126; Chillon P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-61; Chillon P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-10; D'Haese S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0104-1; De Meester F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-631; Defoe IN, 2015, PSYCHOL BULL, V141, P48, DOI 10.1037/a0038088; European Commision Staff, 2017, COMMUNICATION; Forman H, 2008, PREV MED, V46, P311, DOI 10.1016/j.ypmed.2007.12.006; Foster S, 2014, HEALTH PLACE, V26, P60, DOI 10.1016/j.healthplace.2013.11.006; Foster S, 2010, HEALTH PLACE, V16, P1156, DOI 10.1016/j.healthplace.2010.07.007; Fyhri A, 2011, TRANSPORT POLICY, V18, P703, DOI 10.1016/j.tranpol.2011.01.005; Garcia-Cervantes L, 2016, J PHYS ACT HEALTH, V13, P747, DOI 10.1123/jpah.2015-0415; Ghekiere A, 2017, J SCI MED SPORT, V20, P267, DOI 10.1016/j.jsams.2016.08.002; Ghekiere A, 2016, J SCI MED SPORT, V19, P149, DOI 10.1016/j.jsams.2015.01.003; Giles-Corti B, 2009, SPORTS MED, V39, P995, DOI 10.2165/11319620-000000000-00000; Hillman M., 1990, ONE FALSE MOVE STUDY; Hsieh PL, 2014, INT J ENV RES PUB HE, V11, P7275, DOI 10.3390/ijerph110707275; Janssen I, 2014, PREV MED, V66, P113, DOI 10.1016/j.ypmed.2014.06.016; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Huertas-Delgado FJ, 2017, EUR J PUBLIC HEALTH, V27, P416, DOI 10.1093/eurpub/ckw249; Kall LB, 2015, J SCHOOL HEALTH, V85, P704, DOI 10.1111/josh.12303; Larouche R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5005-1; Larouche R, 2013, CAN J PUBLIC HEALTH, V104, pE487, DOI 10.17269/cjph.104.4122; Lubans DR, 2011, RELATIONSHIP ACTIVE; Mackett R., 2005, BUILT ENV, V33, P454; Mammen G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-862; Mandic S, 2015, J SCI MED SPORT, V18, P432, DOI 10.1016/j.jsams.2014.06.012; Oluyomi AO, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-32; Pang B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4648-2; Panter JR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-34; Prezza M, 2007, J COMMUNITY PSYCHOL, V35, P151, DOI 10.1002/jcop.20140; PUTNAM RD, 1995, J DEMOCRACY, V0006; Rosenberg D, 2009, PREV MED, V49, P213, DOI 10.1016/j.ypmed.2009.07.011; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schoeppe S, 2015, BMC PUBLIC HEALTH, P1; Schoeppe S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-91; Seabrook JA, 2012, CAN REV SOCIOL, V49, P50, DOI 10.1111/j.1755-618X.2011.01280.x; Shaw B., 2013, CHILDRENS INDEPENDEN; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Stone MR, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-5; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Tudor-Locke C, 2001, SPORTS MED, V31, P309, DOI 10.2165/00007256-200131050-00001; UNICEF, 2001, DEATHS INJ RICH NAT; Valentine G., 1997, GENDER PLACE CULT, V4, P37, DOI DOI 10.1080/09663699725495; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; Villa-Gonzalez E, 2018, PREV MED, V111, P115, DOI 10.1016/j.ypmed.2018.02.010; Villa-Gonzalez E, 2016, EUR J PUBLIC HEALTH, V26, P272, DOI 10.1093/eurpub/ckv208; Whitzman C., 2009, VERTICAL LIVING KIDS; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Witten K, 2013, CHILD GEOGR, V11, P215, DOI 10.1080/14733285.2013.779839; Wolfe MK, 2016, J PHYS ACT HEALTH, V13, P970, DOI 10.1123/jpah.2015-0662	62	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204454	10.1371/journal.pone.0204454	http://dx.doi.org/10.1371/journal.pone.0204454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265694	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500034
J	Kenagy, RD; Kikuchi, S; Evanko, SP; Ruiter, MS; Piola, M; Longchamp, A; Pesce, M; Soncini, M; Deglise, S; Fiore, GB; Haefliger, JA; Schmidt, TA; Majesky, MW; Sobel, M; Wight, TN				Kenagy, Richard D.; Kikuchi, Shinsuke; Evanko, Steve P.; Ruiter, Matthijs S.; Piola, Marco; Longchamp, Alban; Pesce, Maurizio; Soncini, Monica; Deglise, Sebastien; Fiore, Gianfranco B.; Haefliger, Jacques-Antoine; Schmidt, Tannin A.; Majesky, Mark W.; Sobel, Michael; Wight, Thomas N.			Versican is differentially regulated in the adventitial and medial layers of human vein grafts	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN SAPHENOUS-VEIN; INTERNAL MAMMARY ARTERY; INTIMAL HYPERPLASIA; GROWTH-FACTOR; BYPASS GRAFT; IN-VITRO; OXIDATIVE STRESS; PROGENITOR CELLS; HYALURONAN	Changes in extracellular matrix proteins may contribute significantly to the adaptation of vein grafts to the arterial circulation. We examined the production and distribution of versican and hyaluronan in intact human vein rings cultured ex vivo, veins perfused ex vivo, and cultured venous adventitial and smooth muscle cells. Immunohistochemistry revealed higher levels of versican in the intima/media compared to the adventitia, and no differences in hyaluronan. In the vasa vasorum, versican and hyaluronan associated with CD34(+) pro-genitor cells. Culturing the vein rings for 14 days revealed increased versican immunostaining of 30-40% in all layers, with no changes in hyaluronan. Changes in versican accumulation appear to result from increased synthesis in the intima/media and decreased degradation in the adventitia as versican transcripts were increased in the intima/media, but unchanged in the adventitia, and versikine (the ADAMTS-mediated cleavage product of versican) was increased in the intima/media, but decreased in the adventitia. In perfused human veins, versican was specifically increased in the intima/media in the presence of venous pressure, but not with arterial pressure. Unexpectedly, cultured adventitial cells express and accumulate more versican and hyaluronan than smooth muscle cells. These data demonstrate a differential regulation of versican and hyaluronan in human venous adventitia vs. intima/media and suggest distinct functions for these extracellular matrix macromolecules in these venous wall compartments during the adaptive response of vein grafts to the arterial circulation.	[Kenagy, Richard D.] Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA; [Kenagy, Richard D.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Kikuchi, Shinsuke] Asahikawa Med Univ, Dept Vasc Surg, Asahikawa, Hokkaido, Japan; [Evanko, Steve P.; Wight, Thomas N.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA USA; [Ruiter, Matthijs S.; Pesce, Maurizio] IRCCS, Ctr Cardiol Monzino, Cardiovasc Tissue Engn Unit, Via Parea 4, Milan 4, Italy; [Piola, Marco; Soncini, Monica; Fiore, Gianfranco B.] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Longchamp, Alban; Deglise, Sebastien; Haefliger, Jacques-Antoine] Lausanne Univ Hosp, CHUV, Dept Vasc Surg, Lausanne, Switzerland; [Schmidt, Tannin A.] Univ Connecticut, Hlth Ctr, Sch Dent Med, Biomed Engn Dept, Farmington, CT USA; [Majesky, Mark W.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA USA; [Sobel, Michael] Univ Washington, VA Puget Sound Hlth Care Syst, Div Vasc Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Asahikawa Medical College; Benaroya Research Institute; Polytechnic University of Milan; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Connecticut; Seattle Children's Hospital; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Kenagy, RD (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA.; Kenagy, RD (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	rkenagy@u.washington.edu	Pesce, Maurizio/AAA-4207-2019; Schmidt, Tannin/AAE-3830-2019; Pesce, Maurizio/B-4260-2010; Soncini, Monica/E-9609-2018; Ruiter, Matthijs/H-4287-2017	Pesce, Maurizio/0000-0002-3097-8961; Pesce, Maurizio/0000-0002-3097-8961; Soncini, Monica/0000-0001-8607-7196; Kikuchi, Shinsuke/0000-0002-5314-1603; Deglise, Sebastien/0000-0001-8244-952X; Kenagy, Richard/0000-0002-2021-5565; Ruiter, Matthijs/0000-0002-4834-4561	National Institutes of Health [R01 HL30946, RO01 EB012558, R43 HL10687]; American Heart Association; SNF [3100A_175452/1]; Muschamp Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); SNF; Muschamp Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants R01 HL30946 (RDK, MS) and RO01 EB012558 and R43 HL10687 (TNW); an American Heart Association Grant-in-Aid (RDK); the SNF 3100A_175452/1 (JAH); and the Muschamp Foundation (SD).	Ackers-Johnson M, 2015, ARTERIOSCL THROM VAS, V35, P817, DOI 10.1161/ATVBAHA.114.305218; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Castronuovo JJ, 2002, J VASC SURG, V35, P152, DOI 10.1067/mva.2002.119231; Chang YT, 2016, PULM CIRC, V6, P347, DOI 10.1086/686994; Chen YK, 2013, ARTERIOSCL THROM VAS, V33, P1844, DOI 10.1161/ATVBAHA.113.300902; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; de Vries MR, 2016, NAT REV CARDIOL, V13, P451, DOI 10.1038/nrcardio.2016.76; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Fogelstrand P, 2005, CARDIOVASC RES, V67, P326, DOI 10.1016/j.cardiores.2005.03.027; Frischknecht K, 2006, J VASC RES, V43, P338, DOI 10.1159/000093606; Gentile AT, 1999, CARDIOVASC SURG, V7, P464, DOI 10.1016/S0967-2109(98)00093-3; George SJ, 1996, ATHEROSCLEROSIS, V120, P227, DOI 10.1016/0021-9150(95)05717-X; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; Grandoch M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0340-6; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Harskamp RE, 2014, JAMA SURG, V149, P798, DOI 10.1001/jamasurg.2014.87; Heydarkhan-Hagvall S, 2006, TISSUE ENG, V12, P831, DOI 10.1089/ten.2006.12.831; Hofstra L, 1996, CIRCULATION, V94, P1283, DOI 10.1161/01.CIR.94.6.1283; Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8; Jiang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH1200, DOI 10.1152/ajpheart.00268.2009; Johansson B, 1999, HISTOCHEM J, V31, P723, DOI 10.1023/A:1003948515114; Kaplan-Albuquerque N, 2005, J BIOL CHEM, V280, P19966, DOI 10.1074/jbc.M500917200; Kenagy RD, 2002, ARTERIOSCL THROM VAS, V22, P400, DOI 10.1161/hq0302.105376; Kenagy RD, 2006, TRENDS CARDIOVAS MED, V16, P209, DOI 10.1016/j.tcm.2006.03.011; Kenagy RD, 2018, J VASC SURG, V67, P309, DOI 10.1016/j.jvs.2016.12.113; Kenagy RD, 2009, J VASC SURG, V49, P1282, DOI 10.1016/j.jvs.2008.12.020; Kiene LS, 2016, ARTERIOSCL THROM VAS, V36, pE9, DOI 10.1161/ATVBAHA.115.306607; Kikuchi S, 2018, J VASC SURG, V67, P1556, DOI 10.1016/j.jvs.2017.03.447; Kikuchi S, 2016, J VASC SURG, V63, P1044, DOI 10.1016/j.jvs.2014.10.017; Loesch A, 2009, CURR VASC PHARMACOL, V7, P58, DOI 10.2174/157016109787354150; Longchamp A, 2014, BIOMATERIALS, V35, P2588, DOI 10.1016/j.biomaterials.2013.12.041; Longpre JM, 2008, INT J BIOCHEM CELL B, P12480; Majesky MW, 2017, CIRC RES, V120, P296, DOI 10.1161/CIRCRESAHA.116.309322; Merrilees MJ, 2001, CORONARY ARTERY DIS, V12, P7, DOI 10.1097/00019501-200102000-00002; Mitra AK, 2006, IMMUNOL CELL BIOL, V84, P115, DOI 10.1111/j.1440-1711.2005.01407.x; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Nishimoto M, 2001, J THORAC CARDIOV SUR, V121, P729, DOI 10.1067/mtc.2001.112467; Osgood MJ, 2014, J VASC SURG, V60, P202, DOI 10.1016/j.jvs.2013.06.004; Owens CD, 2015, J VASC SURG, V61, P203, DOI 10.1016/j.jvs.2013.08.019; Passi A, 1999, FEBS LETT, V456, P93, DOI 10.1016/S0014-5793(99)00929-1; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; PERIDES G, 1995, BIOCHEM J, V312, P377, DOI 10.1042/bj3120377; Piola M, 2017, ANN BIOMED ENG, V45, P884, DOI 10.1007/s10439-016-1747-7; Piola M, 2016, ANN BIOMED ENG, V44, P1449, DOI 10.1007/s10439-015-1434-0; Piola M, 2016, J TISSUE ENG REGEN M, V10, pE204, DOI 10.1002/term.1798; Prandi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117409; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schmidt R, 1996, J HISTOTECHNOL, V19, P325; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Shi Y, 2001, CIRCULATION, V103, P2408; Shi Y, 1997, CIRCULATION, V95, P2684, DOI 10.1161/01.CIR.95.12.2684; Siiskonen H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00043; Sobel M, 2018, J VASC SURG, V68, p165S, DOI 10.1016/j.jvs.2018.03.436; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; THIENE G, 1980, THORAX, V35, P519, DOI 10.1136/thx.35.7.519; Tomas JJ, 2003, J VASC RES, V40, P266, DOI 10.1159/000071890; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; van den Boom M, 2006, CIRC RES, V98, P36, DOI 10.1161/01.RES.0000199263.67107.c0; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; WALLER BF, 1985, AM J CARDIOL, V55, P65, DOI 10.1016/0002-9149(85)90301-7; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Weiss S, 2007, J VASC RES, V44, P149, DOI 10.1159/000099141; Wight TN, 2017, MATRIX BIOL, V60-61, P38, DOI 10.1016/j.matbio.2016.12.001; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Yang ZH, 1998, CIRCULATION, V97, P181, DOI 10.1161/01.CIR.97.2.181	71	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204045	10.1371/journal.pone.0204045	http://dx.doi.org/10.1371/journal.pone.0204045			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265729	Green Submitted, gold, Green Published			2022-12-27	WOS:000446005500017
J	Sunday, MA; McGugin, RW; Tamber-Rosenau, BJ; Gauthier, I				Sunday, Mackenzie A.; McGugin, Rankin W.; Tamber-Rosenau, Benjamin J.; Gauthier, Isabel			Visual imagery of faces and cars in face-selective visual areas	PLOS ONE			English	Article							MENTAL-IMAGERY; EXPERTISE; CORTEX; VIVIDNESS; MEMORY; REPRESENTATIONS; RECOGNITION; ADAPTATION; PERCEPTION; INDIVIDUALS	Neuroimaging provides a unique tool to investigate otherwise difficult-to-access mental processes like visual imagery. Prior studies support the idea that visual imagery is a top-down reinstatement of visual perception, and it is likely that this extends to object processing. Here we use functional MRI and multi-voxel pattern analysis to ask if mental imagery of cars engages the fusiform face area, similar to what is found during perception. We test only individuals who we assumed could imagine individual car models based on their above-average perceptual abilities with cars. Our results provide evidence that cars are represented differently from common objects in face-selective visual areas, at least in those with above-average car recognition ability. Moreover, pattern classifiers trained on data acquired during imagery can decode the neural response pattern acquired during perception, suggesting that the tested object categories are represented similarly during perception and visual imagery. The results suggest that, even at high-levels of visual processing, visual imagery mirrors perception to some extent, and that face-selective areas may in part support non-face object imagery.	[Sunday, Mackenzie A.; McGugin, Rankin W.; Tamber-Rosenau, Benjamin J.; Gauthier, Isabel] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Tamber-Rosenau, Benjamin J.] Univ Houston, Houston, TX USA	Vanderbilt University; University of Houston System; University of Houston	Sunday, MA (corresponding author), Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.	mackenzie.a.sunday@vanderbilt.edu	Tamber-Rosenau, Benjamin/AAJ-2835-2021	Tamber-Rosenau, Benjamin/0000-0001-5532-1352; Sunday, Mackenzie/0000-0002-6694-0244	Temporal Dynamics of Learning Center (National Science Foundation) [SBE-0542013]; CTSA from the National Center for Advancing Translational Sciences [UL1TR000445]; National Science Foundation [1445197]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER	Temporal Dynamics of Learning Center (National Science Foundation); CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Temporal Dynamics of Learning Center (National Science Foundation Grant SBE-0542013) and was supported by CTSA award No. UL1TR000445 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. (1445197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AM, 2013, CURR BIOL, V23, P1427, DOI 10.1016/j.cub.2013.05.065; Bergmann J, 2016, CEREB CORTEX, V26, P3838, DOI 10.1093/cercor/bhv186; C CC L CJ, 2011, ACM T INTELL SYST TE, V2; Campos A, 2011, PERCEPT MOTOR SKILL, V113, P454, DOI 10.2466/04.22.PMS.113.5.454-460; Cichy RM, 2012, CEREB CORTEX, V22, P372, DOI 10.1093/cercor/bhr106; Cui X, 2007, VISION RES, V47, P474, DOI 10.1016/j.visres.2006.11.013; D'Ascenzo S, 2014, VISION RES, V96, P45, DOI 10.1016/j.visres.2014.01.002; Dijkstra N, 2017, J NEUROSCI, V37, P1367, DOI 10.1523/JNEUROSCI.3022-16.2016; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Emmerling TC, 2016, NEUROIMAGE, V125, P61, DOI 10.1016/j.neuroimage.2015.10.022; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Golarai G, 2017, CEREB CORTEX, V27, P1229, DOI 10.1093/cercor/bhv314; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Horikawa T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15037; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Johnston MV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00118; Kaas A, 2010, NEUROIMAGE, V49, P794, DOI 10.1016/j.neuroimage.2009.07.055; Klein I, 2000, J COGN NEUROSCI, V12; Kleinhans NM, 2016, J AUTISM DEV DISORD, V46, P232, DOI 10.1007/s10803-015-2565-8; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lee SH, 2012, NEUROIMAGE, V59, P4064, DOI 10.1016/j.neuroimage.2011.10.055; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; McGugin RW, 2018, CEREB CORTEX, V28, P2071, DOI 10.1093/cercor/bhx113; McGugin RW, 2016, BRAIN IMAGING BEHAV, V10, P707, DOI 10.1007/s11682-015-9467-4; McGugin RW, 2012, VISION RES, V69, P10, DOI 10.1016/j.visres.2012.07.014; McGugin RW, 2014, NEUROPSYCHOLOGIA, V63, P135, DOI 10.1016/j.neuropsychologia.2014.08.029; McGugin RW, 2015, CEREB CORTEX, V25, P2610, DOI 10.1093/cercor/bhu060; McGugin RW, 2012, P NATL ACAD SCI USA, V109, P17063, DOI 10.1073/pnas.1116333109; McKelvie SJ, 1995, J MENT IMAG, V19; Mitchell DJ, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Naselaris T, 2015, NEUROIMAGE, V105, P215, DOI 10.1016/j.neuroimage.2014.10.018; Natu VS, 2016, J NEUROSCI, V36, P10893, DOI 10.1523/JNEUROSCI.1886-16.2016; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Pearson J, 2008, CURR BIOL, V18, P982, DOI 10.1016/j.cub.2008.05.048; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Reddy L, 2010, NEUROIMAGE, V50, P818, DOI 10.1016/j.neuroimage.2009.11.084; Richler JJ, 2017, COGNITION, V166, P42, DOI 10.1016/j.cognition.2017.05.019; Rodway P., 2006, J INDIVID DIFFER, V27, P218, DOI [DOI 10.1027/1614-0001.27.4.218, 10.1027/1614-0001.27.4.218]; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; Slotnick SD, 2012, COGN NEUROSCI-UK, V3, P14, DOI 10.1080/17588928.2011.578210; Stokes M, 2009, J NEUROSCI, V29, P1565, DOI 10.1523/JNEUROSCI.4657-08.2009; Sunday MA, 2017, ATTENTION PERCEPTION, V79; Sunday M, 2017, BEHAV RES METHODS, V49, P733, DOI 10.3758/s13428-016-0730-4; Sunday MA, 2018, J VISION, V18, DOI 10.1167/18.1.2; Talairach J., 1988, COPLANAR STEREOTAXIC; Tartaglia EM, 2009, CURR BIOL, V19, P2081, DOI 10.1016/j.cub.2009.10.060; Van Gulick AE, 2016, BEHAV RES METHODS, V48, P1178, DOI 10.3758/s13428-015-0637-5; Vetter P, 2014, CURR BIOL, V24, P1256, DOI 10.1016/j.cub.2014.04.020; Wei F, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00334, 10.3389/fmicb.2016.00502]; Weiner KS, 2010, J NEUROPHYSIOL, V103, P3349, DOI 10.1152/jn.01108.2009; Williams LE, 2013, SCHIZOPHR RES, V151, P124, DOI 10.1016/j.schres.2013.10.017; Xu YD, 2005, CEREB CORTEX, V15, P1234, DOI 10.1093/cercor/bhi006	60	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0205041	10.1371/journal.pone.0205041	http://dx.doi.org/10.1371/journal.pone.0205041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265719	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500064
J	Kim, YH; Her, AY; Jeong, MH; Kim, BK; Hong, SJ; Shin, DH; Kim, JS; Ko, YG; Choi, D; Hong, MK; Jang, Y				Kim, Yong Hoon; Her, Ae-Young; Jeong, Myung Ho; Kim, Byeong-Keuk; Hong, Sung-Jin; Shin, Dong-Ho; Kim, Jung-Sun; Ko, Young-Guk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yangsoo			Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR	PLOS ONE			English	Article							DRUG-ELUTING STENTS; CIGARETTE-SMOKING; VASCULAR-RESPONSE; RISK; THROMBOSIS; IMPLANTATION; CESSATION; NICOTINE; DISEASE; LEADERS	Objective Data concerning the effect of current smoking on solely new-generation drug-eluting stents (DES) are limited. We investigated the impact of current smoking on 2-year clinical outcomes between durable-polymer (DP)-coated DES (zotarolimus-eluting [ZES] and everolimus eluting [EES]) and biodegradable-polymer (BP)-coated biolimus-eluting stent (BES) in acute myocardial infarction (AMI) patients after successful percutaneous coronary intervention (PCI). Methods Finally, a total of 8357 AMI patients with current smoking underwent successful PCI with new-generation DES (ZES, EES, and BES) were enrolled and divided into three groups as ZES (n = 3199), EES (n = 3987), and BES group (n = 1171). The primary endpoint was the occurrence of major adverse cardiac events (MACE) defined as all-cause death (cardiac death [CD] or non-cardiac death), recurrent AMI (re-MI), any revascularization (target lesion revascularization [TLR], target vessel revascularization [TVR], and non-TVR). The secondary endpoint was the incidence of definite or probable stent thrombosis (ST). Results The 2-year adjusted hazard ratio (HR) of MACE for ZES vs. EES (1.055; 95% confidence interval [CI], 0.843 +/- 1.321; p = 0.638), ZES vs. BES (HR, 0.885; 95% CI, 0.626 +/- 1.251; p = 0.488), EES vs. BES ( HR, 0.889; 95% CI, 0.633 +/- 1.250; p = 0.499), and ZES/EES vs. BES ( HR, 0.891; 95% CI, 0.648 +/- 1.126; p = 0.480) were similar. The occurrence of ST after adjustment were also comparable. In addition, the 2-year adjusted HR for all-cause death, CD, re-MI, TLR, TVR, and non-TVR were not different. Conclusions In this study, DP-DES and BP-DES showed comparable safety and efficacy during 2-year follow-up periods. Therefore, DP-DES or BP-DES are equally acceptable in AMI patients with current smoking undergoing PCI.	[Kim, Yong Hoon; Her, Ae-Young] Kangwon Natl Univ, Dept Internal Med, Div Cardiol, Sch Med, Chunchon, South Korea; [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Cardiovasc Ctr, Dept Cardiol, Gwangju, South Korea; [Kim, Byeong-Keuk; Hong, Sung-Jin; Shin, Dong-Ho; Kim, Jung-Sun; Ko, Young-Guk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea	Kangwon National University; Chonnam National University; Chonnam National University Hospital; Yonsei University; Yonsei University Health System	Kim, YH (corresponding author), Kangwon Natl Univ, Dept Internal Med, Div Cardiol, Sch Med, Chunchon, South Korea.	yhkim02@kangwon.ac.kr		Kim, Jung-Sun/0000-0003-2263-3274; Jeong, Myung Ho/0000-0003-2424-810X	Research of Korea Centers for Disease Control and Prevention [2016-ER6304-02]	Research of Korea Centers for Disease Control and Prevention	This research was supported by a fund (2016-ER6304-02) by Research of Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Armani C, 2009, CURR PHARM DESIGN, V15, P1038, DOI 10.2174/138161209787846973; Barua RS, 2003, CIRCULATION, V107, P2342, DOI 10.1161/01.CIR.0000066691.52789.BE; Bossard M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006577; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Czernin J, 2003, PROG CARDIOVASC DIS, V45, P395, DOI 10.1053/pcad.2003.00104; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Hamasaki H, 1997, GEN PHARMACOL, V28, P653, DOI 10.1016/S0306-3623(96)00369-2; Hassan AKM, 2010, EUR HEART J, V31, P1172, DOI 10.1093/eurheartj/ehn553; Honda T, 2014, J CARDIOL, V63, P358, DOI 10.1016/j.jjcc.2013.10.007; Huang X, 2017, J PET EXPLOR PROD TE, V7, P11, DOI 10.1007/s13202-016-0251-9; Iversen B, 2013, EUR J EPIDEMIOL, V28, P659, DOI 10.1007/s10654-013-9785-z; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2015, CIRCULATION, V131, P74, DOI 10.1161/CIRCULATIONAHA.114.013520; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Kubo T, 2014, CIRC J, V78, P2408, DOI 10.1253/circj.CJ-14-0337; Liu JM, 2013, J DIABETES, V5, P10, DOI 10.1111/1753-0407.12008; Nakazawa G, 2014, EUROINTERVENTION, V10, P717, DOI 10.4244/EIJV10I6A124; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Raungaard B, 2015, LANCET, V385, P1527, DOI 10.1016/S0140-6736(14)61794-3; Rooks C, 2011, ATHEROSCLEROSIS, V215, P500, DOI 10.1016/j.atherosclerosis.2011.01.012; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Sochor O, 2015, AM J CARDIOL, V115, P405, DOI 10.1016/j.amjcard.2014.11.020; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Villablanca AC, 1998, J APPL PHYSIOL, V84, P2089, DOI 10.1152/jappl.1998.84.6.2089; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205046	10.1371/journal.pone.0205046	http://dx.doi.org/10.1371/journal.pone.0205046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289945	gold, Green Published, Green Submitted			2022-12-27	WOS:000446545500041
J	Kominiarek, MA; O'Dwyer, LC; Simon, MA; Plunkett, BA				Kominiarek, Michelle A.; O'Dwyer, Linda C.; Simon, Melissa A.; Plunkett, Beth A.			Targeting obstetric providers in interventions for obesity and gestational weight gain: A systematic review	PLOS ONE			English	Review							BODY-MASS INDEX; ADDRESSING OBESITY; PREGNANT-WOMEN; NUTRITION; ADVICE; IMPACT	Background Providers need to be comfortable addressing obesity and gestational weight gain so they may give appropriate care; however, health care providers lack guidelines for the most effective educational strategies to assist in providing optimal care. Objective To identify studies that involved the obstetric provider in interventions for either the perinatal management of obesity and/or gestational weight gain in a systematic review. Search strategy A keyword search of databases was performed up to April 2017. Selection criteria Obstetric providers who participated in an intervention with the aim to change a provider's clinical practice, knowledge, and/or satisfaction with the intervention in relation to the perinatal management of obesity or gestational weight gain were included. Provider intervention could include training or education, changes in systems or organization of care, or resources to support practice. PROSPERO database #42016038921. Data collection and analysis Bias was assessed according to the validated Mixed Methods Appraisal Tool. The following variables were synthesized: study location and setting, provider and patient characteristics, intervention features, outcomes and efficacy, and strengths and weakness. Main results Of the 6,821 abstracts screened, seven studies (4 quantitative, 3 mixed-methods) with a total of 335 providers met the inclusion criteria; two of which focused on the management of obesity, three focused on gestational weight gain, and two focused on both topics. Interventions that incorporated motivational interviewing skills (n = 2), required additional training for the research study and addressed specific knowledge deficits such as nutrition and exercise (n = 3), and interfaced with the electronic medical record (n = 1) demonstrated the greatest impact on provider outcomes. Provider reported satisfaction scores were generally favorable, but none addressed provider-level efficacy in practice change. Conclusions Given the limited number of studies, varying range of provider participation, and lack of provider-level efficacy, further evaluation of provider training and involvement in interventions for perinatal obesity or gestational weight gain is indicated to determine best practices for provider and patient outcomes.	[Kominiarek, Michelle A.] Northwestern Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chicago, IL 60611 USA; [O'Dwyer, Linda C.] Northwestern Univ, Feinberg Sch Med, Galter Hlth Sci Lib, Chicago, IL 60611 USA; [Simon, Melissa A.] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Plunkett, Beth A.] NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Div Maternal Fetal Med, Evanston, IL USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; NorthShore University Health System	Kominiarek, MA (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chicago, IL 60611 USA.	mkominia@nm.org		kominiarek, michelle/0000-0003-0064-2399; O'Dwyer, Linda/0000-0003-0400-778X	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [K23HD076010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD076010] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Grant Number K23HD076010 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (Michelle A. Kominiarek). The funding source had no role in the study design; the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	American College of Obstetricians and Gynecologists, 2009, MOTIVATIONAL INTERVI; Basu A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-218; Campbell F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-491; Daley A J, 2015, BMC Obes, V2, P35, DOI 10.1186/s40608-015-0061-5; Davis DL, 2012, WOMEN BIRTH, V25, P174, DOI 10.1016/j.wombi.2011.08.008; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Eve R, 1996, J Manag Med, V10, P16, DOI 10.1108/02689239610113496; FRAME PS, 1984, J FAM PRACTICE, V19, P341; Gunatilake RP, 2011, AM J OBSTET GYNECOL, V204, P106, DOI 10.1016/j.ajog.2010.10.002; Herring SJ, 2010, J WOMENS HEALTH, V19, P65, DOI 10.1089/jwh.2008.1343; Heslehurst N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127122; Heslehurst N, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0097-9; Heslehurst N, 2011, MIDWIFERY, V27, pE170, DOI 10.1016/j.midw.2010.01.007; Kinnunen Tarja I, 2008, BMC Pregnancy Childbirth, V8, P37, DOI 10.1186/1471-2393-8-37; Knight Bridget A, 2010, Nurs Times, V106, P20; Kominiarek MA, 2016, AM J PERINAT, V33, P433, DOI 10.1055/s-0035-1567856; Kris-Etherton PM, 2014, AM J CLIN NUTR, V99, p1153S, DOI 10.3945/ajcn.113.073502; Lindberg SM, 2014, MATERN CHILD HLTH J, V18, P2188, DOI 10.1007/s10995-014-1467-2; Lindhardt CL, 2014, ACTA OBSTET GYN SCAN, V93, P698, DOI 10.1111/aogs.12401; Lopez-Cepero A, 2018, MATERN CHILD HLTH J, V22, P1127, DOI 10.1007/s10995-018-2497-y; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Marinopoulos S.S., 2007, EVIDENCE REPORTS TEC; McDonald SD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.039; Morin KH, 2007, JOGNN-J OBST GYN NEO, V36, P482, DOI [10.1111/J.1552-6909.2007.00182.x, 10.1111/j.1552-6909.2007.00182.x]; Morris J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018527; Oken E, 2009, AM J EPIDEMIOL, V170, P173, DOI 10.1093/aje/kwp101; Pace R, 2012, INT J NURS STUD, V49, P47, DOI 10.1016/j.ijnurstu.2011.07.002; Perrin EM, 2005, AMBUL PEDIATR, V5, P150, DOI 10.1367/A04-104R.1; Phelan S, 2011, J WOMENS HEALTH, V20, P585, DOI 10.1089/jwh.2010.2316; Power ML, 2006, OBSTET GYNECOL, V108, P961, DOI 10.1097/01.AOG.0000233171.20484.db; Power ML, 2017, J WOMENS HEALTH, V26, P1169, DOI 10.1089/jwh.2016.6236; Regnier K, 2005, J CONTIN EDUC HEALTH, V25, P174, DOI 10.1002/chp.26; Stotland N, 2012, J WOMENS HEALTH, V21, P695, DOI 10.1089/jwh.2011.2922; Stotland NE, 2010, J WOMENS HEALTH, V19, P807, DOI 10.1089/jwh.2009.1462; Stotland NE, 2005, OBSTET GYNECOL, V105, P633, DOI 10.1097/01.AOG.0000152349.84025.35; Swank ML, 2014, OBESITY, V22, P1997, DOI 10.1002/oby.20790; Swank ML, 2014, J MATERN-FETAL NEO M, V27, P795, DOI 10.3109/14767058.2013.845657; Yarnall K S, 1998, J Am Board Fam Pract, V11, P96; Yeo S, 2017, OBES REV, V18, P385, DOI 10.1111/obr.12511	39	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205268	10.1371/journal.pone.0205268	http://dx.doi.org/10.1371/journal.pone.0205268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289912	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500062
J	Nabiee, R; Dubois, B; Green, L; Sharma, A; Wong, SF; Aliabadi, HM				Nabiee, Ramina; Dubois, Barent; Green, Laura; Sharma, Ajay; Wong, Siu Fun; Aliabadi, Hamidreza Montazeri			In vitro and ex-vivo evaluation of topical formulations designed to minimize transdermal absorption of Vitamin K1	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; EGFR INHIBITORS; HUMAN SKIN; PHASE-II; CETUXIMAB; DELIVERY; FOLLICULITIS; PERMEATION; TOXICITIES	Topical application of Vitamin K1 has been demonstrated to effectively treat papulopustular skin rash, a serious and frequently encountered side effect of Epidermal Growth Factor Inhibitors (EGFRIs). Systemic absorption of vitamin K1 from skin and the resultant consequence of antagonizing EGFRIs anticancer effects jeopardizes the clinical acceptability of this rather effective treatment. The purpose of the present study was to rationally formulate and evaluate the release rate and transdermal absorption of a wide range of Vitamin K1 dermal preparations with a variety of physiochemical properties. A library of 33 formulations with were compounded and tested for Vitamin K1 permeation using hydrophobic membranes and porcine skin mounted in a Fran diffusion cells. Our results demonstrate the lowest diffusion for water-in-oil emulsions, which also demonstrated a negligible transdermal absorption. The statistical analysis showed a significant correlation between in vitro and ex vivo results. While viscosity did not have a significant impact on the diffusion or absorption of vitamin K1, an increase in the lipid content was correlated with an increase in transmembrane diffusion (not with transdermal absorption). Overall, formulation design significantly impacts the release rate and transdermal absorption of vitamin K1, and confirms the possibility of minimal systemic distribution of this vitamin for this specific purpose.	[Nabiee, Ramina; Dubois, Barent; Green, Laura; Sharma, Ajay; Aliabadi, Hamidreza Montazeri] Chapman Univ, Dept Biomed & Pharmaceut Sci, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA; [Wong, Siu Fun] Chapman Univ, Dept Pharm Practice, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA USA; [Aliabadi, Hamidreza Montazeri] Chapman Univ, Ctr Targeted Drug Delivery, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA	Chapman University System; Chapman University; Chapman University System; Chapman University; Chapman University System; Chapman University	Aliabadi, HM (corresponding author), Chapman Univ, Dept Biomed & Pharmaceut Sci, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA.; Aliabadi, HM (corresponding author), Chapman Univ, Ctr Targeted Drug Delivery, Sch Pharm, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA.	montazer@chapman.edu		Nabiee, Ramina/0000-0001-9806-8481	Hope Foundation [UG1CA189974]; NATIONAL CANCER INSTITUTE [UG1CA189974] Funding Source: NIH RePORTER	Hope Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Hope Foundation, grant Number: UG1CA189974. URL: https://thehopefoundation.org/research-funding/juried-programs/swog-early-exploration-development-seed-fund/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akash MSH, 2015, J CONTROL RELEASE, V209, P120, DOI 10.1016/j.jconrel.2015.04.032; Albanell J, 2002, J CLIN ONCOL, V20, P110, DOI 10.1200/JCO.20.1.110; [Anonymous], 2016, USP NF, DOI DOI 10.31003/USPNF_M20700_01_01; Bachet JB, 2012, ONCOLOGIST, V17, P555, DOI 10.1634/theoncologist.2011-0365; Borowska K, 2012, INT J PHARMACEUT, V436, P764, DOI 10.1016/j.ijpharm.2012.07.067; El-Kattan AF, 2000, INT J PHARMACEUT, V198, P179, DOI 10.1016/S0378-5173(00)00330-6; Eriksen JG, 2017, SUPPORT CARE CANCER, V25, P2179, DOI 10.1007/s00520-017-3623-x; Fan QX, 2004, J CONTROL RELEASE, V98, P355, DOI 10.1016/j.jconrel.2004.05.005; Filipowicz A, 2011, INT J PHARMACEUT, V408, P152, DOI 10.1016/j.ijpharm.2011.01.033; Goindi S, 2016, AAPS PHARMSCITECH, V17, P597, DOI 10.1208/s12249-015-0383-0; Hathout RM, 2013, COLLOID SURFACE B, V110, P254, DOI 10.1016/j.colsurfb.2013.05.007; Holcmann M, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1004969; Joshi SS, 2010, CANCER-AM CANCER SOC, V116, P3916, DOI 10.1002/cncr.25090; Jung YW, 2013, CURR MED CHEM, V20, P3488, DOI 10.2174/09298673113209990036; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Li TH, 2009, TARGET ONCOL, V4, P107, DOI 10.1007/s11523-009-0114-0; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Ocvirk J, 2008, RADIOL ONCOL, V42, P215, DOI 10.2478/v10019-008-0022-4; Palmer BC, 2016, MOLECULES, V21, DOI 10.3390/molecules21121719; Perez-Soler R, 2005, J CLIN ONCOL, V23, P5235, DOI 10.1200/JCO.2005.00.6916; Perez-Soler R, 2006, J CLIN ONCOL, V24, p129S; Pinta F, 2014, CLIN COLORECTAL CANC, V13, P62, DOI 10.1016/j.clcc.2013.10.001; Robert C, 2005, LANCET ONCOL, V6, P491, DOI 10.1016/S1470-2045(05)70243-6; Roberts MS, 2017, J CONTROL RELEASE, V247, P86, DOI 10.1016/j.jconrel.2016.12.022; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Schmook FP, 2001, INT J PHARM, V215, P51, DOI 10.1016/S0378-5173(00)00665-7; Segaert S, 2005, ANN ONCOL, V16, P1425, DOI 10.1093/annonc/mdi279; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Tomkova H, 2013, J EUR ACAD DERMATOL, V27, P514, DOI 10.1111/j.1468-3083.2011.04324.x	29	1	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204531	10.1371/journal.pone.0204531	http://dx.doi.org/10.1371/journal.pone.0204531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289881	gold, Green Published			2022-12-27	WOS:000446545500018
J	Shin, HW; Lee, NS				Shin, Hye Woo; Lee, Nam Sook			Understanding plastome evolution in Hemiparasitic Santalales: Complete chloroplast genomes of three species, Dendrotrophe varians, Helixanthera parasitica, and Macrosolen cochinchinensis (vol 13, e0200293, 2018)	PLOS ONE			English	Correction													Shin, Hye Woo/AAD-7844-2020					Shin HW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200293	1	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205616	10.1371/journal.pone.0205616	http://dx.doi.org/10.1371/journal.pone.0205616			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289906	Green Published, gold, Green Submitted			2022-12-27	WOS:000446545500074
J	Tetreault, HM; Scully, ED; Gries, T; Palmer, NA; Funnell-Harris, DL; Baird, L; Seravalli, J; Dien, BS; Sarath, G; Clemente, TE; Sattler, SE				Tetreault, Hannah M.; Scully, Erin D.; Gries, Tammy; Palmer, Nathan A.; Funnell-Harris, Deanna L.; Baird, Lisa; Seravalli, Javier; Dien, Bruce S.; Sarath, Gautam; Clemente, Thomas E.; Sattler, Scott E.			Overexpression of the Sorghum bicolor SbCCoAOMT alters cell wall associated hydroxycinnamoyl groups	PLOS ONE			English	Article							COENZYME-A 3-O-METHYLTRANSFERASE; ACID O-METHYLTRANSFERASE; LIGNIN BIOSYNTHESIS; FERULIC ACID; L. MOENCH; MONOLIGNOL BIOSYNTHESIS; SECONDARY METABOLISM; GENETIC-MODIFICATION; DOWN-REGULATION; ALFALFA	Sorghum (Sorghum bicolor) is a drought tolerant crop, which is being developed as a bioenergy feedstock. The monolignol biosynthesis pathway is a major focus for altering the abundance and composition of lignin. Caffeoyl coenzyme-A O-methyltransferase (CCoAOMT) is an S-adenosyl methionine (SAM)-dependent O-methyltransferase that methylates caffeoyl-CoA to generate feruloyl-CoA, an intermediate required for the biosynthesis of both G- and S-lignin. SbCCoAOMT was overexpressed to assess the impact of increasing the amount of this enzyme on biomass composition. SbCCoAOMT overexpression increased both soluble and cell wall-bound (esterified) ferulic and sinapic acids, however lignin concentration and its composition (S/G ratio) remained unaffected. This increased deposition of hydroxycinnamic acids in these lines led to an increase in total energy content of the stover. In stalk and leaf midribs, the increased histochemical staining and autofluorescence in the cell walls of the SbCCoAOMT overexpression lines also indicate increased phenolic deposition within cell walls, which is consistent with the chemical analyses of soluble and wall-bound hydroxycinnamic acids. The growth and development of overexpression lines were similar to wild-type plants. Likewise, RNA-seq and metabolite profiling showed that global gene expression and metabolite levels in overexpression lines were also relatively similar to wild-type plants. Our results demonstrate that SbCCoAOMT overexpression significantly altered cell wall composition through increases in cell wall associated hydroxycinnamic acids without altering lignin concentration or affecting plant growth and development.	[Tetreault, Hannah M.; Scully, Erin D.; Gries, Tammy; Palmer, Nathan A.; Funnell-Harris, Deanna L.; Sarath, Gautam; Sattler, Scott E.] USDA ARS, Wheat Sorghum & Forage Res Unit, Lincoln, NE 68583 USA; [Tetreault, Hannah M.; Scully, Erin D.; Gries, Tammy; Sarath, Gautam; Clemente, Thomas E.; Sattler, Scott E.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Funnell-Harris, Deanna L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Baird, Lisa] Univ San Diego, Shiley Ctr Sci & Technol, Dept Biol, San Diego, CA 92110 USA; [Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA; [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Dien, Bruce S.] USDA ARS, Natl Ctr Agr Utilizat Res, 1815 N Univ St, Peoria, IL 61604 USA; [Clemente, Thomas E.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Scully, Erin D.] USDA ARS, Stored Prod Insect & Engn Res Unit, Manhattan, KS USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of San Diego; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA)	Sattler, SE (corresponding author), USDA ARS, Wheat Sorghum & Forage Res Unit, Lincoln, NE 68583 USA.; Sattler, SE (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	scott.sattler@ars.usda.gov		Sattler, Scott/0000-0002-6814-4073	United States Department of Agriculture - National Institute of Food and Agriculture AFRI [2011-67009-30026]; USDA-ARS, CRIS [3042-21220-032-00D, 3042-21000-030-00D]; National Institute for General Medical Science (NIGMS) [INBRE - P20GM103427-14, COBRE - 1P30GM110768-01]; Fred & Pamela Buffett Cancer Center Support Grant [P30CA036727]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER	United States Department of Agriculture - National Institute of Food and Agriculture AFRI; USDA-ARS, CRIS(United States Department of Agriculture (USDA)); National Institute for General Medical Science (NIGMS); Fred & Pamela Buffett Cancer Center Support Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the United States Department of Agriculture - National Institute of Food and Agriculture AFRI grant number 2011-67009-30026 (SES, TEC, and DLF-H) and additional funding from USDA-ARS, CRIS projects 3042-21220-032-00D (SES and DLF-H) and 3042-21000-030-00D (GS). The University of Nebraska DNA Sequencing Core receives partial support from the National Institute for General Medical Science (NIGMS) INBRE - P20GM103427-14 and COBRE - 1P30GM110768-01 grants as well as The Fred & Pamela Buffett Cancer Center Support Grant - P30CA036727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudet AM, 2003, TRENDS PLANT SCI, V8, P576, DOI 10.1016/j.tplants.2003.10.001; Bout S, 2003, MOL GENET GENOMICS, V269, P205, DOI 10.1007/s00438-003-0824-4; Brett CT, 1999, J SCI FOOD AGR, V79, P421, DOI 10.1002/(SICI)1097-0010(19990301)79:3&lt;421::AID-JSFA281&gt;3.0.CO;2-0; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CASTELLUCCIO C, 1995, FEBS LETT, V368, P188, DOI 10.1016/0014-5793(95)00639-Q; Chen HC, 2011, P NATL ACAD SCI USA, V108, P21253, DOI 10.1073/pnas.1116416109; Compton DL, 2000, J AM OIL CHEM SOC, V77, P513, DOI 10.1007/s11746-000-0082-9; de Oliveira DM, 2015, PLANT BIOTECHNOL J, V13, P1224, DOI 10.1111/pbi.12292; Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Ermawar RA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0624-0; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Funnell-Harris DL, 2018, PLANT PATHOL, V67, P1474, DOI 10.1111/ppa.12863; Funnell-Harris DL, 2014, PLANT DIS, V98, P1300, DOI 10.1094/PDIS-09-13-0980-RE; Funnell-Harris DL, 2010, PHYTOPATHOLOGY, V100, P671, DOI 10.1094/PHYTO-100-7-0671; GRAF E, 1992, FREE RADICAL BIO MED, V13, P435, DOI 10.1016/0891-5849(92)90184-I; Green AR, 2014, PLANT PHYSIOL, V165, P1440, DOI 10.1104/pp.114.241729; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; HARTLEY RD, 1977, PHYTOCHEMISTRY, V16, P1531, DOI 10.1016/0031-9422(77)84017-X; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ikegawa T, 1996, PHYSIOL MOL PLANT P, V48, P245, DOI 10.1006/pmpp.1996.0021; JACQUET G, 1995, J AGR FOOD CHEM, V43, P2746, DOI 10.1021/jf00058a037; Kumar Naresh, 2014, Biotechnol Rep (Amst), V4, P86, DOI 10.1016/j.btre.2014.09.002; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laszlo JA, 2003, GREEN CHEM, V5, P382, DOI 10.1039/b302384b; Li XY, 2013, GENET MOL BIOL, V36, P540, DOI 10.1590/s1415-47572013005000039; Lu J, 2004, PROG NAT SCI-MATER, V14, P1060, DOI 10.1080/10020070412331344801; Makita Y, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu187; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; MCKENZIE HA, 1969, DATA BIOCH RES; MILLER FR, 1984, CROP SCI, V24, P1224, DOI 10.2135/cropsci1984.0011183X002400060074x; Nakashima J, 2008, NEW PHYTOL, V179, P738, DOI 10.1111/j.1469-8137.2008.02502.x; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; PAKUSCH AE, 1989, ARCH BIOCHEM BIOPHYS, V271, P488, DOI 10.1016/0003-9861(89)90299-3; PAKUSCH AE, 1991, PLANT PHYSIOL, V95, P137, DOI 10.1104/pp.95.1.137; Palmer NA, 2008, PLANTA, V229, P115, DOI 10.1007/s00425-008-0814-1; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perlack RD, 2011, IEA BIOENERGY; Pincon G, 2001, PHYTOCHEMISTRY, V57, P1167, DOI 10.1016/S0031-9422(01)00098-X; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rakoczy M, 2018, MOL GENET GENOMICS, V293, P1077, DOI 10.1007/s00438-018-1441-6; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Saballos A, 2012, PLANT J, V70, P818, DOI 10.1111/j.1365-313X.2012.04933.x; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Sarath G, 2008, J IND MICROBIOL BIOT, V35, P343, DOI 10.1007/s10295-007-0296-3; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Scully ED, 2016, PLANT J; Scully ED, 2018, NEW PHYTOL, V217, P82, DOI 10.1111/nph.14815; Shaipulah NFM, 2016, PLANT PHYSIOL, V170, P717, DOI 10.1104/pp.15.01646; Sluiter A., 2008, LAB ANAL PROCED, V1617, P1, DOI DOI 10.1007/S00449-014-1243-0; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Tanger P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00218; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vermerris W, 2015, CURR OPIN BIOTECH, V32, P104, DOI 10.1016/j.copbio.2014.11.024; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Walker AM, 2016, PLANT PHYSL; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wu WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07895-1; Xie SX, 2015, GREEN CHEM, V17, P1657, DOI [10.1039/c4gc01529k, 10.1039/C4GC01529K]; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3; Yang Q, 2017, NAT GENET; Zhong RQ, 1998, PLANT CELL, V10, P2033, DOI 10.1105/tpc.10.12.2033	72	15	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0204153	10.1371/journal.pone.0204153	http://dx.doi.org/10.1371/journal.pone.0204153			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289910	Green Published, gold			2022-12-27	WOS:000446545500013
J	Wang, KJ; Duan, X; Gao, F; Wang, W; Liu, LL; Wang, X				Wang, Kejun; Duan, Xin; Gao, Feng; Wang, Wei; Liu, Liangliang; Wang, Xin			Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines (vol 13, e0203824, 2018)	PLOS ONE			English	Correction									[Wang, Xin] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	City University of Hong Kong	Wang, X (corresponding author), City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.		Wang, Xin/A-1130-2012; Gao, Feng/AAE-4201-2020	Wang, Xin/0000-0002-5122-2418; Gao, Feng/0000-0002-0500-5527	Shenzhen Research Institute, City University of Hong Kong	Shenzhen Research Institute, City University of Hong Kong(City University of Hong Kong)	The following information is missing from the Funding section: The authors acknowledge the support received from Shenzhen Research Institute, City University of Hong Kong.	Wang KJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203824	1	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205548	10.1371/journal.pone.0205548	http://dx.doi.org/10.1371/journal.pone.0205548			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289938	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500070
J	Ferretti, R; Moura, EG; dos Santos, VC; Caldeira, EJ; Conte, M; Matsumura, CY; Pertille, A; Mosqueira, M				Ferretti, Renato; Moura, Eliezer Guimaraes; dos Santos, Veridiana Carvalho; Caldeira, Eduardo Jose; Conte, Marcelo; Matsumura, Cintia Yuri; Pertille, Adriana; Mosqueira, Matias			High-fat diet suppresses the positive effect of creatine supplementation on skeletal muscle function by reducing protein expression of IGF-PI3K-AKT-mTOR pathway	PLOS ONE			English	Article							RESISTANCE-EXERCISE; BODY-COMPOSITION; MESSENGER-RNA; OLDER-ADULTS; C2C12 CELLS; HYPERTROPHY; PERFORMANCE; ACTIVATION; DYSTROPHY; AUTOPHAGY	High-fat (HF) diets in combination with sedentary lifestyle represent one of the major public health concerns predisposing to obesity and diabetes leading to skeletal muscle atrophy, decreased fiber diameter and muscle mass with accumulation of fat tissue resulting in loss of muscle strength. One strategy to overcome the maleficent effects of HF diet is resistance training, a strategy used to improve muscle mass, reverting the negative effects on obesity-related changes in skeletal muscle. Together with resistance training, supplementation with creatine monohydrate (CrM) in the diet has been used to improve muscle mass and strength. Creatine is a non-essential amino acid that is directly involved in the cross-bridge cycle providing a phosphate group to ADP during the initiation of muscle contraction. Besides its antioxidant and anti-inflammatory effects CrM also upregulates IGF-1 resulting in hyperthophy with an increase in muscle function. However, it is unknown whether CrM supplementation during resistance training would revert the negative effects of high-fat diet on the muscle performance. During 8 weeks we measured muscle performance to climb a 1.1m and 80 degrees ladder with increasing load on trained rats that had received standard diet or high-fat diet, supplemented or not with CrM. We observed that the CrM supplementation up-regulated IGF-1 and phospho-AKT protein levels, suggesting an activation of the IGF1P13K-Akt/PKB-mTOR pathway. Moreover, despite the CrM supplementation, HF diet downregulated several proteins of the IGF1-PI3K-Akt/PKB-mTOR pathway, suggesting that diet lipid content is crucial to maintain or improve muscle function during resistance training.	[Ferretti, Renato; dos Santos, Veridiana Carvalho; Matsumura, Cintia Yuri] Sao Paulo State Univ UNESP, Inst Biosci Botucatu, Dept Anat, Botucatu, SP, Brazil; [Moura, Eliezer Guimaraes] Ctr Univ Adventista Sao Paulo, Lab Phys Act Metab & Hlth, Sao Paulo, Brazil; [Caldeira, Eduardo Jose] FMJ, Dept Morphol & Basic Pathol, Sao Paulo, Brazil; [Conte, Marcelo] ESEF, Sao Paulo, Brazil; [Pertille, Adriana] Univ Metodista Piracicaba, Lab Neuromuscular Plast, Grad Program Sci Human Movement, Sao Paulo, Brazil; [Mosqueira, Matias] Heidelberg Univ Hosp, Inst Physiol & Pathophysiol, Cardioventilatory Muscle Physiol Lab, Heidelberg, Germany	Universidade Estadual Paulista; Centro Universitario Adventista de Sao Paulo; Universidade Metodista de Piracicaba; Ruprecht Karls University Heidelberg	Ferretti, R (corresponding author), Sao Paulo State Univ UNESP, Inst Biosci Botucatu, Dept Anat, Botucatu, SP, Brazil.; Mosqueira, M (corresponding author), Heidelberg Univ Hosp, Inst Physiol & Pathophysiol, Cardioventilatory Muscle Physiol Lab, Heidelberg, Germany.	r.ferretti@unesp.br; matias@physiologie.uni-heidelberg.de	Mosqueira, Matias/C-5899-2019; Conte, Marcelo/ABE-4445-2021; Ferretti, Renato/AAH-6049-2019; Matsumura, Cintia Yuri/AFQ-5618-2022; Pertille, Adriana/AAE-3285-2021; Moura, Eliézer Guimarães/B-4505-2018	Mosqueira, Matias/0000-0001-7744-9138; Conte, Marcelo/0000-0003-1034-6921; Ferretti, Renato/0000-0003-3944-1906; Moura, Eliezer Guimaraes/0000-0002-2477-8242				Abrigo J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9047821; Ambery AG, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13363; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Blaauw B, 2013, COMPR PHYSIOL, V3, P1645, DOI 10.1002/cphy.c130009; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Burke DG, 2008, INT J SPORT NUTR EXE, V18, P389, DOI 10.1123/ijsnem.18.4.389; Souza MVC, 2014, CLINICS, V69, P265, DOI 10.6061/clinics/2014(04)08; Candow DG, 2012, BIOGERONTOLOGY, V13, P345, DOI 10.1007/s10522-012-9385-4; Cassilhas RC, 2013, MOTRIZ, V19, P178, DOI 10.1590/S1980-65742013000100018; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38; Chilibeck PD, 2017, OPEN ACCESS J SPORTS, V8, P213, DOI 10.2147/OAJSM.S123529; Choi SJ, 2016, J GERONTOL A-BIOL, V71, P557, DOI 10.1093/gerona/glv169; Clark JF, 1998, NUTRITION, V14, P322, DOI 10.1016/S0899-9007(97)00482-6; Davidson ZE, 2009, J HUM NUTR DIET, V22, P383, DOI 10.1111/j.1365-277X.2009.00979.x; Deldicque L, 2005, EUR J APPL PHYSIOL, V94, P1, DOI 10.1007/s00421-004-1255-6; Deldicque L, 2005, MED SCI SPORT EXER, V37, P731, DOI 10.1249/01.MSS.0000162690.39830.27; Deldicque L, 2007, AM J PHYSIOL-CELL PH, V293, pC1263, DOI 10.1152/ajpcell.00162.2007; Eshima H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13250; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Kirwan JP, 2000, J APPL PHYSIOL, V88, P797, DOI 10.1152/jappl.2000.88.2.797; Kreider RB, 2003, MOL CELL BIOCHEM, V244, P89, DOI 10.1023/A:1022465203458; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; Krisan AD, 2004, J APPL PHYSIOL, V96, P1691, DOI 10.1152/japplphysiol.01054.2003; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Louis M, 2004, FEBS LETT, V557, P243, DOI 10.1016/S0014-5793(03)01504-7; Ma JT, 2016, OBESITY, V24, P526, DOI 10.1002/oby.21356; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Moon Ji Hyun, 2015, J Bone Metab, V22, P99, DOI 10.11005/jbm.2015.22.3.99; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Rahimi R, 2011, J STRENGTH COND RES, V25, P3448, DOI 10.1519/JSC.0b013e3182162f2b; Roy B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00439; Sala D, 2014, J CLIN INVEST, V124, P1914, DOI 10.1172/JCI72327; Santos RVT, 2004, LIFE SCI, V75, P1917, DOI 10.1016/j.lfs.2003.11.036; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Volek JS, 2004, EUR J APPL PHYSIOL, V91, P628, DOI 10.1007/s00421-003-1031-z; Willoughby DS, 2003, INT J SPORTS MED, V24, P15, DOI 10.1055/s-2003-37197; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yaspelkis BB, 2002, ACTA PHYSIOL SCAND, V175, P315, DOI 10.1046/j.1365-201X.2002.00998.x; Young JF, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-9; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	45	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0199728	10.1371/journal.pone.0199728	http://dx.doi.org/10.1371/journal.pone.0199728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286093	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500001
J	Kirkpatrick, L; Graham, J; McGregor, S; Munro, L; Scoarize, M; Park, K				Kirkpatrick, Lucinda; Graham, Jennifer; McGregor, Sean; Munro, Lynn; Scoarize, Matheus; Park, Kirsty			Flexible foraging strategies in Pipistrellus pygmaeus in response to abundant but ephemeral prey	PLOS ONE			English	Article							2 PHONIC TYPES; HABITAT SELECTION; HOME-RANGE; INSECTIVOROUS BAT; FOREST; CONSERVATION; BIODIVERSITY; PLANTATIONS; DISTURBANCE; CALLS	There is growing recognition that with sympathetic management, plantation forests may contain more biodiversity than previously thought. However, the extent to which they may support bat populations is contentious. Many studies have demonstrated active avoidance of coniferous plantations and attributed this to the lack of available roost sites and low invertebrate density. In contrast, other work, carried out in plantation dominated landscapes have shown that certain bat species are able to exploit these areas. However, the extent to which bats use plantations for roosting and foraging, or simply move through the plantation matrix to access more favourable sites is unclear. We radio tracked female Pipistrellus pygmaeus over two summers to establish the extent to which individual bats use Sitka Spruce plantations in southern Scotland for foraging and roosting and assess the implications for felling operations on bats. Maternity roosts identified (n = 17) were in all in buildings and most were large (> 500 individuals). We found no evidence of bats roosting in mature Sitka Spruce crop trees, although several bats used roosts in old or dead beech and oak trees as an alternative to their main maternity roost. Home ranges were much larger (mean 9.6 +/- 3.12 km(2)) than those reported from other studies (0.6-1.6 km(2)), and it is likely that roost availability rather than food abundance constrains P. pygmaeus use of Sitka Spruce plantations. At the landscape scale, most individuals selected coniferous habitats over other habitat types, covering large distances to access plantation areas, whilst at a local scale bats used forest tracks to access water, felled stands or patches of broadleaf cover within the plantation. Sitka Spruce plantations support a high abundance of Culicoides impuctatus, the Highland midge which may act as a reliable and plentiful food source for females during lactation, an energetically expensive period. The use of felled stands for foraging by bats has implications for forest management as wind turbines, following small-scale felling operations, are increasingly being installed in plantations; wind turbines have been associated with high bat mortality in some countries. Decisions about siting wind turbines in upland plantations should consider the likelihood of increased bat activity post felling.	[Kirkpatrick, Lucinda; Graham, Jennifer; Munro, Lynn; Park, Kirsty] Univ Stirling, Biol & Ecol Sci, Stirling, Scotland; [Kirkpatrick, Lucinda] Univ Antwerp, EVECO, Antwerp, Belgium; [Graham, Jennifer] Scottish Dolphin Ctr, WDC, Fochabers, Moray, Scotland; [McGregor, Sean] Univ Lausanne, Biophore, Lausanne, Switzerland; [Scoarize, Matheus] Univ Estadual Maringa, PEA, Maringa, Parana, Brazil	University of Stirling; University of Antwerp; University of Lausanne; Universidade Estadual de Maringa	Kirkpatrick, L (corresponding author), Univ Stirling, Biol & Ecol Sci, Stirling, Scotland.; Kirkpatrick, L (corresponding author), Univ Antwerp, EVECO, Antwerp, Belgium.	lucinda.kirkpatrick@uantwerpen.be		Park, Kirsty/0000-0001-6080-7197; Ratz Scoarize, Matheus Maximilian/0000-0003-3234-9808	IMPACT studentship; Forestry Commission; University of Stirling; CNPq; CAPES	IMPACT studentship; Forestry Commission; University of Stirling; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding for Lucinda Kirkpatrick was provided as part of an IMPACT studentship, funded by Forestry Commission and the University of Stirling. We would also like to acknowledge CNPq and CAPES for partial funding support.	Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Altringham JD, 1996, BATS BIOL BEHAV; [Anonymous], 2015, SCOTTISH NATURAL HER; Arnett EB, IMPACTS WIND ENERGY, P295, DOI [10.1007/978-3-319-25220-9, DOI 10.1007/978-3-319-25220-9]; Arrizabalaga-Escudero A, 2013, MAMM BIOL; August TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112225; Barlow KE, 2015, BIOL CONSERV, V182, P14, DOI 10.1016/j.biocon.2014.11.022; Barlow KE, 1997, J ZOOL, V243, P597, DOI 10.1111/j.1469-7998.1997.tb02804.x; Barlow KE, 1999, Z SAUGETIERKD, V64, P257; Bartonicka T, 2008, ANN ZOOL FENN, V45, P503, DOI 10.5735/086.045.0605; Bender MJ, 2015, FOREST ECOL MANAG, V336, P1, DOI 10.1016/j.foreco.2014.10.004; Blakey RV, 2016, J APPL ECOL, V53, P1694, DOI 10.1111/1365-2664.12691; Bonaccorso FJ, 2015, J MAMMAL, V96, P64, DOI 10.1093/jmammal/gyu003; Borkin KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086163; Borkin KM, 2011, BIODIVERS CONSERV, V20, P3537, DOI 10.1007/s10531-011-0144-7; Borkin KM, 2011, FOREST ECOL MANAG, V262, P845, DOI 10.1016/j.foreco.2011.05.018; Borkin KM, 2010, NEW ZEAL J ZOOL, V37, P35, DOI 10.1080/03014221003602190; Borkin KM, 2010, NEW ZEAL J ZOOL, V37, P13, DOI 10.1080/03014221003602174; Boughey KL, 2011, BIOL CONSERV, V144, P2300, DOI 10.1016/j.biocon.2011.06.008; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Burgar JM, 2015, FOREST ECOL MANAG, V356, P112, DOI 10.1016/j.foreco.2015.07.027; Calenge C, 2006, ECOLOGY, V87, P2349, DOI 10.1890/0012-9658(2006)87[2349:EOSRFA]2.0.CO;2; CARR GM, 1986, ANIM BEHAV, V34, P1540, DOI 10.1016/S0003-3472(86)80223-8; Chambers CL, 2016, LANDSCAPE ECOL, V31, P1299, DOI 10.1007/s10980-016-0343-4; Charbonnier Y, 2016, LANDSCAPE ECOL, V31, P291, DOI 10.1007/s10980-015-0242-0; Christie JE, 2014, ACTA CHIROPTEROL, V16, P369, DOI 10.3161/150811014X687323; Ciechanowski M, 2015, EUR J WILDLIFE RES, V61, P415, DOI 10.1007/s10344-015-0911-y; Cistrone L, 2015, HYSTRIX, V26, P125, DOI 10.4404/hystrix-26.2-11477; Davidson-Watts I, 2006, J ZOOL, V268, P55, DOI 10.1111/j.1469-7998.2005.00016.x; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; Dodd LE, 2012, FOREST ECOL MANAG, V267, P262, DOI 10.1016/j.foreco.2011.12.016; Flaquer C, 2006, BIOL CONSERV, V128, P223, DOI 10.1016/j.biocon.2005.09.030; Grindal SD, 1998, J WILDLIFE MANAGE, V62, P996, DOI 10.2307/3802552; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Haupt M, 2006, J MAMMAL, V87, P351, DOI 10.1644/05-MAMM-A-193R1.1; Heer K, 2015, J MAMMAL, V96, P720, DOI 10.1093/jmammal/gyv068; Hein CD, 2008, THESIS; Hill DA, 2005, MAMMAL REV, V35, P116, DOI 10.1111/j.1365-2907.2005.00058.x; Humphrey JW, 2005, FORESTRY, V78, P33, DOI 10.1093/forestry/cpi004; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones G, 2009, DETERMINING POTENTIA, V11, P12; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Kirkpatrick L., 2017, BAT EXPLOITATION SIT; Kirkpatrick L, 2017, FOREST ECOL MANAG, V395, P1, DOI 10.1016/j.foreco.2017.03.033; Kirkpatrick L, 2017, BIOL CONSERV, V206, P1, DOI 10.1016/j.biocon.2016.11.018; Kunz Thomas H., 1996, P105; Law B, 2015, INSECTIVOROUS BATS S, P105; Lintott PR, 2013, WILDLIFE RES, V40, P675, DOI 10.1071/WR13153; Lopez-Baucells A, 2016, URBAN ECOSYST URBAN, DOI [10.1007/s11252-015-0519-8, DOI 10.1007/S11252-015-0519-8]; Manly BFL., 2007, RESOURCE SELECTION A; Mathews F, 2016, WC0753 DEFRA; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; Mortimer G., 2006, THESIS; Morton D., 2011, 1107 NERC CTR EC HYD; Nicholls B, 2006, BEHAV ECOL SOCIOBIOL, V61, P131, DOI 10.1007/s00265-006-0244-7; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Park KJ, 1998, J ZOOL, V244, P379, DOI 10.1017/S0952836998003094; Patriquin KJ, 2003, J APPL ECOL, V40, P646, DOI 10.1046/j.1365-2664.2003.00831.x; Reiter G, 2013, MAMM BIOL, V78, P283, DOI 10.1016/j.mambio.2012.11.003; Rodriguez-San Pedro A, 2015, EUR J WILDLIFE RES, V61, P177, DOI 10.1007/s10344-014-0871-7; Russ JM, 2002, BIOL CONSERV, V108, P49, DOI 10.1016/S0006-3207(02)00089-7; Russo D, 2016, FRONT ECOL EVOL, V4, DOI [10.3389/fevo.2016.00115, DOI 10.3389/FEVO.2016.00115]; Russo D, 2010, BIODIVERS CONSERV, V19, P2501, DOI 10.1007/s10531-010-9856-3; Rydell J., 2017, DIET PARTI COLOURED, V15, P195; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; Schnitzler H.-U., 1988, ANIMAL SONAR, P619; Stephens SS, 2007, J FOREST, V105, P307; Verboom B, 1999, CAN J ZOOL, V77, P1393, DOI 10.1139/cjz-77-9-1393; Voigt C. C, 2016, BATS ANTHROPOCENE CO, DOI [10.1007/978-3-319-25220-9, DOI 10.1007/978-3-319-25220-9]; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; White G.C., 1990, ANAL WILDLIFE RADIO	73	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204511	10.1371/journal.pone.0204511	http://dx.doi.org/10.1371/journal.pone.0204511			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286111	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500023
J	Nagappa, M; Wong, DT; Cozowicz, C; Ramachandran, SK; Memtsoudis, SG; Chung, F				Nagappa, Mahesh; Wong, David T.; Cozowicz, Crispiana; Ramachandran, Satya Krishna; Memtsoudis, Stavros G.; Chung, Frances			Is obstructive sleep apnea associated with difficult airway? Evidence from a systematic review and meta-analysis of prospective and retrospective cohort studies	PLOS ONE			English	Review							IMPOSSIBLE MASK VENTILATION; STOP-BANG QUESTIONNAIRE; NATIONAL AUDIT PROJECT; TRACHEAL INTUBATION; RESPIRATORY COMPLICATIONS; ENDOTRACHEAL INTUBATION; MAJOR COMPLICATIONS; SCREENING TOOL; ROYAL-COLLEGE; RISK-FACTOR	Background Difficult airway management and obstructive sleep apnea may contribute to increased risk of perioperative morbidity and mortality. The objective of this systematic review and metaanalysis (SRMA) is to evaluate the evidence of a difficult airway being associated with obstructive sleep apnea (OSA) patients undergoing surgery. Methods The standard databases were searched from 1946 to April 2017 to identify the eligible articles. The studies which included adult surgical patients with either suspected or diagnosed obstructive sleep apnea must report at least one difficult airway event [either difficult intubation (DI), difficult mask ventilation (DMV), failed supraglottic airway insertion or difficult surgical airway] in sleep apnea and non-sleep apnea patients were included. Results Overall, DI was 3.46-fold higher in the sleep apnea vs non-sleep apnea patients (OSA vs. non-OSA: 13.5% vs 2.5%; OR 3.46; 95% CI: 2.32 +/- 5.16, p < 0.00001). DMV was 3.39-fold higher in the sleep apnea vs non-sleep apnea patients (OSA vs. non-OSA: 4.4% vs 1.1%; OR 3.39; 95% CI: 2.74 +/- 4.18, p < 0.00001). Combined DI and DMV was 4.12-fold higher in the OSA vs. non-OSA patients (OSA vs. non-OSA: 1.1% vs 0.3%; OR 4.12; 95% CI: 2.93 +/- 5.79, p < 0.00001). There was no significant difference in the supraglottic airway failure rates in the sleep apnea vs non-sleep apnea patients (OR: 1.34; 95% CI: 0.70 +/- 2.59; p = 0.38). Meta-regression to adjust for various subgroups and baseline confounding factors did not impact the final inference of our results. Conclusion This SRMA found that patients with obstructive sleep apnea had a three to four-fold higher risk of difficult intubation or mask ventilation or both, when compared to non-sleep apnea patients.	[Nagappa, Mahesh] Western Univ, Dept Anesthesia & Perioperat Med, Univ Hosp, Victoria Hosp, London, ON, Canada; [Nagappa, Mahesh] Western Univ, St Joseph Hosp, London Hlth Sci Ctr, London, ON, Canada; [Nagappa, Mahesh] Western Univ, St Joseph Hlth Care, London, ON, Canada; [Wong, David T.; Chung, Frances] Univ Toronto, Dept Anesthesia & Pain Med, Toronto Western Hosp, Univ Hlth Network, Toronto, ON, Canada; [Cozowicz, Crispiana; Memtsoudis, Stavros G.] Hosp Special Surg, Dept Anesthesiol Crit Care & Pain Management, 535 E 70th St, New York, NY 10021 USA; [Cozowicz, Crispiana; Memtsoudis, Stavros G.] Weill Cornell Med Coll, New York, NY USA; [Cozowicz, Crispiana] Paracelsus Med Univ, Dept Anesthesiol Perioperat Med & Intens Care Med, Salzburg, Austria; [Ramachandran, Satya Krishna] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Harvard Med Sch, Boston, MA 02215 USA	University of Victoria; Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cornell University; Paracelsus Private Medical University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Chung, F (corresponding author), Univ Toronto, Dept Anesthesia & Pain Med, Toronto Western Hosp, Univ Hlth Network, Toronto, ON, Canada.	frances.chung@uhn.ca	Ramachandran, Satya Krishna/P-6636-2016; Chung, Frances/F-5618-2015; Cozowicz, Crispiana/U-5874-2019; Nagappa, Mahesh/AAA-7389-2022	Ramachandran, Satya Krishna/0000-0002-7176-6375; Chung, Frances/0000-0001-9576-3606; Nagappa, Mahesh/0000-0001-8036-3319				Acar HV, 2014, EUR REV MED PHARMACO, V18, P1869; Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; BELLHOUSE CP, 1988, ANAESTH INTENS CARE, V16, P329, DOI 10.1177/0310057X8801600315; Brodsky JB, 2002, ANESTH ANALG, V94, P732, DOI 10.1097/00000539-200203000-00047; Cattano D, 2014, F1000RESEARCH, V3, P1, DOI DOI 10.12688/F1000RESEARCH.3-1.V2; Chou HC, 2001, ANESTHESIOLOGY, V94, P936, DOI 10.1097/00000542-200105000-00043; CHOU HC, 1993, BRIT J ANAESTH, V71, P335, DOI 10.1093/bja/71.3.335; Chung F, 2008, ANESTH ANALG, V107, P915, DOI 10.1213/ane.0b013e31817bd36f; Chung F, 2016, ANESTH ANALG, V123, P452, DOI 10.1213/ANE.0000000000001416; Cook TM, 2011, BRIT J ANAESTH, V106, P632, DOI 10.1093/bja/aer059; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Corso RM, 2014, MINERVA ANESTESIOL, V80, P877; Crosby ET, 1998, CAN J ANAESTH, V45, P757, DOI 10.1007/BF03012147; DAVIES RJO, 1990, EUR RESPIR J, V3, P509; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fouladpour N, 2016, ANESTH ANALG, V122, P145, DOI 10.1213/ANE.0000000000000841; Gokay P, 2016, J CLIN NURS, V25, P1238, DOI 10.1111/jocn.13133; Gross JB, 2014, ANESTHESIOLOGY, V120, P268, DOI 10.1097/ALN.0000000000000053; Han R, 2004, ANESTHESIOLOGY, V101, P267, DOI 10.1097/00000542-200407000-00059; HAPONIK EF, 1983, AM REV RESPIR DIS, V127, P221; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hiremath AS, 1998, BRIT J ANAESTH, V80, P606, DOI 10.1093/bja/80.5.606; HOFFSTEIN V, 1993, SLEEP, V16, P118; Kheterpal S, 2006, ANESTHESIOLOGY, V105, P885, DOI 10.1097/00000542-200611000-00007; Kheterpal S, 2013, ANESTHESIOLOGY, V119, P1360, DOI 10.1097/ALN.0000435832.39353.20; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P891, DOI 10.1097/ALN.0b013e31819b5b87; Kim JA, 2006, CAN J ANAESTH, V53, P393, DOI 10.1007/BF03022506; Leong SM, 2018, J CLIN ANESTH, V45, P63, DOI 10.1016/j.jclinane.2017.12.024; Liao P, 2009, CAN J ANAESTH, V56, P819, DOI 10.1007/s12630-009-9190-y; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Nagappa M, 2017, ANESTH ANALG, V125, P1301, DOI 10.1213/ANE.0000000000002344; Opperer M, 2016, ANESTH ANALG, V122, P1321, DOI 10.1213/ANE.0000000000001178; Ramachandran SK, 2017, ANESTH ANALG, V125, P272, DOI 10.1213/ANE.0000000000002132; Ramachandran SK, 2012, ANESTHESIOLOGY, V116, P1217, DOI 10.1097/ALN.0b013e318255e6ab; Ravesloot MJL, 2012, EUR ARCH OTO-RHINO-L, V269, P1865, DOI 10.1007/s00405-012-1948-0; Sabers C, 2003, ANESTH ANALG, V96, P1328, DOI 10.1213/01.ANE.0000061585.09157.66; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002; Shah Prerana N, 2012, J Anaesthesiol Clin Pharmacol, V28, P451, DOI 10.4103/0970-9185.101901; Shiga T, 2005, ANESTHESIOLOGY, V103, P429, DOI 10.1097/00000542-200508000-00027; Singh M, 2013, BRIT J ANAESTH, V110, P629, DOI 10.1093/bja/aes465; Siyam MA, 2002, ANESTH ANALG, V95, P1098, DOI 10.1097/00000539-200210000-00058; Solow B, 1996, EUR J ORTHODONT, V18, P571; STRELZOW VV, 1988, LARYNGOSCOPE, V98, P1149; Subramani Y, 2017, BRIT J ANAESTH, V119, P885, DOI 10.1093/bja/aex341; Toshniwal G, 2014, J CLIN ANESTH, V26, P360, DOI 10.1016/j.jclinane.2014.01.010; Wells G., 2014, NEWCASTLE OTTAWA SCA; WHITE A, 1975, BRIT J ANAESTH, V47, P468, DOI 10.1093/bja/47.4.468	49	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204904	10.1371/journal.pone.0204904	http://dx.doi.org/10.1371/journal.pone.0204904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286122	Green Submitted, gold, Green Published			2022-12-27	WOS:000446383500061
J	Owens, CA; Peterson, CB; Tang, C; Koay, EJ; Yu, W; Mackin, DS; Li, J; Salehpour, MR; Fuentes, DT; Court, LE; Yang, JZ				Owens, Constance A.; Peterson, Christine B.; Tang, Chad; Koay, Eugene J.; Yu, Wen; Mackin, Dennis S.; Li, Jing; Salehpour, Mohammad R.; Fuentes, David T.; Court, Laurence E.; Yang, Jinzhong			Lung tumor segmentation methods: Impact on the uncertainty of radiomics features for non-small cell lung cancer	PLOS ONE			English	Article							CT; REPRODUCIBILITY; RELIABILITY; DELINEATION	Purpose To evaluate the uncertainty of radiomics features from contrast-enhanced breath-hold helical CT scans of non-small cell lung cancer for both manual and semi-automatic segmentation due to intra-observer, inter-observer, and inter-software reliability. Methods Three radiation oncologists manually delineated lung tumors twice from 10 CT scans using two software tools (3D-Slicer and MIM Maestro). Additionally, three observers without formal clinical training were instructed to use two semi-automatic segmentation tools, Lesion Sizing Toolkit (LSTK) and GrowCut, to delineate the same tumor volumes. The accuracy of the semi-automatic contours was assessed by comparison with physician manual contours using Dice similarity coefficients and Hausdorff distances. Eighty-three radiomics features were calculated for each delineated tumor contour. Informative features were identified based on their dynamic range and correlation to other features. Feature reliability was then evaluated using intra-class correlation coefficients (ICC). Feature range was used to evaluate the uncertainty of the segmentation methods. Results From the initial set of 83 features, 40 radiomics features were found to be informative, and these 40 features were used in the subsequent analyses. For both intra-observer and interobserver reliability, LSTK had higher reliability than GrowCut and the two manual segmentation tools. All observers achieved consistently high ICC values when using LSTK, but the ICC value varied greatly for each observer when using GrowCut and the manual segmentation tools. For inter-software reliability, features were not reproducible across the software tools for either manual or semi-automatic segmentation methods. Additionally, no feature category was found to be more reproducible than another feature category. Feature ranges of LSTK contours were smaller than those of manual contours for all features. Conclusion Radiomics features extracted from LSTK contours were highly reliable across and among observers. With semi-automatic segmentation tools, observers without formal clinical training were comparable to physicians in evaluating tumor segmentation.	[Owens, Constance A.; Mackin, Dennis S.; Salehpour, Mohammad R.; Court, Laurence E.; Yang, Jinzhong] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Owens, Constance A.; Peterson, Christine B.; Mackin, Dennis S.; Court, Laurence E.; Yang, Jinzhong] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Peterson, Christine B.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Tang, Chad; Koay, Eugene J.; Li, Jing] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Yu, Wen] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Radiat Oncol, Shanghai, Peoples R China; [Fuentes, David T.; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center	Owens, CA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.; Owens, CA (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA.	caowens@mdanderson.org	Mackin, Dennis/Y-1503-2019	Mackin, Dennis/0000-0002-2557-5340; Court, Laurence/0000-0002-3241-6145; Peterson, Christine/0000-0003-3316-0468; Owens, Constance/0000-0001-7208-394X	Cancer Prevention Research Institute of Texas [RP110562]; National Institutes of Health/National Cancer Institute through Cancer Center Support Grant [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; National Institutes of Health/National Cancer Institute through Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge financial support from the Cancer Prevention Research Institute of Texas (URL: http://www.cprit.state.tx.us/) grant under award number RP110562. J.Y. and L.C. are the authors that received this fund. The authors acknowledge financial support from the National Institutes of Health/National Cancer Institute (URL: https://cancercenters.cancer.gov/) through Cancer Center Support Grant under award number P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, DECODING TUMOR PHENO, V5, DOI [10.1038/ncomms5006, DOI 10.1038/NCOMMS5006]; Aerts HJWL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33860; Ashraf H, 2010, EUR RADIOL, V20, P1878, DOI 10.1007/s00330-010-1749-z; Balagurunathan Y, 2014, J DIGIT IMAGING, V27, P805, DOI 10.1007/s10278-014-9716-x; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; CICCHETTI DV, 1985, APPL PSYCH MEAS, V9, P31, DOI 10.1177/014662168500900103; Court LE, 2016, TRANSL CANCER RES, V5, P340, DOI 10.21037/tcr.2016.06.17; Echegaray S, 2017, J DIGIT IMAGING JOUR, V4, P1, DOI [10.1007/s10278-016-9926-5, DOI 10.1007/S10278-016-9926-5]; Fave X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00665-z; Fave X, 2015, COMPUT MED IMAG GRAP, V44, P54, DOI 10.1016/j.compmedimag.2015.04.006; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gu YH, 2013, PATTERN RECOGN, V46, P692, DOI 10.1016/j.patcog.2012.10.005; Hodkinson DJ, 2013, NEUROIMAGE-CLIN, V3, P301, DOI 10.1016/j.nicl.2013.09.004; Huang YQ, 2016, RADIOLOGY, V281, P947, DOI 10.1148/radiol.2016152234; Hunter LA, 2013, MED PHYS, V40, DOI 10.1118/1.4829514; Jackson SE, 2015, INT J CANCER, V137, P262, DOI 10.1002/ijc.28940; Jameson MG, 2010, J MED IMAG RADIAT ON, V54, P401, DOI 10.1111/j.1754-9485.2010.02192.x; Kalpathy-Cramer J, 2016, TOMOGRAPHY, V2, P430, DOI 10.18383/j.tom.2016.00235; Kalpathy-Cramer J, 2016, J DIGIT IMAGING, V29, P476, DOI 10.1007/s10278-016-9859-z; Kong FM, 2017, JAMA ONCOL, V3, P1358, DOI 10.1001/jamaoncol.2017.0982; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Krishnan K, 2010, OPT EXPRESS, V18, P15256, DOI 10.1364/OE.18.015256; Kumar V, 2013, QIN RADIOMICS PROCES, V30, P1234, DOI [10.1016/j.mri.2012.06.010.QIN, DOI 10.1016/J.MRI.2012.06.010.QIN]; Lee M, 2017, KOREAN J RADIOL, V18, P498, DOI 10.3348/kjr.2017.18.3.498; Liu B, 2015, MED PHYS, V42, P3458, DOI 10.1118/1.4924898; Lu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166550; Mackin D, 2017, HARMONIZING PIXEL SI, V9, DOI [10.1371/journal.pone.0178524, DOI 10.1371/JOURNAL.PONE.0178524]; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Njeh CF, 2008, J MED PHYS, V33, P136, DOI 10.4103/0971-6203.44472; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Qiu QT, 2017, TRANSL CANCER RES, V6, P940, DOI 10.21037/tcr.2017.09.47; Stewart J, 2012, RTOG 1106 ACRIN 6697; Velazquez ER, 2013, SCI REP-UK, V3, DOI 10.1038/srep03529; Vinod SK, 2016, J MED IMAG RADIAT ON, V60, P393, DOI 10.1111/1754-9485.12462; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Yang JZ, 2016, COMPUT MED IMAG GRAP, V48, P1, DOI 10.1016/j.compmedimag.2015.12.001; Yip SSF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178944; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zhang ZJ, 2018, EUR RADIOL, V28, P2255, DOI 10.1007/s00330-017-5154-8; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428	43	41	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205003	10.1371/journal.pone.0205003	http://dx.doi.org/10.1371/journal.pone.0205003			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286184	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500073
J	Yen, FS; Chen, WS; Wei, JCC; Hsu, CC; Hwu, CM				Yen, Fu-Shun; Chen, Weishan; Wei, James Cheng-Chung; Hsu, Chih-Cheng; Hwu, Chii-Min			Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RISK; VALIDATION; MELLITUS; CANCER; LUNG; EXACERBATIONS; TAIWAN; COPD; AMPK	Backgrounds Few studies have investigated the therapeutic effects of metformin in patients with type 2 diabetes mellitus (T2DM) and chronic obstructive pulmonary disease (COPD). We compared the risk of all-cause mortality between metformin users and nonusers. Methods We conducted a retrospective cohort study for patients with T2DM and COPD who were enrolled between January 1, 2000 and June 30, 2012. Individuals with exacerbated symptoms who were hospitalized or sent to the emergency department (ED) were identified as having exacerbated COPD; outpatient claims were identified as having stable COPD. A total of 40,597 metformin users and 39,529 nonusers comprised the cohort of stable COPD; 14,001 metformin users and 21,613 nonusers comprised the cohort of exacerbated COPD. Users and nonusers were matched using propensity score (1:1). Our primary outcome was all-cause mortality. Results A total of 19,505 metformin users were matched to 19,505 nonusers in the cohort of diabetes with stable COPD. The mean follow-up time was 3.91 years. All-cause mortality was reported in 1326 and 1609 metformin users and nonusers, respectively. After multivariate adjustment, metformin users had lower risk of mortality (adjusted hazard ratio [aHR] = 0.84, p < 0.0001). Metformin users had significantly lower risk of noncardiovascular death (aHR = 0.86, p = 0.0008). A total of 7721 metformin users were matched to 7721 nonusers in the cohort of diabetes with exacerbated COPD. The mean follow-up time was 3.18 years. Allcause mortality was reported in 1567 and 1865 metformin users and nonusers, respectively. After multivariate adjustment, metformin users had significantly lower risk of mortality (aHR = 0.89, p = 0.002) and cardiovascular death (aHR = 0.70, p = 0.01). Conclusion This large-series, nationwide cohort study demonstrated that metformin use could significantly lower the risk of all-cause mortality in patients with T2DM and either stable or exacerbated COPD.	[Yen, Fu-Shun] Dr Yens Clin, Taoyuan, Taiwan; [Chen, Weishan] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Weishan] China Med Univ, Coll Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan; [Hwu, Chii-Min] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Hwu, Chii-Min] Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; National Health Research Institutes - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Hsu, CC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.; Hsu, CC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Hsu, CC (corresponding author), Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan.; Hwu, CM (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Hwu, CM (corresponding author), Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan.	cch@nhri.org.tw; chhwu@vghtpe.gov.tw	Wei, James Cheng-Chung/AAL-8947-2020; Yen, Fu-Shun/K-3854-2019; Hwu, Chii-Min/AAZ-7384-2021; Chen, Wei/GZK-7348-2022	Wei, James Cheng-Chung/0000-0002-1235-0679; YEN, FU-SHUN/0000-0002-4677-2415	Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005).", Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan (WC received the funding). The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding authors had full access to all data in the study and had final responsibility for the decision to submit for publication.	Abbasi A A, 2000, Endocr Pract, V6, P442; Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; Caughey GE, 2010, DIABETES RES CLIN PR, V87, P385, DOI 10.1016/j.diabres.2009.10.019; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Garnett JP, 2013, THORAX, V68, P835, DOI 10.1136/thoraxjnl-2012-203178; Glaser S, 2015, RESPIRATION, V89, P253, DOI 10.1159/000369863; Glucophage (metformin hydrochloride) tablets, 2009, GLUC METF HYDR TABL; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Hicks KA, STANDARDIZED DEFINIT; Hitchings AW, 2016, THORAX, V71, P587, DOI 10.1136/thoraxjnl-2015-208035; Hitchings AW, 2015, COPD, V12, P126, DOI [10.3109/15412555.2014.898052, 10.3109/15412555.2015.898052]; Iezzoni LI, 1997, RISK ADJUSTMENT MEAS; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Ito K, 2014, EXP GERONTOL, V59, P21, DOI 10.1016/j.exger.2014.03.014; Kim HJ, 2010, INT J TUBERC LUNG D, V14, P362; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9; Rana JS, 2004, DIABETES CARE, V27, P2478, DOI 10.2337/diacare.27.10.2478; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Sexton P, 2014, COPD, V11, P133, DOI 10.3109/15412555.2013.808614; Song P, 2012, FREE RADICAL BIO MED, V52, P1607, DOI 10.1016/j.freeradbiomed.2012.01.025; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Tseng CH, 2019, DIABETES METAB, V45, P184, DOI 10.1016/j.diabet.2018.05.001; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Young BA, 2008, AM J MANAG CARE, V14, P15; Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	41	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204859	10.1371/journal.pone.0204859	http://dx.doi.org/10.1371/journal.pone.0204859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286138	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500052
J	Hollund, HI; Blank, M; Sjogren, KG				Hollund, Hege Ingjerd; Blank, Malou; Sjogren, Karl-Goran			Dead and buried? Variation in post-mortem histories revealed through histotaphonomic characterisation of human bone from megalithic graves in Sweden	PLOS ONE			English	Article							DIAGENETIC ALTERATION; ARCHAEOLOGICAL BONE; MICROBIAL ATTACK; CAVES; MUMMIFICATION; DEGRADATION; MANGANESE; BRITAIN; CARRION	This study investigates possible variation in post-mortem histories during the Neolithic period in southwestern Sweden based on microscopic studies of human bone. Numerous megalithic graves were built in this region and good preservation conditions have left a rich skeletal record. After more than a hundred years of research, it is still a controversy whether or not these skeletal assemblages were the result of primary burials, or ossuaries where skeletonized remains were deposited. In this study we apply histological analysis to obtain insights into post-mortem histories and taphonomic processes affecting the human remains, potentially including funerary rituals. This type of analysis records the condition and traces of degradation found in skeletal material at a microscopic level. Human skeletal material from four different megalithic tombs in the Falbygden area has been sampled and analysed by thin-section light microscopy, and by scanning electron microscopy. The results of the study provide evidence of variation and changes in burial conditions for skeletal remains from the different graves, also for remains from the same grave. Extent of bioerosion varied, from extensive to moderate/arrested, to none. Bone samples from the same graves also differed in the type of staining and mineral inclusions, showing that the non-bioeroded samples relatively early post-mortem must have experienced an anoxic environment, and later a change to an aerated environment. This could be taken as an indication of primary burial somewhere else, but more likely reflect a special micro-environment occurring temporarily in some graves and parts of graves after the tombs were filled with soil and sealed by roof slabs. The study illustrates the usefulness of bone histological analysis in the reconstruction of post-mortem histories, revealing variations not discernible at macro-level that may aid in the interpretations of funerary rituals. However, the results also highlight the issues of equifinality. Based on current data and knowledge, several scenarios are possible. Further histotaphonomic work is advisable, including archaeological remains from megalithic tombs, and bones from taphonomic experiments.	[Hollund, Hege Ingjerd] Univ Stavanger, Museum Archaeol, Stavanger, Norway; [Blank, Malou; Sjogren, Karl-Goran] Univ Gothenburg, Dept Hist Studies, Gothenburg, Sweden	Universitetet i Stavanger; University of Gothenburg	Hollund, HI (corresponding author), Univ Stavanger, Museum Archaeol, Stavanger, Norway.	hege.hollund@uis.no		Sjogren, Karl-Goran/0000-0003-1791-3175; Hollund, Hege Ingjerd/0000-0002-1274-669X	Wilhelm & Martina Lundgrens stiftelser	Wilhelm & Martina Lundgrens stiftelser	Preparation of thin-sections for histological analyses was funded by a grant from Wilhelm & Martina Lundgrens stiftelser (http://www.wmlundgren.se/) (M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom T, 2004, COAST COAST ARRIVAL, V10, P233; Ahlstrom T., 2009, UNDERJORDISKA DODSRI; Algotsson A., 1996, SLM RAPPORT; Anderbjork JE, 1932, V STERG TLANDS FORNM, VIV, P5; Anderson GS, 2011, J FORENSIC SCI, V56, P136, DOI 10.1111/j.1556-4029.2010.01539.x; Anderson GS, 1996, J FORENSIC SCI, V41, P617; [Anonymous], 1995, ANN SOC GEOL POL; BELL LS, 1991, SCANNING, V13, P173, DOI 10.1002/sca.4950130204; Bell LS, 1996, FORENSIC SCI INT, V82, P129, DOI 10.1016/0379-0738(96)01984-6; Bell LS, 2012, Bone Histology: An Anthropological Perspective, P241; Bianucci R., 2012, J ARCHAEOLOGY LOW CO, V4, P37; Blank M., 2016, LUND ARCHAEOL REV, V21, P49; Booth TJ, 2016, ARCHAEOMETRY, V58, P484, DOI 10.1111/arcm.12190; Booth TJ, 2016, J ARCHAEOL SCI, V74, P124, DOI 10.1016/j.jas.2016.08.007; Booth TJ, 2016, J ARCHAEOL SCI, V67, P14, DOI 10.1016/j.jas.2016.01.010; Booth TJ, 2015, ANTIQUITY, V89, P1155, DOI 10.15184/aqy.2015.111; Chambon P, 2003, MORTS SEPILTURES COL; Dal Sasso G, 2014, PALAEOGEOGR PALAEOCL, V416, P30, DOI 10.1016/j.palaeo.2014.06.034; During E., 1986, FAUNA ALVASTRA OSTEO; Fernandez-Jalvo Y, 2010, PALAEOGEOGR PALAEOCL, V288, P62, DOI 10.1016/j.palaeo.2009.12.016; Fischer C., 1985, MUMMIES DIS ANCIENT, P177; Force ER, 1989, MANGANESE CONTENTS S; Fowler C, 2010, DOC PRAEHIST, V37, P1, DOI 10.4312/dp.37.1; Fries M., 1951, POLLENANALYTISKA VIT; Fries M., 1958, VEGETATIONSUTVECKLIN; Garland A. N., 1993, HISTOLOGY ANCIENT HU, DOI [10.1007/978-3-642-77001-2, DOI 10.1007/978-3-642-77001-2]; Garland AN, 1989, APPL GEOCHEM, V4, P215, DOI DOI 10.1016/0883-2927(89)90021-8; Gill-Robinson HC, 2000, BRIT ARCHAEOLOGICAL, V1035, P111; GOFF ML, 1991, J FORENSIC SCI, V36, P748; GREENSLATE J, 1974, SCIENCE, V186, P529, DOI 10.1126/science.186.4163.529; HACKETT CJ, 1981, MED SCI LAW, V21, P243, DOI 10.1177/002580248102100403; Hanson M, 2007, J ARCHAEOL SCI, V34, P1902, DOI 10.1016/j.jas.2007.01.009; HEDGES REM, 1995, J ARCHAEOL SCI, V22, P201, DOI 10.1006/jasc.1995.0022; Hildebrand BE, 1864, ANTIQVARISK TIDSKRIF, VI, P255; HILL C A, 1982, NSS Bulletin, V44, P15; Hollund HI, 2012, INT J OSTEOARCHAEOL, V22, P537, DOI 10.1002/oa.1273; Huisman H, 2017, J ARCHAEOL SCI, V85, P13, DOI 10.1016/j.jas.2017.06.016; Jans MME, 2004, J ARCHAEOL SCI, V31, P87, DOI 10.1016/j.jas.2003.07.007; Jans MME, 2005, HISTOLOGIAL CHARACTE; Karkanas P, 2000, J ARCHAEOL SCI, V27, P915, DOI 10.1006/jasc.1999.0506; Kendall C, 2018, PALAEOGEOGR PALAEOCL, V491, P21, DOI 10.1016/j.palaeo.2017.11.041; Lelong O., 2014, P SOC ANTIQUARIES SC, V144, P65; Liljegren R., 1993, FRAN MAMMUTSTAPP KOH; Lopez-Gonzalez F, 2006, J ARCHAEOL SCI, V33, P707, DOI 10.1016/j.jas.2005.10.006; Lynnerup N, 2007, YEARB PHYS ANTHROPOL, V50, P162, DOI 10.1002/ajpa.20728; McBride M. B., 1994, ENV CHEM SOILS; MIDDELBURG JJ, 1988, MAR CHEM, V23, P353, DOI 10.1016/0304-4203(88)90104-1; Midgley MS, 2008, MEGALITHS NO EUROPE; Millard A., 2001, HDB ARCHAEOLOGICAL S, P637; Montelius, 1873, MBL, V2, P10; Muller K, 2011, PALAEOGEOGR PALAEOCL, V310, P39, DOI 10.1016/j.palaeo.2011.03.023; Nicholson RA, 1998, J ARCHAEOL SCI, V25, P393, DOI 10.1006/jasc.1997.0208; Nielsen-Marsh CM, 2007, J ARCHAEOL SCI, V34, P1523, DOI 10.1016/j.jas.2006.11.012; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Owocki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146293; Painter T. J., 1995, BOG BODIES NEW DISCO, P88; Pearson MP, 2007, ANTIQUITY, V81, P617, DOI 10.1017/S0003598X00095624; Pearson MP, 2005, ANTIQUITY, V79, P529; Persson P., 2001, FALBYGDENS GANGGRIFT, V34; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Sahlstrom KE, 1932, GUDHEMS HARADS FORNM; Sahlstrom KE, 1927, UNDERSOKNING BERGA H; Salesse K, 2014, PALAEOGEOGR PALAEOCL, V416, P43, DOI 10.1016/j.palaeo.2014.07.021; Shanks M., 1982, SYMBOLIC STRUCTURAL, P129, DOI DOI 10.1017/CB09780511558252.013; Sjogren K., 2011, EXPLORING TIME MATTE, P103; Sjogren K.G, 2003, MEGALITGRAVAR SAMHAL; Sjogren K. G, 2015, NEOLITHIC DIVERSITIE, P200; Sjogren K- G, 2017, J NEOLITHIC ARCHAEOL, V19, P97, DOI DOI 10.12766/JNA.2017.4; Sjogren K-G, 2008, 62 GOT U; Sjogren KG, 2017, J ARCHAEOL SCI-REP, V12, P295, DOI 10.1016/j.jasrep.2017.01.044; Sjogren KG, 2009, J ANTHROPOL ARCHAEOL, V28, P85, DOI 10.1016/j.jaa.2008.10.001; Sjogren Karl-Goran, 2015, OXFORD HDB NEOLITHIC, P1005; Smith CI, 2007, J ARCHAEOL SCI, V34, P1485, DOI 10.1016/j.jas.2006.11.006; Smith MJ, 2016, J ARCHAEOL SCI-REP, V10, P744, DOI 10.1016/j.jasrep.2016.05.034; Sorensen TF, 2016, J ARCHAEOL METHOD TH, V23, P741, DOI 10.1007/s10816-015-9257-8; Stenskold Eva, 2004, ATT BERATTA SENNEOLI; Stromberg M., 1971, PROBLEMATIK GRABBAUT; Terrell-Nield Chris, 1997, Cave and Karst Science, V24, P53; Tilley C, 1996, ETNOGRAPHY NEOLITHIC; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; Trueman CNG, 2004, J ARCHAEOL SCI, V31, P721, DOI 10.1016/j.jas.2003.11.003; Turner-Walker G., 2007, 10 TRIENN M ICOM CC, P659; Turner-Walker G, 2008, PALAEOGEOGR PALAEOCL, V266, P227, DOI 10.1016/j.palaeo.2008.03.024; Turner-Walker G, 2008, PALAEOGEOGR PALAEOCL, V266, P151, DOI 10.1016/j.palaeo.2008.03.027; Ullenius G, 1948, GRAVNINGSBERATTELSE; van der Sluis LG, 2014, PALAEOGEOGR PALAEOCL, V416, P80, DOI 10.1016/j.palaeo.2014.06.003; Weiler E., 1977, FORNLAMNING, V5; Weiler E, STUDIA ARCHAEOLOGICA, V5; White L, 2014, FORENSIC SCI INT, V239, P92, DOI 10.1016/j.forsciint.2014.03.024	89	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204662	10.1371/journal.pone.0204662	http://dx.doi.org/10.1371/journal.pone.0204662			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281639	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400053
J	Tsuchiya, K; Tabe, Y; Ai, T; Ohkawa, T; Usui, K; Yuri, M; Misawa, S; Morishita, S; Takaku, T; Kakimoto, A; Yang, H; Matsushita, H; Hanami, T; Yamanaka, Y; Okuzawa, A; Horii, T; Hayashizaki, Y; Ohsaka, A				Tsuchiya, Koji; Tabe, Yoko; Ai, Tomohiko; Ohkawa, Takahiro; Usui, Kengo; Yuri, Maiko; Misawa, Shigeki; Morishita, Soji; Takaku, Tomoiku; Kakimoto, Atsushi; Yang, Haeun; Matsushita, Hiromichi; Hanami, Takeshi; Yamanaka, Yasunari; Okuzawa, Atsushi; Horii, Takashi; Hayashizaki, Yoshihide; Ohsaka, Akimichi			Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes	PLOS ONE			English	Article							MINIMAL-RESIDUAL-DISEASE; ACUTE MYELOID-LEUKEMIA; PCR; TIME; TRANSCRIPTS; BIOLOGY; SYSTEM	The detection and quantification of leukemia-associated fusion gene transcripts play important roles in the diagnosis and follow-up of leukemias. To establish a standardized method without interlaboratory discrepancies, we developed a novel one-step reverse transcription quantitative PCR (RT-qPCR) assay, called "the Eprobe leukemia assay," for major and minor BCR-ABL1, RUNX1-RUNX1T1, and various isoforms of PML-RARA. This assay is comprised of Eprobes that are exciton-controlled hybridization-sensitive fluorescent oligonucleotides. Melting curve analyses were performed on synthetic quantitative standard RNAs with strict quality control. Quantification capacity was evaluated by comparison with TaqMan RT-qPCR using 67 primary leukemia patient samples. The lower limit of detection and the limit of quantification of this assay were less than 31.3 copies/reaction and 62.5 copies/reaction, respectively. This assay correctly detected the fusion genes in samples with 100% sensitivity and specificity. The specificity of the reactions was confirmed by melting curve analyses. The assay detected low-level expression of minor BCR-ABL1 co-expressed with major BCR-ABL1. These results illustrate the feasibility and high accuracy of the Eprobe leukemia assay, even for minimal residual disease monitoring.	[Tsuchiya, Koji; Yuri, Maiko; Misawa, Shigeki; Horii, Takashi; Ohsaka, Akimichi] Juntendo Univ Hosp, Div Clin Lab, Tokyo, Japan; [Tsuchiya, Koji; Morishita, Soji; Kakimoto, Atsushi; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo, Japan; [Tabe, Yoko; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan; [Tabe, Yoko; Ai, Tomohiko; Yang, Haeun] Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Ohkawa, Takahiro; Usui, Kengo] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Nucle Acid Diagnost Syst Dev Unit, Yokohama, Kanagawa, Japan; [Usui, Kengo; Hanami, Takeshi] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Genet Diag Technol Unit, Yokohama, Kanagawa, Japan; [Takaku, Tomoiku] Juntendo Univ, Dept Hematol, Sch Med, Tokyo, Japan; [Matsushita, Hiromichi] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan; [Yamanaka, Yasunari; Hayashizaki, Yoshihide] RIKEN, Prevent Med & Diag Innovat Program, Wako, Saitama, Japan; [Okuzawa, Atsushi] Juntendo Univ, Innovat Med Technol Res & Dev Ctr, Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; RIKEN; RIKEN; Juntendo University; National Cancer Center - Japan; RIKEN; Juntendo University	Tabe, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan.; Tabe, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan.	tabe@juntendo.ac.jp	松下, 弘道/AEX-6164-2022	松下, 弘道/0000-0002-1629-6630; Tabe, YOKO/0000-0002-3734-0346; Ai, Tomohiko/0000-0003-0376-0227	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan [S1311011];  [C15K08653];  [C16K08984]	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan; ; 	This work was supported in part by a Grant-in-Aid for Scientific Research (C15K08653, C16K08984), Japan, a Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan (to Y.T.).	Arber DA, 2017, ARCH PATHOL LAB MED, V141, P1342, DOI 10.5858/arpa.2016-0504-CP; Atsumi J, 2015, ONCOL REP, V33, P2719, DOI 10.3892/or.2015.3883; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bibault JE, 2015, ONCOTARGET, V6, P22812, DOI 10.18632/oncotarget.4333; Cazzaniga Giovanni, 2003, Rev Clin Exp Hematol, V7, P292; Corradi B, 2008, LEUKEMIA, V22, P294, DOI 10.1038/sj.leu.2404987; de Reynies A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-51; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Goulden N, 2006, BRIT J HAEMATOL, V134, P273, DOI 10.1111/j.1365-2141.2006.06182.x; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; Keen-Kim D, 2006, EXPERT REV MOL DIAGN, V6, P287, DOI 10.1586/14737159.6.3.287; Kern W, 2005, CRIT REV ONCOL HEMAT, V56, P283, DOI 10.1016/j.critrevonc.2004.06.004; Kern Wolfgang, 2005, Rev Clin Exp Hematol, V9, pE1; Kimura Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146950; Kimura Y, 2012, BIOCHEMISTRY-US, V51, P6056, DOI 10.1021/bi300293d; Mrozek Krzysztof, 2006, Hematology Am Soc Hematol Educ Program, P169; Pui Ching-Hon, 2004, Hematology Am Soc Hematol Educ Program, P118; Rodriguez-Lazaro D, 2005, APPL ENVIRON MICROB, V71, P9008, DOI 10.1128/AEM.71.12.9008-9012.2005; Ruiz MS, 2016, LEUKEMIA, V30, P2258, DOI 10.1038/leu.2016.197; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; vanRhee F, 1996, BLOOD, V87, P5213, DOI 10.1182/blood.V87.12.5213.bloodjournal87125213; Wu D, 2014, CLIN CANCER RES, V20, P4540, DOI 10.1158/1078-0432.CCR-13-3231; Yamada H, 2015, INT J LAB HEMATOL, V37, pe29, DOI 10.1111/ijlh.12274	23	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202429	10.1371/journal.pone.0202429	http://dx.doi.org/10.1371/journal.pone.0202429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281597	gold, Green Submitted, Green Published			2022-12-27	WOS:000446342400011
J	Wronska, AK; Bogus, MI; Kaczmarek, A; Kazek, M				Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena; Kaczmarek, Agata; Kazek, Michalina			Harman and norharman, metabolites of entomopathogenic fungus Conidiobolus coronatus (Entomopthorales), disorganize development of Galleria mellonella (Lepidoptera) and affect serotonin-regulating enzymes	PLOS ONE			English	Article							BETA-CARBOLINE ALKALOIDS; CONIDIOBOLUS-CORONATUS; TOLYPOCLADIUM; METARHIZIUM; DROSOPHILA; GROWTH; INHIBITION; SUBSTANCES; DOPAMINE; INSECTS	Naturally occurring entomopathogenic fungi such as Conidiobolus coronatus are important regulatory factors of insect populations. GC-MS analysis of fungal cell-free filtrates showed that C. coronatus synthesizes two beta-carboline alkaloids: harman and norharman. Significantly higher levels of both alkaloids are produced by C. coronatus in minimal postincubation medium than in rich medium. The beta-carboline alkaloids may have an effect on the nervous system of insects and their behavior. Harman and norharman were applied to Galleria mellonella larvae (a parasite of honeybees) either topically or mixed with food. Larvae received alkaloids in three concentrations: 750, 1000 or 1250 ppm. The effect on the survival and further development of larvae was examined. Both harman and norharman delayed pupation and adult eclosion, and inhibit total monoamine oxidase activity. In addition, they increased the serotonin concentration and decreased the monoamine oxidase A level in the heads of the moths. It is likely that the alkaloids were metabolized by the insects, as their effect wore off 24 hours after topical application. This is the first study to show that C. coronatus produces alkaloids. Its aim was to identify the actions of beta-carboline alkaloids on insect development and serotonin-regulating enzymes. Knowledge of the potential role of harman and norharman in the process of fungal infection might lead to the development of more effective and environmentally-friendly means of controlling insect pests.	[Wronska, Anna Katarzyna; Bogus, Mieczyslawa Irena; Kaczmarek, Agata; Kazek, Michalina] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [Bogus, Mieczyslawa Irena] BIOMIBO, Warsaw, Poland	Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Wronska, AK (corresponding author), Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland.	a.wronska@twarda.pan.pl	Wrońska, Anna/HHZ-6185-2022; Kaczmarek, Agata/ABG-3202-2020; Kaczmarek, Agata/ABG-3240-2020; Wrońska, Anna/AAN-8684-2020	Wrońska, Anna/0000-0001-5171-0828; Kaczmarek, Agata/0000-0001-7319-7973; Kaczmarek, Agata/0000-0001-7319-7973; 	Institute of Parasitology PAS in Warsaw; National Science Center Poland [2017/01/X/NZ3/00265]	Institute of Parasitology PAS in Warsaw; National Science Center Poland(National Science Centre, Poland)	The main source of financing were statutory funds from the resources of the Institute of Parasitology PAS in Warsaw. This work was partly supported by National Science Center Poland grant 2017/01/X/NZ3/00265; project manager Dr. Anna Wronska. Biomibo provided support in the form of a salary to MIB and made laboratory equipment available for AKW, MK, and AK. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELL A, 1995, NEUROCHEM RES, V20, P209, DOI 10.1007/BF00970546; Contreras-Cornejo HA, 2018, APPL SOIL ECOL, V124, P45, DOI 10.1016/j.apsoil.2017.10.004; Bandani AR, 2000, MYCOL RES, V104, P537, DOI 10.1017/S0953756299001859; Bania J, 2006, ARCH INSECT BIOCHEM, V62, P186, DOI 10.1002/arch.20134; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Benny GL, 2001, MYCOTA, V7, P113; Bogus MI, 2017, B ENTOMOL RES, V107, P66, DOI 10.1017/S0007485316000638; Bogus MI, 2002, ACTA PARASITOL, V47, P66; Bortolato M, 2010, HBK BEHAV NEUROSCI, V21, P203, DOI 10.1016/S1569-7339(10)70079-5; Bouayad N, 2012, SAUDI J BIOL SCI, V19, P73, DOI 10.1016/j.sjbs.2010.12.004; Cao RH, 2007, CURR MED CHEM, V14, P479, DOI 10.2174/092986707779940998; CAVIN JC, 1988, J CHEM ECOL, V14, P475, DOI 10.1007/BF01013899; Chang Y, 2015, GENOME BIOL EVOL, V7, P1590, DOI 10.1093/gbe/evv090; Coleman CM, 2005, ARCH INSECT BIOCHEM, V59, P12, DOI 10.1002/arch.20050; Dacks AM, 2003, J INSECT BEHAV, V16, P1, DOI 10.1023/A:1022817610378; Eamvijarn A, 2013, TETRAHEDRON, V69, P8583, DOI 10.1016/j.tet.2013.07.078; French AS, 2014, J INSECT PHYSIOL, V61, P8, DOI 10.1016/j.jinsphys.2013.12.005; Glennon RA, 2000, DRUG ALCOHOL DEPEN, V60, P121, DOI 10.1016/S0376-8716(99)00148-9; Golebiowski M, 2017, CHEM PAP, V71, P1183, DOI 10.1007/s11696-017-0178-8; Harding CR, 2013, JOVE-J VIS EXP, DOI 10.3791/50964; He J, 2005, J NAT PROD, V68, P1397, DOI 10.1021/np058018g; Heinz CA, 1996, ENTOMOL EXP APPL, V80, P443, DOI 10.1007/BF00343467; Herraiz T, 2008, CHEM RES TOXICOL, V21, P2172, DOI 10.1021/tx8002565; Hoge KT, 1996, MYCOLOGIA, V88, P715, DOI 10.2307/3760965; KODAIRA Y, 1961, AGR BIOL CHEM TOKYO, V25, P261, DOI 10.1080/00021369.1961.10857803; Kwadha CA, 2017, INSECTS, V8, DOI 10.3390/insects8020061; Lubeck I, 2008, FUNGAL ECOL, V1, P78, DOI 10.1016/j.funeco.2008.09.002; MAY T, 1991, J NEUROCHEM, V56, P490, DOI 10.1111/j.1471-4159.1991.tb08177.x; Muszewska A, 2014, EUR J CLIN MICROBIOL, V33, P1273, DOI 10.1007/s10096-014-2076-0; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; NOVAK MG, 1994, J MED ENTOMOL, V31, P600, DOI 10.1093/jmedent/31.4.600; Patel K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P660, DOI 10.1016/S2221-1691(12)60116-6; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Roberts D.W., 1981, BIOL CONIDIAL FUNGI, P201; ROMMELSPACHER H, 1994, EUR J PHARMACOL, V252, P51, DOI 10.1016/0014-2999(94)90574-6; Roy HE, 2008, EUR J ENTOMOL, V105, P391, DOI 10.14411/eje.2008.049; SEHNAL F, 1966, Z WISS ZOOL ABT A, V174, P53; Shah FA, 2005, FEMS MICROBIOL LETT, V251, P259, DOI 10.1016/j.femsle.2005.08.010; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690; Vey A., 2001, Fungi as biocontrol agents: progress, problems and potential, P311, DOI 10.1079/9780851993560.0311; Vikhe A., 2016, INT J PURE APPL BIOS, V4, P97, DOI DOI 10.18782/2320-7051.2303; WARNER HR, 1981, NUCLEIC ACIDS RES, V9, P6083, DOI 10.1093/nar/9.22.6083; WIELOCH W, 2007, ACTA BIOCHIM POL, V54, P79; Wieloch W, 2011, TOXICON, V58, P369, DOI 10.1016/j.toxicon.2011.07.007; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhao T, 2012, FOOD CHEM, V134, P1096, DOI 10.1016/j.foodchem.2012.03.024	48	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204828	10.1371/journal.pone.0204828	http://dx.doi.org/10.1371/journal.pone.0204828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281642	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400060
J	McWethy, DB; Pauchard, A; Garcia, RA; Holz, A; Gonzalez, ME; Veblen, TT; Stahl, J; Currey, B				McWethy, David B.; Pauchard, Anibal; Garcia, Rafael A.; Holz, Andres; Gonzalez, Mauro E.; Veblen, Thomas T.; Stahl, Julian; Currey, Bryce			Landscape drivers of recent fire activity (2001-2017) in south-central Chile (vol 13, e0201195, 2018)	PLOS ONE			English	Correction													Veblen, Thomas T./U-6461-2018; González, Mauro E./AAH-7569-2019; Holz, Andres/D-1826-2014; Pauchard, Anibal/B-5034-2008	Holz, Andres/0000-0002-8587-2603; Pauchard, Anibal/0000-0003-1284-3163; Gonzalez, Mauro/0000-0002-4333-724X				McWethy DB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201195	1	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205287	10.1371/journal.pone.0205287	http://dx.doi.org/10.1371/journal.pone.0205287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278062	Green Submitted, Green Published, gold			2022-12-27	WOS:000446010200041
J	Burkard, T; Trendelenburg, M; Daikeler, T; Hess, C; Bremerich, J; Haaf, P; Buser, P; Zellweger, MJ				Burkard, Thilo; Trendelenburg, Marten; Daikeler, Thomas; Hess, Christoph; Bremerich, Jens; Haaf, Philip; Buser, Peter; Zellweger, Michael J.			The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; REVISED CRITERIA; INVOLVEMENT; ENHANCEMENT; PERFUSION; CLASSIFICATION; PREVALENCE; PROGNOSIS; SYMPTOMS	Background In systemic lupus erythematosus (SLE), cardiac manifestations, e.g. coronary artery disease (CAD) and myocarditis are leading causes of morbidity and mortality. The prevalence of subclinical heart disease in SLE is unknown. We studied whether a comprehensive cardiovascular magnetic resonance (CMR) protocol may be useful for early diagnosis of heart disease in SLE patients without known CAD. Methods In this prospective, observational, cross-sectional study CMR including cine, late gadolinium enhancement (LGE) and stress perfusion sequences, ECG, and blood sampling were performed in 30 consecutive SLE patients without known CAD. All patients fulfilled at least 4/11 American College of Rheumatology (ACR) Criteria for the classification of SLE. Results 30 patients (83% female) were enrolled, mean age was 45 +/- 14 years and mean SLE disease duration was 10 +/- 8 years. 80% had low to moderate disease activity. All had a low SLE damage index. CMR was abnormal in 13/30 (43%), showing LGE in 9/13, stress perfusion deficits in 5/13 and pericardial effusion (PE) in 7/13. Patients with non-ischemic LGE had more often microalbuminuria while patients with stress perfusion deficits a history of hypertension, renal disorder as ACR criterion, repolarisation abnormalities on ECG and larger LV enddiastolic volume index. There was no correlation between clinical symptoms and CMR results. Conclusion Our study shows that cardiac involvement as observed by CMR is frequent in SLE and not necessarily associated with typical symptoms. CMR may thus help to detect subclinical cardiac involvement, which could lead to earlier treatment. Additionally we identify possible risk factors associated with cardiac involvement.	[Burkard, Thilo; Haaf, Philip; Buser, Peter; Zellweger, Michael J.] Univ Hosp Basel, Dept Cardiol, Basel, Switzerland; [Burkard, Thilo; Hess, Christoph] Univ Hosp Basel, Med Outpatient Dept, Basel, Switzerland; [Burkard, Thilo; Trendelenburg, Marten; Daikeler, Thomas; Hess, Christoph; Bremerich, Jens; Haaf, Philip; Buser, Peter; Zellweger, Michael J.] Univ Basel, Basel, Switzerland; [Trendelenburg, Marten] Univ Hosp Basel, Div Internal Med, Basel, Switzerland; [Daikeler, Thomas] Univ Hosp Basel, Dept Rheumatol, Basel, Switzerland; [Bremerich, Jens] Univ Hosp Basel, Dept Radiol, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Burkard, T (corresponding author), Univ Hosp Basel, Dept Cardiol, Basel, Switzerland.; Burkard, T (corresponding author), Univ Hosp Basel, Med Outpatient Dept, Basel, Switzerland.; Burkard, T (corresponding author), Univ Basel, Basel, Switzerland.	thilo.burkard@usb.ch	Zellweger, Michael/AAB-4859-2022; Trendelenburg, Marten/AAM-1626-2020; Burkard, Thilo/N-7533-2014	Trendelenburg, Marten/0000-0001-7036-8386; Burkard, Thilo/0000-0001-6373-9820	Nycomed	Nycomed	This work was supported by a research grant from Nycomed, contributed to the Research Funds of the University Hospital Basel, Basel, Switzerland (TB). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty H, 2008, LUPUS, V17, P561, DOI 10.1177/0961203308089401; BEEN M, 1988, EUR HEART J, V9, P1250, DOI 10.1093/oxfordjournals.eurheartj.a062437; BENCIVELLI W, 1992, CLIN EXP RHEUMATOL, V10, P549; Bjornadal L, 2004, J RHEUMATOL, V31, P713; CERVERA R, 1992, ANN RHEUM DIS, V51, P156, DOI 10.1136/ard.51.2.156; Chen JZ, 2016, CLIN RHEUMATOL, V35, P2437, DOI 10.1007/s10067-016-3373-z; Chizzolini Carlo, 2009, Rev Med Suisse, V5, P808; Coleman GC, 2017, JACC-CARDIOVASC IMAG, V10, P411, DOI 10.1016/j.jcmg.2016.05.009; de Cobelli F, 2006, J AM COLL CARDIOL, V47, P1649, DOI 10.1016/j.jacc.2005.11.067; DOHERTY NE, 1985, AM HEART J, V110, P1257, DOI 10.1016/0002-8703(85)90023-7; Edwards NC, 2007, RHEUMATOLOGY, V46, P1208, DOI 10.1093/rheumatology/kem077; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ishimori ML, 2011, JACC-CARDIOVASC IMAG, V4, P27, DOI 10.1016/j.jcmg.2010.09.019; Klem I, 2006, J AM COLL CARDIOL, V47, P1630, DOI 10.1016/j.jacc.2005.10.074; Kouranos V, 2017, JACC-CARDIOVASC IMAG, V10, P1437, DOI 10.1016/j.jcmg.2016.11.019; Kwong RY, 2008, CIRCULATION, V118, P1011, DOI 10.1161/CIRCULATIONAHA.107.727826; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mavrogeni S, 2018, LUPUS, V27, P564, DOI 10.1177/0961203317731533; Mavrogeni S, 2017, LUPUS, V26, P227, DOI 10.1177/0961203316671810; Mavrogeni S, 2016, LUPUS, V25, P289, DOI 10.1177/0961203315611496; Mavrogeni S, 2013, LUPUS, V22, P34, DOI 10.1177/0961203312462265; Mavrogeni S, 2012, LUPUS, V21, P821, DOI 10.1177/0961203312437437; Mavrogeni S, 2017, INT J CARDIOL, V236, P151, DOI 10.1016/j.ijcard.2017.01.104; Mavrogeni S, 2017, INT J CARDIOL, V228, P444, DOI 10.1016/j.ijcard.2016.11.242; Mavrogeni Sophie, 2015, Inflammation & Allergy Drug Targets, V14, P111, DOI 10.2174/1871528114666160105112758; Messroghli DR, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0389-8; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nieves CEF, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0571-2; Panchal L, 2006, J POSTGRAD MED, V52, P5; Seneviratne MG, 2016, LUPUS, V25, P573, DOI 10.1177/0961203315622275; Singh J. A., 2005, Lupus, V14, P137, DOI 10.1191/0961203305lu2050oa; Sun SS, 2001, RHEUMATOLOGY, V40, P1106, DOI 10.1093/rheumatology/40.10.1106; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thiele H, 2006, J AM COLL CARDIOL, V47, P1641, DOI 10.1016/j.jacc.2005.11.065; VONFELDT JM, 1995, POSTGRAD MED, V97, P79, DOI 10.1080/00325481.1995.11945982; Weir-McCall JR, 2017, EUR HEART J-CARD IMG, V18, P657, DOI 10.1093/ehjci/jew155; Wijetunga M, 2002, AM J MED, V113, P419, DOI 10.1016/S0002-9343(02)01223-8; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018	42	26	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0202105	10.1371/journal.pone.0202105	http://dx.doi.org/10.1371/journal.pone.0202105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273933	Green Submitted, gold, Green Published			2022-12-27	WOS:000446124700002
J	Esteva, M; Ruiz-Diaz, M; Sanchez, MA; Pertega, S; Pita-Fernandez, S; Macia, F; Posso, M; Gonzalez-Lujan, L; Bosca-Wats, MM; Leiva, A; Ripoll, J				Esteva, Magdalena; Ruiz-Diaz, Mercedes; Antonia Sanchez, M.; Pertega, Sonia; Pita-Fernandez, Salvador; Macia, Francesc; Posso, Margarita; Gonzalez-Lujan, Luis; Bosca-Wats, Marta M.; Leiva, Alfonso; Ripoll, Joana		DECCIRE GRP	Emergency presentation of colorectal patients in Spain	PLOS ONE			English	Article							CANCER-DIAGNOSIS; COLON-CANCER; ADMISSION; MORTALITY; RESECTION; PATTERNS; SURVIVAL; FEATURES; SURGERY; ENGLAND	Background Colorectal cancer (CRC) is the leading cause of cancer deaths in Europe. Survival is poorer in patients admitted to hospitals through the emergency department than in electively admitted patients. Knowledge of factors associated with a cancer diagnosis through presentation at an emergency department may reduce the likelihood of an emergency diagnosis. This study evaluated factors influencing the diagnosis of CRC in the emergency department. Methods and findings This is a cross-sectional study in 5 Spanish regions; subjects were incident cases of CRC diagnosed in 9 public hospitals, between 2006 and 2008. Data were obtained from patient interviews and primary care and hospital clinical records. We found that approximately 40% of CRC patients first contacted a hospital for CRC through an emergency service. Women were more likely than men to be emergency presenters. The type of symptom associated with emergency presentation differed between patients with colon cancer and those with rectal cancer, in that the frequency of "alarm symptoms" was significantly lower in colon than in rectal cancer patients who initially presented to emergency services. Soon after symptom onset, some patients went to a hospital emergency service, whereas others contacted their GP. Lack of contact with a GP for CRC-related symptoms was consistently related to emergency presentation. Among patients who contacted a GP, a higher number of consultations for CRC symptoms and any referral to outpatient consultations reduced the likelihood of emergency presentation. All diagnostic time intervals were shorter in emergency presenters than in elective patients. Conclusions Emergency presenters are not a uniform category and can be divided into categories according to their symptoms, help seeking behavior trajectory and interaction with their GPs. Time constraints for testing and delays in obtaining outpatient appointments led patients to visit a hospital service either on their own or after referral by their GP.	[Esteva, Magdalena; Leiva, Alfonso; Ripoll, Joana] Balearic Isl Hlth Res Inst IdISBa, Baleares Hlth Serv IbSalut, Primary Care Res Unit, Majorca Dept Primary Care, Mallorca, Spain; [Ruiz-Diaz, Mercedes] Univ Zaragoza, Fac Hlth Sci, Zaragoza, Spain; [Antonia Sanchez, M.] Univ Zaragoza, Ctr Salud Fuentes Norte Zaragoza, Dept Med Psychiat & Dermatol, Zaragoza, Spain; [Pertega, Sonia; Pita-Fernandez, Salvador] Univ A Coruna, Clin Epidemiol & Biostat Res Grp, Inst Invest Biomed A Coruna INIBIC, CHUAC,SERGAS, La Coruna, Spain; [Macia, Francesc; Posso, Margarita] Hosp Mar, Epidemiol & Evaluat Dept, Barcelona, Spain; [Macia, Francesc; Posso, Margarita] IMIM Hosp Mar Med Res Inst, Barcelona, Spain; [Macia, Francesc; Posso, Margarita] REDISSEC Hlth Serv Res Chron Patients Network, Madrid, Spain; [Gonzalez-Lujan, Luis] Valencia Inst Hlth, Serreria Primary Care Ctr 2, Valencia, Spain; [Bosca-Wats, Marta M.] Hosp Clin Univ Valencia, Digest Med Unit, Valencia, Spain	Atencio Primaria de Mallorca; Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Zaragoza; University of Zaragoza; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM)	Esteva, M (corresponding author), Balearic Isl Hlth Res Inst IdISBa, Baleares Hlth Serv IbSalut, Primary Care Res Unit, Majorca Dept Primary Care, Mallorca, Spain.	mesteva@ibsalut.caib.es	Leiva, Alfonso/ABF-1361-2020; Pértega-Díaz, Sonia/E-4353-2013; Posso, Margarita/N-3824-2017; Peña, Mercedes Ruidíaz/AAB-5382-2019; Gonzalez Timoneda, Alba/C-8205-2019	Pértega-Díaz, Sonia/0000-0003-3891-3203; Posso, Margarita/0000-0002-5053-257X; Peña, Mercedes Ruidíaz/0000-0002-8153-1473; Esteva, Magdalena/0000-0001-8238-7891; Gonzalez Timoneda, Alba/0000-0003-1871-7758; Ripoll, Joana/0000-0002-5251-7234	Ministry of Health; Carlos III Institute [PI: 052273, PI050787, PI050700, PI052692, PI052141]; Health Promotion and Preventive Activities-Primary Health Care Network; Ministry of Health ISCIII-RETCI [G03/170, RD06/0018, RD12/0005/0011]; Instituto de Salud Carlos III	Ministry of Health; Carlos III Institute(Instituto de Salud Carlos III); Health Promotion and Preventive Activities-Primary Health Care Network; Ministry of Health ISCIII-RETCI; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was funded by the Ministry of Health. Carlos III Institute; grants PI: 052273, PI050787, PI050700, PI052692, PI052141. This study was also supported by the Health Promotion and Preventive Activities-Primary Health Care Network and by the Ministry of Health ISCIII-RETCI awards G03/170 and RD06/0018, RD12/0005/0011, http://www.isciii.es/. Instituto de Salud Carlos III is a public funder of investigation in health sciences depending of the Ministry of Economy. It has no role in design, data collection and analysis, decision to publish or preparation of the manuscript.; This study was funded by the Ministry of Health. Carlos III Institute; grants PI: 052273, PI050787, PI050700, PI052692, PI052141. This study was also supported by the Health Promotion and Preventive Activities-Primary Health Care Network and by the Ministry of Health ISCIII-RETCI awards G03/170 and RD06/0018, RD12/0005/0011. The authors would like to thank the surgeons, gastroenterologists and general practitioners who assisted with contacting their patients.	Abel GA, 2015, BRIT J CANCER, V112, pS129, DOI 10.1038/bjc.2015.52; Black G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135027; Bottle A, 2012, BRIT J CANCER, V107, P1213, DOI 10.1038/bjc.2012.320; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Brewster DH, 2011, BRIT J CANCER, V104, P60, DOI 10.1038/sj.bjc.6606036; Chiarugi M, 2007, SURG ONCOL, V16, pS73, DOI 10.1016/j.suronc.2007.10.019; Cleary J, 2007, FAM PRACT, V24, P3, DOI 10.1093/fampra/cml059; Diggs JC, 2007, AM J MANAG CARE, V13, P157; Downing A, 2013, BRIT J CANCER, V108, P681, DOI 10.1038/bjc.2012.585; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Esteva M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-87; Esteva M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-86; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Frattini M, 2004, CLIN CANCER RES, V10, P4015, DOI 10.1158/1078-0432.CCR-04-0031; Gunnarsson H, 2013, EJSO-EUR J SURG ONC, V39, P831, DOI 10.1016/j.ejso.2013.04.004; Hamilton W, 2012, BRIT J CANCER, V107, P1205, DOI 10.1038/bjc.2012.423; Iversen LH, 2008, BRIT J SURG, V95, P1012, DOI 10.1002/bjs.6114; Larsen MB, 2014, CANCER EPIDEMIOL, V38, P100, DOI 10.1016/j.canep.2013.10.006; Lyratzopoulos G, 2014, FUTURE ONCOL, V10, P1329, DOI [10.2217/fon.14.80, 10.2217/FON.14.80]; McArdle CS, 2004, BRIT J SURG, V91, P605, DOI 10.1002/bjs.4456; McPhail S, 2013, BRIT J CANCER, V109, P2027, DOI 10.1038/bjc.2013.569; Mitchell AD, 2007, ANN SURG ONCOL, V14, P1099, DOI 10.1245/s10434-006-9245-z; Mitchell ED, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006965; Murchie P, 2017, BRIT J CANCER, V116, P1148, DOI 10.1038/bjc.2017.71; National Institute for Health and Clinical Excellence, 2005, REF GUID SUSP CANC C; Neal RD, 2014, BRIT J CANCER, V110, P584, DOI 10.1038/bjc.2013.791; Polednak AP, 2000, CANCER DETECT PREV, V24, P283; Porta M, 1998, BRIT J CANCER, V77, P477, DOI 10.1038/bjc.1998.76; Rabeneck L, 2006, AM J GASTROENTEROL, V101, P1098, DOI 10.1111/j.1572-0241.2006.00488.x; Renzi C, 2016, BRIT J CANCER, V115, P866, DOI 10.1038/bjc.2016.250; Sheringham JR, 2014, BRIT J CANCER, V111, P1490, DOI 10.1038/bjc.2014.424; Sikka V, 2012, AM J EMERG MED, V30, P283, DOI 10.1016/j.ajem.2010.11.029; Singh H, 2009, AM J GASTROENTEROL, V104, P2543, DOI 10.1038/ajg.2009.324; Sjo OH, 2009, COLORECTAL DIS, V11, P733, DOI 10.1111/j.1463-1318.2008.01613.x; Torring ML, 2011, BRIT J CANCER, V104, P934, DOI 10.1038/bjc.2011.60; Tsang C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-308; Wallace D, 2014, BRIT J CANCER, V111, P577, DOI 10.1038/bjc.2014.300; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68; Zhou Y, 2017, NAT REV CLIN ONCOL, V14, P45, DOI 10.1038/nrclinonc.2016.155	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203556	10.1371/journal.pone.0203556	http://dx.doi.org/10.1371/journal.pone.0203556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273339	Green Submitted, gold, Green Published			2022-12-27	WOS:000446124700006
J	Niu, LN; Zhao, F; Chen, JL; Nong, JQ; Wang, CM; Wang, J; Gao, NS; Zhu, XX; Wu, L; Hu, SK				Niu, Lina; Zhao, Fan; Chen, Jinlong; Nong, Jinqing; Wang, Chunmei; Wang, Jing; Gao, Naishu; Zhu, Xiaoxue; Wu, Lei; Hu, Shoukui			Isothermal amplification and rapid detection of Klebsiella pneumoniae based on the multiple cross displacement amplification (MCDA) and gold nanoparticle lateral flow biosensor (LFB)	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BETA-LACTAMASE; OUTBREAK; ASSAY; GENE; LAMP	Klebsiella pneumoniae (K. pneumoniae) is a frequent pathogen causing nosocomial infections and outbreaks. We developed a multiple cross displacement amplification (MCDA) assay for the detection of K. pneumoniae, which can get the positive results within 40 minutes' isothermal amplification. Gold-nanoparticle lateral flow biosensor (LFB) and colorimetric indicators were used for the rapid readouts of MCDA amplification. The detection limit of this assay was 100 fg per reaction at 65 degrees C, which was confirmed to be the optimal amplification temperature according to the real time turbidimeters. For specificity, all of the 30 clinical-source K. pneumoniae strains were positive for the MCDA, and all of the non-K. pneumoniae strains belonging to 31 different species were negative for this MCDA assay. To evaluate the practical applicability of this method, we assessed its detection limit for K. pneumoniae strains in sputum samples (24 CFU per reaction), and DNA templates of 100 sputum samples further underwent the MCDA-LFB tests. All of the sputum samples being positive for K. pneumoniae (30/100) with the culture method were successfully identified with the MCDA assay, the detection power of which was higher than that of polymerase chain reaction (PCR) (25/100). Thus, the MCDA test for K. pneumoniae combined with the gold nanoparticle LFB as the results readout scheme, are simple, specific, and sensitive methods for the rapid diagnosis of K. pneumoniae in clinical samples.	[Niu, Lina; Chen, Jinlong] Hainan Med Univ, Sch Basic Med & Lifesci, Dept Pathogen Biol, Haikou, Hainan, Peoples R China; [Niu, Lina; Zhao, Fan; Nong, Jinqing; Wang, Chunmei; Wang, Jing; Gao, Naishu; Zhu, Xiaoxue; Wu, Lei; Hu, Shoukui] Peking Univ, Dept Clin Lab, Shougang Hosp, Beijing, Peoples R China	Hainan Medical University; Peking University	Hu, SK (corresponding author), Peking Univ, Dept Clin Lab, Shougang Hosp, Beijing, Peoples R China.	shoukuihu@163.com	niu, lina/GWR-3585-2022	Hu, Shoukui/0000-0001-6339-3954; Nong, Jinqing/0000-0002-1955-9790; wu, lei/0000-0002-5619-8074; Zhu, Xiaoxue/0000-0001-9019-060X; Zhao, Fan/0000-0002-8164-5016	National Natural Science Foundation of China [81760376]; Beijing Natural Science Foundation [7162031]; Peking University Shougang Hospital [2017-Yuan-LC-08, SGYYZ201602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking University Shougang Hospital	This work was supported by the National Natural Science Foundation of China [grant number 81760376] for LN, the Beijing Natural Science Foundation [grant number 7162031] for FZ, and the Peking University Shougang Hospital [grant numbers 2017-Yuan-LC-08, SGYYZ201602] for SH.	Ang GY, 2015, J MICROBIOL METH, V118, P99, DOI 10.1016/j.mimet.2015.08.024; Bialek-Davenet S, 2014, EMERG INFECT DIS, V20, P1812, DOI 10.3201/eid2011.140206; Chen YT, 2016, BIOSENS BIOELECTRON, V81, P317, DOI 10.1016/j.bios.2016.03.006; Dong DR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00519; Kim HJ, 2016, ANN LAB MED, V36, P15, DOI 10.3343/alm.2016.36.1.15; Kola A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0049-4; Kontopidou F, 2014, CLIN MICROBIOL INFEC, V20, pO117, DOI 10.1111/1469-0691.12341; Liu DX, 2018, J MICROBIOL METH, V145, P59, DOI 10.1016/j.mimet.2017.11.003; MCCALLUM KL, 1991, INFECT IMMUN, V59, P494, DOI 10.1128/IAI.59.2.494-502.1991; Misawa Yoshiki, 2007, Journal of Infection and Chemotherapy, V13, P134, DOI 10.1007/s10156-007-0508-9; Naas T, 2010, J ANTIMICROB CHEMOTH, V65, P1305, DOI 10.1093/jac/dkq117; Nakano R, 2015, J INFECT CHEMOTHER, V21, P202, DOI 10.1016/j.jiac.2014.11.010; Pandey BD, 2008, J MED MICROBIOL, V57, P439, DOI 10.1099/jmm.0.47499-0; Sanchez GV, 2013, EMERG INFECT DIS, V19, P133, DOI 10.3201/eid1901.120310; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Soo PC, 2013, J MICROBIOL METH, V92, P197, DOI 10.1016/j.mimet.2012.11.020; Starlander G, 2012, J HOSP INFECT, V82, P122, DOI 10.1016/j.jhin.2012.07.004; Toubanaki DK, 2016, J MICROBIOL METH, V127, P51, DOI 10.1016/j.mimet.2016.05.027; Wang Y, 2018, NANO RES, V11, P2632, DOI 10.1007/s12274-017-1893-z; Wang Y, 2018, ARTIF CELL NANOMED B, V46, P1671, DOI 10.1080/21691401.2017.1389748; Wang Y, 2017, INT J NANOMED, V12, P473, DOI 10.2147/IJN.S123625; Wang Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02047; Wang Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01834; Wang Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00753; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11902; Zweigner J, 2014, AM J INFECT CONTROL, V42, P936, DOI 10.1016/j.ajic.2014.04.022	26	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204332	10.1371/journal.pone.0204332	http://dx.doi.org/10.1371/journal.pone.0204332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273362	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700019
J	Smogorzewska, J; Szumski, G; Grygiel, P				Smogorzewska, Joanna; Szumski, Grzegorz; Grygiel, Pawel			Same or different? Theory of mind among children with and without disabilities	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; TEST-RETEST RELIABILITY; HIGH-FUNCTIONING AUTISM; FALSE-BELIEF TASKS; MIDDLE CHILDHOOD; MEASUREMENT INVARIANCE; FACTORIAL INVARIANCE; MENTAL-RETARDATION; EXECUTIVE FUNCTION; SOCIAL COMPETENCE	Assessing theory of mind (ToM) with reliable and valid measures is important, as ToM plays a significant role in children's social and cognitive functioning. With this in mind, a thorough analysis of the Theory of Mind scale and the Faux Pas Recognition Test was conducted. Over 750 school-age (Mage = 7.7) children with disabilities (mild intellectual disability, hearing impairment) and without disabilities took part in our study. The psychometric properties of measures in these groups of children were checked, using confirmatory item factor analysis, reliability, and validity analyses. Thanks to groups' invariance it was possible to compare mean results of children in the groups. Both measures showed well-fitted models with acceptable goodness of fit as well as scalar and strict invariance. An IRT analysis showed significant differences in the difficulty of the tasks in all groups, but the same order of passing tasks in comparison to other studies, conducted in Western countries, has been observed. Our results showed that the tasks were the easiest for children without disabilities, and most difficult for children with mild intellectual disability. We obtained significant and positive correlations between ToM and social skills and language abilities. The findings are discussed in relation to results from other studies in the field.	[Smogorzewska, Joanna; Szumski, Grzegorz] Univ Warsaw, Dept Educ, Warsaw, Poland; [Grygiel, Pawel] Jagiellonian Univ, Fac Philosophy, Inst Pedag, Krakow, Poland	University of Warsaw; Jagiellonian University	Smogorzewska, J (corresponding author), Univ Warsaw, Dept Educ, Warsaw, Poland.	j.smogorzewska@gmail.com	Grygiel, Paweł/AAV-8389-2021; Smogorzewska, Joanna/K-7668-2019	Grygiel, Paweł/0000-0001-9790-3772; Smogorzewska, Joanna/0000-0002-4377-9136	National Science Centre (Narodowe Centrum Nauki) in Poland [2014/13/B/HS6/02663]; National Centre for Science, Poland [2014/13/B/HS6/02663]	National Science Centre (Narodowe Centrum Nauki) in Poland; National Centre for Science, Poland	The study was funded by the National Science Centre (Narodowe Centrum Nauki) in Poland. The grant number is 2014/13/B/HS6/02663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study has been financed by National Centre for Science (no. 2014/13/B/HS6/02663), Poland	Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Colle L, 2007, J AUTISM DEV DISORD, V37, P716, DOI 10.1007/s10803-006-0198-7; Devine RT, 2018, CHILD DEV, V89, P971, DOI 10.1111/cdev.12682; Devine RT, 2014, CHILD DEV, V85, P1777, DOI 10.1111/cdev.12237; DODGE KA, 1985, J CONSULT CLIN PSYCH, V53, P344, DOI 10.1037/0022-006X.53.3.344; Fink E, 2015, BRIT J DEV PSYCHOL, V33, P1, DOI 10.1111/bjdp.12060; Fink E, 2014, CHILD DEV, V85, P2389, DOI 10.1111/cdev.12302; Flavell JH, 1988, HDB CHILD PSYCHOL, V2, P851; GOPNIK A, 1991, CHILD DEV, V62, P98, DOI 10.2307/1130707; Greenfield PM, 2003, ANNU REV PSYCHOL, V54, P461, DOI 10.1146/annurev.psych.54.101601.145221; Haeberlin U, 1989, INTEGRATION SCHULKLA; Hayward EO, 2017, BRIT J DEV PSYCHOL, V35, P454, DOI 10.1111/bjdp.12186; Hoftede G., 2010, CULTURES ORG SOFTWAR; HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916; Hughes C, 2004, SOC DEV, V13, P590, DOI 10.1111/j.1467-9507.2004.00285.x; Hughes C, 2000, J CHILD PSYCHOL PSYC, V41, P483, DOI 10.1017/S0021963099005533; Hughes C, 2016, J EXP CHILD PSYCHOL, V149, P1, DOI 10.1016/j.jecp.2016.01.017; Ibanez A, 2013, PERS INDIV DIFFER, V54, P616, DOI 10.1016/j.paid.2012.11.022; Im-Bolter N, 2016, J EXP CHILD PSYCHOL, V149, P98, DOI 10.1016/j.jecp.2015.12.006; Joseph RM, 2004, DEV PSYCHOPATHOL, V16, P137, DOI 10.1017/S095457940404444X; Karwowski M., 2012, TEST UMIEJETNOSCI ST; Kimhi Y, 2014, TOP LANG DISORD, V34, P329, DOI 10.1097/TLD.0000000000000033; Kristen S, 2006, Z ENTWICKL PADAGOGIS, V38, P190, DOI 10.1026/0049-8637.38.4.186; Kuntoro IA, 2013, INT J BEHAV DEV, V37, P266, DOI 10.1177/0165025413478258; Lagattuta KH, 2016, J EXP CHILD PSYCHOL, V149, P116, DOI 10.1016/j.jecp.2016.01.013; Lam YG, 2012, RES AUTISM SPECT DIS, V6, P560, DOI 10.1016/j.rasd.2011.07.017; Leekam S, 1997, BRIT J DEV PSYCHOL, V15, P77, DOI 10.1111/j.2044-835X.1997.tb00726.x; Li AS, 2011, J AUTISM DEV DISORD, V41, P185, DOI 10.1007/s10803-010-1045-4; Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3; Little TD, 2007, INT J BEHAV DEV, V31, P357, DOI 10.1177/0165025407077757; Lubke GH, 2003, BRIT J MATH STAT PSY, V56, P231, DOI 10.1348/000711003770480020; Mayes LC, 1996, J CHILD PSYCHOL PSYC, V37, P313, DOI 10.1111/j.1469-7610.1996.tb01408.x; McConnell SR, 1999, TOP EARLY CHILD SPEC, V19, P67, DOI 10.1177/027112149901900201; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; MEREDITH W, 1964, PSYCHOMETRIKA, V29, P177, DOI 10.1007/BF02289699; Meredith W, 2006, MED CARE, V44, pS69, DOI 10.1097/01.mlr.0000245438.73837.89; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Millsap RE, 2011, STAT APPROACHES MEAS; Moran JM, 2011, P NATL ACAD SCI USA, V108, P2688, DOI 10.1073/pnas.1011734108; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nilsson KK, 2016, CHILD DEV, V87, P143, DOI 10.1111/cdev.12462; Osterhaus C, 2016, CHILD DEV, V87, P1971, DOI 10.1111/cdev.12566; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Peskin J, 2003, SOC DEV, V12, P496, DOI 10.1111/1467-9507.00245; Peteron CC, 2016, J EXP CHILD PSYCHOL, V149, P146, DOI 10.1016/j.jecp.2015.11.008; Peterson CC, 2012, CHILD DEV, V83, P469, DOI 10.1111/j.1467-8624.2011.01728.x; Peterson CC, 2005, CHILD DEV, V76, P502, DOI 10.1111/j.1467-8624.2005.00859.x; Phillips W, 1998, BRIT J DEV PSYCHOL, V16, P337, DOI 10.1111/j.2044-835X.1998.tb00756.x; Rajkumar AP, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-51; Ronald A, 2005, SOC DEV, V14, P664, DOI 10.1111/j.1467-9507.2005.00323.x; Shahaeian A, 2014, J CROSS CULT PSYCHOL, V45, P1110, DOI 10.1177/0022022114534772; Slaughter V, 2015, CHILD DEV, V86, P1159, DOI 10.1111/cdev.12372; Smogorzewska J, 2018, INT J DISABIL DEV ED, V65, P318, DOI 10.1080/1034912X.2017.1368461; Szumski G, 2019, J AUTISM DEV DISORD, V49, P2822, DOI 10.1007/s10803-017-3377-9; Tager-Flusberg H, 2007, CURR DIR PSYCHOL SCI, V16, P311, DOI 10.1111/j.1467-8721.2007.00527.x; Tahiroglu D, 2014, DEV PSYCHOL, V50, P2485, DOI 10.1037/a0037914; Talwar V, 2012, FOCUS AUTISM DEV DIS, V27, P122, DOI 10.1177/1088357612441828; Thirion-Marissiaux AF, 2008, RES DEV DISABIL, V29, P414, DOI 10.1016/j.ridd.2007.07.001; Thirion-Marissiaux AF, 2008, RES DEV DISABIL, V29, P547, DOI 10.1016/j.ridd.2007.09.004; Wang ZL, 2016, J EXP CHILD PSYCHOL, V149, P6, DOI 10.1016/j.jecp.2015.09.028; Wellman H.M., 2002, HDB CHILDHOOD COGNIT, P167, DOI DOI 10.1002/9780470996652.CH8; Wellman HM, 2011, CHILD DEV, V82, P780, DOI 10.1111/j.1467-8624.2011.01583.x; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; WHEELER VA, 1982, DEV PSYCHOL, V18, P795, DOI 10.1037/0012-1649.18.6.795; Yirmiya N, 1996, J CHILD PSYCHOL PSYC, V37, P1003, DOI 10.1111/j.1469-7610.1996.tb01497.x; Yirmiya N, 1998, PSYCHOL BULL, V124, P283, DOI 10.1037/0033-2909.124.3.283; Zhang T, 2016, RES AUTISM SPECT DIS, V23, P210, DOI 10.1016/j.rasd.2015.10.005; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180	71	11	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0202553	10.1371/journal.pone.0202553	http://dx.doi.org/10.1371/journal.pone.0202553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273356	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700004
J	Wegermann, K; Henao, R; Diehl, AM; Murphy, SK; Abdelmalek, MF; Moylan, CA				Wegermann, Kara; Henao, Ricardo; Diehl, Anna Mae; Murphy, Susan K.; Abdelmalek, Manal F.; Moylan, Cynthia A.			Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study	PLOS ONE			English	Article							GENE-EXPRESSION; FIBROSIS SCORE; NAFLD; STEATOHEPATITIS; EPIDEMIOLOGY; METABOLISM; PROFILES	Background and objectives Although the burden of non-alcoholic fatty liver disease (NAFLD) continues to increase worldwide, genetic factors predicting progression to cirrhosis and decompensation in NAFLD remain poorly understood. We sought to determine whether gene expression profiling was associated with clinical decompensation and death in patients with NAFLD, and to assess whether altered DNA methylation contributes to these changes in gene expression. Methods We performed a retrospective analysis of 86 patients in the Duke NAFLD Clinical Database and Biorepository with biopsy-proven NAFLD whose liver tissue was previously evaluated for gene expression and DNA methylation using array based technologies. We assessed the prospective development of liver and cardiovascular disease related outcomes, including hepatic decompensation as identified by the development of ascites, hepatic encephalopathy, hepatocellular carcinoma, or variceal bleeding as well as stroke and myocardial infarction via medical chart review. Results Of the 86 patients, 47 had F0-F1 fibrosis and 39 had F3-F4 fibrosis at index liver biopsy. Gene expression probe sets (n = 54,675) were analyzed; 42 genes showed significant differential expression (p<0.05) and a two-fold change in expression between patients with and without any outcome. Two expression probes of the branched chain amino-acid transaminase 1 (BCAT1) gene were upregulated (p = 0.02; fold change 2.1 and 2.2 respectively) in patients with a clinical outcome. Methylation of three of the 34 BCAT1 CpG methylation probes were significantly inversely correlated with BCAT1 expression specific to the probes predictive of clinical deterioration. Conclusion We found differential gene expression, correlated to changes in DNA methylation, at multiple BCAT1 loci in patients with cardiovascular outcomes and/or hepatic decompensation. BCAT1 catalyzes the transformation of alpha-ketoglutarate to glutamate and has been linked to the presence and severity of NAFLD, possibly through derangements in the balance between glutamate and alpha-ketoglutarate. Given the potential for BCAT1 to identify patients at risk for poor outcomes, and the potential therapeutic implications, these results should be validated in larger prospective studies.	[Wegermann, Kara; Diehl, Anna Mae; Abdelmalek, Manal F.; Moylan, Cynthia A.] Duke Univ Hlth Syst, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Henao, Ricardo] Duke Univ, Biostat & Bioinformat, Durham, NC USA; [Murphy, Susan K.] Duke Univ Hlth Syst, Dept Obstet & Gynecol, Durham, NC USA; [Moylan, Cynthia A.] Durham Vet Affairs Hlth Syst, Dept Med, Durham, NC 27705 USA	Duke University; Duke University; Duke University	Moylan, CA (corresponding author), Duke Univ Hlth Syst, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.; Moylan, CA (corresponding author), Durham Vet Affairs Hlth Syst, Dept Med, Durham, NC 27705 USA.	cynthia.moylan@duke.edu	Abdelmalek, Manal F/AAW-2203-2020; Murphy, Susan/R-3903-2019	Murphy, Susan/0000-0001-8298-7272; Henao, Ricardo/0000-0003-4980-845X; Abdelmalek, Manal/0000-0002-5001-8618; Moylan, Cynthia/0000-0001-8454-7086	Medicine Endowment Fund, National Institutes of Health [5RC2-AA019399]; American College of Gastroenterology Junior Faculty Development Award (2015)	Medicine Endowment Fund, National Institutes of Health; American College of Gastroenterology Junior Faculty Development Award (2015)	This work was supported by Florence McAlister Professor of Medicine Endowment Fund, National Institutes of Health 5RC2-AA019399 (PI: Diehl); American College of Gastroenterology Junior Faculty Development Award (2015; PI: Moylan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva MM, 2012, AMINO ACIDS, V43, P171, DOI 10.1007/s00726-011-1088-7; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Guajardo-Salinas GE, 2010, OBES SURG, V20, P1647, DOI 10.1007/s11695-009-0027-0; Hattori A, 2017, NATURE, V545, P500, DOI 10.1038/nature22314; Honda T, 2017, METABOLISM, V69, P177, DOI 10.1016/j.metabol.2016.12.013; Kaikkonen JE, 2017, HEPATOLOGY, V65, P491, DOI 10.1002/hep.28899; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; Mitchell SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-54; Miyake T, 2012, INTERNAL MED, V51, P2151, DOI 10.2169/internalmedicine.51.7578; Moylan CA, 2014, HEPATOLOGY, V59, P471, DOI 10.1002/hep.26661; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Panosyan EH, 2016, J NEURO-ONCOL, V128, P57, DOI 10.1007/s11060-016-2073-5; Papathanassiu AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16040; Raszeja-Wyszomirska J, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-67; Ruffillo G, 2011, J HEPATOL, V54, P160, DOI 10.1016/j.jhep.2010.06.028; Sun WJ, 2016, HEPATOL RES, V46, P862, DOI 10.1111/hepr.12647; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Tajiri K, 2013, WORLD J GASTROENTERO, V19, P7620, DOI 10.3748/wjg.v19.i43.7620; Thewes V, 2017, ONCOGENE, V36, P4124, DOI 10.1038/onc.2017.32; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang HG, 2016, CLIN RES HEPATOL GAS, V40, pE55, DOI 10.1016/j.clinre.2016.03.003; Xu M, 2016, ONCOL LETT, V12, P2648, DOI 10.3892/ol.2016.4969; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zelber-Sagi S, 2017, WORLD J HEPATOL, V9, P91, DOI 10.4254/wjh.v9.i2.91; Zheng YH, 2016, LIVER INT, V36, P1836, DOI 10.1111/liv.13178	32	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204308	10.1371/journal.pone.0204308	http://dx.doi.org/10.1371/journal.pone.0204308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265706	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500028
J	Dally, M; Butler-Dawson, J; Krisher, L; Monaghan, A; Weitzenkamp, D; Sorensen, C; Johnson, RJ; Carlton, EJ; Asensio, C; Tenney, L; Newman, LS				Dally, Miranda; Butler-Dawson, Jaime; Krisher, Lyndsay; Monaghan, Andrew; Weitzenkamp, David; Sorensen, Cecilia; Johnson, Richard J.; Carlton, Elizabeth J.; Asensio, Claudia; Tenney, Liliana; Newman, Lee S.			The impact of heat and impaired kidney function on productivity of Guatemalan sugarcane workers	PLOS ONE			English	Article							CLIMATE-CHANGE; LABOR PRODUCTIVITY; UNITED-STATES; NONLINEAR MODELS; CENTRAL-AMERICA; TEMPERATURE; STRESS; DISEASE; NEPHROPATHY; MORTALITY	Background Climate change has implications for human health and productivity. Models suggest that heat extremes affect worker health, reduce labor capacity, and commodity supply. Chronic health conditions are on the rise internationally. However there is a paucity of direct empirical evidence relating increasing temperatures to both agricultural worker health and productivity. Methods and findings We evaluated the relationship between temperature exposure, kidney function, and two measures of productivity-tons of commodity produced and job attrition, of 4,095 Guatemalan sugarcane cutters over a 6-month harvest. We used distributed lag non-linear models to evaluate associations between wet bulb globe temperature (WBGT) and productivity of workers with normal or impaired kidney function. The cumulative effect of exposure to a max WBGT of 34 degrees C was 1.16 tons (95% CI: -2.87, 0.54) less sugarcane cut over the next five days by workers with impaired kidney function, compared to exposure to 29 degrees C. Impaired kidney function was associated with premature workforce attrition. Workers starting the harvest season with impaired kidney function were more than twice as likely to leave employment (HR: 2.92, 95% CI: 1.88, 4.32). Conclusions Heat extremes may be associated with loss of agricultural worker productivity and employment, especially among those with impaired kidney function. Agricultural workers who develop health conditions, such as kidney disease, are particularly vulnerable in the face of climate change and increasing heat extremes. The resultant loss of employment and productivity has significant implications for global commodity supplies.	[Dally, Miranda; Butler-Dawson, Jaime; Krisher, Lyndsay; Weitzenkamp, David; Tenney, Liliana; Newman, Lee S.] Univ Colorado, Colorado Sch Publ Hlth, Ctr Hlth Work & Environm, Anschutz Med Campus, Aurora, CO 80045 USA; [Dally, Miranda; Butler-Dawson, Jaime; Krisher, Lyndsay; Sorensen, Cecilia; Johnson, Richard J.; Carlton, Elizabeth J.; Tenney, Liliana; Newman, Lee S.] Univ Colorado Denver, Colorado Consortium Climate Change & Human Hlth, Aurora, CO 80204 USA; [Monaghan, Andrew] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Weitzenkamp, David] Univ Colorado, Dept Biostat & Informat, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Sorensen, Cecilia] Univ Colorado, Sch Med, Dept Emergency Med, Anschutz Med Campus, Aurora, CO USA; [Johnson, Richard J.] Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA; [Carlton, Elizabeth J.; Tenney, Liliana; Newman, Lee S.] Univ Colorado, Dept Environm & Occupat Hlth, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Asensio, Claudia] Pantaleon, Guatemala City, Guatemala; [Newman, Lee S.] Univ Colorado, Div Pulm Sci & Crit Care Med, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Newman, Lee S.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Center Atmospheric Research (NCAR) - USA; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Dally, M (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Ctr Hlth Work & Environm, Anschutz Med Campus, Aurora, CO 80045 USA.; Dally, M (corresponding author), Univ Colorado Denver, Colorado Consortium Climate Change & Human Hlth, Aurora, CO 80204 USA.	miranda.dally@ucdenver.edu	Dally, Miranda/GXV-9250-2022	Carlton, Elizabeth/0000-0002-8664-9606; Monaghan, Andrew/0000-0002-8170-2359	Pantaleon; University of Colorado, Denver - Anschutz; Centers for Disease Control and Prevention [U19 OH01127]; National Institutes of Health [R21 ES028826]; National Science Foundation; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U19OH011227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES028826] Funding Source: NIH RePORTER	Pantaleon; University of Colorado, Denver - Anschutz; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This evaluation was supported in part by Pantaleon; the Chancellor, University of Colorado, Denver - Anschutz; Centers for Disease Control and Prevention (https://www.cdc.gov) (U19 OH01127; LSN) and National Institutes of Health (https://www.nih.gov) (R21 ES028826; LSN). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Department of Health and Human Services. The National Center for Atmospheric Research is sponsored by the National Science Foundation. Pantaleon provided the University of Colorado investigators with de-identified productivity data and pre-employment medical screening data, all of which were collected by the company for business purposes prior to the analysis. The funder had no role in data analysis or data interpretation. A co-author employed by the company (CA) participated on the writing team. They provided details regarding work practices, but did not modify the results or conclusions of this report. The corresponding author had full access to all the raw data and had final responsibility for the decision to submit for publication.	Alexandratos N, 2012, 1203 FAO ESA; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 1986, NIOSH PUB, V86-112; Bobb JF, 2014, ENVIRON HEALTH PERSP, V122, P811, DOI 10.1289/ehp.1307392; Chen K, 2016, ENVIRON HEALTH PERSP, V124, P1863, DOI 10.1289/EHP204; Cohen J, 2014, SCIENCE, V344, P143, DOI 10.1126/science.344.6180.143; Correa-Rotter R, 2014, AM J KIDNEY DIS, V63, P506, DOI 10.1053/j.ajkd.2013.10.062; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Dimiceli VE, 2011, LECT NOTES ENG COMP, P591; Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Glaser J, 2016, CLIN J AM SOC NEPHRO, V11, P1472, DOI 10.2215/CJN.13841215; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Janetos A., 2017, RISKS MULTIPLE BREAD; Kiefer M, 2016, REV PANAM SALUD PUBL, V40, P192; Kjellstrom T, 2018, INT J BIOMETEOROL, V62, P291, DOI 10.1007/s00484-017-1407-0; Kjellstrom T, 2009, ARCH ENVIRON OCCUP H, V64, P217, DOI 10.1080/19338240903352776; Krishnamurthy M, 2017, SAF HEALTH WORK-KR, V8, P99, DOI 10.1016/j.shaw.2016.08.005; Laux TS, 2016, REV PANAM SALUD PUBL, V39, P186; Laws RL, 2015, INT J OCCUP ENV HEAL, V21, P241, DOI 10.1179/2049396714Y.0000000102; Lemke B, 2012, IND HEALTH, V50, P267, DOI 10.2486/indhealth.MS1352; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy BS, 2015, ANN GLOB HEALTH, V81, P310, DOI 10.1016/j.aogh.2015.08.008; Li XD, 2016, BUILD ENVIRON, V95, P42, DOI 10.1016/j.buildenv.2015.09.005; Lundgren K, 2013, IND HEALTH, V51, P3, DOI 10.2486/indhealth.2012-0089; Magrin GO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1499; Occupational Safety and Health Administration (OSHA), 2008, TED0100015 OSHA; Ordunez P, 2014, LANCET GLOB HEALTH, V2, pE440, DOI 10.1016/S2214-109X(14)70217-7; Quiller G, 2017, ARCH ENVIRON OCCUP H, V72, P313, DOI 10.1080/19338244.2017.1288077; Sahu S, 2013, IND HEALTH, V51, P424, DOI 10.2486/indhealth.2013-0006; Stull R, 2011, J APPL METEOROL CLIM, V50, P2267, DOI 10.1175/JAMC-D-11-0143.1; United Nations Development Programme, 2016, CLIM CHANG LAB IMP H; Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9; Weatherly JW, 2017, J APPL METEOROL CLIM, V56, P863, DOI 10.1175/JAMC-D-16-0068.1; Weaver VM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0105-6; Wegman DH, 2018, SCAND J WORK ENV HEA, V44, P16, DOI 10.5271/sjweh.3659; Wijetunge S, 2013, CEYLON MED J, V58, P142, DOI 10.4038/cmj.v58i4.6304; Zander KK, 2015, NAT CLIM CHANGE, V5, P647, DOI [10.1038/nclimate2623, 10.1038/NCLIMATE2623]	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205181	10.1371/journal.pone.0205181	http://dx.doi.org/10.1371/journal.pone.0205181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0HY	30289894	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500055
J	Fonoberova, M; Mezic, I; Mezic, J; Mohr, R				Fonoberova, Maria; Mezic, Igor; Mezic, Jadranka; Mohr, Ryan			An agent-based model of urban insurgence: Effect of gathering sites and Koopman mode analysis	PLOS ONE			English	Article							SYSTEMS; VIOLENCE; SOCIOLOGY; BEHAVIOR	The paper investigates the effect of preferential gathering sites on urban insurgency in an agent-based model (ABM). The ABM model was proposed in earlier work and has been validated using FBI data. There is a nonlinear tradeoff between the local density of citizens due to the number of preferential gathering sites and the ability of law enforcement officers (LEOs) to adequately patrol that leads to a non-monotonic behavior in the number of large scale outburst of insurgency with respect to the number of gathering sites. The inclusion of a moderate number of sites decreases the number of large-scale outbursts. Having no gathering sites or a large number of gathering sites has a dilutive effect on the number of large-scale outbursts. Thus, this non-monotonicity indicates that a small number of organized units produces a larger insurgency effect than a larger number of distributed units. It is also shown, using Koopman mode analysis, that the spatial morphology of agents due to the gathering sites gives rise to temporal organization of the model dynamics; there is a prominent quasi-periodic component in the number of active and intimidated citizens and in the spatial distribution of the LEOs.	[Fonoberova, Maria; Mezic, Igor; Mezic, Jadranka; Mohr, Ryan] Aimdyn Inc, Santa Barbara, CA 93101 USA; [Mezic, Igor] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Fonoberova, M (corresponding author), Aimdyn Inc, Santa Barbara, CA 93101 USA.	mfonoberova@aimdyn.com			AFOSR [FA9550-12-1-0230, FA9550-17-C-0012]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was partially supported under AFOSR grant FA9550-12-1-0230 (Program Managers: Dr. Fariba Fahroo and Dr. Frederick Leve) and AFOSR grant FA9550-17-C-0012 (Program Manager: Dr. Jean-Luc Cambier and Dr. Fariba Fahroo). All authors are affiliated with AIMdyn, Inc. The funders provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Bahgat K., 2013, TERRORISM, V7, P38; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Budisic M, 2012, CHAOS, V22, DOI 10.1063/1.4772195; Dhattiwala R, 2016, QUAL SOCIOL, V39, P71, DOI 10.1007/s11133-015-9320-5; Edling CR, 2002, ANNU REV SOCIOL, V28, P197, DOI 10.1146/annurev.soc.28.110601.140942; Epstein JM, 2002, P NATL ACAD SCI USA, V99, P7243, DOI 10.1073/pnas.092080199; Flint C, 2003, PROF GEOGR, V55, P161; Fonoberova M, 2018, SIMULATION RESULTS A, DOI [10.5281/zenodo.1284618, DOI 10.5281/ZENODO.1284618]; Fonoberova M, 2013, RELIAB ENG SYST SAFE, V118, P8, DOI 10.1016/j.ress.2013.04.004; Fonoberova M, 2012, JASSS-J ARTIF SOC S, V15, DOI 10.18564/jasss.1921; Hegselmann R, 1996, SOCIAL SCI MICROSIMU, P283; Levine M, 2011, PSYCHOL SCI, V22, P406, DOI 10.1177/0956797611398495; Macy MW, 2002, ANNU REV SOCIOL, V28, P143, DOI 10.1146/annurev.soc.28.110601.141117; Medina RM, 2011, STUD CONFL TERROR, V34, P862, DOI 10.1080/1057610X.2011.611933; Mezic I, 2005, NONLINEAR DYNAM, V41, P309, DOI 10.1007/s11071-005-2824-x; Mezic I, 2004, PHYSICA D, V197, P101, DOI 10.1016/j.physd.2004.06.015; Penzar D., 2004, International Transactions in Operational Research, V11, P63, DOI 10.1111/j.1475-3995.2004.t01-1-00439.x; Philpot R, 2017, THESIS U AUCKLAND AU; Rowley CW, 2009, J FLUID MECH, V641, P115, DOI 10.1017/S0022112009992059; Schaefer Robert W., 2010, INSURGENCY CHECHNYA; Susuki Y, 2009, NONLINEAR KOOPMAN MO; Susuki Y, 2010, 2010 IEEE POW EN SOC; Turner A, 2002, ENVIRON PLANN B, V29, P473, DOI 10.1068/b12850; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; Weisburd D, 2015, CRIMINOLOGY, V53, P133, DOI 10.1111/1745-9125.12070; Zajko M, 2008, ENVIRON PLANN D, V26, P719, DOI 10.1068/d0707	26	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2018	13	10							e0205259	10.1371/journal.pone.0205259	http://dx.doi.org/10.1371/journal.pone.0205259			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW0HY	30289939	Green Published, Green Submitted, gold			2022-12-27	WOS:000446545500060
J	Meirelles, J; Neto, CR; Ferreira, FF; Ribeiro, FL; Binder, CR				Meirelles, Joao; Rodrigues Neto, Camilo; Ferreira, Fernando Fagundes; Ribeiro, Fabiano Lemes; Binder, Claudia Rebeca			Evolution of urban scaling: Evidence from Brazil	PLOS ONE			English	Article							CITIES; LAWS	During the last years, the new science of cities has been established as a fertile quantitative approach to systematically understand the urban phenomena. One of its main pillars is the proposition that urban systems display universal scaling behavior regarding socioeconomic, infrastructural and individual basic services variables. This paper discusses the extension of the universality proposition by testing it against a broad range of urban metrics in a developing country urban system. We present an exploration of the scaling exponents for over 60 variables for the Brazilian urban system. Estimating those exponents is challenging from the technical point of view because the Brazilian municipalities' definition follows local political criteria and does not regard characteristics of the landscape, density, and basic utilities. As Brazilian municipalities can deviate significantly from urban settlements, urban-like municipalities were selected based on a systematic density cut-off procedure and the scaling exponents were estimated for this new subset of municipalities. To validate our findings we compared the results for overlaying variables with other studies based on alternative methods. It was found that the analyzed socioeconomic variables follow a superlinear scaling relationship with the population size, and most of the infrastructure and individual basic services variables follow expected sublinear and linearscaling, respectively. However, some infrastructural and individual basic services variables deviated from their expected regimes, challenging the universality hypothesis of urban scaling. We propose that these deviations are a product of top-down decisions/policies. Our analysis spreads over a time-range of 10 years, what is not enough to draw conclusive observations, nevertheless we found hints that the scaling exponent of these variables are evolving towards the expected scaling regime, indicating that the deviations might be temporally constrained and that the urban systems might eventually reach the expected scaling regime.	[Meirelles, Joao; Binder, Claudia Rebeca] Swiss Fed Inst Technol Lausanne, Dept Civil & Environm Engn, Lausanne, VD, Switzerland; [Meirelles, Joao; Rodrigues Neto, Camilo; Ferreira, Fernando Fagundes] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil; [Ribeiro, Fabiano Lemes] Univ Fed Lavras, Dept Phys, Lavras, MG, Brazil; [Ribeiro, Fabiano Lemes] City Univ London, Dept Math, London, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universidade de Sao Paulo; Universidade Federal de Lavras; City University London	Meirelles, J (corresponding author), Swiss Fed Inst Technol Lausanne, Dept Civil & Environm Engn, Lausanne, VD, Switzerland.; Meirelles, J (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil.	joao.meirelles@epfl.ch	Rodrigues Neto, Camilo/C-9126-2011; Meirelles, Joao/K-2889-2019; Ribeiro, Fabiano L/G-9519-2014	Rodrigues Neto, Camilo/0000-0001-6783-6695; Meirelles, Joao/0000-0001-5951-1284; Ribeiro, Fabiano L/0000-0002-2719-6061; Binder, Claudia, R./0000-0002-2921-9896	Swiss Mobiliar; Ecole polytechnique federale de Lausanne; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Swiss Mobiliar; Ecole polytechnique federale de Lausanne; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Swiss Mobiliar (Joao Meirelles), Ecole polytechnique federale de Lausanne (Joao Meirelles), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Fabiano Lemes Ribeiro), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Fabiano Lemes Ribeiro), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fabiano Lemes Ribeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2014, PHYSICA A, V409, P175, DOI 10.1016/j.physa.2014.04.046; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Batty M., 2013, NEW SCI CITIES; Bettencourt L., 2013, ARXIV13015919; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0005; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Cesaretti R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162678; Cottineau C, 2017, COMPUT ENVIRON URBAN, V63, P80, DOI 10.1016/j.compenvurbsys.2016.04.006; Cura R, 2017, GEOGR ANAL, V49, P363, DOI 10.1111/gean.12129; Dijkstra L, 2012, CITIES EUROPE NEW OE; Faria R, 2005, ESTUDOS EC, V35, P481; Fragkias M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064727; Gomez-Lievano A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0012; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Habitat U.N., 2016, URB DEV EM FUT WORLD; IBGE-Instituto Brasileiro de Geografia e Estatistica, CENS DEM 2010; Ignazzi A. C., 2015, THESIS; Ignazzi C.A., 2014, ESPACE GEOGRAPHIQUE, V43, P324, DOI [DOI 10.3917/EG.434.0324, 10.3917/eg.434.0324]; Kuhnert C, 2006, PHYSICA A, V363, P96, DOI 10.1016/j.physa.2006.01.058; Leitao JC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150649; Louf R, 2014, ENVIRON PLANN B, V41, P767, DOI 10.1068/b4105c; Louf R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102007; Martine G., 2010, BRAZILS EARLY URBAN; MMA D Brazilian Ministry for the Environment, 2016, NAT REG CONS UN; Muller NZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181407; NELSON RR, 1956, AM ECON REV, V46, P894; Ortman SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087902; OSM-Open Street Maps, BRAZ DAT; Pumain D, 2006, CYBERGEO, DOI 10.4000/cybergeo.2519; Ribeiro FL, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160926; Rybski D, 2017, ENVIRON PLAN B-URBAN, V44, P425, DOI 10.1177/0265813516638340; SNIS D National system of information on sanitation, 2014, DIAGN SERV A; SNIS-National Sanitation Information System. Ministry of Cities, HIST SER; Strano E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159465; West G., 2017, SCALE UNIVERSAL LAWS	38	17	21	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204574	10.1371/journal.pone.0204574	http://dx.doi.org/10.1371/journal.pone.0204574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286102	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500025
J	Yamamoto, T; Kadoya, N; Morishita, Y; Sato, Y; Matsushita, H; Umezawa, R; Ishikawa, Y; Takahashi, N; Katagiri, Y; Takeda, K; Jingu, K				Yamamoto, Takaya; Kadoya, Noriyuki; Morishita, Yohei; Sato, Yoshinao; Matsushita, Haruo; Umezawa, Rei; Ishikawa, Yojiro; Takahashi, Noriyoshi; Katagiri, Yu; Takeda, Ken; Jingu, Keiichi			Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer	PLOS ONE			English	Article							RISK-FACTORS; THERAPY; PNEUMONITIS; TUMORS; TOXICITY; METAANALYSIS; PATIENT; SBRT	Purpose Radiographic severity of radiation-induced lung injury (RILI) has not been well-studied. The goal of this study was to assess the CT appearance pattern and severity of RILI without consideration of the clinical presentation. Material and methods A total of 49 patients, 41 with primary lung cancer and 8 with metastatic lung cancer, were treated by 4-fraction stereotactic body radiotherapy (SBRT). RILI after SBRT was separately assessed by two observers. The early and late CT appearance patterns and CT-based severity grading were explored. Results The median follow-up period was 39.0 months. In the early CT findings of observers 1 and 2, there was diffuse consolidation in 15 and 8, diffuse ground glass opacity (GGO) in 0 and 0, patchy consolidation and GGO in 17 and 20, patchy GGO in 3 and 3, and no changes in 10 and 14, respectively (kappa = 0.61). In late CT findings of observer 1 and 2, there were modified conventional pattern in 28 and 24, mass-like pattern in 8 and 11, scar-like pattern in 12 and 12, and no changes in 1 and 2, respectively (kappa = 0.63). In the results of the CT-based grading by observers 1 and 2, there were grade 0 in 1 and 2, grade 1 in 10 and 14, grade 2 in 31 and 29, grade 3 in 7 and 4, and none of grade 4 or more, respectively (kappa = 0.66). According to multivariate analyses (MVA), the significant predicting factors of grade 2 or more CT-based RILI were age (p = 0.01), oxygen dependence (p = 0.03) and interstitial shadow (p = 0.03). Conclusions The agreement of the CT appearance and CT-based grading between two observers was good. These indicators may be able to provide us with more objective information and a better understanding of RILI.	[Yamamoto, Takaya; Kadoya, Noriyuki; Matsushita, Haruo; Umezawa, Rei; Ishikawa, Yojiro; Takahashi, Noriyoshi; Katagiri, Yu; Takeda, Ken; Jingu, Keiichi] Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, Sendai, Miyagi, Japan; [Morishita, Yohei; Sato, Yoshinao] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Yamamoto, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, Sendai, Miyagi, Japan.	t.yamamoto@rad.med.tohoku.ac.jp	Takahashi, Noriyoshi/GPP-0779-2022; Takeda, Ken/L-1914-2019; Yamamoto, Takaya/AAO-6488-2020	Yamamoto, Takaya/0000-0003-3562-1037				Aoki T, 2004, RADIOLOGY, V230, P101, DOI 10.1148/radiol.2301021226; Avanzo M, 2015, PHYS MEDICA, V31, P1, DOI 10.1016/j.ejmp.2014.10.006; Avanzo M, 2017, PHYS MEDICA, V42, P150, DOI 10.1016/j.ejmp.2017.09.127; Barriger RB, 2012, INT J RADIAT ONCOL, V82, P457, DOI 10.1016/j.ijrobp.2010.08.056; Bernchou U, 2017, RADIOTHER ONCOL, V123, P93, DOI 10.1016/j.radonc.2017.02.001; Cha JH, 2009, AM J ROENTGENOL, V193, pW95, DOI [10.2214/AJR.08.1833, 10.2214/AJR.08.2298]; Dahele M, 2015, ACTA ONCOL, V54, P1237, DOI 10.3109/0284186X.2014.1003961; Dahele M, 2011, J THORAC ONCOL, V6, P1221, DOI 10.1097/JTO.0b013e318219aac5; Deng GD, 2017, ONCOL LETT, V14, P501, DOI 10.3892/ol.2017.6268; Graves PR, 2010, SEMIN RADIAT ONCOL, V20, P201, DOI 10.1016/j.semradonc.2010.01.010; Guckenberger M, 2007, RADIOTHER ONCOL, V85, P435, DOI 10.1016/j.radonc.2007.10.044; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kimura T, 2012, BRIT J RADIOL, V85, P135, DOI 10.1259/bjr/32629867; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Linda A, 2011, EUR J RADIOL, V79, P147, DOI 10.1016/j.ejrad.2009.10.029; Matsuo Y, 2012, INT J RADIAT ONCOL, V83, pE545, DOI 10.1016/j.ijrobp.2012.01.018; Nagata Y, 2009, INT J RADIAT ONCOL, V75, P343, DOI 10.1016/j.ijrobp.2009.02.087; Okubo M, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160508; Palma DA, 2013, INT J RADIAT ONCOL, V85, P444, DOI 10.1016/j.ijrobp.2012.04.043; Pan H, 2011, CANCER-AM CANCER SOC, V117, P4566, DOI 10.1002/cncr.26067; Takeda A, 2008, RADIAT MED, V26, P504, DOI 10.1007/s11604-008-0261-8; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Trovo M, 2010, LUNG CANCER, V69, P77, DOI 10.1016/j.lungcan.2009.09.006; Vogelius IR, 2012, ACTA ONCOL, V51, P975, DOI 10.3109/0284186X.2012.718093; Wang JB, 2013, INT J RADIAT ONCOL, V85, P798, DOI 10.1016/j.ijrobp.2012.06.040; Yamaguchi S, 2013, LUNG CANCER, V82, P260, DOI 10.1016/j.lungcan.2013.08.024; Zhao J, 2016, INT J RADIAT ONCOL, V95, P1357, DOI 10.1016/j.ijrobp.2016.03.024	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204734	10.1371/journal.pone.0204734	http://dx.doi.org/10.1371/journal.pone.0204734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286105	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500037
J	Yuda, M				Yuda, Michio			The medical assistance system and inpatient health care provision: Empirical evidence from short-term hospitalizations in Japan	PLOS ONE			English	Article							SUPPLIER-INDUCED DEMAND; INSURANCE EXPERIMENT; RED HERRINGS; COST; EXPENDITURES; POPULATION; MORTALITY; TIMES; VARIABLES; PAYMENTS	This paper uses two nationally representative sets of medical claims data from medical assistance and universal public health insurance systems to examine how medical assistance system assignment affects short-term inpatient health care provision. In Japan, the medical assistance system, which is part of a public assistance system, provides medical care services for its beneficiaries without imposing any financial burdens, such as copayments or advance premium payments. These circumstances can lead to inpatient costs, as physicians may provide more treatments because there is a financial incentive. Because the assignment of public assistance in Japan is not random but is subject to means testing by the local government, I employ the instrumental variable model to control the potential correlation. I find that medical expenditure is significantly higher for medical assistance patients than for universal public health insurance patients, with an arc elasticity of approximately 0.20. This elasticity is slightly greater than that found for inpatient care in the randomized RAND Health Insurance Experiment and recent empirical studies on low-income populations. In addition, the elasticities for patients who receive medication, treatment and surgery are greater.	[Yuda, Michio] Tohoku Univ, Grad Sch Econ & Management, Sendai, Miyagi, Japan	Tohoku University	Yuda, M (corresponding author), Tohoku Univ, Grad Sch Econ & Management, Sendai, Miyagi, Japan.	myuda@tohoku.ac.jp			Japan Society for the Promotion of Science [26780180]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study is financially supported by the Grand-in-Aid for Young Scientists (B) (#26780180) from the Japan Society for the Promotion of Science. http://www.jsps.go.jp/english/e-grants/grants01.html.	Aron-Dine A, 2013, J ECON PERSPECT, V27, P197, DOI 10.1257/jep.27.1.197; Baker LC, 2000, J HUM RESOUR, V35, P480, DOI 10.2307/146389; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Chandra A, 2014, J HEALTH ECON, V33, P57, DOI 10.1016/j.jhealeco.2013.10.008; Choi MK, 2011, J HEALTH ECON, V30, P1020, DOI 10.1016/j.jhealeco.2011.08.002; CURRIE J, 1995, AM ECON REV, V85, P106; Currie J, 2009, J ECON LIT, V47, P87, DOI 10.1257/jel.47.1.87; Felder S, 2000, J HEALTH ECON, V19, P679, DOI 10.1016/S0167-6296(00)00039-4; Felder S, 2010, J HEALTH ECON, V29, P205, DOI 10.1016/j.jhealeco.2009.11.014; Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Fukushima K, 2016, J HEALTH ECON, V45, P115, DOI 10.1016/j.jhealeco.2015.10.005; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Granados JAT, 2008, DEMOGRAPHY, V45, P323, DOI 10.1353/dem.0.0008; Gross T, 2011, J PUBLIC ECON, V95, P767, DOI 10.1016/j.jpubeco.2011.01.012; Haaland VF, 2015, J HEALTH ECON, V39, P248, DOI 10.1016/j.jhealeco.2014.08.005; Hashimoto H, 2010, INT J ENV RES PUB HE, V7, P3022, DOI 10.3390/ijerph7083022; Hayashi M., 2012, NEW RISK SOCIAL SECU, P273; Hayashi M, 2011, INT J HEALTH CARE FI, V11, P287, DOI 10.1007/s10754-011-9098-2; HECKMAN JJ, 1978, ECONOMETRICA, V46, P931, DOI 10.2307/1909757; Iizuka T, 2007, RAND J ECON, V38, P844, DOI 10.1111/j.0741-6261.2007.00115.x; Iizuka T, 2012, AM ECON REV, V102, P2826, DOI 10.1257/aer.102.6.2826; Kan M, 2010, JPN WORLD ECON, V22, P1, DOI 10.1016/j.japwor.2009.06.005; Kawaguchi H., 2012, SEIJO EC REV, V196, P59; Keeler EB, 1988, RAND PUBLICATION SER; Kondo A, 2013, J PUBLIC ECON, V99, P1, DOI 10.1016/j.jpubeco.2012.12.004; Kumagai N., 2002, J HLTH CARE SOC, V12, P39, DOI [10.4091/iken1991.12.3_39, DOI 10.4091/IKEN1991.12.3_39]; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ J, 1995, NEW ENGL J MED, V332, P999, DOI 10.1056/NEJM199504133321506; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; MANNING WG, 1987, AM ECON REV, V77, P251; National Institute of Population and Social Security Studies, 2014, SOC SEC JAP; Newhouse JP, 1993, FREE ALL LESSONS RAN; Nishikawa M., 2010, AOYAMA J EC, V62, P195; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2005, J HEALTH ECON, V24, P341, DOI 10.1016/j.jhealeco.2004.09.007; Ruhm CJ, 2003, J HEALTH ECON, V22, P637, DOI 10.1016/S0167-6296(03)00041-9; Sato E, 2009, HEALTH ECON, V18, P843, DOI 10.1002/hec.1410; SCITOVSKY AA, 1984, MILBANK Q, V62, P591, DOI 10.2307/3349838; Shigeoka H, 2014, AM ECON REV, V104, P2152, DOI 10.1257/aer.104.7.2152; Shigeoka H, 2014, J HEALTH ECON, V35, P162, DOI 10.1016/j.jhealeco.2014.03.003; Suzuki W., 2007, J INCOME DISTRIB, V16, P88, DOI [10.25071/1874-6322.7232, DOI 10.25071/1874-6322.7232]; Takaku R, 2016, SOC SCI MED, V151, P46, DOI 10.1016/j.socscimed.2015.12.038; The Fiscal System Council, 2013, POL FISC YEAR 2013 B; The Government Revitalization Unit, 2011, SOC SEC REV PUBL ASS; Travis KM, 1999, ECON INQ, V37, P86, DOI 10.1111/j.1465-7295.1999.tb01418.x; Werblow A, 2007, HEALTH ECON, V16, P1109, DOI 10.1002/hec.1213; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yuda M, 2013, 9 WORLD C INT HLTH E; Yuda M, 2013, HITOTSUB J ECON, V54, P79, DOI 10.15057/25780; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	53	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204798	10.1371/journal.pone.0204798	http://dx.doi.org/10.1371/journal.pone.0204798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286118	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500044
J	Correa, MG; Pires, PR; Ribeiro, FV; Pimentel, SP; Cirano, FR; Napimoga, MH; Casati, MZ; Casarin, RCV				Correa, Monica G.; Pires, Paula Rodrigues; Ribeiro, Fernanda Vieira; Pimentel, Suzana Peres; Cirano, Fabiano Ribeiro; Napimoga, Marcelo Henrique; Casati, Marcio Z.; Viana Casarin, Renato Correa			Systemic treatment with resveratrol reduces the progression of experimental periodontitis and arthritis in rats	PLOS ONE			English	Article							ARGININE DEIMINASE SYSTEM; GINGIVAL CREVICULAR FLUID; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; PORPHYROMONAS-GINGIVALIS; DENDRITIC CELLS; AGGRESSIVE PERIODONTITIS; GENE-THERAPY; TNF-ALPHA; INTERLEUKIN-4	Rheumatoid arthritis and periodontitis are chronic inflammatory diseases which has been closely associated due to the nature of immune-inflammatory imbalance response. Resveratrol is a naturall product with biological proprieties that may promote immunomodulatory effects on host response. This study investigated resveratrol continuous administration effect on experimental periodontitis and arthritis progression in rats. Thirty-five rats were assigned to the following groups: 1-experimental arthritis + experimental periodontitis + placebo (RA+EP +PL) (n = 12); 2 -RA+EP+ ibuprofen (RA+PE+IB) (n =11); 3-RA+EP+ resveratrol (RA+PE+RSV) (n = 11). After euthanasia, the specimens were processed for morphometric analysis of bone loss, and the gingival tissue surrounding the first molar was collected for quantification of inflammatory markers using a Luminex/MAGpix assay and anti-citrullinated protein antibody (ACCPA) levels were measured by ELISA assay. Serum level of rheumatoid factor (RF) was measured by ELISA assay. Paw edema was analyzed using a plethysmometer. Higher bone loss was observed in PL group, when compared to IB and RSV groups. RSV group presented higher IL-4 concentration than PL and IB groups. Resveratrol reduced RF serum levels and both IB and RSV decreased ACCPA gingival levels. Besides, paw swelling level was significantly lower in IB and RSV groups in the 21th day and only in RSV group in the 28th day. Histological analyzes showed smooth articular surface and higher width of the subchondral cortical in RSV group. Resveratrol showed modulatory effect and seems to reduce the inflammatory signs of arthritis and articular damage throughout the time.	[Correa, Monica G.; Pires, Paula Rodrigues; Ribeiro, Fernanda Vieira; Pimentel, Suzana Peres; Cirano, Fabiano Ribeiro; Casati, Marcio Z.; Viana Casarin, Renato Correa] Univ Paulista, Sch Dent, Dent Res Div, Sao Paulo, SP, Brazil; [Napimoga, Marcelo Henrique] Sao Leopoldo Mandic Inst & Res Ctr, Lab Immunol & Mol Biol, Campinas, SP, Brazil	Universidade Paulista; Faculdade Sao Leopoldo Mandic	Correa, MG; Casarin, RCV (corresponding author), Univ Paulista, Sch Dent, Dent Res Div, Sao Paulo, SP, Brazil.	monica.grazieli@hotmail.com; casarinrcv@yahoo.com.br	Cirano, Fabiano R/J-2092-2014; Cirano, Fabiano/ABA-1897-2020; Napimoga, Marcelo/S-2434-2019; CORREA, MONICA GRAZIELI/E-8661-2013; casati, marcio zaffalon/ABA-2670-2020; Ribeiro, Fernanda/I-4030-2012	Cirano, Fabiano R/0000-0002-7331-4612; Cirano, Fabiano/0000-0002-7331-4612; Napimoga, Marcelo/0000-0003-4472-365X; CORREA, MONICA GRAZIELI/0000-0003-1895-3283; casati, marcio zaffalon/0000-0001-9234-0536; Ribeiro, Fernanda/0000-0002-2697-620X; Casarin, Renato/0000-0003-1743-5855	National Counsel of Technological and Scientific Development - (CNPq - Brasilia, Distrito Federal, Brazil) [442275/2014-5]; Research Productivity Fellowship from CNPq	National Counsel of Technological and Scientific Development - (CNPq - Brasilia, Distrito Federal, Brazil); Research Productivity Fellowship from CNPq	This study was partially supported by grant from the National Counsel of Technological and Scientific Development - (CNPq - Brasilia, Distrito Federal, Brazil) (442275/2014-5). This work was also supported by Research Productivity Fellowship to M.H.N, and M.Z.C. from CNPq.	Barrella GE, 2012, BRAZ ORAL RES, V26, P158, DOI 10.1590/S1806-83242012000200012; Bastos MF, 2009, ORAL DIS, V15, P82, DOI 10.1111/j.1601-0825.2008.01491.x; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bello-Gualtero JM, 2016, J PERIODONTOL, V87, P346, DOI 10.1902/jop.2015.150455; Bhatt SR, 2011, EUR J PHARMACOL, V667, P258, DOI 10.1016/j.ejphar.2011.05.026; Breen DM, 2012, ATHEROSCLEROSIS, V222, P375, DOI 10.1016/j.atherosclerosis.2012.03.021; Calderaro DC, 2016, REV BRAS REUMATOL; Candelario-Jalil E, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-25; Carregaro V, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9626427; Casati MZ, 2013, J PERIODONTOL, V84, pE58, DOI 10.1902/jop.2013.120746; CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Choi IA, 2016, KOREAN J INTERN MED, V31, P977, DOI 10.3904/kjim.2015.202; Chou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139693; Correa MG, 2017, J PERIODONTAL RES, V52, P201, DOI 10.1111/jre.12382; Correa MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174442; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Dietrich T, 2008, J RHEUMATOL, V5; Dutzan N, 2009, J CLIN PERIODONTOL, V36, P396, DOI 10.1111/j.1600-051X.2009.01390.x; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fuggle NR, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00080; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Ghanim H, 2011, J CLIN ENDOCR METAB, V96, P1409, DOI 10.1210/jc.2010-1812; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Havemose-Poulsen A, 2006, J PERIODONTOL, V77, P280, DOI 10.1902/jop.2006.050051; Hecht C, 2015, ANN RHEUM DIS, V74, P2151, DOI 10.1136/annrheumdis-2014-205428; Hitchon CA, 2011, CURR OPIN RHEUMATOL, V23, P352, DOI 10.1097/BOR.0b013e3283477b7b; Jiang CP, 2014, PHYTOMEDICINE, V21, P830, DOI 10.1016/j.phymed.2014.01.009; Joosten LAB, 1999, ARTHRITIS RES, V1, P81, DOI 10.1186/ar14; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kabashima H, 1996, J ORAL PATHOL MED, V25, P449, DOI 10.1111/j.1600-0714.1996.tb00295.x; Kaur Shamsherjit, 2011, Inflammopharmacology, V19, P265, DOI 10.1007/s10787-011-0090-8; Khojah HM, 2018, CLIN RHEUMATOL, V37, P2035, DOI 10.1007/s10067-018-4080-8; Kinane DF, 2011, J CLIN PERIODONTOL, V38, P44, DOI 10.1111/j.1600-051X.2010.01682.x; Li Z, 2012, BRAIN RES, V1450, P116, DOI 10.1016/j.brainres.2012.02.019; Liao F, 2009, MED HYPOTHESES, V72, P732, DOI 10.1016/j.mehy.2008.12.040; Lubberts E, 2000, J CLIN INVEST, V105, P1697, DOI 10.1172/JCI7739; MARQUIS RE, 1987, APPL ENVIRON MICROB, V53, P198, DOI 10.1128/AEM.53.1.198-200.1987; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Mercado FB, 2001, J PERIODONTOL, V72, P779, DOI 10.1902/jop.2001.72.6.779; Militaru C, 2013, NUTRITION, V29, P178, DOI 10.1016/j.nut.2012.07.006; Mitani A, 2015, J PERIODONTOL, V86, P301, DOI 10.1902/jop.2014.140293; Morita Y, 2001, J CLIN INVEST, V107, P1275, DOI 10.1172/JCI11490; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; OFFENBACHER S, 1992, J PERIODONTAL RES, V27, P207, DOI 10.1111/j.1600-0765.1992.tb01670.x; Orsu P, 2013, J NEURAL TRANSM, V120, P1217, DOI 10.1007/s00702-013-0982-4; Padua TA, 2014, ARCH PHARM RES, V37, P1487, DOI 10.1007/s12272-014-0345-1; PAUL WE, 1991, BLOOD, V77, P1859; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Preshaw PM, 2008, PERIODONTOL 2000, V48, P92, DOI 10.1111/j.1600-0757.2008.00252.x; Queiroz CM, 2012, J CLIN PERIODONTOL, V39, P608, DOI 10.1111/j.1600-051X.2012.01886.x; Ramamurthy HS, 2005, J PERIODONTOL, V76, P229, DOI 10.1902/jop.2005.76.2.229; Reddy Michael S, 2003, Ann Periodontol, V8, P12, DOI 10.1902/annals.2003.8.1.12; Ribeiro FV, 2012, BRAZ J ORAL SCI, V11, P42; Ribeiro J, 2005, J CLIN PERIODONTOL, V32, P412, DOI 10.1111/j.1600-051X.2005.00689.x; Riveiro-Naveira RR, 2016, RHEUMATOLOGY, V55, P1889, DOI 10.1093/rheumatology/kew255; Rotondo S, 1998, BRIT J PHARMACOL, V123, P1691, DOI 10.1038/sj.bjp.0701784; Rutten K, 2014, EUR J PAIN, V18, P204, DOI 10.1002/j.1532-2149.2013.00358.x; Santegoets KCM, 2016, ARTHRITIS RHEUMATOL, V68, P795, DOI 10.1002/art.39514; Sarkar S, 2007, ARTHRITIS RHEUM-US, V56, P89, DOI 10.1002/art.22311; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; Silvestre FJ, 2016, MED ORAL PATOL ORAL, V21, pE349, DOI 10.4317/medoral.20974; Silvestre-Rangil J, 2016, CLIN ORAL INVEST, V20, P2575, DOI 10.1007/s00784-016-1745-z; Soufi F G, 2012, Endocr Regul, V46, P83; Tang QQ, 2017, INT J PERIODONT REST, V37, P79, DOI 10.11607/prd.2656; TEVELDE AA, 1990, BLOOD, V76, P1392; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; Trombone AP, 2010, GENES IMMUN, V11, P479, DOI 10.1038/gene.2010.13; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Vander Cruyssen B, 2005, AUTOIMMUN REV, V4, P468, DOI 10.1016/j.autrev.2005.04.018; Wahba MGF, 2016, PHARM BIOL, V54, P1705, DOI 10.3109/13880209.2015.1125931; Whitlock NC, 2012, NUTR CANCER, V64, P493, DOI 10.1080/01635581.2012.667862; Zhang CF, 2014, J ETHNOPHARMACOL, V153, P793, DOI 10.1016/j.jep.2014.03.046	81	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204414	10.1371/journal.pone.0204414	http://dx.doi.org/10.1371/journal.pone.0204414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281626	Green Published, gold, Green Submitted			2022-12-27	WOS:000446342400050
J	Farrokhvar, L; Ansari, A; Kamali, B				Farrokhvar, Leily; Ansari, Azadeh; Kamali, Behrooz			Predictive models for charitable giving using machine learning techniques	PLOS ONE			English	Article							DONATIONS; ORGANIZATIONS; GENDER	Private giving represents more than three fourths of all U.S. charitable donations, about 2% of total Gross Domestic Product (GDP). Private giving is a significant factor in funding the nonprofit sector of the U.S. economy, which accounts for more than 10% of total GDP. Despite the abundance of data available through tax forms and other sources, it is unclear which factors influence private donation, and a reliable predictive mechanism remains elusive. This study aims to develop predictive models to accurately estimate future charitable giving based on a set of potentially influential factors. We have selected several factors, including unemployment rate, household income, poverty level, population, sex, age, ethnicity, education level, and number of vehicles per household. This study sheds light on the relationship between donation and these variables. We use Stepwise Regression to identify the most influential variables among the available variables, based on which predictive models are developed. Multiple Linear Regression (MLR) and machine learning techniques, including Artificial Neural Networks (ANN) and Support Vector Regression (SVR) are used to develop the predictive models. The results suggest that population, education level, and the amount of charitable giving in the previous year are the most significant, independent variables. We propose three predictive models (MLR, ANN, and SVR) and validate them using 10-fold cross-validation method, then evaluate the performance using 9 different measuring criteria. All three models are capable of predicting the amount of future donations in a given region with good accuracy. Based on the evaluation criteria, using a test data set, ANN outperforms SVR and MLR in predicting the amount of charitable giving in the following year.	[Farrokhvar, Leily; Ansari, Azadeh; Kamali, Behrooz] West Virginia Univ, Dept Ind & Management Syst Engn, Morgantown, WV 26506 USA	West Virginia University	Farrokhvar, L (corresponding author), West Virginia Univ, Dept Ind & Management Syst Engn, Morgantown, WV 26506 USA.	leily.farrokhvar@mail.wvu.edu		Farrokhvar, Leily/0000-0003-4692-4500				BARRETT KS, 1991, NATL TAX J, V44, P365; Bekkers R, 2011, VOLUNT SECT REV, V2, P337, DOI 10.1332/204080511X6087712; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; Brown Melissa S., 2010, GIVING FOLLOWING CRI; Brown S, 2015, ECON MODEL, V50, P228, DOI 10.1016/j.econmod.2015.06.018; Chiang K-P., 2003, ADV MARKETING, P138; de Vries NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122133; Dickert S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148274; Gittell R, 2006, NONPROF VOLUNT SEC Q, V35, P721, DOI 10.1177/0899764006289768; Hernandez-Murillo R., 2005, REGIONAL EC      OCT, P12; Lacasse R-M, 2016, INT J TECHNOL MANAGE, V15, P159; Leslie LM, 2013, J APPL PSYCHOL, V98, P49, DOI 10.1037/a0029943; McKeever B.S., 2015, NONPROFIT SECTOR BRI; Mularz C. M., 2014, ENCY BUSINESS ANAL O, P115, DOI DOI 10.4018/978-1-4666-5202-6.CH012; Navigator C. Giving USA, 2015, GIVING US 2015; Ostrower F, 1997, WHY WEALTHY GIVE CUL; Ranganathan SK, 2008, INT J NONPROFIT VOLU, V13, P1, DOI 10.1002/nvsm.297; Sargeant A., 1999, J MARKET MANAG, V15, P215, DOI DOI 10.1362/026725799784870351; Saunders TJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150710; Schalkoff R.J., 1997, ARTIFICIAL NEURAL NE; Schervish PG., 1997, VOLUNTAS, V8, P235, DOI DOI 10.1007/BF02354199; Sikkel D, 2012, INT J NONPROFIT VOLU, V17, P183, DOI 10.1002/nvsm.1421; Steinberg KS, 2005, NONPROF VOLUNT SEC Q, V34, P110, DOI 10.1177/0899764004269738; Steuerle C. Eugene, 2002, MANAGING CHARITABLE; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; Ulku MA, 2015, ANN OPER RES, V230, P153, DOI 10.1007/s10479-014-1623-5; Vapnik V., 2013, NATURE STAT LEARNING; Vapnik V., 1963, AUTOM REMOTE, V24, P774; Webb DJ, 2000, J ACAD MARKET SCI, V28, P299, DOI 10.1177/0092070300282010; Wiepking P, 2012, VOLUNT SECT REV, V3, P217, DOI 10.1332/204080512X649379; Winterich KP, 2013, J MARKETING, V77, P121, DOI 10.1509/jm.11.0477; Yen ST, 2002, APPL ECON LETT, V9, P837, DOI 10.1080/13504850210148189; Yoruk BK, 2009, J PUBLIC ECON, V93, P1111, DOI 10.1016/j.jpubeco.2009.06.001; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7	34	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203928	10.1371/journal.pone.0203928	http://dx.doi.org/10.1371/journal.pone.0203928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281644	gold, Green Published, Green Submitted			2022-12-27	WOS:000446342400034
J	Otsuka, M; Monzen, H; Matsumoto, K; Tamura, M; Inada, M; Kadoya, N; Nishimura, Y				Otsuka, Masakazu; Monzen, Hajime; Matsumoto, Kenji; Tamura, Mikoto; Inada, Masahiro; Kadoya, Noriyuki; Nishimura, Yasumasa			Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; RADIATION PNEUMONITIS; REGISTRATION ALGORITHMS; PULMONARY VENTILATION; GUIDED RADIOTHERAPY; ALLOWS	Background Four-dimensional computed tomography (4D-CT) ventilation is an emerging imaging modality. Functional avoidance of regions according to 4D-CT ventilation may reduce lung toxicity after radiation therapy. This study evaluated associations between 4D-CT ventilation-based dosimetric parameters and clinical outcomes. Methods Pre-treatment 4D-CT data were used to retrospectively construct ventilation images for 40 thoracic cancer patients retrospectively. Fifteen patients were treated with conventional radiation therapy, 6 patients with hyperfractionated radiation therapy and 19 patients with stereotactic body radiation therapy (SBRT). Ventilation images were calculated from 4D-CT data using a deformable image registration and Jacobian-based algorithm. Each ventilation map was normalized by converting it to percentile images. Ventilation-based dosimetric parameters (Mean Dose, V5 [percent lung volume receiving >= 5 Gy], and V20 [percent lung volume receiving >= 20 Gy]) were calculated for highly and poorly ventilated regions. To test whether the ventilation-based dosimetric parameters could be used predict radiation pneumonitis of >= Grade 2, the area under the curve (AUC) was determined from the receiver operating characteristic analysis. Results For Mean Dose, poorly ventilated lung regions in the 0-30% range showed the highest AUC value (0.809; 95% confidence interval [CI], 0.663-0.955). For V20, poorly ventilated lung regions in the 0-20% range had the highest AUC value (0.774; 95% [CI], 0.598-0.915), and for V5, poorly ventilated lung regions in the 0-30% range had the highest AUC value (0.843; 95% [CI], 0.732-0.954). The highest AUC values for Mean Dose, V20, and V5 were obtained in poorly ventilated regions. There were significant differences in all dosimetric parameters between radiation pneumonitis of Grade 1 and Grade >= 2. Conclusions Poorly ventilated lung regions identified on 4D-CT had higher AUC values than highly ventilated regions, suggesting that functional planning based on poorly ventilated regions may reduce the risk of lung toxicity in radiation therapy.	[Otsuka, Masakazu; Monzen, Hajime; Matsumoto, Kenji; Tamura, Mikoto] Kindai Univ, Grad Sch Med Sci, Dept Med Phys, Osakasayama, Japan; [Monzen, Hajime; Inada, Masahiro; Nishimura, Yasumasa] Kindai Univ, Dept Radiat Oncol, Fac Med, Osakasayama, Japan; [Kadoya, Noriyuki] Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, Sendai, Miyagi, Japan	Tohoku University	Monzen, H (corresponding author), Kindai Univ, Grad Sch Med Sci, Dept Med Phys, Osakasayama, Japan.; Monzen, H (corresponding author), Kindai Univ, Dept Radiat Oncol, Fac Med, Osakasayama, Japan.	hmon0709@gmail.com	Otsuka, Masakazu/ABG-7713-2020	Otsuka, Masakazu/0000-0003-3925-5011				Aibe N, 2014, J RADIAT RES, V55, P575, DOI 10.1093/jrr/rrt146; Borst GR, 2009, RADIOTHER ONCOL, V91, P307, DOI 10.1016/j.radonc.2009.02.003; Castillo R, 2010, PHYS MED BIOL, V55, P4661, DOI 10.1088/0031-9155/55/16/004; Chen SF, 2008, PHYS MED BIOL, V53, P203, DOI 10.1088/0031-9155/53/1/014; Du KF, 2012, MED PHYS, V39, P1595, DOI 10.1118/1.3685589; Gayed IW, 2008, J THORAC ONCOL, V3, P858, DOI 10.1097/JTO.0b013e31818020d5; Guerrero T, 2006, PHYS MED BIOL, V51, P777, DOI [10.1088/0031-9155/51/4/002, 10.1088/0031-9155/-51/4/002]; Ireland RH, 2016, CLIN ONCOL-UK, V28, P695, DOI 10.1016/j.clon.2016.08.005; Ireland RH, 2007, INT J RADIAT ONCOL, V68, P273, DOI 10.1016/j.ijrobp.2006.12.068; Kabus S, 2008, P 1 INT WORKSH PULM, P77; Kadoya N, 2015, PRACTICAL RAD ONCOL, V5, P505; Kadoya N, 2014, J RADIAT RES, V55, P175, DOI 10.1093/jrr/rrt093; Kanai T, 2014, J RADIAT RES, V55, P1163, DOI 10.1093/jrr/rru062; Kimura T, 2012, BRIT J RADIOL, V85, P135, DOI 10.1259/bjr/32629867; Kin H T, 2005, RADIOLOGY, V235, P735; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kong FM, 2015, SEMIN RADIAT ONCOL, V25, P100, DOI 10.1016/j.semradonc.2014.12.003; Kwa SLS, 1998, INT J RADIAT ONCOL, V42, P1, DOI 10.1016/S0360-3016(98)00196-5; Lind PA, 2002, INT J RADIAT ONCOL, V54, P340, DOI 10.1016/S0360-3016(02)02932-2; McGuire SM, 2006, INT J RADIAT ONCOL, V66, P1543, DOI 10.1016/j.ijrobp.2006.07.1377; Ministry of Health Labour and Welfare, 2017, VIT STAT JAP LAT TRE, P18; Murphy K, 2011, IEEE T MED IMAGING, V30, P1901, DOI 10.1109/TMI.2011.2158349; Qinghui Z, 2015, PHYS MEDICA, V31, P1060, DOI [10.1016/j.ejmp.2015.07.145, DOI 10.1016/J.EJMP.2015.07.145]; Reinhardt JM, 2008, MED IMAGE ANAL, V12, P752, DOI 10.1016/j.media.2008.03.007; Rietzel E, 2005, MED PHYS, V32, P874, DOI 10.1118/1.1869852; Siva S, 2016, TECHNOL CANCER RES T, V15, P114, DOI 10.1177/1533034614565534; Siva S, 2015, RADIOTHER ONCOL, V115, P157, DOI 10.1016/j.radonc.2015.04.013; Tsujino K, 2014, J THORAC ONCOL, V9, P983, DOI 10.1097/JTO.0000000000000187; Vinogradskiy Y, 2013, INT J RADIAT ONCOL, V86, P366, DOI 10.1016/j.ijrobp.2013.01.004; Yamamoto T, 2016, RADIOTHER ONCOL, V118, P227, DOI 10.1016/j.radonc.2015.11.006; Yamamoto T, 2011, MED PHYS, V38, P1348, DOI 10.1118/1.3547719; Zhang GG, 2016, J APPL CLIN MED PHYS, V17, P550, DOI 10.1120/jacmp.v17i2.5985; Zhou Z, 2017, SCI REP-UK, V7, P1; Zhou ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02739-4	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204721	10.1371/journal.pone.0204721	http://dx.doi.org/10.1371/journal.pone.0204721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281625	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400056
J	Pedersen, TM; Boardman, NT; Hafstad, AD; Aasum, E				Pedersen, Tina M.; Boardman, Neoma T.; Hafstad, Anne D.; Aasum, Ellen			Isolated perfused working hearts provide valuable additional information during phenotypic assessment of the diabetic mouse heart	PLOS ONE			English	Article							CARDIOMYOCYTE-SPECIFIC EXCISION; INDUCED OBESE MICE; CARDIAC EFFICIENCY; DIASTOLIC DYSFUNCTION; CONTRACTILE DYSFUNCTION; INSULIN-RESISTANCE; DB/DB MICE; METABOLISM; GLUCOSE; HYPERTROPHY	Although murine models for studying the development of cardiac dysfunction in diabetes mellitus are well established, their reported cardiac phenotypes vary. These reported divergences may, in addition to the severity of different models, also be linked to the methods used for cardiac functional assessment. In the present study, we examined the functional changes using conventional transthoracic echocardiography (in vivo) and isolated heart perfusion techniques (ex vivo), in hearts from two mouse models; one with an overt type 2 diabetes (the db/db mouse) and one with a prediabetic state, where obesity was induced by a high-fat diet (HFD). Analysis of left ventricular function in the isolated working hearts from HFD-fed mice, suggested that these hearts develop diastolic dysfunction with preserved systolic function. Accordingly, in vivo examination demonstrated maintained systolic function, but we did not find parameters of diastolic function to be altered. In db/db mice, ex vivo working hearts showed both diastolic and systolic dysfunction. Although in vivo functional assessment revealed signs of diastolic dysfunction, the hearts did not display reduced systolic function. The contrasting results between ex vivo and in vivo function could be due to systemic changes that may sustain in vivo function, or a lack of sensitivity using conventional transthoracic echocardiography. Thus, this study demonstrates that the isolated perfused working heart preparation provides unique additional information related to the development of cardiomyopathy, which might otherwise go unnoticed when only using conventional echocardiographic assessment.	[Pedersen, Tina M.; Boardman, Neoma T.; Hafstad, Anne D.; Aasum, Ellen] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso	Aasum, E (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway.	ellen.aasum@uit.no	Hafstad, Anne D/AAK-4269-2021	Pedersen, Tina Myhre/0000-0001-7950-4647; Aasum, Ellen/0000-0002-5731-3273; Hafstad, Anne/0000-0003-0711-9736	Norwegian Council on Cardiovascular Disease; UiT - The Arctic University of Norway	Norwegian Council on Cardiovascular Disease; UiT - The Arctic University of Norway	This work was supported by grants from The Norwegian Council on Cardiovascular Disease (TMP, ADH, NTB). This publication also arises from research funded by UiT - The Arctic University of Norway.	Aasum E, 2005, CAN J PHYSIOL PHARM, V83, P183, DOI 10.1139/Y04-139; Aasum E, 2003, DIABETES, V52, P434, DOI 10.2337/diabetes.52.2.434; Aasum E, 2002, AM J PHYSIOL-HEART C, V283, pH949, DOI 10.1152/ajpheart.00226.2001; Abdurrachim D, 2014, BBA-MOL CELL BIOL L, V1841, P1525, DOI 10.1016/j.bbalip.2014.07.016; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Boardman NT, 2014, AM J PHYSIOL-HEART C, V306, pH1018, DOI 10.1152/ajpheart.00741.2013; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DANIELS A, 2010, DEV POLICY REV, V28, P11, DOI DOI 10.1111/J.1748-1716.2010.02102.X; Dludla PV, 2017, HEART VESSELS, V32, P1025, DOI 10.1007/s00380-017-0978-3; Dong F, 2006, J ENDOCRINOL, V188, P25, DOI 10.1677/joe.1.06241; FEIN FS, 1990, DIABETES CARE, V13, P1169, DOI 10.2337/diacare.13.11.1169; GALINANES M, 1990, CARDIOSCIENCE, V1, P127; GRUPP IL, 1993, AM J PHYSIOL, V265, pH1401, DOI 10.1152/ajpheart.1993.265.4.H1401; Hafstad AD, 2007, AM J PHYSIOL-ENDOC M, V292, pE1288, DOI 10.1152/ajpendo.00504.2006; Hafstad AD, 2013, DIABETES, V62, P2287, DOI 10.2337/db12-1580; Hamdani N, 2014, CARDIOVASC RES, V104, P423, DOI 10.1093/cvr/cvu223; How O. -J., 2007, Archives of Physiology and Biochemistry, V113, P211, DOI 10.1080/13813450701783281; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; How OJ, 2005, AM J PHYSIOL-HEART C, V288, pH2979, DOI 10.1152/ajpheart.00084.2005; Jeong EM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003046; Khalid AM, 2011, AM J PHYSIOL-HEART C, V300, pH2116, DOI 10.1152/ajpheart.00357.2010; Ko KY, 2017, ONCOTARGET, V8, P87795, DOI 10.18632/oncotarget.21202; Kuzmiak-Glancy S, 2018, AM J PHYSIOL-HEART C, V314, pH704, DOI 10.1152/ajpheart.00321.2017; Land S, 2013, BIOPHYS J, V104, P1349, DOI 10.1016/j.bpj.2013.01.042; Larsen TS, 1999, PFLUG ARCH EUR J PHY, V437, P979, DOI 10.1007/s004240050870; Li RJ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-141; Lindsey ML, 2018, AM J PHYSIOL-HEART C, V314, pH733, DOI 10.1152/ajpheart.00339.2017; Lund J, 2015, AM J PHYSIOL-HEART C, V308, pH823, DOI 10.1152/ajpheart.00734.2014; Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672; Naresh NK, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0273-y; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Nilsson J, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0132-8; Panagia M, 2007, CAN J PHYSIOL PHARM, V85, P289, DOI 10.1139/Y07-028; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Pei XM, 2015, ACTA DIABETOL, V52, P293, DOI 10.1007/s00592-014-0637-4; Plante E, 2014, DIABETOLOGIA, V57, P1257, DOI 10.1007/s00125-014-3201-4; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; Roberts NW, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0286-0; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Schnelle M, 2018, J MOL CELL CARDIOL, V114, P20, DOI 10.1016/j.yjmcc.2017.10.006; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; SHEHADEH A, 1995, CLIN CARDIOL, V18, P301, DOI 10.1002/clc.4960180604; Nguyen S, 2017, J NUTR BIOCHEM, V46, P137, DOI 10.1016/j.jnutbio.2017.05.009; Stolen TO, 2009, CIRC RES, V105, P527, DOI 10.1161/CIRCRESAHA.109.199810; Stuckey DJ, 2008, MAGN RESON MED, V60, P582, DOI 10.1002/mrm.21677; Ussher JR, 2009, DIABETES, V58, P1766, DOI 10.2337/db09-0011; van Bilsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085078; Van den Bergh A, 2006, EUR J HEART FAIL, V8, P777, DOI 10.1016/j.ejheart.2006.03.001; Wang SD, 2016, TOXICOL LETT, V258, P134, DOI 10.1016/j.toxlet.2016.06.020; Yan J, 2009, CIRCULATION, V119, P2818, DOI 10.1161/CIRCULATIONAHA.108.832915; Yue P, 2007, AM J PHYSIOL-HEART C, V292, pH2106, DOI 10.1152/ajpheart.00856.2006; Zeng H, 2015, J CELL MOL MED, V19, P1847, DOI 10.1111/jcmm.12556; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204843	10.1371/journal.pone.0204843	http://dx.doi.org/10.1371/journal.pone.0204843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273374	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700040
J	da Silva, RB; Machado, CR; Rodrigues, ARA; Pedrosa, AL				da Silva, Raissa Bernardes; Machado, Carlos Renato; Aquiles Rodrigues, Aldo Rogelis; Pedrosa, Andre Luiz			Selective human inhibitors of ATR and ATM render Leishmania major promastigotes sensitive to oxidative damage	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA FIBROBLASTS; MULTIPLE SEQUENCE ALIGNMENT; DNA-DAMAGE; CANCER-CELLS; TRYPANOSOMA-BRUCEI; STRUCTURE PREDICTION; TUMOR-CELLS; KINASE ATM; STRESS; CYCLE	All cellular processes, including those involved in normal cell metabolism to those responsible for cell proliferation or death, are finely controlled by cell signaling pathways, whose core proteins constitute the family of phosphatidylinositol 3-kinase-related kinases (PIKKs). Ataxia Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and Rad3 related (ATR) are two important PIKK proteins that act in response to DNA damage, phosphorylating a large number of proteins to exert control over genomic integrity. The genus Leishmania belongs to a group of early divergent eukaryotes in evolution and has a highly plastic genome, probably owing to the existence of signaling pathways designed to maintain genomic integrity. The objective of this study was to evaluate the use of specific human inhibitors of ATR and ATM in Leishmania major. Bioinformatic analyses revealed the existence of the putative PIKK genes ATR and ATM, in addition to mTOR and DNA-PKcs in Leishmania spp. Moreover, it was possible to suggest that the inhibitors VE-821 and KU-55933 have binding affinity for the catalytic sites of putative L. major ATR and ATM, respectively. Promastigotes of L. major exposed to these inhibitors show slight growth impairment and minor changes in cell cycle and morphology. It is noteworthy that treatment of promastigotes with inhibitors VE-821 and KU-55933 enhanced the oxidative damage caused by hydrogen peroxide. These inhibitors could significantly reduce the number of surviving L. majorcells following H2O2 exposure whilst also decreasing their evaluated IC50 to H2O2 to less than half of that observed for non-treated cells. These results suggest that the use of specific inhibitors of ATR and ATM in Leishmania interferes in the signaling pathways of this parasite, which can impair its tolerance to DNA damage and affect its genome integrity. ATR and ATM could constitute novel targets for drug development and/or repositioning for treatment of leishmaniases.	[da Silva, Raissa Bernardes; Aquiles Rodrigues, Aldo Rogelis; Pedrosa, Andre Luiz] Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Dept Bioquim Farmacol & Fisiol, Uberaba, MG, Brazil; [Machado, Carlos Renato] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal de Minas Gerais	Pedrosa, AL (corresponding author), Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Dept Bioquim Farmacol & Fisiol, Uberaba, MG, Brazil.	andre.pedrosa@uftm.edu.br	MACHADO, CARLOS/AAW-1492-2020; da Silva, Raíssa Bernardes/AAE-6357-2020; Pedrosa, Andre/C-1559-2014	da Silva, Raíssa Bernardes/0000-0002-2802-3808; Pedrosa, Andre/0000-0001-8682-813X	Fundacao de Amparo A Pesquisa do Estado de Minas Gerais [APQ-00644-16]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [408355/2016-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo A Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funded by Fundacao de Amparo A Pesquisa do Estado de Minas Gerais. Grant number APQ-00644-16 (www.fapemig.br) - ALP. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. Grant number 408355/2016-6 (www.cnpq.br) - ALP. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) - RBdaS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambit A, 2011, EUKARYOT CELL, V10, P1429, DOI 10.1128/EC.05118-11; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Bagley J, 2007, J IMMUNOL, V178, P4757, DOI 10.4049/jimmunol.178.8.4757; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Baretic D, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700933; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Biskup E, 2016, J DERMATOL SCI, V84, P239, DOI 10.1016/j.jdermsci.2016.09.010; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Brown EJ, 2000, GENE DEV, V14, P397; Bruni N, 2017, INT J NANOMED, V12, P5289, DOI 10.2147/IJN.S140363; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi M, 2016, MOL CANCER THER, V15, P1781, DOI 10.1158/1535-7163.MCT-15-0945; CODERRE JA, 1983, P NATL ACAD SCI-BIOL, V80, P2132, DOI 10.1073/pnas.80.8.2132; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Damasceno JD, 2016, MOL MICROBIOL, V101, P1054, DOI 10.1111/mmi.13441; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Famulski KS, 2003, ONCOGENE, V22, P471, DOI 10.1038/sj.onc.1206167; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fujisawa H, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0464-y; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huntoon CJ, 2013, CANCER RES, V73, P3683, DOI 10.1158/0008-5472.CAN-13-0110; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Josse R, 2014, CANCER RES, V74, P6968, DOI 10.1158/0008-5472.CAN-13-3369; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kozlov SV, 2016, MOL CELL PROTEOMICS, V15, P1032, DOI 10.1074/mcp.M115.055723; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Liu JH, 2017, INT J MED SCI, V14, P523, DOI 10.7150/ijms.19033; Luzwick JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099397; Manna PT, 2013, MOL PHYLOGENET EVOL, V67, P123, DOI 10.1016/j.ympev.2013.01.002; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509; Mishra A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4074357; Mittra B, 2013, TRENDS PARASITOL, V29, P489, DOI 10.1016/j.pt.2013.07.007; Moiseeva T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01401-x; Monte-Neto R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003476; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Nadkarni A, 2012, J NEURO-ONCOL, V110, P349, DOI 10.1007/s11060-012-0979-0; Ng N, 2018, FEBS J, V285, P1563, DOI 10.1111/febs.14377; Nuhs A, 2014, INT J PARASITOL-DRUG, V4, P37, DOI 10.1016/j.ijpddr.2013.11.004; Palou R, 2017, CURR GENET, V63, P275, DOI 10.1007/s00294-016-0634-y; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pires IM, 2012, BRIT J CANCER, V107, P291, DOI 10.1038/bjc.2012.265; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Rao QH, 2018, CELL RES, V28, P143, DOI 10.1038/cr.2017.158; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Requena JM, 2017, FRONTIERS PARASITOLO, P303; Rhodes N, 1998, GENE DEV, V12, P3686, DOI 10.1101/gad.12.23.3686; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Saini S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10041-6; Salovska B, 2014, INT J MOL SCI, V15, P12007, DOI 10.3390/ijms150712007; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Teixeira DE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003594; Toulany M, 2014, RADIOTHER ONCOL, V111, P228, DOI 10.1016/j.radonc.2014.04.001; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Ubeda JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001868; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001; Willis J, 2013, P NATL ACAD SCI USA, V110, P10592, DOI 10.1073/pnas.1301445110; Yamamoto K, 2016, ELIFE, V5, DOI 10.7554/eLife.14709; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yang Y, 2013, NUCLEIC ACIDS RES, V41, P2296, DOI 10.1093/nar/gks1325; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhang TT, 2015, INT J RADIAT BIOL, V91, P368, DOI 10.3109/09553002.2015.1001531	90	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0205033	10.1371/journal.pone.0205033	http://dx.doi.org/10.1371/journal.pone.0205033			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265735	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500062
J	Garcia-Leon, MA; Peralta-Ramirez, MI; Arco-Garcia, L; Romero-Gonzalez, B; Caparros-Gonzalez, RA; Seez-Sanz, N; Santos-Ruiz, AM; Montero-Lopez, E; Gonzalez, A; Gonzalez-Perez, R				Garcia-Leon, Maria Angeles; Peralta-Ramirez, Maria Isabel; Arco-Garcia, Laura; Romero-Gonzalez, Borja; Caparros-Gonzalez, Rafael A.; Seez-Sanz, Noelia; Santos-Ruiz, Ana Maria; Montero-Lopez, Eva; Gonzalez, Andres; Gonzalez-Perez, Raquel			Hair cortisol concentrations in a Spanish sample of healthy adults	PLOS ONE			English	Article							LIFE-STYLE; STRESS; DETERMINANTS; CORTICOSTEROIDS; TRIMESTER; INSIGHTS; HUMANS	Background Hair cortisol concentration (HCC), as a novel promising method to retrospectively measure hypothalamic-pituitary-adrenal (HPA) axis activation, is being increasingly studied. We tested the relationships between HCC and a range of possible confounding variables in a Spanish sample of healthy adults and pregnant women. Methods The number of healthy adults who participated in the study was 529, being 270 males and 259 females, with a combined mean age of 37.88 years (SD = 15.66). Additionally, a separate sample of 62 pregnant women was also recruited with a mean age of 32.95 (SD = 3.67), and in the first trimester of pregnancy. Each participant was interviewed before the study to obtain sociodemographic and lifestyle variables, and a hair sample was taken from the posterior vertex of the head, cut as close to the scalp as possible. Assuming the average growth rate of head hair is 1 cm per month, a 3-cm segment was analysed, in order to measure the cortisol concentrations from a three-month period. For the pregnant women, hair samples for each trimester of pregnancy were analysed. Results The mean hair cortisol concentration was 127.91 (111.52) pg/mg for the general sample. The variables of age, education, employment status, use of hair dyes, use of oral contraceptives, and physical exercise had a significant relation to HCC. When adjusted for further variables, only education and physical exercise remained statistically significant. When including the use of oral contraceptives and only with respect to females, only physical exercise remains statistically significant. For the subsample of pregnant woman, the mean hair cortisol concentration was 334.51 (409.77) pg/mg for the first trimester, 302.18 (270.24) pg/mg for the second trimester, and 331.31 (295.46) pg/mg for the third trimester of pregnancy. None of the assessed confounding variables (age, body mass index, previous miscarriages, employment status, hair dyes, dependent children and physical exercise), except education level, was related to HCC. Conclusions In this sample of healthy Spaniards, results suggested an association between HCC and physical exercise and educational level. In pregnant women, the prevalence of HCC was higher than in non-pregnant woman, and was related to educational level. This study emphasises the need to determine the relationship between HCC and confounders such as sociodemographic and lifestyle variables in the general population and specific groups formed by individuals such as pregnant women.	[Garcia-Leon, Maria Angeles; Peralta-Ramirez, Maria Isabel; Arco-Garcia, Laura; Romero-Gonzalez, Borja; Caparros-Gonzalez, Rafael A.; Seez-Sanz, Noelia; Montero-Lopez, Eva; Gonzalez, Andres] Univ Granada, Sch Psychol, Granada, Spain; [Garcia-Leon, Maria Angeles; Peralta-Ramirez, Maria Isabel; Romero-Gonzalez, Borja; Caparros-Gonzalez, Rafael A.; Seez-Sanz, Noelia; Montero-Lopez, Eva] Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain; [Santos-Ruiz, Ana Maria] Univ Alicante, Sch Sci Hlth, Hlth Psychol, Alicante, Spain; [Gonzalez-Perez, Raquel] Univ Granada, Sch Pharm, Dept Pharmacol, CIBERehd, Granada, Spain	University of Granada; Universitat d'Alacant; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada	Peralta-Ramirez, MI (corresponding author), Univ Granada, Sch Psychol, Granada, Spain.; Peralta-Ramirez, MI (corresponding author), Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain.	mperalta@ugr.es	Romero-Gonzalez, Borja/ABF-5918-2020; Romero-Gonzalez, Borja/X-7551-2018; Peralta, Maria Isabel MI/I-3920-2015; Garcia-Leon, Maria Angeles/ABF-1125-2021; Caparros-Gonzalez, Rafael A./P-1519-2015; Santos-Ruiz, Ana/C-4292-2015	Romero-Gonzalez, Borja/0000-0002-6350-1836; Romero-Gonzalez, Borja/0000-0002-6350-1836; Peralta, Maria Isabel MI/0000-0001-8201-8906; Garcia-Leon, Maria Angeles/0000-0002-9329-3732; Caparros-Gonzalez, Rafael A./0000-0002-0565-1123; Santos-Ruiz, Ana/0000-0002-2096-059X; Gonzalez Gomez, Andres/0000-0001-5134-8363	Spanish Ministry of Economy and Competitiveness (MINECO) [PSI2015-63494-P]; FEDER	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); FEDER(European Commission)	This research is part of a doctoral thesis. It has been economically supported by the "PSI2015-63494-P" I+D Project of the Spanish Ministry of Economy and Competitiveness (MINECO) and FEDER (http://www.mineco.gob.es). Dr. Maria Isabel Peralta-Ramirez received the funding.	Abell JG, 2016, PSYCHONEUROENDOCRINO, V73, P148, DOI 10.1016/j.psyneuen.2016.07.214; Adam EK, 2006, P NATL ACAD SCI USA, V103, P17058, DOI 10.1073/pnas.0605053103; American Psychological Association, 2010, AM PSYCHOL, V65, P493, DOI [DOI 10.1037/A0020168, 10.1037/a0020168]; [Anonymous], 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; Boesch M, 2015, STRESS, V18, P35, DOI 10.3109/10253890.2014.974028; Braig S, 2015, PSYCHONEUROENDOCRINO, V52, P289, DOI 10.1016/j.psyneuen.2014.12.006; Burke CW, 1969, J CLIN PATHOL S, V1, P11, DOI [10.1136/jcp.s1-3.1.11, DOI 10.1136/JCP.S1-3.1.11]; Caparros-Gonzalez RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182817; Chen Z, 2013, J CHROMATOGR B, V929, P187, DOI 10.1016/j.jchromb.2013.04.026; Cirimele V, 2000, FORENSIC SCI INT, V107, P381, DOI 10.1016/S0379-0738(99)00180-2; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Feller S, 2014, PSYCHONEUROENDOCRINO, V39, P132, DOI 10.1016/j.psyneuen.2013.10.007; Field A., 2013, DISCOVERING STAT USI; Fischer S, 2017, PSYCHONEUROENDOCRINO, V76, P144, DOI 10.1016/j.psyneuen.2016.11.011; Gerber M, 2013, STRESS, V16, P593, DOI 10.3109/10253890.2013.823599; Gibson EL, 1999, PSYCHOSOM MED, V61, P214, DOI 10.1097/00006842-199903000-00014; Glynn LM, 2013, NEUROPEPTIDES, V47, P363, DOI 10.1016/j.npep.2013.10.007; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Vives AH, 2015, J PSYCHIATR RES, V70, P38, DOI [10.1016/j.psychires.2015.08.007, 10.1016/j.jpsychires.2015.08.007]; Hoffman MC, 2017, DEV PSYCHOBIOL, V59, P123, DOI 10.1002/dev.21433; Iglesias S, 2015, LIFE SCI, V141, P188, DOI 10.1016/j.lfs.2015.10.006; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; Keeley JW, 2016, INT J CLIN HLTH PSYC, V16, P109, DOI 10.1016/j.ijchp.2015.09.002; King Shirley L, 2002, Biol Res Nurs, V4, P92, DOI 10.1177/1099800402238334; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Manenschijn L, 2013, J CLIN ENDOCR METAB, V98, P2078, DOI 10.1210/jc.2012-3663; Noppe G, 2014, CLIN ENDOCRINOL, V81, P820, DOI 10.1111/cen.12551; Russell E, 2015, THER DRUG MONIT, V37, P71, DOI 10.1097/FTD.0000000000000148; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894; Scharlau F, 2018, STRESS, V21, P43, DOI 10.1080/10253890.2017.1392507; Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141; Stalder T, 2017, PSYCHONEUROENDOCRINO, V77, P261, DOI 10.1016/j.psyneuen.2016.12.017; Stalder T, 2012, PSYCHONEUROENDOCRINO, V37, P602, DOI 10.1016/j.psyneuen.2011.08.007; Staufenbiel SM, 2015, PSYCHONEUROENDOCRINO, V60, P182, DOI 10.1016/j.psyneuen.2015.06.011; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; Steudte S, 2011, PSYCHONEUROENDOCRINO, V36, P1193, DOI 10.1016/j.psyneuen.2011.02.012; Thomson S, 2010, EXP CLIN ENDOCR DIAB, V118, P133, DOI 10.1055/s-0029-1220771; Weisser JJ, 2016, J CHROMATOGR B, V1017, P45, DOI 10.1016/j.jchromb.2016.02.029; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; Wester VL, 2015, EUR J ENDOCRINOL, V173, pM1, DOI 10.1530/EJE-15-0313; Wheeler MJ, 1998, J ENDOCRINOL, V159, pR5, DOI 10.1677/joe.0.159R005; Wolfram M, 2013, STRESS HEALTH, V29, P143, DOI 10.1002/smi.2439; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wosu AC, 2015, ANN EPIDEMIOL, V25, P90, DOI 10.1016/j.annepidem.2014.11.022; Wosu AC, 2013, ANN EPIDEMIOL, V23, P797, DOI 10.1016/j.annepidem.2013.09.006; Yang HZ, 1998, J STEROID BIOCHEM, V67, P447, DOI 10.1016/S0960-0760(98)00120-4	50	12	12	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204807	10.1371/journal.pone.0204807	http://dx.doi.org/10.1371/journal.pone.0204807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265722	Green Submitted, Green Published, gold			2022-12-27	WOS:000446005500050
J	Bresin, A; Ragone, G; Cristofoletti, C; Arcelli, D; Bassi, C; Caprini, E; Fiorenza, MT; Citterich, MH; Russo, G; Narducci, MG				Bresin, Antonella; Ragone, Gianluca; Cristofoletti, Cristina; Arcelli, Diego; Bassi, Cristian; Caprini, Elisabetta; Fiorenza, Maria Teresa; Citterich, Mauro Helmer; Russo, Giandomenico; Narducci, Maria Grazia			T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PROTEIN-KINASE-C; TCL1 EXPRESSION; TRANSGENIC MICE; SELF-RENEWAL; PROTOONCOGENE TCL1; STEM-CELLS; DIFFERENTIATION; AKT; JUN	T Cell Leukemia/Lymphoma 1 A is expressed during B-cell differentiation and, when over-expressed, acts as an oncogene in mouse (Tcl1a) and human (TCL1A) B-cell chronic lymphocytic leukemia (B-CLL) and T-cell prolymphocytic leukemia (T-PLL). Furthermore, in the murine system Tcl1a is expressed in the ovary, testis and in pre-implantation embryos, where it plays an important role in blastomere proliferation and in embryonic stem cell (ESC) proliferation and self-renewal. We have also observed that Tcl1-/- adult mice exhibit alopecia and deep ulcerations. This finding has led us to investigate the role of TCL1 in mouse skin and hair follicles. We have found that TCL1 is expressed in the proliferative structure (i.e. the secondary hair germ) and in the stem cell niche (i.e. the bulge) of the hair follicle during regeneration phase and it is constitutively expressed in the basal layer of epidermis where it is required for the correct proliferative-differentiation program of the keratinocytes (KCs). Taking advantage of the murine models we have generated, including the Tcl1-/- and the K14-TCL1 transgenic mouse, we have analysed the function of TCL1 in mouse KCs and the molecular pathways involved. We provide evidence that in the epidermal compartment TCL1 has a role in the regulation of KC proliferation, differentiation, and apoptosis. In particular, the colony-forming efficiency (CFE) and the insulin-like growth factor 1 (IGF1)-induced proliferation are dramatically impaired, while apoptosis is increased, in KCs from Tcl1-/- mice when compared to WT. Moreover, the expression of differentiation markers such as cytokeratin 6 (KRT6), filaggrin (FLG) and involucrin (IVL) are profoundly altered in mutant mice (Tcl1-/-). Importantly, by over-expressing TCL1A in basal KCs of the K14-TCL1 transgenic mouse model, we observed a significant rescue of cell proliferation, differentiation and apoptosis of the mutant phenotype. Finally, we found TCL1 to act, at least in part, via increasing phospho-ERK1/2 and decreasing phospho-P38 MAPK. Hence, our data demonstrate that regulated levels of Tcl1a are necessary for the correct proliferation and differentiation of the interfollicular KCs.	[Bresin, Antonella; Ragone, Gianluca; Cristofoletti, Cristina; Arcelli, Diego; Caprini, Elisabetta; Citterich, Mauro Helmer; Russo, Giandomenico; Narducci, Maria Grazia] IDI IRCCS, Ist Dermopat Immacolata, Mol Oncol Lab, Rome, Italy; [Bassi, Cristian] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Fiorenza, Maria Teresa] Univ Roma La Sapienza, Dipartimento Psicol, Sez Neurosci, Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Ferrara; Sapienza University Rome	Russo, G (corresponding author), IDI IRCCS, Ist Dermopat Immacolata, Mol Oncol Lab, Rome, Italy.	russo@idi.it	Bassi, Cristian/K-2356-2018; Cristofoletti, Cristina/AAE-5684-2021; Russo, Giandomenico/K-9566-2016; Narducci, Maria Grazia/L-3093-2018; Caprini, Elisabetta/AAG-8523-2020; Fiorenza, Maria Teresa/AAC-2181-2019; bresin, antonella/AAG-7189-2020	Bassi, Cristian/0000-0002-5823-709X; Russo, Giandomenico/0000-0002-7718-9687; Narducci, Maria Grazia/0000-0002-9066-186X; Fiorenza, Maria Teresa/0000-0002-5079-4019; BRESIN, antonella/0000-0003-3954-5481; Narducci, Maria Grazia/0000-0002-8877-4611	Ministero della Salute; AIRC; Associazione Italiana Ricerca sul Cancro	Ministero della Salute(Ministry of Health, Italy); AIRC(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Ministero della Salute and AIRC to GR.; We thank Dr. Monica Napolitano for critically reviewing the manuscript and Dr. Caterina Cattani for the support in mouse keratinocyte isolation and culture. This work was supported by grants from Associazione Italiana Ricerca sul Cancro and Ministero della salute to GR.	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bresin A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.419; Bresin A, 2015, ONCOTARGET, V6, P19807, DOI 10.18632/oncotarget.4415; Cao L, 2010, J APPL TOXICOL, V30, P416, DOI 10.1002/jat.1513; Cianfarani F, 2011, J INVEST DERMATOL, V131, P1821, DOI 10.1038/jid.2011.137; Cursons J, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0187-6; Eckert RL, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/537028; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Efanov A, 2010, LEUKEMIA, V24, P970, DOI 10.1038/leu.2010.46; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Enzler T, 2009, BLOOD, V114, P4469, DOI 10.1182/blood-2009-06-230169; Fiorenza MT, 2008, CELL DEATH DIFFER, V15, P420, DOI 10.1038/sj.cdd.4402228; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Hager B, 1999, J INVEST DERMATOL, V112, P971, DOI 10.1046/j.1523-1747.1999.00605.x; Herling M, 2006, LEUKEMIA, V20, P280, DOI 10.1038/sj.leu.2404017; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laine J, 2002, J BIOL CHEM, V277, P3743, DOI 10.1074/jbc.M107069200; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Miyazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071645; Narducci MG, 1997, CANCER RES, V57, P5452; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Narducci MG, 2000, CANCER RES, V60, P2095; Nishimura K, 2017, STEM CELL REP, V8, P787, DOI 10.1016/j.stemcr.2017.01.026; Noguchi M, 2007, FASEB J, V21, P2273, DOI 10.1096/fj.06-7684com; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Ragone G, 2009, ONCOGENE, V28, P1329, DOI 10.1038/onc.2008.489; RUSSO G, 1988, CELL, V53, P137, DOI 10.1016/0092-8674(88)90495-3; Sadagurski M, 2006, MOL CELL BIOL, V26, P2675, DOI 10.1128/MCB.26.7.2675-2687.2006; Saha K, 2014, J BIOL CHEM, V289, P11443, DOI 10.1074/jbc.M113.543165; Santos M, 2002, J BIOL CHEM, V277, P19122, DOI 10.1074/jbc.M201001200; Simon R, 2007, CANCER INFORM, V3, P11; Sivina M, 2012, LEUKEMIA, V26, P1812, DOI 10.1038/leu.2012.63; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; Zanesi N, 2006, CANCER RES, V66, P915, DOI 10.1158/0008-5472.CAN-05-3426; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang JY, 2012, AM J CANCER RES, V2, P691	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							0204775	10.1371/journal.pone.0204775	http://dx.doi.org/10.1371/journal.pone.0204775			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286151	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500043
J	Ehrenbrusthoff, K; Ryan, CG; Gruneberg, C; Wand, BM; Martin, DJ				Ehrenbrusthoff, Katja; Ryan, Cormac G.; Grueneberg, Christian; Wand, Benedict M.; Martin, Denis J.			The translation, validity and reliability of the German version of the Fremantle Back Awareness Questionnaire	PLOS ONE			English	Article							TACTILE ACUITY; BODY-IMAGE; 2-POINT DISCRIMINATION; SOMATOSENSORY CORTEX; CLINICAL-PRACTICE; PAIN PATIENTS; REORGANIZATION; DISABILITY; PEOPLE; EFFICACY	Background The Fremantle Back Awareness Questionnaire (FreBAQ) claims to assess disrupted self-perception of the back. The aim of this study was to develop a German version of the FreBAQ (FreBAQ-G) and assess its test-retest reliability, its known-groups validity and its convergent validity with another purported measure of back perception. Methods The FreBaQ-G was translated following international guidelines for the transcultural adaptation of questionnaires. Thirty-five patients with non-specific CLBP and 48 healthy participants were recruited. Assessor one administered the FreBAQ-G to each patient with CLBP on two separate days to quantify intra-observer reliability. Assessor two administered the FreBaQ-G to each patient on day 1. The scores were compared to those obtained by assessor one on day 1 to assess inter-observer reliability. Known-groups validity was quantified by comparing the FreBAQ-G score between patients and healthy controls. To assess convergent validity, patient's FreBAQ-G scores were correlated to their two-point discrimination (TPD) scores. Results Intra- and Inter-observer reliability were both moderate with ICC3.1 = 0.88 (95%CI: 0.77 to 0.94) and 0.89 (95%CI: 0.79 to 0.94), respectively. Intra- and inter-observer limits of agreement (LoA) were 6.2 (95%CI: 5.0-8.1) and 6.0 (4.8-7.8), respectively. The adjusted mean difference between patients and controls was 5.4 (95%CI: 3.0 to 7.8, p<0.01). Patient's FreBAQ-G scores were not associated with TPD thresholds (Pearson's r = -0.05, p = 0.79). Conclusions The FreBAQ-G demonstrated a degree of reliability and known-groups validity. Interpretation of patient level data should be performed with caution because the LoA were substantial. It did not demonstrate convergent validity against TPD. Floor effects of some items of the FreBAQ-G may have influenced the validity and reliability results. The clinimetric properties of the FreBAQ-G require further investigation as a simple measure of disrupted self-perception of the back before firm recommendations on its use can be made.	[Ehrenbrusthoff, Katja; Ryan, Cormac G.; Martin, Denis J.] Teesside Univ, Hlth & Social Care Inst, Middlesbrough, Tees Valley, England; [Ehrenbrusthoff, Katja; Grueneberg, Christian] Hsch Gesundheit, Dept Appl Hlth Sci, Bochum, Germany; [Wand, Benedict M.] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia	University of Teesside; University of Notre Dame Australia	Ehrenbrusthoff, K (corresponding author), Teesside Univ, Hlth & Social Care Inst, Middlesbrough, Tees Valley, England.; Ehrenbrusthoff, K (corresponding author), Hsch Gesundheit, Dept Appl Hlth Sci, Bochum, Germany.	katja.ehrenbrusthoff@hs-gesundheit.de		Wand, Benedict/0000-0002-0297-0292; Ryan, Cormac/0000-0001-5864-4325				Adamczyk W, 2018, CLIN J PAIN, V34, P82, DOI 10.1097/AJP.0000000000000499; Altman D.G., 1991, PRACTICAL STAT MED R; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Barker KL, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-97; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bot SDM, 2004, ANN RHEUM DIS, V63, P335, DOI 10.1136/ard.2003.007724; Bray H, 2011, BRIT J SPORT MED, V45, P168, DOI 10.1136/bjsm.2009.061978; Bredow J, 2016, ORTHOPADE, V45, P573, DOI 10.1007/s00132-016-3248-7; Catley MJ, 2014, J PAIN, V15, P985, DOI 10.1016/j.jpain.2014.06.009; Catley MJ, 2013, RHEUMATOLOGY, V52, P1454, DOI 10.1093/rheumatology/ket140; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Daffada PJ, 2015, PHYSIOTHERAPY, V101, P25, DOI 10.1016/j.physio.2014.07.002; Vieira EBD, 2014, PAIN MANAG NURS, V15, P593, DOI 10.1016/j.pmn.2013.04.004; de Vet HW, 2011, MEASUREMENT MED PRAC; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Ehrenbrusthoff K, 2016, PHYSIOL MEAS, V37, P1074, DOI 10.1088/0967-3334/37/7/1074; Ehrenbrusthoff K, 2018, MUSCULOSKEL SCI PRAC, V35, P73, DOI 10.1016/j.msksp.2018.02.007; EuroQol G., USE EQ 5D2012; Fahrmeir L, 2016, STAT WEG DATAEANALYS; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Grieve G.P., 2015, GRIEVES MODERN MUSCU, V4th ed.; Gutknecht M, 2015, J BODYW MOV THER, V19, P722, DOI 10.1016/j.jbmt.2014.12.003; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Hodges P., 2015, GRIEVES MODERN MUSCU; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hotz-Boendermaker S, 2016, SPINE, V41, pE667, DOI 10.1097/BRS.0000000000001348; Janssens L, 2017, MUSCULOSKEL SCI PRAC, V32, P84, DOI 10.1016/j.msksp.2017.09.003; Jensen MP, 2001, PAIN, V91, P317, DOI 10.1016/S0304-3959(00)00459-0; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Lauche R, 2012, FORSCH KOMPLEMENTMED, V19, P68, DOI 10.1159/000337688; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Levenig CG, 2016, SCHMERZ, P1, DOI [10.1007/s00482-015-0086-1, DOI 10.1007/S00482-015-0086-1]; Lotze Martin, 2007, Curr Rheumatol Rep, V9, P488; Luomajoki H, 2011, BRIT J SPORT MED, V45, P437, DOI 10.1136/bjsm.2009.060731; Luomajoki H, 2016, C IFOMPT 2016 C UN K, V25, pe93; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Nishigami T, 2017, PAIN PRACTICE; Nishigami T, 2015, MANUAL THER, V20, P63, DOI 10.1016/j.math.2014.06.010; NOLAN MF, 1985, PHYS THER, V65, P181, DOI 10.1093/ptj/65.2.181; Oesch P, 2011, ASSESSMENTS REHABILI, V2; Portney L, 1993, FDN CLIN RES APPL PR, V2, P427; Radbruch L, 1999, J PAIN SYMPTOM MANAG, V18, P180, DOI 10.1016/S0885-3924(99)00064-0; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Rowe D. A., 2006, MEASUREMENT THEORY P, P9; Ryan C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-59; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Statista, 2017, MEISTG SPRACH WELTW; Stucki G, 1999, CLIN RHEUMATOL, V18, P101, DOI 10.1007/s100670050065; Vrana A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00578; Waddell G, 2004, BACK PAIN REVOLUTION; Wand BM, 2010, PHYSIOTHERAPY, V96, P317, DOI 10.1016/j.physio.2010.02.005; Wand BM, 2016, J PAIN, V17, P1001, DOI 10.1016/j.jpain.2016.06.003; Wand BM, 2013, BRIT J SPORT MED, V47, P1085, DOI 10.1136/bjsports-2013-092949; Wand BM, 2017, DISRUPTED BODY IMAGE; Wand BM, 2014, J BACK MUSCULOSKELET, P1, DOI [10.3233/BMR-130409, DOI 10.3233/BMR-130409]; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005; 2017, J PHYSIOTHER, V63, P186, DOI DOI 10.1016/J.JPHYS.2017.04.005	61	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205244	10.1371/journal.pone.0205244	http://dx.doi.org/10.1371/journal.pone.0205244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286171	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500101
J	Sano, Y; Iwata, A; Wanaka, H; Matsui, M; Yamamoto, S; Koyanagi, J; Iwata, H				Sano, Yuki; Iwata, Akira; Wanaka, Hideyuki; Matsui, Mina; Yamamoto, Saki; Koyanagi, Junichiro; Iwata, Hiroshi			An easy and safe training method for trunk function improves mobility in total knee arthroplasty patients: A quasi-randomized controlled trial	PLOS ONE			English	Article							GAIT SPEED; MUSCLE STRENGTH; SEATED POSITION; OLDER-ADULTS; PERFORMANCE; VELOCITY; BALANCE; REHABILITATION; STIMULATION; MOVEMENTS	Objective Total knee arthroplasty (TKA) is aimed mainly at reducing pain and restoring mobility. However, mobility deficits can persist even longer than 1 year. The trunk function and movement velocity of any region have been recently recognized to be critical for determining mobility in older people. Therefore, the main goal of this quasi-randomized trial is to clarify the effectiveness of a novel training method, the seated side tapping (SST) training, for improving mobility by focusing on movement velocity of trunk function in the short term after TKA. Methods SST training consists of side trunk movements repeated as quickly as possible in a seated position. All participants after TKA were randomly assigned to the SST training group (n = 37) or control training group (n = 38). The participants in the SST group performed SST training plus the standard rehabilitation program 5 days per week for 3 weeks after TKA, while the control group performed only the standard rehabilitation programs. The primary outcome was the effect of SST training on mobility, indicated by gait speed and the timed up and go test (TUG) time. Measurements were performed before and 1, 2, and 3 weeks after surgery. Results At all-time points, the patients in the SST group showed significantly better mobility, despite that knee function, represented by muscle strength, range of motion, and degree of pain at the knee joint, was similar in both groups. The difference in gait speed between the groups was >0.1 m/s at all time points, which is clinically significant. Conclusion SST training significantly improved patients' mobility within 3 weeks after TKA, despite that no additional benefit was observed in knee function. The findings in this study indicate that SST training may be considered as a part of the rehabilitation program after TKA, although further evaluation of its long-term effectiveness is needed.	[Sano, Yuki; Iwata, Akira; Wanaka, Hideyuki; Yamamoto, Saki] Osaka Prefecture Univ, Dept Phys Therapy, Fac Comprehens Rehabil, Habikino, Osaka, Japan; [Sano, Yuki; Wanaka, Hideyuki; Matsui, Mina] Osaka Gen Med Ctr, Dept Rehabil, Osaka, Osaka, Japan; [Koyanagi, Junichiro] Osaka Gen Med Ctr, Dept Orthopaed Surg, Osaka, Osaka, Japan; [Iwata, Hiroshi] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan	Osaka Metropolitan University; Juntendo University	Iwata, A (corresponding author), Osaka Prefecture Univ, Dept Phys Therapy, Fac Comprehens Rehabil, Habikino, Osaka, Japan.	iwata@rehab.osakafu-u.ac.jp		Iwata, Akira/0000-0002-5002-2553	JSPS KAKENHI [26350628]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 26350628. https://www.jsps.go.jp/english/index.html.	Aalund PK, 2013, ARCH PHYS MED REHAB, V94, P384, DOI 10.1016/j.apmr.2012.09.031; Arai T, 2012, ARCH GERONTOL GERIAT, V54, pE175, DOI 10.1016/j.archger.2011.10.012; Bade MJ, 2011, J ORTHOP SPORT PHYS, V41, P932, DOI 10.2519/jospt.2011.3734; Bade MJ, 2010, J ORTHOP SPORT PHYS, V40, P559, DOI 10.2519/jospt.2010.3317; Bellamy N, 1997, J RHEUMATOL, V24, P768; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Glenn JM, 2015, AGE AGEING, V44, P926, DOI 10.1093/ageing/afv081; Granacher U, 2013, GERONTOLOGY, V59, P105, DOI 10.1159/000343152; Helbostad JL, 2003, GAIT POSTURE, V18, P27, DOI 10.1016/S0966-6362(02)00197-2; Higuchi Yumi, 2012, Nihon Ronen Igakkai Zasshi, V49, P449; Iwata A, 2014, GERIATR GERONTOL INT, V14, P886, DOI 10.1111/ggi.12186; Iwata A, 2014, ARCH GERONTOL GERIAT, V59, P107, DOI 10.1016/j.archger.2014.02.001; Iwata A, 2013, ARCH GERONTOL GERIAT, V56, P482, DOI 10.1016/j.archger.2012.12.002; Kennedy DM, 2008, PHYS THER, V88, P22, DOI 10.2522/ptj.20070051; Kim NJ, 2015, J PHYS THER SCI, V27, P1685, DOI 10.1589/jpts.27.1685; Li K, 2013, GAIT POSTURE, V38, P79, DOI 10.1016/j.gaitpost.2012.10.018; Lunn TH, 2013, PAIN, V154, P1878, DOI 10.1016/j.pain.2013.06.008; Mandeville D, 2008, GAIT POSTURE, V27, P103, DOI 10.1016/j.gaitpost.2007.02.009; Moffet H, 2004, ARCH PHYS MED REHAB, V85, P546, DOI 10.1016/j.apmr.2003.08.080; NIH Consensus Statement on total knee replacement, 2003, NIH CONSENS STATE SC, V20, P1; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Perera S, 2014, J GERONTOL A-BIOL, V69, P1260, DOI 10.1093/gerona/glu033; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pua YH, 2018, AGE AGEING, V47, P144, DOI 10.1093/ageing/afx148; Pua YH, 2015, ARTHRIT CARE RES, V67, P1397, DOI 10.1002/acr.22584; Ramirez-Campillo R, 2014, EXP GERONTOL, V58, P51, DOI 10.1016/j.exger.2014.07.001; Rankin EA, 2004, J BONE JOINT SURG AM, V86A, P1328; Saeys W, 2012, NEUROREHAB NEURAL RE, V26, P231, DOI 10.1177/1545968311416822; Sayers SP, 2005, J AM GERIATR SOC, V53, P467, DOI 10.1111/j.1532-5415.2005.53166.x; Stevens-Lapsley JE, 2012, PHYS THER, V92, P210, DOI 10.2522/ptj.20110124; Suri P, 2009, PM&R, V1, P916, DOI 10.1016/j.pmrj.2009.09.009; Walsh M, 1998, PHYS THER, V78, P248, DOI 10.1093/ptj/78.3.248; Yercan HS, 2006, KNEE, V13, P111, DOI 10.1016/j.knee.2005.10.001; Zeni JA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-86	36	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204884	10.1371/journal.pone.0204884	http://dx.doi.org/10.1371/journal.pone.0204884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286130	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500056
J	Schupp, JC; Fichtner, UA; Frye, BC; Heyduck-Weides, K; Birring, SS; Windisch, W; Criee, CP; Muller-Quernheim, J; Farin, E				Schupp, Jonas Christian; Fichtner, Urs Alexander; Frye, Bjoern Christian; Heyduck-Weides, Katja; Birring, Surinder S.; Windisch, Wolfram; Criee, Carl-Peter; Mueller-Quernheim, Joachim; Farin, Erik			Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; CYSTIC-FIBROSIS; CLINICAL-TRIALS; KOREAN VERSION; RASCH ANALYSIS; DOUBLE-BLIND; FIT INDEXES; RELIABILITY; VALIDATION; VALIDITY	Background Cough is one of the most common symptoms in general and pulmonary medicine with profound negative impact on health-related quality of life (HRQL). The Leicester Cough Questionnaire (LCQ) is a validated HRQL questionnaire, yet a validated German version of the LCQ is not available and it has never been tested in a cohort with sarcoidosis. Objectives To translate the LCQ into German and determine its psychometric properties. Methods The LCQ was translated in a forward-backward approach. Structured interviews in sarcoidosis patients were performed. Subsequently, sarcoidosis patients were asked to answer the German LCQ and comparative questionnaires. Distribution properties, item difficulty, concurrent validity, Rasch model fit and internal consistency of the German LCQ were determined. Results 200 patients with sarcoidosis were included. We provide evidence for reliability, unidimensionality and internal consistency. However, only a moderate correlation with general and respiratory-specific HRQL questionnaires, no Rasch model fit could be shown. Skewed responses caused by floor effects were detected. Conclusion We demonstrate that the German LCQ is valid and reliable and its psychometric properties fulfil the standards required for its use in clinical settings as well as in interventional trials.	[Schupp, Jonas Christian; Frye, Bjoern Christian; Mueller-Quernheim, Joachim] Univ Med Ctr, Dept Pneumol, Fac Med, Freiburg, Germany; [Schupp, Jonas Christian] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA; [Fichtner, Urs Alexander; Heyduck-Weides, Katja; Farin, Erik] Univ Med Ctr, Fac Med, Inst Qual Management & Social Med, Freiburg, Germany; [Birring, Surinder S.] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England; [Windisch, Wolfram] Witten Herdecke Univ Hosp, Kliniken Stadt Koln gGmbH, Cologne Merheim Hosp, Dept Pneumol, Cologne, Germany; [Criee, Carl-Peter] Evangel Hosp Gottingen Weende, Dept Sleep & Resp Med, Bovenden, Germany	University of Freiburg; Yale University; University of Freiburg; University of London; King's College London	Farin, E (corresponding author), Univ Med Ctr, Fac Med, Inst Qual Management & Social Med, Freiburg, Germany.	erik.farin@uniklinik-freiburg.de	Birring, Surinder/GWU-6967-2022; Windisch, Wolfram/ABI-7381-2020; Windisch, Wolfram/AFV-2171-2022	Farin-Glattacker, Erik/0000-0001-6867-0316; Schupp, Jonas/0000-0002-7714-8076	German Research Foundation [SCHU 3147/1]; German Research Foundation (DFG); University of Freiburg in the Open-Access Publishing funding programme	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg in the Open-Access Publishing funding programme	This manuscript was partially supported by the German Research Foundation (SCHU 3147/1) to JCS. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the Open-Access Publishing funding programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This study was made possible by intramural funding.	Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; Baughman RP, 2012, SARCOIDOSIS VASC DIF, V29, P90; Berkhof FF, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-4; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chamberlain SAF, 2015, LUNG, V193, P401, DOI 10.1007/s00408-015-9701-2; Chang CC, 2018, ASSESSMENT, V25, P777, DOI 10.1177/1073191116658547; Chang CC, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0213-y; Chang CC, 2015, J CLIN EPIDEMIOL, V68, P674, DOI 10.1016/j.jclinepi.2015.01.018; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Christensen KS, 2017, J PSYCHOSOM RES, V97, P18, DOI 10.1016/j.jpsychores.2017.03.117; Conrad KJ, 2004, MED CARE, V42, P1, DOI 10.1097/01.mlr.0000103527.52821.1c; Coster WJ, 2004, MED CARE, V42, P62, DOI 10.1097/01.mlr.0000103521.84103.21; Cox CE, 2004, CHEST, V125, P997, DOI 10.1378/chest.125.3.997; Dabrowska M, 2016, ADV CLIN EXP MED, V25, P649, DOI 10.17219/acem/59512; del Corral T, 2016, ARCH BRONCONEUMOL, V52, P63, DOI 10.1016/j.arbres.2015.01.016; Drent M, 1998, SARCOIDOSIS VASC DIF, V15, P59; Farin E, 2013, BIOMED CENTRAL, V11, P135, DOI [10.1186/1477-7525-11-135, DOI 10.1186/1477-7525-11-135]; Faruqi S, 2011, RESPIROLOGY, V16, P1150, DOI 10.1111/j.1440-1843.2011.02014.x; Felisbino MB, 2014, J BRAS PNEUMOL, V40, P213, DOI 10.1590/S1806-37132014000300003; Fisseni H.J., 2004, LEHRBUCH PSYCHOLOGIS, V3rd ed.; Gao YH, 2014, INT J TUBERC LUNG D, V18, P1431, DOI 10.5588/ijtld.14.0195; Han JM, 2014, CHRON RESP DIS, V11, P147, DOI 10.1177/1479972314536206; Harrison Nicholas Kim, 2013, Cough, V9, P9, DOI 10.1186/1745-9974-9-9; Hodgson D, 2016, CHEST, V149, P1052, DOI 10.1016/j.chest.2015.12.036; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huisman Arnold N, 2007, Cough, V3, P3, DOI 10.1186/1745-9974-3-3; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Judson MA, 2017, LUNG, V195, P587, DOI 10.1007/s00408-017-0040-3; Kline R.B., 2011, PRINCIPLES PRACTICE; Kwon JW, 2015, ALLERGY ASTHMA IMMUN, V7, P230, DOI 10.4168/aair.2015.7.3.230; Lim L, 2008, BIOMED CENTRAL, V6, P52, DOI [10.1186/1477-7525-6-52, DOI 10.1186/1477-7525-6-52]; Lin CY, 2013, CHILD PSYCHIAT HUM D, V44, P583, DOI 10.1007/s10578-012-0352-8; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Merkyte I, 2016, J LUNG PULM RESP RES, V3, P1; Morice AH, OPIATE THERAPY CHRON, DOI [10.1164/rccm.200607-892OC, DOI 10.1164/RCCM.200607-892OC]; Munoz G, 2016, CHRON RESP DIS, V13, P128, DOI 10.1177/1479972316632005; Murray MP, 2009, EUR RESPIR J, V34, P125, DOI 10.1183/09031936.00160508; Ogawa Haruhiko, 2013, Cough, V9, P1, DOI 10.1186/1745-9974-9-1; Pornsuriyasak P, 2016, ASIAN PAC J ALLERGY, V34, P212, DOI 10.12932/AP0685; Raj A. A., 2009, V187, P311, DOI 10.1007/978-3-540-79842-2_16; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Reychler G, 2015, CHRON RESP DIS, V12, P313, DOI 10.1177/1479972315602618; Schupp JC, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00991-2017; Simpson CB, 2006, OTOLARYNG HEAD NECK, V134, P693, DOI 10.1016/j.otohns.2005.11.014; Sinha A, 2016, EUR RESPIR J, V47, P1461, DOI 10.1183/13993003.01369-2015; Sonnerfors P, 2018, DISABIL REHABIL, V40, P2662, DOI 10.1080/09638288.2017.1353648; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Wu TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117592; Yousaf Nadia, 2011, Cough, V7, P4, DOI 10.1186/1745-9974-7-4	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205308	10.1371/journal.pone.0205308	http://dx.doi.org/10.1371/journal.pone.0205308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286204	gold, Green Submitted, Green Published			2022-12-27	WOS:000446383500105
J	Garske, LA; Kunarajah, K; Zimmerman, PV; Adams, L; Stewart, IB				Garske, Luke A.; Kunarajah, Kuhan; Zimmerman, Paul, V; Adams, Lewis; Stewart, Ian B.			In patients with unilateral pleural effusion, restricted lung inflation is the principal predictor of increased dyspnoea	PLOS ONE			English	Article							HEMIDIAPHRAGM SECONDARY; PULMONARY MECHANICS; NORMAL VALUES; GAS-EXCHANGE; THORACENTESIS; STANDARDIZATION; SPIROMETRY; PRESSURES; DRAINAGE; SAMPLE	Background and objective The mechanism of dyspnoea associated with pleural effusion is uncertain. A cohort of patients requiring thoracoscopy for unilateral exudative effusion were investigated for associations between dyspnoea and suggested predictors: impaired ipsilateral diaphragm movement, effusion volume and restricted lung inflation. Methods Baseline Dyspnoea Index, respiratory function, and ultrasound assessment of ipsilateral diaphragm movement were assessed prior to thoracoscopy, when effusion volume was measured. Transitional Dyspnoea Index (change from baseline) was assessed 4 and 8 weeks after thoracoscopy. Pearson product moment assessed bivariate correlations and a general linear model examined how well total lung capacity (measuring restricted lung inflation), effusion volume and impaired diaphragm movement predicted Baseline Dyspnoea Index. Un-paired t tests compared the groups with normal and impaired diaphragm movement. Results 19 patients were studied (14 malignant etiology). Total lung capacity was associated with Baseline Dyspnoea Index (r = 0.68, P = 0.003). Effusion volume (r = -0.138, P = 0.60) and diaphragm movement (P = 0.09) were not associated with Baseline Dyspnoea Index. Effusion volume was larger with impaired diaphragm movement compared to normal diaphragm movement (2.16 +/- SD 0.95 vs.1.16 +/- 0.92 L, P = 0.009). Total lung capacity was lower with impaired diaphragm movement compared to normal diaphragm movement (65.4 +/- 10.3 vs 78.2 +/- 8.6% predicted, P = 0.011). The optimal general linear model to predict Baseline Dyspnoea Index used total lung capacity alone (adjusted R-2 = 0.42, P = 0.003). In nine participants with controlled effusion, baseline effusion volume (r = 0.775, P = 0.014) and total lung capacity (r = -0.690, P = 0.040) were associated with Transitional Dyspnoea Index. Conclusions Restricted lung inflation was the principal predictor of increased dyspnoea prior to thoracoscopic drainage of effusion, with no independent additional association with either effusion volume or impaired ipsilateral diaphragm movement. Restricted lung inflation may be an important determinant of the dyspnoea associated with pleural effusion.	[Garske, Luke A.; Stewart, Ian B.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Garske, Luke A.; Zimmerman, Paul, V] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld, Australia; [Kunarajah, Kuhan; Zimmerman, Paul, V] Univ Queensland, Brisbane, Qld, Australia; [Adams, Lewis] Griffith Univ, Allied Hlth Sci & Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia	Queensland University of Technology (QUT); Prince Charles Hospital; University of Queensland; Griffith University	Garske, LA (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.; Garske, LA (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld, Australia.	luke.garske@connect.qut.edu.au	Stewart, Ian B/I-9927-2012; Garske, Luke/AAV-4965-2021	Stewart, Ian/0000-0003-1741-718X	Australian Postgraduate Award PhD scholarship	Australian Postgraduate Award PhD scholarship	Dr Luke Garske received Australian Postgraduate Award PhD scholarship funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Antony VB, 2000, AM J RESP CRIT CARE, V162, P1987, DOI 10.1164/ajrccm.162.5.ats8-00; Boshuizen RC, 2013, SUPPORT CARE CANCER, V21, P3109, DOI 10.1007/s00520-013-1895-3; BROWN NE, 1978, CHEST, V74, P540, DOI 10.1378/chest.74.5.540; Cartaxo AM, 2011, CHEST, V139, P1424, DOI 10.1378/chest.10-1679; Dresler CM, 2005, CHEST, V127, P909, DOI 10.1378/chest.127.3.909; ESTENNE M, 1983, AM J MED, V74, P813, DOI 10.1016/0002-9343(83)91072-0; Formenti P, 2014, J CRIT CARE, V29, P808, DOI 10.1016/j.jcrc.2014.04.009; GILMARTIN JJ, 1985, THORAX, V40, P60, DOI 10.1136/thx.40.1.60; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; LIGHT RW, 1986, AM REV RESPIR DIS, V133, P658; Light RW, 2001, PLEURAL DIS; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHLER DA, 1987, AM REV RESPIR DIS, V135, P1229; MAREL M, 1993, CHEST, V104, P1486, DOI 10.1378/chest.104.5.1486; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mishra EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123798; Mitrouska I, 2004, Can Respir J, V11, P499; MULVEY RB, 1965, RADIOLOGY, V84, P1080, DOI 10.1148/84.6.1080; Norman GR, 2003, PDQ STATISTICS, P67; O'Donnell DE, 2009, RESP PHYSIOL NEUROBI, V167, P116, DOI 10.1016/j.resp.2009.01.010; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Pellegrino R, 2005, EUR RESPIR J, V26, P1104, DOI 10.1183/09031936.05.00026705; Sheel AW, 2011, CURR OPIN PHARMACOL, V11, P195, DOI 10.1016/j.coph.2011.04.004; Thomas R, 2015, CURR OPIN PULM MED, V21, P338, DOI 10.1097/MCP.0000000000000174; Thomas R, 2014, RESPIROLOGY, V19, P809, DOI 10.1111/resp.12328; WANG JS, 1995, CHEST, V107, P1610, DOI 10.1378/chest.107.6.1610; Wang LM, 2007, RESPIROLOGY, V12, P719, DOI 10.1111/j.1440-1843.2007.01124.x; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535	32	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202621	10.1371/journal.pone.0202621	http://dx.doi.org/10.1371/journal.pone.0202621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281613	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400014
J	Murphy, MLM; Janicki-Deverts, D; Cohen, S				Murphy, Michael L. M.; Janicki-Deverts, Denise; Cohen, Sheldon			Receiving a hug is associated with the attenuation of negative mood that occurs on days with interpersonal conflict	PLOS ONE			English	Article							SOCIAL SUPPORT; PHYSICAL AFFECTION; BLOOD-PRESSURE; DAILY LIVES; HEART-RATE; STRESS; HEALTH; ADJUSTMENT; CORTISOL; COUPLES	Interpersonal touch is emerging as an important topic in the study of adult relationships, with recent research showing that such behaviors can promote better relationship functioning and individual well-being. This investigation considers whether being hugged is associated with reduced conflict-related decreases in positive affect and increases in negative affect as well as whether these associations differ between women and men. A sample of 404 adults were interviewed every night for 14 consecutive days about their conflicts, hug receipt, and positive and negative affect. Results indicated that there was an interaction between hug receipt and conflict exposure such that receiving a hug was associated with a smaller conflict-related decrease in positive affect and a smaller conflict-related increase in negative affect when assessed concurrently. Hug receipt was also prospectively associated with a smaller conflict-related increase in next day negative affect but was not associated with next day positive affect. Associations between hug receipt and conflict-related changes in affect did not differ between women and men, between individuals who were married or in a marital-like relationship and those who were not, or as a function of individual differences in baseline perceived social support. While correlational, these results are consistent with the hypothesis that hugs buffer against deleterious changes in affect associated with experiencing interpersonal conflict. Possible mechanisms through which hugs facilitate positive adaptation to conflict are discussed.	[Murphy, Michael L. M.; Cohen, Sheldon] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Janicki-Deverts, Denise] Univ Pittsburgh, Sch Dent Med, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Murphy, MLM (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	michaelmurphy@cmu.edu		Murphy, Michael/0000-0001-7776-3186	National Institutes of Health's National Center for Complementary and Alternative Medicine [AT006694]; National Institute of Allergy and Infectious Diseases [AI066367]; National Heart, Lung, and Blood Institute [HL65111, HL65112]; National Institutes of Health [UL1 RR024153, UL1 TR0005]	National Institutes of Health's National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Preparation of this manuscript was supported by a grant from the National Institutes of Health's National Center for Complementary and Alternative Medicine (AT006694; SC); the conduct of the studies was supported by grants from the National Institute of Allergy and Infectious Diseases (AI066367; SC) and the National Heart, Lung, and Blood Institute (HL65111, HL65112; SC); and supplementary support was provided by a grant from the National Institutes of Health to the University of Pittsburgh Clinical and Translational Science Institute (UL1 RR024153, UL1 TR0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Bolger N, 2000, J PERS SOC PSYCHOL, V79, P953, DOI 10.1037//0022-3514.79.6.953; Bolger N, 2007, J PERS SOC PSYCHOL, V92, P458, DOI 10.1037/0022-3514.92.3.458; BRENT DA, 1993, SUICIDE LIFE-THREAT, V23, P179; Brissette I, 2002, PERS SOC PSYCHOL B, V28, P1265, DOI 10.1177/01461672022812011; Bryk A. S., 2002, HIERARCHICAL LINEAR; Burleson MH, 2007, ARCH SEX BEHAV, V36, P357, DOI 10.1007/s10508-006-9071-1; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Cohen S., 2004, ENCY HLTH BEHAV, P696; Cohen S, 2007, HEALTH PSYCHOL, V26, P410, DOI 10.1037/0278-6133.26.4.410; Cohen S, 2006, PSYCHOSOM MED, V68, P809, DOI 10.1097/01.psy.0000245867.92364.3c; Cohen S, 2016, PERSPECT PSYCHOL SCI, V11, P456, DOI 10.1177/1745691616646305; Cohen S, 2015, PSYCHOL SCI, V26, P135, DOI 10.1177/0956797614559284; Debrot A, 2013, PERS SOC PSYCHOL B, V39, P1373, DOI 10.1177/0146167213497592; Ditzen B, 2008, PSYCHOSOM MED, V70, P883, DOI 10.1097/PSY.0b013e318185c4fc; Ditzen B, 2007, PSYCHONEUROENDOCRINO, V32, P565, DOI 10.1016/j.psyneuen.2007.03.011; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Field T, 2010, DEV REV, V30, P367, DOI 10.1016/j.dr.2011.01.001; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; Grewen KM, 2003, BEHAV MED, V29, P123, DOI 10.1080/08964280309596065; Gulledge AK, 2003, AM J FAM THER, V31, P233, DOI 10.1080/01926180390201936; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Holt-Lunstad J, 2008, PSYCHOSOM MED, V70, P976, DOI 10.1097/PSY.0b013e318187aef7; Hox J.J., 2017, MULTILEVEL ANAL TECH, V3rd ed., P13, DOI [10.4324/9781315650982, DOI 10.4324/9781315650982]; Jakubiak BK, 2017, PERS SOC PSYCHOL REV, V21, P228, DOI 10.1177/1088868316650307; Jakubiak BK, 2016, SOC PSYCHOL PERS SCI, V7, P745, DOI 10.1177/1948550616646427; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Light KC, 2005, BIOL PSYCHOL, V69, P5, DOI 10.1016/j.biopsycho.2004.11.002; Maisel NC, 2009, PSYCHOL SCI, V20, P928, DOI 10.1111/j.1467-9280.2009.02388.x; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Newsom JT, 2003, PSYCHOL AGING, V18, P746, DOI 10.1037/0882-7974.18.4.746; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; R Core Team, 2018, R LANG ENV STAT COMP; Raiche G., 2010, NFACTORS R PACKAGE P, V2, p3.1; Raudenbush S. W., 2013, HLM 7 WINDOWS; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; Robinson KJ, 2015, SOC PSYCHOL PERS SCI, V6, P831, DOI 10.1177/1948550615584197; Rook KS., 2001, APPL DEV SCI, V5, P86, DOI [10.1207/S1532480XADS0502_4, DOI 10.1207/S1532480XADS0502_4]; Shrout PE, 2006, PERS RELATIONSHIP, V13, P115, DOI 10.1111/j.1475-6811.2006.00108.x; Smith TW, 2002, J CONSULT CLIN PSYCH, V70, P548, DOI 10.1037//0022-006X.70.3.548; Sneed RS, 2014, HEALTH PSYCHOL, V33, P554, DOI 10.1037/hea0000057; Taylor SE, 2011, OXFORD HDB HLTH PSYC, P192, DOI 10.1093/oxfordhb/9780195342819.013 .0009; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Tymms P., 2004, WHAT DOES IT MEAN US, P55; USALA PD, 1989, RES AGING, V11, P403, DOI 10.1177/0164027589114001; Watson D, 1995, EUR J PERSONALITY, V9, P351, DOI 10.1002/per.2410090505	53	14	14	7	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203522	10.1371/journal.pone.0203522	http://dx.doi.org/10.1371/journal.pone.0203522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281606	Green Submitted, gold, Green Published			2022-12-27	WOS:000446342400024
J	Tsukada, E; Kitamura, S; Enomoto, M; Moriwaki, A; Kamio, Y; Asada, T; Arai, T; Mishima, K				Tsukada, Eriko; Kitamura, Shingo; Enomoto, Minori; Moriwaki, Aiko; Kamio, Yoko; Asada, Takashi; Arai, Tetsuaki; Mishima, Kazuo			Prevalence of childhood obstructive sleep apnea syndrome and its role in daytime sleepiness	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; CHILDREN; QUESTIONNAIRE; COMMUNITY; DURATION; HABITS; EPIDEMIOLOGY; ASSOCIATION; ADOLESCENTS; PERFORMANCE	Objectives To investigate childhood obstructive sleep apnea syndrome (OSAS) and its role in daytime sleepiness among school-age children. Methods A questionnaire survey was conducted with 25,211 children aged 6-15 (mean, 10.39) years attending 148 elementary and 71 middle schools in 10 prefectures across Japan and their parents. Questions concerned 4 sleep habit items (bedtime, sleep onset latency, wake time after sleep onset, wake-up time) and 4 sleep disorder items (loud snoring, snorts/gasps, breathing pauses, seems very sleepy in the daytime). Total sleep time (TST) was calculated with sleep habits. Severe possible OSAS (p-OSAS) was defined as having loud snoring, snorts and gasps, or breathing pauses "frequently" (>= 5 times per week), and mild p-OSAS was rated as having any of these "sometimes" (2-4 times per week). Severe daytime sleepiness was defined as seeming very sleepy "frequently" and mild daytime sleepiness as seeming very sleepy "sometimes". Results Mean prevalence of mild to severe p-OSAS and severe p-OSAS in children across all grade levels was 9.5% and 1.6%, respectively. p-OSAS was particularly prevalent in children at lower elementary levels, decreasing with advancing grade levels. Prevalence of mild and severe daytime sleepiness was 6.1% and 0.9%, respectively, among all children (7.0%). Prevalence of daytime sleepiness increased with advancing grade levels, particularly in middle-school level. Average TST was 8.4 +/- 2.2 h in both elementary and middle-school levels, and decreased as grades advanced, particularly in middle-school levels. Multivariate logistic regression analysis showed that middle-school level, TST < 8 h, and p-OSAS were independent factors for daytime sleepiness. Strong correlations were found between severe daytime sleepiness and severe p-OSAS or TST < 6 h, and between daytime sleepiness and loud snoring or breathing pauses. Conclusion p-OSAS may be an independent factor influencing daytime sleepiness in school-age children. Loud snoring and breathing pauses could be clinical markers for children with severe daytime sleepiness.	[Tsukada, Eriko; Kitamura, Shingo; Enomoto, Minori; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo, Japan; [Tsukada, Eriko; Arai, Tetsuaki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Tsukada, Eriko] Univ Tsukuba Hosp, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Moriwaki, Aiko] Tokyo Gakugei Univ, Support Room Students Disabil, Koganei, Tokyo, Japan; [Kamio, Yoko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Child & Adolescent Mental Hlth, Kodaira, Tokyo, Japan; [Asada, Takashi] Univ Tokyo Med & Dent Univ, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Arai, Tetsuaki] Univ Tsukuba, Fac Med, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Mishima, Kazuo] Akita Univ, Grad Sch Med, Dept Neuropsychiat, Akita, Japan	National Center for Neurology & Psychiatry - Japan; University of Tsukuba; University of Tsukuba; Tokyo Gakugei University; National Center for Neurology & Psychiatry - Japan; University of Tsukuba; Akita University	Mishima, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo, Japan.; Mishima, K (corresponding author), Akita Univ, Grad Sch Med, Dept Neuropsychiat, Akita, Japan.	mishima@med.akits-u.ac.jp	Kitamura, Shingo/G-6727-2013	Kitamura, Shingo/0000-0001-9607-1812; MISHIMA, KAZUO/0000-0003-1182-1181	Ministry of Health, Labour and Welfare of Japan [H20-KOKORO-004, ID11103316]; Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry [23-1, 29-1]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry	This study was supported by research grants from the Ministry of Health, Labour and Welfare of Japan (H20-KOKORO-004 and ID11103316) and an Intramural Research Grant (23-1, 29-1) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry.	Alexopoulos EI, 2013, SLEEP, V36, P1633, DOI 10.5665/sleep.3114; American Academy of Sleep Medicine, 2005, DIAGN COD MAN ICSD 2, V2nd ed.; Archbold KH, 2002, J PEDIATR-US, V140, P97, DOI 10.1067/mpd.2002.119990; Arens R, 2004, SLEEP, V27, P997, DOI 10.1093/sleep/27.5.997; Basner M, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy012; Beebe DW., 2004, NEUROPSYCHOLOGICAL E; Bixler EO, 2009, SLEEP, V32, P731, DOI 10.1093/sleep/32.6.731; BROUILLETTE RT, 1982, J PEDIATR-US, V100, P31, DOI 10.1016/S0022-3476(82)80231-X; Calhoun SL, 2011, SLEEP, V34, P503, DOI 10.1093/sleep/34.4.503; CARROLL JL, 1995, CHEST, V108, P610, DOI 10.1378/chest.108.3.610; Cha J, 2017, J NEUROSCI, V37, P4280, DOI 10.1523/JNEUROSCI.3583-16.2017; Dayyat E, 2007, SLEEP MED CLIN, V2, P433, DOI 10.1016/j.jsmc.2007.05.004; Dollman I, 2007, ACTA PAEDIATR, V96, P1011, DOI 10.1111/j.1651-2227.2007.00278.x; FRANK Y, 1983, PEDIATRICS, V71, P737; Gaina A, 2007, J PEDIATR-US, V151, P518, DOI 10.1016/j.jpeds.2007.04.036; Goodwin JL, 2003, CHEST, V124, P196, DOI 10.1378/chest.124.1.196; Gozal D, 2001, PEDIATRICS, V108, P693, DOI 10.1542/peds.108.3.693; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; Hara C, 2004, SLEEP MED, V5, P31, DOI 10.1016/j.sleep.2003.09.009; Hublin C, 1996, J INTERN MED, V239, P417, DOI 10.1046/j.1365-2796.1996.475826000.x; Hunter SJ, 2016, AM J RESP CRIT CARE, V194, P739, DOI 10.1164/rccm.201510-2099OC; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Kaditis AG, 2004, PEDIATR PULM, V37, P499, DOI 10.1002/ppul.20002; Kaneita Y, 2005, J EPIDEMIOL, V15, P1, DOI 10.2188/jea.15.1; Kheirandish L, 2006, DEVELOPMENTAL SCI, V9, P388, DOI 10.1111/j.1467-7687.2006.00504.x; Kohyama J, 2005, SHOUNIKA S, V46; Kuehni CE, 2008, EUR RESPIR J, V31, P326, DOI 10.1183/09031936.00088407; Kuwada A, 2018, SLEEP MED, V41, P69, DOI 10.1016/j.sleep.2017.07.025; Li AM, 2010, THORAX, V65, P991, DOI 10.1136/thx.2010.134858; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; Marcus CL, 1998, AM J RESP CRIT CARE, V157, P1098, DOI 10.1164/ajrccm.157.4.9704080; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Matricciani L, 2011, SLEEP, V34, P651, DOI 10.1093/sleep/34.5.651; Melendres MCS, 2004, PEDIATRICS, V114, P768, DOI 10.1542/peds.2004-0730; Mid RDC, 2006, SLEEP, V29, P495; Mindell JA, 1999, CHILD ADOL PSYCH CL, V8, P695; Mindell Jodi A, 2003, J Pediatr Health Care, V17, P324, DOI 10.1016/S0891-5245(03)00215-3; MOGRASS MA, 1994, AM J RESP CRIT CARE, V150, P1690, DOI 10.1164/ajrccm.150.6.7952634; O'Brien L M, 2004, Minerva Pediatr, V56, P585; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; O'Brien LM, 2004, J SLEEP RES, V13, P165, DOI 10.1111/j.1365-2869.2004.00395.x; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Ohida T, 2004, SLEEP, V27, P978, DOI 10.1093/sleep/27.5.978; Okada M, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0151-9; Owens JA, 2000, SLEEP, V23, P1043; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; Shimizu S, 2014, SLEEP MED, V15, P451, DOI 10.1016/j.sleep.2013.05.020; Shinkoda H, 2000, PSYCHIAT CLIN NEUROS, V54, P287, DOI 10.1046/j.1440-1819.2000.00681.x; Spruyt K, 2006, SLEEP MED, V7, P269, DOI 10.1016/j.sleep.2005.08.013; Tauman R, 2004, PEDIATRICS, V113, pE564, DOI 10.1542/peds.113.6.e564; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Twenge JM, 2017, SLEEP MED, V39, P47, DOI 10.1016/j.sleep.2017.08.013; Valery PC, 2004, J PAEDIATR CHILD H, V40, P461, DOI 10.1111/j.1440-1754.2004.00428.x; Verhulst SL, 2007, ARCH DIS CHILD, V92, P205, DOI 10.1136/adc.2006.101089; WEBB W, 1969, SLEEP PHYSL PATHOLOG, P53	57	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204409	10.1371/journal.pone.0204409	http://dx.doi.org/10.1371/journal.pone.0204409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281638	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400048
J	Wu, JC; Chi, SC; Wu, CC; Kang, YN				Wu, Jen-Chieh; Chi, Sheng-Chu; Wu, Chien-Chih; Kang, Yi-No			Helps from flipped classroom in learning suturing skill: The medical students' perspective	PLOS ONE			English	Article							BLOOMS TAXONOMY; CURRICULUM; KNOWLEDGE; EDUCATION; ATTITUDE; SURGERY; ANATOMY	Background Today, flipped classroom (FC) has been widely used in medical education. However, the effectiveness of FC remains controversial. The variation may cause by different subjects or different course design. Moreover, those studies did not explain how the association among different domains of learning objective was in FCs. The purpose of this study was to explore the help of learning domains from a FC of suturing skill in year-5 medical students. Design This study determined sample size according to statistical power. A minimum number of 77 participants for regression analysis are needed. Therefore, this study enrolled 78 medical students in a 2-hour suturing course, which consisted of pre-class video and in-class instruction. Both simple and mattress suturing were taught. The students received an anonymous survey with questionnaire of Help from Instruction Questionnaire for Clinical Skills (HIQ-CS) after the course. The HIQ-CS was developed by medical education team according to Bloom's taxonomy, and its reliability was favorable (Cronbach's <^>I = 0.839). Factor loadings among all items in the HIQ-CS was also favorable (0.790 to 0.849). This study determined consensus of students' perspective by median (Me) and interquartile range (IQR), and tested mediation among different learning domains by regression. Results The results showed medical students agreed FC can help them in learning suturing (Me = 4, IQR = 1). The cognitive help (beta = .526, p < .001) was completely mediated by psychomotor help (beta = .399, p < .001) and affective help (beta = .413, p < .001) to overall helps in FC. The affective help (beta = .617, p< .001) was partially mediated by psychomotor help to overall helps in FC. Conclusions FC may help students in learning suturing skill in different domains. Our model explains the cognitive help from FC provides an important foundation for the helps of other domains. Although the model should be examined by different curricula and measurements in future, the model of help from instruction in our study provided an innovated concept and framework in medical education.	[Wu, Jen-Chieh] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Wu, Jen-Chieh; Chi, Sheng-Chu; Wu, Chien-Chih; Kang, Yi-No] Taipei Med Univ Hosp, Dept Educ, Taipei, Taiwan; [Chi, Sheng-Chu] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Wu, Chien-Chih; Kang, Yi-No] Taipei Med Univ, Coll Med, Sch Med, Dept Med Educ & Humanities, Taipei, Taiwan; [Wu, Chien-Chih] Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Wu, CC; Kang, YN (corresponding author), Taipei Med Univ Hosp, Dept Educ, Taipei, Taiwan.; Wu, CC; Kang, YN (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Med Educ & Humanities, Taipei, Taiwan.; Wu, CC (corresponding author), Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan.	ccwu@tmu.edu.tw; academicnono@gmail.com	/AAD-5199-2021	chi, sheng chu/0000-0002-2544-2353; Wu, Jenchieh/0000-0003-3606-0091				Ahmet A, 2018, J SURG EDUC, V75, P1150, DOI 10.1016/j.jsurg.2018.01.014; Anderson L.W., 2001, EDUC HORIZONS, V9, P137; Armson H, 2015, J CONTIN EDUC HEALTH, V35, P166, DOI 10.1002/chp.21303; Barman A, 2005, ANN ACAD MED SINGAP, V34, P478; Bloom B., 1956, HDB 1 COGNITIVE DOMA, P95; Chen F, 2017, MED EDUC, V51, P585, DOI 10.1111/medu.13272; Chiu HY, 2018, J SURG EDUC, V75, P326, DOI 10.1016/j.jsurg.2017.07.007; Cho KK, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-0902-7; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Council GM, 2009, TOM DOCT OUTC STAND; Cox ED, 2008, AM J PREV MED, V34, P442, DOI 10.1016/j.amepre.2008.01.027; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleagle TR, 2018, ANAT SCI EDUC, V11, P385, DOI 10.1002/ase.1755; Gemeda TT, 2017, AFR J REPROD HEALTH, V21, P49, DOI 10.29063/ajrh2017/v21i3.4; Lucchetti ALG, 2018, MED TEACH, V40, P1248, DOI 10.1080/0142159X.2018.1426837; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hurtubise L, 2015, FLIPPED CLASSROOM ME, P35; Hyndman R., 2008, QUANTITATIVE BUSINES; Karabenick SA, 2013, HELP SEEKING SELF RE; Krathwohl D. R., 1964, TAXONOMY ED OBJECTIV; Liebert CA, 2016, AM J SURG, V211, P451, DOI 10.1016/j.amjsurg.2015.10.004; Loftin Camille, 2017, J Physician Assist Educ, V28, P96, DOI 10.1097/JPA.0000000000000119; Louie B, 1996, EVAL HEALTH PROF, V19, P231, DOI 10.1177/016327879601900206; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Mehralian G, 2014, IRAN J PHARM RES, V13, P1457; Morton DA, 2017, ANAT SCI EDUC, V10, P170, DOI 10.1002/ase.1635; Newman, 1994, ADAPTIVE HELP SEEKIN; Nieveen N, 2013, DES RES, P153; Phillips AW, 2013, ACAD RADIOL, V20, P784, DOI 10.1016/j.acra.2013.02.001; Pintrich P. R., 2000, HDB SELF REGULATION, P451, DOI DOI 10.1016/B978-012109890-2/50043-3; Ramnanan CJ, 2017, ADV MED EDUC PRACT, V8, P63, DOI 10.2147/AMEP.S109037; Simpson E., 1971, BEHAV OBJECTIVES CUR, V60; Soper D.S., 2021, POSTHOC STAT POWER C; Stoller J, 2016, J SURG EDUC, V73, P215, DOI 10.1016/j.jsurg.2015.10.003; Tang F, 2017, MED EDUC ONLINE, V22, DOI 10.1080/10872981.2017.1395679; Tune JD, 2013, ADV PHYSIOL EDUC, V37, P316, DOI 10.1152/advan.00091.2013; von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013; Wachtler C, 2003, MED EDUC, V37, P861, DOI 10.1046/j.1365-2923.2003.01624.x; Whillier S, 2015, J CHIPROPR EDUC, V29, P127, DOI 10.7899/JCE-14-28; Zimmerman BJ, 2002, THEOR PRACT, V41, P64, DOI 10.1207/s15430421tip4102_2	41	11	11	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204698	10.1371/journal.pone.0204698	http://dx.doi.org/10.1371/journal.pone.0204698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278060	gold, Green Published, Green Submitted			2022-12-27	WOS:000446010200021
J	Liang, LH; Zhao, P; Zhang, ST; Ji, M; Song, JG; Yuan, J				Liang, Lihua; Zhao, Peng; Zhang, Songtao; Ji, Ming; Song, Jiguang; Yuan, Jia			Simulation and experimental study on control strategy of zero-speed fin stabilizer based on disturbance and compensation	PLOS ONE			English	Article							SHIP; DESIGN	Zero-speed fin stabilizer is applied to reduce the roll motion of ships at zero speed. This paper aims to explore the control strategy of zero-speed fin stabilizer through a composite method of theoretical analysis, simulations and tank tests. The hydrodynamic force model is established using analytical approach and a simplified model is obtained by fitting the CFD simulation data. The control strategy of zero-speed fin stabilizer is obtained based on disturbance and compensation by analyzing the phase matching relationship between the wave disturbance, the roll motion of the ship, the movement of the fin and the fin-induced hydrodynamic force. Simulations and water tank tests are performed to verify the effectiveness and feasibility of the obtained control strategies. The results of simulations and tank tests show that the obtained control strategies of zero-speed fin stabilizer based on disturbance and compensation are effective and practical. The proposed method provides theoretical and experimental support for engineering application, and can also be a reference for the controller design of zero-speed fin stabilizers.	[Liang, Lihua; Zhao, Peng; Zhang, Songtao; Ji, Ming; Song, Jiguang; Yuan, Jia] Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Zhao, P (corresponding author), Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China.	heu_zyy@hrbeu.edu.cn						Andrikov D, 2017, PROCEDIA COMPUT SCI, V103, P470, DOI 10.1016/j.procs.2017.01.027; Brunton SL, 2015, APPL MECH REV, V67, DOI 10.1115/1.4031175; Conolly J.E., 1969, T ROYAL I NAVAL ARCH, V111, P21; Crossland P, 2003, CONTROL ENG PRACT, V11, P423, DOI 10.1016/S0967-0661(01)00156-3; Dallinga R.P., 1999, ROLL STABILIZATION M; Dallinga R.P., 2002, ROLL STABILIZATION A; Fang MC, 2007, OCEAN ENG, V34, P479, DOI 10.1016/j.oceaneng.2006.03.004; Fossen T., 1994, THESIS U TRONDHEIM N; Giannini M, 2005, GUIDELINES DESIGN AC; Ji M, 2014, CHINESE J SHIP RES, V9, p[8, 42]; Ji M, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (IEEE ICMA 2014), P1757, DOI 10.1109/ICMA.2014.6885966; Jin H., 2015, SHIP ANTIROLLING CON; Jin H. Z., 2013, SHIP CONTROL THEORY; Jin Hong-zhang, 2008, Journal of Harbin Engineering University, V29, P368; [金鸿章 Jin Hongzhang], 2012, [自动化学报, Acta Automatica Sinica], V38, P1059; [金鸿章 Jin Hongzhang], 2010, [中国造船, Shipbuilding of China], V51, P1; [金鸿章 JIN Hongzhang], 2007, [海洋工程, The Ocean Engineering], V25, P83; [金鸿章 JIN Hongzhang], 2008, [武汉理工大学学报, Journal of Wuhan University of Technology], V30, P136; [金鸿章 Jin Hongzhang], 2005, [中国造船, Shipbuilding of China], V46, P29; Lewis E.V., 1989, PRINCIPLES NAVAL ARC, VIII; Liang L., 2015, INT J SMART HOME, V9, P1, DOI DOI 10.HTTPS://D0I.0RG/10.14257/IJSH.2015.9.6.01; Liang LH., 2005, HYDRAULIC TRANSMISSI; Liang LH, 2018, OCEAN ENG, V164, P733, DOI 10.1016/j.oceaneng.2018.07.015; Liang LH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196107; Liang LH, 2017, OCEAN ENG, V142, P491, DOI 10.1016/j.oceaneng.2017.07.012; Liang LH, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P2413, DOI 10.1109/ICMA.2016.7558944; Liu ZQ, 2013, OCEAN ENG, V72, P25, DOI 10.1016/j.oceaneng.2013.06.009; Mark A, 2006, QUANTUM MARINE ENG I; Ochi M.K., 1998, OCEAN WAVES STOCHAST; Oertel H., 2004, PRANDTLS ESSENTIALS; Ooms J., 2002, USE ROLL STABILIZER; Perez T., 2005, SHIP MOTION CONTROL; Perez T, 2012, ANNU REV CONTROL, V36, P129, DOI 10.1016/j.arcontrol.2012.03.010; Song Ji-guang, 2015, Control Theory & Applications, V32, P703, DOI 10.7641/CTA.2015.40499; Song Ji-guang, 2011, Control and Decision, V26, P1343; [宋吉广 Song Jiguang], 2013, [中国造船, Shipbuilding of China], V54, P1; Su XY, 2018, INT J FUZZY SYST, V20, P611, DOI 10.1007/s40815-017-0402-2; Talha M, 2017, INT J FUZZY LOG INTE, V17, P210, DOI 10.5391/IJFIS.2017.17.3.210; van Wieringen H.M., 2002, DESIGN CONSIDERATION; Wang Fan, 2009, OCEAN ENG, V36, P1425, DOI DOI 10.1016/J.OCEANENG.2009.07.013	40	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204446	10.1371/journal.pone.0204446	http://dx.doi.org/10.1371/journal.pone.0204446			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273372	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700023
J	Petersen, GL; Pedersen, JLM; Rod, NH; Mortensen, EL; Kawachi, I; Osler, M; Hansen, AM; Lund, R				Petersen, Gitte Lindved; Pedersen, Jolene Lee Masters; Rod, Naja Hulvej; Mortensen, Erik Lykke; Kawachi, Ichiro; Osler, Merete; Hansen, Ase Marie; Lund, Rikke			Childhood socioeconomic position and physical capability in late-middle age in two birth cohorts from the Copenhagen aging and midlife biobank	PLOS ONE			English	Article							LIFE-COURSE; SOCIAL-CLASS; FUNCTIONAL HEALTH; CIRCUMSTANCES; EPIDEMIOLOGY; INEQUALITIES; PERFORMANCE; ADULTHOOD; PROFILE	This study examines the association between childhood socioeconomic position and objective physical capability including new functional measures of potential relevance to a population in late-middle age. The study population covers two Danish birth cohorts followed-up in the Copenhagen Aging and Midlife Biobank (age 48-58 years, 2009-2011, N = 4,204). Results from linear regression models revealed that being born in higher socioeconomic position was associated with higher jump height: Paternal occupational class four = 0.19 cm (95% confidence interval (CI): -0.44, 0.82), three = 0.59 cm (95% CI: -0.02, 1.19), two = 1.29 cm (95% CI: 0.64, 1.94), and one = 1.29 cm (95% CI: 0.45, 2.13) (reference = five); medium parental social class = 0.88 cm (95% CI: 0.03, 1.72) and high = 1.79 cm (95% CI: 0.94, 2.63) (reference = low). Higher childhood socioeconomic position was also associated with better chair rise performance and hand grip strength, while among women it was related to reduced flexibility: Medium parental social class = -1.31 cm (95% CI: -3.05, 0.42) and high = -2.20 cm (95% CI: -3.94, -0.47) (reference = low); unwed mother = 1.75 cm (95% CI: 0.36, 3.14) (reference = married). Overall, the findings suggest that higher childhood socioeconomic position is primarily related to moderately better scores in the most strenuous physical capability measures and hand grip strength among healthy adults in late-middle age.	[Petersen, Gitte Lindved; Pedersen, Jolene Lee Masters; Hansen, Ase Marie; Lund, Rikke] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Petersen, Gitte Lindved; Pedersen, Jolene Lee Masters; Mortensen, Erik Lykke; Lund, Rikke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Rod, Naja Hulvej; Osler, Merete] Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Dept Publ Hlth, Unit Med Psychol, Sect Environm Hlth, Copenhagen, Denmark; [Petersen, Gitte Lindved; Kawachi, Ichiro] Harvard Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Osler, Merete] Bispebjerg Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark; [Osler, Merete] Frederiksberg Univ Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark; [Hansen, Ase Marie] Natl Res Ctr Working Environm, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Harvard University; Harvard T.H. Chan School of Public Health; University of Copenhagen; Bispebjerg Hospital; National Research Centre for the Working Environment	Petersen, GL (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark.; Petersen, GL (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.; Petersen, GL (corresponding author), Harvard Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.	gilp@sunu.ku.dk	Petersen, Gitte Lindved/AAQ-1190-2020; Hansen, Åse/AAJ-1043-2020; Osler, Merete/AAF-7885-2019	Petersen, Gitte Lindved/0000-0001-8920-4015; Hansen, Åse/0000-0002-4075-3918; Lund, Rikke/0000-0002-0381-4291; PEdersen, Jolene MAsters/0000-0002-7592-422X	Center for Healthy Aging from Nordea Foundation; VELUX FOUNDATION [VELUX26145, 31539]; NordForsk [74637]	Center for Healthy Aging from Nordea Foundation; VELUX FOUNDATION(Velux Fonden); NordForsk	This work was supported by the Center for Healthy Aging (http://healthyaging.ku.dk/) established by a grant from by the Nordea Foundation. The Copenhagen Aging and Midlife Biobank (http://www.camb.dk/) has been supported by a generous grant from the VELUX FOUNDATION (grants VELUX26145, 31539). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the staff at Department of Public Health and National Research Centre for the Working Environment, who undertook the data collection. Further thanks to Kirsten Avlund dagger, Helle Brunsgaard, Nils-Erik Fiehn, and Poul Holm-Pedersen, who participated in the initiation and establishment of the Copenhagen Aging and Midlife Biobank from 2009-2011. The authors acknowledge the crucial role of the initiators and steering groups of The Metropolit Cohort, The Copenhagen Perinatal Cohort and The Danish Longitudinal Study in Work, Unemployment and Health. Further, the authors would like to thank the Social Inequalities in Ageing (SIA) project, funded by NordForsk, project no. 74637 for valuable collaboration relating to this project.	Agahi N, 2014, J EPIDEMIOL COMMUN H, V68, P734, DOI 10.1136/jech-2013-203698; Avlund K, 2014, J AGING HEALTH, V26, P5, DOI 10.1177/0898264313509277; Beard JR, 2009, ACTA OBSTET GYN SCAN, V88, P575, DOI 10.1080/00016340902818170; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Birnie K, 2011, J EPIDEMIOL COMMUN H, V65, P1014, DOI 10.1136/jech.2009.103648; Birnie K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015564; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Sousa ACPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102299; Ferrucci L, 2016, J GERONTOL A-BIOL, V71, P1184, DOI 10.1093/gerona/glw043; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Haas S, 2008, SOC SCI MED, V66, P849, DOI 10.1016/j.socscimed.2007.11.004; Hansen AM, 2014, J AGING HEALTH, V26, P88, DOI 10.1177/0898264313508188; Henretta JC, 2016, J AGING HEALTH, V28, P440, DOI 10.1177/0898264315594135; Hertzman C, 2003, DEV NEUROPSYCHOL, V24, P719, DOI 10.1207/S15326942DN242&3_10; House JS, 2005, J GERONTOL B-PSYCHOL, V60, P15; Hurst L, 2013, AM J PUBLIC HEALTH, V103, P1641, DOI 10.2105/AJPH.2013.301240; Juneau C, 2015, INT J PUBLIC HEALTH, V60, P799, DOI 10.1007/s00038-015-0710-y; Laaksonen E, 2009, EUR J PUBLIC HEALTH, V19, P38, DOI 10.1093/eurpub/ckn123; Lara J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0470-9; Larsen AH, 2007, SCAND J MED SCI SPOR, V17, P43, DOI 10.1111/j.1600-0838.2006.00560.x; Lash TL, 2011, APPL QUANTITATIVE BI; Lund R, 2016, INT J EPIDEMIOL, V45, P1044, DOI 10.1093/ije/dyv149; Mishra GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088524; Modin B, 2003, SOC SCI MED, V57, P487, DOI 10.1016/S0277-9536(02)00374-X; Mollborn S, 2014, ADV LIFE COURSE RES, V20, P56, DOI 10.1016/j.alcr.2014.03.001; Osler M, 2006, INT J EPIDEMIOL, V35, P541, DOI 10.1093/ije/dyi300; Osler M, 2009, SOC SCI MED, V68, P1425, DOI 10.1016/j.socscimed.2009.01.014; Pattenden S, 1999, J EPIDEMIOL COMMUN H, V53, P355, DOI 10.1136/jech.53.6.355; Petersen GL, 2018, J AGING HEALTH, V30, P1263, DOI 10.1177/0898264317714928; Ploubidis GB, 2014, SOC SCI MED, V119, P258, DOI 10.1016/j.socscimed.2014.02.018; Ritchie C, 2005, J SCI MED SPORT, V8, P61, DOI 10.1016/S1440-2440(05)80025-8; Smyth B., 2000, FAMILY MATTERS, V55, P10; Sternang O, 2015, AGE AGEING, V44, P269, DOI 10.1093/ageing/afu170; Strachan DP, 2004, LIFE COURSE APPROACH, p[240, 10]; Strand BH, 2011, EUR J EPIDEMIOL, V26, P475, DOI 10.1007/s10654-011-9562-9; Turrell G, 2007, J EPIDEMIOL COMMUN H, V61, P723, DOI 10.1136/jech.2006.050609; UCLA Institute for Digital Research and Education, 2016, FAQ DO I INT REGR MO; Weinstein G, 2016, EUR J AGEING, V13, P335, DOI 10.1007/s10433-016-0380-5	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205019	10.1371/journal.pone.0205019	http://dx.doi.org/10.1371/journal.pone.0205019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273400	Green Submitted, Green Published, gold			2022-12-27	WOS:000446124700060
J	Lu, DCC; Boulay, C; Chan, ADC; Sachs, AJ				Lu, David Chao-Chia; Boulay, Chadwick; Chan, Adrian D. C.; Sachs, Adam J.			Realtime phase-amplitude coupling analysis of micro electrode recorded brain signals	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; STIMULATION; OSCILLATIONS; SPIKING; POWER; DBS	Objective To demonstrate a method to calculate phase amplitude coupling (PAC) quickly and robustly for realtime applications. Methods We designed and implemented a multirate PAC algorithm with efficient filter bank processing and efficient computation of PAC for many frequency-pair combinations. We tested the developed algorithm for computing PAC on simulated data and on intraoperative neural recording data obtained during deep brain stimulation (DBS) electrode implantation surgery. Results A combination of parallelized frequency-domain filtering and modulation index for PAC estimation provided robust results that could be calculated in real time on modest computing hardware. Conclusion The standard methods for calculating PAC can be optimized for quick and robust performance. Significance These results demonstrated that PAC can be extracted in real time and is suitable for neuro-feedback applications.	[Lu, David Chao-Chia; Chan, Adrian D. C.; Sachs, Adam J.] Carleton Univ, Dept Syst & Comp Engn, Ottawa, ON, Canada; [Lu, David Chao-Chia; Boulay, Chadwick; Sachs, Adam J.] Ottawa Hosp Res Inst, Dept Neurosci, Ottawa, ON, Canada; [Boulay, Chadwick; Sachs, Adam J.] Univ Ottawa, Fac Med & Brian, Ottawa, ON, Canada; [Boulay, Chadwick; Sachs, Adam J.] Univ Ottawa, Mind Res Inst, Ottawa, ON, Canada	Carleton University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Boulay, C (corresponding author), Ottawa Hosp Res Inst, Dept Neurosci, Ottawa, ON, Canada.; Boulay, C (corresponding author), Univ Ottawa, Fac Med & Brian, Ottawa, ON, Canada.; Boulay, C (corresponding author), Univ Ottawa, Mind Res Inst, Ottawa, ON, Canada.	chboulay@ohri.ca		Sachs, Adam/0000-0002-3630-4562; Boulay, Chadwick/0000-0003-1747-3931	2016 Larry Haffner Fellowship from the Parkinson Research Consortium Fellowship Award	2016 Larry Haffner Fellowship from the Parkinson Research Consortium Fellowship Award	This study is funded with 2016 Larry Haffner Fellowship from the Parkinson Research Consortium Fellowship Award (http://www.ohri.ca/prc/research.asp). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; de Hemptinne C, 2015, NAT NEUROSCI, V18, P779, DOI 10.1038/nn.3997; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Dellavale D, 2013, C ICT RES NETH, V1, P68; Dupre la Tour T, 2017, BIORXIV, P1, DOI [10.1101/159731, DOI 10.1101/159731]; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Khanna P, 2017, IEEE T NEUR SYS REH, V25, P1715, DOI 10.1109/TNSRE.2016.2597243; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Ozkurt TE, 2011, J NEUROSCI METH, V201, P438, DOI 10.1016/j.jneumeth.2011.08.014; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Pittman-Polletta B, 2014, J NEUROSCI METH, V226, P15, DOI 10.1016/j.jneumeth.2014.01.006; Rajpurohit V, 2015, CLIN NEUROPHYSIOL, V126, P975, DOI 10.1016/j.clinph.2014.05.039; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Telkes Ilknur, 2016, Front Neurosci, V10, P198, DOI 10.3389/fnins.2016.00198; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; van Wijk BCM, 2015, J NEUROSCI METH, V243, P94, DOI 10.1016/j.jneumeth.2015.01.032; van Wijk BCM, 2016, CLIN NEUROPHYSIOL, V127, P2010, DOI 10.1016/j.clinph.2016.01.015; Verhagen R, 2015, J NEUROSCI METH, V253, P116, DOI 10.1016/j.jneumeth.2015.06.006; Voytek B, 2013, NEUROIMAGE, V64, P416, DOI 10.1016/j.neuroimage.2012.09.023; Wong S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026006; Wong S, 2012, STEREOT FUNCT NEUROS, V90, P51, DOI 10.1159/000334494; Yang AI, 2014, J NEUROSCI, V34, P12816, DOI 10.1523/JNEUROSCI.1895-14.2014	23	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204260	10.1371/journal.pone.0204260	http://dx.doi.org/10.1371/journal.pone.0204260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265705	Green Submitted, gold, Green Published			2022-12-27	WOS:000446005500023
J	Chowdhury, SK; Billah, SM; El Arifeen, S; Hoqueid, DME				Chowdhury, Suman Kanti; Billah, Sk Masum; El Arifeen, Shams; Hoqueid, Dewan Md Emdadul			Care-seeking practices for sick neonates: Findings from cross-sectional survey in 14 rural sub-districts of Bangladesh	PLOS ONE			English	Article							INTEGRATED MANAGEMENT; FORMATIVE RESEARCH; CHILDHOOD ILLNESS; INTERVENTION; MORBIDITY; BEHAVIOR; HEALTH; TRIAL	Objectives Neonatal deaths account for 45% of all under-five deaths globally and 60% in Bangladesh. This study aimed to investigate the most common symptoms and complications in neonates, care-seeking practices of the mothers for their sick neonates, and factors associated with the care-seeking practices. Methods This cross-sectional study analysed data from an Endline Household Survey (as part of an evaluation of a paired cluster-randomised controlled trial study in 14 rural sub-districts in Bangladesh) of 2,931 women who gave birth recently. Descriptive analysis and logistic regressions were conducted to identify the care-seeking practices of mothers of sick neonates and the factors associated with the care-seeking from trained providers. Results Of the 2868 neonates, 886 (30.9%) were reported ill during first 28 days after birth. For those with reported symptoms, 748 (84.4%) of their mothers sought care. Of those who sought care, 65.2% sought care from untrained providers. Multiple logistic regression analysis showed significantly higher odds of care-seeking from trained providers when neonates had 3 or more concurrent symptoms (OR: 1.82; 95% CI: 1.07-3.08); when mothers perceived their neonates' symptoms as severe (OR: 4.08; 95% CI: 2.92-5.70); when mothers received skilled care during pregnancy (OR: 1.95; 95% CI: 1.34-2.84); and when mothers had their delivery in a facility (OR: 3.50; 95% CI: 2.18-5.62). Mothers who delivered their babies at a facility, 43.1% of them sought care for their sick neonates at the same type of public hospital and 34.9% from same type of private hospitals where their deliveries took place. Conclusion Skilled care for mothers during pregnancy and delivery, and mothers' perceptions of the severity of symptoms are the key associated factors of care-seeking for sick neonates from trained providers. Interventions should be tailored to increase care from trained providers during pregnancy and delivery at facilities to improve care-seeking for neonates from trained providers and for the survival of neonates.	[Chowdhury, Suman Kanti; Billah, Sk Masum; El Arifeen, Shams; Hoqueid, Dewan Md Emdadul] Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Chowdhury, SK (corresponding author), Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh.	suman@icddrb.org	Hoque, Dewan Md. Emdadul/J-1999-2019; Chowdhury, Suman Kanti/L-4769-2019	Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Arifeen, Shams/0000-0002-5372-5932; Chowdhury, Suman Kanti/0000-0003-1533-3601	Australian Agency for International Development through UNICEF (SEA);  [GR-00699]	Australian Agency for International Development through UNICEF (SEA); 	This study was financially supported by Australian Agency for International Development through UNICEF (SEA). The grant number and URL are GR-00699 and www.unicef.org.bd. The funder had no role in study design, data collection and analysis or preparations of the manuscript.	Ahmed S, 2001, J TROP PEDIATRICS, V47, P98, DOI 10.1093/tropej/47.2.98; Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2007, J HEALTH POPUL NUTR, V25, P179; Bari S, 2006, J HEALTH POPUL NUTR, V24, P519; Chowdhury HR, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-88; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; El Arifeen S, 2008, J HEALTH POPUL NUTR, V26, P22; Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183; Hill Z, 2008, J PERINATOL, V28, pS38, DOI 10.1038/jp.2008.172; Lander T., 2006, NEON PER MORT COUNTR; Lawn J. E., 2010, SEMINARS PERINATOLOG; Mahejabin F., 2015, PULSE, V7, P5, DOI [10.3329/pulse.v7i1.23232, DOI 10.3329/PULSE.V7I1.23232]; Moinuddin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189365; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; (NIPORT) NIoPRaT, 2011, BANGL HLTH SEM SURV; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Srivastava NM, 2008, INDIAN PEDIATR, V45, P229; Syed U, 2008, J PERINATOL, V28, pS9, DOI 10.1038/jp.2008.165; Tinuade O, 2010, J PAEDIATR CHILD H, V46, P238, DOI 10.1111/j.1440-1754.2009.01677.x	25	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204902	10.1371/journal.pone.0204902	http://dx.doi.org/10.1371/journal.pone.0204902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261083	Green Submitted, Green Published, gold			2022-12-27	WOS:000445907400112
J	Woo, Y; Shin, JS; Shim, CY; Kim, JS; Kim, BK; Park, S; Chang, HJ; Hong, GR; Ko, YG; Kang, SM; Choi, D; Ha, JW; Hong, MK; Jang, Y; Lee, SH				Woo, Yeongmin; Shin, Jeong-soo; Shim, Chi-Young; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Lee, Sang-Hak			Effect of fenofibrate in 1113 patients at low-density lipoprotein cholesterol goal but high triglyceride levels: Real-world results and factors associated with triglyceride reduction	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MIXED DYSLIPIDEMIA; THERAPY; ACID; HYPERTRIGLYCERIDEMIA; PREDICTORS; MANAGEMENT; VARIANTS; EFFICACY; IMPACT	Fibrates are used in patients with dyslipidemia and high cardiovascular risk. However, information regarding drug response to fibrate has been highly limited. We investigated treatment results and factors associated with triglyceride reduction after fenofibrate therapy using large-scale real-world data. Patients with one or more cardiovascular risk factors, at low-density lipoprotein-cholesterol goal but with triglyceride level >= 150 mg/dL, and undergoing treatment with fenofibrate 135-160 mg for the first time were included in this retrospective observational study. The outcome variable was the percentage changes of TG levels. The achievement rate of triglyceride <150 mg/dL was additionally analyzed. Factors associated with treatment results were also analyzed. Among 2546 patients who were initially screened, 1113 patients were enrolled (median age: 61 years; male: 71%). After median follow-up of 4 months, the median change in triglyceride was -60%, and 49% of the patients reached triglyceride <150 mg/dL. After adjusting for confounding variables, female sex, non-diabetic status, coronary artery disease, lower baseline triglyceride, and no statin use were identified to be independently associated with achievement of triglyceride <150 mg/dL. Among them, female sex, non-diabetic status, and coronary artery disease were also related to median or greater percentage reduction of triglyceride. In conclusion, only half of the study patients reached triglyceride levels <150 mg/dL after real-world fenofibrate therapy. This study indicates that more attention is needed on some subgroups to obtain optimal triglyceride levels when treating with fenofibrate.	[Woo, Yeongmin] Univ Ulsan, Gangneung Asan Hosp, Div Cardiol, Dept Internal Med,Coll Med, Kangnung, South Korea; [Shin, Jeong-soo] Yonsei Univ, Dept Biostat & Comp, Coll Med, Seoul, South Korea; [Shim, Chi-Young; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Lee, Sang-Hak] Yonsei Univ, Severance Hosp, Div Cardiol, Dept Internal Med,Coll Med, Seoul, South Korea; [Shim, Chi-Young; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Lee, Sang-Hak] Yonsei Univ, Cardiovasc Res Inst, Coll Med, Seoul, South Korea	University of Ulsan; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SH (corresponding author), Yonsei Univ, Severance Hosp, Div Cardiol, Dept Internal Med,Coll Med, Seoul, South Korea.; Lee, SH (corresponding author), Yonsei Univ, Cardiovasc Res Inst, Coll Med, Seoul, South Korea.	shl1106@yuhs.ac	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Kang, Seok-Min/0000-0001-9856-9227; Park, Sungha/0000-0001-5362-478X; Hong, Geu-Ru/0000-0003-4981-3304; Chang, Hyuk-Jae/0000-0002-6139-7545; Ha, Jong-Won/0000-0002-8260-2958; Woo, Yeongmin/0000-0002-4390-2915; Hong, Myeong-Ki/0000-0002-2090-2031; Choi, Donghoon/0000-0002-2009-9760; Ko, Young-Guk/0000-0001-7748-5788; Kim, Byeong-Keuk/0000-0003-2493-066X; Jang, Yangsoo/0000-0002-2169-3112; Kim, Jung-Sun/0000-0003-2263-3274	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2017R1D1B03029399]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9B6029138]; Ministry of Food and Drug Safety, Korea [18182MFD410]; National Research Council of Science & Technology grant by the Korean government, MSIP [CAP-12-2-KBSI]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Bio & Medical Technology Development Program of the NRF - Korean government, MSIP(National Research Foundation of Korea); Ministry of Food and Drug Safety, Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Council of Science & Technology grant by the Korean government, MSIP	This research was financially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2017R1D1B03029399), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138), the Ministry of Food and Drug Safety, Korea (18182MFD410), and the National Research Council of Science & Technology grant by the Korean government, MSIP (No. CAP-12-2-KBSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar C, 2015, ATHEROSCLEROSIS SUPP, V19, DOI 10.1016/S1567-5688(15)30001-5; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Christian JB, 2014, AM J MED, V127, P36, DOI 10.1016/j.amjmed.2013.09.018; d'Emden MC, 2014, DIABETOLOGIA, V57, P2296, DOI 10.1007/s00125-014-3344-3; Davidson MH, 2014, ARTERIOSCL THROM VAS, V34, P1298, DOI 10.1161/ATVBAHA.113.302926; Davis TME, 2011, DIABETOLOGIA, V54, P280, DOI 10.1007/s00125-010-1951-1; Ferrari R, 2016, EUR HEART J SUPPL, V18, pC2, DOI 10.1093/eurheartj/suw009; Filippatos TD, 2012, CARDIOVASC DRUG THER, V26, P245, DOI 10.1007/s10557-012-6394-0; Frank ATH, 2014, CIRCULATION, V129, P570, DOI 10.1161/CIRCULATIONAHA.113.005757; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Ho LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116513; Irvin MR, 2016, PHARMACOGENET GENOM, V26, P324, DOI 10.1097/FPC.0000000000000219; Ito MK, 2015, ATHEROSCLEROSIS, V242, P647, DOI 10.1016/j.atherosclerosis.2015.06.012; Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Lee SH, 2012, ATHEROSCLEROSIS, V221, P169, DOI 10.1016/j.atherosclerosis.2011.12.042; Maki KC, 2016, J CLIN LIPIDOL, V10, P905, DOI 10.1016/j.jacl.2016.03.008; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Oikawa S, 2017, J ATHEROSCLER THROMB, V24, P77, DOI 10.5551/jat.35626; Pepine CJ, 2010, CLIN CARDIOL, V33, P609, DOI 10.1002/clc.20830; Rotroff DM, 2018, CLIN PHARMACOL THER, V103, P712, DOI 10.1002/cpt.798; Smith JA, 2008, EUR J HUM GENET, V16, P603, DOI 10.1038/sj.ejhg.5202003; Sudhop T, 1996, EUR J CLIN PHARMACOL, V50, P365, DOI 10.1007/s002280050124; Wi J, 2010, ATHEROSCLEROSIS, V213, P235, DOI 10.1016/j.atherosclerosis.2010.08.068; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963; Zhao SP, 2016, INT J CARDIOL, V221, P832, DOI 10.1016/j.ijcard.2016.06.234; Zhao SP, 2014, ATHEROSCLEROSIS, V235, P463, DOI 10.1016/j.atherosclerosis.2014.05.916	30	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0205006	10.1371/journal.pone.0205006	http://dx.doi.org/10.1371/journal.pone.0205006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286170	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500075
J	Kim, Y; Kang, H; Powathil, G; Kim, H; Trucu, D; Lee, W; Lawler, S; Chaplain, M				Kim, Yangjin; Kang, Hyunji; Powathil, Gibin; Kim, Hyeongi; Trucu, Dumitru; Lee, Wanho; Lawler, Sean; Chaplain, Mark			Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma	PLOS ONE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCANS; GLIOMA-CELL MIGRATION; SPINAL-CORD-INJURY; ADULT-RAT BRAIN; REACTIVE ASTROCYTES; FACTOR RECEPTOR; HYBRID MODEL; IN-VITRO; FUNCTIONAL RECOVERY; ALZHEIMERS-DISEASE	The cellular dispersion and therapeutic control of glioblastoma, the most aggressive type of primary brain cancer, depends critically on the migration patterns after surgery and intracellular responses of the individual cancer cells in response to external biochemical cues in the microenvironment. Recent studies have shown that miR-451 regulates downstream molecules including AMPK/CAB39/MARK and mTOR to determine the balance between rapid proliferation and invasion in response to metabolic stress in the harsh tumor microenvironment. Surgical removal of the main tumor is inevitably followed by recurrence of the tumor due to inaccessibility of dispersed tumor cells in normal brain tissue. In order to address this complex process of cell proliferation and invasion and its response to conventional treatment, we propose a mathematical model that analyzes the intracellular dynamics of the miR-451-AMPK- mTOR-cell cycle signaling pathway within a cell. The model identifies a key mechanism underlying the molecular switches between proliferative phase and migratory phase in response to metabolic stress in response to fluctuating glucose levels. We show how up- or down-regulation of components in these pathways affects the key cellular decision to infiltrate or proliferate in a complex microenvironment in the absence and presence of time delays and stochastic noise. Glycosylated chondroitin sulfate proteoglycans (CSPGs), a major component of the extracellular matrix (ECM) in the brain, contribute to the physical structure of the local brain microenvironment but also induce or inhibit glioma invasion by regulating the dynamics of the CSPG receptor LAR as well as the spatiotemporal activation status of resident astrocytes and tumor-associated microglia. Using a multi-scale mathematical model, we investigate a CSPG-induced switch between invasive and non-invasive tumors through the coordination of ECM-cell adhesion and dynamic changes in stromal cells. We show that the CSPG-rich microenvironment is associated with non-invasive tumor lesions through LAR-CSGAG binding while the absence of glycosylated CSPGs induce the critical glioma invasion. We illustrate how high molecular weight CSPGs can regulate the exodus of local reactive astrocytes from the main tumor lesion, leading to encapsulation of non-invasive tumor and inhibition of tumor invasion. These different CSPG conditions also change the spatial profiles of ramified and activated microglia. The complex distribution of CSPGs in the tumor microenvironment can determine the nonlinear invasion behaviors of glioma cells, which suggests the need for careful therapeutic strategies.	[Kim, Yangjin] Konkuk Univ, Dept Math, Seoul, South Korea; [Kim, Yangjin] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Kang, Hyunji; Kim, Hyeongi] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Powathil, Gibin] Swansea Univ, Dept Math, Swansea, W Glam, Wales; [Trucu, Dumitru] Univ Dundee, Div Math, Dundee, Scotland; [Lee, Wanho] Natl Inst Math Sci, Daejeon, South Korea; [Lawler, Sean] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Lawler, Sean] Harvard Med Sch, Boston, MA USA; [Chaplain, Mark] Univ St Andrews, Sch Math & Stat, Math Inst, St Andrews, Fife, Scotland	Konkuk University; University System of Ohio; Ohio State University; Korea Institute of Radiological & Medical Sciences; Swansea University; University of Dundee; National Institute for Mathematical Sciences (NIMS), Republic of Korea; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of St Andrews	Kim, Y (corresponding author), Konkuk Univ, Dept Math, Seoul, South Korea.; Kim, Y (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	ahyouhappy@konkuk.ac.kr	POWATHIL, GIBIN/D-4711-2014; Chaplain, Mark AJ/A-5355-2010; Kim, Yangjin/C-9681-2014	POWATHIL, GIBIN/0000-0002-8372-7349; Chaplain, Mark AJ/0000-0001-5727-2160; Kim, Yangjin/0000-0002-8905-8481	Konkuk University	Konkuk University	This paper was supported by Konkuk University in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Alfonso JCL, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0490; Alfonso JCL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37283; Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Angeli S, 2016, J BIOMECH, V49, P1524, DOI 10.1016/j.jbiomech.2016.03.029; Arslan F, 2007, BRIT J CANCER, V96, P1560, DOI 10.1038/sj.bjc.6603766; Aubert M, 2008, ACTA BIOTHEOR, V56, P297, DOI 10.1007/s10441-008-9061-x; Baker GJ, 2014, NEOPLASIA, V16, P543, DOI 10.1016/j.neo.2014.06.003; Barbero S, 2002, ANN NY ACAD SCI, V973, P60, DOI 10.1111/j.1749-6632.2002.tb04607.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Biasoli D, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.36; Black PC, 2007, UROL ONCOL-SEMIN ORI, V25, P433, DOI 10.1016/j.urolonc.2007.05.011; Boele FW, 2015, NEUROPSYCH DIS TREAT, V11, P1413, DOI 10.2147/NDT.S65874; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Chistiakov DA, 2012, EUR J PHARMACOL, V684, P8, DOI 10.1016/j.ejphar.2012.03.031; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Coniglio SJ, 2013, MATRIX BIOL, V32, P372, DOI 10.1016/j.matbio.2013.07.008; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; COOPER NGF, 1986, J COMP NEUROL, V249, P157, DOI 10.1002/cne.902490204; Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Dallon JC, 2004, J THEOR BIOL, V231, P203, DOI 10.1016/j.jtbi.2004.06.015; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; Davis ME, 2016, CLIN J ONCOL NURS, V20, P2, DOI 10.1188/16.CJON.S1.2-8; de los Reyes AA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1392; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Dmitrieva N, 2011, CLIN CANCER RES, V17, P1362, DOI 10.1158/1078-0432.CCR-10-2213; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FAISSNER A, 1995, GLIA, V13, P233, DOI 10.1002/glia.440130402; Fernandez-Gonzalez R, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2101pe78; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Floyd D, 2014, NEURO-ONCOLOGY, V16, P622, DOI 10.1093/neuonc/nou049; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Gagliano N, 2009, ONCOL REP, V22, P1349, DOI 10.3892/or_00000574; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Golding JP, 1999, DEV BIOL, V216, P85, DOI 10.1006/dbio.1999.9497; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Green NK, 2008, J GENE MED, V10, P280, DOI 10.1002/jgm.1121; Griveau A, 2018, CANCER CELL, V33, P874, DOI 10.1016/j.ccell.2018.03.020; Grumet M, 1996, PERSPECT DEV NEUROBI, V3, P319; Gu WL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-128; Guan X, 2018, MOL NEUROBIO, V55, P1; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Han JF, 2015, AM J CANCER RES, V5, P945; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Hayashi N, 2007, BIOCHEM BIOPH RES CO, V364, P410, DOI 10.1016/j.bbrc.2007.10.040; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HEYMAN I, 1995, DEV DYNAM, V204, P301, DOI 10.1002/aja.1002040308; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Hosseinahli N, 2018, J CELL PHYSIOL, V233, P5574, DOI 10.1002/jcp.26514; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; JAIN RK, 1987, CANCER RES, V47, P3039; Jhaveri S, 1993, Perspect Dev Neurobiol, V1, P237; Juratli TA, 2013, PHARMACOL THERAPEUT, V139, P341, DOI 10.1016/j.pharmthera.2013.05.003; Katsushima K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00014; Khain E, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031920; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Kim J, 2012, BIOMATERIALS, V33, P1838, DOI 10.1016/j.biomaterials.2011.11.020; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2018, P NATL ACAD SCI USA, V115, P4927, DOI 10.1073/pnas.1715295115; Kim Y, 2017, IEEE T BIO-MED ENG, V64, P519, DOI 10.1109/TBME.2016.2637828; Kim Y, 2015, MATH BIOSCI ENG, V12, P1141, DOI 10.3934/mbe.2015.12.1141; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114370; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102499; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Kim Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00053; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Kobayashi Takashi, 2017, Biochem Biophys Rep, V9, P72, DOI 10.1016/j.bbrep.2016.11.009; Koh I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22681-3; Kundu S, 2014, EUR ASS NEUROONCOL M, V4, P75; Kwon SJ, 2005, CLIN CANCER RES, V11, P4694, DOI 10.1158/1078-0432.CCR-04-2530; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lang BT, 2011, SOC NEUR ABSTR, V37, P892; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Le DM, 2003, J NEUROSCI, V23, P4034; Lee S, 2017, J CONTROL RELEASE, V263, P68, DOI 10.1016/j.jconrel.2017.02.035; Lee W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171312; LI CKN, 1982, CANCER-AM CANCER SOC, V50, P2066, DOI 10.1002/1097-0142(19821115)50:10<2066::AID-CNCR2820501017>3.0.CO;2-X; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Lokody I, 2014, NAT REV CANCER, V14, DOI 10.1038/nrc3727; Manini I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010147; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matias D, 2017, BBA-REV CANCER, V1868, P333, DOI 10.1016/j.bbcan.2017.05.007; MCCABE M, 1975, BIOCHIM BIOPHYS ACTA, V399, P131, DOI 10.1016/0304-4165(75)90219-6; Mens MMJ, 2018, STEM CELL REV REP, V14, P309, DOI 10.1007/s12015-018-9808-y; Mentlein R, 2012, BBA-REV CANCER, V1825, P178, DOI 10.1016/j.bbcan.2011.12.001; Mettang M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23592-z; Mok W, 2007, CANCER RES, V67, P10664, DOI 10.1158/0008-5472.CAN-07-3107; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Morrison J, 2008, MOL THER, V16, P244, DOI 10.1038/sj.mt.6300363; MUELLERKLIESER WF, 1984, ADV EXP MED BIOL, V180, P311; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Novak B, 2003, BIOCHEM SOC T, V31, P1526; O'Brien ER, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00040; Okolie O, 2016, NEURO-ONCOLOGY, V18, P1622, DOI 10.1093/neuonc/now117; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Paolillo M, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010015; Pearson JRD, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.40; Placone AL, 2016, TUMOR BIOL, V37, P61, DOI 10.1007/s13277-015-4242-0; Powathil G, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/410602; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Rajesh Y, 2017, EXP CELL RES, V359, P299, DOI 10.1016/j.yexcr.2017.08.032; Rape A, 2014, ADV DRUG DELIVER REV, V79-80, P172, DOI 10.1016/j.addr.2014.08.012; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rong ZM, 2006, ANALYST, V131, P816, DOI 10.1039/b600334f; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Schattler H, 2013, IEEE DECIS CONTR P, P1810, DOI 10.1109/CDC.2013.6760145; Silver DJ, 2014, CURR OPIN NEUROBIOL, V27, P171, DOI 10.1016/j.conb.2014.03.016; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; STEINDLER DA, 1988, J COMP NEUROL, V267, P357, DOI 10.1002/cne.902670306; Stolarska MA, 2009, PHILOS T R SOC A, V367, P3525, DOI 10.1098/rsta.2009.0095; Strickland M, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00043; Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006; Subramaniam SR, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00176; Szabo A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016010; Tektonidis M, 2011, J THEOR BIOL, V287, P131, DOI 10.1016/j.jtbi.2011.07.012; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; Verheije MH, 2009, J VIROL, V83, P7507, DOI 10.1128/JVI.00495-09; Viapiano M., 2009, GLIOMA INVASION MECH; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Viapiano MS, 2005, CANCER RES, V65, P6726, DOI 10.1158/0008-5472.CAN-05-0585; Wang Y, 2013, ONCOGENE, V32, P872, DOI 10.1038/onc.2012.104; Wani R, 2011, CELL CYCLE, V10, P3263, DOI 10.4161/cc.10.19.17738; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watts C, 2014, CLIN ONCOL-UK, V26, P385, DOI 10.1016/j.clon.2014.04.001; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Westhoff MA, 2009, DRUG RESIST UPDATE, V12, P127, DOI 10.1016/j.drup.2009.08.001; WINDLE WF, 1950, J COMP NEUROL, V93, P241, DOI 10.1002/cne.900930206; Zhang H, 1998, J NEUROSCI, V18, P2370; Zhou Jing, 2008, Kobe J Med Sci, V53, P283	163	28	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204865	10.1371/journal.pone.0204865	http://dx.doi.org/10.1371/journal.pone.0204865			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286133	Green Published, Green Submitted, gold			2022-12-27	WOS:000446383500053
J	Navarro, L; Harvey, AE; Ali, A; Bergeron, Y; Morin, H				Navarro, Lionel; Harvey, Anne-Elizabeth; Ali, Adam; Bergeron, Yves; Morin, Hubert			A Holocene landscape dynamic multiproxy reconstruction: How do interactions between fire and insect outbreaks shape an ecosystem over long time scales?	PLOS ONE			English	Article							SPRUCE BUDWORM OUTBREAKS; NORTH-AMERICA; CLIMATE-CHANGE; DISTURBANCE; VEGETATION; RESOLUTION; DEFOLIATION; HISTORY; FORESTS; REGIMES	At a multi-millennial scale, various disturbances shape boreal forest stand mosaics and the distribution of species. Despite the importance of such disturbances, there is a lack of studies focused on the long-term dynamics of spruce budworm (Choristoneura fumiferana (Clem.)) (SBW) outbreaks and the interaction of insect outbreaks and fire. Here, we combine macrocharcoal and plant macrofossils with a new proxy-lepidopteran scales-to describe the Holocene ecology around a boreal lake. Lepidopteran scales turned out to be a more robust proxy of insect outbreaks than the traditional proxies such as cephalic head capsules and feces. We identified 87 significant peaks in scale abundance over the last 10 000 years. These results indicate that SBW outbreaks were more frequent over the Holocene than suggested by previous studies. Charcoal accumulation rates match the established fire history in eastern Canada: a more fire-prone early and late Holocene and reduced fire frequency during the mid-Holocene. Although on occasion, both fire and insect outbreaks were coeval, our results show a generally inverse relationship between fire frequency and insect outbreaks over the Holocene.	[Navarro, Lionel; Harvey, Anne-Elizabeth; Morin, Hubert] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Ali, Adam] Univ Montpellier, UMR CNRS IRD 5554, Inst Sci Evolut, EPHE, Montpellier, France; [Bergeron, Yves] Univ Quebec Abitibi Temiscamingue, Inst Rech Forets, Boul Univ, Rouyn Noranda, PQ, Canada	University of Quebec; University of Quebec Chicoutimi; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Quebec; University Quebec Abitibi-Temiscamingue	Navarro, L (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada.	lionel.navarro@uqac.ca			Fonds de recherche du Quebec - Nature et technologies [PR-149036]; Chaire de recherche industrielle du Conseil de recherches en sciences naturelles et en genie du Canada sur la variabilite des paysages en zone boreale et la croissance de l'epinette noire [IRCPJ 499381-15]	Fonds de recherche du Quebec - Nature et technologies; Chaire de recherche industrielle du Conseil de recherches en sciences naturelles et en genie du Canada sur la variabilite des paysages en zone boreale et la croissance de l'epinette noire	Funded by PR-149036 Fonds de recherche du Quebec - Nature et technologies. IRCPJ 499381-15 Chaire de recherche industrielle du Conseil de recherches en sciences naturelles et en genie du Canada sur la variabilite des paysages en zone boreale et la croissance de l'epinette noire.	Ali AA, 2012, P NATL ACAD SCI USA, V109, P20966, DOI 10.1073/pnas.1203467109; ANDERSON RS, 1986, CAN J BOT, V64, P1977, DOI 10.1139/b86-262; Arseneault D, 2004, J ECOL, V92, P490, DOI 10.1111/j.0022-0477.2004.00887.x; Asselin M, 2016, FORESTS, V7, DOI 10.3390/f7090205; Belien E, 2014, TREES-STRUCT FUNCT, V28, P1257, DOI 10.1007/s00468-014-1011-4; BENNETT KD, 2007, PSIMPOLL 4 26 C PROG; Bhiry N, 1996, QUATERNARY RES, V45, P312, DOI 10.1006/qres.1996.0032; BLAIS JR, 1983, CAN J FOREST RES, V13, P539, DOI 10.1139/x83-079; Blarquez O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13356; Blouin J, GUIDE RECONNAISSANCE; Bouchard M, 2008, CAN J FOREST RES, V38, P1621, DOI 10.1139/X07-201; Carcaillet C, 2000, CLIM DYNAM, V16, P549, DOI 10.1007/s003820000062; Cardinale BJ, 2005, ECOLOGY, V86, P716, DOI 10.1890/03-0727; Couillard PL, 2013, CAN J FOREST RES, V43, P188, DOI 10.1139/cjfr-2012-0414; Crow G.E., 2000, AQUATIC WETLAND PLAN, VI; Crow G.E., 2000, AQUATIC WETLAND PLAN, VII; Davis R. B., 1980, 6 BIENN M AM QUAT AS, P21; Dionne J-C, 1986, GEROGR PHYS QUATERN, V40, P93, DOI 10.7202/032626ar; Edwards TWD, 1996, QUATERNARY RES, V46, P211, DOI 10.1006/qres.1996.0061; El Bilali H, 2013, HOLOCENE, V23, P1260, DOI 10.1177/0959683613484617; Fleming RA, 2002, CLIMATIC CHANGE, V55, P251, DOI 10.1023/A:1020299422491; GAGNON R, 1989, Naturaliste Canadien (Quebec), V116, P117; GAUTHIER S, 2001, NAT CAN, V125, P10; Girardin MP, 2013, NEW PHYTOL, V199, P1001, DOI 10.1111/nph.12322; Grondin P, 2014, LANDSCAPE ECOL, V29, P1, DOI 10.1007/s10980-013-9961-2; Hely C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043706; Higuera PE, 2007, QUATERNARY SCI REV, V26, P1790, DOI 10.1016/j.quascirev.2007.03.010; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; James PMA, 2017, ECOL APPL, V27, P532, DOI 10.1002/eap.1463; James PMA, 2011, ECOSYSTEMS, V14, P60, DOI 10.1007/s10021-010-9395-5; Jardon Y, 2003, CAN J FOREST RES, V33, P1947, DOI 10.1139/X03-108; Jasinski JPP, 2007, QUATERNARY RES, V67, P50, DOI 10.1016/j.yqres.2006.07.008; Long CJ, 1998, CAN J FOREST RES, V28, P774, DOI 10.1139/cjfr-28-5-774; Ministere des Forets de la Faune et des Parcs, 2015, AIR INF TORD BOURG E; Ministere des Ressources Naturelles et de la Faune, 2012, AIR INF TORD BOURG E; Ministeredes Ressources Naturelles et de la Faune, 2012, AIR INF ARP PRUCH QU; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Navarro L, 2017, CAN J FOR RES; Power MJ, 2008, CLIM DYNAM, V30, P887, DOI 10.1007/s00382-007-0334-x; Regniere J, 2012, BIOL INVASIONS, V14, P1571, DOI 10.1007/s10530-010-9918-1; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Remy CC, 2017, J BIOGEOGR, V44, P1268, DOI 10.1111/jbi.12921; Schindler DW, 2010, BIOL CONSERV, V143, P1571, DOI 10.1016/j.biocon.2010.04.003; Simard I, 2006, HOLOCENE, V16, P31, DOI 10.1191/0959683606hl904rp; Simard I., 2011, DYNAMIQUE EPIDEMIES; STOCKS BJ, 1987, FOREST CHRON, V63, P8, DOI 10.5558/tfc63008-1; TURNER MG, 1993, LANDSCAPE ECOL, V8, P213, DOI 10.1007/BF00125352; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Viau AE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006031; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013; Young J., 1992, SEEDS WOODY PLANTS N	51	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204316	10.1371/journal.pone.0204316	http://dx.doi.org/10.1371/journal.pone.0204316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278052	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000446010200011
J	Hughesi, S; Mattavelli, S; De Houwer, J				Hughesi, Sean; Mattavelli, Simone; De Houwer, Jan			Examining the impact of distance as a contextual cue in evaluative conditioning	PLOS ONE			English	Article							IMPLICIT MISATTRIBUTION; RELATIONAL INFORMATION; EXPLICIT EVALUATIONS; METAANALYSIS; CONTINGENCY; ORDER	According to a symbolic perspective on EC, pairings constitute a relational contextual cue in the environment. It is the relationship between stimuli as cued by the pairing (i.e., pairings = similar) that determines the observed change in liking. Across five pre-registered studies (N = 747) we manipulated the absolute or relative distance between different pairs of conditioned (CS) and unconditioned stimuli (US) under the assumption that this would influence the type of relation that the pairings would cue (i.e., close = similar; far = different). In all five studies we obtained repeated and strong evidence that stimulus pairings led to changes in implicit and explicit evaluations. Although we found that these effects were moderated by absolute distance manipulations, evidence did not emerge indicating that those same effects were moderated by relative distance manipulations. These findings fail to provide strong support for a symbolic perspective on EC. We discuss the implications of our findings as well as future research in this area.	[Hughesi, Sean; Mattavelli, Simone; De Houwer, Jan] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium	Ghent University	Hughesi, S (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.	sean.hughes@ugent.be	De Houwer, Jan/ABF-6866-2021	De Houwer, Jan/0000-0003-0488-5224; Hughes, Sean/0000-0001-7689-4272; mattavelli, simone/0000-0002-8934-8016	Ghent University [BOF16/MET_V/002]	Ghent University(Ghent University)	This research was conducted with the support of Grant BOF16/MET_V/002 of Ghent University to Jan De Houwer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; Christie J, 1996, PSYCHON B REV, V3, P357, DOI 10.3758/BF03210760; Corneille O, 2009, J EXP SOC PSYCHOL, V45, P279, DOI 10.1016/j.jesp.2008.08.020; De Houwer J, 2016, SOC COGNITION, V34, P480, DOI 10.1521/soco.2016.34.5.480; De Houwer J, 2013, PSYCHON B REV, V20, P631, DOI 10.3758/s13423-013-0386-3; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Deacon T., 1997, SYMBOLIC SPECIES; Fiedler K, 2011, COGNITION EMOTION, V25, P639, DOI 10.1080/02699931.2010.513497; Forderer S, 2012, COGNITION EMOTION, V26, P534, DOI 10.1080/02699931.2011.588687; Gast A, 2016, ACTA PSYCHOL, V170, P177, DOI 10.1016/j.actpsy.2016.07.002; Gawronski B, 2015, COGNITION EMOTION, V29, P816, DOI 10.1080/02699931.2014.947919; Goh JX, 2016, SOC PERSONAL PSYCHOL, V10, P535, DOI 10.1111/spc3.12267; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hofmann W, 2010, PSYCHOL BULL, V136, P390, DOI 10.1037/a0018916; Hu XQ, 2017, PERS SOC PSYCHOL B, V43, P17, DOI 10.1177/0146167216673351; Hutter M, 2013, J EXP PSYCHOL GEN, V142, P638, DOI 10.1037/a0029989; Hughes S, COGNITION EMOTION; Hughes S, 2016, EXP PSYCHOL, V63, P20, DOI 10.1027/1618-3169/a000310; Jones CR, 2009, J PERS SOC PSYCHOL, V96, P933, DOI 10.1037/a0014747; Kim JC, 2016, SOC PSYCHOL PERS SCI, V7, P61, DOI 10.1177/1948550615599237; Kurdi B, 2017, BEHAV RES METHODS, V49, P457, DOI 10.3758/s13428-016-0715-3; Moran T, 2013, COGNITION EMOTION, V27, P743, DOI 10.1080/02699931.2012.732040; Peters KR, 2011, PERS SOC PSYCHOL B, V37, P557, DOI 10.1177/0146167211400423; RESCORLA RA, 1979, J EXP PSYCHOL ANIM B, V5, P152, DOI 10.1037/0097-7403.5.2.152; Unkelbach C, 2016, SOC COGNITION, V34, P413, DOI 10.1521/soco.2016.34.5.413; Zanon R, 2014, Q J EXP PSYCHOL, V67, P2105, DOI 10.1080/17470218.2014.907324	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204855	10.1371/journal.pone.0204855	http://dx.doi.org/10.1371/journal.pone.0204855			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV8IQ	30286125	gold, Green Published, Green Submitted			2022-12-27	WOS:000446383500051
J	Norkaew, T; Brown, JL; Bansiddhi, P; Somgird, C; Thitaram, C; Punyapornwithaya, V; Punturee, K; Vongchan, P; Somboon, N; Khonmee, J				Norkaew, Treepradab; Brown, Janine L.; Bansiddhi, Pakkanut; Somgird, Chaleamchat; Thitaram, Chatchote; Punyapornwithaya, Veerasak; Punturee, Khanittha; Vongchan, Preeyanat; Somboon, Nopphamas; Khonmee, Jaruwan			Body condition and adrenal glucocorticoid activity affects metabolic marker and lipid profiles in captive female elephants in Thailand	PLOS ONE			English	Article							LIPOPROTEIN CONCENTRATIONS; INSULIN-RESISTANCE; CONDITION SCORE; MASS INDEX; DEXAMETHASONE; STRESS; FRUCTOSAMINE; CORTISOL; GLUCOSE; SECRETION	Studies in western zoo elephants have found relationships between body condition and physiological function, and identified mitigating management strategies to optimize health and welfare. A similar methodological approach was used in this study, which evaluated a body condition score (BCS; 1 = thinnest, 5 = fattest) every other month and fecal glucocorticoid metabolite (FGM) concentrations twice monthly in 33 tourist camp elephants in Thailand for a 1-year period to assess seasonal variations, and determine how lipid profiles [total cholesterol (TC), low density lipoproteins (LDL), high density lipoproteins (HDL), triglycerides (TG)] and metabolic parameters [insulin, glucose, fructosamine, glucose to insulin ratio (G:1)] related to measures of body condition and adrenal function. The most prevalent BCS was 3-3.5 (60.6%), with 27.3% at BCS = 4 (overweight) and 12.1% at BCS = 4.5-5 (very overweight); no elephants had a BCS <2. BCSs were higher in rainy and winter seasons compared to summer, with FGM, TG, HDL, LDL, and insulin also higher in the rainy and/or winter seasons (p<0.05). By contrast, TC and glucose were lowest in the rainy season. FGM measures were negatively associated with two environmental factors: temperature and rainfall, but not humidity. Positive correlations were found between BCS and TC, LDL, and HDL, and between FGM and TC, HDL, glucose, and insulin (p<0.05), whereas BCS and FGM were both negatively associated with the G:1 (p<0.05). However, there was no relationship between BCS and FGM among the camp elephants. Using BCS and FGM measures as outcome variables in separate regression models, this study found high BCS and elevated FGM concentrations were associated with altered lipid profiles and metabolic status in elephants. Furthermore, more work hours/day was associated with better body condition and health measures. Thus, being overweight and exposed to factors that increase adrenal activity could adversely affect health status, requiring alterations in management for some individuals, whereas exercise appears to have a protective effect.	[Norkaew, Treepradab] Chiang Mai Univ, Fac Vet Med, Grad Program Vet Sci, Chiang Mai, Thailand; [Norkaew, Treepradab; Bansiddhi, Pakkanut; Somgird, Chaleamchat; Thitaram, Chatchote; Khonmee, Jaruwan] Chiang Mai Univ, Fac Vet Med, Ctr Excellence Elephant & Wildlife Res, Chiang Mai, Thailand; [Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Somgird, Chaleamchat; Thitaram, Chatchote] Chiang Mai Univ, Fac Vet Med, Dept Compan Anim & Wildlife Clin, Chiang Mai, Thailand; [Punyapornwithaya, Veerasak] Chiang Mai Univ, Fac Vet Med, Vet Publ Hlth Ctr Asia Pacific, Chiang Mai, Thailand; [Punturee, Khanittha; Vongchan, Preeyanat] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiang Mai, Thailand; [Somboon, Nopphamas] Chiang Mai Univ, Fac Vet Med, Small Anim Teaching Hosp, Chiang Mai, Thailand; [Khonmee, Jaruwan] Chiang Mai Univ, Fac Vet Med, Dept Vet Biosci & Vet Publ Hlth, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Khonmee, J (corresponding author), Chiang Mai Univ, Fac Vet Med, Ctr Excellence Elephant & Wildlife Res, Chiang Mai, Thailand.; Khonmee, J (corresponding author), Chiang Mai Univ, Fac Vet Med, Dept Vet Biosci & Vet Publ Hlth, Chiang Mai, Thailand.	jaruwan.khonmee@cmu.ac.th	Thitaram, Chatchote/AHD-1584-2022; Punyapornwithaya, Verasak/V-9323-2019; Punyapornwithaya, Veerasak/ABE-5119-2020	Punyapornwithaya, Verasak/0000-0001-9870-7773; Punturee, Khanittha/0000-0003-2506-8530; Khonmee, Jaruwan/0000-0002-3806-9746; Bansiddhi, Pakkanut/0000-0001-6699-4819	Thailand Research Fund [MRG5980072]; Center of Excellence in Elephant and Wildlife Research, Chiang Mai University [002/2559]	Thailand Research Fund(Thailand Research Fund (TRF)); Center of Excellence in Elephant and Wildlife Research, Chiang Mai University	This work was supported by Thailand Research Fund (grant number MRG5980072) www.https://www.trf.or.th/, Center of Excellence in Elephant and Wildlife Research, Chiang Mai University (grant number 002/2559) www.asianelephantresearch.com.	Albon SD, 2017, GLOBAL CHANGE BIOL, V23, P1374, DOI 10.1111/gcb.13435; Asian Elephant Specialist Group, 2017, AS EL RANG STAT M FI; Bertin FR, 2017, EQUINE VET J, V49, P570, DOI 10.1111/evj.12703; Boden G, 2015, GLUCOSE INTAKE UTILI, P95; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; BUBENIK GA, 1989, COMP BIOCHEM PHYS A, V92, P499, DOI 10.1016/0300-9629(89)90356-3; Campos-Arceiz A, 2008, ECOL RES, V23, P1057, DOI 10.1007/s11284-008-0466-4; Chusyd DE, 2018, OBESITY, V26, P103, DOI 10.1002/oby.22046; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Crone EE, 2001, EVOLUTION, V55, P2611; DANTZER R, 1983, J ANIM SCI, V57, P6, DOI 10.2527/jas1983.5716; de Laat MA, 2016, J VET INTERN MED, V30, P1732, DOI 10.1111/jvim.14577; DIVERTIE GD, 1991, DIABETES, V40, P1228, DOI 10.2337/diabetes.40.10.1228; Douhard M, 2018, ECOLOGY, V99, P724, DOI 10.1002/ecy.2141; Fowler M, 2008, BIOL MED SURG ELEPHA; Frank N, 2006, JAVMA-J AM VET MED A, V228, P1383, DOI 10.2460/javma.228.9.1383; FREEDMAN MR, 1986, AM J PHYSIOL, V250, pR595, DOI 10.1152/ajpregu.1986.250.4.R595; Gilor C, 2010, VET CLIN PATH, V39, P322, DOI 10.1111/j.1939-165X.2010.00227.x; GUILLAUMEGENTIL C, 1993, DIABETOLOGIA, V36, P899, DOI 10.1007/BF02374470; Harris DM, 2008, WELFARE HOUSING HUSB; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hayward GS, 2012, VET REC, V170, P202, DOI 10.1136/vr.e1212; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Herbut P, 2012, ANIM SCI PAP REP, V30, P363; HORNER HC, 1987, J BIOL CHEM, V262, P17696; [ IUCN] INTERNATIONAL UNION FOR CONSERVATION OF NATURE, 2012, IUCN RED LIST CATEGO; Jacobson TA, 2013, MAYO CLIN PROC, V88, P1294, DOI 10.1016/j.mayocp.2013.09.003; Jeusette IC, 2005, AM J VET RES, V66, P81, DOI 10.2460/ajvr.2005.66.81; Jung HS, 2014, OBESITY, V22, P1880, DOI 10.1002/oby.20751; Kosecki SM, 2005, ANN PHARMACOTHER, V39, P1557, DOI 10.1345/aph.1G010; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lanktree MB, 2013, GENOMIC AND PERSONALIZED MEDICINE, VOL 1-2, 2ND EDITION, P1006, DOI 10.1016/B978-0-12-382227-7.00083-5; Lee L, 2012, PEDIATR REV, V33, P459, DOI 10.1542/pir.33-10-459; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; LeMura LM, 2000, EUR J APPL PHYSIOL, V82, P451, DOI 10.1007/s004210000234; Lundberg U, 2002, WORK STRESS, V16, P356, DOI 10.1080/0267837021000064427; Malikhao P, 2017, COMMUN CULT CHANGE A, V3, P127, DOI 10.1007/978-981-10-4125-9_9; Manjrekar PA, 2012, J CLIN DIAGN RES, V6, P770; Manlik O, 2016, ECOL EVOL, V6, P3496, DOI 10.1002/ece3.2130; Mearns BM, 2011, NAT REV CARDIOL, V8, P179, DOI [10.1038/nrcardio.2011.55, 10.1038/nrcardio.2011.126, 10.1038/nrcardio.2011.42, 10.1038/nrcardio.2011.109, 10.1038/nrcardio.2011.93, 10.1038/nrcardio.2011.88, 10.1038/nrcardio.2011.52]; Marcilla AM, 2012, GEN COMP ENDOCR, V176, P259, DOI 10.1016/j.ygcen.2012.02.001; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Morfeld KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188701; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2016, REPROD FERT DEVELOP, V28, P640, DOI 10.1071/RD14140; Mudron P, 2005, ACTA VET BRNO, V74, P37, DOI 10.2754/avb200574010037; Mumby HS, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov030; Nelson RW, 2012, SMALL ANIMAL CLIN DI, P156; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Orozco-Beltran D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186196; PHILLIPOU G, 1988, CLIN CHEM, V34, P1561; Proctor C, 2015, J ZOO AQUAR RES; Rabasa C, 2016, CURR OPIN BEHAV SCI, V9, P71, DOI 10.1016/j.cobeha.2016.01.011; Ratnasooriya WD, 2006, GAJAH, V24, P45; Rebuffe-Scrive M, 1988, Acta Med Scand Suppl, V723, P143; Rughetti M, 2012, J MAMMAL, V93, P1301, DOI 10.1644/11-MAMM-A-402.1; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700; SALTZ D, 1991, J WILDLIFE MANAGE, V55, P1, DOI 10.2307/3809235; Sanlier Nevin, 2007, J Pak Med Assoc, V57, P491; Strzelec K, 2011, ACTA VET BRNO, V80, P101, DOI 10.2754/avb201180010101; SUKUMAR R, 1988, ANIM BEHAV, V36, P1233, DOI 10.1016/S0003-3472(88)80084-8; Suter IC, 2014, ENDANGER SPECIES RES, V24, P1, DOI 10.3354/esr00578; Takada H, 1998, INT J OBESITY, V22, P470, DOI 10.1038/sj.ijo.0800610; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Thitaram C., 2012, Japanese Journal of Zoo and Wildlife Medicine, V17, P91; Tipprasert P, 2001, INT WORKSH DOM CAT A; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; WANG CN, 1995, ARTERIOSCL THROM VAS, V15, P1481, DOI 10.1161/01.ATV.15.9.1481; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Wang YT, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0515-5; Watson R, 2013, GEN COMP ENDOCR, V186, P16, DOI 10.1016/j.ygcen.2013.02.001; WATSON TDG, 1990, VET REC, V127, P498; Weerakhun S, 2010, KKU VET J, V20, P208; Weinstein SP, 1998, METABOLISM, V47, P3, DOI 10.1016/S0026-0495(98)90184-6; Wemmer C, 2006, ZOO BIOL, V25, P187, DOI 10.1002/zoo.20099; WESTERN D, 1984, AFR J ECOL, V22, P229, DOI 10.1111/j.1365-2028.1984.tb00699.x; Wijeyamohan S, 2015, ZOO BIOL, V34, P53, DOI 10.1002/zoo.21181; WOO J, 1992, CLIN CHEM, V38, P2190; Young KE, 2011, J APPL SCI TECHOL, V1, P266; YOUSEF MK, 1971, COMP BIOCHEM PHYSIOL, V40, P789, DOI 10.1016/0300-9629(71)90264-7	86	19	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204965	10.1371/journal.pone.0204965	http://dx.doi.org/10.1371/journal.pone.0204965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278087	Green Submitted, Green Published, gold			2022-12-27	WOS:000446010200029
J	Luna-Pineda, VM; Ochoa, SA; Cruz-Cordova, A; Cazares-Dominguez, V; Reyes-Grajeda, JP; Flores-Oropeza, MA; Arellano-Galindo, J; Castro-Hernandez, R; Flores-Encarnacion, M; Ramirez-Vargas, A; Flores-Garcia, HJ; Moreno-Fierros, L; Xicohtencatl-Cortes, J				Luna-Pineda, Victor M.; Ochoa, Sara A.; Cruz-Cordova, Ariadnna; Cazares-Dominguez, Vicenta; Reyes-Grajeda, Juan P.; Flores-Oropeza, Marco A.; Arellano-Galindo, Jose; Castro-Hernandez, Rigoberto; Flores-Encarnacion, Marcos; Ramirez-Vargas, Adriana; Flores-Garcia, Hector J.; Moreno-Fierros, Leticia; Xicohtencatl-Cortes, Juan			Features of urinary Escherichia coli isolated from children with complicated and uncomplicated urinary tract infections in Mexico	PLOS ONE			English	Article							VIRULENCE GENES; PATHOGENICITY ISLAND; PHYLOGENETIC GROUPS; ERIC-PCR; STRAINS; EPIDEMIOLOGY; RESISTANCE; CYSTITIS; CLONE; BACTERIURIA	The Hospital Infantil de Mexico Federico Gomez (HIMFG) is a tertiary care hospital in Mexico City where Escherichia coli is frequently isolated from the urine samples of pediatric patients with urinary tract infections. A collection of 178 urinary Escherichia coli (UEc) isolates associated with complicated and uncomplicated urinary tract infections were evaluated in this study. The patterns of resistance to 9 antibiotic classes showed that 60.7% of the UEc isolates had a highly multidrug-resistant (MDR) profile. Genetic diversity analyses of the UEc isolates showed a high variability and revealed 16 clusters associated with four phylogenetic groups, namely, groups A, B1, B2, and D. Phylogenetic group B2 was widely associated with the 16 clusters as well as with virulence and fitness genes. The virulence and fitness genes in the UEc isolates, which included fimbriae-, siderophore-, toxin-, and mobility-associated genes, were grouped as occurring at a low, variable, or high frequency. Interestingly, only the papF gene could be amplified from some UEc isolates, and the sequence analysis of the pap operon identified an insertion sequence (IS) element and gene loss. These data suggested pathoadaptability and the development of immune system evasion, which was confirmed by the loss of P fimbriae-associated agglutination in the UEc isolates. E. coli clone O25-ST131 had a prevalence of 20.2% among the UEc isolates; these isolates displayed both a highly MDR profile and the presence of the papGII, fimH, papGIII, iutD, sat, hlyA, and motA genes. In conclusion, the UEc isolates from complicated urinary tract infection (cUTI) were characterized as being MDR, highly genetically diverse, and associated with phylogenetic group B2 and many virulence and fitness genes. Additionally, gene loss and IS elements were identified in some UEc isolates identified as clone O25-ST131.	[Luna-Pineda, Victor M.; Ochoa, Sara A.; Cruz-Cordova, Ariadnna; Cazares-Dominguez, Vicenta; Flores-Oropeza, Marco A.; Xicohtencatl-Cortes, Juan] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Bacteriol Intestinal, Mexico City, DF, Mexico; [Luna-Pineda, Victor M.; Moreno-Fierros, Leticia] Univ Nacl Autonoma Mexico, Lab Inmunidad Mucosas, Unidad Biomed, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Reyes-Grajeda, Juan P.] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Arellano-Galindo, Jose] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Mexico City, DF, Mexico; [Castro-Hernandez, Rigoberto] Hosp Gen Dr Manuel Gea Gonzalez, Dept Ecol Agentes Patogenos, Mexico City, DF, Mexico; [Flores-Encarnacion, Marcos] Benemerita Univ Autonoma Puebla, Fac Med, Puebla, Mexico; [Ramirez-Vargas, Adriana; Flores-Garcia, Hector J.] Benemerita Univ Autonoma Puebla, Fac Biol, Puebla, Mexico	Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Hospital Infantil de Mexico Federico Gomez; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla	Xicohtencatl-Cortes, J (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Bacteriol Intestinal, Mexico City, DF, Mexico.	juanxico@yahoo.com	Córdova, Ariadnna Cruz/AAF-9654-2021; Xicohtencatl-Cortes, Juan/ABD-5463-2020; Moreno-Fierros, Leticia/A-6208-2014; Luna-Pineda, Victor M/HIR-5262-2022	Moreno-Fierros, Leticia/0000-0002-2786-885X; Reyes, Juan Pablo/0000-0001-6498-3286; Luna-Pineda, Victor Manuel/0000-0002-3078-9423	Public Federal Funds from the HIMFG [HIM/2017/002 SSA.1298, HIM/2017/136 SSA.1456, HIM 2017-107 FF SSA.1421]; Consejo Nacional de Ciencia y Tecnologia (CONACYT); Direccion General de Asuntos del Personal Academico (DGAPA) at the Universidad Nacional Autonoma de Mexico (UNAM); Fundacion Alberto y Dolores Andrade, Mexico City	Public Federal Funds from the HIMFG; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico (DGAPA) at the Universidad Nacional Autonoma de Mexico (UNAM); Fundacion Alberto y Dolores Andrade, Mexico City	This work was supported by Public Federal Funds grant with the numbers HIM/2017/002 SSA.1298, HIM/2017/136 SSA.1456 and HIM 2017-107 FF SSA.1421 from the HIMFG (http://himfg.com.mx/interior/dir_investiga.html). This work also was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT, https://www.conacyt.gob.mx/index.php/sni/convocatorias-conacyt/convocatorias-apn) at Attention to National Problems with the under account number 1764.; We thank Alfonso Hernandez-Cardena, Israel Parra-Ortega, and Virginia Alcazar-Lopez for their technical assistance. Victor M. Luna-Pineda was supported by a postdoctoral fellowship from Direccion General de Asuntos del Personal Academico (DGAPA) at the Universidad Nacional Autonoma de Mexico (UNAM) under the direction of the Dra. Moreno-Fierro in Facultad de Estudios Superiores Iztacala-UNAM, as well as by a scholarship from Fundacion Alberto y Dolores Andrade, Mexico City.	Ardakani Maryam Afkhami, 2016, Electron Physician, V8, P2291, DOI 10.19082/2291; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Derakhshandeh A, 2015, LETT APPL MICROBIOL, V60, P148, DOI 10.1111/lam.12349; Doi Y, 2009, ANTIMICROB AGENTS CH, V53, P3159, DOI 10.1128/AAC.00133-09; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Guimares AD, 2011, VET MICROBIOL, V153, P299, DOI 10.1016/j.vetmic.2011.06.002; Guyer DM, 1998, INFECT IMMUN, V66, P4411; Hadifar S, 2017, JPN J INFECT DIS, V70, P19, DOI 10.7883/yoken.JJID.2015.652; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Johnson JR, 2017, CLIN INFECT DIS, V64, P390, DOI 10.1093/cid/ciw712; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Lee JH, 2016, LETT APPL MICROBIOL, V62, P84, DOI 10.1111/lam.12517; Lichtenberger Paola, 2008, Curr Infect Dis Rep, V10, P499, DOI 10.1007/s11908-008-0081-0; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Lo Y, 2015, INFECT GENET EVOL, V34, P244, DOI 10.1016/j.meegid.2015.06.023; Lopez-Banda DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/959206; López-Martínez Briceida, 2013, Bol. Med. Hosp. Infant. Mex., V70, P222; Lu ST, 2011, J BACTERIOL, V193, P7005, DOI 10.1128/JB.06284-11; Luna-Pineda VM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00135; Macedo NR, 2011, VET J, V188, P362, DOI 10.1016/j.tvjl.2010.05.024; Manning SD, 2001, CLIN DIAGN LAB IMMUN, V8, P637, DOI 10.1128/CDLI.8.3.637-640.2001; Luna-Pineda VM, 2018, B MED HOSP INFANT M, V75, P67, DOI [10.24875/BMHIM.M18000011, 10.24875/bmhim.m18000011]; Molina-Lopez J, 2011, J INFECT DEV COUNTR, V5, P840, DOI 10.3855/jidc.1703; Mosquito S., 2015, SCI WORLD J, V2015, DOI [10.1155/2015/610403, DOI 10.1155/2015/610403]; Munkhdelger Y, 2017, J INFECT DEV COUNTR, V11, P51, DOI 10.3855/jidc.7903; Nath G, 2010, INFECT GENET EVOL, V10, P530, DOI 10.1016/j.meegid.2010.02.004; Neal DE, 2008, UROL CLIN N AM, V35, P13, DOI 10.1016/j.ucl.2007.09.010; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Norinder BS, 2012, MICROB PATHOGENESIS, V52, P10, DOI 10.1016/j.micpath.2011.08.005; Ochoa SA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02042; Parham NJ, 2005, J CLIN MICROBIOL, V43, P2425, DOI 10.1128/JCM.43.5.2425-2434.2005; Pietrucha-Dilanchian P, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0021-2015; RIVERA IG, 1995, APPL ENVIRON MICROB, V61, P2898, DOI 10.1128/AEM.61.8.2898-2904.1995; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V42, P935; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Rushton HG, 1997, PEDIATR CLIN N AM, V44, P1133, DOI 10.1016/S0031-3955(05)70551-4; Sakellaris H, 2000, INFECT IMMUN, V68, P3780, DOI 10.1128/IAI.68.6.3780-3783.2000; Schlager TA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0022-2016; Schwartz DJ, 2013, P NATL ACAD SCI USA, V110, P15530, DOI 10.1073/pnas.1315203110; Secretaria de Salud, 2015, PAN EP INF VIAS UR M; Secretaria de Salud, 2016, AN MORB 1984 2016; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Sokurenko E, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0020-2015; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; Takahashi A, 2006, J CLIN MICROBIOL, V44, P4589, DOI 10.1128/JCM.02070-06; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valdes I, 2009, J FISH DIS, V32, P351, DOI 10.1111/j.1365-2761.2008.01014.x; VALVANO MA, 1986, INFECT IMMUN, V52, P192, DOI 10.1128/IAI.52.1.192-199.1986; Vigil PD, 2011, MBIO, V2, DOI 10.1128/mBio.00066-11; Vila J, 2002, J INFECT DIS, V186, P1039, DOI 10.1086/342955	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2018	13	10							e0204934	10.1371/journal.pone.0204934	http://dx.doi.org/10.1371/journal.pone.0204934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV8IQ	30286185	Green Published, gold, Green Submitted			2022-12-27	WOS:000446383500063
J	Nalado, AM; Mahlangu, JN; Duarte, R; Paget, G; Olorunfemi, G; Jacobson, BF; Naicker, S				Nalado, Aishatu Muhammad; Mahlangu, Johnny N.; Duarte, Raquel; Paget, Graham; Olorunfemi, Gbenga; Jacobson, Barry F.; Naicker, Saraladevi			Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa	PLOS ONE			English	Article							DIAGNOSIS; ERYTHROPOIESIS; MANAGEMENT; INDEXES	Introduction Iron deficiency anaemia (IDA) worsens the prognosis and outcomes of chronic kidney disease (CKD). However, while the haemoglobin level is unreliable for early detection of IDA, reticulocyte haemoglobin content (CHr) and hypochromic red cells (%HYPO) are early markers of IDA. Methods This was a cross sectional study of black adult participants (n = 258) with CKD and apparently healthy members of staff and patients' relatives (n = 141) at the Charlotte Maxeke Johannesburg Academic Hospital, South Africa, between 1 June 2016 and 31 December 2016. Serum iron, serum ferritin and transferrin were measured using standard laboratory methods, while the haematology analyser was employed to measure CHr and %HYPO. The validity of CHr and %HYPO as markers of IDA were evaluated. Multivariable binary logistic regression was conducted to determine predictors of the relationship between IDA, CHr and %HYPO. The area under the receiver operator characteristics (ROC) curve (AUC) of the final models were utilised to evaluate the discriminatory value of CHr and %HYPO respectively. Results About one-quarter (26.1%) of the participants had IDA which was more than three times more frequent among CKD patients, compared to controls (35.3% vs 9.2%); 32.3% (95%CI: 27.90%- 37.10%) of the study population had iron deficiency without anaemia and the prevalence of iron deficiency without anaemia was lower in CKD patients compared to controls (29.5% vs 37.6%). The mean age of CKD patients was higher than in controls (52.7 +/- 14.3 vs 40.4 +/- 12.6 years, P-value<0.001). The sensitivity and specificity for diagnosing IDA among CKD participants was 62.6% and 80.2% respectively for CHr (at a cut-off value of <28pg) and 63.3% and 79.8% respectively for %HYPO. CKD participants with CHr levels >28pg were 82% less likely to be diagnosed as having IDA as compared to those with CHr levels < 28pg) (adj odds ratio = 0.18, 95% CI: 0.09-0.37). The AUC of CHr (0.81, 95% CI: 0.76-0.87) was higher than the AUC of %HYPO (0.76, 95%CI: 0.70-0.82). Conclusion The diagnostic usefulness of CHr and the screening performance of %HYPO in predicting IDA among CKD patients are high. Their lower cost compared to conventional markers of ID recommend their use in clinical practice. Further cost effectiveness studies of these parameters are warranted.	[Nalado, Aishatu Muhammad; Duarte, Raquel; Paget, Graham; Jacobson, Barry F.; Naicker, Saraladevi] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa; [Nalado, Aishatu Muhammad] Bayero Univ, Coll Hlth Sci, Dept Internal Med, Kano, Nigeria; [Mahlangu, Johnny N.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Olorunfemi, Gbenga] Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa	University of Witwatersrand; Bayero University; University of Witwatersrand; University of Witwatersrand	Nalado, AM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa.; Nalado, AM (corresponding author), Bayero Univ, Coll Hlth Sci, Dept Internal Med, Kano, Nigeria.	aishnld@yahoo.co.uk	Barretti, Pasqual/K-4156-2012; Mahlangu, Johnny Ndoni/H-7558-2019; Olorunfemi, Gbenga/AAU-6640-2021; NALADO, AISHATU/C-7357-2019	Barretti, Pasqual/0000-0003-4979-4836; Mahlangu, Johnny Ndoni/0000-0001-5781-7669; NALADO, AISHATU/0000-0003-3662-8150; Naicker, Saraladevi/0000-0002-7058-9725				Aoun M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191541; Bain BJ, 2005, J CLIN PATHOL, V58, P406, DOI 10.1136/jcp.2004.022178; Brugnara C, 2003, CLIN CHEM, V49, P1573, DOI 10.1373/49.10.1573; Dalimunthe NN, 2016, ROM J INTERN MED, V54, P31, DOI 10.1515/rjim-2016-0003; ESCHBACH JW, 1989, KIDNEY INT, V35, P134, DOI 10.1038/ki.1989.18; Fishbane S, 1997, KIDNEY INT, V52, P217, DOI 10.1038/ki.1997.323; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Kim JM, 2008, INT J LAB HEMATOL, V30, P46, DOI 10.1111/j.1751-553X.2007.00901.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Lorenz L, 2015, ARCH DIS CHILD-FETAL, V100, pF198, DOI 10.1136/archdischild-2014-306076; Lukaszyk E, 2015, KIDNEY BLOOD PRESS R, V40, P366, DOI 10.1159/000368512; McMurray J., 2012, KIDNEY INT SUPPL, V2, P279, DOI [10.1038/kisup.2012.37, DOI 10.1038/KISUP.2012.37]; Mei Chung, 2012, AHRQ COMP EFFECTIVEN; National Clinical Guideline C, 2011, NAT I HLTH CLIN EXC; Ratcliffe LEK, 2016, AM J KIDNEY DIS, V67, P548, DOI 10.1053/j.ajkd.2015.11.012; Riekert PD, 2014, S AFRICAN J CHILD HL, V8, P23; Schapkaitz E, 2016, SAMJ S AFR MED J, V106, P53, DOI [10.7196/SAMJ.2016.v106i1.9934, 10.7196/SAMJ.2016.V106I1.9934]; Suzuki M, 2012, INT HEART J, V53, P238, DOI 10.1536/ihj.53.238; Thomas C, 2002, CLIN CHEM, V48, P1066; Ullrich C, 2005, JAMA-J AM MED ASSOC, V294, P924, DOI 10.1001/jama.294.8.924; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0204899	10.1371/journal.pone.0204899	http://dx.doi.org/10.1371/journal.pone.0204899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281654	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400064
J	Davern, J; O'Donnell, AT				Davern, Jamie; O'Donnell, Aisling T.			Stigma predicts health-related quality of life impairment, psychological distress, and somatic symptoms in acne sufferers	PLOS ONE			English	Article							ANTICIPATED STIGMA; PHYSICAL HEALTH; HOSPITAL ANXIETY; PUBLIC-HEALTH; IMPACT; DEPRESSION; INDEX; SKIN; POPULATION; VULGARIS	Acne vulgaris has been associated with deficits in psychological well-being and health-related quality of life. Few studies have investigated how stigma contributes to our understanding of the well-being of acne sufferers, although it is clear that acne is stigmatized and stigmatization is associated with impaired well-being. The current study aimed to investigate the ability of perceived stigma to predict health-related quality of life, psychological distress, and somatic symptoms over and above established predictors. University students and staff suffering from acne completed self-report measures online. Hierarchical multiple regression analyses showed that perceived stigma significantly contributed to the prediction of all three well-being measures, over and above the effects of gender, acne severity, acne location, and use of medication. Indeed, perceived stigma made the largest unique contribution to predicting well-being. Our findings suggest that interventions that attempt to counter stigma could also improve the overall well-being of people affected by acne.	[O'Donnell, Aisling T.] Univ Limerick, Fac Educ & Hlth Sci, Dept Psychol, Limerick, Ireland; Univ Limerick, Fac Educ & Hlth Sci, Ctr Social Issues Res, Limerick, Ireland	University of Limerick; University of Limerick	O'Donnell, AT (corresponding author), Univ Limerick, Fac Educ & Hlth Sci, Dept Psychol, Limerick, Ireland.	aisling.odonnell@ul.ie		O'Donnell, Aisling/0000-0003-2103-4309; Davern, Jamie/0000-0001-9620-9236				Aghaei S, 2006, SAUDI MED J, V27, P80; Aktan S, 2000, INT J DERMATOL, V39, P354, DOI 10.1046/j.1365-4362.2000.00907.x; Berg M, 2011, J EUR ACAD DERMATOL, V25, P969, DOI 10.1111/j.1468-3083.2010.03907.x; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Both H, 2007, J INVEST DERMATOL, V127, P2726, DOI 10.1038/sj.jid.5701142; Chaudoir SR, 2016, SELF IDENTITY, V15, P139, DOI 10.1080/15298868.2015.1091378; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cohen S, 1996, ANNU REV PSYCHOL, V47, P113, DOI 10.1146/annurev.psych.47.1.113; Collier CN, 2008, J AM ACAD DERMATOL, V58, P56, DOI 10.1016/j.jaad.2007.06.045; Duman H, 2016, DERMATOL SIN, V34, P6, DOI 10.1016/j.dsi.2015.07.002; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Earnshaw VA, 2012, CHRONIC ILLN, V8, P79, DOI 10.1177/1742395311429393; Earnshaw VA, 2012, J HEALTH PSYCHOL, V17, P157, DOI 10.1177/1359105311414952; Field A., 2013, DISCOVERING STAT USI; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Goffman E., 1963, STIGMA NOTES MANAGEM, DOI DOI 10.1007/S12103-017-9422-6; Gupta MA, 1998, BRIT J DERMATOL, V139, P846; Halvorsen JA, 2011, J INVEST DERMATOL, V131, P363, DOI 10.1038/jid.2010.264; Hassan J, 2009, J HEALTH PSYCHOL, V14, P1105, DOI 10.1177/1359105309342470; Hatzenbuehler ML, 2009, PSYCHOL SCI, V20, P1282, DOI 10.1111/j.1467-9280.2009.02441.x; Hongbo Y, 2005, J INVEST DERMATOL, V125, P659, DOI 10.1111/j.0022-202X.2005.23621.x; Hrehorow E, 2012, ACTA DERM-VENEREOL, V92, P67, DOI 10.2340/00015555-1193; Jones-Caballero M, 2008, DERMATOLOGY, V217, P309, DOI 10.1159/000151441; Kacar Seval Dogruk, 2016, Int J Trichology, V8, P135, DOI 10.4103/0974-7753.189005; Kellett SC, 1999, BRIT J DERMATOL, V140, P273; Kent G, 1996, CLIN EXP DERMATOL, V21, P330; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Lasek RJ, 1998, ARCH DERMATOL, V134, P454, DOI 10.1001/archderm.134.4.454; Lewis V, 2004, J INVEST DERM SYMP P, V9, P169, DOI 10.1111/j.1087-0024.2004.09113.x; Liasides J, 2015, EUR PROC SOC BEHAV, V2, P145; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Loney T, 2008, J HEALTH PSYCHOL, V13, P47, DOI 10.1177/1359105307084311; Magin P, 2008, SCAND J CARING SCI, V22, P430, DOI 10.1111/j.1471-6712.2007.00547.x; Mallon E, 1999, BRIT J DERMATOL, V140, P672; Martin AR, 2001, CLIN EXP DERMATOL, V26, P380, DOI 10.1046/j.1365-2230.2001.00839.x; Miller CT, 2016, SOC SCI MED, V162, P97, DOI 10.1016/j.socscimed.2016.06.025; Misery L, 2015, ACTA DERM-VENEREOL, V95, P485, DOI 10.2340/00015555-1998; Murray CD, 2005, BRIT J HEALTH PSYCH, V10, P183, DOI 10.1348/135910705X26128; Nestler S, 2015, INT J INTERNET SCI, V10, P37; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Brien SC, 1998, J DERMATOL TREAT, V9, P215, DOI 10.3109/09546639809160698; O'Connell BH, 2016, PERS INDIV DIFFER, V98, P179, DOI 10.1016/j.paid.2016.04.042; O'Donnell AT, 2018, PSYCHOL WOMEN QUART, V42, P220, DOI 10.1177/0361684317748937; O'Donnell AT, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01263; Papadopoulos L., 2000, PSYCHOL HEALTH MED, V5, P431, DOI [10.1080/713690219, DOI 10.1080/713690219]; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Quinn DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096977; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; Rankin M, 2003, PLAST RECONSTR SURG, V111, P2140, DOI 10.1097/01.PRS.0000060105.63335.0C; Rapp DA, 2004, BRIT J DERMATOL, V151, P183, DOI 10.1111/j.1365-2133.2004.06078.x; Roosta N, 2013, INT J DERMATOL, V52, P432, DOI 10.1111/j.1365-4632.2011.05226.x; Roosta N, 2010, J CUTAN MED SURG, V14, P285, DOI 10.2310/7750.2010.09053; Schafer T, 2001, BRIT J DERMATOL, V145, P100, DOI 10.1046/j.1365-2133.2001.04290.x; Schat ACH, 2005, J OCCUP HEALTH PSYCH, V10, P363, DOI 10.1037/1076-8998.10.4.363; Schipper H., 1996, QUALITY LIFE PHARMAC, V2, P11; SEARS DO, 1986, J PERS SOC PSYCHOL, V51, P515, DOI 10.1037/0022-3514.51.3.515; Shahwan KT, 2016, J AM ACAD DERMATOL, V74, pAB9; Tabachnick B. G., 2007, USING MULTIVARIATE S, V5th; Tasoula E, 2012, AN BRAS DERMATOL, V87, P862, DOI 10.1590/S0365-05962012000600007; Tinlin RM, 2013, BRIT J PSYCHOL, V104, P235, DOI 10.1111/j.2044-8295.2012.02117.x; Toussaint L, 2016, J HEALTH PSYCHOL, V21, P1004, DOI 10.1177/1359105314544132; Vallerand IA, 2018, BRIT J DERMATOL; Vicente P, 2010, SOC SCI COMPUT REV, V28, P251, DOI 10.1177/0894439309340751; Wittkowski A, 2004, J PSYCHOSOM RES, V57, P195, DOI 10.1016/S0022-3999(03)00572-5; Yazici K, 2004, J EUR ACAD DERMATOL, V18, P435, DOI 10.1111/j.1468-3083.2004.00946.x; Yazmalar L, 2016, ARCH RHEUMATOL, V31, P170, DOI 10.5606/ArchRheumatol.2016.5713; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	68	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0205009	10.1371/journal.pone.0205009	http://dx.doi.org/10.1371/journal.pone.0205009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265724	gold, Green Published, Green Submitted			2022-12-27	WOS:000446005500060
J	Zanolli, C; Martinon-Torres, M; Bernardini, F; Boschian, G; Coppa, A; Dreossi, D; Mancini, L; de Pinillos, MM; Martin-Frances, L; de Castro, JMB; Tozzi, C; Tuniz, C; Macchiarelli, R				Zanolli, Clement; Martinon-Torres, Maria; Bernardini, Federico; Boschian, Giovanni; Coppa, Alfredo; Dreossi, Diego; Mancini, Lucia; Martinez de Pinillos, Marina; Martin-Frances, Laura; Bermudez de Castro, Jose Maria; Tozzi, Carlo; Tuniz, Claudio; Macchiarelli, Roberto			The Middle Pleistocene (MIS 12) human dental remains from Fontana Ranuccio (Latium) and Visogliano (Friuli-Venezia Giulia), Italy. A comparative high resolution endostructural assessment	PLOS ONE			English	Article							ESR/U-SERIES CHRONOLOGY; MORPHOMETRIC-ANALYSIS; HOMO-ERECTUS; ENAMEL THICKNESS; SPECIES RECOGNITION; COMPUTED-TOMOGRAPHY; DECIDUOUS MOLARS; TECHNICAL NOTE; NEANDERTHALS; SITE	The penecontemporaneous Middle Pleistocene sites of Fontana Ranuccio (Latium) and Visogliano (Friuli-Venezia Giulia), set c. 450 km apart in central and northeastern Italy, respectively, have yielded some among the oldest human fossil remains testifying to a peopling phase of the Italian Peninsula broadly during the glacial MIS 12, a stage associated with one among the harshest climatic conditions in the Northern hemisphere during the entire Quaternary period. Together with the large samples from Atapuerca Sima de los Huesos, Spain, and Caune de l'Arago at Tautavel, France, the remains from Fontana Ranuccio and Visogliano are among the few mid-Middle Pleistocene dental assemblages from Western Europe available for investigating the presence of an early Neanderthal signature in their inner structure. We applied two- three-dimensional techniques of virtual imaging and geometric morphometrics to the high-resolution X-ray microtomography record of the dental remains from these two Italian sites and compared the results to the evidence from a selected number of Pleistocene and extant human specimens/samples from Europe and North Africa. Depending on their preservation quality and on the degree of occlusal wear, we comparatively assessed: (i) the crown enamel and radicular dentine thickness topographic variation of a uniquely represented lower incisor; (ii) the lateral crown tissue proportions of premolars and molars; (iii) the enamel-dentine junction, and (iv) the pulp cavity morphology of all available specimens. Our analyses reveal in both samples a Neanderthal-like inner structural signal, for some aspects also resembling the condition shown by the contemporary assemblage from Atapuerca SH, and clearly distinct from the recent human figures. This study provides additional evidence indicating that an overall Neanderthal morphological dental template was preconfigured in Western Europe at least 430 to 450 ka ago.	[Zanolli, Clement] Univ Toulouse III Paul Sabatier, Lab AMIS, UMR CNRS 5288, Toulouse, France; [Martinon-Torres, Maria; Martinez de Pinillos, Marina; Martin-Frances, Laura; Bermudez de Castro, Jose Maria] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain; [Martinon-Torres, Maria; Martinez de Pinillos, Marina; Bermudez de Castro, Jose Maria] UCL, Dept Anthropol, London, England; [Bernardini, Federico; Tuniz, Claudio] Museo Stor Fis, Ctr Fermi, Rome, Italy; [Bernardini, Federico; Tuniz, Claudio] Ctr Studi & Ric Enrico Fermi, Rome, Italy; [Bernardini, Federico; Tuniz, Claudio] Abdus Salam Int Ctr Theoret Phys, Multidisciplinary Lab, Trieste, Italy; [Boschian, Giovanni; Tozzi, Carlo] Univ Pisa, Dipartimento Civilta & Forme Sapere, Pisa, Italy; [Coppa, Alfredo] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Dreossi, Diego; Mancini, Lucia] Elettra Sincrotrone Trieste SCpA, SYRMEP Grp, Trieste, Italy; [Martin-Frances, Laura] Univ Bordeaux, Lab PACEA, UMR 5199, Bordeaux, France; [Tuniz, Claudio] Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW, Australia; [Macchiarelli, Roberto] MNHN, Lab HNHP, UMR CNRS 7194, Paris, France; [Macchiarelli, Roberto] Univ Poitiers, Unite Format Geosci, Poitiers, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Pisa; Sapienza University Rome; Elettra Sincrotrone Trieste; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Wollongong; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Universite de Poitiers	Zanolli, C (corresponding author), Univ Toulouse III Paul Sabatier, Lab AMIS, UMR CNRS 5288, Toulouse, France.	clement.zanolli@gmail.com	de Pinillos, Marina Martínez/N-7595-2019; Martínez de Pinillos, Marina/D-9631-2018	de Pinillos, Marina Martínez/0000-0002-8035-337X; Martínez de Pinillos, Marina/0000-0002-8035-337X; coppa, alfredo/0000-0002-7708-2484; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; BOSCHIAN, Giovanni/0000-0003-4324-6353; Bernardini, Federico/0000-0002-3282-8799; Zanolli, Clement/0000-0002-5617-1613; Mancini, Lucia/0000-0003-2416-3464; Martin-Frances Martin de la Fuente, Laura/0000-0001-5853-5014	Centro Fermi (Roma); Regione Friuli-Venezia Giulia; Ministerio de Economia y Competitividad (MINECO) [CGL2015-65387-C3-1, CGL2015-65387-C3-3-P]; Consejeria de Educacion from Junta de Castilla y Leon Government, Spain [CEN074A12]; Leakey Foundation; Junta de Castilla y Leon - European Social Funds [BOCYL-D-20052013-14]; Fundacion Atapuerca	Centro Fermi (Roma); Regione Friuli-Venezia Giulia(Regione Friuli Venezia Giulia); Ministerio de Economia y Competitividad (MINECO); Consejeria de Educacion from Junta de Castilla y Leon Government, Spain; Leakey Foundation; Junta de Castilla y Leon - European Social Funds; Fundacion Atapuerca	Publication of this work was supported by the Centro Fermi (Roma). The ICTP/Elettra. EXACT Project has been funded by the Regione Friuli-Venezia Giulia. We acknowledge the excavation team from Atapuerca-Sima de los Huesos for their arduous work. The excavation, scanning and analysis of the Atapuerca sample has been funded by the CGL2015-65387-C3-1, 3-P project of the Ministerio de Economia y Competitividad (MINECO) and CEN074A12 from Consejeria de Educacion from Junta de Castilla y Leon Government, Spain. Gordon Getty (2013) and Dub Crook (2014, 2015, 2016) of the Leakey Foundation provided financial support to one of the authors (MMT). MMP has a predoctoral contract from the Junta de Castilla y Leon (BOCYL-D-20052013-14), co-financed by the European Social Funds and LMF had a postdoctoral research grant from Fundacion Atapuerca.	Abbazzi L, 2000, J ARCHAEOL SCI, V27, P1173, DOI 10.1006/jasc.1999.0541; Alciati G, 2005, J ANTHR SC S, V83; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Ascenzi A., 2005, J ANTHR SC S, V83, P59; Ascenzi Antonio, 1996, Anthropologie (Brno), V34, P39; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Baddeley A, 2015, SPATIAL POINT PATTER; Bailey SE, 2007, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-1-4020-5845-5; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bayle P., 2012, P EUR SOC STUDY HUM, V1, P36; Bayle P., 2011, WISSENSCHAFTLICHE SC, P29; Bayle P, 2009, J HUM EVOL, V56, P66, DOI 10.1016/j.jhevol.2008.09.002; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; de Castro JMB, 2017, EVOL ANTHROPOL, V26, P157, DOI 10.1002/evan.21540; Bermudez-de-Castro JM, 2017, QUATERN INT, V433, P22, DOI 10.1016/j.quaint.2015.03.049; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Bonhomme V, 2014, J STAT SOFTW, V56, P1; CATTANI L, 1991, ANTHROPOLOGIE, V95, P9; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; Daura J, 2017, P NATL ACAD SCI USA, V114, P3397, DOI 10.1073/pnas.1619040114; de Lumley MA, 2015, ANTHROPOLOGIE, V119, P303, DOI 10.1016/j.anthro.2015.06.001; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Fajardo RJ, 2002, AM J PHYS ANTHROPOL, V118, P1, DOI 10.1002/ajpa.10086; Falgueres C, 2015, QUAT GEOCHRONOL, V30, P547, DOI 10.1016/j.quageo.2015.02.006; Falgueres C, 2008, QUAT GEOCHRONOL, V3, P390, DOI 10.1016/j.quageo.2008.01.007; Falgueres C, 2010, QUATERN INT, V223, P293, DOI 10.1016/j.quaint.2009.10.008; Fornai C, 2016, QUATERN INT, V398, P175, DOI 10.1016/j.quaint.2015.11.102; Fornai C, 2014, J HUM EVOL, V76, P83, DOI 10.1016/j.jhevol.2014.05.013; Gomez-Robles A, 2013, P NATL ACAD SCI USA, V110, P18196, DOI 10.1073/pnas.1302653110; Gomez-Robles A, 2011, J HUM EVOL, V61, P688, DOI 10.1016/j.jhevol.2011.09.004; Hawks J, 2017, P NATL ACAD SCI USA, V114, P9761, DOI 10.1073/pnas.1713163114; Hillson SW, 2010, J HUM EVOL, V59, P493, DOI 10.1016/j.jhevol.2010.06.004; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Irish J. D., 2016, COMPANION DENT ANTHR; Irish JD., 2008, TECHNIQUE APPL DENT, DOI [10.1017/CBO9780511542442, DOI 10.1017/CBO9780511542442]; Kono Reiko T., 2008, Bulletin of the National Science Museum Series D (Anthropology), V34, P1; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Le Cabec A, 2013, J HUM EVOL, V64, P169, DOI 10.1016/j.jhevol.2012.08.011; Le Cabec A, 2012, J HUM EVOL, V63, P667, DOI 10.1016/j.jhevol.2012.07.003; Macchiarelli R., 2008, TECHNIQUE APPL DENT, P426, DOI DOI 10.1017/CBO9780511542442.018; Macchiarelli R., 2013, ANTHR PERSPECTIVES T, P250, DOI DOI 10.1017/CBO9780511984464.011; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; MacDonald K, 2012, QUATERN INT, V271, P84, DOI 10.1016/j.quaint.2011.10.009; Mallegni F, 2001, HOMO, V52, P233; Mallegni F, 1986, ATTI SOC PREIST PROT, V5, P9; Mallegni F, 1992, RIV ANTROPOL, V70, P217; Mallegni F, 2005, J ANTHR SC S, V83, P159; Mancini L, 2007, ELETTRA HIGHLIGHTS 2, P128; Manzi Giorgio, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/582678; Manzi G, 2010, J HUM EVOL, V59, P580, DOI 10.1016/j.jhevol.2010.06.010; de Castro JMB, 2019, QUATERNARY SCI REV, V217, P45, DOI 10.1016/j.quascirev.2018.04.003; de Castro JMB, 2013, QUATERN INT, V295, P102, DOI 10.1016/j.quaint.2012.02.036; Martin RMG, 2017, J HUM EVOL, V103, P20, DOI 10.1016/j.jhevol.2016.12.004; de Pinillos MM, 2017, QUATERN INT, V433, P189, DOI 10.1016/j.quaint.2015.08.050; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2019, QUATERNARY SCI REV, V153, P51; Martinon-Torres M, 2018, CR PALEVOL, V17, P33, DOI 10.1016/j.crpv.2015.09.011; Martinon-Torres M, 2014, CR PALEVOL, V13, P223, DOI 10.1016/j.crpv.2013.12.002; Martinon-Torres M, 2013, J ANAT, V223, P353, DOI 10.1111/joa.12090; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Muttoni G, 2009, EARTH PLANET SC LETT, V286, P255, DOI 10.1016/j.epsl.2009.06.032; Naldini ES, 2009, ANTHROPOLOGIE, V113, P66, DOI 10.1016/j.anthro.2009.01.013; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Ortiz A, 2012, J HUM EVOL, V63, P586, DOI 10.1016/j.jhevol.2012.06.003; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peretto C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140091; Prado-Simon L, 2012, AM J PHYS ANTHROPOL, V147, P452, DOI 10.1002/ajpa.22015; Puymerail L, 2012, J HUM EVOL, V63, P741, DOI 10.1016/j.jhevol.2012.08.003; R Development Core Team, 2017, R LANG ENV STAT COMP; Raymo ME, 2012, NATURE, V483, P453, DOI 10.1038/nature10891; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Rightmire GP, 2013, J HUM EVOL, V65, P223, DOI 10.1016/j.jhevol.2013.04.008; Rogers AR, 2017, P NATL ACAD SCI USA, V114, P9859, DOI 10.1073/pnas.1706426114; Rubini M, 2014, J HUM EVOL, V77, P204, DOI 10.1016/j.jhevol.2014.09.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott RG, 2013, ANTHR PERSPECTIVES T; SEGRE A, 1984, CURR ANTHROPOL, V25, P230, DOI 10.1086/203117; Skinner MM, 2008, J HUM EVOL, V54, P173, DOI 10.1016/j.jhevol.2007.09.012; Skinner MM, 2016, J HUM EVOL, V93, P63, DOI 10.1016/j.jhevol.2016.01.010; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Toussaint M, 2010, J HUM EVOL, V58, P56, DOI 10.1016/j.jhevol.2009.09.006; Tozzi C, 1994, ATT 29 RIUN SC IIPP, P21; Trinkaus E., 2004, MISCEANEA HOMENAJE E, P392; Tuniz C, 2013, NUCL INSTRUM METH A, V711, P106, DOI 10.1016/j.nima.2013.01.046; Tuniz C, 2014, P ESHE, V3, P163; Tuniz C, 2013, P EUR SOC STUD DRUG, V2, P229; Volpato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043949; Weber GW, 2016, QUATERN INT, V398, P159, DOI 10.1016/j.quaint.2015.10.027; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Xing S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114265; Zanolli C, 2014, ATT 49 RIUN SC IST I; Zanolli C, 2014, P ESHE, V3, P173; Zanolli C, 2017, CR PALEVOL, V16, P702, DOI 10.1016/j.crpv.2017.05.002; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004; Zanolli C, 2012, AM J PHYS ANTHROPOL, V147, P472, DOI 10.1002/ajpa.21657	107	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0189773	10.1371/journal.pone.0189773	http://dx.doi.org/10.1371/journal.pone.0189773			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281595	Green Published, Green Submitted, gold			2022-12-27	WOS:000446342400001
J	Gasior-Perczak, D; Palyga, I; Szymonek, M; Kowalik, A; Walczyk, A; Kopczynski, J; Lizis-Kolus, K; Trybek, T; Mikina, E; Szyska-Skrobot, D; Gadawska-Juszczyk, K; Hurej, S; Szczodry, A; Sluszniak, A; Sluszniak, J; Mezyk, R; Gozdz, S; Kowalska, A				Gasior-Perczak, Danuta; Palyga, Iwona; Szymonek, Monika; Kowalik, Artur; Walczyk, Agnieszka; Kopczynski, Janusz; Lizis-Kolus, Katarzyna; Trybek, Tomasz; Mikina, Estera; Szyska-Skrobot, Dorota; Gadawska-Juszczyk, Klaudia; Hurej, Stefan; Szczodry, Artur; Sluszniak, Anna; Sluszniak, Janusz; Mezyk, Ryszard; Gozdz, Stanislaw; Kowalska, Aldona			The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer	PLOS ONE			English	Article							BODY-MASS INDEX; INCREASING INCIDENCE; POOLED ANALYSIS; RISK; OBESITY; PREVALENCE; CARCINOMA; METAANALYSIS; ASSOCIATION; TRENDS	Introduction Obesity is a serious health problem worldwide, particularly in developed countries. It is a risk factor for many diseases, including thyroid cancer. The relationship between obesity and prognostic factors of thyroid cancer is unclear. Aims We sought to ascertain the relationship between body mass index (BMI) and clinicopathological features increasing the risk of poor clinical course, treatment response, and clinical outcome in patients with differentiated thyroid cancer (DTC). Subjects & methods The study included 1181 patients with DTC (88% women and 12% men) treated at a single center from 2000 to 2016. BMI before surgery and aggressive clinicopathological features, according to the American Thyroid Initial Risk stratification system, were analyzed. The relationship between BMI and initial risk, treatment response, and final status of the disease was evaluated, incorporating the revised 2015 American Thyroid Association guidelines and the 8th edition of the American Joint Committee on Cancer/Tumor-Node-Metastasis (AJCC/TNM) staging system. Patients were stratified according to the World Health Organization classification of BMI. Statistical analysis was performed using univariate and multivariate logistic regression analysis. Results Median follow-up was 7.7 years (1-16 years). There were no significant associations between BMI and extrathyroidal extension (microscopic and gross), cervical lymph node metastasis, or distant metastasis in univariate and multivariate analyses. BMI did not affect initial risk, treatment response or disease outcome. Obesity was more prevalent in men (p = 0.035) and in patients >= 55 years old (p = 0.001). There was no statistically significant relationship between BMI and more advanced TNM stage in patients <= 55 years old (stage I vs. stage II) (p = 0.266) or in patients >55 years old (stage I-II vs. III-IV) (p = 0.877). Conclusions Obesity is not associated with more aggressive clinicopathological features of thyroid cancer. Obesity is not a risk factor for progression to more advanced stages of disease, nor is it a prognostic factor for poorer treatment response and clinical outcome.	[Gasior-Perczak, Danuta; Palyga, Iwona; Szymonek, Monika; Walczyk, Agnieszka; Lizis-Kolus, Katarzyna; Trybek, Tomasz; Mikina, Estera; Szyska-Skrobot, Dorota; Gadawska-Juszczyk, Klaudia; Hurej, Stefan; Szczodry, Artur; Kowalska, Aldona] Holycross Canc Ctr, Endocrinol Clin, Kielce, Poland; [Kowalik, Artur] Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland; [Kopczynski, Janusz] Holycross Canc Ctr, Dept Surg Pathol, Kielce, Poland; [Sluszniak, Anna] Holycross Canc Ctr, Lab Tumor Markers, Kielce, Poland; [Sluszniak, Janusz] Holycross Canc Ctr, Dept Surg Oncol, Kielce, Poland; [Mezyk, Ryszard] Holycross Canc Ctr, Canc Epidemiol, Kielce, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Oncol Clin, Kielce, Poland; [Gozdz, Stanislaw; Kowalska, Aldona] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland	Jan Kochanowski University	Gasior-Perczak, D (corresponding author), Holycross Canc Ctr, Endocrinol Clin, Kielce, Poland.	danutagp@o2.pl	Kowalik, Artur/K-2111-2017; KOWALSKA, ALDONA/AAE-9040-2021; Gąsior-Perczak, Danuta/AAM-2668-2020; Walczyk, Agnieszka/ABC-3334-2020; Kowalik, Artur/AAB-5690-2020; Gozdz, Stanislaw/D-3300-2013	Kowalik, Artur/0000-0002-3718-999X; KOWALSKA, ALDONA/0000-0001-5647-5898; Gąsior-Perczak, Danuta/0000-0003-0936-4890; Kowalik, Artur/0000-0002-3718-999X; Gozdz, Stanislaw/0000-0001-6902-3807; Palyga, Iwona/0000-0001-5333-6112; Walczyk, Agnieszka/0000-0002-5083-659X				Agate L, 2012, J ENDOCRINOL INVEST, V35, P3; Al-Ammar Y, 2017, BRAZ J OTORHINOLARYN; Baskin ML, 2005, OBES REV, V6, P5, DOI 10.1111/j.1467-789X.2005.00165.x; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Choi JS, 2015, ENDOCRINE, V48, P264, DOI 10.1007/s12020-014-0293-z; Chung YS, 2017, SURG TODAY, V47, P506, DOI 10.1007/s00595-016-1417-2; Davies L, 2015, ENDOCR PRACT, V21, P686, DOI 10.4158/EP14466.DSCR; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; Dieringer P, 2015, J CANCER RES CLIN, V141, P93, DOI 10.1007/s00432-014-1792-2; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Farfel A, 2014, THYROID, V24, P987, DOI 10.1089/thy.2013.0173; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gasior-Perczak D, 2017, ENDOCR CONNECT, V6, P522, DOI 10.1530/EC-17-0135; Grani G, 2019, J ENDOCRINOL INVEST, V42, P85, DOI 10.1007/s40618-018-0889-x; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; How J, 2007, CAN MED ASSOC J, V177, P1383, DOI 10.1503/cmaj.071464; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Iribarren C, 2001, INT J CANCER, V93, P745, DOI 10.1002/ijc.1377; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim HJ, 2013, CLIN ENDOCRINOL, V78, P134, DOI 10.1111/j.1365-2265.2012.04506.x; Kim JY, 2011, J KOREAN SURG SOC, V80, P241, DOI 10.4174/jkss.2011.80.4.241; Kim SH, 2015, SURG TODAY, V45, P723, DOI 10.1007/s00595-014-0984-3; Kitahara CM, 2016, THYROID, V26, P306, DOI 10.1089/thy.2015.0319; Kitahara CM, 2014, CANCER RES, V74, P235, DOI 10.1158/0008-5472.CAN-13-2228; Kowalska A, 2017, CLIN ENDOCRINOL; Kowalska A, 2013, THYROID RES, V6, pA30, DOI DOI 10.1186/1756-6614-6-S2-A30; Kowalska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153242; Kowalska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133852; Kwon H, 2015, ENDOCRINOL METAB, V30, P305, DOI 10.3803/EnM.2015.30.3.305; Liu ZM, 2015, INT J CLIN EXP MED, V8, P16472; Ljungvall A, 2012, SOC SCI MED, V75, P109, DOI 10.1016/j.socscimed.2012.03.003; Ma J, 2015, MED SCI MONITOR, V21, P283, DOI 10.12659/MSM.892035; Mangano JJ, 2009, INT J HEALTH SERV, V39, P643, DOI 10.2190/HS.39.4.c; Marcello MA, 2014, ENDOCR-RELAT CANCER, V21, pT255, DOI 10.1530/ERC-14-0070; Momesso DP, 2014, ENDOCRIN METAB CLIN, V43, P401, DOI 10.1016/j.ecl.2014.02.010; Paes JE, 2010, J CLIN ENDOCR METAB, V95, P4244, DOI 10.1210/jc.2010-0440; Pappa T, 2014, THYROID, V24, P190, DOI 10.1089/thy.2013.0232; Pazaitou-Panayiotou K, 2013, OBES REV, V14, P1006, DOI 10.1111/obr.12070; Pazaitou-Panayiotou K, 2013, EXP CLIN ENDOCR DIAB, V121, P397, DOI 10.1055/s-0033-1345125; Peterson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029177; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Reynolds JV, 2011, IRISH J MED SCI, V180, P521, DOI 10.1007/s11845-010-0653-5; Rinaldi S, 2012, INT J CANCER, V131, pE1004, DOI 10.1002/ijc.27601; Roman BR, 2017, CURR OPIN ENDOCRINOL, V24, P332, DOI 10.1097/MED.0000000000000359; Rotondi M, 2016, EUR THYROID J, V5, P125, DOI 10.1159/000445054; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Segovia IG, 2004, THYROID, V14, P277, DOI 10.1089/105072504323030933; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Stepaniak U, 2016, POL ARCH MED WEWN, V126, P662, DOI 10.20452/pamw.3499; Tresallet C, 2014, SURGERY, V156, P1145, DOI 10.1016/j.surg.2014.04.020; Tuttle M, 2017, AJCC CANC STAGING MA; Tuttle RM, 2017, THYROID, V27, P751, DOI 10.1089/thy.2017.0102; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; Vaccarella S, 2016, NEW ENGL J MED, V375, P614, DOI 10.1056/NEJMp1604412; Wu CH, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006202, 10.1097/md.0000000000006202]; Xu L, 2014, THYROID, V24, P966, DOI 10.1089/thy.2013.0566; Yu ST, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/5841942; Zhao ZG, 2012, J INT MED RES, V40, P2041, DOI 10.1177/030006051204000601	59	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204668	10.1371/journal.pone.0204668	http://dx.doi.org/10.1371/journal.pone.0204668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273371	Green Published, Green Submitted, gold			2022-12-27	WOS:000446124700031
J	Yin, ZJ; Yu, YT; Huang, JH				Yin, Zhujia; Yu, Yantuan; Huang, Jianhuan			Evaluation and evolution of bank efficiency considering heterogeneity technology: An empirical study from China	PLOS ONE			English	Article							DATA ENVELOPMENT ANALYSIS; SLACKS-BASED MEASURE; REGIONAL TECHNICAL EFFICIENCY; NEURAL NETWORK APPROACH; DEA APPROACH; STRUCTURAL BREAKS; 2-STAGE DEA; BAD OUTPUTS; MODEL; PERFORMANCE	The performances of different types of banks may vary due to heterogeneous technology, which can be examined by metafrontier analysis. However, the metafrontier constructed in most existing literature is concave, resulting in a biased estimation of efficiency. Based on 93 Chinese commercial banks over the period of 2005-2016, we first evaluate the banking efficiency by using the proposed data envelopment analysis (DEA) model, NCMeta-US-NSBM, which simultaneously incorporates a non-concave metafrontier technique, undesirable outputs, and super efficiency into a network slacks-based measure (NSBM) model. Subsequently, the evolution of banking efficiency during the study period is investigated on the basis of the Dagum Gini index and kernel density estimation methods. The main empirical results show the following. 1) There exists significant disparity/heterogeneity in banking efficiency for overall efficiency, productivity efficiency, and profitability efficiency. 2) The results of the technology gap ratio (TGR) and the evaluation of stated-owned banks (SOB), joint-stock banks (JSB), and city commercial banks (CCB) in the productivity stage are higher than those in the profitability stage, indicating that most of the banks have a large space for improvement, especially for SOB and JSB in the profitability stage. 3) The major contribution of the overall difference of banking efficiency in China is the intensity of the transvariation. 4) Although the kernel density estimations for different efficiency scores have similar distributions in corresponding years, the multilevel differentiation phenomenon of banking efficiency may appear after 2008.	[Yin, Zhujia] Changsha Univ Technol & Sci, Sch Econ & Management, Changsha, Hunan, Peoples R China; [Yu, Yantuan; Huang, Jianhuan] Hunan Univ, Sch Econ & Trade, Changsha, Hunan, Peoples R China	Hunan University	Yu, YT (corresponding author), Hunan Univ, Sch Econ & Trade, Changsha, Hunan, Peoples R China.	yantuanyu@hnu.edu.cn		Yu, Yantuan/0000-0002-8728-8793	National Natural Science Foundation of China [41571524]; National Social Science Foundation of China [15BGL041]; Social Science Foundation of Hunan Province [15YBA014]; Collaborative Innovation Center for the Development of Modern Services and New Urbanization in Hunan Province [CIC1502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China; Social Science Foundation of Hunan Province; Collaborative Innovation Center for the Development of Modern Services and New Urbanization in Hunan Province	This research is supported by the National Natural Science Foundation of China (No. 41571524), the National Social Science Foundation of China (No. 15BGL041), the Social Science Foundation of Hunan Province (No. 15YBA014), and the Collaborative Innovation Center for the Development of Modern Services and New Urbanization in Hunan Province (No. CIC1502).	ANDERSEN P, 1993, MANAGE SCI, V39, P1261, DOI 10.1287/mnsc.39.10.1261; Andries AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059686; Avkiran NK, 2014, ANN OPER RES, V217, P31, DOI 10.1007/s10479-014-1568-8; Battese GE, 2004, J PROD ANAL, V21, P91, DOI 10.1023/B:PROD.0000012454.06094.29; Chang SC, 2011, TECHNOL FORECAST SOC, V78, P1389, DOI 10.1016/j.techfore.2011.03.015; Chen CM, 2013, EUR J OPER RES, V226, P258, DOI 10.1016/j.ejor.2012.10.031; Chiu CR, 2016, PAC-BASIN FINANC J, V36, P1, DOI 10.1016/j.pacfin.2015.11.003; Chiu CR, 2013, INT T OPER RES, V20, P595, DOI 10.1111/itor.12008; Chiu YH, 2011, APPL ECON, V43, P587, DOI 10.1080/00036840802599750; Dagum C., 1997, EMPIR ECON, V22, P515, DOI [DOI 10.1007/BF01205777, 10.1007/bf01205777]; Dai ZF, 2018, FINANC RES LETT, V27, P46, DOI 10.1016/j.frl.2018.02.026; Ebrahimnejad A, 2014, MEASUREMENT, V49, P308, DOI 10.1016/j.measurement.2013.11.043; Eken MH, 2011, AFR J BUS MANAGE, V5, P889; Eskelinen J, 2013, J BANK FINANC, V37, P5163, DOI 10.1016/j.jbankfin.2013.03.010; Fang CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154716; Fare R., 2000, SOCIO-ECON PLAN SCI, V34, P35, DOI [10.1016/S0038-0121(99)00012-9, DOI 10.1016/S0038-0121(99)00012-9]; Fievet L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193290; Fukuyama H., 2013, EFFICIENCY PRODUCTIV, P193, DOI DOI 10.1002/9781118541531.CH9; Fukuyama H, 2017, EUR J OPER RES, V259, P721, DOI 10.1016/j.ejor.2016.10.044; Fukuyama H, 2015, J PROD ANAL, V44, P249, DOI 10.1007/s11123-014-0403-1; Fukuyama H, 2010, OMEGA-INT J MANAGE S, V38, P398, DOI 10.1016/j.omega.2009.10.006; Halkos GE, 2004, MANAGE ACCOUNTING, V15, P201, DOI DOI 10.1016/J.MAR.2004.02.001; Hasan MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042215; Hasan MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037047; Holod D, 2011, J BANK FINANC, V35, P2801, DOI 10.1016/j.jbankfin.2011.03.007; Hu C, 2017, EMERGING MARKETS FIN; Huang CW, 2013, J OPER RES SOC, V64, P250, DOI 10.1057/jors.2012.52; Huang J., 2017, ENVIRON RESOUR ECON, P1; Huang JH, 2018, ECOL INDIC, V85, P674, DOI 10.1016/j.ecolind.2017.10.040; Huang JH, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/793192; Huang T H, 2014, ECON MODEL, V44, P188; Huang TH, 2017, PAC-BASIN FINANC J, V41, P93, DOI 10.1016/j.pacfin.2016.12.008; Khodabakhshi M, 2010, EXPERT SYST APPL, V37, P2092, DOI 10.1016/j.eswa.2009.06.091; Kwon HB, 2015, EXPERT SYST APPL, V42, P6758, DOI 10.1016/j.eswa.2015.04.062; Lewis HF, 2004, COMPUT OPER RES, V31, P1365, DOI 10.1016/S0305-0548(03)00095-9; Liang L, 2006, ANN OPER RES, V145, P35, DOI 10.1007/s10479-006-0026-7; Lozano S, 2016, OMEGA-INT J MANAGE S, V60, P73, DOI 10.1016/j.omega.2015.02.012; Lu XH, 2018, HABITAT INT, V77, P32, DOI 10.1016/j.habitatint.2017.11.016; Matthews K, 2013, OMEGA-INT J MANAGE S, V41, P207, DOI 10.1016/j.omega.2012.06.003; Minh NK, 2013, ASIA PAC J OPER RES, V30, DOI 10.1142/S0217595912500479; Nguyen T.P.T., 2016, APPL EC, V48, P1; O'Donnell CJ, 2008, EMPIR ECON, V34, P231, DOI 10.1007/s00181-007-0119-4; Ohsato S, 2015, PROCD SOC BEHV, V172, P511, DOI 10.1016/j.sbspro.2015.01.394; Park KH, 2006, J BANK FINANC, V30, P2371, DOI 10.1016/j.jbankfin.2005.09.013; Puri J, 2017, ANN OPER RES, P1; Puri J, 2017, INT J SYSTEM ASSURAN, P1; Puri J, 2014, EXPERT SYST APPL, V41, P6419, DOI 10.1016/j.eswa.2014.04.013; Sexton T R, 2013, J PROD ANAL, V19, P227; Silverman B W., 1986, DENSITY ESTIMATION S; Tiedemann T, 2011, CENT EUR J OPER RES, V19, P571, DOI 10.1007/s10100-010-0146-7; Tone K, 2003, INT J PROD ECON, V84, P165, DOI 10.1016/S0925-5273(02)00412-7; Tone K, 2001, EUR J OPER RES, V130, P498, DOI 10.1016/S0377-2217(99)00407-5; Tone K, 2009, EUR J OPER RES, V197, P243, DOI 10.1016/j.ejor.2008.05.027; Wang K, 2014, OMEGA-INT J MANAGE S, V44, P5, DOI 10.1016/j.omega.2013.09.005; Wang QW, 2016, TECHNOL FORECAST SOC, V112, P254, DOI 10.1016/j.techfore.2016.04.019; Wanke P, 2016, ECON MODEL, V53, P8, DOI 10.1016/j.econmod.2015.11.005; Webb R., 2003, INT J EC BUSINESS, V10, P305, DOI DOI 10.1080/1357151032000126256; Wen FH, 2018, APPL ECON, V50, P319, DOI 10.1080/00036846.2017.1321838; Wen FH, 2016, ENERG ECON, V59, P400, DOI 10.1016/j.eneco.2016.07.014; Wen FH, 2014, ECON COMPUT ECON CYB, V48, P235; Wu DS, 2006, EXPERT SYST APPL, V31, P108, DOI 10.1016/j.eswa.2005.09.034; Yang W, 2017, SOCIO-ECON PLAN SCI, V57, P14, DOI 10.1016/j.seps.2016.07.003; Yang W, 2014, PROCEDIA COMPUT SCI, V31, P615, DOI 10.1016/j.procs.2014.05.308; Zha Y, 2016, OMEGA-INT J MANAGE S, V60, P60, DOI 10.1016/j.omega.2014.12.008; Zhou L., 2017, J MATH FINANCE, V07, P102, DOI [10.4236/jmf.2017.71006, DOI 10.4236/JMF.2017.71006]; Zhou M, 2017, EMERG MARK FINANC TR, V53, P1973, DOI 10.1080/1540496X.2016.1237353; Zhu J, 2000, EUR J OPER RES, V123, P105, DOI 10.1016/S0377-2217(99)00096-X	67	7	8	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204559	10.1371/journal.pone.0204559	http://dx.doi.org/10.1371/journal.pone.0204559			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278088	gold, Green Submitted, Green Published			2022-12-27	WOS:000446010200017
J	Dou, JL; Lu, XQ; Ali, A; Zhao, SJ; Zhang, L; He, N; Liu, WG				Dou, Junling; Lu, Xuqiang; Ali, Aslam; Zhao, Shengjie; Zhang, Lei; He, Nan; Liu, Wenge			Genetic mapping reveals a marker for yellow skin in watermelon (Citrullus lanatus L.)	PLOS ONE			English	Article							BULKED SEGREGANT ANALYSIS; GENOME-WIDE ASSOCIATION; FRUIT COLOR; LINKAGE MAP; RNA-SEQ; MODEL; DISCOVERY; CUCUMBER; LOCI; IDENTIFICATION	As a diverse species, watermelon [Citrullus lanatus (Thunb.) Matsum. &Nakai var. lanatus] has different kinds of fruit sizes, shapes, flesh colors and skin colors. Skin color is among the major objectives for breeding. Yellow skin is an important trait in watermelon, but the underlying genetic mechanism is unknown. In this study, we identified a locus for yellow skin through BSA-seq and GWAS. A segregation analysis in F-2 and BC1 populations derived from a cross of two inbred lines '94E1'(yellow skin) and 'Qingfeng'(green skin) suggested that skin color is a qualitative trait. BSA-seq mapping confirmed the locus in the F-2 population, which was detected on chromosome 4 by GWAS among 330 varieties. Several major markers, namely, 15 CAPS markers, 6 SSR markers and 2 SNP markers, were designed to delimit the region to 59.8 kb region on chromosome 4. Utilizing the two populations consisting of 10 yellow and 10 green skin watermelons, we found a tightly linked functional SNP marker for the yellow skin phenotype. The application of this marker as a selection tool in breeding programs will help to improve the breeder's ability to make selections at early stages of growth, thus accelerating the breeding program.	[Dou, Junling; Lu, Xuqiang; Ali, Aslam; Zhao, Shengjie; He, Nan; Liu, Wenge] Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China; [Dou, Junling; Zhang, Lei] Huazhong Agr Univ, Coll Hort & Forestry Sci, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS; Huazhong Agricultural University	Liu, WG (corresponding author), Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China.	lwgwm@163.com	Aslam, Ali/GRY-4159-2022; zhang, lei/ABE-2185-2020	Aslam, Ali/0000-0001-7984-4211; zhang, lei/0000-0002-0410-6553	Agricultural Science and Technology Innovation Program (ASTIP) [CAAS-ASTIP-2017-ZFRI]; China Agriculture Research System [CARS-25-03]; National Natural Science Foundation of China [31471893, 31672178]; Central Public-interest Scientific Institution Basal Research Fund, China [1610192016301, 1610192016209]	Agricultural Science and Technology Innovation Program (ASTIP); China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public-interest Scientific Institution Basal Research Fund, China	This work was supported by Agricultural Science and Technology Innovation Program (ASTIP) (CAAS-ASTIP-2017-ZFRI), China Agriculture Research System (CARS-25-03), National Natural Science Foundation of China (No. 31471893 and 31672178), and Central Public-interest Scientific Institution Basal Research Fund, China (1610192016301 and 1610192016209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; BARHAM WARREN S., 1956, PROC AMER SOC HORT SCI, V67, P487; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chandler K, 2013, CROP SCI, V53, P189, DOI 10.2135/cropsci2012.02.0129; Cheng Y, 2016, SCI HORTIC-AMSTERDAM, V202, P25, DOI 10.1016/j.scienta.2016.01.004; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Dou JL, 2018, THEOR APPL GENET, V131, P947, DOI 10.1007/s00122-018-3050-5; Feder A, 2015, PLANT PHYSIOL, V169, P1714, DOI 10.1104/pp.15.01008; Gao ML, 2016, THEOR APPL GENET, V129, P1961, DOI 10.1007/s00122-016-2752-9; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Guner N, 2004, HORTSCIENCE, V39, P1175, DOI 10.21273/HORTSCI.39.6.1175; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Huang HY, 2017, HORTICULT J, V86, P238, DOI [10.2503/hortj.MI-159, 10.2503/hortj.mi-159]; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Inoue E, 2006, SCI HORTIC-AMSTERDAM, V107, P254, DOI 10.1016/j.scienta.2005.07.009; Kayesh E, 2013, ACTA PHYSIOL PLANT, V35, P2879, DOI 10.1007/s11738-013-1332-8; Kong QS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130865; Kumar R, 2011, J HERED, V102, P489, DOI 10.1093/jhered/esr025; Lado J, 2015, PHYSIOL PLANTARUM, V154, P469, DOI 10.1111/ppl.12332; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee YP, 2014, THEOR APPL GENET, V127, P2243, DOI 10.1007/s00122-014-2376-x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Meng R, 2016, J PLANT GROWTH REGUL, V35, P449, DOI 10.1007/s00344-015-9552-3; Miao H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101602; Poole Charles F., 1945, JOUR AGRIC RES, V71, P533; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shang JL, 2016, SCI HORTIC-AMSTERDAM, V203, P38, DOI 10.1016/j.scienta.2016.03.007; Sun G, 2010, HEREDITY, V105, P333, DOI 10.1038/hdy.2010.11; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Weetman LM., 1937, IOWA AGR HOME EC EXP, V20, P1; Yang HB, 2015, KOREAN J HORTIC SCI, V33, P559, DOI 10.7235/hort.2015.14070; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	47	17	17	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0200617	10.1371/journal.pone.0200617	http://dx.doi.org/10.1371/journal.pone.0200617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265662	Green Published, Green Submitted, gold			2022-12-27	WOS:000446005500003
J	Lueschow, SR; Stumphy, J; Gong, HY; Kern, SL; Elgin, TG; Underwood, MA; Kalanetra, KM; Mills, DA; Wong, MH; Meyerholz, DK; Good, M; McElroy, SJ				Lueschow, Shiloh R.; Stumphy, Jessica; Gong, Huiyu; Kern, Stacy L.; Elgin, Timothy G.; Underwood, Mark A.; Kalanetra, Karen M.; Mills, David A.; Wong, Melissa H.; Meyerholz, David K.; Good, Misty; McElroy, Steven J.			Loss of murine Paneth cell function alters the immature intestinal microbiome and mimics changes seen in neonatal necrotizing enterocolitis	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; BACTERIAL-INFECTION; SECRETORY AUTOPHAGY; INFANT GUT; LYSOZYME; MICE; PATHOGENESIS; ASSOCIATION; PREVENTION; SEQUENCES	Necrotizing enterocolitis (NEC) remains the leading cause of gastrointestinal morbidity and mortality in premature infants. Human and animal studies suggest a role for Paneth cells in NEC pathogenesis. Paneth cells play critical roles in host-microbial interactions and epithelial homeostasis. The ramifications of eliminating Paneth cell function on the immature hostmicrobial axis remains incomplete. Paneth cell function was depleted in the immature murine intestine using chemical and genetic models, which resulted in intestinal injury consistent with NEC. Paneth cell depletion was confirmed using histology, electron microscopy, flow cytometry, and real time RT-PCR. Cecal samples were analyzed at various time points to determine the effects of Paneth cell depletion with and without Klebsiella gavage on the microbiome. Deficient Paneth cell function induced significant compositional changes in the cecal microbiome with a significant increase in Enterobacteriacae species. Further, the bloom of Enterobacteriaceae species that occurs is phenotypically similar to what is seen in human NEC. This further strengthens our understanding of the importance of Paneth cells to intestinal homeostasis in the immature intestine.	[Lueschow, Shiloh R.; McElroy, Steven J.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Stumphy, Jessica; Gong, Huiyu; Kern, Stacy L.; Elgin, Timothy G.; McElroy, Steven J.] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA 52242 USA; [Underwood, Mark A.; Kalanetra, Karen M.; Mills, David A.] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA; [Underwood, Mark A.; Kalanetra, Karen M.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Sacramento, CA 95817 USA; [Wong, Melissa H.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Good, Misty] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	University of Iowa; University of Iowa; University of California System; University of California Davis; University of California System; University of California Davis; Oregon Health & Science University; University of Iowa; Washington University (WUSTL)	McElroy, SJ (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.; McElroy, SJ (corresponding author), Univ Iowa, Stead Family Dept Pediat, Iowa City, IA 52242 USA.	steven.mcelroy@uiowa.edu	Good, Misty/AAI-6192-2020; McElroy, Steven/AAC-7204-2019; Kalanetra, Karen/AAP-3669-2021; Mills, David/GXF-1821-2022; Meyerholz, David/J-8131-2019; McElroy, Steven/AGR-6835-2022; Mills, David Andrew/G-2282-2011	Good, Misty/0000-0002-0264-5721; McElroy, Steven/0000-0002-4321-723X; Meyerholz, David/0000-0003-1552-3253; McElroy, Steven/0000-0002-4321-723X; Mills, David Andrew/0000-0003-1913-9865; Lueschow, Shiloh/0000-0001-6185-7612; Elgin, Timothy/0000-0001-5936-0463	National Institutes of Health [DK083677, DK097335, DK101608, DK111473, DK085525, CA060533, AT007079, AT008759]; March of Dimes [MG: 5-FY17-79]; Children's Miracle Network; Stead Family Department of Pediatrics at the University of Iowa; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine - NCI Cancer Center Support Grant [P30 CA91842]; National Center for Research Resources (NCRR) [UL1 TR000448]; National Institutes of Health (NIH); NIH Roadmap for Medical Research; Peter J. Shields Endowed Chair in Dairy Food Science; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK111473, U01DK085525, K08DK101608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Children's Miracle Network; Stead Family Department of Pediatrics at the University of Iowa; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine - NCI Cancer Center Support Grant; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peter J. Shields Endowed Chair in Dairy Food Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this work was provided from the National Institutes of Health (SJM: DK083677, SJM: DK097335, MG: DK101608, MG: DK111473, MHW: DK085525, and MHW: CA060533), The March of Dimes (MG: 5-FY17-79), the Children's Miracle Network, the Stead Family Department of Pediatrics at the University of Iowa, and the Children's Discovery Institute of Washington University and St. Louis Children's Hospital. RNA-seq data and analysis was supported by the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine which is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1 TR000448 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Microbial analysis supported through the Peter J. Shields Endowed Chair in Dairy Food Science and National Institutes of Health awards AT007079 and AT008759 (DAM). This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.	Bel S, 2018, AUTOPHAGY, V14, P719, DOI 10.1080/15548627.2018.1430462; Bel S, 2017, SCIENCE, V357, P1047, DOI 10.1126/science.aal4677; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Brown KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/852378; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chelius MK, 2000, APPL ENVIRON MICROB, V66, P783, DOI 10.1128/AEM.66.2.783-787.2000; Chen AC, 2014, J PEDIATR GASTR NUTR, V58, P7, DOI 10.1097/MPG.0b013e3182a7dc74; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Coggins SA, 2015, CLIN PERINATOL, V42, P133, DOI 10.1016/j.clp.2014.10.012; Coutinho HB, 1998, J CLIN PATHOL, V51, P512, DOI 10.1136/jcp.51.7.512; Delorme-Axford E, 2018, AUTOPHAGY, V14, P365, DOI 10.1080/15548627.2017.1401425; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elgin TG, 2016, CLIN THER, V38, P706, DOI 10.1016/j.clinthera.2016.01.005; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Fricke EM, 2017, AM J OBSTET GYNECOL, V216, pS225, DOI 10.1016/j.ajog.2016.11.631; Fung CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146542; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; Heida FH, 2016, PEDIATR RES, V80, P306, DOI 10.1038/pr.2016.67; Kinsella RL, 2018, VET PATHOL, V55, P366, DOI 10.1177/0300985818754967; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Liu TC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86907; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McElroy SJ, 2014, AM J PATHOLOGY; McElroy SJ, 2008, AM J PHYSIOL-GASTR L, V295, pG285, DOI 10.1152/ajpgi.00425.2007; McElroy SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG656, DOI 10.1152/ajpgi.00550.2010; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Nino DF, 2016, NAT REV GASTRO HEPAT, V13, P590, DOI 10.1038/nrgastro.2016.119; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; SAWADA M, 1993, LAB INVEST, V68, P338; SAWADA M, 1991, INT J EXP PATHOL, V72, P407; Sherman MP, 2005, INFECT IMMUN, V73, P6143, DOI 10.1128/IAI.73.9.6143-6146.2005; Sherman MP, 2005, MED HYPOTHESES, V65, P478, DOI 10.1016/j.mehy.2005.04.010; Timmerman HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08268-4; Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warner BB, 2016, LANCET, V387, P1928, DOI 10.1016/S0140-6736(16)00081-7; White JR, 2017, DIS MODEL MECH, V10, P727, DOI 10.1242/dmm.028589; Yee WH, 2012, PEDIATRICS, V129, pE298, DOI 10.1542/peds.2011-2022; Zhang CX, 2012, DIS MODEL MECH, V5, P522, DOI 10.1242/dmm.009001	46	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204967	10.1371/journal.pone.0204967	http://dx.doi.org/10.1371/journal.pone.0204967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273395	Green Published, gold, Green Submitted			2022-12-27	WOS:000446124700055
